PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hughes, WE; Woscholski, R; Cooke, FT; Patrick, RS; Dove, SK; McDonald, NQ; Parker, PJ				Hughes, WE; Woscholski, R; Cooke, FT; Patrick, RS; Dove, SK; McDonald, NQ; Parker, PJ			SAC1 encodes a regulated lipid phosphoinositide phosphatase, defects in which can be suppressed by the homologous Inp52p and Inp53p phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PROTEIN TRANSLOCATION; INOSITOL; 5-KINASE; CELLS; PHOSPHOLIPIDS; CYTOSKELETON	The yeast protein Sac1p is involved in a range of cellular functions, including inositol metabolism, actin cytoskeletal organization, endoplasmic reticulum ATP transport, phosphatidylinositol-phosphatidylcholine transfer protein function, and multiple-drug sensitivity. The activity of Sac1p and its relationship to these phenotypes are unresolved. We show here that the regulation of lipid phosphoinositides in sac1 mutants is defective, resulting in altered levels of all lipid phosphoinositides, particularly phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate. We have identified two proteins with homology to Sac1p that can suppress drug sensitivity and also restore the levels of the phosphoinositides in sac1 mutants. Overexpression of truncated forms of these suppressor genes confirmed that suppression was due to phosphoinositide phosphatase activity within these proteins. We have now demonstrated this activity for Sac1p and have characterized its specificity. The in vitro phosphatase activity and specificity of Sac1p were not altered by some mutations. Indeed, in vivo mutant Sac1p phosphatase activity also appeared unchanged under conditions in which cells were drug-resistant. However, under different growth conditions, both drug sensitivity and the phosphatase defect were manifest. It is concluded that SAC1 encodes a novel lipid phosphoinositide phosphatase in which specific mutations can cause the sac1 phenotypes by altering the in vivo regulation of the protein rather than by destroying phosphatase activity.	Imperial Canc Res Fund, Prot Phosphorylat Lab, London WC2A 3PX, England; Imperial Canc Res Fund, Struct Biol Lab, London WC2A 3PX, England; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AY, England; Univ Birmingham, Sch Med, Dept Anat, Birmingham B15 2TT, W Midlands, England; Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England	Cancer Research UK; Cancer Research UK; Imperial College London; University of Birmingham; University of London; Birkbeck University London	Hughes, WE (corresponding author), Imperial Canc Res Fund, Prot Phosphorylat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Parker, Peter j/D-5192-2013	parker, peter/0000-0002-6218-2933; Hughes, William/0000-0002-7149-3987				BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; CLEVES AE, 1989, J CELL BIOL, V109, P2939, DOI 10.1083/jcb.109.6.2939; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Erdman S, 1998, J CELL BIOL, V140, P461, DOI 10.1083/jcb.140.3.461; FOLCH J, 1949, J BIOL CHEM, V177, P497; Guilherme A, 1998, BIOSCIENCE REP, V18, P79, DOI 10.1023/A:1020184210183; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; HAARER BK, 1990, J CELL BIOL, V110, P105, DOI 10.1083/jcb.110.1.105; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Hsuan JJ, 1998, ADV CANCER RES, V74, P167, DOI 10.1016/S0065-230X(08)60767-8; Hughes WE, 1999, YEAST, V15, P1111, DOI 10.1002/(SICI)1097-0061(199908)15:11<1111::AID-YEA440>3.0.CO;2-H; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kochendorfer KU, 1999, EMBO J, V18, P1506, DOI 10.1093/emboj/18.6.1506; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; MAYINGER P, 1993, EMBO J, V12, P659, DOI 10.1002/j.1460-2075.1993.tb05699.x; MAYINGER P, 1995, J CELL BIOL, V131, P1377, DOI 10.1083/jcb.131.6.1377; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MEMON AR, 1989, BIOCHEM BIOPH RES CO, V162, P1295, DOI 10.1016/0006-291X(89)90814-0; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; NOVICK P, 1989, GENETICS, V121, P659; PETITOU M, 1978, ANAL BIOCHEM, V91, P350, DOI 10.1016/0003-2697(78)90849-7; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SIKORSKI RS, 1989, GENETICS, V122, P19; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; Srinivasan S, 1997, EUR J CELL BIOL, V74, P350; STEPHENS L, 1989, BIOCHEM J, V259, P267, DOI 10.1042/bj2590267; Stolz LE, 1998, J BIOL CHEM, V273, P11852, DOI 10.1074/jbc.273.19.11852; THIYAGARAJAH P, 1984, BIOCHEM INT, V9, P625; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WHITTERS EA, 1993, J CELL BIOL, V122, P79, DOI 10.1083/jcb.122.1.79; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Woscholski R, 1995, J BIOL CHEM, V270, P31001, DOI 10.1074/jbc.270.52.31001; Woscholski R, 1997, TRENDS BIOCHEM SCI, V22, P427, DOI 10.1016/S0968-0004(97)01120-1; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416	42	94	98	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					801	808		10.1074/jbc.275.2.801	http://dx.doi.org/10.1074/jbc.275.2.801			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625610	hybrid			2022-12-27	WOS:000084836600014
J	Sakash, JB; Chan, RS; Tsuruta, H; Kantrowitz, ER				Sakash, JB; Chan, RS; Tsuruta, H; Kantrowitz, ER			Three of the six possible intersubunit stabilizing interactions involving Glu-239 are sufficient for restoration of the homotropic and heterotropic properties of Escherichia coli aspartate transcarbamoylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; REGULATORY CHAIN; CATALYTIC CHAIN; CARBAMOYLTRANSFERASE; MODEL; COOPERATIVITY; PURIFICATION; REPLACEMENT; RESOLUTION; PROTEINS	A hybrid version of Escherichia coli aspartate transcarbamoylase was investigated in which one catalytic subunit has the wild-type sequence, and the other catalytic subunit has Glu-239 replaced by Gln, Since Glu-239 is involved in intersubunit interactions, this hybrid could be used to evaluate the extent to which T state stabilization is required for homotropic cooperativity and for heterotropic effects. Reconstitution of the hybrid holoenzyme (two different catalytic subunits with three wild-type regulatory subunits) was followed by separation of the mixture by anion-exchange chromatography. To make possible the resolution of the three holoenzyme species formed by the reconstitution, the charge of one of the catalytic subunits was altered by the addition of six aspartic acid residues to the C terminus of each of the catalytic chains (AT-C catalytic subunit). Control experiments indicated that the AT-C catalytic subunit as well as the holoenzyme formed with AT-C and wild-type regulatory subunits had essentially the same homotropic and heterotropic properties as the native catalytic subunit and holoenzyme, indicating that the addition of the aspartate tail did not influence the function of either enzyme. The control reconstituted holoenzyme, in which both catalytic subunits have Glu-239 replaced by Gln, exhibited no cooperativity, an enhanced affinity for aspartate, and essentially no heterotropic response identical to the enzyme isolated without reconstitution. The hybrid containing one normal and one mutant catalytic subunit exhibited homotropic cooperativity with a Hill coefficient of 1.4 and responded to the nucleotide effecters at about 50% of the level of the wild-type enzyme. Small angle x-ray scattering experiments with the hybrid enzyme indicated that in the absence of ligands it was structurally similar, but not identical, to the T state of the wild-type enzyme. In contrast to the wild-type enzyme, addition of carbamoyl phosphate induced a significant alteration in the scattering pattern, whereas the bisubstrate analog N-phosphonoacetyl-L-aspartate induced a significant change in the scattering pattern indicating the transition to the R-structural state. These data indicate that in the hybrid enzyme only three of the usual six interchain interactions involving Glu-239 are sufficient to stabilize the enzyme in a low affinity, low activity state and allow an allosteric transition to occur.	Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA; Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA	Boston College; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Kantrowitz, ER (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026237] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR01209] Funding Source: Medline; NIGMS NIH HHS [GM26237] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANGEUX JP, 1968, BIOCHEMISTRY-US, V7, P531, DOI 10.1021/bi00842a007; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P680; DEMBOWSKI NJ, 1993, PROTEIN ENG, V6, P123, DOI 10.1093/protein/6.1.123; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; GERHART JC, 1963, COLD SPRING HARB SYM, V28, P491, DOI 10.1101/SQB.1963.028.01.065; GERHART JC, 1967, J BIOL CHEM, V242, P2886; GERHART JC, 1962, J BIOL CHEM, V237, P891; GOUAUX JE, 1990, BIOCHEMISTRY-US, V29, P7702, DOI 10.1021/bi00485a020; GOUAUX JE, 1989, BIOCHEMISTRY-US, V28, P1798, DOI 10.1021/bi00430a056; HONZATKO RB, 1982, P NATL ACAD SCI-BIOL, V79, P7171, DOI 10.1073/pnas.79.23.7171; KE HM, 1988, J MOL BIOL, V204, P725, DOI 10.1016/0022-2836(88)90365-8; KRAUSE KL, 1987, J MOL BIOL, V193, P527, DOI 10.1016/0022-2836(87)90265-8; LADJIMI MM, 1985, J MOL BIOL, V186, P715, DOI 10.1016/0022-2836(85)90391-2; LADJIMI MM, 1988, BIOCHEMISTRY-US, V27, P276, DOI 10.1021/bi00401a042; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANIATIS T, 1982, MOL CLONING LABORATO, P368; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NOWLAN SF, 1985, J BIOL CHEM, V260, P4712; ONUFFER JJ, 1994, PROTEIN ENG, V7, P413, DOI 10.1093/protein/7.3.413; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; PASTRALANDIS SC, 1981, ANAL BIOCHEM, V118, P358, DOI 10.1016/0003-2697(81)90594-7; PASTRALANDIS SC, 1978, J BIOL CHEM, V253, P4624; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sakash JB, 1998, BIOCHEMISTRY-US, V37, P281, DOI 10.1021/bi972102g; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILVER RS, 1983, J MOL BIOL, V168, P729, DOI 10.1016/S0022-2836(83)80072-2; STEBBINS JW, 1989, J BIOL CHEM, V264, P14860; Svergun DI, 1997, PROTEINS, V27, P110; TAUC P, 1990, J MOL BIOL, V214, P327, DOI 10.1016/0022-2836(90)90164-H; TAUC P, 1982, J MOL BIOL, V155, P155, DOI 10.1016/0022-2836(82)90442-9; Tsuruta H, 1998, J APPL CRYSTALLOGR, V31, P672, DOI 10.1107/S0021889898002702; WENTE SR, 1987, P NATL ACAD SCI USA, V84, P31, DOI 10.1073/pnas.84.1.31; WILD JR, 1989, P NATL ACAD SCI USA, V86, P46, DOI 10.1073/pnas.86.1.46; XU W, 1988, BIOCHEMISTRY-US, V27, P5507, DOI 10.1021/bi00415a018	36	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					752	758		10.1074/jbc.275.2.752	http://dx.doi.org/10.1074/jbc.275.2.752			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625604	hybrid			2022-12-27	WOS:000084836600008
J	Hirata, T; Nakamura, N; Omote, H; Wade, Y; Futai, M				Hirata, T; Nakamura, N; Omote, H; Wade, Y; Futai, M			Regulation and reversibility of vacuolar H+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING ADENOSINE-TRIPHOSPHATASE; YEAST SACCHAROMYCES-CEREVISIAE; MEMBRANE-VESICLES; INORGANIC PYROPHOSPHATASE; HETEROLOGOUS EXPRESSION; TONOPLAST VESICLES; PROTON TRANSPORT; SUBUNIT; PROTEIN; ACIDIFICATION	Arabidopsis thaliana vacuolar H+-translocating pyrophosphatase (V-PPase) was expressed functionally in yeast vacuoles with endogenous vacuolar H+-ATPase (V-ATPase), and the regulation and reversibility of V-ATPase were studied using these vacuoles. Analysis of electrochemical proton gradient (Delta mu H) formation with ATP and pyrophosphate indicated that the proton transport by V-ATPase or V-PPase is not regulated strictly by the proton chemical gradient (Delta pH). On the other hand, vacuolar membranes may have a regulatory mechanism for maintaining a constant membrane potential (Delta Psi). Chimeric vacuolar membranes showed ATP synthesis coupled with Delta mu H established by V-PPase. The ATP synthesis was sensitive to bafilomycin A(1) and exhibited two apparent K-m values for ADP. These results indicate that V-ATPase is a reversible enzyme. The ATP synthesis was not observed in the presence of nigericin, which dissipates Delta pH but not Delta Psi, suggesting that Delta pH is essential for ATP synthesis.	Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Osaka Univ, Inst Sci & Ind Res,Div Biol Sci, Osaka 5670047, Japan	Japan Science & Technology Agency (JST); Osaka University	Futai, M (corresponding author), Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Osaka Univ, Inst Sci & Ind Res,Div Biol Sci, Osaka 5670047, Japan.	m-futai@sanken.osaka-u.ac.jp	OMOTE, Hiroshi/B-1635-2011					ANRAKU Y, 1996, HDB BIOL PHYS, V2, P93; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; DUPAIX A, 1989, FEBS LETT, V249, P13, DOI 10.1016/0014-5793(89)80005-5; Facanha AR, 1998, PLANT PHYSIOL, V116, P1487, DOI 10.1104/pp.116.4.1487; Forgac M, 1998, FEBS LETT, V440, P258, DOI 10.1016/S0014-5793(98)01425-2; Futai M, 1998, J BIOCHEM-TOKYO, V124, P259, DOI 10.1093/oxfordjournals.jbchem.a022105; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; Futai M, 1996, J BIOENERG BIOMEMBR, V28, P409, DOI 10.1007/BF02113982; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; HANADA H, 1990, BIOCHEM BIOPH RES CO, V170, P873, DOI 10.1016/0006-291X(90)92172-V; IHARA K, 1991, ARCH BIOCHEM BIOPHYS, V286, P111, DOI 10.1016/0003-9861(91)90015-B; INATOMI KI, 1989, J BIOL CHEM, V264, P10954; Inoue K, 1997, PLANT CELL PHYSIOL, V38, P366, DOI 10.1093/oxfordjournals.pcp.a029176; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; KASHO VN, 1989, P NATL ACAD SCI USA, V86, P8708, DOI 10.1073/pnas.86.22.8708; KIM EJ, 1995, J BIOL CHEM, V270, P2630, DOI 10.1074/jbc.270.6.2630; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; MATSUNOYAGI A, 1985, J BIOL CHEM, V260, P4424; MORIYAMA Y, 1989, J BIOL CHEM, V264, P3577; Nakamura N, 1997, J BIOL CHEM, V272, P11344; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; ROISIN MP, 1980, FEBS LETT, V115, P143, DOI 10.1016/0014-5793(80)80745-9; ROS R, 1995, J BIOL CHEM, V270, P4368, DOI 10.1074/jbc.270.9.4368; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; SCHMIDT AL, 1993, ARCH BIOCHEM BIOPHYS, V306, P407, DOI 10.1006/abbi.1993.1530; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; UCHIDA E, 1988, J BIOL CHEM, V263, P45; WADA Y, 1992, BIOCHIM BIOPHYS ACTA, V1101, P296, DOI 10.1016/0005-2728(92)90085-G; WADA Y, 1994, J BIOENERG BIOMEMBR, V26, P631, DOI 10.1007/BF00831538; WADA Y, 1987, J BIOL CHEM, V262, P17260; Wada Y, 1997, J CELL SCI, V110, P1299; WANG YZ, 1986, PLANT PHYSIOL, V81, P497, DOI 10.1104/pp.81.2.497; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340	39	50	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					386	389		10.1074/jbc.275.1.386	http://dx.doi.org/10.1074/jbc.275.1.386			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617629	hybrid			2022-12-27	WOS:000085951600053
J	Wilkinson, BM; Tyson, JR; Reid, PJ; Stirling, CJ				Wilkinson, BM; Tyson, JR; Reid, PJ; Stirling, CJ			Distinct domains within yeast Sec61p involved in post-translational translocation and protein dislocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; SACCHAROMYCES-CEREVISIAE; SECRETORY PROTEIN; ER DEGRADATION; COMPLEX; TRANSPORT; PROTEASOME; GENE; COMPONENTS	The translocation of secretory polypeptides into and across the membrane of the endoplasmic reticulum (ER) occurs at the translocon, a pore-forming structure that orchestrates the transport and maturation of polypeptides at the ER membrane. Recent data also suggest that misfolded or unassembled polypeptides exit the ER via the translocon for degradation by the cytosolic ubiquitin/proteasome pathway. Sec61p is a highly conserved multispanning membrane protein that constitutes a core component of the translocon, We have found that the essential function of the Saccharomyces cerevisiae Sec61p is retained upon deletion of either of two internal regions that include transmembrane domains 2 and 3, respectively, However, a deletion mutation encompassing both of these domains was found to be nonfunctional, Characterization of yeast mutants expressing the viable deletion alleles of Sec61p has revealed defects in post-translational translocation. In addition, the transmembrane domain 3 deletion mutant is induced for the unfolded protein response and is defective in the dislocation of a misfolded ER protein. These data demonstrate that the various activities of Sec61p can be functionally dissected, In particular, the transmembrane domain 2 region plays a role in post-translational translocation that is required neither for cotranslational translocation nor for protein dislocation.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Stirling, CJ (corresponding author), Univ Manchester, Sch Biol Sci, 2-2-5 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.							Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Broughton J, 1997, J CELL SCI, V110, P2715; Chen Y, 1998, J BIOL CHEM, V273, P11887, DOI 10.1074/jbc.273.19.11887; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DESHAIES RJ, 1989, J CELL BIOL, V109, P2653, DOI 10.1083/jcb.109.6.2653; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; ESNAULT Y, 1993, EMBO J, V12, P4083, DOI 10.1002/j.1460-2075.1993.tb06092.x; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; HAMMAN BD, 1997, CELL, V89, P534; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KIPPERT F, 1995, FEMS MICROBIOL LETT, V128, P201, DOI 10.1016/0378-1097(95)00113-J; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; Matlack KES, 1997, SCIENCE, V277, P938, DOI 10.1126/science.277.5328.938; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Pahl HL, 1997, TRENDS CELL BIOL, V7, P50, DOI 10.1016/S0962-8924(96)10050-7; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; PARKER R, 1988, MOL CELL BIOL, V8, P3150, DOI 10.1128/MCB.8.8.3150; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; Sambrook J., 2002, MOL CLONING LAB MANU; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; STIRLING CJ, 1992, NATURE, V356, P534, DOI 10.1038/356534a0; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; STIRLING CJ, 1993, NATO ASI SERIES H, V71, P293; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson BM, 1997, J MEMBRANE BIOL, V155, P189, DOI 10.1007/s002329900171; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Wilkinson BM, 1997, EMBO J, V16, P4549, DOI 10.1093/emboj/16.15.4549	50	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					521	529		10.1074/jbc.275.1.521	http://dx.doi.org/10.1074/jbc.275.1.521			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617647	hybrid			2022-12-27	WOS:000085951600071
J	Yu, B; Gu, LJ; Simon, MI				Yu, B; Gu, LJ; Simon, MI			Inhibition of subsets of G protein-coupled receptors by empty mutants of G protein alpha subunits in G(0), G(11), and G(16)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C; CELLS; NUCLEOTIDES; ACTIVATION; SIGNALS; FAMILY	We previously reported that the xanthine nucleotide binding G(o)alpha mutant, G(o)alpha X, inhibited the activation of G(i)-coupled receptors. We constructed similar mutations in G(11)alpha and G(16)alpha and characterized their nucleotide binding and receptor interaction. First, we found that G(11)alpha X and G(16)alpha X expressed in COS-7 cells bound xanthine 5'-O-(thiotriphosphate) instead of guanosine 5'-O-(thiotriphosphate). Second, we found that G(11)alpha X and G(16)alpha X interacted with beta gamma subunits in the presence of xanthine diphosphate. These experiments demonstrated that G(11)alpha X and G(16)alpha X were xanthine nucleotide-binding proteins, similar to G(o)alpha X. Third, in COS-7 cells, both G(11)alpha X and G(16)alpha X inhibited the activation of G(q)-coupled receptors, whereas only G(16)alpha X inhibited the activation of G(i)-coupled receptors. Therefore, when in the nucleotide-free state, empty G(11)alpha X and G(16)alpha X appeared to retain the same receptor binding specificity as their wild-type counterparts. Finally, we found that G(o)alpha X, G(11)alpha X, and G(16)alpha X all inhibited the endogenous thrombin receptors and lysophosphatidic acid receptors in NIH3T3 cells, whereas G(11)alpha X and G(16)alpha X, but not G(o)alpha X, inhibited the activation of transfected m1 muscarinic receptor in these cells. We conclude that these empty G protein mutants of G(o)alpha, G(11)alpha, and G(16)alpha can act as dominant negative inhibitors against specific subsets of G protein-coupled receptors.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Yu, B (corresponding author), CALTECH, Div Biol, 147-75, Pasadena, CA 91125 USA.							ARAGAY AM, 1992, J BIOL CHEM, V267, P24983; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOODY RS, 1972, BIOCHIM BIOPHYS ACTA, V276, P155, DOI 10.1016/0005-2744(72)90016-2; GRAND RJA, 1996, BIOCHEM J, V313, P356; HENDERSON JF, 1973, NUCLEOTIDE METABOLIS, P97; HILL CS, 1995, CELL, V81, P1156; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; PARKER EM, 1991, J BIOL CHEM, V266, P519; QUICK MW, 1994, J BIOL CHEM, V269, P30164; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; WU DQ, 1992, J BIOL CHEM, V267, P25798; WU DQ, 1992, J BIOL CHEM, V267, P1811; Yu B, 1997, J BIOL CHEM, V272, P18015, DOI 10.1074/jbc.272.29.18015; Yu B, 1998, J BIOL CHEM, V273, P30183, DOI 10.1074/jbc.273.46.30183	19	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					71	76		10.1074/jbc.275.1.71	http://dx.doi.org/10.1074/jbc.275.1.71			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617587	Green Accepted, hybrid			2022-12-27	WOS:000085951600011
J	Wijesuriya, SD; Zhang, GR; Dardis, A; Miller, WL				Wijesuriya, SD; Zhang, GR; Dardis, A; Miller, WL			Transcriptional regulatory elements of the human gene for cytochrome P450c21 (steroid 21-hydroxylase) lie within intron 35 of the linked C4B gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; TENASCIN-X; FACTOR-I; MURINE 21-HYDROXYLASE; NUCLEOTIDE-SEQUENCE; NUCLEAR PROTEINS; PROMOTER ELEMENT; RECEPTOR GENE; TUMOR-CELLS; BOVINE GENE	The CYP21 gene, which encodes P450c21, the adrenal steroid SI-hydroxylase needed for glucocorticoid synthesis, lies in the major histocompatibility locus only 2.3 kilobase pairs (kb) downstream from the C4 gene. A 300-base pair (bp) proximal promoter and two upstream regions within C4 are needed for expression of mouse CYP21; the human gene also has a proximal promoter, but upstream elements have not been studied. To search for upstream regulatory elements in human CYP21B, we examined up to 9 kb of 5'-flanking DNA by transient transfection into human adrenal NCI-H295A cells. The 300-bp proximal promoter had substantial activity, but constructs retaining the DNA between -4.6 and -5.6 kb had increased activity, indicating the presence of distal elements. This region does not correspond to the mouse upstream regions, lying further upstream within intron 35 of C4B, which encompasses the previously described "Z promoter," DNase I footprinting located two elements, F1 and F2, lying -186 to -195 bp and -142 to -151 bp upstream from the Z cap site (-4862 to -4871 and -4818 to -4827 bp upstream of the CYP21B cap site). Each element formed a specific DNA-protein complex and conferred orientation-independent expression to a heterologous promoter. Mutations abolished formation of the DNA-protein complexes but only partially decreased expression. We identified a third site, F3, lying at -33 to -42 bp from Z. Competitive gel mobility supershift assays and co-transfection studies with SF-1 produced in vitro indicate F2 and F3 bind SF-1; BLAST searches and Southwestern blotting suggest that NF-W2 may bind F1. These results indicate that the Z promoter is a component of the CYP21 promoter needed to drive its adrenal-specific expression and that CYP21 transcription elements within C4 have kept these two genes linked during evolution.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, Bldg MR-4,Rm 209, San Francisco, CA 94143 USA.		Miller, Walter L/J-3696-2012		NIDDK NIH HHS [DK4254, DK37922] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; BRISTOW J, 1993, J BIOL CHEM, V268, P12919; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; BURCH GH, 1995, DEV DYNAM, V203, P491, DOI 10.1002/aja.1002030411; CARROLL MC, 1985, P NATL ACAD SCI USA, V82, P521, DOI 10.1073/pnas.82.2.521; CHANG SF, 1995, MOL ENDOCRINOL, V9, P1330, DOI 10.1210/me.9.10.1330; CHAPLIN DD, 1986, P NATL ACAD SCI USA, V83, P9601, DOI 10.1073/pnas.83.24.9601; CHUNG BC, 1985, DNA-J MOLEC CELL BIO, V4, P211, DOI 10.1089/dna.1985.4.211; CHUNG BC, 1986, P NATL ACAD SCI USA, V83, P4243, DOI 10.1073/pnas.83.12.4243; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; DORN A, 1989, MOL CELL BIOL, V9, P312, DOI 10.1128/MCB.9.1.312; Endoh A, 1998, MOL CELL ENDOCRINOL, V137, P13, DOI 10.1016/S0303-7207(97)00224-4; GAZDAR AF, 1990, CANCER RES, V50, P5488; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; Halvorson LM, 1998, J BIOL CHEM, V273, P14712, DOI 10.1074/jbc.273.24.14712; HANDLER JD, 1988, J BIOL CHEM, V263, P13068; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; HUM DW, 1995, DNA CELL BIOL, V14, P451, DOI 10.1089/dna.1995.14.451; JOHN ME, 1986, BIOCHEMISTRY-US, V25, P2846, DOI 10.1021/bi00358a016; KAGAWA N, 1990, J BIOL CHEM, V265, P11299; KAGAWA N, 1991, J BIOL CHEM, V266, P11199; KOHLER PO, 1971, J CLIN ENDOCR METAB, V65, P122; KOMINAMI S, 1980, J BIOL CHEM, V255, P3386; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; Marchal R, 1998, BIOCHEM BIOPH RES CO, V247, P28, DOI 10.1006/bbrc.1998.8733; MARTIN H, 1989, MACROPHAGE DERIVED C, P155; MATTESON KJ, 1987, P NATL ACAD SCI USA, V84, P5858, DOI 10.1073/pnas.84.16.5858; MCKNIGHT SL, 1981, CELL, V25, P385, DOI 10.1016/0092-8674(81)90057-X; MELLON SH, 1989, J CLIN INVEST, V84, P1497, DOI 10.1172/JCI114325; MILLER WL, 1987, J PEDIATR-US, V111, P1, DOI 10.1016/S0022-3476(87)80334-7; MILSTONE DS, 1992, J BIOL CHEM, V267, P21924; MISKIMINS WK, 1985, P NATL ACAD SCI USA, V82, P6741, DOI 10.1073/pnas.82.20.6741; MOORE CCD, 1992, MOL ENDOCRINOL, V6, P2045, DOI 10.1210/me.6.12.2045; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; Morel Y, 1991, Adv Hum Genet, V20, P1; Morohashi K, 1999, TRENDS ENDOCRIN MET, V10, P169, DOI 10.1016/S1043-2760(98)00142-8; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Morohashi KI, 1996, FASEB J, V10, P1569, DOI 10.1096/fasebj.10.14.9002548; PARISSENTI AM, 1993, MOL ENDOCRINOL, V7, P283, DOI 10.1210/me.7.2.283; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; PARKER KL, 1986, J BIOL CHEM, V261, P5353; PARKER KL, 1985, P NATL ACAD SCI USA, V82, P7860, DOI 10.1073/pnas.82.23.7860; RICE DA, 1990, J BIOL CHEM, V265, P8052; RICE DA, 1991, MOL ENDOCRINOL, V5, P1552, DOI 10.1210/mend-5-10-1552; RODRIGUES NR, 1987, EMBO J, V6, P1653, DOI 10.1002/j.1460-2075.1987.tb02414.x; Rodriguez H, 1997, J CLIN ENDOCR METAB, V82, P365, DOI 10.1210/jc.82.2.365; SKOW LC, 1988, DNA-J MOLEC CELL BIO, V7, P143, DOI 10.1089/dna.1988.7.143; Speek M, 1996, HUM MOL GENET, V5, P1749, DOI 10.1093/hmg/5.11.1749; SPEEK M, 1995, MOL ENDOCRINOL, V9, P1655, DOI 10.1210/me.9.12.1655; STAELS B, 1993, MOL ENDOCRINOL, V7, P423, DOI 10.1210/me.7.3.423; TEE MK, 1995, HUM MOL GENET, V4, P2109, DOI 10.1093/hmg/4.11.2109; TEE MK, 1995, GENOMICS, V28, P171, DOI 10.1006/geno.1995.1128; Therrell BL, 1998, PEDIATRICS, V101, P583, DOI 10.1542/peds.101.4.583; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; WHITE PC, 1994, HUM MUTAT, V3, P373, DOI 10.1002/humu.1380030408; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; WHITE PC, 1984, NATURE, V312, P465, DOI 10.1038/312465a0; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; YASAMURA Y, 1966, CANCER RES, V26, P529; YU CY, 1991, J IMMUNOL, V146, P1057; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891; Zhang PL, 1996, MOL ENDOCRINOL, V10, P147, DOI 10.1210/me.10.2.147	64	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38097	38106		10.1074/jbc.274.53.38097	http://dx.doi.org/10.1074/jbc.274.53.38097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608879	hybrid			2022-12-27	WOS:000084528000079
J	Yang, Y; Wu, JA; Watson, JT				Yang, Y; Wu, JA; Watson, JT			Probing the folding pathways of long R-3 insulin-like growth factor-I (LR(3)IGF-I) and IGF-I via capture and identification of disulfide intermediates by cyanylation methodology and mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC RIBONUCLEASE-A; TRYPSIN-INHIBITOR; BIOLOGICAL PROPERTIES; KINETIC ROLE; REGENERATION; DEPENDENCE; PROTEINS; PRODUCTS; STATE; VITRO	This report describes an integrated investigation of the refolding and reductive unfolding of insulin-like growth factor (IGF-I) and its variant, long R-3 IGF-I (LR(3)IGF-I), which has a Glu(3) to Arg(3) substitution and a hydrophobic 13-amino acid N-terminal extension. The refolding performed in glutathione redox buffer was quenched at different time points by adjusting the pH to 2.0-3.0 with a 1 N HCl solution of 1-cyano-4-dimethylaminopyridinium tetrafluoroborate, which trapped intermediates via cyanylation of free sulfhydryl groups. The disulfide structure of the intermediates was determined by chemical cleavage followed by mass mapping with mass spectrometry. Six refolding intermediates of IGF-I and three refolding intermediates of LR(3)IGF-I were isolated and characterized. Folding pathways of IGF-I and LR(3)IGF-I are proposed based on the time-dependent distribution and disulfide structure of the corresponding trapped intermediates. Similarities and differences in the refolding behavior of IGF-I and LR(3)IGF-I are discussed.	Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Watson, JT (corresponding author), Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.							CHANG JY, 1995, J BIOL CHEM, V270, P9207, DOI 10.1074/jbc.270.16.9207; Chang JY, 1996, BIOCHEMISTRY-US, V35, P11702, DOI 10.1021/bi9606915; CREIGHTON TE, 1994, BIOCHEMISTRY-US, V33, P1534, DOI 10.1021/bi00172a033; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; CREIGHTON TE, 1992, BIOESSAYS, V14, P195, DOI 10.1002/bies.950140310; CREIGHTON TE, 1974, J MOL BIOL, V87, P563, DOI 10.1016/0022-2836(74)90104-1; DARBY NJ, 1995, J MOL BIOL, V249, P463, DOI 10.1006/jmbi.1995.0309; FROESCH ER, 1963, J CLIN INVEST, V42, P1816, DOI 10.1172/JCI104866; GLOCKER O, 1994, P NATL ACAD SCI USA, V91, P5868; HOBER S, 1992, BIOCHEMISTRY-US, V31, P1749, DOI 10.1021/bi00121a024; Hober S, 1997, BIOCHEMISTRY-US, V36, P4616, DOI 10.1021/bi9611265; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; LI YJ, 1995, NAT STRUCT BIOL, V2, P489, DOI 10.1038/nsb0695-489; MATTHEWS CR, 1993, ANNU REV BIOCHEM, V62, P653, DOI 10.1146/annurev.bi.62.070193.003253; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; MILNER SJ, 1995, BIOCHEM J, V308, P865, DOI 10.1042/bj3080865; PAIN RH, 1994, MECHANISMS PROTEIN F, P112; PTITSYN OB, 1995, CURR OPIN STRUC BIOL, V5, P74, DOI 10.1016/0959-440X(95)80011-O; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; RINDERKNECHT E, 1976, P NATL ACAD SCI USA, V73, P2365, DOI 10.1073/pnas.73.7.2365; Rosenfeld RD, 1997, ARCH BIOCHEM BIOPHYS, V342, P298, DOI 10.1006/abbi.1997.9996; ROTHWARF DM, 1993, BIOCHEMISTRY-US, V32, P2690, DOI 10.1021/bi00061a029; ROTHWARF DM, 1991, J AM CHEM SOC, V113, P6293, DOI 10.1021/ja00016a068; ROTHWARF DM, 1993, BIOCHEMISTRY-US, V32, P2680, DOI 10.1021/bi00061a028; ROTHWARF DM, 1993, BIOCHEMISTRY-US, V32, P2671, DOI 10.1021/bi00061a027; ROTHWARF DM, 1993, BIOCHEMISTRY-US, V32, P2698, DOI 10.1021/bi00061a030; SCHERAGA HA, 1984, ADV BIOPHYS, V18, P21, DOI 10.1016/0065-227X(84)90005-4; TOMAS FM, 1993, J ENDOCRINOL, V137, P413, DOI 10.1677/joe.0.1370413; WEISSMAN JS, 1992, P NATL ACAD SCI USA, V89, P9900, DOI 10.1073/pnas.89.20.9900; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Wu J, 1998, PROTEIN SCI, V7, P1017; Wu J, 1997, PROTEIN SCI, V6, P391; Xu XB, 1996, BIOCHEMISTRY-US, V35, P6406, DOI 10.1021/bi960090d; Yang Y, 1998, J AM CHEM SOC, V120, P5834, DOI 10.1021/ja9736018	35	35	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37598	37604		10.1074/jbc.274.53.37598	http://dx.doi.org/10.1074/jbc.274.53.37598			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608814	hybrid			2022-12-27	WOS:000084528000014
J	Biggs, JR; Kraft, AS				Biggs, JR; Kraft, AS			The role of the Smad3 protein in phorbol ester-induced promoter expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WAF1/CIP1 GENE PROMOTER; DNA-BINDING ACTIVITY; U937 LEUKEMIC-CELLS; TRANSCRIPTIONAL ACTIVATION; TERMINAL DIFFERENTIATION; SP1 SITES; INHIBITOR; KINASE; PHOSPHORYLATION; INDUCTION	The Spl transcription factor plays an important role in mediating the p53-independent activation of the p21(WAF1) (WAF1) promoter by phorbol 12-myristate13-acetate (PMA) in hematopoietic cells. Using GAL4-Sp1 fusion proteins and a luciferase reporter, PMA is shown to activate the transcriptional activity of Sp1 independent of the WAF1 promoter. This activation does not require the Ser/Thr-rich region of Sp1 and can be mediated by 41 amino acids (152-193) of Sp1 that are important for the interaction with human TAF130, Because transforming growth factor-beta enhances WAF1 promoter activity through both Sp1 and Smad proteins, the role of Smads in PMA transcriptional activation was examined. PMA addition to hematopoietic cells was found to activate a GAL4/Smad-dependent promoter and the transforming growth factor-beta-responsive promoter, p3TP-lux. Immunofluorescence data demonstrate that PMA addition to hematopoietic cells induces the translocation of Smads to the nucleus. However, Smad3 does not stimulate the WAF1 promoter, but rather slightly inhibits the PMA-mediated induction of transcription from this upstream region. Additionally, transfection of Smad3 did not enhance the activation of GAL4/Sp1 by PMA. These results demonstrate that, while PMA can activate Smad-mediated transcription Smad proteins do not appear to play a major role in the PMA induction of the WAF1 promoter.	Univ Colorado, Hlth Sci Ctr, Dept Med Oncol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Biggs, JR (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med Oncol, 4200 E 9th Ave, Denver, CO 80262 USA.				NATIONAL CANCER INSTITUTE [R01CA042533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044741] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA42533] Funding Source: Medline; NIDDK NIH HHS [R01-DK44741] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Biggs JR, 1998, CELL GROWTH DIFFER, V9, P667; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Billon N, 1996, ONCOGENE, V13, P2047; Datto MB, 1997, MOL CELL BIOL, V17, P2030, DOI 10.1128/MCB.17.4.2030; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; FRANKLIN CC, 1992, P NATL ACAD SCI USA, V89, P7247, DOI 10.1073/pnas.89.15.7247; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; HARPER JW, 1993, CELL, V75, P805; Hunt KK, 1998, CANCER RES, V58, P5656; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Janknecht R, 1996, CURR BIOL, V6, P951, DOI 10.1016/S0960-9822(02)00636-X; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shiohara M, 1996, J CELL PHYSIOL, V166, P568, DOI 10.1002/(SICI)1097-4652(199603)166:3<568::AID-JCP11>3.0.CO;2-3; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; STEINMAN RA, 1994, ONCOGENE, V9, P3389; TAIPALE J, 1994, CELL GROWTH DIFFER, V5, P1309; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; YANG JY, 1996, NATURE, P319; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	41	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36987	36994		10.1074/jbc.274.52.36987	http://dx.doi.org/10.1074/jbc.274.52.36987			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601254	hybrid			2022-12-27	WOS:000084382700025
J	Chatterjee, S; Han, H; Rollins, S; Cleveland, T				Chatterjee, S; Han, H; Rollins, S; Cleveland, T			Molecular cloning, characterization, and expression of a novel human neutral sphingomyelinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; APOPTOSIS; TNF	Neutral sphingomyelinase (N-SMase) has emerged as an important cell membrane-associated enzyme that participates in several signal transduction and cell regulatory phenomena. Using expression cloning, we have identified a 3.7-kilobase pair cDNA transcript for N-SMase whose open reading frame predicts a 397-amino acid polypeptide. Transfection of COS-7 cells with cDNA for N-SMase resulted in a marked increase in N-SMase activity. Recombinant N-SMase (r-N-SMase) had the following physical-chemical properties. Mg2+ activated and Cu2+ and glutathione inhibited the activity of r-N-SMase, In contrast, dithiothreitol did not alter the activity of the enzyme, Of several phospholipids examined, sphingomyelin was the preferred substrate for r-N-SMase, The apparent molecular mass of r-N-SMase derived from COS-7 cells was similar to 90 kDa, similar to the native neutral sphingomyelinase prepared from human urine. However, upon expression in Escherichia coli, the apparent molecular mass of the recombinant enzyme was similar to 45 kDa, We speculate that this apparent difference in recombinant enzymes derived from COS-7 and E. coli cells may be due to extensive post-transcriptional changes. r-N-SMase has numerous post-transcriptional modification sites such as phosphorylation sites via protein kinase C, casein kinase II, tyrosine kinase, and cAMP- and cGMP-dependent protein kinases as well as sites for glycosylation and myristoylation, Amino acid sequence alignment studies revealed that r-N-SMase has some similarity to acid sphingomyelinase and significant homology to the death domains of tumor necrosis factor-alpha receptor-1 and Fas/Apo-I. We believe that the molecular cloning and characterization of N-SMase cDNA will accelerate the process to define its role as a key regulator in apoptosis, lipid and lipoprotein metabolism, and other cell regulatory pathways.	Johns Hopkins Hosp, Dept Pediat, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Chatterjee, S (corresponding author), Johns Hopkins Hosp, Dept Pediat, 600 N Wolfe St,CMSC 6-124, Baltimore, MD 21287 USA.				NHLBI NIH HHS [1-P50-HL47212] Funding Source: Medline; NIDDK NIH HHS [R01-DK31722] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL047212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031722] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Chatterjee S, 1999, CHEM PHYS LIPIDS, V102, P79, DOI 10.1016/S0009-3084(99)00077-8; CHATTERJEE S, 1994, J BIOL CHEM, V269, P879; CHATTERJEE S, 1993, ADV LIPID RES, V26, P25; CHIMUA SJ, 1996, CANCER RES, V56, P2711; Ghosh N, 1998, MOL CELL BIOCHEM, V189, P161, DOI 10.1023/A:1006910200656; Hofmann K, 1999, TRENDS BIOCHEM SCI, V24, P227, DOI 10.1016/S0968-0004(99)01410-3; ITOH N, 1993, J BIOL CHEM, V268, P10932; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; LUI B, 1997, CELL DEV BIOL, V8, P311; LUI B, 1997, J BIOL CHEM, V272, P16281; Mansat V, 1997, FASEB J, V11, P695, DOI 10.1096/fasebj.11.8.9240970; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; SPENCE MW, 1993, ADV LIPID RES, V26, P3; TAKI T, 1995, ANAL BIOCHEM, V224, P490, DOI 10.1006/abio.1995.1077; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	22	57	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37407	37412		10.1074/jbc.274.52.37407	http://dx.doi.org/10.1074/jbc.274.52.37407			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601312	hybrid			2022-12-27	WOS:000084382700083
J	Duan, CM; Liimatta, MB; Bottum, OL				Duan, CM; Liimatta, MB; Bottum, OL			Insulin-like growth factor (IGF)-I regulates IGF-binding protein-5 gene expression through the phosphatidylinositol 3-kinase, protein kinase B/Akt, and p70 S6 kinase signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; FACTOR-I; ELASTIN GENE; TRANSCRIPTIONAL ACTIVATION; PROLIFERATION; 3'-KINASE; RAPAMYCIN; SURVIVAL; DIFFERENTIATION; MECHANISMS	Expression of the insulin-like growth factor-binding protein 5 (IGFBP-5) gene in vascular smooth muscle cells is up-regulated by IGF-I through an IGF-I receptor-mediated mechanism. In this study, we studied the possible involvement of the mitogen-activated protein kinase (MAPK) and PI 3-kinase signaling pathways in mediating IGF-I-regulated IGFBP-5 gene expression. The addition of Des(1-3)IGF-1, an IGF analog with reduced affinity to IGFBPs, resulted in a transient activation of p44 and p42 MAPK. Inhibition of the MAPK activation by PD98059, however, did not affect IGF-I-stimulated IGFBP-5 expression. Des(1-3)IGF-I treatment also strongly activated PI 3-kinase. This activation was probably mediated through IRS-1, because IGF-1 stimulation resulted in a significant increase in IRS-1- but not IRS-2-associated PI 3-kinase activity, This activation occurred within 5 min and was sustained at high levels for over 6 h. Likewise, Des(1-3)IGF-I caused a long lasting activation of PKB/Akt and p70(s6k). When LY294002 and wortmannin, two specific inhibitors of PI 3-kinase, were added with Des(1-3)IGF-I, the IGF-I-regulated IGFBP-5 expression was negated. The addition of rapamycin, which inhibits IGF-I-induced p70(s6k) activation, significantly inhibited IGF-I-regulated IGFBP-5 gene expression, These results suggest that the action of IGF-I on IGFBP-5 gene expression requires the activation of the PI 3-kinase-PKB/Akt-p70(s6k) pathway but not the MAPK pathway in vascular smooth muscle cells.	Univ Michigan, Dept Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Duan, CM (corresponding author), Univ Michigan, Dept Biol, Nat Sci Bldg, Ann Arbor, MI 48109 USA.	cduan@umich.edu			NIDDK NIH HHS [5P60DK-20572] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Band CJ, 1997, J BIOL CHEM, V272, P138; Boes M, 1996, ENDOCRINOLOGY, V137, P5357, DOI 10.1210/en.137.12.5357; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; CHEN LI, 1994, MOL CELL BIOL, V14, P4380, DOI 10.1128/MCB.14.7.4380; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; COHICK WS, 1993, J CELL PHYSIOL, V157, P52, DOI 10.1002/jcp.1041570107; COHICK WS, 1995, J CELL PHYSIOL, V164, P187, DOI 10.1002/jcp.1041640123; Conn KJ, 1996, J BIOL CHEM, V271, P28853, DOI 10.1074/jbc.271.46.28853; DEGROOT RP, 1994, CELL, V79, P81, DOI 10.1016/0092-8674(94)90402-2; DUAN C, 1998, AM ZOOL, V38, P29; Duan CM, 1996, J BIOL CHEM, V271, P4280; DUAN CM, 1995, J BIOL CHEM, V270, P24844, DOI 10.1074/jbc.270.42.24844; Duan CM, 1998, J BIOL CHEM, V273, P16836, DOI 10.1074/jbc.273.27.16836; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; FRANCIS GL, 1992, J MOL ENDOCRINOL, V8, P213, DOI 10.1677/jme.0.0080213; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GIANNELLANETO D, 1992, CIRC RES, V71, P646, DOI 10.1161/01.RES.71.3.646; Graves LM, 1996, J BIOL CHEM, V271, P505, DOI 10.1074/jbc.271.1.505; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Imai Y, 1999, ENDOCRINOLOGY, V140, P4228, DOI 10.1210/en.140.9.4228; JENSEN DE, 1995, J BIOL CHEM, V270, P6555, DOI 10.1074/jbc.270.12.6555; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KAMYAR A, 1994, CIRC RES, V74, P576, DOI 10.1161/01.RES.74.4.576; Koyama H, 1996, CIRC RES, V79, P757, DOI 10.1161/01.RES.79.4.757; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Liu Q, 1998, J IMMUNOL, V160, P1393; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; MARX SO, 1995, CIRC RES, V76, P412, DOI 10.1161/01.RES.76.3.412; Moriya S, 1996, P NATL ACAD SCI USA, V93, P151, DOI 10.1073/pnas.93.1.151; Parrizas M, 1997, J BIOL CHEM, V272, P154; PAVLOVICSURJANCEV B, 1992, J NEUROCHEM, V59, P2134; Proud CG, 1996, TRENDS BIOCHEM SCI, V21, P181, DOI 10.1016/0968-0004(96)10016-5; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rousse S, 1998, ENDOCRINOLOGY, V139, P1487, DOI 10.1210/en.139.4.1487; TAKAGI Y, 1995, ATHEROSCLEROSIS, V113, P19, DOI 10.1016/0021-9150(94)05422-F; Thommes KB, 1996, EXP CELL RES, V226, P59, DOI 10.1006/excr.1996.0202; Urban RJ, 1996, J BIOL CHEM, V271, P31695, DOI 10.1074/jbc.271.49.31695; VERVERIS J, 1994, AM J MED SCI, V307, P77, DOI 10.1097/00000441-199402000-00001; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; WOLFE BL, 1993, J BIOL CHEM, V268, P12418; YAMAMOTOHONDA R, 1995, J BIOL CHEM, V270, P2729, DOI 10.1074/jbc.270.6.2729; Yano KJ, 1999, ENDOCRINOLOGY, V140, P4622, DOI 10.1210/en.140.10.4622; Yao R, 1996, ONCOGENE, V13, P343	48	69	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37147	37153		10.1074/jbc.274.52.37147	http://dx.doi.org/10.1074/jbc.274.52.37147			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601276	hybrid			2022-12-27	WOS:000084382700047
J	Korhonen, JM; Said, FA; Wong, AJ; Kaplan, DR				Korhonen, JM; Said, FA; Wong, AJ; Kaplan, DR			Gab1 mediates neurite outgrowth DNA synthesis, and survival in PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE-GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; NEURONAL DIFFERENTIATION; SIGNAL-TRANSDUCTION; INHIBITS APOPTOSIS; FACTOR RECEPTOR; TRK RECEPTORS; DOCKING SITE; IN-VITRO	The Gab1-docking protein has been shown to regulate phosphatidylinositol 3-kinase PI3K activity and potentiate nerve growth factor (NGF)-induced survival in PC12 cells. Here, we investigated the potential of Gab1 to induce-neurite outgrowth and DNA synthesis, two other important aspects of NGF-induced neuronal differentiation of PC12 cells and NGF independent survival. We generated a recombinant adenovirus encoding hemagglutinin (HA)-epitope-tagged Gab1 and expressed this protein in PC12 cells. HA-Gab1 was constitutively tyrosine-phosphorylated in PC12 cells and induced the phosphorylation of Akt/protein kinase B and p44/42 mitogen-activated protein kinase. HA-Gab1-stimulated a 10-fold increase in neurite outgrowth in the absence of NGF and a 5-fold increase in NGF-induced neurite outgrowth, HA-Gab1 also stimulated DNA synthesis and caused NGF-independent survival in PC12 cells. Finally, we found that HA-Gab1-induced neuritogenesis was completely suppressed by pharmacological inhibition of mitogen-activated protein kinase kinase (MEK) activity and 50% suppressed by inhibition of PI3K activity. In contrast, HA-Gab1-stimulated cell survival was efficiently suppressed only by inhibition of both PI3K and MEK activities. These results indicate that Gab1 is capable of mediating differentiation, DNA synthesis, and cell survival and uses both PI3K and MEK signaling pathways to achieve its effects.	McGill Univ, Montreal Neurol Inst, Brain Tumor Res Ctr, Montreal, PQ H3A 2B4, Canada; Thomas Jefferson Univ, Coll Med, Philadelphia, PA 19107 USA; Exogen Neurosci Inc, Montreal, PQ H2W 2P2, Canada	McGill University; Jefferson University	Kaplan, DR (corresponding author), McGill Univ, Montreal Neurol Inst, Brain Tumor Res Ctr, F-116,3801 Univ St, Montreal, PQ H3A 2B4, Canada.	mcdv@musica.mcgill.ca						ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Bardelli A, 1997, ONCOGENE, V15, P3103, DOI 10.1038/sj.onc.1201561; BAXTER RM, 1995, EUR J BIOCHEM, V234, P84, DOI 10.1111/j.1432-1033.1995.084_c.x; BURSTEIN DE, 1982, DEV BIOL, V94, P477, DOI 10.1016/0012-1606(82)90364-5; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Downward J, 1999, NAT CELL BIOL, V1, pE33, DOI 10.1038/10026; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Hallberg B, 1998, ONCOGENE, V17, P691, DOI 10.1038/sj.onc.1201980; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Ingham RJ, 1998, J BIOL CHEM, V273, P30630, DOI 10.1074/jbc.273.46.30630; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KIMURA K, 1994, J BIOL CHEM, V269, P18961; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Kobayashi M, 1997, J BIOL CHEM, V272, P16089, DOI 10.1074/jbc.272.26.16089; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lecoq-Lafon C, 1999, BLOOD, V93, P2578, DOI 10.1182/blood.V93.8.2578.408k24_2578_2585; Lehr S, 1999, BIOCHEMISTRY-US, V38, P151, DOI 10.1021/bi9818265; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Moscatello DK, 1998, J BIOL CHEM, V273, P200, DOI 10.1074/jbc.273.1.200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Niemann C, 1998, J CELL BIOL, V143, P533, DOI 10.1083/jcb.143.2.533; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Parrizas M, 1997, J BIOL CHEM, V272, P154; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Rocchi S, 1998, MOL ENDOCRINOL, V12, P914, DOI 10.1210/me.12.7.914; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Slack RS, 1996, J CELL BIOL, V135, P1085, DOI 10.1083/jcb.135.4.1085; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	47	61	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37307	37314		10.1074/jbc.274.52.37307	http://dx.doi.org/10.1074/jbc.274.52.37307			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601297	hybrid			2022-12-27	WOS:000084382700068
J	Murata, LB; Dodson, MS				Murata, LB; Dodson, MS			The herpes simplex virus type 1 origin-binding protein - Sequence-specific activation of adenosine triphosphatase activity by a double-stranded DNA containing box I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION ORIGIN; NUCLEOPROTEIN COMPLEX; HELICASE ACTIVITY; VIRAL ORIGIN; UL9 PROTEIN; DOMAIN; ORIS; IDENTIFICATION; PURIFICATION; RECOGNITION	Origin-dependent replication of the herpes simplex virus type 1 genome requires the virally encoded origin-binding protein, UL9. UL9 binds specifically to the herpes simplex virus type 1 replication origin at two high affinity binding sites on the DNA, Boxes I and II. UL9 also has ATP-dependent DNA helicase and DNA-stimulated ATPase activities that are used to unwind the origin DNA. Origin-specific binding is mediated by the C-terminal domain (C-domain) of the enzyme. ATPase and helicase activities are mediated by the N-terminal domain (N-domain). Previous studies have shown that single-stranded DNA is a good coeffector for ATPase activity. We have analyzed several DNAs for their ability to stimulate the ATPase activity of UL9 and of a truncated UL9 protein (UL9/N) consisting only of the N-domain. We report here that duplex Box I DNA specifically and potently stimulates the ATPase activity of UL9 but not of UL9/N. We also find that removal of the C-domain significantly increases the ATPase activity of UL9. We have incorporated these results into a model for initiation in which the C-domain of UL9 serves to regulate the enzymatic activity of the N-domain.	Univ Arizona, Dept Biochem, Tucson, AZ 85721 USA	University of Arizona	Dodson, MS (corresponding author), Univ Arizona, Dept Biochem, Biol Sci W Bldg,1041 E Lowell St, Tucson, AZ 85721 USA.	dodson@u.arizona.edu						ABBOTTS AP, 1995, J GEN VIROL, V76, P3125, DOI 10.1099/0022-1317-76-12-3125; Aguilar RM, 1999, ANAL BIOCHEM, V267, P344, DOI 10.1006/abio.1998.3018; BOEHMER PE, 1993, J BIOL CHEM, V268, P1220; BOEHMER PE, 1994, J BIOL CHEM, V269, P29329; BOEHMER PE, 1993, P NATL ACAD SCI USA, V90, P8444, DOI 10.1073/pnas.90.18.8444; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; BRUCKNER RC, 1991, J BIOL CHEM, V266, P2669; Bullock PA, 1997, CRIT REV BIOCHEM MOL, V32, P503, DOI 10.3109/10409239709082001; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; DAVISON BL, 1979, J BIOL CHEM, V254, P9220; DEB S, 1991, J VIROL, V65, P2829, DOI 10.1128/JVI.65.6.2829-2838.1991; DODSON MS, 1993, J BIOL CHEM, V268, P1213; EARNSHAW DL, 1994, BIOCHEM BIOPH RES CO, V199, P1333, DOI 10.1006/bbrc.1994.1377; Edwards AM, 1998, CURR OPIN STRUC BIOL, V8, P49, DOI 10.1016/S0959-440X(98)80009-2; ELIAS P, 1992, J BIOL CHEM, V267, P17424; ELIAS P, 1990, J BIOL CHEM, V265, P17167; ELIAS P, 1988, P NATL ACAD SCI USA, V85, P2959, DOI 10.1073/pnas.85.9.2959; FIERER DS, 1992, J VIROL, V66, P3986, DOI 10.1128/JVI.66.7.3986-3995.1992; FIERER DS, 1995, J BIOL CHEM, V270, P7330, DOI 10.1074/jbc.270.13.7330; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; GUSTAFSSON CM, 1994, P NATL ACAD SCI USA, V91, P4629, DOI 10.1073/pnas.91.11.4629; HARDWICKE MA, 1995, J VIROL, V69, P1377, DOI 10.1128/JVI.69.3.1377-1388.1995; HAZUDA DJ, 1991, J BIOL CHEM, V266, P24621; HAZUDA DJ, 1992, J BIOL CHEM, V267, P14309; KOFF A, 1988, J VIROL, V62, P4096, DOI 10.1128/JVI.62.11.4096-4103.1988; KOFF A, 1991, J VIROL, V65, P3284, DOI 10.1128/JVI.65.6.3284-3292.1991; Kornberg A, 1992, DNA REPLICATION, P471; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee SSK, 1999, J BIOL CHEM, V274, P18613, DOI 10.1074/jbc.274.26.18613; Lee SSK, 1997, P NATL ACAD SCI USA, V94, P2838, DOI 10.1073/pnas.94.7.2838; LOCKSHON D, 1988, MOL CELL BIOL, V8, P4018, DOI 10.1128/MCB.8.10.4018; Makhov AM, 1996, EMBO J, V15, P1742, DOI 10.1002/j.1460-2075.1996.tb00520.x; MARTIN DW, 1994, VIROLOGY, V198, P71, DOI 10.1006/viro.1994.1009; MARTINEZ R, 1992, J VIROL, V66, P6735, DOI 10.1128/JVI.66.11.6735-6746.1992; MCGEOCH DJ, 1988, J VIROL, V62, P444, DOI 10.1128/JVI.62.2.444-453.1988; MCLEAN GW, 1994, J GEN VIROL, V75, P2699, DOI 10.1099/0022-1317-75-10-2699; OLIVO PD, 1988, P NATL ACAD SCI USA, V85, P5414, DOI 10.1073/pnas.85.15.5414; RABKIN SD, 1991, P NATL ACAD SCI USA, V88, P10946, DOI 10.1073/pnas.88.23.10946; Simonsson S, 1998, J BIOL CHEM, V273, P24633, DOI 10.1074/jbc.273.38.24633; STENLUND A, 1996, DNA REPLICATION EUKA, P679; Stow ND, 1998, VIROLOGY, V240, P183, DOI 10.1006/viro.1997.8910; STOW ND, 1993, VIROLOGY, V196, P413, DOI 10.1006/viro.1993.1496; SUMMERS MD, 1987, 1555 TEX A M U TEX A; WEIR HM, 1989, NUCLEIC ACIDS RES, V17, P1409, DOI 10.1093/nar/17.4.1409; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988	46	10	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37079	37086		10.1074/jbc.274.52.37079	http://dx.doi.org/10.1074/jbc.274.52.37079			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601266	hybrid			2022-12-27	WOS:000084382700037
J	Patra, D; Wang, SX; Kumagai, A; Dunphy, WG				Patra, D; Wang, SX; Kumagai, A; Dunphy, WG			The Xenopus Suc1/Cks protein promotes the phosphorylation of G(2)/M regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-PROLYL ISOMERASE; CELL-CYCLE CONTROL; CRYSTAL-STRUCTURE; MITOSIS; KINASE; CDC25; PIN1; PURIFICATION; ACTIVATION; P13(SUC1)	The entry into mitosis is controlled by Cdc2/cyclin B, also known as maturation or M-phase promoting factor (MPF), In Xenopus egg extracts, the inhibitory phosphorylations of Cdc2 on Tyr-15 and Thr-14 are controlled by the phosphatase Cdc25 and the kinases Myt1 and Wee1, At mitosis, Cdc25 is activated and Myt1 and Wee1 are inactivated through phosphorylation by multiple kinases, including Cdc2 itself, The Cdc2-associated Suc1/Cks1 protein (p9) is also essential for entry of egg ex. tracts into mitosis, but the molecular basis of this requirement has been unknown. We find that p9 strongly stimulates the regulatory phosphorylations of Cdc25, Myt1, and Wee1 that are carried out by the Cdc2/cyclin B complex. Overexpression of the prolyl isomerase Pin1, which binds to the hyperphosphorylated forms of Cdc25, Myt1, and Wee1 found at M-phase, is known to block the initiation of mitosis in egg extracts. We have observed that Pin1 specifically antagonizes the stimulatory effect of p9 on phosphorylation of Cdc25 by Cdc2/cyclin B, This observation could explain why overexpression of Pin1 inhibits mitotic initiation. These findings suggest that p9 promotes the entry into mitosis by facilitating phosphorylation of the key upstream regulators of Cdc2.	CALTECH, Howard Hughes Med Inst, Div Biol 21676, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Dunphy, WG (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol 21676, Pasadena, CA 91125 USA.							Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; BOURNE Y, 1995, P NATL ACAD SCI USA, V92, P10232, DOI 10.1073/pnas.92.22.10232; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; ENDICOTT JA, 1995, EMBO J, V14, P1004, DOI 10.1002/j.1460-2075.1995.tb07081.x; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337; Kaiser P, 1999, GENE DEV, V13, P1190, DOI 10.1101/gad.13.9.1190; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Patra D, 1996, GENE DEV, V10, P1503, DOI 10.1101/gad.10.12.1503; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Shteinberg M, 1999, BIOCHEM BIOPH RES CO, V257, P12, DOI 10.1006/bbrc.1999.0409; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Sudakin V, 1997, J BIOL CHEM, V272, P18051, DOI 10.1074/jbc.272.29.18051; TANG Y, 1993, GENE DEV, V7, P822, DOI 10.1101/gad.7.5.822; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x	25	92	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36839	36842		10.1074/jbc.274.52.36839	http://dx.doi.org/10.1074/jbc.274.52.36839			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601234	hybrid, Green Accepted			2022-12-27	WOS:000084382700005
J	Sasaki, Y; Takahashi, Y; Nakayama, K; Kamataki, T				Sasaki, Y; Takahashi, Y; Nakayama, K; Kamataki, T			Cooperative regulation of CYP2C12 gene expression by STAT5 and liver-specific factors in female rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEX-SPECIFIC FORMS; GROWTH-HORMONE SECRETION; DNA-BINDING PROTEIN; TYROSINE PHOSPHORYLATION; PITUITARY REGULATION; NUCLEAR FACTOR; TRANSCRIPTIONAL ACTIVATION; SIGNAL TRANSDUCER; CYTOCHROME-P-450; RECEPTOR	The purpose of this study was to clarify the mechanism(s) responsible for the growth hormone (GH)-induced expression of the CYP2C12 gene. To identify a functional GH-responsive element (GHRF) in vivo, we performed the direct injection of promoter-luciferase chimeric genes into female rat livers. The results showed that the luciferase activity was decreased to approximately 20% by the deletion of the sequence between nucleotides -4213 and -4161, Within this region, two copies of a possible GHRE were present. The sequence of the GHRE was overlapped with that of an interferon-gamma-activated sequence, known to be recognized by the signal transducer and activator of transcription (STAT) proteins, In fact, a supershift assay showed that STAT5 was capable of binding to the core sequence of the GHRE. Furthermore, a luciferase assay with reporter plasmids, Delta-4161/-3781, mutated hepatocyte nuclear factor-4 (HNF-4), and mutated HNF-6, revealed that the GH-stimulated expression of the CYP2C12 gene was regulated cooperatively by STAT5, HNF-4, HNF-6, and the factor(s) that binds to the elements, 2C12-I (-4095 to -4074) and 2C12-II (-4072 to -4045), The cooperative regulation by STAT5 and the liver-enriched transcription factors account for the GH-dependent and the liver-specific expression of the CYP2C12 gene in female rats.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Div Pharmacobiodynam, Lab Drug Metab,Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Kamataki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Div Pharmacobiodynam, Lab Drug Metab,Kita Ku, N12W6, Sapporo, Hokkaido 0600812, Japan.	kamataki@pharm.hokudai.ac.jp						ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Argetsinger LS, 1996, PHYSIOL REV, V76, P1089, DOI 10.1152/physrev.1996.76.4.1089; Buggs C, 1998, MOL ENDOCRINOL, V12, P1294, DOI 10.1210/me.12.9.1294; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555; Fernandez L, 1998, ENDOCRINOLOGY, V139, P1815, DOI 10.1210/en.139.4.1815; Gebert CA, 1999, MOL ENDOCRINOL, V13, P213, DOI 10.1210/me.13.2.213; Gebert CA, 1997, MOL ENDOCRINOL, V11, P400, DOI 10.1210/me.11.4.400; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRONOWSKI AM, 1995, MOL ENDOCRINOL, V9, P171, DOI 10.1210/me.9.2.171; KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222; KAMATAKI T, 1983, ARCH BIOCHEM BIOPHYS, V225, P758, DOI 10.1016/0003-9861(83)90087-5; KAMATAKI T, 1985, BIOCHEM BIOPH RES CO, V130, P1247, DOI 10.1016/0006-291X(85)91748-6; KATO R, 1986, J BIOCHEM-TOKYO, V100, P895, DOI 10.1093/oxfordjournals.jbchem.a121802; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; Lahuna O, 1997, P NATL ACAD SCI USA, V94, P12309, DOI 10.1073/pnas.94.23.12309; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; Lecine P, 1996, MOL CELL BIOL, V16, P6829; LEGRAVEREND C, 1992, MOL ENDOCRINOL, V6, P259, DOI 10.1210/me.6.2.259; MACGEOCH C, 1984, J BIOL CHEM, V259, P5433; MACGEOCH C, 1985, ENDOCRINOLOGY, V117, P2085, DOI 10.1210/endo-117-5-2085; MACGEOCH C, 1987, BIOCHEM BIOPH RES CO, V143, P782, DOI 10.1016/0006-291X(87)91422-7; MALONE RW, 1994, J BIOL CHEM, V269, P29903; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MISKIMINS WK, 1985, P NATL ACAD SCI USA, V82, P6741, DOI 10.1073/pnas.82.20.6741; MODE A, 1993, J REPROD FERTIL, P77; NITSCH D, 1993, MOL CELL BIOL, V13, P4494, DOI 10.1128/MCB.13.8.4494; Ooi GT, 1998, MOL ENDOCRINOL, V12, P675, DOI 10.1210/me.12.5.675; Park SH, 1999, J BIOL CHEM, V274, P7421, DOI 10.1074/jbc.274.11.7421; Park YK, 1996, J BIOL CHEM, V271, P23725, DOI 10.1074/jbc.271.39.23725; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Ram PA, 1996, J BIOL CHEM, V271, P5929, DOI 10.1074/jbc.271.10.5929; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SLIVA D, 1994, J BIOL CHEM, V269, P26208; STROM A, 1995, J BIOL CHEM, V270, P11276, DOI 10.1074/jbc.270.19.11276; SUBRAMANIAN A, 1995, MOL CELL BIOL, V15, P4672; SUNDSETH SS, 1992, J BIOL CHEM, V267, P3907; TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562; TOLLET P, 1995, MOL ENDOCRINOL, V9, P1771, DOI 10.1210/me.9.12.1771; TOLLET P, 1995, J BIOL CHEM, V270, P12569, DOI 10.1074/jbc.270.21.12569; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Varin-Blank N, 1998, P NATL ACAD SCI USA, V95, P8750, DOI 10.1073/pnas.95.15.8750; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Waxman DJ, 1996, J BIOL CHEM, V271, P29978, DOI 10.1074/jbc.271.47.29978; WAXMAN DJ, 1995, J BIOL CHEM, V270, P13262, DOI 10.1074/jbc.270.22.13262; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WOOD TJJ, 1995, J BIOL CHEM, V270, P9448, DOI 10.1074/jbc.270.16.9448; YAMAZOE Y, 1986, JPN J PHARMACOL, V42, P371, DOI 10.1254/jjp.42.371; ZAPHIROPOULOS PG, 1990, DNA CELL BIOL, V9, P49, DOI 10.1089/dna.1990.9.49; ZAPHIROPOULOS PG, 1988, P NATL ACAD SCI USA, V85, P4214, DOI 10.1073/pnas.85.12.4214	55	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37117	37124		10.1074/jbc.274.52.37117	http://dx.doi.org/10.1074/jbc.274.52.37117			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601272	hybrid			2022-12-27	WOS:000084382700043
J	Yao, XY; Grade, S; Wriggers, W; Rubenstein, PA				Yao, XY; Grade, S; Wriggers, W; Rubenstein, PA			His(73), often methylated, is an important structural determinant for actin - A mutagenic analysis of His(73) of yeast actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; PROTEOLYTIC DIGESTION; SUBDOMAIN 3/4-LOOP; ATP-ACTIN; DYNAMICS; FILAMENT; MUTATION; METHYLHISTIDINE; POLYMERIZATION; PHALLOIDIN	His(73), has been proposed to regulate the release of P-i from the interior of actin following polymerization-dependent hydrolysis of bound ATP, Although it is a 3-methylhistidine in the vast majority of actins, His(73) is unmethylated in S. cerevisiae actin, We mutated His(73) in yeast actin to Arg, Lys, Ala, Gln, and Glu and detected no altered phenotypes associated with the mutations in vivo, However, they significantly affect actin function in vitro. Substitution of the more basic residues resulted in enhanced thermal stability, decreased rate of nucleotide exchange, and decreased susceptibility to controlled proteolysis relative to wild-type actin, The opposite effects are observed with the neutral and anionic substitutions. All mutations reduced the rate of polymerization, Molecular dynamics simulations predict a new conformation for the His(73) imidazole in the absence of a methyl group. It also predicts that Arg(73) tightens and stabilizes the actin and that Glu(73) causes a rearrangement of the bottom of actin's interdomain cleft leading possibly to our observed destabilization of actin, Considering the exterior location of His(73), this work indicates a surprisingly important role for the residue as a major Structural determinant of actin and provides a clue to the impact caused by methylation of His(73).	Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Iowa; University of California System; University of California San Diego	Rubenstein, PA (corresponding author), Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA.			Rubenstein, Peter/0000-0003-1225-4414; Wriggers, Willy/0000-0001-5326-3152	NIGMS NIH HHS [GM33689] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1991, METHOD ENZYMOL, V194, P729; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CARLIER MF, 1986, BIOCHEMISTRY-US, V25, P7789, DOI 10.1021/bi00372a001; CARLIER MF, 1984, J BIOL CHEM, V259, P7349; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; CHEN X, 1995, J BIOL CHEM, V270, P11406, DOI 10.1074/jbc.270.19.11406; COOK RK, 1992, PRACTICAL APPROACHES, P99; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P13; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; Kuang B, 1997, J BIOL CHEM, V272, P1237, DOI 10.1074/jbc.272.2.1237; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Orlova A, 1997, J MOL BIOL, V265, P469, DOI 10.1006/jmbi.1996.0761; ORLOVA A, 1995, J MOL BIOL, V245, P582, DOI 10.1006/jmbi.1994.0048; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Phillips JC, 1997, BIOPHYS J, V73, P2337, DOI 10.1016/S0006-3495(97)78264-X; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; RICH SA, 1976, J MOL BIOL, V104, P777, DOI 10.1016/0022-2836(76)90181-9; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SOLOMON LR, 1987, J BIOL CHEM, V262, P11382; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; SUSSMAN DJ, 1984, J BIOL CHEM, V259, P7349; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Wriggers W, 1997, BIOPHYS J, V73, P624, DOI 10.1016/S0006-3495(97)78098-6; Wriggers W, 1998, BIOPHYS J, V75, P646, DOI 10.1016/S0006-3495(98)77555-1	32	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37443	37449		10.1074/jbc.274.52.37443	http://dx.doi.org/10.1074/jbc.274.52.37443			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601317	hybrid			2022-12-27	WOS:000084382700088
J	Wada, H; Yeh, ETH; Kamitani, T				Wada, H; Yeh, ETH; Kamitani, T			The von Hippel-Lindau tumor suppressor gene product promotes, but is not essential for, NEDD8 conjugation to Cullin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; NUCLEAR-PORE COMPLEX; SENTRIN FAMILY; VHL GENE; MUTATIONS; DISEASE; RANGAP1; MEMBER; PML	We have previously shown that human cullin-2 (Cul-2) is covalently modified at Lys-689 by NEDD8 (Wada, H., Yeh, E. T. H., and Kamitani, T. (1999) Biochem. Biophys. Res. Commun. 257, 100-105). Cul-2 has also been reported to form a multiprotein complex, Cul-2 VBC, with the von Hippel-Lindau tumor suppressor gene product (pVHL) and elongins B and C. In this study, using an in vivo coexpression system in COS cells, we show that NEDD8 conjugation to Cul-2 is promoted by coexpression with wild-type pVHL and elongins B and C. Interestingly, tumorigenic mutants and deletion mutants of pVHL, which are unable to form a Cul-2 VBC complex, do not have the activity to promote NEDD8 conjugation to Cul-2, These results suggest that the complex formation is required for NEDD8 conjugation to Cul-2. Furthermore, we used a pVHL-deficient cell. line, 786-0, to show that Cul-2 is poorly but clearly conjugated by NEDD8, indicating that pVHL is not the only molecule that promotes NEDD8 conjugation to Cul-2. Taken together, the VBC complex appears to have ligase activity in the conjugation of NEDD8 to Cul-2.	Univ Texas, Hlth Sci Ctr, Div Mol Med, Dept Internal Med, Houston, TX 77030 USA; Univ Texas, Res Ctr Cardiovasc Dis, Inst Mol Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System	Kamitani, T (corresponding author), Univ Texas, Hlth Sci Ctr, Div Mol Med, Dept Internal Med, 6431 Fannin,Suite 4-200, Houston, TX 77030 USA.	tetsuk@heart.med.uth.tmc.edu		Kamitani, Tetsu/0000-0002-3257-9630	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056298] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-45851] Funding Source: Medline; NIDDK NIH HHS [1 RO1 DK56298-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Boddy MN, 1996, ONCOGENE, V13, P971; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; Gnarra JR, 1996, BBA-REV CANCER, V1242, P201, DOI 10.1016/0304-419X(95)00012-5; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; Iliopoulos O, 1997, MOL MED, V3, P289, DOI 10.1007/BF03401807; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Kaelin WG, 1999, NATURE, V399, P203, DOI 10.1038/20309; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Kamitani T, 1997, J BIOL CHEM, V272, P22307, DOI 10.1074/jbc.272.35.22307; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kroll M, 1999, J BIOL CHEM, V274, P7941, DOI 10.1074/jbc.274.12.7941; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liakopoulos D, 1999, P NATL ACAD SCI USA, V96, P5510, DOI 10.1073/pnas.96.10.5510; LINEHAN WM, 1995, JAMA-J AM MED ASSOC, V273, P564; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Okura T, 1996, J IMMUNOL, V157, P4277; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Wada H, 1999, BIOCHEM BIOPH RES CO, V257, P100, DOI 10.1006/bbrc.1999.0339; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3	36	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					36025	36029		10.1074/jbc.274.50.36025	http://dx.doi.org/10.1074/jbc.274.50.36025			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585493	hybrid			2022-12-27	WOS:000084187900105
J	Gary-Gouy, H; Bruhns, P; Schmitt, C; Dalloul, A; Daeron, M; Bismuth, G				Gary-Gouy, H; Bruhns, P; Schmitt, C; Dalloul, A; Daeron, M; Bismuth, G			The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-CBL PROTOONCOGENE; ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHATASE 1C; NEGATIVE REGULATION; CYTOPLASMIC DOMAIN; IN-VIVO; TRANSDUCTION MOLECULE; FC-RECEPTORS; ZETA-CHAIN	Genetic studies revealed that CD5 could be a negative regulator of the B-cell antigen receptor (BCR). We explore here the effect of human CD5 on BCR-triggered responses. B cells were obtained expressing a chimera composed of extracellular and transmembrane domains of Fc gamma type IIB receptor fused to CD5 cytoplasmic domain (CD5cyt). Coligation of the chimera with the BCR induces CD5cyt tyrosine phosphorylation. A rapid inhibition of BCR-induced calcium response is observed, as well as a partial but delayed inhibition of phospholipase C gamma-1 phosphorylation. Activation of extracellular regulated kinase-2 is also severely impaired. Moreover, at the functional level, interleukin-2 production is abolished. Src homology 2 domain-bearing tyrosine phosphatase SHP-1 and Src homology 2 domain-bearing inositol 5'-phosphatase SHIP usually participate in negative regulation of the BCR. We show that they do not associate with the phosphorylated CD5 chimera. We finally demonstrate that the pseudo-immunoreceptor tyrosine based activation motif present in CD5cyt is involved because its deletion eliminates the inhibitory effect of the chimera, both at biochemical and functional levels. These results demonstrate the inhibitory role of CD5 pseudo-immunoreceptor tyrosine based activation motif tyrosine phosphorylation on BCR signaling. They further support the idea that CD5 uses mechanisms different from those already described to negatively regulate the BCR pathway.	Ctr Hosp Pitie Salpetriere, CERVI, CNRS,UMR 7627, Lab Immunol Cellulaire, F-75013 Paris, France; Inst Curie, INSERM, U255, Lab Immunol Cellulaire & Clin, F-75005 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Bismuth, G (corresponding author), Ctr Hosp Pitie Salpetriere, CERVI, CNRS,UMR 7627, Lab Immunol Cellulaire, 83 Blvd Hop, F-75013 Paris, France.	gbismuth@ccr.jussieu.fr	Bruhns, Pierre/F-5567-2013	Bruhns, Pierre/0000-0002-4709-8936; GARY, HELENE/0000-0002-9555-5484				ALBEROLAILA J, 1993, J IMMUNOL, V151, P4423; AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; Bauch A, 1998, EUR J IMMUNOL, V28, P2167, DOI 10.1002/(SICI)1521-4141(199807)28:07<2167::AID-IMMU2167>3.0.CO;2-L; Biancone L, 1996, J EXP MED, V184, P811, DOI 10.1084/jem.184.3.811; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Bruhns P, 1999, J IMMUNOL, V162, P3168; BURGESS KE, 1992, P NATL ACAD SCI USA, V89, P9311, DOI 10.1073/pnas.89.19.9311; Calvo J, 1998, J IMMUNOL, V161, P6022; Campbell KS, 1996, J EXP MED, V184, P93, DOI 10.1084/jem.184.1.93; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Cerutti A, 1996, J IMMUNOL, V157, P1854; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; CORY GOC, 1995, J EXP MED, V182, P611, DOI 10.1084/jem.182.2.611; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DAmbrosio D, 1996, IMMUNOL LETT, V54, P77, DOI 10.1016/S0165-2478(96)02653-3; DAVIES AA, 1992, P NATL ACAD SCI USA, V89, P6368, DOI 10.1073/pnas.89.14.6368; Dennehy KM, 1998, EUR J IMMUNOL, V28, P1617, DOI 10.1002/(SICI)1521-4141(199805)28:05<1617::AID-IMMU1617>3.0.CO;2-7; Dennehy KM, 1997, EUR J IMMUNOL, V27, P679, DOI 10.1002/eji.1830270316; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; GaryGouy H, 1997, J IMMUNOL, V159, P3739; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; Gringhuis SI, 1997, J BIOL CHEM, V272, P31809, DOI 10.1074/jbc.272.50.31809; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gupta N, 1997, J EXP MED, V186, P473, DOI 10.1084/jem.186.3.473; GUTHMANN MD, 1995, P NATL ACAD SCI USA, V92, P9397, DOI 10.1073/pnas.92.20.9397; Hartley D, 1996, J BIOL CHEM, V271, P21939, DOI 10.1074/jbc.271.36.21939; HAYAKAWA K, 1988, ANNU REV IMMUNOL, V6, P197, DOI 10.1146/annurev.iy.06.040188.001213; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; Jamin C, 1996, EUR J IMMUNOL, V26, P57, DOI 10.1002/eji.1830260109; JONES B, 1986, J IMMUNOL, V136, P348; KANTOR AB, 1991, IMMUNOL TODAY, V12, P389, DOI 10.1016/0167-5699(91)90136-H; KIPPS TJ, 1989, ADV IMMUNOL, V47, P117, DOI 10.1016/S0065-2776(08)60663-X; LANKESTER AC, 1994, EUR J IMMUNOL, V24, P812, DOI 10.1002/eji.1830240406; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Malbec O, 1998, J IMMUNOL, V160, P1647; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; OSMAN N, 1992, EUR J IMMUNOL, V22, P2995, DOI 10.1002/eji.1830221135; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Pesesse X, 1997, BIOCHEM BIOPH RES CO, V239, P697, DOI 10.1006/bbrc.1997.7538; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Pospisil R, 1996, J EXP MED, V184, P1279, DOI 10.1084/jem.184.4.1279; RAAB M, 1994, MOL CELL BIOL, V14, P2862, DOI 10.1128/MCB.14.5.2862; Raab M, 1996, BIOCHEM BIOPH RES CO, V222, P50, DOI 10.1006/bbrc.1996.0696; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Simarro M, 1997, J IMMUNOL, V159, P4307; Simarro M, 1999, J IMMUNOL, V162, P5149; Smith KGC, 1998, J EXP MED, V187, P807, DOI 10.1084/jem.187.5.807; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Tarakhovsky A, 1997, J EXP MED, V185, P981, DOI 10.1084/jem.185.6.981; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Tridandapani S, 1999, J IMMUNOL, V162, P1408; Tridandapani S, 1997, J IMMUNOL, V158, P1125; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VAN DE VELDE H, 1991, NATURE, V351, P662; Vely F, 1997, EUR J IMMUNOL, V27, P1994, DOI 10.1002/eji.1830270825; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; WEISS A, 1987, J IMMUNOL, V139, P3245	76	61	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					548	556		10.1074/jbc.275.1.548	http://dx.doi.org/10.1074/jbc.275.1.548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617650	hybrid			2022-12-27	WOS:000085951600074
J	Kwon, T; Kwon, DY; Chun, J; Kim, JH; Kang, SS				Kwon, T; Kwon, DY; Chun, J; Kim, JH; Kang, SS			Akt protein kinase inhibits Rac1-GTP binding through phosphorylation at serine 71 of Rac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CDC42 GTPASES; REGULATED EXPRESSION; INDEPENDENT PATHWAYS; LIPID PRODUCTS; P115 RHOGEF; S6 KINASE; ACTIVATION; ONCOGENE; FAMILY	A putative Akt kinase phosphorylation site ((64)ydRIR-plSYp(73)) was found in Rac1/CDC42 and Rho family proteins (RhoA, RhoB, RhoC, and RhoG). Phosphorylation of Rac1 by Akt kinase was assayed with recombinant Rac1 protein and the fluorescein-labeled Rac1 peptide. It was shown that the Rac1 peptide and the recombinant protein were phosphorylated by the activated recombinant Akt kinase and the lysate of SK-MEL28 cells, a human melanoma cell line. The phosphorylation of Rac1 inhibited its GTP-binding activity without any significant change in GTPase activity, Both the GTP-binding and GTPase activities of Rac1 S71A protein (with the serine residue to be phosphorylated replaced with alanine) were abolished regardless of the treatment of Akt kinase. Akt kinase activity and Rac1 peptide phosphorylation were down-regulated by the treatment of SK-MEL28 cells with wortmannin or LY294002 (a phosphoinositide 3-kinase inhibitor), but JNK/SAPK kinase activity was up-regulated. Thus, the results suggest that Akt kinase of the phosphoinositide 3-kinase signal transduction pathway phosphorylates serine 71 of Rac1 as one of its authentic substrates and modulates the Rac1 signal transduction pathway through phosphorylation.	Chongbuk Natl Univ, Dept Sci Educ, Div Sci Educ, Chongju 361763, South Korea; Samsung Biomed Res Inst, Clin Res Ctr, Seoul 135230, South Korea; Seoul Natl Univ Hosp, Seoul 110530, South Korea; Univ Wisconsin, Dept Entomol, Madison, WI 53705 USA; Kwangju Inst Sci & Technol, Dept Life Biol, Kwangju 500712, South Korea	Jeonbuk National University; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; University of Wisconsin System; University of Wisconsin Madison; Gwangju Institute of Science & Technology (GIST)	Kang, SS (corresponding author), Chongbuk Natl Univ, Dept Sci Educ, Div Sci Educ, Chongju 361763, South Korea.	95324JIN@mail.hitel.net	Kim, Jae-Hong/B-2530-2009	Kim, Jae-Hong/0000-0002-8019-0208; Kwon, Taegun/0000-0002-0205-8535				Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Barthel A, 1998, BIOCHEM BIOPH RES CO, V243, P509, DOI 10.1006/bbrc.1998.8134; Bazenet CE, 1998, P NATL ACAD SCI USA, V95, P3984, DOI 10.1073/pnas.95.7.3984; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; delPeso L, 1997, SCIENCE, V278, P687; DISDSBURRY J, 1989, J BIOL CHEM, V264, P16378; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; FAGAN KP, 1994, EXP EYE RES, V59, P235, DOI 10.1006/exer.1994.1102; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fritz G, 1999, MOL CELL BIOL, V19, P1768; Gringhuis SI, 1998, MOL CELL BIOL, V18, P1725, DOI 10.1128/MCB.18.3.1725; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hemmings BA, 1997, SCIENCE, V277, P534, DOI 10.1126/science.277.5325.534; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Jones GE, 1998, CELL ADHES COMMUN, V6, P237, DOI 10.3109/15419069809004479; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MARTIN GA, 1995, EMBO J, V14, P4385, DOI 10.1002/j.1460-2075.1995.tb00113.x; Missy K, 1998, J BIOL CHEM, V273, P30279, DOI 10.1074/jbc.273.46.30279; MOLL J, 1991, ONCOGENE, V6, P863; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roberts ML, 1998, BIOCHEM BIOPH RES CO, V251, P166, DOI 10.1006/bbrc.1998.9434; RON D, 1988, EMBO J, V7, P2465, DOI 10.1002/j.1460-2075.1988.tb03093.x; Roux P, 1997, CURR BIOL, V7, P629, DOI 10.1016/S0960-9822(06)00289-2; Seo HS, 1997, EUR J BIOCHEM, V249, P293, DOI 10.1111/j.1432-1033.1997.00293.x; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; VINCENT S, 1992, MOL CELL BIOL, V12, P3138, DOI 10.1128/MCB.12.7.3138; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; WHITEHEAD I, 1995, J BIOL CHEM, V270, P18388, DOI 10.1074/jbc.270.31.18388; Whitehead IP, 1998, MOL CELL BIOL, V18, P4689, DOI 10.1128/MCB.18.8.4689; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	53	180	186	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					423	428		10.1074/jbc.275.1.423	http://dx.doi.org/10.1074/jbc.275.1.423			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617634	hybrid			2022-12-27	WOS:000085951600058
J	O'Keeffe, B; Fong, Y; Chen, D; Zhou, S; Zhou, Q				O'Keeffe, B; Fong, Y; Chen, D; Zhou, S; Zhou, Q			Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL DOMAIN; CELL-FREE SYSTEM; PROTEIN-KINASE; IN-VIVO; ELONGATION-FACTOR; GLUCOCORTICOID RECEPTOR; CATALYTIC SUBUNIT; HSP90; TRANSACTIVATION	Tat activation of HIV-1 transcription is mediated by human transcription elongation factor P-TEFb, which interacts with Tat and phosphorylates the C-terminal domain of RNA polymerase II. The catalytic subunit of the P-TEFb complex, Cdk9, has been shown to interact with cyclin T and several other proteins of unknown identity, Consequently, the exact subunit composition of active P-TEFb has not been determined. Here we report the affinity purification and identification of the Cdk9 associated proteins. In addition to forming a heterodimer with cyclin T1, Cdk9 interacted with the molecular chaperone Hsp76 or a kinase-specific chaperone complex, Hsp90/Cdc37, to form two separate chaperone-Cdk9 complexes, Although the Cdk9/cyclin T1 dimer was exceptionally stable and produced slowly in the cell, free and unprotected Cdk9 appeared to be degraded rapidly, Several lines of evidence indicate the heterodimer of Cdk9/cyclin T1 to be the mature, active form of P-TEFb responsible for phosphorylation of the C-terminal domain of RNA polymerase II interaction with the Tat activation domain, and mediation of Tat activation of HIV-1 transcription. Pharmacological inactivation of Hsp90/Cdc37 function by geldanamycin revealed an essential role for the chaperone-Cdk9 complexes in generation of Cdk9/cyclin TI, Our data suggest a previously unrecognized chaperone-dependent pathway involving the sequential actions of Hsp70 and Hsp90/Cdc37 in the stabilization/folding of Cdk9 as well as the assembly of an active Cdk9/cyclin T1 complex responsible for P-TEFb-mediated Tat transactivation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zhou, Q (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 206 Stanley Hall,3206, Berkeley, CA 94720 USA.	qzhou@uclink4.berkeley.edu			NIAID NIH HHS [AI-41757] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041757] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chen D, 1999, MOL CELL BIOL, V19, P2863; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Chun RF, 1996, J BIOL CHEM, V271, P27888, DOI 10.1074/jbc.271.44.27888; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; FERNANDEZ J, 1994, ANAL BIOCHEM, V218, P112, DOI 10.1006/abio.1994.1148; Fujinaga K, 1999, P NATL ACAD SCI USA, V96, P1285, DOI 10.1073/pnas.96.4.1285; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Garriga J, 1996, BIOCHEM J, V319, P293, DOI 10.1042/bj3190293; GERBER MR, 1995, P NATL ACAD SCI USA, V92, P4651, DOI 10.1073/pnas.92.10.4651; Gold MO, 1998, J VIROL, V72, P4448, DOI 10.1128/JVI.72.5.4448-4453.1998; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; GRANA X, 1994, P NATL ACAD SCI USA, V91, P3834, DOI 10.1073/pnas.91.9.3834; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; HUTCHISON KA, 1992, J BIOL CHEM, V267, P2902; HUTCHISON KA, 1994, J BIOL CHEM, V269, P5043; Johnson JL, 1997, CELL, V90, P201, DOI 10.1016/S0092-8674(00)80327-X; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; Kim JB, 1999, MOL CELL BIOL, V19, P5960; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Lamphere L, 1997, ONCOGENE, V14, P1999, DOI 10.1038/sj.onc.1201036; Li XY, 1998, GENE DEV, V12, P2992, DOI 10.1101/gad.12.19.2992; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Okamoto H, 1996, P NATL ACAD SCI USA, V93, P11575, DOI 10.1073/pnas.93.21.11575; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Parada CA, 1996, NATURE, V384, P375, DOI 10.1038/384375a0; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; PRATT WB, 1993, J BIOL CHEM, V268, P21455; RICE AP, 1990, J VIROL, V64, P6018, DOI 10.1128/JVI.64.12.6018-6026.1990; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Yang XZ, 1996, J VIROL, V70, P4576, DOI 10.1128/JVI.70.7.4576-4584.1996; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	46	121	123	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					279	287		10.1074/jbc.275.1.279	http://dx.doi.org/10.1074/jbc.275.1.279			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617616	hybrid			2022-12-27	WOS:000085951600040
J	Alldridge, LC; Harris, HJ; Plevin, R; Hannon, R; Bryant, CE				Alldridge, LC; Harris, HJ; Plevin, R; Hannon, R; Bryant, CE			The annexin protein lipocortin 1 regulates the MAPK/ERK pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN RECOMBINANT LIPOCORTIN-1; ADENOCARCINOMA CELL-LINE; TUMOR-NECROSIS-FACTOR; MAP KINASE KINASE; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; MAMMALIAN-CELLS; CYCLE ARREST	Lipocortin 1 (annexin 1) is a calcium- and phospholipid-binding protein that modulates anti-inflammatory responses including those induced by lipopolysaccharide. To investigate the precise role of lipocortin 1 in regulating the lipopolysaccharide-induced signal transduction pathways, we generated stable RAW 264.7 macrophage cell lines expressing decreased and increased lipocortin 1 protein. Several RAW 264.7 clones with increased lipocortin 1 protein levels showed constitutive activation of the mitogen-activated protein kinase extracellular signal-regulated kinase, which was down-regulated following lipopolysaccharide treatment. Conversely, clones with decreased lipocortin 1 protein expression showed prolonged extracellular signal-regulated kinase activity, following lipopolysaccharide activation. Lipocortin 1 specifically regulates the components of the extracellular signal-regulated kinase pathway, since changes in lipocortin 1 protein expression had no affect on the related mitogen-activated protein kinases p38 and c-Jun N-terminal kinase. Lipocortin 1 modulated upstream components of the extracellular signal-regulated kinase pathway and associated with the adaptor protein growth factor binding protein. The downstream consequences of altered extracellular signal-regulated kinase activity were independent of the proinflammatory transcription factor nuclear factor kappa B. These data indicate that Lipocortin 1 specifically regulates proximal signaling components of the extracellular signal-regulated kinase signal transduction pathway, resulting in the modulation of biochemical functions in RAW macrophages.	Univ Cambridge, Dept Clin Vet Med, Cambridge CB3 0ES, England; Univ Strathclyde, Dept Physiol & Pharmacol, Glasgow, Lanark, Scotland; Queen Mary Univ London, St Bartholomews & Royal London Sch Med & Dent, Dept Biochem Pharmacol, London EC1M 6BQ, England	University of Cambridge; University of Strathclyde; University of London; Queen Mary University London	Bryant, CE (corresponding author), Univ Cambridge, Dept Clin Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	ceb27@cus.cam.ac.uk		Plevin, Robin/0000-0002-7849-1220				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Briant L, 1998, J IMMUNOL, V160, P1875; Bryant CE, 1998, BIOCHEM PHARMACOL, V55, P279, DOI 10.1016/S0006-2952(97)00462-0; Chu J, 1998, BLOOD, V92, P1697, DOI 10.1182/blood.V92.5.1697.417a06_1697_1706; CIRINO G, 1989, P NATL ACAD SCI USA, V86, P3428, DOI 10.1073/pnas.86.9.3428; CROMPTON MR, 1988, CELL, V55, P1, DOI 10.1016/0092-8674(88)90002-5; CROXTALL JD, 1992, P NATL ACAD SCI USA, V89, P3571, DOI 10.1073/pnas.89.8.3571; Croxtall JD, 1998, BRIT J PHARMACOL, V123, P975, DOI 10.1038/sj.bjp.0701679; Curto M, 1998, BIOCHEM BIOPH RES CO, V243, P555, DOI 10.1006/bbrc.1997.7982; DAVIDSON J, 1991, BRIT J PHARMACOL, V102, P7, DOI 10.1111/j.1476-5381.1991.tb12122.x; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Diakonova M, 1997, J CELL SCI, V110, P1199; DINARELLO CA, 1992, BACTERIAL ENDOTOXIC, P105; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; GENG Y, 1993, J IMMUNOL, V151, P6692; GEPPERT TD, 1994, MOL MED, V1, P93; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hildt E, 1999, J EXP MED, V189, P1707, DOI 10.1084/jem.189.11.1707; Hu Y, 1998, J BIOL CHEM, V273, P27170, DOI 10.1074/jbc.273.42.27170; KIEHEN TL, 1995, IMMUNOPHARMACOLOGY, V29, P187; LI SF, 1993, P NATL ACAD SCI USA, V90, P9247, DOI 10.1073/pnas.90.20.9247; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MCCALLUM RE, 1992, BACTERIAL ENDOTOXIC, P145; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; Mollenhauer J, 1997, CELL MOL LIFE SCI, V53, P506, DOI 10.1007/s000180050063; MORGAN RO, 1995, MOL BIOL EVOL, V12, P967; MorishimaKawashima M, 1996, MOL BIOL CELL, V7, P893, DOI 10.1091/mbc.7.6.893; MOSS SE, 1995, NATURE, V378, P446, DOI 10.1038/378446a0; PERRETTI M, 1993, J IMMUNOL, V150, P992; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; Pouliot M, 1997, J IMMUNOL, V158, P4930; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rose DM, 1997, J IMMUNOL, V158, P3433; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Tombes RM, 1998, BIOCHEM J, V330, P1451; Traverso V, 1998, J CELL SCI, V111, P1405; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Ward AC, 1998, BBA-MOL CELL RES, V1448, P70, DOI 10.1016/S0167-4889(98)00120-7; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; WU CC, 1995, P NATL ACAD SCI USA, V92, P3473, DOI 10.1073/pnas.92.8.3473; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	52	121	128	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37620	37628		10.1074/jbc.274.53.37620	http://dx.doi.org/10.1074/jbc.274.53.37620			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608817	hybrid			2022-12-27	WOS:000084528000017
J	Delmotte, MH; Tahayato, A; Formstecher, P; Lefebvre, P				Delmotte, MH; Tahayato, A; Formstecher, P; Lefebvre, P			Serine 157, a retinoic acid receptor alpha residue phosphorylated by protein kinase C in vitro, is involved in RXR center dot RAR alpha heterodimerization and transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; DNA-BINDING; TERATOCARCINOMA DIFFERENTIATION; ESTROGEN-RECEPTOR; NUCLEAR RECEPTOR; CARCINOMA CELLS; ACTIVATION; EXPRESSION; PATHWAY; TRANSLOCATION	Retinoic acid (RA) regulation of cellular proliferation and differentiation is mediated, at least in part, through two related nuclear receptors, RAR and RXR. RA-induced modulation of gene expression leads generally to cellular differentiation, whereas stimulation of the protein kinase C (PHC) signaling pathway is associated with cellular proliferation. Pursuant to our discovery that prolonged activation of PKCs induced a strong decrease in RA responsiveness of a retinoid-inducible reporter gene, we have further investigated the connections between these two signaling pathways. We demonstrate that PKC isoforms alpha and gamma are able to phosphorylate human RAR alpha (hRAR alpha) in vitro on a single serine residue located in the extended DNA binding domain (T box). The introduction of a negative charge at this position (serine 157) strongly decreased hRAR alpha transcriptional activity, whereas a similar mutation at other PKC consensus phosphorylation sites had no effect. The effect on transcriptional activation was correlated with a decrease in the capacity of hRAR alpha to heterodimerize with hRXR alpha. Thus hRAR alpha is a direct target for PKC alpha and gamma, which may control retinoid receptor transcriptional activities during cellular proliferation and differentiation.	Fac Med Henri Warembourg, INSERM, U459, F-59045 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Lefebvre, P (corresponding author), Fac Med Henri Warembourg, INSERM, U459, 1 Pl Verdun, F-59045 Lille, France.		Lefebvre, Philippe/F-2685-2010	Lefebvre, Philippe/0000-0002-9366-5129				BENO DWA, 1995, J BIOL CHEM, V270, P3642, DOI 10.1074/jbc.270.8.3642; Berry DM, 1996, J BIOL CHEM, V271, P16090, DOI 10.1074/jbc.271.27.16090; Blobe GC, 1996, CANCER SURV, V27, P213; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chernov MV, 1998, P NATL ACAD SCI USA, V95, P2284, DOI 10.1073/pnas.95.5.2284; Cho YH, 1997, J CELL PHYSIOL, V172, P306, DOI 10.1002/(SICI)1097-4652(199709)172:3<306::AID-JCP4>3.0.CO;2-S; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; GRUBER JR, 1992, J BIOL CHEM, V267, P13356; Gundimeda U, 1996, J BIOL CHEM, V271, P13504, DOI 10.1074/jbc.271.23.13504; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; HSIEH JC, 1991, P NATL ACAD SCI USA, V88, P9315, DOI 10.1073/pnas.88.20.9315; HSIEH JC, 1993, J BIOL CHEM, V268, P15118; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; JAMES G, 1992, J CELL BIOL, V116, P863, DOI 10.1083/jcb.116.4.863; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Khuri FR, 1996, CELL GROWTH DIFFER, V7, P595; KINDREGAN HC, 1994, J BIOL CHEM, V269, P27756; KRISHNAN AV, 1991, MOL ENDOCRINOL, V5, P605, DOI 10.1210/mend-5-4-605; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; KURIE JM, 1993, BIOCHIM BIOPHYS ACTA, V1179, P203, DOI 10.1016/0167-4889(93)90142-C; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Lefebvre B, 1998, BIOCHEMISTRY-US, V37, P9240, DOI 10.1021/bi9804840; LEFEBVRE P, 1995, J BIOL CHEM, V270, P10806, DOI 10.1074/jbc.270.18.10806; LISSOOS TW, 1993, J BIOL CHEM, V268, P25132; Marino M, 1998, BIOCHEM BIOPH RES CO, V245, P254, DOI 10.1006/bbrc.1998.8413; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mouchon A, 1999, MOL CELL BIOL, V19, P3073; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; POLLOK KE, 1991, CELL SIGNAL, V3, P435, DOI 10.1016/0898-6568(91)90074-5; Quack M, 1998, NUCLEIC ACIDS RES, V26, P5372, DOI 10.1093/nar/26.23.5372; Rachez C, 1996, J BIOL CHEM, V271, P17996, DOI 10.1074/jbc.271.30.17996; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Rosewicz S, 1996, ENDOCRINOLOGY, V137, P3340, DOI 10.1210/en.137.8.3340; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; SIMBOLICAMPBELL M, 1994, J BIOL CHEM, V269, P3257; TAHAYATO A, 1993, MOL ENDOCRINOL, V7, P1642, DOI 10.1210/me.7.12.1642; TAHAYATO A, 1997, RETINOID PROTOCOLS, P277; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; YANG YL, 1994, MOL ENDOCRINOL, V8, P1370, DOI 10.1210/me.8.10.1370; Ye Y, 1996, EMBO J, V15, P5606, DOI 10.1002/j.1460-2075.1996.tb00945.x; ZHANG XK, 1994, MOL CELL BIOL, V14, P4311, DOI 10.1128/MCB.14.6.4311	46	70	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38225	38231		10.1074/jbc.274.53.38225	http://dx.doi.org/10.1074/jbc.274.53.38225			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608897	hybrid			2022-12-27	WOS:000084528000097
J	Kim, ST; Lim, DS; Canman, CE; Kastan, MB				Kim, ST; Lim, DS; Canman, CE; Kastan, MB			Substrate specificities and identification of putative substrates of ATM kinase family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIJMEGEN BREAKAGE SYNDROME; CYCLE CHECKPOINT PATHWAY; TELANGIECTASIA GENE ATM; ATAXIA-TELANGIECTASIA; CELL-CYCLE; PROTEIN-KINASE; DNA-DAMAGE; P53; PRODUCT; BREAST	Ataxia telangiectasia mutated (ATM) phosphorylates p53 protein in response to ionizing radiation, but the complex phenotype of AT cells suggests that it must have other cellular substrates as well. To identify substrates for ATM and the related kinases ATR and DNA-PK, we optimized in vitro kinase assays and developed a rapid peptide screening method to determine general phosphorylation consensus sequences. ATM and ATR require Mn2+, but not DNA ends or Ku proteins, for optimal in vitro activity while DNA-PKCs requires Mg2+, DNA ends, and Bh proteins. From p53 peptide mutagenesis analysis, me found that the sequence S/TQ is a minimal essential requirement for all three kinases. In addition, hydrophobic amino acids and negatively charged amino acids immediately NH2-terminal to serine or threonine are positive determinants and positively charged amino acids in the region are negative determinants for substrate phosphorylation. We determined a general phosphorylation consensus sequence for ATM and identified putative in vitro targets by using glutathione S-transferase peptides as substrates. Putative ATM in vitro targets include p95/nibrin, Mre11, Brca1, Rad17, PTS, WRN, and ATM (S440) itself. Brca2, phosphatidylinositol 3-kinase, and DNA-5B peptides were phosphorylated specifically by ATR, and DNA Ligase IV is a specific in vitro substrate of DNA-PK.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kastan, MB (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Lim, Dae-Sik/C-1599-2011; Kim, Seong-Tae/A-9917-2013	Lim, Dae-Sik/0000-0003-2356-7555; , Christine/0000-0001-8892-7430	NCI NIH HHS [CA71387, CA21765] Funding Source: Medline; NIEHS NIH HHS [ES0577] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071387, P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bao SD, 1998, CELL GROWTH DIFFER, V9, P961; Bluyssen HAR, 1999, GENOMICS, V55, P219, DOI 10.1006/geno.1998.5642; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Canman CE, 1998, ONCOGENE, V17, P3301, DOI 10.1038/sj.onc.1202577; CANMAN CE, 1994, CANCER RES, V54, P5054; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carr AM, 1997, CURR OPIN GENET DEV, V7, P93, DOI 10.1016/S0959-437X(97)80115-3; Chen G, 1996, J BIOL CHEM, V271, P33693, DOI 10.1074/jbc.271.52.33693; Featherstone C, 1998, CURR BIOL, V8, pR622, DOI 10.1016/S0960-9822(98)70392-6; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; Jeggo PA, 1998, TRENDS GENET, V14, P312, DOI 10.1016/S0168-9525(98)01511-X; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; KHANNA KK, 1995, ONCOGENE, V11, P609; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lakin ND, 1996, ONCOGENE, V13, P2707; Lavin M, 1998, BRIT MED J, V317, P486; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Li L, 1999, ONCOGENE, V18, P1689, DOI 10.1038/sj.onc.1202469; Lim DS, 1998, P NATL ACAD SCI USA, V95, P10146, DOI 10.1073/pnas.95.17.10146; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0; Oka A, 1998, NEUROSCI LETT, V252, P195, DOI 10.1016/S0304-3940(98)00576-X; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; SCHROTER H, 1985, EMBO J, V4, P3867, DOI 10.1002/j.1460-2075.1985.tb04159.x; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Swift M, 1999, BRIT MED J, V318, P400, DOI 10.1136/bmj.318.7180.400; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Westphal CH, 1998, CANCER RES, V58, P5637; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	44	619	672	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37538	37543		10.1074/jbc.274.53.37538	http://dx.doi.org/10.1074/jbc.274.53.37538			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608806	hybrid			2022-12-27	WOS:000084528000006
J	Vinion-Dubiel, AD; McClain, MS; Czajkowsky, DM; Iwamoto, H; Ye, D; Cao, P; Schraw, W; Szabo, G; Blanke, SR; Shao, ZF; Cover, TL				Vinion-Dubiel, AD; McClain, MS; Czajkowsky, DM; Iwamoto, H; Ye, D; Cao, P; Schraw, W; Szabo, G; Blanke, SR; Shao, ZF; Cover, TL			A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIN; PROTEIN; BINDING; MEMBRANE; ACID; CYTOSOL; GENE	Most Helicobacter pylori strains secrete a toxin (VacA) that causes structural and functional alterations in epithelial cells and is thought to play an important role in the pathogenesis of H. pylori-associated gastroduodenal diseases, The amino acid sequence, ultrastructural morphology, and cellular effects of VacA are unrelated to those of any other known bacterial protein toxin, and the VacA mechanism of action remains poorly understood. To analyze the functional role of a unique strongly hydrophobic region near the VacA amino terminus, we constructed an H pylori strain that produced a mutant VacA protein (VacA-(Delta 6-27)) in which this hydrophobic segment was deleted. VacA-(Delta 6-27) was secreted by H. pylori, oligomerized properly, and formed two-dimensional lipid-bound crystals with structural features that were indistinguishable from those of wild-type VacA However, VacA-(Delta 6-27) formed ion-conductive channels in planar Lipid bilayers significantly more slowly than did wild-type VacA and the mutant channels were less anion-selective. Mixtures of wild-type VacA and VacA-(Delta 6-27) formed membrane channels with properties intermediate between those formed by either isolated species, VacA-(Delta 6-27) did not exhibit any detectable defects in binding or uptake by HeLa cells, but this mutant toxin failed to induce cell. vacuolation, Moreover, when an equimolar mixture of purified VacA(Delta 6-27) and purified wild-type VacA were added simultaneously to HeLa cells, the mutant toxin exhibited a dominant negative effect, completely inhibiting the vacuolating activity of wild-type VacA A dominant negative effect also was observed when HeLa cells were cotransfected with plasmids encoding wild-type and mutant toxins. me propose a model in which the dominant negative effects of VacA-(Delta 6-27) result from protein-protein interactions between the mutant and wild-type VacA proteins, thereby resulting in the formation of mixed oligomers with defective functional activity.	Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Vet Affairs Med Ctr, Nashville, TN 37232 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; Univ Virginia, Biophys Program, Charlottesville, VA 22908 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Houston System; University of Houston; University of Virginia; University of Virginia	Cover, TL (corresponding author), Vanderbilt Univ, Sch Med, Div Infect Dis, A3310 Med Ctr N, Nashville, TN 37232 USA.		Shao, Zhifeng/B-6075-2013; Cover, Timothy/I-3814-2015; McClain, Mark S/A-6942-2009	Cover, Timothy/0000-0001-8503-002X; McClain, Mark S/0000-0002-9857-4883	NCRR NIH HHS [RR07720] Funding Source: Medline; NIAID NIH HHS [AI39657] Funding Source: Medline; NIDDK NIH HHS [DK53623] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR007720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053623] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Burroni D, 1998, INFECT IMMUN, V66, P5547, DOI 10.1128/IAI.66.11.5547-5550.1998; Copass M, 1997, INFECT IMMUN, V65, P1949, DOI 10.1128/IAI.65.5.1949-1952.1997; COVER TL, 1991, INFECT IMMUN, V59, P1264, DOI 10.1128/IAI.59.4.1264-1270.1991; COVER TL, 1993, INFECT IMMUN, V61, P5008, DOI 10.1128/IAI.61.12.5008-5012.1993; Cover TL, 1996, MOL MICROBIOL, V20, P241, DOI 10.1111/j.1365-2958.1996.tb02612.x; COVER TL, 1992, J BIOL CHEM, V267, P10570; COVER TL, 1994, J BIOL CHEM, V269, P10566; Cover TL, 1997, J CELL BIOL, V138, P759, DOI 10.1083/jcb.138.4.759; Czajkowsky DM, 1998, FEBS LETT, V430, P51, DOI 10.1016/S0014-5793(98)00461-X; Czajkowsky DM, 1999, P NATL ACAD SCI USA, V96, P2001, DOI 10.1073/pnas.96.5.2001; de Bernard M, 1998, INFECT IMMUN, V66, P6014, DOI 10.1128/IAI.66.12.6014-6016.1998; deBernard M, 1997, MOL MICROBIOL, V26, P665, DOI 10.1046/j.1365-2958.1997.5881952.x; DEBERNARD M, 1995, J BIOL CHEM, V270, P23937, DOI 10.1074/jbc.270.41.23937; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Engel A, 1999, CURR BIOL, V9, pR133, DOI 10.1016/S0960-9822(99)80081-5; ENGLEMAN DM, 1996, SCIENCE, V274, P1850; FUCHS CS, 1995, NEW ENGL J MED, V333, P32, DOI 10.1056/NEJM199507063330107; Garner JA, 1996, INFECT IMMUN, V64, P4197, DOI 10.1128/IAI.64.10.4197-4203.1996; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Iwamoto H, 1999, FEBS LETT, V450, P101, DOI 10.1016/S0014-5793(99)00474-3; Lupetti P, 1996, J CELL BIOL, V133, P801, DOI 10.1083/jcb.133.4.801; MANETTI R, 1995, INFECT IMMUN, V63, P4476, DOI 10.1128/IAI.63.11.4476-4480.1995; Massari P, 1998, INFECT IMMUN, V66, P3981, DOI 10.1128/IAI.66.8.3981-3984.1998; Miles E W, 1977, Methods Enzymol, V47, P431; Molinari M, 1998, BIOCHEM BIOPH RES CO, V248, P334, DOI 10.1006/bbrc.1998.8808; Molinari M, 1998, J EXP MED, V187, P135, DOI 10.1084/jem.187.1.135; Molinari M, 1997, J BIOL CHEM, V272, P25339, DOI 10.1074/jbc.272.40.25339; Montecucco C, 1998, CURR OPIN CELL BIOL, V10, P530, DOI 10.1016/S0955-0674(98)80069-0; Papini E, 1998, J CLIN INVEST, V102, P813, DOI 10.1172/JCI2764; Papini E, 1997, EMBO J, V16, P15, DOI 10.1093/emboj/16.1.15; PAPINI E, 1994, P NATL ACAD SCI USA, V91, P9720, DOI 10.1073/pnas.91.21.9720; Reyrat JM, 1999, J MOL BIOL, V290, P459, DOI 10.1006/jmbi.1999.2877; Satin B, 1997, J BIOL CHEM, V272, P25022, DOI 10.1074/jbc.272.40.25022; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Seto K, 1998, FEBS LETT, V431, P347, DOI 10.1016/S0014-5793(98)00788-1; STENMARK H, 1988, J BIOL CHEM, V263, P13449; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; Tombola F, 1999, BIOPHYS J, V76, P1401, DOI 10.1016/S0006-3495(99)77301-7; Yahiro K, 1997, BIOCHEM BIOPH RES CO, V238, P629, DOI 10.1006/bbrc.1997.7345; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Ye D, 1999, J BIOL CHEM, V274, P9277, DOI 10.1074/jbc.274.14.9277; 1994, IARC MONOGR EVAL CAR, V61, P177	43	112	116	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37736	37742		10.1074/jbc.274.53.37736	http://dx.doi.org/10.1074/jbc.274.53.37736			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608833	hybrid			2022-12-27	WOS:000084528000033
J	Vollmer, JY; Alix, P; Chollet, A; Takeda, K; Galzi, JL				Vollmer, JY; Alix, P; Chollet, A; Takeda, K; Galzi, JL			Subcellular compartmentalization of activation and desensitization of responses mediated by NK2 neurokinin receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-FLUORESCENT PROTEIN; P NK-1 RECEPTOR; SUBSTANCE-P; LIGAND-BINDING; KINASE-C; ACETYLCHOLINE-RECEPTOR; SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; CAVEOLAE; CELLS	A functional fluorescent neurokinin NK2 receptor was constructed by joining enhanced green fluorescent protein to the amino-terminal end of the rat NK2 receptor and was expressed in human embryonic kidney cells. On cell suspensions, the binding of fluorescent Bodipy-labeled neurokinin A results in a saturatable and reversible decrease of NK2 receptor fluorescence via fluorescence resonance energy transfer. This can be quantified for nM to mu M agonist concentrations and monitored in parallel with intracellular calcium responses. On single cells, receptor site occupancy and local agonist concentration can be determined in real time from the decrease in receptor fluorescence. Simultaneous measurement of intracellular calcium responses and agonist binding reveals that partial receptor site occupancy is sufficient to desensitize cellular response to a second agonist application to the same membrane area. Subsequent stimulation of a distal membrane area leads to a second response to agonist, provided that it had not been exposed to agonist during the first application. Together with persistent translocation of fluorescent protein kinase C to the membrane area exposed to agonist, the present data support that not only homologous desensitization but also heterologous desensitization of NK2 receptors is compartmentalized to discrete membrane domains.	Ecole Super Biotechnol Strasbourg, Dept Recepteurs & Prot Membranaires, CNRS, F-67400 Illkirch Graffenstaden, France; Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland; Univ Strasbourg 1, Fac Pharm, CNRS, UMR 7034, F-67401 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Galzi, JL (corresponding author), Ecole Super Biotechnol Strasbourg, Dept Recepteurs & Prot Membranaires, CNRS, UPR 9050,Blvd Sebastien Brant, F-67400 Illkirch Graffenstaden, France.	galzi@esbs.u-strasbg.fr						ALBLAS J, 1995, J BIOL CHEM, V270, P8944, DOI 10.1074/jbc.270.15.8944; Alblas J, 1996, EMBO J, V15, P3351, DOI 10.1002/j.1460-2075.1996.tb00700.x; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Barak LS, 1999, J BIOL CHEM, V274, P7565, DOI 10.1074/jbc.274.11.7565; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Boyd ND, 1996, P NATL ACAD SCI USA, V93, P433, DOI 10.1073/pnas.93.1.433; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; DIMARZO V, 1993, J NEUROSCI, V13, P4846; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; EMONDSALT X, 1992, LIFE SCI, V50, pPL101, DOI 10.1016/0024-3205(92)90352-P; FAY SP, 1991, BIOCHEMISTRY-US, V30, P5066, DOI 10.1021/bi00234a033; Feron O, 1999, LIFE SCI, V64, P471, DOI 10.1016/S0024-3205(98)00590-6; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; GALZI JL, 1994, CURR OPIN STRUC BIOL, V4, P554, DOI 10.1016/S0959-440X(94)90218-6; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gudermann T, 1997, ANNU REV NEUROSCI, V20, P399, DOI 10.1146/annurev.neuro.20.1.399; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HUANG RRC, 1995, BIOCHEMISTRY-US, V34, P10048, DOI 10.1021/bi00031a029; Karlin A, 1993, Curr Opin Neurobiol, V3, P299, DOI 10.1016/0959-4388(93)90121-E; LAKEY JH, 1991, J MOL BIOL, V218, P639, DOI 10.1016/0022-2836(91)90707-D; Lefkowitz RJ, 1996, NAT BIOTECHNOL, V14, P283, DOI 10.1038/nbt0396-283; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; LI YM, 1995, J BIOL CHEM, V270, P1213, DOI 10.1074/jbc.270.3.1213; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; McConalogue K, 1998, MOL BIOL CELL, V9, P2305, DOI 10.1091/mbc.9.8.2305; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; NAKANISHI S, 1993, REGUL PEPTIDES, V46, P37, DOI 10.1016/0167-0115(93)90009-W; NEMETH K, 1995, J BIOL CHEM, V270, P27601, DOI 10.1074/jbc.270.46.27601; NEUBIG RR, 1993, MOL PHARMACOL, V43, P734; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Periasamy A, 1997, P SOC PHOTO-OPT INS, V2983, P58, DOI 10.1117/12.274324; POSNER RG, 1994, MOL PHARMACOL, V45, P65; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SASAI Y, 1989, BIOCHEM BIOPH RES CO, V165, P695, DOI 10.1016/S0006-291X(89)80022-1; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1994, J CELL BIOL, V124, P307, DOI 10.1083/jcb.124.3.307; Tarasova NI, 1997, J BIOL CHEM, V272, P14817, DOI 10.1074/jbc.272.23.14817; THASTRUP O, 1996, Patent No. 23898; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; VARRAULT A, 1992, N-S ARCH PHARMACOL, V346, P367; VUONG TM, 1991, P NATL ACAD SCI USA, V88, P9813, DOI 10.1073/pnas.88.21.9813; Weill C, 1999, J RECEPT SIGNAL TR R, V19, P423, DOI 10.3109/10799899909036662; Weill C, 1999, J NEUROCHEM, V73, P791, DOI 10.1046/j.1471-4159.1999.0730791.x; WERGE TM, 1994, J BIOL CHEM, V269, P22054; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	61	43	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37915	37922		10.1074/jbc.274.53.37915	http://dx.doi.org/10.1074/jbc.274.53.37915			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608858	Green Published, hybrid			2022-12-27	WOS:000084528000058
J	Zhen, YJ; Hoganson, CW; Babcock, GT; Ferguson-Miller, S				Zhen, YJ; Hoganson, CW; Babcock, GT; Ferguson-Miller, S			Definition of the interaction domain for cytochrome c on cytochrome c oxidase - I. Biochemical, spectral, and kinetic characterization of surface mutants in subunit II of Rhodobacter sphaeroides cytochrome aa(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEADY-STATE KINETICS; PARACOCCUS-DENITRIFICANS; ELECTRON-TRANSFER; CHEMICAL MODIFICATION; BINDING DOMAINS; RHODOPSEUDOMONAS-SPHAEROIDES; HIGH-AFFINITY; 2.8 ANGSTROM; SITE; PURIFICATION	To determine the interaction site for cytochrome c (Cc) on cytochrome c oxidase (CcO), a number of conserved carboxyl residues in subunit TI of Rhodobacter sphaeroides CcO were mutated to neutral forms. A highly conserved tryptophan, Trp(143), was also mutated to phenylalanine and alanine. Spectroscopic and metal analyses of the surface carboxyl mutants revealed no overall structural changes. The double mutants D188Q/E189N and D151Q/E152N exhibit similar steady-state kinetic behavior as wild-type oxidase with horse Cc and R sphaeroides Cc(2), showing that these residues are not involved in Cc binding. The single mutants E148Q, E157Q, D195N, and D214N have decreased activities and increased K-m values, indicating they contribute to the Cc:CcO interface. However, their reactions with horse and R. sphaeroides Cc are different, as expected from the different distribution of surface lysines on these cytochromes a. Mutations at Trp(143) severely inhibit activity without changing the K-m for Cc or disturbing the adjacent Cu-A center. From these data, we identify a Cc binding area on CcO with Trp(143) and Asp(214) close to the site of electron transfer and Glu(148), Glu(157) and Asp(195) providing electrostatic guidance. The results are completely consistent with time-resolved kinetic measurements (Wang, K, Zhen, Y., Sadoski, R,, Grinnell, S., Geren, L., Ferguson-Miller, S., Durham, B., and Millett, F.(1999) J. Biol Chem. 274, 38042-38050) and computational docking analysis (Roberts, V. A, and Pique, M. E. (1999) J. Biol. Chem. 274, 38051-38060).	Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Ferguson-Miller, S (corresponding author), Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.	fergus20@pilot.msu.edu		Zhen, Eugene/0000-0002-0162-5665	NIGMS NIH HHS [GM26916, GM57323, GM25480] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026916, R01GM025480, P01GM057323, R37GM026916] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERRY EA, 1985, J BIOL CHEM, V260, P2458; BISSON R, 1982, FEBS LETT, V144, P359, DOI 10.1016/0014-5793(82)80672-8; BLAIR DF, 1983, CHEM SCRIPTA, V21, P43; BRANDNER JP, 1989, J BACTERIOL, V171, P360, DOI 10.1128/jb.171.1.360-368.1989; BRAUTIGAN DL, 1978, J BIOL CHEM, V253, P130; CAO JL, 1991, GENE, V101, P133, DOI 10.1016/0378-1119(91)90235-4; COOPER CE, 1990, BIOCHIM BIOPHYS ACTA, V1017, P187, DOI 10.1016/0005-2728(90)90184-6; ERREDE B, 1978, BIOCHEMISTRY-US, V17, P1015, DOI 10.1021/bi00599a012; FERGUSONMILLER S, 1978, J BIOL CHEM, V253, P149; FERGUSONMILLER S, 1976, J BIOL CHEM, V251, P1104; GARBER EAE, 1990, BIOCHIM BIOPHYS ACTA, V1015, P279, DOI 10.1016/0005-2728(90)90032-Y; GENNIS RB, 1982, EUR J BIOCHEM, V125, P189, DOI 10.1111/j.1432-1033.1982.tb06667.x; GREENWOOD C, 1983, BIOCHEM J, V215, P303, DOI 10.1042/bj2150303; HILL BC, 1991, J BIOL CHEM, V266, P2219; HOSLER JP, 1992, J BIOL CHEM, V267, P24264; HOSLER JP, 1995, BIOCHEMISTRY-US, V34, P7586, DOI 10.1021/bi00023a004; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KANG CH, 1978, J BIOL CHEM, V253, P6502; KITUCHI G, 1965, BIOCHIM BIOPHYS ACTA, V94, P1; LAPPALAINEN P, 1995, BIOCHEMISTRY-US, V34, P5824, DOI 10.1021/bi00017a014; Malatesta F, 1998, FEBS LETT, V434, P322, DOI 10.1016/S0014-5793(98)01006-0; MARGOLIASH E, 1996, CYTOCHROME C MULTIDI; Margoliash E., 1979, PORPHYRINS, V7, P149; MEYER TE, 1985, BIOCHIM BIOPHYS ACTA, V807, P308, DOI 10.1016/0005-2728(85)90263-4; Miller MA, 1996, BIOCHEMISTRY-US, V35, P667, DOI 10.1021/bi952557a; MILLETT F, 1983, BIOCHEMISTRY-US, V22, P546, DOI 10.1021/bi00272a004; MILLETT F, 1982, BIOCHEMISTRY-US, V21, P3857, DOI 10.1021/bi00259a021; MYERS D, 1988, ANN NY ACAD SCI, V550, P85, DOI 10.1111/j.1749-6632.1988.tb35325.x; Myllykallio H, 1999, P NATL ACAD SCI USA, V96, P4348, DOI 10.1073/pnas.96.8.4348; OSHEROFF N, 1979, CYTOCHROME OXIDASE, P281; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; PAN LP, 1993, BIOCHEMISTRY-US, V32, P8492, DOI 10.1021/bi00084a014; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; RIEDER R, 1980, J BIOL CHEM, V255, P4732; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; SINJORGO KMC, 1984, BIOCHIM BIOPHYS ACTA, V767, P48, DOI 10.1016/0005-2728(84)90078-1; SMITH HT, 1977, BIOCHEMISTRY-US, V16, P4971, DOI 10.1021/bi00642a005; SPECK SH, 1984, J BIOL CHEM, V259, P1064; STEFFENS GJ, 1979, CYTOCHROME OXIDASE, P79; TAHA TSM, 1992, BIOCHEMISTRY-US, V31, P9090, DOI 10.1021/bi00152a053; TIEDE DM, 1993, BIOCHEMISTRY-US, V32, P4515, DOI 10.1021/bi00068a006; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TURBA A, 1995, EUR J BIOCHEM, V231, P259, DOI 10.1111/j.1432-1033.1995.0259f.x; Wang KF, 1999, J BIOL CHEM, V274, P38042, DOI 10.1074/jbc.274.53.38042; Wang KF, 1996, BIOCHEMISTRY-US, V35, P15107, DOI 10.1021/bi9611117; Witt H, 1997, FEBS LETT, V409, P128, DOI 10.1016/S0014-5793(97)00485-7; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; WITT H, 1995, BBA-BIOENERGETICS, V1230, P74, DOI 10.1016/0005-2728(95)00050-S; Witt H, 1998, EUR J BIOCHEM, V251, P367, DOI 10.1046/j.1432-1327.1998.2510367.x; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Zhen Y, 1998, PROTEIN EXPRES PURIF, V13, P326, DOI 10.1006/prep.1998.0903; ZHEN Y, 1998, THESIS MICHIGAN STAT; ZUMFT WG, 1992, EUR J BIOCHEM, V208, P31, DOI 10.1111/j.1432-1033.1992.tb17156.x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	57	90	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38032	38041		10.1074/jbc.274.53.38032	http://dx.doi.org/10.1074/jbc.274.53.38032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608872	hybrid			2022-12-27	WOS:000084528000072
J	Cristofari, G; Gabus, C; Ficheux, D; Bona, M; Le Grice, SFJ; Darlix, JL				Cristofari, G; Gabus, C; Ficheux, D; Bona, M; Le Grice, SFJ; Darlix, JL			Characterization of active reverse transcriptase and nucleoprotein complexes of the yeast retrotransposon Ty3 in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 NUCLEOCAPSID PROTEIN; RNA ANNEALING ACTIVITIES; PROVIRAL DNA-SYNTHESIS; TERMINAL ZINC-FINGER; PRIMER-BINDING-SITE; IN-VITRO; STRAND TRANSFER; VIRUS; NCP7; RECOMBINATION	Human immunodeficiency virus (HIV) and the distantly related yeast Ty3 retrotransposon encode reverse transcriptase (RT) and a nucleic acid-binding protein designated nucleocapsid protein (NCp) with either one or two zinc fingers, required for HIV-1 replication and Ty3 transposition, respectively. In vitro binding of HIV-1 NCp7 to viral 5' RNA and primer tRNA(3)(Lys) catalyzes formation of nucleoprotein complexes resembling the virion nucleocapsid. Nucleocapsid complex formation functions in viral RNA dimerization and tRNA annealing to the primer binding site (PBS). RT is recruited in these nucleoprotein complexes and synthesizes minus-strand cDNA initiated at the PBS. Recent results on yeast Ty3 have shown that the homologous NCp9 promotes annealing of primer tRNA(i)(Met) to a 5'-3' bipartite PBS, allowing RNA:tRNA dimer formation and initiation of cDNA synthesis at the 5' PBS (1), To compare specific cDNA synthesis in a retrotransposon and HIV-1, we have established a Ty3 model system comprising Ty3 RNA with the 5'-3' PBS, primer tRNA(i)(Met), NCp9, and for the first time, highly purified Ty3 RT. Here we report that Ty3 RT is as active as retroviral HIV-1 or murine leukemia virus RT using a synthetic template-primer system, Moreover, and in contrast to what was found with retroviral RTs, retrotransposon Ty3 RT was unable to direct cDNA synthesis by self-priming. We also show that Ty3 nucleoprotein complexes were formed in vitro and that the N terminus of NCp9, but not the zinc finger, is required for complex formation, tRNA annealing to the PBS, RNA dimerization, and primer tRNA-directed cDNA synthesis by Ty3 RT. These results indicate that NCp9 chaperones bona fide cDNA synthesis by RT in the yeast Ty3 retrotransposon, as illustrated for NCp7 in HIV-1, reinforcing the notion that Ty3 NCp9 is an ancestor of HIV-1 NCp7.	Ecole Normale Super Lyon, INSERM, LaboRetro, Unite Virol Humaine,U412, F-69364 Lyon 07, France; Inst Biol & Chim Prot, F-69367 Lyon, France; NCI, Frederick Canc Res & Dev Ctr, HIV Drug Resistance Program, Div Basic Sci,NIH, Frederick, MD 21702 USA	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Darlix, JL (corresponding author), Ecole Normale Super Lyon, INSERM, LaboRetro, Unite Virol Humaine,U412, 46 Allee Italie, F-69364 Lyon 07, France.		Cristofari, Gael/A-2831-2011; LUC, DARLIX JEAN/AAE-9268-2020	Cristofari, Gael/0000-0001-5620-3091; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031147] Funding Source: NIH RePORTER; NIAID NIH HHS [AI31147] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAIN B, 1994, EMBO J, V13, P973, DOI 10.1002/j.1460-2075.1994.tb06342.x; Auxilien S, 1999, J BIOL CHEM, V274, P4412, DOI 10.1074/jbc.274.7.4412; BARAT C, 1989, EMBO J, V8, P3279, DOI 10.1002/j.1460-2075.1989.tb08488.x; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; Berthoux L, 1997, J VIROL, V71, P6973, DOI 10.1128/JVI.71.9.6973-6981.1997; BOEKE JD, 1991, MOL CELLULAR BIOL YE, P193; CHEN MJ, 1980, P NATL ACAD SCI-BIOL, V77, P1296, DOI 10.1073/pnas.77.3.1296; COFFIN JM, 1985, RNA TUMOR VIRUSES, P261; DANNULL J, 1994, EMBO J, V13, P1525, DOI 10.1002/j.1460-2075.1994.tb06414.x; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; DEROCQUIGNY H, 1992, P NATL ACAD SCI USA, V89, P6472, DOI 10.1073/pnas.89.14.6472; Gabus C, 1998, EMBO J, V17, P4873, DOI 10.1093/emboj/17.16.4873; Gregoire CJ, 1997, J BIOL CHEM, V272, P25143, DOI 10.1074/jbc.272.40.25143; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; KHAN R, 1992, J BIOL CHEM, V267, P6689; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; KIRCHNER J, 1993, J VIROL, V67, P19, DOI 10.1128/JVI.67.1.19-28.1993; LapadatTapolsky M, 1997, J MOL BIOL, V268, P250, DOI 10.1006/jmbi.1997.0978; LAPADATTAPOLSKY M, 1995, NUCLEIC ACIDS RES, V23, P2434, DOI 10.1093/nar/23.13.2434; LAPADATTAPOLSKY M, 1993, NUCLEIC ACIDS RES, V21, P831, DOI 10.1093/nar/21.4.831; Lauermann V, 1997, EMBO J, V16, P6603, DOI 10.1093/emboj/16.21.6603; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; Lener D, 1998, J BIOL CHEM, V273, P33781, DOI 10.1074/jbc.273.50.33781; Li XG, 1996, J VIROL, V70, P4996, DOI 10.1128/JVI.70.8.4996-5004.1996; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; MORELLET N, 1994, J MOL BIOL, V235, P287, DOI 10.1016/S0022-2836(05)80033-6; Morellet N, 1998, J MOL BIOL, V283, P419, DOI 10.1006/jmbi.1998.2098; PELISKA JA, 1994, BIOCHEMISTRY-US, V33, P13817, DOI 10.1021/bi00250a036; PRATS AC, 1991, NUCLEIC ACIDS RES, V19, P3533, DOI 10.1093/nar/19.13.3533; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; RICE WG, 1993, NATURE, V361, P473, DOI 10.1038/361473a0; RODRIGUEZRODRIGUEZ L, 1995, J BIOL CHEM, V270, P15005, DOI 10.1074/jbc.270.25.15005; SENGER B, 1992, P NATL ACAD SCI USA, V89, P10768, DOI 10.1073/pnas.89.22.10768; SUMMERS MF, 1992, PROTEIN SCI, V1, P563, DOI 10.1002/pro.5560010502; Tanchou V, 1998, J VIROL, V72, P4442, DOI 10.1128/JVI.72.5.4442-4447.1998; TANCHOU V, 1995, J MOL BIOL, V252, P563, DOI 10.1006/jmbi.1995.0520; VARMUS H, 1985, RNA TUMOR VIRUSES MO, P369	41	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36643	36648		10.1074/jbc.274.51.36643	http://dx.doi.org/10.1074/jbc.274.51.36643			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593967	hybrid			2022-12-27	WOS:000084279200086
J	Kondo, R; Tikunova, SB; Cho, MJ; Johnson, JD				Kondo, R; Tikunova, SB; Cho, MJ; Johnson, JD			A point mutation in a plant calmodulin is responsible for its inhibition of nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER; CYCLIC-GMP; BINDING DOMAIN; ACTIVATION; CALCINEURIN; CALCIUM; MUTANTS; ISOFORM; SIGNAL; MUSCLE	The calcium/calmodulin-dependent activation of nitric-oxide synthase (NOS) and its production of nitric oxide (NO) play a key regulatory role in plant and animal cell function. SCaM-1 is a plant calmodulin (CaM) isoform that is 91% identical to mammalian CaM (wild type CaM (wtCaM)) and a selective competitive antagonist of NOS (Cho, M. J., Vaghy, P. L., Kondo, R., Lee, S. H., Davis, J. P., Rehl, R., Heo, W. D., and Johnson, J. D. (1998) Biochemistry 37, 15593-15597), We have used site-directed mutagenesis to show that a point mutation, involving the substitution of valine for methionine at position 144, is responsible for SCaM-1's inhibition of mammalian NOS. An M144V mutation in wild type CaM produced a mutant (M144V) which exhibited nearly identical inhibition of NOS's NO production and NADPH oxidation, with a similar K-i (similar to 15 nM) as SCaM-1, A V144M back mutation in SCaM-1 significantly restored its ability to activate NOS's catalytic functions. The length of the hydrophobic amino acid side chain at position 144 appears to be critical for NOS activation, since M144L and M144F activated NOS while M144V and M144C did not. Despite their competitive antagonism of NOS, M144V, like SCaM-1, exhibited a similar dose-dependent activation of phosphodiesterase and calcineurin as wtCaM. SCaM-1 and M144V produced greater inhibition of NOS's oxygenase domain function (NO production) than its reductase domain functions (NADPH oxidation and cytochrome c reduction). Thus, CaM's methionine 144 plays a critical role the activation of NOS, presumably by influencing the function of NOS's oxygenase domain.	Ohio State Univ, Med Ctr, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; Gyeongsang Natl Univ, Dept Biochem, Plant Mol Biol & Biotechnol Res Ctr, Chinju 660701, South Korea	University System of Ohio; Ohio State University; Gyeongsang National University	Johnson, JD (corresponding author), Ohio State Univ, Med Ctr, Dept Mol & Cellular Biochem, 333 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.		Cho, Moo Je/F-1649-2010		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033727] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33727] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Chin D, 1996, J BIOL CHEM, V271, P30465, DOI 10.1074/jbc.271.48.30465; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Cho MJ, 1998, BIOCHEMISTRY-US, V37, P15593, DOI 10.1021/bi981497g; Christopoulos A., 1999, Life Sciences, V64, P1; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Edwards RA, 1998, BIOCHEM J, V331, P149, DOI 10.1042/bj3310149; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; HANSEN RS, 1986, J BIOL CHEM, V261, P4636; Heo WD, 1999, P NATL ACAD SCI USA, V96, P766, DOI 10.1073/pnas.96.2.766; JOHNSON JD, 1987, ANAL BIOCHEM, V162, P291, DOI 10.1016/0003-2697(87)90039-X; KUO WN, 1995, BIOCHEM ARCH, V11, P73; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SJ, 1998, J BIOL CHEM, V273, P27430, DOI 10.1074/jbc.273.42.27430; Leshem YY, 1996, PLANT GROWTH REGUL, V18, P155, DOI 10.1007/BF00024375; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; McDonald LJ, 1996, P SOC EXP BIOL MED, V211, P1; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Ninnemann H, 1996, PHOTOCHEM PHOTOBIOL, V64, P393, DOI 10.1111/j.1751-1097.1996.tb02477.x; Persechini A, 1996, J BIOL CHEM, V271, P32217, DOI 10.1074/jbc.271.50.32217; Ribeiro EA, 1999, FEBS LETT, V445, P283, DOI 10.1016/S0014-5793(99)00138-6; Richards MK, 1996, BIOCHEMISTRY-US, V35, P7772, DOI 10.1021/bi952582g; ROADS AR, 1997, FASEB J, V11, P331; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; StevensTruss R, 1997, BIOCHEMISTRY-US, V36, P12337, DOI 10.1021/bi970973k; Stuehr DJ, 1996, METHOD ENZYMOL, V268, P324; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; SU ZZ, 1995, J BIOL CHEM, V270, P29117, DOI 10.1074/jbc.270.49.29117; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; ZHANG MJ, 1994, J BIOL CHEM, V269, P981	34	35	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36213	36218		10.1074/jbc.274.51.36213	http://dx.doi.org/10.1074/jbc.274.51.36213			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593908	hybrid			2022-12-27	WOS:000084279200027
J	Yahagi, N; Shimano, H; Hasty, AH; Amemiya-Kudo, M; Okazaki, H; Tamura, Y; Iizuka, Y; Shionoiri, F; Ohashi, K; Osuga, J; Harada, K; Gotoda, T; Nagai, R; Ishibashi, S; Yamada, N				Yahagi, N; Shimano, H; Hasty, AH; Amemiya-Kudo, M; Okazaki, H; Tamura, Y; Iizuka, Y; Shionoiri, F; Ohashi, K; Osuga, J; Harada, K; Gotoda, T; Nagai, R; Ishibashi, S; Yamada, N			A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; ATP CITRATE-LYASE; TRANSGENIC MICE; CHOLESTEROL-SYNTHESIS; DIETARY-REGULATION; RAT-LIVER; TRANSCRIPTION; SYNTHASE; EICOSANOIDS; METABOLISM	Dietary polyunsaturated fatty acids (PUFA) are negative regulators of hepatic lipogenesis that exert their effects primarily at the level of transcription. Sterol regulatory element-binding proteins (SREBPs) are transcription factors responsible for the regulation of cho lesterol, fatty acid, and triglyceride synthesis. In particular, SREBP-1 is known to play a crucial role in the regulation of lipogenic gene expression in the liver. To explore the possible involvement of SREBP-1 in the suppression of hepatic lipogenesis by PUFA, we challenged wild-type mice and transgenic mice overexpressing a mature form of SREBP-1 in the liver with dietary PUFA. In the liver of wild-type mice, dietary PUFA drastically decreased the mature, cleaved form of SREBP-1 protein in the nucleus, whereas the precursor, uncleaved form in the membranes was not suppressed. The decreases in mature SREBP-1 paralleled those in mRNAs for Lipogenic enzymes such as fatty acid synthase and acetyl-CoA carboxylase. In the transgenic mice, dietary PUFA did not reduce the amount of transgenic SREBP-1 protein, excluding the possibility that PUFA accelerated the degradation of mature SREBP-1. The resulting sustained expression of mature SREBP-1 almost completely canceled the suppression of lipogenic gene expression by PUFA in the SREBP-1 transgenic mice. These results demonstrate that the suppressive effect of PUFA on Lipogenic enzyme genes in the liver is caused by a decrease in the mature form of SREBP-1 protein, which is presumably due to the reduced cleavage of SREBP-1 precursor protein.	Univ Tokyo, Fac Med, Dept Metab Dis, Tokyo 1138655, Japan	University of Tokyo	Shimano, H (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.		Shimano, Hitoshi/AAI-5648-2020; Harada, Kenji/J-2230-2016; Shimano, Hitoshi/V-1761-2019; Hasty, Alyssa/AAA-2757-2020; Yahagi, Naoya/D-2360-2014	Shimano, Hitoshi/0000-0002-5562-5572; Hasty, Alyssa/0000-0001-7302-8045; Yahagi, Naoya/0000-0002-1823-1865				ALLMANN DW, 1965, J LIPID RES, V6, P51; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CLARKE SD, 1993, PROG LIPID RES, V32, P139, DOI 10.1016/0163-7827(93)90013-M; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fukuda H, 1996, FEBS LETT, V380, P204, DOI 10.1016/0014-5793(96)00031-2; FUKUDA H, 1992, EUR J BIOCHEM, V209, P217, DOI 10.1111/j.1432-1033.1992.tb17279.x; Fukuda H, 1997, FEBS LETT, V406, P243, DOI 10.1016/S0014-5793(97)00219-6; GOODRIDGE AG, 1987, ANNU REV NUTR, V7, P157, DOI 10.1146/annurev.nu.07.070187.001105; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; IRITANI N, 1992, EUR J BIOCHEM, V205, P433, DOI 10.1111/j.1432-1033.1992.tb16797.x; Jump DB, 1996, PROG LIPID RES, V35, P227, DOI 10.1016/S0163-7827(96)00007-0; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; LIIMATTA M, 1994, MOL ENDOCRINOL, V8, P1147, DOI 10.1210/me.8.9.1147; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Ren B, 1997, J BIOL CHEM, V272, P26827, DOI 10.1074/jbc.272.43.26827; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; SHORT MK, 1992, MOL CELL BIOL, V12, P1007, DOI 10.1128/MCB.12.3.1007; Tabor DE, 1998, J BIOL CHEM, V273, P22052, DOI 10.1074/jbc.273.34.22052; Waters KM, 1997, BBA-LIPID LIPID MET, V1349, P33, DOI 10.1016/S0005-2760(97)00069-6; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537	28	275	282	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35840	35844		10.1074/jbc.274.50.35840	http://dx.doi.org/10.1074/jbc.274.50.35840			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585468	hybrid			2022-12-27	WOS:000084187900080
J	Doliana, R; Canton, A; Bucciotti, F; Mongiat, M; Bonaldo, P; Colombatti, A				Doliana, R; Canton, A; Bucciotti, F; Mongiat, M; Bonaldo, P; Colombatti, A			Structure, chromosomal localization, and promoter analysis of the human elastin microfibril interfase located protein (EMILIN) gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BINDING-PROTEIN; 5'-FLANKING REGION; MOLECULAR-CLONING; FUNCTIONAL PROMOTER; CONNECTIVE-TISSUE; MARFAN-SYNDROME; GLYCOPROTEIN; FIBRILLIN; KETOHEXOKINASE; SEQUENCE	Elastin microfibril interfase-located protein (EMILIN) is an extracellular matrix glycoprotein abundantly expressed in elastin-rich tissues such as the blood vessels, skin, heart, and lung. It occurs with elastic fibers at the interface between amorphous elastin and microfibrils. In vitro experiments suggested a role for EMILIN in the process of elastin deposition. This multimodular protein consists of 995 amino acids; the domain organization includes a C1q-like globular domain at the C terminus, a short collagenous stalk, a region containing two leucine zippers, and at least four heptad repeats with a high potential for forming coiled-coil alpha-helices and, at the N terminus, a cysteine-rich sequence characterized by a partial epidermal growth factor-like motif and homologous to a region of multimerin. Here we report the complete characterization of the human and murine EMILIN gene, their chromosomal assignment, and preliminary functional data of the human promoter, A cDNA probe corresponding to the C terminus of EMILIN was used to isolate two genomic clones from a human BAC library. Sequencing of several derived subclones allowed the characterization of the whole gene that was found to be about 8 kilobases in size and to contain 8 exons and 7 introns, The internal exons range in size from 17 base pairs to 1929 base pairs. All internal intron/exon junctions are defined by canonical splice donor and acceptor sites, and the different domains potentially involved in the formation of a coiled-coil structure are clustered in the largest exon, The 3'-end of the EMILIN gene overlaps with the 5'-end of the promoter region of the ketohexokinase gene, whose chromosomal position is between markers D2S305 and D2S165 on chromosome 2. A 1600-base pair-long sequence upstream of the translation starting point was evaluated for its promoter activity; five deletion constructs were assayed after transfection in primary chicken fibroblasts and in a human rhabdomyosarcoma cell line. This analysis indicates the existence of two contiguous regions able to modulate luciferase expression in both cell types used, one with a strong activatory function, ranging from positions -204 to -503, and the other, ranging from positions -504 to -683, with a strong inhibitory function.	Ctr Riferimento Oncol, Div Oncol Sperimentale 2, I-33081 Aviano, Italy; Univ Padua, Ist Istol & Embriol, I-35100 Padua, Italy; Univ Udine, Dept Sci & Tecnol Biomed, I-33100 Udine, Italy	IRCCS Aviano (CRO); University of Padua; University of Udine	Colombatti, A (corresponding author), Ctr Riferimento Oncol, Div Oncol Sperimentale 2, I-33081 Aviano, Italy.		Doliana, Roberto/AAA-1479-2019; Bucciotti, Francesco/AAZ-1255-2020; Mongiat, Maurizio/H-8297-2018	Doliana, Roberto/0000-0002-8324-7564; Bucciotti, Francesco/0000-0002-4253-855X; Mongiat, Maurizio/0000-0001-6509-0068; colombatti, alfonso/0000-0002-3676-2379; Bonaldo, Paolo/0000-0002-9571-8140	Telethon [E.0704] Funding Source: Medline	Telethon(Fondazione Telethon)		ABRAMS WR, 1995, GENOMICS, V26, P47, DOI 10.1016/0888-7543(95)80081-V; BASHIR MM, 1989, J BIOL CHEM, V264, P8887; BASHIR MM, 1994, BIOCHEMISTRY-US, V33, P593, DOI 10.1021/bi00168a026; Biery NJ, 1999, GENOMICS, V56, P70, DOI 10.1006/geno.1998.5697; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bork P, 1996, CURR OPIN STRUC BIOL, V6, P366, DOI 10.1016/S0959-440X(96)80057-1; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; BRESSAN GM, 1983, J BIOL CHEM, V258, P3262; CHEN YP, 1993, J BIOL CHEM, V268, P27381; COLOMBATTI A, 1985, COLLAGEN REL RES, V5, P181; COLOMBATTI A, 1988, J BIOL CHEM, V263, P17534; COLOMBATTI A, 1985, J CELL BIOL, V100, P18, DOI 10.1083/jcb.100.1.18; COLOMBATTI A, 1987, COLLAGEN REL RES, V7, P259; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Doliana R, 1999, J BIOL CHEM, V274, P16773, DOI 10.1074/jbc.274.24.16773; FAZIO MJ, 1990, J INVEST DERMATOL, V94, P191, DOI 10.1111/1523-1747.ep12874495; Gibson MA, 1996, J BIOL CHEM, V271, P1096, DOI 10.1074/jbc.271.2.1096; GIBSON MA, 1995, MOL CELL BIOL, V15, P6932; GLESBY MJ, 1989, JAMA-J AM MED ASSOC, V262, P523, DOI 10.1001/jama.262.4.523; Hatzinikolas G, 1998, J BIOL CHEM, V273, P29309, DOI 10.1074/jbc.273.45.29309; Hayward BE, 1996, MAMM GENOME, V7, P454, DOI 10.1007/s003359900132; Hayward BE, 1998, EUR J BIOCHEM, V257, P85, DOI 10.1046/j.1432-1327.1998.2570085.x; Hayward BE, 1997, BIOCHEM SOC T, V25, P140, DOI 10.1042/bst0250140; HAYWARD CPM, 1995, J BIOL CHEM, V270, P18246, DOI 10.1074/jbc.270.31.18246; Henderson M, 1996, J HISTOCHEM CYTOCHEM, V44, P1389, DOI 10.1177/44.12.8985131; KAHARI VM, 1990, J BIOL CHEM, V265, P9485; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Pollner R, 1997, FEBS LETT, V405, P31, DOI 10.1016/S0014-5793(97)00152-X; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Raghunath M, 1999, J INVEST DERMATOL, V112, P97, DOI 10.1046/j.1523-1747.1999.00483.x; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; ROAK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401; SAADAT M, 1994, JPN J GENET, V69, P697, DOI 10.1266/jjg.69.697; Saharinen J, 1998, J BIOL CHEM, V273, P18459, DOI 10.1074/jbc.273.29.18459; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Speek M, 1996, HUM MOL GENET, V5, P1749, DOI 10.1093/hmg/5.11.1749; Wightman PJ, 1997, MAMM GENOME, V8, P700, DOI 10.1007/s003359900544; YEH H, 1989, BIOCHEMISTRY-US, V28, P2365, DOI 10.1021/bi00432a003; YIN WS, 1995, J BIOL CHEM, V270, P10147, DOI 10.1074/jbc.270.17.10147; ZHAO ZY, 1995, HUM MOL GENET, V4, P589, DOI 10.1093/hmg/4.4.589	44	27	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					785	792		10.1074/jbc.275.2.785	http://dx.doi.org/10.1074/jbc.275.2.785			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625608	hybrid			2022-12-27	WOS:000084836600012
J	Feliciello, A; Gallo, A; Mele, E; Porcellini, A; Troncone, G; Garbi, C; Gottesman, ME; Avvedimento, EV				Feliciello, A; Gallo, A; Mele, E; Porcellini, A; Troncone, G; Garbi, C; Gottesman, ME; Avvedimento, EV			The localization and activity of cAMP-dependent protein kinase affect cell cycle progression in thyroid cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT; MOLECULAR-CLONING; II-BETA; EPITHELIAL-CELLS; CDNA STRUCTURE; GOLGI-COMPLEX; AMP; EXPRESSION; TRANSCRIPTION; ACTIVATION	cAMP signals are received and transmitted by multiple isoforms of cAMP-dependent protein kinases (PKAs), typically determined by their specific regulatory subunits. We describe changes in the cAMP signal transduction pathway during cell cycle progression in synchronized rat thyroid cells. Both PKA type II (PKAII) localization and nuclear cAMP signaling are significantly modified during G(0) and G(1)-S transitions. G(1) is characterized by PKA activation and amplified cAMP signal transduction. This is associated with a decrease in the concentration of RI and RII regulatory subunits and enhanced anchoring of PKAII to the Golgi-centrosome region. Just prior to S, the cAMP pathway is depressed. Up-regulation of the pathway by exogenous cAMP in G(1) inhibited the subsequent decay of the Cdk inhibitor p27 and delayed the onset of S phase. Forced translocation of endogenous PKAII to the cytosol downregulated cAMP signaling, advancing the timing of p27 decay and inducing premature exit from G(1). These data indicate that membrane-bound PKA amplifies the transduction of cAMP signals in G(1) and that the length of G(1) is influenced by cAMP-PKA.	Univ Naples Federico II, CNR, Ctr Endocrinol & Oncol Sperimentale, Dipartimento Biol & Patol Mol & Cellulare, I-80131 Naples, Italy; Univ Naples Federico II, Fac Med, Dipartimento Sci Biomorfol & Funzionali, I-80131 Naples, Italy; Univ Catanzaro, Fac Med, Dipartimento Med Sperimentale & Clin, I-88100 Catanzaro, Italy; Columbia Univ, Inst Canc Res, New York, NY 10032 USA	Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Naples Federico II; Magna Graecia University of Catanzaro; Columbia University	Avvedimento, EV (corresponding author), II Policlin, Fac Med, Dipartimento Biol & Patol Mol & Cellulare, Via S Pansini 5, I-80131 Naples, Italy.		Porcellini, Antonio/E-1900-2011; Porcellini, Antonio/AAC-6097-2019	Porcellini, Antonio/0000-0001-6882-9518; Feliciello, Antonio/0000-0002-7932-2170				AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; ARMSTRONG R, 1995, MOL CELL BIOL, V15, P1826; BARONI MD, 1994, NATURE, V371, P339, DOI 10.1038/371339a0; BATTAGLIA C, 1993, CELL GROWTH DIFFER, V4, P185; Cassano S, 1996, J BIOL CHEM, V271, P29870, DOI 10.1074/jbc.271.47.29870; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLETTA G, 1986, SCIENCE, V233, P458, DOI 10.1126/science.3726540; Depoortere F, 1998, J CELL BIOL, V140, P1427, DOI 10.1083/jcb.140.6.1427; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Dremier S, 1997, MOL CELL BIOL, V17, P6717, DOI 10.1128/MCB.17.11.6717; ERLICHMAN J, 1980, J BIOL CHEM, V255, P8179; Feliciello A, 1997, CURR BIOL, V7, P1011, DOI 10.1016/S0960-9822(06)00424-6; Feliciello A, 1998, J BIOL CHEM, V273, P23361, DOI 10.1074/jbc.273.36.23361; Feliciello A, 1996, J BIOL CHEM, V271, P25350, DOI 10.1074/jbc.271.41.25350; GALLO A, 1992, GENE DEV, V6, P1621, DOI 10.1101/gad.6.9.1621; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grieco D, 1996, SCIENCE, V271, P1718, DOI 10.1126/science.271.5256.1718; Hennig D, 1998, J BIOL CHEM, V273, P19602, DOI 10.1074/jbc.273.31.19602; HIRSCH AH, 1992, J BIOL CHEM, V267, P2131; JAHNSEN T, 1986, J BIOL CHEM, V261, P2352; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; KUNO T, 1987, BIOCHEM BIOPH RES CO, V146, P878, DOI 10.1016/0006-291X(87)90612-7; Li Y, 1996, J BIOL CHEM, V271, P16862, DOI 10.1074/jbc.271.28.16862; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; OYEN O, 1988, MOL ENDOCRINOL, V2, P1070, DOI 10.1210/mend-2-11-1070; Paolillo M, 1999, J BIOL CHEM, V274, P6546, DOI 10.1074/jbc.274.10.6546; Porcellini A, 1997, ONCOGENE, V15, P781, DOI 10.1038/sj.onc.1201240; RIOS RM, 1992, EMBO J, V11, P1723, DOI 10.1002/j.1460-2075.1992.tb05224.x; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SMETS LA, 1987, J CELL PHYSIOL, V133, P395, DOI 10.1002/jcp.1041330227; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TRAMONTANO D, 1988, ENDOCRINOLOGY, V122, P133, DOI 10.1210/endo-122-1-133; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0; Zheng JY, 1998, J CELL SCI, V111, P1061	40	41	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					303	311		10.1074/jbc.275.1.303	http://dx.doi.org/10.1074/jbc.275.1.303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617619	hybrid			2022-12-27	WOS:000085951600043
J	Hach, A; Hon, T; Zhang, L				Hach, A; Hon, T; Zhang, L			The coiled coil dimerization element of the yeast transcriptional activator Hap1, a Gal4 family member, is dispensable for DNA binding but differentially affects transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZN(2)CYS(6) BINUCLEAR CLUSTER; SACCHAROMYCES-CEREVISIAE; POSITIVE CONTROL; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; GENE-EXPRESSION; ZINC FINGER; PROTEIN; COMPLEX; MECHANISM	The heme activator protein Hap1 is a member of the yeast Gal4 family, which consists of transcription factors with a conserved Zn(2)Cys(6) cluster that recognizes a CGG triplet. Many members of the Gal4 family contain a coiled coil dimerization element and bind symmetrically to DNA as homodimers. However, Hap1 possesses two unique properties. First, Hap1 binds asymmetrically to a direct repeat of two CGG triplets. Second, Hap1 binds to two classes of DNA elements, UAS1/CYC1 and UAS/CYC7, and permits differential transcriptional activation at these sites. Here we determined the residues of the Hap1 dimerization domain critical for DNA binding and differential transcriptional activation. We found that the Hap1 dimerization domain is composed of functionally redundant elements that can substitute each other in DNA binding and transcriptional activation. Remarkably, deletion of the coiled coil dimerization element did not severely diminish DNA binding and transcriptional activation at UAS1/CYC1 but completely abolished transcriptional activation at UAS/CYC7. Furthermore, Ala substitutions in the dimerization element selectively diminished transcriptional activation at UAS/CYC7. These results strongly suggest that the coiled coil dimerization element is responsible for differential transcriptional activation at UAS1/CYC1 and UAS/CYC7 and for making contacts with a putative coactivator or part of the transcription machinery.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University	Zhang, L (corresponding author), NYU, Sch Med, Dept Biochem, 550 1st Ave, New York, NY 10016 USA.	zhang102@mcrcr0.med.nyu.edu	Zhang, Li/L-5206-2013	Zhang, Li/0000-0001-9242-0763	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053453] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53453] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENGAL E, 1994, P NATL ACAD SCI USA, V91, P6221, DOI 10.1073/pnas.91.13.6221; Buisson N, 1998, J BIOL CHEM, V273, P9527, DOI 10.1074/jbc.273.16.9527; CREUSOT F, 1988, J MOL BIOL, V204, P263, DOI 10.1016/0022-2836(88)90574-8; GARDNER KH, 1995, NAT STRUCT BIOL, V2, P898, DOI 10.1038/nsb1095-898; Gosink KK, 1996, J BACTERIOL, V178, P5182, DOI 10.1128/jb.178.17.5182-5187.1996; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P2236, DOI 10.1073/pnas.79.7.2236; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Hach A, 1999, MOL CELL BIOL, V19, P4324; Hellauer K, 1996, MOL CELL BIOL, V16, P6096; HOCHSCHILD A, 1983, CELL, V32, P319, DOI 10.1016/0092-8674(83)90451-8; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; KIM KS, 1990, P NATL ACAD SCI USA, V87, P4524, DOI 10.1073/pnas.87.12.4524; KIM KS, 1989, NATURE, V342, P200, DOI 10.1038/342200a0; King DA, 1999, NAT STRUCT BIOL, V6, P22; King DA, 1999, NAT STRUCT BIOL, V6, P64; LODI T, 1991, MOL CELL BIOL, V11, P3762, DOI 10.1128/MCB.11.7.3762; LOWRY CV, 1988, MOL CELL BIOL, V8, P4651, DOI 10.1128/MCB.8.11.4651; MARMORSTEIN R, 1994, GENE DEV, V8, P2504, DOI 10.1101/gad.8.20.2504; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; PFEIFER K, 1987, CELL, V49, P19, DOI 10.1016/0092-8674(87)90751-3; PREZANT T, 1987, MOL CELL BIOL, V7, P3252, DOI 10.1128/MCB.7.9.3252; REECE RJ, 1993, SCIENCE, V261, P909, DOI 10.1126/science.8346441; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; SCHNEIDER JC, 1991, MOL CELL BIOL, V11, P4934, DOI 10.1128/MCB.11.10.4934; SIDDIQUI AH, 1989, MOL CELL BIOL, V9, P4706, DOI 10.1128/MCB.9.11.4706; STERN S, 1991, GENE DEV, V5, P2555, DOI 10.1101/gad.5.12b.2555; Swaminathan K, 1997, NAT STRUCT BIOL, V4, P751, DOI 10.1038/nsb0997-751; TURCOTTE B, 1992, GENE DEV, V6, P2001, DOI 10.1101/gad.6.10.2001; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; WINKLER H, 1988, EMBO J, V7, P1799, DOI 10.1002/j.1460-2075.1988.tb03011.x; ZHANG L, 1994, J BIOL CHEM, V269, P14643; ZHANG L, 1994, GENETICS, V136, P813; ZHANG L, 1993, P NATL ACAD SCI USA, V90, P2851, DOI 10.1073/pnas.90.7.2851; Zhang L, 1996, EMBO J, V15, P4676, DOI 10.1002/j.1460-2075.1996.tb00844.x; ZHANG L, 1994, GENE DEV, V8, P2110, DOI 10.1101/gad.8.17.2110; Zhang L, 1998, MOL CELL BIOL, V18, P3819, DOI 10.1128/MCB.18.7.3819; Zhao XJ, 1996, J BIOL CHEM, V271, P25131, DOI 10.1074/jbc.271.41.25131; Zitomer RS, 1997, KIDNEY INT, V51, P507, DOI 10.1038/ki.1997.71	39	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					248	254		10.1074/jbc.275.1.248	http://dx.doi.org/10.1074/jbc.275.1.248			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617612	hybrid			2022-12-27	WOS:000085951600036
J	Kharbanda, S; Saxena, S; Yoshida, K; Pandey, P; Kaneki, M; Wang, QZ; Cheng, K; Chen, YN; Campbell, A; Sudha, T; Yuan, ZM; Narula, J; Weichselbaum, R; Nalin, C; Kufe, D				Kharbanda, S; Saxena, S; Yoshida, K; Pandey, P; Kaneki, M; Wang, QZ; Cheng, K; Chen, YN; Campbell, A; Sudha, T; Yuan, ZM; Narula, J; Weichselbaum, R; Nalin, C; Kufe, D			Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-PROTEIN-KINASE; RADIATION-INDUCED APOPTOSIS; PROGRAMMED CELL-DEATH; TUMOR-NECROSIS-FACTOR; ABL TYROSINE KINASE; CYTOCHROME-C; SIGNAL-TRANSDUCTION; IONIZING-RADIATION; GAMMA-RADIATION; BCL-2	Activation of the stress-activated protein kinase (SAPK/JNK) by genotoxic agents is necessary for induction of apoptosis, We report here that ionizing radiation ionizing radiation exposure induces translocation of SAPK to mitochondria and association of SAPK with the anti-apoptotic Bcl-x(L) protein. SAPK phosphorylates Bcl-x(L) on threonine 47 (Thr-47) and threonine 115 (Thr-115) in vitro and in vivo. In contrast to wild-type Bcl-x(L), a mutant Bcl-x(L) with the two threonines substituted by alanines (Ala-47, Ala-115) is a more potent inhibitor of ionizing radiation-induced apoptosis, These findings indicate that translocation of SAPK to mitochondria is functionally important for interactions with Bcl-x(L) in the apoptotic response to genotoxic stress.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol,Div Canc Pharmacol, Boston, MA 02115 USA; Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; Novartis Pharmaceut, Preclin Res, Oncol Res Program, E Hanover, NJ 07936 USA; Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Manitoba; Novartis; University of Chicago	Kharbanda, S (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol,Div Canc Pharmacol, 44 Binney St, Boston, MA 02115 USA.	surender_kharbanda@dfci.harvard.edu			NCI NIH HHS [CA 55421, CA 75216] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075216, R44CA055421, R43CA055421] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; DATTA R, 1995, CELL GROWTH DIFFER, V6, P363; Datta R, 1997, J BIOL CHEM, V272, P1965, DOI 10.1074/jbc.272.3.1965; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HALL EJ, 1988, RADIOBIOLOGY RADIOLO, P128; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kawasaki H, 1996, EUR J BIOCHEM, V241, P315, DOI 10.1111/j.1432-1033.1996.00315.x; KHARBANDA S, 1995, J BIOL CHEM, V270, P18871, DOI 10.1074/jbc.270.32.18871; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kharbanda S, 1995, J BIOL CHEM, V270, P30278, DOI 10.1074/jbc.270.51.30278; KHARBANDA S, 1994, J BIOL CHEM, V269, P20739; Kharbanda S, 1997, P NATL ACAD SCI USA, V94, P6939, DOI 10.1073/pnas.94.13.6939; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Mizukami Y, 1997, J BIOL CHEM, V272, P16657, DOI 10.1074/jbc.272.26.16657; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; SALEEM A, 1995, J IMMUNOL, V154, P4150; SALEEM A, 1995, CELL GROWTH DIFFER, V6, P1651; SCHEIDTMANN KH, 1982, J VIROL, V44, P116, DOI 10.1128/JVI.44.1.116-133.1982; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Woodgett JR, 1996, CANCER SURV, V27, P127; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAN MH, 1994, NATURE, V372, P798; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yu K, 1997, CELL GROWTH DIFFER, V8, P731; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	54	376	394	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					322	327		10.1074/jbc.275.1.322	http://dx.doi.org/10.1074/jbc.275.1.322			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617621	hybrid			2022-12-27	WOS:000085951600045
J	Lill, NL; Douillard, P; Awwad, RA; Ota, S; Lupher, ML; Miyake, S; Meissner-Lula, N; Hsu, VW; Band, H				Lill, NL; Douillard, P; Awwad, RA; Ota, S; Lupher, ML; Miyake, S; Meissner-Lula, N; Hsu, VW; Band, H			The evolutionarily conserved n-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDUCED INTERNALIZATION; PHOSPHOTYROSINE-BINDING DOMAIN; TYROSINE KINASE-ACTIVITY; PROTOONCOGENE C-CBL; FACTOR EGF RECEPTOR; ACTIVATED T-CELLS; V-CBL; INDUCED ENDOCYTOSIS; POSTENDOCYTIC TRAFFICKING; PHOSPHORYLATION SITES	The mammalian proto-oncoprotein Cbl and its homologues in Caenorhabditis elegans and Drosophila are evolutionarily conserved negative regulators of the epidermal growth factor receptor (EGF-R), Overexpression of wild-type Cbl enhances down-regulation of activated EGF-R from the cell surface. We report that the Cbl tyrosine kinase-binding (TKB) domain is essential for this activity. Whereas wild-type Cbl enhanced ligand-dependent EGF-R ubiquitination, down-regulation from the cell surface, accumulation in intracellular vesicles, and degradation, a Cbl TKB domain-inactivated mutant (G306E) did not. Furthermore, the transforming truncation mutant Cbl-N (residues 1-357), comprising only the Cbl TKB domain, functioned as a dominant negative protein. It colocalized with EGF-R in intracellular vesicular structures, yet it suppressed down-regulation of EGF-R from the surface of cells expressing endogenous wild-type Cbl. Therefore, Chi-mediated down-regulation of EGF-R requires the integrity of both the N-terminal TKB domain and additional C-terminal sequences. A Cbl truncation mutant comprising amino acids 1-440 functioned like wild-type Cbl in down-regulation assays. This mutant includes the evolutionarily conserved TKB and RING finger domains but lacks the less conserved C-terminal sequences, We conclude that the evolutionarily conserved N terminus of Cbl is sufficient to effect enhancement of EGF-R ubiquitination and down-regulation from the cell surface.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Lymphocyte Biol Sect, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Band, H (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Lymphocyte Biol Sect, Dept Med,Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 538C,1 Jimmy Fund Way, Boston, MA 02115 USA.	hband@rics.bwh.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA076118, R01CA075075] Funding Source: NIH RePORTER; NCI NIH HHS [CA75075, CA76118] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn SJ, 1998, BIOCHEM BIOPH RES CO, V244, P62, DOI 10.1006/bbrc.1998.8220; Andoniou CE, 1996, ONCOGENE, V12, P1981; Ausubel FM, 1988, MOL REPROD DEV; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Baulida J, 1996, J BIOL CHEM, V271, P5251; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; BLAKE TJ, 1991, ONCOGENE, V6, P653; BLAKE TJ, 1993, EMBO J, V12, P2017, DOI 10.1002/j.1460-2075.1993.tb05851.x; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; BOWTELL DDL, 1995, ONCOGENE, V11, P1561; CANTLEY LC, 1994, J CELL SCI, P121; CHANG CP, 1993, J BIOL CHEM, V268, P19312; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Emlet DR, 1997, J BIOL CHEM, V272, P4079, DOI 10.1074/jbc.272.7.4079; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FELDER S, 1992, J CELL BIOL, V117, P203, DOI 10.1083/jcb.117.1.203; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; FLIER JS, 1989, NEW ENGL J MED, V321, P1383, DOI 10.1056/NEJM198911163212007; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; GalchevaGargova Z, 1995, ONCOGENE, V11, P2649; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; GILL GN, 1984, J BIOL CHEM, V259, P7755; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; HEISERMANN GJ, 1990, J BIOL CHEM, V265, P12820; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; JONGEWARD GD, 1995, GENETICS, V139, P1553; KAHANA JA, 1996, CURRENT PROTOCOLS MO; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; LAMAZE C, 1995, J CELL BIOL, V129, P47, DOI 10.1083/jcb.129.1.47; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; LEE JH, 1994, GENE DEV, V8, P60, DOI 10.1101/gad.8.1.60; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1996, ONCOGENE, V12, P1117; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lill NL, 1997, J VIROL, V71, P129, DOI 10.1128/JVI.71.1.129-137.1997; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Liu YC, 1997, J BIOL CHEM, V272, P168; Lohi O, 1998, J BIOL CHEM, V273, P21408, DOI 10.1074/jbc.273.33.21408; LOVERING R, 1993, P NATL ACAD SCI USA, V90, P2112, DOI 10.1073/pnas.90.6.2112; Lupher ML, 1999, IMMUNOL TODAY, V20, P375, DOI 10.1016/S0167-5699(99)01484-X; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Lupher ML, 1998, INT J BIOCHEM CELL B, V30, P439, DOI 10.1016/S1357-2725(97)00075-7; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Maki CG, 1996, CANCER RES, V56, P2649; Marengere LEM, 1997, J IMMUNOL, V159, P70; MEISNER H, 1995, J BIOL CHEM, V270, P25332, DOI 10.1074/jbc.270.43.25332; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; MILLER K, 1986, J CELL BIOL, V102, P500, DOI 10.1083/jcb.102.2.500; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; NESTEROV A, 1995, P NATL ACAD SCI USA, V92, P8719, DOI 10.1073/pnas.92.19.8719; OPRESKO LK, 1995, J BIOL CHEM, V270, P4325, DOI 10.1074/jbc.270.9.4325; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Sato J D, 1983, Mol Biol Med, V1, P511; Smit L, 1997, CRIT REV ONCOGENESIS, V8, P359, DOI 10.1615/CritRevOncog.v8.i4.50; Soltoff SP, 1996, J BIOL CHEM, V271, P563, DOI 10.1074/jbc.271.1.563; SORKIN A, 1992, J BIOL CHEM, V267, P8672; SORKIN A, 1991, J BIOL CHEM, V266, P8355; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; TANAKA S, 1995, J BIOL CHEM, V270, P14347, DOI 10.1074/jbc.270.24.14347; TANAKA Y, 1988, J IMMUNOL, V140, P4348; Thien CBF, 1997, ONCOGENE, V14, P2239, DOI 10.1038/sj.onc.1201193; Thien CBF, 1997, ONCOGENE, V15, P2909, DOI 10.1038/sj.onc.1201468; Thien CBF, 1998, IMMUNOL CELL BIOL, V76, P473, DOI 10.1046/j.1440-1711.1998.00768.x; Ueno H, 1997, J BIOL CHEM, V272, P8739, DOI 10.1074/jbc.272.13.8739; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; Wang ZX, 1996, SCIENCE, V272, P1935, DOI 10.1126/science.272.5270.1935; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; WILEY HS, 1991, J BIOL CHEM, V266, P11083; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	95	119	121	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					367	377		10.1074/jbc.275.1.367	http://dx.doi.org/10.1074/jbc.275.1.367			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617627	hybrid			2022-12-27	WOS:000085951600051
J	Lombard, M; Fontecave, M; Touati, D; Niviere, V				Lombard, M; Fontecave, M; Touati, D; Niviere, V			Reaction of the desulfoferrodoxin from Desulfoarculus baarsii with superoxide anion - Evidence for a superoxide reductase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-DESULFURICANS ATCC-27774; SULFATE-REDUCING BACTERIA; RBO GENE-PRODUCT; ESCHERICHIA-COLI; NITRIC-OXIDE; IRON; DISMUTASE; PROTEINS; OVERPRODUCTION; PEROXYNITRITE	Desulfoferrodoxin is a small protein found in sulfate-reducing bacteria that contains two independent mononuclear iron centers, one ferric and one ferrous. Expression of desulfoferrodoxin from Desulfoarculus baarsii has been reported to functionally complement a superoxide dismutase deficient Escherichia coli strain. To elucidate by which mechanism desulfoferrodoxin could substitute for superoxide dismutase in E. coli, we have purified the recombinant protein and studied its reactivity toward O-2(radical anion). Desulfoferrodoxin exhibited only a weak, superoxide dismutase activity (20 units mg(-1)) that could hardly account for its antioxidant properties. UV-visible and electron paramagnetic resonance spectroscopy studies revealed that the ferrous center of desulfoferrodoxin could specifically and efficiently reduce O-2(radical anion), with a rate constant of 6-7 x 10(8) M-1 s(-1). In addition, we showed that membrane and cytoplasmic E. coli protein extracts, using NADH and NADPH as electron donors, could reduce the O-2(radical anion) oxidized form of desulfoferrodoxin. Taken together, these results strongly suggest that desulfoferrodoxin behaves as a superoxide reductase enzyme and thus provide new insights into the biological mechanisms designed for protection from oxidative stresses.	Univ Grenoble 1, CNRS, CEA, DBMS,Lab Chim & Biochim,Ctr Redox Biol, F-38054 Grenoble 9, France; Univ Paris 06, CNRS, Inst Jacques Monod, F-75251 Paris, France; Univ Paris 07, CNRS, Inst Jacques Monod, F-75251 Paris 05, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Niviere, V (corresponding author), Univ Grenoble 1, CNRS, CEA, DBMS,Lab Chim & Biochim,Ctr Redox Biol, 17 Ave Martyrs, F-38054 Grenoble 9, France.		Lombard, Murielle/E-4974-2019	Lombard, Murielle/0000-0002-4775-3494; Niviere, Vincent/0000-0002-5132-457X				BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULL C, 1985, J AM CHEM SOC, V107, P3295, DOI 10.1021/ja00297a040; CASTRO L, 1994, J BIOL CHEM, V269, P29409; Coelho AV, 1997, J BIOL INORG CHEM, V2, P680, DOI 10.1007/s007750050184; CYPIONKA H, 1985, FEMS MICROBIOL ECOL, V31, P39, DOI 10.1016/0378-1097(85)90045-X; Devreese B, 1996, FEBS LETT, V385, P138, DOI 10.1016/0014-5793(96)00364-X; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Gort AS, 1998, J BACTERIOL, V180, P1402, DOI 10.1128/JB.180.6.1402-1410.1998; HALLIWELL B, 1989, FREE RADICAL BIO MED, P71; HANSEN TA, 1994, ANTON LEEUW INT J G, V66, P165, DOI 10.1007/BF00871638; HARDY JA, 1981, CURR MICROBIOL, V6, P259, DOI 10.1007/BF01566873; HATCHIKIAN EC, 1977, BIOCHIMIE, V59, P153, DOI 10.1016/S0300-9084(77)80286-1; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; KLUG D, 1972, J BIOL CHEM, V247, P4839; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Link AJ, 1997, ELECTROPHORESIS, V18, P1259, DOI 10.1002/elps.1150180807; Liochev SI, 1997, J BIOL CHEM, V272, P25573, DOI 10.1074/jbc.272.41.25573; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MOURA I, 1990, J BIOL CHEM, V265, P21596; Pianzzola MJ, 1996, J BACTERIOL, V178, P6736, DOI 10.1128/jb.178.23.6736-6742.1996; Romao CV, 1999, EUR J BIOCHEM, V261, P438, DOI 10.1046/j.1432-1327.1999.00278.x; TAVARES P, 1994, J BIOL CHEM, V269, P10504; VERHAGEN MFJM, 1993, FEBS LETT, V336, P13, DOI 10.1016/0014-5793(93)81599-U; Voordouw JK, 1998, APPL ENVIRON MICROB, V64, P2882	25	135	139	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					115	121		10.1074/jbc.275.1.115	http://dx.doi.org/10.1074/jbc.275.1.115			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617593	Green Submitted, hybrid			2022-12-27	WOS:000085951600017
J	Day, JM; Murdoch, AD; Hardingham, TE				Day, JM; Murdoch, AD; Hardingham, TE			The folded protein modules of the C-terminal G3 domain of aggrecan can each facilitate the translocation and secretion of the extended chondroitin sulfate attachment sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE PROTEOGLYCAN; CORE PROTEIN; GENE; BIOSYNTHESIS; CHONDROCYTES; EXPRESSION; LECTIN; CHONDRODYSTROPHY; NANOMELIA; PRECURSOR	Aggrecan is a multidomain proteoglycan containing both extended and folded protein modules. The C-terminal G3 domain contains a lectin-like, complement regulatory protein-like, and two alternatively spliced epidermal growth factor-like modules. It has been proposed that the lectin module alone has a necessary role in the intracellular translocation and secretion of proteins expressed containing G3. Constructs containing human aggrecan G3 together with 1155 bases of the adjacent chondroitin sulfate attachment region (CS-2) were prepared with different combinations and deletions of the protein modules and transfected into mammalian cells of monkey or hamster origin. The results showed that the products containing only the unfolded protein sequences (CS-2 with or without the C-terminal tail sequence) were translated and accumulated intracellularly but were not secreted. In contrast the constructs containing any of the folded protein modules and the extended CS-2 region were translated and secreted from the cells. The results show that the lectin module was not unique in facilitating the intracellular translocation and secretion of the G3 domain. The conservation of G3-like domains within the aggrecan family of proteoglycans may therefore result from their participation in other extracellular functions.	Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Hardingham, TE (corresponding author), Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.			Hardingham, Timothy/0000-0001-8271-6763				Amara J F, 1992, Trends Cell Biol, V2, P145, DOI 10.1016/0962-8924(92)90101-R; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; Brissett NC, 1998, BIOCHEM J, V329, P415; CAMPBELL SC, 1988, J CELL BIOL, V106, P2191, DOI 10.1083/jcb.106.6.2191; CIZDZIEL PE, 1991, MOL CARCINOGEN, V4, P14, DOI 10.1002/mc.2940040105; COUCHMAN JR, 1984, NATURE, V307, P650, DOI 10.1038/307650a0; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; Dudhia J, 1996, BIOCHEM J, V313, P933, DOI 10.1042/bj3130933; FULOP C, 1993, J BIOL CHEM, V268, P17377; HALBERG DF, 1988, J BIOL CHEM, V263, P9486; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; KIMURA JH, 1984, J CELL BIOCHEM, V26, P261, DOI 10.1002/jcb.240260406; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI H, 1993, J BIOL CHEM, V268, P23504; Luo W, 1996, J BIOL CHEM, V271, P16447, DOI 10.1074/jbc.271.28.16447; MCLACHLAN JA, 1982, CANCER RES, V42, P3040; Miura R, 1999, J BIOL CHEM, V274, P11431, DOI 10.1074/jbc.274.16.11431; RATCLIFFE A, 1985, J CELL BIOL, V101, P2355, DOI 10.1083/jcb.101.6.2355; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; SALEQUE S, 1993, GLYCOBIOLOGY, V3, P185, DOI 10.1093/glycob/3.2.185; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALHMU WB, 1995, BIOCHEM J, V309, P535, DOI 10.1042/bj3090535; VERTEL BM, 1994, BIOCHEM J, V301, P211, DOI 10.1042/bj3010211; VERTEL BM, 1993, J CELL SCI, V104, P939; VERTEL BM, 1995, TRENDS CELL BIOL, V5, P458, DOI 10.1016/S0962-8924(00)89115-1; Zheng J, 1998, J BIOL CHEM, V273, P12999, DOI 10.1074/jbc.273.21.12999	29	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38107	38111		10.1074/jbc.274.53.38107	http://dx.doi.org/10.1074/jbc.274.53.38107			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608880	hybrid			2022-12-27	WOS:000084528000080
J	Lee, BI; Wilson, DM				Lee, BI; Wilson, DM			The RAD2 domain of human exonuclease 1 exhibits 5 ' to 3 ' exonuclease and flap structure-specific endonuclease activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE EXO1; EUKARYOTIC DNA-REPLICATION; DOUBLE-STRAND BREAKS; ESCHERICHIA-COLI; MUTATION AVOIDANCE; MISMATCH REPAIR; SCHIZOSACCHAROMYCES-POMBE; CONDITIONAL LETHALITY; POLYMERASE-I	The RAD2 family of nucleases includes human XPG (Class I), FEN1 (Class II), and HEX1/hEXO1 (Class In) products gene. These proteins exhibit a blend of substrate specific exo- and endonuclease activities and contribute to repair, recombination, and/or replication. To date, the substrate preferences of the EXO1-liIre Glass III proteins have not been thoroughly defined, We report here that the RAD2 domain of human exonuclease 1 (HEX1-N2) exhibits both a robust 5' to 3' exonuclease activity on single- and double-stranded DNA substrates as well as a flap structure-specific endonuclease activity but does not show specific endonuclease activity at 10-base pair bubble-like structures, G:T mismatches, or uracil residues. Both the 5' to 3' exonuclease and flap endonuclease activities require a divalent metal cofactor, with Mg2+ being the preferred metal ion. HEX1-N2 is similar to 3-fold less active in Mn2+-containing buffers and exhibits <5% activity in the presence of Co2+, Zn2+, or Ca2+, The optimal pH range for the nuclease activities: of HEX1-N2 is 7.2-8.2, The specific activity of its 5' to 3' exonuclease function is 2.5-7-fold higher on blunt end and 5'-recessed double-stranded DNA substrates compared with duplex 5'-overhang or single-stranded DNAs, The Bap endonuclease activity of HEX1-N2 is similar to that of human flap endonuclease-1, both in terms of turnover efficiency (k(cat)) and site of incision, and is as efficient (k(cat)/K-m) as its exonuclease function. The nuclease activities of HEX1-N2 described here indicate functions for the EXO1-like proteins in replication, repair, and/or recombination that may overlap with human flap endonuclease-1.	Univ Calif Lawrence Livermore Natl Lab, Mol & Struct Biol Div, Livermore, CA 94551 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System	Wilson, DM (corresponding author), Univ Calif Lawrence Livermore Natl Lab, Mol & Struct Biol Div, L-452, Livermore, CA 94551 USA.		Wilson, David M/AAK-5409-2021	Wilson, David M/0000-0002-8945-0395	NATIONAL CANCER INSTITUTE [R01CA079056] Funding Source: NIH RePORTER; NCI NIH HHS [CA79056] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alani E, 1997, J MOL BIOL, V265, P289, DOI 10.1006/jmbi.1996.0743; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bhandari P, 1997, J BACTERIOL, V179, P4403, DOI 10.1128/jb.179.13.4403-4406.1997; Ceska TA, 1998, TRENDS BIOCHEM SCI, V23, P331, DOI 10.1016/S0968-0004(98)01259-6; DELUCIA P, 1969, NATURE, V224, P1164, DOI 10.1038/2241164a0; Digilio FA, 1996, DEV BIOL, V178, P90, DOI 10.1006/dbio.1996.0200; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; FISHEL R, 1994, SCIENCE, V266, P1403, DOI 10.1126/science.7973733; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Johnson RE, 1998, CURR GENET, V34, P21, DOI 10.1007/s002940050362; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; KONRAD EB, 1977, J BACTERIOL, V130, P167, DOI 10.1128/JB.130.1.167-172.1977; Kornberg A., 1980, DNA REPLICATION; Lee BI, 1999, NUCLEIC ACIDS RES, V27, P4114, DOI 10.1093/nar/27.20.4114; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; MONK M, 1972, J BACTERIOL, V109, P971, DOI 10.1128/JB.109.3.971-978.1972; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Nickoloff JA, 1998, DNA DAMAGE REPAIR, V2; NICKOLOFF JA, 1998, DNA DAMAGE REPAIR, V1; Nouspikel T, 1997, P NATL ACAD SCI USA, V94, P3116, DOI 10.1073/pnas.94.7.3116; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Qiu JZ, 1999, J BIOL CHEM, V274, P17893, DOI 10.1074/jbc.274.25.17893; Qiu JZ, 1998, NUCLEIC ACIDS RES, V26, P3077, DOI 10.1093/nar/26.13.3077; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Richard GF, 1999, MOL GEN GENET, V261, P871, DOI 10.1007/s004380050031; ROBINS P, 1994, J BIOL CHEM, V269, P28535; Sayers JR, 1998, NAT STRUCT BIOL, V5, P668, DOI 10.1038/1358; Schmutte C, 1998, CANCER RES, V58, P4537; Shen BH, 1998, TRENDS BIOCHEM SCI, V23, P171, DOI 10.1016/S0968-0004(98)01199-2; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; SZANKASI P, 1992, J BIOL CHEM, V267, P3014; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Tishkoff DX, 1998, CANCER RES, V58, P5027; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; VALLEN EA, 1995, MOL CELL BIOL, V15, P4291; van Steeg H, 1999, MOL MED TODAY, V5, P86, DOI 10.1016/S1357-4310(98)01394-X; WAGA S, 1994, J BIOL CHEM, V269, P10923; Wilson DM, 1998, NUCLEIC ACIDS RES, V26, P3762, DOI 10.1093/nar/26.16.3762; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Yonemasu R, 1997, NUCLEIC ACIDS RES, V25, P1553, DOI 10.1093/nar/25.8.1553; Yu Z, 1999, ENVIRON MOL MUTAGEN, V33, P3, DOI 10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L	55	152	157	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37763	37769		10.1074/jbc.274.53.37763	http://dx.doi.org/10.1074/jbc.274.53.37763			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608837	hybrid			2022-12-27	WOS:000084528000037
J	Outten, CE; Outten, FW; O'Halloran, TV				Outten, CE; Outten, FW; O'Halloran, TV			DNA distortion mechanism for transcriptional activation by ZntR, a Zn(II)-responsive MerR homologue in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; SOXR PROTEIN; METALLOREGULATORY PROTEIN; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; BINDING; PROMOTER; COMPLEX; ZINC	MerR-like DNA distortion mechanisms have been proposed for a variety of stress-responsive transcription factors. The Escherichia coli ZntR protein, a homologue of MerR, has recently been shown to mediate Zn(II)responsive regulation of zntA, a gene involved in Zn(II) detoxification. To determine whether the MerR DNA distortion mechanism is conserved among MerR family members, we have purified ZntR to homogeneity and shown that it is a zinc receptor that is necessary and sufficient to stimulate Zn-responsive transcription at the zntA promoter. Biochemical, DNA footprinting, and in vitro transcription assays indicate that apo-ZntR binds in the atypical 20-base pair spacer region of the promoter and distorts the DNA in a manner that is similar to apo-MerR. The addition of Zn(II) to ZntR converts it to a transcriptional activator protein that introduces changes in the DNA conformation. These changes apparently make the promoter a better substrate for RNA polymerase. We propose that this zinc-sensing homologue of MerR restructures the target promoter in a manner similar to that of other stress-responsive transcription factors. The ZntR metalloregulatory protein is a direct Zn(II) sensor that catalyzes transcriptional activation of a zinc efflux gene, thus preventing intracellular Zn(II) from exceeding an optimal but as yet unknown concentration.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	O'Halloran, TV (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	t-ohalloran@nwu.edu	O'Halloran, Thomas/ABE-6125-2021; Outten, Caryn E./I-9433-2019	O'Halloran, Thomas/0000-0001-8732-5059; Outten, Caryn E./0000-0003-0335-6531; Outten, Franklin/0000-0002-9095-0194	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, T32GM008382, R01GM038784] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM08382, R01 GM038784, T32 GM08061, R01 GM38784] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMED M, 1995, J BACTERIOL, V177, P3904, DOI 10.1128/jb.177.14.3904-3910.1995; AHMED M, 1994, J BIOL CHEM, V269, P28506; AMOUYAL M, 1987, J MOL BIOL, V195, P795, DOI 10.1016/0022-2836(87)90485-2; ANSARI AZ, 1992, NATURE, V355, P87, DOI 10.1038/355087a0; ANSARI AZ, 1995, NATURE, V374, P371; ANSARI AZ, 1994, TRANSCRIPTION MECHAN, P369; Baranova NN, 1999, MOL MICROBIOL, V31, P1549, DOI 10.1046/j.1365-2958.1999.01301.x; Beard SJ, 1997, MOL MICROBIOL, V25, P883, DOI 10.1111/j.1365-2958.1997.mmi518.x; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Brocklehurst KR, 1999, MOL MICROBIOL, V31, P893, DOI 10.1046/j.1365-2958.1999.01229.x; BROWN NL, 1986, MOL GEN GENET, V202, P143, DOI 10.1007/BF00330531; BROWN NL, 1991, J CELL BIOCHEM, V46, P106; Chen XH, 1998, BIOCHEMISTRY-US, V37, P11152, DOI 10.1021/bi980843r; Chiu ML, 1999, J BIOL CHEM, V274, P20578, DOI 10.1074/jbc.274.29.20578; COMESS KM, 1994, BIOCHEMISTRY-US, V33, P4175, DOI 10.1021/bi00180a010; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; CRAIG ML, 1995, BIOCHEMISTRY-US, V34, P15624, DOI 10.1021/bi00048a004; Dai X, 1999, CURR OPIN MICROBIOL, V2, P126, DOI 10.1016/S1369-5274(99)80022-8; Dalet K, 1999, FEMS MICROBIOL LETT, V174, P111, DOI 10.1016/S0378-1097(99)00128-7; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; FRANTZ B, 1990, BIOCHEMISTRY-US, V29, P4747, DOI 10.1021/bi00472a001; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; GASTON K, 1992, NUCLEIC ACIDS RES, V20, P3391, DOI 10.1093/nar/20.13.3391; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HELTZEL A, 1990, BIOCHEMISTRY-US, V29, P9572, DOI 10.1021/bi00493a011; HIDALGO E, 1994, EMBO J, V13, P138, DOI 10.1002/j.1460-2075.1994.tb06243.x; Hidalgo E, 1997, TRENDS BIOCHEM SCI, V22, P207, DOI 10.1016/S0968-0004(97)01068-2; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; HOLMES DJ, 1993, EMBO J, V12, P3183, DOI 10.1002/j.1460-2075.1993.tb05987.x; JOHNSON BH, 1994, BIO-TECHNOL, V12, P1357, DOI 10.1038/nbt1294-1357; Kuroda M, 1999, MICROBIOL IMMUNOL, V43, P115, DOI 10.1111/j.1348-0421.1999.tb02382.x; LAHM A, 1991, NUCLEIC ACIDS MOL BI, V5, P171; Loh J, 1999, J BACTERIOL, V181, P1544, DOI 10.1128/JB.181.5.1544-1554.1999; LUND P, 1989, NUCLEIC ACIDS RES, V17, P5517, DOI 10.1093/nar/17.14.5517; Maniatis T., 1989, MOL CLONING LAB MANU; MARTELL AE, 1998, 46 NIST; MORBY AP, 1993, NUCLEIC ACIDS RES, V21, P921, DOI 10.1093/nar/21.4.921; Muller HP, 1995, SOMAT CELL MOLEC GEN, V21, P289, DOI 10.1007/BF02257464; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; OHALLORAN T, 1987, SCIENCE, V235, P211, DOI 10.1126/science.3798107; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; OHALLORAN TV, 1989, CELL, V56, P119, DOI 10.1016/0092-8674(89)90990-2; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; RALSTON DM, 1990, P NATL ACAD SCI USA, V87, P3846, DOI 10.1073/pnas.87.10.3846; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Rensing C, 1998, J BIOL CHEM, V273, P32614, DOI 10.1074/jbc.273.49.32614; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; ROSS W, 1989, J BACTERIOL, V171, P4009, DOI 10.1128/jb.171.7.4009-4018.1989; ROUCH DA, 1995, J IND MICROBIOL, V14, P249; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SIGMAN DS, 1990, BIOCHEMISTRY-US, V29, P9097, DOI 10.1021/bi00491a001; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; SPASSKY A, 1988, EMBO J, V7, P1871, DOI 10.1002/j.1460-2075.1988.tb03020.x; SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992; THEDERAHN T, 1990, BIOCHEM BIOPH RES CO, V168, P756, DOI 10.1016/0006-291X(90)92386-E; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Travers A. A., 1990, DNA TOPOLOGY ITS BIO, P57; WATTON SP, 1990, J AM CHEM SOC, V112, P2824, DOI 10.1021/ja00163a067; Winge DR, 1998, CURR OPIN CHEM BIOL, V2, P216, DOI 10.1016/S1367-5931(98)80063-X; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713	64	153	158	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37517	37524		10.1074/jbc.274.53.37517	http://dx.doi.org/10.1074/jbc.274.53.37517			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608803	hybrid, Green Published			2022-12-27	WOS:000084528000003
J	Qin, JZ; Chaturvedi, V; Denning, MF; Choubey, D; Diaz, MO; Nickoloff, BJ				Qin, JZ; Chaturvedi, V; Denning, MF; Choubey, D; Diaz, MO; Nickoloff, BJ			Role of NF-kappa B in the apoptotic-resistant phenotype of keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; CELL-DEATH; BCL-X; ACTIVATION; KINASE; SKIN; ALPHA; PATHOGENESIS; EXPRESSION; INDUCTION	Several studies point to a role for NF-kappa B in modulating epidermal thickness and apoptotic susceptibility of keratinocytes. When phorbol esters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) are topically applied, prominent epidermal thickening occurs, and exposure to interferon (IFN)-gamma promotes increased epidermal thickness producing psoriatic lesions, While keratinocytes derived from psoriatic plaque resist apoptosis, and combination of TPA and IFN-gamma activates NF-kappa B, the molecular mechanism linking NE-kappa B activation and keratinocyte apoptosis resistance was unknown. Therefore, we examined the ability of IFN-gamma plus TPA to influence NF-kappa B activity, gene expression, and response to UV light-induced apoptosis, These responses in normal keratinocytes were compared with immortalized keratinocytes (HaCaT cells). Exposure of normal keratinocytes to IFN-gamma plus TPA produced a synergistic activation: of NF-kappa B, compared with when each reagent was used individually. Normal keratinocytes when exposed to IFN-gamma plus TPA acquired a resistance to UV light-induced apoptosis, which was dependent on NF-kappa B because expression of a dominant negative form of I kappa B alpha overcame the resistance. Compared with normal keratinocytes, HaCaT cells have a dysfunctional constitutive NF-kappa B signaling pathway not induced by IFN-gamma and TPA, rendering HaCaT cells highly susceptible to W-induced apoptosis, Thus, immortalized HaCaT cells have an abnormal constitutive and dysfunctional NF-kappa B signaling system. These results provide evidence that activation and proper regulation of NF-kappa B is essential for acquisition of an apoptotic-resistant phenotype for epidermal-derived keratinocytes.	Loyola Univ, Med Ctr, Dept Pathol, Skin Canc Res Labs,Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Radiat Oncol, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Med, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Nickoloff, BJ (corresponding author), Loyola Univ, Med Ctr, Dept Pathol, Skin Canc Res Labs,Cardinal Bernardin Canc Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA.	Bnickol@luc.edu	Choubey, Divaker/A-4771-2008					BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Foo SY, 1999, TRENDS GENET, V15, P229; GERBER HP, 1992, NUCLEIC ACIDS RES, V20, P5855, DOI 10.1093/nar/20.21.5855; GRIFFITHS CEM, 1990, BRIT J DERMATOL, V122, P333, DOI 10.1111/j.1365-2133.1990.tb08281.x; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; Pena JC, 1998, CANCER RES, V58, P2111; Pena JC, 1997, CELL GROWTH DIFFER, V8, P619; RASMUSSEN HH, 1993, J INVEST DERMATOL, V101, P560, DOI 10.1111/1523-1747.ep12365986; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rodriguez-Villanueva J, 1998, ONCOGENE, V16, P853, DOI 10.1038/sj.onc.1201610; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Salvesen GS, 1999, APMIS, V107, P73, DOI 10.1111/j.1699-0463.1999.tb01528.x; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; WRONESMITH T, 1995, AM J PATHOL, V146, P1079; WroneSmith T, 1997, AM J PATHOL, V151, P1321; YUSPA SH, 1994, CANCER RES, V54, P1178; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	39	106	111	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37957	37964		10.1074/jbc.274.53.37957	http://dx.doi.org/10.1074/jbc.274.53.37957			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608863	hybrid			2022-12-27	WOS:000084528000063
J	Rao, S; He, LF; Chakravarty, S; Ojima, I; Orr, GA; Horwitz, SB				Rao, S; He, LF; Chakravarty, S; Ojima, I; Orr, GA; Horwitz, SB			Characterization of the taxol binding site on the microtubule - Identification of Arg(282) in beta-tubulin as the site of photoincorporation of a 7-benzophenone analogue of taxol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACLITAXEL TAXOL; MITOTIC BLOCK; AMINO-ACIDS; INVITRO; CELLS; POLYMERIZATION; PHOTOLABELS	Photoaffinity labeling methods have allowed a definition of the sites of interaction between Taxol and its cellular target, the microtubule, specifically beta-tubulin. Our previous studies have indicated that [H-3]3'-(p-azidobenzamido)Taxol photolabels the N-terminal 31 amino acids of beta-tubulin (Rao, S., Krauss, N. E., Heerding, J. M., Swindell, C. S., Ringel, I., Orr, G. A, and Horwitz, S. B. (1994) J. Biol. Chem. 269, 3132-3134) and [H-3]2-(m-azidobenzoyl)Taxol photolabels a peptide containing amino acid residues 217-233 of beta-tubulin (Rao, S., Orr, G. A, Chaudhary, A G., Kingston, D. G. I., and Horwitz, S. B. (1995) J. Biol Chem. 270, 20235-20238). The site of photoincorporation of a third photoaffinity analogue of Taxol, [H-3]7-(benzoyldihydrocinnamoyl) Taxol, has been determined. This analogue stabilizes microtubules polymerized in the presence of GTP, but in contrast to Taxol, does not by itself enhance the polymerization of tubulin to its polymer form. CNBr digestion of [H-3]7-(benzoyldihydrocinnamoyl)Taxol-labeled tubulin, with further arginine-specific cleavage by clostripain resulted in the isolation of a peptide containing amino acid residues 277-293. Amino acid sequence analysis indicated that the photoaffinity analogue crosslinks to Arg(282) in beta-tubulin. Advances made by electron crystallography in understanding the structure of the tubulin dimer have allowed us to visualize the three sites of photoincorporation by molecular modeling. There is good agreement between the binding site of Taxol in beta-tubulin as determined by photoaffinity labeling and electron crystallography.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Horwitz, SB (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Kingston, David G. I./B-4272-2009	Kingston, David G. I./0000-0001-8944-246X; Ojima, Iwao/0000-0002-3628-1161	NATIONAL CANCER INSTITUTE [R01CA083185, R01CA077263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042798] Funding Source: NIH RePORTER; NCI NIH HHS [CA77263, CA83185] Funding Source: Medline; NIGMS NIH HHS [GM42798] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P2747, DOI 10.1021/bi00062a003; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; GEORG GI, 1992, BIOORG MED CHEM LETT, V2, P735, DOI 10.1016/S0960-894X(00)80402-3; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; GILLES AM, 1979, J BIOL CHEM, V254, P1462; Gonzalez-Garay ML, 1999, J BIOL CHEM, V274, P23875, DOI 10.1074/jbc.274.34.23875; GROVER S, 1995, BIOCHEMISTRY-US, V34, P3927, DOI 10.1021/bi00012a009; GUERITTEVOEGELEIN F, 1990, ACTA CRYSTALLOGR C, V46, P781, DOI 10.1107/S0108270189009376; Jordan MA, 1996, CANCER RES, V56, P816; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; KINGSTON DGI, 1995, ACS SYM SER, V583, P203; KRAUHS E, 1981, P NATL ACAD SCI-BIOL, V78, P4156, DOI 10.1073/pnas.78.7.4156; LUO KX, 1991, METHOD ENZYMOL, V201, P149; MANFREDI JJ, 1982, J CELL BIOL, V94, P688, DOI 10.1083/jcb.94.3.688; MASTROPAOLO D, 1995, P NATL ACAD SCI USA, V92, P6920, DOI 10.1073/pnas.92.15.6920; Monzo M, 1999, J CLIN ONCOL, V17, P1786, DOI 10.1200/JCO.1999.17.6.1786; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Ojima I, 1997, J AM CHEM SOC, V119, P5519, DOI 10.1021/ja9633777; Ojima I, 1999, BIOORG MED CHEM LETT, V9, P1189, DOI 10.1016/S0960-894X(99)00161-4; PARNESS J, 1981, J CELL BIOL, V91, P479, DOI 10.1083/jcb.91.2.479; RAO S, 1994, J BIOL CHEM, V269, P3132; RAO S, 1992, J NATL CANCER I, V84, P785, DOI 10.1093/jnci/84.10.785; RAO S, 1995, J BIOL CHEM, V270, P20235, DOI 10.1074/jbc.270.35.20235; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; Wu Q, 1998, BIOCHEMISTRY-US, V37, P11272, DOI 10.1021/bi980598b	32	162	168	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37990	37994		10.1074/jbc.274.53.37990	http://dx.doi.org/10.1074/jbc.274.53.37990			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608867	hybrid			2022-12-27	WOS:000084528000067
J	Saenko, EL; Yakhyaev, AV; Mikhailenko, I; Strickland, DK; Sarafanov, AG				Saenko, EL; Yakhyaev, AV; Mikhailenko, I; Strickland, DK; Sarafanov, AG			Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; CELL-SURFACE PROTEOGLYCANS; ACTIVATOR INHIBITOR TYPE-1; FACTOR PATHWAY INHIBITOR; RECOMBINANT FACTOR-VIII; ALPHA-2-MACROGLOBULIN RECEPTOR; PLASMINOGEN-ACTIVATOR; VONWILLEBRAND-FACTOR; PROTEIN/ALPHA(2)-MACROGLOBULIN RECEPTOR; LIVER-TRANSPLANTATION	In the present study, we found that catabolism of coagulation factor VIII (fVIII) is mediated by the low density lipoprotein receptor-related protein (LPR), a liver multiligand endocytic receptor. In a solid phase assay, fVIII was shown to bind to LRP (K-d 116 nM). The specificity was confirmed by a complete inhibition of fVII/LRP binding by 39-kDa receptor-associated protein (RAP), an antagonist of all LRP ligands. The region of fVIII involved in its binding to LRP was localized within the A2 domain residues 484-509, based on the ability of the isolated A2 domain and the synthetic A2 domain peptide 484-509 to prevent fVIII interaction with LRP, Since vWf did not inhibit fVIII binding to LRP, we proposed that LRP receptor may internalize fVIII from its complex with vWf, Consistent with this hypothesis, mouse embryonic fibroblasts that express LRP, but not fibroblasts genetically deficient in LRP, were able to catabolize I-125-fVIII complexed with vWf, which was not internalized by the cells. These processes could be inhibited by RAP and A2 subunit of fVIII, indicating that cellular internalization and degradation were mediated by interaction of the A2 domain of fVIII with LRP. In vivo studies of I-125-fVIII vWf complex clearance in mice demonstrated that RAP completely inhibited the fast phase of the biphasic I-125-fVIII clearance that is responsible for removal of 60% of fVIII from circulation. Inhibition of the RAP-sensitive phase prolonged the half-life of I-125-fVIII in circulation by 3.3-fold, indicating that LRP receptor plays an important role in fVIII clearance.	Amer Red Cross, Holland Lab, Rockville, MD 20855 USA	American Red Cross	Saenko, EL (corresponding author), Amer Red Cross, Holland Lab, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.			Sarafanov, Andrey/0000-0001-6124-9713	NHLBI NIH HHS [HL50784] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050784] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BONTEMPO FA, 1987, BLOOD, V69, P1721; CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; CONNELLY S, 1995, HUM GENE THER, V6, P185, DOI 10.1089/hum.1995.6.2-185; Connelly S, 1996, BLOOD, V87, P4671, DOI 10.1182/blood.V87.11.4671.bloodjournal87114671; FAY PJ, 1993, J BIOL CHEM, V268, P17861; FAY PJ, 1991, J BIOL CHEM, V266, P8957; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; FAY PJ, 1991, J BIOL CHEM, V266, P2172; FAY PJ, 1986, THROMB RES, V37, P425; Fijnvandraat K, 1997, THROMB HAEMOSTASIS, V77, P298; FULCHER CA, 1985, J CLIN INVEST, V76, P117, DOI 10.1172/JCI111933; GILBERT GE, 1992, J BIOL CHEM, V267, P15861; GIRMA JP, 1986, BIOCHEMISTRY-US, V25, P3156, DOI 10.1021/bi00359a013; HEALEY JF, 1995, J BIOL CHEM, V270, P14505, DOI 10.1074/jbc.270.24.14505; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Ho GY, 1996, J BIOL CHEM, V271, P9497, DOI 10.1074/jbc.271.16.9497; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; HOYER LW, 1980, BLOOD, V55, P1056; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P1233, DOI 10.1128/MCB.9.3.1233; Knauer MF, 1997, J BIOL CHEM, V272, P12261, DOI 10.1074/jbc.272.19.12261; KOPPELMAN SJ, 1994, J LAB CLIN MED, V123, P585; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P9307, DOI 10.1074/jbc.270.16.9307; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; LETHAGEN S, 1992, ANN HEMATOL, V65, P253, DOI 10.1007/BF01836069; LEWIS JH, 1985, NEW ENGL J MED, V312, P1189; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1994, J CLIN INVEST, V93, P2497, DOI 10.1172/JCI117259; MACGREGOR IR, 1995, VOX SANG, V69, P319, DOI 10.1111/j.1423-0410.1995.tb00367.x; Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; MOESTRUP SK, 1993, J BIOL CHEM, V268, P13691; MOESTRUP SK, 1994, BBA-REV BIOMEMBRANES, V1197, P197, DOI 10.1016/0304-4157(94)90005-1; Mordenti J, 1996, TOXICOL APPL PHARM, V136, P75, DOI 10.1006/taap.1996.0008; MORFINI M, 1992, THROMB HAEMOSTASIS, V68, P433; MORFINI M, 1993, THROMB HAEMOSTASIS, V70, P270; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Narita M, 1998, BLOOD, V91, P555, DOI 10.1182/blood.V91.2.555.555_555_560; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; OVER J, 1978, J CLIN INVEST, V62, P223, DOI 10.1172/JCI109120; Rodenburg KW, 1998, BIOCHEM J, V329, P55; Saenko EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/jbc.272.29.18007; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; VLOT AJ, 1995, BLOOD, V85, P3150, DOI 10.1182/blood.V85.11.3150.bloodjournal85113150; WARSHAWSKY I, 1994, P NATL ACAD SCI USA, V91, P6664, DOI 10.1073/pnas.91.14.6664; WILLIAMS SE, 1994, J BIOL CHEM, V269, P8653; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; WILLNOW TE, 1994, J CELL SCI, V107, P719; WION KL, 1985, NATURE, V317, P726, DOI 10.1038/317726a0; WISE RJ, 1991, J BIOL CHEM, V266, P21948	57	182	205	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37685	37692		10.1074/jbc.274.53.37685	http://dx.doi.org/10.1074/jbc.274.53.37685			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608826	hybrid			2022-12-27	WOS:000084528000026
J	Hertig, CM; Kubalak, SW; Wang, YB; Chien, KR				Hertig, CM; Kubalak, SW; Wang, YB; Chien, KR			Synergistic roles of neuregulin-1 and insulin-like growth factor-I in activation of the phosphatidylinositol 3-kinase pathway and cardiac chamber morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TYROSINE KINASES; EMBRYONIC HEART; MICE LACKING; IGF-I; RECEPTOR; CELLS; MOUSE; ERBB2; ACETYLCHOLINESTERASE	Cardiac chamber morphogenesis requires the coordinated growth of both cardiac muscle and endocardial cell lineages. Paracrine growth factors may modulate the coordinated cellular specification and differentiation during cardiac chamber morphogenesis, as suggested by the essential role of endothelial-derived growth factors, neuregulin-1, and insulin-like growth factor-I. Using the whole mouse embryo culture system for delivery of diffusible factors into the cardiac chamber, neuregulin-1 was shown to promote trabeculation of the ventricular wall. Another factor, insulin-like growth factor-I, had no apparent effect by itself. Combined treatment with neuregulin-1 and insulin-like growth factor-I strongly induced DNA synthesis of cardiomyocytes and expansion of both the ventricular compact zone and the atrioventricular cushions leading to chamber growth and maturation. In cultured cardiomyocytes, combined neuregulin-1 and insulin-like growth factor-I also had a synergistic effect to promote DNA synthesis and cellular growth, which were prevented by wortmannin, an inhibitor of phosphatidylinositol 3-kinase, Adenoviral delivery of dominant negative Rad, which acts downstream of phosphatidylinositol S-kinase, blocked the effect of combined neuregulin-1/insulin-like growth factor-I treatment. These studies support the concept that the interaction of neuregulin-1 and insulin-like growth factor-I pathways plays an important role in coordinating cardiac chamber morphogenesis and may occur through convergent activation of phosphatidylinositol 3-kinase.	Univ Calif San Diego, Dept Med, Salk Program Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Med Univ S Carolina, Dept Anat & Cell Biol, Charleston, SC 29425 USA; Univ Maryland, Dept Physiol, Washington, DC 20212 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Medical University of South Carolina	Chien, KR (corresponding author), Univ Calif San Diego, Dept Med, Salk Program Mol Med, 0613-C,9500 Gilman Dr, La Jolla, CA 92093 USA.			Wang, Yibin/0000-0003-0852-0767				Arkell R, 1997, DEVELOPMENT, V124, P1; Bonassar LJ, 1997, EXP CELL RES, V234, P1, DOI 10.1006/excr.1997.3574; BONDY CA, 1990, MOL ENDOCRINOL, V4, P1386, DOI 10.1210/mend-4-9-1386; Burgaud JL, 1996, EXP CELL RES, V223, P412, DOI 10.1006/excr.1996.0096; Chen J, 1998, DEVELOPMENT, V125, P1943; CohenGould L, 1996, DEV BIOL, V177, P265, DOI 10.1006/dbio.1996.0161; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; COPP AJ, 1990, POST IMPLANTATION MA, P31; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Crovello CS, 1998, J BIOL CHEM, V273, P26954, DOI 10.1074/jbc.273.41.26954; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DERCOLE AJ, 1996, HORM RES, V1, P5; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Foncea R, 1997, J BIOL CHEM, V272, P19115, DOI 10.1074/jbc.272.31.19115; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gruber PJ, 1996, J CLIN INVEST, V98, P1332, DOI 10.1172/JCI118920; Gruber PJ, 1998, DEVELOPMENT, V125, P4427; Hertig CM, 1996, J CELL SCI, V109, P11; IWAKI K, 1990, J BIOL CHEM, V265, P13809; KAUFMAN MH, 1992, ATLAS MOUSE DEV, P375; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; LAMERS WH, 1987, ANAT REC, V217, P361, DOI 10.1002/ar.1092170407; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; Luo ZD, 1996, J NEUROCHEM, V67, P111; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; NAKAMURA T, 1994, ANAT EMBRYOL, V190, P367; Okajima Y, 1998, J BIOL CHEM, V273, P22877, DOI 10.1074/jbc.273.36.22877; Okubo Y, 1998, J BIOL CHEM, V273, P25961, DOI 10.1074/jbc.273.40.25961; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Parrizas M, 1997, J BIOL CHEM, V272, P154; PEXIEDER T, 1986, TERATOLOGY, V33, P91; Pinkas-Kramarski R, 1998, MOL CELL BIOL, V18, P6090, DOI 10.1128/MCB.18.10.6090; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; POWELLBRAXTON L, 1993, ANN NY ACAD SCI, V692, P300; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Ramsdell AF, 1997, DEV BIOL, V188, P64, DOI 10.1006/dbio.1997.8637; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Ruiz-Lozano P, 1998, DEVELOPMENT, V125, P533; Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; STURM K, 1993, METHOD ENZYMOL, V225, P164; Sugi Y, 1996, DEV BIOL, V175, P66, DOI 10.1006/dbio.1996.0096; Tansey MG, 1996, J CELL BIOL, V134, P465, DOI 10.1083/jcb.134.2.465; Tessarollo L, 1998, TRENDS CARDIOVAS MED, V8, P34, DOI 10.1016/S1050-1738(97)00119-9; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; VUILLEMIN M, 1989, AM J ANAT, V184, P114, DOI 10.1002/aja.1001840203; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	57	73	76	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37362	37369		10.1074/jbc.274.52.37362	http://dx.doi.org/10.1074/jbc.274.52.37362			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601306	hybrid			2022-12-27	WOS:000084382700077
J	Shiota, C; Coffey, J; Grimsby, J; Grippo, JF; Magnuson, MA				Shiota, C; Coffey, J; Grimsby, J; Grippo, JF; Magnuson, MA			Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER GLUCOKINASE; AMINO-ACID-SEQUENCE; TRANSGENIC MICE; MESSENGER-RNA; GLUCOSE; GENE; INSULIN; HEPATOCYTES; IDENTIFICATION; TRANSLOCATION	Hepatic glucokinase (GK) moves between the nucleus and cytoplasm in response to metabolic alterations. Here, using heterologous cell systems, we have found that at least two different mechanisms are involved in the intracellular movement of GK. In the absence of the GK regulatory protein (GKRP) GK resides only in the cytoplasm. However, in the presence of GKRP, GK moves to the nucleus and resides there in association with this protein until changes in the metabolic milieu prompt its release. GK does not contain a nuclear localization signal sequence and does not enter the nucleus in a GKRP-independent manner because cells treated with leptomycin B, a specific inhibitor of leucine-rich NES-dependent nuclear export, do not accumulate GR in the nucleus. Instead, entry of GK into the nucleus appears to occur via a piggy-back mechanism that involves binding to GKRP. Nuclear export of GK, which occurs after its release from GKRP, is due to a leucine-rich nuclear export signal within the protein ((ELVR)-E-300-LVLLKLV310). Thus, GKRP appears to function as both a nuclear chaperone and metabolic sensor and is a critical component of a hepatic GK translocation cycle for regulating the activity of this enzyme in response to metabolic alterations.	Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA	Vanderbilt University; Roche Holding	Magnuson, MA (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 723 Light Hall, Nashville, TN 37232 USA.	mark.magnuson@mcmail.vanderbilt.edu	Magnuson, Mark/AAY-7172-2021; Magnuson, Mark A/B-1335-2009	Magnuson, Mark/0000-0002-8824-6499; Magnuson, Mark A/0000-0002-8824-6499	NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042612] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485] Funding Source: Medline; NIDDK NIH HHS [DK42502, DK42612] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGIUS L, 1995, BIOCHEM J, V309, P711, DOI 10.1042/bj3090711; AGIUS L, 1993, BIOCHEM J, V296, P785, DOI 10.1042/bj2960785; ANDREONE TL, 1989, J BIOL CHEM, V264, P363; Ardehali H, 1999, J BIOL CHEM, V274, P15986, DOI 10.1074/jbc.274.23.15986; BEDOYA FJ, 1986, J BIOL CHEM, V261, P760; Brown KS, 1997, DIABETES, V46, P179, DOI 10.2337/diabetes.46.2.179; CHARLES RS, 1994, DIABETES, V43, P784, DOI 10.2337/diab.43.6.784; DETHEUX M, 1991, EUR J BIOCHEM, V200, P553, DOI 10.1111/j.1432-1033.1991.tb16218.x; DWORETZKY SI, 1988, J CELL BIOL, V106, P575, DOI 10.1083/jcb.106.3.575; FELDHERR CM, 1984, J CELL BIOL, V99, P2216, DOI 10.1083/jcb.99.6.2216; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; GERACE L, 1992, Current Opinion in Cell Biology, V4, P637, DOI 10.1016/0955-0674(92)90083-O; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740; IYNEDJIAN PB, 1987, J BIOL CHEM, V262, P6032; Jans DA, 1997, FEBS LETT, V410, P368, DOI 10.1016/S0014-5793(97)00622-4; JETTON TL, 1994, J BIOL CHEM, V269, P3641; JETTON TL, 1992, P NATL ACAD SCI USA, V89, P2619, DOI 10.1073/pnas.89.7.2619; KOGURE K, 1993, J BIOL CHEM, V268, P8422; Kogure K, 1996, J BIOL CHEM, V271, P15230, DOI 10.1074/jbc.271.25.15230; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; LIANG Y, 1991, J BIOL CHEM, V266, P6999; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Miller J.H., 1992, SHORT COURSE BACTERI, P74; Mizuno T, 1996, J CELL SCI, V109, P2627; NISHI K, 1994, J BIOL CHEM, V269, P6320; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; ODoherty RM, 1996, J BIOL CHEM, V271, P20524, DOI 10.1074/jbc.271.34.20524; PETERS R, 1986, BIOCHIM BIOPHYS ACTA, V864, P305, DOI 10.1016/0304-4157(86)90003-1; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PRINTZ RL, 1993, ANNU REV NUTR, V13, P463, DOI 10.1146/annurev.nu.13.070193.002335; PRINTZ RL, 1993, J BIOL CHEM, V268, P5209; TOYODA Y, 1995, HISTOCHEM CELL BIOL, V103, P31, DOI 10.1007/BF01464473; TOYODA Y, 1994, BIOCHEM BIOPH RES CO, V204, P252, DOI 10.1006/bbrc.1994.2452; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; VANDERCAMMEN A, 1993, BIOCHEM J, V294, P551, DOI 10.1042/bj2940551; VANDERCAMMEN A, 1990, EUR J BIOCHEM, V191, P483, DOI 10.1111/j.1432-1033.1990.tb19147.x; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P173; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; VeigadaCunha M, 1996, DIABETOLOGIA, V39, P1173, DOI 10.1007/BF02658503; VeigadaCunha M, 1996, J BIOL CHEM, V271, P6292, DOI 10.1074/jbc.271.11.6292; Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2	49	109	112	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37125	37130		10.1074/jbc.274.52.37125	http://dx.doi.org/10.1074/jbc.274.52.37125			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601273	hybrid			2022-12-27	WOS:000084382700044
J	Williamson, RA; Muskett, FW; Howard, MJ; Freedman, RB; Carr, MD				Williamson, RA; Muskett, FW; Howard, MJ; Freedman, RB; Carr, MD			The effect of matrix metalloproteinase complex formation on the conformational mobility of tissue inhibitor of metalloproteinases-2 (TIMP-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; DNA-BINDING DOMAIN; HETERONUCLEAR NMR-SPECTROSCOPY; BACKBONE DYNAMICS; PROTEIN DYNAMICS; CATALYTIC DOMAIN; PROGELATINASE-A; EXPRESSION; RESOLUTION; CLONING	The backbone mobility of the N-terminal domain of tissue inhibitor of metalloproteinases-2 (N-TIMP-2) was determined both for the free protein and when bound to the catalytic domain of matrix metalloproteinase-3 (N-MMP-3). Regions of the protein with internal motion were identified by comparison of the T-1 and T-2 relaxation times and H-1-N-15 nuclear Overhauser effect values for the backbone amide N-15 signals for each residue in the sequence. This analysis revealed rapid internal motion on the picosecond to nanosecond time scale for several regions of free N-TIMP-2, including the extended beta-hairpin between beta-strands A and B, which forms part of the MMP binding site. Evidence of relatively slow motion indicative of exchange between two or more local conformations on a microsecond to millisecond time scale was also found in the free protein, including two other regions of the MMP binding site (the CD and EF loops). On formation of a tight N-TIMP-2, N-MMP-3 complex, the rapid internal motion of the AB beta-hairpin was largely abolished, a change consistent with tight binding of this region to the MMP-3 catalytic domain. The extended AB beta-hairpin is not a feature of all members of the TIMP family; therefore, the binding of this highly mobile region to a site distant from the catalytic cleft of the MMPs suggests a key role in TIMP-2 binding specificity.	Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	University of Kent	Carr, MD (corresponding author), Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England.			Carr, Mark/0000-0002-3939-0996; Howard, Mark/0000-0002-0762-2887				APTE SS, 1994, GENOMICS, V19, P86, DOI 10.1006/geno.1994.1016; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; BOONE TC, 1990, P NATL ACAD SCI USA, V87, P2800, DOI 10.1073/pnas.87.7.2800; Broadhurst RW, 1995, BIOCHEMISTRY-US, V34, P16608, DOI 10.1021/bi00051a008; Butler GS, 1999, J BIOL CHEM, V274, P10846, DOI 10.1074/jbc.274.16.10846; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Carr MD, 1996, EUR J BIOCHEM, V235, P721, DOI 10.1111/j.1432-1033.1996.00721.x; Cawson T, 1998, MOL MED TODAY, V4, P130, DOI 10.1016/S1357-4310(97)01192-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; GORMEZ DE, 1997, EUR J CELL BIOL, V74, P111; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; JARDETZKY O, 1994, FEBS LETT, V338, P246, DOI 10.1016/0014-5793(94)80277-7; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kay LE, 1996, BIOCHEMISTRY-US, V35, P361, DOI 10.1021/bi9522312; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; MARCY AI, 1991, BIOCHEMISTRY-US, V30, P6476, DOI 10.1021/bi00240a018; McIntosh PB, 1998, BIOCHEMISTRY-US, V37, P9619, DOI 10.1021/bi972861z; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Noggle J. H., 1971, NUCL OVERHAUSER EFFE; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Polshakov VI, 1997, J MOL BIOL, V267, P418, DOI 10.1006/jmbi.1997.0896; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Tuuttila A, 1998, J MOL BIOL, V284, P1133, DOI 10.1006/jmbi.1998.2223; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; WILLENBROCK F, 1993, BIOCHEMISTRY-US, V32, P4330, DOI 10.1021/bi00067a023; WILLIAMSON RA, 1994, PROTEIN ENG, V7, P1035, DOI 10.1093/protein/7.8.1035; Williamson RA, 1996, EUR J BIOCHEM, V241, P476, DOI 10.1111/j.1432-1033.1996.00476.x; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Yong VW, 1998, TRENDS NEUROSCI, V21, P75	37	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37226	37232		10.1074/jbc.274.52.37226	http://dx.doi.org/10.1074/jbc.274.52.37226			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601286	hybrid			2022-12-27	WOS:000084382700057
J	Zhang, JH; Wang, XS; Bove, KE; Xu, M				Zhang, JH; Wang, XS; Bove, KE; Xu, M			DNA fragmentation factor 45-deficient cells are more resistant to apoptosis and exhibit different dying morphology than wild-type control cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 GENE FAMILY; CYTOCHROME-C; CHROMATIN CONDENSATION; MEDIATED APOPTOSIS; DEATH RECEPTORS; ELEGANS; PROTEIN; ACTIVATION; SURVIVAL; ENCODES	The DNA fragmentation factor 45 (DFF45) is a subunit of a heterodimeric DNase complex critical for the induction of DNA fragmentation in vitro, To understand the in vivo role of DFF45 in programmed cell death, we measured the expression of DFF45 during mouse development and compared DNA fragmentation and viability of DFF45-deficient cells with wild-type control cells after activation of apoptosis, We found that DFF45 is ubiquitously expressed throughout mouse development, Moreover, DFF45-deficient thymocytes are resistant to DNA fragmentation with in vivo dexamethasone treatment, Furthermore, primary thymocytes from DFF45 mutant mice are also more resistant to apoptosis than wild-type control cells on exposure to several apoptotic stimuli. Dying DFF45-deficient thymocytes exhibit different morphology than wild-type control cells in that they show reduced degree of chromatin condensation, absent nuclear fragmentation, intranuclear cytoplasmic invagination, and striking nuclear chromatin conglutination after release from disintegrating cells. These results indicate that DFF45 is essential during normal apoptosis.	Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Childrens Hosp Res Fdn, Div Pathol, Cincinnati, OH 45229 USA	University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Xu, M (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA.		zhang, jianhua/D-3404-2009	Zhang, Jianhua/0000-0002-2128-9574	NIDA NIH HHS [DA11005, DA11284] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA011284, R29DA011005] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Cory S, 1998, P NATL ACAD SCI USA, V95, P12077, DOI 10.1073/pnas.95.21.12077; CORY S, 1995, ANNU REV IMMUNOL, V13, P513, DOI 10.1146/annurev.iy.13.040195.002501; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Cuvillier O, 1998, J BIOL CHEM, V273, P2910, DOI 10.1074/jbc.273.5.2910; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Montague JW, 1997, J BIOL CHEM, V272, P6677, DOI 10.1074/jbc.272.10.6677; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Peitsch Manuel C., 1994, Trends in Cell Biology, V4, P37, DOI 10.1016/0962-8924(94)90002-7; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Sakahira H, 1999, J BIOL CHEM, V274, P15740, DOI 10.1074/jbc.274.22.15740; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1; Sambrook J., 2002, MOL CLONING LAB MANU; Samejima K, 1998, J CELL BIOL, V143, P225, DOI 10.1083/jcb.143.1.225; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; SCHULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15, DOI 10.1083/jcb.127.1.15; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	54	70	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37450	37454		10.1074/jbc.274.52.37450	http://dx.doi.org/10.1074/jbc.274.52.37450			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601318	hybrid			2022-12-27	WOS:000084382700089
J	Heeb, MJ; Kojima, Y; Rosing, J; Tans, G; Griffin, JH				Heeb, MJ; Kojima, Y; Rosing, J; Tans, G; Griffin, JH			C-terminal residues 621-635 of protein S are essential for binding to factor Va	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR XA; BLOOD-COAGULATION; C4B-BINDING PROTEIN; PROTHROMBINASE COMPLEX; THROMBOTIC DISEASE; ANTICOAGULANT ACTIVITY; MONOCLONAL-ANTIBODIES; PURPURA FULMINANS; HUMAN-PLASMA; LIGHT-CHAIN	Protein S is anticoagulant in the absence of activated protein C because of direct interactions with coagulation Factors Xa and Va. Synthetic peptides corresponding to amino acid sequences of protein S were tested for their ability to inhibit prothrombinase activity. The peptide containing the C-terminal sequence of protein S, residues 621-635 (PSP14), reversibly inhibited prothrombinase activity in the presence but not in the absence of Factor Va (K-i similar to 2 mu M). PSP14 inhibition of prothrombinase was independent of phospholipids but could be competitively overcome by increasing Factor Xa concentrations, suggesting that the C-terminal region of protein S may compete for a Factor Xa binding site on Factor Va. Studies using peptides with amino acid substitutions suggested that lysines 630, 631, and 633 were critical residues. PSP14 inhibited Factor Va activity in Factor Xa-one-stage clotting assays. PSP14 inhibited protein S binding to immobilized Factor Va. When preincubated with protein S, antibodies raised against PSP14 inhibited binding of protein S to Factor Va and blocked inhibition of prothrombinase activity by protein S, These results show that the C-terminal region of protein S containing residues 621-635 is essential for binding of protein S to Factor Va and that this interaction contributes to anticoagulant action.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA; Univ Maastricht, Dept Biochem, NL-6229 ER Maastricht, Netherlands	Scripps Research Institute; Scripps Research Institute; Maastricht University	Heeb, MJ (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, MEM180,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Griffin, John/0000-0002-4302-2547	NHLBI NIH HHS [R01HL21544] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021544] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANNAMALAI AE, 1987, BLOOD, V70, P139; BERTINA RM, 1982, THROMB HAEMOSTASIS, V48, P1; BRANSON HE, 1983, LANCET, V2, P1165; BROEKMANS AW, 1985, THROMB HAEMOSTASIS, V53, P273; CHANG CTG, 1994, THROMB HAEMOSTASIS, V71, P461; CHATTOPADHYAY A, 1992, J BIOL CHEM, V267, P12323; COMP PC, 1984, J CLIN INVEST, V74, P2082, DOI 10.1172/JCI111632; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; DISCIPIO RG, 1979, BIOCHEMISTRY-US, V18, P899, DOI 10.1021/bi00572a026; FERNANDEZ JA, 1993, J BIOL CHEM, V268, P16788; Fernandez JA, 1998, BLOOD CELL MOL DIS, V24, P101, DOI 10.1006/bcmd.1998.0175; Folsom AR, 1998, CIRCULATION, V98, P207; GALE AJ, 1997, THROMB HAEMOSTASIS S, P599; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; HACKENG TM, 1994, J BIOL CHEM, V269, P21051; He XH, 1997, BIOCHEMISTRY-US, V36, P3745, DOI 10.1021/bi962315q; HEEB MJ, 1994, P NATL ACAD SCI USA, V91, P2728, DOI 10.1073/pnas.91.7.2728; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; HEEB MJ, 1995, THROMB HAEMOSTASIS, V73, P1121; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; JANE SM, 1991, BLOOD COAGUL FIBRIN, V2, P723, DOI 10.1097/00001721-199112000-00005; KALAFATIS M, 1994, BIOCHEMISTRY-US, V33, P6538, DOI 10.1021/bi00187a022; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; Linse S, 1997, J BIOL CHEM, V272, P14658, DOI 10.1074/jbc.272.23.14658; LUNDWALL A, 1986, P NATL ACAD SCI USA, V83, P6716, DOI 10.1073/pnas.83.18.6716; MAHASANDANA C, 1990, LANCET, V335, P61, DOI 10.1016/0140-6736(90)90201-F; MESTERS RM, 1993, PROTEIN SCI, V2, P1482, DOI 10.1002/pro.5560020912; MESTERS RM, 1991, J BIOL CHEM, V266, P24514; MESTERS RM, 1993, BIOCHEMISTRY-US, V32, P12656, DOI 10.1021/bi00210a014; Nyberg P, 1998, FEBS LETT, V433, P28, DOI 10.1016/S0014-5793(98)00877-1; Sabharwal AK, 1997, J BIOL CHEM, V272, P22037, DOI 10.1074/jbc.272.35.22037; SCHWARZ HP, 1984, BLOOD, V64, P1297; SCHWARZ HP, 1989, THROMB HAEMOSTASIS, V62, P25; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; SHEN L, 1994, J BIOL CHEM, V269, P18735; SOLYMOSS S, 1988, J BIOL CHEM, V263, P14884; THOMMEN D, 1989, SCHWEIZ MED WSCHR, V119, P493; TRACY PB, 1983, P NATL ACAD SCI-BIOL, V80, P2380, DOI 10.1073/pnas.80.8.2380; UPDYKE TV, 1984, J IMMUNOL METHODS, V73, P83, DOI 10.1016/0022-1759(84)90034-6; van Wijnen M, 1998, THROMB HAEMOSTASIS, V80, P930; VANTVEER C, 1995, BLOOD, V85, P1815, DOI 10.1182/blood.V85.7.1815.bloodjournal8571815; vanWijnen M, 1996, THROMB HAEMOSTASIS, V76, P397; WALKER FJ, 1981, J BIOL CHEM, V256, P1128; WALKER FJ, 1990, J BIOL CHEM, V265, P1484; WALKER FJ, 1980, J BIOL CHEM, V255, P5521; WIESEL ML, 1990, THROMB RES, V58, P461, DOI 10.1016/0049-3848(91)90251-Q	47	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36187	36192		10.1074/jbc.274.51.36187	http://dx.doi.org/10.1074/jbc.274.51.36187			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593904	hybrid			2022-12-27	WOS:000084279200023
J	Limatola, C; Mileo, AM; Giovannelli, A; Vacca, F; Ciotti, MT; Mercanti, D; Santoni, A; Eusebi, F				Limatola, C; Mileo, AM; Giovannelli, A; Vacca, F; Ciotti, MT; Mercanti, D; Santoni, A; Eusebi, F			The growth-related gene product beta induces sphingomyelin hydrolysis and activation of c-Jun N-terminal kinase in rat cerebellar granule neurones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN INTERLEUKIN-8 RECEPTORS; STRESS-INDUCED APOPTOSIS; PROGRAMMED CELL-DEATH; PROTEIN-KINASE; ACIDIC SPHINGOMYELINASE; CHEMOKINE RECEPTORS; PHOSPHOLIPASE-D; CERAMIDE; RELEASE	The growth-related gene product beta (GRO beta) is a small chemoattractant cytokine that belongs to the CXC chemokine family, and GRO beta receptors are expressed in the brain, including the cerebellum. We demonstrate that rat cerebellar granule neurones express the GRO beta receptor CXCR2. We also show that, in addition to the known stimulation of a phosphoinositide-specific phospholipase C, GRO beta activates both neutral (N-) and acidic (A-) sphingomyelinases (SMase) and the stress-activated c-Jun N-terminal kinase I (JNK1). Although both exogenous ceramide and bacterial SMase stimulate JNH1, GRO beta-induced JNK1 activation is an event probably in dependent of ceramide generated by A-SMase, since it is maintained in the presence of compounds that block A-SMase activity. This is the first report on the activation of the SMase pathway by chemokines.	Univ La Sapienza, Dip Med Sperimentale & Patol, I-00161 Rome, Italy; Ist Regina Elena, Ctr Ric Sperimentale, Lab Biofis, I-00158 Rome, Italy; Univ Aquila, Dipartimento Med Sperimentale, I-67100 Laquila, Italy; CNR, Ist Neurobiol, I-00137 Rome, Italy	Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR)	Limatola, C (corresponding author), Univ La Sapienza, Dip Med Sperimentale & Patol, Viale Regina Elena 324, I-00161 Rome, Italy.		santoni, angela/K-8997-2016; Mileo, Anna Maria/J-3667-2016; Vacca, Fabrizio/A-5113-2009	santoni, angela/0000-0003-1206-7731; Mileo, Anna Maria/0000-0002-1970-3297; Mercanti, Delio/0000-0001-8301-2098; giovannelli, aldo/0000-0003-1863-6202; limatola, cristina/0000-0001-7504-8197				Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Boldin S, 1997, J NEUROCHEM, V68, P882; BOUCHER LM, 1995, J EXP MED, V181, P2059, DOI 10.1084/jem.181.6.2059; Brenner B, 1998, CELL DEATH DIFFER, V5, P29, DOI 10.1038/sj.cdd.4400307; CAO YH, 1995, J EXP MED, V182, P2069, DOI 10.1084/jem.182.6.2069; CasacciaBonnefil P, 1996, J NEUROSCI RES, V43, P382, DOI 10.1002/(SICI)1097-4547(19960201)43:3<382::AID-JNR13>3.0.CO;2-7; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Courtney MJ, 1997, J NEUROSCI, V17, P4201; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; DDAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DRISCOLL KE, 1995, J LEUKOCYTE BIOL, V58, P359, DOI 10.1002/jlb.58.3.359; Dunstan CAN, 1996, J BIOL CHEM, V271, P32770, DOI 10.1074/jbc.271.51.32770; Giovannelli A, 1998, J NEUROIMMUNOL, V92, P122, DOI 10.1016/S0165-5728(98)00192-1; Glabinski AR, 1997, AM J PATHOL, V150, P617; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HAREL R, 1993, J BIOL CHEM, V268, P14476; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Hida H, 1998, J NEUROSCI, V18, P8712; Hofmeister R, 1997, J BIOL CHEM, V272, P27730, DOI 10.1074/jbc.272.44.27730; Horuk R, 1997, J IMMUNOL, V158, P2882; Huang CS, 1997, J BIOL CHEM, V272, P27753, DOI 10.1074/jbc.272.44.27753; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Ibitayo AI, 1998, AM J PHYSIOL-GASTR L, V275, pG705, DOI 10.1152/ajpgi.1998.275.4.G705; ITO A, 1995, J NEUROCHEM, V65, P463; JONES SA, 1995, FEBS LETT, V364, P211, DOI 10.1016/0014-5793(95)00397-R; KOLESNICK RN, 1987, J BIOL CHEM, V262, P16759; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEE J, 1992, J BIOL CHEM, V267, P16283; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; Limatola C, 1997, BIOCHEM J, V321, P497, DOI 10.1042/bj3210497; LOCATI M, 1994, J BIOL CHEM, V269, P4746; LOZANO J, 1994, J BIOL CHEM, V269, P19200; Manev H, 1997, NEUROCHEM INT, V31, P203, DOI 10.1016/S0197-0186(96)00149-0; OHANIAN J, 1997, FEBS SPEC M AMST JUN; Owen JD, 1997, INT J CANCER, V73, P94, DOI 10.1002/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5; PACINI L, 1993, BIOCHEM J, V289, P269, DOI 10.1042/bj2890269; Pena LA, 1997, BIOCHEM PHARMACOL, V53, P615, DOI 10.1016/S0006-2952(96)00834-9; Ragozzino D, 1998, NEUROREPORT, V9, P3601, DOI 10.1097/00001756-199811160-00011; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; Ransohoff RM, 1997, METHOD ENZYMOL, V287, P319; SCHRAW W, 1995, BIOCHEMISTRY-US, V34, P13760, DOI 10.1021/bi00042a006; Schwarz A, 1997, J NEUROSCI, V17, P2929; SOZZANI S, 1994, BLOOD, V84, P3895, DOI 10.1182/blood.V84.11.3895.bloodjournal84113895; Tani M, 1996, J CLIN INVEST, V98, P529, DOI 10.1172/JCI118821; VAN MEIR E, 1992, CANCER RES, V52, P4297; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Watson A, 1998, J NEUROSCI, V18, P751; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	55	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36537	36543		10.1074/jbc.274.51.36537	http://dx.doi.org/10.1074/jbc.274.51.36537			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593952	hybrid			2022-12-27	WOS:000084279200071
J	Oren, M				Oren, M			Regulation of the p53 tumor suppressor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							WILD-TYPE P53; DNA-BINDING FUNCTION; CELL-CYCLE; ATAXIA-TELANGIECTASIA; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; TERMINAL DOMAIN; UV IRRADIATION; MESSENGER-RNA; G(1) ARREST		Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Oren, M (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.			Oren, Moshe/0000-0003-4311-7172	NCI NIH HHS [R01 CA-40099] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040099] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Almog Nava, 1998, Biochimica et Biophysica Acta, V1378, pR43; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; BAYLE JH, 1995, P NATL ACAD SCI USA, V92, P5729, DOI 10.1073/pnas.92.12.5729; Blattner C, 1999, ONCOGENE, V18, P1723, DOI 10.1038/sj.onc.1202480; Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen JD, 1996, MOL CELL BIOL, V16, P2445; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fontoura BMA, 1997, MOL CELL BIOL, V17, P3146, DOI 10.1128/MCB.17.6.3146; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Fu LN, 1996, EMBO J, V15, P4392, DOI 10.1002/j.1460-2075.1996.tb00812.x; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GINSBERG D, 1990, ONCOGENE, V5, P1285; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hansen R, 1997, CURR OPIN GENET DEV, V7, P46, DOI 10.1016/S0959-437X(97)80108-6; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Haupt Y, 1996, EMBO J, V15, P1596, DOI 10.1002/j.1460-2075.1996.tb00504.x; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Hupp TR, 1999, CELL MOL LIFE SCI, V55, P88, DOI 10.1007/s000180050272; HUPP TR, 1995, J BIOL CHEM, V270, P18165, DOI 10.1074/jbc.270.30.18165; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Jayaraman L, 1999, CELL MOL LIFE SCI, V55, P76, DOI 10.1007/s000180050271; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Juven-Gershon T, 1999, MOL MED, V5, P71, DOI 10.1007/BF03402141; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KHANNA KK, 1995, ONCOGENE, V11, P609; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kubbutat MHG, 1999, CELL GROWTH DIFFER, V10, P87; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; LANDERS JE, 1994, ONCOGENE, V9, P2745; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Leri A, 1999, AM J PATHOL, V154, P567, DOI 10.1016/S0002-9440(10)65302-3; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Lozano G, 1998, BBA-REV CANCER, V1377, pM55, DOI 10.1016/S0304-419X(97)00037-1; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; LUNA RMD, 1995, NATURE, V378, P203; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Maki CG, 1996, CANCER RES, V56, P2649; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Mayo LD, 1997, CANCER RES, V57, P5013; Meek DW, 1998, CELL SIGNAL, V10, P159, DOI 10.1016/S0898-6568(97)00119-8; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Offer H, 1999, FEBS LETT, V450, P197, DOI 10.1016/S0014-5793(99)00505-0; Ohnishi T, 1996, J BIOL CHEM, V271, P14510, DOI 10.1074/jbc.271.24.14510; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prives C, 1999, J PATHOL, V187, P112; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; REISMAN D, 1993, CELL GROWTH DIFFER, V4, P57; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaulian E, 1997, ONCOGENE, V15, P2717, DOI 10.1038/sj.onc.1201453; SHAULSKY G, 1990, ONCOGENE, V5, P1707; Shaw P, 1996, ONCOGENE, V12, P921; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; SMITH ML, 1995, ONCOGENE, V10, P1053; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; WOLKOWICZ R, 1995, P NATL ACAD SCI USA, V92, P6842, DOI 10.1073/pnas.92.15.6842; Wu L, 1997, MOL MED, V3, P441, DOI 10.1007/BF03401691; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	91	464	487	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36031	36034		10.1074/jbc.274.51.36031	http://dx.doi.org/10.1074/jbc.274.51.36031			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593882	hybrid			2022-12-27	WOS:000084279200001
J	Yahiro, K; Niidome, T; Kimura, M; Hatakeyama, T; Aoyagi, H; Kurazono, H; Imagawa, K; Wada, A; Moss, J; Hirayama, T				Yahiro, K; Niidome, T; Kimura, M; Hatakeyama, T; Aoyagi, H; Kurazono, H; Imagawa, K; Wada, A; Moss, J; Hirayama, T			Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLATING CYTOTOXIN; LECTIN; CELLS; GASTRITIS; DISEASE; UREASE; ZETA; PH	Helicobacter pylori, a Gram-negative gastric bacterium, secretes VacA, a cytotoxin that causes vacuolar degeneration of susceptible cells. Velocity sedimentation analysis showed that treatment of VacA at alkaline pH led to disassembly of VacA oligomers, an observation reported previously for acid-treated VacA, Exposure of VacA to acid or alkali increased its binding to AZ-521 cells, as shown by indirect immunofluorescence and flow cytometry, Moreover, immunoprecipitates with polyclonal antibodies against VacA from AZ-521 cells previously exposed to acid- or alkali-treated VacA had a 250-kDa glycoprotein containing galactose-beta(1-3)-N-acetylgalactosamine and galactose-beta(1-4)-N-acetylglucosamine, p250, purified by chromatography on peanut agglutinin affinity and Superose 6 columns, contained N-terminal and internal amino acid sequences of YRQQRKLVEEIGWSYT and LIIQDHILEATQDDY, respectively. These sequences are identical to those of a receptor protein-tyrosine phosphatase (RPTP beta/PTP zeta); in agreement, p250 reacted with anti-human RPTP beta monoclonal antibody. Immunoprecipitation with antihuman RPTP beta antibody of solubilized membrane preparations previously incubated with VacA or heat-inactivated VacA demonstrated that RPTP beta bound native, but not denatured, VacA. Acidic and alkaline treatments were associated with activation of VacA and increased binding to the cell surface RPTP beta.	Nagasaki Univ, Inst Trop Med, Dept Bacteriol, Nagasaki 8528523, Japan; Nagasaki Univ, Fac Engn, Dept Appl Chem, Nagasaki 8528523, Japan; Univ Tsukuba, Dept Microbiol, Inst Basic Med Sci, Tsukuba, Ibaraki 3050006, Japan; Otsuka Pharmaceut Co Ltd, Tokushima 7710192, Japan; NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	Nagasaki University; Nagasaki University; University of Tsukuba; Otsuka Pharmaceutical; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hirayama, T (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Bacteriol, Nagasaki 8528523, Japan.	hirayama@net.nagasaki-u.ac.jp	Niidome, Takuro/F-1508-2010	Niidome, Takuro/0000-0002-8070-8708; Hatakeyama, Tomomitsu/0000-0002-9505-1980; Yahiro, Kinnosuke/0000-0002-9813-0780	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000659, ZIAHL000659] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASELLI M, 1989, AM J GASTROENTEROL, V84, P511; CHEN XG, 1983, AM J CLIN PATHOL, V86, P575; COVER TL, 1991, INFECT IMMUN, V59, P1264, DOI 10.1128/IAI.59.4.1264-1270.1991; COVER TL, 1992, J BIOL CHEM, V267, P10570; COVER TL, 1994, J BIOL CHEM, V269, P10566; Cover TL, 1997, J CELL BIOL, V138, P759, DOI 10.1083/jcb.138.4.759; CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X; Czajkowsky DM, 1999, P NATL ACAD SCI USA, V96, P2001, DOI 10.1073/pnas.96.5.2001; DEBERNARD M, 1995, J BIOL CHEM, V270, P23937, DOI 10.1074/jbc.270.41.23937; EATON KA, 1991, INFECT IMMUN, V59, P2470, DOI 10.1128/IAI.59.7.2470-2475.1991; FRIERI G, 1995, DIGESTION, V56, P107, DOI 10.1159/000201229; GHIRA P, 1995, INFECT IMMUN, V63, P4154, DOI 10.1128/IAI.63.10.4154-4160.1995; HESSEY SJ, 1990, GUT, V31, P134, DOI 10.1136/gut.31.2.134; Iwamatsu A, 1996, J BIOCHEM-TOKYO, V120, P29; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVY JB, 1993, J BIOL CHEM, V268, P10573; MANETTI R, 1995, INFECT IMMUN, V63, P4476, DOI 10.1128/IAI.63.11.4476-4480.1995; Massari P, 1998, INFECT IMMUN, V66, P3981, DOI 10.1128/IAI.66.8.3981-3984.1998; NEUROHR KJ, 1980, J BIOL CHEM, V255, P9205; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Pai R, 1998, AM J PATHOL, V152, P1617; SHIBUYA N, 1988, J BIOL CHEM, V263, P728; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; SMOOT DT, 1993, INFECT IMMUN, V61, P350, DOI 10.1128/IAI.61.1.350-355.1993; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; WANG WC, 1988, J BIOL CHEM, V263, P4576; Yahiro K, 1997, BIOCHEM BIOPH RES CO, V238, P629, DOI 10.1006/bbrc.1997.7345; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65	31	140	151	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36693	36699		10.1074/jbc.274.51.36693	http://dx.doi.org/10.1074/jbc.274.51.36693			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593974	hybrid			2022-12-27	WOS:000084279200093
J	Li, ZG; Kim, SH; Higgins, JMG; Brenner, MB; Sacks, DB				Li, ZG; Kim, SH; Higgins, JMG; Brenner, MB; Sacks, DB			IQGAP1 and calmodulin modulate E-cadherin function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; CGS 9343B; PROTEIN; ACTIN; CDC42; BINDING; COMPLEX; ALPHA(E)BETA(7); IDENTIFICATION; CYTOKINESIS	Ca2+-dependent cell-cell adhesion is mediated by the cadherin family of transmembrane proteins. Adhesion is achieved by homophilic interaction of the extracellular domains of cadherins on adjacent cells, with the cytoplasmic regions serving to couple the complex to the cytoskeleton. IQGAP1, a novel RasGAP-related protein that interacts with the cytoskeleton, binds to actin, members of the Rho family, and E-cadherin, Calmodulin binds to IQGAP1 and regulates its association with Cdc42 and actin. Here we demonstrate competition between calmodulin and E-cadherin for binding to IQGAP1 both in vitro and in a normal cellular milieu. Immunocytochemical analysis in MCF-7 (E-cadherin positive) and MDA-MB-231 (E-cadherin negative) epithelial cells revealed that E-cadherin is required for accumulation of IQGAP1 at cell-cell junctions. The cell-permeable calmodulin antagonist CGS9343B significantly increased IQGAP1 at areas of MCF-7 cell-cell contact, with a concomitant decrease in the amount of E-cadherin at cell-cell junctions. Analysis of E-cadherin function revealed that CGS9343B significantly decreased homophilic E-cadherin adhesion, On the basis of these data, we propose that disruption of the binding of calmodulin to IQGAP1 enhances the association of IQGAP1 with components of the cadherin-catenin complex at cell-cell junctions, resulting in impaired E-cadherin function.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, DB (corresponding author), Brigham & Womens Hosp, Dept Pathol, Tthorn 530,75 Francis St, Boston, MA 02115 USA.			Sacks, David/0000-0003-3100-0735; Higgins, Jonathan/0000-0001-6622-8268	NCI NIH HHS [CA 75205] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA075205, R01CA075205] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		APODACA G, 1994, J BIOL CHEM, V269, P19005; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cohen P, 1988, CALMODULIN; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Epp JA, 1997, CURR BIOL, V7, P921, DOI 10.1016/S0960-9822(06)00411-8; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; GEHM BD, 1991, BIOCHEMISTRY-US, V30, P11302, DOI 10.1021/bi00111a016; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Higgins JMG, 1998, J CELL BIOL, V140, P197, DOI 10.1083/jcb.140.1.197; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Jiang WG, 1996, BRIT J SURG, V83, P437, DOI 10.1002/bjs.1800830404; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; MOTOHASHI N, 1991, ANTICANCER RES, V11, P1125; Moyers JS, 1997, J BIOL CHEM, V272, P11832, DOI 10.1074/jbc.272.18.11832; NORMAN JA, 1987, MOL PHARMACOL, V31, P535; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; PIERCEALL WE, 1995, ONCOGENE, V11, P1319; REDDY GPV, 1992, BIOCHEMISTRY-US, V31, P10426, DOI 10.1021/bi00158a002; RIMM DL, 1994, BIOCHEM BIOPH RES CO, V200, P1754, DOI 10.1006/bbrc.1994.1656; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHASHKIN P, 1995, J BIOL CHEM, V270, P25613, DOI 10.1074/jbc.270.43.25613; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TANAKA T, 1982, MOL PHARMACOL, V22, P403; Taules M, 1998, J BIOL CHEM, V273, P33279, DOI 10.1074/jbc.273.50.33279; Tolosa E, 1996, J IMMUNOL METHODS, V192, P165, DOI 10.1016/0022-1759(96)00042-7; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; Weiss B, 1980, Ann N Y Acad Sci, V356, P319, DOI 10.1111/j.1749-6632.1980.tb29621.x; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517	34	119	121	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37885	37892		10.1074/jbc.274.53.37885	http://dx.doi.org/10.1074/jbc.274.53.37885			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608854	hybrid			2022-12-27	WOS:000084528000054
J	Saavedra, HI; Fukasawa, K; Conn, CW; Stambrook, PJ				Saavedra, HI; Fukasawa, K; Conn, CW; Stambrook, PJ			MAPK mediates RAS-induced chromosome instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NIH 3T3 CELLS; SPINDLE ASSEMBLY CHECKPOINT; XENOPUS-OOCYTE MATURATION; GTP-BINDING PROTEINS; WILD-TYPE P53; HA-RAS; GENOMIC INSTABILITY; GENE AMPLIFICATION; SIGNALING PATHWAY	The generation of micronuclei is a reflection of DNA damage, defective mitosis, and loss of genetic material, The involvement of the MAPK pathway in mediating v-ras-induced micronuclei in NIH 3T3 cells was examined by inhibiting MAPK activation, Conversely, the MAPK pathway was constitutively activated by infecting cells with a v-mos retrovirus, Micronucleus formation was inhibited by the MAPK kinase inhibitors PD98059 and U0126, but not by wortmannin, an inhibitor of the Ras/phosphatidylinositol 3-kinase pathway. Transduction of cells with v-mos resulted in an increase in micronucleus formation, also consistent with the involvement of the MAPK pathway. Staining with the anti-centromeric CREST antibody revealed that instability induced by constitutive activation of MAPK is due predominantly to aberrant mitotic segregation, since most of the micronuclei were CREST-positive, reflective of lost chromosomes. A significant fraction of the micronuclei were CREST-negative, reflective of lost acentric chromosome fragments. Some of the instability observed was due to mitotic events, consistent with the increased formation of bi-nucleated cells, which result from perturbations of the mitotic spindle and failure to undergo cytokinesis, This chromosome instability, therefore, is a consequence of mitotic aberrations, mediated by the MAPK pathway, including centrosome amplification and formation of mitotic chromosome bridges.	Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Stambrook, PJ (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA.				NATIONAL CANCER INSTITUTE [R01CA065769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250] Funding Source: NIH RePORTER; NCI NIH HHS [CA65769] Funding Source: Medline; NIEHS NIH HHS [ES07250] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; Basu S, 1998, J BIOL CHEM, V273, P30419, DOI 10.1074/jbc.273.46.30419; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CAMPBELL MS, 1995, J CELL BIOL, V129, P1195, DOI 10.1083/jcb.129.5.1195; Chen CY, 1998, J BIOL CHEM, V273, P16700, DOI 10.1074/jbc.273.27.16700; Clark GJ, 1997, J BIOL CHEM, V272, P1677, DOI 10.1074/jbc.272.3.1677; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DARZYNKIEWICZ Z, 1997, CURRENT PROTOCOLS CY, V1; Daum JR, 1998, J BIOL CHEM, V273, P30622, DOI 10.1074/jbc.273.46.30622; DEGRASSI F, 1988, MUTAT RES, V203, P339, DOI 10.1016/0165-1161(88)90030-1; DENKO N, 1995, SOMAT CELL MOLEC GEN, V21, P241, DOI 10.1007/BF02255779; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEVRIES JE, 1993, CANCER GENET CYTOGEN, V67, P35, DOI 10.1016/0165-4608(93)90041-J; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; FENECH M, 1989, MUTAGENESIS, V4, P98, DOI 10.1093/mutage/4.2.98; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Fukasawa K, 1997, MOL CELL BIOL, V17, P506, DOI 10.1128/MCB.17.1.506; FUKASAWA K, 1995, P NATL ACAD SCI USA, V92, P3430, DOI 10.1073/pnas.92.8.3430; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; Goillot E, 1997, P NATL ACAD SCI USA, V94, P3302, DOI 10.1073/pnas.94.7.3302; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; GUDI R, 1990, MUTAT RES, V234, P263, DOI 10.1016/0165-1161(90)90038-P; GULBINS E, 1995, IMMUNITY, V2, P341, DOI 10.1016/1074-7613(95)90142-6; HACCARD O, 1995, DEV BIOL, V168, P677, DOI 10.1006/dbio.1995.1112; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; HAGAG N, 1990, ONCOGENE, V5, P1481; Harlow E., 1988, ANTIBODIES LAB MANUA; HENNIG UGG, 1988, MUTAT RES, V203, P405, DOI 10.1016/0165-1161(88)90013-1; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; ICHIKAWA T, 1990, CANCER RES, V50, P6349; ICHIKAWA T, 1991, PROSTATE, V18, P163, DOI 10.1002/pros.2990180209; JESSUS C, 1991, DEVELOPMENT, V111, P813; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; KOONG AC, 1994, CANCER RES, V54, P5273; KOSAKO H, 1994, J BIOL CHEM, V269, P28354; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LARIN Z, 1994, HUM MOL GENET, V3, P689, DOI 10.1093/hmg/3.5.689; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Liu HS, 1998, BRIT J CANCER, V77, P1777, DOI 10.1038/bjc.1998.296; LIU HS, 1992, CANCER RES, V52, P983; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MILLER BM, 1993, MUTAGENESIS, V8, P35, DOI 10.1093/mutage/8.1.35; MILLER BM, 1991, MUTAGENESIS, V6, P297, DOI 10.1093/mutage/6.4.297; MILLER BM, 1990, MUTAGENESIS, V5, P411, DOI 10.1093/mutage/5.4.411; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MINDEN A, 1997, BIOCHIM BIOPHYS ACTA, V1333, pF86; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; NEBREDA AR, 1993, FEBS LETT, V333, P183, DOI 10.1016/0014-5793(93)80401-F; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; NUSSE M, 1994, METHOD CELL BIOL, V42, P149; OKAZAKI K, 1992, EMBO J, V11, P2447, DOI 10.1002/j.1460-2075.1992.tb05309.x; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; POSADA J, 1991, MOL CELL BIOL, V11, P2517, DOI 10.1128/MCB.11.5.2517; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RUSSO CA, 1995, CANCER RES, V55, P1122; Sagata N, 1997, BIOESSAYS, V19, P13, DOI 10.1002/bies.950190105; SCHRIEVERSCHWEMMER G, 1994, MUTAGENESIS, V9, P333, DOI 10.1093/mutage/9.4.333; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; Skibbens RV, 1998, ANNU REV GENET, V32, P307, DOI 10.1146/annurev.genet.32.1.307; THOMSON EJ, 1988, MUTAGENESIS, V3, P415, DOI 10.1093/mutage/3.5.415; Trent JC, 1996, EMBO J, V15, P4497, DOI 10.1002/j.1460-2075.1996.tb00827.x; VANDENBERG S, 1991, MOL CARCINOGEN, V4, P460, DOI 10.1002/mc.2940040609; Wang XM, 1997, J CELL BIOL, V137, P433, DOI 10.1083/jcb.137.2.433; WANI MA, 1994, CANCER RES, V54, P2504; Wani MA, 1997, SOMAT CELL MOLEC GEN, V23, P123, DOI 10.1007/BF02679971; WINDLE BE, 1992, MUTAT RES, V276, P199, DOI 10.1016/0165-1110(92)90009-X; WOESSNER RD, 1990, CANCER RES, V50, P2901; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547	87	83	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38083	38090		10.1074/jbc.274.53.38083	http://dx.doi.org/10.1074/jbc.274.53.38083			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608877	hybrid			2022-12-27	WOS:000084528000077
J	Hishikawa, K; Oemar, BS; Tanner, FC; Nakaki, T; Luscher, TF; Fujii, T				Hishikawa, K; Oemar, BS; Tanner, FC; Nakaki, T; Luscher, TF; Fujii, T			Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; IMMEDIATE EARLY GENE; ALPHA ANTAGONIST; IN-VIVO; EXPRESSION; INHIBITION; FAMILY; TUMORS; DEATH; BCL-2	Connective tissue growth factor (CTGF) is a member of an emerging CCN gene family that is implicated in various diseases associated with fibro-proliferative disorder including scleroderma and atherosclerosis. The function of CTGF in human cancer is largely unknown. We now show that CTGF induces apoptosis in the human breast cancer cell line MCF-7. CTGF mRNA was completely absent in MCF-7 but strongly induced by treatment with transforming growth factor beta (TGF-beta). TGF-beta by itself induced apoptosis in MCF-7, and this effect was reversed by co-treatment with CTGF antisense oligonucleotide. Overexpression of CTGF gene in transiently transfected MCF-7 cells significantly augmented apoptosis. Moreover, recombinant CTGF protein significantly enhanced apoptosis in MCF-7 cells as evaluated by DNA fragmentation, Tdt-mediated dUTP biotin nick end-labeling staining, flow cytometry analysis, and nuclear staining using Hoechst 33258. Finally, recombinant CTGF showed no effect on Bar protein expression but significantly reduced Bcl2 protein expression. Taken together, these results suggest that CTGF is a major inducer of apoptosis in the human breast cancer cell line MCF-7 and that TGF-beta-induced apoptosis in MCF-7 cells is mediated, in part, by CTGF.	Teikyo Univ, Sch Med, Dept Pharmacol, Itabashi Ku, Tokyo 1738605, Japan; Univ Zurich, Inst Physiol, Zurich, Switzerland; Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland	Teikyo University; University of Zurich; University of Zurich; University Zurich Hospital	Hishikawa, K (corresponding author), Teikyo Univ, Sch Med, Dept Pharmacol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.		Hishikawa, Keiichi/A-8661-2011; Nakaki, Toshio/C-4832-2009	Oemar, Barry/0000-0003-1996-5817				Antoshina Elena, 1997, In Vitro Cellular and Developmental Biology Animal, V33, P212; Babic AM, 1999, MOL CELL BIOL, V19, P2958; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; CHEN H, 1996, J CELL BIOCHEM, V61, P19; Choi KS, 1998, HEPATOLOGY, V27, P415, DOI 10.1002/hep.510270215; DelBufalo D, 1996, J CLIN INVEST, V98, P1165, DOI 10.1172/JCI118900; Eck KM, 1998, BRIT J CANCER, V77, P2129, DOI 10.1038/bjc.1998.357; Frazier KS, 1997, INT J BIOCHEM CELL B, V29, P153, DOI 10.1016/S1357-2725(96)00127-6; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hashimoto Y, 1998, J EXP MED, V187, P289, DOI 10.1084/jem.187.3.289; HISHIKAWA K, 1995, FEBS LETT, V360, P291, DOI 10.1016/0014-5793(95)00124-R; Hishikawa K, 1997, CIRCULATION, V96, P3610; Hu SM, 1998, J BIOL CHEM, V273, P29648, DOI 10.1074/jbc.273.45.29648; Igarashi A, 1998, J CUTAN PATHOL, V25, P143, DOI 10.1111/j.1600-0560.1998.tb01706.x; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; KHOSLA S, 1994, ENDOCRINOLOGY, V135, P1887, DOI 10.1210/en.135.5.1887; Kubo M, 1998, BRIT J DERMATOL, V139, P192; Kurokawa H, 1999, ONCOL REP, V6, P33; KYPRIANOU N, 1991, CANCER RES, V51, P162; NAUMOVSKI L, 1994, BLOOD, V83, P2261; Nishida T, 1998, BIOCHEM BIOPH RES CO, V247, P905, DOI 10.1006/bbrc.1998.8895; Noviello C, 1996, CLIN CANCER RES, V2, P1601; Oemar BS, 1997, ARTERIOSCL THROM VAS, V17, P1483, DOI 10.1161/01.ATV.17.8.1483; Oemar BS, 1997, CIRCULATION, V95, P831; OHMORI T, 1993, BIOCHEM BIOPH RES CO, V192, P30, DOI 10.1006/bbrc.1993.1377; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; PERRY RR, 1995, BRIT J CANCER, V72, P1441, DOI 10.1038/bjc.1995.527; PIETENPOL JA, 1994, CANCER RES, V54, P3714; RYSECK RP, 1991, CELL GROWTH DIFFER, V2, P225; Sakakura C, 1996, INT J CANCER, V67, P101, DOI 10.1002/(SICI)1097-0215(19960703)67:1<101::AID-IJC17>3.0.CO;2-H; Samejima K, 1999, J BIOL CHEM, V274, P4335, DOI 10.1074/jbc.274.7.4335; Sathyamoorthy N, 1998, ANTICANCER RES, V18, P2449; Scholz G, 1996, MOL CELL BIOL, V16, P481; Shimo T, 1998, J BIOCHEM-TOKYO, V124, P130, DOI 10.1093/oxfordjournals.jbchem.a022071; Tamatani T, 1998, BIOCHEM BIOPH RES CO, V251, P748, DOI 10.1006/bbrc.1998.9543; Tatsuta M, 1998, BRIT J CANCER, V78, P857, DOI 10.1038/bjc.1998.593; Theile M, 1996, ONCOGENE, V13, P677; Toma S, 1998, INT J CANCER, V78, P86, DOI 10.1002/(SICI)1097-0215(19980925)78:1<86::AID-IJC14>3.0.CO;2-3; TSUKADA T, 1995, BIOCHEM BIOPH RES CO, V210, P1076, DOI 10.1006/bbrc.1995.1766; Wang Q, 1998, EXP CELL RES, V238, P177, DOI 10.1006/excr.1997.3820; WARRI AM, 1993, JNCI-J NATL CANCER I, V85, P1412, DOI 10.1093/jnci/85.17.1412; Wenger C, 1999, ONCOGENE, V18, P1073, DOI 10.1038/sj.onc.1202395; YANG GP, 1991, CELL GROWTH DIFFER, V2, P351	47	138	162	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37461	37466		10.1074/jbc.274.52.37461	http://dx.doi.org/10.1074/jbc.274.52.37461			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601320	hybrid			2022-12-27	WOS:000084382700091
J	Wang, YR; Windh, RT; Chen, CA; Manning, DR				Wang, YR; Windh, RT; Chen, CA; Manning, DR			N-myristoylation and beta gamma play roles beyond Anchorage in the palmitoylation of the G protein alpha(o) subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ATTACHMENT; LIPID MODIFICATIONS; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; ADRENERGIC-RECEPTOR; ADENYLATE-CYCLASE; ADP-RIBOSYLATION; HORMONE RECEPTOR; PERTUSSIS TOXIN; FUSION PROTEIN	Many of the alpha subunits of heterotrimeric GTP-binding regulatory proteins (G proteins) are palmitoylated, a modification proposed to play a key role in the stable anchorage of the subunits to the plasma membrane. Palmitoylation of alpha subunits from the G(i) family is preceded by N-myristoylation, which alone or together with beta gamma probably supports a reversible interaction of the alpha subunit with membrane as a prerequisite to the eventual incorporation of palmitate, Previous studies have not addressed, however, the question of whether membrane association alone, carried out through N-myristoylation, interaction with beta gamma, or other events, is sufficient for palmitoylation, We report here for alpha(o) that it is not. We found that N-myristoylation is required for palmitoylation at least in part because it supports events subsequent to membrane attachment. Mutants of alpha(o) designed to target the subunit to membrane without an N-myristoyl group are unable to be palmitoylated as evaluated by incorporation of [H-3]palmitate. Mutants of alpha(o) unable to interact normally with beta gamma yet still attach to membrane demonstrate that beta gamma, in contrast, is not required for palmitoylation. beta gamma becomes necessary, however, when the N-myristoyl group is absent. Our results suggest that N-myristoylation and beta gamma, while almost certainly relevant to the reversible interaction of alpha(o) with membrane, also play at least partly overlapping, post-anchorage roles in palmitoylation.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Manning, DR (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	manning@pharm.med.upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014654] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53156] Funding Source: Medline; NIMH NIH HHS [MH14654] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BERTIN B, 1994, P NATL ACAD SCI USA, V91, P8827, DOI 10.1073/pnas.91.19.8827; Bhamre S, 1998, J PHARMACOL EXP THER, V286, P1482; Burt AR, 1998, J BIOL CHEM, V273, P10367, DOI 10.1074/jbc.273.17.10367; BUTKERAIT P, 1995, J BIOL CHEM, V270, P18691, DOI 10.1074/jbc.270.31.18691; CARTY DJ, 1994, METHOD ENZYMOL, V237, P63; CASEY PJ, 1994, CURR OPIN CELL BIOL, V6, P219, DOI 10.1016/0955-0674(94)90139-2; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; CHEN CA, 1999, CRC METH SIG TRANS, P99; CODINA J, 1986, FEBS LETT, V207, P187, DOI 10.1016/0014-5793(86)81486-7; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; DEGTYAREV MY, 1993, J BIOL CHEM, V268, P23769; DEGTYAREV MY, 1993, BIOCHEMISTRY-US, V32, P8057, DOI 10.1021/bi00083a001; DENKER BM, 1992, J BIOL CHEM, V267, P6272; Drmota T, 1998, J BIOL CHEM, V273, P24000, DOI 10.1074/jbc.273.37.24000; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; FARGIN A, 1988, NATURE, V335, P358, DOI 10.1038/335358a0; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; GALBIATI F, 1994, BIOCHEM J, V303, P697, DOI 10.1042/bj3030697; Galbiati F, 1996, BIOCHEM J, V313, P717, DOI 10.1042/bj3130717; GAUTAM N, 1989, SCIENCE, V244, P971, DOI 10.1126/science.2499046; GRASSIE MA, 1994, BIOCHEM J, V302, P913, DOI 10.1042/bj3020913; HALLAK H, 1994, J BIOL CHEM, V269, P4571; Huang CF, 1999, P NATL ACAD SCI USA, V96, P412, DOI 10.1073/pnas.96.2.412; Huang CF, 1997, MOL BIOL CELL, V8, P2365, DOI 10.1091/mbc.8.12.2365; Iiri T, 1996, P NATL ACAD SCI USA, V93, P14592, DOI 10.1073/pnas.93.25.14592; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; JONES DT, 1987, J BIOL CHEM, V262, P14241; JONES TLZ, 1990, P NATL ACAD SCI USA, V87, P568, DOI 10.1073/pnas.87.2.568; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; KWONG J, 1995, BIOCHEM BIOPH RES CO, V207, P868, DOI 10.1006/bbrc.1995.1266; LEE E, 1992, J BIOL CHEM, V267, P1212; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LINDER ME, 1991, J BIOL CHEM, V266, P4654; LOUNSBURY KM, 1993, J BIOL CHEM, V268, P3494; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Morales J, 1998, MOL BIOL CELL, V9, P1, DOI 10.1091/mbc.9.1.1; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; NADLER MJS, 1993, BIOCHEMISTRY-US, V32, P9250, DOI 10.1021/bi00086a034; NEER EJ, 1984, J BIOL CHEM, V259, P4222; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; PAIGE LA, 1990, BIOCHEMISTRY-US, V29, P10566, DOI 10.1021/bi00498a021; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Song KS, 1997, CELL MOL BIOL, V43, P293; Stanislaus D, 1997, MOL ENDOCRINOL, V11, P738, DOI 10.1210/me.11.6.738; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; TSAI SC, 1984, J BIOL CHEM, V259, P5320; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; VEIT M, 1994, FEBS LETT, V339, P160, DOI 10.1016/0014-5793(94)80406-0; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351	62	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37435	37442		10.1074/jbc.274.52.37435	http://dx.doi.org/10.1074/jbc.274.52.37435			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601316	hybrid			2022-12-27	WOS:000084382700087
J	Bubb, MR; Lenox, RH; Edison, AS				Bubb, MR; Lenox, RH; Edison, AS			Phosphorylation-dependent conformational changes induce a switch in the actin-binding function of MARCKS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SUBSTRATE MARCKS; RAT-BRAIN; CALMODULIN; PEPTIDES; MEMBRANE; MICE; ASSOCIATION; EXPRESSION; RECEPTOR	Phosphorylation of myristoylated alanine-rich protein kinase C substrate (MARCKS) by protein kinase C eliminates actin filament cross-linking activity, but residual filament binding activity docks phosphorylated MARCKS on filamentous actin. The postulated actin-binding region of MARCKS, which includes a Ca2+-calmodulin-binding site, has been portrayed with alpha-helical structure, analogous to other calmodulin-binding domains. Previous speculation suggested that MARCKS may dimerize to form the two functional actin-binding sites requisite for cross-linking activity. Contrary to these hypotheses, we show that MARCKS peptide with actin-cross-linking activity has an extended structure in aqueous solution but assumes a more compact structure upon phosphorylation. We hypothesize that structural changes in the MARCKS peptide induced by phosphorylation create a dynamic structure that, on average, has only one actin-binding site. Moreover, independent of the state of phosphorylation, this peptide is monomeric rather than dimeric, implying that two distinct actin-binding sites are responsible for the actin-crosslinking activity of unphosphorylated MARCKS. These studies uniquely elucidate the mechanism by which phosphorylation of MARCKS induces structural changes and suggest how these structural changes determine biological activity.	Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Univ Florida, Dept Med, Gainesville, FL 32610 USA; Univ Florida, Dept Biochem, Gainesville, FL 32610 USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Edison, AS (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.			Edison, Arthur/0000-0002-5686-2350				ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Blackshear PJ, 1997, EXP NEUROL, V145, P46, DOI 10.1006/exnr.1997.6475; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BUBB MR, 1991, J BIOL CHEM, V266, P3820; Callihan D, 1996, J MAGN RESON SER B, V112, P82, DOI 10.1006/jmrb.1996.0114; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; EDELSTEIN SJ, 1967, J BIOL CHEM, V242, P306; GEORGE DJ, 1992, J BIOL CHEM, V267, P24879; GRAFF JM, 1989, SCIENCE, V246, P503, DOI 10.1126/science.2814478; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HEEMSKERK FMJ, 1993, BIOCHEM BIOPH RES CO, V190, P236, DOI 10.1006/bbrc.1993.1036; HERGET T, 1995, EUR J BIOCHEM, V233, P448, DOI 10.1111/j.1432-1033.1995.448_2.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KIRSCHNER MW, 1971, BIOCHEMISTRY-US, V10, P1900, DOI 10.1021/bi00786a027; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lenox RH, 1996, J CLIN PSYCHIAT, V57, P23; MAHONEY CW, 1995, CELL SIGNAL, V7, P679, DOI 10.1016/0898-6568(95)00043-O; MANENTI S, 1992, J BIOL CHEM, V267, P22310; Matsubara M, 1998, FEBS LETT, V421, P203, DOI 10.1016/S0014-5793(97)01557-3; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; McNamara RK, 1997, J COMP NEUROL, V379, P48; McNamara RK, 1998, J COMP NEUROL, V397, P337; McNamara RK, 1998, P NATL ACAD SCI USA, V95, P14517, DOI 10.1073/pnas.95.24.14517; MIICK SM, 1992, NATURE, V359, P653, DOI 10.1038/359653a0; Porumb T, 1997, EUR BIOPHYS J BIOPHY, V25, P239, DOI 10.1007/s002490050036; Qin ZH, 1996, BIOCHEMISTRY-US, V35, P2917, DOI 10.1021/bi9521452; Qin ZH, 1996, BIOCHEMISTRY-US, V35, P13272, DOI 10.1021/bi961747y; ROBINSON PJ, 1991, MOL NEUROBIOL, V5, P87, DOI 10.1007/BF02935541; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; Watson DG, 1996, J NEUROCHEM, V67, P767; Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709; Wuthrich K, 1986, NMR PROTEINS NUCL AC	39	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36472	36478		10.1074/jbc.274.51.36472	http://dx.doi.org/10.1074/jbc.274.51.36472			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593944	hybrid			2022-12-27	WOS:000084279200063
J	Friedman, KJ; Kole, J; Cohn, JA; Knowles, MR; Silverman, LM; Kole, R				Friedman, KJ; Kole, J; Cohn, JA; Knowles, MR; Silverman, LM; Kole, R			Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; EPITHELIAL-CELLS; RECEPTOR GENE; GLOBIN GENE; MOLECULAR MECHANISMS; MEDIATED INSERTION; PULMONARY-DISEASE; BETA-THALASSEMIA; LEPTIN RECEPTOR; POINT MUTATION	The CFTR splicing mutation 3849 + 10 kb C --> T creates a novel donor site 10 kilobases (kb) into intron 19 of the gene and is one of the more common splicing mutations that causes cystic fibrosis (CF). It has an elevated prevalence among patients with atypically mild disease and normal sweat electrolytes and is especially prominent in Ashkenazi Jews. This class of splicing mutations, reported in several genes, involves novel splice sites activated deep within introns while leaving wild type splice elements intact. CFTR cDNA constructs that modeled the 3849 + 10 kb C --> T mutation were expressed in 3T3 mouse fibroblasts and in CFT1 human tracheal and C127 mouse mammary epithelial cells. In all three cell types, aberrant splicing of CFTR pre-mRNA was comparable to that reported in vivo in CF patients. Treatment of the cells with 2'-O-methyl phosphorothioate oligoribonucleotides antisense toward the aberrant donor and acceptor splice sites or to the retained exon-like sequence, disfavored aberrant splicing and enhanced normal processing of CFTR pre-mRNA. This antisense-mediated correction of splicing was dose- and sequence-dependent and was accompanied by increased production of CFTR protein that was appropriately glycosylated. Antisense-mediated correction of splicing in a mutation-specific context represents a potential gene therapy modality with applicability to many inherited disorders.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Vet Affairs Med Ctr, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kole, R (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB7295, Chapel Hill, NC 27599 USA.							ABELIOVICH D, 1992, AM J HUM GENET, V51, P951; AUGARTEN A, 1993, LANCET, V342, P25, DOI 10.1016/0140-6736(93)91885-P; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bruggenwirth HT, 1997, AM J HUM GENET, V61, P1067, DOI 10.1086/301605; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; CHENG TC, 1984, P NATL ACAD SCI-BIOL, V81, P2821, DOI 10.1073/pnas.81.9.2821; CHILLON M, 1995, AM J HUM GENET, V56, P623; COHN JA, 1992, P NATL ACAD SCI USA, V89, P2340, DOI 10.1073/pnas.89.6.2340; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Crooke ST, 1998, BIOTECHNOL GENET ENG, V15, P121, DOI 10.1080/02648725.1998.10647954; CUTTING GR, 1993, SEM RESP CRIT CARE M, P356; DOBKIN C, 1983, P NATL ACAD SCI-BIOL, V80, P1184, DOI 10.1073/pnas.80.5.1184; DOMINSKI Z, 1994, MOL CELL BIOL, V14, P7445, DOI 10.1128/MCB.14.11.7445; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Dreyfus DH, 1996, AM J RESP CRIT CARE, V153, P858, DOI 10.1164/ajrccm.153.2.8564145; Dunckley MG, 1998, HUM MOL GENET, V7, P1083, DOI 10.1093/hmg/7.7.1083; GILBERT F, 1995, AM J MED GENET, V58, P356, DOI 10.1002/ajmg.1320580411; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gorman L, 1998, P NATL ACAD SCI USA, V95, P4929, DOI 10.1073/pnas.95.9.4929; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; Hovnanian A, 1997, AM J HUM GENET, V61, P599, DOI 10.1086/515495; Ikeda H, 1997, HUM GENET, V100, P637, DOI 10.1007/s004390050566; JONES DH, 1990, BIOTECHNIQUES, V8, P178; KNEBELMANN B, 1995, HUM MOL GENET, V4, P675, DOI 10.1093/hmg/4.4.675; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LEE LG, 1992, NUCLEIC ACIDS RES, V20, P2471, DOI 10.1093/nar/20.10.2471; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; MAQUAT LE, 1995, RNA, V1, P453; MARSHALL J, 1994, J BIOL CHEM, V269, P2987; McConville CM, 1996, AM J HUM GENET, V59, P320; MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815; Nyce JW, 1997, NATURE, V385, P721, DOI 10.1038/385721a0; Nyce JW, 1999, TRENDS PHARMACOL SCI, V20, P79, DOI 10.1016/S0165-6147(99)01305-X; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; Okuyama E, 1997, J CLIN ENDOCR METAB, V82, P2337, DOI 10.1210/jc.82.7.2337; OLSEN JC, 1992, HUM GENE THER, V3, P253, DOI 10.1089/hum.1992.3.3-253; OLSEN JC, 1995, HUM GENE THER, V6, P1195, DOI 10.1089/hum.1995.6.9-1195; OLSEN JC, 1995, METHODS MOL MED, P153; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; Perrin G, 1996, HUM MUTAT, V7, P172, DOI 10.1002/(SICI)1098-1004(1996)7:2<172::AID-HUMU15>3.0.CO;2-#; Roest PAM, 1996, J MED GENET, V33, P935, DOI 10.1136/jmg.33.11.935; SANDHU GS, 1989, BIOTECHNIQUES, V7, P689; SATOKATA I, 1995, HUM MOL GENET, V4, P1993, DOI 10.1093/hmg/4.10.1993; Seeberger PH, 1998, APPLIED ANTISENSE OLIGONUCLEOTIDE TECHNOLOGY, P51; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Sierakowska H, 1996, P NATL ACAD SCI USA, V93, P12840, DOI 10.1073/pnas.93.23.12840; SPRITZ RA, 1981, P NATL ACAD SCI-BIOL, V78, P2455, DOI 10.1073/pnas.78.4.2455; TASSARA C, 1995, HUM MOL GENET, V4, P1693, DOI 10.1093/hmg/4.9.1693; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Tsuruta M, 1998, J HUM GENET, V43, P91, DOI 10.1007/s100380050047; Urban Z, 1999, HUM GENET, V104, P135, DOI 10.1007/s004390050926; Vervoort R, 1998, HUM GENET, V103, P686, DOI 10.1007/PL00008709; Wang M, 1997, BREAST CANCER RES TR, V44, P145, DOI 10.1023/A:1005753117205; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; WELSH MJ, 1995, METABOLIC MOL BASES, V3, P3799; Wilton SD, 1999, NEUROMUSCULAR DISORD, V9, P330, DOI 10.1016/S0960-8966(99)00010-3; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Yew NS, 1997, HUM GENE THER, V8, P575, DOI 10.1089/hum.1997.8.5-575	61	114	144	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36193	36199		10.1074/jbc.274.51.36193	http://dx.doi.org/10.1074/jbc.274.51.36193			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593905	hybrid, Green Published			2022-12-27	WOS:000084279200024
J	Labbe, S; Pena, MMO; Fernandes, AR; Thiele, DJ				Labbe, S; Pena, MMO; Fernandes, AR; Thiele, DJ			A copper-sensing transcription factor regulates iron uptake genes in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE ENCODES; FISSION YEAST; DNA-BINDING; MOLECULAR CHARACTERIZATION; FUNCTIONALLY SUBSTITUTE; SUPEROXIDE-DISMUTASE; METALLOTHIONEIN GENE; FERRIC REDUCTASE; CANDIDA-GLABRATA; SHUTTLE VECTORS	Copper and iron serve essential functions as catalytic co-factors in a wide variety of critical cellular enzymes. Studies in yeast have demonstrated an absolute dependence upon copper acquisition for proper assembly and function of the iron transport machinery. We have cloned genes for a high affinity copper transporter (Ctr4) and copper-sensing transcription factor (Cuf1) from Schizosaccharomyces pombe. Interestingly, the primary structure of Ctr4 and a putative human high affinity copper transport protein, hCtr1, suggests that they are derived from a fusion of the functionally redundant but structurally distinct Ctr1 and Ctr3 copper transporters from Saccharomyces cerevisiae. Furthermore, although Cuf1 activates ctr4(+) gene expression under copper starvation conditions, under these same conditions Cuf1 directly represses expression of genes encoding components of the iron transport machinery. These studies have identified an evolutionary step in which copper transport modules have been fused, and describe a mechanism by which a copper-sensing factor directly represses expression of the iron uptake genes under conditions in which the essential copper co-factor is scarce.	Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; Ctr Engn Biol & Quim, Inst Super Tecn, P-1046001 Lisbon, Portugal	University of Michigan System; University of Michigan; Universidade de Lisboa; Instituto Superior Tecnico	Thiele, DJ (corresponding author), Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA.	dthiele@umich.edu	Fernandes, Alexandra R/C-7465-2011	Fernandes, Alexandra R/0000-0003-2054-4438; Labbe, Simon/0000-0002-4947-523X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018089, R01GM041840] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM41840, F32 GM18089] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALFA C, 1993, EXPT FISSION YEAST L, P1; Anderson GJ, 1999, LANCET, V353, P2089, DOI 10.1016/S0140-6736(99)00113-0; ANDERSON GJ, 1994, ADV EXP MED BIOL, V356, P81; Andrews NC, 1999, NUTR REV, V57, P114, DOI 10.1111/j.1753-4887.1999.tb06934.x; Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; Askwith C, 1997, J BIOL CHEM, V272, P401; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BARBET N, 1992, GENE, V114, P59, DOI 10.1016/0378-1119(92)90707-V; Borghouts C, 1998, MOL GEN GENET, V260, P492, DOI 10.1007/s004380050922; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; Chang F, 1996, CELL, V84, P191, DOI 10.1016/S0092-8674(00)80973-3; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Dancis A, 1998, J PEDIATR-US, V132, pS24, DOI 10.1016/S0022-3476(98)70524-4; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; DESILVA DM, 1995, J BIOL CHEM, V270, P1098, DOI 10.1074/jbc.270.3.1098; DiDonato M, 1997, BBA-MOL BASIS DIS, V1360, P3, DOI 10.1016/S0925-4439(96)00064-6; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; GUBLER CJ, 1952, BLOOD, V7, P1075, DOI 10.1182/blood.V7.11.1075.1075; Harris ZL, 1996, AM J CLIN NUTR, V63, P836; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hassett RF, 1998, J BIOL CHEM, V273, P23274, DOI 10.1074/jbc.273.36.23274; HAYLES J, 1992, ANNU REV GENET, V26, P373, DOI 10.1146/annurev.ge.26.120192.002105; Jensen LT, 1998, J BIOL CHEM, V273, P23805, DOI 10.1074/jbc.273.37.23805; Jensen LT, 1998, EMBO J, V17, P5400, DOI 10.1093/emboj/17.18.5400; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Kaplan J, 1996, SCIENCE, V271, P1510, DOI 10.1126/science.271.5255.1510; Kim J, 1998, GENETICS, V149, P795; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Koch KA, 1997, CHEM BIOL, V4, P549, DOI 10.1016/S1074-5521(97)90241-6; Koch KA, 1996, MOL CELL BIOL, V16, P724; Kumagai, 1997, FOREIGN GENE EXPRESS, P3; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; LEE GR, 1968, J CLIN INVEST, V47, P2058, DOI 10.1172/JCI105891; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; Morano KA, 1999, MOL CELL BIOL, V19, P402; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Osiewacz HD, 1996, MOL GEN GENET, V252, P115, DOI 10.1007/BF02173211; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Petris MJ, 1999, ADV EXP MED BIOL, V448, P53; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Radisky D, 1999, J BIOL CHEM, V274, P4481, DOI 10.1074/jbc.274.8.4481; ROMAN DG, 1993, MOL CELL BIOL, V13, P4342, DOI 10.1128/MCB.13.7.4342; SANTORO N, 1997, YEAST STRESS RESPONS, P171; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG311, DOI 10.1152/ajpgi.1999.276.2.G311; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; TAMAI KT, 1993, P NATL ACAD SCI USA, V90, P8013, DOI 10.1073/pnas.90.17.8013; THIELE DJ, 1986, SCIENCE, V231, P854, DOI 10.1126/science.3080806; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; Turner RB, 1998, NAT STRUCT BIOL, V5, P551, DOI 10.1038/805; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; Winzerling JJ, 1997, ANNU REV NUTR, V17, P501, DOI 10.1146/annurev.nutr.17.1.501; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yu JM, 1998, J BIOL CHEM, V273, P6909, DOI 10.1074/jbc.273.12.6909; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; ZHOU PB, 1991, P NATL ACAD SCI USA, V88, P6112, DOI 10.1073/pnas.88.14.6112; Zhu ZW, 1998, J BIOL CHEM, V273, P1277, DOI 10.1074/jbc.273.3.1277	75	92	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36252	36260		10.1074/jbc.274.51.36252	http://dx.doi.org/10.1074/jbc.274.51.36252			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593913	hybrid			2022-12-27	WOS:000084279200032
J	Lee, H; Raskin, I				Lee, H; Raskin, I			Purification, cloning, and expression of a pathogen inducible UDP-glucose: Salicylic acid glucosyltransferase from tobacco	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DISEASE RESISTANCE; MOSAIC-VIRUS; GENE; CONJUGATION; INDUCTION; SIGNAL; PLANTS; PROTEINS	Salicylic acid (SA) plays an important role in plant disease resistance. Inoculation of tobacco leaves with incompatible pathogens triggers the biosynthesis of SA which accumulates primarily as the SA 8-O-beta-D-glucoside (SAG) and glucosyl salicylate (GS). The tobacco UDP-glucose:salicylic acid glucosyltransferase (SA GTase) capable of forming both SAG and GS was purified, characterized, and partially sequenced. It has an apparent molecular mass of 48 kDa, a pH optimum of 7.0, and an isoelectric point at pH 4.4. UDP-glucose was the sole sugar donor for the enzyme. However, SA and several phenolics served as glucose accepters. The apparent K-m values for UDP-glucose and SA were 0.27 and 1-2 mar, respectively. Zn2+ and UDP inhibited its activity. The corresponding cDNA clone which encoded a protein of 459 amino acids was isolated from an SA-induced tobacco cDNA library and overexpressed in Escherichia coli. The recombinant protein catalyzed the formation of SAG and GS, and exhibited a broad specificity to simple phenolics, similar to that of the purified enzyme. Northern blot analysis showed that the SA GTase mRNA was induced both by SA and incompatible pathogens. The rapid induction timing of the mRNA by SA indicates that it belongs to the early SA response genes.	Rutgers State Univ, Cook Coll, Biotech Ctr, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Lee, H (corresponding author), Rutgers State Univ, Cook Coll, Biotech Ctr, 59 Dudley Rd, New Brunswick, NJ 08901 USA.							Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Draper J, 1997, TRENDS PLANT SCI, V2, P162, DOI 10.1016/S1360-1385(97)01030-3; Durner J, 1997, TRENDS PLANT SCI, V2, P266, DOI 10.1016/S1360-1385(97)86349-2; EDWARDS R, 1994, J PLANT PHYSIOL, V143, P609, DOI 10.1016/S0176-1617(11)81146-6; ENYEDI AJ, 1992, P NATL ACAD SCI USA, V89, P2480, DOI 10.1073/pnas.89.6.2480; ENYEDI AJ, 1993, PLANT PHYSIOL, V101, P1375, DOI 10.1104/pp.101.4.1375; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; HammondKosack KE, 1996, PLANT PHYSIOL, V110, P1381, DOI 10.1104/pp.110.4.1381; Horvath DM, 1996, PLANT MOL BIOL, V31, P1061, DOI 10.1007/BF00040724; Horvath DM, 1998, MOL PLANT MICROBE IN, V11, P895, DOI 10.1094/MPMI.1998.11.9.895; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HI, 1998, PHYTOPATHOLOGY, V88, P692, DOI 10.1094/PHYTO.1998.88.7.692; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Martin RC, 1999, P NATL ACAD SCI USA, V96, P284, DOI 10.1073/pnas.96.1.284; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; RALSTON EJ, 1988, GENETICS, V119, P185; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; SZERSZEN JB, 1994, SCIENCE, V265, P1699, DOI 10.1126/science.8085154; YALPANI N, 1992, PLANT PHYSIOL, V100, P457, DOI 10.1104/pp.100.1.457; YALPANI N, 1991, PLANT CELL, V3, P809, DOI 10.1105/tpc.3.8.809	25	102	116	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36637	36642		10.1074/jbc.274.51.36637	http://dx.doi.org/10.1074/jbc.274.51.36637			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593966	hybrid			2022-12-27	WOS:000084279200085
J	Rusterucci, C; Montillet, JL; Agnel, JP; Battesti, C; Alonso, B; Knoll, A; Bessoule, JJ; Etienne, P; Suty, L; Blein, JP; Triantaphylides, C				Rusterucci, C; Montillet, JL; Agnel, JP; Battesti, C; Alonso, B; Knoll, A; Bessoule, JJ; Etienne, P; Suty, L; Blein, JP; Triantaphylides, C			Involvement of lipoxygenase-dependent production of fatty acid hydroperoxides in the development of the hypersensitive cell death induced by cryptogein on tobacco leaves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE RESISTANCE RESPONSE; PLANT-PATHOGEN INTERACTIONS; ACQUIRED-RESISTANCE; FUNGAL ELICITOR; OXIDATIVE BURST; CHEMOENZYMATIC SYNTHESIS; PHOSPHOLIPASE-ACTIVITY; LIPID-PEROXIDATION; METHYL JASMONATE; TOMATO LEAVES	Lipid peroxidation was investigated in relation with the hypersensitive reaction in cryptogein-elicited tobacco leaves. A massive production of free polyunsaturated fatty acid (PUFA) hydroperoxides dependent on a 9-lipoxygenase (LOX) activity was characterized during the development of leaf necrosis. The process occurred after a lag phase of 12 h, was accompanied by the concomitant increase of 9-LOX activity, and preceded by a transient accumulation of LOX transcripts. Free radical-mediated lipid peroxidation represented 10% of the process. Inhibition and activation of the LOX pathway was shown to inhibit or to activate cell death, and evidence was provided that fatty acid hydroperoxides are able to mimic leaf necrotic symptoms. Within 24 h, about 50% of leaf PUFAs were consumed, chloroplast lipids being the major source of PUFAs. The results minimize the direct participation of active oxygen species from the oxidative burst in membrane lipid peroxidation. They suggest, furthermore, the involvement of lipase activity to provide the free PUFA substrates for LOX. The LOX-dependent peroxidative pathway, responsible for tissue necrosis, appears as being one of the features of hypersensitive programmed cell death.	CEA, Lab Radiobiol Vegetale, Dept Ecophysiol Vegetable & Microbiol, Ctr Etud Cadarache,Direct Sci Vivant, F-13108 St Paul Durance, France; Univ Victor Segalan Bordeaux 2, Lab Biogenese Membranaire, CNRS UMR 5544, F-33076 Bordeaux, France; Univ Bourgogne 692, UA INRA, Lab Phytopharm & Biochim Interact Cellulaires, Dijon, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; INRAE; Universite de Bourgogne	Triantaphylides, C (corresponding author), CEA, Lab Radiobiol Vegetale, Dept Ecophysiol Vegetable & Microbiol, Ctr Etud Cadarache,Direct Sci Vivant, F-13108 St Paul Durance, France.		ETIENNE, Philippe/AAS-2211-2021; Knoll-Gellida, Anja/B-3886-2011	ETIENNE, Philippe/0000-0002-4531-3874; Knoll-Gellida, Anja/0000-0002-3687-1778				ADAM A, 1989, PHYSIOL MOL PLANT P, V34, P13, DOI 10.1016/0885-5765(89)90013-1; Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; AVDIUSHKO S, 1995, PLANT PHYSIOL, V109, P1227, DOI 10.1104/pp.109.4.1227; Blee E, 1996, PLANT PHYSIOL, V110, P445, DOI 10.1104/pp.110.2.445; Blee Elizabeth, 1996, P138, DOI 10.1201/9781439831977.ch8; Bonnet P, 1996, EUR J PLANT PATHOL, V102, P181, DOI 10.1007/BF01877105; BOSTOCK RM, 1992, PLANT PHYSIOL, V100, P1448, DOI 10.1104/pp.100.3.1448; BOTTIN A, 1994, PLANT PHYSIOL BIOCH, V32, P373; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; Chapman KD, 1998, TRENDS PLANT SCI, V3, P419, DOI 10.1016/S1360-1385(98)01326-0; CROFT KPC, 1990, PHYSIOL MOL PLANT P, V36, P49, DOI 10.1016/0885-5765(90)90091-B; DEGOUSEE N, 1995, ANAL BIOCHEM, V224, P524, DOI 10.1006/abio.1995.1082; DEGOUSEE N, 1994, PLANT PHYSIOL, V104, P945, DOI 10.1104/pp.104.3.945; del Pozo O, 1998, CURR BIOL, V8, P1129, DOI 10.1016/S0960-9822(98)70469-5; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; DILVA L, 1988, EXP CELL ES, V245, P389; DOKE N, 1988, PHYSIOL MOL PLANT P, V32, P163, DOI 10.1016/S0885-5765(88)80013-4; DOKE N, 1997, OXIDATIVE STRESS MOL, V1, P785; Farmer EE, 1998, PLANTA, V206, P167, DOI 10.1007/s004250050388; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; FARMER EE, 1994, PLANT MOL BIOL, V26, P1423, DOI 10.1007/BF00016483; Feussner I, 1997, J BIOL CHEM, V272, P21635, DOI 10.1074/jbc.272.34.21635; FOURNIER J, 1993, PLANT J, V3, P63, DOI 10.1111/j.1365-313X.1993.tb00011.x; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Heitz T, 1997, PLANT PHYSIOL, V114, P1085, DOI 10.1104/pp.114.3.1085; HILDEBRAND DF, 1989, PHYSIOL PLANTARUM, V76, P249, DOI 10.1111/j.1399-3054.1989.tb05641.x; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hunt MD, 1996, CRIT REV PLANT SCI, V15, P583, DOI 10.1080/07352689609382371; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; KATO T, 1992, BIOSCI BIOTECH BIOCH, V56, P373, DOI 10.1271/bbb.56.373; Kenton P, 1999, MOL PLANT MICROBE IN, V12, P74, DOI 10.1094/MPMI.1999.12.1.74; KONDO Y, 1993, BIOCHIM BIOPHYS ACTA, V1170, P301, DOI 10.1016/0005-2760(93)90014-Z; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Malcomson RDG, 1996, BIOLOGICALS, V24, P295, DOI 10.1006/biol.1996.0040; MARTINI D, 1994, BIOCATALYSIS, V11, P47, DOI 10.3109/10242429409034376; Martini D, 1996, TETRAHEDRON-ASYMMETR, V7, P1489, DOI 10.1016/0957-4166(96)00167-X; May MJ, 1996, PLANT PHYSIOL, V110, P1367, DOI 10.1104/pp.110.4.1367; MILAT ML, 1991, PHYTOPATHOLOGY, V81, P1364, DOI 10.1094/Phyto-81-1364; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; MITTLER R, 1995, PLANT CELL, V7, P1951, DOI 10.1105/tpc.7.11.1951; Mittler R, 1996, PLANT CELL, V8, P1991, DOI 10.1105/tpc.8.11.1991; Mittler R, 1997, J CELL SCI, V110, P1333; PENG YL, 1994, J BIOL CHEM, V269, P3755; Pike SM, 1998, PHYSIOL MOL PLANT P, V53, P39, DOI 10.1006/pmpp.1998.0167; Pontier D, 1998, MOL PLANT MICROBE IN, V11, P544, DOI 10.1094/MPMI.1998.11.6.544; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Rance I, 1998, P NATL ACAD SCI USA, V95, P6554, DOI 10.1073/pnas.95.11.6554; RICCI P, 1989, EUR J BIOCHEM, V183, P555, DOI 10.1111/j.1432-1033.1989.tb21084.x; Rosahl S, 1996, Z NATURFORSCH C, V51, P123; ROY S, 1995, PLANT SCI, V107, P17, DOI 10.1016/0168-9452(95)04086-A; Rusterucci C, 1996, PLANT PHYSIOL, V111, P885, DOI 10.1104/pp.111.3.885; Ryerson DE, 1996, PLANT CELL, V8, P393, DOI 10.1105/tpc.8.3.393; SANDSTROM PA, 1995, FEBS LETT, V365, P66, DOI 10.1016/0014-5793(95)00443-D; Simon-Plas F, 1997, PLANT CELL ENVIRON, V20, P1573, DOI 10.1046/j.1365-3040.1997.d01-45.x; Slusarenko Alan J., 1996, P176, DOI 10.1201/9781439831977.ch10; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Suty L, 1996, PLANT PHYSIOL BIOCH, V34, P443; TENHAKEN R, 1995, P NATL ACAD SCI USA, V92, P4158, DOI 10.1073/pnas.92.10.4158; Veronesi C, 1996, PLANT PHYSIOL, V112, P997, DOI 10.1104/pp.112.3.997; VERONESI C, 1995, PLANT PHYSIOL, V108, P1342; Weber H, 1999, PLANT CELL, V11, P485, DOI 10.1105/tpc.11.3.485; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zhuang H, 1996, PLANT PHYSIOL, V111, P805, DOI 10.1104/pp.111.3.805	66	202	217	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36446	36455		10.1074/jbc.274.51.36446	http://dx.doi.org/10.1074/jbc.274.51.36446			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593941	Green Published, hybrid			2022-12-27	WOS:000084279200060
J	Estavillo, D; Ritchie, A; Diacovo, TG; Cruz, MA				Estavillo, D; Ritchie, A; Diacovo, TG; Cruz, MA			Functional analysis of a recombinant glycoprotein Ia/IIa (integrin alpha(2)beta(1)) I domain that inhibits platelet adhesion to collagen and endothelial matrix under flow conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; ALPHA-2-BETA-1 VLA-2; CRYSTAL-STRUCTURE; LAMININ RECEPTOR; BINDING-SITE; CELLS; IDENTIFICATION; DEFICIENCY; ACTIVATION; CD49B/CD29	The interaction of platelets with collagen plays an important role in primary hemostasis. Glycoprotein Ia/IIa (GPIa/IIa, integrin alpha(2)beta(1)) is a major platelet receptor for collagen, The binding site for collagen has been mapped to the I domain within the alpha(2) subunit (GPIa), In order to assess the role of the alpha(2)-I domain structure in GPIa/IIa binding to collagen, a recombinant I domain (amino acids 126-337) was expressed in Escherichia coli, The alpha(2)-I protein bound human types I and III collagen in a saturable and divalent cation-dependent manner and was blocked by the alpha(2)beta(1) function blocking antibody 6F1. The alpha(2)-I protein inhibited collagen-induced platelet aggregation (IC50 = 600 nM). Unexpectedly, 6F1, an antibody that fails to inhibit platelet aggregation in platelet-rich plasma, blocked the inhibitory effect of the alpha(2)-I protein, The alpha(2)-I protein was able to prevent platelet adhesion to a collagen surface exposed to flowing blood under low shear stress. Interestingly, it inhibited platelet adhesion to extracellular matrix at high shear stress. These results, taken together, provide firm evidence that GPIa/IIa directly mediates the first contact of platelets with collagen under both stirring and flow conditions.	Brigham & Womens Hosp, Div Hematol, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Cruz, MA (corresponding author), Brigham & Womens Hosp, Div Hematol, Dept Med, 221 Longwood Ave,LMRC-605, Boston, MA 02115 USA.	cruz@calvin.bwh.harvard.edu			NHLBI NIH HHS [R01 HL54876] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054876] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAHOU WF, 1994, BLOOD, V84, P3734, DOI 10.1182/blood.V84.11.3734.bloodjournal84113734; BERGELSON JM, 1992, SCIENCE, V255, P1718, DOI 10.1126/science.1553561; Chiang TM, 1997, J CLIN INVEST, V100, P514, DOI 10.1172/JCI119560; Cines DB, 1998, BLOOD, V91, P3527; COLLER BS, 1989, BLOOD, V74, P182; CRUZ MA, 1995, J BIOL CHEM, V270, P10822, DOI 10.1074/jbc.270.18.10822; DECKMYN H, 1990, THROMB HAEMOSTASIS, V64, P74; Depraetere H, 1997, THROMB HAEMOSTASIS, V77, P981; DIAZRICART M, 1993, BLOOD, V82, P491; Dickeson SK, 1997, J BIOL CHEM, V272, P7661, DOI 10.1074/jbc.272.12.7661; ELICES MJ, 1989, P NATL ACAD SCI USA, V86, P9906, DOI 10.1073/pnas.86.24.9906; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; HANDA M, 1995, THROMB HAEMOSTASIS, V73, P521; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ichinohe T, 1997, J BIOL CHEM, V272, P63; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KAMATA T, 1994, J BIOL CHEM, V269, P9659; KEHREL B, 1993, BLOOD, V82, P3364; KEHREL B, 1988, BLOOD, V71, P1074; KUNICKI TJ, 1993, BLOOD, V82, P2693; LANGUINO LR, 1989, J CELL BIOL, V109, P2455, DOI 10.1083/jcb.109.5.2455; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Matsuno K, 1996, BRIT J HAEMATOL, V92, P960, DOI 10.1046/j.1365-2141.1996.422962.x; MCKEOWN L, 1994, BLOOD, V83, P2866, DOI 10.1182/blood.V83.10.2866.2866; Nakamura T, 1999, J BIOL CHEM, V274, P11897, DOI 10.1074/jbc.274.17.11897; Nakamura T, 1998, J BIOL CHEM, V273, P4338, DOI 10.1074/jbc.273.8.4338; NIEUWENHUIS HK, 1985, NATURE, V318, P470, DOI 10.1038/318470a0; PISCHEL KD, 1987, J IMMUNOL, V138, P226; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; SAELMAN EUM, 1994, BLOOD, V83, P1244; SANTORO SA, 1995, THROMB HAEMOSTASIS, V74, P813; TANDON NN, 1989, J BIOL CHEM, V264, P7576; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Verkleij MW, 1998, BLOOD, V91, P3808; Wu YP, 1996, ARTERIOSCL THROM VAS, V16, P611, DOI 10.1161/01.ATV.16.5.611; YAMADA KM, 1991, J BIOL CHEM, V266, P12809; YAMAMOTO N, 1992, BRIT J HAEMATOL, V81, P86, DOI 10.1111/j.1365-2141.1992.tb08177.x	38	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35921	35926		10.1074/jbc.274.50.35921	http://dx.doi.org/10.1074/jbc.274.50.35921			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585478	hybrid			2022-12-27	WOS:000084187900090
J	Frick, DN; Richardson, CC				Frick, DN; Richardson, CC			Interaction of bacteriophage T7 gene 4 primase with its template recognition site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND DNA-SYNTHESIS; NUCLEOSIDE 5'-TRIPHOSPHATASE ACTIVITY; ACID REPLICATION INVITRO; NUCLEOTIDE-BINDING SITE; RNA PRIMER SYNTHESIS; DEOXYRIBONUCLEIC-ACID; HELICASE ACTIVITY; HEXAMERIC HELICASE; ZINC MOTIF; PROTEIN	The primase fragment of the bacteriophage T7 63-kDa gene 4 helicase/primase protein contains the 271 N-terminal amino acid residues and lacks helicase activity. The primase fragment catalyzes the synthesis of oligoribonucleotides at rates similar to those catalyzed by the full-length protein in the presence of a 5-nucleotide DNA template containing a primase recognition site (5'-GGGTC-3', 5'-TGGTC-3', 5'-GTGTC-3', or 5'-TTGTC-3'). Although it is not copied into the oligoribonucleotides, the cytosine at the 3'-position is essential for synthesis and template binding. Two nucleotides flanking the 3'-end of the recognition site are required for tight DNA binding and rapid oligoribonucleotide synthesis. Nucleotides added to the 5'-end have no effect on the rate of oligoribonucleotide synthesis or the affinity of the primase for DNA, The binding of either ATP or CTP significantly increases the affinity of the primase for its DNA template. DNA lacking a primase recognition site does not inhibit oligoribonucleotide synthesis, suggesting that the primase binds DNA in a sequence-specific manner. The affinity of the primase for templates is weak, ranging from 10 to 150 mu M. The tight DNA binding (<1 mu M) observed with the 63-kDa gene 4 protein occurs via interactions between DNA templates and the helicase domain.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.			Frick, David/0000-0002-2434-7223	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI006045, R01AI006045] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-06045] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; ARAI K, 1979, P NATL ACAD SCI USA, V76, P4308, DOI 10.1073/pnas.76.9.4308; BERNSTEIN JA, 1988, J BIOL CHEM, V263, P14891; BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7; Dong F, 1996, J BIOL CHEM, V271, P19625, DOI 10.1074/jbc.271.32.19625; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Frick DN, 1999, J BIOL CHEM, V274, P35899, DOI 10.1074/jbc.274.50.35899; GRIEP MA, 1995, INDIAN J BIOCHEM BIO, V32, P171; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; HINE AV, 1994, P NATL ACAD SCI USA, V91, P12327, DOI 10.1073/pnas.91.25.12327; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; HINTON DM, 1987, J BIOL CHEM, V262, P10873; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; KOLODNER R, 1977, P NATL ACAD SCI USA, V74, P1525, DOI 10.1073/pnas.74.4.1525; Kusakabe T, 1998, EMBO J, V17, P1542, DOI 10.1093/emboj/17.5.1542; Kusakabe T, 1999, P NATL ACAD SCI USA, V96, P4295, DOI 10.1073/pnas.96.8.4295; Kusakabe T, 1997, J BIOL CHEM, V272, P12446, DOI 10.1074/jbc.272.19.12446; Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563; Kusakabe T, 1997, J BIOL CHEM, V272, P5943, DOI 10.1074/jbc.272.9.5943; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LIU CC, 1981, J BIOL CHEM, V256, P2821; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MENDELMAN LV, 1994, EMBO J, V13, P3909, DOI 10.1002/j.1460-2075.1994.tb06702.x; MENDELMAN LV, 1995, BIOCHEMISTRY-US, V34, P10187, DOI 10.1021/bi00032a012; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; MENDELMAN LV, 1993, J BIOL CHEM, V268, P27208; MENDELMAN LV, 1991, J BIOL CHEM, V266, P23240; NAKAI H, 1986, J BIOL CHEM, V261, P5217; NAKAI H, 1986, J BIOL CHEM, V261, P5208; NAKAI H, 1988, J BIOL CHEM, V263, P9831; NAKAI H, 1988, J BIOL CHEM, V263, P9818; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; ROMANO LJ, 1979, J BIOL CHEM, V254, P483; ROSENBERG AH, 1992, J BIOL CHEM, V267, P15005; SCHERZINGER E, 1977, EUR J BIOCHEM, V72, P543, DOI 10.1111/j.1432-1033.1977.tb11278.x; SCHERZINGER E, 1977, NUCLEIC ACIDS RES, V4, P4151, DOI 10.1093/nar/4.12.4151; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Swart JR, 1995, BIOCHEMISTRY-US, V34, P16097, DOI 10.1021/bi00049a025; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Washington MT, 1998, J BIOL CHEM, V273, P7880, DOI 10.1074/jbc.273.14.7880; YONG YQ, 1995, J BIOL CHEM, V270, P24509, DOI 10.1074/jbc.270.41.24509	54	50	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35889	35898		10.1074/jbc.274.50.35889	http://dx.doi.org/10.1074/jbc.274.50.35889			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585474	Green Published, hybrid			2022-12-27	WOS:000084187900086
J	Levy, H; Kindle, KL; Stern, DB				Levy, H; Kindle, KL; Stern, DB			Target and specificity of a nuclear gene product that participates in mRNA 3 '-end formation in Chlamydomonas chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA ACCUMULATION; 5' UNTRANSLATED REGION; 3' INVERTED REPEATS; ESCHERICHIA-COLI; REINHARDTII CHLOROPLASTS; 3'-UNTRANSLATED REGIONS; ARABIDOPSIS-THALIANA; TRANSCRIPTION UNIT; BINDING PROTEIN; EXPRESSION	Chloroplast mRNA maturation is catalyzed by nucleus-encoded processing enzymes. We previously described a recessive nuclear mutation (crp3) that affects 3'-end formation of several chloroplast mRNAs in Chlamydomonas reinhardtii (Levy, H,, Kindle, K, L., and Stern, D, B, (1997) Plant Cell 9, 825-836). In the crp3 background, atpB mRNA lacking a 3'-inverted repeat normally required for stability accumulates as a discrete transcript. The mutation also affects the atpA gene cluster; polycistronic mRNAs with psbI or cemA 3'-ends accumulate to a lower level in the crp3 background. Here, we demonstrate that the crp3 mutation also alters S'-end formation of psbI mRNA and cemA-containing mRNAs. A novel 3'-end is formed in monocistronic psbI transcripts, and this is the only terminus observed when the psbI 3'-untranslated region is fused to an aadA reporter gene. Accumulation of mRNAs with 3'-ends between cemA and atpH, which is immediately downstream, was reduced. However, this sequence was not recognized as a 3'-end formation element in chimeric genes. The crp3 mutation was able to confer stability to three different atpB 3'-stem-loop-disrupting mutations that lack sequence similarity, but are located at a similar distance from the translation termination codon, We propose that the wild-type CRP3 gene product is part of the general 3' --> 5' processing machinery.	Cornell Univ, Bruce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Cornell Univ, Plant Sci Ctr, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stern, DB (corresponding author), Cornell Univ, Bruce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	ds28@cornell.edu						BARKAN A, 1988, EMBO J, V7, P2637, DOI 10.1002/j.1460-2075.1988.tb03116.x; BARKAN A, 1994, EMBO J, V13, P3170, DOI 10.1002/j.1460-2075.1994.tb06616.x; BLOWERS AD, 1993, MOL GEN GENET, V238, P339, DOI 10.1007/BF00291992; CHEN HC, 1991, MOL CELL BIOL, V11, P4380, DOI 10.1128/MCB.11.9.4380; Dinkins RD, 1997, PLANT PHYSIOL, V113, P1023, DOI 10.1104/pp.113.4.1023; Drager RG, 1996, RNA, V2, P652; Drager RG, 1998, PLANT J, V13, P85, DOI 10.1046/j.1365-313X.1998.00016.x; Drapier D, 1998, PLANT PHYSIOL, V117, P629, DOI 10.1104/pp.117.2.629; DRAPIER D, 1992, PLANT CELL, V4, P283, DOI 10.2307/3869540; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; Gumpel NJ, 1995, PLANT MOL BIOL, V29, P921, DOI 10.1007/BF00014966; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; Jenkins BD, 1997, PLANT CELL, V9, P283, DOI 10.1105/tpc.9.3.283; KINDLE KL, 1994, PLANT CELL, V6, P187, DOI 10.2307/3869638; KLUG G, 1992, GENE, V121, P95, DOI 10.1016/0378-1119(92)90166-M; KUCHKA MR, 1989, CELL, V58, P869, DOI 10.1016/0092-8674(89)90939-2; KUNSTNER P, 1995, J BIOL CHEM, V270, P9651; Lee H, 1996, PLANT MOL BIOL, V31, P337, DOI 10.1007/BF00021794; Levy H, 1997, PLANT CELL, V9, P825, DOI 10.2307/3870435; MAYFIELD SP, 1994, J CELL BIOL, V127, P1537, DOI 10.1083/jcb.127.6.1537; Memon AR, 1996, PLANT MOL BIOL, V30, P1195, DOI 10.1007/BF00019552; Meurer J, 1998, MOL GEN GENET, V258, P342, DOI 10.1007/s004380050740; Meurer J, 1996, PLANT CELL, V8, P1193, DOI 10.1105/tpc.8.7.1193; MONOD C, 1992, MOL GEN GENET, V231, P449, DOI 10.1007/BF00292715; NICKELSEN J, 1993, PLANT J, V3, P537, DOI 10.1046/j.1365-313X.1993.03040537.x; NICKELSEN J, 1994, EMBO J, V13, P3182, DOI 10.1002/j.1460-2075.1994.tb06617.x; Nickelsen J, 1999, PLANT CELL, V11, P957, DOI 10.1105/tpc.11.5.957; PATEL AM, 1992, J BACTERIOL, V174, P3541, DOI 10.1128/JB.174.11.3541-3548.1992; REGNIER P, 1991, J MOL BIOL, V217, P283, DOI 10.1016/0022-2836(91)90542-E; Rochaix JD, 1996, PLANT MOL BIOL, V32, P327, DOI 10.1007/BF00039389; Rolland N, 1997, EMBO J, V16, P6713, DOI 10.1093/emboj/16.22.6713; Rott R, 1996, MOL GEN GENET, V252, P676, DOI 10.1007/BF02173973; Rott R, 1998, PLANT MOL BIOL, V36, P307, DOI 10.1023/A:1005943701253; Rott R, 1998, MOL CELL BIOL, V18, P4605, DOI 10.1128/MCB.18.8.4605; SAKAMOTO W, 1994, MOL CELL BIOL, V14, P6180, DOI 10.1128/MCB.14.9.6180; SAKAMOTO W, 1994, PLANT J, V6, P503, DOI 10.1046/j.1365-313X.1994.6040503.x; SCHUSTER G, 1991, EMBO J, V10, P1493, DOI 10.1002/j.1460-2075.1991.tb07669.x; SIEBURTH LE, 1991, PLANT CELL, V3, P175, DOI 10.2307/3869287; STAUB JM, 1994, PLANT J, V6, P547, DOI 10.1046/j.1365-313X.1994.6040547.x; STERN DB, 1993, MOL CELL BIOL, V13, P2277, DOI 10.1128/MCB.13.4.2277; STERN DB, 1989, J BIOL CHEM, V264, P18742; STERN DB, 1987, CELL, V51, P1145, DOI 10.1016/0092-8674(87)90600-3; STERN DB, 1991, PLANT CELL, V3, P285; STOLLAR NE, 1994, J PLANT PHYSIOL, V144, P141, DOI 10.1016/S0176-1617(11)80535-3; STURM NR, 1994, MOL CELL BIOL, V14, P6171, DOI 10.1128/MCB.14.9.6171; WESTHOFF P, 1988, EUR J BIOCHEM, V171, P551, DOI 10.1111/j.1432-1033.1988.tb13824.x; Yang JJ, 1996, PLANT CELL, V8, P1409, DOI 10.1105/tpc.8.8.1409	48	10	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35955	35962		10.1074/jbc.274.50.35955	http://dx.doi.org/10.1074/jbc.274.50.35955			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585484	hybrid			2022-12-27	WOS:000084187900096
J	Pierce, KL; Fujino, H; Srinivasan, D; Regan, JW				Pierce, KL; Fujino, H; Srinivasan, D; Regan, JW			Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT VENTRICULAR MYOCYTES; STRESS FIBER FORMATION; TYROSINE PHOSPHORYLATION; COUPLED RECEPTOR; CORPUS-LUTEUM; PROSTAGLANDIN-F2-ALPHA; CLONING; EXPRESSION; GROWTH; CDNA	Prostaglandin F-2 alpha (PGF(2 alpha)) exerts its biological effects by binding to and activating FP prostanoid receptors. These receptors, which include two isoforms, the FPA and FPB, have been cloned from a number of species and are members of the superfamily of G-protein-coupled receptors. Previous studies have shown that the activation of FP receptors leads to phosphatidylinositol hydrolysis, intracellular calcium release, and activation of protein kinase C. Here, we demonstrate that PGF(2 alpha) treatment of 293-EBNA (Epstein-Barr nuclear antigen) cells that have been stably transfected with either the FPA or FPB receptor isoforms leads to changes in cell morphology and in the cell cytoskeleton. Specifically, cells treated with PGF(2 alpha) show retraction of filopodia and become rounded, and actin stress fibers are formed. Pretreatment of the cells with bisindolylmaleimide I, a protein kinase C inhibitor, has no effect on the PGF(2 alpha)-induced changes in cell morphology, although it does block the effects of phorbol myristate acetate on cell morphology. On the other hand, the PGF(2 alpha)-induced changes in cell morphology and formation of actin stress fibers can be blocked by pretreatment of the cells with C3 exoenzyme, a specific inhibitor of the small G-protein, Rho. Consistent with FP receptor induced formation of actin stress fibers and focal adhesions, FPA receptor activation also leads to rapid (within two minutes) tyrosine phosphorylation of p125 focal adhesion kinase (FAK) which can be blocked by pretreating the cells with C3 exoenzyme. Taken together, these results suggest that the FP receptor isoforms are coupled to at least two second messenger pathways, one pathway associated with protein kinase C activation, and the other with activation of Rho.	Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; Univ Arizona, Coll Pharm, Dept Physiol, Tucson, AZ 85721 USA; Univ Arizona, Coll Pharm, Neurosci Program, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona	Regan, JW (corresponding author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.				NEI NIH HHS [EY11291] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011291] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAMOVITZ M, 1994, J BIOL CHEM, V269, P2632; Adams JW, 1998, CIRC RES, V83, P167, DOI 10.1161/01.RES.83.2.167; Adams JW, 1996, J BIOL CHEM, V271, P1179, DOI 10.1074/jbc.271.2.1179; Betuing S, 1998, J BIOL CHEM, V273, P15804, DOI 10.1074/jbc.273.25.15804; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; CAMRAS CB, 1992, ARCH OPHTHALMOL-CHIC, V110, P1733, DOI 10.1001/archopht.1992.01080240073034; DILLON ST, 1995, METHOD ENZYMOL, V256, P174; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; GRAVES PE, 1995, ENDOCRINOLOGY, V136, P3430, DOI 10.1210/en.136.8.3430; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasegawa H, 1997, BIOCHEM BIOPH RES CO, V234, P631, DOI 10.1006/bbrc.1997.6655; KATOH H, 1996, J BIOL CHEM, V271, P29978; Kunapuli P, 1998, J BIOL CHEM, V273, P22442, DOI 10.1074/jbc.273.35.22442; Lai J, 1996, AM J PHYSIOL-HEART C, V271, pH2197, DOI 10.1152/ajpheart.1996.271.6.H2197; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Majumdar M, 1998, J BIOL CHEM, V273, P10099, DOI 10.1074/jbc.273.17.10099; MCCRACKEN JA, 1970, J CLIN ENDOCR METAB, V30, P544, DOI 10.1210/jcem-30-4-544; Needham LK, 1998, J BIOL CHEM, V273, P14626, DOI 10.1074/jbc.273.23.14626; Pierce KL, 1997, J BIOL CHEM, V272, P883, DOI 10.1074/jbc.272.2.883; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SAKAMOTO K, 1994, J BIOL CHEM, V269, P3881; SUGIMOTO Y, 1994, J BIOL CHEM, V269, P1356; WATANABE T, 1994, J BIOL CHEM, V269, P17619	23	88	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35944	35949		10.1074/jbc.274.50.35944	http://dx.doi.org/10.1074/jbc.274.50.35944			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585482	hybrid			2022-12-27	WOS:000084187900094
J	Takao, N; Mori, R; Kato, H; Shinohara, A; Yamamoto, K				Takao, N; Mori, R; Kato, H; Shinohara, A; Yamamoto, K			c-abl tyrosine kinase is not essential for ataxia telangiectasia mutated functions in chromosomal maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; VERTEBRATE CELLS; NUCLEAR FOCI; IONIZING-RADIATION; PROTEIN; REPAIR; GENE; ATM	c-Abl is activated by DNA damage in an ataxia telangiectasia mutated (ATM)-dependent manner and plays important roles in growth arrest and apoptosis induced by DNA damage. c-Abl also interacts physically and functionally with Rad51, a key molecule in homologous recombinational (HR) DNA repair. To study further the roles of c-Abl in HR DNA repair, we generated c-Abl(-/-) and ATM(-/-)/c-Abl(-/-) mutant cell lines from a chicken B lymphocyte DT40 cell line, comparing the phenotypes of these mutants to those of ATM(-/-) DT40 cells that we had created previously. We found that the time course of radiation-induced Rad51 focus formation is abnormal in ATM(-/-) DT40 cells, consistent with the observation that ATM(-/-) DT40 cells display hypersensitivity to ionizing radiation and highly elevated frequencies of both spontaneous and radiation-induced chromosomal aberrations. In contrast, c-Abl(-/-) cells did not show these ATM-related defects in their cellular response to radiation, nor did the disruption of c-Abl in ATM(-/-) DT40 cells exacerbate these ATM-related defects. However, c-Abl(-/-) DT40 cells, but not ATM(-/-) DT40 cells, were resistant to radiation-induced apoptosis, indicating an important role for c-Abl in this cellular response to ionizing radiation. These results therefore indicate that, although ATM plays an important role in genome maintenance, c-Abl is not essential for this ATM function. These findings suggest that c-Abl and ATM play important roles in the maintenance of the cell homeostasis in response to DNA damage that are, at least in part, independent.	Kanazawa Univ, Canc Res Inst, Dept Mol Pathol, Kanazawa, Ishikawa 9200934, Japan; Kanazawa Univ, Dept Surg 1, Kanazawa, Ishikawa 9200934, Japan; Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA	Kanazawa University; Kanazawa University; University of Chicago	Yamamoto, K (corresponding author), Kanazawa Univ, Canc Res Inst, Dept Mol Pathol, 13-1 Takaramachi, Kanazawa, Ishikawa 9200934, Japan.			Mori, Ryoichi/0000-0002-7596-9620				ABELSON HT, 1970, CANCER RES, V30, P2213; Agami R, 1999, NATURE, V399, P809; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Foray N, 1997, INT J RADIAT BIOL, V72, P271, DOI 10.1080/095530097143266; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Gong JG, 1999, NATURE, V399, P806; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; Jeggo PA, 1998, TRENDS GENET, V14, P312, DOI 10.1016/S0168-9525(98)01511-X; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; KRUH GD, 1990, P NATL ACAD SCI USA, V87, P5802, DOI 10.1073/pnas.87.15.5802; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LEHMANN AR, 1995, TRENDS GENET, V11, P375, DOI 10.1016/S0168-9525(00)89112-X; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; SHINOHARA A, 1995, TRENDS BIOCHEM SCI, V20, P387, DOI 10.1016/S0968-0004(00)89085-4; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; TAKAO N, 1999, IN PRESS ONCOGENE; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tashiro S, 1996, ONCOGENE, V12, P2165; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Yuan ZM, 1998, J BIOL CHEM, V273, P3799, DOI 10.1074/jbc.273.7.3799; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8	29	36	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					725	728		10.1074/jbc.275.2.725	http://dx.doi.org/10.1074/jbc.275.2.725			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625600	hybrid			2022-12-27	WOS:000084836600004
J	Rasmussen, CD				Rasmussen, CD			Cloning of a calmodulin kinase I homologue from Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; FISSION YEAST; ASPERGILLUS-NIDULANS; TRANSCRIPTION FACTOR; CA2+/CALMODULIN-DEPENDENT KINASE; SEXUAL DEVELOPMENT; BINDING DOMAINS; GENE-EXPRESSION; CDNA CLONING; RAT-BRAIN	By using S-35-labeled calmodulin (CaM), we have isolated a full-length cDNA clone expressing the Schizosaccharomyces pombe homologue of calmodulin kinase I (CaMK-I), a gene we have named cmk1. It has been previously been shown in mammals that CaMK-I is a member of a CaM-dependent protein kinase cascade that ultimately regulates transcription factors such as ATF and cAMP-response element-binding protein. The cmk1 cDNA encodes a 335-amino acid protein with significant homology to mammalian CaMK-I, including a conserved sequence for phosphorylation by CaM kinase kinase. We have expressed the cmk1 cDNA in bacteria and yeast, and we have shown that it is a CaM-dependent protein kinase, A truncation mutant of cmk1 (d320) failed to bind CaM, indicating that the CaM-binding domain is at the extreme C terminus of the protein. The mRNA for cmk1 is expressed in a cell. cycle-dependent manner, peaking at or near the G(1)/S boundary. Overexpression of wild-type cmk1 in S, pombe caused no apparent effects on growth and division. However, mutation of a predicted regulatory site (Thr-192) to aspartic acid resulted in hyperactivation of CMK1 activity in the presence of CaM and causes cell cycle arrest in vivo. Arrest is also accompanied by morphological defects, These results suggest the presence of a CaM-dependent protein kinase cascade in yeast and indicate that cmk1 may be important in cell cycle progression, a process known to be dependent on CaM in eukaryotic cells.	Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada	University of Saskatchewan	Rasmussen, CD (corresponding author), Univ Saskatchewan, Dept Anat & Cell Biol, 107 Wiggins Rd, Saskatoon, SK, Canada.							Aletta JM, 1996, J BIOL CHEM, V271, P20930, DOI 10.1074/jbc.271.34.20930; ALFA C, 1992, EXPT FISSION YEAST L; COX DE, 1987, ARCH BIOCHEM BIOPHYS, V259, P350, DOI 10.1016/0003-9861(87)90501-7; DAVIS TN, 1986, CELL, V47, P423, DOI 10.1016/0092-8674(86)90599-4; Dayton JS, 1997, J BIOL CHEM, V272, P3223, DOI 10.1074/jbc.272.6.3223; Dayton JS, 1996, MOL BIOL CELL, V7, P1511, DOI 10.1091/mbc.7.10.1511; DEREMER MF, 1992, J BIOL CHEM, V267, P13460; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; JONES DA, 1991, FEBS LETT, V289, P105, DOI 10.1016/0014-5793(91)80919-T; KILHOFFER MC, 1992, BIOCHIM BIOPHYS ACTA, V1160, P8, DOI 10.1016/0167-4838(92)90033-A; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; Lydan M A, 1994, Methods Mol Biol, V31, P389; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; McInerny CJ, 1995, NUCLEIC ACIDS RES, V23, P4761; MEANS AR, 1991, PHARMACOL THERAPEUT, V50, P255, DOI 10.1016/0163-7258(91)90017-G; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; MITSUI K, 1993, J BIOL CHEM, V268, P13422; MORENO S, 1991, METHOD ENZYMOL, V194, P795; PICCIOTTO MR, 1995, SYNAPSE, V20, P75, DOI 10.1002/syn.890200111; PICCIOTTO MR, 1993, J BIOL CHEM, V268, P26512; PLOCHOCKAZULINSKA D, 1995, J BIOL CHEM, V270, P24794, DOI 10.1074/jbc.270.42.24794; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; PUTKEY JA, 1983, J BIOL CHEM, V258, P1864; RASMUSSEN C, 1994, MOL BIOL CELL, V5, P785, DOI 10.1091/mbc.5.7.785; RASMUSSEN CD, 1990, J BIOL CHEM, V265, P13767; RASMUSSEN CD, 1989, EMBO J, V8, P73, DOI 10.1002/j.1460-2075.1989.tb03350.x; RASMUSSEN CD, 1987, EMBO J, V6, P3961, DOI 10.1002/j.1460-2075.1987.tb02738.x; RASMUSSEN G, 1995, BIOCHEM CELL BIOL, V73, P201, DOI 10.1139/o95-024; REYMOND A, 1993, EMBO J, V12, P4325, DOI 10.1002/j.1460-2075.1993.tb06117.x; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; TAKEDA T, 1987, P NATL ACAD SCI USA, V84, P3580, DOI 10.1073/pnas.84.11.3580; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; YOKOKURA H, 1995, J BIOL CHEM, V270, P23851, DOI 10.1074/jbc.270.40.23851; YOSHIDA T, 1994, J CELL SCI, V107, P1725	44	28	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					685	690		10.1074/jbc.275.1.685	http://dx.doi.org/10.1074/jbc.275.1.685			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617667	hybrid			2022-12-27	WOS:000085951600091
J	Lee, W; Ryu, JW; Souto, RP; Pilch, PF; Jung, CY				Lee, W; Ryu, JW; Souto, RP; Pilch, PF; Jung, CY			Separation and partial characterization of three distinct intracellular GLUT4 compartments in rat adipocytes - Subcellular fractionation without homogenization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER GLUT4; INSULIN-STIMULATED TRANSLOCATION; 3T3-L1 ADIPOCYTES; GLUT4-CONTAINING VESICLES; PLASMA-MEMBRANE; STORAGE-VESICLES; ADIPOSE-TISSUE; MAJOR PROTEIN; CELL-SURFACE; ENDOCYTOSIS	Insulin recruits GLUT4 from an intracellular location to the plasma membrane in rat adipocytes. The process involves multiple intracellular compartments and multiple protein functions, details of which are largely unknown partly due to our inability to separate individual GLUT4 compartments. Here, by hypotonic lysis, differential centrifugation, and glycerol density gradient sedimentation, we separated intracellular GLUT4 compartments in rat adipocytes into three fractions: plasma membrane-containing fraction T and plasma mem brane-free fractions H and L, The GLUT4 contents in fractions T, H, and L were similar to 25, 56, and 18% of total GLUT4, respectively, in basal adipocytes and 55, 42, and 3-4% in insulin-stimulated adipocytes, The plasma membrane GLUT4 contents estimated separately further revealed that intracellular GLUT4 in fraction T amounts to similar to 20% in both basal and insulin-stimulated adipocytes, Organelle-specific marker and membrane traffic related protein distribution data suggested that intracellular GLUT4 in fraction T represents sorting endosomes, whereas GLUT4 in fractions H and L represents storage endosomes and exocytic vesicles, respectively. The subcellular fractionation without homogenization described here should be useful in identifying the role of the individual GLUT4 compartments and the associated proteins in insulin-induced GLUT4 recruitment in rat adipocytes.	Vet Adm Med Ctr, Biophys Lab, Buffalo, NY 14215 USA; SUNY Buffalo, Sch Med, Dept Physiol & Biophys, Buffalo, NY 14215 USA; Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Boston University	Jung, CY (corresponding author), Vet Adm Med Ctr, Biophys Lab, 3495 Bailey Ave, Buffalo, NY 14215 USA.		Souto, Ricardo/F-7828-2012; Lee, Wan/B-6252-2013	Souto, Ricardo/0000-0002-6281-5956; Lee, Wan/0000-0002-5181-2135; Pilch, Paul/0000-0003-1997-0499; Ryu, Jiwon/0000-0003-0251-7858	NIDDK NIH HHS [R01 DK13376, R01 DK30425] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030425, R01DK013376] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAIN CC, 1992, J BIOL CHEM, V267, P11681; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; CHAKRABARTI R, 1994, J BIOL CHEM, V269, P7926; Charron MJ, 1999, J BIOL CHEM, V274, P3253, DOI 10.1074/jbc.274.6.3253; CORMONT M, 1993, J BIOL CHEM, V268, P19491; CZECH MP, 1993, J BIOL CHEM, V268, P9187; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; DELVECCHIO RL, 1991, J BIOL CHEM, V266, P13278; HellerHarrison RA, 1996, J BIOL CHEM, V271, P10200, DOI 10.1074/jbc.271.17.10200; HERMAN GA, 1994, P NATL ACAD SCI USA, V91, P12750, DOI 10.1073/pnas.91.26.12750; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1987, J BIOL CHEM, V262, P11817; JHUN BH, 1992, J BIOL CHEM, V267, P17710; JHUN BH, 1991, J BIOL CHEM, V266, P22260; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kandror KV, 1996, AM J PHYSIOL-ENDOC M, V271, pE1, DOI 10.1152/ajpendo.1996.271.1.E1; Kandror KV, 1998, BIOCHEM J, V331, P829, DOI 10.1042/bj3310829; Kandror KV, 1996, J BIOL CHEM, V271, P21703, DOI 10.1074/jbc.271.36.21703; KITAGAWA K, 1989, BIOCHIM BIOPHYS ACTA, V1014, P83, DOI 10.1016/0167-4889(89)90244-9; Kupriyanova TA, 1999, J BIOL CHEM, V274, P1458, DOI 10.1074/jbc.274.3.1458; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURIE SM, 1993, J BIOL CHEM, V268, P19110; Lee W, 1997, BIOCHEM BIOPH RES CO, V240, P409, DOI 10.1006/bbrc.1997.7671; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; Malide D, 1997, FEBS LETT, V409, P461, DOI 10.1016/S0014-5793(97)00563-2; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; MARTZ A, 1986, J BIOL CHEM, V261, P3606; MASTICK CC, 1994, J BIOL CHEM, V269, P6089; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; PAGE LJ, 1995, J CELL BIOL, V131, P619, DOI 10.1083/jcb.131.3.619; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; ROBINSON MS, 1990, J CELL BIOL, V111, P2319, DOI 10.1083/jcb.111.6.2319; RODBELL M, 1967, J BIOL CHEM, V242, P5751; RODBELL M, 1964, J BIOL CHEM, V239, P375; SHISHEVA A, 1994, J BIOL CHEM, V269, P23865; Sleeman MW, 1998, J BIOL CHEM, V273, P3132, DOI 10.1074/jbc.273.6.3132; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SMITH RM, 1991, P NATL ACAD SCI USA, V88, P6893, DOI 10.1073/pnas.88.15.6893; TANNER LI, 1989, J CELL BIOL, V108, P1537, DOI 10.1083/jcb.108.4.1537; THOIDIS G, 1993, J BIOL CHEM, V268, P11691; TSAKIRIDIS T, 1994, J BIOL CHEM, V269, P29934; Volchuk A, 1998, J BIOL CHEM, V273, P8169, DOI 10.1074/jbc.273.14.8169; VOLCHUK A, 1995, J BIOL CHEM, V270, P8233, DOI 10.1074/jbc.270.14.8233; YANG J, 1993, J BIOL CHEM, V268, P4600	55	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37755	37762		10.1074/jbc.274.53.37755	http://dx.doi.org/10.1074/jbc.274.53.37755			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608836	hybrid			2022-12-27	WOS:000084528000036
J	Borngraber, S; Browner, M; Gillmor, S; Gerth, C; Anton, M; Fletterick, R; Kuhn, H				Borngraber, S; Browner, M; Gillmor, S; Gerth, C; Anton, M; Fletterick, R; Kuhn, H			Shape and specificity in mammalian 15-lipoxygenase active site - The functional, interplay of sequence determinants for the reaction specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIONAL SPECIFICITY; SOYBEAN LIPOXYGENASE-1; LINOLEIC-ACID; 12-LIPOXYGENASE; STEREOCHEMISTRY; 5-LIPOXYGENASE; LEUKOTRIENES; MUTAGENESIS; MECHANISM; PRODUCTS	Previous mutagenesis studies along with molecular modeling using the x-ray coordinates of the rabbit 15-lipoxygenase have led to the suggestion that the size of the substrate binding pocket may play an essential role in determining the oxygenation specificity of 5-, 12-, and 15-lipoxygenases, Based on the x-ray crystal structure of rabbit 15-lipoxygenase, Ile(593) appeared to be important in defining size and shape of the substrate-binding site in 15-lipoxygenases, We found that substitution of Ile593 with alanine shifted the positional specificity of this enzyme toward 12-lipoxygenation, To compare the importance of position 593 with previously defined determinants for the oxygenation specificity, we introduced small (alanine-scan) or large amino acids (phenylalanine-scan) at critical positions surrounding the putative fatty acid-binding site, so that the volume of the pocket was either increased or decreased. Enlargement or alteration in packing density within the substrate binding pocket in the rabbit 15-lipoxygenase increased the share of 12-lipoxygenase products, whereas a smaller active site favored 15-lipoxygenation. Simultaneous substitution of both large and small residues in the context of either a 15- or 12-lipoxygenase indicated that there is a functional interplay of the sequence determinants for Lipoxygenation specificity. If the 15-lipoxygenase active site is enlarged excessively, however, no lipoxygenation was observed anymore. Together these results indicate the importance of the overall size and shape of the arachidonic acid binding pocket in defining the specificity of lipoxygenase reaction.	Humboldt Univ, Univ Clin Charite, Inst Biochem, D-10115 Berlin, Germany; Roche Biosci, Inflammatory Dis Unit, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Roche Holding; University of California System; University of California San Francisco	Kuhn, H (corresponding author), Humboldt Univ, Univ Clin Charite, Inst Biochem, Hess Str 3-4, D-10115 Berlin, Germany.							AHARONY D, 1986, J BIOL CHEM, V261, P1512; Borngraber S, 1996, J MOL BIOL, V264, P1145, DOI 10.1006/jmbi.1996.0702; Browner MF, 1998, NAT STRUCT BIOL, V5, P179, DOI 10.1038/nsb0398-179; CHEN XS, 1993, FASEB J, V7, P694, DOI 10.1096/fasebj.7.8.8500694; DEGROOT JJM, 1975, BIOCHIM BIOPHYS ACTA, V377, P71, DOI 10.1016/0005-2744(75)90287-9; DRAHEIM JE, 1989, ARCH BIOCHEM BIOPHYS, V269, P208, DOI 10.1016/0003-9861(89)90102-1; EGMOND MR, 1973, BIOCHEM BIOPH RES CO, V54, P1178, DOI 10.1016/0006-291X(73)90816-4; Funk CD, 1997, NAT STRUCT BIOL, V4, P966, DOI 10.1038/nsb1297-966; Gan QF, 1996, J BIOL CHEM, V271, P25412, DOI 10.1074/jbc.271.41.25412; GARDNER HW, 1989, BIOCHIM BIOPHYS ACTA, V1001, P274, DOI 10.1016/0005-2760(89)90111-2; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; HAY DWP, 1995, TRENDS PHARMACOL SCI, V16, P304, DOI 10.1016/S0165-6147(00)89059-8; Hornung E, 1999, P NATL ACAD SCI USA, V96, P4192, DOI 10.1073/pnas.96.7.4192; Kuhn H, 1997, CURR OPIN LIPIDOL, V8, P111; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1168, P73, DOI 10.1016/0005-2760(93)90268-E; KUHN H, 1986, ADV ENZYMOL RAMB, V58, P273; KUHN H, 1990, J BIOL CHEM, V265, P16300; LEHMANN WD, 1994, FREE RADICAL BIO MED, V16, P241, DOI 10.1016/0891-5849(94)90149-X; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; LUDWIG P, 1987, EUR J BIOCHEM, V168, P325, DOI 10.1111/j.1432-1033.1987.tb13424.x; Prigge ST, 1998, NAT STRUCT BIOL, V5, P178, DOI 10.1038/nsb0398-178; Prigge ST, 1996, PROTEINS, V24, P275; RAPOPORT SM, 1990, BLOOD CELL BIOCH, V1, P151; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; SIEDOW JN, 1991, ANNU REV PLANT PHYS, V42, P145, DOI 10.1146/annurev.pp.42.060191.001045; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; SLOANE DL, 1995, PROTEIN ENG, V8, P275, DOI 10.1093/protein/8.3.275; SUZUKI H, 1994, BBA-LIPID LIPID MET, V1210, P308, DOI 10.1016/0005-2760(94)90234-8; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; WATANABE T, 1993, BIOCHEM BIOPH RES CO, V192, P1023, DOI 10.1006/bbrc.1993.1519; WIESNER R, 1983, BIOMED BIOCHIM ACTA, V5, P431; YAMAMOTO S, 1989, PROSTAG LEUKOTR ESS, V35, P219, DOI 10.1016/0952-3278(89)90005-7; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9	33	111	113	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37345	37350		10.1074/jbc.274.52.37345	http://dx.doi.org/10.1074/jbc.274.52.37345			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601303	hybrid			2022-12-27	WOS:000084382700074
J	Krauss, K; Altevogt, P				Krauss, K; Altevogt, P			Integrin leukocyte function-associated antigen-1-mediated cell binding can be activated by clustering of membrane rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; CROSS-LINKING; PHOSPHATIDYLINOSITOL 3-KINASE; CONFORMATIONAL CHANGE; SIGNAL-TRANSDUCTION; ADHESION; SURFACE; DOMAINS; LIGAND; CHOLESTEROL	The leukocyte function-associated antigen-1 (LFA-1) integrin (CD11a/CD18) is an important adhesion molecule for lymphocyte migration and the initiation of an immune response, At the cell surface, LFA-1 activity can be regulated by divalent cations that enhance receptor affinity but also by membrane clustering induced by treatment of cells with substances such as phorbol esters. Membrane clustering leads to increased LFA-1 avidity. We report here that LFA-1-mediated binding of mouse thymocytes or activated T lymphocytes to intercellular adhesion molecule 1 can be rapidly induced by clustering of membrane rafts using antibodies to the glycosylphophatidylinositol-anchored molecule CD24 or cholera toxin (CTx). CD24 and CD18 were found to colocalize in rafts and cross-linking with CTx lead to enhanced LFA-1 clustering. We observed that disruption of raft, integrity by lowering the membrane cholesterol content abolished the CTx and the phorbol la-myristate 13-acetate-induced LFA-1 binding but left the ability to activate LFA-1 with Mg2+/EGTA unimpaired. In contrast to activation with Mg2+/EGTA, activation via raft clustering was dependent on PI3-kinase, required cytoskeletal mobility, and was accompanied by Tyr phosphorylation of a 18-kDa protein. Our results support the notion that rafts as preformed adhesion platforms could be important for the rapid regulation of lymphocyte adhesion.	German Canc Res Ctr, Tumor Immunol Programme, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Altevogt, P (corresponding author), German Canc Res Ctr, Tumor Immunol Programme, G0100,Neuenheimer Feld 280, D-69120 Heidelberg, Germany.							ALTEVOGT P, 1994, EUR J IMMUNOL, V24, P731, DOI 10.1002/eji.1830240336; ALTEVOGT P, 1995, J EXP MED, V182, P345, DOI 10.1084/jem.182.2.345; BARRETT TB, 1991, J IMMUNOL, V146, P1722; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; BEEKHUIZEN H, 1993, J IMMUNOL, V150, P950; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BUBB MR, 1994, J BIOL CHEM, V269, P14869; CINEK T, 1992, J IMMUNOL, V149, P2262; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; Duronio V, 1998, CELL SIGNAL, V10, P233, DOI 10.1016/S0898-6568(97)00129-0; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hmama Z, 1999, J BIOL CHEM, V274, P1050, DOI 10.1074/jbc.274.2.1050; HooshmandRad R, 1997, EXP CELL RES, V234, P434, DOI 10.1006/excr.1997.3636; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0; Jones SM, 1997, J CELL BIOL, V139, P339, DOI 10.1083/jcb.139.2.339; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; McDowall A, 1998, J BIOL CHEM, V273, P27396, DOI 10.1074/jbc.273.42.27396; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Nagel W, 1998, J BIOL CHEM, V273, P14853, DOI 10.1074/jbc.273.24.14853; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; ROBINSON PJ, 1991, IMMUNOL TODAY, V12, P35, DOI 10.1016/0167-5699(91)90110-F; Ruppert M, 1995, J CELL BIOL, V131, P1881, DOI 10.1083/jcb.131.6.1881; Sammar M, 1997, BIOCHEM BIOPH RES CO, V234, P330, DOI 10.1006/bbrc.1997.6639; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Stulnig TM, 1997, J BIOL CHEM, V272, P19242, DOI 10.1074/jbc.272.31.19242; VANKOOYK Y, 1994, J CELL BIOL, V124, P1061, DOI 10.1083/jcb.124.6.1061; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WENGER RH, 1991, EUR J IMMUNOL, V21, P1039, DOI 10.1002/eji.1830210427; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yauch RL, 1997, J EXP MED, V186, P1347, DOI 10.1084/jem.186.8.1347; Zauli G, 1997, BLOOD, V89, P883, DOI 10.1182/blood.V89.3.883; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	46	153	153	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36921	36927		10.1074/jbc.274.52.36921	http://dx.doi.org/10.1074/jbc.274.52.36921			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601245	hybrid			2022-12-27	WOS:000084382700016
J	Loland, CJ; Norregaard, L; Gether, U				Loland, CJ; Norregaard, L; Gether, U			Defining proximity relationships in the tertiary structure of the dopamine transporter - Identification of a conserved glutamic acid as a third coordinate in the endogenous Zn2+-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TACHYKININ NK-1 RECEPTOR; METAL-BINDING SITES; SEROTONIN TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; NOREPINEPHRINE TRANSPORTERS; TRANSMEMBRANE DOMAIN; COCAINE BINDING; AMINO-ACID; ZINC IONS; RECOGNITION	Recently, we have described a distance constraint in the unknown tertiary structure of the human dopamine transporter (hDAT) by identification of two histidines, His(193) in the second extracellular loop and His(375) at the top of transmembrane (TM) 7, that form two coordinates in an endogenous, high affinity Zn2+-binding site. To achieve further insight into the tertiary organization of hDAT, we set out to identify additional residues involved in Zn2+ binding and subsequently to engineer artificial Zn2+-binding sites. Ten aspartic acids and glutamic acids, predicted to be on the extracellular side, were mutated to asparagine and glutamine, respectively. Mutation of Glu(396) (E396Q) at the top of TM 8 increased the IC50 value for Zn2+ inhibition of [H-3]dopamine uptake from 1.1 to 530 mu M and eliminated Zn2+ induced potentiation of [H-3]WIN 35,428 binding. These data suggest that Glu(396) is involved in Zn2+ binding to hDAT, Importantly, Zn2+ sensitivity was preserved following substitution of Glu(396) with histidine, indicating that the effect of mutating Glu(396) is not an indirect effect because of the removal of a negatively charged residue. The common participation of Glu(396), His(193), and His(375) in binding the small Zn2+ ion implies their proximity in the unknown tertiary structure of hDAT, The close association between TM. 7 and 8 was further established by engineering of a Zn2+-binding site between His(375) and a cysteine inserted in position 400 in TM 8, Summarized, our data define an important set of proximity relationships in hDAT that should prove an important template for further exploring the molecular architecture of Na+/Cl--dependent neurotransmitter transporters.	Univ Copenhagen, Panum Inst, Dept Med Physiol 12522, Div Cellular& Mol Physiol, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Gether, U (corresponding author), Univ Copenhagen, Panum Inst, Dept Med Physiol 12522, Div Cellular& Mol Physiol, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	gether@mfi.ku.dk	Loland, Claus/E-5975-2014	Loland, Claus/0000-0002-1773-1446; Gether, Ulrik/0000-0002-0020-3807				Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1996, MOL PHARMACOL, V50, P957; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; BARKER EL, 1994, MOL PHARMACOL, V46, P799; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Buck KJ, 1995, MOL PHARMACOL, V48, P1030; BUCK KJ, 1994, P NATL ACAD SCI USA, V91, P12584, DOI 10.1073/pnas.91.26.12584; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Elling CE, 1996, EMBO J, V15, P6213, DOI 10.1002/j.1460-2075.1996.tb01011.x; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; FREDERICKSON CJ, 1984, NEUROBIOLOGY ZINC NE; GETHER U, 1992, FEBS LETT, V296, P241, DOI 10.1016/0014-5793(92)80295-R; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1994, J BIOL CHEM, V269, P15985; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; GIROS B, 1992, MOL PHARMACOL, V42, P383; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; HE MM, 1995, BIOCHEMISTRY-US, V34, P15667, DOI 10.1021/bi00048a010; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; Horenstein J, 1998, MOL PHARMACOL, V53, P870; HORN AS, 1990, PROG NEUROBIOL, V34, P387, DOI 10.1016/0301-0082(90)90033-D; Huang EP, 1997, P NATL ACAD SCI USA, V94, P13386, DOI 10.1073/pnas.94.25.13386; JOHANSEN TE, 1990, FEBS LETT, V267, P289, DOI 10.1016/0014-5793(90)80947-H; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; Nelson N, 1998, J NEUROCHEM, V71, P1785; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Penado KMY, 1998, J BIOL CHEM, V273, P28098, DOI 10.1074/jbc.273.43.28098; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; PIFL C, 1993, J NEUROSCI, V13, P4246, DOI 10.1523/jneurosci.13-10-04246.1993; REGAN L, 1995, TRENDS BIOCHEM SCI, V20, P280, DOI 10.1016/S0968-0004(00)89044-1; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Schetz JA, 1999, J PHARMACOL EXP THER, V289, P956; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vandenberg RJ, 1998, MOL PHARMACOL, V54, P189, DOI 10.1124/mol.54.1.189; WANG TL, 1995, J NEUROSCI, V15, P7684; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535	49	92	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36928	36934		10.1074/jbc.274.52.36928	http://dx.doi.org/10.1074/jbc.274.52.36928			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601246	hybrid			2022-12-27	WOS:000084382700017
J	Wotton, D; Lo, RS; Swaby, LAC; Massague, J				Wotton, D; Lo, RS; Swaby, LAC; Massague, J			Multiple modes of repression by the Smad transcriptional corepressor TGIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; HISTONE DEACETYLASE; HOMEOBOX GENE; HOMEODOMAIN PROTEINS; N-COR; COMPLEX; SEQUENCE; DOMAIN; HOX; COACTIVATORS	TGIF is a DNA-binding homeodomain protein that has been demonstrated to play a role in transforming growth factor P-regulated transcription and implicated in the control of retinoid-responsive transcription. We investigated the intrinsic transcriptional activity of TGIF fused to a heterologous DNA-binding domain. Our results demonstrate that TGIF is a transcriptional repressor able to repress transcription from several different promoters. Repression by TGIF is insensitive to the distance at which it is bound from the promoter, Moreover, the wild type TGIF effectively represses transcription when bound to its cognate DNA-binding site via its homeodomain, Deletion analysis revealed the presence of at least two separable repression domains within TGIF, Repression by one of these is dependent on the activity of histone deacetylases (HDACs), whereas the other appears not to require HDAC activity. Finally, we demonstrate that TGIF interacts with HDACs via its carboxyl-terminal repression domain. Together, these results suggest that TGIF is a multifunctional transcriptional repressor, which acts in part by recruiting HDAC activity.	Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Cell Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Cell Biol Program, Box 116,1275 York Ave, New York, NY 10021 USA.			Massague, Joan/0000-0001-9324-8408; Wotton, David/0000-0002-4652-5350	NCI NIH HHS [CA34610] Funding Source: Medline; NIGMS NIH HHS [GM07739] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA034610, R37CA034610] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Bertolino E, 1996, DEV DYNAM, V205, P410, DOI 10.1002/(SICI)1097-0177(199604)205:4<410::AID-AJA5>3.0.CO;2-L; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Edwards MC, 1997, GENETICS, V147, P1063; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; JOHNSON AD, 1995, CELL, V81, P655, DOI 10.1016/0092-8674(95)90524-3; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Li C, 1998, MOL CELL BIOL, V18, P3771, DOI 10.1128/MCB.18.7.3771; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; Ming JE, 1998, CLIN GENET, V53, P155; MONCOLLIN V, 1986, EMBO J, V5, P2577, DOI 10.1002/j.1460-2075.1986.tb04537.x; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; OVERHAUSER J, 1995, AM J HUM GENET, V57, P1080; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Schnabel CA, 1996, MOL CELL BIOL, V16, P2678; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; Wolffe AP, 1996, SCIENCE, V272, P371, DOI 10.1126/science.272.5260.371; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Zhang HL, 1996, P NATL ACAD SCI USA, V93, P1764, DOI 10.1073/pnas.93.5.1764; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	42	156	162	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37105	37110		10.1074/jbc.274.52.37105	http://dx.doi.org/10.1074/jbc.274.52.37105			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601270	hybrid			2022-12-27	WOS:000084382700041
J	Bera, AK; Chen, SH; Smith, JL; Zalkin, H				Bera, AK; Chen, SH; Smith, JL; Zalkin, H			Interdomain signaling in glutamine phosphoribosylpyrophosphate amidotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SITE	The glutamine phosphoribosylpyrophosphate (PRPP) amidotransferase-catalyzed synthesis of phosphoribosylamine from PRPP and glutamine is the sum of two half-reactions at separated catalytic sites in different domains. Binding of PRPP to a C-terminal phosphoribosyltransferase domain is required to activate the reaction at the N-terminal glutaminase domain. Interdomain signaling was monitored by intrinsic tryptophan fluorescence and by measurements of glutamine binding and glutamine site catalysis. Enzymes were engineered to contain a single tryptophan fluorescence reporter in key positions in the glutaminase domain. Trp(83) in the glutamine loop (residues 73-84) and Trp(482) in the C-terminal helix (residues 471-492) reported fluorescence changes in the glutaminase domain upon binding of PRPP and glutamine. The fluorescence changes were perturbed by Ile(335) and Tyr(74) mutations that disrupt interdomain signaling. Fluoresence titrations of PRPP and glutamine binding indicated that signaling defects increased the K-d for glutamine but had little or no effect on PRPP binding. It was concluded that the contact between Ile(335) in the phosphoribosyltransferase domain and Tyr(74) in the glutamine site is a primary molecular interaction for interdomain signaling. Analysis of enzymes with mutations in the glutaminase domain C-terminal helix and a 404-420 peptide point to additional signaling interactions that activate the glutamine site when PRPP binds.	Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zalkin, H (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.		Bera, Aloke Kumar/AAD-9541-2022		NIDDK NIH HHS [R37 DK042303, DK42303] Funding Source: Medline; NIGMS NIH HHS [GM 24658] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042303, R37DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024658, R37GM024658] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen SH, 1999, BIOCHEMISTRY-US, V38, P11659, DOI 10.1021/bi991060o; DOHERTY AJ, 1995, NUCLEIC ACIDS RES, V23, P2074, DOI 10.1093/nar/23.11.2074; GOTO Y, 1976, J BIOL CHEM, V251, P941; Kim JH, 1996, J BIOL CHEM, V271, P15549, DOI 10.1074/jbc.271.26.15549; Krahn JM, 1997, BIOCHEMISTRY-US, V36, P11061, DOI 10.1021/bi9714114; KRAHN JM, 1998, THESIS PURDUE U; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MESSENGER LJ, 1979, J BIOL CHEM, V254, P3382; Miles BW, 1998, BIOCHEMISTRY-US, V37, P16773, DOI 10.1021/bi982018g; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Muchmore CRA, 1998, PROTEIN SCI, V7, P39, DOI 10.1002/pro.5560070104; Smith JL, 1998, CURR OPIN STRUC BIOL, V8, P686, DOI 10.1016/S0959-440X(98)80087-0; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87	13	18	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36498	36504		10.1074/jbc.274.51.36498	http://dx.doi.org/10.1074/jbc.274.51.36498			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593947	hybrid			2022-12-27	WOS:000084279200066
J	Connolly, CN; Kittler, JT; Thomas, P; Uren, JM; Brandon, NJ; Smart, TG; Moss, SJ				Connolly, CN; Kittler, JT; Thomas, P; Uren, JM; Brandon, NJ; Smart, TG; Moss, SJ			Cell surface stability of gamma-aminobutyric acid type A receptors - Dependence on protein kinase C activity and subunit composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A RECEPTOR; PHOSPHORYLATION SITES; GABA(A) RECEPTORS; BETA-SUBUNITS; NEUROTRANSMITTER; FIBROBLASTS; TRANSFERRIN; ENDOCYTOSIS; EXPRESSION; SUBTYPES	Type A gamma-aminobutyric acid receptors (GABA(A)), the major sites of fast synaptic inhibition in the brain, are believed to be composed predominantly of alpha, beta, and gamma subunits, Although cell surface expression is essential for GABA,receptor function, little is known regarding its regulation, To address this issue, the membrane stability of recombinant alpha(1)beta(2) or alpha(1)beta(2)gamma(2) receptors was analyzed in human embryonic kidney cells. alpha(1)beta(2)gamma(2), but not alpha(1)beta(2) receptors were found to recycle constitutively between the cell surface and a microtubule-dependent, perinuclear endosomal compartment. Similar GABA, receptor endocytosis was also seen in cultured hippocampal and cortical neurons. GABA, receptor surface levels were reduced upon protein kinase C (PKC) activation. Like basal endocytosis, this response required the gamma(2) subunit but not receptor phosphorylation. Although inhibiting PKC activity did not block alpha(1)beta(2)gamma(2) receptor endocytosis, it did prevent receptor down-regulation, suggesting that PKC activity may block alpha(1)beta(2)gamma(2) receptor recycling to the cell surface, In agreement with this observation, blocking recycling from endosomes with wortmannin selectively reduced surface levels of gamma(2)-containing receptors, Together, our results demonstrate that the surface stability of GABA(A) receptors can be dynamically and specifically regulated, enabling neurons to modulate cell surface receptor number upon the appropriate cues.	UCL, MRC, LMCB, London WC1E 6BT, England; UCL, Dept Pharmacol, London WC1E 6BT, England; Sch Pharm, Dept Pharmacol, London WC1E 1AX, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London School of Pharmacy	Moss, SJ (corresponding author), UCL, MRC, LMCB, Gower St, London WC1E 6BT, England.	steve.moss@ucl.ac.uk	Kittler, Josef T/E-9113-2010; Kittler, Josef/N-7589-2019	Kittler, Josef T/0000-0002-3437-9456; Kittler, Josef/0000-0002-3437-9456; Brandon, Nicholas/0000-0002-3917-0096; Connolly, Christopher/0000-0002-0445-8874				Barnes EM, 1996, INT REV NEUROBIOL, V39, P53, DOI 10.1016/S0074-7742(08)60663-7; BORDEN LA, 1984, SCIENCE, V226, P857, DOI 10.1126/science.6093257; Brickley SG, 1999, J NEUROSCI, V19, P2960; CALKIN PA, 1994, J BIOL CHEM, V269, P1548; Chapell R, 1998, J BIOL CHEM, V273, P32595, DOI 10.1074/jbc.273.49.32595; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; GAROFALO RS, 1992, J BIOL CHEM, V267, P11470; Goslin K., 1991, CULTURING NERVE CELL, P251; GYENES M, 1994, MOL PHARMACOL, V46, P542; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; Jess TJ, 1996, CELL SIGNAL, V8, P297, DOI 10.1016/0898-6568(96)00054-X; KELLENBERGER S, 1992, J BIOL CHEM, V267, P25660; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Martys JL, 1996, J BIOL CHEM, V271, P10953, DOI 10.1074/jbc.271.18.10953; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; Poisbeau P, 1997, J NEUROSCI, V17, P3467; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; SUR C, 1995, EUR J NEUROSCI, V7, P1323, DOI 10.1111/j.1460-9568.1995.tb01123.x; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8	33	151	159	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36565	36572		10.1074/jbc.274.51.36565	http://dx.doi.org/10.1074/jbc.274.51.36565			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593956	hybrid			2022-12-27	WOS:000084279200075
J	Park, JE; Lenter, MC; Zimmermann, RN; Garin-Chesa, P; Old, LJ; Rettig, WJ				Park, JE; Lenter, MC; Zimmermann, RN; Garin-Chesa, P; Old, LJ; Rettig, WJ			Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL ACTIVATION; DIPEPTIDYLPEPTIDASE-IV; EPITHELIAL CANCERS; DIFFERENTIAL EXPRESSION; MOLECULAR-CLONING; TISSUE INHIBITOR; GROWTH-FACTORS; UP-REGULATION; GELATINASE-A; FREE ENZYME	Proteolytic degradation of extracellular matrix (ECM) components during tissue remodeling plays a pivotal role in normal and pathological processes including wound healing, inflammation, tumor invasion, and metastasis. Proteolytic enzymes in tumors may activate or release growth factors from the ECM or act directly on the ECM itself thereby facilitating angiogenesis or tumor cell migration. Fibroblast activation protein (FAP) is a cell surface antigen of reactive tumor stromal fibroblasts found in epithelial cancers and in granulation tissue during wound healing. It is absent from most normal adult human tissues. FAP is conserved throughout chordate evolution, with homologues in mouse and Xenopus laevis, whose expression correlates with tissue remodeling events. Using recombinant and purified natural FAP, we show that FAP has both dipeptidyl peptidase activity and a collagenolytic activity capable of degrading gelatin and type I collagen; by sequence, FAP belongs to the serine protease family rather than the matrix metalloprotease family. Mutation of the putative catalytic serine residue of FAP to alanine abolishes both enzymatic activities. Consistent with its in vivo expression pattern determined by immunohistochemistry, FAP enzyme activity was detected by an immunocapture assay in human cancerous tissues but not in matched normal tissues. This study demonstrates that FAP is present as an active cell surface-bound collagenase in epithelial tumor stroma and opens up investigation into physiological substrates of its novel, tumor-associated dipeptidyl peptidase activity.	Boehringer Ingelheim Pharma KG, Dept Oncol Res, D-88397 Biberach, Germany; Mem Sloan Kettering Canc Ctr, Biochem Pharmacol Lab, Ludwig Inst Canc Res, New York, NY 10021 USA	Boehringer Ingelheim; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Park, JE (corresponding author), Boehringer Ingelheim Pharma KG, Dept Oncol Res, Birkendorferstr 65, D-88397 Biberach, Germany.							Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; Bermpohl F, 1998, FEBS LETT, V428, P152, DOI 10.1016/S0014-5793(98)00515-8; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Brown DD, 1996, P NATL ACAD SCI USA, V93, P1924, DOI 10.1073/pnas.93.5.1924; Brubaker PL, 1997, ENDOCRINOLOGY, V138, P4837, DOI 10.1210/en.138.11.4837; CAMPO E, 1992, HUM PATHOL, V23, P1395, DOI 10.1016/0046-8177(92)90060-G; Davidson B, 1997, PATHOL RES PRACT, V193, P491, DOI 10.1016/S0344-0338(97)80102-1; DOCHERTY K, 1982, P NATL ACAD SCI-BIOL, V79, P4613, DOI 10.1073/pnas.79.15.4613; DVORAK AM, 1980, J INVEST DERMATOL, V75, P388, DOI 10.1111/1523-1747.ep12523627; FLEISCHER B, 1994, IMMUNOL TODAY, V15, P180, DOI 10.1016/0167-5699(94)90316-6; FRIDMAN R, 1993, BIOCHEM J, V289, P411, DOI 10.1042/bj2890411; FRIDMAN R, 1995, CANCER RES, V55, P2548; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; GORDON SG, 1981, J CLIN INVEST, V67, P1665, DOI 10.1172/JCI110203; GORVEL JP, 1991, GASTROENTEROLOGY, V101, P618, DOI 10.1016/0016-5085(91)90517-O; HAYASHI R, 1975, J BIOCHEM-TOKYO, V77, P1313; Hayashi T, 1996, AM J PATHOL, V149, P1241; Jackson RC, 1997, SEMIN ONCOL, V24, P164; Kinoh H, 1996, J CELL SCI, V109, P953; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; KOHN EC, 1995, CANCER RES, V55, P1856; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE P, 1993, J EXP MED, V177, P1209, DOI 10.1084/jem.177.4.1209; Liotta L A, 1990, Semin Cancer Biol, V1, P99; MANTEUFFEL R, 1983, J BIOCHEM BIOPH METH, V7, P293, DOI 10.1016/0165-022X(83)90054-4; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; MEDEIROS MD, 1994, ENDOCRINOLOGY, V134, P2088, DOI 10.1210/en.134.5.2088; Medeiros MD, 1996, NEUROCHEM RES, V21, P1125, DOI 10.1007/BF02532423; MEDEIROS MS, 1994, BIOCHIMIE, V76, P283, DOI 10.1016/0300-9084(94)90159-7; MONSKY WL, 1994, CANCER RES, V54, P5702; Mountain A, 1992, Biotechnol Genet Eng Rev, V10, P1; NAGATSU T, 1985, ANAL BIOCHEM, V147, P80, DOI 10.1016/0003-2697(85)90011-9; Niedermeyer J, 1997, INT J CANCER, V71, P383, DOI 10.1002/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; PARK JE, 1991, SOMAT CELL MOLEC GEN, V17, P137, DOI 10.1007/BF01232971; PARK JE, 1994, J BIOL CHEM, V269, P25646; PEDERSEN H, 1994, CANCER RES, V54, P4671; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; Proost P, 1998, J BIOL CHEM, V273, P7222, DOI 10.1074/jbc.273.13.7222; Rasmussen HS, 1997, PHARMACOL THERAPEUT, V75, P69, DOI 10.1016/S0163-7258(97)00023-5; RETTIG WJ, 1993, CANCER RES, V53, P3327; RETTIG WJ, 1994, INT J CANCER, V58, P385, DOI 10.1002/ijc.2910580314; RETTIG WJ, 1988, P NATL ACAD SCI USA, V85, P3110, DOI 10.1073/pnas.85.9.3110; RIEMANN D, 1995, CLIN EXP IMMUNOL, V100, P277; RYAN DH, 1988, CLIN CHIM ACTA, V171, P125, DOI 10.1016/0009-8981(88)90142-8; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; SCHUTKOWSKI M, 1994, EUR J BIOCHEM, V221, P455, DOI 10.1111/j.1432-1033.1994.tb18758.x; STETLERSTEVENSON WG, 1993, FASEB J, V7, P1434, DOI 10.1096/fasebj.7.15.8262328; Su SM, 1998, J CELL BIOCHEM, V70, P517, DOI 10.1002/(SICI)1097-4644(19980915)70:4<517::AID-JCB8>3.0.CO;2-M; TANAKA T, 1992, J IMMUNOL, V149, P481; TOMBIN H, 1979, P NATL ACAD SCI USA, V76, P4350; vonBonin A, 1997, IMMUNOL LETT, V55, P179, DOI 10.1016/S0165-2478(97)02705-3; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; WAHLBY S, 1968, BIOCHIM BIOPHYS ACTA, V151, P402, DOI 10.1016/0005-2744(68)90107-1; WEAVER TE, 1992, AM J PHYSIOL, V263, pL95, DOI 10.1152/ajplung.1992.263.1.L95; YOKOTANI N, 1993, HUM MOL GENET, V2, P1037, DOI 10.1093/hmg/2.7.1037; YUN SL, 1977, BIOCHIM BIOPHYS ACTA, V480, P1, DOI 10.1016/0005-2744(77)90315-1	60	418	464	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36505	36512		10.1074/jbc.274.51.36505	http://dx.doi.org/10.1074/jbc.274.51.36505			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593948	hybrid			2022-12-27	WOS:000084279200067
J	Sun, MF; Zhao, MM; Gailani, D				Sun, MF; Zhao, MM; Gailani, D			Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; HUMAN-PLASMA PREKALLIKREIN; KININOGEN BINDING-SITE; 4 TANDEM REPEATS; FUNCTIONAL-CHARACTERIZATION; DISULFIDE BONDS; HEAVY-CHAIN; PURIFICATION; THROMBIN; MECHANISM	Activated coagulation factor XI (factor XIa) proteolytically cleaves its substrate, factor IX, in an interaction requiring the factor XI A3 domain (Sun, Y., and Gailani, D, (1996) J, Biol, Chem, 271, 29023-29028). To identify key amino acids involved in factor IX activation, recombinant factor XIa proteins containing alanine substitutions for wild-type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay. Substitutions for Ile(183)-Val(191) and Ser(195)-Ile(197) at the N terminus and for Ser(258)-Ser(264) at the C terminus of the A3 domain markedly decreased factor XI coagulant activity. The plasma protease prekallikrein is structurally homologous to factor XI, but activated factor IX poorly. A chimeric factor XIa molecule with the AS domain replaced with A3 from prekallikrein (FXI/PKA3) activated factor M with a K-m 35-fold greater than that of wild-type factor XI. FXI/PKA3 was used as a template for a series of proteins in which prekallikrein A3 sequence was replaced with factor XI sequence to restore factor M activation. Clotting and kinetics studies using these chimeras confirmed the results obtained with alanine mutants. Amino acids between Ile(183) and Val(191) are necessary for proper factor M activation, but additional sequence between Ser(195) and Ile(197) or between Phe(260) and Ser(265) is required for complete restoration of activation.	Vanderbilt Univ, Div Hematol Oncol, Dept Pathol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Gailani, D (corresponding author), Vanderbilt Univ, Div Hematol Oncol, Dept Pathol, 538 MRB 2,2220 Pierce Ave, Nashville, TN 37232 USA.	dave.gailani@mcmail.vanderbilt.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058837, K08HL002917] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL02917, HL58837] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAGLIA FA, 1995, J BIOL CHEM, V270, P6734, DOI 10.1074/jbc.270.12.6734; BAGLIA FA, 1992, J BIOL CHEM, V267, P4247; BAGLIA FA, 1990, J BIOL CHEM, V265, P4149; Baglia FA, 1996, J BIOL CHEM, V271, P3652; BAGLIA FA, 1993, J BIOL CHEM, V268, P3838; Baglia FA, 1998, BIOCHEMISTRY-US, V37, P2271, DOI 10.1021/bi972113+; BELL WN, 1954, NATURE, V174, P880, DOI 10.1038/174880a0; BOUMA BN, 1977, J BIOL CHEM, V252, P6432; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Gailani D, 1997, BLOOD, V90, P1055, DOI 10.1182/blood.V90.3.1055.1055_1055_1064; Ho DH, 1998, J BIOL CHEM, V273, P16382, DOI 10.1074/jbc.273.26.16382; Ho DH, 1996, BLOOD, V88, P1120; KOIDE T, 1977, BIOCHEMISTRY-US, V16, P2279, DOI 10.1021/bi00629a037; MASHIKO H, 1994, BIOL CHEM H-S, V375, P481; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2050, DOI 10.1021/bi00222a007; MEIJERS JCM, 1992, BIOCHEMISTRY-US, V31, P4680, DOI 10.1021/bi00134a021; NAITO K, 1991, J BIOL CHEM, V266, P7353; OSTERUD B, 1978, J BIOL CHEM, V253, P5946; SINHA D, 1985, J BIOL CHEM, V260, P714; SINHA D, 1987, BIOCHEMISTRY-US, V26, P3768, DOI 10.1021/bi00387a005; Sun YH, 1996, J BIOL CHEM, V271, P29023, DOI 10.1074/jbc.271.46.29023; VANDERGRAAF F, 1983, J BIOL CHEM, V258, P9669; WAGENVOORD R, 1990, HAEMOSTASIS, V20, P276; WALSH PN, 1984, J CLIN INVEST, V73, P1392, DOI 10.1172/JCI111343; WIGGINS RC, 1979, THROMB RES, V15, P475, DOI 10.1016/0049-3848(79)90153-1; Zhao MM, 1998, J BIOL CHEM, V273, P31153, DOI 10.1074/jbc.273.47.31153	32	59	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36373	36378		10.1074/jbc.274.51.36373	http://dx.doi.org/10.1074/jbc.274.51.36373			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593931	hybrid			2022-12-27	WOS:000084279200050
J	Cheng, DM; Marner, J; Rubenstein, PA				Cheng, DM; Marner, J; Rubenstein, PA			Interaction in vivo and in vitro between the yeast fimbrin, SAC6P, and a polymerization-defective yeast actin (V266G and L267G)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERELY DECREASED HYDROPHOBICITY; F-ACTIN; SACCHAROMYCES-CEREVISIAE; BINDING PROTEINS; ATP HYDROLYSIS; CROSS-LINKING; ATOMIC MODEL; FILAMENTS; SUPPRESSION; MUTATION	A mutant yeast actin (GG) has decreased hydrophobicity in a subdomain 3/4 hydrophobic plug believed to be involved in a hydrophobic cross-strand "plug-pocket" interaction necessary for actin filament stability. This actin will not polymerize in vitro but is compatible with cell viability. We have assessed the ability of Sac6p, the yeast homologue of the actin filament stabilizing and bundling protein fimbrin, to restore polymerization in vitro and to facilitate GG-actin function in vivo. Sac6p rescues GG-actin polymerization at 25 degrees C but not at 4 degrees C. The actin polymerizes into bundles at room temperature with a fimbrin:actin molar ratio of 1:4. At this ratio, every actin monomer contacts a Sac6p actin binding domain. Following cold-induced depolymerization, actin/Sac6p mixtures repolymerize beginning at 15 degrees C instead of the 25 degrees C required for de novo assembly, because of the presence of residual actin-Sac6p nuclei. Generation of haploid Delta sac6/GG-actin cells from either diploid or haploid cells was unsuccessful. The facile isolation of cells with either mutation alone indicates a synthetic lethal relationship between this actin allele and the SAC6 gene. Sac6p may allow GG-actin function in vivo by stabilizing the actin in bundles thereby helping maintain sufficient levels of an otherwise destabilized actin monomer within the cell.	Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-33689] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1989, SCIENCE, V243, P231, DOI 10.1126/science.2643162; ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; ADAMS AEM, 1995, MOL CELL BIOL, V15, P69, DOI 10.1128/MCB.15.1.69; BRETSCHER A, 1980, J CELL BIOL, V86, P335, DOI 10.1083/jcb.86.1.335; BUTLER G, 1988, CURR GENET, V14, P405, DOI 10.1007/BF00521261; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; COOK RK, 1992, PRACTICAL APPROACHES, P99; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; DRUBIN DG, 1988, J CELL BIOL, V107, P2551, DOI 10.1083/jcb.107.6.2551; GLENNEY JR, 1981, J BIOL CHEM, V256, P9283; Hanein D, 1998, NAT STRUCT BIOL, V5, P787, DOI 10.1038/1828; Hanein D, 1997, J CELL BIOL, V139, P387, DOI 10.1083/jcb.139.2.387; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HONTS JE, 1994, J CELL BIOL, V126, P413, DOI 10.1083/jcb.126.2.413; KARPOVA TS, 1995, J CELL BIOL, V131, P1483, DOI 10.1083/jcb.131.6.1483; KRON SJ, 1992, P NATL ACAD SCI USA, V89, P4466, DOI 10.1073/pnas.89.10.4466; Kuang B, 1997, J BIOL CHEM, V272, P1237, DOI 10.1074/jbc.272.2.1237; Kuang B, 1997, J BIOL CHEM, V272, P4412, DOI 10.1074/jbc.272.7.4412; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; LIN CS, 1994, MOL CELL BIOL, V14, P2457, DOI 10.1128/MCB.14.4.2457; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Prassler J, 1997, MOL BIOL CELL, V8, P83, DOI 10.1091/mbc.8.1.83; Sandrock TM, 1997, GENETICS, V147, P1635; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529	31	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35873	35880		10.1074/jbc.274.50.35873	http://dx.doi.org/10.1074/jbc.274.50.35873			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585472	hybrid			2022-12-27	WOS:000084187900084
J	Uh, ST; Van Linden, A; Riches, DWH				Uh, ST; Van Linden, A; Riches, DWH			Phosphorylation of 130-and 95-kDa substrates associated with tumor necrosis factor-alpha receptor CD120a (p55)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERLEUKIN-1 SIGNAL-TRANSDUCTION; PROTEIN-KINASE; TNF RECEPTOR; DEATH DOMAIN; CELL-DEATH; INTRACELLULAR DOMAIN; CYTOPLASMIC DOMAIN; MOUSE MACROPHAGES; EARLY EVENTS	Cross-linking of CD120a (p55), a receptor for tumor necrosis factor (alpha (TNF alpha), initiates downstream events, including the activation of protein Ser/Thr kinases. In this report, we have characterized two protein Ser/Thr kinase substrates that are intrinsically associated with CD120a (p55) in mouse macrophages, and we have investigated the mechanism involved in their phosphorylation, pp130 and pp95 were detected by co-immunoprecipitation with CD120a (p55) from lysates of mouse bone marrow-derived macrophages and were phosphorylated on Ser and Thr residues during in vitro kinase assays in the presence of [gamma-P-32]ATP. The level of phosphorylation of pp130 and pp95 was rapidly and transiently increased in response to TNF alpha in [P-32]orthophosphate-labeled macrophages, although the level of pp130 protein associated with CD120a (p55) remained unchanged as detected by [S-35]methionine labeling. In contrast, pp130 and pp95 were efficiently phosphorylated in in vitro kinase assays of CD120a (p55) immunoprecipitates from unstimulated cells, and the level of phosphorylation was rapidly and transiently reduced in response to TNF alpha. Both pp130 and pp95 were sensitive to dephosphorylation with purified protein phosphatase 2A, and okadaic acid, a PP1/PP2A inhibitor, mimicked the ability of TNF alpha to stimulate the phosphorylation of pp130 and pp95 in intact P-32-labeled macrophages. Collectively, these findings suggest that pp130 and pp95 are constitutively associated with CD120a (p55) and become inducibly phosphorylated in macrophages in response to TNF alpha. We propose that the underlying mechanism of their phosphorylation may involve the inactivation of a cytoplasmic pp130/pp95 Ser/Thr phosphatase.	Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Dept Med,Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Riches, DWH (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Neustadt Rm D405,1400 Jackson St, Denver, CO 80206 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056556, R01HL055549] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL55549, HL56556] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BEYAERT R, 1995, J BIOL CHEM, V270, P23293, DOI 10.1074/jbc.270.40.23293; BOLDIN MP, 1995, FEBS LETT, V367, P39, DOI 10.1016/0014-5793(95)00534-G; Castellino AM, 1997, J BIOL CHEM, V272, P5861, DOI 10.1074/jbc.272.9.5861; CAVAILLES V, 1994, P NATL ACAD SCI USA, V91, P10009, DOI 10.1073/pnas.91.21.10009; DARNAY BG, 1994, J BIOL CHEM, V269, P20299; Darnay BG, 1997, J LEUKOCYTE BIOL, V61, P559, DOI 10.1002/jlb.61.5.559; Dunbar JD, 1997, J IMMUNOL, V158, P4252; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GUY GR, 1995, EUR J BIOCHEM, V229, P503, DOI 10.1111/j.1432-1033.1995.0503k.x; GUY GR, 1992, J BIOL CHEM, V267, P1846; GUY GR, 1993, J BIOL CHEM, V268, P2141; HIGUCHI M, 1993, J BIOL CHEM, V268, P5624; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; PACE JL, 1985, J IMMUNOL, V134, P977; RICHES DWH, 1991, J BIOL CHEM, V266, P24785; Riches DWH, 1996, MOL CELLULAR BIOL WO, P95; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONG HY, 1995, J BIOL CHEM, V270, P3574, DOI 10.1074/jbc.270.8.3574; SONG HY, 1994, J BIOL CHEM, V269, P22492; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; VANARSDALE TL, 1994, J IMMUNOL, V153, P3043; VANDERGEER P, 1993, PROTEIN PHOSPHORYLAT, P38; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WINSTON BW, 1995, J IMMUNOL, V155, P1525; WINSTON BW, 1995, J BIOL CHEM, V270, P27391, DOI 10.1074/jbc.270.46.27391; Wu MY, 1997, J BIOL CHEM, V272, P17154, DOI 10.1074/jbc.272.27.17154; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	39	3	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					793	800		10.1074/jbc.275.2.793	http://dx.doi.org/10.1074/jbc.275.2.793			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625609	hybrid			2022-12-27	WOS:000084836600013
J	Armand, S; Wagemaker, MJM; Sanchez-Torres, P; Kester, HCM; van Santen, Y; Dijkstra, BW; Visser, J; Benen, JAE				Armand, S; Wagemaker, MJM; Sanchez-Torres, P; Kester, HCM; van Santen, Y; Dijkstra, BW; Visser, J; Benen, JAE			The active site topology of Aspergillus niger endopolygalacturonase II as studied by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; CRYSTAL-STRUCTURE; GLYCOSYL HYDROLASES; POLYGALACTURONASE; MECHANISMS; CLONING; CLASSIFICATION; HYDROLYSIS; HISTIDINE	Strictly conserved charged residues among polygalacturonases (Asp-180, Asp-201, Asp-202, His-223, Arg-256, and Lys-258) were subjected to site-directed mutagenesis in Aspergillus niger endopolygalacturonase II. Specific activity, product progression, and kinetic parameters (K-m and V-max) were determined on polygalacturonic acid for the purified mutated enzymes, and bond cleavage frequencies on oligogalacturonates were calculated, Depending on their specific activity, the mutated endopolygalacturonases II were grouped into three classes, The mutant enzymes displayed bond cleavage frequencies on penta- and/or hexagalacturonate different from the wild type endopolygalacturonase II. Eased on the biochemical characterization of endopolygalacturonase II mutants together with the three-dimensional structure of the wild type enzyme, we suggest that the mutated residues are involved in either primarily substrate binding (Arg-256 and Lys-258) or maintaining the proper ionization state of a catalytic residue (His-223). The individual roles of Asp-180, Asp-201, and Asp-202 in catalysis are discussed. The active site topology is different from the one commonly found in inverting glycosyl hydrolases.	Agr Univ Wageningen, Sect Mol Genet Ind Microorganisms, NL-6703 HA Wageningen, Netherlands; Univ Groningen, BIOSON Res Inst, NL-9747 AG Groningen, Netherlands; Univ Groningen, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands	Wageningen University & Research; University of Groningen; University of Groningen	Benen, JAE (corresponding author), Agr Univ Wageningen, Sect Mol Genet Ind Microorganisms, Dreijenlaan 2, NL-6703 HA Wageningen, Netherlands.	jac.benen@algemeen.mgim.wau.nl	Dijkstra, Bauke W./H-4308-2019; Sánchez-Torres, Paloma/T-1306-2019	Dijkstra, Bauke W./0000-0001-9731-6586; Sánchez-Torres, Paloma/0000-0002-1691-4777; Sanchez-Torres, Paloma/0000-0002-6300-9032				Bacic A., 1988, BIOCHEM PLANT, V14, P297, DOI [DOI 10.1016/B978-0-08-092615-5.50014-X, 10.1016/B978-0-08-092615-5.50014-X]; Baxa U, 1996, BIOPHYS J, V71, P2040, DOI 10.1016/S0006-3495(96)79402-X; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; Biely P, 1996, FEBS LETT, V382, P249, DOI 10.1016/0014-5793(96)00171-8; BUSSINK HJD, 1990, FEBS LETT, V273, P127, DOI 10.1016/0014-5793(90)81066-W; Caprari C, 1996, MOL PLANT MICROBE IN, V9, P617, DOI 10.1094/MPMI-9-0617; COOKE RD, 1976, BIOCHIM BIOPHYS ACTA, V452, P440, DOI 10.1016/0005-2744(76)90194-7; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; ELVING PJ, 1956, ANAL CHEM, V28, P1179, DOI 10.1021/ac60115a034; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; KESTER HCM, 1990, BIOTECHNOL APPL BIOC, V12, P150; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Parenicova L, 1998, EUR J BIOCHEM, V251, P72, DOI 10.1046/j.1432-1327.1998.2510072.x; Petersen TN, 1997, STRUCTURE, V5, P533, DOI 10.1016/S0969-2126(97)00209-8; Pickersgill R, 1998, J BIOL CHEM, V273, P24660, DOI 10.1074/jbc.273.38.24660; Rao MN, 1996, BBA-PROTEIN STRUCT M, V1296, P167; REXOVABENKOVA L, 1978, BIOCHIM BIOPHYS ACTA, V523, P162; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SOMEREN MAK, 1991, CURR GENET, V20, P293, DOI 10.1007/BF00318518; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; STEPHENS BG, 1974, ANAL CHEM, V46, P692, DOI 10.1021/ac60342a013; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Suykerbuyk MEG, 1997, APPL ENVIRON MICROB, V63, P2507, DOI 10.1128/AEM.63.7.2507-2515.1997; VANDENHOMBERGH JPTW, 1995, CURR GENET, V28, P299, DOI 10.1007/BF00326427; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957; WHITE A, 1994, BIOCHEMISTRY-US, V33, P12546, DOI 10.1021/bi00208a003; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	30	74	76	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					691	696		10.1074/jbc.275.1.691	http://dx.doi.org/10.1074/jbc.275.1.691			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617668	Green Published, hybrid			2022-12-27	WOS:000085951600092
J	Bieberich, E; Kawaguchi, T; Yu, RK				Bieberich, E; Kawaguchi, T; Yu, RK			N-acylated serinol is a novel ceramide mimic inducing apoptosis in neuroblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; GLUCOCEREBROSIDE SYNTHETASE; SIGNAL-TRANSDUCTION; DEATH; INHIBITOR; STRESS; PURIFICATION; BIOSYNTHESIS; SUPPRESSION	A novel structural analog of ceramide was synthesized by N-acylation of serinol (2-amino-1,3-propanediol) and studied for its effects on glycolipid biosynthesis and cell differentiation of neuroblastoma cells. Incubation with N-palmitoylated serinol (C16-serinol) increased the concentration of endogenous ceramide by 50-80% and caused apoptosis in rapidly dividing low density cells but not in confluent cells. Cell death was not suppressed by simultaneous incubation with phorbol ester, known to antagonize ceramide-induced apoptosis by activation of protein kinase C (PKC). Purification of potential target proteins of C16-serinol was achieved by affinity chromatography of a protein preparation from rat brain on immobilized C16-serinol. A gel activity assay revealed that the eluate from C16-serinol-Sepharose contained three serine/threonine-specific protein kinases with molecular masses of 50, 70, and 95 kDa. The 70-kDa protein was immunostained on a Western blot using a PKC zeta-specific antibody. The purified PKC zeta could be activated directly by C16-serinol in an in vitro phosphorylation assay. Induction of apoptosis in neuroblastoma cells was suppressed by inhibition of PKC zeta with Go 6983. Our overall results indicate that apoptosis in neuroblastoma cells induced by C16-serinol was at least partially mediated by activation of PKC zeta on condition of ongoing cell division. N-Acylated serinols may thus be useful for induction of apoptosis in mitotic cells and may be of therapeutic potential for treatment of cancer in the nervous system.	Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA	Virginia Commonwealth University	Bieberich, E (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Med Coll Virginia Campus, 1101 E Marshall St,POB 980614, Richmond, VA 23298 USA.				NINDS NIH HHS [NS 11853] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011853] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE A, 1995, J LIPID RES, V36, P611; Ariga T, 1998, J LIPID RES, V39, P1; ARORA RC, 1972, J LIPID RES, V13, P86; Ballou LR, 1996, BBA-LIPID LIPID MET, V1301, P273, DOI 10.1016/0005-2760(96)00004-5; BERNARDO K, 1995, J BIOL CHEM, V270, P11098, DOI 10.1074/jbc.270.19.11098; Bieberich E, 1999, J NEUROCHEM, V72, P1040, DOI 10.1046/j.1471-4159.1999.0721040.x; Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; FEWSTER ME, 1969, J CHROMATOGR, V43, P120, DOI 10.1016/S0021-9673(00)99173-8; Freischutz B, 1997, J NEUROCHEM, V68, P2070; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; GERSHONI JM, 1983, ANAL BIOCHEM, V131, P1, DOI 10.1016/0003-2697(83)90128-8; Haimovitz-Friedman A, 1997, BRIT MED BULL, V53, P539; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P223, DOI 10.1016/0304-4157(93)90001-5; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; INOKUCHI JI, 1987, J LIPID RES, V28, P565; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; JI L, 1995, FEBS LETT, V358, P211, DOI 10.1016/0014-5793(94)01428-4; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; Kapitonov D, 1997, BIOCHEM BIOPH RES CO, V232, P449, DOI 10.1006/bbrc.1997.6240; KRUEGER BK, 1995, J NEUROSCI, V15, P3366; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU J, 1994, J BIOL CHEM, V269, P3047; MACALA LJ, 1983, J LIPID RES, V24, P1243; Mangoura D, 1998, J NEUROCHEM, V70, P130; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; MILLIGAN CE, 1997, BR MED B, V52, P570; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PLATT FM, 1994, J BIOL CHEM, V269, P8362; RYU EK, 1979, J LIPID RES, V20, P561; Schwab M, 1999, NATURWISSENSCHAFTEN, V86, P71, DOI 10.1007/s001140050574; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; VUNNAM RR, 1980, CHEM PHYS LIPIDS, V26, P265; WANG CS, 1975, ANAL BIOCHEM, V63, P414, DOI 10.1016/0003-2697(75)90363-2; Wang YM, 1999, J NEUROSCI RES, V55, P293, DOI 10.1002/(SICI)1097-4547(19990201)55:3<293::AID-JNR4>3.3.CO;2-0; WEISNER DA, 1996, GLYCOCONJ J, V13, P327; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; YU RK, 1994, PROG BRAIN RES, V101, P31	43	78	88	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					177	181		10.1074/jbc.275.1.177	http://dx.doi.org/10.1074/jbc.275.1.177			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617602	hybrid			2022-12-27	WOS:000085951600026
J	Chang, CH; Frey, PA				Chang, CH; Frey, PA			Cloning, sequencing, heterologous expression, purification, and characterization of adenosylcobalamin-dependent D-lysine 5,6-aminomutase from Clostridium sticklandii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE; 2,3-AMINOMUTASE; MUTASE; PROTEIN	D-Lysine 5,6-aminomutase from Clostridium sticklandii catalyzes the 1,2-shift of the epsilon-amino group of D-lysine and reverse migration of C5(H). The two genes encoding 5,6-aminomutase have been cloned, sequenced, and expressed in Escherchia coli. They are adjacent on the Clostridial chromosome and encode polypeptides of 57.3 and 29.2 kilodaltons. The predicted amino acid sequence includes a conserved base-off 5'-deoxyadenosylcobalamin binding motif and a 3-cysteine cluster in the small subunit, as well as a P-loop sequence in the large subunit, Activity of the recombinant enzyme exceeds that of the 5,6-aminomutase purified from C. sticklandii by 6-fold, presumably due to the absence of bound, inactive corrinoids in the recombinant enzyme. The K-m values for adenosylcobalamin and pyridoxal 5'-phosphate are 6.6 and 1.0 mu M, respectively. ATP does not have a regulatory effect on the recombinant protein. The rapid turnover associated inactivation reported for the enzyme purified from Clostridium is also seen with the recombinant form. Aminomutase activity does not depend on structural or catalytic metal ions. Electron paramagnetic resonance experiments with [N-15-dimethylbenz-imidazole]adenosylcobalamin demonstrate base-off binding, consistent with other B-12-dependent enzymes that break unactivated C-H bonds.	Univ Wisconsin, Grad Sch, Inst Enzyme Res, Madison, WI 53705 USA; Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Frey, PA (corresponding author), Univ Wisconsin, Grad Sch, Inst Enzyme Res, Madison, WI 53705 USA.	frey@enzyme.wisc.edu	Chang, Christopher H/A-1404-2012	Chang, Christopher H/0000-0003-3800-6021	NIDDK NIH HHS [DK28607] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028607, R37DK028607] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abend A, 1999, ARCH BIOCHEM BIOPHYS, V370, P138, DOI 10.1006/abbi.1999.1382; BAKER JJ, 1973, BIOCHEMISTRY-US, V12, P1054, DOI 10.1021/bi00730a006; BAKER JJ, 1984, B12, V2, P203; BARANIAK J, 1989, J BIOL CHEM, V264, P1357; Chen HP, 1997, BIOCHEMISTRY-US, V36, P14939, DOI 10.1021/bi971374g; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; *GEN COMP GROUP, 1991, 70 ED; JUDD RC, 1990, METHOD ENZYMOL, V182, P613; Lawrence CC, 1999, J BIOL CHEM, V274, P7039, DOI 10.1074/jbc.274.11.7039; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LU WP, 1993, J BIOL CHEM, V268, P5605; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; MORLEY C G D, 1972, Biochemistry, V11, P600, DOI 10.1021/bi00754a019; MORLEY CGD, 1970, BIOCHEMISTRY-US, V9, P4890, DOI 10.1021/bi00827a010; MORLEY CGD, 1971, BIOCHEMISTRY-US, V10, P2325; PETROVICH RM, 1992, BIOCHEMISTRY-US, V31, P10774, DOI 10.1021/bi00159a019; RIORDAN JF, 1988, METHOD ENZYMOL, V158, P3, DOI 10.1016/0076-6879(88)58041-2; RUZICKA FJ, 2000, IN PRESS J BACTERIOL; Sambrook J, 1989, MOL CLONING LAB MANU, V3; STADTMAN TC, 1973, ADV ENZYMOL RAMB, V38, P413; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Toraya T, 1999, J BIOL CHEM, V274, P3372, DOI 10.1074/jbc.274.6.3372; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Yamanishi M, 1998, BIOCHEMISTRY-US, V37, P4799, DOI 10.1021/bi972572a	24	70	73	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					106	114		10.1074/jbc.275.1.106	http://dx.doi.org/10.1074/jbc.275.1.106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617592	hybrid			2022-12-27	WOS:000085951600016
J	Hindson, VJ; Moody, PCE; Rowe, AJ; Shaw, WV				Hindson, VJ; Moody, PCE; Rowe, AJ; Shaw, WV			Serine acetyltransferase from Escherichia coli is a dimer of trimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; RHIZOBIUM; NODL; GENE	Equilibrium sedimentation studies show that the serine acetyltransferase (SAT) of Escherichia coli is a hexamer. The results of velocity sedimentation and quasielastic light scattering experiments suggest that the identical subunits are loosely packed and/or arranged in an ellipsoidal fashion. Chemical cross-linking studies indicate that the fundamental unit of quaternary structure is a trimer. The likelihood, therefore, is that in solution SAT exists as an open arrangement of paired trimers. Crystals of SAT have 32 symmetry, consistent with such an arrangement, and the cell density function is that expected for a hexamer, Electron microscopy with negative staining provides further evidence that SAT has an ellipsoidal subunit organization, the dimensions of the particles consistent with the proposed paired trimeric subunit arrangement. A bead model analysis supports the view that SAT has a low packing density and, furthermore, indicates that the monomers may have an ellipsoidal shape. Such a view is in keeping with the ellipsoidal subunit shape of trimeric LpxA, an acyltransferase with which SAT shares contiguous repeats of a hexapeptide motif.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Nottingham, Sch Biol Sci, Natl Ctr Mol Hydrodynam Business Ctr, Loughborough LE12 5RD, Leics, England	University of Leicester; University of Nottingham	Hindson, VJ (corresponding author), Christie Hosp NHS Trust, Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	vhindson@picr.man.ac.uk	Moody, Peter/A-6832-2008	Moody, Peter/0000-0003-1762-9238				BAECKER PA, 1980, ANAL BIOCHEM, V102, P16, DOI 10.1016/0003-2697(80)90310-3; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beaman TW, 1998, BIOCHEMISTRY-US, V37, P6689, DOI 10.1021/bi980106v; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COOK PF, 1978, J BIOL CHEM, V253, P7874; DELATORRE JG, 1981, Q REV BIOPHYS, V14, P81, DOI 10.1017/S0033583500002080; DENK D, 1987, J GEN MICROBIOL, V133, P515; DOWNIE JA, 1989, MOL MICROBIOL, V3, P1649, DOI 10.1111/j.1365-2958.1989.tb00150.x; Dunn SM, 1996, PROTEIN SCI, V5, P538; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; HARDING SE, 1992, LASER LIGHT SCATTERI, P7; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LESLIE AGW, 1990, J MOL BIOL, V213, P167, DOI 10.1016/S0022-2836(05)80129-9; LEU LS, 1994, BIOCHEMISTRY-US, V33, P2667, DOI 10.1021/bi00175a040; LEWENDON A, 1995, J BIOL CHEM, V270, P26326, DOI 10.1074/jbc.270.44.26326; MCPHERSON A, 1982, PREPARATION ANAL PRO, P96; Murray IA, 1997, ANTIMICROB AGENTS CH, V41, P1; NAKAMURA K, 1987, PLANT CELL PHYSIOL, V28, P885, DOI 10.1093/oxfordjournals.pcp.a077370; OTWINOWSKI Z, 1993, OSCILLATION DATA RED, P56; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; ROWE AJ, 1984, TECHNIQUES DETERMINI; SMITH IK, 1969, BIOCHEM BIOPH RES CO, V36, P111; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; WEBER G, 1975, ADV PROTEIN CHEM, V29, P314; WIEBERS JL, 1967, J BIOL CHEM, V242, P12; WIGLEY DB, 1990, FEBS LETT, V277, P267, DOI 10.1016/0014-5793(90)80862-D	29	45	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					461	466		10.1074/jbc.275.1.461	http://dx.doi.org/10.1074/jbc.275.1.461			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617639	hybrid			2022-12-27	WOS:000085951600063
J	Miyahara, M; Nakanishi, H; Takahashi, K; Satoh-Horikawa, K; Tachibana, K; Takai, Y				Miyahara, M; Nakanishi, H; Takahashi, K; Satoh-Horikawa, K; Tachibana, K; Takai, Y			Interaction of nectin with afadin is necessary for its clustering at cell-cell contact sites but not for its cis dimerization or trans interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLIOVIRUS RECEPTOR GENE; E-CADHERIN; CYTOPLASMIC DOMAIN; ALPHA-CATENIN; ADHESION MOLECULES; COMPLEX-FORMATION; STRUCTURAL BASIS; EXPRESSION; PROTEIN; REGION	We have recently found a novel functional unit of cell-cell adhesion at cadherin-based adherens junctions, consisting of at least nectin, a hemophilic cell adhesion molecule, and afadin, an actin filament-binding protein, which connects nectin to the actin cytoskeleton. Here we studied a mechanism of cell-cell adhesion of the nectin-afadin system by use of a cadherin-deficient L cell line stably expressing the intact form of mouse nectin-2 alpha, a truncated form of nectin-2 alpha incapable of interacting with afadin (nectin-2 alpha-Delta C), or a point-mutated form of nectin-2 alpha capable of interacting with afadin and a cadherin-expressing EL cell. line, which transiently expressed the point-mutated form of nectin-2 alpha, We found that the interaction of nectin-2 alpha with afadin was necessary for their clustering at cell-cell contact sites. However, nectin-2 alpha-Delta C showed cis dimerization and trans interaction, both of which did not require the interaction of nectin-2 alpha with afadin. We have previously shown in EL cells that the interaction of nectin-1 with afadin is necessary for its recruitment to adherens junctions. We found that the trans interaction of nectin-2 alpha was furthermore necessary for this recruitment. On the basis of these observations, we propose a model for the mechanism of cell-cell adhesion of nectin and roles of afadin in this mechanism.	Osaka Univ, Fac Med, Grad Sch Med, Dept Mol Biol & Biochem, Osaka 5650871, Japan; JCR Pharmaceut Co Ltd, Japan Sci & Technol Corp, ERATO, Takai Biotimer Project,Nishi Ku, Kobe, Hyogo 6512241, Japan	Osaka University; Japan Science & Technology Agency (JST)	Takai, Y (corresponding author), Osaka Univ, Fac Med, Grad Sch Med, Dept Mol Biol & Biochem, Osaka 5650871, Japan.			Nakanishi, Hiroyuki/0000-0002-9765-0266				ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Aoki J, 1997, EXP CELL RES, V235, P374, DOI 10.1006/excr.1997.3685; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buck C A, 1992, Semin Cell Biol, V3, P179; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; EBERLE F, 1995, GENE, V159, P267, DOI 10.1016/0378-1119(95)00180-E; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; GEIGER B, 1991, CELL MOTIL CYTOSKEL, V20, P1, DOI 10.1002/cm.970200102; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leahy DJ, 1997, ANNU REV CELL DEV BI, V13, P363, DOI 10.1146/annurev.cellbio.13.1.363; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; LOPEZ M, 1995, GENE, V155, P261, DOI 10.1016/0378-1119(94)00842-G; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; MORRISON ME, 1992, J VIROL, V66, P2807, DOI 10.1128/JVI.66.5.2807-2813.1992; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; PRASAD R, 1993, CANCER RES, V53, P5624; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sambrook J., 2002, MOL CLONING LAB MANU; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHIMOYAMA Y, 1992, CANCER RES, V52, P5770; SIEBER F, 1981, J CELL BIOL, V90, P55, DOI 10.1083/jcb.90.1.55; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Tsukita Shoichiro, 1992, Current Opinion in Cell Biology, V4, P834, DOI 10.1016/0955-0674(92)90108-O; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779	49	125	131	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					613	618		10.1074/jbc.275.1.613	http://dx.doi.org/10.1074/jbc.275.1.613			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617658	hybrid			2022-12-27	WOS:000085951600082
J	Vasilyeva, E; Liu, Q; MacLeod, KJ; Baleja, JD; Forgac, M				Vasilyeva, E; Liu, Q; MacLeod, KJ; Baleja, JD; Forgac, M			Cysteine scanning mutagenesis of the noncatalytic nucleotide binding site of the yeast V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; CLATHRIN-COATED VESICLES; ADENOSINE-TRIPHOSPHATASE; DIRECTED MUTAGENESIS; B-SUBUNIT; MUTATIONAL ANALYSIS; STRUCTURAL-CHANGES; CATALYTIC SUBUNIT; CDNA SEQUENCE	To investigate residues involved in the formation of the noncatalytic nucleotide binding sites of the vacuolar proton-translocating adenosine triphosphatase (V-ATPase), cysteine scanning mutagenesis of the VMA2 gene that encodes the B subunit in yeast was performed. Replacement of the single endogenous cysteine residue at position 188 gave rise to a Cys-less form of the B subunit (Vma2p) which had near wild-type levels of activity and which was used in the construction of 16 single cysteine-containing mutants. The ability of adenine nucleotides to prevent reaction of the introduced cysteine residues with the sulfhydryl reagent 3-(N-maleimidopropionyl)biocytin (biotin-maleimide) was evaluated by Western blot. Biotin-maleimide labeling of the purified V-ATPase from the wild-type and the mutants S152C, L178C, N181C, A184C, and T279C was reduced after reaction with the nucleotide analog 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate (BzATP). These results suggest the proximity of these residues to the nucleotide binding site on the B subunit, In addition, we have examined the level of endogenous nucleotide bound to the wild-type V-ATPase and to a mutant (the A subunit mutant R483Q) which is postulated to be altered at the noncatalytic site and which displays a marked nonlinearity in ATP hydrolysis (MacLeod, K. J., Vasilyeva, E., Baleja, J. D., and Forgac, M. (1998) J. Biol. Chem. 273, 150-156), The R483Q mutant contained 2.6 mol of ATP/mol of V-ATPase compared with the wild-type enzyme, which contained 0.8 mol of ATP/mol of V-ATPase, These results suggest that binding of additional ATP to the noncatalytic sites may modulate the catalytic activity of the enzyme.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	mforgac@opal.tufts.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM034478, R01 GM034478, GM 34478] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; ARAI H, 1988, J BIOL CHEM, V263, P8796; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; BOWMAN BJ, 1988, J BIOL CHEM, V263, P14002; BRUNGER AT, 1987, XPLOR SYSTEM XRAY CR; Capaldi RA, 1996, J BIOENERG BIOMEMBR, V28, P397, DOI 10.1007/BF02113980; CHATTERJEE D, 1992, P NATL ACAD SCI USA, V89, P6257, DOI 10.1073/pnas.89.14.6257; Cross RL, 1996, J BIOENERG BIOMEMBR, V28, P403, DOI 10.1007/BF02113981; FENG Y, 1992, J BIOL CHEM, V267, P5817; Fillingame RH, 1997, J EXP BIOL, V200, P217; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Futai M, 1996, J BIOENERG BIOMEMBR, V28, P409, DOI 10.1007/BF02113982; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; HIRATA R, 1990, J BIOL CHEM, V265, P6726; JOUNOUCHI M, 1993, J BIOCHEM-TOKYO, V114, P171, DOI 10.1093/oxfordjournals.jbchem.a124150; Kane PM, 1999, J BIOENERG BIOMEMBR, V31, P49, DOI 10.1023/A:1005444513542; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIMGRUBER RM, 1976, J BIOL CHEM, V251, P7103; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Liu Q, 1996, J BIOL CHEM, V271, P2018, DOI 10.1074/jbc.271.4.2018; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; MANOLSON MF, 1985, J BIOL CHEM, V260, P2273; MANOLSON MF, 1988, J BIOL CHEM, V263, P17987; Margolles-Clark E, 1999, J BIOENERG BIOMEMBR, V31, P29, DOI 10.1023/A:1005440412633; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; NELSON H, 1989, J BIOL CHEM, V264, P1775; NELSON N, 1992, J BIOENERG BIOMEMBR, V24, P407, DOI 10.1007/BF00762533; Pedersen PL, 1996, J BIOENERG BIOMEMBR, V28, P389, DOI 10.1007/BF02113979; PENG SB, 1995, J BIOL CHEM, V270, P16926; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PUOPOLO K, 1992, J BIOL CHEM, V267, P3696; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; STEVENS TH, 1991, METHOD ENZYMOL, V194, P644; SWALLOW CJ, 1990, J BIOL CHEM, V265, P7645; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; Vasilyeva E, 1996, J BIOL CHEM, V271, P12775, DOI 10.1074/jbc.271.22.12775; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WEBER J, 1993, J BIOL CHEM, V268, P6241; WISHART DS, 1994, COMPUT APPL BIOSCI, V10, P121; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; ZHANG JM, 1995, J BIOL CHEM, V270, P15494, DOI 10.1074/jbc.270.26.15494; ZIMNIAK L, 1988, J BIOL CHEM, V263, P9102	55	44	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					255	260		10.1074/jbc.275.1.255	http://dx.doi.org/10.1074/jbc.275.1.255			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617613	hybrid			2022-12-27	WOS:000085951600037
J	Dajani, R; Cleasby, A; Neu, M; Wonacott, AJ; Jhoti, H; Hood, AM; Modi, S; Hersey, A; Taskinen, J; Cooke, RM; Manchee, GR; Coughtrie, MWH				Dajani, R; Cleasby, A; Neu, M; Wonacott, AJ; Jhoti, H; Hood, AM; Modi, S; Hersey, A; Taskinen, J; Cooke, RM; Manchee, GR; Coughtrie, MWH			X-ray crystal structure of human dopamine sulfotransferase, SULT1A3 - Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENOL SULFOTRANSFERASE; ESTROGEN SULFOTRANSFERASE; SULFURYL TRANSFER; SULFATION; SALBUTAMOL; MECHANISM; BIOLOGY; PLASMA	Humans are one of the few species that produce large amounts of catecholamine sulfates, and they have evolved a specific sulfotransferase, SULT1A3 (M-PST), to catalyze the formation of these conjugates. An orthologous protein has yet to be found in other species. To further our understanding of the molecular basis for the unique substrate selectivity of this enzyme, we have solved the crystal structure of human SULT1A3, complexed with 3'-phosphoadenosine 5'-phosphate (PAP), at 2.5 Angstrom resolution and carried out quantitative structure-activity relationship (QSAR) analysis with a series of phenols and catechols. SULT1A3 adopts a similar fold to mouse estrogen sulfotransferase, with a central five-stranded beta-sheet surrounded by alpha-helices. SULT1A3 is a dimer in solution but crystallized with a monomer in the asymmetric unit of the cell, although dimer interfaces were formed by interaction across crystallographic 2-fold axes. QSAR analysis revealed that the enzyme is highly selective for catechols, and catecholamines in particular, and that hydrogen bonding groups and lipophilicity (cLogD) strongly influenced K-m. We also investigated further the role of Glu(146) in SULT1A3 using site-directed mutagenesis and showed that it plays a key role not only in defining selectivity for dopamine but also in preventing many phenolic xenobiotics fi om binding to the enzyme.	Univ Dundee, Ninewells Hosp & Med Sch, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland; Glaxo Wellcome Med Res Ctr, Prot Sci Unit, Stevenage SG1 2NY, Herts, England; Glaxo Wellcome Res & Dev, Res Biomet, Ware SG12 0DP, Herts, England; Univ Helsinki, Viikki Bioctr, Dept Pharm, FIN-00014 Helsinki, Finland	University of Dundee; GlaxoSmithKline; GlaxoSmithKline; University of Helsinki	Coughtrie, MWH (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland.		Coughtrie, Michael/C-3855-2009	Coughtrie, Michael/0000-0003-1989-1416; Hersey, Anne/0000-0003-4679-6211				Brix LA, 1999, BIOCHEM J, V337, P337, DOI 10.1042/0264-6021:3370337; BRONAUGH RL, 1975, J PHARMACOL EXP THER, V195, P441; CAMPBELL NRC, 1987, MOL PHARMACOL, V32, P813; Coughtrie MWH, 1996, HUM EXP TOXICOL, V15, P547, DOI 10.1177/096032719601500701; Coughtrie MWH, 1998, CHEM-BIOL INTERACT, V109, P3, DOI 10.1016/S0009-2797(97)00117-8; Dajani R, 1998, MOL PHARMACOL, V54, P942, DOI 10.1124/mol.54.6.942; Dajani R, 1999, PROTEIN EXPRES PURIF, V16, P11, DOI 10.1006/prep.1999.1030; DOUSA MK, 1988, P SOC EXP BIOL MED, V188, P427; Duffel MW, 1997, COMPREHENSIVE TOXICO, V3, P365; Eaton EA, 1996, BRIT J CLIN PHARMACO, V41, P201, DOI 10.1111/j.1365-2125.1996.tb00183.x; FOLDES A, 1973, BIOCHIM BIOPHYS ACTA, V327, P365, DOI 10.1016/0005-2744(73)90419-1; Glatt H, 1997, FASEB J, V11, P314, DOI 10.1096/fasebj.11.5.9141497; HOCHHAUS G, 1992, INT J CLIN PHARM TH, V30, P342; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kakuta Y, 1998, J BIOL CHEM, V273, P27325, DOI 10.1074/jbc.273.42.27325; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REITER C, 1983, N-S ARCH PHARMACOL, V324, P140, DOI 10.1007/BF00497020; Rubin GL, 1996, XENOBIOTICA, V26, P1113, DOI 10.3109/00498259609050256; SCOTT MC, 1987, J CHROMATOGR-BIOMED, V413, P17, DOI 10.1016/0378-4347(87)80209-8; STROBEL G, 1990, BIOCHEM INT, V20, P343; Suiko M, 1998, J BIOCHEM-TOKYO, V124, P707, DOI 10.1093/oxfordjournals.jbchem.a022170; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	26	126	127	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37862	37868		10.1074/jbc.274.53.37862	http://dx.doi.org/10.1074/jbc.274.53.37862			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608851	hybrid			2022-12-27	WOS:000084528000051
J	Fujii, Y; Shimokawa, H; Sekiguchi, M; Nakabeppu, Y				Fujii, Y; Shimokawa, H; Sekiguchi, M; Nakabeppu, Y			Functional significance of the conserved residues for the 23-residue module among MTH1 and MutT family proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI MUTT; NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE; DNA-SYNTHESIS; ENCODING 8-OXO-DGTPASE; MUTAGENIC SUBSTRATE; NUDIX HYDROLASES; ADP-RIBOSE; ENZYME; GENE; MECHANISM	Human MTH1 and Escherichia coli MutT proteins hydrolyze 7,8-dihydro-8-oxo-dGTP (8-oxo-dGTP) to monophosphate, thus avoiding the incorporation of 8-oxo-7,8-dihydroguanine into nascent DNA. Although only 30 amino acid residues (23%) are identical between MTH1 and MutT, there is a highly conserved region consisting of 23 residues (MTH1, Gly(36)-Gly(58)) With 14 identical residues. A chimeric protein MTH1-Ec, in which the 23-residue sequence of MTH1 was replaced with that of MutT, retains its capability to hydrolyze 8-oxo-dGTP, thereby indicating that the 23-residue sequences of MTH1 and MutT are functionally and structurally equivalent and constitute functional modules. By saturation mutagenesis of the module in MTH1, 14 of the 23 residues proved to be essential to exert 8-oxo-dGTPase activity. For the other 9 residues (40, 42, 44, 46, 47, 40, 50, 54, and 58), positive mutants were obtained, and Arg(50) can be replaced with hydrophobic residues (Val, Leu, or Re), with a greater stability and higher specific activity of the enzyme. Indispensabilities of Val(39), Ile(45), and Leu(53) indicate that an amphipathic property of alpha-helix I consisting of 14 residues of the module (Thr(44)-Gly(58)) is essential to maintain the stable catalytic surface:for 8-oxo-dGTPase.	Kyushu Univ, Med Inst Bioregulat, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan; Fukuoka Dent Coll, Dept Biol, Fukuoka 8140175, Japan; Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140175, Japan; Japan Sci & Technol Corp, CREST, Osaka, Japan	Kyushu University; Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Japan Science & Technology Agency (JST)	Nakabeppu, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.		Nakabeppu, Yusaku/A-8902-2011	Nakabeppu, Yusaku/0000-0002-6739-242X				ABEYGUNAWARDANA C, 1995, BIOCHEMISTRY-US, V34, P14997, DOI 10.1021/bi00046a006; AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; CAI JP, 1995, CARCINOGENESIS, V16, P2343, DOI 10.1093/carcin/16.10.2343; Cai JP, 1997, NUCLEIC ACIDS RES, V25, P1170, DOI 10.1093/nar/25.6.1170; CAPIZZI RL, 1973, MUTAT RES, V17, P147, DOI 10.1016/0027-5107(73)90265-0; CHENG KC, 1992, J BIOL CHEM, V267, P166; FRICK DN, 1995, BIOCHEMISTRY-US, V34, P5577, DOI 10.1021/bi00016a032; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; FURUICHI M, 1994, GENOMICS, V24, P485, DOI 10.1006/geno.1994.1657; Hayakawa H, 1999, BIOCHEMISTRY-US, V38, P3610, DOI 10.1021/bi982361l; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; KAKUMA T, 1995, J BIOL CHEM, V270, P25942, DOI 10.1074/jbc.270.43.25942; KAMATH AV, 1993, GENE, V134, P99, DOI 10.1016/0378-1119(93)90180-B; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; Lin J, 1996, BIOCHEMISTRY-US, V35, P6715, DOI 10.1021/bi953071x; Lin J, 1997, BIOCHEMISTRY-US, V36, P1199, DOI 10.1021/bi962619c; Luria SE, 1943, GENETICS, V28, P491; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MEJEAN V, 1994, MOL MICROBIOL, V11, P323, DOI 10.1111/j.1365-2958.1994.tb00312.x; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; O'Handley SF, 1998, J BIOL CHEM, V273, P3192, DOI 10.1074/jbc.273.6.3192; Oda H, 1997, J BIOL CHEM, V272, P17843, DOI 10.1074/jbc.272.28.17843; OHandley SF, 1996, J BIOL CHEM, V271, P24649, DOI 10.1074/jbc.271.40.24649; Rost B, 1996, METHOD ENZYMOL, V266, P525; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Sekiguchi M, 1996, GENES CELLS, V1, P139, DOI 10.1046/j.1365-2443.1996.d01-232.x; Sheikh S, 1998, J BIOL CHEM, V273, P20924, DOI 10.1074/jbc.273.33.20924; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Yakushiji H, 1997, MUTAT RES-DNA REPAIR, V384, P181, DOI 10.1016/S0921-8777(97)00025-6; YANOFSKY C, 1966, P NATL ACAD SCI USA, V55, P274, DOI 10.1073/pnas.55.2.274	37	36	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38251	38259		10.1074/jbc.274.53.38251	http://dx.doi.org/10.1074/jbc.274.53.38251			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608900	hybrid			2022-12-27	WOS:000084528000100
J	Prigent-Tessier, A; Tessier, C; Hirosawa-Takamori, M; Boyer, C; Ferguson-Gottschall, S; Gibori, G				Prigent-Tessier, A; Tessier, C; Hirosawa-Takamori, M; Boyer, C; Ferguson-Gottschall, S; Gibori, G			Rat decidual prolactin - Identification, molecular cloning, and characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL GENE-EXPRESSION; HETEROLOGOUS EXPRESSION; LUTEINIZING-HORMONE; LUTEOTROPHIC ACTION; CORPUS-LUTEUM; PROTEIN-B; TISSUE; PREGNANCY; RECEPTORS; CELLS	Establishment and maintenance of pregnancy require the activity of a highly specialized maternal tissue, the decidua. It is well established that the human decidua synthesizes and releases prolactin. However, in the rat, no study has been able to demonstrate the production of prolactin by the decidua. In this report, we established for the first time using Northern blot analysis and reverse transcription-polymerase chain reaction, Western blot analysis, immunocytochemistry, and enzyme-linked immunosorbent assay, that a defined cell population located in the rat antimesometrial decidua ex presses prolactin mRNA, as well as synthesizes and secretes this hormone. By reverse transcription-polymerase chain reaction and rapid amplification of cDNA ends, we cloned a fall-length cDNA for rat decidua prolactin, whose sequence was identical to that of pituitary prolactin. Our results also showed that pituitary prolactin appeared to down-regulate decidual prolactin levels. Under these circumstances, inhibition of pituitary prolactin secretion led to a rise in both decidual prolactin mRNA and protein expression. Moreover, addition of exogenous prolactin to primary decidual cells in culture also caused a marked decrease in decidual prolactin mRNA expression. Finally, treatment of primary decidual cells with steroid hormones or 8-bromo-cAMP revealed a differential regulation of decidual prolactin expression from that of pituitary suggesting a tissue-specific regulation of prolactin gene expression, possibly through the use of an alternative promoter in rat decidua.	Univ Illinois, Coll Med, Dept Physiol & Biophys MC 901, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gibori, G (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys MC 901, 835 S Wolcott Ave, Chicago, IL 60612 USA.	ggibori@uic.edu		tessier, anne/0000-0001-6655-5074	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012356] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-12356] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABRAHAMSOHN PA, 1993, J EXP ZOOL, V266, P603, DOI 10.1002/jez.1402660610; Akcali KC, 1996, ENDOCRINOLOGY, V137, P3123, DOI 10.1210/en.137.7.3123; ALBARRACIN CT, 1994, J BIOL CHEM, V269, P7772; ALBARRACIN CT, 1991, ENDOCRINOLOGY, V129, P1821, DOI 10.1210/endo-129-4-1821; BASURAY R, 1980, BIOL REPROD, V23, P507, DOI 10.1095/biolreprod23.3.507; BASURAY R, 1983, BIOL REPROD, V28, P551, DOI 10.1095/biolreprod28.3.551; BELL SC, 1983, OXFORD REV REPRODUCT, V5, P220; CHAN YL, 1987, J BIOL CHEM, V262, P1111; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEMENTS J, 1983, ENDOCRINOLOGY, V112, P1133, DOI 10.1210/endo-112-3-1133; Cohick CB, 1997, J ENDOCRINOL, V152, P291, DOI 10.1677/joe.0.1520291; COOKE NE, 1982, NATURE, V297, P603, DOI 10.1038/297603a0; CROZE F, 1990, ENDOCRINOLOGY, V127, P2665, DOI 10.1210/endo-127-6-2665; DAVIS JRE, 1990, J ENDOCRINOL, V125, P171, DOI 10.1677/joe.0.1250171; DEFEO VJ, 1967, CELLULAR BIOL UTERUS, P191; DIMATTIA GE, 1990, J BIOL CHEM, V265, P16412; DUCKWORTH ML, 1988, MOL ENDOCRINOL, V2, P912, DOI 10.1210/mend-2-10-912; DUNN SD, 1986, ANAL BIOCHEM, V157, P144, DOI 10.1016/0003-2697(86)90207-1; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GELLERSEN B, 1989, MOL CELL ENDOCRINOL, V64, P127, DOI 10.1016/0303-7207(89)90073-7; Gellersen B, 1997, MOL ENDOCRINOL, V11, P97, DOI 10.1210/me.11.1.97; GIBORI G, 1981, ENDOCRINOLOGY, V108, P2060, DOI 10.1210/endo-108-6-2060; GIBORI G, 1985, ENDOCRINOLOGY, V116, P1784, DOI 10.1210/endo-116-5-1784; GIBORI G, 1994, REPROD BIOL, P217; GIBORI G, 1984, ENDOCRINOLOGY, V115, P1157, DOI 10.1210/endo-115-3-1157; GIBORI G, 1974, ENDOCRINOLOGY, V95, P1113, DOI 10.1210/endo-95-4-1113; GIBORI G, 1987, REGULATION OVARIAN T, P379; GIBORI G, 1995, MOL CELLULAR ASPECTS, P67; GLASSER SR, 1990, TROPOBLAST INVASION, P377; GOLANDER A, 1978, SCIENCE, V202, P311, DOI 10.1126/science.694535; GU Y, 1994, ENDOCRINOLOGY, V135, P1272, DOI 10.1210/en.135.3.1272; GU Y, 1995, ENDOCRINOLOGY, V136, P2451, DOI 10.1210/en.136.6.2451; GU Y, 1992, ENDOCRINOLOGY, V131, P1321, DOI 10.1210/en.131.3.1321; Gu Y, 1996, ENDOCRINOLOGY, V137, P4878, DOI 10.1210/en.137.11.4878; GU Y, 1994, ENDOCRINOLOGY, V135, P1422, DOI 10.1210/en.135.4.1422; HERZ Z, 1986, ENDOCRINOLOGY, V118, P2203, DOI 10.1210/endo-118-6-2203; JACKSON SM, 1992, MOL CELL BIOL, V12, P2708, DOI 10.1128/MCB.12.6.2708; JAYATILAK PG, 1984, BIOL REPROD, V31, P556, DOI 10.1095/biolreprod31.3.556; JAYATILAK PG, 1989, ENDOCRINOLOGY, V125, P659, DOI 10.1210/endo-125-2-659; JAYATILAK PG, 1985, P NATL ACAD SCI USA, V82, P217, DOI 10.1073/pnas.82.1.217; JAYATILAK PG, 1986, J ENDOCRINOL, V110, P115, DOI 10.1677/joe.0.1100115; KALISON B, 1985, J ENDOCRINOL, V104, P241, DOI 10.1677/joe.0.1040241; LABRIE F, 1980, J STEROID BIOCHEM, V12, P323, DOI 10.1016/0022-4731(80)90287-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lockwood CJ, 1996, J SOC GYNECOL INVEST, V3, P159, DOI 10.1016/1071-5576(96)00005-6; MACMANUS JP, 1989, BIOCHEM BIOPH RES CO, V159, P278, DOI 10.1016/0006-291X(89)92434-0; MARTEL D, 1984, ENDOCRINOLOGY, V114, P1627, DOI 10.1210/endo-114-5-1627; Orwig KE, 1997, ENDOCRINOLOGY, V138, P2491, DOI 10.1210/en.138.6.2491; Parr MB., 1989, BIOL UTERUS, P233; Rasmussen CA, 1996, ENDOCRINOLOGY, V137, P5558, DOI 10.1210/en.137.12.5558; Rasmussen CA, 1997, BIOL REPROD, V56, P647, DOI 10.1095/biolreprod56.3.647; RIDDICK DH, 1978, LIFE SCI, V23, P1913, DOI 10.1016/0024-3205(78)90557-X; ROBY KF, 1993, J BIOL CHEM, V268, P3136; ROTHCHILD I, 1975, ENDOCRINOLOGY, V97, P838, DOI 10.1210/endo-97-4-838; SMITH MS, 1976, ENDOCRINOLOGY, V98, P696, DOI 10.1210/endo-98-3-696; Soares MJ, 1998, BIOL REPROD, V58, P273, DOI 10.1095/biolreprod58.2.273; SOARES MJ, 1991, ENDOCR REV, V12, P402, DOI 10.1210/edrv-12-4-402; SORTINO MA, 1989, ENDOCRINOLOGY, V124, P2013, DOI 10.1210/endo-124-4-2013; TANG BQ, 1993, ENDOCRINOLOGY, V133, P2197, DOI 10.1210/en.133.5.2197; Telgmann R, 1998, HUM REPROD UPDATE, V4, P472, DOI 10.1093/humupd/4.5.472; Zhong L, 1997, BIOCHEM BIOPH RES CO, V235, P587, DOI 10.1006/bbrc.1997.6833	61	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37982	37989		10.1074/jbc.274.53.37982	http://dx.doi.org/10.1074/jbc.274.53.37982			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608866	hybrid			2022-12-27	WOS:000084528000066
J	Foger, B; Chase, M; Amar, MJ; Vaisman, BL; Shamburek, RD; Paigen, B; Furchart-Najib, J; Paiz, JA; Koch, CA; Hoyt, RF; Brewer, HB; Santamarina-Fojo, S				Foger, B; Chase, M; Amar, MJ; Vaisman, BL; Shamburek, RD; Paigen, B; Furchart-Najib, J; Paiz, JA; Koch, CA; Hoyt, RF; Brewer, HB; Santamarina-Fojo, S			Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; DIET-INDUCED ATHEROSCLEROSIS; HUMAN ADENOVIRUS TYPE-5; OXIDATIVE MODIFICATION; EARLY ATHEROGENESIS; HEPATIC LIPASE; HEART-DISEASE; HUMAN-PLASMA; EXPRESSION; GENE	Expression of human lecithin cholesterol acyltransferase (LCAT) in mice (LCAT-Tg) leads to increased high density lipoprotein (HDL) cholesterol levels but paradoxically, enhanced atherosclerosis, We have hypothesized that the absence of cholesteryl ester transfer protein (CETP) in LCAT-Tg mice facilitates the accumulation of dysfunctional HDL leading to impaired reverse cholesterol transport and the development of a pro-atherogenic state. To test this hypothesis we crossbred LCAT-Tg with CETP-Tg mice. On both regular chow and high fat, high cholesterol diets, expression of CETP in LCAT-Tg mice reduced total cholesterol (-39% and -13%, respectively; p < 0.05), reflecting a decrease in HDL cholesterol levels. CETP normalized both the plasma clearance of [H-3]cholesteryl esters ([H-3]CE) from HDL (fractional catabolic rate in days(-1): LCAT-Tg = 3.7 +/- 0.34, LCATxCETP-Tg = 6.1 +/- 0.16, and controls = 6.4 +/- 0.16) as well as the liver uptake of [H-3]CE from HDL (LCAT-Tg = 36%, LCATxCETP-Tg = 65%, and controls = 63%) in LCAT Tg mice. On the pro-atherogenic diet the mean aortic lesion area was reduced by 41% in LCATx- CETP-Tg (21.2 +/- 2.0 mu m(2) x 10(3)) compared with LCAT-Tg mice (35.7 +/- 2.0 mu m(2) x 10(3); p < 0.001), Adenovirus-mediated expression of scavenger receptor class B (SR-BI) failed to normalize the plasma clearance and liver up take of [H-3]CE from LCAT-Tg HDL, Thus, the ability of SR-BI to facilitate the selective uptake of CE from LCAT-Tg HDL is impaired, indicating a potential mechanism leading to impaired reverse cholesterol transport and atherosclerosis in these animals. We conclude that CETP expression reduces atherosclerosis in LCAT-Tg mice by restoring the functional properties of LCAT-Tg mouse HDL and promoting the hepatic uptake of HDL CE. These findings provide definitive in vivo evidence supporting the proposed anti-atherogenic role of CETP in facilitating HDL-mediated reverse cholesterol transport and demonstrate that CETP expression is beneficial in pro-atherogenic states that result from impaired reverse cholesterol transport.	NHLBI, Mol Dis Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Lab Anim Med Surg, NIH, Bethesda, MD 20892 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Inst Pasteur, Fac Pharm, INSERM, U325, F-59019 Lille, France	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Jackson Laboratory; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Santamarina-Fojo, S (corresponding author), NHLBI, Mol Dis Branch, NIH, Bldg 10,Rm 7N115,10 Ctr Dr,MSC 1666, Bethesda, MD 20892 USA.		Vaisman, Boris L/B-3453-2008; Amar, Marcelo/AAD-5599-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086, R01HL032087] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 32087, HL 30086] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; AGELLON LB, 1991, J BIOL CHEM, V266, P10796; Albanese N, 1998, CIRCULATION, V98, P450; ALBERS JJ, 1984, ARTERIOSCLEROSIS, V4, P49, DOI 10.1161/01.ATV.4.1.49; Amar MJA, 1998, CIRCULATION, V98, P35; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Berard AM, 1997, NAT MED, V3, P744, DOI 10.1038/nm0797-744; CALVO D, 1993, J BIOL CHEM, V268, P18929; CHEN CH, 1982, J LIPID RES, V23, P680; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Dugi KA, 1997, J LIPID RES, V38, P1822; Duverger N, 1996, CIRCULATION, V94, P713, DOI 10.1161/01.CIR.94.4.713; FIELDING CJ, 1995, J LIPID RES, V36, P211; Francone OL, 1997, J LIPID RES, V38, P813; FRANCONE OL, 1995, J CLIN INVEST, V96, P1440, DOI 10.1172/JCI118180; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; HARRISON T, 1977, VIROLOGY, V77, P319, DOI 10.1016/0042-6822(77)90428-7; HAYEK T, 1993, J CLIN INVEST, V92, P1143, DOI 10.1172/JCI116683; HAYEK T, 1995, J CLIN INVEST, V96, P2071, DOI 10.1172/JCI118255; HAYEK T, 1992, J CLIN INVEST, V90, P505, DOI 10.1172/JCI115887; HIRANO K, 1995, ARTERIOSCL THROM VAS, V15, P1849, DOI 10.1161/01.ATV.15.11.1849; Hirano K, 1997, ARTERIOSCL THROM VAS, V17, P1053, DOI 10.1161/01.ATV.17.6.1053; Hoeg JM, 1996, J BIOL CHEM, V271, P4396; Hoeg JM, 1996, P NATL ACAD SCI USA, V93, P11448, DOI 10.1073/pnas.93.21.11448; IKEWAKI K, 1993, J CLIN INVEST, V92, P1650, DOI 10.1172/JCI116750; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; ISHIGAMI M, 1994, J BIOCHEM-TOKYO, V116, P257, DOI 10.1093/oxfordjournals.jbchem.a124516; KASHYAP VS, 1995, J CLIN INVEST, V96, P1612, DOI 10.1172/JCI118200; KHOO JC, 1990, J LIPID RES, V31, P645; KUNITAKE ST, 1992, J LIPID RES, V33, P1807; MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; MasucciMagoulas L, 1997, SCIENCE, V275, P391, DOI 10.1126/science.275.5298.391; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; MCKINNON RD, 1982, GENE, V19, P33, DOI 10.1016/0378-1119(82)90186-X; Mehlum A, 1997, APMIS, V105, P861, DOI 10.1111/j.1699-0463.1997.tb05095.x; MEHLUM A, 1995, EUR J BIOCHEM, V230, P567; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; MILLER NE, 1985, NATURE, V314, P109, DOI 10.1038/314109a0; MORTON RE, 1981, J BIOL CHEM, V256, P1992; MORTON RE, 1983, J BIOL CHEM, V258, P1751; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; NEWNHAM HH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P57, DOI 10.1016/0005-2760(90)90218-M; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; PAPE ME, 1991, BIOCHIM BIOPHYS ACTA, V1086, P326, DOI 10.1016/0005-2760(91)90177-J; PARTHASARATHY S, 1990, BIOCHIM BIOPHYS ACTA, V1044, P275, DOI 10.1016/0005-2760(90)90314-N; Plump AS, 1999, ARTERIOSCL THROM VAS, V19, P1105, DOI 10.1161/01.ATV.19.4.1105; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sacks FM, 1998, CIRCULATION, V98, P791; SAITO F, 1984, METABOLISM, V33, P629, DOI 10.1016/0026-0495(84)90061-1; SAKAI N, 1995, CIRCULATION S, V92, P495; SAKU K, 1985, THROMB RES, V39, P1, DOI 10.1016/0049-3848(85)90116-1; SHAMBUREK RD, 1993, CIRCULATION, V88, P75; Sugano M, 1998, J BIOL CHEM, V273, P5033, DOI 10.1074/jbc.273.9.5033; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; TALL AR, 1993, J LIPID RES, V34, P1255; Tollefson J H, 1986, Methods Enzymol, V129, P797; VAISMAN BL, 1995, J BIOL CHEM, V270, P12269, DOI 10.1074/jbc.270.20.12269; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; YAMASHITA S, 1990, J CLIN INVEST, V86, P688, DOI 10.1172/JCI114764; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751; [No title captured]	69	181	189	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36912	36920		10.1074/jbc.274.52.36912	http://dx.doi.org/10.1074/jbc.274.52.36912			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601244	hybrid			2022-12-27	WOS:000084382700015
J	Halappanavar, SS; Le Rhun, Y; Mounir, S; Martins, LM; Huot, J; Earnshaw, WC; Shah, GM				Halappanavar, SS; Le Rhun, Y; Mounir, S; Martins, LM; Huot, J; Earnshaw, WC; Shah, GM			Survival and proliferation of cells expressing caspase-uncleavable poly(ADP-ribose) polymerase in response to death-inducing DNA damage by an alkylating agent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ICE/CED-3 PROTEASE; INDUCED APOPTOSIS; NUCLEAR PROTEINS; ADP-RIBOSYLATION; C3H10T1/2 CELLS; ICE-LIKE; CLEAVAGE; ACTIVATION; INHIBITORS; METABOLISM	To determine whether caspase-3-induced cleavage of poly(ADP-ribose) polymerase (PARP), a DNA damage-sensitive enzyme, alters the balance between survival and death of the cells following DNA damage, we created stable cell lines that express either caspase-uncleavable mutant or wild type PARP in the background of PARP (-/-) fibroblasts. The survival and apoptotic responses of these cells were compared after exposure to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), a DNA-damaging agent that activates PARP, or to tumor necrosis factor-alpha, which causes apoptosis without initial DNA damage. In response to MNNG, the cells with caspase-uncleavable PARP were very resistant to loss of viability or induction of apoptosis. Most significantly, similar to 25% of these cells survived and retained clonogenicity at a level of DNA damage that eliminated the cells with wild type PARP or PARP (-/-) cells. Expression of caspase-uncleavable PARP could not protect the cells from death induced by tumor necrosis factor, although there was a slower progression of apoptotic events in these cells. Therefore, one of the functions for cleavage of PARP during apoptosis induced by alkylating agents is to prevent survival of the extensively damaged cells.	Univ Laval, Fac Med, Ctr Hosp Univ Quebec, Med Res Ctr,Lab Skin Canc Res, Quebec City, PQ G1V 4G2, Canada; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Laval, Hotel Dieu, Ctr Rech Cancerol, Quebec City, PQ G1K 7P4, Canada	Laval University; University of Edinburgh; Laval University	Shah, GM (corresponding author), Univ Laval, Med Res Ctr, CHUL, Lab Skin Canc Res, RC-9700,2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada.	girish.shah@crchul.ulaval.ca	Earnshaw, William/AAY-7438-2020; Shah, Girish M/A-5153-2008	Earnshaw, William/0000-0002-7191-0621; Shah, Girish/0000-0002-9291-1164	Wellcome Trust [073915] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Babiychuk E, 1998, PLANT J, V15, P635, DOI 10.1046/j.1365-313x.1998.00240.x; BANASIK M, 1992, J BIOL CHEM, V267, P1569; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Berghammer H, 1999, FEBS LETT, V449, P259, DOI 10.1016/S0014-5793(99)00448-2; Boise LH, 1997, P NATL ACAD SCI USA, V94, P3759, DOI 10.1073/pnas.94.8.3759; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Casiano CA, 1998, CELL DEATH DIFFER, V5, P183, DOI 10.1038/sj.cdd.4400336; Charron MJ, 1999, NAT MED, V5, P269, DOI 10.1038/6479; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Fagagna F., 1999, NAT GENET, V23, P76; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Herceg Z, 1999, MOL CELL BIOL, V19, P5124; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; JACOBSON EL, 1985, CARCINOGENESIS, V6, P715, DOI 10.1093/carcin/6.5.715; Jeggo PA, 1998, CURR BIOL, V8, pR49, DOI 10.1016/S0960-9822(98)70032-6; Johansson M, 1999, GENOMICS, V57, P442, DOI 10.1006/geno.1999.5799; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KAWAMITSU H, 1984, BIOCHEMISTRY-US, V23, P3771, DOI 10.1021/bi00311a032; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Masutani M, 1999, P NATL ACAD SCI USA, V96, P2301, DOI 10.1073/pnas.96.5.2301; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Oei S L, 1997, Rev Physiol Biochem Pharmacol, V131, P127; Oliver FJ, 1999, AM J HUM GENET, V64, P1282, DOI 10.1086/302389; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Pieper AA, 1999, P NATL ACAD SCI USA, V96, P3059, DOI 10.1073/pnas.96.6.3059; Ramsamooj P, 1996, INT J ONCOL, V8, P803; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Rosen A, 1997, J CELL BIOCHEM, V64, P50, DOI 10.1002/(SICI)1097-4644(199701)64:1<50::AID-JCB8>3.0.CO;2-Z; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Ruscetti T, 1998, J BIOL CHEM, V273, P14461, DOI 10.1074/jbc.273.23.14461; Scovassi AI, 1998, EUR J HISTOCHEM, V42, P251; Shah GM, 1996, BBA-MOL CELL RES, V1312, P1, DOI 10.1016/0167-4889(96)00004-3; Shah GM, 1995, ANAL BIOCHEM, V232, P251, DOI 10.1006/abio.1995.0016; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Shah GM, 1996, BIOCHEM BIOPH RES CO, V229, P838, DOI 10.1006/bbrc.1996.1889; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; Simbulan-Rosenthal CM, 1998, J BIOL CHEM, V273, P13703, DOI 10.1074/jbc.273.22.13703; SIMONIN F, 1990, J BIOL CHEM, V265, P19249; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smulson ME, 1998, CANCER RES, V58, P3495; Tan XQ, 1998, TRENDS CELL BIOL, V8, P116, DOI 10.1016/S0962-8924(97)01208-7; TERUI Y, 1995, J CELL PHYSIOL, V164, P74, DOI 10.1002/jcp.1041640110; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Wohrl W, 1999, BIOCHEM BIOPH RES CO, V254, P552, DOI 10.1006/bbrc.1998.9982	63	45	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37097	37104		10.1074/jbc.274.52.37097	http://dx.doi.org/10.1074/jbc.274.52.37097			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601269	hybrid			2022-12-27	WOS:000084382700040
J	Lazo, ND; Downing, DT				Lazo, ND; Downing, DT			A mixture of alpha-helical and 3(10)-helical conformations for involucrin in the human epidermal corneocyte envelope provides a scaffold for the attachment of both lipids and proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNIFIED CELL-ENVELOPE; INTERMEDIATE FILAMENTS; CIRCULAR-DICHROISM; GENE-EXPRESSION; STRATUM-CORNEUM; TRIFLUOROETHANOL; KERATINOCYTES; PEPTIDES; WATER; POLYPEPTIDES	Involucrin plays an important role in the lipid and protein compound envelopes of mammalian epidermal corneocytes. In the present study, model peptides containing the consensus repeating units PEQQEGQLEL and LEQQEGQLEH, found in the central region of human involucrin, were studied by circular dichroism spectroscopy, molecular modeling, and energy minimization, These peptides have intrinsic alpha-helix-forming properties as indicated by their circular dichroic spectra obtained in the presence of 2,2,2-trifluoroethanol. Peptide (LEQQEGQLEH)(3) had an alpha-helix content of 100% in 100% 2,2,2-trifluoroethanol at 0 degrees C, The energy-minimized alpha-helix showed that only 50% of the glutamate side chains may be available for the attachment of lipids. However, when a 3(10)-helix was assumed for the GQL or GQLE residues in LEQQEGQLEH, all of the glutamate side chains were arrayed on one face of the helix, and all of the glutamine side chains were arrayed on the opposite face. A similar result was obtained when the nonhelical part of PEQQEGQLEL was assumed to contain a beta-turn III, which is equivalent to a short portion of 3(10)-helix, The results of this study suggest that when the central segment of human involucrin is predominantly alpha-helical, accompanied by short 3(10)-helical segments, the protein can function as a scaffold for the attachment of both lipids and proteins.	Univ Iowa, Dept Dermatol, Iowa City, IA 52242 USA	University of Iowa	Lazo, ND (corresponding author), Univ Iowa, Dept Dermatol, Iowa City, IA 52242 USA.		Lazo, Noel/U-8393-2019	Lazo, Noel/0000-0003-1769-7572	NIAMS NIH HHS [AR 32374] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032374] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; CammersGoodwin A, 1996, J AM CHEM SOC, V118, P3082, DOI 10.1021/ja952900z; Creighton T. E., 1993, PROTEINS STRUCTURES; DOWNING DT, 1992, J LIPID RES, V33, P301; DOWNING DT, 1995, PROTEINS, V23, P204, DOI 10.1002/prot.340230210; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; GERSTEIN M, 1991, J MOL BIOL, V220, P133, DOI 10.1016/0022-2836(91)90387-L; GRECO MA, 1995, J INVEST DERMATOL, V104, P204, DOI 10.1111/1523-1747.ep12612759; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HOHL D, 1991, J BIOL CHEM, V266, P6626; HOLZWARTH G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2195, DOI 10.1128/MCB.8.5.2195; KARTASOVA T, 1987, NUCLEIC ACIDS RES, V15, P5945, DOI 10.1093/nar/15.15.5945; Kentsis A, 1998, BIOCHEMISTRY-US, V37, P14613, DOI 10.1021/bi981641y; LAZO ND, 1995, J INVEST DERMATOL, V105, P296, DOI 10.1111/1523-1747.ep12318985; Lazo ND, 1997, BIOCHEMISTRY-US, V36, P2559, DOI 10.1021/bi963061b; LEE SC, 1993, J BIOL CHEM, V268, P12164; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; MAHREL T, 1990, CELL, V61, P1103; Marekov LN, 1998, J BIOL CHEM, V273, P17763, DOI 10.1074/jbc.273.28.17763; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; MILLHAUSER GL, 1995, BIOCHEMISTRY-US, V34, P3873, DOI 10.1021/bi00012a001; NONOMURA K, 1994, J INVEST DERMATOL, V103, P88, DOI 10.1111/1523-1747.ep12391802; PIELA L, 1987, BIOPOLYMERS, V26, P1587, DOI 10.1002/bip.360260910; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; Robinson NA, 1996, J INVEST DERMATOL, V107, P101, DOI 10.1111/1523-1747.ep12298323; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; SMYTHE ML, 1993, J AM CHEM SOC, V115, P11594, DOI 10.1021/ja00077a067; SOMAN KV, 1991, BIOPOLYMERS, V31, P1351, DOI 10.1002/bip.360311202; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Steinert P M, 1995, Cell Death Differ, V2, P33; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; STEVEN AC, 1994, J CELL SCI, V107, P693; SUDHA TS, 1983, INT J PEPT PROT RES, V22, P464; SWARTZENDRUBER DC, 1987, J INVEST DERMATOL, V88, P709, DOI 10.1111/1523-1747.ep12470383; TAKAHASHI M, 1992, FEBS LETT, V308, P79, DOI 10.1016/0014-5793(92)81055-Q; TONIOLO C, 1991, TRENDS BIOCHEM SCI, V16, P350; TSENG H, 1990, MOL BIOL EVOL, V7, P293; WERTZ PW, 1989, J INVEST DERMATOL, V92, P109, DOI 10.1111/1523-1747.ep13071317; WERTZ PW, 1987, BIOCHIM BIOPHYS ACTA, V917, P108, DOI 10.1016/0005-2760(87)90290-6; WHITE SH, 1988, BIOCHEMISTRY-US, V27, P3725, DOI 10.1021/bi00410a031; YAFFE MB, 1992, J BIOL CHEM, V267, P12233; YONEDA K, 1992, J BIOL CHEM, V267, P18060	45	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37340	37344		10.1074/jbc.274.52.37340	http://dx.doi.org/10.1074/jbc.274.52.37340			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601302	hybrid			2022-12-27	WOS:000084382700073
J	Billin, AN; Eilers, AL; Queva, C; Ayer, DE				Billin, AN; Eilers, AL; Queva, C; Ayer, DE			Mix, a novel max-like BHLHZip protein that interacts with the max network of transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE ACTIVITY; DNA-BINDING PROTEIN; C-MYC; CELL-GROWTH; EPIDERMAL DIFFERENTIATION; RAS COTRANSFORMATION; OPPOSITE REGULATION; REPRESSION; COMPLEX; MXI1	Mad:Max heterodimers oppose the growth-promoting action of Myc:Max heterodimers by recruiting the mSin3-histone deacetylase (mSin3.HDAC) complex to DNA and functioning as potent transcriptional repressors. There are four known members of the Mad family that are indistinguishable in their abilities to interact with Max, bind DNA, repress transcription, and block Myc + Ras co-transformation. To investigate functional differences between Mad family proteins, we have identified additional proteins that interact with this family. Here we present the identification and characterization of the novel basic-helix-loop-helix zipper protein M1x (Max-like protein x), which is structurally and functionally related to Max. The similarities between M1x and Max include 1) broad expression in many tissues, 2) long protein half-life, and 3) formation of heterodimers with Mad family proteins that are capable of specific CACGTG binding. We show that transcriptional repression by Mad1:M1x heterodimers is dependent on dimerization, DNA binding, and recruitment of the mSin3A.HDAC corepressor complex. In contrast with Max, M1x interacts only with Mad1 and Mad4. Together, these findings suggest that M1x may act to diversify Mad family function by its restricted association with a subset of the Mad family of transcriptional repressors.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Fred Hutchinson Cancer Center	Ayer, DE (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 East North Campus Dr, Salt Lake City, UT 84112 USA.			Billin, Andrew/0000-0001-7752-0934; Ayer, Donald/0000-0002-5595-3269	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055668] Funding Source: NIH RePORTER; NCI NIH HHS [3P30CA42014] Funding Source: Medline; NIGMS NIH HHS [R01 GM055668, GM5568-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; AYER DE, 1993, GENE DEV, V7, P2110, DOI 10.1101/gad.7.11.2110; BERBERICH S, 1992, ONCOGENE, V7, P775; BERNARDS R, 1995, CURR BIOL, V5, P859, DOI 10.1016/S0960-9822(95)00173-4; Bjerknes M, 1996, GENE, V181, P7, DOI 10.1016/S0378-1119(96)00376-9; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; BLACKWOOD EM, 1992, GENE DEV, V6, P71, DOI 10.1101/gad.6.1.71; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; CHEN J, 1995, NAT MED, V1, P638, DOI 10.1038/nm0795-638; CHIN L, 1995, P NATL ACAD SCI USA, V92, P8488, DOI 10.1073/pnas.92.18.8488; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; DELGADO MD, 1995, ONCOGENE, V10, P1659; EDELHOFF S, 1994, ONCOGENE, V9, P665; FERRE DA, 1994, EMBO J, V13, P180; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; Foley KP, 1998, EMBO J, V17, P774, DOI 10.1093/emboj/17.3.774; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Hurlin PJ, 1995, ONCOGENE, V11, P2487; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; Kasten MM, 1996, MOL CELL BIOL, V16, P4215; KATO GJ, 1992, GENE DEV, V6, P81, DOI 10.1101/gad.6.1.81; KOSKINEN PJ, 1995, CELL GROWTH DIFFER, V6, P623; Kretzner L, 1992, Curr Top Microbiol Immunol, V182, P435; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LARSSON LG, 1994, ONCOGENE, V9, P1247; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Queva C, 1998, ONCOGENE, V16, P967, DOI 10.1038/sj.onc.1201611; Roussel MF, 1996, MOL CELL BIOL, V16, P2796; Schreiber-Agus N, 1998, NATURE, V393, P483, DOI 10.1038/31008; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Sommer A, 1997, CURR BIOL, V7, P357, DOI 10.1016/S0960-9822(06)00183-7; VASTRIK I, 1995, J CELL BIOL, V128, P1197, DOI 10.1083/jcb.128.6.1197; Wu SJ, 1996, ONCOGENE, V12, P621; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	52	77	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36344	36350		10.1074/jbc.274.51.36344	http://dx.doi.org/10.1074/jbc.274.51.36344			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593926	hybrid			2022-12-27	WOS:000084279200045
J	Fong, LG; Le, D				Fong, LG; Le, D			The processing of ligands by the class A scavenger receptor is dependent on signal information located in the cytoplasmic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MOUSE PERITONEAL-MACROPHAGES; MONOCYTE-DERIVED MACROPHAGES; LIPID-PROTEIN ADDUCTS; SMOOTH-MUSCLE CELLS; INSULIN-RECEPTOR; GROWTH-FACTOR; ATHEROSCLEROTIC LESIONS; MESSENGER-RNA; TRANSFERRIN RECEPTOR	The mechanisms that regulate the transport of the macrophage class A scavenger receptor during ligand uptake were investigated. Kinetic analysis of the changes in receptor phosphorylation demonstrated that serine phosphorylation increased during the internalization of acetyl-low density lipoproteins (LDL) by macrophages. The increase was maximal at about 2.5 min after the initiation of ligand uptake. Oxidized LDL also stimulated serine phosphorylation, but the relative increase was smaller and the time to maximum was shorter. Receptor mutants expressed in Chinese hamster ovary and COS cells showed that elimination of the potential phosphorylation site at Ser(21) increased acetyILDL metabolism, whereas inactivation of the site at Ser(49) reduced acetyl-LDL uptake. The increase in uptake by the Ser(21) mutant was due to an increase in surface receptor expression. in contrast, elimination of the site at Ser(49) did not affect receptor expression but slowed receptor internalization. To identify potential internalization signal sequences, beta-turn structure in the cytosolic domain was targeted for mutagenesis. Disruption of one region near Asp(25) inhibited receptor activity. The studies support a model whereby receptor internalization requires the presence of an internalization signal motif but that the rate of receptor internalization is governed by the pattern of receptor phosphorylation induced by the ligand.	Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA	Palo Alto Medical Foundation Research Institute	Fong, LG (corresponding author), Palo Alto Med Fdn, Res Inst, 860 Bryant St, Palo Alto, CA 94301 USA.	lgfong@pamfri.org						ACTON SL, 1994, J BIOL CHEM, V269, P21003; AJIOKA RS, 1986, P NATL ACAD SCI USA, V83, P6445, DOI 10.1073/pnas.83.17.6445; ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Andersson L, 1998, J BIOL CHEM, V273, P19592, DOI 10.1074/jbc.273.31.19592; ARUFFO A, 1991, CURRENT PROTOCOLS MO, V2; ASHKENAS J, 1993, J LIPID RES, V34, P983; BACKER JM, 1992, J CELL BIOL, V118, P831, DOI 10.1083/jcb.118.4.831; BERNINI F, 1995, ARTERIOSCL THROM VAS, V15, P1352, DOI 10.1161/01.ATV.15.9.1352; BICKEL PE, 1992, J CLIN INVEST, V90, P1450, DOI 10.1172/JCI116012; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; CARPENTIER JL, 1993, J CELL BIOL, V122, P1243, DOI 10.1083/jcb.122.6.1243; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; DOI T, 1994, J BIOL CHEM, V269, P25598; DOI T, 1993, J BIOL CHEM, V268, P2126; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; FALLON RJ, 1994, J BIOL CHEM, V269, P11011; FONG LG, 1991, J LIPID RES, V32, P1899; FONG LG, 1990, J BIOL CHEM, V265, P11751; Fong LG, 1996, J LIPID RES, V37, P574; FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; FROSTEGARD J, 1990, P NATL ACAD SCI USA, V87, P904, DOI 10.1073/pnas.87.3.904; FUKUDA S, 1986, VIRCHOWS ARCH B, V52, P1, DOI 10.1007/BF02889945; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; HAFT CR, 1994, J BIOL CHEM, V269, P26286; Hamer I, 1997, J BIOL CHEM, V272, P21685, DOI 10.1074/jbc.272.35.21685; HAMILTON TA, 1990, J IMMUNOL, V144, P2343; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; Hsu HY, 1998, J BIOL CHEM, V273, P1240, DOI 10.1074/jbc.273.2.1240; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; KINGSTON RE, 1990, CURRENT PROTOCOLS MO, V1; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LOUGHEED M, 1991, J BIOL CHEM, V266, P14519; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALDEN LT, 1991, J BIOL CHEM, V266, P13901; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; Maxeiner H, 1998, J EXP MED, V188, P2257, DOI 10.1084/jem.188.12.2257; Miki S, 1996, FEBS LETT, V399, P241, DOI 10.1016/S0014-5793(96)01332-4; MOMMAASKIENHUIS AM, 1985, HISTOCHEMISTRY, V83, P29, DOI 10.1007/BF00495296; MORI T, 1994, LAB INVEST, V71, P409; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NAITO M, 1991, AM J PATHOL, V139, P1411; NESTEROV A, 1995, J BIOL CHEM, V270, P6320, DOI 10.1074/jbc.270.11.6320; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PYTOWSKI B, 1995, J BIOL CHEM, V270, P9067, DOI 10.1074/jbc.270.16.9067; QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995; RAMPRASAD MP, 1995, P NATL ACAD SCI USA, V92, P9580, DOI 10.1073/pnas.92.21.9580; ROBENEK H, 1984, J HISTOCHEM CYTOCHEM, V32, P1017, DOI 10.1177/32.10.6481148; ROMA P, 1992, J LIPID RES, V33, P819; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P336, DOI 10.1161/01.ATV.10.3.336; ROSENFELD ME, 1991, J CLIN INVEST, V87, P90, DOI 10.1172/JCI115006; Sakai M, 1996, J BIOL CHEM, V271, P27346, DOI 10.1074/jbc.271.44.27346; Sambrook J., 1989, MOL CLONING, pA1; SHACKELFORD RE, 1995, J BIOL CHEM, V270, P3475, DOI 10.1074/jbc.270.8.3475; SPARROW CP, 1989, J BIOL CHEM, V264, P2599; STANTON LW, 1992, J BIOL CHEM, V267, P22446; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Sulistiyani, 1997, ARTERIOSCL THROM VAS, V17, P1691, DOI 10.1161/01.ATV.17.9.1691; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; TORONTONOZ P, 1998, CELL, V93, P241; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; VANBERKEL TJC, 1981, FEBS LETT, V132, P61; VANDERGEER P, 1994, CELL BIOL LAB HDB, V3, P422; WILEY HS, 1991, J BIOL CHEM, V266, P11083; Yoshida H, 1998, ARTERIOSCL THROM VAS, V18, P794, DOI 10.1161/01.ATV.18.5.794	75	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36808	36816		10.1074/jbc.274.51.36808	http://dx.doi.org/10.1074/jbc.274.51.36808			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593991	hybrid			2022-12-27	WOS:000084279200110
J	Guan, ZH; Buckman, SY; Springer, LD; Morrison, AR				Guan, ZH; Buckman, SY; Springer, LD; Morrison, AR			Both p38 alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1 beta in rat glomerular mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ACTIVATED PROTEIN-KINASES; JUN NH2-TERMINAL KINASE; TRANSCRIPTIONAL REGULATION; P38; EXPRESSION; GENE; REQUIRES; STRESS; ALPHA	Interleukin 1 beta (IL-1 beta) induces expression of the inducible nitric-oxide synthase (iNOS) with concomitant release of nitric oxide (NO) from glomerular mesangial cells. These events are preceded by activation of the c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) and p38(MAPK). Our current study demonstrates that overexpression of the dominant negative form of JNK1 or p54 SAPK beta/JNK2 significantly reduces the iNOS protein expression and NO production induced by IL-1 beta. Similarly, overexpression of the kinase-dead mutant form of p38 alpha(MAPK) also inhibits IL-1 beta-induced iNOS expression and NO production. In previous studies we demonstrated that IL-1 beta can activate MKK4/SEK1, MKK3, and MKK6 in renal mesangial cells; therefore, we examined the role of these MAPK kinases in the modulation of iNOS induced by IL-1 beta. Overexpression of the dominant negative form of MKK4/SEK1 decreases IL-1 beta-induced iNOS expression and NO production with inhibition of both SAPK/JNK and p38(MAPK) phosphorylation. Overexpression of the kinase-dead mutant form of MKK3 or MKK6 demonstrated that either of these two mutant kinase inhibited IL-1 beta-induced p38(MAPK) (but not JNK/SAPK) phosphorylation and iNOS expression. Interestingly overexpression of wild type MKK3/6 was associated with phosphorylation of p38(MAPK); however, in the absence of IL-1 beta, iNOS expression was not enhanced. This study suggests that the activation of both SAPK/JNK and p38 alpha(MAPK) Signaling cascades are necessary for the IL-1 beta-induced expression of iNOS and production of NO in renal mesangial cells.	Washington Univ, Sch Med, Dept Med & Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Morrison, AR (corresponding author), Barnes Jewish Hosp, Div Renal, 216 S Kings Highway,Box 8305, St Louis, MO 63110 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050606] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 50606] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; DaSilva J, 1997, J BIOL CHEM, V272, P28373, DOI 10.1074/jbc.272.45.28373; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; Ellwood K, 1999, MOL CELL BIOL, V19, P2613; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gaudreau L, 1999, P NATL ACAD SCI USA, V96, P2668, DOI 10.1073/pnas.96.6.2668; Grabowski PS, 1997, BRIT J RHEUMATOL, V36, P651; Guan ZH, 1997, J BIOL CHEM, V272, P8083, DOI 10.1074/jbc.272.12.8083; Guan ZH, 1996, AM J PHYSIOL-RENAL, V270, pF634, DOI 10.1152/ajprenal.1996.270.4.F634; Guan ZH, 1998, J BIOL CHEM, V273, P28670, DOI 10.1074/jbc.273.44.28670; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hu MCT, 1999, J BIOL CHEM, V274, P7095, DOI 10.1074/jbc.274.11.7095; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kinugawa K, 1997, CIRC RES, V81, P911; Kleinert H, 1998, BRIT J PHARMACOL, V123, P1716, DOI 10.1038/sj.bjp.0701782; Kunz D, 1996, P NATL ACAD SCI USA, V93, P255, DOI 10.1073/pnas.93.1.255; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Larsen CM, 1998, J BIOL CHEM, V273, P15294, DOI 10.1074/jbc.273.24.15294; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Marks-Konczalik J, 1998, J BIOL CHEM, V273, P22201, DOI 10.1074/jbc.273.35.22201; McCafferty DM, 1997, GASTROENTEROLOGY, V112, P1022, DOI 10.1053/gast.1997.v112.pm9041266; Miller BW, 1997, AM J PHYSIOL-CELL PH, V273, pC130, DOI 10.1152/ajpcell.1997.273.1.C130; Mosley K, 1999, EXP NEPHROL, V7, P26; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Tetsuka T, 1996, J BIOL CHEM, V271, P11689, DOI 10.1074/jbc.271.20.11689; TETSUKA T, 1995, AM J PHYSIOL-CELL PH, V269, pC55, DOI 10.1152/ajpcell.1995.269.1.C55; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355; Zheng J, 1999, ENDOCRINOLOGY, V140, P1399, DOI 10.1210/en.140.3.1399	41	70	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36200	36206		10.1074/jbc.274.51.36200	http://dx.doi.org/10.1074/jbc.274.51.36200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593906	hybrid			2022-12-27	WOS:000084279200025
J	Johnson, TK; Schweppe, RE; Septer, J; Lewis, RE				Johnson, TK; Schweppe, RE; Septer, J; Lewis, RE			Phosphorylation of B-Myb regulates its transactivation potential and DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; C-MYB; SELECTIVE ACTIVATION; FUNCTIONAL DOMAINS; DEPENDENT KINASE; GENE-PRODUCT; S-PHASE; EXPRESSION; PROTEIN; TRANSCRIPTION	The transcription factor B-Myb is a cell cycle-regulated phosphoprotein and a potent regulator of cell cycle progression. Previous studies demonstrated that B-Myb was phosphorylated at the onset of S phase, suggesting that it could be due to cyclin-dependent kinases. We identified 10 B-Myb phosphorylation sites by automated peptide radiosequencing of tryptic phosphopeptides derived from in vivo P-32-labeled B-Myb. Each B-Myb phosphorylation site contained a phosphoserine or phosphothreonine followed by a proline, suggesting that this phosphorylation is due to a proline-directed kinase, Cyclin A-Cdk2 and cyclin E-Cdk2 complexes each phosphorylated B-Myb in a cell-free system on the same sites as in intact cells. Furthermore, the ability of B-Myb to activate a reporter plasmid was enhanced by the cotransfection of cyclin A, whereas mutagenesis of the 10 identified phosphorylation sites from B-Myb blocked the effect of cyclin A coexpression, Additional analysis revealed that the effect of phosphorylation on B-Myb transactivation potential was enhanced by phosphorylation sites in its carboxyl-terminal half. One phosphorylation site (Ser(581)) appeared to negatively regulate DNA binding, as mutation of this site enhanced the ability of B-Myb to bind a Myb-binding sequence. These data suggest that B-Myb is a target for phosphorylation by cyclin-Cdk2 and that phosphorylation of B-Myb regulates its transcriptional activity.	Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Lewis, RE (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 600 S 42nd St, Omaha, NE 68198 USA.		Lewis, Robert E./H-3404-2019	Schweppe, Rebecca/0000-0001-7502-0151	NCI NIH HHS [CA09476, P30 CA36727] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA036727, T32CA009476] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Shami A, 1998, J BIOL CHEM, V273, P1058, DOI 10.1074/jbc.273.2.1058; ARSURA M, 1992, BLOOD, V79, P2708; Bartsch O, 1999, EUR J BIOCHEM, V260, P384, DOI 10.1046/j.1432-1327.1999.00191.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; FOOS G, 1993, ONCOGENE, V8, P1775; FOOS G, 1992, EMBO J, V11, P4619, DOI 10.1002/j.1460-2075.1992.tb05564.x; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; HOWE KM, 1991, NUCLEIC ACIDS RES, V19, P3913, DOI 10.1093/nar/19.14.3913; LAM EWF, 1992, ONCOGENE, V7, P1885; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Lane S, 1997, ONCOGENE, V14, P2445, DOI 10.1038/sj.onc.1201086; LIN D, 1992, P NATL ACAD SCI USA, V89, P9210, DOI 10.1073/pnas.89.19.9210; LIN D, 1994, P NATL ACAD SCI USA, V91, P10079, DOI 10.1073/pnas.91.21.10079; Marhamati DJ, 1996, J BIOL CHEM, V271, P3359; NAKAGOSHI H, 1992, ONCOGENE, V7, P1233; NAKAGOSHI H, 1993, J BIOL CHEM, V268, P14161; Ness SA, 1996, BBA-REV CANCER, V1288, pF123, DOI 10.1016/S0304-419X(96)00027-3; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Robinson C, 1996, ONCOGENE, V12, P1855; Rogers JA, 1996, J BIOL CHEM, V271, P17519, DOI 10.1074/jbc.271.29.17519; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SALA A, 1992, P NATL ACAD SCI USA, V89, P10415, DOI 10.1073/pnas.89.21.10415; Sala A, 1996, J BIOL CHEM, V271, P9363, DOI 10.1074/jbc.271.16.9363; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Sala A, 1996, J BIOL CHEM, V271, P28738, DOI 10.1074/jbc.271.46.28738; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Saville MK, 1998, ADV CANCER RES, V72, P109; TASHIRO S, 1995, ONCOGENE, V10, P1699; Tauer TJ, 1996, J BIOL CHEM, V271, P331, DOI 10.1074/jbc.271.1.331; Volle DJ, 1999, BIOCHEMISTRY-US, V38, P5130, DOI 10.1021/bi983050d; WATSON RJ, 1993, NUCLEIC ACIDS RES, V21, P267, DOI 10.1093/nar/21.2.267; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; Ziebold U, 1997, CURR BIOL, V7, P253, DOI 10.1016/S0960-9822(06)00121-7	35	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36741	36749		10.1074/jbc.274.51.36741	http://dx.doi.org/10.1074/jbc.274.51.36741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593981	hybrid			2022-12-27	WOS:000084279200100
J	Okino, N; Ichinose, S; Omori, A; Imayama, S; Nakamura, T; Ito, M				Okino, N; Ichinose, S; Omori, A; Imayama, S; Nakamura, T; Ito, M			Molecular cloning, sequencing, and expression of the gene encoding alkaline ceramidase from Pseudomonas aeruginosa - Cloning of a ceramidase homologue from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ACID CERAMIDASE; PROTEIN; SPHINGOSINE; INHIBITION; SPHINGOMYELINASE; PURIFICATION; BIOSYNTHESIS; ACTIVATION; RECEPTOR; INVITRO	We previously reported the purification and characterization of a novel type of alkaline ceramidase from Pseudomonas aeruginosa strain AN17 (Okino, N., Tani, M., Imayama, S., and Ito, IM. (1998) J. Biol. Chem. 273, 14368-14373). Here, we report the molecular cloning, sequencing, and expression of the gene encoding the ceramidase of this strain. Specific oligonucleotide primers were synthesized using the peptide sequences of the purified ceramidase obtained by digestion with lysylendopeptidase and used for polymerase chain reaction. DNA fragments thus amplified were used as probes to clone the gene encoding the ceramidase from a genomic library of strain AN17. The open reading frame of 2,010 nucleotides encoded a polypeptide of 670 amino acids including a signal sequence of 24 residues, 64 residues of which matched the amino acid sequence determined for the purified enzyme. The molecular weight of the mature enzyme was estimated to be 70,767 from the deduced amino acid sequence. Expression of the ceramidase gene in Escherichia coli, resulted in production of a soluble enzyme with the identical N-terminal amino acid sequence. Recombinant ceramidase was purified to homogeneity from the lysate of E. coli cells and con firmed to be identical to the Pseudomonas enzyme in its specificity and other enzymatic properties. No significant sequence similarities were found in other known functional proteins including human acid ceramidase. However, we found a sequence homologous to the ceramidase in hypothetical proteins encoded in Mycobacterium tuberculosis, Dictyostelium discoideum, and Arabidopsis thaliana. The homologue of the ceramidase gene was thus cloned from an M. tuberculosis cosmid and expressed in E. coli, and the gene was demonstrated to encode an alkaline ceramidase. This is the first report for the cloning of an alkaline ceramidase.	Kyushu Univ, Grad Sch, Dept Biosci & Biotechnol, Div Bioresource & Bioenvironm Sci,Higashi Ku, Fukuoka 8128581, Japan; Kyushu Univ, Grad Sch, Fac Med, Dept Dermatol,Higashi Ku, Fukuoka 8128581, Japan; Mitsubishi Kasei Inst Life Sci, Machida, Tokyo 1948511, Japan	Kyushu University; Kyushu University	Ito, M (corresponding author), Kyushu Univ, Grad Sch, Dept Biosci & Biotechnol, Div Bioresource & Bioenvironm Sci,Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.		Ito, Makoto/Q-6164-2019; Okino, Nozomu/AAY-2635-2021	ito, Makoto/0000-0003-3159-7818				ABRAHMSEN L, 1985, EMBO J, V4, P3901, DOI 10.1002/j.1460-2075.1985.tb04164.x; BERNARDO K, 1995, J BIOL CHEM, V270, P11098, DOI 10.1074/jbc.270.19.11098; Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; BODEY GP, 1983, REV INFECT DIS, V5, P279; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CORONEOS E, 1995, J BIOL CHEM, V270, P23305, DOI 10.1074/jbc.270.40.23305; DAINESE HP, 1997, EUR J BIOCHEM, V264, P336; GATT S, 1966, J BIOL CHEM, V241, P3724; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HASSLER DF, 1993, ADV LIPID RES, V26, P49; ITO M, 1995, J BIOL CHEM, V270, P24370, DOI 10.1074/jbc.270.41.24370; Koch J, 1996, J BIOL CHEM, V271, P33110, DOI 10.1074/jbc.271.51.33110; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Li CM, 1998, GENOMICS, V50, P267, DOI 10.1006/geno.1998.5334; MERRILL AH, 1986, J BIOL CHEM, V261, P3764; NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718; OISHI K, 1990, J BIOL CHEM, V265, P70; Okamoto H, 1998, J BIOL CHEM, V273, P27104, DOI 10.1074/jbc.273.42.27104; Okino N, 1998, J BIOL CHEM, V273, P14368, DOI 10.1074/jbc.273.23.14368; PUSHKAREVA MY, 1992, J BIOL CHEM, V267, P15246; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Sambrook H., 1989, MOL CLONING LAB MANU; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; STOFFEL W, 1974, H-S Z PHYSIOL CHEM, V355, P61, DOI 10.1515/bchm2.1974.355.1.61; SUGITA M, 1972, SCIENCE, V178, P1100, DOI 10.1126/science.178.4065.1100; Tani M, 1998, ANAL BIOCHEM, V263, P183, DOI 10.1006/abio.1998.2781; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zhang P, 1997, J BIOL CHEM, V272, P9609; ZUHERINGDORF DM, 1997, FEBS LETT, V410, P34	32	61	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36616	36622		10.1074/jbc.274.51.36616	http://dx.doi.org/10.1074/jbc.274.51.36616			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593963	hybrid			2022-12-27	WOS:000084279200082
J	Paka, L; Goldberg, IJ; Obunike, JC; Choi, SY; Saxena, U; Goldberg, ID; Pillarisetti, S				Paka, L; Goldberg, IJ; Obunike, JC; Choi, SY; Saxena, U; Goldberg, ID; Pillarisetti, S			Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells - An underlying mechanism for the modulation of smooth muscle cell growth?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; ACTIVATED PROTEIN-KINASE; LOW-DENSITY-LIPOPROTEIN; IN-VIVO; ENDOTHELIAL-CELLS; SUBENDOTHELIAL MATRIX; NEOINTIMAL FORMATION; STABLE EXPRESSION; GENE-EXPRESSION; CORE PROTEIN	Apolipoprotein E (apoE) is known to inhibit cell proliferation; however, the mechanism of this inhibition is not clear. We recently showed that apoE stimulates endothelial production of heparan sulfate (I-IS) enriched in heparin-like sequences. Because heparin and HS are potent inhibitors of smooth muscle cell (SMC) proliferation, in this study we determined apoE effects on SMC HS production and cell growth. In confluent SMCs, apoE (10 mu g/ml) increased (SO4)-S-35 incorporation into PG in media by 25-30%. The increase in the medium was exclusively due to an increase in HSPGs (2.2-fold), and apoE did not alter chondroitin and dermatan sulfate proteoglycans. In proliferating SMCs, apoE inhibited [H-3]thymidine incorporation into DNA by 50%; however, despite decreasing cell number, apoE increased the ratio of (SO4)-S-35 to [H-3]thymidine from 2 to 3.6, suggesting increased HS per cell. Purified HSPGs from apoE-stimulated cells inhibited cell proliferation in the absence of apoE, ApoE did not inhibit proliferation of endothelial cells, which are resistant to heparin inhibition. Analysis of the conditioned medium from apoE stimulated cells revealed that the HSPG increase was in perlecan and that apoE also stimulated perlecan mRNA expression by >2-fold. The ability of apoE isoforms to inhibit cell proliferation correlated with their ability to stimulate perlecan expression. An anti-perlecan antibody completely abrogated the antiproliferative effect of apoE. Thus, these data show that perlecan is a potent inhibitor of SMC proliferation and is required to mediate the antiproliferative effect of apoE. Because other growth modulators also regulate perlecan expression, this may be a key pathway in the regulation of SMC growth.	N Shore Long Isl Jewish Hlth Syst, Dept Radiat Oncol, Manhasset, NY 11030 USA; Columbia Univ, Dept Med, Div Prevent Med, New York, NY 10032 USA; Palo Alto Med Fdn, Palo Alto, CA 94301 USA; Atherogen Inc, Alpharetta, GA 30004 USA	Northwell Health; Columbia University; Palo Alto Medical Foundation Research Institute	Pillarisetti, S (corresponding author), N Shore Long Isl Jewish Hlth Syst, Dept Radiat Oncol, Boas Marks Biomed Res Bldg,Rm 129,350 Community D, Manhasset, NY 11030 USA.	heparin@email.com			NHLBI NIH HHS [HL62301, HLK14-03323, HL56984] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K14HL003323, P50HL056984, R01HL062301] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adatia R, 1997, ANN ONCOL, V8, P1257, DOI 10.1023/A:1008243115385; AU YPT, 1992, J BIOL CHEM, V267, P3438; Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; BATTAGLIA C, 1992, EUR J BIOCHEM, V208, P359, DOI 10.1111/j.1432-1033.1992.tb17195.x; Belknap JK, 1999, AM J RESP CELL MOL, V20, P24, DOI 10.1165/ajrcmb.20.1.3321; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; Bingley JA, 1998, J VASC SURG, V28, P308, DOI 10.1016/S0741-5214(98)70167-3; Brown CT, 1999, J BIOL CHEM, V274, P7111, DOI 10.1074/jbc.274.11.7111; CASTELLOT JJ, 1981, J CELL BIOL, V90, P372, DOI 10.1083/jcb.90.2.372; Chai YC, 1996, J BIOL CHEM, V271, P17791, DOI 10.1074/jbc.271.30.17791; CHOI SSY, 1994, J LIPID RES, V35, P848; CLOWES AW, 1977, NATURE, V265, P625, DOI 10.1038/265625a0; de Beer F, 1999, ARTERIOSCL THROM VAS, V19, P633, DOI 10.1161/01.ATV.19.3.633; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Fujii N, 1997, THROMB RES, V88, P299, DOI 10.1016/S0049-3848(97)00257-0; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; Gauer S, 1996, EUR J CELL BIOL, V70, P233; HAMMERLE H, 1991, VASA-J VASCULAR DIS, V20, P207; HAYASHI K, 1992, J CELL BIOL, V119, P945, DOI 10.1083/jcb.119.4.945; HUANG YD, 1994, P NATL ACAD SCI USA, V91, P1834, DOI 10.1073/pnas.91.5.1834; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Ishigami M, 1998, CIRCULATION, V98, P734; Ji ZS, 1998, J BIOL CHEM, V273, P13452, DOI 10.1074/jbc.273.22.13452; JI ZS, 1994, ARTERIOSCLER THROMB, V14, P2025, DOI 10.1161/01.ATV.14.12.2025; KELLY ME, 1994, CELL IMMUNOL, V159, P124, DOI 10.1006/cimm.1994.1302; KINSELLA MG, 1988, BIOCHEMISTRY-US, V27, P2136, DOI 10.1021/bi00406a048; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; KLEIN G, 1995, MATRIX BIOL, V14, P457, DOI 10.1016/0945-053X(95)90003-9; Koyama N, 1998, CIRC RES, V83, P305, DOI 10.1161/01.RES.83.3.305; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAJACK RA, 1988, J CELL BIOL, V107, P1207, DOI 10.1083/jcb.107.3.1207; MCCAFFREY TA, 1989, J CELL BIOL, V109, P441, DOI 10.1083/jcb.109.1.441; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; OTTLINGER ME, 1993, J BIOL CHEM, V268, P19173; Paka L, 1999, J BIOL CHEM, V274, P4816, DOI 10.1074/jbc.274.8.4816; Pillarisetti S, 1997, J CLIN INVEST, V100, P867, DOI 10.1172/JCI119602; Pillarisetti S, 1995, J BIOL CHEM, V270, P29760; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; REILLY CF, 1988, J CELL PHYSIOL, V136, P23, DOI 10.1002/jcp.1041360104; Riddell DR, 1997, J BIOL CHEM, V272, P89; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; SAXENA U, 1993, J BIOL CHEM, V268, P14812; SCHREIBER BM, 1994, J LIPID RES, V35, P1177; Schwartz SM, 1998, ANNU REV MED, V49, P437; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; SHIMANO H, 1995, J CLIN INVEST, V95, P469, DOI 10.1172/JCI117687; Silver PJ, 1998, EUR J PHARMACOL, V351, P79, DOI 10.1016/S0014-2999(98)00293-3; SIVARAM P, 1992, J BIOL CHEM, V267, P16517; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; Sperinde GV, 1998, BIOCHEMISTRY-US, V37, P13153, DOI 10.1021/bi980600z; VOGEL T, 1994, J CELL BIOCHEM, V54, P299, DOI 10.1002/jcb.240540306; Wang WZ, 1996, J CLIN INVEST, V98, P443, DOI 10.1172/JCI118810; Weiser MCM, 1997, MOL BIOL CELL, V8, P999, DOI 10.1091/mbc.8.6.999; Weiser MCM, 1996, MATRIX BIOL, V15, P331, DOI 10.1016/S0945-053X(96)90136-5; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249	58	45	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36403	36408		10.1074/jbc.274.51.36403	http://dx.doi.org/10.1074/jbc.274.51.36403			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593935	hybrid			2022-12-27	WOS:000084279200054
J	Yuan, YP; Kulkarni, S; Ulsemer, P; Cranmer, SL; Yap, CL; Nesbitt, WS; Harper, I; Mistry, N; Dopheide, SM; Hughan, SC; Williamson, D; de la Salle, C; Salem, HH; Lanza, F; Jackson, SP				Yuan, YP; Kulkarni, S; Ulsemer, P; Cranmer, SL; Yap, CL; Nesbitt, WS; Harper, I; Mistry, N; Dopheide, SM; Hughan, SC; Williamson, D; de la Salle, C; Salem, HH; Lanza, F; Jackson, SP			The von Willebrand factor-glycoprotein Ib/V/IX interaction induces actin polymerization and cytoskeletal reorganization in rolling platelets and glycoprotein Ib/V/IX-transfected cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VONWILLEBRAND-FACTOR BINDING; IIB-IIIA; SHEAR-STRESS; SIGNAL-TRANSDUCTION; THROMBUS FORMATION; GP-IB; ACTIVATION; ADHESION; AGGREGATION; FIBRINOGEN	Platelet adhesion to sites of vascular injury is initiated by the binding of the platelet glycoprotein (GP) Ib-V-M complex to matrix-bound von Willebrand factor (vWf). This receptor-ligand interaction is characterized by a rapid on-off rate that enables efficient platelet tethering and rolling under conditions of rapid blood flow. We demonstrate here that platelets adhering to immobilized vWf under flow conditions undergo rapid morphological conversion from flat discs to spiny spheres during surface translocation. Studies of Glanzmann thrombasthenic platelets (lacking integrin alpha(IIb)beta(3)) and Chinese hamster ovary (CHO) cells transfected with GPIb/IX (CHO-Ib/IX) confirmed that vWf binding to GPIb/IX was sufficient to induce actin polymerization and cytoskeletal reorganization independent of integrin alpha(IIb)beta(3). vWf-induced cytoskeletal reorganization occurred independently of several well characterized signaling processes linked to platelet activation, including calcium influx, prostaglandin metabolism, protein tyrosine phosphorylation, activation of protein kinase C or phosphatidylinositol 3-kinase but was critically dependent on the mobilization of intracellular calcium. Studies of Oregon Green 488 1,2-bis(o-amino-5-fluorophenoxy)ethane-N,N,N',N-tetraacetic acid tetraacetoxymethyl ester-loaded platelets and CHO-Ib/IX cells demonstrated that these cells mobilize intracellular calcium in a shear-dependent manner during surface translocation on vWf. Taken together, these studies suggest that the vWf-GPIb interaction stimulates actin polymerization and cytoskeletal reorganization in rolling platelets via a shear-sensitive signaling pathway linked to intracellular calcium mobilization.	Australian Ctr Blood Dis, Dept Med, Monash Med Sch, Box Hill, Vic, Australia; Box Hill Hosp, Dept Pathol, Box Hill, Vic, Australia; INSERM, Etab Transfus Sanguine, U311, F-67065 Strasbourg, France	Monash University; Box Hill Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Jackson, SP (corresponding author), Box Hill Hosp, Australian Ctr Blood Dis, Dept Med, Monash Med Sch, Arnold St, Box Hill, Vic 3128, Australia.	Shaun.Jackson@med.monash.edu.au	Lanza, Francois/H-9252-2016	Lanza, Francois/0000-0002-5802-4748; Harper, Ian/0000-0002-5499-2231; Jackson, Shaun/0000-0002-4750-1991; Nesbitt, Warwick/0000-0001-5644-7053				ASAZUMA N, 1998, BLOOD, V90, P727; BLIKSTAD I, 1978, CELL, V15, P935, DOI 10.1016/0092-8674(78)90277-5; CARRELL NA, 1985, J BIOL CHEM, V260, P1743; CHOW TW, 1992, BLOOD, V80, P113; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Cranmer SL, 1999, J BIOL CHEM, V274, P6097, DOI 10.1074/jbc.274.10.6097; Cunningham JG, 1996, J BIOL CHEM, V271, P11581, DOI 10.1074/jbc.271.19.11581; DEMARCO L, 1985, J CLIN INVEST, V75, P1198, DOI 10.1172/JCI111816; ESCOLAR G, 1994, J LAB CLIN MED, V123, P536; FOX JEB, 1993, J BIOL CHEM, V268, P25973; FOX JEB, 1981, ANAL BIOCHEM, V117, P170, DOI 10.1016/0003-2697(81)90707-7; Goto S, 1998, J CLIN INVEST, V101, P479, DOI 10.1172/JCI973; GRALNICK HR, 1985, J CLIN INVEST, V75, P19; HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421; Hartwig JH, 1996, J BIOL CHEM, V271, P32986, DOI 10.1074/jbc.271.51.32986; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; HENSLER ME, 1992, AM J PATHOL, V141, P707; HEPTINSTALL S, 1992, THROMB HAEMOSTASIS, V68, P727; IKEDA Y, 1993, THROMB HAEMOSTASIS, V69, P496; JACKSON SP, 1994, J BIOL CHEM, V269, P27093; Kovacsovics TJ, 1996, BLOOD, V87, P618, DOI 10.1182/blood.V87.2.618.bloodjournal872618; KROLL MH, 1991, J CLIN INVEST, V88, P1568, DOI 10.1172/JCI115468; KROLL MH, 1993, J BIOL CHEM, V268, P3520; Kuwahara M, 1999, BLOOD, V94, P1149, DOI 10.1182/blood.V94.4.1149.416k18_1149_1155; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Meyer SC, 1997, THROMB HAEMOSTASIS, pSC677; MONTGOMERY RR, 1978, J CLIN INVEST, V61, P1498, DOI 10.1172/JCI109070; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; QUILLIAM AL, 1993, IMMUNOLOGY, V78, P358; RAZDAN K, 1994, BIOCHEM J, V302, P681, DOI 10.1042/bj3020681; REDDICK RL, 1982, P NATL ACAD SCI-BIOL, V79, P5076, DOI 10.1073/pnas.79.16.5076; Ruggeri ZM, 1993, CURR OPIN CELL BIOL, V5, P898, DOI 10.1016/0955-0674(93)90041-N; Ruggeri ZM, 1997, J CLIN INVEST, V99, P559, DOI 10.1172/JCI119195; RUGGERI ZM, 1983, J CLIN INVEST, V72, P1, DOI 10.1172/JCI110946; SAKARIASSEN KS, 1986, BRIT J HAEMATOL, V63, P681, DOI 10.1111/j.1365-2141.1986.tb07552.x; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sullam PM, 1998, J BIOL CHEM, V273, P5331, DOI 10.1074/jbc.273.9.5331; Torti M, 1999, J BIOL CHEM, V274, P13690, DOI 10.1074/jbc.274.19.13690; WEISS HJ, 1986, BLOOD, V67, P322; YABUSAKI K, 1997, THROMB HAEMOSTASIS S, V465; Yuan YP, 1997, J BIOL CHEM, V272, P21847, DOI 10.1074/jbc.272.35.21847	45	97	99	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36241	36251		10.1074/jbc.274.51.36241	http://dx.doi.org/10.1074/jbc.274.51.36241			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593912	hybrid			2022-12-27	WOS:000084279200031
J	Shimano, H; Yahagi, N; Amemiya-Kudo, M; Hasty, AH; Osuga, J; Tamura, Y; Shionoiri, F; Iizuka, Y; Ohashi, K; Harada, K; Gotoda, T; Ishibashi, S; Yamada, N				Shimano, H; Yahagi, N; Amemiya-Kudo, M; Hasty, AH; Osuga, J; Tamura, Y; Shionoiri, F; Iizuka, Y; Ohashi, K; Harada, K; Gotoda, T; Ishibashi, S; Yamada, N			Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; CARBOHYDRATE RESPONSE ELEMENT; UPSTREAM STIMULATORY FACTOR; ACTIVATED RECEPTOR-ALPHA; LEUCINE ZIPPER PROTEIN; PYRUVATE-KINASE GENE; MOLECULAR-CLONING; TRANSGENIC MICE; MESSENGER-RNA; DIFFERENTIATION FACTOR-1	To elucidate the physiological role of sterol regulatory element-binding protein-1 (SREBP-1), the hepatic mRNA levels of genes encoding various lipogenic enzymes were estimated in SREBP-1 gene knockout mice after a fasting-refeeding treatment, which is an established dietary manipulation for the induction of lipogenic enzymes. In the fasted state, the mRNA levels of all lipogenic enzymes were consistently low in both wildtype and SREBP-1(-/-) mice. However, the absence of SREBP-1 severely impaired the marked induction of hepatic mRNAs of fatty acid synthetic genes, such as acetyl-CoA carboxylase, fatty acid synthase, and stearoyl-CoA desaturase, that was observed upon refeeding in the wild-type mice. Furthermore, the refeeding responses of other lipogenic enzymes, glycerol-3-phosphate acyltransferase, ATP citrate lyase, malic enzyme, glucose-6-phosphate dehydrogenase, and S14 mRNAs, were completely abolished in SREBP-1(-/-) mice. In contrast, mRNA levels for cholesterol biosynthetic genes were elevated in the refed SREBP-1(-/-) livers accompanied by an increase in nuclear SREBP-8 protein. When fed a high carbohydrate diet for 14 days, the mRNA levels for these lipogenic enzymes were also strikingly lower in SREBP-1(-/-) mice than those in wild-type mice. These data demonstrate that SREBP-1 plays a crucial role in the induction of lipogenesis but not cholesterol biosynthesis in liver when excess energy by carbohydrates is consumed.	Univ Tokyo, Fac Med, Dept Metab Dis, Tokyo 1138655, Japan	University of Tokyo	Shimano, H (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.		Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019; Yahagi, Naoya/D-2360-2014; Hasty, Alyssa/AAA-2757-2020; Harada, Kenji/J-2230-2016	Shimano, Hitoshi/0000-0002-5562-5572; Yahagi, Naoya/0000-0002-1823-1865; Hasty, Alyssa/0000-0001-7302-8045; 				AMRI EZ, 1995, J BIOL CHEM, V270, P2367, DOI 10.1074/jbc.270.5.2367; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; ELSHOURBAGY NA, 1990, J BIOL CHEM, V265, P1430; Ericsson J, 1996, P NATL ACAD SCI USA, V93, P945, DOI 10.1073/pnas.93.2.945; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; GOODRIDGE AG, 1987, ANNU REV NUTR, V7, P157, DOI 10.1146/annurev.nu.07.070187.001105; GRANNER D, 1990, J BIOL CHEM, V265, P10173; GUAN GM, 1995, J BIOL CHEM, V270, P21958, DOI 10.1074/jbc.270.37.21958; Hasegawa J, 1999, J BIOL CHEM, V274, P1100, DOI 10.1074/jbc.274.2.1100; Heng YM, 1997, BIOCHEM J, V325, P741, DOI 10.1042/bj3250741; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Kaytor EN, 1997, J BIOL CHEM, V272, P7525, DOI 10.1074/jbc.272.11.7525; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581; KROWCZYNSKA AM, 1989, NUCLEIC ACIDS RES, V17, P6408, DOI 10.1093/nar/17.15.6408; LIU ZR, 1993, J BIOL CHEM, V268, P12787; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; MOUSTAID N, 1994, J BIOL CHEM, V269, P5629; NOGUCHI T, 1983, J BIOL CHEM, V258, P5220; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Ren B, 1997, J BIOL CHEM, V272, P26827, DOI 10.1074/jbc.272.43.26827; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; SATO R, 1994, J BIOL CHEM, V269, P17267; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; SHIH HM, 1994, J BIOL CHEM, V269, P9380; SHIH HM, 1992, J BIOL CHEM, V267, P13222; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; SIMON MP, 1983, J BIOL CHEM, V258, P4576; Sommer A, 1998, J BIOL CHEM, V273, P6632, DOI 10.1074/jbc.273.12.6632; SUL HS, 1984, J BIOL CHEM, V259, P555; Tabor DE, 1998, J BIOL CHEM, V273, P22052, DOI 10.1074/jbc.273.34.22052; THOMPSON KS, 1991, J BIOL CHEM, V266, P8679; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; TOWLE HC, 1995, J BIOL CHEM, V270, P23235, DOI 10.1074/jbc.270.40.23235; Vallet VS, 1997, J BIOL CHEM, V272, P21944, DOI 10.1074/jbc.272.35.21944; Vallet VS, 1998, J BIOL CHEM, V273, P20175, DOI 10.1074/jbc.273.32.20175; WANG D, 1995, J BIOL CHEM, V270, P28716, DOI 10.1074/jbc.270.48.28716; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	54	542	556	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35832	35839		10.1074/jbc.274.50.35832	http://dx.doi.org/10.1074/jbc.274.50.35832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585467	hybrid			2022-12-27	WOS:000084187900079
J	Nguyen, BD; Xia, ZC; Cutruzzola, F; Allocatelli, CT; Brunori, R; La Mar, GN				Nguyen, BD; Xia, ZC; Cutruzzola, F; Allocatelli, CT; Brunori, R; La Mar, GN			Solution H-1 NMR study of the influence of distal hydrogen bonding and N terminus acetylation on the active site electronic and molecular structure of Aplysia limacina cyanomet myoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; AMINO-ACID-SEQUENCES; HEME CAVITY; PARAMAGNETIC PROTEIN; ASCARIS HEMOGLOBIN; 2-DIMENSIONAL NMR; CYANIDE COMPLEXES; CRYSTAL-STRUCTURE; MET MYOGLOBIN; AXIAL LIGANDS	The sea hare Aplysia limacina possesses a myoglobin in which a distal H-bond is provided by Arg E10 rather than the common His E7. Solution H-1 NMR studies of the cyanomet complexes of true wild-type (WT), recombinant wild-type (rWT), and the V(E7)H/R(E10)T and V(E7)H mutants of Aplysia Mb designed to mimic the mammalian Rib heme pocket reveal that the distal His in the mutants is rotated out of the heme pocket and is unable to provide a stabilizing H-bond to bound ligand and that WT and rWT differ both in the thermodynamics of heme orientational disorder and in heme contact shift pattern. The mean of the four heme methyl shifts is shown to serve as a sensitive indicator of variations in distal H-bonding among a set of mutant cyanomet globins. The heme pocket perturbations in rWT relative to WT were traced to the absence of the N-terminal acetyl group ill rWT that participates in an H-bond to the EF corner in WT. Analysis of dipolar contacts between heme and axial His and between heme and the protein matrix reveal a small similar to 2 degrees rotation of the axial His in rWT relative to true WT and a similar to 3 degrees rotation of the heme in the double mutant relative to rWT Mb. It is demonstrated that both the direction and magnitude of the rotation of the axial His relative to the heme can be determined from the change in the pattern of the contact-dominated heme methyl shift and from the dipolar-dominated heme meso-H shift. However, only NOE data can determine whether it is the His or heme that actually rotates in the protein matrix.	Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy	University of California System; University of California Davis; Sapienza University Rome	La Mar, GN (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	lamar@indigo.ucdavis.edu	Cutruzzola', Francesca/G-4052-2011	Cutruzzola', Francesca/0000-0002-4621-2135; Brunori, Maurizio/0000-0002-7795-1635	NHLBI NIH HHS [HL 16087] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016087, R01HL016087] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; BAX A, 1982, 2 DIMENSIONAL NUCLEA, P50; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; BOLOGNESI M, 1990, J MOL BIOL, V213, P621, DOI 10.1016/S0022-2836(05)80249-9; BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206; CROSS KJ, 1985, J MAGN RESON, V64, P220, DOI 10.1016/0022-2364(85)90346-4; Cutruzzola F, 1996, BIOCHEM J, V314, P83, DOI 10.1042/bj3140083; DEBAERE I, 1994, P NATL ACAD SCI USA, V91, P1594, DOI 10.1073/pnas.91.4.1594; DICKERSON RE, 1983, HEMOGLOBIN STRUCTURE, P65; EMERSON SD, 1990, BIOCHEMISTRY-US, V29, P1545, DOI 10.1021/bi00458a028; EMERSON SD, 1990, BIOCHEMISTRY-US, V29, P1556, DOI 10.1021/bi00458a029; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; INUBUSHI T, 1983, J MAGN RESON, V51, P128, DOI 10.1016/0022-2364(83)90109-9; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KLOEK AP, 1994, J BIOL CHEM, V269, P2377; Krzywda S, 1998, BIOCHEMISTRY-US, V37, P15896, DOI 10.1021/bi9812470; KURIYAN J, 1986, J MOL BIOL, V192, P133, DOI 10.1016/0022-2836(86)90470-5; La Mar G.N., 2000, PORPHYRIN HDB, V5, P185; LAMAR GN, 1977, BIOCHIM BIOPHYS ACTA, V498, P422, DOI 10.1016/0304-4165(77)90280-X; LECOMTE JTJ, 1987, J AM CHEM SOC, V109, P7219, DOI 10.1021/ja00257a068; Nguyen BD, 1999, J AM CHEM SOC, V121, P208, DOI 10.1021/ja982555o; Nguyen BD, 1998, J BIOL CHEM, V273, P9517, DOI 10.1074/jbc.273.16.9517; PANDE U, 1986, BIOCHEMISTRY-US, V25, P5638, DOI 10.1021/bi00367a044; PEYTON DH, 1989, BIOCHEMISTRY-US, V28, P4880, DOI 10.1021/bi00437a053; PHILLIPS SEV, 1981, NATURE, V292, P81, DOI 10.1038/292081a0; QIN J, 1993, BIOPHYS J, V65, P2178, DOI 10.1016/S0006-3495(93)81270-0; QIN J, 1992, J BIOMOL NMR, V2, P597, DOI 10.1007/BF02192849; QIN J, 1992, J MOL BIOL, V224, P891, DOI 10.1016/0022-2836(92)90456-T; QIN J, 1993, J MOL BIOL, V231, P1009, DOI 10.1006/jmbi.1993.1348; RAJARATHNAM K, 1994, BIOCHEMISTRY-US, V33, P5493, DOI 10.1021/bi00184a018; RAJARATHNAM K, 1993, BIOCHEMISTRY-US, V32, P5670, DOI 10.1021/bi00072a024; Shokhirev NV, 1998, J BIOL INORG CHEM, V3, P581, DOI 10.1007/s007750050271; Shokhirev NV, 1998, J AM CHEM SOC, V120, P981, DOI 10.1021/ja972265s; SHULMAN RG, 1971, J MOL BIOL, V57, P93, DOI 10.1016/0022-2836(71)90121-5; SMERDON SJ, 1995, BIOCHEMISTRY-US, V34, P8715, DOI 10.1021/bi00027a022; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; STEIGEMANN W, 1979, J MOL BIOL, V127, P309, DOI 10.1016/0022-2836(79)90332-2; SUZUKI T, 1986, J BIOL CHEM, V261, P3692; TENTORI L, 1973, INT J PEPT PROT RES, V5, P187; TRAVAGLINI ALLOCATELLI C, 1994, FEBS LETT, V352, P63, DOI 10.1016/0014-5793(94)00918-X; TRAYLOR TG, 1980, J AM CHEM SOC, V102, P2844, DOI 10.1021/ja00528a058; TURNER DL, 1995, EUR J BIOCHEM, V227, P829, DOI 10.1111/j.1432-1033.1995.tb20208.x; VINOGRADOV SN, 1993, COMP BIOCHEM PHYS B, V106, P1, DOI 10.1016/0305-0491(93)90002-M; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wu YY, 1998, BIOCHEMISTRY-US, V37, P6979, DOI 10.1021/bi9728295; Wu YY, 1996, BBA-PROTEIN STRUCT M, V1298, P261, DOI 10.1016/S0167-4838(96)00137-9; WUTHRICH K, 1986, NMR PROTEINS NUCL AC, P131; Yamamoto Y, 1998, ANNU REP NMR SPECTRO, V36, P1, DOI 10.1016/S0066-4103(08)60005-8; YAMAMOTO Y, 1990, FEBS LETT, V264, P113; Yamamoto Y, 1998, BBA-PROTEIN STRUCT M, V1388, P349, DOI 10.1016/S0167-4838(98)00193-9; YAMAMOTO Y, 1992, J MOL BIOL, V228, P343, DOI 10.1016/0022-2836(92)90823-3; Zhang W, 1997, BIOPHYS J, V73, P1019, DOI 10.1016/S0006-3495(97)78135-9; Zhang W, 1996, EUR J BIOCHEM, V237, P841, DOI 10.1111/j.1432-1033.1996.0841p.x; ZHAO XF, 1995, J BIOL CHEM, V270, P20763, DOI 10.1074/jbc.270.35.20763	55	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					742	751		10.1074/jbc.275.2.742	http://dx.doi.org/10.1074/jbc.275.2.742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625603	hybrid			2022-12-27	WOS:000084836600007
J	Celie, PHN; Lenting, PJ; Mertens, K				Celie, PHN; Lenting, PJ; Mertens, K			Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA THROMBOPLASTIN ANTECEDENT; HUMAN FACTOR-VIII; X-RAY STRUCTURE; HEMOPHILIA-B; LIGHT-CHAIN; CHRISTMAS FACTOR; CA2+ BINDING; EGF DOMAIN; IN-VITRO; ACTIVATION	The three-dimensional structure of activated factor IX comprises multiple contacts between the two epidermal growth factor (EGF)-like domains. One of these is a salt bridge between Glu(78) and Arg(94), which is essential for binding of factor Ma to its cofactor factor VIII and for factor VIII-dependent factor X activation (Christophe, O. D., Lenting, P. J., Kolkman, J. A. Brownlee, G. G., and Mertens, K. (1998) J. Biol. Chem. 273, 222-227). We now addressed the putative hydrophobic contact at the interface between the EGF-like domains, Recombinant factor IX chimeras were constructed in which hydrophobic regions Phe(75)-Phe(77) and Lys(106)-Val(108) were replaced by the corresponding sites of factor X and factor VII, Activated factor IX/factor X chimeras were indistinguishable from normal factor Ma with respect to factor Ma enzymatic activity. In contrast, factor IXa(75-77)/factor VII displayed similar to 2-fold increased factor X activation in the presence of factor VIII, suggesting that residues 75-77 contribute to cofactor-dependent factor X activation. Activation of factor X by factor IX106-108/factor VII was strongly decreased, both in the absence and presence of factor VIII. Activity could be restored by simultaneous substitution of the hydrophobic sites in both EGF-like domains for factor VII residues. These data suggest that factor Ma enzymatic activity requires hydrophobic contact between the two EGF-like domains.	CLB, Dept Plasma Prot Technol, NL-1066 CX Amsterdam, Netherlands; Univ Utrecht, UIPS, Dept Pharmaceut, NL-3584 CA Utrecht, Netherlands	Utrecht University	Mertens, K (corresponding author), CLB, Dept Plasma Prot Technol, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.		Lenting, Peter/AAH-5663-2019; Lenting, Peter/F-8269-2013; Celie, Patrick/AAY-9559-2021	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; 				AHMAD SS, 1992, J BIOL CHEM, V267, P8571; AJAJ SP, 1999, THROMB HAEMOSTASIS, V82, P218; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Bode W, 1997, THROMB HAEMOSTASIS, V78, P501; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; Celie PHN, 1999, BRIT J HAEMATOL, V106, P792, DOI 10.1046/j.1365-2141.1999.01590.x; Chang JY, 1997, J CLIN INVEST, V100, P886, DOI 10.1172/JCI119604; Christophe OD, 1998, J BIOL CHEM, V273, P222, DOI 10.1074/jbc.273.1.222; CURTIS JE, 1994, J BIOL CHEM, V269, P6246; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Fay PJ, 1999, THROMB HAEMOSTASIS, V82, P193; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P4508, DOI 10.1021/bi00719a006; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Giannelli F, 1998, NUCLEIC ACIDS RES, V26, P265, DOI 10.1093/nar/26.1.265; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Hopfner KP, 1999, STRUCTURE, V7, P989, DOI 10.1016/S0969-2126(99)80125-7; Kolkman JA, 1999, BIOCHEM J, V339, P217, DOI 10.1042/0264-6021:3390217; Lenting PJ, 1996, J BIOL CHEM, V271, P25332, DOI 10.1074/jbc.271.41.25332; LENTING PJ, 1995, J BIOL CHEM, V270, P14884, DOI 10.1074/jbc.270.25.14884; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; MANN KG, 1990, BLOOD, V76, P1; Mathus A, 1999, J BIOL CHEM, V274, P18477, DOI 10.1074/jbc.274.26.18477; MERTENS K, 1980, BIOCHEM J, V185, P647, DOI 10.1042/bj1850647; MERTENS K, 1985, THROMB HAEMOSTASIS, V54, P654; Mertens K, 1999, THROMB HAEMOSTASIS, V82, P209; MERTENS K, 1993, BRIT J HAEMATOL, V85, P133, DOI 10.1111/j.1365-2141.1993.tb08656.x; NISHIMURA H, 1993, J BIOL CHEM, V268, P24041; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; ROBERTS HR, 1993, THROMB HAEMOSTASIS, V70, P1; STENFLO J, 1991, BLOOD, V78, P1637; Sunnerhagen M, 1996, BIOCHEMISTRY-US, V35, P11547, DOI 10.1021/bi960633j; TAO BY, 1994, PCR TECHNOLOGY CURRE, P71; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433	40	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					229	234		10.1074/jbc.275.1.229	http://dx.doi.org/10.1074/jbc.275.1.229			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617609	hybrid			2022-12-27	WOS:000085951600033
J	Dong, JY; Wiley, HS				Dong, JY; Wiley, HS			Trafficking and proteolytic release of epidermal growth factor receptor ligands are modulated by their membrane-anchoring domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; AMYLOID PRECURSOR PROTEIN; MAMMARY EPITHELIAL-CELLS; CANINE KIDNEY-CELLS; PHORBOL-ESTER; TGF-ALPHA; EGF PRECURSOR; METALLOPROTEASE INHIBITOR; ECTODOMAIN CLEAVAGE; SIGNAL-TRANSDUCTION	Ligands that bind to the epidermal growth factor (EGF) receptor are initially synthesized as integral membrane proteins that are released from the cell surface by regulated proteolysis. To study the role of the membrane-anchoring domain in ligand release, we made two artificial ligands. The first possessed the membrane-anchoring domain from EGF whereas the second had the corresponding domain from heparin binding EGF-like growth factor (HB-EGF). Both ligands lacked amino-terminal extensions, and were epitope-tagged at the carboxyl terminus, Following stable expression in human mammary epithelial cells, their cellular localization and rate of proteolytic release were examined. We found that constructs with the membrane-anchoring domain from EGF were found primarily at the cell surface and displayed a relatively high rate of constitutive release. Constructs with the HB-EGF membrane-anchoring domain displayed a higher internalized fraction and a very low rate of constitutive release, The two ligand constructs also displayed different patterns of stimulated release. Proteolysis of the chimera with the HB-EGF membrane-anchoring domain was stimulated by activation of protein kinase C, but release of EGF from constructs with the EGF membrane-anchoring domain was insensitive to this. Calcium ionophores, calmodulin antagonists, and tyrosine phosphatase inhibitors stimulated the release of both ligands, Furthermore, the release of the two constructs showed different sensitivity to metalloprotease inhibitors. Despite a large fold-increase in ligand proteolysis following cell stimulation, only a small fraction of total cell-associated ligand was released per hour. Our results show that the membrane-anchoring domain of EGF-like ligands can specify both their localization and proteolytic processing. The structures of the membrane-anchoring region of this class of ligands can thus regulate their activity.	Univ Utah, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Wiley, HS (corresponding author), Univ Utah, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84132 USA.			Wiley, Steven/0000-0003-0232-6867	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD028528] Funding Source: NIH RePORTER; NICHD NIH HHS [P01-HD28528] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALMOND BD, 1994, J BIOL CHEM, V269, P26635; Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; BERDICHEVSKY F, 1994, J CELL SCI, V107, P3557; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; BOSENBERG MW, 1992, CELL, V71, P1157, DOI 10.1016/S0092-8674(05)80064-9; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; Briley GP, 1997, MOL BIOL CELL, V8, P1619, DOI 10.1091/mbc.8.8.1619; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Burke PM, 1999, J CELL PHYSIOL, V180, P448, DOI 10.1002/(SICI)1097-4652(199909)180:3<448::AID-JCP16>3.0.CO;2-8; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; DEMPSEY PJ, 1994, J BIOL CHEM, V269, P16878; Dempsey PJ, 1997, J CELL BIOL, V138, P747, DOI 10.1083/jcb.138.4.747; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; EMING SA, 1995, J INVEST DERMATOL, V105, P756, DOI 10.1111/1523-1747.ep12325550; GILL GN, 1984, J BIOL CHEM, V259, P7755; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Hansen LA, 1997, AM J PATHOL, V150, P1959; HARANO T, 1994, J BIOL CHEM, V269, P20305; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; LAKSHMANAN J, 1992, AM J PHYSIOL, V263, pE142, DOI 10.1152/ajpendo.1992.263.1.E142; LANZREIN M, 1995, BIOCHEM J, V310, P285, DOI 10.1042/bj3100285; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Merlos-Suarez A, 1998, J BIOL CHEM, V273, P24955, DOI 10.1074/jbc.273.38.24955; Miyoshi E, 1997, J BIOL CHEM, V272, P14349, DOI 10.1074/jbc.272.22.14349; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; MROCZKOWSKI B, 1993, ENDOCRINOLOGY, V132, P417, DOI 10.1210/en.132.1.417; Nakagawa T, 1996, J BIOL CHEM, V271, P30858, DOI 10.1074/jbc.271.48.30858; Niikura H, 1997, INT J GYNECOL PATHOL, V16, P60, DOI 10.1097/00004347-199701000-00010; NISHIKAWA K, 1987, METHOD ENZYMOL, V146, P11; ONO M, 1994, J BIOL CHEM, V269, P31315; PANDIELLA A, 1991, J BIOL CHEM, V266, P5769; PANDIELLA A, 1991, P NATL ACAD SCI USA, V88, P1726, DOI 10.1073/pnas.88.5.1726; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; RAAB G, 1994, BIOCHEM BIOPH RES CO, V204, P592, DOI 10.1006/bbrc.1994.2500; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; STAMPFER MR, 1993, EXP CELL RES, V208, P175, DOI 10.1006/excr.1993.1236; Suzuki M, 1997, J BIOL CHEM, V272, P31730, DOI 10.1074/jbc.272.50.31730; Tada H, 1999, J CELL BIOCHEM, V72, P423, DOI 10.1002/(SICI)1097-4644(19990301)72:3<423::AID-JCB11>3.3.CO;2-G; Takemura T, 1997, J BIOL CHEM, V272, P31036, DOI 10.1074/jbc.272.49.31036; TOYODA H, 1995, J BIOL CHEM, V270, P7495, DOI 10.1074/jbc.270.13.7495; Tsao MS, 1996, EXP CELL RES, V223, P268, DOI 10.1006/excr.1996.0081; Vecchi M, 1998, J BIOL CHEM, V273, P20589, DOI 10.1074/jbc.273.32.20589; WILEY HS, 1991, J BIOL CHEM, V266, P11083; Wiley HS, 1998, J CELL BIOL, V143, P1317, DOI 10.1083/jcb.143.5.1317; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3	59	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					557	564		10.1074/jbc.275.1.557	http://dx.doi.org/10.1074/jbc.275.1.557			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617651	hybrid			2022-12-27	WOS:000085951600075
J	Genini, D; Budihardjo, I; Plunkett, W; Wang, XD; Carrera, CJ; Cottam, HB; Carson, DA; Leoni, LM				Genini, D; Budihardjo, I; Plunkett, W; Wang, XD; Carrera, CJ; Cottam, HB; Carson, DA; Leoni, LM			Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CELL-FREE-EXTRACTS; CYTOCHROME-C; DNA-POLYMERASES; IN-VITRO; INDUCTION; 2-CHLORODEOXYADENOSINE; DEATH; EXPRESSION; THERAPY	Adenine deoxynucleosides, such as 2-chloradeoxyadenosine (2CdA) and fludarabine, induce apoptosis in quiescent lymphocytes, and are thus useful drugs for the treatment of indolent lymphoproliferative diseases, We previously demonstrated that that the 5'-triphosphate metabolite of 2CdA (2CdATP), similar to dATP, can co-operate with cytochrome c and apoptosis protein-activating factor-1 (APAF-1) to trigger a caspase pathway in a HeLa cell-free system. We used a fluorometry-based assay of caspase activation to extend the analysis to several other clinically relevant adenine deoxynucleotides in B-chronic lymphocytic leukemia extracts. The nucleotide-induced caspase activation displayed typical Michaelis-Menten kinetics. As estimated by the V-max/K-m ratios, the relative efficiencies of different nucleotides were Ara-ATP > 9-fluoro-9-beta-D-arabinofuranosyladenine 5'-triphosphate > dATP > SCdATP > 9-beta-D-arabinofuranosylguanine 5'-triphosphate > dADP > ATP. In contrast to dADP, both ADP and its nonhydrolyzable alpha,beta-methylphosphonate analog were strong inhibitors of APAF-1-dependent caspase activation. The hierarchy of nucleotide activation was confirmed in a fully reconstituted system using recombinant APAF-1 and recombinant procaspase-9. These results suggest that the potency of adenine deoxynucleotides as co-factors for APAF-1-dependent caspase activation is due bath to stimulation by the 5'-triphosphates and lack of inhibition by the 5'-diphosphates, The capacity of adenine deoxynucleoside metabolites to activate the apoptosome pathway may be an additional biochemical mechanism that plays a role in the chemotherapy of indolent lymphoproliferative diseases.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, La Jolla, CA 92093 USA; Univ Texas, SW Med Ctr, Dept Biochem, Howard Hughes Med Inst, Dallas, TX 75235 USA; Univ Texas, MD Anderson Canc Ctr, Dept Clin Invest, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Leoni, LM (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.				NATIONAL CANCER INSTITUTE [P01CA081534, P20CA081534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023200] Funding Source: NIH RePORTER; NCI NIH HHS [CA81534] Funding Source: Medline; NIGMS NIH HHS [GM23200] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAJAJ S, 1983, BLOOD, V62, P75; Carlucci F, 1997, BBA-MOL BASIS DIS, V1360, P203, DOI 10.1016/S0925-4439(96)00077-4; CARSON DA, 1992, P NATL ACAD SCI USA, V89, P2970, DOI 10.1073/pnas.89.7.2970; CARSON DA, 1983, BLOOD, V62, P737; Eguchi Y, 1997, CANCER RES, V57, P1835; Fenaux P, 1996, LANCET, V347, P1432; GANDHI V, 1993, LEUKEMIA LYMPHOMA, V10, P49, DOI 10.3109/10428199309147356; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; HANADA M, 1993, BLOOD, V82, P1820; HENTOSH P, 1990, J BIOL CHEM, V265, P4033; HOARD DE, 1965, J AM CHEM SOC, V87, P1785, DOI 10.1021/ja01086a031; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Juliusson G, 1996, J CLIN ONCOL, V14, P2160, DOI 10.1200/JCO.1996.14.7.2160; Juliusson G, 1996, ANN ONCOL, V7, P373; KAWASAKI H, 1993, BLOOD, V81, P597; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krippner A, 1996, J BIOL CHEM, V271, P21629, DOI 10.1074/jbc.271.35.21629; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; KUSE R, 1985, BLUT, V50, P243, DOI 10.1007/BF00320301; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Leoni LM, 1998, P NATL ACAD SCI USA, V95, P9567, DOI 10.1073/pnas.95.16.9567; LIEBES LF, 1983, CANCER RES, V43, P5608; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Marton A, 1997, EUR J BIOCHEM, V250, P467, DOI 10.1111/j.1432-1033.1997.0467a.x; Meisenholder GW, 1996, J BIOL CHEM, V271, P16260, DOI 10.1074/jbc.271.27.16260; MOFFATT JG, 1964, CAN J CHEM, V42, P599, DOI 10.1139/v64-087; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; OBRIEN S, 1995, BLOOD, V85, P307; PARKER WB, 1988, MOL PHARMACOL, V34, P485; Pepper C, 1997, BRIT J CANCER, V76, P935, DOI 10.1038/bjc.1997.487; Reed JC, 1997, SEMIN HEMATOL, V34, P9; Robertson LE, 1996, LEUKEMIA, V10, P456; ROBERTSON LE, 1993, BLOOD, V81, P143; SETO S, 1985, J CLIN INVEST, V75, P377, DOI 10.1172/JCI111710; SHEWACH DS, 1989, CANCER RES, V49, P6498; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Wang XN, 1997, EXP CELL RES, V235, P210, DOI 10.1006/excr.1997.3667; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	43	137	146	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					29	34		10.1074/jbc.275.1.29	http://dx.doi.org/10.1074/jbc.275.1.29			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617581	hybrid			2022-12-27	WOS:000085951600005
J	Nakamura, K; Liu, XB; Ascoli, M				Nakamura, K; Liu, XB; Ascoli, M			Seven non-contiguous intracellular residues of the lutropin/choriogonadotropin receptor dictate the rate of agonist-induced internalization and its sensitivity to non-visual arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEYDIG TUMOR-CELLS; HUMAN CHORIO-GONADOTROPIN; LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; PROTEIN-COUPLED RECEPTORS; MEDIATED ENDOCYTOSIS; LUTEINIZING-HORMONE; CYTOPLASMIC TAIL; BETA(2)-ADRENERGIC RECEPTOR; INDUCED PHOSPHORYLATION; SIGNAL-TRANSDUCTION	The amino acid sequences of the human (h) and rat (r) lutropin/choriogonadotropin receptors (LHR) are 87% identical, but the rate of agonist-induced internalization of the hLHR is similar to 7 times faster than that of the rLHR, Chimeras of the hLHR and the rLHR showed that this rate is dictated by the serpentine domain and the cytoplasmic tail. Further mutational analysis identified seven residues, two adjacent residues in the second intracellular loop (Val/Gln in the rLHR and Ile/His in the hLHR), four non-contiguous residues in the third intracellular loop (Arg/Gln/Thr/Pro in the rLHR and Lys/Arg/Met/Thr in the hLHR), and one in the C-terminal tail (Leu in the rLHR and Phe in the hLHR), that are necessary and sufficient to impart the slow rate of internalization of the rLHR and the fast rate of internalization of the hLHR. The internalization of the rLHR and the hLHR display different sensitivities to the non-visual arrestins, Therefore, we also tested if the simultaneous exchange of these seven residues resulted in the exchange of this property. Since this was found to be the case, we propose that these seven residues identified here form a non-visual arrestin-binding site.	Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Ascoli, M (corresponding author), Univ Iowa, Dept Pharmacol, 2-319A BSB,51 Newton Rd, Iowa City, IA 52242 USA.				NCI NIH HHS [CA-40629] Funding Source: Medline; NIDDK NIH HHS [DK-25295] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASCOLI M, 1984, J CELL BIOL, V99, P1242, DOI 10.1083/jcb.99.4.1242; ASCOLI M, 1982, J BIOL CHEM, V257, P13306; ASCOLI M, 1987, ENDOCRINOLOGY, V120, P1161, DOI 10.1210/endo-120-3-1161; ASCOLI M, 1978, P NATL ACAD SCI USA, V75, P99, DOI 10.1073/pnas.75.1.99; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dhanwada KR, 1996, MOL ENDOCRINOL, V10, P544, DOI 10.1210/me.10.5.544; ENNS CA, 1983, J CELL BIOL, V97, P579, DOI 10.1083/jcb.97.2.579; Faussner A, 1998, J BIOL CHEM, V273, P2617, DOI 10.1074/jbc.273.5.2617; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Ferguson SSG, 1997, NEWS PHYSIOL SCI, V12, P145; Gabilondo AM, 1997, P NATL ACAD SCI USA, V94, P12285, DOI 10.1073/pnas.94.23.12285; GHINEA N, 1992, J CELL BIOL, V118, P1347, DOI 10.1083/jcb.118.6.1347; GOODMAN J, 1996, NATURE, V383, P447; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; HOELSCHER SR, 1991, ENDOCRINOLOGY, V128, P2837, DOI 10.1210/endo-128-6-2837; HUANG ZM, 1995, J BIOL CHEM, V270, P151, DOI 10.1074/jbc.270.1.151; KAWATE N, 1994, J BIOL CHEM, V269, P30651; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lazari MDM, 1999, MOL ENDOCRINOL, V13, P866, DOI 10.1210/me.13.6.866; Lazari RDM, 1998, J BIOL CHEM, V273, P18316, DOI 10.1074/jbc.273.29.18316; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LLOYD CE, 1983, J CELL BIOL, V96, P521, DOI 10.1083/jcb.96.2.521; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Min KS, 1998, J BIOL CHEM, V273, P34911, DOI 10.1074/jbc.273.52.34911; MINEGISH T, 1990, BIOCHEM BIOPH RES CO, V172, P1049, DOI 10.1016/0006-291X(90)91552-4; Mukherjee S, 1999, J BIOL CHEM, V274, P12984, DOI 10.1074/jbc.274.19.12984; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nakamura K, 1998, MOL ENDOCRINOL, V12, P580, DOI 10.1210/me.12.4.580; Nakamura K, 1999, J BIOL CHEM, V274, P25426, DOI 10.1074/jbc.274.36.25426; Nakamura K, 1999, MOL PHARMACOL, V56, P728; Nakamura K, 1999, MOL ENDOCRINOL, V13, P1295, DOI 10.1210/me.13.8.1295; Nakamura K, 1998, J BIOL CHEM, V273, P24346, DOI 10.1074/jbc.273.38.24346; Orsini MJ, 1998, J BIOL CHEM, V273, P34616, DOI 10.1074/jbc.273.51.34616; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Riezman H, 1997, CELL, V91, P731, DOI 10.1016/S0092-8674(00)80461-4; RODRIGUEZ MC, 1992, MOL ENDOCRINOL, V6, P327, DOI 10.1210/me.6.3.327; SEGALOFF DL, 1981, J BIOL CHEM, V256, P1420; TSENG MJ, 1995, J BIOL CHEM, V270, P18858, DOI 10.1074/jbc.270.32.18858; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; WANG H, 1991, J BIOL CHEM, V266, P780; Wang Z, 1997, MOL ENDOCRINOL, V11, P183, DOI 10.1210/me.11.2.183; Wang Z, 1996, MOL ENDOCRINOL, V10, P748, DOI 10.1210/me.10.6.748; WILEY HS, 1982, J BIOL CHEM, V257, P4222; WILEY HS, 1981, CELL, V25, P433, DOI 10.1016/0092-8674(81)90061-1; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; ZHU HY, 1995, MOL ENDOCRINOL, V9, P141, DOI 10.1210/me.9.2.141	58	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					241	247		10.1074/jbc.275.1.241	http://dx.doi.org/10.1074/jbc.275.1.241			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617611	hybrid			2022-12-27	WOS:000085951600035
J	Poukka, H; Aarnisalo, P; Santti, H; Janne, OA; Palvimo, JJ				Poukka, H; Aarnisalo, P; Santti, H; Janne, OA; Palvimo, JJ			Coregulator small nuclear RING finger protein (SNURF) enhances Sp1-and steroid receptor-mediated transcription by different mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ANDROGEN RECEPTOR; DNA-BINDING DOMAIN; GLUCOCORTICOID RECEPTOR; HORMONE RECEPTORS; ESTROGEN-RECEPTOR; FUNCTIONAL SYNERGY; THYROID-HORMONE; BREAST-CANCER; SP1; COACTIVATOR	The small nuclear RING finger protein SNURF is not only a coactivator in steroid receptor-dependent transcription but also activates transcription from steroid-independent promoters. In this work, we show that SNURF, via the RING finger domain, enhances protein binding to Sp1 elements/GC boxes and interacts and cooperates with Sp1 in transcriptional activation. The activation of androgen receptor (AR) function requires regions other than the RING finger of SNURF, and SNURF does not influence binding of AR to cognate DNA elements. The zinc finger region (ZFR) together with the hinge region of AR are sufficient for contacting SNURF. The nuclear localization signal in the boundary between ZFR and the hinge region participates in the association of AR with SNURF, and a receptor mutant lacking the C-terminal part of the bipartite nuclear localization signal shows attenuated response to coexpressed SNURF. Some AR ZFR point mutations observed in patients with partial androgen insensitivity syndrome or male breast cancer impair the interaction of AR with SNURF and also render AR refractory to the transcription-activating effect of SNURF. Collectively, SNURF modulates the transcriptional activities of androgen receptor and Sp1 via different domains, and it may act as a functional link between steroid- and Sp1-regulated transcription.	Univ Helsinki, Inst Biomed, Dept Physiol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Clin Chem, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Palvimo, JJ (corresponding author), Univ Helsinki, Inst Biomed, Dept Physiol, POB 9,Siltavuorenpenger 20 J, FIN-00014 Helsinki, Finland.	jorma.palvimo@helsinki.fi		Palvimo, Jorma/0000-0003-2373-0578				Aarnisalo P, 1999, ENDOCRINOLOGY, V140, P3097, DOI 10.1210/en.140.7.3097; Aarnisalo P, 1998, P NATL ACAD SCI USA, V95, P2122, DOI 10.1073/pnas.95.5.2122; ALLERA A, 1995, J CLIN ENDOCR METAB, P2697; ALROY I, 1992, NUCLEIC ACIDS RES, V20, P1045, DOI 10.1093/nar/20.5.1045; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Budhram-Mahadeo V, 1998, MOL CELL BIOL, V18, P1029, DOI 10.1128/MCB.18.2.1029; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Ding H, 1999, J BIOL CHEM, V274, P19573, DOI 10.1074/jbc.274.28.19573; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; FREEDMAN LP, 1992, ENDOCR REV, V13, P129, DOI 10.1210/er.13.2.129; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Gottlieb B, 1998, NUCLEIC ACIDS RES, V26, P234, DOI 10.1093/nar/26.1.234; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hiort O, 1996, AM J MED GENET, V63, P218, DOI 10.1002/(SICI)1096-8628(19960503)63:1<218::AID-AJMG38>3.0.CO;2-P; IKONEN T, 1994, ENDOCRINOLOGY, V135, P1359, DOI 10.1210/en.135.4.1359; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; JENSTER G, 1993, BIOCHEM J, V293, P761, DOI 10.1042/bj2930761; KALLIO PJ, 1995, MOL ENDOCRINOL, V9, P1017, DOI 10.1210/me.9.8.1017; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Moilanen A, 1997, FEBS LETT, V412, P355, DOI 10.1016/S0014-5793(97)00791-6; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; Moilanen AM, 1998, MOL CELL BIOL, V18, P5128, DOI 10.1128/MCB.18.9.5128; Moilanen AM, 1998, MOL BIOL CELL, V9, P2527, DOI 10.1091/mbc.9.9.2527; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; PALVIMO JJ, 1993, MOL ENDOCRINOL, V7, P1399, DOI 10.1210/me.7.11.1399; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; Palvimo JJ, 1996, BIOCHEM J, V316, P993, DOI 10.1042/bj3160993; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Poujol N, 1997, MOL CELL ENDOCRINOL, V130, P43, DOI 10.1016/S0303-7207(97)00072-5; Poukka H, 1999, J BIOL CHEM, V274, P19441, DOI 10.1074/jbc.274.27.19441; Powers CA, 1998, MOL ENDOCRINOL, V12, P4, DOI 10.1210/mend.12.1.0043; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prefontaine GG, 1998, MOL CELL BIOL, V18, P3416, DOI 10.1128/MCB.18.6.3416; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Safer JD, 1998, J BIOL CHEM, V273, P30175, DOI 10.1074/jbc.273.46.30175; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Vallian S, 1998, MOL CELL BIOL, V18, P7147, DOI 10.1128/MCB.18.12.7147; Weidemann W, 1998, J CLIN ENDOCR METAB, V83, P1173, DOI 10.1210/jc.83.4.1173; WOOSTER R, 1992, NAT GENET, V2, P132, DOI 10.1038/ng1092-132; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	63	67	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					571	579		10.1074/jbc.275.1.571	http://dx.doi.org/10.1074/jbc.275.1.571			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617653	hybrid			2022-12-27	WOS:000085951600077
J	Webb, Y; Hermida-Matsumoto, L; Resh, MD				Webb, Y; Hermida-Matsumoto, L; Resh, MD			Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSOLUBLE MEMBRANE DOMAINS; ALPHA-SUBUNITS; TYROSINE KINASE; FISH-OIL; BIOCHEMICAL-CHARACTERIZATION; MYRISTOYLATED PROTEINS; N-MYRISTOYLTRANSFERASE; CYSTEINE RESIDUES; S-ACYLATION; ACTIVATION	The ability of the Src family kinases Fyn and Lck to participate in signaling through the T cell receptor is critically dependent on their dual fatty acylation with myristate and palmitate. Here we identify a palmitate analog, 2-bromopalmitate, that effectively blocks Fyn fatty acylation in general and palmitoylation in particular. Treatment of COS-1 cells with 2-bromopalmitate blocked myristoylation and palmitoylation of Fyn and inhibited membrane binding and localization of Fyn to detergent-resistant membranes (DRMs), In Jurkat T cells, 2-bromopalmitate blocked localization of the endogenous palmitoylated proteins Fyn, Lck, and LAT to DRMs. This resulted in impaired signaling through the T cell receptor as evidenced by reductions in tyrosine phosphorylation, calcium release, and activation of mitogen-activated protein kinase. We also examined the ability of long chain polyunsaturated fatty acids (PUFAs) to inhibit protein fatty acylation, PUFAs have been reported to inhibit T cell signaling by excluding Src family kinases from DRMs. Here we show that the PUFAs arachidonic acid and eicosapentaenoic acid inhibit Fyn palmitoylation and consequently block Fyn localization to DRMs, We propose that inhibition of protein palmitoylation represents a novel mechanism by which PUFAs exert their immunosuppressive effects.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10021 USA.			Resh, Marilyn/0000-0001-6118-9466	NATIONAL CANCER INSTITUTE [P01CA029502, P30CA029502, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966] Funding Source: NIH RePORTER; NCI NIH HHS [CA29502, P30-CA08748] Funding Source: Medline; NIGMS NIH HHS [GM57966] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAND L, 1994, J BIOL CHEM, V269, P16701; Arni S, 1998, J BIOL CHEM, V273, P28478, DOI 10.1074/jbc.273.43.28478; Bano MC, 1998, BIOCHEM J, V330, P723, DOI 10.1042/bj3300723; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Cappelli P, 1997, J NEPHROL, V10, P157; CLELAND LG, 1988, J RHEUMATOL, V15, P1171; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; Das AK, 1997, J BIOL CHEM, V272, P11021; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; GORDON JI, 1991, J BIOL CHEM, V266, P8647; HALLAK H, 1994, J BIOL CHEM, V269, P4713; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hepler JR, 1996, J BIOL CHEM, V271, P496, DOI 10.1074/jbc.271.1.496; Ilangumaran S, 1999, MOL BIOL CELL, V10, P891, DOI 10.1091/mbc.10.4.891; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; KREMER JM, 1987, ANN INTERN MED, V106, P497, DOI 10.7326/0003-4819-106-4-497; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LIU YC, 1993, BIOCHEMISTRY-US, V32, P10714, DOI 10.1021/bi00091a023; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MUSTELIN T, 1993, TRENDS BIOCHEM SCI, V18, P215, DOI 10.1016/0968-0004(93)90192-P; PAIGE LA, 1990, BIOCHEMISTRY-US, V29, P10566, DOI 10.1021/bi00498a021; PAIGE LA, 1989, J MED CHEM, V32, P1665, DOI 10.1021/jm00128a001; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; PESECKIS SM, 1993, J BIOL CHEM, V268, P5107; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; RESH MD, 1994, CELL, V76, P422; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Towers TL, 1999, MOL CELL BIOL, V19, P4191; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; van't Hof W, 1999, J CELL BIOL, V145, P377, DOI 10.1083/jcb.145.2.377; VanCott EM, 1997, PROSTAG LEUKOTR ESS, V57, P33, DOI 10.1016/S0952-3278(97)90490-7; VANDERHEIDE JJH, 1993, NEW ENGL J MED, V329, P769, DOI 10.1056/NEJM199309093291105; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZURIER RB, 1993, PROSTAG LEUKOTR ESS, V48, P57, DOI 10.1016/0952-3278(93)90010-T	52	357	369	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					261	270		10.1074/jbc.275.1.261	http://dx.doi.org/10.1074/jbc.275.1.261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617614	hybrid			2022-12-27	WOS:000085951600038
J	Liu, JA; Shriver, Z; Blaiklock, P; Yoshida, K; Sasisekharan, R; Rosenberg, RD				Liu, JA; Shriver, Z; Blaiklock, P; Yoshida, K; Sasisekharan, R; Rosenberg, RD			Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; L-SELECTIN; DEACETYLASE/N-SULFOTRANSFERASE; UNSATURATED DISACCHARIDES; FLAVOBACTERIUM-HEPARINUM; MONOCLONAL-ANTIBODY; ANTITHROMBIN-III; CDNA CLONING; AMINO-GROUPS; EXPRESSION	3-O-Sulfation of glucosamine by heparan sulfate D-glucosaminyl 3-O-sulfotransferase (3-OST-1) is the key modification in anticoagulant heparan sulfate synthesis. However, the heparan sulfates modified by 3-OST-2 and 3-OST-3A, isoforms of 3-OST-1, do not have anticoagulant activity, although these isoforms transfer sulfate to the 3-OH position of glucosamine residues. In this study, we characterize the substrate specificity of purified 3-OST-3A at the tetrasaccharide level. The 3-OST-3A enzyme was purified from Sf9 cells infected with recombinant baculovirus containing 3-OST-3A cDNA. Two S-OST-3A-modified tetrasaccharides were purified from the 3-O-S-35-sulfated heparan sulfate that was digested by heparin lyases. These tetrasaccharides were analyzed using nitrous acid and enzymatic degradation combined with matrix-assisted laser desorption/ionization-mass spectrometry. Two novel tetrasaccharides were discovered with proposed structures of Delta UA2S-G-1cNS-IdoUA2S-[S-35]GlcNH(2)3S and Delta UA2S-GlcNS-IdoUA-2S-[3-S-35]GlcNH(2)3S6S. The results demonstrate that 3-OST-3A sulfates N-unsubstituted glucosamine residues, and the 3-OST-3A modification sites are probably located in defined oligosaccharide sequences. Our study suggests that oligosaccharides with N-unsubstituted glucosamine are precursors for sulfation by 3-OST-3A. The intriguing linkage between N-unsubstituted glucosamine and the 3-O-sulfation by 3-OST-3A may provide a clue to the potential biological functions of 3-OST-3A-modified heparan sulfate.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Div Bioengn & Environm Hlth Sci, Cambridge, MA 02139 USA; Beth Israel Hosp, Mol Med Unit, Boston, MA 02215 USA; Seikagaku Corp, Tokyo Res Inst, Higashiyamato, Tokyo 207, Japan	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Seikagaku Corporation	Rosenberg, RD (corresponding author), MIT, Dept Biol, 68-480,31 Ames St, Cambridge, MA 02139 USA.				NHLBI NIH HHS [5.POL.HL41484] Funding Source: Medline; NIGMS NIH HHS [R01.GM57073] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057073] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; BAME KJ, 1991, J BIOL CHEM, V266, P12461; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; COLLIECJOUAULT S, 1994, J BIOL CHEM, V269, P24953; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; Ernst S, 1998, P NATL ACAD SCI USA, V95, P4182, DOI 10.1073/pnas.95.8.4182; Giuffre L, 1997, J CELL BIOL, V136, P945, DOI 10.1083/jcb.136.4.945; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; Hom LG, 1998, BIOTECHNIQUES, V25, P18, DOI 10.2144/98251bm01; HOOK M, 1982, ANAL BIOCHEM, V119, P236, DOI 10.1016/0003-2697(82)90580-2; JUHASZ P, 1995, CARBOHYD RES, V270, P131, DOI 10.1016/0008-6215(94)00012-5; KARIYA Y, 1992, COMP BIOCHEM PHYS B, V103, P473, DOI 10.1016/0305-0491(92)90323-J; KATO M, 1994, J BIOL CHEM, V269, P18881; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; LINHARDT RJ, 1992, J BIOL CHEM, V267, P2380; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; MCLEAN MW, 1984, EUR J BIOCHEM, V145, P607, DOI 10.1111/j.1432-1033.1984.tb08600.x; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; NORGARDSUMNICHT KE, 1993, SCIENCE, V261, P480, DOI 10.1126/science.7687382; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Rhomberg AJ, 1998, P NATL ACAD SCI USA, V95, P4176, DOI 10.1073/pnas.95.8.4176; ROSENBERG RD, 1979, P NATL ACAD SCI USA, V76, P1218, DOI 10.1073/pnas.76.3.1218; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; SHWORAK NW, 1994, J BIOL CHEM, V269, P24941; TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; Toma L, 1998, J BIOL CHEM, V273, P22458, DOI 10.1074/jbc.273.35.22458; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; YOSHIDA K, 1989, ANAL BIOCHEM, V177, P327, DOI 10.1016/0003-2697(89)90061-4; Zhang LJ, 1999, J BIOL CHEM, V274, P5681, DOI 10.1074/jbc.274.9.5681; Zhang LJ, 1998, J BIOL CHEM, V273, P27998, DOI 10.1074/jbc.273.43.27998	45	87	101	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38155	38162		10.1074/jbc.274.53.38155	http://dx.doi.org/10.1074/jbc.274.53.38155			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608887	hybrid			2022-12-27	WOS:000084528000087
J	Castro, DS; Arvidsson, M; Bolin, MB; Perlmann, T				Castro, DS; Arvidsson, M; Bolin, MB; Perlmann, T			Activity of the Nur1 carboxy-terminal domain depends on cell type and integrity of the activation function 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; LIGAND-BINDING DOMAIN; STEROID-HORMONE RECEPTORS; NUCLEAR RECEPTORS; ACID RECEPTOR; NGFI-B; TRANSCRIPTIONAL ACTIVATION; THYROID-HORMONE; RESPONSE PATHWAYS; CONSERVED REGION	Nurr1, a member of the nuclear hormone receptor superfamily, was recently demonstrated to be of critical importance in the developing central nervous system, where it is required for the generation of midbrain dopamine cells. Nuclear receptors encompass a transcriptional activation function (activation function 2; AF2) within their carboxyl-terminal domains important for ligand-induced transcriptional activation. Since a Nurr1 ligand remains to be identified, the role of the Nurr1 AF2 region in transcriptional activation is unclear. However, here we show that the Nurr1 AF2 contributes to constitutive activation independent of exogenously added ligands in human embryo kidney 293 cells and in neural cell lines. Extensive mutagenesis indicated a crucial role of the AF2 core region for transactivation but also identified unique features differing from previously characterized receptors, In addition, Nurr1 did not appear to interact with, and was not stimulated by, several previously identified coactivators such as the steroid receptor coactivator 1. In contrast, adenovirus protein E1A, stably expressed in 293 cells, was shown to contribute to AF2-dependent activation. Finally, while the AF2 core of RXR is required for ligand-induced transcriptional activation by Nurr1-RXR heterodimers, the functional integrity of Nurr1 AF2 core is not critical. These results establish that the ligand binding domain of Nurr1 has intrinsic capacity for transcriptional activation depending on cell type and mode of DNA binding. Furthermore, these results are consistent with the possibility that gene expression in the central nervous system can be modulated by an as yet unidentified ligand interacting with the ligand binding domain of Nurr1.	Ludwig Inst Canc Res, Stockholm Branch, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Ludwig Institute for Cancer Research; Karolinska Institutet	Perlmann, T (corresponding author), Ludwig Inst Canc Res, Stockholm Branch, Box 240, S-17177 Stockholm, Sweden.		Bondesson, Maria/H-3027-2012; Castro, Diogo S/I-6217-2016	Bondesson, Maria/0000-0001-6358-5788; Castro, Diogo S/0000-0001-8178-9565				BARRETTINO D, 1994, EMBO J, V13, P3039; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BERKENSTAM A, 1992, CELL, V69, P401, DOI 10.1016/0092-8674(92)90443-G; Botling J, 1997, J BIOL CHEM, V272, P9443; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chen JY, 1996, NATURE, V382, P819, DOI 10.1038/382819a0; Collingwood TN, 1997, P NATL ACAD SCI USA, V94, P248, DOI 10.1073/pnas.94.1.248; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; DAVIS IJ, 1993, MOL ENDOCRINOL, V7, P953, DOI 10.1210/me.7.8.953; DURAND B, 1994, EMBO J, V13, P5370, DOI 10.1002/j.1460-2075.1994.tb06872.x; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; FOLKERS GE, 1995, MOL CELL BIOL, V15, P5868; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Gong WR, 1997, MOL ENDOCRINOL, V11, P1476, DOI 10.1210/me.11.10.1476; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Jurutka PW, 1997, J BIOL CHEM, V272, P14592, DOI 10.1074/jbc.272.23.14592; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lala DS, 1996, NATURE, V383, P450, DOI 10.1038/383450a0; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Maruyama K, 1998, INT J ONCOL, V12, P1237; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Minucci S, 1997, MOL CELL BIOL, V17, P644, DOI 10.1128/MCB.17.2.644; Montminy M, 1997, NATURE, V387, P654, DOI 10.1038/42594; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; ONATE SA, 1995, SCIENCE, V270, P1354; PAULSEN RE, 1992, J BIOL CHEM, V267, P16491; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; SCHULMAN IG, 1995, P NATL ACAD SCI USA, V92, P8288, DOI 10.1073/pnas.92.18.8288; Schulman IG, 1998, MOL CELL BIOL, V18, P3483, DOI 10.1128/MCB.18.6.3483; Schulman IG, 1996, MOL CELL BIOL, V16, P3807; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; TONE Y, 1994, J BIOL CHEM, V269, P31157; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Tremblay GB, 1999, MOL CELL BIOL, V19, P1919; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Vivat V, 1997, EMBO J, V16, P5697, DOI 10.1093/emboj/16.18.5697; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Wahlstrom GM, 1999, MOL ENDOCRINOL, V13, P1119, DOI 10.1210/me.13.7.1119; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; WILSON TE, 1991, SCIENCE, V252, P1297; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; YUA C, 1998, P NATL ACAD SCI USA, V95, P7939; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	61	59	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37483	37490		10.1074/jbc.274.52.37483	http://dx.doi.org/10.1074/jbc.274.52.37483			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601324	hybrid			2022-12-27	WOS:000084382700095
J	Engel, ME; McDonnell, MA; Law, BK; Moses, HL				Engel, ME; McDonnell, MA; Law, BK; Moses, HL			Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; BINDING PROTEIN; RECEPTOR; GENE; IDENTIFICATION; PATHWAY; DPC4; TRANSDUCTION; SAPK/JNK; PROMOTER	SMAD and JNK cascades are essential components of the transforming growth factor-beta (TGF-beta) signaling machinery and are implicated in common transcriptional responses. However, the relationship of these pathways to one another downstream of the TGF-beta receptor complex is unknown. We show that JNK is rapidly activated by TGF-beta in a SMAD-independent manner and phosphorylates Smad3 outside its -SSXS motif. Smad3 phosphorylation by JNK facilitates both its activation by the TGF-beta receptor complex and its nuclear accumulation. JNK regulates SMAD- and TGF-beta-mediated transcriptional responses, yet JNK activators only partially stimulate transcriptional responses characteristic of TGF-beta without coincident SMAD pathway activation. These results suggest an interdependent relationship between the JNK and SMAD pathways in TGF-beta-mediated transcription.	Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Moses, HL (corresponding author), Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Sch Med, 649 Med Res Bldg 11, Nashville, TN 37232 USA.	hal.moses@mcmail.vanderbilt.edu	Law, Brian/L-6043-2019		NATIONAL CANCER INSTITUTE [R35CA042572, P01CA048799] Funding Source: NIH RePORTER; NCI NIH HHS [CA42572, CA48799] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKTORIES K, 1992, CURR TOP MICROBIOL, V175, P115; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Atfi A, 1997, J BIOL CHEM, V272, P24731, DOI 10.1074/jbc.272.40.24731; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Brown JD, 1999, J BIOL CHEM, V274, P8797, DOI 10.1074/jbc.274.13.8797; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; DEGROOT RP, 1990, BIOCHEM BIOPH RES CO, V168, P1074, DOI 10.1016/0006-291X(90)91139-J; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Engel ME, 1998, J CELL BIOCHEM, P111; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KEETON MR, 1991, J BIOL CHEM, V266, P23048; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Schutte M, 1996, CANCER RES, V56, P2527; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	34	431	455	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37413	37420		10.1074/jbc.274.52.37413	http://dx.doi.org/10.1074/jbc.274.52.37413			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601313	hybrid			2022-12-27	WOS:000084382700084
J	Krause, E; Schmid, A; Gonzalez, A; Schulz, I				Krause, E; Schmid, A; Gonzalez, A; Schulz, I			Low cytoplasmic [Ca2+] activates I-CRAC independently of global Ca2+ store depletion in RBL-1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; BASOPHILIC LEUKEMIA-CELLS; FLUORESCENT INDICATORS; PROTEIN-KINASE; T-LYMPHOCYTES; RELEASE; INFLUX; INACTIVATION; RETICULUM; ATP	Release of Ca2+ from inositol (1,4,5)-trisphosphate-sensitive Ca2+ stores causes "capacitative calcium entry," which is mediated by the so-called "Ca2+ release-activated Ca2+ current" (I-CRAC) in RBL-1 cells. Refilling of the Ca2+ stores or high cytoplasmic [Ca2+] ([Ca2+](cyt)) inactivate I-CRAC. Here we address the question if also [Ca2+](cyt) lower than the resting [Ca2+](cyt) influences store operated channels. We therefore combined patch clamp and mag fura-2 fluorescence methods to determine simultaneously both I-CRAC and [Ca2+] within Ca2+ stores of RBL-1 cells ([Ca2+](store)). We found that low [Ca2+](cyt) in the range of 30-50 nM activates I-CRAC and Ca2+ influx spontaneously and independently of global Ca2+ store depletion, while elevation of [Ca2+](cyt) to the resting [Ca2+](cyt) (100 nM) resulted in store dependence of I-CRAC activation. We conclude that spontaneous activation of I-CRAC by low [Ca2+](cyt) could serve as a feedback mechanism keeping the resting [Ca2+](cyt) constant.	Univ Saarlandes, Inst Physiol 2, D-66421 Homburg, Germany	Saarland University	Schulz, I (corresponding author), Univ Saarlandes, Inst Physiol 2, D-66421 Homburg, Germany.		Gonzalez, Antonio/C-5428-2018	Gonzalez, Antonio/0000-0001-8380-0270; Krause, Elmar/0000-0003-0891-2373				Barritt GJ, 1998, CELL CALCIUM, V23, P65, DOI 10.1016/S0143-4160(98)90075-6; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Christian EP, 1996, BRIT J PHARMACOL, V119, P647, DOI 10.1111/j.1476-5381.1996.tb15722.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hofer AM, 1996, FASEB J, V10, P302, DOI 10.1096/fasebj.10.2.8641563; Hofer AM, 1996, CELL CALCIUM, V20, P235, DOI 10.1016/S0143-4160(96)90029-9; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huang Y, 1998, J BIOL CHEM, V273, P19554, DOI 10.1074/jbc.273.31.19554; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; Krause E, 1996, J BIOL CHEM, V271, P32523, DOI 10.1074/jbc.271.51.32523; Liu XB, 1998, J BIOL CHEM, V273, P33295, DOI 10.1074/jbc.273.50.33295; Louzao MC, 1996, J BIOL CHEM, V271, P14807, DOI 10.1074/jbc.271.25.14807; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; PAREKH AB, 1995, P NATL ACAD SCI USA, V92, P7907, DOI 10.1073/pnas.92.17.7907; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 1997, CELL, V89, P973, DOI 10.1016/S0092-8674(00)80282-2; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Schofield GG, 1996, J MEMBRANE BIOL, V153, P217, DOI 10.1007/s002329900125; Scott SR, 1998, PFLUG ARCH EUR J PHY, V436, P928, DOI 10.1007/s004240050725; Sims SM, 1997, AM J PHYSIOL-CELL PH, V273, pC1679, DOI 10.1152/ajpcell.1997.273.5.C1679; TOYOFUKU T, 1993, J BIOL CHEM, V268, P2809; WORLEY JF, 1994, J BIOL CHEM, V269, P32055; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	32	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36957	36962		10.1074/jbc.274.52.36957	http://dx.doi.org/10.1074/jbc.274.52.36957			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601250	hybrid			2022-12-27	WOS:000084382700021
J	Barthel, TK; Walker, GC				Barthel, TK; Walker, GC			Inferences concerning the ATPase properties of DnaK and other HSP70s are affected by the ADP kinase activity of copurifying nucleoside-diphosphate kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONE DNAK; ESCHERICHIA-COLI; SUBSTRATE-BINDING; MYXOCOCCUS-XANTHUS; CRYSTAL-STRUCTURE; RNA-POLYMERASE; GRPE; HYDROLYSIS; REPLICATION	Preparations of Escherichia coli DnaK from our lab as well as preparations of DnaK and other HSP70 proteins from several major labs in the field produce a stoichiometric initial burst of [alpha-P-32]ADP when incubated with [alpha-P-32]ATP and contain an ADP kinase activity. We determined that the initial burst activity results from the transfer of gamma-phosphate from the radiolabeled substrate [alpha-P-32]ATP to unlabeled ADP bound by the DnaK and is the same activity that results in ADP phosphorylation. The purification of DnaK from E. coli cells that carry a disrupted ndk gene, ndk::km, results in preparations with greatly reduced ADP kinase activities compared with preparations of DnaK purified from ndk(+) cells. The reduction in the amount of ADP kinase activity in preparations of DnaK purified from ndk::lm cells shows that nucleoside-diphosphate kinase (NDP kinase) is responsible for most of the ADP kinase activity present in DnaK preparations isolated from ndk(+) cells. The remaining ADP kinase activity in preparations hom ndk::km cells, which varies between preparations, is also a property of NDP kinase, which is most likely expressed because of a low frequency reversion of the disrupted ndk gene. A weak, but measurable physical interaction exists between DnaK. and NDP kinase and may be at least partially responsible for the co-purification of NDP kinase with DnaK The presence of contaminating NDP kinase can explain the range of k(cat) values reported for the ATPase activity of DnaK as well as recent reports of initial burst kinetics by DnaK (Banecki, B., and Zylicz, M. (1996) J. Biol. Chem. 271, 6137-6143) and an ADP-ATP exchange activity of DnaK (Hiromura, M., Yano, M., Mori, H., Inoue, M., and Kido, H. (1998) J. Biol. Chem. 273, 5435-5438).	MIT, Dept Biol 68633, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Walker, GC (corresponding author), MIT, Dept Biol 68633, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			/0000-0001-7243-8261	NCI NIH HHS [CA21615] Funding Source: Medline; NIGMS NIH HHS [GM28988] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA021615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028988] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMAULA N, 1995, J BACTERIOL, V177, P2524, DOI 10.1128/jb.177.9.2524-2529.1995; ANG D, 1991, J BIOL CHEM, V266, P24233; Banecki B, 1996, J BIOL CHEM, V271, P6137, DOI 10.1074/jbc.271.11.6137; Beissinger M, 1998, BIOL CHEM, V379, P245; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; BUKAU B, 1993, MOL MICROBIOL, V9, P671, DOI 10.1111/j.1365-2958.1993.tb01727.x; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; BURKHOLDER WF, 1994, J MOL BIOL, V242, P364, DOI 10.1006/jmbi.1994.1587; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; deCrouyChanel A, 1996, J BIOL CHEM, V271, P15486, DOI 10.1074/jbc.271.26.15486; Farr CD, 1998, J BIOL CHEM, V273, P9744, DOI 10.1074/jbc.273.16.9744; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; GAO BC, 1994, BIOCHEMISTRY-US, V33, P2048, DOI 10.1021/bi00174a010; HAMA H, 1991, GENE, V105, P31, DOI 10.1016/0378-1119(91)90510-I; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; HARTL FU, 1994, TRENDS BIOCHEM SCI, V19, P20, DOI 10.1016/0968-0004(94)90169-4; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HOFFMANN HJ, 1992, P NATL ACAD SCI USA, V89, P12108, DOI 10.1073/pnas.89.24.12108; JORDAN R, 1995, J BIOL CHEM, V270, P4563, DOI 10.1074/jbc.270.9.4563; KAVANAUGHBLACK A, 1994, P NATL ACAD SCI USA, V91, P5883, DOI 10.1073/pnas.91.13.5883; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Leung SM, 1997, J BIOL CHEM, V272, P2607, DOI 10.1074/jbc.272.5.2607; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; MCCARTY JS, 1994, J BACTERIOL, V176, P764, DOI 10.1128/jb.176.3.764-780.1994; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; MUNOZDORADO J, 1990, J BIOL CHEM, V265, P2707; Osipiuk J, 1997, BBA-GENE STRUCT EXPR, V1353, P253, DOI 10.1016/S0167-4781(97)00071-7; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; Slepenkov SV, 1998, BIOCHEMISTRY-US, V37, P1015, DOI 10.1021/bi9720484; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; WICKNER S, 1992, P NATL ACAD SCI USA, V89, P10345, DOI 10.1073/pnas.89.21.10345; WICKNER S, 1991, P NATL ACAD SCI USA, V88, P7903, DOI 10.1073/pnas.88.18.7903; WILD J, 1992, P NATL ACAD SCI USA, V89, P7139, DOI 10.1073/pnas.89.15.7139; WILLIAMS RL, 1993, J MOL BIOL, V234, P1230, DOI 10.1006/jmbi.1993.1673; Zaborina O, 1999, MOL MICROBIOL, V31, P1333, DOI 10.1046/j.1365-2958.1999.01240.x; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; ZYLICZ M, 1983, P NATL ACAD SCI-BIOL, V80, P6431, DOI 10.1073/pnas.80.21.6431; [No title captured]	57	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36670	36678		10.1074/jbc.274.51.36670	http://dx.doi.org/10.1074/jbc.274.51.36670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593971	hybrid			2022-12-27	WOS:000084279200090
J	Berman, B; Ostrovsky, O; Shlissel, M; Lang, T; Regan, D; Vlodavsky, I; Ishai-Michaeli, R; Ron, D				Berman, B; Ostrovsky, O; Shlissel, M; Lang, T; Regan, D; Vlodavsky, I; Ishai-Michaeli, R; Ron, D			Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTOR; BINDING SPECIFICITIES; CELL-SURFACE; KGF RECEPTOR; SULFATE; LIGAND; EXPRESSION; MOLECULES; FGF; ACTIVATION	The keratinocyte growth factor (KGF or FGF-7) is unique among its family members both in its target cell specificity and its inhibition by the addition of heparin and the native heparan-sulfate proteoglycan (HSPG), glypican-1 in cells expressing endogenous HSPGs. FGF-1, which binds the FGF-7 receptor with a similar affinity as FGF-7, is stimulated by both molecules. In the present study, we investigated the modulation of FGF-7 activities by heparin and glypican-1 in MS-free background utilizing either HS-deficient cells expressing the FGF-7 receptor (designated BaF/KGFR cells) or soluble extracellular domain of the receptor. At physiological concentrations of FGF-7, heparin was required for high affinity receptor binding and for signaling in BaF/KGFR cells. In contrast, binding of FGF-7 to the soluble form of the receptor did not require heparin, However, high concentrations of heparin inhibited the binding of FGF-7 to both the cell surface and the soluble receptor, similar to the reported effect of heparin in cells expressing endogenous HSPGs. The difference in heparin dependence for high affinity interaction between the cell surface and soluble receptor may be due to other molecule(s) present on cell surfaces, Glypican-1 differed from heparin in that it stimulated FGF-1 but not FGF-7 activities in BaF/KGFR cells. Glypican-1 abrogated the stimulatory effect of heparin, and heparin reversed the inhibitory effect of glypican-1, indicating that this HSPG inhibits FGF-7 activities by acting, most likely, as a competitive inhibitor of stimulatory HSPG species for FGF-7, The regulatory effect of glypican-1 is mediated at the level of interaction with the growth factor as glypican-1 did not bind the KGFR. The effect of heparin and glypican-1 on FGF-I and FGF-7 oligomerization was studied employing high and physiological concentrations of growth factors, We did not find a correlation between the effects of these glycosaminoglycans on FGFs biological activity and oligomerization, Altogether, our findings argue against the heparin-linked dimer presentation model as key in FGFR activation, and support the notion that HSPGs primarily affect high affinity interaction of FGFs with their receptors.	Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; Hadassah Univ Hosp, Dept Oncol, IL-21120 Jerusalem, Israel	Technion Israel Institute of Technology; Hebrew University of Jerusalem	Ron, D (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	DinaR@tx.technion.ac.il						Asaka M, 1997, GASTROENTEROLOGY, V113, pS56, DOI 10.1016/S0016-5085(97)80013-3; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; BonnehBarkay D, 1997, J BIOL CHEM, V272, P12415, DOI 10.1074/jbc.272.19.12415; BOTTARO DP, 1990, J BIOL CHEM, V265, P12767; Brauchle M, 1996, AM J PATHOL, V149, P521; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Gengrinovitch S, 1999, J BIOL CHEM, V274, P10816, DOI 10.1074/jbc.274.16.10816; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Hsu YR, 1999, BIOCHEMISTRY-US, V38, P2523, DOI 10.1021/bi9821317; Jang JH, 1997, IN VITRO CELL DEV-AN, V33, P819; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; LaRochelle WJ, 1999, BIOCHEMISTRY-US, V38, P1765, DOI 10.1021/bi982092z; Lopez-Otin C, 1998, ENDOCR REV, V19, P365, DOI 10.1210/er.19.4.365; MACH H, 1993, BIOCHEMISTRY-US, V32, P5480, DOI 10.1021/bi00071a026; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Moy FJ, 1997, BIOCHEMISTRY-US, V36, P4782, DOI 10.1021/bi9625455; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; PINEDALUCENA A, 1994, EUR J BIOCHEM, V222, P425, DOI 10.1111/j.1432-1033.1994.tb18881.x; Pye DA, 1999, J BIOL CHEM, V274, P13456, DOI 10.1074/jbc.274.19.13456; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; REICHSLOTKY R, 1994, J BIOL CHEM, V269, P32279; REICHSLOTKY R, 1995, J BIOL CHEM, V270, P29813; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; RON D, 1993, J BIOL CHEM, V268, P2984; RON D, 1993, J BIOL CHEM, V268, P5388; Rubin J. S., 1995, V74, P191; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; SHAOUL E, 1995, ONCOGENE, V10, P1553; Sher I, 1999, J BIOL CHEM, V274, P35016, DOI 10.1074/jbc.274.49.35016; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; SPRINGER BA, 1994, J BIOL CHEM, V269, P26879; STRAIN AJ, 1994, EXP CELL RES, V210, P253, DOI 10.1006/excr.1994.1037; Venkataraman G, 1999, P NATL ACAD SCI USA, V96, P1892, DOI 10.1073/pnas.96.5.1892; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; VLODAVSKY I, 1991, ANN NY ACAD SCI, V638, P207; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; WERNER S, 1992, MOL CELL BIOL, V12, P82, DOI 10.1128/MCB.12.1.82; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; YUEN S, 1991, METHOD ENZYMOL, V198, P91	51	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36132	36138		10.1074/jbc.274.51.36132	http://dx.doi.org/10.1074/jbc.274.51.36132			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593896	hybrid			2022-12-27	WOS:000084279200015
J	Hofmann, MW; Honing, S; Rodionov, D; Dobberstein, B; von Figura, K; Bakke, O				Hofmann, MW; Honing, S; Rodionov, D; Dobberstein, B; von Figura, K; Bakke, O			The leucine-based sorting motifs in the cytoplasmic domain of the invariant chain are recognized by the clathrin adaptors AP1 and AP2 and their medium chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II MOLECULES; SURFACE-PLASMON RESONANCE; COATED VESICLES; HLA-DR; INTRACELLULAR-TRANSPORT; RAPID INTERNALIZATION; ENDOCYTIC PATHWAY; SELECTIVE BINDING; MDCK CELLS; IN-VITRO	Recognition of sorting signals within the cytoplasmic tail of membrane proteins by adaptor protein complexes is a crucial step in membrane protein sorting. The three known adaptor complexes, AP1, AP2, and AP3, have all been shown to recognize tyrosine- and leucine-based sorting signals, which are the most common sorting signals within membrane protein cytoplasmic tails, Although tyrosine-based signals are recognized by the mu-chains of adaptor complexes, the subunit recognizing leucine-based sorting signals is less clear. In this report we show by surface plasmon resonance that the two leucine-based sorting signals within the cytoplasmic tail of the invariant chain bind independently from each other to API and AP2 but not to AP3, We also show that both motifs can be recognized by the mu-chains of API and AP2, Moreover, by using monomeric as well as trimeric invariant chain constructs, we show that adaptor binding does not require trimerization of the invariant chain.	Univ Oslo, Dept Biol, N-0316 Oslo, Norway; Univ Gottingen, Inst Biochem 2, D-37073 Gottingen, Germany	University of Oslo; University of Gottingen	Bakke, O (corresponding author), Univ Oslo, Dept Biol, Box 1050 Blindern, N-0316 Oslo, Norway.			Hofmann, Michael Werner/0000-0002-2729-6062; Bakke, Oddmund/0000-0003-4843-7626				BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BOLL W, 1995, CURR BIOL, V5, P1168, DOI 10.1016/S0960-9822(95)00233-8; BREMNES B, 1994, J CELL SCI, V107, P2021; Bremnes T, 1998, J BIOL CHEM, V273, P8638, DOI 10.1074/jbc.273.15.8638; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; GeddeDahl M, 1997, J BIOL CHEM, V272, P8281, DOI 10.1074/jbc.272.13.8281; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Honing S, 1997, J BIOL CHEM, V272, P19884, DOI 10.1074/jbc.272.32.19884; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; LAMB CA, 1992, J IMMUNOL, V148, P3478; LINDNER R, 1994, CELL BIOL LAB HDB, V1, P525; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MANFREDI JJ, 1987, J BIOL CHEM, V262, P12182; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; MOTTA A, 1995, J BIOL CHEM, V270, P27165, DOI 10.1074/jbc.270.45.27165; Nordeng TW, 1998, CURR TOP MICROBIOL, V232, P179; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; PIETERS J, 1993, J CELL SCI, V106, P831; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; ROCHE PA, 1993, P NATL ACAD SCI USA, V90, P8581, DOI 10.1073/pnas.90.18.8581; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; Rodionov DG, 1998, J BIOL CHEM, V273, P6005, DOI 10.1074/jbc.273.11.6005; Salamero J, 1996, J BIOL CHEM, V271, P30318, DOI 10.1074/jbc.271.48.30318; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; Simonsen A, 1997, J CELL SCI, V110, P597; Simonsen A, 1998, EUR J CELL BIOL, V76, P25, DOI 10.1016/S0171-9335(98)80014-9; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Traub LM, 1997, TRENDS CELL BIOL, V7, P43, DOI 10.1016/S0962-8924(96)20042-X; VOGT AB, 1995, J IMMUNOL, V155, P4757; Wang K, 1997, J BIOL CHEM, V272, P17055, DOI 10.1074/jbc.272.27.17055	46	85	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36153	36158		10.1074/jbc.274.51.36153	http://dx.doi.org/10.1074/jbc.274.51.36153			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593899	hybrid			2022-12-27	WOS:000084279200018
J	Hruz, PW; Mueckler, MM				Hruz, PW; Mueckler, MM			Cysteine-scanning mutagenesis of transmembrane segment 7 of the GLUT1 glucose transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOFACIAL LIGAND-BINDING; XENOPUS OOCYTES; MEMBRANE; SITE; EXPRESSION; PROTEINS; TOPOLOGY; RESIDUES; PATHWAY; FAMILY	The human erythrocyte facilitative glucose transporter (Glut1) is predicted to contain 12 transmembrane spanning alpha-helices based upon hydropathy plot analysis of the primary sequence. Five of these helices (3, 5, 7, 8, and 11) are capable of forming amphipathic structures, A model of GLUT1 tertiary structure has therefore been proposed in which the hydrophilic faces of several amphipathic helices are arranged to form a central aqueous channel through which glucose traverses the hydrophobic lipid bilayer. In order to test this model, we individually mutated each of the amino acid residues in transmembrane segment 7 to cysteine in an engineered GLUT1 molecule devoid of all native cysteines (C-less). Measurement of 2-deoxyglucose uptake in a Xenopus oocyte expression system revealed that nearly all of these mutants retain measurable transport activity, Over one-half of the cysteine mutants had significantly reduced specific activity relative to the C-less protein. The solvent accessibility and relative orientation of the residues within the helix was investigated by determining the sensitivity of the mutant transporters to inhibition by the sulfhydryl directed reagent p-chloromercuribenzene sulfonate (pCMBS). Cysteine replacement at six positions (GLn(282), Gln(283), Ile(287), Ala(289), Val(290), and Phe(291)), all near the exofacial side of the cell membrane, produced transporters that were inhibited by incubation with extracellular pCMBS. Residues predicted to be near the cytoplasmic side of the cell membrane were minimally affected by pCMBS. These data demonstrate that the exofacial portion of transmembrane segment 7 is accessible to the external solvent and provide evidence for the positioning of this alpha-helix within the glucose permeation pathway.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mueckler, MM (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	mike@cellbio.wustl.edu	Mueckler, Mike M/F-6115-2012	Hruz, Paul/0000-0002-1478-3355	NIDDK NIH HHS [DK 43695] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043695] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALVAREZ J, 1987, J BIOL CHEM, V262, P3502; BALDWIN SA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P17, DOI 10.1016/0304-4157(93)90015-G; CAIRNS MT, 1987, BIOCHIM BIOPHYS ACTA, V905, P295, DOI 10.1016/0005-2736(87)90458-5; CARRUTHERS A, 1990, PHYSIOL REV, V70, P1135, DOI 10.1152/physrev.1990.70.4.1135; CHIN JJ, 1987, P NATL ACAD SCI USA, V84, P4113, DOI 10.1073/pnas.84.12.4113; DAVIES A, 1990, BIOCHEM J, V266, P799; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; HRESKO RC, 1994, J BIOL CHEM, V269, P32110; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; KELLER K, 1989, J BIOL CHEM, V264, P18884; MORI H, 1994, J BIOL CHEM, V269, P11578; Mueckler M, 1999, J BIOL CHEM, V274, P10923, DOI 10.1074/jbc.274.16.10923; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1994, J BIOL CHEM, V269, P17765; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; Mueckler M, 1997, J BIOL CHEM, V272, P30141, DOI 10.1074/jbc.272.48.30141; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Olsowski A, 1998, BIOCHEMISTRY-US, V37, P10738, DOI 10.1021/bi980440r; WELLNER M, 1994, BIOCHEM J, V299, P813, DOI 10.1042/bj2990813; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Zeng H, 1996, BIOPHYS J, V70, P14, DOI 10.1016/S0006-3495(96)79560-7	25	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36176	36180		10.1074/jbc.274.51.36176	http://dx.doi.org/10.1074/jbc.274.51.36176			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593902	hybrid			2022-12-27	WOS:000084279200021
J	Athenstaedt, K; Daum, G				Athenstaedt, K; Daum, G			1-acyldihydroxyacetone-phosphate reductase (Ayr1p) of the yeast Saccharomyces cerevisiae encoded by the open reading frame YIL124w is a major component of lipid particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROXYACETONE PHOSPHATE ACYLTRANSFERASE; ENDOPLASMIC-RETICULUM; GENE DISRUPTIONS; BIOSYNTHESIS; PROTEINS; PCR; CHROMATOGRAPHY; MEMBRANES; STEROLS	Biosynthesis of phosphatidic acid through the dihydroxyacetone phosphate pathway requires NADPH-dependent reduction of the intermediate 1-acyldihydroxyacetone phosphate before the second step of acylation. Studies with isolated subcellular fractions of the yeast Saccharomyces cerevisiae revealed that lipid particles and the endoplasmic reticulum harbor 1-acyldihydroxyacetone-phosphate reductase (ADR) activity, Deletion of the open reading frame YIL124w (in the following named AYR1) abolished reduction of 1-acyldihydroxyacetone phosphate in lipid particles, whereas ADR activity in microsomes of the deletion strain was decreased approximately 3-fold as compared with the wild-type level, This result indicates that (i) both lipid particles and microsomes harbor Ayr1p, which was confirmed by immunological detection of the protein in these two cellular compartments, and (ii) microsomes contain at least one additional ADR activity. As a consequence of this redundancy, deletion of AYR1 neither results in an obvious growth phenotype nor affects the lipid composition of a haploid deletion strain. When a heterozygous AYR1(+)/layr1(-) diploid strain was subjected to sporulation; however, spores bearing the ary1 defect failed to germinate, suggesting that Ayr1p plays an essential role at this stage. Overexpression of Ayr1p at a 5- to 10-fold level of wild type caused growth arrest. Heterologous expression of Ayr1p in Escherichia coli resulted in gain of ADR activity in the prokaryote, confirming that YIL124w is the structural gene of the enzyme and does not encode a regulatory or auxiliary component required for reduction of 1-acyldihydroxyacetone phosphate. Taken together, these results identified Ayr1p of the yeast as the first ADR from any organism at the molecular level.	Graz Univ Technol, Inst Biochem & Lebensmittelchem, A-8010 Graz, Austria; Biomembrane Res Ctr, Spezialforsch Bereich, A-8010 Graz, Austria	Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem & Lebensmittelchem, Petersgasse 12-2, A-8010 Graz, Austria.	f548daum@mbox.tu-graz.ac.at		Athenstaedt, Karin/0000-0001-7198-3989				Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; BATES EJ, 1979, BIOCHEM J, V182, P751, DOI 10.1042/bj1820751; Bell R. M., 1983, ENZYMES; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; Broekhuyse R. M., 1968, BIOCHIM BIOPHYS ACTA, V260, P449; CHRISTIANSEN K, 1978, BIOCHIM BIOPHYS ACTA, V530, P78, DOI 10.1016/0005-2760(78)90128-5; DATTA SC, 1990, J BIOL CHEM, V265, P8268; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAIGG B, 1995, BBA-BIOMEMBRANES, V1234, P214, DOI 10.1016/0005-2736(94)00287-Y; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; HAID A, 1983, METHOD ENZYMOL, V96, P192; Hajra AK, 1997, BBA-LIPID LIPID MET, V1348, P27, DOI 10.1016/S0005-2760(97)00120-3; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; JIMENEZ A, 1980, NATURE, V287, P869, DOI 10.1038/287869a0; JOHNSTON JM, 1970, BIOCHIM BIOPHYS ACTA, V218, P124, DOI 10.1016/0005-2760(70)90099-8; JONES CL, 1980, J BIOL CHEM, V255, P8289; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; LEWIS TA, 1987, BIOCHIM BIOPHYS ACTA, V921, P205, DOI 10.1016/0005-2760(87)90020-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; Martonosi, 1985, ENZYMES BIOL MEMBR, V2, P1; MORRISON WR, 1964, J LIPID RES, V5, P600; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; PATTERSON GW, 1971, ANAL CHEM, V43, P1165, DOI 10.1021/ac60304a015; RACENIS PV, 1992, J BACTERIOL, V174, P5702, DOI 10.1128/JB.174.17.5702-5710.1992; SCHLOSSMAN DM, 1978, J BACTERIOL, V133, P1368, DOI 10.1128/JB.133.3.1368-1376.1978; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; VANDENBOSCH H, 1974, ANNU REV BIOCHEM, V43, P243; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; XU SH, 1988, J CHROMATOGR, V452, P377, DOI 10.1016/S0021-9673(01)81462-X; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; [No title captured]	43	66	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					235	240		10.1074/jbc.275.1.235	http://dx.doi.org/10.1074/jbc.275.1.235			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617610	hybrid			2022-12-27	WOS:000085951600034
J	Kelner, GS; Lee, MH; Clark, ME; Maciejewski, D; McGrath, D; Rabizadeh, S; Lyons, T; Bredesen, D; Jenner, P; Maki, RA				Kelner, GS; Lee, MH; Clark, ME; Maciejewski, D; McGrath, D; Rabizadeh, S; Lyons, T; Bredesen, D; Jenner, P; Maki, RA			The copper transport protein Atox1 promotes neuronal survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; NEURAL CELLS; ATX1 GENE; HOMEOSTASIS; EXPRESSION; MUTATIONS; DISEASE; ENCODES; YEAST	Atox1, a copper transport protein, was recently identified as a copper dependent suppressor of oxidative damage in yeast lacking superoxide dismutase. We have previously reported that Atox1 in the rat brain is primarily expressed in neurons, with the highest levels in distinct neuronal subtypes that are characterized by their high levels of metal, like copper, iron, and zinc. In this report, we have transfected the Atox1 gene into several neuronal cell lines to increase the endogenous level of Atox1 expression and have demonstrated that, under conditions of serum starvation and oxidative injury, the transfected neurons are significantly protected against this stress. This level of protection is comparable with the level of protection seen with copper/zinc superoxide dismutase and the anti-apoptotic gene bcl-2 that had been similarly transfected. Furthermore, neuronal cell lines transfected with a mutant Atox1 gene, where the copper binding domain has been modified to prevent metal binding, do not afford protection against serum starvation resulting in apoptosis. Therefore, Atox1 is a component of the cellular pathways used for protection against oxidative stress.	Neurocrine Biosci, Dept Mol Biol, San Diego, CA 92121 USA; Kings Coll London, London SW3 6LX, England; Burnham Inst, La Jolla, CA 92037 USA; Buck Ctr Res Aging, Novato, CA 94948 USA	Neurocrine Biosciences; University of London; King's College London; Sanford Burnham Prebys Medical Discovery Institute; Buck Institute for Research on Aging	Maki, RA (corresponding author), Neurocrine Biosci, Dept Mol Biol, 10555 Sci Ctr Dr, San Diego, CA 92121 USA.	rmaki@neurocrine.com	Jenner, Peter G/M-3288-2013					BIEDLER JL, 1973, CANCER RES, V33, P2643; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Compston A., 1912, BRAIN, V34, P295, DOI DOI 10.1093/BRAIN/34.4.295; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; deSilva D, 1997, J BIOL CHEM, V272, P14208, DOI 10.1074/jbc.272.22.14208; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; FUJII T, 1995, BIOL PHARM BULL, V18, P1446; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Klomp LWJ, 1997, J BIOL CHEM, V272, P9221, DOI 10.1074/jbc.272.14.9221; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; Lin SJ, 1997, J BIOL CHEM, V272, P9215; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MISRA TK, 1985, GENE, V34, P253, DOI 10.1016/0378-1119(85)90134-9; Naeve GS, 1999, NEUROSCIENCE, V93, P1179, DOI 10.1016/S0306-4522(99)00175-X; Pike CJ, 1997, J NEUROCHEM, V69, P1601; Portnoy ME, 1999, J BIOL CHEM, V274, P15041, DOI 10.1074/jbc.274.21.15041; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; SAHLMAN L, 1993, BIOCHEM BIOPH RES CO, V196, P583, DOI 10.1006/bbrc.1993.2289; WOLF BA, 1995, J BIOL CHEM, V270, P4916, DOI 10.1074/jbc.270.9.4916; ZHONG LT, 1993, P NATL ACAD SCI USA, V90, P4533, DOI 10.1073/pnas.90.10.4533	24	61	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					580	584		10.1074/jbc.275.1.580	http://dx.doi.org/10.1074/jbc.275.1.580			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617654	hybrid			2022-12-27	WOS:000085951600078
J	Tjoelker, LW; Gosting, L; Frey, S; Hunter, CL; Le Trong, H; Steiner, B; Brammer, H; Gray, PM				Tjoelker, LW; Gosting, L; Frey, S; Hunter, CL; Le Trong, H; Steiner, B; Brammer, H; Gray, PM			Structural and functional definition of the human chitinase chitin-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST-CELL WALL; SACCHAROMYCES-CEREVISIAE; PROTEIN FAMILY; CHITOTRIOSIDASE; IDENTIFICATION; SEQUENCE; MEMBER; GENE; MACROPHAGES; BACTERIUM	Mammalian chitinase, a chitinolytic enzyme expressed by macrophages, has been detected in atherosclerotic plaques and is elevated in blood and tissues of guinea pigs infected with Aspergillus, Its normal physiological function is unknown, To understand how the enzyme interacts with its substrate, we have characterized the chitin-binding domain, The C-terminal 49 amino acids make up the minimal sequence required for chitin binding activity, The absence of this domain does not affect the ability of the enzyme to hydrolyze the soluble substrate, triacetylchitotriose, but abolishes hydrolysis of insoluble chitin, Within the minimal chitin-binding domain are six cysteines; mutation of any one of these to serine results in complete loss of chitin binding activity. Analysis of purified recombinant chitin-binding domain revealed the presence of three disulfide linkages. The recombinant domain binds specifically to chitin but does not bind chitosan, cellulose, xylan, beta-1,3-glucan, beta-1,3-1,4-glucan, or mannan, Fluorescently tagged chitin-binding domain was used to demonstrate chitin-specific binding to Saccharomyces cerevisiae, Candida albicans, Mucor rouxii, and Neurospora crassa, These experiments define structural features of the minimal domain of human chitinase required for both specifically binding to and hydrolyzing insoluble chitin and demonstrate relevant binding within the context of the fungal cell wall.	ICOS Corp, Bothell, WA 98021 USA; Gryphon Sci, S San Francisco, CA 94080 USA	Icos Corporation	Tjoelker, LW (corresponding author), ICOS Corp, 22021 20th Ave SE, Bothell, WA 98021 USA.							BARTNICKIGARCIA S, 1962, BIOCHIM BIOPHYS ACTA, V58, P102, DOI 10.1016/0006-3002(62)90822-3; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642; BROEKAERT WF, 1989, SCIENCE, V245, P1100, DOI 10.1126/science.245.4922.1100; Cabib E, 1997, BIOCHEM SOC T, V25, P200, DOI 10.1042/bst0250200; Chantry D, 1998, J LEUKOCYTE BIOL, V64, P49, DOI 10.1002/jlb.64.1.49; DENTANDT WR, 1988, INT J BIOCHEM, V20, P7413; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Garcia-Casado G, 1998, GLYCOBIOLOGY, V8, P1021, DOI 10.1093/glycob/8.10.1021; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Harlow E., 1988, ANTIBODIES LAB MANUA; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; JOHANSEN JS, 1995, EUR J CANCER, V31A, P1437, DOI 10.1016/0959-8049(95)00196-P; KITAMURA K, 1982, AGR BIOL CHEM TOKYO, V46, P2093, DOI 10.1080/00021369.1982.10865384; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; MALETTE B, 1995, MOL REPROD DEV, V41, P384, DOI 10.1002/mrd.1080410315; MAUCH F, 1988, PLANT PHYSIOL, V88, P936, DOI 10.1104/pp.88.3.936; MORRISON BW, 1994, ONCOGENE, V9, P3417; OVERDIJK B, 1994, GLYCOBIOLOGY, V4, P797, DOI 10.1093/glycob/4.6.797; Overdijk B, 1996, GLYCOBIOLOGY, V6, P627, DOI 10.1093/glycob/6.6.627; Overdijk B, 1999, MICROBIOL-UK, V145, P259, DOI 10.1099/13500872-145-1-259; REJMAN JJ, 1988, BIOCHEM BIOPH RES CO, V150, P329, DOI 10.1016/0006-291X(88)90524-4; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; SCHNELLMANN J, 1994, MOL MICROBIOL, V13, P807, DOI 10.1111/j.1365-2958.1994.tb00473.x; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SELITRENNIKOFF CP, 1999, EMERGING THERAPEUTIC, V3, P53; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Shen ZC, 1999, J MOL EVOL, V48, P341, DOI 10.1007/PL00006478; SLEEP D, 1991, BIO-TECHNOL, V9, P183, DOI 10.1038/nbt0291-183; SVENSSON B, 1989, BIOCHEM J, V264, P309, DOI 10.1042/bj2640309; Tsujibo H, 1998, APPL ENVIRON MICROB, V64, P472; VazquezTorres A, 1997, MICROBIOL MOL BIOL R, V61, P170; VRSANSKA M, 1977, Z ALLG MIKROBIOL, V17, P465, DOI 10.1002/jobm.3630170608; Yamagami T, 1996, BIOSCI BIOTECH BIOCH, V60, P1081, DOI 10.1271/bbb.60.1081	39	103	111	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					514	520		10.1074/jbc.275.1.514	http://dx.doi.org/10.1074/jbc.275.1.514			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617646	hybrid			2022-12-27	WOS:000085951600070
J	Yanai, K; Saito, T; Kakinuma, Y; Kon, Y; Hirota, K; Taniguchi-Yanai, K; Nishijo, N; Shigematsu, Y; Horiguchi, H; Kasuya, Y; Sugiyama, F; Yagami, K; Murakami, K; Fukamizu, A				Yanai, K; Saito, T; Kakinuma, Y; Kon, Y; Hirota, K; Taniguchi-Yanai, K; Nishijo, N; Shigematsu, Y; Horiguchi, H; Kasuya, Y; Sugiyama, F; Yagami, K; Murakami, K; Fukamizu, A			Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN SYSTEM; MACULA DENSA; PRESSURE; GENE	Renin plays a key role in controlling blood pressure through its specific cleavage of angiotensinogen to generate angiotensin I (AI), Although possible existence of the other angiotensin forming enzymes has been discussed to date, its in vivo function remains to be elucidated. To address the contribution of renin, we generated renin knockout mice. Homozygous mutant mice show neither detectable levels of plasma renin activity nor plasma AI, lowered blood pressure 20-30 mm Hg less than normal, increased urine and drinking volume, and altered renal morphology as those observed in angiotensinogen-deficient mice. We recently found the decreased density in granular layer cells of hippocampus and the impaired blood-brain barrier function in angiotensinogen-deficient mice. Surprisingly, however, such brain phenotypes were not observed in renin-deficient mice. Our results demonstrate an indispensable role for renin in the circulating angiotensin generation and in the maintenance of blood pressure, but suggest a dispensable role for renin in the blood-brain barrier function.	Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Lab Anim Res Ctr, Tsukuba, Ibaraki 3058577, Japan; Hokkaido Univ, Grad Sch Vet Med, Lab Expt Anim Sci, Sapporo, Hokkaido 0600818, Japan; Ibaraki Prefectural Univ Hlth Sci, Mol Pathol Ctr, Ibaraki, Osaka 3000331, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; Hokkaido University	Fukamizu, A (corresponding author), Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan.		Kon, Yasuhiro/F-8525-2012; fukamizu, akiyoshi/J-5350-2012	fukamizu, akiyoshi/0000-0002-8786-6020; Kasuya, Yoshitoshi/0000-0003-0614-5836; Kakinuma, Yoshihiko/0000-0001-5470-9128				BOUCHER R, 1977, CIRC RES, V41, P26, DOI 10.1161/01.RES.41.4.26; BUNNEMANN B, 1993, REGUL PEPTIDES, V46, P487, DOI 10.1016/0167-0115(93)90251-3; Clark AF, 1997, J BIOL CHEM, V272, P18185, DOI 10.1074/jbc.272.29.18185; FUKAMIZU A, 1993, J BIOL CHEM, V268, P11617; FUKAMIZU A, 1995, TRENDS ENDOCRIN MET, V6, P279, DOI 10.1016/1043-2760(95)00156-5; HACKENTHAL E, 1978, BIOCHIM BIOPHYS ACTA, V522, P574, DOI 10.1016/0005-2744(78)90089-X; INAGAMI T, 1985, ASPARTIC PROTEINASES, P319; Kakinuma Y, 1998, NAT MED, V4, P1078, DOI 10.1038/2070; Kakinuma Y, 1997, NEUROSCI LETT, V232, P167, DOI 10.1016/S0304-3940(97)00605-8; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; MOFFETT RB, 1987, LIFE SCI, V41, P1867; Nagata M, 1996, LAB INVEST, V75, P745; NIIMURA F, 1995, J CLIN INVEST, V96, P2945; PHILLIPS MI, 1993, REGUL PEPTIDES, V43, P1; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Sharp MGF, 1996, HYPERTENSION, V28, P1126, DOI 10.1161/01.HYP.28.6.1126; SKOTT O, 1987, SCIENCE, V237, P1618, DOI 10.1126/science.3306925; Taniguchi K, 1998, INT J MOL MED, V1, P583; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; TONNESEN MG, 1982, J CLIN INVEST, V69, P25, DOI 10.1172/JCI110437; WRIGHT JW, 1992, BRAIN RES REV, V17, P227, DOI 10.1016/0165-0173(92)90018-H; Wrobel KH, 1997, ACTA ANAT, V160, P1; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458	24	114	117	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					5	8		10.1074/jbc.275.1.5	http://dx.doi.org/10.1074/jbc.275.1.5			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617578	hybrid			2022-12-27	WOS:000085951600002
J	Chow, CW; Khurana, S; Woodside, M; Grinstein, S; Orlowski, J				Chow, CW; Khurana, S; Woodside, M; Grinstein, S; Orlowski, J			The epithelial Na+/H+ exchanger, NHE3, is internalized through a clathrin-mediated pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLECTING DUCT CELLS; THICK ASCENDING LIMB; COATED PIT FORMATION; RAT NA/H EXCHANGER; PLASMA-MEMBRANE; BRUSH-BORDER; EPSILON-COP; RECYCLING ENDOSOMES; TRANSPORT VESICLES; MAMMALIAN-CELLS	Trafficking of the Na+/H+ exchanger isoform 3 (NHE3) between sub-apical vesicles and apical membrane of epithelial cells is a suggested mechanism of regulation of NHE3 activity. When epitope-tagged NHE3 was stably expressed in NHE-deficient Chinese hamster ovary cells, a sizable fraction was found in recycling endosomes. This system was used to analyze the mechanism of endocytosis of NHE3. Immunofluorescence and radiolabeling experiments showed that inhibition of clathrin-mediated endocytosis using hypertonicity, acid treatment, or K+ depletion inhibited internalization of NHE3. Moreover, transient transfection of an inhibitory mutant of dynamin (DynS45N) blocked the clathrin-mediated uptake of transferrin, as well as the endocytosis of NHE3. In ileal villus cells, endogenous NHE3 was also found to co-purify with isolated clathrin-coated vesicles, thereby confirming their association in native tissues. The role of COP-I subunits in the intracellular traffic of NHE3 was evaluated using ldlF cells, which bear a temperature-sensitive mutation in the epsilon-COP subunit. At the permissive temperature, NHE3 distributed normally, whereas at the restrictive temperature, which induces rapid degradation of epsilon-COP, NHE3 was still internalized, but its subcellular distribution was altered. These results indicate that endocytosis of NHE3 occurs primarily via clathrin-coated pits and vesicles and that normal intracellular trafficking of NHE3 involves an epsilon-COP-dependent step.	McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; Hosp Sick Children, Res Inst, Div Cell Biol, Toronto, ON M5G 1X8, Canada; Johns Hopkins Univ, Sch Med, Div Gastroenterol, Baltimore, MD 21205 USA; Univ Toronto, Dept Med, Div Resp Med, Toronto, ON M5S 1A8, Canada; Johns Hopkins Univ, Sch Med, Div Gastroenterol, Baltimore, MD 21205 USA; Hosp Sick Children, Res Inst, Div Cell Biol, Toronto, ON M5G 1X8, Canada	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University; University of Toronto; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, McIntyre Med Sci Bldg,3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	orlowski@med.mcgill.ca	Chow, Chung-Wai/AAP-5533-2020	Chow, Chung-Wai/0000-0001-9344-8522; Khurana, Seema/0000-0002-6884-810X; Orlowski, John/0000-0001-7371-175X				Ambuhl PM, 1996, AM J PHYSIOL-RENAL, V271, pF917, DOI 10.1152/ajprenal.1996.271.4.F917; AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; AMEMIYA M, 1995, AM J PHYSIOL-CELL PH, V269, pC126, DOI 10.1152/ajpcell.1995.269.1.C126; Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; BLOCH DR, 1993, CONTRIB NEPHROL, V101, P19; BOOKSTEIN C, 1994, J CLIN INVEST, V93, P106, DOI 10.1172/JCI116933; BRANT SR, 1995, AM J PHYSIOL-CELL PH, V269, pC198, DOI 10.1152/ajpcell.1995.269.1.C198; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028; CHAKRABARTI R, 1994, J BIOL CHEM, V269, P7926; Chow CW, 1997, J GEN PHYSIOL, V110, P185, DOI 10.1085/jgp.110.2.185; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Damke H, 1996, FEBS LETT, V389, P48, DOI 10.1016/0014-5793(96)00517-0; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; DAVOUST J, 1987, EMBO J, V6, P3601, DOI 10.1002/j.1460-2075.1987.tb02691.x; Dunbar LA, 1998, ACTA PHYSIOL SCAND, V163, P289; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Guerra L, 1998, KIDNEY INT, V53, P1269, DOI 10.1046/j.1523-1755.1998.00897.x; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HANSEN SH, 1993, J CELL BIOL, V123, P89, DOI 10.1083/jcb.123.1.89; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HENSLEY CB, 1989, AM J PHYSIOL, V257, pC637, DOI 10.1152/ajpcell.1989.257.4.C637; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HILDEN SA, 1990, AM J PHYSIOL, V258, pF1311; HOBBIE L, 1994, J BIOL CHEM, V269, P20958; Janecki AJ, 1998, J BIOL CHEM, V273, P8790, DOI 10.1074/jbc.273.15.8790; Khurana S, 1996, BIOCHEM J, V313, P509, DOI 10.1042/bj3130509; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Kurzchalia TV, 1996, FEBS LETT, V389, P52, DOI 10.1016/0014-5793(96)00585-6; Laghmani K, 1997, J CLIN INVEST, V99, P24, DOI 10.1172/JCI119128; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; LINDNER R, 1994, CELL BIOL LAB HDB, P525; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Noel J, 1996, J CELL SCI, V109, P929; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; PEARSE BMF, 1989, METHOD CELL BIOL, V31, P229; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SABOLIC I, 1990, AM J PHYSIOL, V258, pF1245, DOI 10.1152/ajprenal.1990.258.5.F1245; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; SOLEIMANI M, 1994, J BIOL CHEM, V269, P27973; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; VANDYKE RW, 1995, AM J PHYSIOL-CELL PH, V269, pC943, DOI 10.1152/ajpcell.1995.269.4.C943; Volchuk A, 1998, J BIOL CHEM, V273, P8169, DOI 10.1074/jbc.273.14.8169; WANG Z, 1993, J BIOL CHEM, V268, P11925; WEISER MM, 1973, J BIOL CHEM, V248, P2536; WHITNEY JA, 1995, CELL, V83, P703; Wormmeester L, 1998, AM J PHYSIOL-CELL PH, V274, pC1261, DOI 10.1152/ajpcell.1998.274.5.C1261; Yoshioka S, 1997, J BIOCHEM-TOKYO, V122, P641; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; Zhang YB, 1996, AM J PHYSIOL-RENAL, V270, pF1004, DOI 10.1152/ajprenal.1996.270.6.F1004; Zhang YB, 1999, AM J PHYSIOL-RENAL, V276, pF711, DOI 10.1152/ajprenal.1999.276.5.F711	67	90	90	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37551	37558		10.1074/jbc.274.53.37551	http://dx.doi.org/10.1074/jbc.274.53.37551			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608808	hybrid			2022-12-27	WOS:000084528000008
J	Balendran, A; Currie, R; Armstrong, CG; Avruch, J; Alessi, DR				Balendran, A; Currie, R; Armstrong, CG; Avruch, J; Alessi, DR			Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 56 kinase in vivo at Thr-412 as well as Thr-252	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S6 KINASE; PHOSPHOINOSITIDE 3-KINASE; MAPKAP KINASE-1; B-ALPHA; IN-VIVO; ACTIVATION; MECHANISM; P70(S6K); INSULIN; PDK1	Protein kinase B and p70 S6 kinase are members of the cyclic AMP-dependent/cyclic GMP-dependent/protein kinase C subfamily of protein kinases and are activated by a phosphatidylinositol 3-kinase-dependent pathway when cells are stimulated with insulin or growth factors. Both of these kinases are activated in cells by phosphorylation of a conserved residue in the kinase domain (Thr-308 of protein kinase B (PKB) and Thr-252 of p70 S6 kinase) and another conserved residue located C-terminal to the kinase domain (Ser-473 of PKB and Thr-412 of p70 S6 kinase). Thr-308 of PKB alpha and Thr-252 of p70 S6 kinase are phosphorylated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) in vitro. Recent work has shown that PDK1 interacts with a region of protein kinase C-related kinase-2, termed the PDK1 interacting fragment (PIF). Interaction with PIF converts PDK1 from a form that phosphorylates PKB at Thr-308 alone to a species capable of phosphorylating Ser-473 as well as Thr-308. This suggests that PDK1 may be the enzyme that phosphorylates both residues in vivo. Here we demonstrate that PDK1 is capable of phosphorylating p70 S6 kinase at Thr-412 in vitro. We study the effect of PIF on the ability of PDK1 to phosphorylate p70 S6 kinase. Surprisingly, we find that PDK1 bound to PIF is no longer able to interact with or phosphorylate p70 S6 kinase in vitro at either Thr-252 or Thr-412, The expression of PIF in cells prevents insulin-like growth factor 1 from inducing the activation of the p70 S6 kinase and its phosphorylation at Thr-412, Overexpression of PDK1 in cells induces the phosphorylation of p70 S6 kinase at Thr-412 in unstimulated cells, and a catalytically inactive mutant of PDK1 prevents the phosphorylation of p70 S6K at Thr-412 in insulin-like growth factor 1-stimulated cells. These observations indicate that PDK1 regulates the activation of p70 S6 kinase and provides evidence that PDK1 mediates the phosphorylation of p70 S6 kinase at Thr-412.	Univ Dundee, Dept Biochem, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; Univ Dundee, Dept Biochem, Div Signal Transduct Therapy Unit, Dundee DD1 5EH, Scotland; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Diabet Unit, Boston, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Med Serv, Boston, MA 02129 USA	University of Dundee; University of Dundee; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Alessi, DR (corresponding author), Univ Dundee, Dept Biochem, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland.		Currie, Richard/N-6074-2017	Currie, Richard/0000-0002-6528-3326; Alessi, Dario/0000-0002-2140-9185				AKIMOTO K, 1998, BIOCHEM J, V273, P16621; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Hara K, 1998, J BIOL CHEM, V273, P22160; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; PEARSON RB, 1995, EMBO J, V14, P5278; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Proud CG, 1996, TRENDS BIOCHEM SCI, V21, P181, DOI 10.1016/0968-0004(96)10016-5; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Ziegler WH, 1999, CURR BIOL, V9, P522, DOI 10.1016/S0960-9822(99)80236-X	37	116	116	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37400	37406		10.1074/jbc.274.52.37400	http://dx.doi.org/10.1074/jbc.274.52.37400			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601311	hybrid			2022-12-27	WOS:000084382700082
J	Fischer, AE; Beuning, PJ; Musier-Forsyth, K				Fischer, AE; Beuning, PJ; Musier-Forsyth, K			Identification of discriminator base atomic groups that modulate the alanine aminoacylation reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; ESCHERICHIA-COLI TRNA(ALA); ACCEPTOR STEM MICROHELICES; MINOR-GROOVE; CRYSTAL-STRUCTURE; HUMAN TRNA(LEU); HELIX; PAIR; RECOGNITION; IDENTITY	Specific aminoacylation of tRNAs involves activation of an amino acid with ATP followed by amino acid transfer to the tRNA. Previous work showed that the transfer of alanine from Escherichia coli alanyl-tRNA synthetase to a cognate RNA minihelix involves a transition state sensitive to changes in the tRNA acceptor stem. Specifically, the "discriminator" base at position 73 of minihelix(Ala) is a critical determinant of the transfer step of aminoacylation, This single-stranded nucleotide has previously been shown by solution NMR to be stacked predominantly onto G(1) of the first base pair of the alanine acceptor stem helix. In this work, RNA duplex(Ala) variants were prepared to investigate the role of specific discriminator base atomic groups in aminoacylation catalytic efficiency. Results indicate that the purine structure appears to be important for stabilization of the transition state and that major groove elements are more critical than those located in the minor groove. This result is in accordance with the predicted orientation of a class II synthetase at the end of the acceptor helix. In particular, substitution of the exocyclic amino group of A(73) with a keto-oxygen resulted in negative discrimination at this site. Taken together, these new results are consistent with the involvement of major groove atomic groups of the discriminator base in the formation of the transition state for the amino acid transfer step.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Musier-Forsyth, K (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	musier@chem.umn.edu			NIGMS NIH HHS [GM49928] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM049928, R29GM049928, R01GM049928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beuning PJ, 1997, J AM CHEM SOC, V119, P8397, DOI 10.1021/ja971020c; Breitschopf K, 1996, NUCLEIC ACIDS RES, V24, P405, DOI 10.1093/nar/24.3.405; BREITSCHOPF K, 1994, EMBO J, V13, P3166, DOI 10.1002/j.1460-2075.1994.tb06615.x; BUECHTER DD, 1995, BIOCHEMISTRY-US, V34, P6014, DOI 10.1021/bi00018a002; CROTHERS DM, 1972, P NATL ACAD SCI USA, V69, P3063, DOI 10.1073/pnas.69.10.3063; Cusack S, 1996, EMBO J, V15, P2834, DOI 10.1002/j.1460-2075.1996.tb00644.x; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Hou YM, 1997, CHEM BIOL, V4, P93, DOI 10.1016/S1074-5521(97)90252-0; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; LIMMER S, 1993, P NATL ACAD SCI USA, V90, P6199, DOI 10.1073/pnas.90.13.6199; Limmer S, 1996, FEBS LETT, V385, P15, DOI 10.1016/0014-5793(96)00339-0; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; MCCLAIN WH, 1991, P NATL ACAD SCI USA, V88, P9272, DOI 10.1073/pnas.88.20.9272; Metzger AU, 1997, NUCLEIC ACIDS RES, V25, P4551, DOI 10.1093/nar/25.22.4551; Musier-Forsyth K, 1999, ACCOUNTS CHEM RES, V32, P368, DOI 10.1021/ar970148w; MUSIERFORSYTH K, 1991, P NATL ACAD SCI USA, V88, P209, DOI 10.1073/pnas.88.1.209; MUSIERFORSYTH K, 1992, NATURE, V357, P513, DOI 10.1038/357513a0; MUSIERFORSYTH K, 1991, SCIENCE, V253, P784, DOI 10.1126/science.1876835; PUGLISI EV, 1994, P NATL ACAD SCI USA, V91, P11467, DOI 10.1073/pnas.91.24.11467; Ramos A, 1997, NUCLEIC ACIDS RES, V25, P2083, DOI 10.1093/nar/25.11.2083; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; SANTALUCIA J, 1991, J AM CHEM SOC, V113, P4313, DOI 10.1021/ja00011a039; SCARINGE SA, 1990, NUCLEIC ACIDS RES, V18, P5433, DOI 10.1093/nar/18.18.5433; SHI JP, 1991, J BIOL CHEM, V266, P2705; SHI JP, 1990, BIOCHEMISTRY-US, V29, P3621, DOI 10.1021/bi00467a005; SHIMIZU M, 1992, J MOL EVOL, V35, P436; SPROAT B, 1995, NUCLEOS NUCLEOT, V14, P255, DOI 10.1080/15257779508014668; SUGIMOTO N, 1987, BIOCHEMISTRY-US, V26, P4554, DOI 10.1021/bi00388a058; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; TURNER DH, 1987, J AM CHEM SOC, V109, P3783, DOI 10.1021/ja00246a047	30	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37093	37096		10.1074/jbc.274.52.37093	http://dx.doi.org/10.1074/jbc.274.52.37093			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601268	hybrid			2022-12-27	WOS:000084382700039
J	Ren, YS; Reddy, SAG; Liao, WSL				Ren, YS; Reddy, SAG; Liao, WSL			Purification and identification of a tissue-specific repressor involved in serum amyloid A1 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR AP-2; ACUTE-PHASE RESPONSE; NF-KAPPA-B; NUCLEAR FACTOR; C/EBP-LIKE; PROTEIN; ACTIVATION; DROSOPHILA; BINDING; POLYMERASE	We have previously demonstrated that the 5'-flanking regions from the rat serum amyloid A1 (SAA1) promoter are necessary and sufficient to confer specific cytokine induced expression in cultured hepatoma cells. Deletion analysis identified a tissue-specific repressor (TSR) regulatory element, located between bp -289 and -256, that functioned as a silencer, contributing to the transcription repression on SAA1 promoter in nonliver cells. When this 34-base pair TSR-binding element was used as a probe in electrophoretic mobility shift assays, an intense DNA-protein complex was detected in nuclear extracts from HeLa and several other nonliver tissues, This TSR binding activity, however, was undetectable in extracts from liver or liver-derived cells. The distribution of TSR binding activity is therefore consistent with its regulatory role in repressing SAA1 expression in a tissue-specific manner. In this study, we purified TSR protein from HeLa nuclear extracts and showed that it has a molecular mass of approximately 50 kDa. Surprisingly, protein sequencing and antibody supershift experiments identified TSR as transcription factor AP-2. Subsequent functional analysis showed that forced expression of AP-2 in HepG2 cells could indeed inhibit conditioned medium-induced SAA1 promoter activation. Moreover, expression of a dominant-negative mutant of AP-2 in HeLa cells or mutation of the AP-2-binding site led to derepression of the SAA1 promoter, presumably by neutralizing the inhibitory effects of the endogenous wild-type AP-2. Our results therefore demonstrate a novel function for AP-2 in the transcriptional repression of SAA1 promoter. Together with its tissue distribution, AP-2 may contribute to SAA1's highly liver-specific expression pattern by restricting its expression in nonliver cells.	Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Liao, WSL (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Box 117, Houston, TX 77030 USA.	wliao@odin.mdacc.tmc.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR038858, R01AR038858] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 38858] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BENSON MD, 1979, J IMMUNOL, V122, P2077; BENSON MD, 1980, J IMMUNOL, V124, P495; BETTS JC, 1993, J BIOL CHEM, V268, P25624; Bisgrove DA, 1997, MOL CELL BIOL, V17, P5935, DOI 10.1128/MCB.17.10.5935; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUETTNER R, 1993, MOL CELL BIOL, V13, P4174, DOI 10.1128/MCB.13.7.4174; Butler A, 1996, IMMUNOGENETICS, V44, P468, DOI 10.1007/BF02602809; Chen AP, 1996, J BIOL CHEM, V271, P25994, DOI 10.1074/jbc.271.42.25994; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; COWELL IG, 1994, TRENDS BIOCHEM SCI, V19, P38, DOI 10.1016/0968-0004(94)90172-4; DEBEER MC, 1994, J BIOL CHEM, V269, P4661; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EDBROOKE MR, 1989, MOL CELL BIOL, V9, P1908, DOI 10.1128/MCB.9.5.1908; GABRIELSEN OS, 1993, METHOD ENZYMOL, V218, P508; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; GETMAN DK, 1995, J BIOL CHEM, V270, P23511, DOI 10.1074/jbc.270.40.23511; GOREVIC PD, 1981, ANNU REV MED, V32, P261, DOI 10.1146/annurev.me.32.020181.001401; Gray S, 1996, GENE DEV, V10, P700, DOI 10.1101/gad.10.6.700; HERSCHBACH BM, 1993, ANNU REV CELL BIOL, V9, P479, DOI 10.1146/annurev.cellbio.9.1.479; HOCH M, 1992, SCIENCE, V256, P94, DOI 10.1126/science.1348871; HUANG JH, 1990, MOL CELL BIOL, V10, P3619, DOI 10.1128/MCB.10.7.3619; HUANG JH, 1994, MOL CELL BIOL, V14, P4475, DOI 10.1128/MCB.14.7.4475; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3467, DOI 10.1073/pnas.95.7.3467; JOHNSON AD, 1995, CELL, V81, P655, DOI 10.1016/0092-8674(95)90524-3; JOHNSON FB, 1992, GENE DEV, V6, P2177, DOI 10.1101/gad.6.11.2177; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KANNAN F, 1994, GENE DEV, V8, P1258, DOI 10.1101/gad.8.11.1258; Kirchhamer CV, 1996, P NATL ACAD SCI USA, V93, P13849, DOI 10.1073/pnas.93.24.13849; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Li L, 1999, BIOCHEM BIOPH RES CO, V264, P395, DOI 10.1006/bbrc.1999.1527; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LI X, 1992, NUCLEIC ACIDS RES, V20, P4765, DOI 10.1093/nar/20.18.4765; LI XX, 1991, J BIOL CHEM, V266, P15192; LIU YH, 1994, MOL CELL BIOL, V14, P7046, DOI 10.1128/MCB.14.11.7046; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; LU SY, 1994, MOL CELL BIOL, V14, P6253, DOI 10.1128/MCB.14.9.6253; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MEIER P, 1995, DEV BIOL, V169, P1, DOI 10.1006/dbio.1995.1121; MOSER M, 1995, DEVELOPMENT, V121, P2779; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OHSAKO S, 1994, GENE DEV, V8, P2743, DOI 10.1101/gad.8.22.2743; Pannen B H, 1995, New Horiz, V3, P183; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; RIENHOFF HY, 1990, MOL BIOL MED, V7, P287; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	58	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37154	37160		10.1074/jbc.274.52.37154	http://dx.doi.org/10.1074/jbc.274.52.37154			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601277	hybrid			2022-12-27	WOS:000084382700048
J	Croce, K; Flaumenhaft, R; Rivers, M; Furie, B; Furie, BC; Herman, IM; Potter, DA				Croce, K; Flaumenhaft, R; Rivers, M; Furie, B; Furie, BC; Herman, IM; Potter, DA			Inhibition of calpain blocks platelet secretion, aggregation, and spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NUCLEAR-LOCALIZATION SEQUENCE; CALCIUM-DEPENDENT PROTEASE; MARCKS-RELATED DOMAIN; ACTIN-FILAMENTS; BARBED ENDS; II CELLS; INTEGRIN ALPHA(IIB)BETA(3); CA2+-DEPENDENT PROTEASE; THROMBIN RECEPTOR	Previous studies have indicated that the Ca2+-dependent protease, calpain, is activated in platelets within 30-60 s of thrombin stimulation, but specific roles of calpain in platelets remain to be identified. To directly test the functions of calpain during platelet activation, a novel strategy was developed for introducing calpain's specific biological inhibitor, calpastatin, into platelets prior to activation. This method involves treatment of platelets with a fusion peptide, calpastat, consisting of the cell-penetrating signal sequence from Kaposi's fibroblast growth factor connected to a calpain-inhibiting consensus sequence derived from calpastatin.Calpastat specifically inhibits thrombin peptide (SFLLR)-induced alpha-granule secretion (IC50 = 20 mu M) during the first 30 s of activation, thrombin-induced platelet aggregation (IC50 = 50 mu M), and platelet spreading on glass surfaces (IC50 = 34 mu M). Calpastat-Ala, a mutant peptide in which alanine is substituted at conserved calpastatin residues, lacks calpain inhibitory activity and fails to inhibit secretion, aggregation, or spreading. The peptidyl calpain inhibitors calpeptin, MDL 28,170 (MDL) and E64d also inhibit secretion, aggregation and spreading, but require 3-10fold higher concentrations than calpastat for biological activity. Together, these findings demonstrate that calpain regulates platelet secretion, aggregation, and spreading and indicate that calpain plays an earlier role in platelet activation following thrombin receptor stimulation than had been previously detected.	Tufts Univ New England Med Ctr, Dept Med, Tupper Res Inst, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Div Hematol Oncol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Beth Israel Deaconess Med Ctr, Ctr Hemostasis & Thrombosis Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts Medical Center; Tufts Medical Center; Tufts University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Tufts University; Tufts University	Potter, DA (corresponding author), Tufts Univ New England Med Ctr, Dept Med, Tupper Res Inst, 245,750 Washington St, Boston, MA 02111 USA.	dpotter_mhc@opal.tufts.edu			NATIONAL CANCER INSTITUTE [K08CA001562] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL042443, R01HL051926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055110] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA001562-04, K08-CA 1562] Funding Source: Medline; NHLBI NIH HHS [R01 HL051926, P01 HL042443] Funding Source: Medline; NIDDK NIH HHS [P30 DK034928, P30 DK34928] Funding Source: Medline; NIGMS NIH HHS [GM55110] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMIEVA MR, 1995, EXP CELL RES, V219, P180, DOI 10.1006/excr.1995.1218; ANAGLI J, 1993, BIOCHEM J, V289, P93, DOI 10.1042/bj2890093; ANAGLI J, 1991, BIOCHEM J, V274, P497, DOI 10.1042/bj2740497; Banfic H, 1998, J BIOL CHEM, V273, P11630, DOI 10.1074/jbc.273.19.11630; BOTTECCHIA D, 1976, HAEMOSTASIS, V5, P176; BRONK SF, 1993, AM J PHYSIOL, V264, pG744, DOI 10.1152/ajpgi.1993.264.4.G744; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Cooray P, 1996, BIOCHEM J, V318, P41, DOI 10.1042/bj3180041; CRAMER EM, 1994, BLOOD, V84, P1722; Crawford C., 1990, INTRACELLULAR CALCIU, P75; CROALL DE, 1994, BIOCHEMISTRY-US, V33, P13223, DOI 10.1021/bi00249a008; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; DELLIBOVI P, 1988, MOL CELL BIOL, V8, P2933, DOI 10.1128/MCB.8.7.2933; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; Flaumenhaft R, 1999, J BIOL CHEM, V274, P2492, DOI 10.1074/jbc.274.4.2492; FOX JEB, 1987, BLOOD, V69, P537; FOX JEB, 1983, J BIOL CHEM, V258, P9973; FOX JEB, 1993, J CELL BIOL, V120, P1501, DOI 10.1083/jcb.120.6.1501; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Furman MI, 1998, P NATL ACAD SCI USA, V95, P3082, DOI 10.1073/pnas.95.6.3082; GARTNER TK, 1981, BLOOD, V58, P153; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; HOPGOOD MF, 1977, BIOCHEM J, V164, P399, DOI 10.1042/bj1640399; HSULIN SC, 1984, J BIOL CHEM, V259, P9121; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Inomata M, 1996, ARCH BIOCHEM BIOPHYS, V328, P129, DOI 10.1006/abbi.1996.0152; JACOBS M, 1994, J BIOL CHEM, V269, P25494; KAWASAKI H, 1989, J BIOCHEM, V106, P274, DOI 10.1093/oxfordjournals.jbchem.a122844; Kuhlman PA, 1996, J BIOL CHEM, V271, P7986, DOI 10.1074/jbc.271.14.7986; Kuhlman PA, 1997, BIOCHEMISTRY-US, V36, P13461, DOI 10.1021/bi970601b; Li HL, 1998, CELL SIGNAL, V10, P137, DOI 10.1016/S0898-6568(97)00101-0; Li XL, 1998, J BIOL CHEM, V273, P19329, DOI 10.1074/jbc.273.30.19329; Lin YZ, 1996, J BIOL CHEM, V271, P5305, DOI 10.1074/jbc.271.10.5305; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu XY, 1996, P NATL ACAD SCI USA, V93, P11819, DOI 10.1073/pnas.93.21.11819; MAKI M, 1989, J BIOL CHEM, V264, P18866; MAKI M, 1988, J BIOL CHEM, V263, P10254; Maki M., 1990, INTRACELLULAR CALCIU, P37; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Murachi T, 1980, Adv Enzyme Regul, V19, P407; NISHIURA I, 1979, EXPERIENTIA, V35, P1006, DOI 10.1007/BF01949908; Norris FA, 1997, J BIOL CHEM, V272, P10987; ODA A, 1993, J BIOL CHEM, V268, P12603; PHILLIPS DR, 1977, J BIOL CHEM, V252, P5602; PONTREMOLI S, 1990, J BIOL CHEM, V265, P706; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; SAIDO TC, 1993, J BIOL CHEM, V268, P7422; SCARAMUZZINO DA, 1993, P NATL ACAD SCI USA, V90, P3398, DOI 10.1073/pnas.90.8.3398; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHMAIER AH, 1990, BLOOD, V75, P1273; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P1694, DOI 10.1074/jbc.272.3.1694; Shcherbina A, 1999, FEBS LETT, V443, P31, DOI 10.1016/S0014-5793(98)01674-3; SHUSTER CB, 1995, J CELL BIOL, V128, P837, DOI 10.1083/jcb.128.5.837; Shuster CB, 1996, CELL MOTIL CYTOSKEL, V35, P175; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; VUORI K, 1993, J BIOL CHEM, V268, P21459; WALLACE RW, 1987, BIOCHEMISTRY-US, V26, P2766, DOI 10.1021/bi00384a017; WAXMAN L, 1978, J BIOL CHEM, V253, P5888; WHITE JG, 1974, AM J PATHOL, V77, P135; YOSHIDA K, 1986, FEBS LETT, V206, P273, DOI 10.1016/0014-5793(86)80995-4; Zimmerman UJP, 1999, IUBMB LIFE, V48, P453, DOI 10.1080/713803537; ZIMMERMAN UJP, 1995, CELL CALCIUM, V18, P1, DOI 10.1016/0143-4160(95)90040-3; ZIMMERMAN UJP, 1992, BIOCHIM BIOPHYS ACTA, V1137, P127, DOI 10.1016/0167-4889(92)90193-F	65	104	105	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36321	36327		10.1074/jbc.274.51.36321	http://dx.doi.org/10.1074/jbc.274.51.36321			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593923	Green Accepted, hybrid			2022-12-27	WOS:000084279200042
J	Olsson, PA; Korhonen, L; Mercer, EA; Lindholm, D				Olsson, PA; Korhonen, L; Mercer, EA; Lindholm, D			MIR is a novel ERM-like protein that interacts with myosin regulatory light chain and inhibits neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE MORPHOLOGY; PLASMA-MEMBRANE; SMOOTH-MUSCLE; CELLS; RHO; KINASE; EZRIN; CYTOSKELETON; RADIXIN; NEURONS	The ERM protein family members ezrin, radixin, and moesin are cytoskeletal effector proteins linking actin to membrane-bound proteins at the cell surface. Here we report on the cloning of myosin regulatory light chain interacting protein (MIR), a protein with an ERM-homology domain and a carboxyl-terminal RING finger, that is expressed, among other tissues, in brain. MIR is distributed in cultured COS cells, in a punctated manner as shown using enhanced green fluorescent protein (EGFP)-tagged MIR and by staining with a specific antibody for MIR. In the yeast two-hybrid system and in transfected COS cells, MIR interacts with myosin regulatory light chain B, which in turn regulates the activity of the actomyosin complex. Overexpression of MIR cDNA in PC12 cells abrogated neurite outgrowth induced by nerve growth factor (NGF) without affecting TrkA signaling. The results show that MIR, a novel ERM-like protein, affects cytoskeleton interactions regulating cell motility, such as neurite outgrowth.	Uppsala Univ, Dept Neurosci, S-75123 Uppsala, Sweden	Uppsala University	Lindholm, D (corresponding author), Uppsala Univ, Dept Neurosci, Box 587 Biomed Ctr, S-75123 Uppsala, Sweden.	dan.lindholm@neuro.uu.se	Lindholm, Dan/B-3777-2014; Korhonen, Laura/AAW-3256-2020	Korhonen, Laura/0000-0002-1837-5930				AMIEVA MR, 1995, EXP CELL RES, V219, P180, DOI 10.1006/excr.1995.1218; ASPENSTROM P, 1995, METHOD ENZYMOL, V256, P228; Bretscher A, 1997, J CELL SCI, V110, P3011; Clem RJ, 1997, TRENDS CELL BIOL, V7, P337, DOI 10.1016/S0962-8924(97)01088-X; FEINSTEIN DL, 1991, MOL BRAIN RES, V10, P97, DOI 10.1016/0169-328X(91)90099-J; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; Frisen J, 1998, J NEUROSCI, V18, P5714; GonzalezAgosti C, 1996, CELL MOTIL CYTOSKEL, V34, P122, DOI 10.1002/(SICI)1097-0169(1996)34:2<122::AID-CM4>3.0.CO;2-D; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; Hasson T, 1997, CURR OPIN NEUROBIOL, V7, P615, DOI 10.1016/S0959-4388(97)80080-3; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; INAGAKI N, 1995, EUR J NEUROSCI, V7, P1125, DOI 10.1111/j.1460-9568.1995.tb01102.x; Katoh H, 1998, J BIOL CHEM, V273, P2489, DOI 10.1074/jbc.273.5.2489; Korhonen L, 1997, EUR J NEUROSCI, V9, P2489, DOI 10.1111/j.1460-9568.1997.tb01666.x; Machesky LM, 1996, TRENDS CELL BIOL, V6, P304, DOI 10.1016/0962-8924(96)10026-X; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; SATO N, 1992, J CELL SCI, V103, P131; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TAUBMAN MB, 1987, J CELL BIOL, V104, P1505, DOI 10.1083/jcb.104.6.1505; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vaheri A, 1997, CURR OPIN CELL BIOL, V9, P659, DOI 10.1016/S0955-0674(97)80119-6; Wylie SR, 1998, P NATL ACAD SCI USA, V95, P12967, DOI 10.1073/pnas.95.22.12967; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7; ZHANG SH, 1995, J BIOL CHEM, V270, P20067, DOI 10.1074/jbc.270.34.20067	31	64	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36288	36292		10.1074/jbc.274.51.36288	http://dx.doi.org/10.1074/jbc.274.51.36288			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593918	hybrid			2022-12-27	WOS:000084279200037
J	Qiu, XY; Janson, CA; Konstantinidis, AK; Nwagwu, S; Silverman, C; Smith, WW; Khandekar, S; Lonsdale, J; Abdel-Meguid, SS				Qiu, XY; Janson, CA; Konstantinidis, AK; Nwagwu, S; Silverman, C; Smith, WW; Khandekar, S; Lonsdale, J; Abdel-Meguid, SS			Crystal structure of beta-ketoacyl-acyl carrier protein synthase III - A key condensing enzyme in bacterial fatty acid biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL 3-KETOACYL-COA THIOLASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; FABH; INITIATION; DOMAINS; GENE	beta-Ketoacyl-acyl carrier protein synthase III (FabH), the most divergent member of the family of condensing enzymes, is a key catalyst in bacterial fatty acid biosynthesis and a promising target for novel antibiotics, We report here the crystal structures of FabH determined in the presence and absence of acetyl-CoA. These structures display a fold that is common for condensing enzymes. The observed acetylation of Cys(112) proves its catalytic role and clearly defines the primer binding pocket, Modeling based on a bound CoA molecule suggests catalytic roles for His(244) and Asn(274), The structures provide the molecular basis for FabH substrate specificity and reaction mechanism and are important for structure-based design of novel antibiotics.	SmithKline Beecham Pharmaceut, King Of Prussia, PA 19406 USA	GlaxoSmithKline	Qiu, XY (corresponding author), SmithKline Beecham Pharmaceut, King Of Prussia, PA 19406 USA.		ID, IMCACAT/D-5867-2014					Brunger A.T., 1993, X PLOR VERSION 3 1 S; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; CLARK JD, 1988, BIOCHEMISTRY-US, V27, P5961, DOI 10.1021/bi00416a020; CLOUGH RC, 1992, J BIOL CHEM, V267, P20992; Collaborative Computational Project, 1994, ACTA CRYST D, V50, P760; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P612; Han L, 1998, J BACTERIOL, V180, P4481, DOI 10.1128/JB.180.17.4481-4486.1998; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRESZE GB, 1977, EUR J BIOCHEM, V79, P191, DOI 10.1111/j.1432-1033.1977.tb11797.x; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Mathieu M, 1997, J MOL BIOL, V273, P714, DOI 10.1006/jmbi.1997.1331; MATHIEU M, 1994, STRUCTURE, V2, P797, DOI 10.1016/S0969-2126(94)00081-6; MAYO KH, 1985, BIOCHEMISTRY-US, V24, P7834, DOI 10.1021/bi00347a049; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Moche M, 1999, J BIOL CHEM, V274, P6031, DOI 10.1074/jbc.274.10.6031; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; OMURA S, 1976, BACTERIOL REV, V40, P681, DOI 10.1128/MMBR.40.3.681-697.1976; Qiu XY, 1996, NATURE, V383, P275, DOI 10.1038/383275a0; Siggaard-Andersen Mads, 1993, Protein Sequences and Data Analysis, V5, P325; Stinson SC, 1996, CHEM ENG NEWS, V74, P75, DOI 10.1021/cen-v074n039.p075; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TRAVIS J, 1994, SCIENCE, V264, P360, DOI 10.1126/science.8153615; TSAY JT, 1992, J BIOL CHEM, V267, P6807; VERWOERT IIGS, 1995, PLANT MOL BIOL, V27, P875, DOI 10.1007/BF00037016	29	140	145	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36465	36471		10.1074/jbc.274.51.36465	http://dx.doi.org/10.1074/jbc.274.51.36465			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593943	hybrid			2022-12-27	WOS:000084279200062
J	Basu-Modak, S; Braissant, O; Escher, P; Desvergne, B; Honegger, P; Wahli, W				Basu-Modak, S; Braissant, O; Escher, P; Desvergne, B; Honegger, P; Wahli, W			Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; ALPHA PPAR-ALPHA; FATTY-ACIDS; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; TISSUE DISTRIBUTION; GAMMA; LIGANDS; PATHWAY; THIAZOLIDINEDIONE	Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate the expression of many genes involved in lipid metabolism. The biological roles of PPAR alpha and PPAR gamma are relatively well understood, but little is known about the function of PPAR beta. To address this question, and because PPAR beta is expressed to a high level in the developing brain, we used reaggregated brain cell cultures prepared from dissociated fetal rat telencephalon as experimental model. In these primary cultures, the fetal cells initially form random aggregates, which progressively acquire a tissue-specific pattern resembling that of the brain. PPARs are differentially expressed in these aggregates, with PPAR beta being the prevalent isotype. PPAR alpha is present at a very low level, and PPAR gamma is absent. Cell type-specific expression analyses revealed that PPAR beta is ubiquitous and most abundant in some neurons, whereas PPARa is predominantly astrocytic. We chose acyl-CoA synthetases (ACSs) 1, 2, and 3 as potential target genes of PPAR beta and first analyzed their temporal and cell type-specific pattern. This analysis indicated that ACS2 and PPAR beta mRNAs have overlapping expression patterns, thus designating the ACS2 gene as a putative target of PPAR beta. Using a selective PPAR beta activator, we found that the ACS2 gene is transcriptionally regulated by PPARP beta, demonstrating a role for PPAR beta in brain lipid metabolism.	Univ Lausanne, Inst Biol Anim, CH-1015 Lausanne, Switzerland; Univ Lausanne, Inst Physiol, CH-1005 Lausanne, Switzerland	University of Lausanne; University of Lausanne	Wahli, W (corresponding author), Univ Lausanne, Inst Biol Anim, Batiment Biol, CH-1015 Lausanne, Switzerland.		Wahli, Walter/B-1398-2009; Wahli, Walter/I-3194-2019; Desvergne, Beatrice/C-8892-2016	Wahli, Walter/0000-0002-5966-9089; Desvergne, Beatrice/0000-0001-5483-288X				Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Berger J, 1999, J BIOL CHEM, V274, P6718, DOI 10.1074/jbc.274.10.6718; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brown PJ, 1997, CHEM BIOL, V4, P909, DOI 10.1016/S1074-5521(97)90299-4; CAMPAGNONI AT, 1988, MOL NEUROBIOL, V2, P41, DOI 10.1007/BF02935632; CORTHESYTHEULAZ I, 1990, AM J PHYSIOL, V258, pC1062, DOI 10.1152/ajpcell.1990.258.6.C1062; Cullingford TE, 1998, J NEUROCHEM, V70, P1366; DESVERGNE B, 1995, INDUCIBLE GENE EXPRE, V1, P142; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; DUMONTEIL E, 1994, J PHYSIOL-LONDON, V479, P29, DOI 10.1113/jphysiol.1994.sp020275; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; FULCERI R, 1994, CELL CALCIUM, V15, P109, DOI 10.1016/0143-4160(94)90049-3; FULCERI R, 1993, BIOCHEM J, V295, P663, DOI 10.1042/bj2950663; Garbay B, 1997, DEV BRAIN RES, V98, P197, DOI 10.1016/S0165-3806(96)00169-1; Granneman J, 1998, J NEUROSCI RES, V51, P563, DOI 10.1002/(SICI)1097-4547(19980301)51:5<563::AID-JNR3>3.0.CO;2-D; Honegger P, 1998, DEV BRAIN RES, V105, P219, DOI 10.1016/S0165-3806(97)00194-6; HONEGGER P, 1979, NATURE, V282, P305, DOI 10.1038/282305a0; HONEGGER P, 1988, EXPERIENTIA, V44, P817, DOI 10.1007/BF01941177; HONEGGER P, 1985, CELL CULTURE NEUROSC, P223; Honegger Paul, 1997, P25; Iijima H, 1996, EUR J BIOCHEM, V242, P186, DOI 10.1111/j.1432-1033.1996.0186r.x; Jumpsen J., 1995, BRAIN DEV RELATIONSH; KAKAR SS, 1987, J BIOL CHEM, V262, P42; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Larsson O, 1996, J BIOL CHEM, V271, P10623, DOI 10.1074/jbc.271.18.10623; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; MASTERS CJ, 1995, MECH AGEING DEV, V80, P69, DOI 10.1016/0047-6374(94)01563-2; MONNETTSCHUDI F, 1993, DEV NEUROSCI-BASEL, V15, P395, DOI 10.1159/000111363; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; PFANNER N, 1989, CELL, V59, P95, DOI 10.1016/0092-8674(89)90872-6; REDDY TS, 1985, NEUROCHEM RES, V10, P377, DOI 10.1007/BF00964606; RIEDERER BM, 1992, J NEUROCHEM, V58, P649, DOI 10.1111/j.1471-4159.1992.tb09767.x; Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; Sleeman MW, 1998, J BIOL CHEM, V273, P3132, DOI 10.1074/jbc.273.6.3132; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; TYRRELL RM, 1994, METHOD ENZYMOL, V234, P224; VASWANI KK, 1987, J NEUROSCI RES, V17, P65, DOI 10.1002/jnr.490170110; WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4; Willson TM, 1997, CURR OPIN CHEM BIOL, V1, P235, DOI 10.1016/S1367-5931(97)80015-4; Xing GQ, 1995, BIOCHEM BIOPH RES CO, V217, P1015, DOI 10.1006/bbrc.1995.2871	54	107	112	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35881	35888		10.1074/jbc.274.50.35881	http://dx.doi.org/10.1074/jbc.274.50.35881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585473	hybrid, Green Submitted			2022-12-27	WOS:000084187900085
J	Ogino, T; Iwama, M; Kinouchi, J; Shibagaki, Y; Tsukamoto, T; Mizumoto, K				Ogino, T; Iwama, M; Kinouchi, J; Shibagaki, Y; Tsukamoto, T; Mizumoto, K			Involvement of a cellular glycolytic enzyme, phosphoglycerate kinase, in Sendai virus transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MESSENGER-RNA SYNTHESIS; MICROTUBULE-ASSOCIATED PROTEINS; P-PROTEIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; IN-VITRO; GENOME REPLICATION; INVITRO SYSTEM; BINDING DOMAIN; TYPE-3	In vitro mRNA synthesis of Sendai virus is almost entirely dependent on the addition of cellular proteins (host factors). Previous studies indicated that the host factor activity from bovine brain was resolved into at least two complementary fractions, one of which may be tubulin. In this study, the host factor activity that stimulates the transcription in the presence of tubulin was further purified from bovine brain. This fraction was found to contain at least two complementary factors, and one of them was purified to a single polypeptide chain with an apparent M-r of 46,000 (p46). From the amino acid sequence, biochemical, and immunological analyses, p46 was identified as a glycolytic enzyme, phosphoglycerate kinase (PGK). Purified native PGK from rabbit and yeast, and a recombinant human PGK substituted for p46. Although, as previously suggested, tubulin was involved in the transcription initiation complex formation by being integrated into the complex, p46 and its complementary factor had little effect on the complex formation. On the other hand, when p46 and the complementary factor were added to the RNA chain elongation reaction from the isolated initiation complex formed with tubulin, mRNA synthesis was dramatically stimulated. The enzymatic activity per se of PGK did not seem Do be required for its activity. West-Western blot analysis showed that PGK could directly interact with tubulin. These data suggest that PGK stimulates Sendai virus mRNA synthesis at the elongation step, probably through its interaction with tubulin in the initiation complex.	Kitasato Univ, Sch Pharmaceut Sci, Dept Biochem, Minato Ku, Tokyo 1088641, Japan; Kitasato Inst, Biol Res Ctr, Minato Ku, Tokyo 1088642, Japan	Kitasato University	Mizumoto, K (corresponding author), Kitasato Univ, Sch Pharmaceut Sci, Dept Biochem, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	mizumotok@pharm.kitasato-u.ac.jp	Ogino, Tomoaki/M-2824-2017	Ogino, Tomoaki/0000-0002-4154-1781				BARIK S, 1992, P NATL ACAD SCI USA, V89, P6570, DOI 10.1073/pnas.89.14.6570; BARIK S, 1992, J VIROL, V66, P6813, DOI 10.1128/JVI.66.11.6813-6818.1992; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke E, 1998, VIROLOGY, V252, P137, DOI 10.1006/viro.1998.9471; Collins P. L., 1996, FIELDS VIROLOGY, P1205; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; CURRAN J, 1994, VIROLOGY, V202, P875, DOI 10.1006/viro.1994.1409; Das T, 1998, P NATL ACAD SCI USA, V95, P1449, DOI 10.1073/pnas.95.4.1449; Das T, 1996, METHOD ENZYMOL, V275, P99; DAS T, 1995, VIROLOGY, V211, P218, DOI 10.1006/viro.1995.1394; DE BP, 1990, J VIROL, V64, P1135, DOI 10.1128/JVI.64.3.1135-1142.1990; DE BP, 1993, J BIOL CHEM, V268, P5703; DE BP, 1991, J VIROL, V65, P3268, DOI 10.1128/JVI.65.6.3268-3275.1991; De BP, 1996, J BIOL CHEM, V271, P24728, DOI 10.1074/jbc.271.40.24728; De BP, 1997, ADV VIRUS RES, V48, P169, DOI 10.1016/S0065-3527(08)60288-2; DE BP, 1995, P NATL ACAD SCI USA, V92, P5204, DOI 10.1073/pnas.92.11.5204; Fields B. N, 1996, FIELDS VIROLOGY, V1, P1177; Ghosh A, 1996, VIRUS RES, V41, P69, DOI 10.1016/0168-1702(95)01276-1; Gupta S, 1998, J VIROL, V72, P2655, DOI 10.1128/JVI.72.4.2655-2662.1998; HILL VM, 1986, P NATL ACAD SCI USA, V83, P5410, DOI 10.1073/pnas.83.15.5410; HILL VM, 1990, J GEN VIROL, V71, P289, DOI 10.1099/0022-1317-71-2-289; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; HUANG YT, 1993, VIROLOGY, V193, P862, DOI 10.1006/viro.1993.1195; HUITOREL P, 1985, EUR J BIOCHEM, V150, P265, DOI 10.1111/j.1432-1033.1985.tb09016.x; Huntley CC, 1997, J BIOL CHEM, V272, P16578, DOI 10.1074/jbc.272.26.16578; JINDAL HK, 1990, J BIOL CHEM, V265, P6540; KUNTZ GWK, 1982, METHOD ENZYMOL, V90, P103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CY, 1982, METHOD ENZYMOL, V90, P121; LEHOTZKY A, 1993, J BIOL CHEM, V268, P10888; Liu Z, 1997, VIROLOGY, V232, P198, DOI 10.1006/viro.1997.8548; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MALHOTRA OP, 1995, EUR J BIOCHEM, V227, P556, DOI 10.1111/j.1432-1033.1995.tb20424.x; MEJEAN C, 1989, BIOCHEM J, V264, P671, DOI 10.1042/bj2640671; MICHELSON AM, 1985, P NATL ACAD SCI USA, V82, P6965, DOI 10.1073/pnas.82.20.6965; MINASCHEK G, 1992, EUR J CELL BIOL, V58, P418; MIZUMOTO K, 1995, J BIOCHEM-TOKYO, V117, P527, DOI 10.1093/oxfordjournals.jbchem.a124740; MORI N, 1986, GENE, V45, P275; MOSCONA A, 1991, J VIROL, V65, P4470, DOI 10.1128/JVI.65.8.4470-4474.1991; MOYER SA, 1986, P NATL ACAD SCI USA, V83, P5405, DOI 10.1073/pnas.83.15.5405; MOYER SA, 1990, J GEN VIROL, V71, P775, DOI 10.1099/0022-1317-71-4-775; MOYER SA, 1991, PARAMYXOVIRUSES, P249; Oglesbee MJ, 1996, J GEN VIROL, V77, P2125, DOI 10.1099/0022-1317-77-9-2125; PAGLIARO L, 1988, J CELL BIOL, V107, P981, DOI 10.1083/jcb.107.3.981; PERKINS RE, 1983, BIOCHEM J, V211, P199, DOI 10.1042/bj2110199; Pringle CR, 1997, SEMIN VIROL, V8, P49, DOI 10.1006/smvy.1997.0105; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SHIBUTA H, 1979, MICROBIOL IMMUNOL, V23, P617, DOI 10.1111/j.1348-0421.1979.tb00502.x; SMALLWOOD S, 1994, VIROLOGY, V202, P154, DOI 10.1006/viro.1994.1331; TAKAGI T, 1995, J BIOCHEM-TOKYO, V118, P390, DOI 10.1093/oxfordjournals.jbchem.a124919; Takagi T, 1996, ARCH VIROL, V141, P1623, DOI 10.1007/BF01718287; TAKEUCHI K, 1993, ARCH VIROL, V128, P177, DOI 10.1007/BF01309799; TOMPA P, 1986, EUR J BIOCHEM, V154, P643, DOI 10.1111/j.1432-1033.1986.tb09446.x; Tsukamoto T, 1998, BIOCHEM BIOPH RES CO, V251, P27, DOI 10.1006/bbrc.1998.9402; Vertessy BG, 1997, J BIOL CHEM, V272, P25542, DOI 10.1074/jbc.272.41.25542; VILLANUEVA N, 1994, J GEN VIROL, V75, P555, DOI 10.1099/0022-1317-75-3-555; VISHWANATHA JK, 1992, J CELL SCI, V101, P25; Volker KW, 1997, ARCH BIOCHEM BIOPHYS, V338, P237, DOI 10.1006/abbi.1996.9819; WALSH JL, 1989, BIOCHIM BIOPHYS ACTA, V999, P64, DOI 10.1016/0167-4838(89)90031-9; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858	61	48	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35999	36008		10.1074/jbc.274.50.35999	http://dx.doi.org/10.1074/jbc.274.50.35999			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585490	hybrid			2022-12-27	WOS:000084187900102
J	Dorion, S; Berube, J; Huot, J; Landry, J				Dorion, S; Berube, J; Huot, J; Landry, J			A short lived protein involved in the heat shock sensing mechanism responsible for stress-activated protein kinase 2 (SAPK2/p38) activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; MAMMALIAN-CELLS; SIGNAL-TRANSDUCTION; CONFERS RESISTANCE; INDUCED APOPTOSIS; HUMAN HSP27; HELA-CELLS; CONSTITUTIVE EXPRESSION; PROTEASOME INHIBITORS; TYROSINE KINASES	The stress-activated protein kinase 2 (SAPK2/p38) is activated by various environmental stresses and also by a vast array of agonists including growth factors and cytokines, This implies the existence of multiple proximal signaling pathways converging to the SAPK2/p38 activation cascade. Here, we show that there is a sensing mechanism highly specific to heat shock for activation of SAPK2/p38, After mild heat shock, cells became refractory to reinduction of the SAPK2/p38 pathway by a second heat shock. This was not the result of a toxic effect because the cells remained fully responsive to reinduction by other stresses, cytokines, or growth factors. Neither the activity of SAPK2/p38 itself nor the accumulation of the heat shock proteins was essential in the desensitization process. The cells were not desensitized to heat shock by other treatments that activated SAPK2/p38, Moreover, inhibiting SAPK2/p38 activity during heat shock did not block desensitization. Also, overexpression of HSP70, HSP27, or HSP90 by gene transfection did not cause desensitization, and inhibiting their synthesis after heat shock did not prevent desensitization. Desensitization rather appeared to be Linked closely to the turnover of a putative upstream activator of SAPK2/p38. Cycloheximide induced a progressive and eventually complete desensitization. The effect was specific to heat shock and minimally affected activation by other stress inducers. Inhibiting protein degradation with MG132 caused the constitutive activation of SAPK2/p38, which was blocked by a pretreatment with either cycloheximide or heat shock. The results thus indicate that there is a sensing pathway highly specific to heat shock upstream of SAPK2/p38 activation. The pathway appears to involve a short Lived protein that is the target of rapid successive up- and downregulation by heat shock.	Univ Laval, Ctr Rech Cancerol, Hotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada	Laval University	Landry, J (corresponding author), Univ Laval, Ctr Rech Cancerol, Hotel Dieu Quebec, 11 Cote de Palais, Quebec City, PQ G1R 2J6, Canada.	jacques.landry@med.ulaval.ca						ADLER V, 1995, J BIOL CHEM, V270, P26071, DOI 10.1074/jbc.270.44.26071; Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; ANGELIDIS CE, 1991, EUR J BIOCHEM, V199, P35, DOI 10.1111/j.1432-1033.1991.tb16088.x; Bellmann K, 1996, FEBS LETT, V391, P185, DOI 10.1016/0014-5793(96)00730-2; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; Buzzard KA, 1998, J BIOL CHEM, V273, P17147, DOI 10.1074/jbc.273.27.17147; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; CARLSON N, 1987, J CELL BIOL, V104, P547, DOI 10.1083/jcb.104.3.547; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 1998, BIOCHEM J, V333, P11, DOI 10.1042/bj3330011; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DUBOIS MF, 1993, FEBS LETT, V324, P191, DOI 10.1016/0014-5793(93)81391-C; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Garrido C, 1997, CANCER RES, V57, P2661; GERNER EW, 1975, NATURE, V256, P500, DOI 10.1038/256500a0; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Guay J, 1997, J CELL SCI, V110, P357; Guenal I, 1997, ONCOGENE, V15, P347, DOI 10.1038/sj.onc.1201182; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HICKEY E, 1989, MOL CELL BIOL, V9, P2615, DOI 10.1128/MCB.9.6.2615; HICKEY ED, 1982, BIOCHEMISTRY-US, V21, P1513, DOI 10.1021/bi00536a008; HUOT J, 1991, CANCER RES, V51, P5245; HUOT J, 1995, EUR J BIOCHEM, V227, P416, DOI 10.1111/j.1432-1033.1995.tb20404.x; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Huot J, 1996, CANCER RES, V56, P273; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Imamura T, 1998, J BIOL CHEM, V273, P11183, DOI 10.1074/jbc.273.18.11183; JAATTELA M, 1992, EMBO J, V11, P3507, DOI 10.1002/j.1460-2075.1992.tb05433.x; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Jurivich D.A., 1994, BIOL HEAT SHOCK PROT, P417; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LANDRY J, 1992, J BIOL CHEM, V267, P794; LANDRY J, 1991, J CELL PHYSIOL, V147, P93, DOI 10.1002/jcp.1041470113; LANDRY J, 1982, CANCER RES, V42, P2457; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Landry J, 1999, BIOCHEM SOC SYMP, P79; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LI GC, 1991, P NATL ACAD SCI USA, V88, P1681, DOI 10.1073/pnas.88.5.1681; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; Lin RZ, 1997, J BIOL CHEM, V272, P31196, DOI 10.1074/jbc.272.49.31196; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; MEHLEN P, 1995, J IMMUNOL, V154, P363; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; PARAG HA, 1987, EMBO J, V6, P55, DOI 10.1002/j.1460-2075.1987.tb04718.x; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; TANGUAY RM, 1993, DEV GENET, V14, P112, DOI 10.1002/dvg.1020140205; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Wagstaff MJD, 1999, J BIOL CHEM, V274, P5061, DOI 10.1074/jbc.274.8.5061; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wu C., 1994, BIOL HEAT SHOCK PROT, P395; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zechner D, 1998, J BIOL CHEM, V273, P8232, DOI 10.1074/jbc.273.14.8232; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133	73	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37591	37597		10.1074/jbc.274.53.37591	http://dx.doi.org/10.1074/jbc.274.53.37591			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608813	hybrid			2022-12-27	WOS:000084528000013
J	Leber, A; Hemmens, B; Klosch, B; Goessler, W; Raber, G; Mayer, B; Schmidt, K				Leber, A; Hemmens, B; Klosch, B; Goessler, W; Raber, G; Mayer, B; Schmidt, K			Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeast Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAHYDROBIOPTERIN BINDING-KINETICS; C REDUCTASE-ACTIVITY; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; SUPEROXIDE GENERATION; BRAIN; HEME; EXPRESSION; SUBSTRATE; DOMAIN	Human endothelial nitric-oxide synthase (eNOS) was expressed in the methylotrophic yeast Pichia pastoris, making use of the highly inducible alcohol oxidase promoter. The recombinant protein constituted approximately 3% of total protein and was largely soluble (>75%). About 1 mg of purified eNOS was obtained from 100-ml yeast cell cultures by affinity chromatography of crude cell supernatants. The purified enzyme had a V-max of 192 +/- 18 nmol of L-citrulline x mg(-1) x min(-1), had a K-m for L-arginine of 3.9 +/- 0.2 mu M, and showed an absolute requirement for tetrahydrobiopterin (H(4)biopterin). NADPH oxidase activity was 136 +/- 9 and 342 +/- 24 nmol x mg(-1) x min(-1) in the absence and presence of 0.1 mM L-arginine, respectively, and not affected by H(4)biopterin. The protein contained 0.56 +/- 0.06 equivalents of FAD and 0.79 +/- 0.08 equivalents of FMN. On-line gel filtration/inductively coupled plasma mass spectrometry analysis confirmed that both iron (0.80 +/- 0.09 mol/subunit) and zinc (0.43 +/- 0.03 mol/subunit) were bound to the enzyme. Graphite furnace-atomic absorption spectroscopy yielded a value for bound iron of 0.84 +/- 0.04 mol/subunit. The absorbance of the enzyme at 398 nm implied a heme content of 0.85 +/- 0.09 mol/subunit, and the high pressure liquid chromatography heme assay gave an estimate of 0.71 +/- 0.02 mol heme/subunit. Gel permeation chromatography yielded one single peak with a Stokes radius of 6.62 +/- 0.7 nm, indicating that the native protein is dimeric, Upon low temperature gel electrophoresis the untreated protein appeared mainly as a monomer (88 +/- 3%), but pretreatment with H(4)biopterin and L-arginine led to a pronounced shift toward dimers (77 +/- 4%). Thus,in contrast to bovine eNOS (List,B.M., Klosch, B., Volker, C., Gorren, A C. F., Sessa, W. C., Werner, E. R, Kukovetz, W. R, Schmidt, a, and Mayer, B. (1997) Biochem J; 323, 159-165; Rodriguez-Crespo, L, Gerber, N, C., and Ortiz de Montellano, P.R (1996) J. Biol. Chem 271, 11462-11467), the human eNOS appears to be markedly stabilized by H(4)biopterin.	Karl Franzens Univ Graz, Inst Pharmakol & Toxikol, A-8010 Graz, Austria; Karl Franzens Univ Graz, Inst Analyt Chem, A-8010 Graz, Austria	University of Graz; University of Graz	Schmidt, K (corresponding author), Karl Franzens Univ Graz, Inst Pharmakol & Toxikol, Univ Pl 2, A-8010 Graz, Austria.	kurt.schmidt@kfunigraz.ac.at	Goessler, Walter/A-1084-2016; Mayer, Bernd/B-9391-2008	Goessler, Walter/0000-0002-0142-9373; Raber, Georg/0000-0002-7674-5995; Mayer, Bernd/0000-0002-2921-3494				Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; BLACK SM, 1995, DNA CELL BIOL, V14, P789, DOI 10.1089/dna.1995.14.789; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN PF, 1995, BIOCHEM BIOPH RES CO, V215, P1119, DOI 10.1006/bbrc.1995.2579; COSENTINO F, 1995, CIRCULATION, V91, P139, DOI 10.1161/01.CIR.91.1.139; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Gorren ACF, 1996, BIOCHEMISTRY-US, V35, P16735, DOI 10.1021/bi961931j; HEINZEL B, 1992, BIOCHEM J, V281, P627, DOI 10.1042/bj2810627; Hellermann GR, 1997, J BIOL CHEM, V272, P12030, DOI 10.1074/jbc.272.18.12030; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Jones S, 1996, J BIOTECHNOL, V48, P37, DOI 10.1016/0168-1656(96)01394-6; KLATT P, 1994, J BIOL CHEM, V269, P13861; Klatt P, 1996, METHOD ENZYMOL, V268, P358; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; KLATT P, 1992, J BIOL CHEM, V267, P11374; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; List BM, 1997, BIOCHEM J, V323, P159, DOI 10.1042/bj3230159; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; Martasek P, 1999, METHOD ENZYMOL, V301, P70; MAYER B, 1994, NEUROPHARMACOLOGY, V33, P1253, DOI 10.1016/0028-3908(94)90024-8; Mayer B, 1996, METHOD ENZYMOL, V268, P420; Mayer B, 1998, N-S ARCH PHARMACOL, V358, P127, DOI 10.1007/PL00005233; MAYER B, 1991, FEBS LETT, V288, P187, DOI 10.1016/0014-5793(91)81031-3; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; Mayer B, 1997, BIOCHEMISTRY-US, V36, P8422, DOI 10.1021/bi970144z; MCMILLAN K, 1993, BIOCHEMISTRY-US, V32, P9875, DOI 10.1021/bi00089a001; Miller RT, 1999, J BIOL CHEM, V274, P14537, DOI 10.1074/jbc.274.21.14537; Miller RT, 1997, BIOCHEMISTRY-US, V36, P15277, DOI 10.1021/bi972022c; Narayanasami R, 1997, NITRIC OXIDE-BIOL CH, V1, P39, DOI 10.1006/niox.1996.0103; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Pfeiffer S, 1999, ANGEW CHEM INT EDIT, V38, P1715, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1714::AID-ANIE1714>3.0.CO;2-3; Pieper GM, 1997, J CARDIOVASC PHARM, V29, P8, DOI 10.1097/00005344-199701000-00002; POU S, 1992, J BIOL CHEM, V267, P24173; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Riethmuller C, 1999, J BIOL CHEM, V274, P16047, DOI 10.1074/jbc.274.23.16047; RodriguezCrespo I, 1996, ARCH BIOCHEM BIOPHYS, V336, P151, DOI 10.1006/abbi.1996.0543; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sari MA, 1996, BIOCHEMISTRY-US, V35, P7204, DOI 10.1021/bi960087u; Schmidt K, 1999, EUR J BIOCHEM, V259, P25, DOI 10.1046/j.1432-1327.1999.00003.x; SESSA WC, 1993, CIRC RES, V72, P921, DOI 10.1161/01.RES.72.4.921; SONO M, 1995, J BIOL CHEM, V270, P19943, DOI 10.1074/jbc.270.34.19943; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770	53	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37658	37664		10.1074/jbc.274.53.37658	http://dx.doi.org/10.1074/jbc.274.53.37658			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608822	hybrid			2022-12-27	WOS:000084528000022
J	Tang, PZ; Tsai-Morris, CH; Dufau, ML				Tang, PZ; Tsai-Morris, CH; Dufau, ML			A novel gonadotropin-regulated testicular RNA helicase - A new member of the DEAD-box family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE RECEPTOR GENE; RAT LEYDIG-CELL; MESSENGER-RNA; CHORIONIC-GONADOTROPIN; PROTEIN; TRANSLATION; INITIATION; DESENSITIZATION; STEROIDOGENESIS; TESTIS	A gonadotropin-regulated testicular RNA helicase (GRTH) was identified and characterized GRTH cloned from rat Leydig cell, mouse testis, and human testis cDNA Libraries is a novel member of the DEAD-box protein family. GRTH is transcriptionally up-regulated by chorionic gonadotropin via cyclic AMP-induced androgen formation in the Leydig cell. It has ATPase and RNA helicase activities and increases translation in vitro. This helicase is highly expressed in rat, mouse, and human testes and weakly expressed in the pituitary and hypothalamus. GRTH is produced in both somatic (Leydig. cells) and germinal (meiotic spermatocytes and round haploid spermatids) cells and is developmentally regulated. GRTH predominantly localized in the cytoplasm may function as a translational activator. This novel helicase could be relevant to the control of steroidogenesis and the paracrine regulation of androgen-dependent spermatogenesis in the testis.	NICHHD, Sect Mol Endocrinol, NIH, Bethesda, MD 20892 USA; NICHHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dufau, ML (corresponding author), NICHHD, Sect Mol Endocrinol, NIH, Bldg 49,Rm 6A36,49 Convent Dr MSC 4510, Bethesda, MD 20892 USA.	dufau@helix.nih.gov		Tsai Morris, Chon Hwa/0000-0002-8113-0979				AQUILANO DR, 1985, ENDOCRINOLOGY, V116, P1745, DOI 10.1210/endo-116-5-1745; AQUILANO DR, 1984, ENDOCRINOLOGY, V114, P499, DOI 10.1210/endo-114-2-499; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; CIGORRAGA SB, 1978, J BIOL CHEM, V253, P4297; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; DAN L, 1992, NUCLEIC ACIDS RES, V20, P1967, DOI 10.1093/nar/20.8.1967; DEVALOIR T, 1991, P NATL ACAD SCI USA, V88, P2113, DOI 10.1073/pnas.88.6.2113; Dufau ML, 1997, STEROIDS, V62, P128, DOI 10.1016/S0039-128X(96)00171-7; DUFAU ML, 1979, J STEROID BIOCHEM, V11, P193, DOI 10.1016/0022-4731(79)90296-6; DUFAU ML, 1988, ANNU REV PHYSIOL, V50, P483, DOI 10.1146/annurev.ph.50.030188.002411; DUFAU ML, 1978, VITAM HORM, V36, P461; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; FOX CH, 1993, CURRENT PROTOCOLS IM; GEE SL, 1994, GENE, V140, P171, DOI 10.1016/0378-1119(94)90541-X; GILMAN M, 1987, CURRENT PROTOCOLS MO; GREENBERG ME, 1990, CURRENT PROTOCOLS MO; GURURAJAN R, 1991, NATURE, V349, P717, DOI 10.1038/349717a0; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Hu ZZ, 1997, J BIOL CHEM, V272, P14263, DOI 10.1074/jbc.272.22.14263; HUHTANIEMI IT, 1982, ENDOCRINOLOGY, V111, P1711, DOI 10.1210/endo-111-5-1711; JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992; Khanum A, 1997, ENDOCRINOLOGY, V138, P1612, DOI 10.1210/en.138.4.1612; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MAEKAWA H, 1994, MOL GEN GENET, V244, P456, DOI 10.1007/BF00583896; Merrick WC, 1997, METHODS, V11, P333, DOI 10.1006/meth.1996.0431; NISHIHARA M, 1988, BIOCHEM BIOPH RES CO, V154, P151, DOI 10.1016/0006-291X(88)90663-8; NOZU K, 1981, J BIOL CHEM, V256, P12; NOZU K, 1981, J BIOL CHEM, V256, P2875; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Tang PZ, 1998, ENDOCRINOLOGY, V139, P4496, DOI 10.1210/en.139.11.4496; Tsai-Morris CH, 1999, ENDOCRINOLOGY, V140, P3534, DOI 10.1210/en.140.8.3534; Tsai-Morris CH, 1998, J CLIN ENDOCR METAB, V83, P288, DOI 10.1210/jc.83.1.288; TSAIMORRIS CH, 1994, J BIOL CHEM, V269, P15868; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651	39	54	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37932	37940		10.1074/jbc.274.53.37932	http://dx.doi.org/10.1074/jbc.274.53.37932			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608860	hybrid			2022-12-27	WOS:000084528000060
J	Arnold, RJ; Polevoda, B; Reilly, JP; Sherman, F				Arnold, RJ; Polevoda, B; Reilly, JP; Sherman, F			The action of N-terminal acetyltransferases on yeast ribosomal proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; METHIONINE AMINOPEPTIDASE; LONG-ISLAND; PHOSPHORYLATION; METHYLATION; ACETYLATION; EXTENSION; CHAIN	Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry was used to determine the state of N-terminal acetylation of 68 ribosomal proteins from a normal strain of Saccharomyces cerevisiae and from the ard1-Delta, nat3-Delta, and mak3-Delta mutants (4), each lacking a catalytic subunit of three different N-terminal acetyltransferases. A total 30 of the of 68 ribosomal proteins were N-terminal-acetylated, and 24 of these (80%) were NatA substrates, unacetylated in solely the ard1-Delta mutant and having mainly Ac-Ser- termini and a few with Ac-Ala- or Ac-Thr- termini, Only 4 (13%) were NatB substrates, unacetylated in solely the nat3-Delta mutant, and having Ac-Met-Asp- or Ac-Met-Glu- termini. No NatC substrates were uncovered, e.g. unacetylated in solely mak3-Delta mutants, consistent with finding that none of the ribosomal proteins had Ac-Met-Ile-, Ac-Met-Leu-, or Ac-Met-Phe- termini, Interestingly, two new types of the unusual Nato substrates were uncovered, having either Ac-Ser-Asp-Phe- or Ac-Ser-Asp-Ala- termini that were unacetylated in the ard1-Delta mutant, and only partially acetylated in the mak3-Delta mutant and, for one case, also only partially in the nat3-Delta mutant. We suggest that the acetylation of Nato substrates requires not only Ard1p and Nat1p, but also auxiliary factors that are acetylated by the Mak3p and Nat3p N-terminal acetyltransferases.	Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	Indiana University System; Indiana University Bloomington; University of Rochester	Sherman, F (corresponding author), Univ Rochester, Sch Med, Dept Biochem & Biophys, Box 712, Rochester, NY 14642 USA.		Polevoda, Bogdan/A-4880-2008		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM012702] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM12702] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold RJ, 1999, ANAL BIOCHEM, V269, P105, DOI 10.1006/abio.1998.3077; BARWICK RC, 1985, P NATL ACAD SCI USA, V82, P4602, DOI 10.1073/pnas.82.14.4602; Colby SM, 1996, ANAL CHEM, V68, P1419, DOI 10.1021/ac950716q; DEVLIN PE, 1988, GENE, V65, P13, DOI 10.1016/0378-1119(88)90412-X; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; HUANG S, 1987, BIOCHEMISTRY-US, V26, P8242, DOI 10.1021/bi00399a033; KIMURA Y, 2000, IN PRESS J BIOL CHEM; KRUISWIJK T, 1978, BIOCHEM J, V175, P213, DOI 10.1042/bj1750213; KRUISWIJK T, 1978, BIOCHEM J, V175, P221, DOI 10.1042/bj1750221; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; MOERSCHELL RP, 1990, J BIOL CHEM, V265, P19638; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; NARANDA T, 1991, P NATL ACAD SCI USA, V88, P10563, DOI 10.1073/pnas.88.23.10563; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; PRCHAL JT, 1986, P NATL ACAD SCI USA, V83, P24, DOI 10.1073/pnas.83.1.24; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; SPEDDING G, 1990, RIBOSOMES PROTEIN SY, P1; TAKAKURA H, 1992, J BIOL CHEM, V267, P5442; TERCERO JC, 1993, J BACTERIOL, V175, P3192, DOI 10.1128/JB.175.10.3192-3194.1993; Williamson NA, 1997, EUR J BIOCHEM, V246, P786, DOI 10.1111/j.1432-1033.1997.00786.x; YAMADA T, 1986, BIOCHEM BIOPH RES CO, V135, P837, DOI 10.1016/0006-291X(86)91004-1; ZINKER S, 1976, J BIOL CHEM, V251, P1799	24	68	131	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37035	37040		10.1074/jbc.274.52.37035	http://dx.doi.org/10.1074/jbc.274.52.37035			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601260	hybrid			2022-12-27	WOS:000084382700031
J	Kester, HCM; Magaud, D; Roy, C; Anker, D; Doutheau, A; Shevchik, V; Hugouvieux-Cotte-Pattat, N; Benen, JAE; Visser, J				Kester, HCM; Magaud, D; Roy, C; Anker, D; Doutheau, A; Shevchik, V; Hugouvieux-Cotte-Pattat, N; Benen, JAE; Visser, J			Performance of selected microbial pectinases on synthetic monomethyl-esterified di- and trigalacturonates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIGER; ERWINIA-CHRYSANTHEMI; MOLECULAR-CLONING; GENE; POLYGALACTURONASES; DERIVATIVES; FAMILY	Two monomethyl esters of alpha-(1-4)-linked D-galacturonic dimers and three monomethyl esters of alpha-(1-4)-linked D-galacturonic acid trimers were synthesized chemically and further used as substrates in order to establish the substrate specificity of six different endopolygalacturonases from Aspergillus niger, one exopolygalacturonase from Aspergillus tubingensis, and four selected Erwinia chrysanthemi pectinases; exopolygalacturonan hydrolase X (PehX), exopolygalacturonate lyase X (PelX), exopectate lyase W (PelW), and oligogalacturonan lyase (Ogl). All A. niger endopolygalacturonases (PGs) were unable to hydrolyze the two monomethyldigalacturonates and 2-methyltrigalacturonate, whereas 1-methyltrigalacturonate was only cleaved by PGI, PGII, and PGB albeit at an extremely low rate. The hydrolysis of 3-methyltrigalacturonate into 2-methyldigalaeturonate and galacturonate by all endopolygalacturonases demonstrates that these enzymes can accommodate a methylgalacturonate at subsite -2. The A. tubingensis exopolygalacturonase hydrolyzed the monomethyl-esterified digalacturonates and trigalacturonates although at lower rates than for the corresponding oligogalacturonates. 1-Methyltrigalacturonate was hydrolyzed at the same rate as trigalacturonate which demonstrates that the presence of a methyl ester at the third galacturonic acid from the nonreducing end does not have any effect on the performance of exopolygalacturonase. Of the four E. chrysanthemi pectinases, Ogl was the only enzyme able to cleave digalacturonate, whereas all four enzymes cleaved trigalacturonate. Ogl does not cleave monomethyl-esterified digalacturonate and trigalacturonate in case the second galacturonic acid residue from the reducing end is methyl-esterified. PehX did not hydrolyze any of the monomethyl-esterified trigalacturonates. The two lyases, PelX and PelW, were both only able to cleave 1-methyltrigalacturonate into Delta 4,5-unsaturated 1-methyldigalacturonate and galacturonate.	Agr Univ Wageningen, Sect Mol Genet Ind Microorganisms, NL-6703 HA Wageningen, Netherlands; Inst Natl Sci Appl, Lab Genet Mol Microorganismes & Interact Cellulai, CNRS, URA 1486, F-69621 Villeurbanne, France; Inst Natl Sci Appl, Chim Organ Lab, CNRS, UMR 5622, F-69621 Villeurbanne, France	Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Visser, J (corresponding author), Agr Univ Wageningen, Sect Mol Genet Ind Microorganisms, Dreijenlaan 2, NL-6703 HA Wageningen, Netherlands.			Shevchik, Vladimir/0000-0002-8031-8638; COTTE-PATTAT, Nicole/0000-0002-4322-160X				Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; BUSSINK HJD, 1991, CURR GENET, V20, P301, DOI 10.1007/BF00318519; BUSSINK HJD, 1990, FEBS LETT, V273, P127, DOI 10.1016/0014-5793(90)81066-W; BUSSINK HJD, 1992, APPL MICROBIOL BIOT, V37, P324, DOI 10.1007/BF00210987; BUSSINK HJD, 1992, EUR J BIOCHEM, V208, P83, DOI 10.1111/j.1432-1033.1992.tb17161.x; De Vries J, 1982, CARBOHYD POLYM, V2, P25, DOI DOI 10.1016/0144-8617(82)90043-1; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Kester HCM, 1999, BIOTECHNOL APPL BIOC, V30, P53; Kester HCM, 1996, EUR J BIOCHEM, V240, P738, DOI 10.1111/j.1432-1033.1996.0738h.x; KESTER HCM, 1990, BIOTECHNOL APPL BIOC, V12, P150; Korner R, 1999, ANAL CHEM, V71, P1421, DOI 10.1021/ac981240o; LIPTAK A, 1983, ACTA CHIM HUNG, V113, P415; Magaud D, 1997, TETRAHEDRON LETT, V38, P241, DOI 10.1016/S0040-4039(96)02308-8; Magaud D, 1998, CARBOHYD RES, V314, P189, DOI 10.1016/S0008-6215(98)00312-7; Parenicova L, 1998, EUR J BIOCHEM, V251, P72, DOI 10.1046/j.1432-1327.1998.2510072.x; RANA SS, 1980, CARBOHYD RES, V83, P170, DOI 10.1016/S0008-6215(00)85380-X; REVERCHON S, 1987, GENE, V55, P125, DOI 10.1016/0378-1119(87)90255-1; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Shevchik VE, 1999, J BACTERIOL, V181, P3912, DOI 10.1128/JB.181.13.3912-3919.1999; Shevchik VE, 1999, J BACTERIOL, V181, P1652, DOI 10.1128/JB.181.5.1652-1663.1999; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997	22	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37053	37059		10.1074/jbc.274.52.37053	http://dx.doi.org/10.1074/jbc.274.52.37053			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601263	hybrid			2022-12-27	WOS:000084382700034
J	Kim, HP; Roe, JH; Chock, PB; Yim, MB				Kim, HP; Roe, JH; Chock, PB; Yim, MB			Transcriptional activation of the human manganese superoxide dismutase gene mediated by tetradecanoylphorbol acetate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; SIGNAL TRANSDUCTION PATHWAYS; PROTEIN-KINASE-C; CYCLIC-AMP; PHORBOL ESTER; MNSOD GENE; SELECTIVE INHIBITOR; OXIDASE ACTIVATION; BINDING-PROTEINS	Transcriptional activation of human manganese superoxide dismutase (MnSOD) mRNA induced by a phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), was examined to identify the responsive transcriptional regulator. The effect of various deletions and mutations within the 5'-flanking region of the human MnSOD gene promoter was evaluated using the luciferase reporter system in A549 human lung carcinoma cells. Deletion of a region between -1292 and -1202 nucleotides upstream of the transcription start site abolished TPA-responsive induction, whereas deletion of the putative binding sequence for NF-kappa B or AP-1 did not. The region between -1292 and -1202 contains a cAMP-responsive element-like sequence, TGACGTCT, which we identified as the manganese Superoxide dismutase TPA-responsive element, MSTRE. Site-specific mutation of the MSTRE abolished the TPA-responsive induction, validating the critical role of this sequence. We detected specific MSTRE activity from nuclear extracts and demonstrated by antibody supershift assay that this activity is closely related to CREB-1/ATF-1. TPA treatment rap idly induced phosphorylation of the CREB-1/ATF-1-like factor via the protein kinase C pathway. These results led us to conclude that the human MnSOD gene having the promoter construct used in this study is induced by TPA via activation of a CREB-1/ATF-1-like factor and not via either NF-kappa B or AP-1, In addition, we found that this induction was blocked by inhibitors of flavoproteins and NADPH oxidases, indicating involvement of enhanced generation of superoxide radical anion as an upstream signal.	NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; Seoul Natl Univ, Coll Nat Sci, Dept Microbiol, Seoul 151742, South Korea; Seoul Natl Univ, Res Ctr Mol Microbiol, Seoul 151742, South Korea	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Seoul National University (SNU); Seoul National University (SNU)	Yim, MB (corresponding author), NHLBI, Biochem Lab, NIH, Bldg 3,Rm 202,3 Ctr Dr,MSC-0342, Bethesda, MD 20892 USA.							AEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43; AKASHI M, 1995, J BIOL CHEM, V270, P15864, DOI 10.1074/jbc.270.26.15864; Borrello S, 1997, ARCH BIOCHEM BIOPHYS, V348, P289, DOI 10.1006/abbi.1997.0355; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; CHURCH SL, 1992, GENOMICS, V14, P823, DOI 10.1016/S0888-7543(05)80202-2; CHURCH SL, 1992, DEV BIOL, V149, P177, DOI 10.1016/0012-1606(92)90274-K; DAS KC, 1995, MOL CELL BIOCHEM, V148, P45, DOI 10.1007/BF00929502; DAS KC, 1995, AM J PHYSIOL-LUNG C, V269, pL588, DOI 10.1152/ajplung.1995.269.5.L588; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; DOUSSIERE J, 1992, EUR J BIOCHEM, V208, P61, DOI 10.1111/j.1432-1033.1992.tb17159.x; FINDIK D, 1995, J CELL BIOCHEM, V57, P12, DOI 10.1002/jcb.240570103; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FUJII J, 1994, BIOCHEM J, V301, P31, DOI 10.1042/bj3010031; FUJII J, 1991, J BIOL CHEM, V266, P23142; GEILEN CC, 1992, FEBS LETT, V309, P381, DOI 10.1016/0014-5793(92)80811-T; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HARRIS CA, 1991, J IMMUNOL, V147, P149; HO YS, 1991, AM J RESP CELL MOL, V4, P278, DOI 10.1165/ajrcmb/4.3.278; HOEFFLER JP, 1989, MOL ENDOCRINOL, V3, P868, DOI 10.1210/mend-3-5-868; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jones PL, 1997, MOL CELL BIOL, V17, P6970, DOI 10.1128/MCB.17.12.6970; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; KARIN M, 1992, FASEB J, V6, P2581, DOI 10.1096/fasebj.6.8.1317309; LEE JH, 1990, CANCER RES, V50, P2724; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Maniatis T., 1982, MOL CLONING LAB MANU; MEIR B, 1991, BIOCHEM J, V275, P241; MEYRICK B, 1994, AM J RESP CELL MOL, V10, P113, DOI 10.1165/ajrcmb.10.1.8292376; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Muthusamy N, 1998, J BIOL CHEM, V273, P22841, DOI 10.1074/jbc.273.35.22841; OBERLEY LW, 1987, ARCH BIOCHEM BIOPHYS, V254, P69, DOI 10.1016/0003-9861(87)90082-8; OBERLEY LW, 1979, CANCER RES, V39, P1141; PAHL HL, 1994, BIOESSAYS, V16, P497, DOI 10.1002/bies.950160709; Prestridge DS, 1996, COMPUT APPL BIOSCI, V12, P157; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; SASSONECORSI P, 1990, ONCOGENE, V5, P427; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHULZEOSTHOFF K, 1995, BIOCHEM PHARMACOL, V50, P735, DOI 10.1016/0006-2952(95)02011-Z; STCLAIR DK, 1992, MOL CARCINOGEN, V6, P238, DOI 10.1002/mc.2940060404; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; VISNER GA, 1990, J BIOL CHEM, V265, P2856; WAN XS, 1994, DNA CELL BIOL, V13, P1127, DOI 10.1089/dna.1994.13.1127; Warner BB, 1996, AM J PHYSIOL-LUNG C, V271, pL150, DOI 10.1152/ajplung.1996.271.1.L150; WHITSETT JA, 1992, AM J PHYSIOL, V262, pL688, DOI 10.1152/ajplung.1992.262.6.L688; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Yim HS, 1997, J BIOL CHEM, V272, P8861; Zhang N, 1996, BIOCHEM BIOPH RES CO, V220, P171, DOI 10.1006/bbrc.1996.0376	57	82	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37455	37460		10.1074/jbc.274.52.37455	http://dx.doi.org/10.1074/jbc.274.52.37455			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601319	hybrid			2022-12-27	WOS:000084382700090
J	Ravanti, L; Hakkinen, L; Larjava, H; Saarialho-Kere, U; Foschi, M; Han, JH; Kahari, VM				Ravanti, L; Hakkinen, L; Larjava, H; Saarialho-Kere, U; Foschi, M; Han, JH; Kahari, VM			Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMAS; MATRIX METALLOPROTEINASE-13; TISSUE INHIBITOR; GENE-EXPRESSION; MESSENGER-RNA; BREAST CARCINOMAS; MAP KINASE; I COLLAGEN; MMP-13; KERATINOCYTES	Human collagenase-3 (matrix metalloproteinase 13 (MMP-13)) is characterized by exceptionally wide substrate specificity and restricted tissue specific expression. Human skin fibroblasts in culture express MMP-13 only when they are in three-dimensional collagen (Ravanti, L., Heino, J., Lopez-Otin, C,, and Kahari. V.-M. (1999) J. Biol. Chem. 274, 2446-2455). Here we show that MMP-13 is expressed by fibroblasts during normal human gingival wound repair. Expression of MMP-13 by human gingival fibroblasts cultured in monolayer or in collagen gel was induced by transforming growth factor-beta 1 (TGF-beta 1). Treatment of gingival fibroblasts with TGF-beta 1 activated two distinct mitogen-activated protein kinases (MAPKs): extracellular signal-regulated kinase 1/2 (ERK1/2) in 15 min and p38 MAPK in 1 and 2 h. Induction of MMP-13 expression by TGF-beta 1 was blocked by SB203580, a specific inhibitor of p38 MAPK, but not by PD98059, a selective inhibitor of ERK1/2 activation. Adenovirus-mediated expression of dominant negative p38 alpha and c-Jun potently inhibited induction of MMP-13 expression in gingival fibroblasts by TGF-beta 1. Infection of gingival fibroblasts with adenovirus for constitutively active MEK1 resulted in activation of ERK1/2 and JNK1 and up-regulation of collagenase-1 (MMP-1) and stromelysin-1 (MMP-3) production but did not induce MMP-13 expression. In addition, activation of p38 MAPK by constitutively active MKK6b or MKK3b was not sufficient to induce MMP-13 expression. These results show that TGF-beta-elicited induction of MMP-13 expression by gingival fibroblasts is dependent on the activity of p38 MAPK and the presence of functional AP-1 dimers. These observations demonstrate a fundamental difference in the regulation of collagenolytic capacity between gingival and dermal fibroblasts and suggest a role for MMP-13 in rapid turnover of collagenous matrix during repair of gingival wounds, which heal with minimal scarring.	Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; Univ Turku, Dept Biochem Med, FIN-20520 Turku, Finland; Univ Turku, Cent Hosp, Dept Dermatol, FIN-20520 Turku, Finland; Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; Univ Helsinki, Cent Hosp, Dept Dermatol, FIN-00250 Helsinki, Finland; Univ Florence, Dept Internal Med, I-50134 Florence, Italy; Scripps Res Inst, Dept Immunol, La Jolla, CA 92121 USA	University of Turku; University of Turku; University of Turku; University of British Columbia; University of Helsinki; Helsinki University Central Hospital; University of Florence; Scripps Research Institute	Kahari, VM (corresponding author), Univ Turku, MediCity Res Lab, Tykistokatu 6A, FIN-20520 Turku, Finland.	veli-matti.kahari@utu.fi	Larjava, Hannu/GRO-4325-2022; Kähäri, Veli-Matti/E-5144-2011; Han, J/G-4671-2010; Hakkinen, Lari/B-2228-2016; Kahari, Veli-Matti/T-4925-2019	Kähäri, Veli-Matti/0000-0003-2421-9368; Kahari, Veli-Matti/0000-0003-2421-9368				Ahonen M, 1998, CANCER RES, V58, P2310; Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417; Airola K, 1997, J INVEST DERMATOL, V109, P225, DOI 10.1111/1523-1747.ep12319441; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Auer KL, 1998, MOL BIOL CELL, V9, P561, DOI 10.1091/mbc.9.3.561; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Cazorla M, 1998, J PATHOL, V186, P144, DOI 10.1002/(SICI)1096-9896(1998100)186:2<144::AID-PATH147>3.0.CO;2-#; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Garlick JA, 1996, J DENT RES, V75, P912, DOI 10.1177/00220345960750030801; GHAHARY A, 1995, CYTOKINE, V7, P184, DOI 10.1006/cyto.1995.1025; Giambernardi TA, 1998, MATRIX BIOL, V16, P483, DOI 10.1016/S0945-053X(98)90019-1; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; Heppner KJ, 1996, AM J PATHOL, V149, P273; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; INOUE M, 1995, J INVEST DERMATOL, V104, P479, DOI 10.1111/1523-1747.ep12605917; Johansson N, 1999, AM J PATHOL, V154, P469, DOI 10.1016/S0002-9440(10)65293-5; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Johansson N, 1997, CELL GROWTH DIFFER, V8, P243; Johansson N, 1997, AM J PATHOL, V151, P499; Kahari VM, 1999, ANN MED, V31, P34, DOI 10.3109/07853899909019260; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Krane SM, 1996, J BIOL CHEM, V271, P28509, DOI 10.1074/jbc.271.45.28509; Kumar S, 1996, J BIOL CHEM, V271, P30864, DOI 10.1074/jbc.271.48.30451; LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719; Lindy O, 1997, ARTHRITIS RHEUM-US, V40, P1391, DOI 10.1002/art.1780400806; MAKELA JK, 1988, NUCLEIC ACIDS RES, V16, P349, DOI 10.1093/nar/16.1.349; Mattila L, 1998, J INVEST DERMATOL, V110, P416, DOI 10.1046/j.1523-1747.1998.00138.x; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; PELTONEN J, 1990, J INVEST DERMATOL, V94, P365, DOI 10.1111/1523-1747.ep12874491; PELTONEN J, 1991, J INVEST DERMATOL, V97, P240, DOI 10.1111/1523-1747.ep12480289; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Ravanti L, 1999, J BIOL CHEM, V274, P2446, DOI 10.1074/jbc.274.4.2446; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Saarialho-Kere UK, 1998, ARCH DERMATOL RES, V290, pS47, DOI 10.1007/PL00007453; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; SALO T, 1994, LAB INVEST, V70, P176; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; SAUS J, 1988, J BIOL CHEM, V263, P6742; Schor S L, 1996, Oral Dis, V2, P155; SCIUBBA JJ, 1978, J ORAL PATHOL MED, V7, P214, DOI 10.1111/j.1600-0714.1978.tb01596.x; SHAH M, 1994, J CELL SCI, V107, P1137; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Taichman NS, 1998, LAB INVEST, V78, P869; Uitto VJ, 1998, AM J PATHOL, V152, P1489; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Uria JA, 1998, AM J PATHOL, V153, P91, DOI 10.1016/S0002-9440(10)65549-6; Uria JA, 1997, CANCER RES, V57, P4882; Vaalamo M, 1998, AM J PATHOL, V152, P1005; Vaalamo M, 1997, J INVEST DERMATOL, V109, P96, DOI 10.1111/1523-1747.ep12276722; Vindevoghel L, 1998, P NATL ACAD SCI USA, V95, P14769, DOI 10.1073/pnas.95.25.14769; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233; Yang J, 1996, AM J PHYSIOL-GASTR L, V270, pG191, DOI 10.1152/ajpgi.1996.270.1.G191; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	68	189	194	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37292	37300		10.1074/jbc.274.52.37292	http://dx.doi.org/10.1074/jbc.274.52.37292			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601295	hybrid			2022-12-27	WOS:000084382700066
J	Burke, JR; Wood, MK; Ryseck, RP; Walther, S; Meyers, CA				Burke, JR; Wood, MK; Ryseck, RP; Walther, S; Meyers, CA			Peptides corresponding to the N and C termini of I kappa B-alpha, -beta, and -epsilon as probes of the two catalytic subunits of I kappa B kinase, IKK-1 and IKK-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; ACTIVATION; PHOSPHORYLATION; COMPLEX; DEGRADATION; SITE; UBIQUITINATION; PROTEOLYSIS; DOMAIN; ERK	The signal-inducible phosphorylation of serines 32 and 36 of I kappa B-alpha is the key step in regulating the subsequent ubiquitination and proteolysis of I kappa B-alpha, which then releases NF-KB to promote gene transcription, The multisubunit I kappa B kinase (msIKK) responsible for this phosphorylation contains two catalytic subunits, termed IKK-1 and IKK-2. Using recombinant IKK-2, a kinetic pattern consistent with a random, sequential binding mechanism was observed with the use of a peptide corresponding to amino acids 26-42 of I kappa B-alpha Values of 313 mu M 15.5 mu M, and 1.7 min(-1) were obtained for K-peptide, K-ATP, and k(cat), respectively. The value of alpha, a factor by which binding of one substrate changes the dissociation constant for the other substrate, was determined to be 0.2. Interestingly, the recombinant IKK-1 subunit gave similar values for alpha and K-ATP, but values of 1950 mu M and 0.016 min(-1) were calculated for K-peptide and k(cat), respectively. This suggests that the IKK-2 catalytic subunit provides nearly all of the catalytic activity of the msIKK complex with the IKK-1 subunit providing Little contribution to catalysis. Using peptides corresponding to different regions of I kappa B-alpha within amino acids 21-47, it was shown that amino acids 31-37 provide most binding interactions (-4.7 kcal/mol of binding free energy) of the full-length I kappa B-alpha (-7.9 kcal/mol) with the IKK-2, This is consistent with the observation that IKK-2 is able to phosphorylate the I kappa B-beta and I kappa B-epsilon proteins, which have consensus phosphorylation sites nearly identical to that of amino acids 31-37 of I kappa B-alpha A peptide corresponding to amino acids 279-303 in the C-terminal domain of I kappa B-alpha was unable to activate IKK-2 to phosphorylate an N-terminal peptide, which is in contrast to the results observed with the msIKK. Moreover, the IKK-2 catalyzes the phosphorylation of the full-length I kappa B-alpha and the amino acid 26-42 peptide with nearly equal efficiency, while the msIKK catalyzes the phosphorylation of the full-length I kappa B-alpha 25,000 times more efficiently than the 26-42 peptide, Therefore, the C terminus of I kappa B-alpha is important in activating the msIKK through interactions with subunits other than the IKK-2.	Bristol Myers Squibb Pharmaceut Res Inst, Drug Discovery Res, Princeton, NJ 08543 USA	Bristol-Myers Squibb	Burke, JR (corresponding author), Bristol Myers Squibb Pharmaceut Res Inst, Drug Discovery Res, POB 4000, Princeton, NJ 08543 USA.							Aoki T, 1996, ONCOGENE, V12, P1159; Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; Bauerle PA, 1996, CELL, V87, P13; Beauparlant P, 1996, J BIOL CHEM, V271, P10690, DOI 10.1074/jbc.271.18.10690; BHATNAGAR D, 1983, BIOCHEMISTRY-US, V22, P6310, DOI 10.1021/bi00295a042; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Brown K, 1997, MOL CELL BIOL, V17, P3021, DOI 10.1128/MCB.17.6.3021; Burke JR, 1998, J BIOL CHEM, V273, P12041, DOI 10.1074/jbc.273.20.12041; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cleland W W, 1979, Methods Enzymol, V63, P103; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; Fromm H J, 1979, Methods Enzymol, V63, P467; Harhaj EW, 1998, J BIOL CHEM, V273, P25185, DOI 10.1074/jbc.273.39.25185; Horiuchi KY, 1998, BIOCHEMISTRY-US, V37, P8879, DOI 10.1021/bi972731q; Kroll M, 1997, ONCOGENE, V15, P1841, DOI 10.1038/sj.onc.1201560; Lamers MBAC, 1999, J MOL BIOL, V285, P713, DOI 10.1006/jmbi.1998.2369; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li J, 1998, J BIOL CHEM, V273, P30736, DOI 10.1074/jbc.273.46.30736; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; O'Connell MA, 1998, J BIOL CHEM, V273, P30410, DOI 10.1074/jbc.273.46.30410; Prade L, 1997, STRUCTURE, V5, P1627, DOI 10.1016/S0969-2126(97)00310-9; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Roff M, 1996, J BIOL CHEM, V271, P7844, DOI 10.1074/jbc.271.13.7844; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schwarz EM, 1996, MOL CELL BIOL, V16, P3554; SEGEL IH, 1976, ENZYME KINETICS, P274; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; WALSH C, 1979, ENZYMATIC REACTION M, P35; Weil R, 1997, J BIOL CHEM, V272, P9942; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	39	13	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36146	36152		10.1074/jbc.274.51.36146	http://dx.doi.org/10.1074/jbc.274.51.36146			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593898	hybrid			2022-12-27	WOS:000084279200017
J	Huang, C; Zhou, J; Feng, AK; Lynch, CC; Klumperman, J; DeArmond, SJ; Mobley, WC				Huang, C; Zhou, J; Feng, AK; Lynch, CC; Klumperman, J; DeArmond, SJ; Mobley, WC			Nerve growth factor signaling in caveolae-like domains at the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY NEUROTROPHIN RECEPTOR; TRK PROTOONCOGENE PRODUCT; TYROSINE KINASE-ACTIVITY; PC12 CELLS; NEURONAL DIFFERENTIATION; SPHINGOMYELIN HYDROLYSIS; ACCESSORY PROTEIN; FACTOR BINDING; IL-1 RECEPTOR; LOCALIZATION	Nerve growth factor (NGF) binding to its receptors TrkA and p75(NTR) enhances the survival, differentiation, and maintenance of neurons. Recent studies have suggested that NGF receptor activation may occur in caveolae or caveolae-like membranes (CLM). This is an intriguing possibility because caveolae have been shown to contain many of the signaling intermediates in the TrkA signaling cascade. To examine the membrane localization of TrkA and p75NTR, We isolated caveolae from 3T3-TrkA-p75 cells and CLM from PC12 cells. Immunoblot analysis showed that TrkA and p75NTR were enriched about 13- and 25-fold, respectively, in caveolae and CLM. Binding and cross-linking studies demonstrated that the NGF binding to both TrkA and p75NTR was considerably enriched in CLM and that about 90% of high affinity binding to TrkA was present in CLM. When PC12 cells were treated with NGF, virtually all activated (i.e. tyrosine phosphorylated) TrkA was found in the CLM. Remarkably, in NGF-treated cells, it was only in CLM that activated TrkA was coimmunoprecipitated with phosphorylated Shc and PLC gamma. These results document a signaling role for TrkA in CLM and suggest that both TrkA and p75(NTR) Signaling are initiated from these membranes.	Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ Calif San Francisco, Neurosci Program, San Francisco, CA 94143 USA; Univ Utrecht, Sch Med, NL-3584 CX Utrecht, Netherlands; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; Utrecht University; University of California System; University of California San Francisco	Huang, C (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER; NIA NIH HHS [AG10770] Funding Source: Medline; NINDS NIH HHS [NS24054] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BARKER PA, 1994, J BIOL CHEM, V269, P30645; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bilderback TR, 1997, J BIOL CHEM, V272, P10922; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Carter BD, 1997, NEURON, V18, P187, DOI 10.1016/S0896-6273(00)80259-7; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Cullinan EB, 1998, J IMMUNOL, V161, P5614; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; DOBROWSKY RT, 1995, J BIOL CHEM, V270, P22135, DOI 10.1074/jbc.270.38.22135; Galbiati F, 1998, P NATL ACAD SCI USA, V95, P10257, DOI 10.1073/pnas.95.17.10257; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gargano N, 1997, J NEUROSCI RES, V50, P1; Grimes ML, 1996, J NEUROSCI, V16, P7950; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Loughlin, 1993, NEUROTROPHIC FACTORS, P209; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MEAKIN SO, 1991, P NATL ACAD SCI USA, V88, P5862, DOI 10.1073/pnas.88.13.5862; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Orlinick JR, 1998, CELL SIGNAL, V10, P543, DOI 10.1016/S0898-6568(98)00018-7; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; Ross AH, 1996, J CELL BIOL, V132, P945, DOI 10.1083/jcb.132.5.945; Ross GM, 1998, EUR J NEUROSCI, V10, P890, DOI 10.1046/j.1460-9568.1998.00094.x; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; Schlegel A, 1998, CELL SIGNAL, V10, P457, DOI 10.1016/S0898-6568(98)00007-2; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; SUTTER A, 1979, J BIOL CHEM, V254, P5972; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Wesche H, 1998, FEBS LETT, V429, P303, DOI 10.1016/S0014-5793(98)00468-2; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WOLF DE, 1995, J BIOL CHEM, V270, P2133, DOI 10.1074/jbc.270.5.2133; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; WOODRUFF NR, 1986, BIOCHEMISTRY-US, V25, P7956, DOI 10.1021/bi00372a026; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Yuen EC, 1996, ANN NEUROL, V40, P346, DOI 10.1002/ana.410400304; ZHANG L, 1994, J NEUROSCI, V14, P5187; ZHOU J, 1994, P NATL ACAD SCI USA, V91, P3824, DOI 10.1073/pnas.91.9.3824	72	119	128	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36707	36714		10.1074/jbc.274.51.36707	http://dx.doi.org/10.1074/jbc.274.51.36707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593976	hybrid			2022-12-27	WOS:000084279200095
J	Safaiyan, F; Kolset, SO; Prydz, K; Gottfridsson, E; Lindahl, U; Salmivirta, M				Safaiyan, F; Kolset, SO; Prydz, K; Gottfridsson, E; Lindahl, U; Salmivirta, M			Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-DEACETYLASE/N-SULFOTRANSFERASE; HAMSTER OVARY CELLS; FIBROBLAST GROWTH; PROTEOGLYCANS; EXPRESSION; BINDING; MOUSE; DEPOLYMERIZATION; DIFFERENTIATION; BIOSYNTHESIS	We have analyzed the effect of sodium chlorate treatment of Madin-Darby canine kidney cells on the structure of heparan sulfate (HS), to assess how the various sulfation reactions during HS biosynthesis are affected by decreased availability of the sulfate donor 3'-phosphoadenosine 5'-phosphosulfate. Metabolically [H-3]glucosamine-labeled HS was isolated from chlorate-treated and untreated Madin-Darby canine kidney cells and subjected to low pH nitrous acid cleavage. Saccharides representing (i) the N-sulfated domains, (ii) the domains of alternating N-acetylated and N-sulfated disaccharide units, and (iii) the N-acetylated domains were recovered and subjected to compositional disaccharide analysis. Upon treatment with 50 mM chlorate, overall O-sulfation of HS was inhibited by similar to 70%, whereas N-sulfation remained essentially unchanged. Low chlorate concentrations (5 or 2 mM) selectively reduced the 6-O-sulfation of HS, whereas treatment with 50 mM chlorate reduced both 2-O and 6-O-sulfation. Analysis of saccharides representing the different domain types indicated that 6-O-sulfation was preferentially inhibited in the alternating domains. These data suggest that reduced 3'-phosphoadenosine 5'-phosphosulfate availability has distinct effects on the N- and O-sulfation of HS and that O-sulfation is affected in a domain-specific fashion.	Univ Uppsala, Ctr Biomed, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; Univ Oslo, Inst Nutr Res, N-0316 Oslo, Norway; Univ Oslo, Dept Biochem, N-0316 Oslo, Norway	Uppsala University; University of Oslo; University of Oslo	Salmivirta, M (corresponding author), Turku Ctr Biotechnol, Tykistokatu 6, FIN-20520 Turku, Finland.							Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; Delehedde M, 1996, EXP CELL RES, V229, P398, DOI 10.1006/excr.1996.0385; FARLEY JR, 1978, ARCH BIOCHEM BIOPHYS, V185, P376, DOI 10.1016/0003-9861(78)90180-7; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; GALLAGHER JT, 1992, INT J BIOCHEM, V24, P553, DOI 10.1016/0020-711X(92)90326-V; Girard JP, 1998, FASEB J, V12, P603, DOI 10.1096/fasebj.12.7.603; GREVE H, 1988, J BIOL CHEM, V263, P12886; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; HOOGEWERF AJ, 1991, J BIOL CHEM, V266, P16564; Humphries DE, 1997, BIOCHEM J, V325, P351, DOI 10.1042/bj3250351; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; KATO M, 1994, J BIOL CHEM, V269, P18881; Kispert A, 1996, DEVELOPMENT, V122, P3627; KJELLEN L, 1983, DIABETES, V32, P337, DOI 10.2337/diabetes.32.4.337; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Kobayashi M, 1996, J BIOL CHEM, V271, P7645, DOI 10.1074/jbc.271.13.7645; Kolset SO, 1999, J CELL SCI, V112, P1797; Kreuger J, 1999, GLYCOBIOLOGY, V9, P723, DOI 10.1093/glycob/9.7.723; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; LIDHOLT K, 1989, BIOCHEM J, V261, P999, DOI 10.1042/bj2610999; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; PEJLER G, 1987, J BIOL CHEM, V262, P5036; Petersen F, 1999, J BIOL CHEM, V274, P12376, DOI 10.1074/jbc.274.18.12376; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Salmivirta M, 1998, GLYCOBIOLOGY, V8, P1029, DOI 10.1093/glycob/8.10.1029; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; UhlinHansen L, 1997, J BIOL CHEM, V272, P3200, DOI 10.1074/jbc.272.6.3200; WINTERBOURNE DJ, 1981, J BIOL CHEM, V256, P4310; YANAGISHITA M, 1983, J BIOL CHEM, V258, P2857	40	132	136	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36267	36273		10.1074/jbc.274.51.36267	http://dx.doi.org/10.1074/jbc.274.51.36267			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593915	hybrid			2022-12-27	WOS:000084279200034
J	Stoylova, SS; Lenting, PJ; Kemball-Cook, G; Holzenburg, A				Stoylova, SS; Lenting, PJ; Kemball-Cook, G; Holzenburg, A			Electron crystallography of human blood coagulation factor VIII bound to phospholipid monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURE; HUMAN FACTOR-V; FACTOR-IXA; LIGHT-CHAIN; BINDING-SITE; ACTIVE-SITE; CRYSTAL-STRUCTURE; INTERACTIVE SITE; A1 SUBUNIT; C2 DOMAIN	Coagulation factor WI binds to negatively charged platelets prior to assembly with the serine protease, factor Ma, to form the factor X-activating enzyme (FX-ase) complex. The macromolecular organization of membrane-bound factor VIII has been studied by electron crystallography for the first time. For this purpose two-dimensional crystals of human factor VIII were grown onto phosphatidylserine-containing phospholipid monolayers, under near to physiological conditions (pH and salt concentration), Electron crystallographic analysis revealed that the factor VIII molecules were organized as monomers onto the lipid layer,with unit cell dimensions: a = 81.5 Angstrom, b = 67.2 Angstrom, gamma = 66.5 degrees, P1 symmetry. Based on a homology-derived molecular model of the factor VIII (FVIII) A domains, the FVIII projection structure solved at 15-Angstrom resolution presents the A1, A2, and A3 domain heterotrimer tilted approximately 65 degrees relative to the membrane plane. The A1 domain is projecting on top of the A3, C1, and C2 domains and with the A2 domain protruding partially between A1 and A3. This organization of factor VIII allows the factor IXa protease and epidermal growth factor-like domain binding sites (localized in the A2 and A3 domains, respectively) to be situated at the appropriate position for the binding of factor IXa The conformation of the lipid-bound FVIII is therefore very close to that for the activated factor VIIIa predicted in the FX-ase complex.	Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; CLB, Dept Plasma Prot Technol, NL-1066 CX Amsterdam, Netherlands; Hammersmith Hosp, ICMS, MRC, Ctr Clin Sci,Haemostasis Res Grp, London W12 0NN, England	University of Leeds; University of Leeds; Imperial College London	Stoylova, SS (corresponding author), Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	svetla@bmb.leeds.ac.uk	Lenting, Peter/F-8269-2013; Lenting, Peter/AAH-5663-2019	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429				AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; BRISSON A, 1994, BIOL CELL, V80, P221, DOI 10.1016/0248-4900(94)90045-0; Christophe OD, 1998, J BIOL CHEM, V273, P222, DOI 10.1074/jbc.273.1.222; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FAY PJ, 1989, J BIOL CHEM, V264, P14005; FAY PJ, 1994, J BIOL CHEM, V269, P20522; FAY PJ, 1988, ARCH BIOCHEM BIOPHYS, V262, P525, DOI 10.1016/0003-9861(88)90404-3; FOWLER WE, 1990, P NATL ACAD SCI USA, V87, P7648, DOI 10.1073/pnas.87.19.7648; Gilbert GE, 1996, J BIOL CHEM, V271, P11120, DOI 10.1074/jbc.271.19.11120; HOVMOLLER S, 1992, ULTRAMICROSCOPY, V41, P121, DOI 10.1016/0304-3991(92)90102-P; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; KAUFMAN RJ, 1988, J BIOL CHEM, V263, P6352; Kaufman RJ, 1998, HAEMOPHILIA, V4, P370, DOI 10.1046/j.1365-2516.1998.440370.x; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; Kolkman JA, 1999, BIOCHEM J, V339, P217, DOI 10.1042/0264-6021:3390217; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Lapan KA, 1998, THROMB HAEMOSTASIS, V80, P418, DOI 10.1055/s-0037-1615223; Lenting PJ, 1996, J BIOL CHEM, V271, P25332, DOI 10.1074/jbc.271.41.25332; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; MANN KG, 1993, METHOD ENZYMOL, V222, P1; MANN KG, 1990, BLOOD, V76, P1; MISELL DL, 1978, PRACTICAL METHODS EL, V7; MOSESSON MW, 1990, J CLIN INVEST, V85, P1983, DOI 10.1172/JCI114662; MUTUCUMARANA VP, 1992, J BIOL CHEM, V267, P17012; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OBRIEN LM, 1995, J BIOL CHEM, V270, P27087, DOI 10.1074/jbc.270.45.27087; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; Patek AJ, 1937, J CLIN INVEST, V16, P113, DOI 10.1172/JCI100829; Pellequer JL, 1998, BLOOD CELL MOL DIS, V24, P448, DOI 10.1006/bcmd.1998.0214; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; Saenko EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/jbc.272.29.18007; Saenko EL, 1998, J BIOL CHEM, V273, P27918, DOI 10.1074/jbc.273.43.27918; STOYLOVA S, 1994, FEBS LETT, V351, P330, DOI 10.1016/0014-5793(94)00881-7; Stoylova S, 1998, BBA-PROTEIN STRUCT M, V1383, P175, DOI 10.1016/S0167-4838(97)00219-7; Tagliavacca L, 1997, J BIOL CHEM, V272, P27428, DOI 10.1074/jbc.272.43.27428; TUDDENHAM EGD, 1994, MOL GENTICS HAEMOSTA; Veeraraghavan S, 1998, BIOCHEM J, V332, P549, DOI 10.1042/bj3320549; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; Villoutreix BO, 1998, J MOL MODEL, V4, P268, DOI 10.1007/s008940050084; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018	48	44	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36573	36578		10.1074/jbc.274.51.36573	http://dx.doi.org/10.1074/jbc.274.51.36573			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593957	hybrid			2022-12-27	WOS:000084279200076
J	Subbaiah, PV; Subramanian, VS; Wang, KW				Subbaiah, PV; Subramanian, VS; Wang, KW			Novel physiological function of sphingomyelin in plasma - Inhibition of lipid peroxidation in low density lipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; OXIDATIVE SUSCEPTIBILITY; PHOSPHOLIPASE A(2); HEART-DISEASE; LDL; SUBFRACTIONS; ANTIOXIDANTS; MEMBRANE; AGGREGATION; MECHANISMS	Although sphingomyelin (SPH) is a major constituent of all lipoproteins, its physiological function in plasma is not known. In this study, we tested the hypothesis that SPH inhibits lipid peroxidation in low density lipoproteins (LDL) because of its effects on surface fluidity and packing density and that the relative resistance of the buoyant LDL to oxidation, compared with the dense LDL, is partly due to their higher SPH content, Depletion of SPH by treatment with SPHase resulted in shortened lag times and increased rates of oxidation in both LDL subfractions, as measured by the conjugated diene formation in the presence of Cu2+, Oxidation of LDL by soybean lipoxygenase was similarly stimulated by the degradation of SPH, Oxidation-induced fluorescence decay of diphenylhexatriene-labeled phosphatidylcholine (PC), equilibrated with LDL-PC, was accelerated significantly by the enzymatic depletion of SPH from the lipoprotein, Oxidation of 16:0-18:2 PC in the proteoliposomes was inhibited progressively by the incorporation of increasing amounts of egg SPH into the Liposomes, Treatment of SPH-containing proteoliposomes with SPHase reversed the effect of SPH, showing that the presence of intact SPH is necessary for the inhibition of oxidation, Although the incorporation of SPH into the same liposome as the PC (intrinsic SPH) protected the PC against oxidation, the addition of SPH liposomes to PC liposomes (extrinsic SPH) was not effective. Oxidation of 16:0-18:2 PC in liposomes was also inhibited by the incorporation of dipalmitoyl-PC, but not by fi ee cholesterol, These results suggest that SPH acts as a physiological inhibitor of lipoprotein oxidation, possibly by modifying the fluidity of the phospholipid monolayer and thereby inhibiting the lateral propagation of the lipid peroxy radicals.	Rush Med Coll, Sect Endocrinol & Metab, Dept Med, Chicago, IL 60612 USA; Rush Med Coll, Sect Endocrinol & Metab, Dept Biochem, Chicago, IL 60612 USA	Rush University; Rush University	Subbaiah, PV (corresponding author), Rush Med Coll, Sect Endocrinol & Metab, Dept Med, 1653 W Congress Pkway, Chicago, IL 60612 USA.		Subbaiah, Papasani/U-1104-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052597] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-52597] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arimoto I, 1998, J LIPID RES, V39, P143; AUSTIN MA, 1994, INT J CLIN LAB RES, V24, P187, DOI 10.1007/BF02592460; BARENHOLZ Y, 1984, PHYSL MEMBRANE FLUID, P131; Brown RE, 1998, J CELL SCI, V111, P1; CHAIT A, 1993, AM J MED, V94, P350, DOI 10.1016/0002-9343(93)90144-E; Chang YH, 1997, FREE RADICAL BIO MED, V23, P202, DOI 10.1016/S0891-5849(96)00626-0; CHEN CH, 1982, J LIPID RES, V23, P680; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Fruebis J, 1997, J LIPID RES, V38, P2455; HABERLAND ME, 1992, MONOGR HUM GENET, V14, P35; HOFER G, 1995, FREE RADICAL RES, V23, P317, DOI 10.3109/10715769509065253; JANERO DR, 1989, RES COMMUN CHEM PATH, V63, P163; Jeong TS, 1998, J CLIN INVEST, V101, P905, DOI 10.1172/JCI870; Koumanov K, 1997, BIOCHEM J, V326, P227, DOI 10.1042/bj3260227; LIU M, 1992, J BIOL CHEM, V267, P5139; Lobo LIB, 1997, BBA-LIPID LIPID MET, V1349, P122, DOI 10.1016/S0005-2760(97)00127-6; MARINETTI GV, 1962, J LIPID RES, V3, P1; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MOREL DW, 1994, BIOCHEM BIOPH RES CO, V200, P408, DOI 10.1006/bbrc.1994.1464; MYHER JJ, 1989, LIPIDS, V24, P408, DOI 10.1007/BF02535148; Oorni K, 1998, J BIOL CHEM, V273, P29127, DOI 10.1074/jbc.273.44.29127; Patel RP, 1996, J LIPID RES, V37, P2361; RANKIN SM, 1991, J LIPID RES, V32, P449; REICHL D, 1992, BIOCHIM BIOPHYS ACTA, V1127, P28, DOI 10.1016/0005-2760(92)90197-4; Schissel SL, 1996, J CLIN INVEST, V98, P1455, DOI 10.1172/JCI118934; SLOTTE JP, 1990, J LIPID RES, V31, P2235; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; SUBBAIAH PV, 1993, J BIOL CHEM, V268, P20156; SUBBAIAH PV, 1992, BIOCHIM BIOPHYS ACTA, V1128, P83, DOI 10.1016/0005-2760(92)90261-S; TRIBBLE DL, 1992, ATHEROSCLEROSIS, V93, P189, DOI 10.1016/0021-9150(92)90255-F; TRIBBLE DL, 1995, J LIPID RES, V36, P662; TRIBBLE DL, 1994, P NATL ACAD SCI USA, V91, P1183, DOI 10.1073/pnas.91.3.1183; WISEMAN H, 1993, FEBS LETT, V330, P53, DOI 10.1016/0014-5793(93)80918-K	35	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36409	36414		10.1074/jbc.274.51.36409	http://dx.doi.org/10.1074/jbc.274.51.36409			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593936	hybrid			2022-12-27	WOS:000084279200055
J	Vanoni, M; Bertini, R; Sacco, E; Fontanella, L; Rieppi, M; Colombo, S; Martegani, E; Carrera, V; Moroni, A; Bizzarri, C; Sabbatini, V; Cattozzo, M; Colagrande, A; Alberghina, L				Vanoni, M; Bertini, R; Sacco, E; Fontanella, L; Rieppi, M; Colombo, S; Martegani, E; Carrera, V; Moroni, A; Bizzarri, C; Sabbatini, V; Cattozzo, M; Colagrande, A; Alberghina, L			Characterization and properties of dominant-negative mutants of the Ras-specific guanine nucleotide exchange factor CDC25(Mm)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE CELL-PROLIFERATION; SDC25 C-DOMAIN; SACCHAROMYCES-CEREVISIAE; TYROSINE-KINASE; CORONARY ANGIOPLASTY; SIGNALING PATHWAY; MOLECULAR-CLONING; GENE-EXPRESSION; PROTEINS; ACTIVATION	Res proteins are small GTPases playing a pivotal role in cell proliferation and differentiation. Their activation depends on the competing action of GTPase activating proteins and guanine nucleotide exchange factors (GEF). The properties of two dominant-negative mutants within the catalytic domains of the ras-specific GEF, CDC25(Mm), are described. In vitro, the mutant GEF(W1056E) and GEF(T1184E) proteins are catalytically inactive, are able to efficiently displace wild-type GEF from p21(ras), and strongly reduce affinity of the nucleotide-free ras GEF complex for the incoming nucleotide, thus resulting in the formation of a stable ras GEF binary complex. Consistent with their in vitro properties, the two mutant GEFs bring about a dramatic reduction in ras-dependent fos-luciferase activity in mouse fibroblasts. The stable ectopic expression of the GEF(W1056E) mutant in smooth muscle cells effectively reduced growth rate and DNA synthesis with no detectable morphological changes.	Univ Milan Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy; Consorzio Biolaq, Laquila, Italy; Ctr Ric Dompe, Laquila, Italy	University of Milano-Bicocca; Dompe	Alberghina, L (corresponding author), Univ Milan Bicocca, Dipartimento Biotecnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.		Sacco, Elena/T-3274-2018	Sacco, Elena/0000-0002-3190-7671; VANONI, MARCO ERCOLE/0000-0002-8690-2587; Martegani, Enzo/0000-0001-9196-4224; Alberghina, Lilia/0000-0003-1694-931X; Colombo, Sonia/0000-0001-5104-508X				Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BARLAT I, 1993, ONCOGENE, V8, P215; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CAMONIS JH, 1990, GENE, V86, P263, DOI 10.1016/0378-1119(90)90288-3; CAMUS C, 1995, ONCOGENE, V11, P951; Carrera V, 1998, FEBS LETT, V440, P291, DOI 10.1016/S0014-5793(98)01481-1; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; Crechet JB, 1996, J BIOL CHEM, V271, P17234, DOI 10.1074/jbc.271.29.17234; DAMAK F, 1991, MOL CELL BIOL, V11, P202, DOI 10.1128/MCB.11.1.202; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; FEIG LA, 1994, CURR OPIN CELL BIOL, V6, P204, DOI 10.1016/0955-0674(94)90137-6; FRASCOTTI G, 1991, BIOCHIM BIOPHYS ACTA, V1089, P206, DOI 10.1016/0167-4781(91)90009-B; Freshney NW, 1997, FEBS LETT, V407, P111, DOI 10.1016/S0014-5793(97)00309-8; Giglione C, 1997, J BIOL CHEM, V272, P25128, DOI 10.1074/jbc.272.40.25128; Giglione C, 1998, J BIOL CHEM, V273, P34737, DOI 10.1074/jbc.273.52.34737; INDOLFI C, 1995, NAT MED, V1, P541, DOI 10.1038/nm0695-541; IRANI K, 1994, BIOCHEM BIOPH RES CO, V202, P1252, DOI 10.1006/bbrc.1994.2065; JACQUET E, 1992, J BIOL CHEM, V267, P24181; JACQUET E, 1995, BIOCHEMISTRY-US, V34, P12347, DOI 10.1021/bi00038a031; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Leonardsen L, 1996, ONCOGENE, V13, P2177; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MARTEGANI E, 1986, EMBO J, V5, P2363, DOI 10.1002/j.1460-2075.1986.tb04505.x; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MCBRIDE W, 1988, NEW ENGL J MED, V318, P1734, DOI 10.1056/NEJM198806303182606; MEDEMA RH, 1991, MOL CELL BIOL, V11, P5963, DOI 10.1128/MCB.11.12.5963; MISTOU MY, 1992, EMBO J, V11, P2391, DOI 10.1002/j.1460-2075.1992.tb05303.x; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; Park WM, 1997, ONCOGENE, V14, P831, DOI 10.1038/sj.onc.1200893; PARK WM, 1994, MOL CELL BIOL, V14, P8117, DOI 10.1128/MCB.14.12.8117; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; SAKAUE M, 1995, MOL CELL BIOL, V15, P379, DOI 10.1128/MCB.15.1.379; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHWEIGHOFFER F, 1993, ONCOGENE, V8, P1477; SEGAL M, 1995, EUR J BIOCHEM, V228, P96, DOI 10.1111/j.1432-1033.1995.tb20235.x; Sherman F., 1986, METHODS YEAST GENETI; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Sturani E, 1997, EXP CELL RES, V235, P117, DOI 10.1006/excr.1997.3660; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; VIRMANI R, 1994, AM HEART J, V127, P163, DOI 10.1016/0002-8703(94)90522-3; ZIPPEL R, 1994, INT J ONCOL, V4, P175; Zippel R, 1996, ONCOGENE, V12, P2697	53	21	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36656	36662		10.1074/jbc.274.51.36656	http://dx.doi.org/10.1074/jbc.274.51.36656			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593969	hybrid			2022-12-27	WOS:000084279200088
J	Ying, ZT; Mulligan, RM; Janney, N; Houtz, RL				Ying, ZT; Mulligan, RM; Janney, N; Houtz, RL			Rubisco small and large subunit N-methyltransferases - Bi- and mono-functional methyltransferases that methylate the small and large subunits of Rubisco	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE; EPSILON-METHYLTRANSFERASE; MESSENGER-RNA; BINDING MOTIF; CHLOROPLASTS; GENE; PURIFICATION; ORGANIZATION; PROTEINS; ENZYME	Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco)is methylated at the alpha-amino group of the N-terminal methionine of the processed form of the small subunit (SS), and at the epsilon-amino group of lysine-14 of the large subunit (LS) in some species. The Rubisco LS methyltransferase (LSMT) gene has been cloned and ex pressed from pea and specifically methylates lysine-14 of the LS of Rubisco. We determine here that both pea and tobacco Rubisco LSMT also exhibit N-alpha-methyltransferase activity toward the SS of Rubisco, suggesting that a single gene product can produce a bifunctional protein methyltransferase capable of catalyzing both N-alpha-methylation of the SS and N-epsilon-methylation of the LS. A homologue of the Rubisco LSMT gene (rbcMT-S) has also been identified in spinach that is closely related to Rubisco LSMT sequences from pea and tobacco. Two mRNAs are produced from rbcMT-S, and both long and short forms of the spinach cDNAs were expressed in Escherichia coli cells and shown to catalyze methylation of the alpha-amino group of the N-terminal methionine of the SS of Rubisco. Thus, the absence of lysine-14 methylation in species like spinach is apparently a consequence of a monofunctional protein methyltransferase incapable of methylating Lys-14, with activity limited to methylation of the SS.	Univ Kentucky, Dept Hort, Plant Physiol Biochem Mol Biol Program, Lexington, KY 40546 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of Kentucky; University of California System; University of California Irvine	Houtz, RL (corresponding author), Univ Kentucky, Dept Hort, Plant Physiol Biochem Mol Biol Program, N318 Agr Sci N, Lexington, KY 40546 USA.							BACK E, 1988, MOL GEN GENET, V212, P20, DOI 10.1007/BF00322440; Brown JWS, 1996, PLANT J, V10, P771, DOI 10.1046/j.1365-313X.1996.10050771.x; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; Grimm R, 1997, FEBS LETT, V408, P350, DOI 10.1016/S0014-5793(97)00462-6; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; HOUTZ RL, 1992, PLANT PHYSIOL, V98, P1170, DOI 10.1104/pp.98.3.1170; HOUTZ RL, 1991, PLANT PHYSIOL, V97, P913, DOI 10.1104/pp.97.3.913; HOUTZ RL, 1989, P NATL ACAD SCI USA, V86, P1855, DOI 10.1073/pnas.86.6.1855; HUBBS A, 1992, PLANT PHYSIOL, V100, P272, DOI 10.1104/pp.100.1.272; Keeling PJ, 1996, TRENDS BIOCHEM SCI, V21, P285; KLEIN RR, 1995, PLANT MOL BIOL, V27, P249, DOI 10.1007/BF00020181; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kohler RH, 1997, SCIENCE, V276, P2039, DOI 10.1126/science.276.5321.2039; LIU XQ, 1986, PLANT PHYSIOL, V81, P603, DOI 10.1104/pp.81.2.603; Lory S, 1997, GENE, V192, P117, DOI 10.1016/S0378-1119(96)00830-X; Martin W, 1996, PLANT MOL BIOL, V32, P485, DOI 10.1007/BF00019100; MILLS WR, 1980, PLANTA, V148, P75, DOI 10.1007/BF00385445; MULLIGAN RM, 1988, P NATL ACAD SCI USA, V85, P1513, DOI 10.1073/pnas.85.5.1513; PAIK WK, 1990, PROTEIN METHYLATION; PETTIGREW GW, 1977, NATURE, V265, P661, DOI 10.1038/265661a0; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT GW, 1983, P NATL ACAD SCI-BIOL, V80, P2632, DOI 10.1073/pnas.80.9.2632; Simpson GG, 1996, PLANT MOL BIOL, V32, P1, DOI 10.1007/BF00039375; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; STOCK A, 1988, ADV POSTTRANSLATIONA, P201; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; VANDERVERE PS, 1995, P NATL ACAD SCI USA, V92, P7177, DOI 10.1073/pnas.92.16.7177; VANET A, 1994, MOL MICROBIOL, V14, P947, DOI 10.1111/j.1365-2958.1994.tb01330.x; VESK MARET, 1965, AUSTRALIAN J BOT, V13, P161; WANG P, 1995, PROTEIN EXPRES PURIF, V6, P528, DOI 10.1006/prep.1995.1070; WEIER TE, 1962, AM J BOT, V49, P807, DOI 10.2307/2439692; WILDMAN SG, 1962, SCIENCE, V138, P434, DOI 10.1126/science.138.3538.434; Ying ZT, 1996, GENE, V171, P243, DOI 10.1016/0378-1119(95)00891-8; Ying ZT, 1996, PLANT MOL BIOL, V32, P663, DOI 10.1007/BF00020207	37	49	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36750	36756		10.1074/jbc.274.51.36750	http://dx.doi.org/10.1074/jbc.274.51.36750			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593982	hybrid, Green Submitted			2022-12-27	WOS:000084279200101
J	Georgellis, D; Kwon, O; Lin, ECC				Georgellis, D; Kwon, O; Lin, ECC			Amplification of signaling activity of the are two-component system of Escherichia coli by anaerobic metabolites - An in vitro study with different protein modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSOR PROTEIN; TRANSDUCTION SYSTEM; REGULATOR PROTEIN; AEROBIC PATHWAYS; DNA-BINDING; ARCB; PHOSPHORYLATION; PHOSPHORELAY; REPRESSION; TRANSPHOSPHORYLATION	In Escherichia coli, changes in redox condition of growth are sensed and signaled by the Are two-component system. This system consists of ArcB as the membrane-associated sensor kinase and ArcA as the cytoplasmic response regulator. ArcB is a tripartite kinase, possessing a primary transmitter, a receiver, and a secondary transmitter domain that catalyzes the phosphorylation of ArcA via a His --> Asp --> His --> Asp phosphorelay, as well as the dephosphorylation of ArcA-P by a reverse phosphorelay. When ArcA and ArcB were incubated with ATP, the peak levels of phosphorylated proteins increased in the presence of the fermentation metabolites D-lactate, acetate, or pyruvate. In this study, we report that these effecters accelerate the autophosphorylation activity of ArcB and enhance the transphosphorylation of ArcA, but have no effect on the dephosphorylation of ArcA-P. Moreover, the presence of the receiver domain of ArcB is essential for the effecters to influence the autophosphorylation rate of the primary transmitter domain of ArcB.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lin, ECC (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.		Georgellis, Dimitris/U-2517-2017	Georgellis, Dimitris/0000-0002-6114-795X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030693, R01GM040993] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30693, GM40993] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Hoch JA, 1995, 2 COMPONENT SIGNAL T; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; IUCHI S, 1992, J BACTERIOL, V174, P3972, DOI 10.1128/jb.174.12.3972-3980.1992; IUCHI S, 1993, J BIOL CHEM, V268, P23972; IUCHI S, 1990, MOL MICROBIOL, V4, P715, DOI 10.1111/j.1365-2958.1990.tb00642.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lin ECC, 1996, ESCHERICHIA COLI SAL, P1526; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Matsushika A, 1998, J BACTERIOL, V180, P3973, DOI 10.1128/JB.180.15.3973-3977.1998; McGuire AM, 1999, MOL MICROBIOL, V32, P219, DOI 10.1046/j.1365-2958.1999.01347.x; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x	17	78	79	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35950	35954		10.1074/jbc.274.50.35950	http://dx.doi.org/10.1074/jbc.274.50.35950			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585483	Green Submitted, hybrid			2022-12-27	WOS:000084187900095
J	Aono, S; Keino, H; Ono, T; Yasuda, Y; Tokita, Y; Matsui, F; Taniguchi, M; Sonta, SI; Oohira, A				Aono, S; Keino, H; Ono, T; Yasuda, Y; Tokita, Y; Matsui, F; Taniguchi, M; Sonta, SI; Oohira, A			Genomic organization and expression pattern of mouse neuroglycan C in the cerebellar development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; PROTEIN-TYROSINE-PHOSPHATASE; IN-SITU HYBRIDIZATION; O2A PROGENITOR CELLS; PDGF ALPHA-RECEPTOR; EXTRACELLULAR VARIANT; NG2 PROTEOGLYCAN; RAT-BRAIN; BETA; ASSIGNMENT	Neuroglycan C (NGC) is a membrane-spanning chondroitin sulfate proteoglycan with an epidermal growth factor module that is expressed predominantly in the brain. Cloning studies with mouse NGC cDNA revealed the expression of three distinct isoforms (NGC-I, -II, and -III) in the brain and revealed that the major isoform showed 94.3% homology with the rat counterpart. The NGC gene comprised six exons, was approximately 17 kilobases in size, and was assigned to mouse chromosome band 9F1 by fluorescence in situ hybridization, Western blot analysis demonstrated that, although NGC in the immature cerebellum existed in a proteoglycan form, most NGC in the mature cerebellum did not bear chondroitin sulfate chain(s), indicating that NGC is a typical part-time proteoglycan, Immunohistochemical studies showed that only the Purkinje cells were immunopositive in the cerebellum. In the immature Purkinje cells, NGC, probably the proteoglycan form, was immunolocalized to the soma and thick dendrites on which the climbing fibers formed synapses, not to the thin branches on which the parallel fibers formed synapses, This finding suggests the involvement of NGC in the differential adhesion and synaptogenesis of the climbing and parallel fibers with the Purkinje cell dendrites.	Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Aichi 4800392, Japan; Aichi Human Serv Ctr, Inst Dev Res, Dept Genet, Aichi 4800392, Japan; Aichi Human Serv Ctr, Inst Dev Res, Dept Morphol, Aichi 4800392, Japan		Aono, S (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Aichi 4800392, Japan.		Ono, Takao/C-6065-2017	Ono, Takao/0000-0002-0498-8293				BARNEA G, 1994, J BIOL CHEM, V269, P14349; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; DAVISSON MT, 1991, CYTOGENET CELL GENET, V58, P1152, DOI 10.1159/000133726; Ito M., 1984, CEREBELLUM NEURAL CO, P21; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; MARGOLIS RK, 1993, EXPERIENTIA, V49, P429, DOI 10.1007/BF01923587; Margolis RU, 1997, CELL TISSUE RES, V290, P343, DOI 10.1007/s004410050939; MATSUDA Y, 1992, CYTOGENET CELL GENET, V61, P282, DOI 10.1159/000133423; MATSUI F, 1994, NEUROCHEM INT, V25, P425, DOI 10.1016/0197-0186(94)90018-3; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; NESBITT MN, 1973, CHROMOSOMA, V41, P145, DOI 10.1007/BF00319691; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; ONO T, 1993, JPN J GENET, V68, P617, DOI 10.1266/jjg.68.617; Ono T, 1997, CYTOGENET CELL GENET, V79, P101, DOI 10.1159/000134692; OOHIRA A, 1994, NEUROSCI RES, V20, P195, DOI 10.1016/0168-0102(94)90088-4; OOHIRA A, 1998, CONNECT TISSUE, V30, P49; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Small DH, 1996, J NEUROCHEM, V67, P889; STALLCUP WB, 1981, DEV BIOL, V83, P154, DOI 10.1016/S0012-1606(81)80018-8; WATANABE E, 1995, J BIOL CHEM, V270, P26876, DOI 10.1074/jbc.270.45.26876; Yasuda Y, 1998, NEUROSCI RES, V32, P313, DOI 10.1016/S0168-0102(98)00098-4	24	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					337	342		10.1074/jbc.275.1.337	http://dx.doi.org/10.1074/jbc.275.1.337			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617623	hybrid			2022-12-27	WOS:000085951600047
J	Johnson, RP; Craig, SW				Johnson, RP; Craig, SW			Actin activates a cryptic dimerization potential of the vinculin tail domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ASSOCIATION; ACIDIC PHOSPHOLIPIDS; BINDING-SITE; SIGNAL-TRANSDUCTION; ELECTRON-MICROSCOPY; SELF-ASSOCIATION; PROTEIN VINCULIN; FOCAL ADHESIONS; SMOOTH-MUSCLE; TALIN-BINDING	The tail domain of vinculin (V-t) is an actin binding module containing two regions that interact with F-actin. Although intact V-t purified from a bacterial expression system is a globular monomer, each actin binding region dimerizes when expressed individually, suggesting the presence of cryptic self-association sites whose exposure is regulated. We show that actin modulates V-t self-association by inducing or stabilizing a conformational change in V-t that allows dimerization. Chemical cross-linking studies implicate one of the actin binding regions in mediating dimerization in the presence of actin. Actin induced V-t dimers may play a role in the filament cross-linking activity of this protein. The V-t dimers induced by actin are biochemically distinct from the V-t dimers and higher oligomers induced by acidic phospholipids such as phosphatidylinositol 4,5-bisphosphate, suggesting structural differences in V-t bound to these two ligands that may provide a mechanistic basis for inhibition of F-actin binding by phosphatidylinositol 4,5-bisphosphate. The ability of actin to regulate the dimerization state of an actin binding protein suggests that, rather than serving a passive structural role, actin filaments may directly participate in signal transduction and other cellular events that are known to depend on cytoskeletal integrity.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Craig, SW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.				NIGMS NIH HHS [GM41605] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041605, R56GM041605] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COUTU MD, 1988, P NATL ACAD SCI USA, V85, P8535, DOI 10.1073/pnas.85.22.8535; DANOWSKI BA, 1992, J CELL BIOL, V118, P1411, DOI 10.1083/jcb.118.6.1411; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; EVANS RR, 1984, J BIOL CHEM, V259, P3916; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; Furukawa R, 1997, INT REV CYTOL, V175, P29, DOI 10.1016/S0074-7696(08)62125-7; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gilmore AP, 1996, STRUCTURE, V4, P647, DOI 10.1016/S0969-2126(96)00069-X; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; GIMONA M, 1987, J MUSCLE RES CELL M, V8, P329, DOI 10.1007/BF01568889; GROESCH ME, 1990, CELL MOTIL CYTOSKEL, V15, P41, DOI 10.1002/cm.970150107; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; JOHNSON RA, 1995, ENVIRONMETRICS, V6, P341, DOI 10.1002/env.3170060403; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1995, BIOCHEM BIOPH RES CO, V210, P159, DOI 10.1006/bbrc.1995.1641; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; MAGENDANTZ M, 1995, J BIOL CHEM, V270, P25324, DOI 10.1074/jbc.270.43.25324; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; MENKEL AR, 1994, J CELL BIOL, V126, P1231, DOI 10.1083/jcb.126.5.1231; MILAM LM, 1985, J MOL BIOL, V184, P543, DOI 10.1016/0022-2836(85)90301-8; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; OTTO JJ, 1994, CURR OPIN CELL BIOL, V6, P105, DOI 10.1016/0955-0674(94)90123-6; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 1996, METHOD ENZYMOL, V266, P525; Sanders MC, 1996, J BIOL CHEM, V271, P2651, DOI 10.1074/jbc.271.5.2651; SCHMID MF, 1994, J CELL BIOL, V124, P341, DOI 10.1083/jcb.124.3.341; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; TEMPEL M, 1995, BIOPHYS J, V69, P228, DOI 10.1016/S0006-3495(95)79894-0; Tilney LG, 1998, J CELL BIOL, V143, P121, DOI 10.1083/jcb.143.1.121; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042; Xu WM, 1998, J CELL SCI, V111, P1535; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3	47	63	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					95	105		10.1074/jbc.275.1.95	http://dx.doi.org/10.1074/jbc.275.1.95			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617591	hybrid			2022-12-27	WOS:000085951600015
J	Lau, D; Kunzler, M; Braunwarth, A; Hellmuth, R; Podtelejnikov, A; Mann, M; Hurt, E				Lau, D; Kunzler, M; Braunwarth, A; Hellmuth, R; Podtelejnikov, A; Mann, M; Hurt, E			Purification of protein A-tagged yeast Ran reveals association with a novel karyopherin beta family member, Pdr6p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSPORT; BINDING-PROTEINS; IMPORT RECEPTOR; RNA; PHOSPHORYLATION; LOCALIZATION; RELEASE; COMPLEX	The small GTPase Ran (encoded by GSP1 and GSP2 in yeast) plays a central role in nucleocytoplasmic transport. GSP1 and GSP2 were tagged with protein A and functionally expressed in a gsp1 null mutant. After affinity purification of protein A-tagged Gsp1p or Gsp2p by IgG-Sepharose chromatography, known karyopherin beta transport receptors (e.g. Kap121p and Kap123p) and a novel member of this protein family, Pdr6p, were found to be associated with yeast Ran. Subsequent tagging of Pdr6p with green fluorescent protein revealed association with the nuclear pore complexes in vivo, Thus, functional tagging of yeast Ran allowed the study of its in vivo distribution and interaction with known and novel Ran-binding proteins.	Zentrum Biochem Heidelberg, D-69120 Heidelberg, Germany; Odense Univ, Ctr Expt Bioinformat, DK-5230 Odense, Denmark	University of Southern Denmark	Hurt, E (corresponding author), Zentrum Biochem Heidelberg, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	cg5@ix.urz.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019; Mann, Matthias/A-3454-2013; Podtelejnikov, Alexandre/B-6120-2017	Ed Hurt, Dr./0000-0002-4535-8255; Mann, Matthias/0000-0003-1292-4799; Podtelejnikov, Alexandre/0000-0002-8124-6584; Kunzler, Markus/0000-0003-1275-0629				BALZI E, 1991, BIOCHIM BIOPHYS ACTA, V1073, P241, DOI 10.1016/0304-4165(91)90128-4; BELHUMEUR P, 1993, MOL CELL BIOL, V13, P2152, DOI 10.1128/MCB.13.4.2152; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; KADOWAKI T, 1993, EMBO J, V12, P2929, DOI 10.1002/j.1460-2075.1993.tb05955.x; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Koepp DM, 1996, CELL, V87, P1, DOI 10.1016/S0092-8674(00)81315-X; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Maniatis T., 1982, MOL CLONING; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MELCHIOR F, 1995, CURR OPIN CELL BIOL, V7, P310, DOI 10.1016/0955-0674(95)80084-0; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; Sazer S, 1996, TRENDS CELL BIOL, V6, P81, DOI 10.1016/0962-8924(96)80992-5; Scherf U, 1998, BIOCHEM BIOPH RES CO, V250, P623, DOI 10.1006/bbrc.1998.9367; SCHLENSTEDT G, 1995, P NATL ACAD SCI USA, V92, P225, DOI 10.1073/pnas.92.1.225; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Simos G, 1996, EMBO J, V15, P2270, DOI 10.1002/j.1460-2075.1996.tb00580.x; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416	31	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					467	471		10.1074/jbc.275.1.467	http://dx.doi.org/10.1074/jbc.275.1.467			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617640	hybrid			2022-12-27	WOS:000085951600064
J	Xu, YY; Circolo, A; Jing, H; Wang, Y; Narayana, SVL; Volanakis, JE				Xu, YY; Circolo, A; Jing, H; Wang, Y; Narayana, SVL; Volanakis, JE			Mutational analysis of the primary substrate specificity pocket of complement factor B - Asp(226) is a major structural determinant for P-1-Arg binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATHEPSIN-G; CRYSTAL-STRUCTURE; COLLAGENOLYTIC SERINE-PROTEASE-1; DIRECTED MUTAGENESIS; SERINE PROTEASES; PROTEIN-B; TRYPSIN; SITE; CHYMOTRYPSIN; RESOLUTION	Factor B is a serine protease, which despite its trypsin-like specificity has Asn instead of the typical Asp at the bottom of the S-1 pocket (position 189, chymotrypsinogen numbering). Asp residues are present at positions 187 and 226 and either one could conceivably provide the negative charge for binding the P-1-Arg of the substrate. Determination of the crystal structure of the factor B serine protease domain has revealed that the side chain of Asp(226) is within the S-1 pocket, whereas Asp(187) is located outside the pocket. To investigate the possible role of these atypical structural features in substrate binding and catalysis, we constructed a panel of mutants of these residues. Replacement of Asp(187) caused moderate (50-60%) decrease in hemolytic activity, compared with wild type factor B, whereas replacement of Asn(189) resulted in more profound reductions (71-95%). Substitutions at these two positions did not significantly affect assembly of the alternative pathway C3 convertase. In contrast, elimination of the negative charge from Asp(296) completely abrogated hemolytic activity and also affected formation of the C3 convertase. Kinetic analyses of the hydrolysis of a P-1-Arg containing thioester by selected mutants confirmed that residue Asp(226) is a primary structural determinant for P-1-Arg binding and catalysis.	Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; Univ Alabama, Ctr Macromol Crystallog, Birmingham, AL 35294 USA; Harvard Univ, Sch Med, Ctr Blood Res, Cambridge, MA 02138 USA; Biomed Sci Res Ctr A Fleming, Vari 16672, Greece	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Alexander Fleming Biomedical Sciences Research Center	Xu, YY (corresponding author), Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, THT,Rm 437,1900 Univ Blvd, Birmingham, AL 35294 USA.				NIAID NIH HHS [AI21067, AI39818] Funding Source: Medline; NIAMS NIH HHS [P60AR20614] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039818, R01AI021067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020614] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AGRAWAL A, 1992, J BIOL CHEM, V267, P25353; Arlaud GJ, 1998, ADV IMMUNOL, V69, P249, DOI 10.1016/S0065-2776(08)60609-4; CAPORALE LH, 1981, J IMMUNOL, V126, P1963; CIRCOLO A, 1997, COMPLEMENT PRACTICAL, P199; COHEN GH, 1981, J MOL BIOL, V148, P449, DOI 10.1016/0022-2836(81)90186-8; COOPER NR, 1975, BIOCHEMISTRY-US, V14, P4245, DOI 10.1021/bi00690a015; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; Czapinska H, 1999, EUR J BIOCHEM, V260, P571, DOI 10.1046/j.1432-1327.1999.00160.x; EVNIN LB, 1990, P NATL ACAD SCI USA, V87, P6659, DOI 10.1073/pnas.87.17.6659; Fujinaga M, 1996, J MOL BIOL, V261, P267, DOI 10.1006/jmbi.1996.0458; GRAF L, 1987, BIOCHEMISTRY-US, V26, P2616, DOI 10.1021/bi00383a031; GRAF L, 1988, P NATL ACAD SCI USA, V85, P4961, DOI 10.1073/pnas.85.14.4961; GREER J, 1990, PROTEINS, V7, P317, DOI 10.1002/prot.340070404; GRESHAM HD, 1986, ANAL BIOCHEM, V154, P454, DOI 10.1016/0003-2697(86)90014-X; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; HORIUCHI T, 1993, MOL IMMUNOL, V30, P1587; Hourcade DE, 1998, J BIOL CHEM, V273, P25996, DOI 10.1074/jbc.273.40.25996; IKARI N, 1983, BIOCHIM BIOPHYS ACTA, V742, P318, DOI 10.1016/0167-4838(83)90317-5; ITAKURA K, 1984, ANNU REV BIOCHEM, V53, P323; Jing H, 1999, EMBO J, V18, P804, DOI 10.1093/emboj/18.4.804; KAM CM, 1987, J BIOL CHEM, V262, P3444; KIM S, 1994, BIOCHEMISTRY-US, V33, P14393, DOI 10.1021/bi00252a004; KULICS J, 1994, IMMUNOLOGY, V82, P509; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; PERONA JJ, 1993, J MOL BIOL, V230, P934, DOI 10.1006/jmbi.1993.1211; Polanowska J, 1998, BBA-PROTEIN STRUCT M, V1386, P189, DOI 10.1016/S0167-4838(98)00085-5; RAPP HJ, 1970, MOL BASIS COMPLEMENT; SCHELLENBERGER V, 1991, EUR J BIOCHEM, V199, P623, DOI 10.1111/j.1432-1033.1991.tb16163.x; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TSU CA, 1994, J BIOL CHEM, V269, P19565; Tsu CA, 1997, BIOCHEMISTRY-US, V36, P5393, DOI 10.1021/bi961753u; Tuckwell DS, 1997, BIOCHEMISTRY-US, V36, P6605, DOI 10.1021/bi963155l; UEDA A, 1987, J IMMUNOL, V138, P1143; Volanakis J E, 1989, Year Immunol, V4, P218; VOLANAKIS JE, 1987, ANAL BIOCHEM, V163, P242, DOI 10.1016/0003-2697(87)90119-9; Volanakis JE, 1998, HUMAN COMPLEMENT SYS, V20, P9, DOI DOI 10.1201/B14212-3; Xu YY, 1997, J IMMUNOL, V158, P5958; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	40	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					378	385		10.1074/jbc.275.1.378	http://dx.doi.org/10.1074/jbc.275.1.378			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617628	hybrid			2022-12-27	WOS:000085951600052
J	Armulik, A; Nilsson, I; von Heijne, G; Johansson, S				Armulik, A; Nilsson, I; von Heijne, G; Johansson, S			Determination of the border between the transmembrane and cytoplasmic domains of human integrin subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CORE-GLYCOSYLATION EFFICIENCY; OUT SIGNAL-TRANSDUCTION; MAJOR COAT PROTEIN; CELL-ADHESION; AMINO-ACID; TYROSINE PHOSPHORYLATION; AMPHIPATHIC HELIX; ALPHA-ACTININ; MEMBRANE	In this study we have determined the position of the C-terminal end of the transmembrane domains of human integrin subunits (alpha 2, alpha 5, beta 1, beta 2) in microsomal membranes using the glycosylation mapping technique. In contrast to the common view, the transmembrane helices were found to extend roughly to Phe(1129) in alpha 2, to Phe(1026) in alpha 5, to Ile(757) in beta 1, and to His(728) in beta 2. The alpha-carbon of the conserved lysine present near the C-terminal end of the transmembrane helix (Lys(1125) in alpha 2, Lys(1022) in alpha 5, Lys(752) in beta 1, and Lys(724) in beta 2) is buried in the plasma membrane, and the charged amino group most likely reaches into the polar head-group region of the lipid bilayer. A possible role for the conserved lysine in integrin function is discussed.	Univ Uppsala, Ctr Biomed, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; Univ Stockholm, Dept Biochem, S-10691 Stockholm, Sweden; Karolinska Inst, NOVUM, Dept Biosci, S-14157 Huddinge, Sweden	Uppsala University; Stockholm University; Karolinska Institutet	Johansson, S (corresponding author), Univ Uppsala, Ctr Biomed, Dept Med Biochem & Microbiol, Box 575, S-75123 Uppsala, Sweden.		von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019	von Heijne, Gunnar/0000-0002-4490-8569; Keller, Annika/0000-0003-1466-3633				ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; Briesewitz R, 1996, MOL BIOL CELL, V7, P1499, DOI 10.1091/mbc.7.10.1499; CHEN YP, 1994, J BIOL CHEM, V269, P18307; COPPOLINO M, 1995, J BIOL CHEM, V270, P23132, DOI 10.1074/jbc.270.39.23132; Coppolino MG, 1999, BIOCHEM J, V340, P41, DOI 10.1042/0264-6021:3400041; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; deMelker AA, 1997, BIOCHEM J, V328, P529, DOI 10.1042/bj3280529; FERNANDEZ C, 1998, FRONT BIOSCI, V3, P684; GAVEL Y, 1988, FEBS LETT, V235, P173, DOI 10.1016/0014-5793(88)81257-2; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Haas TA, 1997, PROTEIN ENG, V10, P1395, DOI 10.1093/protein/10.12.1395; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; Hemler ME, 1996, BBA-REV CANCER, V1287, P67, DOI 10.1016/0304-419X(96)00007-8; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; KASSNER PD, 1994, J BIOL CHEM, V269, P19859; KAWAGUCHI S, 1994, MOL BIOL CELL, V5, P977, DOI 10.1091/mbc.5.9.977; KAWAGUCHI S, 1993, J BIOL CHEM, V268, P16279; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; LILJESTROM P, 1991, J VIROL, V65, P147; Lu CF, 1997, J IMMUNOL, V159, P268; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; MISHRA VK, 1994, J BIOL CHEM, V269, P7185; Monne M, 1998, J MOL BIOL, V284, P1177, DOI 10.1006/jmbi.1998.2218; Nilsson I, 1998, J MOL BIOL, V284, P1165, DOI 10.1006/jmbi.1998.2217; OTEY CA, 1993, J BIOL CHEM, V268, P21193; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PARDI R, 1995, J IMMUNOL, V155, P1252; PETER K, 1995, J EXP MED, V181, P315, DOI 10.1084/jem.181.1.315; Reddy KB, 1998, J BIOL CHEM, V273, P35039, DOI 10.1074/jbc.273.52.35039; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; SHAW ARE, 1995, J BIOL CHEM, V270, P24092, DOI 10.1074/jbc.270.41.24092; SHAW LM, 1995, J BIOL CHEM, V270, P23648, DOI 10.1074/jbc.270.40.23648; Spruijt RB, 1996, BIOCHEMISTRY-US, V35, P10383, DOI 10.1021/bi960410t; Stopar D, 1996, BIOCHEMISTRY-US, V35, P15467, DOI 10.1021/bi961770j; VUORI K, 1993, J BIOL CHEM, V268, P21459; Wennerberg K, 1998, J CELL SCI, V111, P1117; Williams Michael J., 1994, Trends in Cell Biology, V4, P109, DOI 10.1016/0962-8924(94)90059-0; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161	50	63	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37030	37034		10.1074/jbc.274.52.37030	http://dx.doi.org/10.1074/jbc.274.52.37030			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601259	hybrid			2022-12-27	WOS:000084382700030
J	Huang, XD; Cuajungco, MP; Atwood, CS; Hartshorn, MA; Tyndall, JDA; Hanson, GR; Stokes, KC; Leopold, M; Multhaup, G; Goldstein, LE; Scarpa, RC; Saunders, AJ; Lim, J; Moir, RD; Glabe, C; Bowden, EF; Masters, CL; Fairlie, DP; Tanzi, RE; Bush, AI				Huang, XD; Cuajungco, MP; Atwood, CS; Hartshorn, MA; Tyndall, JDA; Hanson, GR; Stokes, KC; Leopold, M; Multhaup, G; Goldstein, LE; Scarpa, RC; Saunders, AJ; Lim, J; Moir, RD; Glabe, C; Bowden, EF; Masters, CL; Fairlie, DP; Tanzi, RE; Bush, AI			Cu(II) potentiation of Alzheimer A beta neurotoxicity - Correlation with cell-free hydrogen peroxide production and metal reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBROSPINAL-FLUID; LIPID-PEROXIDATION; OXIDATIVE STRESS; SENILE PLAQUES; IN-VIVO; DISEASE; PROTEIN; TOXICITY; PRECURSOR; PEPTIDE	Oxidative stress markers as well as high concentrations of copper are found in the vicinity of A beta amyloid deposits in Alzheimer's disease. The neurotoxicity of A beta in cell culture has been linked to H2O2 generation by an unknown mechanism. We now report that Cu(II) markedly potentiates the neurotoxicity exhibited by A beta in cell culture. The potentiation of toxicity is greatest for A beta 1-42 > A beta 1-40 >> mouse/rat A beta 1-40, corresponding to their relative capacities to reduce Cu(II) to Cu(I), form H2O2 in cell-free assays and to exhibit amyloid pathology. The copper complex of A beta 1-42 has a highly positive formal reduction potential (approximate to+500-550 mV versus Ag/AgCl) characteristic of strongly reducing cupro-proteins. These findings suggest that certain redox active metal ions may be important in exacerbating and perhaps facilitating A beta-mediated oxidative damage in Alzheimer's disease.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Lab Oxidat Biol,Genet & Aging Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; Univ Heidelberg, ZMBH, Ctr Mol Biol, D-69120 Heidelberg, Germany; N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; Mental Hlth Res Inst Victoria, Neuropathol Lab, Parkville, Vic 3052, Australia; Univ Queensland, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Magnet Resonance, Brisbane, Qld 4072, Australia	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Ruprecht Karls University Heidelberg; University of North Carolina; North Carolina State University; University of California System; University of California Irvine; University of Melbourne; University of Queensland; University of Queensland	Huang, XD (corresponding author), Massachusetts Gen Hosp E, Lab Oxidat Biol, Genet & Aging Unit, Bldg 149,13th St, Charlestown, MA 02129 USA.		tyndall, joel/C-2803-2008; Fairlie, David P/F-8865-2014; Cuajungco, Math/B-2647-2008; Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007; Moir, Robert D./M-7612-2017; Tanzi, Rudolph/AAE-9622-2019; /C-3940-2008; , Craig/AAB-3963-2022	tyndall, joel/0000-0003-0783-1635; Fairlie, David P/0000-0002-7856-8566; Cuajungco, Math/0000-0003-0749-9564; Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Moir, Robert D./0000-0001-5431-3553; Tanzi, Rudolph/0000-0002-7032-1454; /0000-0003-0306-4360; Saunders, Aleister/0000-0002-7298-7823; Goldstein, Lee/0000-0001-8419-9800; Bowden, Edmond/0000-0002-1908-7594				Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P231; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bondy SC, 1998, BRAIN RES, V799, P91, DOI 10.1016/S0006-8993(98)00461-2; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; DASILVA JJR, 1991, BIOL CHEM EL; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Dikalov SI, 1999, J BIOL CHEM, V274, P9392, DOI 10.1074/jbc.274.14.9392; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Han J, 1996, ANAL BIOCHEM, V234, P107, DOI 10.1006/abio.1996.0059; HARTTER DE, 1988, J BIOL CHEM, V263, P799; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; HERSHEY CO, 1983, NEUROLOGY, V33, P1350, DOI 10.1212/WNL.33.10.1350; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LANDERS JW, 1958, AM J CLIN PATHOL, V29, P590; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Mark RJ, 1997, J NEUROCHEM, V68, P255; Mattson MP, 1997, BRAIN RES, V771, P147, DOI 10.1016/S0006-8993(97)00824-X; PALMER AM, 1994, BRAIN RES, V645, P338, DOI 10.1016/0006-8993(94)91670-5; PILBROW JR, 1993, METHOD ENZYMOL, V227, P330, DOI 10.1016/0076-6879(93)27013-7; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Sayre LM, 1996, SCIENCE, V274, P1933, DOI 10.1126/science.274.5294.1933; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SCHUBERT D, 1995, BIOCHEM BIOPH RES CO, V216, P702, DOI 10.1006/bbrc.1995.2678; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; VAUGHAN DW, 1981, J NEUROPATH EXP NEUR, V40, P472, DOI 10.1097/00005072-198107000-00009; WANG DM, 1995, J MAGN RESON SER A, V117, P1, DOI 10.1006/jmra.1995.9978; White AR, 1999, J NEUROCHEM, V72, P2092, DOI 10.1046/j.1471-4159.1999.0722092.x	40	691	715	1	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37111	37116		10.1074/jbc.274.52.37111	http://dx.doi.org/10.1074/jbc.274.52.37111			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601271	hybrid			2022-12-27	WOS:000084382700042
J	Sato, T; Kondo, T; Fujisawa, T; Seiki, M; Ito, A				Sato, T; Kondo, T; Fujisawa, T; Seiki, M; Ito, A			Furin-independent pathway of membrane type 1-matrix metalloproteinase activation in rabbit dermal fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTERINE CERVICAL FIBROBLASTS; PRO-GELATINASE-A; PROHORMONE CONVERTASES PC1; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR; DEVELOPMENTAL EXPRESSION; IV COLLAGENASE; PROPROTEIN CONVERTASES; EXTRACELLULAR-MATRIX; INSITU HYBRIDIZATION	We investigated the gene expression and intracellular activity of processing protease furin and its involvement in the process of membrane type 1-matrix metalloproteinase (MT1-MMP) activation in rabbit dermal fibroblasts, When the rabbit fibroblasts were treated with concanavalin A (ConA), pro-MMP-2 was converted to an active 62-kDa MMP-2 through the appearance of a 64-kDa intermediate MMP-2. The ConA-induced pro-MMP-2 activation resulted from increasing the gene expression and production of MT1-MMP in the rabbit fibroblasts, Reverse transcriptase-polymerase chain reaction demonstrated that in rabbit dermal fibroblasts furin mRNA was detected and, unlike MT1-MMP, was not increased by ConA, These findings are further supported by the fact that the intracellular furin activity also was constitutively detected and was unchanged by the ConA. treatment. Very similar phenomena were also observed in human uterine cervical fibroblasts, which are known to produce MT1-MMP by ConA stimulation. These results suggest that the expression of the furin gene and the intracellular activity are not regulated by Conk On the other hand, neither a synthetic furin inhibitor, decanoyl-RVKR-CH2Cl (25-100 mu M) nor a furin antisense oligonucleotide (40 mu M) inhibited the MT1-MMP-mediated pro-MMP-2 activation in ConA-treated rabbit dermal fibroblasts, whereas these compounds interfered with pro-MMP-2 activation in ConA-treated human uterine cervical fibroblasts. Nonetheless, the furin antisense oligonucleotide completely suppressed furin gene expression in both rabbit and human fibroblasts, These results suggest that furin does not participate in the process of MT1-MMP activation induced by ConA in rabbit dermal fibroblasts.	Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biochem, Tokyo 1920392, Japan; Fuji Chem Ind Ltd, Res Inst, Toyama 9338511, Japan; Univ Tokyo, Inst Med Sci, Dept Canc Cell Res, Minato Ku, Tokyo 1080071, Japan	Tokyo University of Pharmacy & Life Sciences; University of Tokyo	Sato, T (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biochem, 1432-1 Horinouchi, Tokyo 1920392, Japan.		Seiki, Motoharu/K-9443-2015					ANGLIKER H, 1993, BIOCHEM J, V293, P75, DOI 10.1042/bj2930075; BROWN PD, 1993, CLIN EXP METASTAS, V11, P183, DOI 10.1007/BF00114976; Buttner FH, 1997, ARTHRITIS RHEUM, V40, P704, DOI 10.1002/art.1780400415; Cao JA, 1996, J BIOL CHEM, V271, P30174, DOI 10.1074/jbc.271.47.30174; Chan VT, 1998, J INVEST DERMATOL, V111, P1153, DOI 10.1046/j.1523-1747.1998.00416.x; Fosang AJ, 1998, FEBS LETT, V430, P186, DOI 10.1016/S0014-5793(98)00667-X; HATSUZAWA K, 1992, J BIOCHEM-TOKYO, V111, P296, DOI 10.1093/oxfordjournals.jbchem.a123753; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; Ito A, 1998, EUR J BIOCHEM, V251, P353, DOI 10.1046/j.1432-1327.1998.2510353.x; ITO A, 1991, J BIOL CHEM, V266, P13598; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Kinoh H, 1996, J CELL SCI, V109, P953; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lohi J, 1996, EUR J BIOCHEM, V239, P239, DOI 10.1111/j.1432-1033.1996.0239u.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maquoi E, 1998, FEBS LETT, V424, P262, DOI 10.1016/S0014-5793(98)00187-2; MARCINKIEWICZ M, 1994, ENDOCRINOLOGY, V135, P1651, DOI 10.1210/en.135.4.1651; MARCINKIEWICZ M, 1993, P NATL ACAD SCI USA, V90, P4922, DOI 10.1073/pnas.90.11.4922; Migita K, 1996, IMMUNOLOGY, V89, P553, DOI 10.1046/j.1365-2567.1996.d01-789.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Nagase H, 1997, BIOL CHEM, V378, P151; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OJIMA Y, 1989, BIOCHIM BIOPHYS ACTA, V1011, P61, DOI 10.1016/0167-4889(89)90079-7; Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; OVERALL CM, 1989, J BIOL CHEM, V264, P1860; Puente XS, 1996, CANCER RES, V56, P944; PYKE C, 1992, CANCER RES, V52, P1336; SALO T, 1991, J BIOL CHEM, V266, P11436; Santavicca M, 1996, BIOCHEM J, V315, P953, DOI 10.1042/bj3150953; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, J BIOCHEM-TOKYO, V119, P209; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Sato T, 1996, FEBS LETT, V392, P175, DOI 10.1016/0014-5793(96)00808-3; Sato T, 1997, J CELL SCI, V110, P589; SCHAFER MKH, 1993, J NEUROSCI, V13, P1258; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; Shofuda K, 1998, J BIOCHEM-TOKYO, V124, P462, DOI 10.1093/oxfordjournals.jbchem.a022136; SIEZEN RJ, 1994, EUR J BIOCHEM, V222, P255, DOI 10.1111/j.1432-1033.1994.tb18864.x; STEARNS ME, 1993, CANCER RES, V53, P878; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; Ueno H, 1997, CANCER RES, V57, P2055; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VATER CA, 1983, J BIOL CHEM, V258, P9374; Wang H, 1998, J VASC RES, V35, P45, DOI 10.1159/000025564; WARD RV, 1991, BIOCHIM BIOPHYS ACTA, V1079, P242, DOI 10.1016/0167-4838(91)90132-J; WILL H, 1995, EUR J BIOCHEM, V231, P602, DOI 10.1111/j.1432-1033.1995.0602d.x; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yamamoto M, 1996, CANCER RES, V56, P384; Zheng M, 1997, DEV BIOL, V181, P268, DOI 10.1006/dbio.1996.8402; ZHENG M, 1994, J NEUROSCI, V14, P4656	54	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37280	37284		10.1074/jbc.274.52.37280	http://dx.doi.org/10.1074/jbc.274.52.37280			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601293	hybrid			2022-12-27	WOS:000084382700064
J	Yokota, S; Yanagi, H; Yura, T; Kubota, H				Yokota, S; Yanagi, H; Yura, T; Kubota, H			Cytosolic chaperonin is up-regulated during cell growth - Preferential, expression and binding to tubulin at G(1)/S transition through early S phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-COMPLEX POLYPEPTIDE-1; CYTOPLASMIC CHAPERONIN; EUKARYOTIC CYTOSOL; CONTAINING TCP-1; MOLECULAR CHAPERONES; CCT CHAPERONIN; SACCHAROMYCES-CEREVISIAE; SUBUNIT COMPOSITION; BETA-ACTIN; IN-VITRO	The chaperonin containing t-complex polypeptide 1 (CCT) is a heterooligomeric molecular chaperone assisting in the folding of actin, tubulin, and other cytosolic proteins. The expression levels of CCT subunits varied among seven mouse cell lines tested but showed a close correlation with growth rate. Both the CCT protein and mRNA levels in the human promyelolytic cell HL60 decreased concomitant with growth arrest during differentiation. More rapid decrease in CCT level occurred when the mouse interleukin (IL)-3-dependent myeloid DA3 cells were starved for IL-3. Readdition of IL-3 caused rapid resumption of CCT synthesis during synchronous growth: the maximum CCT protein and mRNA levels were observed at G(1)/S transition through early S phase. The turnover rate of CCT was nearly constant regardless of growth. Gel filtration and immunoprecipitation analyses indicated that CCT in vivo is associated with tubulin at early S phase, but not at G(0)/G(1) phase. These results demonstrated that CCT expression is strongly up-regulated during cell growth especially from G(1)/S transition to early S phase and is primarily controlled at the mRNA level. CCT appears to play important roles for cell growth by assisting in the folding of tubulin and other proteins.	HSP Res Inst, Shimogyo Ku, Kyoto 6008813, Japan		Kubota, H (corresponding author), HSP Res Inst, Shimogyo Ku, Kyoto Res Pk,17 Chudoji Minami Machi, Kyoto 6008813, Japan.		Yokota, Shin-ichi/K-8139-2019	Yokota, Shin-ichi/0000-0002-0831-3429				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLLINS SJ, 1987, BLOOD, V70, P1233; CREUTZ CE, 1994, J BIOL CHEM, V269, P32035; Cyrne L, 1996, FEBS LETT, V383, P277, DOI 10.1016/0014-5793(96)00240-2; Dittmar G, 1997, CELL BIOL INT, V21, P383, DOI 10.1006/cbir.1997.0158; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gebauer M, 1998, J BIOL CHEM, V273, P29475, DOI 10.1074/jbc.273.45.29475; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hynes G, 1996, ELECTROPHORESIS, V17, P1720, DOI 10.1002/elps.1150171109; HYNES G, 1995, FEBS LETT, V358, P129, DOI 10.1016/0014-5793(94)01408-S; IHLE JN, 1985, CONTEMP TOP MOLEC IM, V10, P93; Iijima M, 1998, GENE, V213, P101, DOI 10.1016/S0378-1119(98)00190-5; KATAGIRI K, 1993, J IMMUNOL, V150, P585; KUBOTA H, 1995, EUR J BIOCHEM, V230, P3, DOI 10.1111/j.1432-1033.1995.0003i.x; Kubota H, 1999, EUR J BIOCHEM, V262, P492, DOI 10.1046/j.1432-1327.1999.00405.x; KUBOTA H, 1992, GENE, V120, P207, DOI 10.1016/0378-1119(92)90095-7; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; Kubota H, 1997, FEBS LETT, V402, P53, DOI 10.1016/S0014-5793(96)01501-3; KUBOTA H, 1995, GENE, V154, P231, DOI 10.1016/0378-1119(94)00880-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Lin P, 1997, P NATL ACAD SCI USA, V94, P10780, DOI 10.1073/pnas.94.20.10780; Liou AKF, 1997, EMBO J, V16, P4311, DOI 10.1093/emboj/16.14.4311; Llorca O, 1998, J BIOL CHEM, V273, P10091, DOI 10.1074/jbc.273.17.10091; MARCO S, 1994, BIOPHYS J, V67, P364, DOI 10.1016/S0006-3495(94)80489-8; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Pause B, 1997, FEBS LETT, V414, P95, DOI 10.1016/S0014-5793(97)00975-7; Rademacher F, 1998, MICROBIOL-SGM, V144, P2951, DOI 10.1099/00221287-144-11-2951; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; ROOBOL A, 1995, J CELL SCI, V108, P1477; ROVERA G, 1980, NATURE, V284, P69, DOI 10.1038/284069a0; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZ ER, 1985, J EMBRYOL EXP MORPH, V89, P113; SEVIGNY G, 1995, BIOCHEM BIOPH RES CO, V216, P279, DOI 10.1006/bbrc.1995.2621; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; SOARES H, 1994, J BIOL CHEM, V269, P29299; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Stoldt V, 1996, YEAST, V12, P523, DOI 10.1002/(SICI)1097-0061(199605)12:6<523::AID-YEA962>3.3.CO;2-3; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; TIAN GL, 1995, NATURE, V375, P250, DOI 10.1038/375250a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; VANSNICK J, 1986, CONTRIB MICROBIOL IM, V11, P73; Willison Keith R., 1996, P107, DOI 10.1016/B978-012237455-5/50006-3; WILLISON KR, 1990, GENET RES, V56, P193, DOI 10.1017/S0016672300035291; WILLISON KR, 1986, CELL, V44, P727, DOI 10.1016/0092-8674(86)90839-1; Won KA, 1998, MOL CELL BIOL, V18, P7584, DOI 10.1128/MCB.18.12.7584; XIE XL, 1994, BLOOD, V84, P2171	57	106	113	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37070	37078		10.1074/jbc.274.52.37070	http://dx.doi.org/10.1074/jbc.274.52.37070			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601265	hybrid			2022-12-27	WOS:000084382700036
J	Grabenhorst, E; Conradt, HS				Grabenhorst, E; Conradt, HS			The cytoplasmic, transmembrane, and stem regions of glycosyltransferases specify their in vivo functional sublocalization and stability in the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-TRACE PROTEIN; N-ACETYLGLUCOSAMINYLTRANSFERASE-I; MEMBRANE-SPANNING DOMAIN; GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; IMMUNOELECTRON MICROSCOPY; FUCOSYL-TRANSFERASE; KIN RECOGNITION; HELA-CELLS; MOLECULAR CHARACTERIZATION; EXPRESSION CLONING	We provide evidence for the presence of targeting signals in the cytoplasmic, transmembrane, and stem (CTS) regions of Golgi glycosyltransferases that mediate sorting of their intracellular catalytic activity into different functional subcompartmental areas of the Golgi, We have constructed chimeras of human alpha 1,3-fucosyltransferase VI (FT6) by replacement of its CTS region with those of late and early acting Golgi glycosyltransferases and have stably coexpressed these constructs in BHK-81 cells together with the secretory reporter glycoprotein human beta-trace protein. The sialyl Lewis X:Lewis X ratios detected in beta-trace protein indicate that the CTS regions of the early acting GlcNAc-transferases I (GnT-I) and III (GnT-III) specify backward targeting of the FT6 catalytic domain, whereas the CTS region of the late acting human alpha 1,3-fucosyltransferase VII (FT7) causes forward targeting of the FT6 in vivo activity in the biosynthetic glycosylation pathway. The analysis of the in vivo functional activity of nine different CTS chimeras toward beta-trace protein allowed for a mapping of the CTS donor glycosyltransferases within the Golgi/trans-Golgi network: GnT-I < (ST6Gal I, ST3Gal III) < GnT-III < ST8Sia IV < GalT-I < (FT3, FT6) < ST3Gal TV < FT7, The sensitivity or resistance of the donor glycosyl transferases toward intracellular proteolysis is transferred to the chimeric enzymes together with their CTS regions. Apparently, there are at least three different signals contained in the CTS regions of glycosyltransferases mediating: first, their Golgi retention; second, their targeting to specific in vivo functional areas; and third, their susceptibility toward intracellular proteolysis as a tool for the regulation of the intracellular turnover.	Gesell Biotechnol Forsch mbH, Prot Glycosylat Grp, D-38124 Braunschweig, Germany	Gesellschaft fur Biotechnologische Forschung mbH	Grabenhorst, E (corresponding author), Gesell Biotechnol Forsch mbH, Prot Glycosylat Grp, Mascheroder Weg 1, D-38124 Braunschweig, Germany.	egr@gbf.de						AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; BJORK I, 1992, BIOCHEM J, V286, P793; Borsig L, 1998, GLYCOBIOLOGY, V8, P259, DOI 10.1093/glycob/8.3.259; Borsig L, 1996, EUR J CELL BIOL, V70, P42; BOSSHART H, 1992, EUR J BIOCHEM, V208, P341, DOI 10.1111/j.1432-1033.1992.tb17192.x; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Britten CJ, 1998, GLYCOBIOLOGY, V8, P321, DOI 10.1093/glycob/8.4.321; Burger PC, 1998, GLYCOBIOLOGY, V8, P245, DOI 10.1093/glycob/8.3.245; BURKE J, 1992, J BIOL CHEM, V267, P24433; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; Costa J, 1997, J BIOL CHEM, V272, P11613; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Gleeson PA, 1998, HISTOCHEM CELL BIOL, V109, P517, DOI 10.1007/s004180050252; Grabenhorst E, 1998, J BIOL CHEM, V273, P30985, DOI 10.1074/jbc.273.47.30985; Grabenhorst E, 1999, GLYCOCONJUGATE J, V16, P81, DOI 10.1023/A:1026466408042; GRABENHORST E, 1995, EUR J BIOCHEM, V232, P718, DOI 10.1111/j.1432-1033.1995.718zz.x; Hoffmann A, 1997, GLYCOBIOLOGY, V7, P499, DOI 10.1093/glycob/7.4.499; HOFFMANN A, 1994, J NEUROCHEM, V63, P2185; IHARA Y, 1993, J BIOCHEM-TOKYO, V113, P692, DOI 10.1093/oxfordjournals.jbchem.a124105; Jaskiewicz E, 1996, J BIOL CHEM, V271, P26395, DOI 10.1074/jbc.271.42.26395; JOHNSON PH, 1993, GLYCOCONJUGATE J, V10, P152, DOI 10.1007/BF00737712; JOHNSON PH, 1992, GLYCOCONJUGATE J, V9, P241, DOI 10.1007/BF00731136; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; KOBATA A, 1992, EUR J BIOCHEM, V209, P483, DOI 10.1111/j.1432-1033.1992.tb17313.x; Kotani N, 1999, BIOCHEM BIOPH RES CO, V260, P94, DOI 10.1006/bbrc.1999.0872; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE EU, 1989, J BIOL CHEM, V264, P13848; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; Lovelock C, 1998, EUR J CELL BIOL, V76, P18, DOI 10.1016/S0171-9335(98)80013-7; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; MASRI KA, 1988, BIOCHEM BIOPH RES CO, V157, P657, DOI 10.1016/S0006-291X(88)80300-0; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Nakayama J, 1998, PATHOL INT, V48, P665, DOI 10.1111/j.1440-1827.1998.tb03967.x; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Nilsson T, 1996, J CELL SCI, V109, P1975; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; NILSSON T, 1993, J CELL BIOL, V120, P5, DOI 10.1083/jcb.120.1.5; NILSSON T, 1991, EMBO J, V10, P3567, DOI 10.1002/j.1460-2075.1991.tb04923.x; Nimtz M, 1998, GLYCOCONJUGATE J, V15, P873, DOI 10.1023/A:1006907031940; NIMTZ M, 1993, EUR J BIOCHEM, V213, P39, DOI 10.1111/j.1432-1033.1993.tb17732.x; Osman N, 1996, J BIOL CHEM, V271, P33105, DOI 10.1074/jbc.271.51.33105; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Pohl S, 1997, GLYCOBIOLOGY, V7, P1077, DOI 10.1093/glycob/7.8.1077; RABOUILLE C, 1995, J CELL SCI, V108, P1617; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; RUSSO RN, 1992, J BIOL CHEM, V267, P9241; SASAKI K, 1993, J BIOL CHEM, V268, P22782; SASAKI K, 1994, J BIOL CHEM, V269, P14730; Shinoda K, 1997, J BIOL CHEM, V272, P31992, DOI 10.1074/jbc.272.51.31992; Skrincosky D, 1997, J BIOL CHEM, V272, P22695, DOI 10.1074/jbc.272.36.22695; STROUS GJAM, 1982, J BIOL CHEM, V257, P7623; SUEYOSHI S, 1994, J BIOL CHEM, V269, P32342; SUGANUMA T, 1991, J HISTOCHEM CYTOCHEM, V39, P299, DOI 10.1177/39.3.1899684; TAATJES DJ, 1988, J BIOL CHEM, V263, P6302; TANG BL, 1992, J BIOL CHEM, V267, P10122; TEASDALE RD, 1992, J BIOL CHEM, V267, P4084; TEASDALE RD, 1994, GLYCOBIOLOGY, V4, P917, DOI 10.1093/glycob/4.6.917; Ujita M, 1998, J BIOL CHEM, V273, P34843, DOI 10.1074/jbc.273.52.34843; Ujita M, 1999, J BIOL CHEM, V274, P16717, DOI 10.1074/jbc.274.24.16717; Ujita M, 1999, J BIOL CHEM, V274, P9296, DOI 10.1074/jbc.274.14.9296; WATZELE G, 1990, NUCLEIC ACIDS RES, V18, P7174, DOI 10.1093/nar/18.23.7174; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; Xu XH, 1996, J BIOL CHEM, V271, P8818, DOI 10.1074/jbc.271.15.8818	68	68	92	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36107	36116		10.1074/jbc.274.51.36107	http://dx.doi.org/10.1074/jbc.274.51.36107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593893	hybrid			2022-12-27	WOS:000084279200012
J	Murray, I; Sniderman, AD; Havel, PJ; Cianflone, K				Murray, I; Sniderman, AD; Havel, PJ; Cianflone, K			Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LIPOPROTEIN-LIPASE; HIGH-FAT DIET; IMPAIRED GLUCOSE-TOLERANCE; TRANSGENIC MICE; HUMAN ADIPOCYTES; ALTERNATIVE PATHWAY; DENSITY-LIPOPROTEIN; INSULIN-RESISTANCE; IN-VIVO; OBESITY	Acylation stimulating protein (ASP) is a potent stimulator of triglyceride synthesis in adipocytes. In the present study, we have examined the effect of an ASP functional knockout (ASP(-/-)) on lipid metabolism in male mice. In both young (14 weeks) and older (26 weeks) mice there were marked delays in postprandial triglyceride clearance (80% increase at 14 weeks and 120% increase at 26 weeks versus wild type (+/+)). Postprandial nonesterified fatty acids were also increased in ASP(-/-) mice versus ASP(+/+) mice by 37% (low fat 10% Kcal) and by 73% (high fat 40% Kcal) diets, although there were no differences in fasting lipid levels. The ASP(-/-) mice had moderately increased energy intake (16% +/- 2% p < 0.0001) and reduced feed efficiency (33% increase in calories/g of body weight gained on low fat diet) versus wild type, The ASP(-/-) mice also had modest changes in insulin/glucose metabolism (30% to 40% decrease ill insulin glucose product), implying increased insulin sensitivity. As well, there were decreases in leptin (29% shift in leptin to body weight ratio) and up to a 26% decrease in specific adipose tissue depots versus the wild type mice on both low fat and high fat diets, These results demonstrate that ASP plays an important role in adipose tissue metabolism and fat partitioning.	McGill Univ, Mike Rosenbloom Lab Cardiovasc Res, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	McGill University; University of California System; University of California Davis	Cianflone, K (corresponding author), Royal Victoria Hosp, H 7-30,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	mdkc@musica.mcgill.ca	Murray, Ian/O-5983-2015	Murray, Ian/0000-0003-1196-1360; Havel, Peter/0000-0003-3652-8301	NIDDK NIH HHS [DK-35747, DK-50129] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035747, R01DK050129] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; APPEL B, 1992, AM J PHYSIOL, V262, pE695, DOI 10.1152/ajpendo.1992.262.5.E695; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; BENGTSSON G, 1979, FEBS LETT, V106, P345, DOI 10.1016/0014-5793(79)80529-3; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; Bjorntorp Per, 1997, Human Reproduction (Oxford), V12, P21; Charlesworth JA, 1998, INT J OBESITY, V22, P1096, DOI 10.1038/sj.ijo.0800733; Choy LN, 1996, OBES RES, V4, P521, DOI 10.1002/j.1550-8528.1996.tb00266.x; CIANFLONE K, 1995, EUR J CLIN INVEST, V25, P817, DOI 10.1111/j.1365-2362.1995.tb01690.x; CIANFLONE K, 1994, BIOCHEMISTRY-US, V33, P9489, DOI 10.1021/bi00198a014; Cianflone K, 1999, SEMIN CELL DEV BIOL, V10, P31, DOI 10.1006/scdb.1998.0272; CIANFLONE KM, 1990, J CLIN INVEST, V85, P722, DOI 10.1172/JCI114497; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Despres J.-P., 1991, CURR OPIN LIPIDOL, V2, P5; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; GERMINARIO R, 1993, METABOLISM, V42, P574, DOI 10.1016/0026-0495(93)90215-A; GNUDI L, 1995, ENDOCRINOLOGY, V136, P995, DOI 10.1210/en.136.3.995; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Jensen DR, 1997, AM J PHYSIOL-REG I, V273, pR683, DOI 10.1152/ajpregu.1997.273.2.R683; JESMOK GJ, 1981, JPEN-PARENTER ENTER, V5, P200, DOI 10.1177/0148607181005003200; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; LESAVRE PH, 1979, J IMMUNOL, V123, P529; LIU MS, 1994, J BIOL CHEM, V269, P11417; LOMBARDO YB, 1983, HORM METAB RES, V16, P37; Lubinski JM, 1998, J VIROL, V72, P8257, DOI 10.1128/JVI.72.10.8257-8263.1998; MAEDA N, 1994, J BIOL CHEM, V269, P23610; Maslowska M, 1997, INT J OBESITY, V21, P261, DOI 10.1038/sj.ijo.0800396; Maslowska M, 1997, J LIPID RES, V38, P1; McGarry JD, 1998, AM J CLIN NUTR, V67, p500S, DOI 10.1093/ajcn/67.3.500S; McKnight SL, 1998, GENE DEV, V12, P3145, DOI 10.1101/gad.12.20.3145; MENAHAN LA, 1983, METABOLISM, V32, P172, DOI 10.1016/0026-0495(83)90225-1; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Moller DE, 1996, ENDOCRINOLOGY, V137, P2397, DOI 10.1210/en.137.6.2397; Morin CL, 1997, ENDOCRINOLOGY, V138, P4665, DOI 10.1210/en.138.11.4665; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; Murray I, 1999, AM J PHYSIOL-ENDOC M, V277, pE474, DOI 10.1152/ajpendo.1999.277.3.E474; Murray I, 1997, J LIPID RES, V38, P2492; Murray I, 1999, J LIPID RES, V40, P1671; PETERSON J, 1990, P NATL ACAD SCI USA, V87, P909, DOI 10.1073/pnas.87.3.909; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; RANDLE PJ, 1963, LANCET, V1, P785; Ranheim T, 1997, ARTERIOSCL THROM VAS, V17, P3286, DOI 10.1161/01.ATV.17.11.3286; REUE K, 1993, J LIPID RES, V34, P893; Saleh J, 1998, J LIPID RES, V39, P884; SAXENA U, 1989, J BIOL CHEM, V264, P4349; Scantlebury T, 1998, J BIOL CHEM, V273, P20903, DOI 10.1074/jbc.273.33.20903; SHENG J, 1990, METABOLISM, V39, P155, DOI 10.1016/0026-0495(90)90069-O; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; SHIMADA M, 1995, BIOCHEM BIOPH RES CO, V211, P761, DOI 10.1006/bbrc.1995.1878; SHIMADA M, 1993, J BIOL CHEM, V268, P17924; SNIDERMAN AD, 1987, NIH PUBLICATION; SRIVASTAVA RAK, 1991, BIOCHIM BIOPHYS ACTA, V1086, P29, DOI 10.1016/0005-2760(91)90151-7; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tao YH, 1997, BBA-LIPID LIPID MET, V1344, P221, DOI 10.1016/S0005-2760(96)00144-0; Van Hermelen V, 1999, J BIOL CHEM, V274, P18243, DOI 10.1074/jbc.274.26.18243; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Wetsel RA, 1999, J BIOL CHEM, V274, P19429, DOI 10.1074/jbc.274.27.19429; YASUSHI I, 1990, SCIENCE, V249, P790; Zhang XJ, 1998, EUR J CLIN INVEST, V28, P730	63	68	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36219	36225		10.1074/jbc.274.51.36219	http://dx.doi.org/10.1074/jbc.274.51.36219			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593909	Green Published, hybrid			2022-12-27	WOS:000084279200028
J	Shi, J; Vlamis-Gardikas, V; Aslund, F; Holmgren, A; Rosen, BP				Shi, J; Vlamis-Gardikas, V; Aslund, F; Holmgren, A; Rosen, BP			Reactivity of glutaredoxins 1, 2, and 3 from Escherichia coli shows that glutaredoxin 2 is the primary hydrogen donor to ArsC-catalyzed arsenate reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOTIDE REDUCTASE; MIXED DISULFIDE; THIOREDOXIN; GLUTATHIONE; PROTEIN; CLONING; MUTANT	In Escherichia coli ArsC catalyzes the reduction of arsenate to arsenite using GSH with glutaredoxin as electron donors. E. coli has three glutaredoxins: 1, 2, and 3, each with a classical -Cys-Pro-Tyr-Cys- active site. Glutaredoxin 2 is the major glutathione disulfide oxidoreductase in E. coli, but its function remains unknown. In this report glutaredoxin 2 is shown to be the most effective hydrogen donor for the reduction of arsenate by ArsC. Analysis of single or double cysteine-to-serine substitutions in the active site of the three glutaredoxins indicated that only the N-terminal cysteine residue is essential for activity. This suggests that, during the catalytic cycle, ArsC forms a mixed disulfide with GSH before being reduced by glutaredoxin to regenerate the active ArsC reductase.	Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48201 USA; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Wayne State University; Karolinska Institutet	Rosen, BP (corresponding author), Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, 540 E Canfield Ave, Detroit, MI 48201 USA.		Vlamis, Alexios/AAF-5152-2020	Vlamis, Alexios/0000-0001-5068-6459; Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052216] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52216] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Bjornberg O, 1991, Protein Expr Purif, V2, P287, DOI 10.1016/1046-5928(91)90085-W; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLADYSHEVA TB, 1994, BIOCHEMISTRY-US, V33, P7288, DOI 10.1021/bi00189a033; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; JI GY, 1994, BIOCHEMISTRY-US, V33, P7294, DOI 10.1021/bi00189a034; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Liu JY, 1997, J BIOL CHEM, V272, P21084, DOI 10.1074/jbc.272.34.21084; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; MIRANDAVIZUETE A, 1994, J BIOL CHEM, V269, P16631; ODEN KL, 1994, MOL MICROBIOL, V12, P301, DOI 10.1111/j.1365-2958.1994.tb01018.x; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; RUSSEL M, 1990, J BACTERIOL, V172, P1923, DOI 10.1128/jb.172.4.1923-1929.1990; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236	23	116	121	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36039	36042		10.1074/jbc.274.51.36039	http://dx.doi.org/10.1074/jbc.274.51.36039			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593884	hybrid			2022-12-27	WOS:000084279200003
J	Marque, PE; Spuntarelli, R; Juliano, L; Aiach, M; Le Bonniec, BF				Marque, PE; Spuntarelli, R; Juliano, L; Aiach, M; Le Bonniec, BF			The role of Glu(192) in the allosteric control of the S-2 ' and S-3 ' subsites of thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C ACTIVATION; HUMAN ALPHA-THROMBIN; ACTIVE-SITE; PROTHROMBIN FRAGMENT-2; ANTITHROMBIN-III; FIBRIN MONOMER; THROMBOMODULIN COMPLEX; ENZYME SPECIFICITY; STRUCTURAL-CHANGES; KUNITZ INHIBITORS	Thrombin is an allosteric protease controlled through exosites flanking the catalytic groove. Binding of a peptide derived from hirudin (Hir(52-65)) and/or of heparin to these opposing exosites alters catalysis, We have investigated the contribution of subsites S-2' and S-3' to this allosteric transition by comparing the hydrolysis of two sets of fluorescence-quenched substrates having all natural amino acids at positions P-2' and P-3'. Regardless of the amino acids, Hir(52-65) decreased, and heparin increased the k(cat)/K-m value of hydrolysis by thrombin. Several lines of evidence have suggested that Glu(192) participates in this modulation. We have examined the role of Glu(192) by comparing the catalytic activity of thrombin and its E192Q mutant. Mutation substantially diminishes the selectivity of thrombin, The substrate with the "best" P-2' residue was cleaved with a k(cat)/K-m value only 49 times higher than the one having the "least favorable" P-2' residue (versus 636-fold with thrombin). Mutant E192Q also lost the strong preference of thrombin for positively charged P-3' residues and its strong aversion for negatively charged P-3' residues. Furthermore, both Hir(52-65) and heparin increased the k(cat)/K-m value of substrate hydrolysis. We conclude that Glu(192) is critical for the P-2' and P-3' specificities of thrombin and for the allostery mediated through exosite 1.	Univ Paris 05, INSERM, Fac Pharm, F-75270 Paris 06, France; Escola Paulista Med, Dept Biofis, BR-04044020 Sao Paulo, SP, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade Federal de Sao Paulo (UNIFESP)	Le Bonniec, BF (corresponding author), Univ Paris 05, INSERM, Fac Pharm, 4 Ave Observ, F-75270 Paris 06, France.		Le Bonniec, Bernard/S-5756-2016; Juliano, Luiz/D-7204-2012; Le Bonniec, Bernard/ABA-1366-2020	Le Bonniec, Bernard/0000-0002-8432-7363; Juliano, Luiz/0000-0002-5589-2822; Le Bonniec, Bernard/0000-0002-8432-7363				ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Arocas V, 1996, BIOCHEMISTRY-US, V35, P9083, DOI 10.1021/bi960043l; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Becker DL, 1999, J BIOL CHEM, V274, P6226, DOI 10.1074/jbc.274.10.6226; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BODE W, 1992, PROTEIN SCI, V1, P426; BOUTON MC, 1993, EUR J BIOCHEM, V215, P143, DOI 10.1111/j.1432-1033.1993.tb18016.x; BOUTON MC, 1995, EUR J BIOCHEM, V229, P526, DOI 10.1111/j.1432-1033.1995.0526k.x; Bouton MC, 1998, THROMB HAEMOSTASIS, V80, P310, DOI 10.1055/s-0037-1615193; Colwell NS, 1998, BIOCHEMISTRY-US, V37, P15057, DOI 10.1021/bi980925f; De Cristofaro R, 1999, EUR J BIOCHEM, V260, P97, DOI 10.1046/j.1432-1327.1999.00118.x; DECRISTOFARO R, 1993, BIOCHEM J, V289, P475, DOI 10.1042/bj2890475; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; Duffy EJ, 1997, BIOCHEM J, V321, P361, DOI 10.1042/bj3210361; Engh RA, 1996, STRUCTURE, V4, P1353, DOI 10.1016/S0969-2126(96)00142-6; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; GUINTO ER, 1994, J BIOL CHEM, V269, P18395; GUTFREUND H, 1995, KINETICS LIFE SCI, P248; Han JH, 1998, BIOCHEMISTRY-US, V37, P3203, DOI 10.1021/bi9722195; HOGG PJ, 1990, J BIOL CHEM, V265, P248; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; Hogg PJ, 1996, J BIOL CHEM, V271, P26088, DOI 10.1074/jbc.271.42.26088; HORTIN GL, 1991, J BIOL CHEM, V266, P6866; JACKMAN MP, 1992, J BIOL CHEM, V267, P15375; KARSHIKOV A, 1992, PROTEIN SCI, V1, P727, DOI 10.1002/pro.5560010605; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P6970; LEBONNIEC BF, 1993, J BIOL CHEM, V268, P19055; LEBONNIEC BF, 1995, BIOCHEMISTRY-US, V34, P12241, DOI 10.1021/bi00038a019; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P19341; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; LeBonniec BF, 1996, BIOCHEMISTRY-US, V35, P7114, DOI 10.1021/bi952701s; Liaw PCY, 1998, J BIOL CHEM, V273, P8932, DOI 10.1074/jbc.273.15.8932; LIU LW, 1991, J BIOL CHEM, V266, P16977; LIU LW, 1994, J BIOL CHEM, V269, P11807; Malkowski MG, 1997, PROTEIN SCI, V6, P1438, DOI 10.1002/pro.5560060708; MARAGANORE JM, 1989, J BIOL CHEM, V264, P8692; Martin PD, 1996, BIOCHEMISTRY-US, V35, P13030, DOI 10.1021/bi960656y; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P13547, DOI 10.1021/bi00250a006; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; MUSCI G, 1988, BIOCHEMISTRY-US, V27, P769, DOI 10.1021/bi00402a042; MUSCI G, 1987, J BIOL CHEM, V262, P13889; NESHEIM ME, 1983, J BIOL CHEM, V258, P4708; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P8701, DOI 10.1021/bi00027a020; NI F, 1992, BIOCHEMISTRY-US, V31, P11551, DOI 10.1021/bi00161a037; PARRY MAA, 1993, BIOCHEM J, V290, P665, DOI 10.1042/bj2900665; PRATT CW, 1992, J BIOL CHEM, V267, P8789; QIU XY, 1992, BIOCHEMISTRY-US, V31, P11689, DOI 10.1021/bi00162a004; Rezaie AR, 1998, BIOCHEMISTRY-US, V37, P693, DOI 10.1021/bi971271y; REZAIE AR, 1993, J BIOL CHEM, V268, P19943; REZAIE AR, 1995, J BIOL CHEM, V270, P25336, DOI 10.1074/jbc.270.43.25336; REZAIE AR, 1995, J BIOL CHEM, V270, P16176, DOI 10.1074/jbc.270.27.16176; SCHMITZ T, 1991, EUR J BIOCHEM, V195, P251, DOI 10.1111/j.1432-1033.1991.tb15701.x; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; STEARNS DJ, 1989, J BIOL CHEM, V264, P3352; STONE SR, 1987, EUR J BIOCHEM, V169, P373, DOI 10.1111/j.1432-1033.1987.tb13622.x; Stone SR, 1997, J MOL BIOL, V265, P344, DOI 10.1006/jmbi.1996.0727; STONE SR, 1998, HDB PROTEOLYTIC ENZY; vandeLocht A, 1997, EMBO J, V16, P2977, DOI 10.1093/emboj/16.11.2977; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; YE J, 1991, J BIOL CHEM, V266, P23016; YE J, 1993, J BIOL CHEM, V268, P2373; YE J, 1992, J BIOL CHEM, V267, P11023; Zhang YL, 1999, J BIOL CHEM, V274, P7153, DOI 10.1074/jbc.274.11.7153	67	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					809	816		10.1074/jbc.275.2.809	http://dx.doi.org/10.1074/jbc.275.2.809			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625611	hybrid			2022-12-27	WOS:000084836600015
J	Perera, LP				Perera, LP			The TATA motif specifies the differential activation of minimal promoters by varicella zoster virus immediate-early regulatory protein IE62	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR TFIIB; BINDING-PROTEIN; DNA COMPLEX; HUMAN CYTOMEGALOVIRUS; ZTA TRANSACTIVATOR; GENE-EXPRESSION; DOMAIN; ELEMENTS; YEAST; TBP	The immediate-early IE62 protein of varicella tester virus is an acidic transcriptional activator capable of up-regulating many viral and cellular promoters with varying efficiencies. We demonstrate that, in the context of a minimal promoter, a TATA element is both sufficient and essential for IE62-mediated transcriptional activation. Differential levels of activation by IE62 in this context were conferred by a panel of naturally occurring sequence variations within the TATA motif itself. TATA motif-specific, differential induction was not obtained when the IE62 acidic activation domain was targeted as a GALE fusion protein to the same panel. The prototype acidic transactivator, VP16 of herpes simplex virus, failed to discriminate between these different TATA motifs when they were placed into an appropriate responsive promoter context. Nonetheless, a chimeric IE62 polypeptide substituted with the VP16 activation domain retained the ability to differentially modulate minimal promoters with various TATA motifs. Taken together with its binding to TATA box-binding protein (TBP) and transcription factor IIB in vitro, we suggest that IE62 has the unusual ability to achieve differential levels of transcriptional activation through different TATA motifs, which may be accomplished either directly or indirectly by recognizing conformational variations in DNA-bound TBP, TBP-transcription factor IIA/B, or TBP-TATA-associated factor complexes.	NCI, Metab Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Perera, LP (corresponding author), NCI, Metab Branch, Div Clin Sci, NIH, Bldg 10,Rm 4B40,MSC 1374, Bethesda, MD 20892 USA.	lperera@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000687] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 00687] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APRHYS CMJ, 1989, J VIROL, V63, P2798, DOI 10.1128/JVI.63.6.2798-2812.1989; ARNDT KM, 1994, MOL CELL BIOL, V14, P3719, DOI 10.1128/MCB.14.6.3719; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; BOYER TG, 1993, GENE DEV, V7, P1810, DOI 10.1101/gad.7.9.1810; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; Burley SK, 1998, COLD SPRING HARB SYM, V63, P33, DOI 10.1101/sqb.1998.63.33; Carrozza MJ, 1996, MOL CELL BIOL, V16, P3085; CASWELL R, 1993, J GEN VIROL, V74, P2691, DOI 10.1099/0022-1317-74-12-2691; CHANG YN, 1990, J VIROL, V64, P3358, DOI 10.1128/JVI.64.7.3358-3369.1990; CHOY B, 1993, NATURE, V366, P531, DOI 10.1038/366531a0; COHEN JI, 1993, J VIROL, V67, P4246, DOI 10.1128/JVI.67.7.4246-4251.1993; COLEMAN RA, 1995, J BIOL CHEM, V270, P13850, DOI 10.1074/jbc.270.23.13850; COLEMAN RA, 1995, J BIOL CHEM, V270, P13842, DOI 10.1074/jbc.270.23.13842; COOK WJ, 1995, MOL CELL BIOL, V15, P4998; DAVISON AJ, 1986, J GEN VIROL, V67, P2279, DOI 10.1099/0022-1317-67-10-2279; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; Goodrich JA, 1996, CELL, V84, P825, DOI 10.1016/S0092-8674(00)81061-2; GU BH, 1995, MOL CELL BIOL, V15, P3618; HAGEMEIER C, 1992, J VIROL, V66, P4452, DOI 10.1128/JVI.66.7.4452-4456.1992; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; HARBURY PAB, 1989, MOL CELL BIOL, V9, P5298, DOI 10.1128/MCB.9.12.5298; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; HUANG DH, 1988, J BIOL CHEM, V263, P12596; INCHAUSPE G, 1989, VIROLOGY, V173, P700, DOI 10.1016/0042-6822(89)90583-7; INGLES CJ, 1991, NATURE, V351, P588, DOI 10.1038/351588a0; KELLEY KA, 1985, NUCLEIC ACIDS RES, V13, P825, DOI 10.1093/nar/13.3.825; KIM JL, 1994, NAT STRUCT BIOL, V1, P638, DOI 10.1038/nsb0994-638; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LILY W, 1987, NATURE, V326, P512, DOI 10.1038/326512a0; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MARTIN KJ, 1990, GENE DEV, V4, P2376, DOI 10.1101/gad.4.12b.2376; MOFFAT JF, 1995, J VIROL, V69, P5236, DOI 10.1128/JVI.69.9.5236-5242.1995; NABEL GJ, 1988, SCIENCE, V239, P1299, DOI 10.1126/science.2830675; OHARE P, 1988, CELL, V52, P435, DOI 10.1016/S0092-8674(88)80036-9; PERERA LP, 1992, J VIROL, V66, P5298, DOI 10.1128/JVI.66.9.5298-5304.1992; PERERA LP, 1993, J VIROL, V67, P4474, DOI 10.1128/JVI.67.8.4474-4483.1993; PERERA LP, 1992, VIROLOGY, V191, P346, DOI 10.1016/0042-6822(92)90197-W; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; PIZZORNO MC, 1991, J VIROL, V65, P3839, DOI 10.1128/JVI.65.7.3839-3852.1991; PIZZORNO MC, 1988, J VIROL, V62, P1167, DOI 10.1128/JVI.62.4.1167-1179.1988; PUGH BF, 1992, J BIOL CHEM, V267, P679; RUSCONI TM, 1990, J MOL BIOL, V215, P301; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SHARP PA, 1992, CELL, V68, P819, DOI 10.1016/0092-8674(92)90023-6; Shen WC, 1998, COLD SPRING HARB SYM, V63, P219, DOI 10.1101/sqb.1998.63.219; SIMON MC, 1988, CELL, V52, P723, DOI 10.1016/0092-8674(88)90410-2; SMITH CA, 1993, J VIROL, V67, P4676, DOI 10.1128/JVI.67.8.4676-4687.1993; STARGELL LA, 1995, SCIENCE, V269, P75, DOI 10.1126/science.7604282; STARR DB, 1995, J MOL BIOL, V250, P434; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; TAYLOR ICA, 1990, MOL CELL BIOL, V10, P165, DOI 10.1128/MCB.10.1.165; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TYLER JK, 1993, NUCLEIC ACIDS RES, V21, P513, DOI 10.1093/nar/21.3.513; WEFALD FC, 1990, NATURE, V344, P260, DOI 10.1038/344260a0; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859; Xiao WM, 1997, J VIROL, V71, P1757, DOI 10.1128/JVI.71.3.1757-1765.1997; YOSHIMURA M, 1989, GENE, V78, P267, DOI 10.1016/0378-1119(89)90229-1; Zaman Z, 1998, COLD SPRING HARB SYM, V63, P167, DOI 10.1101/sqb.1998.63.167	68	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					487	496		10.1074/jbc.275.1.487	http://dx.doi.org/10.1074/jbc.275.1.487			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617643	hybrid			2022-12-27	WOS:000085951600067
J	Szczesna, D; Zhang, R; Zhao, JJ; Jones, M; Guzman, G; Potter, JD				Szczesna, D; Zhang, R; Zhao, JJ; Jones, M; Guzman, G; Potter, JD			Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; SKELETAL-MUSCLE; MISSENSE MUTATION; ALPHA-TROPOMYOSIN; PROTEIN-C; MOLECULAR-BASIS; CA2+ REGULATION; THIN FILAMENT; MYOSIN; BINDING	To study the effect of troponin (Tn) T mutations that cause familial hypertrophic cardiomyopathy (FHC) on cardiac muscle contraction, wild-type, and the following recombinant human cardiac TnT mutants were cloned and expressed: I79N, R92Q, F110I, E163K, R278C, and intron 16(G(1) --> A) (In16). These TnT FHC mutants were reconstituted into skinned cardiac muscle preparations and characterized for their effect on maximal steady state force activation, inhibition, and the Ca2+ sensitivity of force development. Troponin complexes containing these mutants were tested for their ability to regulate actin-tropomyosin(Tm)-activated myosin-ATPase activity. TnT(R278C) and TnT(F110I) reconstituted preparations demonstrated dramatically increased Ca2+ sensitivity of force development, while those with TnT(R92Q) and TnT(I79N) showed a moderate increase. The deletion mutant, TnT(In16), significantly decreased both the activation and the inhibition of force, and substantially decreased the activation and the inhibition of actin-Tm-activated myosin-ATPase activity. ATPase activation was also impaired by TnT(F110I), while its inhibition was reduced by TnT(R278C). The TnT(E163K) mutation had the smallest effect on the Ca2+ sensitivity of force; however, it produced an elevated activation of the ATPase activity in reconstituted thin filaments. These observed changes in the Ca2+ regulation of force development caused by these mutations would likely cause altered contractility and contribute to the development of FHC.	Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Potter, JD (corresponding author), Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave, Miami, FL 33136 USA.				NHLBI NIH HHS [2 RO1 HL42325-11] Funding Source: Medline; NIAMS NIH HHS [AR 45391-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045391] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anan R, 1998, CIRCULATION, V98, P391, DOI 10.1161/01.CIR.98.5.391; ANDERSON PAW, 1995, CIRC RES, V76, P681, DOI 10.1161/01.RES.76.4.681; AUSUBEL FM, 1995, CURRENT PROTOCOLS MO, pCH8; Barton PJR, 1997, ANN HUM GENET, V61, P519, DOI 10.1017/S0003480097006556; Bing W, 1997, BIOCHEM BIOPH RES CO, V236, P760, DOI 10.1006/bbrc.1997.7045; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Carrier L, 1997, CIRC RES, V80, P427, DOI 10.1161/01.res.0000435859.24609.b3; Charron P, 1998, EUR HEART J, V19, P139, DOI 10.1053/euhj.1997.0575; EPSTEIN ND, 1992, CIRCULATION, V86, P345, DOI 10.1161/01.CIR.86.2.345; Epstein ND, 1998, ADV EXP MED BIOL, V453, P105; Farza H, 1998, J MOL CELL CARDIOL, V30, P1247, DOI 10.1006/jmcc.1998.0698; Fiske CH, 1925, J BIOL CHEM, V66, P375; Flavigny J, 1998, J MOL MED-JMM, V76, P208, DOI 10.1007/s001090050210; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Gergely J, 1998, ADV EXP MED BIOL, V453, P169; GREASER ML, 1971, J BIOL CHEM, V246, P4226; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; ISHII Y, 1991, J BIOL CHEM, V266, P6894; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin D, 1996, J CLIN INVEST, V97, P2842, DOI 10.1172/JCI118740; Malnic B, 1998, J BIOL CHEM, V273, P10594, DOI 10.1074/jbc.273.17.10594; Marian AJ, 1997, CIRC RES, V81, P76, DOI 10.1161/01.RES.81.1.76; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; Morimoto S, 1998, AM J PHYSIOL-CELL PH, V275, pC200, DOI 10.1152/ajpcell.1998.275.1.C200; MURAKAMI U, 1976, J BIOCHEM, V80, P611, DOI 10.1093/oxfordjournals.jbchem.a131316; NakajimaTaniguchi C, 1997, J MOL CELL CARDIOL, V29, P839, DOI 10.1006/jmcc.1996.0322; Ogut O, 1999, AM J PHYSIOL-CELL PH, V276, pC1162, DOI 10.1152/ajpcell.1999.276.5.C1162; Palmiter KA, 1997, BASIC RES CARDIOL, V92, P63, DOI 10.1007/BF00794070; PAN BS, 1992, J BIOL CHEM, V267, P23052; PEARLSTONE JR, 1978, CAN J BIOCHEM CELL B, V56, P521, DOI 10.1139/o78-080; PEARLSTONE JR, 1985, CAN J BIOCHEM CELL B, V63, P212, DOI 10.1139/o85-030; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Reinach FC, 1997, CELL STRUCT FUNCT, V22, P219, DOI 10.1247/csf.22.219; Rust EM, 1999, J CLIN INVEST, V103, P1459, DOI 10.1172/JCI6377; SHENG ZL, 1992, J BIOL CHEM, V267, P25407; STRZELECKAGOLASZEWSKA H, 1975, EUR J BIOCHEM, V55, P221, DOI 10.1111/j.1432-1033.1975.tb02154.x; Sweeney HL, 1998, P NATL ACAD SCI USA, V95, P14406, DOI 10.1073/pnas.95.24.14406; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; SZCZESNA D, 2000, MOL INTERACTIONS ACT, V2; Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; WATKINS H, 1995, HUM MOL GENET, V4, P1721, DOI 10.1093/hmg/4.suppl_1.1721; Watkins H, 1996, J CLIN INVEST, V98, P2456, DOI 10.1172/JCI119063; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806; Yu QT, 1999, P ASSOC AM PHYSICIAN, V111, P45, DOI 10.1046/j.1525-1381.1999.09416.x; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	51	122	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					624	630		10.1074/jbc.275.1.624	http://dx.doi.org/10.1074/jbc.275.1.624			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617660	hybrid			2022-12-27	WOS:000085951600084
J	Chen, XM; Van Valkenburgh, C; Fang, H; Green, N				Chen, XM; Van Valkenburgh, C; Fang, H; Green, N			Signal peptides having standard and nonstandard cleavage sites can be processed by Imp1p of the mitochondrial inner membrane protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI LEADER PEPTIDASE; POTENTIAL ACTIVE-SITE; SACCHAROMYCES-CEREVISIAE; INTERMEMBRANE SPACE; YEAST MITOCHONDRIA; MATRIX ATP; 2 STEPS; PROTEINS; SEQUENCE; IMPORT	We have performed a site-directed mutagenesis study showing that residues comprising the type I signal peptidase signature in the two catalytic subunits of the yeast inner membrane protease, Imp1p and Imp2p, are functionally important, consistent with the idea that these subunits contain a serine/lysine catalytic dyad, Previous studies have shown that Imp1p cleaves signal peptides having asparagine at the -1 position, which deviates from the typical signal peptide possessing a small uncharged amino acid at this position, To determine whether asparagine is responsible for the nonoverlapping substrate specificities exhibited by the inner membrane protease subunits, we have substituted asparagine with 19 amino acids in the Imp1p substrate i-cytochrome (cyt) b(2). The resulting signal peptides containing alanine, serine, cysteine, leucine, and methionine can be cleaved efficiently by Imp1p, The remaining mutant signal peptides are cleaved inefficiently or not at all. Surprisingly, none of the amino acid changes results in the recognition of i-cyt b(2) by Imp2p, whose natural substrate, i-cyt c(1), has alanine at the -1 position. The data demonstrate that (i) although the -1 residue is important in substrates recognized by Imp1p, signal peptides having standard and nonstandard cleavage sites can be processed by Imp1p, and (ii) a -1 asparagine does not govern the substrate specificity of the inner membrane protease subunits.	Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Green, N (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.				NATIONAL CANCER INSTITUTE [T32CA009385] Funding Source: NIH RePORTER; NCI NIH HHS [2 T32 CA09385-11] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; BLACK MT, 1993, J BACTERIOL, V175, P4957, DOI 10.1128/JB.175.16.4957-4961.1993; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; FIKES JD, 1990, J BIOL CHEM, V265, P3417; FOLZ RJ, 1988, J BIOL CHEM, V263, P2070; GASSER SM, 1982, P NATL ACAD SCI-BIOL, V79, P267, DOI 10.1073/pnas.79.2.267; GLICK BS, 1993, PROTEIN SCI, V2, P1901, DOI 10.1002/pro.5560021112; GREEN N, 1992, MOL CELL BIOL, V12, P276, DOI 10.1128/MCB.12.1.276; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; JENSEN RE, 1988, EMBO J, V7, P3863, DOI 10.1002/j.1460-2075.1988.tb03272.x; Luciano P, 1996, EXPERIENTIA, V52, P1077, DOI 10.1007/BF01952105; MULLINS C, 1995, J BIOL CHEM, V270, P17139, DOI 10.1074/jbc.270.29.17139; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; OHASHI A, 1982, J BIOL CHEM, V257, P3042; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; PRATJE E, 1986, EMBO J, V5, P1313, DOI 10.1002/j.1460-2075.1986.tb04361.x; SCHNEIDER A, 1994, J BIOL CHEM, V269, P8635; SHEN LM, 1991, BIOCHEMISTRY-US, V30, P11775, DOI 10.1021/bi00115a006; STUART RA, 1994, EUR J BIOCHEM, V220, P9, DOI 10.1111/j.1432-1033.1994.tb18593.x; SUNG M, 1992, J BIOL CHEM, V267, P13154; TSCHANTZ WR, 1993, J BIOL CHEM, V268, P27349; VANDIJL JM, 1995, J BIOL CHEM, V270, P3611, DOI 10.1074/jbc.270.8.3611; VanValkenburgh C, 1999, J BIOL CHEM, V274, P11519, DOI 10.1074/jbc.274.17.11519; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1989, FEBS LETT, V244, P439, DOI 10.1016/0014-5793(89)80579-4; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; YANG M, 1988, EMBO J, V7, P3857, DOI 10.1002/j.1460-2075.1988.tb03271.x	32	23	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37750	37754		10.1074/jbc.274.53.37750	http://dx.doi.org/10.1074/jbc.274.53.37750			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608835	hybrid			2022-12-27	WOS:000084528000035
J	Gunjan, A; Alexander, BT; Sittman, DB; Brown, DT				Gunjan, A; Alexander, BT; Sittman, DB; Brown, DT			Effects of H1 histone variant overexpression on chromatin structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA GENE; MICROCOCCAL NUCLEASE; LINKER HISTONES; H-1 HISTONES; NUCLEOSOMES; DNA; TRANSCRIPTION; EXPRESSION; BINDING; CELLS	The importance of histone H1 heterogeneity and total H1 stoichiometry in chromatin has been enigmatic Here we report a detailed characterization of the chromatin structure of cells overexpressing either H1(0) or H1c. Nucleosome spacing was found to change during cell cycle progression, and overexpression of either variant in exponentially growing cells results in a Iii-base pair increase in nucleosome repeat length. H1 histones can also assemble on chromatin and influence nucleosome spacing in the absence of DNA replication. Overexpression of H1(0) and, to a lesser extent, H1c results in a decreased rate of digestion of chromatin by micrococcal nuclease. Using green fluorescent protein-tagged H1 variants, we show that micrococcal nuclease-resistant chromatin is specifically enriched in the H1(0) variant. Overexpression of H1(0) results in the appearance of a unique mononucleosome species of higher mobility on nucleoprotein gels. Domain switch mutagenesis revealed that either the N-terminal tail or the central globular domain of the H1(0) protein could independently give rise to this unique mononucleosome species. These results in part explain the differential effects of H1(0) and H1c in regulating chromatin structure and function.	Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Physiol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Sittman, DB (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, 2500 N State St, Jackson, MS 39216 USA.	dsittman@biochem.umsmed.edu	alexander, barbara t/J-3776-2013	Gunjan, Akash/0000-0001-8478-3978				AFFOLTER M, 1987, MOL CELL BIOL, V7, P3663, DOI 10.1128/MCB.7.10.3663; ALBRIGHT SC, 1980, J BIOL CHEM, V255, P3673; ALLAN J, 1980, P NATL ACAD SCI-BIOL, V77, P885, DOI 10.1073/pnas.77.2.885; APPELS R, 1972, J MOL BIOL, V70, P425, DOI 10.1016/0022-2836(72)90550-5; BATES DL, 1981, NUCLEIC ACIDS RES, V9, P5883, DOI 10.1093/nar/9.22.5883; BLANK TA, 1995, J MOL BIOL, V252, P305, DOI 10.1006/jmbi.1995.0498; BOUVET P, 1994, GENE DEV, V8, P1147, DOI 10.1101/gad.8.10.1147; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; Brown DT, 1997, NUCLEIC ACIDS RES, V25, P5003, DOI 10.1093/nar/25.24.5003; BROWN DT, 1993, J BIOL CHEM, V268, P713; COLE RD, 1987, INT J PEPT PROT RES, V30, P433; DELUCIA F, 1994, BIOCHEM BIOPH RES CO, V198, P32, DOI 10.1006/bbrc.1994.1005; Gunjan A, 1999, NUCLEIC ACIDS RES, V27, P3355, DOI 10.1093/nar/27.16.3355; HANNON R, 1984, J MOL BIOL, V180, P131, DOI 10.1016/0022-2836(84)90434-0; Howe L, 1998, BIOCHEMISTRY-US, V37, P7077, DOI 10.1021/bi980410o; HUANG HC, 1984, J BIOL CHEM, V259, P4237; HUANG SY, 1989, METHOD ENZYMOL, V170, P116; LENNOX RW, 1984, DEV BIOL, V103, P80, DOI 10.1016/0012-1606(84)90009-5; LENNOX RW, 1984, J BIOL CHEM, V259, P669; LENNOX RW, 1988, BIOCHEM CELL BIOL, V66, P636, DOI 10.1139/o88-073; LEUBA SH, 1994, J MOL BIOL, V235, P871, DOI 10.1006/jmbi.1994.1045; Lu ZH, 1997, J CELL SCI, V110, P2745; NELSON PP, 1979, J BIOL CHEM, V254, P1751; NEWROCK KM, 1977, COLD SPRING HARB SYM, V42, P421, DOI 10.1101/SQB.1978.042.01.045; Nightingale KP, 1996, J BIOL CHEM, V271, P7090, DOI 10.1074/jbc.271.12.7090; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; PARSEGHIAN MH, 1994, PROTEIN SCI, V3, P575; PEHRSON J, 1980, NATURE, V285, P43, DOI 10.1038/285043a0; PEHRSON JR, 1981, BIOCHEMISTRY-US, V20, P2298, DOI 10.1021/bi00511a035; POCCIA DL, 1992, TRENDS BIOCHEM SCI, V17, P223, DOI 10.1016/0968-0004(92)90382-J; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; RODRIGUEZCAMPOS A, 1989, J MOL BIOL, V209, P135, DOI 10.1016/0022-2836(89)90177-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANDALTZOPOULOS R, 1994, EMBO J, V13, P373, DOI 10.1002/j.1460-2075.1994.tb06271.x; Schulze E, 1995, J MOL EVOL, V41, P833; SEYEDIN SM, 1981, EXP CELL RES, V136, P399, DOI 10.1016/0014-4827(81)90019-7; STEIN GS, 1984, HISTONE GENES STRUCT; SUN JM, 1990, EMBO J, V9, P1651, DOI 10.1002/j.1460-2075.1990.tb08285.x; SUN JM, 1989, SCIENCE, V245, P68, DOI 10.1126/science.2740916; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Travers A, 1999, TRENDS BIOCHEM SCI, V24, P4, DOI 10.1016/S0968-0004(98)01339-5; van Holde KE., 1989, SPRINGER SERIES MOL; vanHolde K, 1996, P NATL ACAD SCI USA, V93, P10548, DOI 10.1073/pnas.93.20.10548; Widom J, 1998, CURR BIOL, V8, pR788, DOI 10.1016/S0960-9822(07)00500-3; Wolffe A., 1995, CHROMATIN STRUCTURE; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311; ZLATANOVA J, 1992, J CELL SCI, V103, P889; Zweidler A., 1980, DEV BIOCHEM, V15, P47	48	60	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37950	37956		10.1074/jbc.274.53.37950	http://dx.doi.org/10.1074/jbc.274.53.37950			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608862	hybrid			2022-12-27	WOS:000084528000062
J	Kaytor, MD; Warren, ST				Kaytor, MD; Warren, ST			Aberrant protein deposition and neurological disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NEURONAL INTRANUCLEAR INCLUSIONS; BULBAR MUSCULAR-ATROPHY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; ANDROGEN RECEPTOR; GLUTAMINE REPEATS; PRION PROTEIN; GENE-PRODUCTS; POLYGLUTAMINE; AGGREGATION		Emory Univ, Sch Med, Howard Hughes Med Inst, Rollins Res Ctr 4035, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA	Emory University; Howard Hughes Medical Institute; Emory University; Emory University; Emory University	Warren, ST (corresponding author), Emory Univ, Sch Med, Howard Hughes Med Inst, Rollins Res Ctr 4035, 1510 Clifton Rd, Atlanta, GA 30322 USA.		Warren, Stephen T/A-2498-2012					Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Butler R, 1998, HUM MOL GENET, V7, P121, DOI 10.1093/hmg/7.1.121; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Duvoisin RC, 1996, ADV NEUROL, V69, P33; Ellerby LM, 1999, J BIOL CHEM, V274, P8730, DOI 10.1074/jbc.274.13.8730; Gregori L, 1997, J BIOL CHEM, V272, P58; Gusella JF, 1998, CURR OPIN NEUROBIOL, V8, P425, DOI 10.1016/S0959-4388(98)80071-8; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1999, HUM MOL GENET, V8, P25, DOI 10.1093/hmg/8.1.25; Hackam AS, 1998, CLIN GENET, V53, P233; Hardy J, 1996, ANN MED, V28, P255, DOI 10.3109/07853899609033127; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ishikawa K, 1999, HUM MOL GENET, V8, P1185, DOI 10.1093/hmg/8.7.1185; Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580; Kato S, 1999, HISTOL HISTOPATHOL, V14, P973, DOI 10.14670/HH-14.973; Kaytor MD, 1999, HUM MOL GENET, V8, P1657, DOI 10.1093/hmg/8.9.1657; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Koshy BT, 1997, BRAIN PATHOL, V7, P927, DOI 10.1111/j.1750-3639.1997.tb00894.x; KUEMMERLE S, 1999, IN PRESS ANN NEUROL; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Li SH, 1999, J NEUROSCI, V19, P5159; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; MORISHIMAKAWASHIMA M, 1993, NEURON, V10, P1151, DOI 10.1016/0896-6273(93)90063-W; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Ross CA, 1997, BRAIN PATHOL, V7, P1003, DOI 10.1111/j.1750-3639.1997.tb00898.x; Rubinsztein DC, 1999, J MED GENET, V36, P265; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Takeda A, 1998, AM J PATHOL, V152, P367; Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wisniewski T, 1997, NEUROBIOL DIS, V4, P313, DOI 10.1006/nbdi.1997.0147; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	58	101	108	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37507	37510		10.1074/jbc.274.53.37507	http://dx.doi.org/10.1074/jbc.274.53.37507			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608801	hybrid			2022-12-27	WOS:000084528000001
J	Kessen, U; Schaloske, R; Aichem, A; Mutzel, R				Kessen, U; Schaloske, R; Aichem, A; Mutzel, R			Ca2+/calmodulin-independent activation of calcineurin from Dictyostelium by unsaturated long chain fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN PHOSPHATASE; LIMITED PROTEOLYSIS; BOVINE BRAIN; CALMODULIN; CALCIUM; DISCOIDEUM; BINDING; IDENTIFICATION; PHOSPHOLIPIDS; CHEMOTAXIS	This study describes a novel mode of activation for the Ca2+/calmodulin-dependent protein phosphatase calcineurin, Using purified calcineurin from Dictyostelium discoideum we found a reversible, Ca2+/calmodulin-independent activation by the long chain unsaturated fatty acids arachidonic acid, linoleic acid, and oleic acid, which was of the same magnitude as activation by Ca2+/calmodulin, Half-maximal stimulation of calcineurin occurred at fatty acid concentrations of approximately 10 mu M with either p-nitrophenyl phosphate or RII phosphopeptide as substrates, The methyl ester of arachidonic acid and the saturated fatty acids palmitic acid and arachidic acid did not activate calcineurin, The activation was shown to be independent of the regulatory subunit, calcineurin B. Activation by Ca2+/calmodulin and fatty acids was not additive. In binding assays with immobilized calmodulin, arachidonic acid inhibited binding of calcineurin to calmodulin, Therefore fatty acids appear to mimic Ca2+/calmodulin action by binding to the calmodulin-binding site.	Univ Konstanz, Fak Biol, D-78457 Constance, Germany	University of Konstanz	Mutzel, R (corresponding author), Univ Konstanz, Fak Biol, D-78457 Constance, Germany.							ALJOBORE A, 1981, CAN J BIOCHEM CELL B, V59, P880, DOI 10.1139/o81-123; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; BUMANN J, 1984, J CELL BIOL, V98, P173, DOI 10.1083/jcb.98.1.173; CHATTOPADHYAY A, 1984, ANAL BIOCHEM, V139, P408, DOI 10.1016/0003-2697(84)90026-5; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Dammann H, 1996, EUR J BIOCHEM, V238, P391, DOI 10.1111/j.1432-1033.1996.0391z.x; Demant EJF, 1999, ANAL BIOCHEM, V267, P366, DOI 10.1006/abio.1998.3019; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; Hellstern S, 1997, RES MICROBIOL, V148, P335, DOI 10.1016/S0923-2508(97)81589-6; HIGUCHI S, 1991, J BIOL CHEM, V266, P18104; Horn F, 1996, DIFFERENTIATION, V60, P269, DOI 10.1046/j.1432-0436.1996.6050269.x; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; JARRETT HW, 1986, J BIOL CHEM, V261, P4967; KINCAID R, 1993, ADV SEC MESS PHOSPH, V27, P1; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Klumpp S, 1998, FEBS LETT, V437, P229, DOI 10.1016/S0014-5793(98)01237-X; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALCHOW D, 1982, BIOPHYS STRUCT MECH, V9, P131, DOI 10.1007/BF00539112; Moniakis J, 1999, J CELL SCI, V112, P405; Newell PC, 1995, EXPERIENTIA, V51, P1155, DOI 10.1007/BF01944733; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; PICHARD AL, 1977, J BIOL CHEM, V252, P4872; POLESKY AJM, 1995, MOL BIOL CELL S, V6, P91; POLITINO M, 1990, J BIOL CHEM, V265, P7619; POLITINO M, 1987, J BIOL CHEM, V262, P10109; Schaloske R, 1997, BIOCHEM J, V327, P233, DOI 10.1042/bj3270233; Schaloske R, 1998, BIOCHEM J, V332, P541, DOI 10.1042/bj3320541; SCHLATTERER C, 1994, J CELL SCI, V107, P2107; Skinner J, 1997, J BIOL CHEM, V272, P22464, DOI 10.1074/jbc.272.36.22464; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; TANAKA T, 1980, J BIOL CHEM, V255, P1078; UNTERWEGER N, 1995, CELL CALCIUM, V17, P97, DOI 10.1016/0143-4160(95)90079-9; WINCKLER T, 1991, RES MICROBIOL, V142, P509, DOI 10.1016/0923-2508(91)90184-C; WOLF BA, 1991, BIOCHEMISTRY-US, V30, P6372, DOI 10.1021/bi00240a004; WOLFF DJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P720, DOI 10.1016/0003-9861(76)90310-6; Yumura S, 1996, J CELL SCI, V109, P2673	42	28	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37821	37826		10.1074/jbc.274.53.37821	http://dx.doi.org/10.1074/jbc.274.53.37821			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608845	hybrid			2022-12-27	WOS:000084528000045
J	Mortensen, K; Skouv, J; Hougaard, DM; Larsson, LI				Mortensen, K; Skouv, J; Hougaard, DM; Larsson, LI			Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; HYDROGEN-PEROXIDE; DNA FRAGMENTATION; LYMPHOMA-CELLS; GROWTH ARREST; TUMOR-CELLS; EXPRESSION; GENE; BCL-2; SUPPRESSOR	Nitric oxide can both stimulate and suppress apoptosis. By reverse transcriptase-polymerase chain reaction and sequencing we show that human breast cancer (MCF-7) cells express endothelial cell nitric-oxide synthase (ecNOS), but not other nitric-oxide synthase isoforms. Inhibition of ecNOS activity in MCF-7 cells increased tumor cell apoptosis, and this effect was also seen following treatment with an NO scavenger. In addition, low concentrations of the NO donor sodium nitroprusside inhibited, whereas high concentrations stimulated MCF-7 cell apoptosis. The ecNOS promoter was found to contain a specific binding site for the apoptosis-regulating protein p53. In co-transfection studies wild-type, but not mutant, p53 down-regulated transcription of an ecNOS promoter-luciferase reporter gene construct. In addition, NO donors up-regulated p53 protein levels in MCF-7 cells. These data point to a previously unrecognized p53-dependent regulation of ecNOS expression that may be important both for regulating apoptosis and for avoiding the generation of genotoxic quantities of NO.	Royal Vet & Agr Univ, Inst Anat & Physiol, Div Cell Biol, DK-1870 Frederiksberg C, Denmark; Exiqon AS, Vedbaek, Denmark; Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark	University of Copenhagen; Exiqon; Statens Serum Institut	Larsson, LI (corresponding author), Royal Vet & Agr Univ, Inst Anat & Physiol, Div Cell Biol, Gronnegaardsvej 7, DK-1870 Frederiksberg C, Denmark.		Hougaard, David/AAD-6368-2019					Ambs S, 1997, FASEB J, V11, P443, DOI 10.1096/fasebj.11.6.9194524; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BANI D, 1995, CANCER RES, V55, P5272; Bonfoco E, 1996, NEUROREPORT, V8, P273, DOI 10.1097/00001756-199612200-00054; Cieslik K, 1998, J BIOL CHEM, V273, P14885, DOI 10.1074/jbc.273.24.14885; DARLEYUSMAR V, 1995, FEBS LETT, V369, P131, DOI 10.1016/0014-5793(95)00764-Z; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Ellis G, 1998, CLIN BIOCHEM, V31, P195, DOI 10.1016/S0009-9120(98)00015-0; FariasEisner R, 1996, J BIOL CHEM, V271, P6144, DOI 10.1074/jbc.271.11.6144; Filep JG, 1997, BIOCHEM J, V321, P897, DOI 10.1042/bj3210897; FORNARI FA, 1994, CELL GROWTH DIFFER, V5, P723; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; FORSTERMANN U, 1995, N-S ARCH PHARMACOL, V352, P351; Gopalkrishnan RV, 1998, J BIOL CHEM, V273, P10972, DOI 10.1074/jbc.273.18.10972; Harris SR, 1997, BIOCHEM BIOPH RES CO, V235, P509, DOI 10.1006/bbrc.1997.6820; Ho YS, 1997, MOL CARCINOGEN, V19, P101, DOI 10.1002/(SICI)1098-2744(199707)19:2<101::AID-MC5>3.0.CO;2-I; Ho YS, 1996, MOL CARCINOGEN, V16, P20, DOI 10.1002/(SICI)1098-2744(199605)16:1<20::AID-MC4>3.3.CO;2-I; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; Hortelano S, 1997, FEBS LETT, V410, P373, DOI 10.1016/S0014-5793(97)00623-6; Iotsova V, 1996, ONCOGENE, V13, P2331; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kawaguchi H, 1997, CIRCULATION, V95, P2441, DOI 10.1161/01.CIR.95.10.2441; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Leach SD, 1998, CANCER RES, V58, P3231; LEIST M, 1994, BIOCHEMICA, V11, P20; LI LM, 1991, CANCER RES, V51, P2531; Lind DS, 1997, J SURG RES, V69, P283, DOI 10.1006/jsre.1997.5015; Lopez-Farre A, 1997, AM J PHYSIOL-HEART C, V272, pH760, DOI 10.1152/ajpheart.1997.272.2.H760; Loweth AC, 1997, FEBS LETT, V400, P285, DOI 10.1016/S0014-5793(96)01392-0; Mandal M, 1996, CELL GROWTH DIFFER, V7, P311; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Melkova Z, 1997, FEBS LETT, V403, P273, DOI 10.1016/S0014-5793(97)00065-3; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; MESSMER UK, 1994, FEBS LETT, V355, P23; MIYAHARA K, 1994, EUR J BIOCHEM, V223, P719, DOI 10.1111/j.1432-1033.1994.tb19045.x; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mortensen K, 1999, CLIN CANCER RES, V5, P1093; Nicotera P, 1997, TRENDS PHARMACOL SCI, V18, P189, DOI 10.1016/S0165-6147(97)90619-2; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; OHLSSON H, 1986, CELL, V45, P35, DOI 10.1016/0092-8674(86)90535-0; Pacelli R, 1996, LANCET, V347, P900, DOI 10.1016/S0140-6736(96)91378-1; Peunova N, 1996, COLD SPRING HARB SYM, V61, P417; Pollman MJ, 1996, CIRC RES, V79, P748, DOI 10.1161/01.RES.79.4.748; Polte T, 1997, FEBS LETT, V409, P46, DOI 10.1016/S0014-5793(97)00480-8; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; SANDOVAL M, 1995, MEDIAT INFLAMM, V4, P248, DOI 10.1155/S0962935195000391; Sandri MI, 1996, NUCLEIC ACIDS RES, V24, P4464, DOI 10.1093/nar/24.22.4464; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; SUMANTRAN VN, 1995, CANCER RES, V55, P2507; SUN K, 1995, CANCER RES, V55, P5524; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THOMSEN LL, 1995, BRIT J CANCER, V72, P41, DOI 10.1038/bjc.1995.274; Umansky V, 1997, INT J ONCOL, V10, P465; WANG TTY, 1995, CANCER RES, V55, P2487; Yamabe Y, 1998, MOL CELL BIOL, V18, P6191, DOI 10.1128/MCB.18.11.6191; Zeillinger R, 1996, BREAST CANCER RES TR, V40, P205, DOI 10.1007/BF01806216	59	66	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37679	37684		10.1074/jbc.274.53.37679	http://dx.doi.org/10.1074/jbc.274.53.37679			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608825	hybrid			2022-12-27	WOS:000084528000025
J	Ryan, MP; Jack, RW; Josten, M; Sahl, HG; Jung, G; Ross, RP; Hill, C				Ryan, MP; Jack, RW; Josten, M; Sahl, HG; Jung, G; Ross, RP; Hill, C			Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROAD-SPECTRUM BACTERIOCIN; BIOLOGICAL-ACTIVITIES; NISIN; BIOSYNTHESIS; POLYPEPTIDE; SEQUENCE; PEPTIDES	Lacticin 3147 is a two-component bacteriocin produced by Lactococcus lactis subspecies lactis DPC3147. In order to further characterize the biochemical nature of the bacteriocin, both peptides were isolated which together are responsible for the antimicrobial activity. The first, LtnA1, is a 3,322 Da 30-amino acid peptide and the second component, LtnA2, is a 29-amino acid peptide with a mass of 2,847 Da. Conventional amino acid analysis revealed that both peptides contain the thioether amino acid, lanthionine, as well as an excess of alanine to that predicted from the genetic sequence of the peptides. Chiral phase gas chromatography coupled with mass spectrometry of amino acid composition indicated that both LtnA1 and LtnA2 contain D-alanine residues and amino acid sequence analysis of LtnA1 confirmed that the D-alanine results from post-translational modification of a serine residue in the primary translation product. Taken together, these results demonstrate that lacticin 3147 is a novel, two-component, D-alanine containing lantibiotic that undergoes extensive post-translational modification which may account for its potent antimicrobial activity against a wide range of Grampositive bacteria.	TEAGASC, Dairy Prod Res Ctr, Fermoy, Cork, Ireland; Univ Coll, Natl Food Biotechnol Ctr, Cork, Ireland; Univ Coll, Dept Microbiol, Cork, Ireland; ECHAZ Microcollect, D-720700 Tubingen, Germany; Univ Tubingen, Inst Organ Chem, D-720700 Tubingen, Germany; Univ Bonn, Inst Med Microbiol & Immunol, D-53105 Bonn, Germany	Teagasc; University College Cork; University College Cork; Eberhard Karls University of Tubingen; University of Bonn	Ross, RP (corresponding author), TEAGASC, Dairy Prod Res Ctr, Moorepk, Fermoy, Cork, Ireland.	pross@moorepark.teagasc.ie	Ross, Paul/A-7584-2015; Hill, Colin/A-5611-2012	Ross, Paul/0000-0003-4876-8839; Hill, Colin/0000-0002-8527-1445				Bierbaum G, 1996, APPL ENVIRON MICROB, V62, P385, DOI 10.1128/AEM.62.2.385-392.1996; BOOTH MC, 1996, MOL MICROBIOL, V269, P27183; BYCROFT BW, 1969, NATURE, V224, P595, DOI 10.1038/224595a0; DELVESBROUGHTON J, 1990, FOOD TECHNOL-CHICAGO, V44, P100; DeVuyst L, 1994, BACTERIOCINS LACTIC, P151; Dougherty BA, 1998, MOL MICROBIOL, V29, P1029, DOI 10.1046/j.1365-2958.1998.00988.x; Fenelon MA, 1999, J DAIRY SCI, V82, P10, DOI 10.3168/jds.S0022-0302(99)75203-3; Fredenhagen A., 1991, NISIN NOVEL LANTIBIO, P131; GERHARDT J, 1994, PEPTIDES CHEM STRUCT, P241; GROSS E, 1971, J AM CHEM SOC, V93, P4634, DOI 10.1021/ja00747a073; Hurst A., 1981, ADV APPL MICROBIOL, V27, P85, DOI [10.1016/s0065-2164(08)70342-3, DOI 10.1016/S0065-2164(08)70342-3, 10.1016/S0065-2164(08)70342-3]; Jack R.W., 1998, LANTIBIOTICS RELATED; KELLNER R, 1988, EUR J BIOCHEM, V177, P53, DOI 10.1111/j.1432-1033.1988.tb14344.x; Kellner R, 1991, NISIN NOVEL LANTIBIO, P141; KESSLER H, 1988, HELV CHIM ACTA, V71, P1924, DOI 10.1002/hlca.19880710811; McAuliffe O, 1999, J APPL MICROBIOL, V86, P251, DOI 10.1046/j.1365-2672.1999.00663.x; McAuliffe O, 1998, APPL ENVIRON MICROB, V64, P439; MEYER HE, 1994, ANAL BIOCHEM, V223, P185, DOI 10.1006/abio.1994.1571; MOR A, 1992, TRENDS BIOCHEM SCI, V17, P481, DOI 10.1016/0968-0004(92)90333-5; Navaratna MADB, 1998, APPL ENVIRON MICROB, V64, P4803; Navaratna MADB, 1999, INFECT IMMUN, V67, P4268, DOI 10.1128/IAI.67.8.4268-4271.1999; ROSS RP, 1999, FEMS MICRO REV, V76, P337; Ryan MP, 1996, APPL ENVIRON MICROB, V62, P612, DOI 10.1128/AEM.62.2.612-619.1996; Ryan MP, 1998, APPL ENVIRON MICROB, V64, P2287; SAHL HG, 1995, EUR J BIOCHEM, V230, P827, DOI 10.1111/j.1432-1033.1995.tb20627.x; SAHL HG, 1985, ANTIMICROB AGENTS CH, V27, P836, DOI 10.1128/AAC.27.5.836; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; SKAUGEN M, 1994, J BIOL CHEM, V269, P27183; ZIMMERMANN N, 1995, EUR J BIOCHEM, V228, P786, DOI 10.1111/j.1432-1033.1995.tb20324.x	29	106	109	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37544	37550		10.1074/jbc.274.53.37544	http://dx.doi.org/10.1074/jbc.274.53.37544			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608807	hybrid			2022-12-27	WOS:000084528000007
J	Wang, Z; Gaba, A; Sachs, MS				Wang, Z; Gaba, A; Sachs, MS			A highly conserved mechanism of regulated ribosome stalling mediated by fungal arginine attenuator peptides that appears independent of the charging status of arginyl-tRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID BIOSYNTHESIS; OPEN READING FRAME; TRANSFER-RNA-SYNTHETASE; NEUROSPORA-CRASSA; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL REGULATION; CROSS-PATHWAY; NASCENT-PEPTIDE; LEADER PEPTIDE	The Arg attenuator peptide (AAP) is an evolutionarily conserved peptide involved in Arg-specific negative translational control. It is encoded as an upstream open reading frame (uORF) in fungal mRNAs specifying the small subunit of Arg-specific carbamoyl phosphate synthetase, We examined the functions of the Saccharomyces cerevisiae CPA1 and Neurospora crassa arg-2 AAPs using translation extracts from S. cerevisiae, N. crassa, and wheat germ. Synthetic RNA containing AAP and firefly luciferase (LUC) sequences were used to program translation; analyses of LUC activity indicated that the AAPs conferred Arg-specific negative regulation in each system. The AAPs functioned either as uORFs or fused in-frame at the N terminus of LUG. Mutant AAPs lacking function in vivo did not function in vitro. Therefore, trans-acting factors conferring AAP-mediated regulation are in both fungal and plant systems. Analyses of ribosome stalling in the fungal extracts by primer extension inhibition (toeprint) assays showed that these AAPs acted similarly to stall ribosomes in the region immediately distal to the AAP coding region in response to Arg. The regulatory effect increased as the Arg concentration increased; all of the arginyl-tRNAs examined appeared maximally charged at low Arg concentrations. Therefore, AAP-mediated Arg-specific regulation appeared independent of the charging status of arginyl-tRNA.	Oregon Grad Inst Sci & Technol, Dept Biochem & Mol Biol, Beaverton, OR 97006 USA; Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Oregon Health & Science University	Sachs, MS (corresponding author), Oregon Grad Inst Sci & Technol, Dept Biochem & Mol Biol, 20000 NW Walker Rd, Beaverton, OR 97006 USA.			Sachs, Matthew/0000-0001-9891-9223	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047498, R01GM047498] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47498-S, GM47498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alderete JP, 1999, J VIROL, V73, P8330, DOI 10.1128/JVI.73.10.8330-8337.1999; ALZNERDEWEERD B, 1980, NUCLEIC ACIDS RES, V8, P1023, DOI 10.1093/nar/8.5.1023; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Baek JM, 1998, FUNGAL GENET BIOL, V23, P34, DOI 10.1006/fgbi.1997.1025; BARCISZEWSKA MZ, 1986, BIOCHIMIE, V68, P319, DOI 10.1016/S0300-9084(86)80029-3; Baum M, 1998, NUCLEIC ACIDS RES, V26, P1390, DOI 10.1093/nar/26.6.1390; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Cao JH, 1998, RNA, V4, P181; Child SJ, 1999, J BIOL CHEM, V274, P24335, DOI 10.1074/jbc.274.34.24335; CIGAN AM, 1986, GENE, V41, P343, DOI 10.1016/0378-1119(86)90118-6; CRABEEL M, 1990, MOL CELL BIOL, V10, P1226, DOI 10.1128/MCB.10.3.1226; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; DELBECQ P, 1994, MOL CELL BIOL, V14, P2378, DOI 10.1128/MCB.14.4.2378; EBBOLE DJ, 1991, MOL CELL BIOL, V11, P928, DOI 10.1128/MCB.11.2.928; Freitag M, 1996, GENETICS, V142, P117; GANGLOFF J, 1976, EUR J BIOCHEM, V65, P177, DOI 10.1111/j.1432-1033.1976.tb10403.x; GEBALLE AP, 1996, TRANSLATIONAL CONTRO, P173; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; GHOSH HP, 1982, NUCLEIC ACIDS RES, V10, P3241, DOI 10.1093/nar/10.10.3241; GILLUM AM, 1977, NUCLEIC ACIDS RES, V4, P4109, DOI 10.1093/nar/4.12.4109; HAEUPTLE MT, 1986, NUCLEIC ACIDS RES, V14, P1427, DOI 10.1093/nar/14.3.1427; Harigai M, 1996, ONCOGENE, V12, P1369; Hilleren P, 1999, RNA, V5, P711, DOI 10.1017/S1355838299990519; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Jackson RJ, 1997, CURR OPIN GENET DEV, V7, P233, DOI 10.1016/S0959-437X(97)80133-5; Keenan KA, 1997, FUNGAL GENET BIOL, V22, P177, DOI 10.1006/fgbi.1997.1009; KEITH G, 1980, BIOCHEM BIOPH RES CO, V92, P116, DOI 10.1016/0006-291X(80)91527-2; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; KINNEY DM, 1989, MOL CELL BIOL, V9, P4882, DOI 10.1128/MCB.9.11.4882; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Konan KV, 1999, J BACTERIOL, V181, P1530, DOI 10.1128/JB.181.5.1530-1536.1999; Kozak M, 1998, NUCLEIC ACIDS RES, V26, P4853, DOI 10.1093/nar/26.21.4853; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; LANDICK R, 1996, ESCHERICHIA COLI SAL, V1, P1263; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; LUO ZG, 1995, MOL CELL BIOL, V15, P5235; Luo ZL, 1996, J BACTERIOL, V178, P2172, DOI 10.1128/jb.178.8.2172-2177.1996; Martinez-Garcia JF, 1998, PLANT J, V13, P489, DOI 10.1046/j.1365-313X.1998.00050.x; McCarthy JEG, 1998, MICROBIOL MOL BIOL R, V62, P1492, DOI 10.1128/MMBR.62.4.1492-1553.1998; Mize GJ, 1998, J BIOL CHEM, V273, P32500, DOI 10.1074/jbc.273.49.32500; Ni JP, 1999, NAT STRUCT BIOL, V6, P427; ORBACH MJ, 1990, J BIOL CHEM, V265, P10981; PALACIAN E, 1979, EUR J BIOCHEM, V101, P469, DOI 10.1111/j.1432-1033.1979.tb19741.x; PALUH JL, 1988, P NATL ACAD SCI USA, V85, P3728, DOI 10.1073/pnas.85.11.3728; SACHS MS, 1991, DEV BIOL, V148, P117, DOI 10.1016/0012-1606(91)90322-T; SACHS MS, 1996, MYCOTA, V3, P315; Salomons GS, 1998, INT J CANCER, V79, P273, DOI 10.1002/(SICI)1097-0215(19980619)79:3<273::AID-IJC11>3.3.CO;2-J; Sattlegger E, 1998, J BIOL CHEM, V273, P20404, DOI 10.1074/jbc.273.32.20404; Shen WC, 1997, FUNGAL GENET BIOL, V21, P40, DOI 10.1006/fgbi.1997.0958; TAO JS, 1992, P NATL ACAD SCI USA, V89, P2723, DOI 10.1073/pnas.89.7.2723; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; THURIAUX P, 1972, J MOL BIOL, V67, P277, DOI 10.1016/0022-2836(72)90241-0; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Vilela C, 1999, EMBO J, V18, P3139, DOI 10.1093/emboj/18.11.3139; Wang Z, 1997, J BIOL CHEM, V272, P255; Wang Z, 1998, MOL CELL BIOL, V18, P7528, DOI 10.1128/MCB.18.12.7528; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; WEISSENBACH J, 1975, EUR J BIOCHEM, V56, P521, DOI 10.1111/j.1432-1033.1975.tb02257.x; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; YARUS M, 1989, BIOCHEMISTRY-US, V28, P980, DOI 10.1021/bi00429a010	62	56	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37565	37574		10.1074/jbc.274.53.37565	http://dx.doi.org/10.1074/jbc.274.53.37565			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608810	hybrid			2022-12-27	WOS:000084528000010
J	Peters, CA; Maizels, ET; Hunzicker-Dunn, M				Peters, CA; Maizels, ET; Hunzicker-Dunn, M			Activation of PKC delta in the rat corpus luteum during pregnancy - Potential role of prolactin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GRANULOSA-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; FAMILY MEMBERS; PRL RECEPTOR; PHOSPHORYLATION; TRANSDUCTION; ISOZYMES; HORMONE	Maintenance of pregnancy in the rat requires the corpus luteum, At a time when rat placental lactogens (rPLs) are required to support progesterone production by the corpus luteum and when relaxin expression is initiated, expression of a specific protein kinase C (PKC) isoform, PRC delta, is dramatically increased. We therefore assessed whether prolactin (PRL) receptor activation promotes activation of PKC delta in a luteinized granulosa cell model. We also assessed the activation status of PKC delta in corpora lutea obtained when the corpus luteum is exposed to chronically high concentrations of rPLs. The activity of PKC delta was assessed by two means: an immune complex (IC) assay and Western blotting with a phospho epitope-specific antibody that detects PKC delta phosphorylated on serine 662. PKC delta activation in the IC kinase assay was determined by the ability of immunoprecipitated PKC delta to phosphorylate the PKC delta-preferential substrate small heat shock protein (HSP-27), Treatment of luteinized rat granulosa cells with phorbol myristate acetate, a known activator of PKC, promoted 7-fold increase in HSP-27 phosphorylation by PKC delta, Similarly, immunoreactivity with the phospho-epitope-specific PKC delta antibody was increased in extracts prepared from luteinized granulosa cells treated with phorbol myristate acetate or following in vitro activation of recombinant PKC delta. Using these assays, we assessed whether PRL receptor agonists were capable of activating PKC delta in luteinized granulosa cells. PRL receptor agonists induced translocation PKC delta from the cytosolic to the Triton-soluble membrane fraction and increased PKC delta activity assessed by both IC kinase assay and Western blotting with phospho-epitope-specific PKC delta antibody. Analysis of PKC delta activity in corpora lutes obtained during pregnancy by both the IC kinase assay and We stern blotting with the phospho-epitope-specific PKC delta antibody revealed that PKC delta activity was increased throughout the second half of pregnancy. These results demonstrate that PRL receptor activation promotes the acute activation of PKC delta in luteinized rat granulosa cells, At a time when the rat is exposed to chronically high concentrations of rPLs, PKC delta is increasingly expressed and active.	Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University	Hunzicker-Dunn, M (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	mhd@nwu.edu		Maizels, Evelyn/0000-0001-9072-1095	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021921] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007068] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD 07068, P01 HD 21921] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acs P, 1997, J BIOL CHEM, V272, P28793, DOI 10.1074/jbc.272.45.28793; Billiard J, 1997, P NATL ACAD SCI USA, V94, P12192, DOI 10.1073/pnas.94.22.12192; BLEY MA, 1991, BIOL REPROD, V44, P880, DOI 10.1095/biolreprod44.5.880; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BUCKLEY AR, 1988, P NATL ACAD SCI USA, V85, P8649, DOI 10.1073/pnas.85.22.8649; CARR DW, 1993, J BIOL CHEM, V268, P20729; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; CUTLER RE, 1994, ENDOCRINOLOGY, V135, P1669, DOI 10.1210/en.135.4.1669; CUTLER RE, 1993, BIOCHIM BIOPHYS ACTA, V1179, P260, DOI 10.1016/0167-4889(93)90081-Y; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; DEVITO WJ, 1993, J NEUROCHEM, V60, P835, DOI 10.1111/j.1471-4159.1993.tb03227.x; FANJUL LF, 1993, EUR J BIOCHEM, V216, P747, DOI 10.1111/j.1432-1033.1993.tb18194.x; GIBORI G, 1988, RECENT PROG HORM RES, V44, P377; Gschwendt M, 1999, EUR J BIOCHEM, V259, P555, DOI 10.1046/j.1432-1327.1999.00120.x; HATA A, 1993, J BIOL CHEM, V268, P9122; HICKEY GJ, 1990, MOL ENDOCRINOL, V4, P3, DOI 10.1210/mend-4-1-3; KEYES PL, 1987, BIOL REPROD, V37, P699, DOI 10.1095/biolreprod37.3.699; KIELBASSA K, 1995, J BIOL CHEM, V270, P6156, DOI 10.1074/jbc.270.11.6156; KILEY SC, 1992, MOL ENDOCRINOL, V6, P120, DOI 10.1210/me.6.1.120; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Li WQ, 1997, J BIOL CHEM, V272, P24550, DOI 10.1074/jbc.272.39.24550; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LOZANO J, 1994, J BIOL CHEM, V269, P19200; Maizels ET, 1998, BIOCHEM J, V332, P703, DOI 10.1042/bj3320703; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mochly-Rosen D, 1998, ADV PHARMACOL, V44, P91, DOI 10.1016/S1054-3589(08)60126-X; Moriya S, 1996, P NATL ACAD SCI USA, V93, P151, DOI 10.1073/pnas.93.1.151; MUNICIO MM, 1995, J BIOL CHEM, V270, P15884, DOI 10.1074/jbc.270.26.15884; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ohmori S, 1998, MOL CELL BIOL, V18, P5263, DOI 10.1128/MCB.18.9.5263; OZAWA K, 1993, J BIOL CHEM, V268, P1749; PASQUALINI C, 1994, J NEUROCHEM, V62, P967; Ratovondrahona D, 1998, BIOCHEM BIOPH RES CO, V243, P127, DOI 10.1006/bbrc.1997.7978; RICHARDS JS, 1986, ENDOCRINOLOGY, V118, P1660, DOI 10.1210/endo-118-4-1660; RILLEMA JA, 1989, P SOC EXP BIOL MED, V192, P140, DOI 10.3181/00379727-192-42968; SAURO MD, 1991, J CELL PHYSIOL, V148, P133, DOI 10.1002/jcp.1041480116; Sherwood O D, 1993, Oxf Rev Reprod Biol, V15, P143; SHIMAMOTO T, 1993, ENDOCRINOLOGY, V133, P2127, DOI 10.1210/en.133.5.2127; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; TAYLOR MJ, 1988, BIOL REPROD, V39, P743, DOI 10.1095/biolreprod39.3.743; TOKER A, 1994, J BIOL CHEM, V269, P32358; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Yamauchi T, 1998, J BIOL CHEM, V273, P15719, DOI 10.1074/jbc.273.25.15719	45	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37499	37505		10.1074/jbc.274.52.37499	http://dx.doi.org/10.1074/jbc.274.52.37499			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601326	hybrid, Green Submitted			2022-12-27	WOS:000084382700097
J	Chao, TH; Hayashi, M; Tapping, RI; Kato, Y; Lee, JD				Chao, TH; Hayashi, M; Tapping, RI; Kato, Y; Lee, JD			MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR MEF2C; MAP-KINASE; ERK; RAF-1; EXPRESSION; BMK1/ERK5; DOMAIN; YEAST	Big mitogen-activated protein (MAP) kinase (BMK1), also known as ERK5, is a member of the MAP kinase family whose cellular activity is elevated in response to growth factors, oxidative stress, and hyperosmolar conditions. Previous studies have identified MEK5 as a cellular kinase directly regulating BMK1 activity; however, signaling molecules that directly regulate MEK5 activity have not yet been defined. Through utilization of a yeast two-hybrid screen, we have identified MEKK3 as a molecule that physically interacts with MEK5, This interaction appears to take place in mammalian cells as evidenced by the fact that cellular MEK5 and MEKK3 co-immunoprecipitate. In addition, we show that a dominant active form of MEKK3 stimulates BMK1 activity through MEK5. Moreover, we demonstrate that MEKK3 activity is required for growth factor mediated cellular activation of endogenous BMK1. Taken together, these results identify MEKK3 as a kinase that regulates the activity of MEK5 and BMK1 during growth factor-induced cellular stimulation.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Aichi Med Univ, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan	Scripps Research Institute; Aichi Medical University	Lee, JD (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM053214] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53214] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; CHOW YH, 1995, J BIOL CHEM, V270, P14100, DOI 10.1074/jbc.270.23.14100; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; COBB MH, 1994, CELL MOL BIOL RES, V40, P253; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; DAVIS RJ, 1995, MOL REPROD DEV, V42, P456; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; MAGNUSON NS, 1994, SEMIN CANCER BIOL, V5, P247; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Schlesinger Thomas K., 1998, Frontiers in Bioscience, V3, pD1181; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xu SC, 1996, P NATL ACAD SCI USA, V93, P5291, DOI 10.1073/pnas.93.11.5291; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	27	151	155	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36035	36038		10.1074/jbc.274.51.36035	http://dx.doi.org/10.1074/jbc.274.51.36035			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593883	hybrid			2022-12-27	WOS:000084279200002
J	Goehring, UM; Schmidt, G; Pederson, KJ; Aktories, K; Barbieri, JT				Goehring, UM; Schmidt, G; Pederson, KJ; Aktories, K; Barbieri, JT			The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GENE-PRODUCT; DEAMIDATION; COMPLEX; FAMILY; GLN-63; CDC42; RAS	Pseudomonas aeruginosa exoenzyme S (ExoS) is a bifunctional cytotoxin. The ADP-ribosyltransferase domain is located within the C terminus part of ExoS. Recent studies showed that the N terminus part of ExoS (amino acid residues 1-234, ExoS(1-234)), which does not possess ADP-ribosyltransferase activity, stimulates cell rounding when transfected or microinjected into eukaryotic cells. Here we studied the effects of ExoS(1-234) on nucleotide binding and hydrolysis by Rho GTPases. ExoS(1-234) (100-500 nM) did not influence nucleotide exchange of Rho, Rac, and Cdc42 but increased GTP hydrolysis. A similar increase in GTPase activity was stimulated by full-length ExoS. Half-maximal stimulation of GTP hydrolysis by Rho, Rac, and Cdc42 was observed at 10-11 nM ExoS(1-234), respectively. We identified arginine 146 of ExoS to be essential for the stimulation of GTPase activity of Rho proteins. These data identify ExoS as a GTPase-activating protein for Rho GTPases.	Med Coll Wisconsin, Milwaukee, WI 53226 USA; Univ Freiburg, Inst Pharmakol & Toxikol, D-79104 Freiburg, Germany	Medical College of Wisconsin; University of Freiburg	Barbieri, JT (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.		Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436	NIAID NIH HHS [AI10017, AI30162] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI010017, R01AI030162] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; BARFOD ET, 1993, J BIOL CHEM, V268, P26059; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; COBURN J, 1989, J BIOL CHEM, V264, P9004; COBURN J, 1991, INFECT IMMUN, V59, P4259, DOI 10.1128/IAI.59.11.4259-4262.1991; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Ganesan AK, 1999, J BIOL CHEM, V274, P21823, DOI 10.1074/jbc.274.31.21823; Ganesan AK, 1998, J BIOL CHEM, V273, P7332, DOI 10.1074/jbc.273.13.7332; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Horiguchi Y, 1997, P NATL ACAD SCI USA, V94, P11623, DOI 10.1073/pnas.94.21.11623; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KULICH SM, 1993, INFECT IMMUN, V61, P307, DOI 10.1128/IAI.61.1.307-313.1993; LANCASTER CA, 1994, J BIOL CHEM, V269, P1137; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; PEDERSON KJ, 1998, MICROBIOLOGY, V32, P393; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schmidt G, 1998, NATURWISSENSCHAFTEN, V85, P253, DOI 10.1007/s001140050495; SEKINE A, 1989, J BIOL CHEM, V264, P8602; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295	29	233	243	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36369	36372		10.1074/jbc.274.51.36369	http://dx.doi.org/10.1074/jbc.274.51.36369			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593930	hybrid			2022-12-27	WOS:000084279200049
J	Krief, S; Faivre, JF; Robert, P; Le Douarin, B; Brument-Larignon, N; Lefrere, I; Bouzyk, MM; Anderson, KM; Greller, LD; Tobin, FL; Souchet, M; Bril, A				Krief, S; Faivre, JF; Robert, P; Le Douarin, B; Brument-Larignon, N; Lefrere, I; Bouzyk, MM; Anderson, KM; Greller, LD; Tobin, FL; Souchet, M; Bril, A			Identification and characterization of cvHsp - A novel human small stress protein selectively expressed in cardiovascular and insulin-sensitive tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN; HEAT-SHOCK-PROTEIN; ALPHA-B-CRYSTALLIN; GLYCOPROTEIN IB-ALPHA; FILAMIN; DISEASE; CELLS; MODULATION; BIOLOGY; ABP-280	Starting with computational tools that search for tissue-selective expression of assembled expressed sequenced tags, we have identified by focusing on heart libraries a novel small stress protein of 170 amino acids that we named cvHsp. cvHsp was found as being computationally selectively and highly (0.3% of the total RNA) expressed in human heart. The cvHsp gene mapped to 1p36.23-p34.3 between markers D1S434 and D1S507. The expression of cvHsp was analyzed with RNA dot, Northern blots, or reverse transcription-polymerase chain reaction: expression was high in heart, medium in skeletal muscle, and low in aorta or adipose tissues. In the heart of rat models of cardiac pathologies, cvHsp mRNA ex pression was either unchanged (spontaneous hypertension), up-regulated (right ventricular hypertrophy induced by monocrotaline treatment), or down-regulated (left ventricular hypertrophy following aortic banding). In obese Zucker rats, cvHsp mRNA was increased in skeletal muscle, brown, and white adipose tissues but remained unchanged in the heart. Western blot analysis using antipeptide polyclonal antibodies revealed two specific bands at 23 and 25 kDa for cvHsp in human heart. cvHsp interacted in both yeast two-hybrid and immunoprecipitation experiments with alpha-filamin or actin-binding protein 280. Within cvHsp, amino acid residues 56-119 mere shown to be important for its specific interaction with the C-terminal tail of alpha-filamin.	SmithKline Beecham, Lab Pharmaceut, F-35762 St Gregoire, France; CNRS, Unite Propre 041, Rennes, France; SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex, England; SmithKline Beecham Pharmaceut, King Of Prussia, PA 19406 USA	GlaxoSmithKline; Centre National de la Recherche Scientifique (CNRS); GlaxoSmithKline; GlaxoSmithKline	Krief, S (corresponding author), SmithKline Beecham, Lab Pharmaceut, 4 Rue Chesnay Beauregard,BP 58, F-35762 St Gregoire, France.	Stephane_Krief@sbphrd.com	FAIVRE, Jean-Francois/P-5097-2016	Krief, Stephane/0000-0002-5543-731X; ROBERT, Philippe/0000-0002-5975-9252				Andrade MA, 1997, CURR OPIN BIOTECH, V8, P675, DOI 10.1016/S0958-1669(97)80118-8; ANDREWS RK, 1991, J BIOL CHEM, V266, P7144; Baur EV, 1996, EMBO J, V15, P110, DOI 10.1002/j.1460-2075.1996.tb00339.x; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER LF, 1994, J BIOL CHEM, V269, P7869; CURRIE RW, 1988, CIRC RES, V63, P543, DOI 10.1161/01.RES.63.3.543; Ferrari R, 1996, J MOL CELL CARDIOL, V28, P2383, DOI 10.1006/jmcc.1996.0231; GOOD IJ, 1956, BIOMETRIKA, V43, P45; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Greller LD, 1999, GENOME RES, V9, P282; HONGBROWN LQ, 1994, GLIA, V12, P211, DOI 10.1002/glia.440120306; James P, 1996, GENETICS, V144, P1425; Kato K, 1998, J BIOL CHEM, V273, P28346, DOI 10.1074/jbc.273.43.28346; Kato K, 1996, J NEUROCHEM, V66, P946; KRIEF S, 1994, J BIOL CHEM, V269, P6664; LEDOUARIN B, 1995, NUCLEIC ACIDS RES, V23, P876, DOI 10.1093/nar/23.5.876; LEEDMAN PJ, 1993, P NATL ACAD SCI USA, V90, P5994, DOI 10.1073/pnas.90.13.5994; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LIU AYC, 1990, BIOCHEM BIOPH RES CO, V172, P1, DOI 10.1016/S0006-291X(05)80164-0; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; MARBER MS, 1993, CIRCULATION, V88, P1264, DOI 10.1161/01.CIR.88.3.1264; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Matz JM, 1996, AM J PHYSIOL-REG I, V270, pR525, DOI 10.1152/ajpregu.1996.270.3.R525; MAYER RJ, 1991, BIOCHIM BIOPHYS ACTA, V1089, P141, DOI 10.1016/0167-4781(91)90002-4; Meyer SC, 1997, J BIOL CHEM, V272, P2914, DOI 10.1074/jbc.272.5.2914; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; OHTA Y, 1991, CELL, V67, P275, DOI 10.1016/0092-8674(91)90179-3; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHADIACK AM, 1991, J NEUROBIOL, V22, P617, DOI 10.1002/neu.480220607; SHARMA CP, 1995, J IMMUNOL, V154, P3461; SIKELA JM, 1993, NAT GENET, V3, P189, DOI 10.1038/ng0393-189; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; SWYNGHEDAUW B, 1992, BASIC RES CARDIOL, V87, P1; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; Vasmatzis G, 1998, P NATL ACAD SCI USA, V95, P300, DOI 10.1073/pnas.95.1.300; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vincent HK, 1999, INT J OBESITY, V23, P67, DOI 10.1038/sj.ijo.0800761; WEIHING RR, 1985, CAN J BIOCHEM CELL B, V63, P397, DOI 10.1139/o85-059; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Xu WF, 1998, BLOOD, V92, P1268, DOI 10.1182/blood.V92.4.1268.416k12_1268_1276; Zeng ZZ, 1997, BIOCHEM BIOPH RES CO, V236, P389, DOI 10.1006/bbrc.1997.6935; Zhang WJ, 1998, J NEUROSCI, V18, P914; ZHU Y, 1994, BLOOD, V84, P3715, DOI 10.1182/blood.V84.11.3715.bloodjournal84113715; Zweiger G, 1997, CURR OPIN BIOTECH, V8, P684, DOI 10.1016/S0958-1669(97)80119-X	53	90	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36592	36600		10.1074/jbc.274.51.36592	http://dx.doi.org/10.1074/jbc.274.51.36592			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593960	hybrid			2022-12-27	WOS:000084279200079
J	Counillon, L; Pouyssegur, J				Counillon, L; Pouyssegur, J			The expanding family of eucaryotic Na+/H+ exchangers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RAT NA/H EXCHANGER; MICROVILLUS MEMBRANE-VESICLES; HYDROPHOBIC CLUSTER-ANALYSIS; ERYTHROCYTE ANION-EXCHANGER; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR; CYTOPLASMIC DOMAIN; H+ EXCHANGER; MOLECULAR-CLONING; ATP DEPENDENCE		Ctr Antoine Lacassagne, Inst Signaling Dev Biol & Canc Res, CNRS, UMR 6543, F-06189 Nice, France; Ctr Antoine Lacassagne, Lab Physiol Cellulaire & Mol, CNRS, UMR 6548, F-06189 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Centre Antoine Lacassagne	Pouyssegur, J (corresponding author), Ctr Antoine Lacassagne, Inst Signaling Dev Biol & Canc Res, CNRS, UMR 6543, 33 Av Valombrose, F-06189 Nice, France.	pouysseg@unice.fr						ARONSON PS, 1983, J BIOL CHEM, V258, P6767; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; BIANCHINI L, 1995, AM J PHYSIOL-CELL PH, V269, pC998, DOI 10.1152/ajpcell.1995.269.4.C998; Bianchini L, 1997, J BIOL CHEM, V272, P271; Biemesderfer D, 1998, J BIOL CHEM, V273, P12391, DOI 10.1074/jbc.273.20.12391; Bookstein C, 1996, AM J PHYSIOL-CELL PH, V271, pC1629, DOI 10.1152/ajpcell.1996.271.5.C1629; Bookstein C, 1997, AM J PHYSIOL-CELL PH, V273, pC1496, DOI 10.1152/ajpcell.1997.273.5.C1496; BORGESE F, 1992, P NATL ACAD SCI USA, V89, P6765, DOI 10.1073/pnas.89.15.6765; BORGESE F, 1994, P NATL ACAD SCI USA, V91, P5431, DOI 10.1073/pnas.91.12.5431; Cabado AG, 1996, J BIOL CHEM, V271, P3590; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; CASEY JR, 1991, J BIOL CHEM, V266, P15726; CLARK JD, 1991, AM J PHYSIOL, V261, pC945, DOI 10.1152/ajpcell.1991.261.6.C945; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; COUNILLON L, 1993, BIOCHIM BIOPHYS ACTA, V1172, P343, DOI 10.1016/0167-4781(93)90228-6; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; COUNILLON L, 1994, BIOCHEMISTRY-US, V33, P10463, DOI 10.1021/bi00200a030; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; CoupayeGerard B, 1996, AM J PHYSIOL-CELL PH, V271, pC1639, DOI 10.1152/ajpcell.1996.271.5.C1639; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Cragoe Jr EJ, 1992, AMILORIDE ITS ANALOG; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Demaurex N, 1997, J GEN PHYSIOL, V109, P117, DOI 10.1085/jgp.109.2.117; DUJEDA PK, 1996, AM J PHYSIOL, V271, pG438; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; FLIEGEL L, 1991, FEBS LETT, V279, P25, DOI 10.1016/0014-5793(91)80241-T; FRANCHI A, 1986, J BIOL CHEM, V261, P4614; FRELIN C, 1988, BIOCHIMIE, V70, P1285, DOI 10.1016/0300-9084(88)90196-4; FRELIN C, 1986, EUR J BIOCHEM, V154, P241, DOI 10.1111/j.1432-1033.1986.tb09388.x; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Gebreselassie D, 1998, BIOCHEM CELL BIOL, V76, P837, DOI 10.1139/bcb-76-5-837; Goss G, 1996, AM J PHYSIOL-CELL PH, V270, pC1493, DOI 10.1152/ajpcell.1996.270.5.C1493; GOSS GG, 1994, J BIOL CHEM, V269, P8741; GRINSTEIN S, 1993, EMBO J, V12, P5209, DOI 10.1002/j.1460-2075.1993.tb06216.x; GRINSTEIN S, 1992, J BIOL CHEM, V267, P23823; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Humphreys RA, 1999, AM J PHYSIOL-HEART C, V276, pH749, DOI 10.1152/ajpheart.1999.276.2.H749; KLANKE CA, 1995, GENOMICS, V25, P615, DOI 10.1016/0888-7543(95)80002-4; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kurashima K, 1997, J BIOL CHEM, V272, P28672, DOI 10.1074/jbc.272.45.28672; LALLEMAIN G, 1984, J BIOL CHEM, V259, P4313; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; LIVNE AA, 1991, FEBS LETT, V284, P219, DOI 10.1016/0014-5793(91)80689-Z; Loh SH, 1996, BRIT J PHARMACOL, V118, P1905, DOI 10.1111/j.1476-5381.1996.tb15623.x; Nath SK, 1996, AM J PHYSIOL-GASTR L, V270, pG431, DOI 10.1152/ajpgi.1996.270.3.G431; Noel J, 1996, J CELL SCI, V109, P929; Numata M, 1998, J BIOL CHEM, V273, P6951, DOI 10.1074/jbc.273.12.6951; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; PARIS S, 1983, J BIOL CHEM, V258, P3503; Popov M, 1997, J BIOL CHEM, V272, P18325, DOI 10.1074/jbc.272.29.18325; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; RAMAMOORTHY S, 1991, BIOCHEM J, V280, P317, DOI 10.1042/bj2800317; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SARDET C, 1991, J BIOL CHEM, V266, P19166; SCHOLZ W, 1995, CARDIOVASC RES, V29, P260, DOI 10.1016/S0008-6363(96)88579-8; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Shrode LD, 1998, AM J PHYSIOL-CELL PH, V275, pC431, DOI 10.1152/ajpcell.1998.275.2.C431; SILVA NLCL, 1995, BIOCHEMISTRY-US, V34, P10412, DOI 10.1021/bi00033a013; SOLEIMANI M, 1994, J BIOL CHEM, V269, P15613; SOLEIMANI M, 1994, J BIOL CHEM, V269, P27973; Sun AM, 1998, J MEMBRANE BIOL, V164, P293, DOI 10.1007/s002329900414; Sun AM, 1997, J MEMBRANE BIOL, V160, P85, DOI 10.1007/s002329900297; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; TSE CM, 1992, J BIOL CHEM, V267, P9340; TSE CM, 1994, BIOCHEMISTRY-US, V33, P12954, DOI 10.1021/bi00248a003; TSE CM, 1993, J BIOL CHEM, V268, P11917; VIGNE P, 1984, MOL PHARMACOL, V25, P131; Vince JW, 1997, BBA-BIOMEMBRANES, V1326, P295, DOI 10.1016/S0005-2736(97)00033-3; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; WAKABAYASHI S, 1995, J BIOL CHEM, V270, P26460, DOI 10.1074/jbc.270.44.26460; WANG DH, 1995, AM J PHYSIOL-CELL PH, V269, pC392, DOI 10.1152/ajpcell.1995.269.2.C392; WANG DN, 1994, EMBO J, V13, P3230, DOI 10.1002/j.1460-2075.1994.tb06624.x; Wang H, 1997, BIOCHEMISTRY-US, V36, P9151, DOI 10.1021/bi970802f; WANG Z, 1993, J BIOL CHEM, V268, P11925; Weinman EJ, 1997, EXP NEPHROL, V5, P449; Xue YX, 1996, EUR J PHARMACOL, V317, P309, DOI 10.1016/S0014-2999(96)00755-8; YU FH, 1993, J BIOL CHEM, V268, P25536; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856	96	317	326	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					1	4		10.1074/jbc.275.1.1	http://dx.doi.org/10.1074/jbc.275.1.1			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617577	hybrid			2022-12-27	WOS:000085951600001
J	Harris, RM; Waring, RH; Kirk, CJ; Hughes, PJ				Harris, RM; Waring, RH; Kirk, CJ; Hughes, PJ			Sulfation of "estrogenic" alkylphenols and 17 beta-estradiol by human platelet phenol sulfotransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CYTOSOLIC SULFOTRANSFERASES; TROUT ONCORHYNCHUS-MYKISS; CANCER CELL-LINES; ARYL SULFOTRANSFERASE; BREAST-CANCER; ENVIRONMENTAL ESTROGENS; EPITHELIAL-CELLS; HUMAN LIVER; EXPRESSION; NONYLPHENOL	We have investigated the ability of alkylphenols to act as substrates and/or inhibitors of phenol sulfotransferase enzymes in human platelet cytosolic fractions. Our results indicate: (i) straight chain alkylphenols do not interact with the monoamine-sulfating phenol sulfotransferase (SULT1A3); (ii) short chain 4-n-alkylphenols (C < 8) are substrates for the phenol-sulfating enzymes (SULT1A1/2), which exhibit two activity maxima against substrates with alkyl chain lengths of C1-2 and C4-5; (iii) long chain 4-n-substituted alkylphenols (C greater than or equal to 8) are poor substrates and act as inhibitors of SULT1A1/2; (iv) human platelets contain two activities, of low and high affinity, capable of sulfating 17 beta-estradiol, and 4-n-nonylphenol is a partial mixed inhibitor of the low affinity form of this activity. We conclude that by acting either as substrates or inhibitors of SULT1A1/2, alkylphenols may influence the sulfation, and hence the excretion, of estrogens and other phenol sulfotransferase substrates in humans.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Kirk, CJ (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	C.J.Kirk@bham.ac.uk		Waring, Rosemary/0000-0001-6617-5856				ANDERSON C, 1977, BIOCHEMISTRY-US, V36, P2586; ANDERSON RJ, 1980, CLIN CHIM ACTA, V103, P79, DOI 10.1016/0009-8981(80)90233-8; Ashby J, 1997, REGUL TOXICOL PHARM, V26, P102, DOI 10.1006/rtph.1997.1159; Baldwin WS, 1998, ECOTOX ENVIRON SAFE, V39, P104, DOI 10.1006/eesa.1997.1614; BORTHWICK EB, 1993, BIOCHEM J, V289, P719, DOI 10.1042/bj2890719; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Certa H, 1996, ARCH TOXICOL, V71, P112, DOI 10.1007/s002040050365; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; Coughtrie MWH, 1998, CHEM-BIOL INTERACT, V109, P3, DOI 10.1016/S0009-2797(97)00117-8; CRUICKSHANK D, 1993, EUR J PHARM SCI, V1, P41, DOI 10.1016/0928-0987(93)90016-4; Cunny HC, 1997, REGUL TOXICOL PHARM, V26, P172, DOI 10.1006/rtph.1997.1154; DAJANI A, 1988, MOL PHARM, V54, P942; DAO TL, 1971, NATL CANCER I MONOGR, P205; DUFFEL MW, 1981, J BIOL CHEM, V256, P1123; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; FALANY CN, 1994, J STEROID BIOCHEM, V48, P369, DOI 10.1016/0960-0760(94)90077-9; Falany JL, 1996, CANCER RES, V56, P1551; FALANY JL, 1993, J STEROID BIOCHEM, V46, P481, DOI 10.1016/0960-0760(93)90102-3; FOLDES A, 1983, BIOCHIM BIOPHYS ACTA, V327, P365; FROMM HJ, 1975, INITIAL RATE ENZYME, P145; GANMO A, 1989, ENVIRON POLLUT, V59, P115; Harris RM, 1998, GUT, V42, P272, DOI 10.1136/gut.42.2.272; HERNANDEZ JS, 1992, DRUG METAB DISPOS, V20, P413; Hosea NA, 1998, ARCH BIOCHEM BIOPHYS, V353, P365, DOI 10.1006/abbi.1998.0659; JONES AL, 1992, EARLY HUM DEV, V28, P65, DOI 10.1016/0378-3782(92)90007-4; Kloas W, 1999, SCI TOTAL ENVIRON, V225, P59, DOI 10.1016/S0048-9697(98)00332-5; Le Bail JC, 1998, ANTICANCER RES, V18, P1683; Lee PC, 1998, TOXICOL LETT, V99, P117, DOI 10.1016/S0378-4274(98)00153-2; Lutz I, 1999, SCI TOTAL ENVIRON, V225, P49, DOI 10.1016/S0048-9697(99)80016-3; Majdic G, 1996, ENDOCRINOLOGY, V137, P1063, DOI 10.1210/en.137.3.1063; Meldahl AC, 1996, XENOBIOTICA, V26, P1167, DOI 10.3109/00498259609050261; Miller WR, 1998, ENDOCR-RELAT CANCER, V5, P69, DOI 10.1677/erc.0.0050069; MILLINGTON DS, 1975, J STEROID BIOCHEM, V6, P239, DOI 10.1016/0022-4731(75)90139-9; Muller S, 1998, PURE APPL CHEM, V70, P1847, DOI 10.1351/pac199870091847; Nagel SC, 1999, J STEROID BIOCHEM, V69, P343, DOI 10.1016/S0960-0760(99)00078-3; Odum J, 1999, REGUL TOXICOL PHARM, V29, P184, DOI 10.1006/rtph.1999.1286; OZAWA S, 1995, PHARMACOGENETICS, V5, pS135, DOI 10.1097/00008571-199512001-00015; PASQUALINI JR, 1989, J STEROID BIOCHEM, V34, P155, DOI 10.1016/0022-4731(89)90077-0; Pennie WD, 1998, J ENDOCRINOL, V158, pR11, DOI 10.1677/joe.0.158R011; PURHOIT A, 1999, J STEROID BIOCHEM, V68, P129; Qian YM, 1998, J PHARMACOL EXP THER, V286, P555; Routledge EJ, 1997, J BIOL CHEM, V272, P3280, DOI 10.1074/jbc.272.6.3280; Roy D, 1997, J TOXICOL ENV HEALTH, V50, P1, DOI 10.1080/009841097160573; RUDER HJ, 1972, J CLIN INVEST, V51, P1020, DOI 10.1172/JCI106862; SAGE SO, 1990, J PHYSIOL-LONDON, V420, P31, DOI 10.1113/jphysiol.1990.sp017900; SANTNER SJ, 1984, J CLIN ENDOCR METAB, V59, P29, DOI 10.1210/jcem-59-1-29; Saunders PTK, 1997, ADV EXP MED BIOL, V424, P99; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Sharpe RM, 1998, BIOL REPROD, V59, P1084, DOI 10.1095/biolreprod59.5.1084; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Sumpter JP, 1998, TOXICOL LETT, V103, P337, DOI 10.1016/S0378-4274(98)00328-2; Tabira Y, 1999, EUR J BIOCHEM, V262, P240, DOI 10.1046/j.1432-1327.1999.00422.x; Thibaut R, 1998, XENOBIOTICA, V28, P745, DOI 10.1080/004982598239164; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Tran DQ, 1996, BIOCHEM BIOPH RES CO, V229, P518, DOI 10.1006/bbrc.1996.1836; US Environmental Protection Agency, 1998, END DISR SCREEN TEST; Utsumi T, 1999, CANCER RES, V59, P377; WALLE T, 1995, BIOCHEM PHARMACOL, V50, P731, DOI 10.1016/0006-2952(95)00190-B; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1; Zhu XY, 1996, INT J BIOCHEM CELL B, V28, P565, DOI 10.1016/1357-2725(95)00164-6; Zou EM, 1999, ECOTOX ENVIRON SAFE, V42, P185, DOI 10.1006/eesa.1998.1740	62	55	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					159	166		10.1074/jbc.275.1.159	http://dx.doi.org/10.1074/jbc.275.1.159			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617600	hybrid			2022-12-27	WOS:000085951600024
J	Liao, DF; Jin, ZG; Baas, AS; Daum, G; Gygi, SP; Aebersold, R; Berk, BC				Liao, DF; Jin, ZG; Baas, AS; Daum, G; Gygi, SP; Aebersold, R; Berk, BC			Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; ANGIOTENSIN-II; MAP KINASES; PROTEIN; ACTIVATION; PATHWAY; PROLIFERATION; CYCLOPHILIN; APOPTOSIS; STIMULATION	Reactive oxygen species have been implicated in the pathogenesis of atherosclerosis and hypertension, in part by promoting vascular smooth muscle cell (VSMC) growth, We have previously shown that LY83583, a generator of O-2(.-), activated extracellular signal-regulated kinases (ERK1/2) with early (10 min) and late (2 h) peaks and stimulated VSMC growth. To investigate whether secreted oxidative stress-induced factors (termed SOXF) from VSMC were responsible for late ERK1/2 activation in response to LY83583, we purified putative SOXF proteins from conditioned medium (2 h of LY83583 exposure) by sequential chromatography based on activation of ERK1/2. Proteins identified by capillary chromatography, electrospray ionization tandem mass spectrometry, and data base searching included heat shock protein 90-alpha: (HSP90-alpha) and cyclophilin B, Western blot analysis of conditioned medium showed specific secretion of HSP90-alpha but not HSP90-beta, Immunodepletion of HSP90-alpha from conditioned medium significantly inhibited conditioned medium-induced ERK1/2 activation. Human recombinant HSP90-alpha reproduced the effect of conditioned medium on ERK1/2 activation. These results show that brief oxidative stress causes sustained release of protein factors from VSMC that can stimulate ERK1/2. These factors may be important mediators for the effects of reactive oxygen species on vascular function.	Univ Rochester, Med Ctr, Cardiovasc Res Ctr, Rochester, NY 14642 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA	University of Rochester; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Berk, BC (corresponding author), Univ Rochester, Med Ctr, Cardiovasc Res Ctr, Box 679,601 Elmwood Ave, Rochester, NY 14642 USA.			Berk, Bradford/0000-0002-2767-4115	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009027, P01HL018645, R01HL049192] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL49192, HL18645, F32 HL09027] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; BAAS AS, 1995, CIRC RES, V77, P29, DOI 10.1161/01.RES.77.1.29; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; Billich A, 1997, J EXP MED, V185, P975, DOI 10.1084/jem.185.5.975; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; CARONI P, 1991, J BIOL CHEM, V266, P10739; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Griendling KK, 1998, J LAB CLIN MED, V132, P9, DOI 10.1016/S0022-2143(98)90019-1; Griendling KK, 1997, CIRCULATION, V96, P3264; GYI SP, 1999, MOL CELL BIOL, V19, P1720; ITOH H, 1993, J CLIN INVEST, V91, P2268, DOI 10.1172/JCI116454; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Liu GB, 1997, ARTERIOSCL THROM VAS, V17, P1251, DOI 10.1161/01.ATV.17.7.1251; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Molloy CJ, 1996, J CLIN INVEST, V97, P1173, DOI 10.1172/JCI118531; NAKAMURA Y, 1995, BIOCHEM BIOPH RES CO, V215, P483, DOI 10.1006/bbrc.1995.2490; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SUGO S, 1994, BIOCHEM BIOPH RES CO, V203, P719, DOI 10.1006/bbrc.1994.2241; Tsai JC, 1996, J BIOL CHEM, V271, P3667; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; XU QB, 1995, CIRCULATION, V92, P1223, DOI 10.1161/01.CIR.92.5.1223	27	218	236	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					189	196		10.1074/jbc.275.1.189	http://dx.doi.org/10.1074/jbc.275.1.189			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617604	hybrid			2022-12-27	WOS:000085951600028
J	Wang, JD; Chen, RW; Julin, DA				Wang, JD; Chen, RW; Julin, DA			A single nuclease active site of the Escherichia coli RecBCD enzyme catalyzes single-stranded DNA degradation in both directions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; II RESTRICTION ENDONUCLEASES; RECOMBINATION HOTSPOT-CHI; CONSERVED LYSINE RESIDUE; ATP-BINDING SEQUENCE; RECD SUBUNIT; EXONUCLEASE-V; HOMOLOGOUS RECOMBINATION; BACTERIOPHAGE-LAMBDA; HELICASE ACTIVITY	The RecBCD enzyme of Escherichia coli is an ATP-dependent DNA exonuclease and a helicase. Its exonuclease activity is subject to regulation by an octameric nucleotide sequence called chi. In this study, site-directed mutations were made in the carboxyl-terminal nuclease domain of the RecB subunit,, and their effects on RecB-CD's enzymatic activities were investigated. Mutation of two amino acid residues, Asp(1067) and Lys(1082), abolished nuclease activity on both single- and double-stranded DNA. Together with Asp(1080), these residues compose a motif that is similar to one shown to form the active site of several restriction endonucleases. The nuclease reactions catalyzed by the RecBCD enzyme should therefore follow the same mechanism as these restriction endonucleases. Furthermore, the mutant enzymes were unable to produce chi-specific fragments that are thought to result from the 3'-5' and 5'-3' single-stranded exonuclease activities of the enzyme during its reaction with chi-containing double-stranded DNA. The results show that the nuclease active site in the RecB C-terminal 30-kDa domain is the universal nuclease active site of RecBCD that is responsible for DNA degradation in both directions during the reaction with double-stranded DNA, A novel explanation for the observed nuclease polarity switch and RecBCD-DNA interaction is offered.	Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; Univ Maryland, Cell & Mol Biol Program, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Julin, DA (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.				NIGMS NIH HHS [GM39777] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039777, R01GM039777] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGGARWAL AK, 1995, CURR OPIN STRUC BIOL, V5, P11, DOI 10.1016/0959-440X(95)80004-K; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMUNDSEN SK, 1990, GENETICS, V126, P25; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Ban C, 1998, EMBO J, V17, P1526, DOI 10.1093/emboj/17.5.1526; BOEHMER PE, 1992, J BIOL CHEM, V267, P4981; CARDON LR, 1993, NUCLEIC ACIDS RES, V21, P3875, DOI 10.1093/nar/21.16.3875; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHAUDHURY AM, 1984, J BACTERIOL, V160, P788, DOI 10.1128/JB.160.2.788-791.1984; Chedin F, 1998, MOL MICROBIOL, V29, P1369, DOI 10.1046/j.1365-2958.1998.01018.x; Chen HW, 1997, J BIOL CHEM, V272, P10072; Chen HW, 1998, J MOL BIOL, V278, P89, DOI 10.1006/jmbi.1998.1694; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; DIXON DA, 1994, P NATL ACAD SCI USA, V91, P2980, DOI 10.1073/pnas.91.8.2980; El Karoui M, 1998, P NATL ACAD SCI USA, V95, P626, DOI 10.1073/pnas.95.2.626; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P8583, DOI 10.1093/nar/14.21.8583; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P4437, DOI 10.1093/nar/14.11.4437; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P8573, DOI 10.1093/nar/14.21.8573; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; Handa N, 1997, GENES CELLS, V2, P525, DOI 10.1046/j.1365-2443.1997.1410339.x; HSIEH S, 1992, NUCLEIC ACIDS RES, V20, P5647, DOI 10.1093/nar/20.21.5647; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; KORANGY F, 1992, J BIOL CHEM, V267, P3088; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; KORANGY F, 1992, J BIOL CHEM, V267, P1727; Kovall RA, 1998, P NATL ACAD SCI USA, V95, P7893, DOI 10.1073/pnas.95.14.7893; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; LAM ST, 1974, GENETICS, V77, P425; MUSKAVITCH KMT, 1982, J BIOL CHEM, V257, P2641; MYERS RS, 1994, ANNU REV GENET, V28, P49, DOI 10.1146/annurev.ge.28.120194.000405; Newman M, 1998, EMBO J, V17, P5466, DOI 10.1093/emboj/17.18.5466; OLIVER DB, 1977, J MOL BIOL, V116, P877, DOI 10.1016/0022-2836(77)90276-5; PALAS KM, 1990, J BIOL CHEM, V265, P3447; Phillips RJ, 1997, MOL GEN GENET, V254, P319, DOI 10.1007/PL00008605; Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x; PONTICELLI AS, 1985, CELL, V41, P145, DOI 10.1016/0092-8674(85)90069-8; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; Sambrook J., 2002, MOL CLONING LAB MANU; SASAKI M, 1982, BIOCHEM BIOPH RES CO, V109, P414, DOI 10.1016/0006-291X(82)91737-5; SCHULTZ DW, 1983, J BACTERIOL, V155, P664, DOI 10.1128/JB.155.2.664-680.1983; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; SIMMON VF, 1972, J BACTERIOL, V112, P161, DOI 10.1128/JB.112.1.161-169.1972; SMITH GR, 1995, PHILOS T ROY SOC B, V347, P13, DOI 10.1098/rstb.1995.0003; SMITH GR, 1981, CELL, V24, P429, DOI 10.1016/0092-8674(81)90333-0; Sourice S, 1998, MOL MICROBIOL, V27, P1021, DOI 10.1046/j.1365-2958.1998.00749.x; STAHL FW, 1975, J MOL BIOL, V94, P203, DOI 10.1016/0022-2836(75)90078-9; TAYLOR AF, 1985, CELL, V41, P153, DOI 10.1016/0092-8674(85)90070-4; Taylor AF, 1999, GENE DEV, V13, P890, DOI 10.1101/gad.13.7.890; TAYLOR AF, 1992, P NATL ACAD SCI USA, V89, P5226, DOI 10.1073/pnas.89.12.5226; TAYLOR AF, 1995, J BIOL CHEM, V270, P24459, DOI 10.1074/jbc.270.41.24459; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yu M, 1998, J MOL BIOL, V283, P797, DOI 10.1006/jmbi.1998.2127; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981; Zhang XJJ, 1999, NUCLEIC ACIDS RES, V27, P4200, DOI 10.1093/nar/27.21.4200	60	58	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					507	513		10.1074/jbc.275.1.507	http://dx.doi.org/10.1074/jbc.275.1.507			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617645	hybrid			2022-12-27	WOS:000085951600069
J	Bachand, F; Autexier, C				Bachand, F; Autexier, C			Functional reconstitution of human telomerase expressed in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT GENE; REVERSE-TRANSCRIPTASE; TETRAHYMENA TELOMERASE; YEAST TELOMERASE; RNA COMPONENT; CANCER; OVEREXPRESSION; TEMPLATE; COMPLEX; PROTEIN	Telomerase is a ribonucleoprotein enzyme complex that adds DNA repeats at the ends of chromosomes. In an effort to establish an in vivo heterologous expression system for active human telomerase, we expressed human telomerase reverse transcriptase (hTERT) in Saccharomyces cerevisiae and affinity-purified the protein as a fusion with glutathione S-transferase (GST). Addition of the GST moiety to the N terminus of hTERT did not interfere with telomerase activity when GST-hTERT was expressed in rabbit reticulocyte lysate (RRL) in the presence of the human telomerase RNA (hTR). Active human telomerase was immunoprecipitated from yeast lysates that co-expressed GST-hTERT and hTR. In addition, telomerase activity could be reconstituted in vitro by the addition of HTR to GST-hTERT that was immunoprecipitated from either RRL or S. cerevisiae lysates. The expression and reconstitution of human telomerase activity in yeast will provide powerful biochemical and genetic tools to study the various components required for the assembly and function of this enzyme.	Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	Lady Davis Institute; McGill University; McGill University	Autexier, C (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, 3755 Chemin Cote Ste, Montreal, PQ H3T 1E2, Canada.							Ausubel FM, 1998, CURRENT PROTOCOLS MO; AUTEXIER C, 1994, GENE DEV, V8, P563, DOI 10.1101/gad.8.5.563; Autexier C, 1996, EMBO J, V15, P5928, DOI 10.1002/j.1460-2075.1996.tb00979.x; Autexier C, 1996, TRENDS BIOCHEM SCI, V21, P387, DOI 10.1016/S0968-0004(96)90128-0; Beattie TL, 1998, CURR BIOL, V8, P177, DOI 10.1016/S0960-9822(98)70067-3; COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104; Colgin LM, 1999, CURR OPIN GENET DEV, V9, P97, DOI 10.1016/S0959-437X(99)80014-8; Collins K, 1998, P NATL ACAD SCI USA, V95, P8485, DOI 10.1073/pnas.95.15.8485; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Dubois N, 1998, MICROBIOL-SGM, V144, P2299, DOI 10.1099/00221287-144-8-2299; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Harrington L, 1997, GENE DEV, V11, P3109, DOI 10.1101/gad.11.23.3109; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; Henning KA, 1998, P NATL ACAD SCI USA, V95, P5667, DOI 10.1073/pnas.95.10.5667; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Licht JD, 1999, GENE DEV, V13, P1116, DOI 10.1101/gad.13.9.1116; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; O'Reilly Marc, 1999, Current Opinion in Structural Biology, V9, P56, DOI 10.1016/S0959-440X(99)80008-6; Pardue ML, 1999, CHROMOSOMA, V108, P73, DOI 10.1007/s004120050354; Reddel RR, 1998, BIOESSAYS, V20, P977, DOI 10.1002/(SICI)1521-1878(199812)20:12<977::AID-BIES3>3.0.CO;2-E; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498	31	52	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38027	38031		10.1074/jbc.274.53.38027	http://dx.doi.org/10.1074/jbc.274.53.38027			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608871	hybrid			2022-12-27	WOS:000084528000071
J	Brewer, A; Gove, C; Davies, A; McNulty, C; Barrow, D; Koutsourakis, M; Farzaneh, F; Pizzey, J; Bomford, A; Patient, R				Brewer, A; Gove, C; Davies, A; McNulty, C; Barrow, D; Koutsourakis, M; Farzaneh, F; Pizzey, J; Bomford, A; Patient, R			The human and mouse GATA-6 genes utilize two promoters and two initiation codons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; IN-SITU HYBRIDIZATION; TRANSLATION INITIATION; REGULATORY ELEMENTS; EXPRESSION; EMBRYOS; XENOPUS; CELLS; DIFFERENTIATION; BINDING	GATA-6 has been implicated in the regulation of myocardial differentiation during cardiogenesis. To determine how its expression is controlled, we have characterized the human and mouse genes. We have mapped their transcriptional start sites and demonstrate that two alternative promoters and 5' noncoding exons are utilized. Both transcript isoforms are expressed in the same tissue-specific and developmental stage-specific pattern, and their ratio appears similar wherever examined. The more upstream noncoding exon showed a substantial degree of homology between the two mammalian species, suggesting a conserved regulatory function. Moreover, in transfection assays we show that elements within this exon act to promote its transcription. Positive regulatory elements that effect transcription from the more downstream exon were not apparent in this assay, revealing a regulatory distinction between the two promoters. We also demonstrate alternative initiator codon usage in both the human and mouse GATA-6 genes. Both isoforms of the protein are synthesized in vitro regardless of which 5' noncoding exon is present in the RNA, although the larger protein has greater transcriptional activation potential in transfection assays. Thus, GATA-6 function in the cell is controlled by a complex interplay of transcriptional and translational regulation.	GKT, Rayne Inst, Dept Mol Med, London SE5 9NU, England; Kings Coll London, Randall Inst, Dev Biol Res Ctr, London WC2B 5RL, England; GKT, Inst Liver Studies, London SE5 9PJ, England; Erasmus Univ, Ctr Med Genet, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	University of London; King's College London; University of London; King's College London; University of London; King's College London; Erasmus University Rotterdam	Patient, R (corresponding author), Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England.	roger.patient@nottingham.ac.uk	Farzaneh, Farzin/B-4902-2009; Bomford, Adrian/A-7462-2011; McNulty, Claire/AAJ-6898-2021	Farzaneh, Farzin/0000-0002-9275-2415; McNulty, Claire/0000-0001-8359-2061				Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; BARTH J, 1994, BIOTECHNIQUES, V17, P324; Baskin F, 1997, NEUROSCIENCE, V76, P821; BREWER AC, 1995, EMBO J, V14, P757, DOI 10.1002/j.1460-2075.1995.tb07054.x; BRIEGEL K, 1993, GENE DEV, V7, P1097, DOI 10.1101/gad.7.6.1097; CALLIGARIS R, 1995, P NATL ACAD SCI USA, V92, P11598, DOI 10.1073/pnas.92.25.11598; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Gao XP, 1998, MOL CELL BIOL, V18, P2901, DOI 10.1128/MCB.18.5.2901; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; GHERZI R, 1995, FEBS LETT, V369, P335, DOI 10.1016/0014-5793(95)00778-8; GHOSH D, 1983, TRANSCRIPTION FACTOR; Gove C, 1997, EMBO J, V16, P355, DOI 10.1093/emboj/16.2.355; He CZ, 1997, J BIOL CHEM, V272, P28550, DOI 10.1074/jbc.272.45.28550; Hu ZZ, 1998, J BIOL CHEM, V273, P26225, DOI 10.1074/jbc.273.40.26225; Huggon IC, 1997, BBA-GENE STRUCT EXPR, V1353, P98, DOI 10.1016/S0167-4781(97)00049-3; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Jiang HL, 1999, J BIOL CHEM, V274, P7893, DOI 10.1074/jbc.274.12.7893; Jiang YM, 1996, DEV BIOL, V174, P258, DOI 10.1006/dbio.1996.0071; Jiang YM, 1998, DEV GENET, V22, P263, DOI 10.1002/(SICI)1520-6408(1998)22:3<263::AID-DVG8>3.0.CO;2-4; Korner I, 1997, FEBS LETT, V406, P31, DOI 10.1016/S0014-5793(97)00229-9; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; KURATA H, 1992, FEBS LETT, V312, P10, DOI 10.1016/0014-5793(92)81400-G; LABASTIE MC, 1994, GENOMICS, V21, P1, DOI 10.1006/geno.1994.1217; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN WJ, 1993, HUMAN EMBRYOLOGY, P131; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; LEONARD L, 1995, DEV BIOL, V168, P514, DOI 10.1006/dbio.1995.1099; LEONARD MW, 1993, DEVELOPMENT, V119, P519; Lieuw KH, 1997, DEV BIOL, V188, P1, DOI 10.1006/dbio.1997.8575; MacNeill C, 1997, J BIOL CHEM, V272, P8396, DOI 10.1074/jbc.272.13.8396; Maniatis T., 1982, MOL CLONING LAB MANU; McGlynn LK, 1996, MOL CELL BIOL, V16, P1936; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Mu WT, 1999, MOL BRAIN RES, V67, P137, DOI 10.1016/S0169-328X(99)00049-2; Nony P, 1998, J BIOL CHEM, V273, P32910, DOI 10.1074/jbc.273.49.32910; OKEEFE HP, 1991, METHOD CELL BIOL, V36, P443; Onodera K, 1997, J BIOCHEM, V121, P251; ORKIN SH, 1992, BLOOD, V80, P575; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; PISCHEDDA C, 1995, P NATL ACAD SCI USA, V92, P3511, DOI 10.1073/pnas.92.8.3511; PLUMB M, 1989, NUCLEIC ACIDS RES, V17, P73, DOI 10.1093/nar/17.1.73; Read EM, 1998, INT J DEV BIOL, V42, P763; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SAIFUDEEN Z, 1995, FEBS LETT, V381, P269; Sambrook J., 2002, MOL CLONING LAB MANU; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; Suzuki E, 1996, GENOMICS, V38, P283, DOI 10.1006/geno.1996.0630; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650	59	62	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38004	38016		10.1074/jbc.274.53.38004	http://dx.doi.org/10.1074/jbc.274.53.38004			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608869	hybrid			2022-12-27	WOS:000084528000069
J	Bronnikov, GE; Zhang, SJ; Cannon, B; Nedergaard, J				Bronnikov, GE; Zhang, SJ; Cannon, B; Nedergaard, J			A dual component analysis explains the distinctive kinetics of cAMP accumulation in brown adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN THERMOGENIN; BETA-GAMMA-SUBUNITS; FAT-CELLS; ADIPOSE-TISSUE; ADENYLYL CYCLASE; GENE-EXPRESSION; STIMULATION; CULTURE; RAT; NOREPINEPHRINE	The mechanism behind the distinctive non-Michaelis-Menten, bell-shaped kinetics of cAMP accumulation in brown adipocytes (which underlies the similar kinetics of UCP1 and beta(1)-adrenoreceptor gene expression) was investigated. A theoretical dual component analysis indicated that the observed dose-response curves could be constructed as the resultant of a stimulatory and an inhibitory component. Experimentally, inhibition of the alpha(1)-component of the norepinephrine response revealed the underlying existence of a much larger stimulatory beta(3)-component which displayed monophasic Michaelis-Menten kinetics. The inhibitory alpha(1)-component (which was also monophasic but had a S-fold higher EC50) was mediated via an increase in [Ca2+](i); the protein kinase C pathway was not involved. The [Ca2+](i) increase which resulted in massive inhibition of cAMP accumulation was very low: <100 nM The [Ca2+](i) signal stimulated a calmodulin-controlled phosphodiesterase, possibly PDE-1. The acquirement of this specific interaction pattern between beta- and alpha(1)-adrenergic stimulation was thus part of the differentiation program of the brown adipocytes. It was concluded that an array of synergistic or inhibitory alpha(1)/beta interactions occur in the adrenergic regulation of this cell type which is unique in its dependence upon adrenergic stimulation for cellular proliferation, differentiation, and metabolic function.	Univ Stockholm, Arrhenius Lab F3, Wenner Gren Inst, S-10691 Stockholm, Sweden	Stockholm University	Nedergaard, J (corresponding author), Univ Stockholm, Arrhenius Lab F3, Wenner Gren Inst, S-10691 Stockholm, Sweden.	jan@metabol.su.se	Nedergaard, Jan/Q-8286-2019; Nedergaard, Jan/A-1706-2010; Cannon, Barbara/B-3089-2016	Cannon, Barbara/0000-0001-6594-2363; Nedergaard, Jan/0000-0003-2070-1587				BARGE RM, 1988, AM J PHYSIOL, V254, pE323, DOI 10.1152/ajpendo.1988.254.3.E323; BAZIN R, 1997, KEYSTONE S J, V3, P22; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bengtsson T, 1996, J BIOL CHEM, V271, P33366, DOI 10.1074/jbc.271.52.33366; BENGTSSON T, 1998, BETAADRENERGIC RECEP; BERMAN MI, 1987, ARCH BIOCHEM BIOPHYS, V253, P249, DOI 10.1016/0003-9861(87)90658-8; Bronnikov G, 1999, ENDOCRINOLOGY, V140, P4185, DOI 10.1210/en.140.9.4185; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; BUXTON ILO, 1985, J BIOL CHEM, V260, P6733; CHAUDHRY A, 1994, CELL SIGNAL, V6, P457, DOI 10.1016/0898-6568(94)90093-0; CHOI EJ, 1993, BIOCHEMISTRY-US, V32, P1892; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; GIETZEN K, 1982, BIOCHEM J, V207, P541, DOI 10.1042/bj2070541; GRANNEMAN JG, 1990, J PHARMACOL EXP THER, V254, P508; Granneman JG, 1997, MOL PHARMACOL, V51, P644, DOI 10.1124/mol.51.4.644; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HERRON D, 1990, FEBS LETT, V268, P296, DOI 10.1016/0014-5793(90)81031-I; JACOBOWITZ O, 1993, J BIOL CHEM, V268, P3829; KikuchiUtsumi K, 1997, BIOCHEM J, V322, P417, DOI 10.1042/bj3220417; KLAUS S, 1995, MOL CELL ENDOCRINOL, V109, P189, DOI 10.1016/0303-7207(95)03502-X; KOIVISTO A, 1997, THESIS STOCKHOLM U S; KOPECKY J, 1990, J BIOL CHEM, V265, P22204; Kuusela P, 1997, BIOCHEM J, V321, P759, DOI 10.1042/bj3210759; LEE SC, 1993, AM J PHYSIOL, V264, pC217, DOI 10.1152/ajpcell.1993.264.1.C217; Lindquist JM, 1998, J BIOL CHEM, V273, P30147, DOI 10.1074/jbc.273.46.30147; MANGANIELLO V, 1988, METHOD ENZYMOL, V159, P504; MANGANIELLO VC, 1995, ARCH BIOCHEM BIOPHYS, V322, P1, DOI 10.1006/abbi.1995.1429; MANGANIELLO VC, 1990, CYCLIC NUCLEOTIDE PH; MASON MJ, 1993, BIOCHEM J, V296, P33, DOI 10.1042/bj2960033; MOHELL N, 1987, AM J PHYSIOL, V253, pC301, DOI 10.1152/ajpcell.1987.253.2.C301; Nagaoka Tadasu, 1998, Cell Biochemistry and Biophysics, V29, P49, DOI 10.1007/BF02737828; NANBERG E, 1986, FEBS LETT, V195, P319, DOI 10.1016/0014-5793(86)80185-5; NANBERG E, 1987, BIOCHIM BIOPHYS ACTA, V930, P438, DOI 10.1016/0167-4889(87)90017-6; NECHAD M, 1983, EXP CELL RES, V149, P105, DOI 10.1016/0014-4827(83)90384-1; NISOLI E, 1995, ARCH INT PHARMACOD T, V329, P436; NORONHA M, 1991, METABOLISM, V40, P1327, DOI 10.1016/0026-0495(91)90038-X; RAASMAJA A, 1985, EUR J PHARMACOL, V106, P489; RASMUSSEN H, 1977, PHYSIOL REV, V57, P421, DOI 10.1152/physrev.1977.57.3.421; RASMUSSEN H, 1992, CIBA F SYMP, V164, P98; REHNMARK S, 1989, EXP CELL RES, V182, P75, DOI 10.1016/0014-4827(89)90280-2; REHNMARK S, 1990, J BIOL CHEM, V265, P16464; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; ROVATI GE, 1994, TRENDS PHARMACOL SCI, V15, P140, DOI 10.1016/0165-6147(94)90073-6; Strosberg AD, 1995, OBES RES, V3, pS501, DOI 10.1002/j.1550-8528.1995.tb00219.x; SVOBODA P, 1993, BIOCHEM J, V295, P655, DOI 10.1042/bj2950655; Tanaka E, 1995, JPN J PHYSIOL, V45, P1043, DOI 10.2170/jjphysiol.45.1043; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; THONBERG H, 1994, J BIOL CHEM, V269, P33179; UNELIUS L, 1993, AM J PHYSIOL, V265, pC1340, DOI 10.1152/ajpcell.1993.265.5.C1340; WELLS JN, 1988, METHOD ENZYMOL, V159, P489; WILCKE M, 1989, BIOCHEM BIOPH RES CO, V163, P292, DOI 10.1016/0006-291X(89)92134-7; Zhao J, 1997, J BIOL CHEM, V272, P32847, DOI 10.1074/jbc.272.52.32847	53	40	45	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37770	37780		10.1074/jbc.274.53.37770	http://dx.doi.org/10.1074/jbc.274.53.37770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608838	hybrid			2022-12-27	WOS:000084528000038
J	Ji, HL; Fuller, CM; Benos, DJ				Ji, HL; Fuller, CM; Benos, DJ			Peptide inhibition of constitutively activated epithelial Na+ channels expressed in Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOAD URINARY-BLADDER; CORTICAL COLLECTING TUBULE; SODIUM-CHANNEL; LIDDLE-SYNDROME; BETA-SUBUNIT; HUMAN HYPERTENSION; ACETYLCHOLINE-RECEPTOR; HOMOLOGOUS SUBUNITS; MISSENSE MUTATION; ION SELECTIVITY	The hypothesis that 30-amino acid peptides corresponding to the C-terminal portion of the beta- and/or gamma-rat epithelial sodium channel (rENaC) subunits block constitutively activated ENaC was tested by examining the effects of these peptides on wild-type (wt) rENaC (alpha beta gamma-rENaC), truncated Liddle's mutants (alpha beta(T)gamma-, alpha beta gamma(T)-, and alpha beta(T)gamma(T)-rENaC), and point mutants (alpha beta(Y)gamma-, alpha beta gamma(Y)-rENAC) expressed in Xenopus oocytes, The chord conductances of alpha beta(T)gamma-, alpha beta gamma(T)-, and alpha beta(T)gamma(T)-rENaC were 2- or 3-fold greater than for wt alpha beta gamma-rENaC. Introduction of peptides into oocytes expressing alpha beta(T)gamma-, alpha beta gamma(T)-, and alpha beta(T)gamma(T)-rENaC produced a concentration-dependent inhibition of the amiloride-sensitive Na+ conductances, with apparent dissociation constants (K-d) ranging from 1700 to 160 mu M, depending upon whether individual peptides or their combination was used. Injection of peptides alone or in combination into oocytes expressing wt alpha beta gamma-rENaC or single-point mutants did not affect the amiloride-sensitive whole-cell currents. The single channel conductances of all the mutant ENaCs were the same as that of wild type (alpha beta gamma-). The single channel activities (N.P-o) of the mutants were similar to 2.2-2.6-fold greater than wt alpha beta gamma-rENaC (1.08 +/- 0.24, n = 7) and were reduced to 1.09 +/- 0.17 by 100 mu M peptide mixture (n = 9). The peptides were without effect on the single channel properties of either wt or single-point mutants of rENaC, Our data demonstrate that the C-terminal peptides blocked the Liddle's truncation mutant (alpha beta(T)gamma(T)) expressed in Xenopus oocytes but not the single-point mutants (alpha beta(Y)gamma or alpha beta gamma(T)). Moreover, the blocking effect of both peptides in combination on alpha beta(T)gamma(T)-rENaC was synergistic.	Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, MCLM 704, Birmingham, AL 35294 USA.	Benos@phybio.bhs.uab.edu	Fuller, Cathy/B-4046-2011		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037206, R01DK037206] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK37206] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Awayda MS, 1997, AM J PHYSIOL-CELL PH, V273, pC1889; Baker EH, 1998, LANCET, V351, P1388, DOI 10.1016/S0140-6736(97)07306-6; Bauer RJ, 1996, J NEUROSCI METH, V68, P101, DOI 10.1016/0165-0270(96)00013-1; BENOS DJ, 1995, J MEMBRANE BIOL, V143, P1; BENOS DJ, 1979, J GEN PHYSIOL, V73, P307, DOI 10.1085/jgp.73.3.307; Bubien JK, 1996, AM J PHYSIOL-CELL PH, V270, pC208, DOI 10.1152/ajpcell.1996.270.1.C208; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; CANTIELLO HF, 1995, KIDNEY INT, V48, P970, DOI 10.1038/ki.1995.379; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; Eaholtz G, 1998, J GEN PHYSIOL, V111, P75, DOI 10.1085/jgp.111.1.75; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; French RJ, 1996, NEURON, V16, P407, DOI 10.1016/S0896-6273(00)80058-6; FUCHS W, 1977, J PHYSIOL-LONDON, V267, P137, DOI 10.1113/jphysiol.1977.sp011805; Fuller CM, 1997, BIOPHYS J, V72, P1622, DOI 10.1016/S0006-3495(97)78808-8; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; HAMILL OP, 1988, PFLUGERS ARCH, V991, P85; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Horisberger JD, 1998, CURR OPIN CELL BIOL, V10, P443, DOI 10.1016/S0955-0674(98)80056-2; Inoue T, 1998, EUR J ENDOCRINOL, V138, P691, DOI 10.1530/eje.0.1380691; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Ismailov II, 1999, BIOCHEMISTRY-US, V38, P354, DOI 10.1021/bi981979s; Ismailov II, 1996, AM J PHYSIOL-CELL PH, V270, pC214, DOI 10.1152/ajpcell.1996.270.1.C214; ISMAILOV II, 1995, J GEN PHYSIOL, V106, P445, DOI 10.1085/jgp.106.3.445; Jackson SNJ, 1998, J MED GENET, V35, P510, DOI 10.1136/jmg.35.6.510; Ji HL, 1998, AM J PHYSIOL-CELL PH, V275, pC1182; Ji HL, 1998, AM J PHYSIOL-CELL PH, V274, pC455, DOI 10.1152/ajpcell.1998.274.2.C455; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; LIFTON RP, 1993, J HYPERTENS, V11, P231, DOI 10.1097/00004872-199303000-00002; LINGUEGLIA E, 1994, J BIOL CHEM, V269, P13736; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Palmer LG, 1996, J GEN PHYSIOL, V107, P35, DOI 10.1085/jgp.107.1.35; PALMER LG, 1982, J MEMBRANE BIOL, V67, P91, DOI 10.1007/BF01868651; PALMER LG, 1980, J MEMBRANE BIOL, V57, P59, DOI 10.1007/BF01868986; Palmer LG, 1998, J PHYSIOL-LONDON, V509, P151, DOI 10.1111/j.1469-7793.1998.151bo.x; PALMER LG, 1985, J MEMBRANE BIOL, V83, P57, DOI 10.1007/BF01868738; ROTIN D, 1994, EMBO J, V13, P4440, DOI 10.1002/j.1460-2075.1994.tb06766.x; SARIBANSOHRABY S, 1988, J BIOL CHEM, V263, P13875; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; SMITH PR, 1991, P NATL ACAD SCI USA, V88, P6971, DOI 10.1073/pnas.88.16.6971; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Tamura H, 1996, J CLIN INVEST, V97, P1780, DOI 10.1172/JCI118606; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Warnock DG, 1998, KIDNEY INT, V53, P18, DOI 10.1046/j.1523-1755.1998.00728.x	53	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37693	37704		10.1074/jbc.274.53.37693	http://dx.doi.org/10.1074/jbc.274.53.37693			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608827	hybrid			2022-12-27	WOS:000084528000027
J	Jovov, B; Tousson, A; Ji, HL; Keeton, D; Shlyonsky, V; Ripoll, PJ; Fuller, CM; Benos, DJ				Jovov, B; Tousson, A; Ji, HL; Keeton, D; Shlyonsky, V; Ripoll, PJ; Fuller, CM; Benos, DJ			Regulation of epithelial Na+ channels by actin in planar lipid bilayers and in the Xenopus oocyte expression system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; ENDOPLASMIC-RETICULUM; LIDDLES SYNDROME; CALCIUM-RELEASE; CATION CHANNELS; APICAL MEMBRANE; ALPHA-SUBUNIT; BETA-SUBUNIT; WW DOMAINS; ENAC	The hypothesis that actin interactions account for the signature biophysical properties of cloned epithelial Na+ channels (ENaC) (conductance, ion selectivity, and long mean open and closed times) was tested using planar lipid bilayer reconstitution and patch clamp techniques. We found the following. 1) In bilayers, actin produced a more than 2-fold decrease in single channel conductance, a 5-fold increase in Na+ versus K+ perms electivity, and a substantial increase in mean open and closed times of wild-type alpha beta gamma-rENaC but hard no effect on a mutant form of rENaC in which the majority of the C terminus of the alpha subunit was deleted (alpha(R613X)beta gamma-rENaC), 2) When alpha(R613X)beta gamma-rENaC was heterologously expressed in oocytes and single channels examined by patch clamp, 12.5-pS channels of relatively low cation permeability were recorded, These characteristics were identical to those recorded in bilayers for either alpha(R613X)beta gamma-rENaC or wild type alpha beta gamma-rENaC in the absence of actin, Moreover, we show that rENaC subunits tightly associate, forming either homo- or heteromeric complexes when prepared by in vitro translation or when expressed in oocytes. Finally, we show that alpha-rENaC is properly assembled but retained in the endoplasmic reticulum compartment, We conclude that actin subserves an important regulatory function for ENaC and that planar bilayers are an appropriate system in which to study the biophysical and regulatory properties of these cloned channels.	Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama, Dept Physiol & Biophys, 1918 Univ Blvd,MCLM 704, Birmingham, AL 35294 USA.		Fuller, Cathy/B-4046-2011	Shlyonsky, Vadim/0000-0003-2999-6553	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037206, R56DK037206] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK37206] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Awayda MS, 1997, AM J PHYSIOL-CELL PH, V273, pC1889; Awayda MS, 1999, AM J PHYSIOL-CELL PH, V277, pC216, DOI 10.1152/ajpcell.1999.277.2.C216; Benos DJ, 1997, NEWS PHYSIOL SCI, V12, P55; Berdiev BK, 1996, J BIOL CHEM, V271, P17704, DOI 10.1074/jbc.271.30.17704; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Fyfe GK, 1998, SEMIN NEPHROL, V18, P138; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; HAMILTON KL, 1985, AM J PHYSIOL, V249, pC200, DOI 10.1152/ajpcell.1985.249.3.C200; HAN JK, 1990, J CELL BIOL, V110, P1103, DOI 10.1083/jcb.110.4.1103; HITT AL, 1994, CURR OPIN CELL BIOL, V6, P120, DOI 10.1016/0955-0674(94)90125-2; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Ismailov II, 1995, BIOPHYS J, V69, P1789, DOI 10.1016/S0006-3495(95)80049-4; Ismailov II, 1996, J MEMBRANE BIOL, V149, P123, DOI 10.1007/s002329900013; Jaconi M, 1997, CURR BIOL, V7, P599, DOI 10.1016/S0960-9822(06)00259-4; Ji HL, 1998, AM J PHYSIOL-CELL PH, V275, pC1182; Jovov B, 1998, AM J PHYSIOL-CELL PH, V275, pC449, DOI 10.1152/ajpcell.1998.275.2.C449; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Kieber-Emmons T, 1999, J BIOL CHEM, V274, P9648, DOI 10.1074/jbc.274.14.9648; Kizer N, 1997, P NATL ACAD SCI USA, V94, P1013, DOI 10.1073/pnas.94.3.1013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McCool DJ, 1999, BIOCHEM J, V341, P593, DOI 10.1042/0264-6021:3410593; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; PALMER LG, 1986, P NATL ACAD SCI USA, V83, P2767, DOI 10.1073/pnas.83.8.2767; PALMER LG, 1986, FASEB J, V45, P2708; Rokaw MD, 1998, J BIOL CHEM, V273, P28746, DOI 10.1074/jbc.273.44.28746; Rossier BC, 1998, J GEN PHYSIOL, V112, P95, DOI 10.1085/jgp.112.2.95; Rotin D, 1998, CURR TOP MICROBIOL, V228, P115; ROTIN D, 1994, EMBO J, V13, P4440, DOI 10.1002/j.1460-2075.1994.tb06766.x; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; SMITH PR, 1991, P NATL ACAD SCI USA, V88, P6971, DOI 10.1073/pnas.88.16.6971; SMITH PR, 1995, J MEMBRANE BIOL, V147, P195; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; SORSCHER EJ, 1988, AM J PHYSIOL, V255, pC835, DOI 10.1152/ajpcell.1988.255.6.C835; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1996, STRUCTURE, V4, P495, DOI 10.1016/S0969-2126(96)00054-8; Stockand JD, 1999, J BIOL CHEM, V274, P3842, DOI 10.1074/jbc.274.6.3842; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vallet V, 1998, KIDNEY INT, V54, pS109, DOI 10.1046/j.1523-1755.1998.06721.x; Zuckerman JB, 1999, J BIOL CHEM, V274, P23286, DOI 10.1074/jbc.274.33.23286	46	48	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37845	37854		10.1074/jbc.274.53.37845	http://dx.doi.org/10.1074/jbc.274.53.37845			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608849	hybrid			2022-12-27	WOS:000084528000049
J	Koshimizu, T; Koshimizu, M; Stojilkovic, SS				Koshimizu, T; Koshimizu, M; Stojilkovic, SS			Contributions of the C-terminal domain to the control of P2X receptor desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; P-2X RECEPTOR; EXTRACELLULAR ATP; SENSORY NEURONS; BRAIN; EXPRESSION; SEQUENCES; FAMILY	The P2X purinergic receptor channels (P2XRs) differ among themselves with respect to the rates of desensitization during prolonged agonist stimulation. Here we studied the desensitization of recombinant channels by monitoring the changes in intracellular free Ca2+ concentration in cells stimulated with ATP, the native and common agonist for all P2XRs. The focus in our investigations was on the relevance of the P2XR C terminus in controlling receptor desensitization. When expressed in GT1 cells, the P2XRs desensitized with rates characteristic to each receptor subtype: P2X(1)R = P2X(3)R > P2X(2b)R > P2X(4)R > P2X(2a)R > P2X(7)R. A slow desensitizing pattern of P2X(2a)R was mimicked partially by P2X(3)R and fully by P2X(4)R when the six-amino acid sequences of these channels located in the cytoplasmic C terminus were substituted with the corresponding arginine 371 to proline 376 sequence of P2X(2a)R. Changing the total net charge in the six amino acids of P2X(4)R to a more positive direction also slowed the receptor desensitization. On the other hand, substitution of arginine 371-proline 376 sequence of P2X(2a)R with the corresponding sequences of P2X(1)R, P2X(3)R, and P2X(4)R increased the rate of receptor desensitization. Furthermore, heterologous polymerization of wild-type P2X(2a)R and mutant P2X(3)R having the C-terminal six amino acids of P2X(2a)R at its analogous position resulted in a functional channel whose desensitization was significantly delayed. These results suggest that composition of the C-terminal six-amino acid sequence and its electrostatic force influence the rate of receptor desensitization.	NICHD, Sect Cellular Signaling, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Stojilkovic, SS (corresponding author), NICHD, Sect Cellular Signaling, Endocrinol & Reprod Res Branch, NIH, Bldg 49,Rm 6A-36,49 Convent Dr, Bethesda, MD 20892 USA.	stankos@helix.nih.gov	Koshimizu, Taka-aki/G-2740-2015	Koshimizu, Taka-aki/0000-0001-5292-7535	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000195] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000195] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Brandle U, 1997, FEBS LETT, V404, P294, DOI 10.1016/S0014-5793(97)00128-2; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Buell G, 1996, EUR J NEUROSCI, V8, P2221, DOI 10.1111/j.1460-9568.1996.tb00745.x; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Collo G, 1996, J NEUROSCI, V16, P2495; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; EVANS RJ, 1997, P2 NUCLEOTIDE RECEPT, P43; GarciaGuzman M, 1996, FEBS LETT, V388, P123, DOI 10.1016/0014-5793(96)00499-1; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Koshimizu T, 1998, MOL ENDOCRINOL, V12, P901, DOI 10.1210/me.12.7.901; Koshimizu T, 1998, J BIOL CHEM, V273, P12853, DOI 10.1074/jbc.273.21.12853; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; North RA, 1996, SEMIN NEUROSCI, V8, P187; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PESSIA M, 1995, NEURON, V14, P1039, DOI 10.1016/0896-6273(95)90342-9; Radford KM, 1997, J NEUROSCI, V17, P6529; Ralevic V, 1998, PHARMACOL REV, V50, P413; Seguela P, 1996, J NEUROSCI, V16, P448; Simon J, 1997, MOL PHARMACOL, V52, P237, DOI 10.1124/mol.52.2.237; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Van Goor F, 1999, MOL ENDOCRINOL, V13, P587, DOI 10.1210/me.13.4.587; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7	30	66	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37651	37657		10.1074/jbc.274.53.37651	http://dx.doi.org/10.1074/jbc.274.53.37651			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608821	hybrid			2022-12-27	WOS:000084528000021
J	Roberts, VA; Pique, ME				Roberts, VA; Pique, ME			Definition of the interaction domain for cytochrome c on cytochrome c oxidase - III. Prediction of the docked complex by a complete, systematic search	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER SITE; PARACOCCUS-DENITRIFICANS; 2.8 ANGSTROM; DOCKING; KINETICS; PROTEINS; BINDING; RECOGNITION; PEROXIDASE; SURFACES	The electron transfer complex between bovine cytochrome c oxidase and horse cytochrome c has been predicted with the docking program DOT, which performs a complete, systematic search over all six rotational and translational degrees of freedom. Energies for over 36 billion configurations were calculated, providing a free-energy landscape showing guidance of positively charged cytochrome c to the negative region on the cytochrome c oxidase surface formed by subunit II. In a representative configuration, the solvent-exposed cytochrome c heme edge is within 4 Angstrom of the indole ring of subunit II residue Trp(104), indicating a likely electron transfer path. These two groups are surrounded by a small, hydrophobic contact region, which is surrounded by electrostatically complementary hydrophilic interactions. Cytochrome c/cytochrome c oxidase interactions of Lys(13) with Asp(119) and Lys(72) with Gln(103) and Asp(158) are the most critical polar interactions due to their proximity to the hydrophobic region and exclusion from bulk solvent, The predicted complex matches previous mutagenesis, binding, and time-resolved kinetics studies that implicate Trp(104) in electron transfer and show the importance of specific charged residues to protein affinity, Electrostatic forces not only enhance long range protein/protein association; they also predominate in short range alignment, creating the transient interaction needed for rapid turnover.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Roberts, VA (corresponding author), Scripps Res Inst, Dept Mol Biol, MB4,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Bashford D., 1997, Scientific Computing in Object-Oriented Parallel Environments. First International Conference, ISCOPE 97. Proceedings, P233; Beinert H, 1997, EUR J BIOCHEM, V245, P521, DOI 10.1111/j.1432-1033.1997.t01-1-00521.x; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; FERGUSONMILLER S, 1978, J BIOL CHEM, V253, P149; FERGUSONMILLER S, 1976, J BIOL CHEM, V251, P1104; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; GEREN LM, 1995, J BIOL CHEM, V270, P2466, DOI 10.1074/jbc.270.6.2466; GILSON MK, 1993, J PHYS CHEM-US, V97, P3591, DOI 10.1021/j100116a025; GILSON MK, 1988, PROTEINS, V3, P32, DOI 10.1002/prot.340030104; HILL BC, 1991, J BIOL CHEM, V266, P2219; Huang CC, 1996, BIOCHEMISTRY-US, V35, P3439, DOI 10.1021/bi9526692; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Janin J, 1995, PROG BIOPHYS MOL BIO, V64, P145, DOI 10.1016/S0079-6107(96)00001-6; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; LAPPALAINEN P, 1995, BIOCHEMISTRY-US, V34, P5824, DOI 10.1021/bi00017a014; Malatesta F, 1998, FEBS LETT, V434, P322, DOI 10.1016/S0014-5793(98)01006-0; MILLER MA, 1994, BIOCHEMISTRY-US, V33, P8686, DOI 10.1021/bi00195a009; Miller MA, 1996, BIOCHEMISTRY-US, V35, P667, DOI 10.1021/bi952557a; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; ROBERTS VA, 1991, J BIOL CHEM, V266, P13431; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SHOICHET BK, 1993, PROTEIN ENG, V6, P723, DOI 10.1093/protein/6.7.723; SMITH HT, 1977, BIOCHEMISTRY-US, V16, P4971, DOI 10.1021/bi00642a005; Ten Eyck L.F., 1995, P 1995 ACM IEEE SUP; TIEDE DM, 1993, BIOCHEMISTRY-US, V32, P4515, DOI 10.1021/bi00068a006; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; UPSON C, 1989, IEEE COMPUT GRAPH, V9, P30, DOI 10.1109/38.31462; VAKSER IA, 1994, PROTEINS, V20, P320, DOI 10.1002/prot.340200405; Wang KF, 1999, J BIOL CHEM, V274, P38042, DOI 10.1074/jbc.274.53.38042; WARWICKER J, 1989, J MOL BIOL, V206, P381, DOI 10.1016/0022-2836(89)90487-7; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WILLIAMS PA, 1995, NAT STRUCT BIOL, V2, P975, DOI 10.1038/nsb1195-975; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; Witt H, 1998, EUR J BIOCHEM, V251, P367, DOI 10.1046/j.1432-1327.1998.2510367.x; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Zhen YJ, 1999, J BIOL CHEM, V274, P38032, DOI 10.1074/jbc.274.53.38032	39	135	136	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38051	38060		10.1074/jbc.274.53.38051	http://dx.doi.org/10.1074/jbc.274.53.38051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608874	hybrid			2022-12-27	WOS:000084528000074
J	Tu, YP; Popov, S; Slaughter, C; Ross, EM				Tu, YP; Popov, S; Slaughter, C; Ross, EM			Palmitoylation of a conserved cysteine in the regulator of G protein signaling (RGS) domain modulates the GTPase-activating activity of RGS4 and RGS10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNITS; K+ CHANNELS; RHODOPSIN; ACYLATION; PURIFICATION; HYDROLYSIS; G-ALPHA(Z); PALMITATE; RECEPTOR; STATE	RGS4 and RGS10 expressed in Sf9 cells are palmitoylated at a conserved Cys residue (Cys(95) in RGS4 Cys(66) in RGS10) in the regulator of G protein signaling (RGS) domain that is also autopalmitoylated when the purified proteins are incubated with palmitoyl-CoA. RGS4 also autopalmitoylates at a previously identified cellular palmitoylation site, either Cys(2) or Cys(12). The C2A/C12A mutation essentially eliminates both autopalmitoylation and cellular [H-3]palmitate labeling of Cys(95). Membrane-bound RGS4 is palmitoylated both at Cys(95) and Cys(2/12) but cytosolic RGS4 is not palmitoylated. RGS4 and RGS10 are GTPase-activating proteins (GAPs) for the G(i) and G(q) families of G proteins. Palmitoylation of Cys(95) on RGS4 or Cys(66) On RGS10 inhibits GAP activity 80-100% toward either G alpha(i) or G alpha(z) in a single-turnover, solution-based assay. In contrast, when GAP activity was assayed as acceleration of steady-state GTPase in receptor-a protein proteoliposomes, palmitoylation of RGS10 potentiated GAP activity greater than or equal to 20-fold. Palmitoylation near the N terminus of C95V RGS4 did not alter GAP activity toward soluble G alpha(z) and increased G(z) GAP activity about 2-fold in the vesicle-based assay. Dual palmitoylation of wild-type RGS4 remained inhibitory. RGS protein palmitoylation is thus multi-site, complex in its control, and either inhibitory or stimulatory depending on the RGS protein and its sites of palmitoylation.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ross, EM (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ross@utsw.swmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030355, R01GM030355] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30355] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Bunemann M, 1998, J BIOL CHEM, V273, P31186, DOI 10.1074/jbc.273.47.31186; Caron JM, 1997, MOL BIOL CELL, V8, P621, DOI 10.1091/mbc.8.4.621; Chen CH, 1999, J BIOL CHEM, V274, P19799, DOI 10.1074/jbc.274.28.19799; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; Cohen SL, 1997, ANAL BIOCHEM, V247, P257, DOI 10.1006/abio.1997.2072; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Druey KM, 1999, J BIOL CHEM, V274, P18836, DOI 10.1074/jbc.274.26.18836; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Iiri T, 1996, P NATL ACAD SCI USA, V93, P14592, DOI 10.1073/pnas.93.25.14592; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; MOENCH SJ, 1994, BIOCHEMISTRY-US, V33, P5783, DOI 10.1021/bi00185a016; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; OBRIEN PJ, 1987, J BIOL CHEM, V262, P5210; PARKER EM, 1991, J BIOL CHEM, V266, P519; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Posner BA, 1999, BIOCHEMISTRY-US, V38, P7773, DOI 10.1021/bi9906367; ROSS EM, 1995, CURR BIOL, V5, P107, DOI 10.1016/S0960-9822(95)00026-1; Ross EM, 1999, CRC METH SIG TRANS, P123; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; STJULES RS, 1986, EXP EYE RES, V43, P929, DOI 10.1016/0014-4835(86)90071-0; Stoffel RH, 1998, BIOCHEMISTRY-US, V37, P16053, DOI 10.1021/bi981432d; SUDO Y, 1992, EMBO J, V11, P2095, DOI 10.1002/j.1460-2075.1992.tb05268.x; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; Veit M, 1998, BBA-LIPID LIPID MET, V1394, P90, DOI 10.1016/S0005-2760(98)00097-6; Wang J, 1997, J BIOL CHEM, V272, P5732, DOI 10.1074/jbc.272.9.5732; Wang J, 1998, J BIOL CHEM, V273, P26014, DOI 10.1074/jbc.273.40.26014; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zerangue N, 1998, CURR BIOL, V8, pR313, DOI 10.1016/S0960-9822(98)70196-4	44	84	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38260	38267		10.1074/jbc.274.53.38260	http://dx.doi.org/10.1074/jbc.274.53.38260			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608901	hybrid			2022-12-27	WOS:000084528000101
J	Laliberte, RE; Eggler, J; Gabel, CA				Laliberte, RE; Eggler, J; Gabel, CA			ATP treatment of human monocytes promotes caspase-1 maturation and externalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; CYTOPLASMIC GROUND SUBSTANCE; PROGRAMMED CELL-DEATH; IL-1-BETA-CONVERTING ENZYME; EXTRACELLULAR ATP; (ACYLOXY)METHYL KETONES; IL-1-BETA PRODUCTION; CYSTEINE PROTEASE; 45-KDA PRECURSOR; MATURE IL-1-BETA	Mechanisms that regulate conversion of prointerleukin-1 beta (pro-IL-1 beta) to its mature form by the cysteine protease caspase-1 are not well understood. In this study, we demonstrate that mature caspase-1 subunits are produced when human monocytes are treated with ATP and, like mature IL-1 beta, are released extracellularly. Characterization of the pharmacological sensitivity of this stimulus coupled response revealed that some caspase-1 inhibitors allow pro-IL-1 beta secretion, whereas others do not. Two nonselective alkylating agents, N-ethylmaleimide and phenylarsine oxide, also blocked maturation and release of pro-IL-1 beta. Two inhibitors of anion transport, glyburide and ethacrynic acid, blocked maturation of both caspase-1 and pro-IL-1 beta and prevented release of the propolypeptides, Procaspase-3 was detected in monocyte extracts, but its proteolytic activation was not efficient in the presence of ATP, Maturation of procaspase-1 and release of the mature enzyme subunits therefore accompany stimulus-coupled human monocyte IL-1 post-translational processing. Agents that appear to selectively inhibit mature caspase-1 do not prevent ATP-treated cells from releasing their cytosolic components, On the other hand, anion transport inhibitors and alkylating agents arrest ATP-treated monocytes in a state where membrane latency is maintained. The data provided support the hypothesis that stimulus-coupled IL-1 post-translational processing involves a commitment to cell death.	Pfizer Inc, Dept Resp Allergy Immunol Inflammat & Infect Dis, Groton, CT 06340 USA	Pfizer	Gabel, CA (corresponding author), Pfizer Inc, Dept Resp Allergy Immunol Inflammat & Infect Dis, Eastern Point Rd, Groton, CT 06340 USA.							AYALA JM, 1994, J IMMUNOL, V153, P2592; BHAKDI S, 1990, J CLIN INVEST, V85, P1746, DOI 10.1172/JCI114631; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Buell G, 1998, BLOOD, V92, P3521, DOI 10.1182/blood.V92.10.3521.422k50_3521_3528; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cheneval D, 1998, J BIOL CHEM, V273, P17846, DOI 10.1074/jbc.273.28.17846; CHIN J, 1993, J IMMUNOL, V151, P5574; Chow SC, 1999, EXP CELL RES, V246, P491, DOI 10.1006/excr.1998.4333; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; FROST SC, 1990, BIOCHEM J, V269, P589, DOI 10.1042/bj2690589; Gitler C, 1997, ANAL BIOCHEM, V252, P48, DOI 10.1006/abio.1997.2294; GU Y, 1995, EMBO J, V14, P1923, DOI 10.1002/j.1460-2075.1995.tb07184.x; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; HOGQUIST KA, 1991, J IMMUNOL, V147, P2181; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; KRANTZ A, 1991, BIOCHEMISTRY-US, V30, P4678, DOI 10.1021/bi00233a007; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LALIBERTE R, 1994, J IMMUNOL, V153, P2168; Laliberte RE, 1997, J LEUKOCYTE BIOL, V62, P227, DOI 10.1002/jlb.62.2.227; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Livingston DJ, 1997, J CELL BIOCHEM, V64, P19, DOI 10.1002/(SICI)1097-4644(199701)64:1<19::AID-JCB4>3.0.CO;2-2; MAJNO G, 1995, AM J PATHOL, V146, P3; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; MILLER BE, 1995, J IMMUNOL, V154, P1331; MILLER DK, 1993, J BIOL CHEM, V268, P18062; Miossec C, 1996, EUR J IMMUNOL, V26, P1032, DOI 10.1002/eji.1830260512; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; NettFiordalisi M, 1995, J LEUKOCYTE BIOL, V58, P717, DOI 10.1002/jlb.58.6.717; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ozaki I, 1999, J BIOL CHEM, V274, P5310, DOI 10.1074/jbc.274.9.5310; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1998, AM J PHYSIOL-CELL PH, V275, pC1538, DOI 10.1152/ajpcell.1998.275.6.C1538; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Perregaux DG, 1998, J IMMUNOL, V160, P2469; PLOEMEN JHTM, 1994, CANCER RES, V54, P915; Polverino AJ, 1997, J BIOL CHEM, V272, P7013, DOI 10.1074/jbc.272.11.7013; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; SINGER II, 1988, J EXP MED, V167, P389, DOI 10.1084/jem.167.2.389; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; THORNBERRY NA, 1994, BIOCHEMISTRY-US, V33, P3934, DOI 10.1021/bi00179a020; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Walev I, 1996, INFECT IMMUN, V64, P2974, DOI 10.1128/IAI.64.8.2974-2979.1996; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; WANG SY, 1992, IMMUNOLOGY, V77, P298; Warny M, 1999, AM J PHYSIOL-CELL PH, V276, pC717, DOI 10.1152/ajpcell.1999.276.3.C717; Watanabe N, 1998, CYTOKINE, V10, P645, DOI 10.1006/cyto.1998.0341; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; ZHENG LM, 1991, J CELL BIOL, V112, P279, DOI 10.1083/jcb.112.2.279; ZYCHLINSKY A, 1991, J IMMUNOL, V146, P393	64	106	107	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36944	36951		10.1074/jbc.274.52.36944	http://dx.doi.org/10.1074/jbc.274.52.36944			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601248	hybrid			2022-12-27	WOS:000084382700019
J	Tengholm, A; Hellman, B; Gylfe, E				Tengholm, A; Hellman, B; Gylfe, E			Glucose regulation of free Ca2+ in the endoplasmic reticulum of mouse pancreatic beta cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETING CELLS; K-ATP CHANNELS; INOSITOL 1,4,5-TRISPHOSPHATE; INTRACELLULAR STORES; CYTOPLASMIC CA2+; CALCIUM RELEASE; CYTOSOLIC CA2+; RAT INSULINOMA; CA-2+ RELEASE; STEADY-STATE	Free Ca2+ was measured in organelles of individual mouse pancreatic beta cells loaded with the low affinity indicator furaptra. After removal of cytoplasmic indicator by controlled digitonin permeabilization the organelle Ca2+ was located essentially in the endoplasmic reticulum (ER), >90% being sensitive to inhibition of sarco(endo)plasmic reticulum Ca2+-ATPases. The Ca2+ accumulation in the ER of intact beta cells depended in a hyperbolic fashion on the glucose concentration with half-maximal and maximal filling at 5.5 and >20 mM, respectively. Also elevation of cytoplasmic Ca2+ by K+ depolarization significantly enhanced the Ca2+ accumulation. In permeabilized beta cells 1-3 mM ATP caused rapid Ca2+ filling of the ER reaching almost 500 mu M, At 50 nM, Ca2+ ER became half-maximally filled at 45 mu M ATP, whereas only 3.5 mu M ATP was required at 200 nM Ca2+ Inositol 1,4,5-trisphosphate induced a rapid release of about 65% of the ER Ca2+, and its precursor phosphatidylinositol 4,5-bisphosphate was found to slowly mobilize 75% by another mechanism. It is concluded that glucose is an efficient stimulator of Ca2+ uptake in the ER of pancreatic beta cells both by increasing ATP and cytoplasmic Ca2+. Because physiological concentrations of cytoplasmic ATP are in the mM range, Ca2+ sequestration can be anticipated to be modulated by factors reducing its ATP sensitivity.	Univ Uppsala, Biomedicum, Dept Med Cell Biol, SE-75123 Uppsala, Sweden	Uppsala University	Gylfe, E (corresponding author), Univ Uppsala, Biomedicum, Dept Med Cell Biol, Box 571, SE-75123 Uppsala, Sweden.			Gylfe, Erik/0000-0002-8414-2107				ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Ashcroft FM, 1998, SCIENCE, V282, P1059, DOI 10.1126/science.282.5391.1059; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BERTRAM R, 1995, BIOPHYS J, V68, P2323, DOI 10.1016/S0006-3495(95)80414-5; BERTS A, 1995, BIOCHEM BIOPH RES CO, V208, P644, DOI 10.1006/bbrc.1995.1387; BIDEN TJ, 1984, BIOCHEM J, V223, P467, DOI 10.1042/bj2230467; COLCA JR, 1983, BIOCHIM BIOPHYS ACTA, V729, P176, DOI 10.1016/0005-2736(83)90483-2; ERECINSKA M, 1992, BIOCHIM BIOPHYS ACTA, V1101, P273, DOI 10.1016/0167-4838(92)90555-R; Favre CJ, 1996, J BIOL CHEM, V271, P14925, DOI 10.1074/jbc.271.25.14925; Guest PC, 1997, BIOCHEM J, V323, P445, DOI 10.1042/bj3230445; GYLFE E, 1990, BIOCHIM BIOPHYS ACTA, V1055, P82, DOI 10.1016/0167-4889(90)90094-T; GYLFE E, 1991, PFLUG ARCH EUR J PHY, V419, P639, DOI 10.1007/BF00370308; GYLFE E, 1988, J BIOL CHEM, V263, P13750; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; HELLMAN B, 1965, ANN NY ACAD SCI, V131, P541, DOI 10.1111/j.1749-6632.1965.tb34819.x; HELLMAN B, 1992, BIOCHIM BIOPHYS ACTA, V1113, P295, DOI 10.1016/0304-4157(92)90003-S; HELLMAN B, 1986, BIOCHEM INT, V13, P383; Hellman B., 1986, CALCIUM CELL FUNCTIO, P253; Hellman B., 1992, NUTR REGULATION INSU, P213; Hofer AM, 1996, FASEB J, V10, P302, DOI 10.1096/fasebj.10.2.8641563; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; INESI G, 1989, J BIOL CHEM, V264, P5929; ISLAM MS, 1993, BIOCHEM J, V293, P423, DOI 10.1042/bj2930423; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; LENZEN S, 1991, DIABETES, V40, P323, DOI 10.2337/diabetes.40.3.323; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; Levy J, 1998, METABOLISM, V47, P185, DOI 10.1016/S0026-0495(98)90218-9; Liu YJ, 1998, J PHYSIOL-LONDON, V508, P471, DOI 10.1111/j.1469-7793.1998.471bq.x; Maechler P, 1998, J BIOL CHEM, V273, P20770, DOI 10.1074/jbc.273.33.20770; Maechler P, 1999, J BIOL CHEM, V274, P12583, DOI 10.1074/jbc.274.18.12583; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; NAKAMURA Y, 1987, ENDOCRINOLOGY, V120, P2302, DOI 10.1210/endo-120-6-2302; NILSSON T, 1987, BIOCHEM J, V248, P329, DOI 10.1042/bj2480329; OHO C, 1986, J BIOCHEM-TOKYO, V100, P911, DOI 10.1093/oxfordjournals.jbchem.a121804; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; PRALONG WF, 1994, J BIOL CHEM, V269, P27310; PRENTKI M, 1985, J BIOL CHEM, V260, P9185; PRENTKI M, 1984, J BIOL CHEM, V259, P118; RAJU B, 1989, AM J PHYSIOL, V256, P540; ROE MW, 1994, J BIOL CHEM, V269, P18279; RUTTER GA, 1994, CELL CALCIUM, V16, P71, DOI 10.1016/0143-4160(94)90002-7; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Tengholm A, 1998, DIABETES, V47, P1224, DOI 10.2337/diabetes.47.8.1224; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Varadi A, 1996, BIOCHEM J, V319, P521, DOI 10.1042/bj3190521; WOLF BA, 1985, BIOCHEM J, V227, P965, DOI 10.1042/bj2270965; WOLF BA, 1986, J BIOL CHEM, V261, P6284; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; WORLEY JF, 1994, J BIOL CHEM, V269, P14359	54	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36883	36890		10.1074/jbc.274.52.36883	http://dx.doi.org/10.1074/jbc.274.52.36883			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601240	hybrid			2022-12-27	WOS:000084382700011
J	Chabes, A; Domkin, V; Thelander, L				Chabes, A; Domkin, V; Thelander, L			Yeast Sml1, a protein inhibitor of ribonucleotide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-SUBUNIT; SACCHAROMYCES-CEREVISIAE; RECOMBINANT MOUSE; CALF THYMUS; DNA; IDENTIFICATION; PURIFICATION; GENES; RNA; R1	Ribonucleotide reductase (RNR) catalyzes the reduction of ribonucleotides to deoxyribonucleotides; this step is rate-limiting in DNA precursor synthesis. A number of regulatory mechanisms ensure optimal deoxyribonucleotide pools, which are essential for cell viability. The best studied mechanisms are transcriptional regulation of the RNR genes during the cell cycle and in the response to DNA damage, and the allosteric regulation of ribonucleotide reductase by nucleoside triphosphates, Recently, another mode of RNR regulation has been hypothesized in yeast. A novel protein, Sml1, was shown to bind to the Rnr1 protein of the yeast ribonucleotide reductase; this interaction was proposed to inhibit ribonucleotide reductase activity when DNA synthesis is not required (Zhao, X,, Muller, E.G.D,, and Rothstein, R. (1998) Mol. Cell 2, 329-340). Here, we use highly purified recombinant proteins to directly demonstrate that the Sml1 protein is a strong inhibitor of yeast RNR, The Sml1p specifically binds to the yeast Rnr1p in a 1:1 ratio with a dissociation constant of 0.4 mu M. Interestingly, Sml1p also specifically binds to the mouse ribonucleotide reductase R1 protein. However, the inhibition observed in an in vitro mouse ribonucleotide reductase assay is less pronounced than the inhibition in yeast and probably occurs via a different mechanism.	Umea Univ, Dept Med Biosci Med Biochem, SE-90187 Umea, Sweden	Umea University	Chabes, A (corresponding author), Umea Univ, Dept Med Biosci Med Biochem, SE-90187 Umea, Sweden.			Chabes, Andrei/0000-0003-1708-8259				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANCE B, 1950, BIOCHEM J, V46, P402, DOI 10.1042/bj0460402; DAVIS R, 1994, J BIOL CHEM, V269, P23171; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; ENGSTROM Y, 1979, BIOCHEMISTRY-US, V18, P2941, DOI 10.1021/bi00581a004; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; HURD HK, 1987, MOL CELL BIOL, V7, P3673, DOI 10.1128/MCB.7.10.3673; Ingemarson R, 1996, BIOCHEMISTRY-US, V35, P8603, DOI 10.1021/bi960184n; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; LIUZZI M, 1994, NATURE, V372, P695, DOI 10.1038/372695a0; LYCKSELL PO, 1994, BIOCHEMISTRY-US, V33, P2838, DOI 10.1021/bi00176a013; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; ROVA U, 1995, BIOCHEMISTRY-US, V34, P4267, DOI 10.1021/bi00013a016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THELANDER L, 1980, J BIOL CHEM, V255, P7426; Thelander Lars, 1994, V30, P109; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	22	110	114	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36679	36683		10.1074/jbc.274.51.36679	http://dx.doi.org/10.1074/jbc.274.51.36679			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593972	hybrid			2022-12-27	WOS:000084279200091
J	Planas, JV; Cummings, DE; Idzerda, RL; McKnight, GS				Planas, JV; Cummings, DE; Idzerda, RL; McKnight, GS			Mutation of the RII beta subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; OB MESSENGER-RNA; A MUTANT MICE; RAT ADIPOCYTES; TARGETED DISRUPTION; LIPOGENIC ENZYME; BODY-WEIGHT; FOOD-INTAKE; LEAN MICE; EXPRESSION	Targeted disruption of the RII beta subunit of protein kinase A (PKA) produces lean mice that resist diet-induced obesity. In this report we examine the effects of the RII beta knockout on white adipose tissue physiology, Loss of RII beta is compensated by an increase in the RI alpha isoform, generating an isoform switch from a type II to a type I PKA, Type I holoenzyme binds cAMP more avidly and is more easily activated than the type II enzyme. These alterations are associated with increases in both basal kinase activity and the basal rate of lipolysis, possibly contributing to the lean phenotype, However, the ability of both beta(3)-selective and nonspecific beta-adrenergic agonists to stimulate lipolysis is markedly compromised in mutant white adipose tissue. This defect was found in vitro and in vivo and does not result from reduced expression of beta-adrenergic receptor or hormone-sensitive lipase genes. In contrast, beta-adrenergic stimulated gene transcription remains intact, and the expression of key genes involved in lipid metabolism is normal under both fasted and fed conditions. We suggest that the R subunit isoform switch disrupts the subcellular localization of PHA that is required for efficient transduction of signals that modulate lipolysis but not for those that mediate gene expression.	Univ Washington, Dept Pharmacol, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	McKnight, GS (corresponding author), Univ Washington, Dept Pharmacol, Sch Med, Box 357750, Seattle, WA 98195 USA.	mcknight@u.washington.edu		Planas, Josep/0000-0002-6525-9617	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK001964] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK01964] Funding Source: Medline; NIGMS NIH HHS [GM82375] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MR, 1997, P NATL ACAD SCI USA, V94, P12157, DOI 10.1073/pnas.94.22.12157; ALLEN DO, 1988, J PHARMACOL EXP THER, V244, P852; ALLEN DO, 1986, J PHARMACOL EXP THER, V238, P659; Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; ANTRAS J, 1991, MOL CELL ENDOCRINOL, V82, P183, DOI 10.1016/0303-7207(91)90030-V; Auwerx J, 1998, LANCET, V351, P737, DOI 10.1016/S0140-6736(97)06348-4; BLOOM JD, 1992, J MED CHEM, V35, P3081, DOI 10.1021/jm00094a025; Brandon EP, 1998, J NEUROSCI, V18, P3639; Campfield LA, 1996, HORM METAB RES, V28, P619, DOI 10.1055/s-2007-979867; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; COLLINS S, 1994, MOL ENDOCRINOL, V8, P518, DOI 10.1210/me.8.4.518; Collins S, 1996, J BIOL CHEM, V271, P9437, DOI 10.1074/jbc.271.16.9437; Considine RV, 1997, INT J BIOCHEM CELL B, V29, P1255, DOI 10.1016/S1357-2725(97)00050-2; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; DOSKELAND SO, 1988, METHOD ENZYMOL, V159, P147; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; FAIN JN, 1973, MOL PHARMACOL, V9, P595; FOUFELLE F, 1994, EUR J BIOCHEM, V223, P893, DOI 10.1111/j.1432-1033.1994.tb19066.x; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Friedman JM, 1998, NUTR REV, V56, pS38; Gettys TW, 1996, ENDOCRINOLOGY, V137, P4054, DOI 10.1210/en.137.9.4054; GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448; GOODRIDGE AG, 1987, ANNU REV NUTR, V7, P157, DOI 10.1146/annurev.nu.07.070187.001105; Guthrie CR, 1997, J BIOL CHEM, V272, P29560, DOI 10.1074/jbc.272.47.29560; HIRSCH AH, 1984, J LIPID RES, V25, P665; HOLLENGA C, 1991, EUR J PHARMACOL, V200, P325, DOI 10.1016/0014-2999(91)90590-M; HONNOR RC, 1985, J BIOL CHEM, V260, P5122; KAESTNER KH, 1991, P NATL ACAD SCI USA, V88, P1933, DOI 10.1073/pnas.88.5.1933; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; Krebs E G, 1972, Curr Top Cell Regul, V5, P99; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LANGIN D, 1992, BIOCHIM BIOPHYS ACTA, V1135, P349, DOI 10.1016/0167-4889(92)90242-4; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; LITOSCH I, 1982, MOL PHARMACOL, V22, P109; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; Mantzoros CS, 1996, DIABETES, V45, P909, DOI 10.2337/diabetes.45.7.909; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; MCKNIGHT GS, 1980, J BIOL CHEM, V255, P144; MCKNIGHT GS, 1996, SIGNAL TRANSDUCTION, P95; Mizuno TM, 1996, P NATL ACAD SCI USA, V93, P3434, DOI 10.1073/pnas.93.8.3434; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; MURPHY GJ, 1993, BIOCHEM PHARMACOL, V46, P575, DOI 10.1016/0006-2952(93)90540-D; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; SCHWABE U, 1973, N-S ARCH PHARMACOL, V276, P133, DOI 10.1007/BF00501186; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Slieker LJ, 1996, J BIOL CHEM, V271, P5301, DOI 10.1074/jbc.271.10.5301; STRALFORS P, 1983, J BIOL CHEM, V258, P5146; STRALFORS P, 1984, P NATL ACAD SCI-BIOL, V81, P3317, DOI 10.1073/pnas.81.11.3317; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; SZTALRYD C, 1995, METABOLISM, V44, P1391, DOI 10.1016/0026-0495(95)90135-3; SZTALRYD C, 1994, AM J PHYSIOL, V266, pE179, DOI 10.1152/ajpendo.1994.266.2.E179; UHLE, 1986, P NATL ACAD SCI USA, V83, P1300; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93	59	52	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36281	36287		10.1074/jbc.274.51.36281	http://dx.doi.org/10.1074/jbc.274.51.36281			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593917	hybrid			2022-12-27	WOS:000084279200036
J	Smicun, Y; Campbell, SD; Chen, MA; Gu, H; Rudnick, G				Smicun, Y; Campbell, SD; Chen, MA; Gu, H; Rudnick, G			The role of external loop regions in serotonin transport - Loop scanning mutagenesis of the serotonin transporter external domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE-NOREPINEPHRINE TRANSPORTERS; STRUCTURAL DOMAINS; RAT-BRAIN; SUBSTRATE; TOPOLOGY; RESIDUES; CLONING; BINDING; SITE; ANTIDEPRESSANTS	Chimeric transporters were constructed in which the predicted external loops of the serotonin transporter (SERT) were replaced one at a time with a corresponding sequence from the norepinephrine transporter (NET). All of the chimeric transporters were expressed at levels equal to or greater than those of wild type SERT, but the transport and binding activity of the mutants varied greatly. In particular, mutants in which the NET sequence replaced external loops 4 or 6 of SERT had transport activity 5% or less than that of wild type, and the loop 5 replacement was essentially inactive, In some of these mutants, binding of a high affinity cocaine analog was less affected than transport, suggesting that the mutation had less effect on the initial binding steps in transport than on subsequent conformational changes. The more severely affected mutants also displayed an altered response to Na+. In contrast to the dramatic reduction in transport and binding, the specificity of ligand binding was essentially unchanged. Chimeric transporters did not gain affinity for dopamine, a NET substrate, or desipramine, an inhibitor, at the expense of affinity for serotonin or paroxetine, a selective SERT inhibitor. The results suggest that external loops are not the primary determinants of substrate and inhibitor binding sites. However, they are not merely passive structures connecting transmembrane segments but rather active elements responsible for maintaining the stability and conformational flexibility of the transporter.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University	Rudnick, G (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06510 USA.	gary.rudnick@yale.edu						BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; BLAKELY RD, 1993, SOC GEN PHY, V48, P283; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Buck KJ, 1995, MOL PHARMACOL, V48, P1030; BUCK KJ, 1994, P NATL ACAD SCI USA, V91, P12584, DOI 10.1073/pnas.91.26.12584; BUCK KJ, 1993, SOC NEUR ABSTR, V19; Cao YW, 1998, J NEUROSCI, V18, P7739; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; GIROS B, 1994, J BIOL CHEM, V269, P15985; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Greenberg BD, 1998, MOL PSYCHIATR, V3, P186, DOI 10.1038/sj.mp.4000415; HEISLER S, 1972, ACTA PHYSIOL SCAND, V86, P145, DOI 10.1111/j.1748-1716.1972.tb05321.x; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HUMPHREYS CJ, 1994, BIOCHEMISTRY-US, V33, P9118, DOI 10.1021/bi00197a014; MITCHELL P, 1990, RES MICROBIOL, V141, P286, DOI 10.1016/0923-2508(90)90002-8; MOORE KR, 1994, BIOTECHNIQUES, V17, P130; Olivares L, 1997, J BIOL CHEM, V272, P1211, DOI 10.1074/jbc.272.2.1211; Rudnick G, 1997, NEUROTRANSMITTER TRA, P73; RUDNICK G, 1986, PLATELET FUNCTION ME, V2, P119; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; TAMURA S, 1995, J BIOL CHEM, V270, P28712, DOI 10.1074/jbc.270.48.28712; TATE CG, 1994, J BIOL CHEM, V269, P26303	26	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36058	36064		10.1074/jbc.274.51.36058	http://dx.doi.org/10.1074/jbc.274.51.36058			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593887	hybrid			2022-12-27	WOS:000084279200006
J	Frick, DN; Kumar, S; Richardson, CC				Frick, DN; Kumar, S; Richardson, CC			Interaction of ribonucleoside triphosphates with the gene 4 primase of bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID REPLICATION INVITRO; STRAND DNA-SYNTHESIS; NUCLEOSIDE 5'-TRIPHOSPHATASE ACTIVITY; ESCHERICHIA-COLI PRIMASE; DEOXYRIBONUCLEIC-ACID; TEMPLATE RECOGNITION; HELICASE ACTIVITY; PRIMER SYNTHESIS; RNA-POLYMERASE; TRANSCRIPTION INITIATION	The primase fragment of bacteriophage T7 gene 4 protein catalyzes the synthesis of oligoribonucleotides in the presence of ATP, CTP, Mg2+ (or Mn2+), and DNA containing a primase recognition site. During chain initiation, ATP binds with a K-m of 0.32 mM, and CTP binds with a K-m of 0.85 mM. Synthesis of the dinucleotides proceeds at a rate of 3.8/s. The dinucleotide either dissociates or is extended to a tetranucleotide. The primase preferentially inserts ribonucleotides forming Watson-Crick base pairs with the DNA template >200-fold more rapidly than other ribo- or deoxynucleotides. 3'-dCTP binds the primase with a similar affinity as CTP and is incorporated as a chain terminator at a rate 1/100 that of CTP. ATP analogues alpha,beta-methylene ATP, beta,gamma-methylene ATP, and beta,gamma-imido ATP are incorporated by the primase fragment at the 5'-ends of the oligoribonucleotides but not at the 3'-ends. A model is presented in which the primase fragment utilizes two nucleotide-binding sites, one for the initiating ATP and one for the nucleoside triphosphate which elongates the primer on the 3'-end, The initiation site binds ATP or oligoribonucleotides, whereas the elongation site binds ATP or CTP as directed by the template.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Amersham Pharmacia Biotech, Nucle Acid Chem, Piscataway, NJ 08855 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.			Frick, David/0000-0002-2434-7223	NIAID NIH HHS [AI-06045] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI006045, R01AI006045] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERNSTEIN JA, 1988, J BIOL CHEM, V263, P14891; BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; Hernandez A, 1998, BIOINFORMATICS, V14, P227, DOI 10.1093/bioinformatics/14.2.227; HINTON DM, 1987, J BIOL CHEM, V262, P10873; HORI K, 1979, J BIOL CHEM, V254, P1598; HORI K, 1979, J BIOL CHEM, V254, P1591; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; KIM YT, 1993, P NATL ACAD SCI USA, V90, P10173, DOI 10.1073/pnas.90.21.10173; KOLODNER R, 1977, P NATL ACAD SCI USA, V74, P1525, DOI 10.1073/pnas.74.4.1525; Kusakabe T, 1999, P NATL ACAD SCI USA, V96, P4295, DOI 10.1073/pnas.96.8.4295; Kusakabe T, 1997, J BIOL CHEM, V272, P12446, DOI 10.1074/jbc.272.19.12446; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; MARTIN CT, 1987, BIOCHEMISTRY-US, V26, P2690, DOI 10.1021/bi00384a006; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MENDELMAN LV, 1994, EMBO J, V13, P3909, DOI 10.1002/j.1460-2075.1994.tb06702.x; MENDELMAN LV, 1995, BIOCHEMISTRY-US, V34, P10187, DOI 10.1021/bi00032a012; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; MENDELMAN LV, 1991, J BIOL CHEM, V266, P23240; MODRICH P, 1975, J BIOL CHEM, V250, P5515; MUSTAEV A, 1993, J BIOL CHEM, V268, P19185; MUSTAEV AA, 1995, J BIOL CHEM, V270, P15711, DOI 10.1074/jbc.270.26.15711; NAKAI H, 1986, J BIOL CHEM, V261, P5208; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; PATEL SS, 1993, J BIOL CHEM, V268, P10668; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; ROMANO LJ, 1979, J BIOL CHEM, V254, P476; ROMANO LJ, 1979, J BIOL CHEM, V254, P483; SCHERZINGER E, 1977, NUCLEIC ACIDS RES, V4, P4151, DOI 10.1093/nar/4.12.4151; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; Swart JR, 1995, BIOCHEMISTRY-US, V34, P16097, DOI 10.1021/bi00049a025; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; TABOR S, 1987, J BIOL CHEM, V262, P16212; Washington MT, 1998, J BIOL CHEM, V273, P7880, DOI 10.1074/jbc.273.14.7880	47	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35899	35907		10.1074/jbc.274.50.35899	http://dx.doi.org/10.1074/jbc.274.50.35899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585475	hybrid, Green Published			2022-12-27	WOS:000084187900087
J	Kim, SO; Houtman, JCD; Jiang, J; Ruppert, JI; Bertics, PJ; Frank, SJ				Kim, SO; Houtman, JCD; Jiang, J; Ruppert, JI; Bertics, PJ; Frank, SJ			Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; JAK2 TYROSINE KINASE; NEU DIFFERENTIATION FACTOR; FACTOR-RECEPTOR; EXTRACELLULAR DOMAIN; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; PHOSPHATASE SHP-2; INTERFERON-GAMMA; GH RECEPTOR	The growth hormone receptor (GHR), a cytokine receptor superfamily member, requires the JAK2 tyrosine kinase for signaling. We now examine functional interactions between growth hormone (GH) and epidermal growth factor (EGF) in 3T3-F442A fibroblasts. Although EGF enhanced ErbB-2 tyrosine phosphorylation, GH, while causing retardation of its migration on SDS-polyacrylamide gel electrophoresis, decreased ErbE-2's tyrosine phosphorylation, GH-induced retardation was reversed by treatment of anti-ErbB-2 precipitates with both alkaline phosphatase and protein phosphatase 2A suggesting that GH induced serine/threonine phosphorylation of ErbB-2. Both GH-induced shift in ErbB-2 migration and GH-induced MAP kinase activation were unaffected by a protein kinase C inhibitor but were blocked by the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1 (MEK1) inhibitor, PD98059. Notably, leukemia inhibitory factor, but not interferon-gamma, also promoted ErbB-2 shift and mitogen-activated protein kinase activation. Cotreatment with EGF and GH versus EGF alone resulted in a 35% decline in acute ErbB-2 tyrosine 1248 autophosphorylation, a marked decline (approximately 50%) in DNA synthesis, and substantially decreased cyclin D1 expression. We conclude that in 3T3-F442A cells, 1) the GH-induced decrease in ErbB-2 tyrosine phosphorylation correlates with MEK1/mitogen-activated protein kinase activity and 2) GH antagonizes EGF induced DNA synthesis and cyclin D1 expression in a pattern consistent with its alteration in ErbB-2 phosphorylation status.	Univ Alabama Birmingham, Dept Med, Div Endocrinol & Metab, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; Vet Adm Med Ctr, Birmingham, AL 35294 USA; Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Wisconsin System; University of Wisconsin Madison	Frank, SJ (corresponding author), Univ Alabama Birmingham, Dept Med, Div Endocrinol & Metab, Rm 756,DREB,UAB Stn, Birmingham, AL 35294 USA.	frank@endo.dom.uab.edu		Houtman, Jon/0000-0002-5307-9854	NATIONAL CANCER INSTITUTE [R01CA065686, R29CA065686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046395, R56DK046395, R01DK046395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053271] Funding Source: NIH RePORTER; NCI NIH HHS [CA65686] Funding Source: Medline; NIDDK NIH HHS [DK46395] Funding Source: Medline; NIGMS NIH HHS [GM53271] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; Alaoui-Jamali MA, 1997, BIOCHEM CELL BIOL, V75, P315, DOI 10.1139/bcb-75-4-315; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANDERSON NG, 1992, BIOCHEM J, V284, P649, DOI 10.1042/bj2840649; ARGETSINGER LS, 1995, J BIOL CHEM, V270, P14685, DOI 10.1074/jbc.270.24.14685; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Argetsinger LS, 1996, J BIOL CHEM, V271, P29415, DOI 10.1074/jbc.271.46.29415; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BEERLI RR, 1995, MOL CELL BIOL, V15, P6496; BERGER MS, 1988, CANCER RES, V48, P1238; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; CAMPBELL GS, 1995, J BIOL CHEM, V270, P3974, DOI 10.1074/jbc.270.8.3974; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.ph.58.030196.001155; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; EPSTEIN RJ, 1992, P NATL ACAD SCI USA, V89, P10435, DOI 10.1073/pnas.89.21.10435; EPSTEIN RJ, 1990, J BIOL CHEM, V265, P10746; Fenton SE, 1997, EXP CELL RES, V236, P285, DOI 10.1006/excr.1997.3727; Frank SJ, 1999, ADV MOL CELL ENDOCR, V3, P1; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P2228, DOI 10.1210/en.135.5.2228; FRANK SJ, 1995, J BIOL CHEM, V270, P14776, DOI 10.1074/jbc.270.24.14776; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GRAUSPORTA D, 1995, MOL CELL BIOL, V15, P1182; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GURLAND G, 1990, ENDOCRINOLOGY, V127, P3187, DOI 10.1210/endo-127-6-3187; HAZAN R, 1990, CELL GROWTH DIFFER, V1, P3; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411; Jiang J, 1998, BIOCHEM BIOPH RES CO, V253, P774, DOI 10.1006/bbrc.1998.9793; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kim SO, 1998, J BIOL CHEM, V273, P2344, DOI 10.1074/jbc.273.4.2344; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; Love DW, 1998, ENDOCRINOLOGY, V139, P1965, DOI 10.1210/en.139.4.1965; MEYER DJ, 1994, J BIOL CHEM, V269, P4701; MOLLER C, 1992, J BIOL CHEM, V267, P23403; Morrison P, 1996, J BIOL CHEM, V271, P12891, DOI 10.1074/jbc.271.22.12891; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Quijano VJ, 1998, J BIOL CHEM, V273, P1200, DOI 10.1074/jbc.273.2.1200; SEGATTO O, 1992, ONCOGENE, V7, P1339; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; Smit LS, 1996, MOL ENDOCRINOL, V10, P519, DOI 10.1210/me.10.5.519; SOTIROPOULOS A, 1994, ENDOCRINOLOGY, V135, P1292, DOI 10.1210/en.135.4.1292; STERN DF, 1988, MOL CELL BIOL, V8, P3969, DOI 10.1128/MCB.8.9.3969; Stofega MR, 1998, J BIOL CHEM, V273, P7112, DOI 10.1074/jbc.273.12.7112; TANNER JW, 1995, J BIOL CHEM, V270, P6523, DOI 10.1074/jbc.270.12.6523; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Vanderkuur JA, 1997, ENDOCRINOLOGY, V138, P4301, DOI 10.1210/en.138.10.4301; VANDERKUUR JA, 1994, J BIOL CHEM, V269, P21709; Wiepz GJ, 1997, J CELL PHYSIOL, V173, P44, DOI 10.1002/(SICI)1097-4652(199710)173:1<44::AID-JCP6>3.0.CO;2-J; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837; WINSTON LA, 1992, J BIOL CHEM, V267, P4747; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; Yamauchi T, 1998, ENDOCR J, V45, pS27, DOI 10.1507/endocrj.45.Suppl_S27; ZHAO YM, 1995, J BIOL CHEM, V270, P13814, DOI 10.1074/jbc.270.23.13814	58	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					36015	36024		10.1074/jbc.274.50.36015	http://dx.doi.org/10.1074/jbc.274.50.36015			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585492	hybrid			2022-12-27	WOS:000084187900104
J	Rees, DC; Chang, G; Spencer, RH				Rees, DC; Chang, G; Spencer, RH			Crystallographic analyses of ion channels: Lessons and challenges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MEMBRANE-PROTEINS; MECHANOSENSITIVE CHANNEL; ESCHERICHIA-COLI; STREPTOMYCES-LIVIDANS; POTASSIUM CHANNEL; HELIX PACKING; MSCL; CRYSTALLIZATION; SELECTIVITY; STABILITY		CALTECH, Div Chem & Chem Engn, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Howard Hughes Med Inst, Pasadena, CA 91125 USA.							Aidley D. J., 1996, ION CHANNELS; Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670; Batiza AF, 1999, STRUCTURE, V7, pR99, DOI 10.1016/S0969-2126(99)80061-6; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen GQ, 1997, PROTEIN ENG, V10, P1061, DOI 10.1093/protein/10.9.1061; CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7; Clapham DE, 1999, CELL, V97, P547, DOI 10.1016/S0092-8674(00)80765-5; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; de Kruijff B, 1997, CURR OPIN CHEM BIOL, V1, P564, DOI 10.1016/S1367-5931(97)80053-1; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUNKER AK, 1977, BIOCHEM J, V163, P45, DOI 10.1042/bj1630045; Gouaux E, 1998, STRUCT FOLD DES, V6, P1221, DOI 10.1016/S0969-2126(98)00122-1; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Heginbotham L, 1999, NAT STRUCT BIOL, V6, P811, DOI 10.1038/12266; Hille B., 1992, IONIC CHANNELS EXCIT; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; KENDREW JC, 1957, PROC R SOC LON SER-A, V238, P305, DOI 10.1098/rspa.1957.0002; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; MAKHATADZE GI, 1995, NAT STRUCT BIOL, V2, P852, DOI 10.1038/nsb1095-852; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; McPherson A., 1999, CRYSTALLIZATION BIOL; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Oakley AJ, 1999, PROTEIN SCI, V8, P1915, DOI 10.1110/ps.8.10.1915; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; REES DC, 1989, ANNU REV BIOCHEM, V58, P510; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Shimbo K, 1996, BIOPHYS J, V70, P1335, DOI 10.1016/S0006-3495(96)79690-X; Spencer RH, 1999, CURR OPIN STRUC BIOL, V9, P448, DOI 10.1016/S0959-440X(99)80063-3; STOWELL MHB, 1995, ADV PROTEIN CHEM, V46, P279, DOI 10.1016/S0065-3233(08)60338-1; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; VonHeijne G, 1996, PROG BIOPHYS MOL BIO, V66, P113, DOI 10.1016/S0079-6107(97)85627-1; WALTZ T, 1997, NATURE, V387, P624; Whitelegge JP, 1998, PROTEIN SCI, V7, P1423, DOI 10.1002/pro.5560070619; Yellen G, 1999, CURR OPIN NEUROBIOL, V9, P267, DOI 10.1016/S0959-4388(99)80039-7; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2	53	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					713	716		10.1074/jbc.275.2.713	http://dx.doi.org/10.1074/jbc.275.2.713			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625597	hybrid, Green Accepted			2022-12-27	WOS:000084836600001
J	Bowman, EJ; Kendle, R; Bowman, BJ				Bowman, EJ; Kendle, R; Bowman, BJ			Disruption of vma-1, the gene encoding the catalytic subunit of the vacuolar H+-ATPase, causes severe morphological changes in Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CALCIUM-IONS; GROWTH; INACTIVATION; MUTANTS; TRANSPORT; REVEALS; ROLES; DETOXIFICATION; INHIBITION	By using the process of Repeat-induced Point mutation (Selker, E. U., and Garrett, P. W. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 6870-6874), we inactivated vma-1, the gene encoding subunit A of the V-ATPase of Neurospora crassa. Two vma-1 mutant strains were characterized. One was mutated at multiple sites, did not make a protein product, and produced spores that only rarely germinated. The other had four point mutations, made a protein product, and produced viable spores. Neither strain had detectable V-ATPase activity. The uma-1 mutant strains did not grow in medium buffered to pH 7.0 or above or in medium supplemented with the cation Zn2+. They were completely resistant to inhibition by concanamycin C, supporting our hypothesis that the V-ATPase is the in vivo target of this antibiotic. Inactivation of the vma-1 gene had a pronounced effect on morphology and development of the organism. In the mutants tip growth was inhibited, and multiple branching was induced. The vma-1 mutant strains could not differentiate conidia or perithecia. They could grow slowly as mycelia and could donate nuclei in a sexual cross. A mutation in the plasma membrane ATPase, which suppressed the sensitivity of wild type N. crassa to concanamycin, also proved effective in suppressing the sensitivity of a vma-1 null mutant to basic pH but did not correct the morphological defects.	Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Bowman, EJ (corresponding author), Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA.	rbowman@biology.ucsc.edu						BACHHAWAT AK, 1993, YEAST, V9, P175, DOI 10.1002/yea.320090208; BOWMAN EJ, 1988, J BIOL CHEM, V263, P13994; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; BOWMAN EJ, 1988, METHOD ENZYMOL, V157, P562; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; DICKER JW, 1990, J GEN MICROBIOL, V136, P1413, DOI 10.1099/00221287-136-7-1413; Drose S, 1997, J EXP BIOL, V200, P1; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Ferea TL, 1996, GENETICS, V143, P147; Forster C, 1999, J BIOL CHEM, V274, P9442, DOI 10.1074/jbc.274.14.9442; HARKNESS TAA, 1994, GENETICS, V136, P107; HAROLD FM, 1994, MYCOTA, V1, P89; HEATH IB, 1994, MYCOTA, V1, P43; JACKSON SL, 1993, MICROBIOL REV, V57, P367, DOI 10.1128/MMBR.57.2.367-382.1993; Jones EW., 1997, MOL CELLULAR BIOL YE, VIII, P363; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; MILLER AJ, 1990, P NATL ACAD SCI USA, V87, P9348, DOI 10.1073/pnas.87.23.9348; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; OAKLEY CE, 1987, GENE, V53, P293, DOI 10.1016/0378-1119(87)90019-9; OHYA Y, 1991, J BIOL CHEM, V266, P13971; PERKINS DD, 1982, MICROBIOL REV, V46, P426, DOI 10.1128/MMBR.46.4.426-570.1982; PERKINS DD, 1984, NEUROSPORA NEWSL, V31, P41; Prokisch H, 1997, MOL GEN GENET, V256, P104, DOI 10.1007/s004380050551; RAJU NB, 1992, MYCOL RES, V96, P241, DOI 10.1016/S0953-7562(09)80934-9; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; Riquelme M, 1998, FUNGAL GENET BIOL, V24, P101, DOI 10.1006/fgbi.1998.1074; SCHMID J, 1988, J GEN MICROBIOL, V134, P2623; Seiler S, 1997, EMBO J, V16, P3025, DOI 10.1093/emboj/16.11.3025; SELKER EU, 1988, P NATL ACAD SCI USA, V85, P6870, DOI 10.1073/pnas.85.18.6870; SPRINGER ML, 1989, GENE DEV, V3, P559, DOI 10.1101/gad.3.4.559; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUPEK F, 1994, J BIOL CHEM, V269, P26479; TRINCI APJ, 1994, GROWTH DIFFERENTIATI, P175; Xie YY, 1996, J CELL SCI, V109, P489; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; YARDEN O, 1992, EMBO J, V11, P2159, DOI 10.1002/j.1460-2075.1992.tb05275.x; ZEREZ CR, 1986, J BIOL CHEM, V261, P8877; Zhang JW, 1998, J BIOL CHEM, V273, P18470, DOI 10.1074/jbc.273.29.18470	43	43	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					167	176		10.1074/jbc.275.1.167	http://dx.doi.org/10.1074/jbc.275.1.167			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617601	hybrid			2022-12-27	WOS:000085951600025
J	Jones, BE; Lo, CR; Liu, HL; Srinivasan, A; Streetz, K; Valentino, KL; Czaja, MJ				Jones, BE; Lo, CR; Liu, HL; Srinivasan, A; Streetz, K; Valentino, KL; Czaja, MJ			Hepatocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CYTOCHROME-C RELEASE; INDUCED CELL-DEATH; LIVER-REGENERATION; FACTOR RECEPTOR; ACTIVATION; RAT; MITOCHONDRIA; TRANSITION; PREVENTION	Hepatocytes can be sensitized to tumor necrosis factor (TNF)-alpha toxicity by repression of NF-kappa B activation or inhibition of RNA synthesis. To determine whether both forms of sensitization lead to TNF-alpha cytotoxicity by similar mechanisms, TNF-alpha-induced cell death in RALA255-10G hepatocytes was examined following infection with an adenovirus, Ad5I kappa B, that blocks NF-kappa B activation or following cotreatment with actinomycin D (ActD). TNF-alpha treatment of Ad5I kappa B-infected cells resulted in 44% cell death within 6 h. ActD/TNF-alpha induced no death within 6 h but did lead to 37% cell death by 24 h. In both instances, cell death occurred by apoptosis and was associated with caspase activation, although caspase activation in ActD-sensitized cells was delayed. CrmA and chemical caspase inhibitors blocked Ad5I kappa B/TNF-alpha-induced cell death but did not inhibit ActD/TNF-alpha-induced apoptosis. A Fas-associated protein with death domain (FADD) dominant negative decreased Ad5I kappa B/TNF-alpha- and ActD/TNF-alpha-induced cell death by 81 and 47%, respectively, However, downstream events differed, since Ad5I kappa B/TNF-alpha but not ActD/TNF-alpha treatment caused mitochondrial cytochrome c release. These results suggest that NF-kappa B inactivation and inhibition of RNA synthesis sensitize RALA255-10G hepatocytes to TNF-alpha toxicity through distinct cell death pathways that diverge below the level of FADD, ActD-induced hepatocyte sensitization to TNF-alpha cytotoxicity occurs through a FADD-dependent, caspase-independent pathway of apoptosis.	Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Med, Bronx, NY 10461 USA; IDUN Pharmaceut Inc, La Jolla, CA 92037 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biophys, Chapel Hill, NC 27599 USA	Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Czaja, MJ (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NCI NIH HHS [5P30-CA13330] Funding Source: Medline; NIDDK NIH HHS [DK-44234, R01 DK044234] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK044234, R01DK044234] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387; CHOU JY, 1983, MOL CELL BIOL, V3, P1013, DOI 10.1128/MCB.3.6.1013; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; CZAJA MJ, 1995, GASTROENTEROLOGY, V108, P1849, DOI 10.1016/0016-5085(95)90149-3; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P26; Deas O, 1998, J IMMUNOL, V161, P3375; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Iimuro Y, 1997, HEPATOLOGY, V26, P1530; Jones BE, 1999, HEPATOLOGY, V30, P215, DOI 10.1002/hep.510300146; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; KULL FC, 1981, CANCER RES, V41, P4885; LEIST M, 1994, J IMMUNOL, V153, P1778; Leist M, 1997, GASTROENTEROLOGY, V112, P923, DOI 10.1053/gast.1997.v112.pm9041255; Li JR, 1999, J BIOL CHEM, V274, P17325, DOI 10.1074/jbc.274.24.17325; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Marzo I, 1998, FEBS LETT, V427, P198, DOI 10.1016/S0014-5793(98)00424-4; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Samejima K, 1998, J CELL BIOL, V143, P225, DOI 10.1083/jcb.143.1.225; Schwandner R, 1998, J BIOL CHEM, V273, P5916, DOI 10.1074/jbc.273.10.5916; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Trapani JA, 1998, J BIOL CHEM, V273, P27934, DOI 10.1074/jbc.273.43.27934; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Xu J, 1996, AM J PHYSIOL-GASTR L, V270, pG60, DOI 10.1152/ajpgi.1996.270.1.G60; Xu Y, 1998, GASTROENTEROLOGY, V115, P1229, DOI 10.1016/S0016-5085(98)70095-2; Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	42	95	99	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					705	712		10.1074/jbc.275.1.705	http://dx.doi.org/10.1074/jbc.275.1.705			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617670	Green Published, hybrid			2022-12-27	WOS:000085951600094
J	Bonagura, CA; Bhaskar, B; Sundaramoorthy, M; Poulos, TL				Bonagura, CA; Bhaskar, B; Sundaramoorthy, M; Poulos, TL			Conversion of an engineered potassium-binding site into a calcium-selective site in cytochrome c peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPOUND-I; ASCORBATE PEROXIDASE; MANGANESE PEROXIDASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; IDENTIFICATION; TRYPTOPHAN; CATALYSIS; LIGAND	We have previously shown that the K+ site found in ascorbate peroxidase can be successfully engineered into the closely homologous peroxidase, cytochrome c peroxidase (CCP) (Bonagura, C, A, Sundaramoorthy, M., Pappa, H, S., Patterson, W. R., and Poulos, T, L, (1996) Biochemistry 35, 6107-6115; Bonagura, C, A, Sundaramoorthy, M., Bhaskar, B., and Poulos, T. L, (1999) Biochemistry 38, 5538-5545). All other peroxidases bind Ca2+ rather than K+. Using the K+-binding CCP mutant (CCPK2) as a template protein, together with observations from structural modeling, mutants were designed that should bind Ca2+ selectively, The crystal structure of the first generation mutant, CCPCA1, showed that a smaller cation, perhaps Na+, is bound instead of Ca2+. This is probably because the full eight-ligand coordination sphere did not form owing to a local disordering of one of the essential cation ligands, Eased on these observations, a second mutant, CCPCA2, was designed. The crystal structure showed Ca2+ binding in the CCPCA2 mutant and a well ordered cation-binding loop with the full complement of eight protein to cation ligands, Because cation binding to the engineered loop results in diminished CCP activity and destabilization of the essential Trp(191) radical as measured by EPR spectroscopy, these measurements can be used as sensitive methods for determining cation-binding selectivity. Both activity and EPR titration studies show that CCPCA2 binds Ca2+ more effectively than K+, demonstrating that an iterative protein engineering-based approach is important in switching protein cation selectivity.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Program Macromol Struct, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.							Bonagura CA, 1996, BIOCHEMISTRY-US, V35, P6107, DOI 10.1021/bi960122x; Bonagura CA, 1999, BIOCHEMISTRY-US, V38, P5538, DOI 10.1021/bi982996k; CHOUDHURY K, 1994, J BIOL CHEM, V269, P20239; DARWISH K, 1991, PROTEIN ENG, V4, P701, DOI 10.1093/protein/4.6.701; EDWARDS SL, 1990, J BIOL CHEM, V265, P2588; FISHEL LA, 1987, BIOCHEMISTRY-US, V26, P351, DOI 10.1021/bi00376a004; FITZGERALD MM, 1994, BIOCHEMISTRY-US, V33, P3807, DOI 10.1021/bi00179a004; HAHM S, 1993, J AM CHEM SOC, V115, P3372, DOI 10.1021/ja00061a063; HAHM S, 1994, BIOCHEMISTRY-US, V33, P1463; Jensen GM, 1998, J PHYS CHEM B, V102, P8221, DOI 10.1021/jp9811326; KANG CH, 1977, J BIOL CHEM, V252, P919; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MAURO JM, 1988, BIOCHEMISTRY-US, V27, P6243, DOI 10.1021/bi00417a008; Menyhard DK, 1999, J PHYS CHEM B, V103, P227, DOI 10.1021/jp981765k; MILLER MA, 1994, P NATL ACAD SCI USA, V91, P11118, DOI 10.1073/pnas.91.23.11118; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pappa HS, 1996, BIOCHEMISTRY-US, V35, P4837, DOI 10.1021/bi952935b; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; POULOS TL, 1993, J BIOL CHEM, V268, P4429; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Wilcox SK, 1998, BIOCHEMISTRY-US, V37, P16853, DOI 10.1021/bi9815039; Yeung BKS, 1997, CHEM BIOL, V4, P215, DOI 10.1016/S1074-5521(97)90291-X; YONETANI T, 1966, BIOCHEM PREP, V11, P14; Yonetani T., 1976, ENZYMES, P345	27	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37827	37833		10.1074/jbc.274.53.37827	http://dx.doi.org/10.1074/jbc.274.53.37827			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608846	hybrid			2022-12-27	WOS:000084528000046
J	Gassel, M; Mollenkamp, T; Puppe, W; Altendorf, K				Gassel, M; Mollenkamp, T; Puppe, W; Altendorf, K			The KdpF subunit is part of the K+-translocating Kdp complex of Escherichia coli and is responsible for stabilization of the complex in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COA DECARBOXYLASE; MUSCLE SARCOPLASMIC-RETICULUM; CYTOCHROME-C-OXIDASE; POTASSIUM-TRANSPORT; PARACOCCUS-DENITRIFICANS; VEILLONELLA-PARVULA; STRUCTURAL PROTEINS; REACTIVE PROTEIN; ATPASE; EXPRESSION	The hdpABC operon codes for the high affinity K+-translocating Kdp complex (P-type ATPase) of Escherichia coli, Upon expression of this operon in minicells, a so far unrecognized small hydrophobic polypeptide, KdpF, could be identified on high resolution SDS-polyacrylamide gels in addition to the subunits KdpA, KdpB, and KdpC, Furthermore, it could be demonstrated that KdpF remains associated with the purified complex. As determined by mass spectrometry, this peptide is present in its formylated form and has a molecular mass of 3100 Da, KdpF is not essential for growth on low K+ (0.1 mM) medium, as shown by deletion analysis of KdpF, but proved to be indispensable for a functional enzyme complex in vitro. In the absence of KdpF, the ATPase activity of the membrane-bound Hdp complex was almost indistinguishable from that of the wild type. In contrast, the purified detergent-solubilized enzyme complex showed a dramatic decrease in enzymatic activity. However, addition of purified KdpF to the KdpABC complex restored the activity up to wild type level, It is interesting to note that the addition of high amounts of E. coli lipids had a similar effect. Although KdpF is not essential for the function of the Hdp complex in vivo, it is part of the complex and functions as a stabilizing element in vitro, The corresponding operon should now be referred to as kdpFABC.	Univ Osnabruck, Fachbereich Biol Chem, Abt Mikrobiol, D-49069 Osnabruck, Germany; Christian Albrechts Univ Kiel Klinikum, Klin Allgemeine Padiat Bakteriol Labor, D-24105 Kiel, Germany	University Osnabruck; University of Kiel; Schleswig Holstein University Hospital	Altendorf, K (corresponding author), Univ Osnabruck, Fachbereich Biol Chem, Abt Mikrobiol, D-49069 Osnabruck, Germany.	altendorf@biologie.uni-osnabrueck.de						Altendorf K, 1998, ACTA PHYSIOL SCAND, V163, P137; ALTENDORF K, 1975, FEBS LETT, V59, P268, DOI 10.1016/0014-5793(75)80390-5; ALTENDORF K, 1996, BIOMEMBR, V5, P403; ALTENDORF K, 1979, FUNCTION MOL ASPECTS, P53; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BAKKER EP, 1993, ALKALI CATION TRANSP, P00205; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bott M, 1997, EUR J BIOCHEM, V250, P590, DOI 10.1111/j.1432-1033.1997.0590a.x; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678, DOI 10.1074/jbc.270.12.6678; EPSTEIN W, 1986, FEMS MICROBIOL LETT, V39, P73; EPSTEIN W, 1992, ACTA PHYSIOL SCAND, V146, P193; EPSTEIN W, 1985, CURR TOP MEMBR TRANS, V23, P153; FILLINGAME RH, 1976, J BIOL CHEM, V251, P6630; Gassel M, 1998, BBA-BIOMEMBRANES, V1415, P77, DOI 10.1016/S0005-2736(98)00179-5; GRAF T, 1978, FEBS LETT, V94, P218, DOI 10.1016/0014-5793(78)80941-7; GUTTERSON NI, 1983, P NATL ACAD SCI-BIOL, V80, P4894, DOI 10.1073/pnas.80.16.4894; HARDWICKE PMD, 1981, BIOCHEM BIOPH RES CO, V102, P250, DOI 10.1016/0006-291X(81)91514-X; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hellwig P, 1998, BBA-BIOENERGETICS, V1409, P107, DOI 10.1016/S0005-2728(98)00151-0; HESSE JE, 1984, P NATL ACAD SCI-BIOL, V81, P4746, DOI 10.1073/pnas.81.15.4746; HUDER JB, 1993, J BIOL CHEM, V268, P24564; HUDER JB, 1995, J BACTERIOL, V177, P3623, DOI 10.1128/jb.177.13.3623-3630.1995; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kadambi VJ, 1997, BIOCHEM BIOPH RES CO, V239, P1, DOI 10.1006/bbrc.1997.7340; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIMINS LA, 1978, P NATL ACAD SCI USA, V75, P3216, DOI 10.1073/pnas.75.7.3216; Maniatis T., 1982, MOL CLONING; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; NAVARRE C, 1994, J BIOL CHEM, V269, P21262; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; POLAREK JW, 1992, J BACTERIOL, V174, P2145, DOI 10.1128/JB.174.7.2145-2151.1992; POLAREK JW, 1988, METHOD ENZYMOL, V157, P655; PUPPE W, 1992, MOL MICROBIOL, V6, P3511, DOI 10.1111/j.1365-2958.1992.tb01786.x; PUPPE W, 1991, THESIS U OSNABRUCK O; REEVE JN, 1984, ADV MOL GENETICS, P212; RHOADS DB, 1976, J GEN PHYSIOL, V67, P325, DOI 10.1085/jgp.67.3.325; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAUDER B, 1987, GENE, V52, P279, DOI 10.1016/0378-1119(87)90054-0; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; SIEBERS A, 1988, EUR J BIOCHEM, V178, P131, DOI 10.1111/j.1432-1033.1988.tb14438.x; SIEBERS A, 1989, J BIOL CHEM, V264, P5831; SIEBERS A, 1992, J BIOL CHEM, V267, P12717; SIEBERS A, 1988, METHOD ENZYMOL, V157, P668; SIEBERS A, 1993, ALKALI CATION TRANSP, P225; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; SPIERS AJ, 1992, J BACTERIOL, V174, P7533, DOI 10.1128/JB.174.23.7533-7541.1992; STUMPE S, 1996, HDB BIOL PHYS, V2, P473; SUGIURA A, 1993, BIOSCI BIOTECH BIOCH, V57, P356, DOI 10.1271/bbb.57.356; SUGIURA A, 1992, MOL MICROBIOL, V6, P1769, DOI 10.1111/j.1365-2958.1992.tb01349.x; TreunerLange A, 1997, J BACTERIOL, V179, P4501, DOI 10.1128/jb.179.14.4501-4512.1997; WALDERHAUG MO, 1992, J BACTERIOL, V174, P2152, DOI 10.1128/JB.174.7.2152-2159.1992; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; Witt H, 1997, J BIOL CHEM, V272, P5514, DOI 10.1074/jbc.272.9.5514	61	85	89	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37901	37907		10.1074/jbc.274.53.37901	http://dx.doi.org/10.1074/jbc.274.53.37901			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608856	hybrid			2022-12-27	WOS:000084528000056
J	Lescure, A; Gautheret, D; Carbon, P; Krol, A				Lescure, A; Gautheret, D; Carbon, P; Krol, A			Novel selenoproteins identified in silico and in vivo by using a conserved RNA structural motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; IODOTHYRONINE DEIODINASE; OXIDATIVE STRESS; SELENOCYSTEINE; SEQUENCE; EUKARYOTES; ALIGNMENT; PROTEIN; TISSUES; ELEMENT	Selenocysteine is incorporated into selenoproteins by an in-frame UGA codon whose readthrough requires the selenocysteine insertion sequence (SECIS), a conserved hairpin in the 3'-untranslated region of eukaryotic selenoprotein mRNAs, To identify new selenoproteins, we developed a strategy that obviates the need for prior amino acid sequence information, A computational screen was used to scan nucleotide sequence data bases for sequences presenting a potential SECIS secondary structure, The computer-selected hairpins were then assayed in vivo for their functional capacities, and the cDNAs corresponding to the SECIS winners were identified. Four of them encoded novel selenoproteins as confirmed by in vivo experiments. Among these, SelZf1 and SelZf2 share a common domain with mitochondrial thioredoxin reductase-g. The three proteins, however, possess distinct N-terminal domains, We found that another protein, SelX, displays sequence similarity to a protein involved in bacterial pilus formation. For the first time, four novel selenoproteins were discovered based on a computational screen for the RNA hairpin directing selenocysteine incorporation.	Inst Biol Mol & Cellulaire, CNRS, UPR 9002, F-67084 Strasbourg, France; CNRS, UMR 1889, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS)	Krol, A (corresponding author), Inst Biol Mol & Cellulaire, CNRS, UPR 9002, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	krol@ihmc.u-strasbg.fr		Gautheret, Daniel/0000-0002-1508-8469				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beck MA, 1998, ANNU REV NUTR, V18, P93, DOI 10.1146/annurev.nutr.18.1.93; Behne D, 1996, BIOL TRACE ELEM RES, V55, P99, DOI 10.1007/BF02784172; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Buettner C, 1998, J BIOL CHEM, V273, P33374, DOI 10.1074/jbc.273.50.33374; Burk RF, 1999, BIOESSAYS, V21, P231, DOI 10.1002/(SICI)1521-1878(199903)21:3<231::AID-BIES7>3.3.CO;2-4; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; Dandekar T, 1998, BIOINFORMATICS, V14, P271, DOI 10.1093/bioinformatics/14.3.271; DANDEKAR T, 1995, TRENDS GENET, V11, P45, DOI 10.1016/S0168-9525(00)88996-9; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; Gasdaska PY, 1999, FEBS LETT, V442, P105, DOI 10.1016/S0014-5793(98)01638-X; GAUTHERET D, 1990, COMPUT APPL BIOSCI, V6, P325; Gladyshev VN, 1998, J BIOL CHEM, V273, P8910, DOI 10.1074/jbc.273.15.8910; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; HUANG XQ, 1992, GENOMICS, V14, P18, DOI 10.1016/S0888-7543(05)80277-0; Kollmus H, 1996, NUCLEIC ACIDS RES, V24, P1195, DOI 10.1093/nar/24.7.1195; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; LAFERRIERE A, 1994, COMPUT APPL BIOSCI, V10, P211; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Miranda-Vizuete A, 1999, EUR J BIOCHEM, V261, P405, DOI 10.1046/j.1432-1327.1999.00286.x; Pesole G, 1999, NUCLEIC ACIDS RES, V27, P188, DOI 10.1093/nar/27.1.188; STADTMAN TC, 1991, J BIOL CHEM, V266, P16257; TAHA MK, 1988, EMBO J, V7, P4367, DOI 10.1002/j.1460-2075.1988.tb03335.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walczak R, 1996, RNA, V2, P367; Walczak R, 1998, RNA, V4, P74; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985	29	217	235	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38147	38154		10.1074/jbc.274.53.38147	http://dx.doi.org/10.1074/jbc.274.53.38147			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608886	hybrid			2022-12-27	WOS:000084528000086
J	Matsumura, T; Sakai, M; Matsuda, K; Furukawa, N; Kaneko, K; Shichiri, M				Matsumura, T; Sakai, M; Matsuda, K; Furukawa, N; Kaneko, K; Shichiri, M			Cis-acting DNA elements of mouse granulocyte/macrophage colony-stimulating factor gene responsive to oxidized low density lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PERITONEAL-MACROPHAGES; PROTEIN-KINASE-C; GM-CSF PROMOTER; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; SCAVENGER RECEPTOR; MESSENGER-RNA; GROWTH-FACTOR; T-CELLS; LIGAND ACTIVITY	We previously demonstrated that the induction of granulocyte/macrophage colony-stimulating factor (GM-CSF) played an important role in oxidized low density lipoprotein (Ox-LDL)-induced macrophage growth as a growth priming factor. The present study was undertaken to elucidate the transcriptional regulation of the GM-CSF gene using Raw 264.7 cells, a mouse macrophage cell line, Transient transfection into Raw 264.7 cells of several 5'-flanking regions of GM-CSF gene-luciferase fusion plasmids revealed the presence of two positive regulatory sites in regions spanning from -97 to -59 and hom -59 to -37 and one negative regulatory site hom -120 to -97 in unstimulated cells. When cells were stimulated by Ox-LDL, there was one positive responsive site from -225 to -120 and one negative responsive site from -97 to -59, which contained the NF-kappa B binding site. Computer analysis revealed the presence of a putative AP-2 binding site from -169 to -160, Mutagenesis of a putative AP-2 binding site and tandem repeat of this site in plasmid resulted in a complete loss and increased responsiveness to Ox-LDL, respectively. Electrophoretic mobility shift assay showed that Ox-LDL increased the binding of certain nuclear protein(s) to a putative AP-2 binding site but decreased their binding to NF-kappa B binding site. S kappa upershift assay showed that nuclear proteins bound to NF-kappa B binding site contained, at least, p50 and p65 but could not demonstrate nuclear protein(s) bound to a putative AP-2 binding site. Our results suggested that a putative AP-2 binding site from -169 to -160 was a positive responsive element to Ox-LDL and that the NF-kappa B binding site hom -91 to -82 was a negative responsive element in Ox-LDL-induced GM-CSF transcription.	Kumamoto Univ, Sch Med, Dept Metab Med, Kumamoto 8605886, Japan	Kumamoto University	Sakai, M (corresponding author), Kumamoto Univ, Sch Med, Dept Metab Med, 1-1-1 Honjo, Kumamoto 8605886, Japan.							ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; ARES MPS, 1995, ARTERIOSCL THROM VAS, V15, P1584, DOI 10.1161/01.ATV.15.10.1584; Biwa T, 1998, J BIOL CHEM, V273, P28305, DOI 10.1074/jbc.273.43.28305; Brand K, 1997, ARTERIOSCL THROM VAS, V17, P1901, DOI 10.1161/01.ATV.17.10.1901; BROUDY VC, 1987, J IMMUNOL, V139, P464; BUETTNER R, 1993, MOL CELL BIOL, V13, P4174, DOI 10.1128/MCB.13.7.4174; BURGESS AW, 1980, BLOOD, V56, P947; CHEN BDM, 1986, J IMMUNOL, V137, P563; CHEN BDM, 1988, BLOOD, V71, P997; CHODAKEWITZ JA, 1988, J IMMUNOL, V140, P832; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GHOSH D, 1993, NUCLEIC ACIDS RES, V21, P3117, DOI 10.1093/nar/21.13.3117; HAKAMATA H, 1994, ARTERIOSCLER THROMB, V14, P1860, DOI 10.1161/01.ATV.14.11.1860; Hamilton JA, 1999, ARTERIOSCL THROM VAS, V19, P98, DOI 10.1161/01.ATV.19.1.98; KITA H, 1991, J EXP MED, V174, P745, DOI 10.1084/jem.174.3.745; KOYANONAKAGAWA N, 1993, INT IMMUNOL, V5, P345, DOI 10.1093/intimm/5.4.345; KUPPER TS, 1988, J CLIN INVEST, V82, P1787, DOI 10.1172/JCI113792; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; Martens JS, 1999, J BIOL CHEM, V274, P10903, DOI 10.1074/jbc.274.16.10903; Martens JS, 1998, J BIOL CHEM, V273, P4915, DOI 10.1074/jbc.273.9.4915; MASUDA ES, 1993, MOL CELL BIOL, V13, P7399, DOI 10.1128/MCB.13.12.7399; Matsuda K, 1997, DIABETES, V46, P354, DOI 10.2337/diabetes.46.3.354; Matsumura T, 1997, ARTERIOSCL THROM VAS, V17, P3013, DOI 10.1161/01.ATV.17.11.3013; MEIER P, 1995, DEV BIOL, V169, P1, DOI 10.1006/dbio.1995.1121; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MIYAKE S, 1988, EMBO J, V4, P2561; MIYAZAKI A, 1994, J BIOL CHEM, V269, P5264; MIYAZAKI A, 1991, BIOCHIM BIOPHYS ACTA, V1082, P143; MOSER M, 1995, DEVELOPMENT, V121, P2779; MUNKER R, 1986, NATURE, V323, P79, DOI 10.1038/323079a0; OHTA T, 1989, FEBS LETT, V257, P435, DOI 10.1016/0014-5793(89)81590-X; OuladAbdelghani M, 1996, EXP CELL RES, V225, P338, DOI 10.1006/excr.1996.0184; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sakai M, 1999, ARTERIOSCL THROM VAS, V19, P1726, DOI 10.1161/01.ATV.19.7.1726; Sakai M, 1996, J BIOL CHEM, V271, P27346, DOI 10.1074/jbc.271.44.27346; SAKAI M, 1994, J BIOL CHEM, V269, P31430; SAKAI M, 1992, FEBS LETT, V314, P199, DOI 10.1016/0014-5793(92)80974-L; Sakai M, 1996, ARTERIOSCL THROM VAS, V16, P600, DOI 10.1161/01.ATV.16.4.600; Sambrook J., 2002, MOL CLONING LAB MANU; Sato Y, 1996, ATHEROSCLEROSIS, V125, P15, DOI 10.1016/0021-9150(96)05829-7; SCHRECK R, 1990, MOL CELL BIOL, V10, P1281, DOI 10.1128/MCB.10.3.1281; SHANNON MF, 1988, P NATL ACAD SCI USA, V85, P674, DOI 10.1073/pnas.85.3.674; STANLEY ER, 1976, J EXP MED, V143, P631, DOI 10.1084/jem.143.3.631; STEWART CC, 1978, J RETICULOENDOTH SOC, V23, P269; SUGIMOTO K, 1990, INT IMMUNOL, V2, P787, DOI 10.1093/intimm/2.8.787; THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5; TSUBOI A, 1994, BIOCHEM BIOPH RES CO, V199, P1064, DOI 10.1006/bbrc.1994.1337; TSUBOI A, 1991, INT IMMUNOL, V3, P807, DOI 10.1093/intimm/3.8.807; WANG CY, 1993, SCIENCE, V260, P1330, DOI 10.1126/science.8493578; WANG CY, 1994, MOL CELL BIOL, V14, P1153, DOI 10.1128/MCB.14.2.1153; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; WODNARFILIPOWICZ A, 1989, NATURE, V339, P150, DOI 10.1038/339150a0; WRONG GG, 1985, SCIENCE, V228, P810; YUI S, 1993, ARTERIOSCLER THROMB, V13, P331, DOI 10.1161/01.ATV.13.3.331	55	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37665	37672		10.1074/jbc.274.53.37665	http://dx.doi.org/10.1074/jbc.274.53.37665			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608823	hybrid			2022-12-27	WOS:000084528000023
J	Izaguirre, G; Aguirre, L; Ji, P; Aneskievich, B; Haimovich, B				Izaguirre, G; Aguirre, L; Ji, P; Aneskievich, B; Haimovich, B			Tyrosine phosphorylation of alpha-actinin in activated platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; HUMAN BLOOD-PLATELETS; PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION; CYTOPLASMIC DOMAIN; CELL MOTILITY; 3T3 CELLS; INTEGRIN; THROMBIN; BINDING	The integrin alpha(IIb)beta(3) mediates tyrosine phosphorylation of a 105-kDa protein (pp105) in activated platelets. We have partially purified a 105-kDa tyrosine-phosphorylated protein from platelets stimulated with phorbol 12-myristate 18 acetate and obtained the sequence of an internal 12-mer peptide derived from this protein. The sequence was identical to human alpha-actinin sequences deposited in the Swiss Protein Database. alpha-Actinin, a 105-kDa protein in platelets, was subsequently purified from activated platelets by four sequential chromatographic steps. Fractions were analyzed by Western blotting and probed with alpha-actinin and anti-phosphotyrosine antibodies. The distribution of alpha-actinin and pp105 overlapped throughout the purification. Furthermore, in the course of this purification, a 105-kDa tyrosine-phosphorylated protein was only detected in fractions that contained alpha-actinin, The purified alpha-actinin protein was immunoprecipitated with antibodies to phosphotyrosine in the absence but not in the presence of phenyl phosphate, alpha-Actinin resolved by two-dimensional gel electrophoresis of activated platelet lysates was recognized by the antibodies to phosphotyrosine, whereas pretreatment of the platelets with bisindolylmaleimide, a protein kinase C inhibitor that prevents tyrosine phosphorylation of pp105, inhibited the reactivity of the antibodies to phosphotyrosine with alpha-actinin, Taken together, these data demonstrate that a fraction of alpha-actinin is tyrosine-phosphorylated in activated platelets.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Connecticut	Haimovich, B (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, Res Tower,Rm 234,675 Hoes Lane, Piscataway, NJ 08854 USA.			Aguirre, Lina/0000-0003-0711-314X	NHLBI NIH HHS [HL-54104] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL054104, R01HL054104] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEGGS AH, 1992, J BIOL CHEM, V267, P9281; Cichowski K, 1996, J BIOL CHEM, V271, P7544, DOI 10.1074/jbc.271.13.7544; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; DUBERNARD V, 1995, FEBS LETT, V364, P109, DOI 10.1016/0014-5793(95)00362-D; Egerton M, 1996, BIOCHEM BIOPH RES CO, V224, P666, DOI 10.1006/bbrc.1996.1082; FERNANDEZ J, 1992, ANAL BIOCHEM, V201, P255, DOI 10.1016/0003-2697(92)90336-6; FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234; FOX JEB, 1993, J CELL BIOL, V120, P1501, DOI 10.1083/jcb.120.6.1501; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Giuriato S, 1997, J BIOL CHEM, V272, P26857, DOI 10.1074/jbc.272.43.26857; GLUCK U, 1994, J CELL SCI, V107, P1773; GLUCK U, 1993, P NATL ACAD SCI USA, V90, P383, DOI 10.1073/pnas.90.2.383; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; GOLDEN A, 1990, J CELL BIOL, V111, P3117, DOI 10.1083/jcb.111.6.3117; GRAVEL P, 1995, ELECTROPHORESIS, V16, P1152, DOI 10.1002/elps.11501601191; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; Haimovich B, 1996, BLOOD, V87, P152, DOI 10.1182/blood.V87.1.152.bloodjournal871152; Haimovich B, 1996, J BIOL CHEM, V271, P16332, DOI 10.1074/jbc.271.27.16332; Haimovich B, 1999, THROMB HAEMOSTASIS, V81, P618; Hamazaki Y, 1998, ONCOGENE, V16, P2773, DOI 10.1038/sj.onc.1201799; HAMMINGS L, 1995, BIOCHEM SOC T, V23, P619; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ji P, 1999, BBA-MOL CELL RES, V1448, P543, DOI 10.1016/S0167-4889(98)00160-8; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; KRAMER RM, 1995, J BIOL CHEM, V270, P27395, DOI 10.1074/jbc.270.46.27395; LANDON F, 1983, BIOCHIM BIOPHYS ACTA, V742, P129, DOI 10.1016/0167-4838(83)90368-0; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; LEWIS JM, 1995, MOL BIOL CELL, V6, P151, DOI 10.1091/mbc.6.2.151; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MILLAKE DB, 1989, NUCLEIC ACIDS RES, V17, P6725, DOI 10.1093/nar/17.16.6725; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Mukai H, 1997, J BIOL CHEM, V272, P4740, DOI 10.1074/jbc.272.8.4740; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OTEY CA, 1993, J BIOL CHEM, V268, P21193; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; PAPKOFF J, 1994, MOL CELL BIOL, V14, P463, DOI 10.1128/MCB.14.1.463; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; Raja S, 1997, J BIOL CHEM, V272, P10941; ROSENBERG S, 1981, J BIOL CHEM, V256, P2986; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schoenwaelder SM, 1999, J BIOL CHEM, V274, P14359, DOI 10.1074/jbc.274.20.14359; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P1694, DOI 10.1074/jbc.272.3.1694; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SHATTIL SJ, 1994, CURR OPIN CELL BIOL, V6, P695, DOI 10.1016/0955-0674(94)90096-5; SHATTIL SJ, 1994, J BIOL CHEM, V269, P14738; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; SHIBASAKI F, 1994, BIOCHEM J, V302, P551, DOI 10.1042/bj3020551; TANIGUCHI T, 1993, J BIOL CHEM, V268, P2277; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WACHSSTOCK DH, 1987, BIOCHEM BIOPH RES CO, V146, P554, DOI 10.1016/0006-291X(87)90564-X; WAITES GT, 1992, J BIOL CHEM, V267, P6263; WEHLAND J, 1979, J CELL SCI, V37, P257; YOUSSOUFIAN H, 1990, AM J HUM GENET, V47, P62	60	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37012	37020		10.1074/jbc.274.52.37012	http://dx.doi.org/10.1074/jbc.274.52.37012			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601257	hybrid			2022-12-27	WOS:000084382700028
J	Kristensen, C; Wiberg, FC; Andersen, AS				Kristensen, C; Wiberg, FC; Andersen, AS			Specificity of insulin and insulin-like growth factor I receptors investigated using chimeric mini-receptors - Role of C-teriminal of receptor alpha subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-SCANNING MUTAGENESIS; LIGAND-BINDING DOMAIN; IDENTIFICATION; DETERMINANTS; SITE; EXPRESSION; AFFINITY; REGIONS; FAMILY	We have investigated the role of the C-terminal of the alpha-subunit in the insulin receptor family by characterizing chimeric mini-receptor constructs comprising the first three domains (468 amino acids) of insulin receptor (IR) or insulin-like growth factor I receptor (IGFIR) combined with C-terminal domain from either insulin receptor (IR) (residues 704-719), IGFIR, or insulin receptor-related receptor (IRRR), The constructs were stably expressed in baby hamster kidney cells and purified, and binding affinities were determined for insulin, IGFI, and a single chain insulin/IGFI hybrid. The C-terminal domain of IRRR was found to abolish binding in PR and IGFIR context, whereas other constructs bound ligands, The two constructs with first three domains of the IR demonstrated low specificity for ligands, all affinities ranging from 3.0 to 15 nM. In contrast, the constructs with the first three domains of the IGFIR had high specificity, the affinity of the novel minimized IGFIR for IGFI was 1.5 nM, whereas the affinity for insulin was more than 3000 nM. When swapping the C-terminal domains in either receptor context only minor changes were observed in affinities (<3-fold), demonstrating that the carboxyl-terminal of IR and IGFIR alpha-subunits are interchangeable and suggesting that this domain is part of the common binding site.	Novo Nordisk AS, Insulin Res, DK-2880 Bagsvaerd, Denmark; Novo Nordisk AS, Hlth Care Discovery, Cell Technol, DK-2880 Bagsvaerd, Denmark	Novo Nordisk; Novo Nordisk	Kristensen, C (corresponding author), Novo Nordisk AS, Insulin Res, Novo Alle,6B1-90, DK-2880 Bagsvaerd, Denmark.		Kristensen, Claus/O-8047-2015	Kristensen, Claus/0000-0002-2594-7722				ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; BLUM WF, 1989, ENDOCRINOLOGY, V125, P766, DOI 10.1210/endo-125-2-766; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Kristensen C, 1998, J BIOL CHEM, V273, P17780, DOI 10.1074/jbc.273.28.17780; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; PASHMFOROUSH M, 1994, J BIOL CHEM, V269, P32639; SCHAFFER L, 1992, BIOCHEM BIOPH RES CO, V189, P650, DOI 10.1016/0006-291X(92)92250-2; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; SHIER P, 1989, J BIOL CHEM, V264, P14605; Sparrow LG, 1997, J BIOL CHEM, V272, P29460, DOI 10.1074/jbc.272.47.29460; TAVARE JM, 1993, BIOCHIM BIOPHYS ACTA, V1178, P21, DOI 10.1016/0167-4889(93)90106-Y; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WARD CW, 1995, PROTEINS, V22, P141, DOI 10.1002/prot.340220207; WAUGH SM, 1989, BIOCHEMISTRY-US, V28, P2722, DOI 10.1021/bi00432a053; WEDEKIND F, 1989, BIOL CHEM H-S, V370, P251, DOI 10.1515/bchm3.1989.370.1.251; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; ZHANG B, 1991, BIOCHEMISTRY-US, V30, P5113, DOI 10.1021/bi00235a001; ZHANG B, 1992, J BIOL CHEM, V267, P18320	27	56	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37351	37356		10.1074/jbc.274.52.37351	http://dx.doi.org/10.1074/jbc.274.52.37351			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601304	hybrid			2022-12-27	WOS:000084382700075
J	Ray, WJ; Yao, M; Mumm, J; Schroeter, EH; Saftig, P; Wolfe, M; Selkoe, DJ; Kopan, R; Goate, AM				Ray, WJ; Yao, M; Mumm, J; Schroeter, EH; Saftig, P; Wolfe, M; Selkoe, DJ; Kopan, R; Goate, AM			Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of notch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; CAENORHABDITIS-ELEGANS; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; SEL-12 PRESENILIN; LOCALIZATION; EXPRESSION; BRAIN; DEFICIENCY; CLEAVAGE	Presenilin-1 (PS1), a polytopic membrane protein primarily localized to the endoplasmic reticulum, is required for efficient proteolysis of both Notch and beta-amyloid precursor protein (APP) within their transmembrane domains. The activity that cleaves APP (called gamma-secretase) has properties of an aspartyl protease, and mutation of either of the two aspartate residues located in adjacent transmembrane domains of PS1 inhibits gamma-secretase processing of APP. We show here that these aspartates are required for Notch processing, since mutation of these residues prevents PS1 from inducing the gamma-secretase-like proteolysis of a Notch1 derivative. Thus PSI might function in Notch cleavage as an aspartyl protease or di aspartyl protease cofactor. However, the ER localization of PSI is inconsistent with that hypothesis, since Notch cleavage occurs near the cell surface. Using pulse-chase and biotinylation assays, we provide evidence that PS1 binds Notch in the ER/Golgi and is then co-transported to the plasma membrane as a complex. PS1 aspartate mutants were indistinguishable from wild-type PS1 in their ability to bind Notch or traffic with it to the cell surface, and did not alter the secretion of Notch. Thus, PS1 appears to function specifically in Notch proteolysis near the plasma membrane as an aspartyl protease or cofactor.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Gottingen, Zentrum Biochem & Mol Zellbiol, Abt Biochem 2, D-37073 Gottingen, Germany; Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Gottingen; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Goate, AM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, Box 8134, St Louis, MO 63110 USA.		Kopan, Raphael/AAF-1357-2022; Kopan, Raphael/AFG-3275-2022; Mumm, Jeff S/F-3125-2013; Saftig, Paul/A-7966-2010; Ray, William J/E-9834-2016	Goate, Alison/0000-0002-0576-2472; Kopan, Raphael/0000-0002-0350-2730; Mumm, Jeff/0000-0002-2575-287X; Ray, William/0000-0002-4491-167X				ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Berezovska O, 1997, J NEUROPATH EXP NEUR, V56, P40, DOI 10.1097/00005072-199701000-00004; Berezovska O, 1998, J NEUROPATH EXP NEUR, V57, P738, DOI 10.1097/00005072-199808000-00003; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Capell A, 1997, J NEUROCHEM, V69, P2432; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Haass C, 1997, NEURON, V18, P687, DOI 10.1016/S0896-6273(00)80309-8; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lah JJ, 1997, J NEUROSCI, V17, P1971; Levitan D, 1998, DEVELOPMENT, V125, P3599; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Li XJ, 1997, P NATL ACAD SCI USA, V94, P12204, DOI 10.1073/pnas.94.22.12204; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schwarzman AL, 1999, P NATL ACAD SCI USA, V96, P7932, DOI 10.1073/pnas.96.14.7932; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takashima A, 1996, BIOCHEM BIOPH RES CO, V227, P423, DOI 10.1006/bbrc.1996.1523; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Ye YH, 1998, MECH DEVELOP, V79, P199, DOI 10.1016/S0925-4773(98)00169-5; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang WJ, 1998, J NEUROSCI, V18, P914	39	244	252	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36801	36807		10.1074/jbc.274.51.36801	http://dx.doi.org/10.1074/jbc.274.51.36801			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593990	hybrid			2022-12-27	WOS:000084279200109
J	Grundling, A; Blasi, U; Young, R				Grundling, A; Blasi, U; Young, R			Biochemical and genetic evidence for three transmembrane domains in the class I holin, lambda S	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; LYSIS; RESIDUES; TRANSLOCATION; MOTIF	lambda S, the prototype class I holin gene, encodes three potential transmembrane domains in its 107 codons, whereas 21 S, the class II prototype spans only 71 codons and encodes two transmembrane domains. Many holin genes, including lambda S and 21 S, have the "dual-start" regulatory motif at the N terminus, suggesting that class I and II holins have the same topology. The primary structure of 21 S strongly suggests a bitopic "helical-hairpin" topology, with N and C termini on the cytoplasmic side of the membrane. However, lambda S chimeras with an N-terminal signal sequence show Lep-dependent function, indicating that the N-terminal domain of S requires export. Here the signal sequence chimera is shown to be sensitive to the missense change A52V, which blocks normal S function. Moreover, cysteine-modification studies in isolated membranes using a collection of S variants with single-cysteine substitutions show that the positions in the core of the 3 putative transmembrane domains of lambda S are protected. Also, S proteins with single-cysteine substitutions in the predicted cytoplasmic and periplasmic loops are more efficiently labeled in inverted membrane vesicles and whole cells, respectively. These data constitute direct evidence that the holin S-lambda has three transmembrane domains and indicate that class I and class II holins have different topologies, despite regulatory and functional homology.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Univ Vienna, Vienna Bioctr, Inst Microbiol & Genet, A-1030 Vienna, Austria	Texas A&M University System; Texas A&M University College Station; University of Vienna; Vienna Biocenter (VBC)	Young, R (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.			Grundling, Angelika/0000-0002-6235-8687; Young, Ry/0000-0001-8001-2914	NIGMS NIH HHS [GM27099, R01 GM027099] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027099, R37GM027099] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barenboim M, 1999, MOL MICROBIOL, V32, P715, DOI 10.1046/j.1365-2958.1999.01385.x; Blasi U, 1996, MOL MICROBIOL, V21, P675, DOI 10.1046/j.1365-2958.1996.331395.x; Blasi U, 1999, J BACTERIOL, V181, P2922; BLASI U, 1990, EMBO J, V9, P981, DOI 10.1002/j.1460-2075.1990.tb08200.x; BLASI U, 1989, EMBO J, V8, P3501, DOI 10.1002/j.1460-2075.1989.tb08515.x; BONOVICH MT, 1991, J BACTERIOL, V173, P2897, DOI 10.1128/JB.173.9.2897-2905.1991; CAO GQ, 1995, EMBO J, V14, P866, DOI 10.1002/j.1460-2075.1995.tb07068.x; CHANG CY, 1993, GENE, V133, P9, DOI 10.1016/0378-1119(93)90218-R; CHANG CY, 1995, J BACTERIOL, V177, P3283, DOI 10.1128/jb.177.11.3283-3294.1995; CHANG CY, 1994, SYNTHESIS FUNCTION R; Delgado-Partin VM, 1998, J BIOL CHEM, V273, P9927, DOI 10.1074/jbc.273.16.9927; Fu DX, 1998, J BIOL CHEM, V273, P17962, DOI 10.1074/jbc.273.28.17962; Graschopf A, 1999, MOL MICROBIOL, V33, P569, DOI 10.1046/j.1365-2958.1999.01501.x; JOHNSONBOAZ R, 1994, MOL MICROBIOL, V13, P495, DOI 10.1111/j.1365-2958.1994.tb00444.x; KRISHNASASTRY M, 1994, FEBS LETT, V356, P66, DOI 10.1016/0014-5793(94)01240-7; LEE JI, 1992, J BIOL CHEM, V267, P938; Matos M, 1996, J BIOL CHEM, V271, P18571, DOI 10.1074/jbc.271.31.18571; OSBORN MJ, 1980, ANNU REV MICROBIOL, V34, P369, DOI 10.1146/annurev.mi.34.100180.002101; RAAB R, 1986, J BACTERIOL, V167, P1035, DOI 10.1128/jb.167.3.1035-1042.1986; RAAB R, 1988, J MOL BIOL, V199, P95, DOI 10.1016/0022-2836(88)90381-6; READER RW, 1971, VIROLOGY, V43, P607, DOI 10.1016/0042-6822(71)90286-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNAITMAN CA, 1971, J BACTERIOL, V108, P545, DOI 10.1128/JB.108.1.545-552.1971; Schuenemann TA, 1999, J BIOL CHEM, V274, P6855, DOI 10.1074/jbc.274.11.6855; Smith DL, 1998, GENE EXPRESSION, V7, P39; Smith DL, 1998, J BACTERIOL, V180, P4199, DOI 10.1128/JB.180.16.4199-4211.1998; Smith DL, 1998, J BACTERIOL, V180, P2531, DOI 10.1128/JB.180.9.2531-2540.1998; SMITH DL, 1998, PURIFICATION BIOCH C; STEINER M, 1993, MOL MICROBIOL, V8, P525, DOI 10.1111/j.1365-2958.1993.tb01597.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1990, PROTEIN ENG, V4, P109, DOI 10.1093/protein/4.2.109; WULFING C, 1994, J BIOL CHEM, V269, P2895; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4; YOUNG RY, 1992, MICROBIOL REV, V56, P430, DOI 10.1128/MMBR.56.3.430-481.1992; ZAGOTTA MT, 1990, J BACTERIOL, V172, P912, DOI 10.1128/jb.172.2.912-921.1990	35	67	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					769	776		10.1074/jbc.275.2.769	http://dx.doi.org/10.1074/jbc.275.2.769			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625606	hybrid			2022-12-27	WOS:000084836600010
J	McLarren, KW; Lo, R; Grbavec, D; Thirunavukkarasu, K; Karsenty, G; Stifani, S				McLarren, KW; Lo, R; Grbavec, D; Thirunavukkarasu, K; Karsenty, G; Stifani, S			The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the Runt-related factor Cbfa1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; GENE RUNT; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTIONAL REPRESSORS; DROSOPHILA SEGMENTATION; CLEIDOCRANIAL DYSPLASIA; CELL-DIFFERENTIATION; SEX DETERMINATION; OSTEOCALCIN GENE; EXPRESSION	Drosophila Runt is the founding member of a family of related transcription factors involved in the regulation of a variety of cell-differentiation events in invertebrates and vertebrates. Runt-related proteins act as both transactivators and transcriptional repressors, suggesting that context-dependent mechanisms modulate their transcriptional properties. The aim of this study was to elucidate the molecular mechanisms that contribute to the regulation of the functions of the mammalian Runt-related protein, Cbfa1. Here we provide the first demonstration that Cbfa1 (as well as the related protein, Cbfa2/AML1) physically interacts with the basic helix loop helix transcription factor, HES-1, a mammalian counterpart of the Drosophila Hairy and Enhancer of split proteins. This interaction is mediated by the carboxyl-terminal domains of Cbfa1 and HES-1, but does not require their respective tetrapeptide motifs, WRPY and WRPW. Our studies also show that HES-1 can antagonize the binding of Cbfa1 to mammalian transcriptional corepressors of the Groucho family. Moreover, HES-1 can potentiate Cbfa1-mediated transactivation in transfected cells. Taken together, these findings implicate HES-1 in the transcriptional functions of Cbfa1 and suggest that the concerted activities of Groucho and HES proteins modulate the functions of mammalian Hunt-related proteins.	McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA	McGill University; Baylor College of Medicine	Stifani, S (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.			Stifani, Stefano/0000-0002-2376-7701	NICHD NIH HHS [HD97006] Funding Source: Medline; NIDCR NIH HHS [DE11290] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011290] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; BAE SC, 1994, MOL CELL BIOL, V14, P3242, DOI 10.1128/MCB.14.5.3242; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; DUFFY JB, 1991, GENE DEV, V5, P2176, DOI 10.1101/gad.5.12a.2176; DUFFY JB, 1991, DEVELOPMENT, V113, P1223; FEDER JN, 1993, MOL CELL BIOL, V13, P105, DOI 10.1128/MCB.13.1.105; Grbavec D, 1999, BIOCHEM J, V337, P13, DOI 10.1042/0264-6021:3370013; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; HIMAI Y, 1998, BIOCHEM BIOPH RES CO, V252, P582; Husain J, 1996, BIOCHEM J, V317, P523, DOI 10.1042/bj3170523; ITO Y, 1996, J CANCER RES CLIN, V84, P321; Jen WC, 1999, GENE DEV, V13, P1486, DOI 10.1101/gad.13.11.1486; Jimenez G, 1996, EMBO J, V15, P7088, DOI 10.1002/j.1460-2075.1996.tb01100.x; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Koop KE, 1996, MECH DEVELOP, V59, P73, DOI 10.1016/0925-4773(96)00582-5; Kramer SG, 1999, DEVELOPMENT, V126, P191; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Matsue M, 1997, BONE, V20, P329, DOI 10.1016/S8756-3282(97)00005-7; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; SIMEONE A, 1995, DEV DYNAM, V203, P61, DOI 10.1002/aja.1002030107; Speck NA, 1995, CRIT REV EUKAR GENE, V5, P337, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.60; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; TSAI CC, 1995, DEVELOPMENT, V121, P453; TSAI CC, 1994, DEVELOPMENT, V120, P1671; Tsuji K, 1998, BONE, V22, P87, DOI 10.1016/S8756-3282(97)00267-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; YOUNGERSHEPHERD S, 1992, CELL, V70, P911, DOI 10.1016/0092-8674(92)90242-5	48	148	158	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					530	538		10.1074/jbc.275.1.530	http://dx.doi.org/10.1074/jbc.275.1.530			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617648	hybrid			2022-12-27	WOS:000085951600072
J	Akhmedov, AT; Gross, B; Jessberger, R				Akhmedov, AT; Gross, B; Jessberger, R			Mammalian SMC3 C-terminal and coiled-coil protein domains specifically bind palindromic DNA, do not block DNA ends, and prevent DNA bending	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; CHROMOSOME CONDENSATION; SACCHAROMYCES-CEREVISIAE; STRUCTURAL MAINTENANCE; MITOTIC CHROMOSOME; COMPLEX; SEGREGATION; FAMILY; RECOMBINATION; CONDENSINS	The C-terminal domains of yeast structural maintenance of chromosomes (SMC) proteins were previously shown to bind double-stranded DNA, which generated the idea of the antiparallel SMC heterodimer, such as the SMC1/3 dimer, bridging two DNA molecules. Analysis of bovine SMC1 and SMC3 protein domains now reveals that not only the C-terminal domains, but also the coiled-coil region, binds DNA, while the N terminus is inactive. Duplex DNA and DNA molecules with secondary structures are highly preferred substrates for both the C-terminal and coiled-coil domains. Contrasting other cruciform DNA-binding proteins hire HMG1, the SMC3 C-terminal and coiled-coil domains do not bend DNA, but rather prevent bending in ring closure assays. Phosphatase, exonuclease, and ligase assays showed that neither domain renders DNA ends inaccessible for other enzymes. These observations allow modifications of models for SMC-DNA interactions.	Basel Inst Immunol, CH-4002 Basel, Switzerland		Jessberger, R (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4002 Basel, Switzerland.							Akhmedov AT, 1998, J BIOL CHEM, V273, P24088, DOI 10.1074/jbc.273.37.24088; AMATI B, 1990, EMBO J, V9, P4007, DOI 10.1002/j.1460-2075.1990.tb07622.x; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Chuang PT, 1996, SCIENCE, V274, P1736, DOI 10.1126/science.274.5293.1736; Giese K, 1997, P NATL ACAD SCI USA, V94, P12845, DOI 10.1073/pnas.94.24.12845; Graumann PL, 1998, J BACTERIOL, V180, P5749, DOI 10.1128/JB.180.21.5749-5755.1998; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; HAGERMAN PJ, 1988, ANN REV BIOPHYS CHEM, V17, P266; Heck MMS, 1997, CELL, V91, P5, DOI 10.1016/S0092-8674(01)80002-7; Hirano T, 1998, CURR OPIN CELL BIOL, V10, P317, DOI 10.1016/S0955-0674(98)80006-9; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; JESSBERGER R, 1993, J BIOL CHEM, V268, P15070; Jessberger R, 1998, CURR OPIN GENET DEV, V8, P254, DOI 10.1016/S0959-437X(98)80149-4; Jessberger R, 1996, EMBO J, V15, P4061, DOI 10.1002/j.1460-2075.1996.tb00779.x; KAHN JD, 1992, P NATL ACAD SCI USA, V89, P6343, DOI 10.1073/pnas.89.14.6343; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; KOTLARZ D, 1986, EMBO J, V5, P799, DOI 10.1002/j.1460-2075.1986.tb04284.x; Kupfer C, 1996, EUR J BIOCHEM, V238, P77, DOI 10.1111/j.1432-1033.1996.0077q.x; Lieberman E, 1998, OBSTET GYNECOL, V92, P1; Lloyd RS, 1993, NUCLEASES, P263; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; LYUBCHENKO Y, 1991, P NATL ACAD SCI USA, V88, P5331, DOI 10.1073/pnas.88.12.5331; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; Stros M, 1998, J BIOL CHEM, V273, P10355; Strunnikov AV, 1999, EUR J BIOCHEM, V263, P6, DOI 10.1046/j.1432-1327.1999.00509.x; Strunnikov AV, 1998, TRENDS CELL BIOL, V8, P454, DOI 10.1016/S0962-8924(98)01370-1; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Stursberg S, 1999, GENE, V228, P1, DOI 10.1016/S0378-1119(99)00021-9; Sutani T, 1997, NATURE, V388, P798, DOI 10.1038/42062; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Zlatanova J, 1998, FASEB J, V12, P421, DOI 10.1096/fasebj.12.6.421	40	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38216	38224		10.1074/jbc.274.53.38216	http://dx.doi.org/10.1074/jbc.274.53.38216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608896	hybrid			2022-12-27	WOS:000084528000096
J	Fuentealba, L; Carey, DJ; Brandan, E				Fuentealba, L; Carey, DJ; Brandan, E			Antisense inhibition of syndecan-3 expression during skeletal muscle differentiation accelerates myogenesis through a basic fibroblast growth factor-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; LIMB CARTILAGE DIFFERENTIATION; MYOBLAST DIFFERENTIATION; FACTOR-BETA; N-SYNDECAN; TERMINAL DIFFERENTIATION; CELL-DIFFERENTIATION; PROLIFERATION; FAMILY; ACTIVATION	Syndecan-3 is a member of a family of transmembrane proteoglycans that posses highly homologous cytoplasmic and transmembrane domains and function as extracellular matrix receptors and low-affinity receptors for signaling molecules such as basic fibroblasts growth factor (FGF-2). Syndecan-3 is transiently expressed in developing limb bud and absent in adult skeletal muscle. In this study we investigated the expression of syndecan-3 and its role on FGF-2-dependent inhibition of myogenesis, Syndecan-3 expression was down-regulated during skeletal muscle differentiation of C2C12 myoblasts, as determined by Northern blot analyses and immunoprecipitation. To probe the function of syndecan-3 during myogenesis, C2C12 myoblasts were stably transfected with a plasmid coding for antisense syndecan-3 mRNA The resulting inhibition of syndecan-3 expression caused accelerated skeletal muscle differentiation, as determined by expression of creatine kinase and myosin and myoblast fusion. Expression of a master transcription factor for muscle differentiation, myogenin, was also accelerated in antisense syndecan-3-transfected myoblasts compared with control transfected and wild type cells. Reduced expression of syndecan-3 resulted in a 13-fold decrease in sensitivity to FGF-S-dependent inhibition of myogenin expression. Addition of heparin partially reversed this effect. These results demonstrate that syndecan-3 expression is down-regulated during differentiation and the level of expression of membrane-bound heparan sulfate on myoblast surface is critical for fine modulation of responsiveness to FGF-2. These findings strongly suggest a role for syndecan-3 in regulation of skeletal muscle terminal differentiation.	Catholic Univ Chile, Fac Biol Sci, Dept Cell & Mol Biol, Santiago, Chile; Penn State Coll Med, Sigfried & janet Weis Ctr Res, Henry Hood MD Res Program, Danville, PA 17822 USA	Pontificia Universidad Catolica de Chile; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Brandan, E (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Casilla 114-D, Santiago, Chile.		Brandan, Enrique/A-7063-2017	Brandan, Enrique/0000-0002-6820-5059	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021925] Funding Source: NIH RePORTER; FIC NIH HHS [TW 00093] Funding Source: Medline; NINDS NIH HHS [NS21925] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; BERNFIELD M, 1993, DEVELOPMENT, P205; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BISCHOFF R, 1986, DEV BIOL, V115, P140, DOI 10.1016/0012-1606(86)90235-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDAN E, 1991, EUR J CELL BIOL, V55, P209; BRANDAN E, 1992, J NEUROSCI RES, V32, P51, DOI 10.1002/jnr.490320107; Brandan E, 1998, BASIC APPL MYOL, V8, P107; Brandan E, 1996, EUR J CELL BIOL, V71, P170; BRUNETTI A, 1990, J BIOL CHEM, V265, P5960; CAMPOS A, 1993, EUR J BIOCHEM, V216, P587, DOI 10.1111/j.1432-1033.1993.tb18178.x; CAREY DJ, 1992, J CELL BIOL, V117, P191, DOI 10.1083/jcb.117.1.191; Carey DJ, 1997, J BIOL CHEM, V272, P2873, DOI 10.1074/jbc.272.5.2873; Carey DJ, 1997, BIOCHEM J, V327, P1; CHERNOUSOV MA, 1993, J BIOL CHEM, V268, P16810; Cossu G, 1996, TRENDS GENET, V12, P218, DOI 10.1016/0168-9525(96)10025-1; Dealy CN, 1997, DEV BIOL, V184, P343, DOI 10.1006/dbio.1997.8525; DICKSON G, 1990, NATURE, V344, P348, DOI 10.1038/344348a0; EWTON DZ, 1988, J BIOL CHEM, V263, P4029; FLORINI JR, 1986, J BIOL CHEM, V261, P6509; GOULD SE, 1995, DEV BIOL, V168, P438, DOI 10.1006/dbio.1995.1093; GOULD SE, 1992, P NATL ACAD SCI USA, V89, P3271, DOI 10.1073/pnas.89.8.3271; HU JS, 1990, J BIOL CHEM, V265, P7914; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Klagsbrun M, 1990, CURR OPIN CELL BIOL, V2, P857, DOI 10.1016/0955-0674(90)90084-R; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Larrain J, 1997, J BIOL CHEM, V272, P18418, DOI 10.1074/jbc.272.29.18418; Larrain J, 1998, J BIOL CHEM, V273, P32288, DOI 10.1074/jbc.273.48.32288; Larrain J, 1997, EXP CELL RES, V234, P405, DOI 10.1006/excr.1997.3648; Ludolph DC, 1995, FASEB J, V9, P1595, DOI 10.1096/fasebj.9.15.8529839; MEGE RM, 1992, J CELL SCI, V103, P897; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Nakanishi T, 1997, J BIOCHEM-TOKYO, V121, P197; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; OLWIN BB, 1992, J CELL BIOL, V118, P631, DOI 10.1083/jcb.118.3.631; PACIFICI M, 1980, EXP CELL RES, V126, P143, DOI 10.1016/0014-4827(80)90479-6; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; REYES AA, 1990, CELL REGUL, V1, P567, DOI 10.1091/mbc.1.8.567; Seghatoleslami MR, 1996, DEV DYNAM, V207, P114, DOI 10.1002/(SICI)1097-0177(199609)207:1<114::AID-AJA11>3.3.CO;2-7; Shimazu A, 1996, EXP CELL RES, V229, P126, DOI 10.1006/excr.1996.0350; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	44	66	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37876	37884		10.1074/jbc.274.53.37876	http://dx.doi.org/10.1074/jbc.274.53.37876			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608853	hybrid			2022-12-27	WOS:000084528000053
J	Inoue, SB; Qadota, H; Arisawa, M; Watanabe, T; Ohya, Y				Inoue, SB; Qadota, H; Arisawa, M; Watanabe, T; Ohya, Y			Prenylation of Rho1p is required for activation of yeast 1,3-beta-glucan synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; RAB GERANYLGERANYL TRANSFERASE; VACUOLAR H+-ATPASE; SACCHAROMYCES-CEREVISIAE; COMPONENT-A; 1,3-BETA-D-GLUCAN SYNTHASE; SCHIZOSACCHAROMYCES-POMBE; METAL REQUIREMENTS; CELL POLARIZATION; ESCORT PROTEIN	One of the essential protein substrates of geranylgeranyl transferase type I in the budding yeast Saccharomyces cerevisiae is a rho-type GTPase, Rho1p, which is a regulatory subunit of 1,3-beta-glucan synthase. Previous studies have indicated that modification of Rho1p is significantly reduced in a mutant of the beta subunit of geranylgeranyl transferase type I called cal1-1. Here we present genetic and biochemical evidence showing that modification of Rho1p is required for activity of 1,3-beta-glucan synthase. The 1,3-beta-glucan synthase activity of the cal1-1 membrane was significantly reduced compared with that of the wild-type membrane. The impaired activity was partly due to the reduced amount of Fks1p, a putative catalytic subunit of 1,3-beta-glucan synthase, but also partly due to reduced affinity between unmodified Rho1p and Fks1p. Glutathione S-transferase (GST)-Rho1 proteins with or without the C-terminal motif required for the modification were purified and used to analyze the interaction. The modified form of GST-Rho1p was specifically able to restore the 1,3-beta-glucan synthase of the rho1-3 membrane. Gel overlay analysis indicated that an unmodified form of GST-Rho1p fails to interact with Fks1p. These results indicated that the geranylgeranylation of Rho1p is a prerequisite to the assembly and activation of 1,3-beta-glucan synthase in vitro. Increased cytoplasmic levels of divalent cations such as Ca2+ restored both Rho1p modification and the 1,3-beta-glucan synthase activity of cal1-1, suggesting that cytoplasmic levels of the divalent cations affect geranylgeranyl transferase type I activity in vivo.	Univ Tokyo, Grad Sch Frontier, Dept Integrated Biosci, Bunkyo Ku, Tokyo 1130033, Japan; Nippon Roche Res Ctr, Dept Mycol, Kanagawa 2478530, Japan; Univ Tokyo, Fac Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, PRESTO, Unit Proc & Combined Circuit, Toyonaka, Osaka 5650082, Japan	University of Tokyo; Roche Holding; University of Tokyo; Japan Science & Technology Agency (JST)	Ohya, Y (corresponding author), Univ Tokyo, Grad Sch Frontier, Dept Integrated Biosci, Bunkyo Ku, Tokyo 1130033, Japan.	ohya@biol.s.u-tokyo.ac.jp						ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; Arellano M, 1996, EMBO J, V15, P4584, DOI 10.1002/j.1460-2075.1996.tb00836.x; Arellano M, 1998, MOL MICROBIOL, V29, P1357, DOI 10.1046/j.1365-2958.1998.01009.x; ARMSTRONG SA, 1995, J BIOL CHEM, V270, P7864, DOI 10.1074/jbc.270.14.7864; BENITOMORENO RM, 1994, CURR GENET, V27, P23, DOI 10.1007/BF00326574; Cabib E, 1998, ANNU REV BIOCHEM, V67, P307, DOI 10.1146/annurev.biochem.67.1.307; CAPLIN BE, 1994, BBA-PROTEIN STRUCT M, V1205, P39, DOI 10.1016/0167-4838(94)90089-2; Chang JH, 1998, MOL CELL BIOL, V18, P4986, DOI 10.1128/MCB.18.9.4986; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; FINEGOLD AA, 1991, P NATL ACAD SCI USA, V88, P4448, DOI 10.1073/pnas.88.10.4448; FUJIMURA K, 1994, J BIOL CHEM, V269, P9205; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; GOODMAN LE, 1988, YEAST, V4, P271, DOI 10.1002/yea.320040405; HALACHMI D, 1993, FEBS LETT, V316, P73, DOI 10.1016/0014-5793(93)81739-M; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; INOUE SB, 1995, EUR J BIOCHEM, V231, P845, DOI 10.1111/j.1432-1033.1995.tb20770.x; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; JIANG Y, 1994, P NATL ACAD SCI USA, V91, P4377, DOI 10.1073/pnas.91.10.4377; JIANG Y, 1993, NATURE, V366, P84, DOI 10.1038/366084a0; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Kondoh O, 1997, J BACTERIOL, V179, P7734, DOI 10.1128/jb.179.24.7734-7741.1997; MAYER ML, 1992, J BIOL CHEM, V267, P20589; Mazur P, 1996, J BIOL CHEM, V271, P14604, DOI 10.1074/jbc.271.24.14604; MOOMAW JF, 1992, J BIOL CHEM, V267, P17438; Moser NJ, 1996, MOL CELL BIOL, V16, P4824; Nagahashi S, 1997, MOL GEN GENET, V255, P372, DOI 10.1007/s004380050508; NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x; OHYA Y, 1984, MOL GEN GENET, V193, P389, DOI 10.1007/BF00382073; OHYA Y, 1986, J GEN MICROBIOL, V132, P979; Ohya Y, 1996, MOL GEN GENET, V252, P1, DOI 10.1007/BF02173199; OHYA Y, 1991, J BIOL CHEM, V266, P12356; OHYA Y, 1986, J BACTERIOL, V165, P28, DOI 10.1128/jb.165.1.28-33.1986; Okano H, 1998, J BIOL CHEM, V273, P26375, DOI 10.1074/jbc.273.41.26375; Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON MN, 1995, NATURE, V376, P702, DOI 10.1038/376702a0; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; YOKOYAMA K, 1995, BIOCHEMISTRY-US, V34, P1344, DOI 10.1021/bi00004a029; YOKOYAMA K, 1991, P NATL ACAD SCI USA, V88, P5302, DOI 10.1073/pnas.88.12.5302; YOKOYAMA K, 1993, J BIOL CHEM, V268, P4055	53	35	37	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38119	38124		10.1074/jbc.274.53.38119	http://dx.doi.org/10.1074/jbc.274.53.38119			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608882	hybrid			2022-12-27	WOS:000084528000082
J	Nagai, T; Kawabata, S; Shishikura, F; Sugita, H				Nagai, T; Kawabata, S; Shishikura, F; Sugita, H			Purification, characterization, and amino acid sequence of an embryonic lectin in perivitelline fluid of the horseshoe crab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSIDE-BINDING LECTIN; CDNA CLONING; SUPERFAMILY; PROTEINS	Hemagglutinating activity in perivitelline fluid of the horseshoe crab embryo dramatically increases during the third and fourth molt of the embryo. A 27-kDa lectin, which we named tachylectin-P (TL-P), was newly identified in perivitelline fluid of the horseshoe crab Tachypleus tridentatus, TL-P preferentially agglutinated human A-type erythrocytes, and the activity was inhibited by N-acetyl group-containing monosaccharides, The amino acid sequence analysis indicated that TL-P is almost structurally the same as a hemocyte-derived lectin with no hemagglutinating activity, tachylectin-1 (TL-1), and that 218 out of 221 amino acid residues in total were conserved between the two lectins. Despite the high sequence similarity, biological and biochemical characteristics of TL-P differed from those of TL-1: (i) unlike TL-1, TL-P agglutinates several animal-derived erythrocytes; (ii) unlike TL-1, TL-P has no significant affinity for bacterial lipopolysaccharides or antibacterial activity; (iii) Based on apparent molecular masses determined by gel filtration, TL-P forms a dimer in solution, while TL-1 is present as a monomer; (iv) and TL-P interacts with endogenous proteins of 13 and 14 kDa present in the perivitelline fluid; however, neither has any affinity for TL-I. We propose that TL-P may have an important role in completing embryonic development by interacting with endogenous glycoproteins or N-acetylhexosamines.	Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan; Nihon Univ, Sch Med, Dept Biol, Tokyo 1738610, Japan; Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan	Kyushu University; Nihon University; University of Tsukuba	Kawabata, S (corresponding author), Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan.							Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; HARKEY MA, 1995, DEV BIOL, V168, P549, DOI 10.1006/dbio.1995.1101; HIRABAYASHI J, 1987, J BIOCHEM-TOKYO, V101, P775, DOI 10.1093/jb/101.3.775; Huh CG, 1998, J BIOL CHEM, V273, P6565, DOI 10.1074/jbc.273.11.6565; Inamori K, 1999, J BIOL CHEM, V274, P3272, DOI 10.1074/jbc.274.6.3272; Iwanaga S, 1998, J BIOCHEM, V123, P1; Kamata H, 1997, J VOLCANOL GEOTH RES, V78, P51, DOI 10.1016/S0377-0273(97)00011-5; Killian CE, 1996, J BIOL CHEM, V271, P9150, DOI 10.1074/jbc.271.15.9150; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARRICK JW, 1993, ANTIMICROB AGENTS CH, V37, P2534, DOI 10.1128/AAC.37.12.2534; MIURA Y, 1994, J BIOL CHEM, V269, P542; Okino N, 1995, J BIOL CHEM, V270, P31008, DOI 10.1074/jbc.270.52.31008; Saito T, 1997, J BIOL CHEM, V272, P30703, DOI 10.1074/jbc.272.49.30703; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; SAKAKURA Y, 1990, J BIOL CHEM, V265, P21573; SEKIGUCHI K, 1973, Science Reports of the Tokyo Kyoiku Daigaku Section B, V15, P153; SEKIGUCHI K, 1988, BIOL HORSESHOE CRABS, P139; SHISHIKURA F, 1984, J BIOCHEM, V96, P629, DOI 10.1093/oxfordjournals.jbchem.a134878; SHISHIKURA F, 1984, J BIOCHEM, V96, P621, DOI 10.1093/oxfordjournals.jbchem.a134877; STONE KL, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P31; SUGITA H, 1979, DEV BIOL, V73, P183, DOI 10.1016/0012-1606(79)90062-9; Sugita H., 1988, BIOL HORSESHOE CRABS, P195; TAKEMOTO H, 1985, ANAL BIOCHEM, V145, P245, DOI 10.1016/0003-2697(85)90357-4; Tateno H, 1998, J BIOL CHEM, V273, P19190, DOI 10.1074/jbc.273.30.19190; TETTAMANTI G, 1968, ARCH BIOCHEM BIOPHYS, V124, P41, DOI 10.1016/0003-9861(68)90301-9	27	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37673	37678		10.1074/jbc.274.53.37673	http://dx.doi.org/10.1074/jbc.274.53.37673			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608824	hybrid			2022-12-27	WOS:000084528000024
J	Rao, VR; Corradetti, MN; Chen, JA; Peng, JR; Yuan, JY; Prestwich, GD; Brugge, JS				Rao, VR; Corradetti, MN; Chen, JA; Peng, JR; Yuan, JY; Prestwich, GD; Brugge, JS			Expression cloning of protein targets for 3-phosphorylated phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; GROWTH-FACTOR; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; 3-OH KINASE; INOSITOL POLYPHOSPHATE; HIGH-AFFINITY; ACTIVATION; BINDING	The phosphatidylinositol 3-kinase (PI 3'-K) family of lipid kinases play a critical role in cell proliferation, survival, vesicle trafficking, motility, cytoskeletal rearrangements, and oncogenesis. To identify downstream effecters of PI 3'-K, we developed a novel screen to isolate proteins that bind to the major products of PI 3'-K: phosphatidylinositol-3,4-bisphosphate (PtdIns-3,4-P-2) and PtdIns-3,4,5-trisphosphate (PtdIns-3,4,S-P-3). This screen uses synthetic biotinylated analogs of these lipids in conjunction with libraries of radiolabeled proteins that are produced by coupled in vitro transcription/translation reactions. The feasibility of the screen was initially demonstrated using avidin-coated beads prebound to biotinylated PtdIns-3,4-P-2 and PtdIns-3,4,5-P-3, to specifically isolate the pleckstrin homology domain of the serine/threonine kinase Akt. We then demonstrated the utility of this technique in isolating novel 3'-phosphorylated phosphatidylinositol (3'-PPI)-binding proteins through the preliminary screening of in. vitro transcribed/translated cDNAs fi om a small pool expression library derived from mouse spleen. Three proteins were isolated that bound specifically to 3'PPIs. Two of these proteins have been previously characterized as PIP3BP/p42(IP4) and the PtdIns-3,4,5-P-3-dependent serine/threonine kinase phosphoinositide-dependent kinase 1. The third protein is a novel protein that contains only a Src homology 2 domain and a pleckstrin homology domain; this protein has a higher specificity for both PtdIns-3,4,5-P-3 and PtdIns-3,4-P-2 than for PtdIns-4,5-bisphosphate. Transcripts of this novel gene are present in every tissue analyzed hut are most prominently expressed in spleen. We have renamed this new protein PRISH for 3'-phosphoinositide-interacting Src homology-containing protein. This report demonstrates the utility of this technique for isolating and characterizing 3'-PPI-binding proteins and has broad applicability for the isolation of binding domains for other Lipid products.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.				NCI NIH HHS [CA78773, CA27951] Funding Source: Medline; NINDS NIH HHS [NS29632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA027951, R01CA078773, R01CA027951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ausubel FM, 1998, CURRENT PROTOCOLS MO; Banfic H, 1998, J BIOL CHEM, V273, P13, DOI 10.1074/jbc.273.1.13; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Blader IJ, 1999, MOL BIOL CELL, V10, P581, DOI 10.1091/mbc.10.3.581; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Chen J, 1996, J ORG CHEM, V61, P6305, DOI 10.1021/jo960895r; Chen J, 1998, J ORG CHEM, V63, P6511, DOI 10.1021/jo980501r; Chen J, 1998, J ORG CHEM, V63, P430, DOI 10.1021/jo972046p; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Duronio V, 1998, CELL SIGNAL, V10, P233, DOI 10.1016/S0898-6568(97)00129-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Kivens WJ, 1998, MOL CELL BIOL, V18, P5291, DOI 10.1128/MCB.18.9.5291; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Kotelevets L, 1998, J BIOL CHEM, V273, P14138, DOI 10.1074/jbc.273.23.14138; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mehrotra B, 1997, J BIOL CHEM, V272, P4237, DOI 10.1074/jbc.272.7.4237; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nagel W, 1998, J BIOL CHEM, V273, P14853, DOI 10.1074/jbc.273.24.14853; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Prestwich GD, 1996, ACCOUNTS CHEM RES, V29, P503, DOI 10.1021/ar960136v; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Ren XD, 1998, CURR OPIN GENET DEV, V8, P63, DOI 10.1016/S0959-437X(98)80063-4; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rubnitz JE, 1998, J PEDIAT HEMATOL ONC, V20, P1, DOI 10.1097/00043426-199801000-00001; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shirai T, 1998, BBA-MOL CELL RES, V1402, P292, DOI 10.1016/S0167-4889(98)00014-7; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stricker R, 1997, FEBS LETT, V405, P229, DOI 10.1016/S0014-5793(97)00188-9; Tanaka K, 1999, J BIOL CHEM, V274, P3919, DOI 10.1074/jbc.274.7.3919; Tanaka K, 1997, EUR J BIOCHEM, V245, P512, DOI 10.1111/j.1432-1033.1997.00512.x; Thum O, 1996, TETRAHEDRON LETT, V37, P9017, DOI 10.1016/S0040-4039(96)02117-X; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Venkateswarlu K, 1999, BIOCHEM J, V340, P359, DOI 10.1042/0264-6021:3400359; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; WENNSTROM S, 1994, ONCOGENE, V9, P651; Woscholski R, 1997, TRENDS BIOCHEM SCI, V22, P427, DOI 10.1016/S0968-0004(97)01120-1; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zauli G, 1997, BLOOD, V89, P883, DOI 10.1182/blood.V89.3.883; Zhang J, 1998, J BIOL CHEM, V273, P14081, DOI 10.1074/jbc.273.23.14081; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756; ZHOU SY, 1995, TRENDS BIOCHEM SCI, V20, P470	72	57	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37893	37900		10.1074/jbc.274.53.37893	http://dx.doi.org/10.1074/jbc.274.53.37893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608855	hybrid, Green Published			2022-12-27	WOS:000084528000055
J	Schaaf, SG; Beck, J; Nassal, M				Schaaf, SG; Beck, J; Nassal, M			A small 2 '-OH- and base-dependent recognition element downstream of the initiation site in the RNA encapsidation signal is essential for hepatitis B virus replication initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-LOOP STRUCTURE; REVERSE-TRANSCRIPTASE; CRYSTAL-STRUCTURE; DNA-SYNTHESIS; ANGSTROM RESOLUTION; 2'-HYDROXYL GROUP; TYROSINE RESIDUE; PROTEIN; COMPLEX; SEQUENCE	Hepatitis B viruses replicate through reverse transcription of an RNA intermediate. In contrast to retroviral reverse transcriptases, their replication enzyme, P protein, does not use a nucleic acid primer but initiates DNA synthesis de novo from within an RNA stem-loop structure called epsilon. A short DNA oligonucleotide is copied from epsilon and covalently attached to P protein, and then synthesis is arrested. The information for initiation site selection and synthesis arrest must be contained in the structure of the P protein/epsilon complex. Because P protein activity depends on cellular chaperones this complex can as yet only be generated by in vitro translation of duck hepatitis B virus P protein in rabbit reticulocyte lysate; functional interaction with its cognate RNA element DE can be monitored by the covalent labeling of P protein during primer synthesis. Combining this in vitro priming reaction and a set of chimeric RNA-DNA DE analogues, we found that only five ribose residues in the 57-nucleotide stem-loop were sufficient to provide a functional template; these are a single residue in the template region and the two base pairs at the tip of the lower stem. The base identities in the very same region are essential as well. The presence of this 2'-OH- and base-dependent determinant shortly downstream of the initiation site suggests a mechanism that can account for both initiation site selection and programmed primer synthesis arrest.	Univ Hosp Freiburg, Dept Internal Med & Mol Biol 2, D-79106 Freiburg, Germany	University of Freiburg	Nassal, M (corresponding author), Univ Hosp Freiburg, Dept Internal Med & Mol Biol 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	nassal2@ukl.uni-freiburg.de	Nassal, Michael/U-4529-2019	Nassal, Michael/0000-0003-2204-9158; Beck, Jurgen/0000-0001-8794-9320				BAIDYA N, 1995, BIOCHEMISTRY-US, V34, P12363, DOI 10.1021/bi00038a033; BAN C, 1994, J MOL BIOL, V236, P275, DOI 10.1006/jmbi.1994.1134; BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Beck J, 1996, NUCLEIC ACIDS RES, V24, P4364, DOI 10.1093/nar/24.21.4364; Beck J, 1998, MOL CELL BIOL, V18, P6265, DOI 10.1128/MCB.18.11.6265; Beck J, 1997, J VIROL, V71, P4971, DOI 10.1128/JVI.71.7.4971-4980.1997; Beck J, 1997, VIROLOGY, V227, P500, DOI 10.1006/viro.1996.8329; BOHEN SP, 1995, SCIENCE, V268, P1303, DOI 10.1126/science.7761850; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Chen B, 1997, J MOL BIOL, V271, P311, DOI 10.1006/jmbi.1997.1185; EGLI M, 1993, BIOCHEMISTRY-US, V32, P3221, DOI 10.1021/bi00064a004; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Hu JM, 1997, EMBO J, V16, P59, DOI 10.1093/emboj/16.1.59; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JUNKERNIEPMANN M, 1990, EMBO J, V9, P3389, DOI 10.1002/j.1460-2075.1990.tb07540.x; KNAUS T, 1993, NUCLEIC ACIDS RES, V21, P3967, DOI 10.1093/nar/21.17.3967; LANFORD RE, 1995, J VIROL, V69, P4431, DOI 10.1128/JVI.69.7.4431-4439.1995; Nassal M, 1996, J VIROL, V70, P2764, DOI 10.1128/JVI.70.5.2764-2773.1996; Nassal M, 1996, J VIRAL HEPATITIS, V3, P217, DOI 10.1111/j.1365-2893.1996.tb00047.x; Nassal M, 1993, Trends Microbiol, V1, P221, DOI 10.1016/0966-842X(93)90136-F; Nassal M, 1999, INTERVIROLOGY, V42, P100, DOI 10.1159/000024970; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; POLLACK JR, 1993, J VIROL, V67, P3254, DOI 10.1128/JVI.67.6.3254-3263.1993; POLLACK JR, 1994, J VIROL, V68, P5579, DOI 10.1128/JVI.68.9.5579-5587.1994; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; RIEGER A, 1995, NUCLEIC ACIDS RES, V23, P3909, DOI 10.1093/nar/23.19.3909; Seeger C, 1997, TRENDS MICROBIOL, V5, P447, DOI 10.1016/S0966-842X(97)01141-4; STEITZ TA, 1993, RNA WORLD, P219; TAVIS JE, 1994, J VIROL, V68, P3536, DOI 10.1128/JVI.68.6.3536-3543.1994; USMAN N, 1992, NUCLEIC ACIDS RES, V20, P6695, DOI 10.1093/nar/20.24.6695; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; van den Worm SHE, 1998, NUCLEIC ACIDS RES, V26, P1345, DOI 10.1093/nar/26.5.1345; WANG GH, 1993, J VIROL, V67, P6507, DOI 10.1128/JVI.67.11.6507-6512.1993; WANG GH, 1994, J VIROL, V68, P8437, DOI 10.1128/JVI.68.12.8437-8442.1994; WANG GH, 1992, CELL, V71, P663, DOI 10.1016/0092-8674(92)90599-8; WEBER M, 1994, J VIROL, V68, P2994, DOI 10.1128/JVI.68.5.2994-2999.1994; WITHERELL GW, 1991, PROG NUCLEIC ACID RE, V40, P185; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994	42	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37787	37794		10.1074/jbc.274.53.37787	http://dx.doi.org/10.1074/jbc.274.53.37787			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608840	hybrid			2022-12-27	WOS:000084528000040
J	Chien, YT; Manna, AC; Projan, SJ; Cheung, AL				Chien, YT; Manna, AC; Projan, SJ; Cheung, AL			SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sar-dependent gene regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-A; LOCUS SAR; AGR; RNA; TRANSCRIPTION; EXPRESSION; TRANSDUCTION; PROMOTERS; SEQUENCE; SIGNAL	The expression of many virulence determinants in Staphylococcus aureus including alpha-hemolysin-, protein A-, and fibronectin-binding proteins is controlled by global regulatory loci such as sar and agr. In addition to controlling target gene expression via agr (e.g. alpha-hemolysin), the sar locus can also regulate target gene transcription via agr-independent mechanisms. In particular, we have found that SarA, the major regulatory protein encoded within sar, binds to a conserved sequence, homologous to the SarA-binding site on the agr promoter, upstream of the -35 promoter boxes of several target genes including hla (alpha-hemolysin gene), spa (protein A gene), fnb (fibronectin-binding protein genes), and sec (enterotoxin C gene). Deletion of the SarA recognition motif in the promoter regions of agr and hla in shuttle plasmids rendered the transcription of these genes undetectable in agr and hla mutants, respectively. Likewise, the transcription activity of spa (a gene normally repressed by sar), as measured by a XylE reporter fusion assay, became derepressed in a wild type strain containing a shuttle plasmid in which the SarA recognition site had been deleted from the spa promoter region. However, DNase I footprinting assays demonstrated that the SarA-binding region on the spa and hla promoter is more extensive than the predicted consensus sequence, thus raising the possibility that the consensus sequence is an activation site within a larger binding region. Because the sar and agr regulate an assortment of virulence factors in S. aureus, we propose, based on our data, a unifying hypothesis for virulence gene activation in S. aureus whereby SarA is a regulatory protein that binds to its consensus SarA recognition motif to activate (e.g. hla) or repress (e.g. spa) the transcription of sar target genes, thus accounting for both agr-dependent and agr-independent mode of regulation.	Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; Amer Cyanamid Co, Lederle Labs, Wyeth Ayerst Res, Pearl River, NY 10965 USA	Rockefeller University; Pfizer	Chien, YT (corresponding author), Dartmouth Coll, Sch Med, Dept Microbiol, Hanover, NH 03755 USA.				NIAID NIH HHS [AI37142, AI30061] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037142, R29AI030061] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bayer MG, 1996, J BACTERIOL, V178, P4563, DOI 10.1128/jb.178.15.4563-4570.1996; BOYCE JM, 1997, STAPHYLOCOCCI HUMAN, V12, P309; Chan PF, 1998, J BACTERIOL, V180, P6232; CHEUNG AL, 1994, J BACTERIOL, V176, P580, DOI 10.1128/jb.176.3.580-585.1994; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Cheung AL, 1997, J BACTERIOL, V179, P3963, DOI 10.1128/jb.179.12.3963-3971.1997; Cheung AL, 1997, INFECT IMMUN, V65, P2243, DOI 10.1128/IAI.65.6.2243-2249.1997; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; CHEUNG AL, 1994, ANAL BIOCHEM, V222, P511, DOI 10.1006/abio.1994.1528; CHEUNG AL, 1997, 37 ANN M ICAAC TOR S; Chien YT, 1998, MOL MICROBIOL, V30, P991, DOI 10.1046/j.1365-2958.1998.01126.x; Chien YT, 1998, J BIOL CHEM, V273, P2645, DOI 10.1074/jbc.273.5.2645; Deora R, 1997, J BACTERIOL, V179, P6355, DOI 10.1128/jb.179.20.6355-6359.1997; GASKILL ME, 1988, J BIOL CHEM, V263, P6276; GRAY GS, 1984, INFECT IMMUN, V46, P615, DOI 10.1128/IAI.46.2.615-618.1984; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kornblum J., 1990, MOL BIOL STAPHYLOCOC, P373; Manna AC, 1998, J BACTERIOL, V180, P3828, DOI 10.1128/JB.180.15.3828-3836.1998; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; PATEL AH, 1992, GENE, V114, P25, DOI 10.1016/0378-1119(92)90703-R; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; PROJAN SJ, 1997, MOL BASIS PATHOGENIC, V3, P55; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; SHUTTLEWORTH HL, 1987, GENE, V58, P283, DOI 10.1016/0378-1119(87)90383-0; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Wolz C, 1996, INFECT IMMUN, V64, P3142, DOI 10.1128/IAI.64.8.3142-3147.1996; ZUKOWSKI MM, 1983, P NATL ACAD SCI-BIOL, V80, P1101, DOI 10.1073/pnas.80.4.1101	33	183	192	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37169	37176		10.1074/jbc.274.52.37169	http://dx.doi.org/10.1074/jbc.274.52.37169			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601279	hybrid			2022-12-27	WOS:000084382700050
J	Goodman, SD; Kay, O				Goodman, SD; Kay, O			Replacement of integration host factor protein-induced DNA bending by flexible regions of DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; ESCHERICHIA-COLI; BACTERIOPHAGE-LAMBDA; IHF PROTEIN; HU PROTEIN; BINDING; FLEXIBILITY; SEQUENCES; COMPLEX; INCREASE	The Escherichia coli integration host factor (IHF) protein is required for site-specific recombination of bacteriophage A DNA. Previously, we had shown that alternative modules of static DNA curvature could partially replace IHF in recombination. Now we use regions of single-stranded DNA as a flexible tether to address whether the function of IHF in recombination is simply to reduce persistence length. Although we find that these modules clearly enhance recombination in the absence of IHF, they are not perfect replacements. In addition, evidence is presented that the efficacy of a flexibility swap is specific to a particular IHF site. This may indicate that additional functions beyond simple deformation of DNA are required of IHF. During the course of these experiments we discovered that these flexible sequences are still specific sites for IHF binding and function.	Univ So Calif, Sch Dent, Dept Basic Sci, Los Angeles, CA 90089 USA	University of Southern California	Goodman, SD (corresponding author), Univ So Calif, Sch Dent, Dept Basic Sci, 925 W 34th St, Los Angeles, CA 90089 USA.		Goodman, Steven/C-5732-2013		NIGMS NIH HHS [GM55392] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055392] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BHATTACHARYYA A, 1989, NUCLEIC ACIDS RES, V17, P6821, DOI 10.1093/nar/17.17.6821; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; CANN JR, 1989, J BIOL CHEM, V264, P17032; CASTAING B, 1995, J BIOL CHEM, V270, P10291, DOI 10.1074/jbc.270.17.10291; Chalmers R, 1998, CELL, V93, P897, DOI 10.1016/S0092-8674(00)81449-X; GARDNER JF, 1986, J MOL BIOL, V191, P181, DOI 10.1016/0022-2836(86)90255-X; GARTENBERG MR, 1991, J MOL BIOL, V219, P217, DOI 10.1016/0022-2836(91)90563-L; GILADI H, 1992, J MOL BIOL, V227, P985, DOI 10.1016/0022-2836(92)90514-K; Goodman SD, 1999, J BACTERIOL, V181, P3246, DOI 10.1128/JB.181.10.3246-3255.1999; GOODMAN SD, 1989, NATURE, V341, P251, DOI 10.1038/341251a0; GOODMAN SD, 1992, P NATL ACAD SCI USA, V89, P11910, DOI 10.1073/pnas.89.24.11910; Grove A, 1998, J MOL BIOL, V282, P731, DOI 10.1006/jmbi.1998.2058; HSU PL, 1984, NATURE, V311, P721, DOI 10.1038/311721a0; KAHN JD, 1994, NATURE, V368, P163, DOI 10.1038/368163a0; KIM SH, 1990, CELL, V63, P773, DOI 10.1016/0092-8674(90)90143-3; LUETKE KH, 1995, J MOL BIOL, V251, P493, DOI 10.1006/jmbi.1995.0451; Mills JB, 1999, J MOL BIOL, V285, P245, DOI 10.1006/jmbi.1998.2287; MILLS JB, 1994, BIOCHEMISTRY-US, V33, P1797, DOI 10.1021/bi00173a024; NASH HA, 1989, EMBO J, V8, P3523, DOI 10.1002/j.1460-2075.1989.tb08518.x; NUNESDUBY SE, 1995, J MOL BIOL, V253, P228, DOI 10.1006/jmbi.1995.0548; PATSEY RL, 1995, J MOL BIOL, V252, P47, DOI 10.1006/jmbi.1995.0474; RAMSTEIN J, 1988, P NATL ACAD SCI USA, V85, P7231, DOI 10.1073/pnas.85.19.7231; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rice PA, 1997, CURR OPIN STRUC BIOL, V7, P86, DOI 10.1016/S0959-440X(97)80011-5; RICHET E, 1988, CELL, V52, P9, DOI 10.1016/0092-8674(88)90526-0; Segall AM, 1996, GENES CELLS, V1, P453, DOI 10.1046/j.1365-2443.1996.d01-254.x; SEGALL AM, 1994, EMBO J, V13, P4536, DOI 10.1002/j.1460-2075.1994.tb06775.x; TRAVERS AA, 1990, CELL, V60, P177, DOI 10.1016/0092-8674(90)90729-X; Travers AA, 1991, CURR OPIN STRUC BIOL, V1, P114, DOI 10.1016/0959-440X(91)90019-P; Yang SW, 1995, EMBO J, V14, P6292, DOI 10.1002/j.1460-2075.1995.tb00319.x	30	7	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37004	37011		10.1074/jbc.274.52.37004	http://dx.doi.org/10.1074/jbc.274.52.37004			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601256	hybrid			2022-12-27	WOS:000084382700027
J	Fernandez-Salas, E; Sagar, M; Cheng, C; Yuspa, SH; Weinberg, WC				Fernandez-Salas, E; Sagar, M; Cheng, C; Yuspa, SH; Weinberg, WC			p53 and tumor necrosis factor alpha regulate the expression of a mitochondrial chloride channel protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-KERATINOCYTES; MOLECULAR-CLONING; INDUCED APOPTOSIS; SKIN-CANCER; CELL-LINES; P64; ONCOGENE; GROWTH; PROGRESSION; DATABASE	A novel chloride intracellular channel (CLIC) gene, clone mc3s5/mtCLIC, has been identified from differential display analysis of differentiating mouse keratinocytes from p53+/+ and p53-/- mice. The 4.2-kilobase pair cDNA contains an open reading frame of 762 base pairs encoding a 253-amino acid protein with two putative transmembrane domains. mc3s5/mtCLIC protein shares extensive homology with a family of intracellular organelle chloride channels but is the first shown to be differentially regulated. mc3s5/mtCLIC mRNA is expressed to the greatest extent in vivo in heart, lung, liver, kidney, and skin, with reduced levels in some organs from p53-/- mice, mc3s5/mtCLIC mRNA and protein are higher in p53+/+ compared with p53-/- basal keratinocytes in culture, and both increase in differentiating keratinocytes independent of genotype. Overexpression of p53 in keratinocytes induces mc3s5/mtCLIC mRNA and protein. Exogenous human recombinant tumor necrosis factor alpha also up-regulates mc3s5/mtCLIC mRNA and protein in keratinocytes, Subcellular fractionation of keratinocytes indicates that both the green fluorescent protein-mc3s5 fusion protein and the endogenous mc3s5/mtCLIC are localized to the cytoplasm and mitochondria. Similarly, mc3s5/mtCLIC was localized to mitochondria and cytoplasmic fractions of rat liver homogenates. Furthermore, mc3s5/mtCLIC colocalized with cytochrome oxidase in keratinocyte mitochondria by immunofluorescence and was also detected in the cytoplasmic compartment. Sucrose gradient-purified mitochondria from rat liver confirmed this mitochondrial localization. This represents the first report of localization of a CLIC type chloride channel in mitochondria and the first indication that expression of an organellular chloride channel can be regulated by p53 and tumor necrosis factor alpha.	NCI, Cellular Carcinogenesis & Tumor Promot Lab, NIH, Bethesda, MD 20892 USA; NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Fernandez-Salas, E (corresponding author), NCI, Cellular Carcinogenesis & Tumor Promot Lab, NIH, 37 Convent Dr,MSC 4255,Bldg 37,Rm 3B16, Bethesda, MD 20892 USA.		Weinberg, Wendy/A-8920-2009	Sagar, Manish/0000-0001-9803-6594				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azzoli CG, 1998, MOL CARCINOGEN, V21, P50, DOI 10.1002/(SICI)1098-2744(199801)21:1<50::AID-MC7>3.0.CO;2-T; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Cai ZZ, 1997, ONCOGENE, V15, P2817, DOI 10.1038/sj.onc.1201445; Chuang JZ, 1999, J NEUROSCI, V19, P2919; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; Donato NJ, 1998, J BIOL CHEM, V273, P5067, DOI 10.1074/jbc.273.9.5067; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; Edwards JC, 1998, J MEMBRANE BIOL, V163, P119; Edwards JC, 1999, AM J PHYSIOL-RENAL, V276, pF398, DOI 10.1152/ajprenal.1999.276.3.F398; GORDON HM, 1992, J IMMUNOL, V148, P4021; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; Heiss NS, 1997, GENOMICS, V45, P224, DOI 10.1006/geno.1997.4922; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Jentsch TJ, 1997, BIOESSAYS, V19, P117, DOI 10.1002/bies.950190206; Katayose D, 1995, CLIN CANCER RES, V1, P889; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KOZAK M, 1980, CELL, V22, P7, DOI 10.1016/0092-8674(80)90148-8; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDRY D, 1993, J BIOL CHEM, V268, P14948; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Qian ZJ, 1999, J BIOL CHEM, V274, P1621, DOI 10.1074/jbc.274.3.1621; Redhead C, 1997, MOL BIOL CELL, V8, P691, DOI 10.1091/mbc.8.4.691; Rickwood D., 1997, SUBCELLULAR FRACTION, P71; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; SELIVANOVA G, 1995, ADV CANCER RES, V66, P143, DOI 10.1016/S0065-230X(08)60253-5; STRICKLAND JE, 1988, CANCER RES, V48, P165; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; TULK BM, 1998, AM J PHYSIOL, V274, pF1140; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; WEINBERG WC, 1995, ONCOGENE, V10, P2271; WEINBERG WC, 1994, CANCER RES, V54, P5584; WU HY, 1994, J BIOL CHEM, V269, P20067; Yeung MC, 1998, J BIOL CHEM, V273, P25198, DOI 10.1074/jbc.273.39.25198; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	44	116	121	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36488	36497		10.1074/jbc.274.51.36488	http://dx.doi.org/10.1074/jbc.274.51.36488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593946	hybrid			2022-12-27	WOS:000084279200065
J	Yu, CJ; Chen, J; Lin, S; Liu, J; Chang, CCY; Chang, TY				Yu, CJ; Chen, J; Lin, S; Liu, J; Chang, CCY; Chang, TY			Human acyl-CoA : cholesterol acyltransferase-1 is a homotetrameric enzyme in intact cells and in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HAMSTER OVARY CELLS; COENZYME-A; RADIATION INACTIVATION; COOPERATIVITY; PATHWAY; LIVER; SIZE; PHOSPHATIDYLSERINE; CHROMATOGRAPHY	Acyl-CoA:cholesterol acyltransferase (ACAT) is a key enzyme in cellular cholesterol homeostasis and in atherosclerosis. ACAT-1 may function as an allosteric enzyme, We took a multifaceted approach to investigate the subunit composition of ACAT-1, When ACAT-1 with two different tags were co-expressed in the same Chinese hamster ovary cells, antibody specific to one tag caused co-immunoprecipitation of both types of ACAT-1 proteins. Radioimmunoprecipitations of cells expressing the untagged ACAT-1 or the 6-histidine-tagged ACAT-1 yielded a single radiolabeled band of predicted size on SDS-polyacrylamide gel electrophoresis. These results show that ACAT-1 exists as homo-oligomers in intact Chinese hamster ovary cells. We solubilized HisACAT-1 with the detergent deoxycholate or CHAPS (3-[(3-cholamidopropyl)-dimethylammoniol]-1-propane-sulfonic acid), performed gel filtration chromatography and sucrose density gradient centrifugations in H2O and D2O, and determined the Stokes radii and sedimentation coefficients of the HisACAT1-detergent complexes, The estimated molecular mass of HisACAT-1 is 263 kDa, which is 4 times that of the HisACAT-1 monomer (69 kDa), Finally, cross-linking experiments in intact cells and in vitro show that the increase in cross-linker concentrations causes an increase in size of the HisACAT-1-positive signals, forming material(s) 4 times the size of the monomer, supporting the conclusion that ACAT-I is a homotetrameric enzyme.	Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Chang, TY (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	ta.yuan.chang@dartmouth.edu	Yu, Chunjiang/E-9419-2012	Liu, Jay/0000-0002-4230-1843; Chang, Ta-Yuan/0000-0002-3249-0468	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060306] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 60306] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; BILLHEIMER JT, 1990, J BIOL CHEM, V265, P8632; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CADIGAN KM, 1990, J CELL BIOL, V110, P295, DOI 10.1083/jcb.110.2.295; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; CHANG CCY, 1986, BIOCHEMISTRY-US, V25, P1693, DOI 10.1021/bi00355a038; Chang CCY, 1998, J BIOL CHEM, V273, P35132, DOI 10.1074/jbc.273.52.35132; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; CLARKE S, 1989, METHOD ENZYMOL, V172, P696; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; ERICKSON SK, 1994, J LIPID RES, V35, P763; FORSEN S, 1995, TRENDS BIOCHEM SCI, V20, P495, DOI 10.1016/S0968-0004(00)89115-X; GODAR DE, 1988, BIOCHEMISTRY-US, V22, P2181; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HJELMELAND LM, 1983, ANAL BIOCHEM, V130, P72, DOI 10.1016/0003-2697(83)90651-6; Kawasaki T, 1998, BIOCHEM BIOPH RES CO, V244, P347, DOI 10.1006/bbrc.1998.8268; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Lee O, 1998, J LIPID RES, V39, P1722; LEMAIRE M, 1986, ANAL BIOCHEM, V154, P525, DOI 10.1016/0003-2697(86)90025-4; Li BL, 1999, J BIOL CHEM, V274, P11060, DOI 10.1074/jbc.274.16.11060; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; MCMEEKIN TL, 1952, SCIENCE, V116, P142, DOI 10.1126/science.116.3006.142; MEUNIER JC, 1972, FEBS LETT, V24, P63, DOI 10.1016/0014-5793(72)80827-5; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; OBRIEN RD, 1978, ANAL BIOCHEM, V86, P602, DOI 10.1016/0003-2697(78)90788-1; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4667, DOI 10.1021/bi00134a019; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4661, DOI 10.1021/bi00134a018; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; POTSCHKA M, 1987, ANAL BIOCHEM, V162, P47, DOI 10.1016/0003-2697(87)90009-1; SOBER HA, 1968, HDB BIOCH, pC20; TABAS I, 1995, CURR OPIN LIPIDOL, V6, P260, DOI 10.1097/00041433-199510000-00004; TANFORD C, 1974, BIOCHEMISTRY-US, V13, P2369, DOI 10.1021/bi00708a021; WILSON MD, 1994, J LIPID RES, V35, P943	39	63	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36139	36145		10.1074/jbc.274.51.36139	http://dx.doi.org/10.1074/jbc.274.51.36139			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593897	hybrid			2022-12-27	WOS:000084279200016
J	Willoughby, DA; Vilalta, A; Oshima, RG				Willoughby, DA; Vilalta, A; Oshima, RG			An Alu element from the K18 gene confers position-independent expression in transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN KERATIN-18 GENE; ACID RESPONSE ELEMENT; TRANSCRIPTIONAL INTERFERENCE; PROMOTER ELEMENTS; DOMAIN BOUNDARIES; NUCLEAR MATRIX; GLOBIN GENE; HETEROCHROMATIN; DROSOPHILA; SEQUENCE	We have identified a 323-base pair fragment of the 5'-flanking sequence of the K18 gene, which confers position-independent and copy number-dependent expression on two heterologous transgenes. This fragment is composed primarily of an Alu repetitive element. Its activity in mice is correlated with its RNA polymerase III promoter activity and its orientation-dependent ability to inhibit potential transcriptional interference in a transfection assay. However, the activity of the Alu element is not correlated with its enhancer blocking activity, a characteristic of insulator elements. In addition, this Alu element did not block the suppressive effect of co-injecting mouse or satellite DNA with the transgene. This Alu element is likely responsible for at least part of the protective effects of the sequences flanking the K18. These results suggest that transcriptionally active Alu elements may eliminate transcriptional interference of neighboring genes. This Alu element is one component of the locus control region associated with the K18 gene. Other Alu repetitive elements may also function to define regulatory domains.	Burnham Inst, La Jolla Canc Res Ctr, La Jolla, CA 92037 USA; Univ So Calif, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Southern California	Oshima, RG (corresponding author), Burnham Inst, La Jolla Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL CANCER INSTITUTE [P30CA030199, R01CA042302, F32CA069823] Funding Source: NIH RePORTER; NCI NIH HHS [CA30199, F32 CA69823, CA42302] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE M, 1990, J CELL BIOL, V111, P1197, DOI 10.1083/jcb.111.3.1197; ALSHAWI R, 1990, MOL CELL BIOL, V10, P1192, DOI 10.1128/MCB.10.3.1192; Bell AC, 1999, CURR OPIN GENET DEV, V9, P191, DOI 10.1016/S0959-437X(99)80029-X; BRITTEN RJ, 1994, P NATL ACAD SCI USA, V91, P6148, DOI 10.1073/pnas.91.13.6148; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; DINGERMANN T, 1981, NUCLEIC ACIDS RES, V9, P3907, DOI 10.1093/nar/9.16.3907; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; EMERMAN M, 1984, CELL, V39, P459, DOI 10.1016/0092-8674(84)90453-7; ENGLANDER EW, 1995, J BIOL CHEM, V270, P10091, DOI 10.1074/jbc.270.17.10091; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; GALANG CK, 1994, ONCOGENE, V9, P2913; Geyer PK, 1997, CURR OPIN GENET DEV, V7, P242, DOI 10.1016/S0959-437X(97)80134-7; GUNTHER M, 1995, MOL CELL BIOL, V15, P2490; ICHINOSE Y, 1988, GENE, V70, P85, DOI 10.1016/0378-1119(88)90107-2; JUDD BH, 1955, GENETICS, V40, P739; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Mihaly J, 1998, CELL MOL LIFE SCI, V54, P60, DOI 10.1007/s000180050125; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Milot E, 1996, TRENDS GENET, V12, P123, DOI 10.1016/0168-9525(96)30019-X; NEZNANOV N, 1993, MOL CELL BIOL, V13, P2214, DOI 10.1128/MCB.13.4.2214; Neznanov N, 1996, MOL BIOL CELL, V7, P541, DOI 10.1091/mbc.7.4.541; NEZNANOV NS, 1993, MOL CELL BIOL, V13, P1815, DOI 10.1128/MCB.13.3.1815; OCONNOR KL, 1994, BIOTECHNIQUES, V17, P502; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; PANKOV R, 1994, P NATL ACAD SCI USA, V91, P873, DOI 10.1073/pnas.91.3.873; PEREZSTABLE C, 1986, MOL CELL BIOL, V6, P2041, DOI 10.1128/MCB.6.6.2041; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; RADIC MZ, 1987, CELL, V50, P1101, DOI 10.1016/0092-8674(87)90176-0; Rees S, 1996, BIOTECHNIQUES, V20, P102; Rhodes K, 1998, J BIOL CHEM, V273, P26534, DOI 10.1074/jbc.273.41.26534; ROBINSON SI, 1982, CELL, V28, P99, DOI 10.1016/0092-8674(82)90379-8; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Sambrook J., 2002, MOL CLONING LAB MANU; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOREY IS, 1993, MOL CELL BIOL, V13, P6742, DOI 10.1128/MCB.13.11.6742; VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; WILLOUGHBY DA, 1992, EXP NEUROL, V118, P332, DOI 10.1016/0014-4886(92)90191-R; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; WU J, 1990, MOL CELL BIOL, V10, P1209, DOI 10.1128/MCB.10.3.1209; Yang BS, 1996, MOL CELL BIOL, V16, P538; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219	50	57	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					759	768		10.1074/jbc.275.2.759	http://dx.doi.org/10.1074/jbc.275.2.759			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625605	hybrid			2022-12-27	WOS:000084836600009
J	Bridges, KG; Hua, QX; Brigham-Burke, MR; Martin, JD; Hensley, P; Dahl, CE; Digard, P; Weiss, MA; Coen, DM				Bridges, KG; Hua, QX; Brigham-Burke, MR; Martin, JD; Hensley, P; Dahl, CE; Digard, P; Weiss, MA; Coen, DM			Secondary structure and structure-activity relationships of peptides corresponding to the subunit interface of herpes simplex virus DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINUS; TRANSACTIVATION DOMAIN; TYPE-1; PROTEIN; UL42; PROCESSIVITY; SPECTROSCOPY; REPLICATION; ASSIGNMENT; COUPLINGS	The interaction of the catalytic subunit of herpes simplex virus DNA polymerase with the processivity subunit, UL42, is essential for viral replication and is thus a potential target for antiviral drug discovery. We have previously reported that a peptide analogous to the C-terminal 36 residues of the catalytic subunit, which are necessary and sufficient for its interaction with UL42, forms a monomeric structure with partial alpha-helical character. This peptide and one analogous to the C-terminal 18 residues specifically inhibit UL42-dependent long chain DNA synthesis. Using multidimensional H-1 nuclear magnetic resonance spectroscopy, we have found that the 36-residue peptide contains partially ordered N- and C-terminal alpha-helices separated by a less ordered region. A series of "alanine scan" peptides derived from the C-terminal 18 residues of the catalytic subunit were tested for their ability to inhibit long-chain DNA synthesis and by circular dichroism for secondary structure. The results identify structural aspects and specific side chains that appear to be crucial for interacting with UL42. These findings may aid in the rational design of new drugs for the treatment of herpesvirus infections.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Chicago, Ctr Mol Oncol, Dept Biochem, Chicago, IL 60639 USA; Univ Chicago, Ctr Mol Oncol, Dept Mol Biol, Chicago, IL 60639 USA; Univ Chicago, Ctr Mol Oncol, Dept Chem, Chicago, IL 60639 USA; SmithKline Beecham Pharmaceut, Dept Biol Struct, King Of Prussia, PA 19406 USA; SmithKline Beecham Pharmaceut, Dept Prot Biochem, King Of Prussia, PA 19406 USA	Harvard University; Harvard Medical School; University of Chicago; University of Chicago; University of Chicago; GlaxoSmithKline; GlaxoSmithKline	Coen, DM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.		Digard, Paul/B-7717-2008	Digard, Paul/0000-0002-0872-9440	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI026077, U01AI026077, R21AI126077, R01AI019838, F32AI010111, R01AI026077, R56AI019838] Funding Source: NIH RePORTER; NIAID NIH HHS [AI19838, AI10111, AI26077] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DIGARD P, 1993, J VIROL, V67, P1159, DOI 10.1128/JVI.67.3.1159-1168.1993; DIGARD P, 1995, P NATL ACAD SCI USA, V92, P1456, DOI 10.1073/pnas.92.5.1456; DIGARD P, 1993, J VIROL, V67, P398, DOI 10.1128/JVI.67.1.398-406.1993; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; HAMATAKE RK, 1993, J GEN VIROL, V74, P2181, DOI 10.1099/0022-1317-74-10-2181; Hensley P, 1996, STRUCTURE, V4, P367, DOI 10.1016/S0969-2126(96)00042-1; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; KIM YM, 1989, J MAGN RESON, V84, P9, DOI 10.1016/0022-2364(89)90003-6; Loregian A, 1996, PROTEIN EXPRES PURIF, V8, P381, DOI 10.1006/prep.1996.0114; MARCHETTI ME, 1988, J VIROL, V62, P715, DOI 10.1128/JVI.62.3.715-721.1988; MARCY AI, 1990, NUCLEIC ACIDS RES, V18, P1207, DOI 10.1093/nar/18.5.1207; MARSDEN HS, 1994, J GEN VIROL, V75, P3127, DOI 10.1099/0022-1317-75-11-3127; OSCHKINAT H, 1991, BIOPOLYMERS, V31, P699, DOI 10.1002/bip.360310615; OSHEA EK, 1989, SCIENCE, V243, P238; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; STOW ND, 1993, NUCLEIC ACIDS RES, V21, P87, DOI 10.1093/nar/21.1.87; TENNEY DJ, 1993, J VIROL, V67, P543, DOI 10.1128/JVI.67.1.543-547.1993; Tolman JR, 1996, J MAGN RESON SER B, V112, P245, DOI 10.1006/jmrb.1996.0138; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988; Wuthrich K, 1986, NMR PROTEINS NUCL AC	22	23	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					472	478		10.1074/jbc.275.1.472	http://dx.doi.org/10.1074/jbc.275.1.472			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617641	hybrid			2022-12-27	WOS:000085951600065
J	Dwivedi, PP; Omdahl, JL; Kola, I; Hume, DK; May, BK				Dwivedi, PP; Omdahl, JL; Kola, I; Hume, DK; May, BK			Regulation of rat cytochrome P450C24 (CYP24) gene expression - Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D-3-mediated induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; D-RESPONSIVE ELEMENTS; GM-CSF PROMOTER; 24-HYDROXYLASE GENE; PHORBOL ESTER; CORE PROMOTER; CELLS; IDENTIFICATION; BINDING; D-3	Transcription of the rat CYP24 gene is induced by 1,25-dihydroxyvitamin D-3 (1,25-(OH)(2)D-3) through two vitamin D response elements (VDREs), A functional Ras-dependent Ets-binding site (EBS) was located downstream from the proximal VDRE and was critical to 1,25(OH)(2)D-3-mediated induction. Cotransfection of Ets-1 and Ets-2 stimulated induction, which was lost when the EBS was mutated. Multiple nuclear-protein complexes from COS-1 cells bound to the EBS in which three complexes were immunologically related to Ets-1. Transcriptional synergy was observed between the proximal VDRE and adjacent EBS as was the attendant formation of a ternary complex between vitamin D receptor- retinoid X receptor (VDR.RXR) and Ets-1. In the absence of 1,25-(OH)(2)D-3 or in the presence of an inactive proximal VDRE, the EBS failed to respond to exogenous Ets-1. However, Ets-1 increased basal expression when cotransfected with a mutant VDR. The inductive action of 1,25-(OH)(2)D-3 was substantially increased by Ras, which was ablated by mutagenesis of the EBS or by expression of a mutated Ets-1 protein (T38A). EBS contribution to hormone induction was prevented by manumycin A, an inhibitor of Ras farnesylation. A fundamental role was established for transcriptional cooperation between Ras-activated Ets proteins and the VDR.RXR complex in mediating 1,25-(OH)(2)D-3 action on the CYP24 promoter.	Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; Univ Adelaide, Dept Biochem, Adelaide, SA 5005, Australia; Monash Univ, Inst Reprod & Dev, Mol Genet & Dev Grp, Melbourne, Vic 3168, Australia; Univ Queensland, Ctr Cellular & Mol Biol, St Lucia, Qld 4072, Australia	University of New Mexico; University of Adelaide; Monash University; University of Queensland	Omdahl, JL (corresponding author), Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA.		Kola, Ismail/C-5254-2013	Hume, David/0000-0002-2615-1478				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Berry DM, 1996, J BIOL CHEM, V271, P16090, DOI 10.1074/jbc.271.27.16090; BOYAN BD, 1997, VITAMIN D, P259; Bradford AP, 1997, MOL CELL BIOL, V17, P1065, DOI 10.1128/MCB.17.3.1065; CARLBERG C, 1995, EUR J BIOCHEM, V231, P517, DOI 10.1111/j.1432-1033.1995.0517d.x; CHEN KS, 1995, BBA-GENE STRUCT EXPR, V1263, P1, DOI 10.1016/0167-4781(95)00060-T; CHEN ML, 1993, ENDOCRINOLOGY, V132, P1782, DOI 10.1210/en.132.4.1782; Christakos S, 1996, BIOCHEM J, V316, P361, DOI 10.1042/bj3160361; CREPIEUX P, 1994, CRIT REV ONCOGENESIS, V5, P615; Dittmer J, 1997, J BIOL CHEM, V272, P4953, DOI 10.1074/jbc.272.8.4953; Dwivedi PP, 1998, J MOL ENDOCRINOL, V20, P327, DOI 10.1677/jme.0.0200327; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; GEGONNE A, 1993, EMBO J, V12, P1169, DOI 10.1002/j.1460-2075.1993.tb05758.x; GHYSDAEL J, 1986, P NATL ACAD SCI USA, V83, P1714, DOI 10.1073/pnas.83.6.1714; Graves BJ, 1998, SCIENCE, V279, P1000, DOI 10.1126/science.279.5353.1000; HAHN CN, 1994, NUCLEIC ACIDS RES, V22, P2410, DOI 10.1093/nar/22.12.2410; Halle JP, 1997, MOL CELL BIOL, V17, P4220, DOI 10.1128/MCB.17.8.4220; Haussler M. R., 1997, Vitamin D., P149; Hewison M., 1997, Vitamin D., P447; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; Ishiguro H, 1998, J BIOL CHEM, V273, P21941, DOI 10.1074/jbc.273.34.21941; Issa LL, 1998, INFLAMM RES, V47, P451, DOI 10.1007/s000110050360; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kerry DM, 1996, J BIOL CHEM, V271, P29715, DOI 10.1074/jbc.271.47.29715; KOIZUMI S, 1990, ONCOGENE, V5, P675; KOLA I, 1993, P NATL ACAD SCI USA, V90, P7588, DOI 10.1073/pnas.90.16.7588; KOYAMA H, 1994, J CELL BIOCHEM, V55, P230, DOI 10.1002/jcb.240550210; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; LIU M, 1994, MOL ENDOCRINOL, V8, P1593, DOI 10.1210/me.8.12.1593; Logan SK, 1996, J BIOL CHEM, V271, P774, DOI 10.1074/jbc.271.2.774; MANDLA S, 1990, ENDOCRINOLOGY, V127, P2639, DOI 10.1210/endo-127-6-2639; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; MITSUNOBU H, 1993, P NATL ACAD SCI USA, V90, P2281; Nemere I, 1998, J BONE MINER RES, V13, P1353, DOI 10.1359/jbmr.1998.13.9.1353; Norman A. W., 1997, Vitamin D., P233; Norman AW, 1998, J BONE MINER RES, V13, P1360, DOI 10.1359/jbmr.1998.13.9.1360; Ohyama Y, 1996, J BIOL CHEM, V271, P30381, DOI 10.1074/jbc.271.48.30381; Omdahl J., 1997, Vitamin D., P69; PETERSON JM, 1996, SCIENCE, V269, P1866; REDDY GS, 1989, BIOCHEMISTRY-US, V28, P1763, DOI 10.1021/bi00430a051; Schwachtgen JL, 1997, ONCOGENE, V15, P3091, DOI 10.1038/sj.onc.1201502; SLATER SJ, 1995, J BIOL CHEM, V270, P6639, DOI 10.1074/jbc.270.12.6639; Solomon C, 1998, J BIOL CHEM, V273, P17573, DOI 10.1074/jbc.273.28.17573; StArnaud R, 1997, J BONE MINER RES, V12, P1552, DOI 10.1359/jbmr.1997.12.10.1552; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Thomas RS, 1997, ONCOGENE, V14, P2845, DOI 10.1038/sj.onc.1201125; THOMAS RS, 1995, ONCOGENE, V11, P2135; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675	62	65	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					47	55		10.1074/jbc.275.1.47	http://dx.doi.org/10.1074/jbc.275.1.47			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617584	hybrid			2022-12-27	WOS:000085951600008
J	Knight, CG; Morton, LF; Peachey, AR; Tuckwell, DS; Farndale, RW; Barnes, MJ				Knight, CG; Morton, LF; Peachey, AR; Tuckwell, DS; Farndale, RW; Barnes, MJ			The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-DOMAIN; PLATELET-ADHESION; LIGAND-BINDING; ALPHA-2-BETA-1 VLA-2; CELL-ADHESION; SITE; ALPHA-1; IDENTIFICATION; CD49B/CD29; RECEPTOR	We have previously assigned an integrin alpha(2)beta(1)-recognition site in collagen I to the sequence, GFOGERGVEG-POGPA (O = Hyp), corresponding to residues 502-516 of the alpha(1)(I) chain and located in the fragment alpha(I)(I)CB3 (Knight, C. G., Morton, L. F., Onley, D. J., Peachey, A. R., Messent, A. J., Smethurst, P. A., Tuckwell, D. S., Farndale, R. W., and Barnes, M. J. (1998) J. Biol. Chem. 273, 33287-33294). In this study, we show that recognition is entirely contained within the six-residue sequence GFOGER. This sequence, when in triple-helical conformation, readily supports alpha(2)beta(1)-dependent cell adhesion and exhibits divalent cation-dependent binding of isolated alpha(2)beta(1) and recombinant alpha(2) A-domain, being at least as active as the parent collagen. Replacement of E by D causes loss of recognition. The same sequence binds integrin alpha(2) A-domain and supports integrin alpha(1)beta(1)-mediated cell adhesion. Triple-helical GFOGER completely inhibits alpha(2) A-domain binding to collagens I and IV and alpha(2)beta(1)-dependent adhesion of platelets and HT 1080 cells to these collagens. It also fully inhibits alpha(1) A-domain binding to collagen I and strongly inhibits alpha(1)beta(1)-mediated adhesion of Rugli cells to this collagen but has little effect on either alpha 1 A-domain binding or adhesion of Rugli cells to collagen IV. We conclude that the sequence GFOGER represents a high-affinity binding site in collagens I and IV for alpha(2)beta(1) and in collagen I for alpha(1)beta(1). Other high-affinity sites in collagen IV mediate its recognition of alpha(1)beta(1).	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Cambridge; University of Manchester	Barnes, MJ (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.							BELLAVITE P, 1994, ANAL BIOCHEM, V216, P444, DOI 10.1006/abio.1994.1066; BRAZEL D, 1987, EUR J BIOCHEM, V168, P529, DOI 10.1111/j.1432-1033.1987.tb13450.x; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Chen J, 1996, CELL ADHES COMMUN, V4, P237, DOI 10.3109/15419069609010769; COLLER BS, 1989, BLOOD, V74, P182; Dickeson SK, 1997, J BIOL CHEM, V272, P7661, DOI 10.1074/jbc.272.12.7661; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; GALLOWAY D, 1982, COLLAGEN HLTH DISEAS, P528; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Gotwals PJ, 1999, BIOCHEMISTRY-US, V38, P8280, DOI 10.1021/bi982860m; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KAMATA T, 1994, J BIOL CHEM, V269, P9659; KERN A, 1994, J BIOL CHEM, V269, P22811; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Kuhn K, 1994, Trends Cell Biol, V4, P256, DOI 10.1016/0962-8924(94)90124-4; MORTON LF, 1994, BIOCHEM J, V299, P791, DOI 10.1042/bj2990791; MORTON LF, 1987, BIOCHEM J, V248, P483, DOI 10.1042/bj2480483; Nolte M, 1999, FEBS LETT, V452, P379, DOI 10.1016/S0014-5793(99)00666-3; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; SANTORO SA, 1995, THROMB HAEMOSTASIS, V74, P813; Sixma JJ, 1997, THROMB HAEMOSTASIS, V78, P434; STAATZ WD, 1990, J BIOL CHEM, V265, P4778; TUCKWELL D, 1995, J CELL SCI, V108, P1629; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475	28	504	526	3	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					35	40		10.1074/jbc.275.1.35	http://dx.doi.org/10.1074/jbc.275.1.35			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617582	hybrid			2022-12-27	WOS:000085951600006
J	Ridgeway, AG; Wilton, S; Skerjanc, IS				Ridgeway, AG; Wilton, S; Skerjanc, IS			Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; MYOSIN HEAVY-CHAIN; TRANSCRIPTION FACTOR MEF2C; HELIX-LOOP-HELIX; DNA-BINDING; GENE-EXPRESSION; MOUSE EMBRYOGENESIS; DIFFERENTIAL TRANSACTIVATION; CARDIAC-MUSCLE; E-BOX	Two families of transcription factors, myogenic regulatory factors (MRFs) and myocyte enhancer factor 2 (MEF2), function synergistically to regulate myogenesis, In addition to activating structural muscle-specific genes, MRFs and MEF2 activate each other's expression. The MRF, myogenin, can activate MEF2 DNA binding activity when transfected into fibroblasts and, in turn, the myogenin promoter contains essential MEF2 DNA binding elements. To determine which MEF2 is involved in this regulation, P19 cells stably expressing MyoD and myogenin were compared for their ability to activate the expression of MEF2 family members. There was very little cross-activation of MyoD expression by myogenin and vice versa, Myogenin expression, and not MyoD, was found to up-regulate MEF2C expression. MEF2A, -B, and -D expression levels were not up regulated by overexpression of either MyoD or myogenin. To examine whether MEF2C can differentially regulate MyoD or myogenin expression, P19 cell lines overexpressing MEF2C were analyzed. MEF2C induced myogenesis in P19 cells and up-regulated the expression of myogenin with 25-fold greater efficiency than that of MyoD. Therefore, myogenin and MEF2C participate in a regulatory loop in differentiating stem cells. This positive regulation does not extend to MyoD or the other MEF2 family members. Consequently, MEF2C appears to play a specific role in early events of myogenesis.	Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Skerjanc, IS (corresponding author), Univ Western Ontario, Dept Biochem, Med Sci Bldg, London, ON N6A 5C1, Canada.	skerjanc@julian.uwo.ca	Skerjanc, Ilona/AAN-3318-2020					Angello JC, 1997, DEV BIOL, V192, P93, DOI 10.1006/dbio.1997.8722; ARNOLD TE, 1994, EXP CELL RES, V212, P321, DOI 10.1006/excr.1994.1150; ASAKURA A, 1993, MOL CELL BIOL, V13, P7153, DOI 10.1128/MCB.13.11.7153; AURADE F, 1994, DIFFERENTIATION, V55, P185, DOI 10.1046/j.1432-0436.1994.5530185.x; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; BERBERICH C, 1993, EUR J BIOCHEM, V216, P395, DOI 10.1111/j.1432-1033.1993.tb18157.x; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRENNAN TJ, 1990, J CELL BIOL, V110, P929, DOI 10.1083/jcb.110.4.929; BURRIDGE K, 1975, J MOL BIOL, V99, P1, DOI 10.1016/S0022-2836(75)80154-9; CHAKRABORTY T, 1991, MOL CELL BIOL, V11, P6103, DOI 10.1128/MCB.11.12.6103; CHAKRABORTY T, 1991, J BIOL CHEM, V266, P2878; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DENARDI C, 1993, J CELL BIOL, V123, P823, DOI 10.1083/jcb.123.4.823; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280; FUJISAWASEHARA A, 1992, J BIOL CHEM, V267, P10031; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; GOLDHAMER DJ, 1995, DEVELOPMENT, V121, P637; Grepin C, 1997, DEVELOPMENT, V124, P2387; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; KAUSHAL S, 1994, SCIENCE, V266, P1236, DOI 10.1126/science.7973707; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Lin MH, 1997, DEV BIOL, V182, P240, DOI 10.1006/dbio.1996.8484; MAK KL, 1992, MOL CELL BIOL, V12, P4334, DOI 10.1128/MCB.12.10.4334; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; MARTIN JF, 1993, P NATL ACAD SCI USA, V90, P5282, DOI 10.1073/pnas.90.11.5282; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MERRIFIELD PA, 1989, DEV GENET, V10, P372, DOI 10.1002/dvg.1020100505; MILLER JB, 1993, BIOESSAYS, V15, P191, DOI 10.1002/bies.950150308; MILLER JB, 1990, J CELL BIOL, V111, P1149, DOI 10.1083/jcb.111.3.1149; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; Molkentin JD, 1996, MOL CELL BIOL, V16, P3814; Molkentin JD, 1996, J BIOL CHEM, V271, P17199, DOI 10.1074/jbc.271.29.17199; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; RANGANAYAKULU G, 1995, DEV BIOL, V171, P169, DOI 10.1006/dbio.1995.1269; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; RUDNICKI MA, 1990, DEV BIOL, V138, P348, DOI 10.1016/0012-1606(90)90202-T; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451; Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904; SKERJANC IS, 1994, DEV BIOL, V163, P125, DOI 10.1006/dbio.1994.1128; SKERJANC IS, 1999, IN PRESS TRENDS CARD; Subramanian SV, 1996, MECH DEVELOP, V57, P103, DOI 10.1016/0925-4773(96)00542-4; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; Wilton S, 1999, IN VITRO CELL DEV-AN, V35, P175; Wright WE, 1996, DEV GENET, V19, P131, DOI 10.1002/(SICI)1520-6408(1996)19:2<131::AID-DVG4>3.0.CO;2-A; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; YUTZEY KE, 1990, MOL CELL BIOL, V10, P3934, DOI 10.1128/MCB.10.8.3934; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhao M, 1999, MOL CELL BIOL, V19, P21	72	65	68	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					41	46		10.1074/jbc.275.1.41	http://dx.doi.org/10.1074/jbc.275.1.41			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617583	hybrid			2022-12-27	WOS:000085951600007
J	Santacruz-Toloza, L; Ottolia, M; Nicoll, DA; Philipson, KD				Santacruz-Toloza, L; Ottolia, M; Nicoll, DA; Philipson, KD			Functional analysis of a disulfide bond in the cardiac Na+-Ca2+ exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; DYNAMIC PROPERTIES; STEADY-STATE; PROTEIN; PURIFICATION; DROSOPHILA; TOPOLOGY; REGION; ATP	The electrophoretic mobility of the cardiac Na+-Ca2+ exchange protein is different under reducing and nonreducing conditions, This mobility shift is eliminated in a cysteine-less exchanger, suggesting that the presence or absence of an intramolecular disulfide bond alters the conformation and mobility of the exchanger. Using cysteine mutagenesis and biochemical analysis, we have identified the cysteine residues involved in the disulfide bond. Cysteine 792 in loop h of the exchanger forms a disulfide bond with either cysteine 14 or 20 near the NH2 terminus. Because the NH2 terminus is extracellular, the data establish that loop h must also be extracellular. A rearrangement of disulfide bonds has previously been implicated in the stimulation of exchange activity by combinations of reducing and oxidizing agents. We have investigated the role of cysteines in the stimulation of the exchanger by the combination of FeSO4 and dithiothreitol (Fe-DTT). Using the giant excised patch technique, we find that stimulation of the wild type exchanger by Fe-DTT is primarily due to the removal of a Na+-dependent inactivation process. Analysis of mutated exchangers, however, indicates that cysteines are not responsible for stimulation of the exchange activity by Fe-DTT, Ca2+ blocks modification of the exchanger by Fe-DTT. Disulfide bonds are not involved in redox stimulation of the exchanger, and the modification reaction is unknown. Modulation of Na+-dependent inactivation may be a general mechanism for regulation of Na+-Ca2+ exchange activity and may have physiological significance.	Univ Calif Los Angeles, Sch Med, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Philipson, KD (corresponding author), Univ Calif Los Angeles, Sch Med, Cardiovasc Res Lab, MRL 3-645, Los Angeles, CA 90095 USA.	Kphilipson@mednet.ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049101] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL49101] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERS DM, 1991, EXCITATION CONTRACTI; Cook O, 1998, BBA-BIOMEMBRANES, V1371, P40, DOI 10.1016/S0005-2736(97)00272-1; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; DURKIN JT, 1991, ARCH BIOCHEM BIOPHYS, V290, P369, DOI 10.1016/0003-9861(91)90553-U; Dyck C, 1998, J BIOL CHEM, V273, P12981, DOI 10.1074/jbc.273.21.12981; FRANK JS, 1992, J CELL BIOL, V117, P337, DOI 10.1083/jcb.117.2.337; Goldhaber JI, 1996, AM J PHYSIOL-HEART C, V271, pH823, DOI 10.1152/ajpheart.1996.271.3.H823; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; HRYSHKO LV, 1993, BIOCHIM BIOPHYS ACTA, V1151, P35, DOI 10.1016/0005-2736(93)90068-B; Iwamoto T, 1999, FEBS LETT, V446, P264, DOI 10.1016/S0014-5793(99)00218-5; IWATA T, 1995, CELL CALCIUM, V17, P263, DOI 10.1016/0143-4160(95)90072-1; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Matsuoka S, 1997, J GEN PHYSIOL, V109, P273, DOI 10.1085/jgp.109.2.273; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; PHILIPSON KD, 1988, BIOCHIM BIOPHYS ACTA, V945, P298, DOI 10.1016/0005-2736(88)90492-0; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; REEVES JP, 1986, J BIOL CHEM, V261, P4948; Saba RI, 1999, BIOCHEM J, V338, P139, DOI 10.1042/0264-6021:3380139; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249	26	77	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					182	188		10.1074/jbc.275.1.182	http://dx.doi.org/10.1074/jbc.275.1.182			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617603	hybrid			2022-12-27	WOS:000085951600027
J	Kandror, O; Sherman, M; Goldberg, A				Kandror, O; Sherman, M; Goldberg, A			Rapid degradation of an abnormal protein in Escherichia coli proceeds through repeated cycles of association with GroEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; MOLECULAR CHAPERONE YDJ1; HEAT-SHOCK PROTEIN; CLP PROTEASE; PROCESSIVE DEGRADATION; SPECIFICITY COMPONENT; TRIGGER FACTOR; IN-VIVO; BINDING; DNAK	Molecular chaperones are necessary for the breakdown of many abnormal proteins, but their functions in this process have remained obscure. The rapid degradation of the abnormal fusion protein CRAG in Escherichia coli requires the molecular chaperones GoEL, GroES, and trigger factor and proceeds through the formation of a CRAG-GroEL-trigger factor complex. Also associated with GroEL are smaller discrete fragments of CRAG. Pulse-chase experiments showed that these fragments were short-lived intermediates in CRAG degradation formed by C-terminal cleavages. Thus, CRAG degradation is not highly processive. In cells lacking the ClpP protease, the generation of these fragments and their subsequent degradation were much slower than in the wild type, Dissociation of CRAG from GroEL was necessary for its digestion by the ClpP protease, because in a groES temperature-sensitive mutant, CRAG was stable and accumulated on GroEL. Furthermore, the expression of a dominant GroEL mutant defective in substrate dissociation slowed degradation of both CRAG and the fragments. Therefore, we suggest that CRAG degradation proceeds through multiple rounds of substrate binding to GroEL, followed by their GroES-dependent dissociation, which allows further digestion by the protease, In this multistep process, GroEL and GroES function repeatedly, apparently to allow further degradation of CRAG and its fragments by the protease.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kandror, O (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.							Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; EDMUNDS T, 1986, J CELL BIOCHEM, V32, P187, DOI 10.1002/jcb.240320304; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; GRAGEROV A, 1992, P NATL ACAD SCI USA, V89, P10341, DOI 10.1073/pnas.89.21.10341; Hartl F U, 1991, Semin Immunol, V3, P5; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hayes SA, 1996, J CELL BIOL, V132, P255, DOI 10.1083/jcb.132.3.255; HELLEBUST H, 1990, J BACTERIOL, V172, P5030, DOI 10.1128/jb.172.9.5030-5034.1990; HUANG HC, 1997, THESIS HARVARD U CAM; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; Kandror O, 1997, J BIOL CHEM, V272, P1730, DOI 10.1074/jbc.272.3.1730; KANDROR O, 1995, EMBO J, V14, P6021, DOI 10.1002/j.1460-2075.1995.tb00290.x; KANDROR O, 1994, J BIOL CHEM, V269, P23575; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lorimer G, 1997, NATURE, V388, P720, DOI 10.1038/41892; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SHERMAN MY, 1992, EMBO J, V11, P71; SHERMAN MYS, 1996, STRESS INDUCIBLE CEL, P57; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Welch WJ, 1991, CURR OPIN CELL BIOL, V3, P1033, DOI 10.1016/0955-0674(91)90125-I; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yaglom JA, 1996, MOL CELL BIOL, V16, P3679	37	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37743	37749		10.1074/jbc.274.53.37743	http://dx.doi.org/10.1074/jbc.274.53.37743			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608834	hybrid			2022-12-27	WOS:000084528000034
J	Wen, X; Lin, HH; Shih, HM; Kung, HJ; Ann, DK				Wen, X; Lin, HH; Shih, HM; Kung, HJ; Ann, DK			Kinase activation of the non-receptor tyrosine kinase Etk/BMX alone is sufficient to transactivate STAT-mediated gene expression in salivary and lung epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; PLECKSTRIN-HOMOLOGY DOMAIN; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVATION; SIGNAL-TRANSDUCTION; BINDING DOMAIN; PH DOMAINS; PATHWAY; BMX; PHOSPHORYLATION	Etk/BMX is a non-receptor protein tyrosine kinase that requires a functional phosphatidylinositol 3-kinase via the pleckstrin homology domain to be activated by cytokine. In the present study, a conditionally active form of Etk was constructed by fusing the hormone-binding domain of estrogen receptor (ER) to an amino terminus truncated form of Etk, PH Delta 1-68Etk, to generate Delta Etk:ER. In stably transfected Pa-4 Delta Etk:ER cells, the activity of Delta Etk:ER was stimulated within minutes by the treatment of Delta Etk:ER stimulant, estradiol, and sustained for greater than 24 h. A robust induction in the phosphorylation of signal transducers and activators of transcription (STAT) proteins, including STAT1, STAT3, and STAT5, was accompanied with Delta Etk:ER activation. Moreover, the conditionally activated Etk stimulated STAT1- and STAT5-dependent reporter activities by similar to 160- and similar to 15-fold, respectively, however, elicited only a modest STAT3-mediated reporter activation. Qualitatively comparable results were obtained in lung A549 cells, indicating that Delta Etk:ER inducible system could function in an analogous fashion in different epithelial cells. Furthermore, we demonstrated that Etk activation alone augmented cyclin D1 promoter/enhancer activity via its STAT5 response element in both Pa-4 Delta Etk:ER and A549 cells. Altogether, these findings support the notion that the activation of Etk kinase is sufficient to transactivate STAT-mediated gene expression. Hence, our inducible Delta Etk:ER system represents a novel approach to investigate the biochemical events following Etk activation and to evaluate the contribution by kinase activation of Etk alone or in conjunction with other signaling pathway(s) to the ultimate biological responses.	Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA; Univ So Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; Natl Hlth Res Inst, Div Mol & Genom Med, Taipei, Taiwan; Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	University of Southern California; University of Southern California; National Health Research Institutes - Taiwan; University of California System; University of California Davis	Ann, DK (corresponding author), Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, PSC-210B,1985 Zonal Ave, Los Angeles, CA 90033 USA.		Shih, Hsiu-Ming/S-7023-2018; Kung, Hsing-Jien/C-7651-2013		NIDCR NIH HHS [R01-DE100742] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Baba K, 1999, MOL CELL BIOL, V19, P4405; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Ekman N, 1997, CIRCULATION, V96, P1729, DOI 10.1161/01.CIR.96.6.1729; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; Hemmings BA, 1997, SCIENCE, V275, P1899, DOI 10.1126/science.275.5308.1899; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; LANGHANSRAJASEKARAN SA, 1995, P NATL ACAD SCI USA, V92, P8601, DOI 10.1073/pnas.92.19.8601; Lee CK, 1997, J BIOL CHEM, V272, P21872, DOI 10.1074/jbc.272.35.21872; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Li DX, 1997, J BIOL CHEM, V272, P25062, DOI 10.1074/jbc.272.40.25062; Lin HH, 1996, J BIOL CHEM, V271, P27637, DOI 10.1074/jbc.271.44.27637; Mao JH, 1998, EMBO J, V17, P5638, DOI 10.1093/emboj/17.19.5638; Matsumura I, 1997, MOL CELL BIOL, V17, P2933, DOI 10.1128/MCB.17.5.2933; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Mattsson PT, 1996, BIOESSAYS, V18, P825, DOI 10.1002/bies.950181009; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Saharinen P, 1997, BLOOD, V90, P4341; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; SATOH T, 1992, J BIOL CHEM, V267, P25423; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; Shaw G, 1996, BIOESSAYS, V18, P35, DOI 10.1002/bies.950180109; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stancato LF, 1997, MOL CELL BIOL, V17, P3833, DOI 10.1128/MCB.17.7.3833; TAMAGNONE L, 1994, ONCOGENE, V9, P3683; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tomlinson MG, 1999, J BIOL CHEM, V274, P13577, DOI 10.1074/jbc.274.19.13577; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Weil D, 1997, BLOOD, V90, P4332, DOI 10.1182/blood.V90.11.4332.4332_4332_4340; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WINSTON LA, 1992, J BIOL CHEM, V267, P4747; Xue LY, 1999, ONCOGENE, V18, P3391, DOI 10.1038/sj.onc.1202687; Yamaguchi T, 1999, J BIOL CHEM, V274, P15575, DOI 10.1074/jbc.274.22.15575; Zentner MD, 1998, J BIOL CHEM, V273, P30770, DOI 10.1074/jbc.273.46.30770	44	59	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38204	38210		10.1074/jbc.274.53.38204	http://dx.doi.org/10.1074/jbc.274.53.38204			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608894	hybrid			2022-12-27	WOS:000084528000094
J	Haribabu, B; Zhelev, DV; Pridgen, BC; Richardson, RM; Ali, H; Snyderman, R				Haribabu, B; Zhelev, DV; Pridgen, BC; Richardson, RM; Ali, H; Snyderman, R			Chemoattractant receptors activate distinct pathways for chemotaxis and secretion - Role of G-protein usage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE REGULATORY PROTEIN; CHEMOKINE RECEPTORS; SIGNAL-TRANSDUCTION; HUMAN NEUTROPHILS; COUPLED RECEPTOR; CARBOXYL-TERMINUS; ACTIN; PHOSPHORYLATION; MOTILITY; CDC42	Human leukocyte chemoattractant receptors activate chemotactic and cytotoxic pathways to varying degrees and also activate different G-proteins depending on the receptor and the cell-type. To determine the relationship between G-protein usage and the biological and biochemical responses activated, receptors for the chemoattractants formyl peptides (FR), platelet-activating factor (PAFR), and leukotriene B-4 (BLTR) were transfected into RBL-2H3 cells. Pertussis toxin (Ptx) served as a G alpha(i) inhibitor. These receptors were chosen to represent the spectrum of G(i) usage as Ptx had differential effects on their ability to induce calcium mobilization, phosphoinositide hydrolysis, and exocytosis with complete inhibition of all responses by FR, intermediate effects on BLTR, and little effect on PAFR, Ptx did not affect ligand-induced phosphorylation of PAFR and BLTR but inhibited phosphorylation of FR. In contrast, chemotaxis to formylmethionylleucylphenylalanine, leukotriene B-4, and platelet-activating factor was completely blocked by Ptx. Wortmannin, a phosphotidylinositol 3-kinase inhibitor, also completely blocked ligand-induced chemotaxis by all receptors but did not affect calcium mobilization or phosphoinositide hydrolysis; however, it partially blocked the exocytosis response to formylmethionylleucylphenylalanine and the platelet-activating factor. Membrane ruffling and pseudopod extension via the BLTR was also completely inhibited by both Ptx and wortmannin. These data suggest that of the chemoattractant receptors studied, G-protein usage varies with FR being totally dependent on G(i), whereas BLTR and PAFR utilize both G(i) and a Ptx-insensitive G-protein. Both Ptx-sensitive and -insensitive G-protein usage can mediate the activation of phospholipase C, mobilization of intracellular calcium, and exocytosis by chemoattractant receptors, Chemotaxis, however, had an absolute requirement for a G(i)-mediated pathway.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Haribabu, B (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3680, Durham, NC 27710 USA.		Bodduluri, Haribabu/A-2584-2010	Bodduluri, Haribabu/0000-0002-8261-3294	NIAID NIH HHS [AI-43184] Funding Source: Medline; NIAMS NIH HHS [AR-39162] Funding Source: Medline; NIDCR NIH HHS [DE-03738] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI043184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR039162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003738] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALI H, 1994, J BIOL CHEM, V269, P24557; ALI H, 1993, J BIOL CHEM, V268, P24247; Alteraifi AM, 1997, J CELL SCI, V110, P1967; AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; Arai H, 1996, J BIOL CHEM, V271, P21814, DOI 10.1074/jbc.271.36.21814; BAGGIOLINI M, 1991, BIOCHEM SOC T, V19, P55, DOI 10.1042/bst0190055; BENBARUCH A, 1995, J BIOL CHEM, V270, P9121, DOI 10.1074/jbc.270.16.9121; GERARD C, 1994, CURR OPIN IMMUNOL, V6, P140, DOI 10.1016/0952-7915(94)90045-0; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Kuang YN, 1996, J BIOL CHEM, V271, P3975; LINDER ME, 1990, J BIOL CHEM, V265, P8243; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Niggli V, 1997, EUR J PHARMACOL, V335, P43, DOI 10.1016/S0014-2999(97)01169-2; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; Prossnitz ER, 1999, BIOCHEMISTRY-US, V38, P2240, DOI 10.1021/bi982274t; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SNYDERMAN R, 1986, J LEUKOCYTE BIOL, V40, P785, DOI 10.1002/jlb.40.6.785; SNYDERMAN R, 1999, INFLAMMATION BASIC P, P607; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; TRUETT AP, 1988, P NATL ACAD SCI USA, V85, P1549, DOI 10.1073/pnas.85.5.1549; VERGHESE MW, 1987, J IMMUNOL, V138, P4374; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Zhelev DV, 1996, CELL MOTIL CYTOSKEL, V35, P331; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363; Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0	32	92	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37087	37092		10.1074/jbc.274.52.37087	http://dx.doi.org/10.1074/jbc.274.52.37087			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601267	hybrid			2022-12-27	WOS:000084382700038
J	He, B; Kemppainen, JA; Voegel, JJ; Gronemeyer, H; Wilson, EM				He, B; Kemppainen, JA; Voegel, JJ; Gronemeyer, H; Wilson, EM			Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; NUCLEAR RECEPTORS; TRANSCRIPTIONAL ACTIVATION; COACTIVATOR TIF2; HORMONE RECEPTORS; GENE-MUTATIONS; INSENSITIVITY; SPECIFICITY; ENHANCEMENT; REGION	Activation function 2 in the ligand binding domain of nuclear receptors forms a hydrophobic cleft that binds the LXXLL motif of p160 transcriptional coactivators. Here we provide evidence that activation function 2 in the androgen receptor serves as the contact site for the androgen dependent NH2- and carboxyl-terminal interaction of the androgen receptor and only weakly interacts with p160 coactivators in an LXXLL-dependent manner. Mutagenesis studies indicate that it is the NH2-/ carboxyl-terminal interaction that is required by activation function 2 to stabilize helix 12 and slow androgen dissociation critical for androgen receptor activity in vice. The androgen receptor recruits p160 coactivators through its NH2-terminal and DNA binding domains in an LXXLL motif-independent manner. The results suggest a novel function for activation function 2 and a unique mechanism of nuclear receptor transactivation.	Univ N Carolina, Dept Pediat, Labs Reprod Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ Strasbourg 1, Coll France, CNRS, INSERM,Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wilson, EM (corresponding author), Univ N Carolina, Dept Pediat, Labs Reprod Biol, Med Sci Res Bldg,Rm 374,CB 7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu	Gronemeyer, Hinrich/G-6240-2011; Gronemeyer, Hinrich/AAH-5575-2019; Gronemeyer, Hinrich/H-7002-2016	Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016910, R01HD016910, U54HD035041] Funding Source: NIH RePORTER; NICHD NIH HHS [U54-HD-35041, HD-16910] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alen P, 1999, MOL ENDOCRINOL, V13, P117, DOI 10.1210/me.13.1.117; Berrevoets CA, 1998, MOL ENDOCRINOL, V12, P1172, DOI 10.1210/me.12.8.1172; Bjorklund S, 1999, CELL, V96, P759, DOI 10.1016/S0092-8674(00)80586-3; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; DEBELLIS A, 1994, J CLIN ENDOCR METAB, V78, P513, DOI 10.1210/jc.78.3.513; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Fondell JD, 1999, P NATL ACAD SCI USA, V96, P1959, DOI 10.1073/pnas.96.5.1959; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Gee AC, 1999, MOL ENDOCRINOL, V13, P1912, DOI 10.1210/me.13.11.1912; Gottlieb B, 1998, NUCLEIC ACIDS RES, V26, P234, DOI 10.1093/nar/26.1.234; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; Hiort O, 1998, J PEDIATR-US, V132, P939, DOI 10.1016/S0022-3476(98)70387-7; Hong H, 1999, J BIOL CHEM, V274, P3496, DOI 10.1074/jbc.274.6.3496; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kemppainen JA, 1999, MOL ENDOCRINOL, V13, P440, DOI 10.1210/me.13.3.440; KLEINERMAN DI, 1996, J UROLOGY, V155, P624; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Leers J, 1998, MOL CELL BIOL, V18, P6001, DOI 10.1128/MCB.18.10.6001; McInerney EM, 1996, P NATL ACAD SCI USA, V93, P10069, DOI 10.1073/pnas.93.19.10069; Moilanen A, 1997, FEBS LETT, V412, P355, DOI 10.1016/S0014-5793(97)00791-6; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Norris JD, 1998, J BIOL CHEM, V273, P6679, DOI 10.1074/jbc.273.12.6679; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; ONATE SA, 1995, SCIENCE, V270, P1354; PARER MG, 1999, P STER REC SUP IND W; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	46	276	291	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37219	37225		10.1074/jbc.274.52.37219	http://dx.doi.org/10.1074/jbc.274.52.37219			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601285	Green Published, hybrid			2022-12-27	WOS:000084382700056
J	Blair, AS; Hajduch, E; Litherland, GJ; Hundal, HS				Blair, AS; Hajduch, E; Litherland, GJ; Hundal, HS			Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress - Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKELETAL-MUSCLE; PHOSPHOINOSITIDE 3-KINASE; SYNTHASE KINASE-3; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; MAPKAP KINASE-2; HEAT-SHOCK; EXERCISE; PHOSPHORYLATION; INHIBITION	We have investigated the cellular mechanisms that participate in reducing insulin sensitivity in response to increased oxidant stress in skeletal muscle. Measurement of glucose transport and glycogen synthesis in L6 myotubes showed that insulin stimulated both processes, by 2- and 5-fold, respectively. Acute (30 min) exposure of muscle cells to hydrogen peroxide (H2O2) blocked the hormonal activation of both these processes. Immunoblot analyses of cell lysates prepared after an acute oxidant challenge using phospho-specific antibodies against c-Jun N-terminal kinase (JNK), p38, protein kinase B (PKB), and p42 and p44 mitogen-activated protein (MAP) kinases established that H2O2 induced a dose dependent activation of all five protein kinases, In vitro kinase analyses revealed that 1 mM H2O2 stimulated the activity of JNK by similar to 8-fold, MAP-KAP-K2 (the downstream target of p38 MAP kinase) by similar to 12-fold and that of PKB by up to 34-fold. PKB activation was associated with a concomitant inactivation of glycogen synthase kinase-3, Stimulation of the p38 pathway, but not that of JNK, was blocked by SE 202190 or 8B203580, while that of p42/p44 MAP kinases and PKB was inhibited by PD 98059 and wortmannin respectively. However, of the kinases assayed, only p38 MAP kinase was activated at H2O2 concentrations (50 mu M) that caused an inhibition of insulin-stimulated glucose transport and glycogen synthesis. Strikingly, inhibiting the activation of p38 MAP kinase using either SE 202190 or SE 203580 prevented the loss in insulin-stimulated glucose transport, but not that of glycogen synthesis, by oxidative stress, Our data indicate that activation of the p38 MAP kinase pathway plays a central role in the oxidant-induced inhibition of insulin-regulated glucose transport, and unveils an important biochemical link between the classical stress-activated and insulin signaling pathways in skeletal muscle.	Univ Dundee, Dept Anat & Physiol, Inst Med Sci, Dundee DD1 5EH, Scotland	University of Dundee	Hundal, HS (corresponding author), Univ Dundee, Dept Anat & Physiol, Inst Med Sci, Wellcome Trust Bioctr Complex, Dundee DD1 5EH, Scotland.		Hajduch, Eric/B-7332-2008; Hundal, Hari/A-8990-2008; Litherland, Gary J/K-9755-2015	Hajduch, Eric/0000-0002-0125-7751; Hundal, Hari/0000-0002-7621-4932; Litherland, Gary/0000-0001-5264-0219				ASP S, 1995, J PHYSIOL-LONDON, V482, P705, DOI 10.1113/jphysiol.1995.sp020553; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clerk A, 1998, J BIOL CHEM, V273, P7228, DOI 10.1074/jbc.273.13.7228; Clifton AD, 1996, FEBS LETT, V392, P209, DOI 10.1016/0014-5793(96)00816-2; Cohen P, 1999, CURR OPIN CHEM BIOL, V3, P459, DOI 10.1016/S1367-5931(99)80067-2; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; FERRARI P, 1990, J HYPERTENS, V8, P491, DOI 10.1097/00004872-199006000-00001; Frantz B, 1998, BIOCHEMISTRY-US, V37, P13846, DOI 10.1021/bi980832y; Galuska D, 1998, ADV EXP MED BIOL, V441, P73; Goodyear LJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE403, DOI 10.1152/ajpendo.1996.271.2.E403; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hansen LL, 1999, J BIOL CHEM, V274, P25078, DOI 10.1074/jbc.274.35.25078; Heidenreich KA, 1996, J BIOL CHEM, V271, P9891, DOI 10.1074/jbc.271.17.9891; Holman GD, 1997, DIABETOLOGIA, V40, P991, DOI 10.1007/s001250050780; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; KIRWAN JP, 1992, J APPL PHYSIOL, V72, P2197, DOI 10.1152/jappl.1992.72.6.2197; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kozlovsky N, 1997, J BIOL CHEM, V272, P33367, DOI 10.1074/jbc.272.52.33367; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; LAWRENCE JC, 1977, J BIOL CHEM, V252, P444; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; McDowell HE, 1998, FEBS LETT, V441, P15, DOI 10.1016/S0014-5793(98)01508-7; Moxham CM, 1996, J BIOL CHEM, V271, P30765, DOI 10.1074/jbc.271.48.30765; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Parik T, 1996, J Cardiovasc Risk, V3, P49, DOI 10.1097/00043798-199602000-00007; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rudich A, 1997, AM J PHYSIOL-ENDOC M, V272, pE935, DOI 10.1152/ajpendo.1997.272.5.E935; SEN CK, 1995, J APPL PHYSIOL, V79, P675, DOI 10.1152/jappl.1995.79.3.675; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Sweeney G, 1999, J BIOL CHEM, V274, P10071, DOI 10.1074/jbc.274.15.10071; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; TAYLOR DE, 1995, J CRIT CARE, V10, P122, DOI 10.1016/0883-9441(95)90003-9; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379	51	151	155	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36293	36299		10.1074/jbc.274.51.36293	http://dx.doi.org/10.1074/jbc.274.51.36293			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593919	hybrid			2022-12-27	WOS:000084279200038
J	Kang, YK; Park, JS; Lee, CS; Il Yeom, Y; Chung, AS; Lee, KK				Kang, YK; Park, JS; Lee, CS; Il Yeom, Y; Chung, AS; Lee, KK			Efficient integration of short interspersed element-flanked foreign DNA via homologous recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; MOUSE GENOME; CHROMOSOME BANDS; GAMMA-GLOBIN; SEQUENCES; GENES; PROMOTER; FEATURES; DUPLICATION; EXPRESSION	We investigated whether mouse short interspersed elements (SINEs) could influence the recombination frequency of foreign DNA. Vectors harboring a reporter gene in combinations of SINEs B1 and/or B2 or a portion of long interspersed element-1 were prepared and tested in vitro by a colony assay using HC11 murine mammary epithelial cells and in, vivo by microinjection into fetilized mouse eggs. In transfected HC11 cells, the number of colonies surviving G418 selection increased by 3.5-fold compared with control when the reporter was flanked by fused B1-B2 sequences. Similar results were obtained from microinjection study; in fetuses 11.5 days post coitum, transgene positives in control and SINE-flanked vectors were 16 and 53%, respectively. Individual B1- and B2-harboring vectors showed equivalent activities with each other, as determined by the colony assay (2.8-fold versus 3.2-fold compared with control). We determined the contribution of homologous recombination to the SINE-mediated increase in integration frequency through a polymerase chain reaction-based strategy; in more than half of embryos transgenes underwent homologous recombinations involving B1 sequences. These results demonstrate that the SINE sequences can increase the integration rate of foreign DNA and that such an increase is most likely due to the enhancement of homologous recombination.	Korea Res Inst Biosci & Biotechnol, Anin Dev Biol Res Unit, Taejon 305600, South Korea; Korea Adv Inst Sci & Technol, Dept Sci Biol, Taejon 305701, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST)	Lee, KK (corresponding author), POB 115 Yusong, Taejon 305600, South Korea.							ALLEN ND, 1988, NATURE, V333, P852, DOI 10.1038/333852a0; AYARES D, 1986, P NATL ACAD SCI USA, V83, P5199, DOI 10.1073/pnas.83.14.5199; BARSH GS, 1983, NUCLEIC ACIDS RES, V11, P3939, DOI 10.1093/nar/11.12.3939; BENNETT KL, 1984, MOL CELL BIOL, V4, P1561, DOI 10.1128/MCB.4.8.1561; BERG DE, 1989, MOBILE DNA, P593; BOYLE AL, 1990, P NATL ACAD SCI USA, V87, P7757, DOI 10.1073/pnas.87.19.7757; CHEN CM, 1995, TRANSGENIC RES, V4, P52, DOI 10.1007/BF01976502; CRAIG JM, 1993, BIOESSAYS, V15, P349, DOI 10.1002/bies.950150510; CROSS M, 1990, EMBO J, V9, P1283, DOI 10.1002/j.1460-2075.1990.tb08237.x; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; Edgell M H, 1987, Prog Clin Biol Res, V251, P107; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; HOGAN B, 1994, MANIPULATING MOUSE E, P226; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; JAGADEESWARAN P, 1982, NATURE, V296, P469, DOI 10.1038/296469a0; KATO S, 1986, MOL CELL BIOL, V6, P1787, DOI 10.1128/MCB.6.5.1787; KRAMEROV DA, 1979, NUCLEIC ACIDS RES, V6, P697, DOI 10.1093/nar/6.2.697; KRAYEV AS, 1982, NUCLEIC ACIDS RES, V10, P7461, DOI 10.1093/nar/10.23.7461; KRISHER RL, 1994, TRANSGENIC RES, V3, P226, DOI 10.1007/BF02336775; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; LIN HJ, 1987, J CLIN INVEST, V80, P374, DOI 10.1172/JCI113082; LOEB DD, 1986, MOL CELL BIOL, V6, P168, DOI 10.1128/MCB.6.1.168; MARAIA RJ, 1991, NUCLEIC ACIDS RES, V19, P5695, DOI 10.1093/nar/19.20.5695; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MARTIN DIK, 1989, NATURE, V338, P435, DOI 10.1038/338435a0; Mcfarlane M, 1996, TRANSGENIC RES, V5, P171, DOI 10.1007/BF01969706; MURNANE JP, 1990, NUCLEIC ACIDS RES, V18, P2733, DOI 10.1093/nar/18.9.2733; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; OTTOLENGHI S, 1982, NATURE, V300, P770, DOI 10.1038/300770a0; PAVAN WJ, 1991, P NATL ACAD SCI USA, V88, P7788, DOI 10.1073/pnas.88.17.7788; SAMBROOK J, 1989, MOL CLONING LABORATO, V2, P16; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SHEN MR, 1992, ANAL BIOCHEM, V205, P83; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350; WALLENBURG JC, 1987, NUCLEIC ACIDS RES, V15, P7849, DOI 10.1093/nar/15.19.7849; Watson JEV, 1995, GENOME RES, V5, P444, DOI 10.1101/gr.5.5.444; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215	37	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36585	36591		10.1074/jbc.274.51.36585	http://dx.doi.org/10.1074/jbc.274.51.36585			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593959	hybrid			2022-12-27	WOS:000084279200078
J	Kuznetsova, N; Leikin, S				Kuznetsova, N; Leikin, S			Does the triple helical domain of type I collagen encode molecular recognition and fiber assembly while telopeptides serve as catalytic domains? Effect of proteolytic cleavage on fibrillogenesis and on collagen-collagen interaction in fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; FIBRIL FORMATION; INVITRO; FORCES; SEQUENCE; DRIVEN; CHAIN; CDNA	Over the last several decades, it has been established that proteolytic removal of short, non-helical terminal peptides (telopeptides) from type I collagen significantly alters the kinetics of in vitro fibrillogenesis. However, it has also been observed that the protein is still capable of forming fibers even after complete removal of telopeptides. This study focuses on the characterization of this fibrillogenesis competency of collagen, We have combined traditional kinetic and thermodynamic assays of fibrillogenesis efficacy with direct measurements of interaction between collagen molecules in fibers by osmotic stress and x-ray diffraction. We found that telopeptide cleavage by pepsin or by up to 20 h of Pronase treatment altered fiber assembly kinetics, but the same fraction of the protein still assembled into fibers. Small-angle x-ray diffraction showed that these fibers have normal, native-like D-stagger. Force measurements indicated that collagen-collagen interactions in fibers were not affected by either pepsin or Pronase treatment, In contrast, prolonged (>20 h) Pronase treatment resulted in cleavage of the triple helical domain as indicated by SDS-polyacrylamide gel electrophoresis. The triple-helix cleavage correlated with the observed decrease in the fraction of protein capable of forming fibers and with the measured loss of attraction between helices in fibers, These data suggest that telopeptides play a catalytic role, whereas the information necessary for proper molecular recognition and fiber assembly is encoded in the triple helical domain of collagen.	NICHD, Lab Phys & Struct Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Leikin, S (corresponding author), NICHD, Lab Phys & Struct Biol, NIH, Bldg 12A,Rm 2041, Bethesda, MD 20892 USA.		Leikin, Sergey/A-5518-2008	Leikin, Sergey/0000-0001-7095-0739	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000256] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000256, Z01HD000241] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BRODSKY B, 1982, METHOD ENZYMOL, V82, P127; BRODSKY B, 1982, BIOPOLYMERS, V21, P935, DOI 10.1002/bip.360210507; BRODSKY B, 1978, BIOCHIM BIOPHYS ACTA, P25; BRODSKY B, 1988, COLLAGEN, V1, P95; CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062; COMPER WD, 1977, BIOPOLYMERS, V16, P2113, DOI 10.1002/bip.1977.360161004; COMPER WD, 1977, BIOPOLYMERS, V16, P2133, DOI 10.1002/bip.1977.360161005; DAVISON PF, 1966, BIOCHEMISTRY-US, V5, P313, DOI 10.1021/bi00865a040; DRAKE MP, 1966, BIOCHEMISTRY-US, V5, P301, DOI 10.1021/bi00865a039; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EIKENBERRY EF, 1980, J MOL BIOL, V144, P397, DOI 10.1016/0022-2836(80)90098-4; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fraser R.D.B., 1973, CONFORMATION FIBROUS; GELMAN RA, 1979, J BIOL CHEM, V254, P1741; GHOSH SK, 1975, BIOCHIM BIOPHYS ACTA, V405, P340, DOI 10.1016/0005-2795(75)90099-9; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; KADLER K, 1994, PROTEIN PROFILE, V1, P519; Kuznetsova N, 1998, BIOCHEMISTRY-US, V37, P11888, DOI 10.1021/bi980089+; Kuznetsova N, 1997, BIOPHYS J, V72, P353, DOI 10.1016/S0006-3495(97)78674-0; LEIBOVICH SJ, 1970, BIOCHIM BIOPHYS ACTA, V214, P445, DOI 10.1016/0005-2795(70)90303-X; LEIKIN S, 1995, NAT STRUCT BIOL, V2, P205, DOI 10.1038/nsb0395-205; LEIKIN S, 1994, P NATL ACAD SCI USA, V91, P276, DOI 10.1073/pnas.91.1.276; LI SW, 1995, MATRIX BIOL, V14, P593, DOI 10.1016/S0945-053X(05)80009-5; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; MUDD CP, 1987, REV SCI INSTRUM, V58, P2110, DOI 10.1063/1.1139472; NA GC, 1988, COLLAGEN REL RES, V8, P315; PARSEGIAN VA, 1986, METHOD ENZYMOL, V127, P400; PHILLIPS CL, 1992, GENOMICS, V13, P1345, DOI 10.1016/0888-7543(92)90065-Z; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; RAU DC, 1984, P NATL ACAD SCI-BIOL, V81, P2621, DOI 10.1073/pnas.81.9.2621; Veis A, 1988, COLLAGEN, V1, P113; Weiss J B, 1976, Int Rev Connect Tissue Res, V7, P101; WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578; Yamauchi M, 1988, COLLAGEN, P157	36	94	95	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36083	36088		10.1074/jbc.274.51.36083	http://dx.doi.org/10.1074/jbc.274.51.36083			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593890	hybrid			2022-12-27	WOS:000084279200009
J	Pettitt, TR; Wakelam, MJO				Pettitt, TR; Wakelam, MJO			Diacylglycerol kinase epsilon, but not zeta selectively removes polyunsaturated diacylglycerol, inducing altered protein kinase C distribution in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; PHOSPHOLIPASE-C; GENERATION; ACTIVATION; SYNTHASE; GENE	Porcine aortic endothelial cells have previously been shown to contain particularly high basal levels of polyunsaturated diacylglycerol (DAG) together with a very high degree of membrane associated protein kinase C (PBC), which is largely insensitive to further activation (Pettitt, T. R., Martin, A. Horton, T., Liossis, C., Lord, J. M., and Wakelam, M. J. O. (1997) J. Biol. Chem. 272, 17354-17359), To investigate the possibility that the high polyunsaturated DAG levels were constitutively activating PKC, we transfected porcine aortic endothelial cells with two different forms of human diacylglycerol kinase, epsilon and zeta, In vitro, the former is specific for polyunsaturated structures, whereas the latter shows no apparent selectivity, Overexpression of DAGK epsilon specifically reduced the level of polyunsaturated DAG in the transfected cells while having little effect on the more saturated structures. It also caused the redistribution of PKC alpha and epsilon from the membrane to the cytosol, Overexpression of DAGK zeta caused a general reduction in DAG levels but had little effect on PKC distribution. These results for the first time show that DAGK epsilon specifically phosphorylates polyunsaturated DAG in vivo and that in so doing it regulates PKC localization and activity, This provides support for the proposal that it is the polyunsaturated DAGs that function as messengers and convincing evidence for DAGK epsilon being a physiological terminator of DAG second messenger signaling.	Univ Birmingham, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England	University of Birmingham	Wakelam, MJO (corresponding author), Univ Birmingham, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England.	M.J.O.Wakelam@bham.ac.uk		Wakelam, Michael/0000-0003-4059-9276				Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Ding L, 1997, P NATL ACAD SCI USA, V94, P5519, DOI 10.1073/pnas.94.11.5519; Ding L, 1998, FEBS LETT, V429, P109, DOI 10.1016/S0014-5793(98)00490-6; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Goto K, 1996, P NATL ACAD SCI USA, V93, P11196, DOI 10.1073/pnas.93.20.11196; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; Lykidis A, 1997, J BIOL CHEM, V272, P33402, DOI 10.1074/jbc.272.52.33402; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Olivier AR, 1996, BIOCHEM J, V318, P519, DOI 10.1042/bj3180519; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; PETTITT TR, 1993, BIOCHEM J, V289, P487, DOI 10.1042/bj2890487; PETTITT TR, 1994, BIOCHEM J, V298, P655, DOI 10.1042/bj2980655; Saito S, 1997, J BIOL CHEM, V272, P9503; Sakane F, 1997, INT J BIOCHEM CELL B, V29, P1139, DOI 10.1016/S1357-2725(97)00037-X; Tang W, 1996, J BIOL CHEM, V271, P10237, DOI 10.1074/jbc.271.17.10237; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; WAKELAM MJO, 1986, NATURE, V323, P68, DOI 10.1038/323068a0; Wakelam MJO, 1998, BBA-MOL CELL BIOL L, V1436, P117, DOI 10.1016/S0005-2760(98)00123-4; WALSH JP, 1995, J BIOL CHEM, V270, P28647, DOI 10.1074/jbc.270.48.28647	21	54	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36181	36186		10.1074/jbc.274.51.36181	http://dx.doi.org/10.1074/jbc.274.51.36181			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593903	hybrid			2022-12-27	WOS:000084279200022
J	Teuchert, M; Berghofer, S; Klenk, HD; Garten, W				Teuchert, M; Berghofer, S; Klenk, HD; Garten, W			Recycling of furin from the plasma membrane - Functional importance of the cytoplasmic tail sorting signals and interaction with the AP-2 adaptor medium chain subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; KINASE-II PHOSPHORYLATION; TYROSINE-BASED MOTIF; CELL-SURFACE; INTRACELLULAR TRAFFICKING; PROPROTEIN CONVERTASE; COFACTOR PROTEIN; LOCALIZATION; CLATHRIN; DOMAIN	The predominant intracellular localization of the eukaryotic subtilisin-like endoprotease furin is the trans-Golgi network (TGN), but a small fraction is also found on the cell surface. Furin on the cell surface is internalized and delivered to the TGN, The identification of three endocytosis motifs, a tyrosine (YKGL(765)) motif, a leucine-isoleucine (LI760) motif, and a phenylalanine (Phe(790)) signal, in the furin cytoplasmic domain suggested that endocytosis of furin occurs via an AP-2/clathrin-dependent pathway. Since little is known about proteins containing multiple sorting components in their cytoplasmic domain, the combination of diverse internalization signals in the furin tail raised the question of their individual role, Here we present data showing that the furin tail interacts with the medium (mu 2) subunit of the AP-2 plasma membrane specific adaptor complex in vitro and that this interaction primarily depends on recognition of the tyrosine-based sorting signal and to less extent on the leucine-isoleucine motif, We further provide evidence that the three endocytosis signals are of different functional importance for furin internalization and retrieval to the TGN in vivo, with the tyrosine-based motif being the major determinant, followed by the phenylalanine signal, whereas the leucine-isoleucine motif is only a minor component, Finally, we report that phosphorylation of the furin tail by casein kinase II is not only important for efficient interaction with mu 2 and internalization from the plasma membrane but also determines fast retrieval of the protein from the plasma membrane to the TGN.	Univ Marburg, Inst Virol, D-35037 Marburg, Germany	Philipps University Marburg	Garten, W (corresponding author), Univ Marburg, Inst Virol, Robert Koch Str 17, D-35037 Marburg, Germany.							Alconada A, 1996, EMBO J, V15, P6096, DOI 10.1002/j.1460-2075.1996.tb00998.x; Alconada A, 1999, J VIROL, V73, P377, DOI 10.1128/JVI.73.1.377-387.1999; BENNETT G, 1981, J CELL BIOL, V88, P1, DOI 10.1083/jcb.88.1.1; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; CHAPMAN RE, 1994, EMBO J, V13, P2305, DOI 10.1002/j.1460-2075.1994.tb06514.x; Dittie AS, 1997, EMBO J, V16, P4859, DOI 10.1093/emboj/16.16.4859; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; JIN M, 1989, J BIOL CHEM, V264, P7675; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; Le Borgne R, 1998, CURR OPIN CELL BIOL, V10, P499; LISZEWSKI MK, 1992, CURR TOP MICROBIOL, V178, P45; Maisner A, 1997, J BIOL CHEM, V272, P20793, DOI 10.1074/jbc.272.33.20793; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; REAVES B, 1993, MOL BIOL CELL, V4, P93, DOI 10.1091/mbc.4.1.93; Rodionov DG, 1998, J BIOL CHEM, V273, P6005, DOI 10.1074/jbc.273.11.6005; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; SCHAFER W, 1995, EMBO J, V14, P2424, DOI 10.1002/j.1460-2075.1995.tb07240.x; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STOH A, 1999, EUR J CELL BIOL, V78, P151; TAKAHASHI S, 1995, J BIOL CHEM, V270, P28397; Teuchert M, 1999, J BIOL CHEM, V274, P8199, DOI 10.1074/jbc.274.12.8199; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8	40	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36781	36789		10.1074/jbc.274.51.36781	http://dx.doi.org/10.1074/jbc.274.51.36781			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593987	hybrid			2022-12-27	WOS:000084279200106
J	MacMillan, LB; Bass, MA; Cheng, N; Howard, EF; Tamura, M; Strack, S; Wadzinski, BE; Colbran, RJ				MacMillan, LB; Bass, MA; Cheng, N; Howard, EF; Tamura, M; Strack, S; Wadzinski, BE; Colbran, RJ			Brain actin-associated protein phosphatase 1 holoenzymes containing spinophilin, neurabin, and selected catalytic subunit isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT-BINDING PROTEIN; POSTSYNAPTIC DENSITY; KINASE-II; TARGETING SUBUNITS; DENDRITIC SPINES; RAT LIN-10; RECEPTORS; DOMAIN; PROTEIN-PHOSPHATASE-1; PHOSPHORYLATION	We previously characterized PP1bp134 and PP1bp175, two neuronal proteins that bind the protein phosphatase 1 catalytic subunit (PPI). Here we purify from rat brain actin-cytoskeletal extracts PP1(A) holoenzymes selectively enriched in PP1 gamma(1) over PP1 beta isoforms and also containing PP1bp134 and PP1bp175. PP1bp134 and PP1bp175 were identified as the synapse-localized F-actin-binding proteins spinophilin (Allen, P. B., Ouimet, C. C., and Greengard, P. (1997) Proc. Natl. Acad. Sci. U.S.A. 94, 9956-9561; Satoh, A., Nakanishi, H., Obaishi, H., Wada, M., Takahashi, K., Satoh, K., Hirao, K., Nishioka, H., Hata, Y., Mizoguchi, A., and Takai, Y. (1998) J. Biol. Chem. 273, 3470-3475) and neurabin (Nakanishi, H., Obaishi, H., Satoh, A., Wada, M., Mandai, K., Satoh, K., Nishioka, H., Matsuura, Y., Mizoguchi, A., and Takai, Y. (1997) J. Cell Biol. 139, 951-961), respectively. Recombinant spinophilin and neurabin interacted with endogenous PP1 and also with each other when co-expressed in HEK293 cells. Spinophilin residues 427-470, or homologous neurabin residues 436-479, were sufficient to bind PPI in gel overlay assays, and selectively bound PP1 gamma(1), from a mixture of brain protein phosphatase catalytic subunits; additional N- and C-terminal sequences were required for potent inhibition of PPI. Immunoprecipitation of spinophilin or neurabin from crude brain extracts selectively coprecipitated PP1 gamma(1), over PP1 beta. Moreover, immunoprecipitation of PP1 gamma(1), from brain extracts efficiently coprecipitated spinophilin and neurabin, whereas PP1 beta immunoprecipitation did not. Thus, PP1(A) holoenzymes containing spinophilin and/or neurabin target specific neuronal PP1 isoforms, facilitating efficient regulation of synaptic phosphoproteins.	Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Colbran, RJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Rm 702,Light Hall, Nashville, TN 37232 USA.		Colbran, Roger/AAU-7708-2021	Colbran, Roger/0000-0001-7401-8244; Strack, Stefan/0000-0002-6175-7280; Tamura, Masaaki/0000-0003-4863-3379	NIGMS NIH HHS [GM47973, GM51366] Funding Source: Medline; NINDS NIH HHS [NS37508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051366, R29GM047973, R01GM051366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037508] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BOLLEN M, 1992, CRIT REV BIOCHEM MOL, V27, P227, DOI 10.3109/10409239209082564; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Colbran RJ, 1997, J NEUROCHEM, V69, P920; Connor JH, 1998, J BIOL CHEM, V273, P27716, DOI 10.1074/jbc.273.42.27716; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Greengard P, 1998, BRAIN RES REV, V26, P274, DOI 10.1016/S0165-0173(97)00057-X; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Ide N, 1998, BIOCHEM BIOPH RES CO, V244, P258, DOI 10.1006/bbrc.1998.8243; Ide N, 1998, BIOCHEM BIOPH RES CO, V243, P634, DOI 10.1006/bbrc.1998.8142; Johnson DF, 1996, EUR J BIOCHEM, V239, P317, DOI 10.1111/j.1432-1033.1996.0317u.x; Kennedy M B, 1993, Curr Opin Neurobiol, V3, P732, DOI 10.1016/0959-4388(93)90145-O; KLAUCK TM, 1995, CELL SIGNAL, V7, P747, DOI 10.1016/0898-6568(95)02003-9; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P3536, DOI 10.1073/pnas.94.8.3536; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LEVILLIERS N, 1984, BIOCHIMIE, V66, P531, DOI 10.1016/0300-9084(84)90147-0; LOVINGER DM, 1995, J PHARMACOL EXP THER, V274, P164; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; SIM ATR, 1994, J NEUROCHEM, V62, P1552; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; Strack S, 1999, J COMP NEUROL, V413, P373; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack S, 1997, J NEUROCHEM, V68, P2119; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Whitfield CW, 1999, MOL BIOL CELL, V10, P2087, DOI 10.1091/mbc.10.6.2087; Wu J, 1998, FEBS LETT, V439, P185, DOI 10.1016/S0014-5793(98)01371-4; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Zhao SM, 1997, J BIOL CHEM, V272, P28368, DOI 10.1074/jbc.272.45.28368	40	85	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35845	35854		10.1074/jbc.274.50.35845	http://dx.doi.org/10.1074/jbc.274.50.35845			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585469	hybrid			2022-12-27	WOS:000084187900081
J	Srinivasan, S; Alexander, H; Alexander, S				Srinivasan, S; Alexander, H; Alexander, S			The prespore vesicles of Dictyostelium discoideum - Purification, characterization, and developmental regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORE COAT PROTEINS; SACCHAROMYCES-CEREVISIAE; GLYCOPROTEIN COMPLEX; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; CELL; GENE; ORGANIZATION; LOCALIZATION; PATHWAYS	The coordinate fusion of the prespore vesicles (PSVs) with the plasma membrane at the terminal stage of spore differentiation in Dictyostelium discoideum is an important example of developmentally regulated protein secretion, However, little is known about the composition of the vesicles, the molecular signals regulating secretion, or the mechanics of the membrane fusion, Taking a biochemical approach, we purified PSVs from different developmental stages. These preparations are highly enriched for their specific cargo of spore coat proteins while devoid of markers for other cellular compartments. Electron microscopic observations show that the PSV preparations are homogenous, with the soluble spore coat protein PsB/SP85 distributed throughout the lumen and the acid mucopolysaccharide localized in the central core. During development the PSVs increase in size and density concomitant with an increase in their protein cargo. The PSVs contain approximately 80 proteins, and we have identified a PSV-specific GTP-binding protein that may be involved in regulating vesicle fusion, The PSVs are not clathrin-coated and do not contain the SpiA spore coat protein. The PSV preparations are ideal for a global proteome analysis to identify proteins involved in signal reception, vesicle movement, docking, and fusion in this developmentally regulated organelle.	Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Alexander, S (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.							ADESSI C, 1995, J CELL SCI, V108, P3331; ALEXANDER S, 1988, DIFFERENTIATION, V38, P82, DOI 10.1111/j.1432-0436.1988.tb00201.x; Alexander S., 1992, P29; ALEXANDER S, 1992, DIFFERENTIATION, V51, P149, DOI 10.1111/j.1432-0436.1992.tb00691.x; ALEXANDER S, 1983, CELL, V34, P467, DOI 10.1016/0092-8674(83)90380-X; ALEXANDER S, 1997, DICTYOSTELIUM MODEL, P349; Aunis D, 1998, INT REV CYTOL, V181, P213, DOI 10.1016/S0074-7696(08)60419-2; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BORTS RH, 1981, DEV BIOL, V87, P185, DOI 10.1016/0012-1606(81)90071-3; CHAMPION A, 1995, MICROBIOL-UK, V141, P785, DOI 10.1099/13500872-141-4-785; CHAMPION A, 1991, J GEN MICROBIOL, V137, P2431, DOI 10.1099/00221287-137-10-2431; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DEVINE KM, 1982, P NATL ACAD SCI-BIOL, V79, P7361, DOI 10.1073/pnas.79.23.7361; DEVINE KM, 1983, DEV BIOL, V99, P437, DOI 10.1016/0012-1606(83)90293-2; ERDOS GW, 1989, EXP MYCOL, V13, P169, DOI 10.1016/0147-5975(89)90022-4; ERDOS GW, 1985, MYCOLOGIA, V77, P308, DOI 10.2307/3793083; FOSNAUGH KL, 1991, DEV GENET, V12, P123, DOI 10.1002/dvg.1020120120; GLOMP I, 1985, HISTOCHEMISTRY, V83, P251, DOI 10.1007/BF00953993; Gracz LM, 1996, BBA-PROTEIN STRUCT M, V1292, P293, DOI 10.1016/0167-4838(95)00222-7; GREEN AA, 1974, BIOCHEM J, V140, P313, DOI 10.1042/bj1400313; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; GRIFFITHS KR, 1996, THESIS MACQUARIE U S; HOHL HR, 1969, J ULTRA MOL STRUCT R, V26, P442, DOI 10.1016/S0022-5320(69)90050-1; HOPPER NA, 1993, EMBO J, V12, P2459, DOI 10.1002/j.1460-2075.1993.tb05900.x; IKEDA T, 1981, BIOCHIM BIOPHYS ACTA, V675, P69, DOI 10.1016/0304-4165(81)90070-2; IKEDA T, 1971, DEV GROWTH DIFFER, V13, P221; KHYSEANDERSON J, 1984, J BIOCHEM BIOPH METH, V10, P203; Kraemer J, 1999, EUR J CELL BIOL, V78, P265, DOI 10.1016/S0171-9335(99)80060-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; LENHARD JM, 1989, EXP CELL RES, V182, P242, DOI 10.1016/0014-4827(89)90295-4; LENHARD JM, 1990, J CELL BIOL, V1, P2761; LIVI GP, 1985, DEV BIOL, V110, P514, DOI 10.1016/0012-1606(85)90110-1; Loomis WF, 1998, MICROBIOL MOL BIOL R, V62, P684, DOI 10.1128/MMBR.62.3.684-694.1998; LOOMIS WF, 1969, J BACTERIOL, V100, P417, DOI 10.1128/JB.100.1.417-422.1969; LOOMIS WF, 1970, J BACTERIOL, V103, P375, DOI 10.1128/JB.103.2.375-381.1970; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; MAEDA Y, 1969, DEV GROWTH DIFFER, V11, P232; McGuire V, 1996, J BIOL CHEM, V271, P14596, DOI 10.1074/jbc.271.24.14596; MCGUIRE V, 1996, THESIS U MISSOURI CO; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MIERENDORF RC, 1985, J CELL BIOL, V100, P1777, DOI 10.1083/jcb.100.5.1777; NEWELL PC, 1969, BIOCHIM BIOPHYS ACTA, V177, P610, DOI 10.1016/0304-4165(69)90326-2; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; ORLOWSKI M, 1979, DEV BIOL, V71, P297, DOI 10.1016/0012-1606(79)90171-4; RATNER D, 1983, EXP CELL RES, V143, P1, DOI 10.1016/0014-4827(83)90103-9; RICHARDSON DL, 1992, GENE DEV, V6, P1058, DOI 10.1101/gad.6.6.1058; RICHARDSON DL, 1991, DEV BIOL, V144, P269, DOI 10.1016/0012-1606(91)90421-X; Rothman JE, 1997, SCIENCE, V276, P1212, DOI 10.1126/science.276.5316.1212; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SAXE SA, 1990, MOL CELL BIOL, V10, P2367, DOI 10.1128/MCB.10.5.2367; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; SHAULSKY G, 1995, GENE DEV, V9, P1111, DOI 10.1101/gad.9.9.1111; SMITH E, 1989, GENETICS, V122, P59; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; SUSSMAN R, 1971, ARCH BIOCHEM BIOPHYS, V144, P127, DOI 10.1016/0003-9861(71)90462-0; TAKEUCHI I, 1970, EXP CELL RES, V61, P183, DOI 10.1016/0014-4827(70)90272-7; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; Wang N, 1996, EMBO J, V15, P3890, DOI 10.1002/j.1460-2075.1996.tb00763.x; WATSON N, 1993, J BIOL CHEM, V268, P22634; WATSON N, 1994, J CELL SCI, V107, P2567; WEST CM, 1990, DEV GENET, V11, P492, DOI 10.1002/dvg.1020110526; WILKINSON DG, 1983, BIOCHEM J, V216, P567, DOI 10.1042/bj2160567; YAN JX, 1997, DICTYOSTELIUM MODEL, P455; Zhang YY, 1998, BIOCHEMISTRY-US, V37, P10766, DOI 10.1021/bi9808013	69	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35823	35831		10.1074/jbc.274.50.35823	http://dx.doi.org/10.1074/jbc.274.50.35823			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585466	hybrid			2022-12-27	WOS:000084187900078
J	Tschantz, WR; Zhang, LL; Casey, PJ				Tschantz, WR; Zhang, LL; Casey, PJ			Cloning, expression, and cellular localization of a human prenylcysteine lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PALMITOYL-PROTEIN THIOESTERASE; NEURONAL CEROID-LIPOFUSCINOSIS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; BOVINE BRAIN; PRENYLATION; RAS; BIOCHEMISTRY; TRANSPORTER; ENZYMES	Prenylated proteins contain either a 15-carbon farnesyl or 20-carbon geranylgeranyl isoprenoid covalently attached to cysteine residues at or near their C terminus. These proteins constitute up to 2% of total cellular protein in eukaryotic cells. The degradation of prenylated proteins raises a metabolic challenge to the cell, because the thioether bond of the modified cysteine is quite stable. We recently identified and isolated an enzyme termed prenylcysteine lyase that cleaves the prenylcysteine to free cysteine and an isoprenoid product (Zhang, L., Tschantz, W, R,, and Casey, P, J, (1997) J. Biol. Chem. 272, 23354-23359), To facilitate the molecular characterization of this enzyme, its cloning was undertaken. Overlapping cDNA clones encoding the complete coding sequence of this enzyme were obtained from a human cDNA library. The open reading frame of the gene encoding prenylcysteine lyase is 1515 base pairs and has a nearly ubiquitous expression pattern with a message size of 6 kilobase pairs. Recombinant prenylcysteine lyase was produced in a baculovirus-Sf9 expression system. Analysis of both the recombinant and native enzyme revealed that the enzyme is glycosylated and contains a signal peptide that is cleaved during processing. Additionally, the subcellular localization of this enzyme was determined to be lysosomal. These findings strengthen the notion that prenylcysteine lyase plays an important role in the final step in the degradation of prenylated proteins and will allow further physiological and biochemical characterization of this enzyme.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University	Casey, PJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	casey006@mc.duke.edu		Casey, Patrick/0000-0002-7366-9309	NIGMS NIH HHS [GM46372, GM18069] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046372, F32GM018069] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; BABA T, 1991, BIOCHEMISTRY-US, V30, P500, DOI 10.1021/bi00216a028; CAMP LA, 1994, J BIOL CHEM, V269, P23212; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; CHEN JW, 1985, J CELL BIOL, V101, P85, DOI 10.1083/jcb.101.1.85; DING JB, 1994, J BIOL CHEM, V269, P16837; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; EPSTEIN WW, 1991, P NATL ACAD SCI USA, V88, P9668, DOI 10.1073/pnas.88.21.9668; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GLOMSET JA, 1994, ANNU REV CELL BIOL, V10, P181, DOI 10.1146/annurev.cellbio.10.1.181; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Graham John M., 1993, V19, P51; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lu JY, 1996, P NATL ACAD SCI USA, V93, P10046, DOI 10.1073/pnas.93.19.10046; MARSHALL CJ, 1993, SCIENCE, V259, P1865, DOI 10.1126/science.8456312; MOOMAW JF, 1995, METHOD ENZYMOL, V250, P12; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; PHILIPS MR, 1993, SCIENCE, V259, P977, DOI 10.1126/science.8438158; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; ZHANG L, 1994, J BIOL CHEM, V269, P15973; ZHANG LL, 1995, J BIOL CHEM, V270, P22859, DOI 10.1074/jbc.270.39.22859; Zhang LL, 1997, J BIOL CHEM, V272, P23354, DOI 10.1074/jbc.272.37.23354	29	27	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35802	35808		10.1074/jbc.274.50.35802	http://dx.doi.org/10.1074/jbc.274.50.35802			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585463	hybrid			2022-12-27	WOS:000084187900075
J	Baenziger, JE; Morris, ML; Darsaut, TE; Ryan, SE				Baenziger, JE; Morris, ML; Darsaut, TE; Ryan, SE			Effect of membrane lipid composition on the conformational equilibria of the nicotinic acetylcholine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORPEDO-CALIFORNICA; AGONIST BINDING; CHOLESTEROL; SPECTROSCOPY; ACTIVATION; BILAYER; NMR	The effects of cholesterol (Chol) and an anionic lipid, dioleoylphosphatidic acid (DOPA) on the conformational equilibria of the nicotinic acetylcholine receptor (nAChR) have been investigated using Fourier transform infrared difference spectroscopy. The difference between spectra recorded in the presence and absence of agonist from the nAChR reconstituted into 3:1:1 egg phosphatidylcholine (EPC)/DOPA/Chol membranes exhibits positive and negative bands that serve as markers of the structural changes associated with the resting to desensitized conformational change. These markers are absent in similar difference spectra recorded from the nAChR reconstituted into EPC membranes lacking both Chol and DOPA, indicating that the nAChR cannot undergo conformational change in response to agonist binding. When low levels of either Chol or DOPA up to 25 mol % of the total lipid are included in the EPC membranes, the markers suggest the predominant stabilization of a conformation that is a structural intermediate between the resting and desensitized states. At higher levels of either Chol or DOPA, the nAChR is stabilized in a conformation that is capable of undergoing agonist-induced desensitization, although DOPA appears to be required for the nAChR to adopt a conformation fully equivalent to that found in native and 3:1:1 EPC/DOPA/Chol membranes. The ability of these two structurally diverse lipids, as well as others (Ryan, S. E., Demers, C. N., Chew, J. P., Baenziger, J. E. (1996) J. Biol. Chem. 271, 24590-24597), to modulate the functional state of the nAChR suggests that lipids act on the nAChR via an indirect effect on some physical property of the lipid bilayer, The data also suggest that anionic lipids are essential to stabilize a fully functional nAChR, We propose that membrane fluidity modulates the relative populations of nAChRs in the resting and desensitized states but that subtle structural changes in the presence of anionic lipids are essential for full activity.	Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Baenziger, JE (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.			Baenziger, John/0000-0002-2888-5328				Addona GH, 1998, BBA-BIOMEMBRANES, V1370, P299, DOI 10.1016/S0005-2736(97)00280-0; Baenziger JE, 1999, BIOCHEMISTRY-US, V38, P4905, DOI 10.1021/bi990181l; BHUSHAN A, 1993, BIOPHYS J, V64, P716, DOI 10.1016/S0006-3495(93)81431-0; BUTLER DH, 1993, BIOCHIM BIOPHYS ACTA, V1150, P17, DOI 10.1016/0005-2736(93)90116-H; Corbin J, 1998, BBA-BIOMEMBRANES, V1414, P65, DOI 10.1016/S0005-2736(98)00153-9; DAMLE VN, 1978, BIOCHEM BIOPH RES CO, V84, P845, DOI 10.1016/0006-291X(78)91661-3; Dreger M, 1997, BIOCHEMISTRY-US, V36, P839, DOI 10.1021/bi960666z; FERNANDEZBALLESTER G, 1994, BIOCHEMISTRY-US, V33, P4065, DOI 10.1021/bi00179a035; FONG TM, 1987, BIOCHEMISTRY-US, V26, P3871, DOI 10.1021/bi00387a020; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; MARCELJA S, 1974, BIOCHIM BIOPHYS ACTA, V367, P165, DOI 10.1016/0005-2736(74)90040-6; MCCARTHY MP, 1992, J BIOL CHEM, V267, P7655; MCNAMEE MG, 1988, ADV MEMBRANE FLUIDIT, V2, P43; METHOT N, 1995, BIOCHEMISTRY-US, V34, P15142, DOI 10.1021/bi00046a021; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; OCHOA ELM, 1983, BIOCHIM BIOPHYS ACTA, V727, P151, DOI 10.1016/0005-2736(83)90379-6; Raines DE, 1998, BBA-BIOMEMBRANES, V1374, P83, DOI 10.1016/S0005-2736(98)00133-3; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Ryan SE, 1996, J BIOL CHEM, V271, P24590, DOI 10.1074/jbc.271.40.24590; Ryan SE, 1999, MOL PHARMACOL, V55, P348, DOI 10.1124/mol.55.2.348; SALMON A, 1987, J AM CHEM SOC, V109, P2600, DOI 10.1021/ja00243a010; SUNSHINE C, 1994, BBA-BIOMEMBRANES, V1191, P59, DOI 10.1016/0005-2736(94)90233-X; Williamson PTF, 1998, BIOCHEMISTRY-US, V37, P10854, DOI 10.1021/bi980390q; YEAGLE PL, 1988, BIOL CHOLESTEROL, P121	24	119	119	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					777	784		10.1074/jbc.275.2.777	http://dx.doi.org/10.1074/jbc.275.2.777			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625607	hybrid			2022-12-27	WOS:000084836600011
J	Collins, BE; Ito, H; Sawada, N; Ishida, H; Kiso, M; Schnaar, RL				Collins, BE; Ito, H; Sawada, N; Ishida, H; Kiso, M; Schnaar, RL			Enhanced binding of the neural siglecs, myelin-associated glycoprotein and Schwann cell myelin protein, to Chol-1 (alpha-series) gangliosides and novel sulfated Chol-1 analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINERGIC-SPECIFIC ANTIGEN; SIALYL-LEWIS-X; IMMUNOGLOBULIN SUPERFAMILY; SELECTIN INHIBITORS; BOVINE BRAIN; ACID; SIALOADHESIN; ADHESION; CD22; RECOGNITION	Extended glycoconjugate binding specificities of three sialic acid-dependent immunoglobulin-like family member lectins (siglecs), myelin-associated glycoprotein (MAG), Schwann cell myelin protein (SMP), and sialoadhesin, were compared by measuring siglec-mediated cell adhesion to immobilized gangliosides, Synthetic gangliosides bearing the oc series determinant (NeuAc alpha 2,6-linked to GalNAc on a gangliotetraose core) were tested, including GD1 alpha (IV(3)NeuAc, III(6)NeuAc-Gg(4)OseCer), GD1 alpha with modified sialic acid residues at the III6-position, and the "Chol-1" gangliosides GT1a alpha (IV(3)NeuAc, III(6)NeuAc, II(3)NeuAc-Gg(4)OseCer) and GQ1b alpha (IV(3)NeuAc, III(6)NeuAc, II3(NeuAc)(2)-Gg(4)OseCer). The a-series gangliosides displayed enhanced potency for MAG- and SMP-mediated cell adhesion (GQ1b alpha > GT1a alpha, GD1 alpha > GT1b, GD1a >> GM1 (nonbinding)), whereas sialoadhesin-mediated adhesion was comparable with cu-series and non-a-series gangliosides, GD1 alpha derivatives with modified sialic acids (7-, 8-, or g-deoxy) or sulfate (instead of sialic acid) at the III6-position supported adhesion comparable with that of GD1 alpha. Notably, a novel GT1a alpha analog with sulfates at two internal sites of sialylation (NeuAc alpha 2,3Gal beta 1,4GalNAc-6-sulfate beta 1, 4Gal3-sulfate beta 1,4Glc beta 1,1'ceramide) was the most potent siglec-binding structure tested to date (10-fold more potent than GT1a alpha in supporting MAG and SMP binding). Together with prior studies, these data indicate that MAG and SMP display an extended structural specificity with a requirement for a terminal alpha 2,3-linked NeuAc and great enhancement by nearby precisely spaced anionic charges.	Johns Hopkins Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Gifu Univ, Dept Appl Bioorgan Chem, Gifu 5011193, Japan	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Gifu University	Schnaar, RL (corresponding author), Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, 725 N Wolfe St, Baltimore, MD 21205 USA.	schnaar@jhu.edu	Schnaar, Ronald L/S-8967-2016	Schnaar, Ronald L/0000-0002-7701-5484	NIGMS NIH HHS [GM07626] Funding Source: Medline; NINDS NIH HHS [NS37096] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037096, R37NS037096] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDO S, 1992, J BIOCHEM, V111, P287, DOI 10.1093/oxfordjournals.jbchem.a123751; BERTOZZI CR, 1995, BIOCHEMISTRY-US, V34, P14271, DOI 10.1021/bi00044a001; BRANDLEY BK, 1993, GLYCOBIOLOGY, V3, P633, DOI 10.1093/glycob/3.6.633; Collins BE, 1997, J BIOL CHEM, V272, P16889, DOI 10.1074/jbc.272.27.16889; Collins BE, 1997, J BIOL CHEM, V272, P1248, DOI 10.1074/jbc.272.2.1248; Crocker P R, 1998, Glycobiology, V8, pv; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; CROCKER PR, 1994, EMBO J, V13, P4490, DOI 10.1002/j.1460-2075.1994.tb06771.x; DULAC C, 1992, NEURON, V8, P323, DOI 10.1016/0896-6273(92)90298-R; FERRETTI P, 1986, J NEUROCHEM, V46, P1888; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; Galustian C, 1999, J BIOL CHEM, V274, P18213, DOI 10.1074/jbc.274.26.18213; GREEN PJ, 1992, BIOCHEM BIOPH RES CO, V188, P244, DOI 10.1016/0006-291X(92)92376-9; HANASAKI K, 1995, J BIOL CHEM, V270, P7543, DOI 10.1074/jbc.270.13.7543; HEMMERICH S, 1994, BIOCHEMISTRY-US, V33, P4830, DOI 10.1021/bi00182a011; HIRABAYASHI Y, 1992, J BIOL CHEM, V267, P12973; HIRABAYASHI Y, 1990, J BIOL CHEM, V265, P8144; HOTTA K, 1995, J CARBOHYD CHEM, V14, P491, DOI 10.1080/07328309508005353; Irie F, 1996, GLYCOCONJUGATE J, V13, P177, DOI 10.1007/BF00731492; Ito H, 1998, CARBOHYD RES, V306, P579; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Kelm S, 1996, GLYCOCONJUGATE J, V13, P913, DOI 10.1007/BF01053186; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; KELM S, 1993, EUR J BIOCHEM, V255, P663; Kogan TP, 1995, J MED CHEM, V38, P4976, DOI 10.1021/jm00026a004; Li YT, 1999, J BIOL CHEM, V274, P10014, DOI 10.1074/jbc.274.15.10014; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; POWELL LD, 1995, J BIOL CHEM, V270, P7523, DOI 10.1074/jbc.270.13.7523; PRABHANJAN H, 1992, CARBOHYD RES, V233, P87, DOI 10.1016/S0008-6215(00)90922-4; PRABHANJAN H, 1991, CARBOHYD RES, V220, P127, DOI 10.1016/0008-6215(91)80011-B; RAO BNN, 1994, J BIOL CHEM, V269, P19663; RICHARDSON PJ, 1982, J NEUROCHEM, V38, P1605, DOI 10.1111/j.1471-4159.1982.tb06640.x; Sawada N, 1999, CARBOHYD RES, V316, P1, DOI 10.1016/S0008-6215(99)00081-6; SGROI D, 1993, J BIOL CHEM, V268, P7011; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; Strenge K, 1998, EUR J BIOCHEM, V258, P677, DOI 10.1046/j.1432-1327.1998.2580677.x; SVENNERHOLM L, 1994, PROG BRAIN RES, V101, pR11; TAKI T, 1986, J BIOL CHEM, V261, P3075; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; TRAPP BD, 1989, J CELL BIOL, V109, P2417, DOI 10.1083/jcb.109.5.2417; TYRRELL D, 1991, P NATL ACAD SCI USA, V88, P10372, DOI 10.1073/pnas.88.22.10372; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814; Yang LJS, 1996, ANAL BIOCHEM, V236, P161, DOI 10.1006/abio.1996.0145; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998	46	57	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37637	37643		10.1074/jbc.274.53.37637	http://dx.doi.org/10.1074/jbc.274.53.37637			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608819	hybrid			2022-12-27	WOS:000084528000019
J	de la Rosa, DA; Zhang, P; Naray-Fejes-Toth, A; Fejes-Toth, G; Canessa, CM				de la Rosa, DA; Zhang, P; Naray-Fejes-Toth, A; Fejes-Toth, G; Canessa, CM			The serum and glucocorticoid kinase sgk increases the abundance of epithelial sodium channels in the plasma membrane of Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE FAMILY; EXPRESSION; MEMBER	The serum- and glucocorticoid-induced kinase (sgk) is a serine and threonine kinase that stimulates amiloride-sensitive sodium transport in Xenopus oocytes. Because aldosterone induces phosphorylation on serine/threonine (Ser/Thr) residues in the carboxyl termini of beta and gamma subunits of epithelial sodium channels (ENaCs) and causes an increase in the sgk transcript in mammalian and amphibian renal epithelial cells, it seems likely that sgk mediates the action of aldosterone to stimulate sodium transport. Experiments were performed in Xenopus oocytes to determine the mechanism by which sgk increases sodium conductance by examining its effect on phosphorylation, kinetics, and membrane abundance of ENaC. Our results demonstrate that deletions of the carboxyl termini of the three subunits do not inhibit sgk-induced sodium current, indicating that the effect of sgk is not mediated via phosphorylation within the carboxyl termini of ENaC. They also show no evidence that sgk reduces the removal of ENaC from the plasma membrane because mutations of tyrosine residues in the sequences necessary for endocytosis and degradation did not affect the response to sgk. Further studies performed with the patch-clamp technique indicated that sgk did not increase the open probability or changed the kinetics of ENaC. These studies, however, showed a 3-fold increase in the abundance of ENaC in the plasma membrane in the presence of sgk compared with control. Together, the experiments indicate that sgk stimulates electrogenic sodium transport by increasing the number of ENaCs at the cell surface and suggest that sgk may mediate the early increase in aldosterone-induced sodium current.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; Dartmouth Coll, Sch Med, Dept Physiol, Hanover, NH 03755 USA	Yale University; Dartmouth College	Canessa, CM (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06510 USA.		Alvarez de la Rosa, Diego/H-8500-2015	Alvarez de la Rosa, Diego/0000-0002-4324-2793	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054061] Funding Source: NIH RePORTER; NIDDK NIH HHS [5-RO1-DK54061] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISTON TN, 1997, MOL ENDOCRINOL, V11, P934; Asher C, 1996, AM J PHYSIOL-CELL PH, V271, pC605, DOI 10.1152/ajpcell.1996.271.2.C605; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; IMAIZUMI K, 1994, MOL BRAIN RES, V26, P189, DOI 10.1016/0169-328X(94)90090-6; KEMENDY AE, 1992, AM J PHYSIOL, V263, pC825, DOI 10.1152/ajpcell.1992.263.4.C825; May A, 1997, J AM SOC NEPHROL, V8, P1813; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; PACHA J, 1993, J GEN PHYSIOL, V102, P25, DOI 10.1085/jgp.102.1.25; ROSSIER BC, 1992, KIDNEY PHYSL PATHOPH, V1, P1373; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; VERREY F, 1995, J MEMBRANE BIOL, V144, P93; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031	21	226	228	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37834	37839		10.1074/jbc.274.53.37834	http://dx.doi.org/10.1074/jbc.274.53.37834			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608847	hybrid			2022-12-27	WOS:000084528000047
J	Elmendorf, JS; Boeglin, DJ; Pessin, JE				Elmendorf, JS; Boeglin, DJ; Pessin, JE			Temporal separation of insulin-stimulated GLUT4/IRAP vesicle plasma membrane docking and fusion in 3T3L1 adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER GLUT4; GTP-GAMMA-S; 3T3-L1 ADIPOCYTES; TRANSLOCATION; TRAFFICKING; PROTEIN; AMINOPEPTIDASE; SYNTAXIN-4; MUNC18C; SNARES	Examination of the time and temperature dependence of insulin-stimulated GLUT4/IRAP-containing vesicle trafficking demonstrated an approximate 7-fold increase in the half-time for plasma membrane translocation at 23 degrees C (t(1/2) = similar to 30 min) compared with 37 degrees C (t(1/2) = similar to 4 min) without a significant change in the extent of either GLUT4 or IRAP translocation. Localization of the endogenous GLUT4 and expressed GLUT4-enhanced green fluorescent protein fusion protein in intact 3T3L1 adipocytes demonstrated that at 23 degrees C there was a time-dependent accumulation of discrete GLUT4-containing vesicles adjacent to the inner face of the cell surface membrane but that was not contiguous and/or physically incorporated into the plasma membrane. Together, these data demonstrate that the temperature-dependent decrease in the rate of GLUT4 and IRAP translocation results from a reduction in GLUT4/IRAP-containing vesicle fusion and not trafficking or docking to the plasma membrane.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Pessin, JE (corresponding author), Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA.				NIDDK NIH HHS [DK25925, DK49781, DK33823] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033823, R01DK049781, R37DK033823] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki S, 1997, BIOCHEM BIOPH RES CO, V234, P257, DOI 10.1006/bbrc.1997.6560; BABIA T, 1994, EUR J CELL BIOL, V63, P172; BECKERS CJM, 1990, J BIOL CHEM, V265, P18298; BENNETT MK, 1995, CURR OPIN CELL BIOL, V7, P581, DOI 10.1016/0955-0674(95)80016-6; Blum R, 1999, J CELL SCI, V112, P537; Calakos N, 1996, PHYSIOL REV, V76, P1; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Goda Y, 1997, P NATL ACAD SCI USA, V94, P769, DOI 10.1073/pnas.94.3.769; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Malide D, 1997, FEBS LETT, V409, P461, DOI 10.1016/S0014-5793(97)00563-2; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Martin S, 1997, J CELL SCI, V110, P2281; Martin Sally, 1999, Cell Biochemistry and Biophysics, V30, P89, DOI 10.1007/BF02737886; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Oatey PB, 1997, BIOCHEM J, V327, P637; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; ROBINSON LJ, 1992, AM J PHYSIOL, V263, P383; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; VONGRAFENSTEIN H, 1986, J CELL BIOL, V103, P2343, DOI 10.1083/jcb.103.6.2343; Zorzano A, 1998, INT J MOL MED, V2, P263	29	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37357	37361		10.1074/jbc.274.52.37357	http://dx.doi.org/10.1074/jbc.274.52.37357			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601305	hybrid			2022-12-27	WOS:000084382700076
J	Kirksey, TJ; Pogue-Caley, RR; Frelinger, JA; Collins, EJ				Kirksey, TJ; Pogue-Caley, RR; Frelinger, JA; Collins, EJ			The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTOR; PROTEIN CRYSTALLOGRAPHY; MHC MOLECULES; AMINO; REFINEMENT; STABILITY; HLA-A2.1; BINDING	Designing altered peptide ligands to generate specific immunological reactivity when bound to class I major histocompatibility complexes is important for both therapeutic and prophylactic reasons. We have previously shown that two altered peptides, derived from human immunodeficiency virus (HIV)-reverse transcriptase (RT) residues 309-317, are more immunogenic in vitro than the wild-type peptide. One peptide variant, I1Y, was able to stimulate RT-specific cytotoxic T cells from the blood of three HIV-infected individuals better than the wild-type BT peptide. Both I1Y and I1F peptide variants increase the cell surface half-life of the peptide-class I complex approximately 3-fold over that of the RT peptide but have different immunological activities. These peptides are candidates for the design of vaccines for HN due to their increased immunogenicity, To understand the basis for the increased cell surface stability compared with wild-type peptide and to understand the differences in T cell recognition between I1Y and I1F, we determined the x-ray crystal structures of the two class I MHC-peptide complexes, These structures indicate that the increased cell surface half-life is due to pi-pi stacking interactions between Trp-167 of HLA-A2.1 and the aromatic P1 residues of I1F and I1Y, Comparison of the structures and modeling potential T cell receptor (TCR) interactions suggests that T cell interactions and immunogenicity are different between I1Y and I1F for two reasons. First, subtle changes in the steric and polar properties of the I1Y peptide affect TCR engagement. Second, water-mediated hydrogen bond interactions between the P1-Tyr and the P4-Glu peptide residues increase peptide side chain rigidity of residues critical for TCR engagement.	Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Collins, EJ (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, CB 7290,804 ME Jones Bldg, Chapel Hill, NC 27599 USA.		Frelinger, Jeffrey A/F-2448-2014	Frelinger, Jeffrey A/0000-0002-2503-6267	NIAID NIH HHS [AI20288, AI29324] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029324, R37AI020288, R01AI020288] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Batalia MA, 1997, BIOPOLYMERS, V43, P281, DOI 10.1002/(SICI)1097-0282(1997)43:4<281::AID-BIP3>3.0.CO;2-R; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Morgan CS, 1997, PROTEIN SCI, V6, P1771, DOI 10.1002/pro.5560060819; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	25	46	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37259	37264		10.1074/jbc.274.52.37259	http://dx.doi.org/10.1074/jbc.274.52.37259			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601290	Green Published, hybrid			2022-12-27	WOS:000084382700061
J	Sayas, CL; Moreno-Flores, MT; Avila, J; Wandosell, F				Sayas, CL; Moreno-Flores, MT; Avila, J; Wandosell, F			The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PC12 CELLS; ANTISENSE OLIGONUCLEOTIDES; ABNORMAL PHOSPHORYLATION; PROTEIN; INHIBITION; RHO; LITHIUM; FIBROBLASTS; PATHOLOGY	The bioactive phospholipid lysophosphatidic acid (LPA) causes growth cone collapse and neurite retraction in neuronal cells. These changes are brought about by the action of a cell surface receptor coupled to specific G proteins that control morphology and motility through the action of a group of small GTPases, the Rho family of proteins. Many studies have focused on actin reorganization modulated by Rho-GTPases, but almost no information has been obtained concerning microtubular network reorganization after LPA-induced neurite retraction. In the present study, we demonstrate an increase in site-specific Alzheimer's disease-like Talc phosphorylation during LPA-induced neurite retraction in differentiated SY-SH5Y human neuroblastoma cells. The phosphorylation state of Tau was inferred from its immunoreactivity with antibodies that recognize phosphorylation-sensitive epitopes. The effects of specific kinase inhibitors indicate that this phosphorylation is mediated by glycogen synthase kinase-3 (GSK-3). In support of this idea, we observed an increase of GSK-3 activity upon growth cone collapse. Our results are consistent with the hypothesis that activation of GSK-3 occurs in the Rho pathway and may represent an important link between microtubules and microfilaments dynamics during neuritogenesis and in pathological situations such as Alzheimer's disease.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Wandosell, F (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		Wandosell, Francisco/AAV-6391-2020; Sayas Casanova, Carmen Laura/AAD-9270-2022; Avila, Jesus/I-2610-2015; Moreno-Flores, M. Teresa/E-8949-2018; Moreno-Flores, M. Teresa/ABH-9655-2020; Wandosell, Francisco/G-6105-2015	Sayas Casanova, Carmen Laura/0000-0001-8594-0322; Avila, Jesus/0000-0002-6288-0571; Moreno-Flores, M. Teresa/0000-0002-8494-8143; Moreno-Flores, M. Teresa/0000-0002-8494-8143; Wandosell, Francisco/0000-0001-6537-2321				AVILA J, 1994, INT J DEV BIOL, V38, P13; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; CACERES A, 1991, J NEUROSCI, V11, P1515; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Chen FS, 1998, J NEUROCHEM, V71, P248; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chuprun JK, 1997, J BIOL CHEM, V272, P773, DOI 10.1074/jbc.272.2.773; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DELALONSO CA, 1996, NAT MED, V2, P783; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1147; Fischer DJ, 1998, MOL PHARMACOL, V54, P979, DOI 10.1124/mol.54.6.979; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; ISHIGURO K, 1996, BRAIN MICROTUBULES A, P73; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; JALINK K, 1990, J BIOL CHEM, V265, P12232; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; MANDELL J, 1996, NEUROBIOL AGING, V16, P229; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Munoz-Montano JR, 1999, J NEUROSCI RES, V55, P278, DOI 10.1002/(SICI)1097-4547(19990201)55:3<278::AID-JNR2>3.0.CO;2-2; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; SMALHEISER NR, 1994, BRAIN RES, V660, P309, DOI 10.1016/0006-8993(94)91304-8; STAHL B, 1990, NEURON, V5, P733; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Tigyi G, 1996, J NEUROCHEM, V66, P549; Tigyi G, 1996, J NEUROCHEM, V66, P537; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Welsh GI, 1997, ANAL BIOCHEM, V244, P16, DOI 10.1006/abio.1996.9838	45	143	149	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37046	37052		10.1074/jbc.274.52.37046	http://dx.doi.org/10.1074/jbc.274.52.37046			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601262	hybrid			2022-12-27	WOS:000084382700033
J	Singh, BB; Patel, HH; Roepman, R; Schick, D; Ferreira, PA				Singh, BB; Patel, HH; Roepman, R; Schick, D; Ferreira, PA			The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX PROTEIN; ANTI-FUNGAL ANTIBIOTICS; NF-KAPPA-B; LEPTOMYCIN-B; MESSENGER-RNA; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; TRANSPORT FACTOR; FUSION PROTEINS; RAN/TC4 GTPASE	The Ran-binding protein 2 (RanBP2) is a large scaffold cyclophilin-related protein expressed in photoreceptor cells. Red/green opsin, Ran-GTPase, and the 19 S regulatory complex of the proteasome associate with specific RanBP2 structural modules. Some of these play a role in chaperoning the functional expression of opsin. RanBP2 localization at cytoplasmic fibrils emanating from the nuclear pore complex and interaction with the Ran GTPase support also its role in nucleocytoplasmic transport processes. The degenerate nucleoporin repeat motifs FXFG, GLFG, and XXFG have been proposed to mediate the movement of nucleocytoplasmic transport factors, In particular, RanBP2 has been implicated in nuclear import processes, Here, we show the zinc fingers of RanBP2 associate with high specificity to the nuclear export factor, exportin-1 (CRM1). The bovine RanBP2 transcript contained only five of the eight zinc fingers reported in the human counterpart and are sufficient for exportin-1 association with RanBP2. In contrast to Ran interaction with RanBP2-exportin-1 complex, exportin-1 binding to the zinc finger cluster domain of RanBP2 is insensitive to leptomycin B and nucleotide-bound state of Ran-GTPase. Our results indicate that the zinc finger-rich domain of RanBP2 constitutes a docking site for exportin-1 during nuclear export. Thus, RanBP2 emerges as a key component of the nuclear export pathway.	Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands	Medical College of Wisconsin; Radboud University Nijmegen	Ferreira, PA (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	ferreira@post.its.mcw.edu	Ferreira, Paulo A/S-4209-2016; Roepman, Ronald/B-1339-2014; Ferreira, Paulo/A-3893-2008; Patel, Hemal/C-7325-2019	Ferreira, Paulo A/0000-0003-4585-1717; Roepman, Ronald/0000-0002-5178-8163; Patel, Hemal/0000-0001-6722-9625; Singh, Brij/0000-0003-0535-5997	NATIONAL EYE INSTITUTE [R01EY011993] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011993, EY11993] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; ANDEREGG G, 1967, HELV CHIM ACTA, V50, P2330, DOI 10.1002/hlca.19670500817; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; BEDDOW AL, 1995, P NATL ACAD SCI USA, V92, P3328, DOI 10.1073/pnas.92.8.3328; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; BRINKMANN U, 1995, P NATL ACAD SCI USA, V92, P10427, DOI 10.1073/pnas.92.22.10427; Cheng CL, 1998, J NEUROCHEM, V71, P2401; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Dasso M, 1998, AM J HUM GENET, V63, P311, DOI 10.1086/301990; DAVIS LI, 1995, ANNU REV BIOCHEM, V64, P865, DOI 10.1146/annurev.bi.64.070195.004245; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Fekkes P, 1999, BIOCHEMISTRY-US, V38, P5111, DOI 10.1021/bi982818r; FERREIRA PA, 1995, J BIOL CHEM, V270, P23179, DOI 10.1074/jbc.270.39.23179; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Ferreira PA, 1997, P NATL ACAD SCI USA, V94, P1556, DOI 10.1073/pnas.94.4.1556; Ferreira PA, 2000, METHOD ENZYMOL, V315, P455; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod M, 1996, ONCOGENE, V13, P1801; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAMAMOTO T, 1983, J ANTIBIOT, V36, P639, DOI 10.7164/antibiotics.36.639; HAMAMOTO T, 1983, J ANTIBIOT, V36, P646, DOI 10.7164/antibiotics.36.646; HAMAMOTO T, 1985, J ANTIBIOT, V38, P1573, DOI 10.7164/antibiotics.38.1573; HERKETH TR, 1983, J BIOL CHEM, V258, P4876; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Krebber H, 1997, GENOMICS, V43, P247, DOI 10.1006/geno.1997.4777; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; LOUNSBURY KM, 1994, J BIOL CHEM, V269, P11285; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; MANUTIS M, 1997, J CELL BIOL, V135, P1457; MCMORROW I, 1994, BBA-GENE STRUCT EXPR, V1217, P219, DOI 10.1016/0167-4781(94)90040-X; MELCHIOR F, 1995, J CELL BIOL, V131, P571, DOI 10.1083/jcb.131.3.571; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MICHAEL WM, 1995, CELL, V83, P415; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P4318, DOI 10.1073/pnas.92.10.4318; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Neville M, 1999, EMBO J, V18, P3746, DOI 10.1093/emboj/18.13.3746; Nothwang HG, 1998, GENOMICS, V47, P383, DOI 10.1006/geno.1997.5119; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stutz F, 1997, GENE DEV, V11, P2857, DOI 10.1101/gad.11.21.2857; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Visa N, 1996, CELL, V84, P253, DOI 10.1016/S0092-8674(00)80980-0; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; WILKEN N, 1995, EUR J CELL BIOL, V68, P211; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yaseen NR, 1999, P NATL ACAD SCI USA, V96, P5516, DOI 10.1073/pnas.96.10.5516; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; YOSHIDA M, 1990, EXP CELL RES, V187, P150, DOI 10.1016/0014-4827(90)90129-X	75	66	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37370	37378		10.1074/jbc.274.52.37370	http://dx.doi.org/10.1074/jbc.274.52.37370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601307	Green Published, hybrid			2022-12-27	WOS:000084382700078
J	Stahl, T; Glockmann, C; Soll, J; Heins, L				Stahl, T; Glockmann, C; Soll, J; Heins, L			Tic40, a new "old" subunit of the chloroplast protein import translocon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ENVELOPE MEMBRANE; PEA-CHLOROPLASTS; MACHINERY; IDENTIFICATION; APPARATUS; COMPONENTS; LOCALIZATION; COMPLEXES	The protein import translocon at the inner envelope of chloroplasts (Tic complex) is a heteroligomeric multisubunit:complex. Here, we describe Tic40 from pea as a new component of this complex. Tic40 from pea is a homologue of a protein described earlier from Brassica napus as Cim/Com44 or the Toc36 subunit of the translocon at the outer envelope of chloroplasts, respectively (Wu, C., Seibert, F. S., and Ko, K. (1994) J. Biol. Chem. 269, 32264-32271; Ko, K., Budd, D., Wu, C., Seibert, F., Kourtz, L., and Ko, Z. W, (1995) J. Biol. Chem, 270, 28601-28608; Pang, P., Meathrel, K., and Ko, K. (1997) J. Biol. Chem. 272, 25623-25627), Tic40 can be covalently connected to Tic110 by the formation of a disulfide bridge under oxidizing conditions, indicating its close physical proximity to an established translocon component. The Tic40 protein is synthesized in the cytosol as a precursor with an N-terminal cleavable chloroplast targeting signal and imported into the organelle via the general import pathway. Immunoblotting and immunogold-labeling studies exclusively confine Tic40 to the chloroplastic inner envelope, in which it is anchored by a single putative transmembrane span.	Univ Kiel, Inst Bot, D-24118 Kiel, Germany	University of Kiel	Soll, J (corresponding author), Univ Kiel, Inst Bot, Bot Garten 1-9, D-24118 Kiel, Germany.							Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; ALEFSEN H, 1994, J PLANT PHYSIOL, V144, P339, DOI 10.1016/S0176-1617(11)81196-X; Bolter B, 1998, FEBS LETT, V441, P59, DOI 10.1016/S0014-5793(98)01525-7; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Caliebe A, 1997, EMBO J, V16, P7342, DOI 10.1093/emboj/16.24.7342; Chen XJ, 1999, TRENDS CELL BIOL, V9, P222, DOI 10.1016/S0962-8924(99)01554-8; CLINE K, 1981, P NATL ACAD SCI-BIOL, V78, P3595, DOI 10.1073/pnas.78.6.3595; GRAY MW, 1993, CURR OPIN GENET DEV, V3, P884, DOI 10.1016/0959-437X(93)90009-E; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351; HOHFELD J, 1995, CELL, V83, P589; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; Kessler F, 1996, P NATL ACAD SCI USA, V93, P7684, DOI 10.1073/pnas.93.15.7684; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; KO K, 1995, J BIOL CHEM, V270, P28601, DOI 10.1074/jbc.270.48.28601; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; Kourtz L, 1997, J BIOL CHEM, V272, P2808, DOI 10.1074/jbc.272.5.2808; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lubeck J, 1997, J CELL BIOL, V137, P1279, DOI 10.1083/jcb.137.6.1279; Lubeck J, 1996, EMBO J, V15, P4230, DOI 10.1002/j.1460-2075.1996.tb00797.x; MARSHALL JS, 1990, P NATL ACAD SCI USA, V87, P374, DOI 10.1073/pnas.87.1.374; May T, 1999, FEBS LETT, V452, P52, DOI 10.1016/S0014-5793(99)00527-X; Morin XK, 1997, PLANTA, V201, P119, DOI 10.1007/BF01007696; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; PAIN D, 1988, NATURE, V331, P232, DOI 10.1038/331232a0; Pang P, 1997, J BIOL CHEM, V272, P25623, DOI 10.1074/jbc.272.41.25623; PERRY SE, 1994, PLANT CELL, V6, P93, DOI 10.1105/tpc.6.1.93; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SALOMON M, 1990, P NATL ACAD SCI USA, V87, P5778, DOI 10.1073/pnas.87.15.5778; Sambrook J., 2002, MOL CLONING LAB MANU; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; SEEDORF M, 1995, PLANT J, V7, P401, DOI 10.1046/j.1365-313X.1995.7030401.x; Soll J, 1998, PLANT MOL BIOL, V38, P191, DOI 10.1023/A:1006034020192; Tranel PJ, 1996, PLANT CELL, V8, P2093, DOI 10.1105/tpc.8.11.2093; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; WAEGEMANN K, 1991, PLANT J, V1, P149, DOI 10.1111/j.1365-313X.1991.00149.x	38	99	106	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37467	37472		10.1074/jbc.274.52.37467	http://dx.doi.org/10.1074/jbc.274.52.37467			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601321	hybrid			2022-12-27	WOS:000084382700092
J	Washington, MT; Johnson, RE; Prakash, S; Prakash, L				Washington, MT; Johnson, RE; Prakash, S; Prakash, L			Fidelity and processivity of Saccharomyces cerevisiae DNA polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENTOSUM VARIANT CELLS; ESCHERICHIA-COLI DINB; REPLICATION; DIMER; HYPERMUTABILITY; EFFICIENCIES; PROTEINS; HOMOLOG; GENE	The yeast RAD30 gene functions in error-free replication of UV-damaged DNA, and RAD30 encodes a DNA polymerase, pol eta, that has the ability to efficiently and correctly replicate past a cis-syn-thymine-thymine dimer in template DNA. To better understand the role of pol eta in damage bypass, we examined its fidelity and processivity on nondamaged DNA templates. Steady-state kinetic analyses of deoxynucleotide incorporation indicate that pol eta has a low fidelity, misincorporating deoxynucleotides with a frequency of about 10(-2) to 10(-3) Also pol eta has a low processivity, incorporating only a Pew nucleotides before dissociating. We suggest that pol eta's low fidelity reflects a flexibility in its active site rendering it more tolerant of DNA damage, while its low processivity limits its activity to reduce errors.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, L (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, 6-104 Med Res Bldg,11th & Mech St, Galveston, TX 77555 USA.		Prakash, Satya/C-6420-2013	Prakash, Satya/0000-0001-7228-1444; Washington, Todd/0000-0001-8680-2992; Prakash, Louise/0000-0001-9143-6261	NIGMS NIH HHS [GM19261] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019261] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bambara RA, 1995, METHOD ENZYMOL, V262, P270; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; CIARROCCHI G, 1982, J MOL BIOL, V155, P177, DOI 10.1016/0022-2836(82)90445-4; Creighton S, 1995, METHOD ENZYMOL, V262, P232; CREIGHTON S, 1995, J BIOL CHEM, V270, P4759, DOI 10.1074/jbc.270.9.4759; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Fersht A., 1984, ENZYME STRUCTURE MEC; Goodman MF, 1998, GENETICS, V148, P1475; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 1999, J BIOL CHEM, V274, P15975, DOI 10.1074/jbc.274.23.15975; KEMMINK J, 1987, NUCLEIC ACIDS RES, V15, P4645, DOI 10.1093/nar/15.11.4645; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McDonald JP, 1997, GENETICS, V147, P1557; Osheroff WP, 1999, J BIOL CHEM, V274, P3642, DOI 10.1074/jbc.274.6.3642; Roush AA, 1998, MOL GEN GENET, V257, P686; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; THOMAS DC, 1991, BIOCHEMISTRY-US, V30, P11751, DOI 10.1021/bi00115a003; VONHIPPEL PH, 1994, ANN NY ACAD SCI, V726, P118; WANG CI, 1991, P NATL ACAD SCI USA, V88, P9072, DOI 10.1073/pnas.88.20.9072; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; WATERS HL, 1993, J INVEST DERMATOL, V101, P744, DOI 10.1111/1523-1747.ep12371686	25	155	160	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36835	36838		10.1074/jbc.274.52.36835	http://dx.doi.org/10.1074/jbc.274.52.36835			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601233	hybrid			2022-12-27	WOS:000084382700004
J	Yang, ZH; Hong, SH; Privalsky, ML				Yang, ZH; Hong, SH; Privalsky, ML			Transcriptional anti-repression - Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; CO-REPRESSOR; N-COR; RESPONSE ELEMENT; DOMAIN; IDENTIFICATION; ACTIVATION; EXPRESSION; ISOFORM; ALPHA	Thyroid hormone receptors (TSRs) are hormone-regulated transcription factors. Different T3R isoforms are expressed in a tissue-specific and developmentally regulated manner. The T3R alpha-1, beta-0, and beta-1 isoforms typically repress target gene expression in the absence of hormone and activate transcription in the presence of hormone, intriguingly, however, the T3R beta-2 isoform fails to repress, and instead is able to activate transcription in both the absence and presence of hormone. We investigated the molecular mechanism behind this absence of repression by T3R beta-2. Repression by T3R alpha-1, beta-0, and beta-1 is mediated by the ability of these isoforms to physically recruit a SMRT/N-CoR corepressor complex. We determined that the unliganded T3R beta-2 also recruits the SMRT corepressor; in contrast to the alpha-1, beta-0, and beta-1 isoforms, however, the T3R beta-2 protein interacts not only with the C-terminal "receptor-interaction domain" of SMRT, but also makes additional contacts with the N-terminal "silencing domain" of the SMRT corepressor. These additional, T3R beta-2-specific contacts interfere with the subsequent association of SMRT with mSin3, a crucial second subunit of the corepressor holocomplex. Our results suggest that T3R beta-2 regulates transcription through a novel anti-repression mechanism, recruiting SMRT, but preventing the subsequent formation of a functional corepressor complex.	Univ Calif Davis, Div Biol Sci, Microbiol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Privalsky, ML (corresponding author), Univ Calif Davis, Div Biol Sci, Microbiol Sect, Davis, CA 95616 USA.			Hong, Suk-Hyun/0000-0001-7541-4847	NCI NIH HHS [R37 CA053394, R37 CA053394-06S1, R37 CA-53394] Funding Source: Medline; NIDDK NIH HHS [R01 DK053528, R01 DK053528-02, R01 DK-53528] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA053394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053528] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; BAGY L, 1997, CELL, V89, P373; BANIAHMAD A, 1995, MOL CELL BIOL, V15, P76, DOI 10.1128/MCB.15.1.76; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BIGLER J, 1988, MOL CELL BIOL, V8, P4155, DOI 10.1128/MCB.8.10.4155; CASANOVA J, 1994, MOL CELL BIOL, V14, P5756, DOI 10.1128/MCB.14.9.5756; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; Hollenberg AN, 1996, J BIOL CHEM, V271, P28516, DOI 10.1074/jbc.271.45.28516; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; LECHAN RM, 1994, ENDOCRINOLOGY, V135, P92, DOI 10.1210/en.135.1.92; LECHAN RM, 1993, ENDOCRINOLOGY, V132, P2461, DOI 10.1210/en.132.6.2461; Li H, 1997, MOL ENDOCRINOL, V11, P2025, DOI 10.1210/me.11.13.2025; Li M, 1997, BRAIN RES, V773, P125, DOI 10.1016/S0006-8993(97)00917-7; Lin BC, 1997, MOL CELL BIOL, V17, P6131, DOI 10.1128/MCB.17.10.6131; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P335; Muscat GEO, 1998, NUCLEIC ACIDS RES, V26, P2899, DOI 10.1093/nar/26.12.2899; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; RIBEIRO RC, 1993, ANN NY ACAD SCI, V758, P366; Safer JD, 1997, MOL ENDOCRINOL, V11, P16, DOI 10.1210/me.11.1.16; Sande S, 1996, MOL ENDOCRINOL, V10, P813, DOI 10.1210/me.10.7.813; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; Schulman IG, 1996, MOL CELL BIOL, V16, P3807; SCHWARTZ HL, 1994, J BIOL CHEM, V269, P24777; Seol W, 1996, MOL ENDOCRINOL, V10, P1646, DOI 10.1210/me.10.12.1646; SHOWERS MO, 1991, DNA CELL BIOL, V10, P211, DOI 10.1089/dna.1991.10.211; SJOBERG M, 1995, MOL CELL BIOL, V15, P4718; SJOBERG M, 1992, DEVELOPMENT, V114, P39; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Wolffe AP, 1997, NATURE, V387, P16, DOI 10.1038/387016a0; Wong CW, 1998, MOL CELL BIOL, V18, P5724, DOI 10.1128/MCB.18.10.5724; Wong CW, 1998, MOL CELL BIOL, V18, P5500, DOI 10.1128/MCB.18.9.5500; Yoh SM, 1997, MOL ENDOCRINOL, V11, P470, DOI 10.1210/me.11.4.470; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhang JS, 1997, MOL CELL BIOL, V17, P6887, DOI 10.1128/MCB.17.12.6887; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	52	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37131	37138		10.1074/jbc.274.52.37131	http://dx.doi.org/10.1074/jbc.274.52.37131			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601274	hybrid, Green Accepted			2022-12-27	WOS:000084382700045
J	Balboa, MA; Balsinde, J; Johnson, CA; Dennis, EA				Balboa, MA; Balsinde, J; Johnson, CA; Dennis, EA			Regulation of arachidonic acid mobilization in lipopolysaccharide-activated P388D(1) macrophages by adenosine triphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE A(2) ENZYMES; EXPRESSION; RECEPTOR; ATP; CELLS; MODULATION; P2X(7); PROSTAGLANDIN-E(2); INHIBITION; DEATH	Murine P388D, macrophages exhibit a delayed prostaglandin biosynthetic response when exposed to bacterial lipopolysaccharide (LPS) for prolonged periods of time that is dependent on induction of the genes coding for Group V secretory phospholipase A(2) and cyclooxygenase-2, We herein report that LPS-induced arachidonic acid (AA) metabolite release in P388D(1) macrophages is strongly attenuated by the P2X(7) purinergic receptor antagonists periodate-oxidized ATP and pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid, and this is accompanied by suppression of the expression of both Group V secretory phospholipase A(2) and cyclooxygenase-2, The effect appears to be specific for LPS, because the P2X(7) purinergic receptor antagonists do not affect P388D, cell stimulation by other stimuli such as platelet-activating factor or the Ca2+ ionophore A23187. Moreover, extracellular nucleotides are found to stimulate macrophage AA mobilization with a pharmacological profile that implicates the participation of the P2X(7) receptor and that is inhibited by periodate-oxidized ATP. Collectively these results demonstrate coupling of the P2X(7) receptor to the AA cascade in P388D, macrophages and implicate the participation of this type of receptor in LPS-induced AA mobilization.	Univ Calif San Diego, Dept Biochem & Chem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Dept Biochem & Chem, 4080 BSB M-C 0601,9500 Gilman Dr, La Jolla, CA 92093 USA.	edennis@ucsd.edu	Balboa, María A./V-9493-2018; Balsinde, Jesús/C-7833-2018; Dennis, Edward A./M-5554-2019	Balboa, María A./0000-0002-2130-5298; Balsinde, Jesús/0000-0002-4157-6714; Dennis, Edward A./0000-0003-3738-3140	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026171] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26171] Funding Source: Medline; NIGMS NIH HHS [GM2051] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASMIS R, 1994, BIOCHEM J, V298, P543, DOI 10.1042/bj2980543; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Balsinde J, 1997, BIOCHEM J, V321, P805, DOI 10.1042/bj3210805; BALSINDE J, 1994, P NATL ACAD SCI USA, V91, P11060, DOI 10.1073/pnas.91.23.11060; Balsinde J, 1999, J BIOL CHEM, V274, P25967, DOI 10.1074/jbc.274.37.25967; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; BARBOUR SE, 1993, J BIOL CHEM, V268, P21875; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; ELMOATASSIM C, 1993, J BIOL CHEM, V268, P15571; Ferrari D, 1999, J BIOL CHEM, V274, P13205, DOI 10.1074/jbc.274.19.13205; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Ferrari D, 1997, J CELL BIOL, V139, P1635, DOI 10.1083/jcb.139.7.1635; GLASER KB, 1990, J BIOL CHEM, V265, P8658; Hu Y, 1998, J BIOL CHEM, V273, P27170, DOI 10.1074/jbc.273.42.27170; Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265, DOI 10.1002/jlb.64.2.265; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lio YC, 1996, BBA-LIPID LIPID MET, V1302, P55, DOI 10.1016/0005-2760(96)00002-1; MATSUURA K, 1994, J EXP MED, V179, P1671, DOI 10.1084/jem.179.5.1671; MURGIA M, 1993, J BIOL CHEM, V268, P8199; NUTTLE LC, 1993, MOL PHARMACOL, V44, P93; PROCTOR RA, 1994, P NATL ACAD SCI USA, V91, P6017, DOI 10.1073/pnas.91.13.6017; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Sperlagh B, 1998, NEUROCHEM INT, V33, P209, DOI 10.1016/S0197-0186(98)00025-4; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1	27	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36764	36768		10.1074/jbc.274.51.36764	http://dx.doi.org/10.1074/jbc.274.51.36764			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593984	Green Published, hybrid			2022-12-27	WOS:000084279200103
J	Barroso, JB; Corpas, FJ; Carreras, A; Sandalio, LM; Valderrama, R; Palma, JM; Lupianez, JA; del Rio, LA				Barroso, JB; Corpas, FJ; Carreras, A; Sandalio, LM; Valderrama, R; Palma, JM; Lupianez, JA; del Rio, LA			Localization of nitric-oxide synthase in plant peroxisomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PISUM-SATIVUM-L; SUPEROXIDE-DISMUTASE; MOLECULAR-CLONING; DISEASE RESISTANCE; DEHYDROGENASE; MITOCHONDRIA; EXPRESSION; RAT; GLYOXYSOMES; COTYLEDONS	The presence of nitric-oxide synthase (NOS) in peroxisomes from leaves of pea plants (Pisum sativum L.) was studied. Plant organelles were purified by differential and sucrose density gradient centrifugation. In purified intact peroxisomes a Ca2+-dependent NOS activity of 5.61 nmol of L-[H-3]citrulline mg(-1) protein min(-1) was measured while no activity was detected in mitochondria. The peroxisomal NOS activity was clearly inhibited (60-90%) by different well characterized inhibitors of mammalian NO synthases. The immunoblot analysis of peroxisomes with a polyclonal antibody against the C terminus region of murine iNOS revealed an immunoreactive protein of 130 kDa. Electron microscopy immuno-gold-labeling confirmed the subcellular localization of NOS in the matrix of peroxisomes as well as in chloroplasts. The presence of NOS in peroxisomes suggests that these oxidative organelles are a cellular source of nitric oxide (NO) and implies new roles for peroxisomes in the cellular signal transduction mechanisms.	CSIC, Estac Expt Zaidin, Dept Bioquim Biol Celular & Mol Plantas, E-18080 Granada, Spain; Univ Jaen, Fac Ciencias Expt, Dept Bioquim & Biol Mol, E-23071 Jaen, Spain; Univ Granada, Ctr Ciencias Biol, Dept Bioquim & Biol Mol, E-18001 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Universidad de Jaen; University of Granada	Lupianez, JA (corresponding author), CSIC, Estac Expt Zaidin, Dept Bioquim Biol Celular & Mol Plantas, Apartado 419, E-18080 Granada, Spain.	javier.corpas@eez.csic.es	Barroso, Juan B./G-8041-2014; Albarracín, Juan Bautista Barroso/ABC-2908-2020; Valderrama, Raquel/H-5937-2015; Sandalio, Luisa M/H-7673-2015; Corpas, Francisco J/A-4447-2008; Lupiáñez, José A./M-6664-2015; Palma, Jose M/L-3803-2014	Albarracín, Juan Bautista Barroso/0000-0002-9477-9195; Sandalio, Luisa M/0000-0002-8550-7577; Corpas, Francisco J/0000-0002-1814-9212; Lupiáñez, José A./0000-0001-9095-7145; Palma, Jose M/0000-0001-6673-3571; Carreras Egana, Alfonso Maria/0000-0003-2312-6602; Valderrama Rodriguez, Raquel/0000-0003-2253-0101				AEBI H, 1984, METHOD ENZYMOL, V105, P121; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Corpas FJ, 1998, BIOCHEM J, V330, P777; CORPAS FJ, 1994, EUR J CELL BIOL, V65, P280; Corpas FJ, 1998, NEW PHYTOL, V138, P307, DOI 10.1046/j.1469-8137.1998.00899.x; Cueto M, 1996, FEBS LETT, V398, P159, DOI 10.1016/S0014-5793(96)01232-X; Dangl J, 1998, NATURE, V394, P525, DOI 10.1038/28958; del Rio LA, 1998, PHYSIOL PLANTARUM, V104, P673, DOI 10.1034/j.1399-3054.1998.1040422.x; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; DELRIO LA, 1985, J INORG BIOCHEM, V24, P25; Distefano S, 1997, BIOCHEM J, V327, P399, DOI 10.1042/bj3270399; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5; HUANG AHC, 1983, PLANT PEROXIDSOMES; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Knowles RG, 1996, BIOCHEM SOC T, V24, P875, DOI 10.1042/bst0240875; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Leshem YY, 1996, J PLANT PHYSIOL, V148, P258, DOI 10.1016/S0176-1617(96)80251-3; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; LopezHuertas E, 1997, FREE RADICAL RES, V26, P497, DOI 10.3109/10715769709097820; LOPEZHUERTAS E, 1995, PLANT PHYSIOL BIOCH, V33, P295; LOPEZHUERTAS E, 1989, BIOOCH J, V337, P531; LYONS CR, 1992, J BIOL CHEM, V267, P6370; MARSDEN PA, 1992, FEBS LETT, V307, P287, DOI 10.1016/0014-5793(92)80697-F; McMillan K, 1996, METHOD ENZYMOL, V268, P460; Mullen RT, 1996, TRENDS PLANT SCI, V1, P389, DOI 10.1016/S1360-1385(96)80314-1; Ninnemann H, 1996, PHOTOCHEM PHOTOBIOL, V64, P393, DOI 10.1111/j.1751-1097.1996.tb02477.x; Noritake T, 1996, PLANT CELL PHYSIOL, V37, P113, DOI 10.1093/oxfordjournals.pcp.a028908; Ribeiro EA, 1999, FEBS LETT, V445, P283, DOI 10.1016/S0014-5793(99)00138-6; RIVEROSMORENO V, 1993, EUR J BIOCHEM, V215, P801, DOI 10.1111/j.1432-1033.1993.tb18095.x; Sakuma S, 1997, BIOCHEM BIOPH RES CO, V230, P476, DOI 10.1006/bbrc.1996.5983; SANDALIO LM, 1987, PLANT SCI, V51, P1, DOI 10.1016/0168-9452(87)90213-5; SANDALIO LM, 1988, PLANT PHYSIOL, V87, P1, DOI 10.1104/pp.87.1.1; SESSA WC, 1992, J BIOL CHEM, V267, P15274; SHEPHARD EA, 1992, ARCH BIOCHEM BIOPHYS, V294, P168, DOI 10.1016/0003-9861(92)90152-M; Shirasu K, 1996, CURR OPIN IMMUNOL, V8, P3, DOI 10.1016/S0952-7915(96)80097-5; Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044; Uttenthal LO, 1998, MICROSC RES TECHNIQ, V43, P75, DOI 10.1002/(SICI)1097-0029(19981001)43:1<75::AID-JEMT11>3.0.CO;2-0; Van Camp W, 1998, TRENDS PLANT SCI, V3, P330, DOI 10.1016/S1360-1385(98)01297-7; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; WALK RA, 1977, PLANTA, V134, P277, DOI 10.1007/BF00384194; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522	44	255	303	2	31	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36729	36733		10.1074/jbc.274.51.36729	http://dx.doi.org/10.1074/jbc.274.51.36729			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593979	hybrid			2022-12-27	WOS:000084279200098
J	Bielicki, J; Crawley, AC; Davey, RCA; Varnai, JC; Hopwood, JJ				Bielicki, J; Crawley, AC; Davey, RCA; Varnai, JC; Hopwood, JJ			Advantages of using same species enzyme for replacement therapy in a feline model of mucopolysaccharidosis type VI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAROTEAUX-LAMY SYNDROME; N-ACETYLGALACTOSAMINE 4-SULFATASE; LYSOSOMAL-ENZYMES; GAUCHER-DISEASE; CANINE MODEL; LONG-TERM; EXPRESSION; PURIFICATION; FIBROBLASTS; PROTEINS	In a feline model of mucopolysaccharidosis type VI (IMPS VI), recombinant feline N-acetylgalactosamine-4-sulfatase (rf4S) administered at a dose of 1 mg/kg of body weight, altered the clinical course of the disease in two affected cats treated from birth. After 170 days of therapy, both cats were physically indistinguishable from normal cats with the exception of mild corneal clouding. Feline N-acetylgalactosamine-4-sulfatase was effective in reducing urinary glycosaminoglycan levels and lysosomal storage in all cell types examined except for corneal keratocytes and cartilage chondrocytes. In addition, skeletal pathology was nearly normalized as assessed by radiographic evidence and bone morphometric analysis. Comparison of results with a previous study in which recombinant human 4S (rh4S) was used at an equivalent dose and one 5 times higher indicated that rf4S had a more pronounced effect on reducing pathology than the same dose of rh4S, and in some instances such as bone pathology and lysosomal storage in aorta smooth muscle cells, it was as good as, or better than, the higher dose of rh4S. We conclude that in the feline MPS VI model the use of native or same species enzyme for enzyme replacement therapy has significant benefits.	Womens & Childrens Hosp, Lysosomal Dis Res Unit, Dept Chem Pathol, Adelaide, SA 5006, Australia; Univ New S Wales, Dept Biotechnol, Sydney, NSW 2052, Australia	Womens & Childrens Hospital Australia; University of New South Wales Sydney	Hopwood, JJ (corresponding author), Womens & Childrens Hosp, Lysosomal Dis Res Unit, Dept Chem Pathol, 72 King William Rd, Adelaide, SA 5006, Australia.	jhopwood@medicine.adelaide.edu.au						ANSON DS, 1992, BIOCHEM J, V284, P789, DOI 10.1042/bj2840789; BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; Bielicki J, 1998, BIOCHEM J, V329, P145, DOI 10.1042/bj3290145; BIELICKI J, 1993, BIOCHEM J, V289, P241, DOI 10.1042/bj2890241; BIELICKI J, 1995, BIOCHEM J, V311, P333, DOI 10.1042/bj3110333; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BROOKS DA, 1994, BIOCHEM MED METAB B, V53, P58, DOI 10.1006/bmmb.1994.1058; Brooks DA, 1997, BBA-MOL BASIS DIS, V1361, P203, DOI 10.1016/S0925-4439(97)00036-7; Byers S, 1997, BONE, V21, P425, DOI 10.1016/S8756-3282(97)00175-0; CHANG PL, 1988, EXP CELL RES, V176, P258, DOI 10.1016/0014-4827(88)90329-1; Crawley AC, 1997, J CLIN INVEST, V99, P651, DOI 10.1172/JCI119208; Crawley AC, 1996, J CLIN INVEST, V97, P1864, DOI 10.1172/JCI118617; DORNER AJ, 1989, J BIOL CHEM, V264, P20602; FREEMAN C, 1992, ADV EXP MED BIOL, V313, P121; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GIBSON GJ, 1987, BIOCHEM J, V248, P755, DOI 10.1042/bj2480755; GOLD EW, 1979, ANAL BIOCHEM, V99, P183, DOI 10.1016/0003-2697(79)90061-7; Hopwood J. J., 1989, HEPARIN CHEM BIOL PR, P191; HOPWOOD JJ, 1982, ANAL BIOCHEM, V119, P120, DOI 10.1016/0003-2697(82)90674-1; HOPWOOD JJ, 1993, J INHERIT METAB DIS, V16, P1024, DOI 10.1007/BF00711520; JACKSON CE, 1992, GENOMICS, V14, P403, DOI 10.1016/S0888-7543(05)80233-2; JEZYK PF, 1977, SCIENCE, V198, P834, DOI 10.1126/science.144321; JOSHI L, 1995, ENDOCRINOLOGY, V136, P3839, DOI 10.1210/en.136.9.3839; Kakkis ED, 1996, BIOCHEM MOL MED, V58, P156, DOI 10.1006/bmme.1996.0044; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KRIVIT W, 1984, NEW ENGL J MED, V311, P1606, DOI 10.1056/NEJM198412203112504; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Litjens T, 1997, BIOCHEM J, V327, P89, DOI 10.1042/bj3270089; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MORRELL AG, 1971, J BIOL CHEM, V246, P1461; Neufeld EF, 1995, METABOLIC MOL BASES, P2465; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Ponce E, 1997, BLOOD, V90, P43; Recker RR., 1983, BONE HISTOMORPHOMETR; SHULL RM, 1994, P NATL ACAD SCI USA, V91, P12937, DOI 10.1073/pnas.91.26.12937; TURNBULL JE, 1997, LAB GUIDE GLYCOCONJU, P261; VOGLER C, 1993, PEDIATR RES, V34, P837, DOI 10.1203/00006450-199312000-00028; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; Yogalingam G, 1996, J BIOL CHEM, V271, P27259, DOI 10.1074/jbc.271.44.27259	39	28	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36335	36343		10.1074/jbc.274.51.36335	http://dx.doi.org/10.1074/jbc.274.51.36335			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593925	hybrid			2022-12-27	WOS:000084279200044
J	Fuglsang, AT; Visconti, S; Drumm, K; Jahn, T; Stensballe, A; Mattei, B; Jensen, ON; Aducci, P; Palmgren, MG				Fuglsang, AT; Visconti, S; Drumm, K; Jahn, T; Stensballe, A; Mattei, B; Jensen, ON; Aducci, P; Palmgren, MG			Binding of 14-3-3 protein to the plasma membrane H+-ATPase AHA2 involves the three C-terminal residues Tyr(946)-Thr-Val and requires phosphorylation of Thr(947)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE GELS; NITRATE REDUCTASE; KINASE-ACTIVITY; SPINACH LEAVES; FUSICOCCIN; 14-3-3-PROTEINS; DOMAIN; IDENTIFICATION; ASSOCIATION; TRANSPORT	14-3-3 proteins play a regulatory role in a diverse array of cellular functions such as apoptosis, regulation of the cell cycle, and regulation of gene transcription. The phytotoxin fusicoccin specifically induces association of virtually any 14-3-3 protein to plant plasma membrane Hf-ATPase. The 14-3-3 binding site in the Arabidopsis plasma membrane H+-ATPase AHA2 was localized to the three C-terminal residues of the enzyme (Tyr(946)-Thr-Val). finding of 14-3-3 protein to this target was induced by phosphorylation of Thr(947) (K-D = 88 nM) and was in practice irreversible in the presence of fusicoccin (K-D = 7 nM). Mass spectrometry analysis demonstrated that AHA2 expressed in yeast was phosphorylated at Thr(947). We conclude that the extreme end of AHA2 contains an unusual high-affinity binding site for 14-3-3 protein.	Royal Vet & Agr Univ, Dept Plant Biol, DK-1871 Frederiksberg, Copenhagen, Denmark; Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Odense Univ, Univ So Denmark, Dept Biol Mol, Prot Res Grp, DK-5230 Odense, Denmark; Univ Rome La Sapienza, Dept Plant Biol, I-00185 Rome, Italy	University of Copenhagen; University of Rome Tor Vergata; University of Southern Denmark; Sapienza University Rome	Palmgren, MG (corresponding author), Royal Vet & Agr Univ, Dept Plant Biol, Thorvaldsensvej 40, DK-1871 Frederiksberg, Copenhagen, Denmark.		Mattei, Benedetta/F-1504-2015; Stensballe, Allan/K-6756-2019; fuglsang, anja thoe t/E-1683-2012; Palmgren, Michael/A-9808-2013; Fuglsang, Anja Thoe/A-6733-2015; Jensen, Ole N/J-1763-2012; Mattei, Benedetta/C-3013-2019	Mattei, Benedetta/0000-0003-2927-6329; Stensballe, Allan/0000-0002-9888-1955; fuglsang, anja thoe t/0000-0003-1153-8394; Palmgren, Michael/0000-0002-9982-6114; Fuglsang, Anja Thoe/0000-0003-1153-8394; Jensen, Ole N/0000-0003-1862-8528; Mattei, Benedetta/0000-0003-2927-6329				Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; ANDERSSON L, 1986, ANAL BIOCHEM, V154, P250, DOI 10.1016/0003-2697(86)90523-3; Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Bachmann M, 1996, FEBS LETT, V387, P127, DOI 10.1016/0014-5793(96)00478-4; BALLIO A, 1980, PLANT SCI LETT, V18, P39, DOI 10.1016/0304-4211(80)90019-X; BALLIO A, 1968, Annali dell'Istituto Superiore di Sanita, V4, P317; Baunsgaard L, 1998, PLANT J, V13, P661, DOI 10.1046/j.1365-313X.1998.00083.x; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Fullone MR, 1998, J BIOL CHEM, V273, P7698, DOI 10.1074/jbc.273.13.7698; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gu MY, 1998, J BIOL CHEM, V273, P33465, DOI 10.1074/jbc.273.50.33465; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Jahn T, 1997, PLANT CELL, V9, P1805, DOI 10.1105/tpc.9.10.1805; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; LU GH, 1994, PLANT MOL BIOL, V25, P659, DOI 10.1007/BF00029604; MattoYelin M, 1997, MOL BIOL CELL, V8, P1889, DOI 10.1091/mbc.8.10.1889; MEYER C, 1993, Z NATURFORSCH C, V48, P595; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Moore BE, 1967, PHYSL BIOCH ASPECTS, P343; Moorhead G, 1996, CURR BIOL, V6, P1104, DOI 10.1016/S0960-9822(02)70677-5; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Oecking C, 1997, PLANT J, V12, P441, DOI 10.1046/j.1365-313X.1997.12020441.x; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; Palmgren M.G., 1998, EXP BIOL ONLINE, V3, P1; Palmgren MG, 1998, ADV BOT RES, V28, P1; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Piotrowski M, 1998, J BIOL CHEM, V273, P30018, DOI 10.1074/jbc.273.45.30018; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Sehnke PC, 1996, CURR BIOL, V6, P1403, DOI 10.1016/S0960-9822(96)00742-7; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Wakui H, 1997, J BIOL CHEM, V272, P8153, DOI 10.1074/jbc.272.13.8153; Wang HN, 1998, J BIOL CHEM, V273, P16297, DOI 10.1074/jbc.273.26.16297; Wang WF, 1996, J MOL EVOL, V43, P384; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	44	265	282	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36774	36780		10.1074/jbc.274.51.36774	http://dx.doi.org/10.1074/jbc.274.51.36774			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593986	Green Published, hybrid			2022-12-27	WOS:000084279200105
J	Roberts, BJ; Whitelaw, ML				Roberts, BJ; Whitelaw, ML			Degradation of the basic helix-loop-helix/Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; UBIQUITIN-PROTEASOME PATHWAY; NUCLEAR TRANSLOCATOR PROTEIN; INDUCIBLE FACTOR 1-ALPHA; AH RECEPTOR; IN-VIVO; C-JUN; CELLS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; PHOSPHORYLATION	The basic helix-loop-helix/Per-ARNT-Sim homology domain dioxin receptor (DR) translocates to the nucleus upon binding of aromatic hydrocarbon ligands typified by dioxin, whereupon it partners the Ah receptor nuclear translocator and initiates transcription. Concurrently, ligand binding down-regulates receptor levels via an unknown mechanism. In this study we show that receptor levels are dependent upon cellular compartmentalization, with entry into the nucleus leading to the rapid destruction of the DR. Ligand-induced DR translocation was bypassed by adding a heterologous nuclear localization signal to the DR, creating a constitutively nuclear form of the dioxin receptor (DRNLS). The DRNLS protein was shown to be unstable with a half-life of less than or equal to 1 h whether partnering ARNT or HSP90. Thus, the structural changes induced by ligand binding have no inherent effect on DR stability but are critical in transporting the receptor prior to degradation. The proteolytic pathway that degrades the nuclear receptor is suggested to involve ubiquitination as it was inhibited by the proteasome inhibitor MG132 or co-expression of DRNLS with the ubiquitin mutant UbK48R. Incubation of cells expressing DRNLS with the phosphatase inhibitor calyculin resulted in the rapid phosphorylation and ubiquitination of DRNLS, suggesting that a nuclear kinase is required to trigger receptor proteolysis. Overall, this study demonstrates a novel mechanism of proteolysis whereby the simple relocation of a transcription factor from cytoplasm to nucleus initiates its rapid destruction.	Univ Adelaide, Dept Biochem, Adelaide, SA 5005, Australia	University of Adelaide	Roberts, BJ (corresponding author), Univ Adelaide, Dept Biochem, Adelaide, SA 5005, Australia.	broberts@biochem.adelaide.edu.au						Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cole CN, 1998, CURR BIOL, V8, pR368, DOI 10.1016/S0960-9822(98)70239-8; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Lahvis GP, 1998, BIOCHEM PHARMACOL, V56, P781, DOI 10.1016/S0006-2952(98)00134-8; LEES M, 1999, IN PRESS MOL CELL BI; Ma Q, 1997, J BIOL CHEM, V272, P8878; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; OKEY AB, 1994, TRENDS PHARMACOL SCI, V15, P226, DOI 10.1016/0165-6147(94)90316-6; POLLENZ RS, 1994, MOL PHARMACOL, V45, P428; Pollenz RS, 1996, MOL PHARMACOL, V49, P391; PROKIPCAK RD, 1991, CAN J PHYSIOL PHARM, V69, P1204, DOI 10.1139/y91-176; Ptashne M, 1998, CURR BIOL, V8, pR812, DOI 10.1016/S0960-9822(07)00508-8; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; SWANSON HI, 1993, ARCH BIOCHEM BIOPHYS, V302, P167, DOI 10.1006/abbi.1993.1195; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; TSURUMI C, 1995, MOL CELL BIOL, V15, P5682; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Whitlock JP, 1996, FASEB J, V10, P809, DOI 10.1096/fasebj.10.8.8666157; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032	42	100	102	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36351	36356		10.1074/jbc.274.51.36351	http://dx.doi.org/10.1074/jbc.274.51.36351			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593927	hybrid			2022-12-27	WOS:000084279200046
J	Rogerson, FM; Dimopoulos, N; Sluka, P; Chu, S; Curtis, AJ; Fuller, PJ				Rogerson, FM; Dimopoulos, N; Sluka, P; Chu, S; Curtis, AJ; Fuller, PJ			Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG GLUCOCORTICOID RECEPTOR; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; PROGESTERONE RECEPTORS; CORTISOL RESISTANCE; CRYSTAL-STRUCTURE; TRANSACTIVATION; SPECIFICITY; DOMAIN; SALT; HYPERTENSION	The structural determinants of aldosterone binding specificity in the mineralocorticoid receptor (MR) have not been determined. The MR has greatest sequence identity with the better characterized glucocorticoid receptor (GR), which is reflected in their overlapping ligand binding specificities. There must be subtle sequence differences that can account for the MR-specific binding of aldosterone and the shared binding of cortisol. To characterize ligand binding specificity, chimeras were made between the human MR and GR ligand-binding domains (LBDs). Three points were chosen as break points to generate a total of 16 different constructs, These chimeric LBDs were placed in a human Cat expression vector containing the GR RNA-binding and N-terminal domains and assayed by co-transfection into CV-1 cells with the mouse mammary tumor virus-luciferase reporter plasmid, Binding of [(3)H]aldosterone and [(3)H]dexamethasone was also measured. All of the constructs that are potently activated by aIdosterone contain amino acids 804-874 of the MR. The results of the Ligand binding experiments using [(3)H]aldosterone were consistent with the transactivation assay. Cortisol activation of the chimeras was surprisingly complex. Constructs that are activated by cortisol contain either amino acids 804-874 and 932-984 of the MR or amino acids 598-668 and 726-777 of the GR. However, all of the chimeras retained the ability to bind the synthetic glucocorticoid [(3)H]dexamethasone, and cortisol was able to displace [(3)H]dexamethasone binding, suggesting that the differential effects of cortisol on transcriptional activation are caused by an effect that occurs downstream of ligand binding. These results identify a subregion of the MR LED that confers specificity of aldosterone binding, which contrasts with cortisol binding where differential effects between chimeras appear to be mediated by interactions distal to ligand binding.	Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia	Prince Henry's Institute of Medical Research	Rogerson, FM (corresponding author), Prince Henrys Inst Med Res, POB 5152, Clayton, Vic 3168, Australia.	fraser.rogerson@med.monash.edu.au	Sluka, Pavel/ABH-5049-2020; Chu, Simon/AAJ-7802-2020; Sluka, Pavel/I-1443-2013	Sluka, Pavel/0000-0002-6043-0809; Chu, Simon/0000-0003-4658-215X; Sluka, Pavel/0000-0002-6043-0809; Curtis, Andrea/0000-0003-2407-770X; Fuller, Peter/0000-0002-0948-2072				ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; ARRIZA JL, 1988, NEURON, V1, P887, DOI 10.1016/0896-6273(88)90136-5; ARRIZA JL, 1991, COLLOQ INSE, V215, P13; BENHAMOU B, 1992, SCIENCE, V255, P206, DOI 10.1126/science.1372753; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CATO ACB, 1991, COLLOQ INSE, V215, P23; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; EISEN LP, 1986, ENDOCRINOLOGY, V119, P1419, DOI 10.1210/endo-119-4-1419; Fagart J, 1998, EMBO J, V17, P3317, DOI 10.1093/emboj/17.12.3317; Fuller P.J, 1997, CURR OPIN ENDOCRINOL, V4, P218; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Geller DS, 1998, NAT GENET, V19, P279, DOI 10.1038/966; GomezSanchez EP, 1996, STEROIDS, V61, P184, DOI 10.1016/0039-128X(96)00010-4; GOMEZSANCHEZ EP, 1990, AM J PHYSIOL, V258, pE649, DOI 10.1152/ajpendo.1990.258.4.E649; Govindan MV, 1998, J BIOL CHEM, V273, P24439, DOI 10.1074/jbc.273.38.24439; JAMIESON A, 1993, J MOL ENDOCRINOL, V10, P3, DOI 10.1677/jme.0.0100003; KEIGHTLEY MC, 1995, STEROIDS, V60, P87, DOI 10.1016/0039-128X(94)00014-4; Keightley MC, 1998, ENDOCRINOLOGY, V139, P2479, DOI 10.1210/en.139.5.2479; KEIGHTLEY MC, 1994, MOL ENDOCRINOL, V8, P431, DOI 10.1210/me.8.4.431; Lim-Tio SS, 1998, ENDOCRINOLOGY, V139, P1653, DOI 10.1210/en.139.4.1653; LimTio SS, 1997, ENDOCRINOLOGY, V138, P2537, DOI 10.1210/en.138.6.2537; LOMBES M, 1994, ENDOCRINOLOGY, V135, P834, DOI 10.1210/en.135.3.834; Lupo B, 1998, BIOCHEMISTRY-US, V37, P12153, DOI 10.1021/bi980593e; MCPHERSON GA, 1983, J PHARMACOL METHOD, V10, P231, DOI 10.1016/0160-5402(83)90017-7; NEMOTO T, 1993, J BIOCHEM-TOKYO, V113, P769; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Vivat V, 1997, J MOL ENDOCRINOL, V18, P147, DOI 10.1677/jme.0.0180147; Wagner BL, 1999, ENDOCRINOLOGY, V140, P1449, DOI 10.1210/en.140.3.1449; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Young MJ, 1996, STEROIDS, V61, P233, DOI 10.1016/0039-128X(96)00020-7	35	53	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36305	36311		10.1074/jbc.274.51.36305	http://dx.doi.org/10.1074/jbc.274.51.36305			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593921	hybrid			2022-12-27	WOS:000084279200040
J	Thomas, JW; Cooley, MA; Broome, JM; Salgia, R; Griffin, JD; Lombardo, CR; Schaller, MD				Thomas, JW; Cooley, MA; Broome, JM; Salgia, R; Griffin, JD; Lombardo, CR; Schaller, MD			The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC HOMOLOGY-2 DOMAIN; CELL-ADHESION; HIGH-AFFINITY; SH3 DOMAIN; LIM DOMAIN; V-SRC; DIRECT ASSOCIATION; DEPENDENT BINDING; FAMILY KINASES; PROTEIN BINDS	Focal adhesion kinase (FAK) and paxillin are focal adhesion-associated phosphotyrosine-containing proteins that physically interact. A previous study has demonstrated that paxillin contains two binding sites for FAB Ne have further characterized these two binding sites and have demonstrated that the binding affinity of the carboxyl-terminal domain of FAR is the same for each of the two binding sites. The presence of both binding sites increases the affinity for FAR by 5-10-fold. A conserved paxillin sequence called the LD motif has been implicated in FAK binding. We show that mutations in the LD motifs in both FAK-binding sites are required to dramatically impair FAR binding in vitro. A paxillin mutant containing point mutations in both FAK-binding sites was characterized. The mutant exhibited reduced levels of phosphotyrosine relative to wild type paxillin in subconfluent cells growing in culture, following cell adhesion to fibronectin and in src-transformed fibroblasts. These results suggest that paxillin must bind FAK for maximal phosphorylation in response to cell adhesion and that FAK may function to direct tyrosine phosphorylation of paxillin in the process of transformation by the src oncogene.	Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Macromol Interact Facil, Chapel Hill, NC 27599 USA; Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Dana-Farber Cancer Institute	Schaller, MD (corresponding author), Univ N Carolina, Dept Cell Biol & Anat, Taylor Hall CB 7090, Chapel Hill, NC 27599 USA.			Cooley, Marion A./0000-0002-4286-745X	NCI NIH HHS [1F32CA74490] Funding Source: Medline; NIGMS NIH HHS [GM53668] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA074490] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; BERGMAN M, 1995, MOL CELL BIOL, V15, P711; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cary LA, 1996, J CELL SCI, V109, P1787; CHAN PY, 1994, J BIOL CHEM, V269, P20567; CHAREST A, 1995, BIOCHEM J, V308, P425, DOI 10.1042/bj3080425; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; CousinsWasti RC, 1996, BIOCHEMISTRY-US, V35, P16746, DOI 10.1021/bi9620868; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Fujita H, 1998, J BIOL CHEM, V273, P26516, DOI 10.1074/jbc.273.41.26516; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637, DOI 10.1091/mbc.6.6.637; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; LEMMON MA, 1994, BIOCHEMISTRY-US, V33, P5070, DOI 10.1021/bi00183a010; Lewis JM, 1998, J BIOL CHEM, V273, P14225, DOI 10.1074/jbc.273.23.14225; Lipsky BP, 1998, J BIOL CHEM, V273, P11709, DOI 10.1074/jbc.273.19.11709; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; Mosser EA, 1998, BIOCHEMISTRY-US, V37, P13686, DOI 10.1021/bi981310l; Nishiya N, 1999, J BIOL CHEM, V274, P9847, DOI 10.1074/jbc.274.14.9847; Owen JD, 1999, MOL CELL BIOL, V19, P4806; PAYNE G, 1993, P NATL ACAD SCI USA, V90, P4902, DOI 10.1073/pnas.90.11.4902; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SALGIA R, 1995, ONCOGENE, V11, P1149; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; SASTRY L, 1995, ONCOGENE, V11, P1107; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Thomas SM, 1999, J CELL SCI, V112, P181; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; Tong X, 1997, J BIOL CHEM, V272, P33373, DOI 10.1074/jbc.272.52.33373; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1994, J CELL SCI, V107, P1583; Vande Pol SB, 1998, ONCOGENE, V16, P43, DOI 10.1038/sj.onc.1201504; WENG ZG, 1993, J BIOL CHEM, V268, P14956; Wu RY, 1996, J BIOL CHEM, V271, P15934, DOI 10.1074/jbc.271.27.15934; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997	69	119	120	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36684	36692		10.1074/jbc.274.51.36684	http://dx.doi.org/10.1074/jbc.274.51.36684			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593973	Green Published, hybrid			2022-12-27	WOS:000084279200092
J	Berg, KL; Siminovitch, KA; Stanley, ER				Berg, KL; Siminovitch, KA; Stanley, ER			SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATING FACTOR-I; HEMATOPOIETIC-CELL PHOSPHATASE; GTPASE-ACTIVATING PROTEIN; M-CSF RECEPTOR; SIGNAL-TRANSDUCTION; INHIBITORY RECEPTORS; MOTH-EATEN; BCR-ABL; B-CELLS; C-CBL	SHP-1 plays key roles in the modulation of hematopoietic cell signaling. To ascertain the impact of SHP-1 on colony-stimulating factor-1 (CSF-1)-mediated survival and proliferative signaling, we compared the CSF-1 responses of primary bone marrow macrophages (BMM) from wild-type and SHP-1-deficient motheaten (me/me) mice. CSF-1-induced protein tyrosine phosphorylation levels were similar in wild-type and me/me BMM, except for the constitutive hyperphosphoryIation of a 62-kDa phosphoprotein (pp62) in me/me macrophages. pp62 was identified as the RASGAP-associated p62(DOK) and was shown to be the major CSF-1R-associated tyrosine-phosphorylated protein in CSF-1-treated BMM, p62DOK was found to be constitutively associated with SHP-1 in BMM and in 293T cells, co-expressing p62(dok) and either wild-type or catalytically inert SHP-1 (SHP-1 C453S). In both cell types, the interaction of SHP-1 with p62DOK occurred independently of p62(DOK) tyrosine phosphorylation, but only the tyrosine-phosphorylated p62DOK was bound by SHP-1 C4535 in a far Western analysis. These findings suggest a constitutive association of SHP-1 and p62DOK that is either conformation-dependent or indirect as well as a direct, inducible association of the SHP-1 catalytic domain with tyrosine-phosphorylated p62(DOK). P62(DOK) hyperphosphorylation is not associated with altered CSF-1-induced RAS signaling or proliferation. However, whereas wild-type macrophages undergo cell death following CSF-1 removal, me/me macrophages exhibit prolonged survival in the absence of growth factor. Thus, p62(DOK) is a major SHP-1 substrate whose tyrosine phosphorylation correlates with growth factor-independent survival in macrophages.	Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Univ Toronto, Dept Med & Immunol, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Yeshiva University; Albert Einstein College of Medicine; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Stanley, ER (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Siminovitch, Katherine/K-1475-2013; Stanley, Evan R/J-9154-2013	Stanley, Evan R/0000-0002-2910-2065	NCI NIH HHS [5T32 CA90173, CA26504, P30-CA13330] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA026504, R37CA026504] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEDI A, 1994, BLOOD, V83, P2038; Berg KL, 1998, ONCOGENE, V17, P2535, DOI 10.1038/sj.onc.1202203; BIGNON JS, 1994, CLIN IMMUNOL IMMUNOP, V73, P168, DOI 10.1006/clin.1994.1185; Binstadt BA, 1998, J BIOL CHEM, V273, P27518, DOI 10.1074/jbc.273.42.27518; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Bourette RP, 1998, EMBO J, V17, P7273, DOI 10.1093/emboj/17.24.7273; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; BUSCHER D, 1993, ONCOGENE, V8, P3323; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Dong Q, 1999, J IMMUNOL, V162, P3220; Dustin LB, 1999, J IMMUNOL, V162, P2717; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Frearson JA, 1997, BIOESSAYS, V19, P417, DOI 10.1002/bies.950190509; GERLACH MS, 1995, J BIOL CHEM, V270, P24635, DOI 10.1074/jbc.270.42.24635; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; HEIDARAN MA, 1992, ONCOGENE, V7, P147; HOSOMI Y, 1994, J BIOL CHEM, V269, P11498; Hua CT, 1998, J BIOL CHEM, V273, P28332, DOI 10.1074/jbc.273.43.28332; Jiao HY, 1997, EXP HEMATOL, V25, P592; Kanagasundaram V, 1996, BIOCHEM J, V320, P69, DOI 10.1042/bj3200069; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; LIOUBIN MN, 1994, MOL CELL BIOL, V14, P5682, DOI 10.1128/MCB.14.9.5682; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Lock P, 1996, CELL, V84, P23, DOI 10.1016/S0092-8674(00)80989-7; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; Mizuno K, 1996, J EXP MED, V184, P457, DOI 10.1084/jem.184.2.457; MORAN MF, 1991, MOL CELL BIOL, V11, P1304; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Noguchi T, 1999, EMBO J, V18, P1748, DOI 10.1093/emboj/18.7.1748; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; Roach TIA, 1998, CURR BIOL, V8, P1035, DOI 10.1016/S0960-9822(07)00426-5; Rohrschneider LR, 1997, MOL REPROD DEV, V46, P96; Siminovitch KA, 1998, SEMIN IMMUNOL, V10, P329, DOI 10.1006/smim.1998.0125; Somani AK, 1997, J BIOL CHEM, V272, P21113, DOI 10.1074/jbc.272.34.21113; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; STANLEY ER, 1990, METHOD MOL BIOL, P299; Stein-Gerlach M, 1998, INT J BIOCHEM CELL B, V30, P559, DOI 10.1016/S1357-2725(98)00002-8; TANAKA S, 1995, J BIOL CHEM, V270, P14347, DOI 10.1074/jbc.270.24.14347; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Vuica M, 1997, J EXP MED, V186, P259, DOI 10.1084/jem.186.2.259; Wang Y, 1996, J BIOL CHEM, V271, P17, DOI 10.1074/jbc.271.1.17; WISNIEWSKI D, 1994, LEUKEMIA, V8, P688; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; YEUNG YG, 1992, J BIOL CHEM, V267, P23447; Yeung YG, 1998, J BIOL CHEM, V273, P30638, DOI 10.1074/jbc.273.46.30638; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350; Yokoyama WM, 1997, J EXP MED, V186, P1803, DOI 10.1084/jem.186.11.1803	59	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35855	35865		10.1074/jbc.274.50.35855	http://dx.doi.org/10.1074/jbc.274.50.35855			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585470	hybrid			2022-12-27	WOS:000084187900082
J	Janzen, DM; Torgov, MY; Reddy, MK				Janzen, DM; Torgov, MY; Reddy, MK			In vitro reconstitution of the bacteriophage T4 clamp loader complex (gp44/62)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE ACCESSORY PROTEIN; REPLICATION FACTOR-C; ONE HOLOENZYME PARTICLE; 2 DNA-POLYMERASES; SLIDING CLAMP; ATP HYDROLYSIS; BACTERIAL LUCIFERASE; STRUCTURAL-ANALYSES; ESCHERICHIA-COLI; GENE-CLUSTER	The clamp loader complex (CLC) of bacteriophage T4 is essential for viability and has analogs in both prokaryotes and eukaryotes. The gp44 and gp62 subunits of the T4 CLC, in a 4:1 ratio, tightly associate such that the two proteins co-purify. Using transformed Escherichia coli, we were able to demonstrate for the first time purification of the unique protein gp62 in the absence of gp44. We experimentally determined the isoelectric point for the individual subunits. An in vitro physical interaction could be observed between the native subunits, which resulted in a reconstituted CLC that displayed the signature pattern of the ATPase functions of native CLC. Thus we demonstrate that the CLC forms via a self-assembly pathway rather than through a translational capture mechanism.	Univ Wisconsin, Dept Chem, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Reddy, MK (corresponding author), Univ Wisconsin, Dept Chem, POB 413, Milwaukee, WI 53201 USA.							BARRY J, 1972, P NATL ACAD SCI USA, V69, P2717, DOI 10.1073/pnas.69.9.2717; Berdis AJ, 1997, BIOCHEMISTRY-US, V36, P2733, DOI 10.1021/bi962139l; Berdis AJ, 1996, BIOCHEMISTRY-US, V35, P9253, DOI 10.1021/bi952569w; Bertram JG, 1998, J BIOL CHEM, V273, P24564, DOI 10.1074/jbc.273.38.24564; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai JS, 1996, P NATL ACAD SCI USA, V93, P12896, DOI 10.1073/pnas.93.23.12896; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; GERALD WL, 1984, GENETICS, V107, P537; GOGOL EP, 1992, J MOL BIOL, V224, P395, DOI 10.1016/0022-2836(92)91003-8; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HSU T, 1990, J BIOL CHEM, V265, P5303; Janzen DM, 1999, VIROLOGY, V260, P64, DOI 10.1006/viro.1999.9785; JARVIS TC, 1989, J BIOL CHEM, V264, P12717; JARVIS TC, 1989, J BIOL CHEM, V264, P12709; Kaboord BF, 1996, BIOCHEMISTRY-US, V35, P1084, DOI 10.1021/bi9520747; KABOORD BF, 1995, CURR BIOL, V5, P149, DOI 10.1016/S0960-9822(95)00036-4; KARAM J, 1979, VIROLOGY, V94, P192, DOI 10.1016/0042-6822(79)90449-5; Kroutil LC, 1998, J MOL BIOL, V278, P135, DOI 10.1006/jmbi.1998.1676; Latham GJ, 1997, J BIOL CHEM, V272, P31677, DOI 10.1074/jbc.272.50.31677; LEE SH, 1991, J BIOL CHEM, V266, P594; MACE DC, 1984, J MOL BIOL, V177, P279, DOI 10.1016/0022-2836(84)90457-1; MORRIS CF, 1979, J BIOL CHEM, V254, P6787; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pietroni P, 1997, J BIOL CHEM, V272, P31666, DOI 10.1074/jbc.272.50.31666; PIPERNO JR, 1978, J BIOL CHEM, V253, P5174; REDDY MK, 1993, P NATL ACAD SCI USA, V90, P3211, DOI 10.1073/pnas.90.8.3211; Reddy MK, 1995, METHOD ENZYMOL, V262, P466; RUSH J, 1989, J BIOL CHEM, V264, P10943; Sexton DJ, 1996, J BIOL CHEM, V271, P28045, DOI 10.1074/jbc.271.45.28045; SINCLAIR JF, 1993, BIOCHEMISTRY-US, V32, P5036, DOI 10.1021/bi00070a010; SPICER EK, 1984, J BIOL CHEM, V259, P5425; Torgov MY, 1998, J BACTERIOL, V180, P4339, DOI 10.1128/JB.180.17.4339-4343.1998; TROJANOWSKA M, 1984, NUCLEIC ACIDS RES, V12, P5979, DOI 10.1093/nar/12.15.5979; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Uhlmann F, 1996, P NATL ACAD SCI USA, V93, P6521, DOI 10.1073/pnas.93.13.6521; WADDLE JJ, 1987, BIOCHEMISTRY-US, V26, P4917, DOI 10.1021/bi00390a004; Yeh LS, 1998, J BACTERIOL, V180, P2005, DOI 10.1128/JB.180.8.2005-2013.1998; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001	43	4	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35938	35943		10.1074/jbc.274.50.35938	http://dx.doi.org/10.1074/jbc.274.50.35938			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585481	hybrid			2022-12-27	WOS:000084187900093
J	Weinberger, M; Trabold, PA; Lu, M; Sharma, K; Huberman, JA; Burhans, WC				Weinberger, M; Trabold, PA; Lu, M; Sharma, K; Huberman, JA; Burhans, WC			Induction by adozelesin and hydroxyurea of origin recognition complex-dependent DNA damage and DNA replication checkpoints in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; S-PHASE; BUDDING YEAST; CHROMOSOMAL REPLICATION; PROTEIN-KINASE; ORC; PATHWAY; AGENTS; REPAIR	DNA damaging agents induce a conserved intra-S-phase checkpoint that inhibits DNA replication in eukaryotic cells. To better understand this checkpoint and its role in determining the efficacy of antitumor drugs that damage DNA, we examined the effects of adozelesin, a DNA-alkylating antitumor agent that has a profound inhibitory effect on initiation of DNA replication in mammals, on the replication of Saccharomyces cerevisiae chromosomes. Adozelesin inhibited initiation of S, cerevisiae DNA replication by inducing an intra-S-phase DNA damage checkpoint. This inhibitory effect was abrogated in orc2-1 cells containing a temperature-sensitive mutation in a component of the origin recognition complex (ORC) that also causes a defect in initiation. The orc2-1 mutation also caused a defect in a checkpoint that regulates the activation of origins in late S phase in cells treated with hydroxyurea, Defects in both initiation and checkpoint regulation in the orc2-1 strain were suppressed by deletion of a gene encoding a putative acetyltransferase, SAS2, Adozelesin also induced a cellular response that requires a function of ORC in G(1). A similar G(1)-specific response in mammals may contribute to the cytotoxic and antitumor properties of this and other DNA-damaging drugs.	Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Burhans, WC (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	wburhans@sc3101.med.buffalo.edu			NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA16056-24] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; BHUYAN BK, 1992, CANCER CHEMOTH PHARM, V30, P348, DOI 10.1007/BF00689961; BHUYAN BK, 1992, CANCER RES, V52, P5687; Boger DL, 1996, ANGEW CHEM INT EDIT, V35, P1438, DOI 10.1002/anie.199614381; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BRUNBORG G, 1978, MOL GEN GENET, V162, P277, DOI 10.1007/BF00268853; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Dillin A, 1998, SCIENCE, V279, P1733, DOI 10.1126/science.279.5357.1733; DONALDSON KL, 1994, INT J CANCER, V57, P847, DOI 10.1002/ijc.2910570614; DUBEY DD, 1991, MOL CELL BIOL, V11, P5346, DOI 10.1128/MCB.11.10.5346; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; Foiani M, 1998, BIOL CHEM, V379, P1019; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; FOX CA, 1995, GENE DEV, V9, P911, DOI 10.1101/gad.9.8.911; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P294; HEIGERBERNAYS WJ, 1990, BIOCHEMISTRY-US, V29, P8461, DOI 10.1021/bi00488a037; Huberman JA, 1999, PROG NUCLEIC ACID RE, V62, P369; HUBERMAN JA, 1987, CELL, V51, P473, DOI 10.1016/0092-8674(87)90643-X; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Kaufmann WK, 1996, FASEB J, V10, P238, DOI 10.1096/fasebj.10.2.8641557; Longhese MP, 1996, NUCLEIC ACIDS RES, V24, P3533, DOI 10.1093/nar/24.18.3533; LOO S, 1995, MOL BIOL CELL, V6, P741, DOI 10.1091/mbc.6.6.741; MAINE GT, 1984, GENETICS, V106, P365; Marini F, 1997, EMBO J, V16, P639, DOI 10.1093/emboj/16.3.639; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; RIVIN CJ, 1980, J CELL BIOL, V85, P96, DOI 10.1083/jcb.85.1.96; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SIEDE W, 1994, GENETICS, V138, P271; SIEDE W, 1990, MUTAT RES, V245, P287, DOI 10.1016/0165-7992(90)90158-G; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Sugimoto K, 1997, MOL CELL BIOL, V17, P5905, DOI 10.1128/MCB.17.10.5905; Tannock I, 1998, BASIC SCI ONCOLOGY; Vujcic M, 1999, MOL CELL BIOL, V19, P6098; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932	42	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35975	35984		10.1074/jbc.274.50.35975	http://dx.doi.org/10.1074/jbc.274.50.35975			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585487	hybrid			2022-12-27	WOS:000084187900099
J	Behar, V; Bisello, A; Bitan, G; Rosenblatt, M; Chorev, M				Behar, V; Bisello, A; Bitan, G; Rosenblatt, M; Chorev, M			Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTYPE-SELECTIVE LIGANDS; HUMAN PTH/PTHRP RECEPTOR; OSTEOBLAST-LIKE CELLS; AMINO-ACID-RESIDUES; BINDING DOMAINS; PEPTIDE PTHRP; SUBSTANCE-P; TRANSMEMBRANE DOMAINS; ADRENERGIC-RECEPTOR; COUPLED RECEPTORS	Analogs of parathyroid hormone (PTH)-related protein (PTHrP), singularly substituted with a photoreactive L-p-benzoylphenylalanine (Bpa) at each of the first 6 N-terminal positions, were pharmacologically evaluated in human embryonic kidney cells stably expressing the recombinant human PTH/PTHrP receptor. Two of these analogs, in which the photoreactive residue is either in position 1 or 2 (Bpa(1)- and Bpa(2)-PTHrP, respectively) displayed high affinity binding. Bpa(2)-PTHrP also displayed high efficacy for the stimulation of increased cAMP levels. Surprisingly, Bpa(2)-PTHrP was found to be a potent antagonist, despite the presence of the principal activation domain (sequence 1-6). Analysis of the digestion profiles of the ligand-receptor photoconjugates revealed that both the agonist and the antagonist cross-link to the S-CH3 group of Met(425) in transmembrane domain 6 of the human PTH/PTHrP receptor. However, the antagonist Bpa(2)-PTHrP also cross-links to a proximal site within the receptor domain Pro(415)-Met(425). Unlike the antagonist Bpa(2)-PTHrP, the potent agonist Epa(2)-PTH, also bearing the Bpa residue in position 2, cross-links only to the S CH3 group of Met(425) (similar to Bpa(1)-PTHrP and Bpa(1)-PTH). Taken together, these results suggest that the antagonist Bpa(2)-PTHrP is able to distinguish between two distinct conformations of the receptor. The comparison between PTHrP analogs substituted by Bpa at two consecutive positions and across PTH and PTHrP reveals insights into the PTH/PTHrP ligand-receptor bimolecular interaction at the level of a single amino acid.	Beth Israel Deaconess Med Ctr, Dept Med, Charles A Dana & Thorndike Labs, Div Bone & Mineral Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Chorev, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Charles A Dana & Thorndike Labs, Div Bone & Mineral Metab, 330 Brookline Ave,HIM 944, Boston, MA 02215 USA.		Bitan, Gal/U-2204-2019	Bitan, Gal/0000-0001-7046-3754	NIDDK NIH HHS [R01-DK47940] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047940] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Adams AE, 1998, MOL ENDOCRINOL, V12, P1673, DOI 10.1210/me.12.11.1673; Behar V, 1996, ENDOCRINOLOGY, V137, P4217, DOI 10.1210/en.137.10.4217; BEINBORN M, 1993, NATURE, V362, P348, DOI 10.1038/362348a0; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; Chorev Michael, 1996, P305; CIVITELLI R, 1989, ENDOCRINOLOGY, V125, P1204, DOI 10.1210/endo-125-3-1204; COHEN FE, 1991, J BIOL CHEM, V266, P1997; Dong MQ, 1999, J BIOL CHEM, V274, P4778, DOI 10.1074/jbc.274.8.4778; Du P, 1997, PROTEIN ENG, V10, P109, DOI 10.1093/protein/10.2.109; Fathy DB, 1998, J BIOL CHEM, V273, P12210, DOI 10.1074/jbc.273.20.12210; Fitzpatrick Lorraine A., 1996, P339; FONG TM, 1992, J BIOL CHEM, V267, P25664; Gardella TJ, 1996, J BIOL CHEM, V271, P19888, DOI 10.1074/jbc.271.33.19888; GARDELLA TJ, 1994, ENDOCRINOLOGY, V135, P1186, DOI 10.1210/en.135.3.1186; GARDELLA TJ, 1993, ENDOCRINOLOGY, V132, P2024, DOI 10.1210/en.132.5.2024; GARDELLA TJ, 1991, J BIOL CHEM, V266, P13141; GETHER U, 1995, J BIOL CHEM, V270, P28268; GETHER U, 1993, NATURE, V362, P345, DOI 10.1038/362345a0; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Jarnagin K, 1996, J BIOL CHEM, V271, P28277, DOI 10.1074/jbc.271.45.28277; JI H, 1994, J BIOL CHEM, V269, P16533; JOUISHOMME H, 1994, J BONE MINER RES, V9, P943; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Juppner H, 1994, Curr Opin Nephrol Hypertens, V3, P371; Kage R, 1996, J BIOL CHEM, V271, P25797, DOI 10.1074/jbc.271.42.25797; KAMATSU Y, 1997, J BONE MINER RES  S1, V12, pS163; KOMATSU Y, 1998, BONE, V23, pS253; KOPIN AS, 1995, J BIOL CHEM, V270, P5019, DOI 10.1074/jbc.270.10.5019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanske B, 1998, CRIT REV EUKAR GENE, V8, P297, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.40; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Liaw CW, 1997, MOL ENDOCRINOL, V11, P2048, DOI 10.1210/me.11.13.2048; Mannstadt M, 1998, J BIOL CHEM, V273, P16890, DOI 10.1074/jbc.273.27.16890; NAKAMOTO C, 1995, BIOCHEMISTRY-US, V34, P10546, DOI 10.1021/bi00033a029; NUSSBAUM SR, 1980, J BIOL CHEM, V255, P183; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; PINES M, 1994, ENDOCRINOLOGY, V135, P1713, DOI 10.1210/en.135.4.1713; ROUBINI E, 1992, BIOCHEMISTRY-US, V31, P4026, DOI 10.1021/bi00131a018; SACHAIS BS, 1993, J BIOL CHEM, V268, P2319; Sainz E, 1998, J BIOL CHEM, V273, P15927, DOI 10.1074/jbc.273.26.15927; SCHERMER DT, 1994, J BONE MINER RES, V9, P1041; Segre Gino V., 1996, P377; STRADER CD, 1989, J BIOL CHEM, V264, P16470; Takasu H, 1998, ENDOCRINOLOGY, V139, P4293, DOI 10.1210/en.139.10.4293; Turner PR, 1996, J BIOL CHEM, V271, P9205, DOI 10.1074/jbc.271.16.9205; USDIN TB, 1995, J BIOL CHEM, V270, P15455, DOI 10.1074/jbc.270.26.15455; Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644; ZHOU W, 1995, J BIOL CHEM, V270, P18853, DOI 10.1074/jbc.270.32.18853	50	82	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					9	17		10.1074/jbc.275.1.9	http://dx.doi.org/10.1074/jbc.275.1.9			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617579	hybrid			2022-12-27	WOS:000085951600003
J	Diaz, BV; Lenoir, MC; Ladoux, A; Frelin, C; Demarchez, M; Michel, S				Diaz, BV; Lenoir, MC; Ladoux, A; Frelin, C; Demarchez, M; Michel, S			Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED TRANSCRIPTIONAL ACTIVATION; ACID RECEPTOR-GAMMA; AP1 BINDING-SITE; PERMEABILITY FACTOR; HUMAN-SKIN; EPIDERMAL-KERATINOCYTES; CULTURED KERATINOCYTES; NUCLEAR RECEPTORS; GENE-EXPRESSION; TYROSINE KINASE	Vascular endothelial growth factor (VEGF) is overexpressed in hyperproliferative diseases, such as psoriasis and cancers, which are characterized by increased angiogenesis. Experimentally, VEGF overexpression can be induced by the treatment of cell cultures and biological tissues with phorbol esters, such as 12-O-tetradecanoylphorbol-13-acetate (TPA). Using normal human keratinocytes in conventional cultures and skin grafted onto nude mice in vivo, we show that retinoids can inhibit TPA-mediated VEGF gene induction at the transcriptional level. Because retinoids are biologically active either by interacting with the nuclear retinoic acid receptors or by interfering with the activator protein 1 (AP1) transcription factor, we studied the effect of the retinoic acid derivative CD 2409, which exhibits strong anti-AP1 activity but does not bind to the known retinoic acid receptors in vitro. The results demonstrate that the inhibition of VEGF expression by retinoids only depends on their anti-AP1 activity and does not require gene transactivation via retinoic acid response elements. Because the VEGF promoter contains four potential AP1 binding sites, we used different promoter constructs to identify the functional site responsible for TPA induction and retinoid inhibition. This site turned out to be localized at position -621 of the 5' flanking region of the VEGF gene.	Galderma R&D, F-06902 Valbonne, France; CNRS, Inst Pharmacol Mol & Cellulaire, UPR 411, F-06560 Valbonne, France	Galderma R&D SNC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Michel, S (corresponding author), Galderma R&D, 635 Route Lucioles,BP67, F-06902 Valbonne, France.		LADOUX, ANNIE/S-2077-2019; LADOUX, ANNIE/O-4267-2016	LADOUX, ANNIE/0000-0003-3857-2621; LADOUX, ANNIE/0000-0003-3857-2621				ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ASTROM A, 1991, J BIOL CHEM, V266, P17662; AURON PE, 1994, EUR CYTOKINE NETW, V5, P573; BERNARD BA, 1992, BIOCHEM BIOPH RES CO, V186, P977, DOI 10.1016/0006-291X(92)90842-9; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; Brauchle M, 1996, J BIOL CHEM, V271, P21793, DOI 10.1074/jbc.271.36.21793; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; BROWN LF, 1995, J INVEST DERMATOL, V104, P744, DOI 10.1111/1523-1747.ep12606974; CASATORRES J, 1994, J BIOL CHEM, V269, P20489; CAVEY MT, 1990, ANAL BIOCHEM, V186, P19, DOI 10.1016/0003-2697(90)90565-Q; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Claffey KP, 1996, CANCER RES, V56, P172; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; DEMARCHEZ M, 1986, DEV BIOL, V113, P90, DOI 10.1016/0012-1606(86)90110-7; Detmar M, 1996, J INVEST DERMATOL, V106, P207, DOI 10.1111/1523-1747.ep12340457; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Detmar M, 1997, J INVEST DERMATOL, V108, P263, DOI 10.1111/1523-1747.ep12286453; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; FARR A, 1987, CANCER CELL, V5, P171; FERRARA N, 1993, TRENDS CARDIOVAS MED, V3, P244, DOI 10.1016/1050-1738(93)90046-9; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; Finkenzeller G, 1997, ONCOGENE, V15, P669, DOI 10.1038/sj.onc.1201219; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; FRITSCH PO, 1992, J AM ACAD DERMATOL, V27, P8; Gille J, 1997, EMBO J, V16, P750, DOI 10.1093/emboj/16.4.750; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Lee HY, 1999, MOL CELL BIOL, V19, P1973; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Li JJ, 1996, CANCER RES, V56, P483; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MARTIN B, 1992, SKIN PHARMACOL, V5, P57; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; OIKAWA T, 1989, CANCER LETT, V48, P157, DOI 10.1016/0304-3835(89)90054-2; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; SALBERT G, 1993, MOL ENDOCRINOL, V7, P1347, DOI 10.1210/me.7.10.1347; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; Senger DR, 1996, AM J PATHOL, V149, P293; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Shroot B, 1997, J AM ACAD DERMATOL, V36, pS96, DOI 10.1016/S0190-9622(97)70050-1; Szondy Z, 1997, MOL PHARMACOL, V51, P972, DOI 10.1124/mol.51.6.972; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Triozzi PL, 1996, CANCER INVEST, V14, P293, DOI 10.3109/07357909609012154; VEGA B, 1997, Patent No. 82636; WEINDEL K, 1992, BIOCHEM BIOPH RES CO, V183, P1167, DOI 10.1016/S0006-291X(05)80313-4; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Weninger W, 1998, J INVEST DERMATOL, V111, P907, DOI 10.1046/j.1523-1747.1998.00393.x	62	88	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					642	650		10.1074/jbc.275.1.642	http://dx.doi.org/10.1074/jbc.275.1.642			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617662	hybrid			2022-12-27	WOS:000085951600086
J	Fabunmi, RP; Wigley, WC; Thomas, PJ; DeMartino, GN				Fabunmi, RP; Wigley, WC; Thomas, PJ; DeMartino, GN			Activity and regulation of the centrosome-associated proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; ATP-DEPENDENT ACTIVATOR; GAMMA-TUBULIN; PROTEIN-DEGRADATION; 20-S PROTEASOME; MULTICATALYTIC PROTEINASE; SACCHAROMYCES-CEREVISIAE; ANTIGEN PRESENTATION; CELL-CYCLE; PA28	Regulated proteolysis is important for maintaining appropriate cellular levels of many proteins. The bulk of intracellular protein degradation is catalyzed by the proteasome. Recently, the centrosome was identified as a novel site for concentration of the proteasome and associated regulatory proteins (Wigley, W. C., Fabunmi, R. P., Lee, M. G., Marino, C. R., Muallem, S., DeMartino, G. N., and Thomas, P. J. (1999) J. Cell Biol. 145, 481-490). Here we provide evidence that centrosomes contain the active 26 S proteasome that degrades ubiquitinated-protein and proteasome-specific peptide substrates. Moreover, the centrosomes contain an ubiquitin isopeptidase activity. The proteolytic activity is ATP dependent and is inhibited by proteasome inhibitors, Notably, treatment of cells with inhibitors of proteasome activity promotes redistribution of the proteasome and associated regulatory proteins to the centrosome independent of an intact microtubule system. These data provide biochemical evidence for active proteasomal complexes at the centrosome, highlighting a novel function for this organizing structure.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Thomas, PJ (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.		Thomas, Philip J/F-7115-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181, R01DK049835, R37DK049835, R56DK046181] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK49835, DK46181] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams GM, 1997, J MOL BIOL, V273, P646, DOI 10.1006/jmbi.1997.1334; Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; BAILLY E, 1992, J CELL SCI, V101, P529; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; BROWN CR, 1994, J CELL PHYSIOL, V160, P47, DOI 10.1002/jcp.1041600107; Bush KT, 1997, J BIOL CHEM, V272, P9086; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GORDON C, 1993, NATURE, V366, P357; GRAY CW, 1994, J MOL BIOL, V236, P7, DOI 10.1006/jmbi.1994.1113; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; HEIDEMANN SR, 1980, NATURE, V286, P517, DOI 10.1038/286517a0; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hohfeld J, 1998, BIOL CHEM, V379, P269; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; KAPELLER R, 1995, J BIOL CHEM, V270, P25985, DOI 10.1074/jbc.270.43.25985; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; MA CP, 1994, J BIOL CHEM, V269, P3539; MA CP, 1993, J BIOL CHEM, V268, P22514; MA CP, 1992, J BIOL CHEM, V267, P10515; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; MCGUIRE MJ, 1988, ARCH BIOCHEM BIOPHYS, V262, P273, DOI 10.1016/0003-9861(88)90189-0; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Moudjou M, 1996, J CELL SCI, V109, P875; OAKLEY CE, 1989, NATURE, V338, P662, DOI 10.1038/338662a0; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schmidt PH, 1999, J BIOL CHEM, V274, P3055, DOI 10.1074/jbc.274.5.3055; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; Wigley WC, 1999, J CELL BIOL, V145, P481; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5	50	135	150	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					409	413		10.1074/jbc.275.1.409	http://dx.doi.org/10.1074/jbc.275.1.409			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617632	hybrid			2022-12-27	WOS:000085951600056
J	Panda, M; Gorovits, BM; Horowitz, PM				Panda, M; Gorovits, BM; Horowitz, PM			Productive and nonproductive intermediates in the folding of denatured rhodanese	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELASTIC LIGHT-SCATTERING; ESCHERICHIA-COLI; AGGREGATION; PRESSURE; COMPETITION; TEMPERATURE; KINETICS; COVALENT	The competition between protein aggregation and folding has been investigated using rhodanese (thiosulfate:cyanide sulfurtransferase, EC 2.8.1.1) as a model. During folding from a urea-denatured state, rhodanese rapidly forms associated species or intermediates, some of which are large and/or sticky. The early removal of such particles by filtration results in a decreased refolding yield. With time, a portion of the smaller aggregates can partition back first to intermediates and then to refolded protein, while a fraction of these irreversibly form unproductive higher aggregates. Dynamic light scattering measurements indicate that the average sizes of the aggregates formed during rhodanese folding increase from 225 to 325 nm over 45 min and they become increasingly heterogeneous. Glycerol addition or the application of high hydrostatic pressure improved the final refolding yields by stabilizing smaller particles. Although addition of glycerol into the refolding mixture blocks the formation of unproductive aggregates, it cannot dissociate them back to productive intermediates. The presence of 3.9 M urea keeps the aggregates small, and they can be dissociated to monomers by high hydrostatic pressure even after 1 h of incubation. These studies suggest that early associated intermediates formed during folding can be reversed to give active species.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio	Horowitz, PM (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25177] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; CHRUNYK BA, 1990, BIOCHEMISTRY-US, V29, P2149, DOI 10.1021/bi00460a027; CLELAND JL, 1990, BIOCHEMISTRY-US, V29, P11072, DOI 10.1021/bi00502a009; EWBANK JJ, 1991, NATURE, V350, P518, DOI 10.1038/350518a0; Fink A.L., 1998, MOL CHAPERONES LIFE; GOLDBERG ME, 1991, BIOCHEMISTRY-US, V30, P2790, DOI 10.1021/bi00225a008; Gorovits BM, 1998, BIOCHEMISTRY-US, V37, P6132, DOI 10.1021/bi9730137; Gorovits BM, 1998, BBA-PROTEIN STRUCT M, V1382, P120, DOI 10.1016/S0167-4838(97)00158-1; Gorovits BM, 1997, J BIOL CHEM, V272, P26999, DOI 10.1074/jbc.272.43.26999; HAGIHARA Y, 1998, MOL CHAPERONES LIFE, P1; HOROWITZ PM, 1993, J BIOL CHEM, V268, P2500; HOROWITZ PM, 1995, BBA-PROTEIN STRUCT M, V1249, P161, DOI 10.1016/0167-4838(95)00037-U; HOROWITZ PM, 1990, J BIOL CHEM, V265, P2576; Jaenicke R, 1998, BIOL CHEM, V379, P237; Jaenicke Rainer, 1997, V50, P1; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; King J., 1987, PROTEIN ENG, P109; KLEIN J, 1995, APPL ENVIRON MICROB, V61, P1220, DOI 10.1128/AEM.61.4.1220-1225.1995; Klibanov AM, 1997, TRENDS BIOTECHNOL, V15, P97, DOI 10.1016/S0167-7799(97)01013-5; Markley J. L., 1996, HIGH PRESSURE EFFECT; MENDOZA JA, 1991, J BIOL CHEM, V266, P13587; MENDOZA JA, 1991, J BIOL CHEM, V266, P16973; MILLER DM, 1991, J BIOL CHEM, V266, P4686; MURPHY RM, 1991, BIOPOLYMERS, V31, P1289, DOI 10.1002/bip.360311107; PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Prehoda KE, 1998, BIOCHEMISTRY-US, V37, P5785, DOI 10.1021/bi980384u; Ptitsyn Oleg B., 1992, P243; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; TANDON S, 1989, J BIOL CHEM, V264, P9859; TANDON S, 1987, J BIOL CHEM, V262, P4486; Timasheff S N, 1995, Methods Mol Biol, V40, P253; Weber G., 1992, PROTEIN INTERACTIONS; Xie YS, 1996, PROTEIN SCI, V5, P517; ZETTLMEISSL G, 1979, BIOCHEMISTRY-US, V18, P5567, DOI 10.1021/bi00592a007	35	39	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					63	70		10.1074/jbc.275.1.63	http://dx.doi.org/10.1074/jbc.275.1.63			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617586	hybrid			2022-12-27	WOS:000085951600010
J	Prevot, D; Voeltzel, T; Birot, AM; Morel, AP; Rostan, MC; Magaud, JP; Corbo, L				Prevot, D; Voeltzel, T; Birot, AM; Morel, AP; Rostan, MC; Magaud, JP; Corbo, L			The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING SPECIFICITY; PROGRAMMED CELL-DEATH; NEURONAL PC12 CELLS; HOMEODOMAIN PROTEINS; COOPERATIVE INTERACTIONS; DROSOPHILA EMBRYOS; GENE-PRODUCTS; YPWM MOTIF; IN-VITRO; EXPRESSION	BTG1 and BTG2 belong to a family of functionally related genes involved in the control of the cell cycle. As part of an ongoing attempt to understand their biological functions, we used a yeast two-hybrid screening to look for possible functional partners of Btg1 and Btg2. Here we report the physical and functional association between these proteins and the homeodomain protein Hoxb9. We further show that Btg1 and Btg2 enhance Hoxb9-mediated transcription in transfected cells, and we report the formation of a Hoxb9.Btg2 complex on a Hoxb9-responsive target, and the fact that this interaction facilitates the binding of Hoxb9 to DNA, The transcriptional activity of the Hoxb9.Btg complex is essentially dependent on the activation domain of Hoxb9, located in the N-terminal portion of the protein, Our data indicate that Btg1 and Btg2 act as transcriptional cofactors of the Hoxb9 protein, and suggest that this interaction may mediate their antiproliferative function.	Ctr Leon Berard, INSERM, U453, F-69373 Lyon 08, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Corbo, L (corresponding author), Ctr Leon Berard, INSERM, U453, 28 Rue Laennec, F-69373 Lyon 08, France.							AOKI J, 1991, J CELL BIOL, V115, P1751, DOI 10.1083/jcb.115.6.1751; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; Chan SK, 1996, EMBO J, V15, P2476, DOI 10.1002/j.1460-2075.1996.tb00605.x; Chan SK, 1997, DEVELOPMENT, V124, P2007; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; DiRocco G, 1997, EMBO J, V16, P3644, DOI 10.1093/emboj/16.12.3644; EDELMAN GM, 1995, PHILOS T R SOC B, V349, P305, DOI 10.1098/rstb.1995.0118; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; GOOMER RS, 1994, P NATL ACAD SCI USA, V91, P7985, DOI 10.1073/pnas.91.17.7985; Goudet G, 1999, J BIOL CHEM, V274, P4067, DOI 10.1074/jbc.274.7.4067; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Green NC, 1998, J BIOL CHEM, V273, P13273, DOI 10.1074/jbc.273.21.13273; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; HARPER JW, 1993, CELL, V75, P805; IACOPETTI P, 1994, MECH DEVELOP, V47, P127, DOI 10.1016/0925-4773(94)90085-X; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2086, DOI 10.1073/pnas.89.6.2086; KORNBERG TB, 1993, J BIOL CHEM, V268, P26813; KRUSHEL LA, 1995, P NATL ACAD SCI USA, V92, P4323, DOI 10.1073/pnas.92.10.4323; LAUGHON A, 1991, BIOCHEMISTRY-US, V30, P11357, DOI 10.1021/bi00112a001; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; MALICKI J, 1993, MECH DEVELOP, V42, P139, DOI 10.1016/0925-4773(93)90003-G; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Matsuda S, 1996, ONCOGENE, V12, P705; MESNER PW, 1995, J NEUROSCI, V15, P7357; RIMOKH R, 1991, GENE CHROMOSOME CANC, V3, P24, DOI 10.1002/gcc.2870030106; Rouault JP, 1998, J BIOL CHEM, V273, P22563, DOI 10.1074/jbc.273.35.22563; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Shanmugam K, 1997, J BIOL CHEM, V272, P19081, DOI 10.1074/jbc.272.30.19081; SPORNS O, 1995, P NATL ACAD SCI USA, V92, P542, DOI 10.1073/pnas.92.2.542; Walter J, 1996, P NATL ACAD SCI USA, V93, P2680, DOI 10.1073/pnas.93.7.2680; WALTER J, 1994, GENE DEV, V8, P1678, DOI 10.1101/gad.8.14.1678; Wang SL, 1997, DEV BIOL, V188, P322, DOI 10.1006/dbio.1997.8655; Wang YB, 1996, P NATL ACAD SCI USA, V93, P1892, DOI 10.1073/pnas.93.5.1892	45	121	125	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					147	153		10.1074/jbc.275.1.147	http://dx.doi.org/10.1074/jbc.275.1.147			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617598	hybrid			2022-12-27	WOS:000085951600022
J	Someya, Y; Kimura-Someya, T; Yamaguchi, A				Someya, Y; Kimura-Someya, T; Yamaguchi, A			Role of the charge interaction between Arg(70) and Asp(120) in the Tn10-encoded metal-tetracycline/H+ antiporter of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; 2ND-SITE SUPPRESSOR MUTATIONS; LACTOSE PERMEASE; RESISTANCE PROTEIN; TRANSPOSON TN10; MEMBRANE TOPOLOGY; SEQUENCE; RESIDUES; CARRIER; HELICES	We reported that the positive charge of Arg(70) is mandatory for tetracycline transport activity of Tn10-encoded metal-tetracycline/H+ antiporter (TetA(B)) (Someya, Y., and Yamaguchi, A. (1996) Biochemistry 35, 9385-9391). Arg(70) may function through a charge-pairing with a negatively charged residue in close proximity. Therefore, we mutated Asp(66) and Asp(120), which are only two negatively charged residues located close to Arg(70) in putative secondary structure of TetA(B) and highly conserved throughout transporters of the major facilitator superfamily. Site-directed mutagenesis studies revealed that Asp(66) is essential, but Asp(120) is important for TetA(B) function. Surprisingly, when Asp(120) was replaced by a neutral residue, the R70A mutant recovered tetracycline resistance and transport activity. There was no such effect in the Asp66 mutation. The charge-exchanged mutant, R70D/D120R, also showed significant drug resistance and transport activity (about 50% of the wild type), although the R70D mutant had absolutely no activity, and the D120R mutant retained very low activity (about 10% of the wild type). Both the R70C and D120C mutants were inactivated by N-ethylmaleimide. Mercuric ion (Hg2+), which gives a positive charge to a SH group of a Cys residue through mercaptide formation, had an opposite effect on the R70C and D120C mutants. The activity of the R70C mutant was stimulated by Hg2+; however, on the contrary, the D120C mutant was partially inhibited. On the other hand, the R70C/D120C double mutant was almost completely inactivated by Hg2+, probably because the side chains at positions 70 and 120 are bridged with Hg2+. The close proximity of positions 70 and 120 were confirmed by disulfide cross-linking formation of the R70C/D120C double mutant when it was oxidized by copper-(1,10-phenanthroline). These results indicate that the positive charge of Arg(70) requires the negative charge of Asp(120) for neutralization, probably for properly positioning transmembrane segments in the membrane.	Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan; Osaka Univ, Fac Pharmaceut Sci, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yamaguchi, A (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan.		Kimura-Someya, Tomomi/C-4169-2017	Kimura-Someya, Tomomi/0000-0003-2232-1801				ALLARD JD, 1992, J BIOL CHEM, V267, P17809; DUNTEN RL, 1993, BIOCHEMISTRY-US, V32, P3139, DOI 10.1021/bi00063a028; ECKERT B, 1989, J BIOL CHEM, V264, P11663; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P269, DOI 10.1021/bi9618629; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P14284, DOI 10.1021/bi972314d; HENDERSON PJF, 1990, J BIOENERG BIOMEMBR, V22, P525, DOI 10.1007/BF00762961; HILLEN W, 1983, NUCLEIC ACIDS RES, V11, P525, DOI 10.1093/nar/11.2.525; JESSENMARSHALL AE, 1995, J BIOL CHEM, V270, P16251, DOI 10.1074/jbc.270.27.16251; JessenMarshall AE, 1996, J BIOL CHEM, V271, P1400, DOI 10.1074/jbc.271.3.1400; JessenMarshall AE, 1997, J BACTERIOL, V179, P2616, DOI 10.1128/jb.179.8.2616-2622.1997; KANEKO M, 1985, FEBS LETT, V193, P194, DOI 10.1016/0014-5793(85)80149-6; KATZ BA, 1986, J BIOL CHEM, V261, P5480; Kimura T, 1998, BIOCHEMISTRY-US, V37, P5475, DOI 10.1021/bi973188g; Kimura T, 1997, J BIOL CHEM, V272, P580; KIMURA T, 1995, FEBS LETT, V362, P47, DOI 10.1016/0014-5793(95)00205-N; Kimura T, 1997, BIOCHEMISTRY-US, V36, P6941, DOI 10.1021/bi9631879; KING SC, 1991, BIOCHIM BIOPHYS ACTA, V1062, P177, DOI 10.1016/0005-2736(91)90390-T; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JI, 1993, J BIOL CHEM, V268, P20007; LEE JI, 1992, J BIOL CHEM, V267, P20758; LYNCH BA, 1991, P NATL ACAD SCI USA, V88, P10402, DOI 10.1073/pnas.88.23.10402; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; MCMURRY L, 1980, P NATL ACAD SCI-BIOL, V77, P3974, DOI 10.1073/pnas.77.7.3974; Merickel A, 1997, J BIOL CHEM, V272, P5403, DOI 10.1074/jbc.272.9.5403; NGUYEN TT, 1983, GENE, V25, P83, DOI 10.1016/0378-1119(83)90170-1; SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547; Sato M, 1999, J BIOL CHEM, V274, P24721, DOI 10.1074/jbc.274.35.24721; SEOL W, 1992, BIOCHEMISTRY-US, V31, P3550, DOI 10.1021/bi00128a032; Seyfang A, 1997, J BIOL CHEM, V272, P24210, DOI 10.1074/jbc.272.39.24210; Someya Y, 1996, BIOCHEMISTRY-US, V35, P9385, DOI 10.1021/bi961026z; Someya Y, 1997, BBA-BIOENERGETICS, V1322, P230, DOI 10.1016/S0005-2728(97)00088-1; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; YAMAGUCHI A, 1992, BIOCHEMISTRY-US, V31, P8344, DOI 10.1021/bi00150a031; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P4809; YAMAGUCHI A, 1990, FEBS LETT, V265, P17, DOI 10.1016/0014-5793(90)80872-G; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P15525; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P19155; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P7490; YAMAGUCHI A, 1993, FEBS LETT, V322, P201, DOI 10.1016/0014-5793(93)81568-K; YAMAGUCHI A, 1995, BIOCHEMISTRY-US, V34, P11800, DOI 10.1021/bi00037a018; YAMAMOTO T, 1981, J BACTERIOL, V172, P6942	42	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					210	214		10.1074/jbc.275.1.210	http://dx.doi.org/10.1074/jbc.275.1.210			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617606	hybrid			2022-12-27	WOS:000085951600030
J	van der Vlag, J; den Blaauwen, JL; Sewalt, RGAB; van Driel, R; Otte, AP				van der Vlag, J; den Blaauwen, JL; Sewalt, RGAB; van Driel, R; Otte, AP			Transcriptional repression mediated by polycomb group proteins and other chromatin-associated repressors is selectively blocked by insulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITION-EFFECT VARIEGATION; DROSOPHILA-MELANOGASTER; CHROMOSOMAL PROTEIN; GENE; DNA; ELEMENT; HETEROCHROMATIN; BOUNDARIES; EXPRESSION; ENHANCER	Polycomb group (PcG) proteins repress gene activity over a considerable distance, possibly by spreading along the chromatin fiber. Insulators or boundary elements, genetic elements within the chromatin, may serve to terminate the repressing action of PcG proteins. We studied the ability of insulators to block the action of chromatin-associated repressors such as PcG proteins, HP1, and MeCP2. We found that the Drosophila special chromatin structure insulator completely blocks transcriptional repression mediated by all of the repressors we tested. The Drosophila gypsy insulator was able to block the repression mediated by the PcG proteins Su(z)2 and RING1, as well as mHP1, but not the repression mediated by MeCP2 and the PcG protein HPC2. The 5'-located DNase I-hypersensitive site in the chicken beta-globin locus displayed a limited ability to block repression, and a matrix or scaffold attachment region element was entirely unable to block repression mediated by any repressor tested. Our results indicate that insulators can block repression mediated by PcG proteins and other chromatin-associated repressors, but with a high level of selectivity. This high degree of specificity may provide a useful assay to define and characterize distinct classes of insulators.	Univ Amsterdam, BioCentrum Amsterdam, EC Slater Inst, NL-1018 TV Amsterdam, Netherlands	University of Amsterdam	Otte, AP (corresponding author), Univ Amsterdam, BioCentrum Amsterdam, EC Slater Inst, Plantage Muidergracht 12, NL-1018 TV Amsterdam, Netherlands.		Van der Vlag, Johan/E-4636-2010	Van der Vlag, Johan/0000-0001-7843-5918				BONIFER C, 1997, NUCL ORG CHROMATIN S, P116; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; BUNKER CA, 1994, MOL CELL BIOL, V14, P1721, DOI 10.1128/MCB.14.3.1721; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CORCES VG, 1997, NUCL ORG CHROMATIN S, P83; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; Mallin DR, 1998, GENETICS, V148, P331; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; MIYNAROVA L, 1994, PLANT CELL, V6, P417; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; POLJAK L, 1994, NUCLEIC ACIDS RES, V22, P4386, DOI 10.1093/nar/22.21.4386; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Satijn DPE, 1999, MOL CELL BIOL, V19, P57; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Sigrist CJA, 1997, GENETICS, V147, P209; SINGH PB, 1991, NUCLEIC ACIDS RES, V19, P789, DOI 10.1093/nar/19.4.789; STIEF A, 1989, NATURE, V341, P343, DOI 10.1038/341343a0; Udvardy A, 1999, EMBO J, V18, P1, DOI 10.1093/emboj/18.1.1; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	36	64	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					697	704		10.1074/jbc.275.1.697	http://dx.doi.org/10.1074/jbc.275.1.697			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617669	Green Published, hybrid			2022-12-27	WOS:000085951600093
J	Yoshida, M; Itano, N; Yamada, Y; Kimata, K				Yoshida, M; Itano, N; Yamada, Y; Kimata, K			In vitro synthesis of hyaluronan by a single protein derived from mouse HAS1 gene and characterization of amino acid residues essential for the activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CHITIN OLIGOSACCHARIDES; SYNTHASE; DG42; XENOPUS; CELLS; IDENTIFICATION; BIOSYNTHESIS; BINDING; DOMAINS	HAS1 was expressed as a FLAG-tagged HAS1 fusion protein in COS-1 cells, This recombinant protein was extracted with CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid) from the membrane fraction and purified by anti-FLAG affinity chromatography and subsequent SDS-polyacrylamide gel electrophoresis. A protein solubilized from the one single band on the gel was able to synthesize hyaluronan when incubated with UDP-GlcNAc and UDP-GlcA as donor substrates without any further additions. The detergent-solubilized and purified HAS1 protein, however, exhibited quite different kinetic properties from the membrane-bound protein, When assayed under the reconstitutive conditions where the reaction mixture was layered onto the buffer containing high concentration of CHAPS, the activity was enhanced and the kinetic properties became similar to those of the membrane-bound protein. In addition, a HAS1 gene product by an in vitro transcription/translation system also showed HAS1 activity under the reconstitutive conditions. To our surprise, when incubated with UDP-GlcNAc alone, the protein was found to synthesize chito-oligosaccharide. Taking advantage of these enzyme reaction properties, active sites on the protein involved in for hyaluronan and chito-oligosaccharide synthesis were characterized. Site-directed mutagenesis induced in the cytoplasmic central loop domain of the protein revealed that several amino acid residues conserved among those domains of various proteins of a HAS family were essential for both hyaluronan and chito-oligosaccharide syntheses but one of them was not for chito-oligosaccharide synthesis. The substitutions that caused partial or severe loss of the activity gave no significant changes of the K-m values of the mutated proteins, suggesting that no conformational or other indirect changes were involved in the effect. Taken together, the results suggest that the HAS1 protein alone is able to synthesize hyaluronan and different amino acid residues on the cytoplasmic central loop domain are involved in transferring GlcNAc and GlcA residues, respectively.	Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; Jikei Univ, Sch Med, Dept Orthopaed Surg, Minato Ku, Tokyo 1058461, Japan	Aichi Medical University; Jikei University	Kimata, K (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan.	kimata@amugw.aichi-med-u.ac.jp						Asplund T, 1998, BBA-GEN SUBJECTS, V1380, P377, DOI 10.1016/S0304-4165(98)00010-5; Burchell B, 1998, Adv Pharmacol, V42, P335; DEANGELIS PL, 1994, BIOCHEMISTRY-US, V33, P9033, DOI 10.1021/bi00197a001; DeAngelis PL, 1996, J BIOL CHEM, V271, P23657, DOI 10.1074/jbc.271.39.23657; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; HART GW, 1978, J BIOL CHEM, V253, P5795; HOPWOOD JJ, 1977, J BIOL CHEM, V252, P4777; HOPWOOD JJ, 1977, BIOCHEM BIOPH RES CO, V75, P472, DOI 10.1016/0006-291X(77)91066-X; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Itano N, 1998, TRENDS GLYCOSCI GLYC, V10, P23, DOI 10.4052/tigg.10.23; Itano N, 1996, BIOCHEM BIOPH RES CO, V222, P816, DOI 10.1006/bbrc.1996.0827; KLEIN RG, 1978, J ARCHAEOL SCI, V5, P195, DOI 10.1016/0305-4403(78)90040-7; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; KNUDSON W, 1989, CIBA F SYMP, V143, P150; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; MAPLESON JL, 1981, J CELL PHYSIOL, V109, P215, DOI 10.1002/jcp.1041090204; Meyer MF, 1996, P NATL ACAD SCI USA, V93, P4543, DOI 10.1073/pnas.93.10.4543; NAGAHASHI S, 1995, J BIOL CHEM, V270, P13961, DOI 10.1074/jbc.270.23.13961; NG KF, 1989, J BIOL CHEM, V264, P11776; PILLOT T, 1993, BIOCHEM BIOPH RES CO, V197, P785, DOI 10.1006/bbrc.1993.2547; PREHM P, 1983, BIOCHEM J, V211, P191, DOI 10.1042/bj2110191; SEMINO CE, 1995, P NATL ACAD SCI USA, V92, P3498, DOI 10.1073/pnas.92.8.3498; Semino CE, 1996, P NATL ACAD SCI USA, V93, P4548, DOI 10.1073/pnas.93.10.4548; Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; SUGAHARA K, 1979, J BIOL CHEM, V254, P6252; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4246, DOI 10.1074/jbc.274.7.4246; Tlapak-Simmons VL, 1998, J BIOL CHEM, V273, P26100, DOI 10.1074/jbc.273.40.26100; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Toole BP, 1989, CIBA FDN S, V143, P138; TURCO SJ, 1977, J BIOL CHEM, V252, P2918; TURLEY EA, 1989, CIBA F SYMP, V143, P121; Varki A, 1996, P NATL ACAD SCI USA, V93, P4523, DOI 10.1073/pnas.93.10.4523; von Figura K, 1973, Eur J Biochem, V40, P89; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997	38	98	112	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					497	506		10.1074/jbc.275.1.497	http://dx.doi.org/10.1074/jbc.275.1.497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617644	hybrid			2022-12-27	WOS:000085951600068
J	Buchberger, A; Gassler, CS; Buttner, M; McMacken, R; Bukau, B				Buchberger, A; Gassler, CS; Buttner, M; McMacken, R; Bukau, B			Functional defects of the DnaK756 mutant chaperone of Escherichia coli indicate distinct roles for amino- and carboxyl-terminal residues in substrate and co-chaperone interaction and interdomain communication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMBDA-DNA-REPLICATION; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONE; BACTERIOPHAGE-LAMBDA; NUCLEOPROTEIN STRUCTURES; NUCLEOTIDE EXCHANGE; CELLULAR DEFECTS; ATPASE FRAGMENT; COGNATE PROTEIN; ACTIVE-SITE	The first discovery of an Hsp70 chaperone gene was the isolation of an Escherichia coli mutant, dnaK756, which rendered the cells resistant to lytic infection with bacteriophage lambda, The DnaK756 mutant protein has since been used to establish many of the cellular roles and biochemical properties of DnaK, DnaK756 has three glycine-to-aspartate substitutions at residues 32, 455, and 468, which were reported to result in defects in intrinsic and GrpE-stimulated ATPase activities, substrate binding, stability of the substrate-binding domain, inrerdomain communication, and, consequently, defects in chaperone activity, To dissect the effects of the different amino acid substitutions in DnaK756, we analyzed two DnaK variants carrying only the amino-terminal (residue 32) or the two carboxyl-terminal (residues 455 and 468) substitutions, The amino-terminal substitution interfered with the GrpE-stimulated ATPase activity. The carboxyl-terminal mutations (i) affected stability and function of the substrate-binding domain, (ii) caused a 10-fold elevated ATP hydrolysis rate, but (iii) did not severely affect domain coupling. Surprisingly, DnaK chaperone activity was more severely compromised by the amino-terminal than by the carboxyl-terminal amino acid substitutions both in vivo and in vitro, In the in vitro refolding of denatured firefly luciferase, the defect of the DnaK variant carrying the amino-terminal substitution results from its inability to release, upon GrpE-mediated nucleotide exchange, bound luciferase in a folding competent state. Our results indicate that the DnaK-DnaJ-GrpE chaperone system can tolerate suboptimal substrate binding, whereas the tight kinetic control of substrate dissociation by GrpE is essential.	Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA	University of Freiburg; Johns Hopkins University	Bukau, B (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	bukau@sun2.ruf.uni-freiburg.de	Buchberger, Alexander/J-4070-2019; Buchberger, Alexander/AAF-4728-2019	Buchberger, Alexander/0000-0002-2836-0820; Buchberger, Alexander/0000-0002-2836-0820; Bukau, Bernd/0000-0003-0521-7199	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036526] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36526] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALFANO C, 1989, J BIOL CHEM, V264, P10709; BANECKI B, 1992, J BIOL CHEM, V267, P25051; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; Buchberger A, 1996, J MOL BIOL, V261, P328, DOI 10.1006/jmbi.1996.0465; BUKAU B, 1989, J BACTERIOL, V171, P2337, DOI 10.1128/jb.171.5.2337-2346.1989; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; BUKAU B, MOL CHAPERONES FOLDI; BURKHOLDER WF, 1999, MOL CHAPERONES FOLDI, P105; CEGIELSKA A, 1989, J BIOL CHEM, V264, P21122; DODSON M, 1989, J BIOL CHEM, V264, P10719; EZAKI B, 1989, MOL GEN GENET, V218, P183, DOI 10.1007/BF00331267; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; GEORGOPOULOS C P, 1974, Journal of Supramolecular Structure, V2, P349, DOI 10.1002/jss.400020224; GEORGOPOULOS CP, 1979, MOL GEN GENET, V172, P143, DOI 10.1007/BF00268275; GEORGOPOULOS CP, 1977, MOL GEN GENET, V151, P35, DOI 10.1007/BF00446910; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Herbst R, 1997, J BIOL CHEM, V272, P7099, DOI 10.1074/jbc.272.11.7099; JOHNSON C, 1989, J BACTERIOL, V171, P1590, DOI 10.1128/jb.171.3.1590-1596.1989; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; KELLER JA, 1988, MOL MICROBIOL, V2, P31, DOI 10.1111/j.1365-2958.1988.tb00004.x; KONIECZNY I, 1995, J BIOL CHEM, V270, P9792, DOI 10.1074/jbc.270.17.9792; LANZER M, 1988, THESIS U HEIDELBERG; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Laufen T., 1998, MOL CHAPERONES PROTE, P241; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1990, J BIOL CHEM, V265, P3022; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; MALLORY JB, 1990, J BIOL CHEM, V265, P13297; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; McCarty JS, 1996, J MOL BIOL, V256, P829, DOI 10.1006/jmbi.1996.0129; MENSAWILMOT K, 1989, J BIOL CHEM, V264, P2853; Miller J.H., 1972, EXPT MOL GENETICS; MIYAZAKI T, 1992, J BACTERIOL, V174, P3715, DOI 10.1128/JB.174.11.3715-3722.1992; MONTGOMERY D, 1993, J MOL BIOL, V232, P680, DOI 10.1006/jmbi.1993.1418; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072; Pierpaoli EV, 1998, J BIOL CHEM, V273, P6643, DOI 10.1074/jbc.273.12.6643; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183; Schonfeld HJ, 1995, PROG COLL POL SCI S, V99, P7; SHERMAN MY, 1992, EMBO J, V11, P71; Stephens KM, 1997, J BIOL CHEM, V272, P28800, DOI 10.1074/jbc.272.45.28800; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; STRAUS DB, 1988, GENE DEV, V2, P1851, DOI 10.1101/gad.2.12b.1851; STRAUS DB, 1989, GENE DEV, V3, P2003, DOI 10.1101/gad.3.12a.2003; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; TILLY K, 1989, J BACTERIOL, V171, P1585, DOI 10.1128/jb.171.3.1585-1589.1989; WILBANKS SM, 1995, J BIOL CHEM, V270, P2251, DOI 10.1074/jbc.270.5.2251; YOCHEM J, 1978, MOL GEN GENET, V164, P9, DOI 10.1007/BF00267593; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x	67	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38017	38026		10.1074/jbc.274.53.38017	http://dx.doi.org/10.1074/jbc.274.53.38017			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608870	hybrid			2022-12-27	WOS:000084528000070
J	Cotrim, PC; Garrity, LK; Beverley, SM				Cotrim, PC; Garrity, LK; Beverley, SM			Isolation of genes mediating resistance to inhibitors of nucleoside and ergosterol metabolism in Leishmania by overexpression/selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCTASE-THYMIDYLATE SYNTHASE; MEXICANA-MEXICANA PROMASTIGOTES; DIHYDROFOLATE REDUCTASE; PARASITE LEISHMANIA; DRUG-RESISTANCE; METHOTREXATE RESISTANCE; MULTIDRUG RESISTANCE; H-REGION; AMPLIFICATION; DONOVANI	We tested a general method for the identification of drug resistance loci in the trypanosomatid protozoan parasite Leishmania major. Genomic libraries in a multicopy episomal cosmid vector were transfected into susceptible parasites, and drug selections of these transfectant libraries yielded parasites bearing cosmids mediating resistance. Tests with two antifolates led to the recovery of cosmids encoding DHFR-TS or PTR1, two known resistance genes. Overexpression/selection using the toxic nucleoside tubercidin similarly yielded the TOR (toxic nucleoside resistance) locus, as well as a new locus (TUB2) conferring collateral hypersensitivity to allopurinol. Leishmania synthesize ergosterol rather than cholesterol, making this pathway attractive as a chemotherapeutic target. Overexpression/selection using the sterol synthesis inhibitors terbinafine (TBF, targeting squalene epoxidase) and itraconazole (ITZ, targeting lanosterol C(14)-demethylase) yielded nine new resistance loci. Several conferred resistance to both drugs; several were drug-specific, and two TBF-resistant cosmids induced hypersensitivity to ITZ. One TBF-resistant cosmid encoded squalene synthase (SQS1), which is located upstream of the sites of TBF and ITZ action in the ergosterol biosynthetic pathway. This suggests that resistance to "downstream" inhibitors can be mediated by increased expression of ergosterol biosynthetic intermediates. Our studies establish the feasibility of overexpression/selection in parasites and suggest that many Leishmania drug resistance loci are amenable to identification in this manner.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Sao Paulo, Sch Med, DMIP, Inst Trop Med, BR-05403000 Sao Paulo, Brazil	Washington University (WUSTL); Harvard University; Harvard Medical School; Universidade de Sao Paulo	Beverley, SM (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	beverley@borcim.wustl.edu	Cotrim, Paulo/C-7899-2013	Cotrim, Paulo/0000-0003-2607-8837; Beverley, Stephen/0000-0001-5319-0811	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021903, R37AI021903] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21903] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARREBOLA R, 1994, J BIOL CHEM, V269, P10590; ASHFORD RW, 1992, PARASITOL TODAY, V8, P104, DOI 10.1016/0169-4758(92)90249-2; Barrett-Bee K, 1988, Ann N Y Acad Sci, V544, P231, DOI 10.1111/j.1749-6632.1988.tb40409.x; BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; Berman JD, 1997, CLIN INFECT DIS, V24, P684, DOI 10.1093/clind/24.4.684; BEVERLEY SM, 1984, CELL, V38, P431, DOI 10.1016/0092-8674(84)90498-7; BEVERLEY SM, 1991, ANNU REV MICROBIOL, V45, P417, DOI 10.1146/annurev.mi.45.100191.002221; BEVERLEY SM, 1986, P NATL ACAD SCI USA, V83, P2584, DOI 10.1073/pnas.83.8.2584; Blackwell JM, 1997, T ROY SOC TROP MED H, V91, P107, DOI 10.1016/S0035-9203(97)90187-5; BORST P, 1995, ANNU REV MICROBIOL, V49, P427, DOI 10.1146/annurev.mi.49.100195.002235; CALLAHAN HL, 1991, J BIOL CHEM, V266, P18427; CALLAHAN HL, 1992, J BIOL CHEM, V267, P24165; Chance Michael L., 1997, P163; CHOW LMC, 1993, MOL BIOCHEM PARASIT, V60, P195, DOI 10.1016/0166-6851(93)90131-G; CODERRE JA, 1983, P NATL ACAD SCI-BIOL, V80, P2132, DOI 10.1073/pnas.80.8.2132; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; DESCOTEAUX A, 1995, SCIENCE, V269, P1869, DOI 10.1126/science.7569927; DESCOTEAUX A, 1994, METH MOL G, V3, P22; Detke S, 1997, MOL BIOCHEM PARASIT, V90, P505, DOI 10.1016/S0166-6851(97)00201-6; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; ELLENBERGER TE, 1989, J BIOL CHEM, V264, P15094; ELLENBERGER TE, 1987, J BIOL CHEM, V262, P13501; GOAD LJ, 1984, MOL BIOCHEM PARASIT, V10, P161, DOI 10.1016/0166-6851(84)90004-5; GOAD LJ, 1985, MOL BIOCHEM PARASIT, V15, P257, DOI 10.1016/0166-6851(85)90089-1; GOAD LJ, 1985, BIOCHEM PHARMACOL, V34, P3785, DOI 10.1016/0006-2952(85)90250-3; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; HANSEN BD, 1982, PARASITOLOGY, V85, P271, DOI 10.1017/S0031182000055256; Hardy LW, 1997, EXP PARASITOL, V87, P157, DOI 10.1006/expr.1997.4207; HENDERSON DM, 1992, MOL CELL BIOL, V12, P2855, DOI 10.1128/MCB.12.6.2855; IOVANNISCI DM, 1984, MOL CELL BIOL, V4, P1013, DOI 10.1128/MCB.4.6.1013; IOVANNISCI DM, 1984, J BIOL CHEM, V259, P4617; IOVANNISCI DM, 1984, MOL BIOCHEM PARASIT, V12, P139, DOI 10.1016/0166-6851(84)90131-2; JENNINGS SM, 1991, P NATL ACAD SCI USA, V88, P6038, DOI 10.1073/pnas.88.14.6038; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Kelly S. L., 1992, New approaches for antifungal drugs., P155; KERBY BR, 1993, MOL BIOCHEM PARASIT, V60, P171, DOI 10.1016/0166-6851(93)90129-L; Kundig C, 1999, EMBO J, V18, P2342, DOI 10.1093/emboj/18.9.2342; LABAN A, 1990, NATURE, V343, P572, DOI 10.1038/343572a0; Lemley C, 1999, MOL BIOCHEM PARASIT, V104, P93, DOI 10.1016/S0166-6851(99)00132-2; MERCER EI, 1991, LIPIDS, V26, P584, DOI 10.1007/BF02536422; Nare B, 1997, J BIOL CHEM, V272, P13883, DOI 10.1074/jbc.272.21.13883; OGBUNUDE POJ, 1991, EXP PARASITOL, V73, P369, DOI 10.1016/0014-4894(91)90109-A; Ouellette M, 1998, ADV EXP MED BIOL, V456, P99; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x; PAPADOPOULOU B, 1993, ADV EXP MED BIOL, V338, P559; PETRANYI G, 1984, SCIENCE, V224, P1239, DOI 10.1126/science.6547247; RINE J, 1983, P NATL ACAD SCI-BIOL, V80, P6750, DOI 10.1073/pnas.80.22.6750; ROBINSON GW, 1993, MOL CELL BIOL, V13, P2706, DOI 10.1128/MCB.13.5.2706; RYAN KA, 1993, GENE, V131, P145, DOI 10.1016/0378-1119(93)90684-U; RYAN KA, 1993, P NATL ACAD SCI USA, V90, P8609, DOI 10.1073/pnas.90.18.8609; SEGOVIA M, 1994, ANN TROP MED PARASIT, V88, P123, DOI 10.1080/00034983.1994.11812849; SOGIN ML, 1986, P NATL ACAD SCI USA, V83, P1383, DOI 10.1073/pnas.83.5.1383; URBINA JA, 1997, PARASITOLOGY, V114, P91; Vanden Bossche H, 1994, Trends Microbiol, V2, P393, DOI 10.1016/0966-842X(94)90618-1	57	45	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37723	37730		10.1074/jbc.274.53.37723	http://dx.doi.org/10.1074/jbc.274.53.37723			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608831	hybrid			2022-12-27	WOS:000084528000031
J	Yoon, SC; Choi, MH				Yoon, SC; Choi, MH			Local sequence dependence of polyhydroxyalkanoic acid degradation in Hydrogenophaga pseudoflava	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCALIGENES-EUTROPHUS; GRANULES; POLY(3-HYDROXYBUTYRATE); BIOSYNTHESIS; COPOLYESTERS; INCLUSIONS; SURFACE; PROTEIN; NMR	The first order intracellular degradation of various polyhydroxyalkanoic acid (PHA) inclusions in Hydrogenophaga pseudoflava cells was investigated by analyzing the compositional and microstructural changes of the PHA. using gas chromatography, C-13 NMR spectroscopy, and differential scanning calorimetry. Two types of PEA, copolymers and blend-type polymers, were separately accumulated in cells for comparison. The constituent monomers were S-hydroxybutyric acid (3HB), 4-hydroxybutyric acid (4HB), and 3-hydroxyvaleric acid (3HV), It was found that the 3HB-4HB copolymer was degraded only when the polymer contained a minimal level of 3HB units. With the cells containing a 3HB/4HB blend-type polymer, only poly(3HB) was degraded, whereas poly(4HB) was not degraded, indicating the totally inactive nature of the intracellular depolymerase against poly(4HB). On the basis of the magnitude of the first order degradation rate constants, the relative substrate specificity of the depolymerase toward the constituting monomer units was determined to decrease in the order 3HB > 3KV > 4HB, C-13 NMR resonances of the tetrad, triad, and dyad sequences were analyzed for the samples isolated before and after degradation experiments. The results showed that the intracellular degradation depended on the local monomer sequence of the copolymers, The relative substrate specificity of the depolymerase determined from the NMR local sequence analysis agreed well with that obtained from the kinetics analysis. It is suggested that, without isolation and purification of the intracellular PHA depolymerase and "native" PHA substrates, the relative specificity of the enzyme as well as the microstructural heterogeneity of the PHA could be determined by measuring in situ the first order degradation rate constants of the PHA in cells.	Gyeongsang Natl Univ, Div Life Sci, Biomat Sci Lab, Chinju 660701, South Korea	Gyeongsang National University	Yoon, SC (corresponding author), Gyeongsang Natl Univ, Div Life Sci, Biomat Sci Lab, Chinju 660701, South Korea.		Yoon, Sung/L-5836-2019	Yoon, Sung Chul/0000-0002-8556-423X				AMOR SR, 1991, MACROMOLECULES, V24, P4583, DOI 10.1021/ma00016a017; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; BONTHRONE KM, 1992, FEMS MICROBIOL LETT, V103, P269, DOI 10.1111/j.1574-6968.1992.tb05848.x; CHOI MH, 1995, CAN J MICROBIOL, V41, P60, DOI 10.1139/m95-169; Choi MH, 1999, APPL ENVIRON MICROB, V65, P1570; CHOI MH, 1994, APPL ENVIRON MICROB, V60, P3245, DOI 10.1128/AEM.60.9.3245-3254.1994; CHOI MH, 1999, THESIS GYEONGSANG NA; Curley JM, 1996, INT J BIOL MACROMOL, V19, P29, DOI 10.1016/0141-8130(96)01096-3; DOI Y, 1988, MACROMOLECULES, V21, P2722, DOI 10.1021/ma00187a012; Doi Y., 1990, MICROBIAL POLYESTERS; GERNGROSS TU, 1993, J BACTERIOL, V175, P5289, DOI 10.1128/JB.175.16.5289-5293.1993; Jendrossek D, 1996, APPL MICROBIOL BIOT, V46, P451, DOI 10.1007/s002530050844; KAMIYA N, 1989, MACROMOLECULES, V22, P1676, DOI 10.1021/ma00194a030; KAWAGUCHI Y, 1992, MACROMOLECULES, V25, P2324, DOI 10.1021/ma00035a007; Kichise T, 1999, INT J BIOL MACROMOL, V25, P69, DOI 10.1016/S0141-8130(99)00017-3; Kim BK, 1997, J MICROBIOL BIOTECHN, V7, P391; MARCHESSAULT RH, 1970, MACROMOLECULES, V3, P735, DOI 10.1021/ma60018a005; Olabisi O., 1979, POLYM POLYM MISCIBIL, P31; PIEPERFURST U, 1994, J BACTERIOL, V176, P4328, DOI 10.1128/jb.176.14.4328-4337.1994; SAITO T, 1995, CAN J MICROBIOL, V41, P187, DOI 10.1139/m95-186; Song JJ, 1998, INT J BIOL MACROMOL, V23, P165, DOI 10.1016/S0141-8130(98)00046-4; STEINBUCHEL A, 1995, CAN J MICROBIOL, V41, P94, DOI 10.1139/m95-175; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; WIECZOREK R, 1995, J BACTERIOL, V177, P2425, DOI 10.1128/jb.177.9.2425-2435.1995	24	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37800	37808		10.1074/jbc.274.53.37800	http://dx.doi.org/10.1074/jbc.274.53.37800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608842	hybrid			2022-12-27	WOS:000084528000042
J	Kwong, M; Kan, YW; Chan, JY				Kwong, M; Kan, YW; Chan, JY			The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents - Role for Nrf1 in gamma-gcs(L) and g(ss) expression in mouse fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; BZIP TRANSCRIPTION FACTOR; GLOBIN GENE-EXPRESSION; HEAVY SUBUNIT GENE; EMBRYONIC LETHALITY; FREE-RADICALS; ELEMENT; NF-E2; INDUCTION; CLONING	Nrf1 is a member of the CNC-basic leucine zipper (CNC-bZIP) family of transcription factors. CNC bZIP factors, together with small Maf proteins, bind as heterodimers to the NF-E2/AP-1 element. Similarity between the NF-E2/AP-1 element and the antioxidant response element identified in a number of promoters of genes involved in detoxification and antioxidant response raises the possibility that Nrf1 plays a role in mediating the antioxidant response element response. In this study, we exploited the availability of cells from Nrf1 knockout mice to study the role of Nrf1 transcription factor in the regulation of antioxidant gene expression and in cellular antioxidant response. Fibroblast cells derived from Nrf1 null embryos showed lower levels of glutathione and enhanced sensitivity to the toxic effects of oxidant compounds. Our results indicate that Nrf1 plays a role in the regulation of genes involved in glutathione synthesis and suggest a basis for a correspondingly low GSH concentration and reduced stress response.	Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Chan, JY (corresponding author), Univ Calif San Francisco, Dept Lab Med, 533 Parnassus Ave,Rm U442, San Francisco, CA 94143 USA.				NIDDK NIH HHS [KO8-DK02603, P01-DK50267] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050267, K08DK002603] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHAN JY, 1995, HUM GENET, V95, P265; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11366, DOI 10.1073/pnas.90.23.11366; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; DENEKE SM, 1989, AM J PHYSIOL, V257, P163; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; FAVREAU LV, 1993, J BIOL CHEM, V268, P19875; FAVREAU LV, 1995, J BIOL CHEM, V270, P24468, DOI 10.1074/jbc.270.41.24468; Galloway DC, 1998, BIOCHEM J, V336, P535, DOI 10.1042/bj3360535; Galloway DC, 1997, BIOCHEM J, V328, P99; GretherBeck S, 1996, P NATL ACAD SCI USA, V93, P14586, DOI 10.1073/pnas.93.25.14586; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; GRIFFITH OW, 1997, GLUTATHIONE; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; HALLIWELL B, 1992, J LAB CLIN MED, V119, P598; Hogan B, 1994, MANIPULATING MOUSE E; HUANG CS, 1993, J BIOL CHEM, V268, P19675; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; JACKSON SP, 1993, GENE TRANSCRIPTION, V117, P189; JAISWAL AK, 1994, BIOCHEM PHARMACOL, V48, P439, DOI 10.1016/0006-2952(94)90272-0; JANSSEN YMW, 1993, LAB INVEST, V69, P261; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; JOSHI MS, 1997, ENCY HUMAN BIOL, V4, P107; Knight JA, 1998, ANN CLIN LAB SCI, V28, P331; KRALL J, 1988, J BIOL CHEM, V263, P1910; LI Y, 1994, EUR J BIOCHEM, V226, P31, DOI 10.1111/j.1432-1033.1994.tb20023.x; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; Marini MG, 1997, J BIOL CHEM, V272, P16490, DOI 10.1074/jbc.272.26.16490; Martin F, 1998, BLOOD, V91, P3459, DOI 10.1182/blood.V91.9.3459.3459_3459_3466; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; Meister A., 1995, METABOLIC BASIS INHE, P1461; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Moinova HR, 1998, J BIOL CHEM, V273, P14683, DOI 10.1074/jbc.273.24.14683; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; MULCAHY RT, 1995, BIOCHEM BIOPH RES CO, V209, P227, DOI 10.1006/bbrc.1995.1493; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; Nakagawa Ippei, 1995, Journal of Toxicological Sciences, V20, P557; NEY PA, 1993, MOL CELL BIOL, V13, P5604, DOI 10.1128/MCB.13.9.5604; PRESTERA T, 1995, P NATL ACAD SCI USA, V92, P8965, DOI 10.1073/pnas.92.19.8965; Toki T, 1997, ONCOGENE, V14, P1901, DOI 10.1038/sj.onc.1201024; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wasserman WW, 1997, ARCH BIOCHEM BIOPHYS, V344, P387, DOI 10.1006/abbi.1997.0215; Xie T, 1996, BIOCHEM PHARMACOL, V51, P771, DOI 10.1016/0006-2952(95)02394-1; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	50	142	145	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37491	37498		10.1074/jbc.274.52.37491	http://dx.doi.org/10.1074/jbc.274.52.37491			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601325	hybrid			2022-12-27	WOS:000084382700096
J	Matsuo, M; Kioka, N; Amachi, T; Ueda, K				Matsuo, M; Kioka, N; Amachi, T; Ueda, K			ATP binding properties of the nucleotide-binding folds of SUR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; RESISTANCE-ASSOCIATED PROTEIN; SENSITIVE K+ CHANNELS; SULFONYLUREA RECEPTOR; MULTIDRUG-RESISTANCE; DISTINCT FUNCTIONS; INSULIN-SECRETION; SUBUNIT; RECONSTITUTION	Pancreatic beta cell ATP-sensitive potassium (K-ATP) channels regulate glucose-induced insulin secretion. The activity of the K-ATP channel, composed of SUR1 and Kir6.2 subunits, is regulated by intracellular ATP and ADP, but the molecular mechanism is not clear. To distinguish the ATP binding properties of the two nucleotide-binding folds (NBFs) of SUR1, we prepared antibodies against NBF1 and NBF2, and the tryptic fragment of SUR1 was immunoprecipitated after photoaffinity labeling with 8-azido-[P-32]ATP. The 35-kDa fragment was strongly labeled with 5 mu M 8-azido-[P-32]ATP even in the absence of Mg2+ and was immunoprecipitated with the antibody against NBF1, The 65-kDa fragment labeled with 100 mu M 8-azido-[alpha-P-32]ATP in the presence of Mg2+ was immunoprecipitated with anti-NBF2 and anti-C terminus antibodies. These results indicate that NBF1 of SUR1 binds 8-azido-ATP strongly in a magnesium-independent manner and that NBF2 binds 8-azido-ATP weakly in a magnesium-dependent manner. Furthermore, the 65-kDa tryptic fragment was not photoaffinity-labeled with 8-azido-[gamma-P-32]ATP at 37 degrees C, whereas the 35-kDa tryptic fragment was, suggesting that NBF2 of SUR1 may have ATPase activity and that NBF1 has none or little.	Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Biochem Lab, Kyoto 6068502, Japan	Kyoto University	Ueda, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Biochem Lab, Kyoto 6068502, Japan.	uedak@kais.kyoto-u.ac.jp		Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X				Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BRUGGEMANN EP, 1989, J BIOL CHEM, V264, P15483; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; GEORGES E, 1991, J CELL PHYSIOL, V148, P479, DOI 10.1002/jcp.1041480321; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1994, J BIOL CHEM, V269, P7750; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Muller M, 1996, J BIOL CHEM, V271, P1877; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Proks P, 1999, J BIOL CHEM, V274, P25393, DOI 10.1074/jbc.274.36.25393; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; SHIMABUKU AM, 1992, J BIOL CHEM, V267, P4308; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Szabo K, 1999, J BIOL CHEM, V274, P12209, DOI 10.1074/jbc.274.18.12209; Taguchi Y, 1997, FEBS LETT, V401, P11, DOI 10.1016/S0014-5793(96)01421-4; Takeda Y, 1998, BBA-BIOMEMBRANES, V1373, P131, DOI 10.1016/S0005-2736(98)00099-6; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; YOSHIMURA A, 1989, J BIOL CHEM, V264, P16282; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	42	83	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37479	37482		10.1074/jbc.274.52.37479	http://dx.doi.org/10.1074/jbc.274.52.37479			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601323	hybrid			2022-12-27	WOS:000084382700094
J	Wo, ZG; Chohan, KK; Chen, HY; Sutcliffe, MJ; Oswald, RE				Wo, ZG; Chohan, KK; Chen, HY; Sutcliffe, MJ; Oswald, RE			Cysteine mutagenesis and homology modeling of the ligand-binding site of a kainate-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-RECEPTOR-CHANNEL; GATED ION CHANNELS; 3-DIMENSIONAL MODELS; TETRAMERIC STRUCTURE; ESCHERICHIA-COLI; AMPA RECEPTORS; ACID RECEPTORS; NR1 SUBUNIT; DOMAIN; IDENTIFICATION	Glutamate receptors comprise the most abundant group of neurotransmitter receptors in the vertebrate central nervous system. Cysteine mutagenesis in combination with homology modeling has been used to study the determinants of kainate binding in a glutamate receptor subtype, a low molecular weight goldfish kainate-binding protein, GFKAR beta. A construct of GFKAR beta with no cysteines in the extracellular domain was produced, and single cysteine residues were introduced at selected positions. N Ethylmaleimide or derivatized methanethiosulfonate reagents (neutral or charged) were used to modify the introduced cysteines covalently, and the effect on [H-3]kainate binding was determined. In addition, cysteine mutants of GFKAR beta transiently expressed in HEK293 cells were labeled with a membrane-impermeable biotinylating reagent followed by precipitation with streptavidin beads and specific detection of GFKAR beta by Western blot analysis. The results are consistent with the proposal that the energy driving kainate binding is contributed both from residues within the binding site and from interactions between two regions (i.e, two lobes) of the protein that are brought into contact upon ligand binding in a manner analogous to that seen in bacterial amino acid-binding proteins.	Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England	Cornell University; University of Leicester	Oswald, RE (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.			Sutcliffe, Mike/0000-0003-0414-1700	NIGMS NIH HHS [T32 GM8210] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008210] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abele R, 1998, J BIOL CHEM, V273, P25132, DOI 10.1074/jbc.273.39.25132; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Arvola M, 1996, J BIOL CHEM, V271, P15527, DOI 10.1074/jbc.271.26.15527; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Basiry SS, 1999, J NEUROSCI, V19, P644; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Hall RA, 1997, J NEUROCHEM, V68, P625; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Ivanovic A, 1998, J BIOL CHEM, V273, P19933, DOI 10.1074/jbc.273.32.19933; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Lampinen M, 1998, EMBO J, V17, P4704, DOI 10.1093/emboj/17.16.4704; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Laube B, 1998, J NEUROSCI, V18, P2954; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; Mano I, 1998, NEUROREPORT, V9, P327, DOI 10.1097/00001756-199801260-00027; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Paas Y, 1996, NEURON, V17, P979, DOI 10.1016/S0896-6273(00)80228-7; Paas Y, 1996, EMBO J, V15, P1548, DOI 10.1002/j.1460-2075.1996.tb00499.x; Premkumar LS, 1997, J GEN PHYSIOL, V110, P485, DOI 10.1085/jgp.110.5.485; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sutcliffe MJ, 1996, BIOPHYS J, V70, P1575, DOI 10.1016/S0006-3495(96)79724-2; Sutcliffe MJ, 1998, BIOCHEM SOC T, V26, P450, DOI 10.1042/bst0260450; Sutcliffe MJ, 1998, METHOD ENZYMOL, V293, P589; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; Wo ZG, 1996, MOL PHARMACOL, V50, P770; WO ZGL, 1995, J BIOL CHEM, V270, P2000, DOI 10.1074/jbc.270.5.2000; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882	45	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37210	37218		10.1074/jbc.274.52.37210	http://dx.doi.org/10.1074/jbc.274.52.37210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601284	hybrid			2022-12-27	WOS:000084382700055
J	Coe, NR; Smith, AJ; Frohnert, BI; Watkins, PA; Bernlohr, DA				Coe, NR; Smith, AJ; Frohnert, BI; Watkins, PA; Bernlohr, DA			The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; ESCHERICHIA-COLI; PHOSPHOLIPID-BILAYERS; GAMMA ACTIVATORS; PLASMA-MEMBRANE; EXPRESSION; GENE; ADIPOCYTES; INSULIN; PURIFICATION	The primary sequence of the murine fatty acid transport protein (FATP1) is very similar to the multigene family of very long chain (C20-C26) acyl-CoA synthetases, To determine if FATP1 is a long chain acyl coenzyme A synthetase, FATP1-Myc/His fusion protein was expressed in COS1 cells, and its enzymatic activity was analyzed. In addition, mutations were generated in two domains conserved in acyl-CoA synthetases: a 6-amino acid substitution into the putative active site (amino acids 249-254) generating mutant M1 and a 59-amino acid deletion into a conserved C-terminal domain (amino acids 464-523) generating mutant M2. Immunolocalization revealed that the FATP1-Myc/His forms were distributed between the COS1 cell plasma membrane and intracellular membranes. COS1 cells expressing wild type FATP1-Myc/His exhibited a 8-fold increase in the ratio of lignoceroyl-CoA synthetase activity (C24:0) to palmitoyl-CoA synthetase activity (C16:0), characteristic of very long chain acyl-CoA synthetases, whereas both mutant M1 and M2 were catalytically inactive. Detergent-solubilized FATP1-Myc/His was partially purified using nickel-based affinity chromatography and demonstrated a 10-fold increase in very long chain acyl-CoA specific activity (C24:0/C16:0). These results indicate that FATP1 is a very long chain acyl-CoA synthetase and suggest that a potential mechanism for facilitating mammalian fatty acid uptake is via esterification coupled influx.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; Kennedy Krieger Res Inst, Baltimore, MD 21205 USA	University of Minnesota System; University of Minnesota Twin Cities; Kennedy Krieger Institute	Bernlohr, DA (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 1479 Gortner Ave, St Paul, MN 55108 USA.			Frohnert, Brigitte/0000-0002-6636-4048; Watkins, Paul A./0000-0002-3246-1405	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049807] Funding Source: NIH RePORTER; NICHD NIH HHS [HD10981] Funding Source: Medline; NIDDK NIH HHS [DK49807] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABUMRAD NA, 1984, J BIOL CHEM, V259, P8945; Allgood VE, 1997, BIOCHEMISTRY-US, V36, P224, DOI 10.1021/bi961125c; Berk PD, 1996, P SOC EXP BIOL MED, V212, P1; Berk PD, 1997, J BIOL CHEM, V272, P8830, DOI 10.1074/jbc.272.13.8830; Bernlohr DA, 1999, SEMIN CELL DEV BIOL, V10, P43, DOI 10.1006/scdb.1998.0271; BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; BLACK PN, 1992, J BIOL CHEM, V267, P25513; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; Choi JY, 1999, J BIOL CHEM, V274, P4671, DOI 10.1074/jbc.274.8.4671; Faergeman NJ, 1997, J BIOL CHEM, V272, P8531, DOI 10.1074/jbc.272.13.8531; Fitscher BA, 1996, P SOC EXP BIOL MED, V212, P15; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Gargiulo CE, 1999, J LIPID RES, V40, P881; GOSWITZ VC, 1995, PROTEIN SCI, V4, P534; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hui T.Y., 1997, FRONT BIOSCI, V2, P222; Hui TY, 1998, J BIOL CHEM, V273, P27420, DOI 10.1074/jbc.273.42.27420; KAMEDA K, 1987, BIOCHEM INT, V14, P227; KAMEDA K, 1986, BIOCHEM INT, V13, P343; KAMP F, 1993, BIOCHEMISTRY-US, V32, P11074, DOI 10.1021/bi00092a017; KAMP F, 1995, BIOCHEMISTRY-US, V34, P11928, DOI 10.1021/bi00037a034; Man MZ, 1996, MOL ENDOCRINOL, V10, P1021, DOI 10.1210/me.10.8.1021; MANGROO D, 1993, BIOCHEM CELL BIOL, V71, P51, DOI 10.1139/o93-008; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Steinberg SJ, 1999, BIOCHEM BIOPH RES CO, V257, P615, DOI 10.1006/bbrc.1999.0510; Stuhlsatz-Krouper SM, 1998, J BIOL CHEM, V273, P28642, DOI 10.1074/jbc.273.44.28642; Trigatti BL, 1996, BIOCHEM J, V313, P487, DOI 10.1042/bj3130487; Uchida Y, 1996, J BIOCHEM, V119, P565; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Zakim D, 1996, P SOC EXP BIOL MED, V212, P5	32	185	195	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36300	36304		10.1074/jbc.274.51.36300	http://dx.doi.org/10.1074/jbc.274.51.36300			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593920	hybrid			2022-12-27	WOS:000084279200039
J	Lin, HB; Jurk, M; Gulick, T; Cooper, GM				Lin, HB; Jurk, M; Gulick, T; Cooper, GM			Identification of COUP-TF as a transcriptional repressor of the c-mos proto-oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; THYROID-HORMONE; XENOPUS OOCYTES; SARCOMA-VIRUS; MOUSE-TISSUES; SOMATIC-CELLS; GERM-CELLS; MEIOSIS-II; EXPRESSION; PROMOTER	The c-mos proto-oncogene is specifically expressed in the male and female germ cells of the mouse and other vertebrates. We previously identified a 15-base pair sequence element (B2) as the binding site of a candidate repressor of c-mos transcription in somatic cells. In the present study, we used the yeast one-hybrid system to isolate HeLa cell cDNAs encoding proteins that specifically bound to the c-mos B2 element. Nucleotide sequencing identified several of the clones isolated in this screen as the orphan nuclear receptors COUP-TFI and COUP-TFII. A COUP-TF-binding site was then identified within the B2 sequence. Complexes formed between purified COUP-TFs and the c-mos B2 probe comigrated in electrophoretic mobility shift assays with those formed using whole nuclear extracts of NIH 3T3 or HeLa cells. Moreover, the complexes formed with NIH 3T3 nuclear extracts and B2 probe were supershifted with antibody against COUP-TF, identifying COUP-TF as the candidate repressor previously detected in these somatic cell extracts. Substitution of a consensus COUP-TF-binding site for the c-mos negative regulatory element suppressed expression from the c-mos promoter in transfected somatic cells, demonstrating the functional activity of COUP-TF as a repressor of c-mos transcription.	Boston Univ, Dept Biol, Boston, MA 02215 USA; Massachusetts Gen Hosp, Diabet Res Lab, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Med Serv, Charlestown, MA 02129 USA	Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Cooper, GM (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gmcooper@bu.edu			NICHD NIH HHS [R01-HD35685, R01-HD26594] Funding Source: Medline; NIDDK NIH HHS [K02-DK02461] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K02DK002461] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bauer UM, 1998, FEBS LETT, V439, P208, DOI 10.1016/S0014-5793(98)01327-1; CARTER ME, 1994, MOL CELL BIOL, V14, P4360, DOI 10.1128/MCB.14.7.4360; CHEN F, 1994, MOL ENDOCRINOL, V8, P1434, DOI 10.1210/me.8.10.1434; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; GOLDMAN DS, 1987, P NATL ACAD SCI USA, V84, P4509, DOI 10.1073/pnas.84.13.4509; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; Higgy NA, 1997, BBA-GENE STRUCT EXPR, V1351, P313, DOI 10.1016/S0167-4781(96)00221-7; HUANG HC, 1990, GENE DEV, V4, P287, DOI 10.1101/gad.4.2.287; Hummelke GC, 1998, MOL REPROD DEV, V50, P396, DOI 10.1002/(SICI)1098-2795(199808)50:4<396::AID-MRD3>3.0.CO;2-D; JONK LJC, 1994, MECH DEVELOP, V47, P81, DOI 10.1016/0925-4773(94)90098-1; KANKI JP, 1991, P NATL ACAD SCI USA, V88, P5794, DOI 10.1073/pnas.88.13.5794; Katz D, 1997, ENDOCRINOLOGY, V138, P4364, DOI 10.1210/en.138.10.4364; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MUTTER GL, 1987, P NATL ACAD SCI USA, V84, P5301, DOI 10.1073/pnas.84.15.5301; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; OKEEFE SJ, 1989, P NATL ACAD SCI USA, V86, P7038, DOI 10.1073/pnas.86.18.7038; OSKARSSON M, 1980, SCIENCE, V207, P1222, DOI 10.1126/science.6243788; PAL SK, 1991, MOL CELL BIOL, V11, P5190, DOI 10.1128/MCB.11.10.5190; PAL SK, 1994, FERTIL STERIL, V61, P496; PAPKOFF J, 1982, CELL, V29, P417, DOI 10.1016/0092-8674(82)90158-1; PAULES RS, 1988, ONCOGENE, V3, P59; PEREIRA FA, 1995, J STEROID BIOCHEM, V53, P503, DOI 10.1016/0960-0760(95)00097-J; PROPST F, 1985, NATURE, V315, P516, DOI 10.1038/315516a0; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; Sagata N, 1997, BIOESSAYS, V19, P13, DOI 10.1002/bies.950190105; SCHMIDT M, 1988, MOL CELL BIOL, V8, P923, DOI 10.1128/MCB.8.2.923; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; VANDERHOORN FA, 1991, ONCOGENE, V6, P929; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; XU WH, 1995, MOL CELL BIOL, V15, P5369; ZINKEL SS, 1992, MOL CELL BIOL, V12, P2029, DOI 10.1128/MCB.12.5.2029	38	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36796	36800		10.1074/jbc.274.51.36796	http://dx.doi.org/10.1074/jbc.274.51.36796			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593989	hybrid			2022-12-27	WOS:000084279200108
J	Seshagiri, S; Vucic, D; Lee, J; Dixit, VM				Seshagiri, S; Vucic, D; Lee, J; Dixit, VM			Baculovirus-based genetic screen for antiapoptotic genes identifies a novel IAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; CELL-DEATH; INHIBITION; P35; CLEAVAGE; PROTEASE	The prototype baculovirus, Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) expresses p35, a potent anti cell-death gene that promotes the propagation of the virus by blocking host cell. apoptosis. Infection of insect Sf-21 cells with AcMNPV lacking p35 induces apoptosis. We have used this pro-apoptotic property of the p35 null virus to screen for genes encoding inhibitors of apoptosis that rescue cells infected with the p35 defective virus. We report here the identification of Tn-IAP1, a novel member of the IAP family of cell. death inhibitors. Tn-IAP1 blocks cell death induced by p35 null AcMNPV, actinomycin D, and Drosophila cell-death inducers KID and GRIM. Given the conserved nature of the cell death pathway, this genetic screen can be used for rapid identification of novel inhibitors of apoptosis from diverse sources.	Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA; Genentech Inc, Dept Biol Mol, S San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, S San Francisco, CA 94080 USA.		dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Seshagiri, Somasekar/0000-0003-4272-6443				Bertin J, 1996, J VIROL, V70, P6251, DOI 10.1128/JVI.70.9.6251-6259.1996; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; CLEM JR, 1997, BACULOVIRUSES, P237; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; CLEM RJ, 1993, J VIROL, V67, P3730, DOI 10.1128/JVI.67.7.3730-3738.1993; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Clem RJ, 1996, CELL DEATH DIFFER, V3, P9; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Peter ME, 1997, P NATL ACAD SCI USA, V94, P12736, DOI 10.1073/pnas.94.24.12736; Seshagiri S, 1997, P NATL ACAD SCI USA, V94, P13606, DOI 10.1073/pnas.94.25.13606; SHEN YQ, 1995, CURR OPIN GENET DEV, V5, P105, DOI 10.1016/S0959-437X(95)90061-6; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Vucic D, 1998, J BIOL CHEM, V273, P33915, DOI 10.1074/jbc.273.51.33915; Vucic D, 1997, P NATL ACAD SCI USA, V94, P10183, DOI 10.1073/pnas.94.19.10183; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Vucic D, 1997, MOL CELL BIOL, V17, P667, DOI 10.1128/MCB.17.2.667; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0	22	29	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36769	36773		10.1074/jbc.274.51.36769	http://dx.doi.org/10.1074/jbc.274.51.36769			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593985	hybrid			2022-12-27	WOS:000084279200104
J	An, SZ; Zheng, YH; Bleu, T				An, SZ; Zheng, YH; Bleu, T			Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID; CALCIUM MOBILIZATION; MEMBRANE-RECEPTOR; 2ND MESSENGER; HIGH-AFFINITY; SPHINGOSINE-1-PHOSPHATE; KINASE; GROWTH; ACTIVATION; PATHWAY	Sphingosine l-phosphate (S1P) regulates cell proliferation, apoptosis, motility, and neurite retraction. Contradictory reports propose that S1P acts as either an intracellular second messenger or an extracellular ligand for cell-surface receptors. Hence, the precise signaling mechanisms mediating the diverse cellular effects of S1P remain to be determined. Here, we investigate whether S1P stimulation of cell. proliferation, survival, and related signaling events can be mediated by the recently cloned Edg family members of G protein-coupled receptors. We observed that S1P treatment significantly increased proliferation of HTC4 hepatoma cells stably transfected with human S1P receptor Edg3 or Edg5, which was attributable to stimulation of cell growth and inhibition of apoptosis caused by serum starvation. Edg3 and Edg5 transduced S1P-evoked signaling events relevant to cell proliferation and survival, including activation of the ERK/MAP kinases, and immediate-early induction of c-Jun and c-Fos. Transcriptional activation of reporter genes for the c-fos promoter and the serum response element by Edg3 and Edg5 transfected in Jurkat cells was inhibited by pertussis toxin and C3 exoenzyme, implicating G(i/o)- and Rho-dependent pathways. Our data also indicated that Edg3 and Edg5 mediated the serum response element activation through transcriptional factors Elk-1 and serum response factor. Thus, specific G protein-coupled receptors Edg3 and Edg5 account for, at least in part, S1P-induced cell proliferation, survival, and related signaling events.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	An, SZ (corresponding author), Univ Calif San Francisco, Dept Med, Box 0711,Rm UB8,533 Parnassus Ave, San Francisco, CA 94143 USA.	songzhu@itsa.ucsf.edu						An SZ, 1998, J CELL BIOCHEM, P147; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; An SZ, 1998, MOL PHARMACOL, V54, P881, DOI 10.1124/mol.54.5.881; An SZ, 1999, MOL PHARMACOL, V55, P787; Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Berger A, 1996, MOL PHARMACOL, V50, P451; BORNFELDT KE, 1995, J CELL BIOL, V130, P193, DOI 10.1083/jcb.130.1.193; Bunemann M, 1996, EMBO J, V15, P5527, DOI 10.1002/j.1460-2075.1996.tb00937.x; Choi OH, 1996, NATURE, V380, P634; Chun Jerold, 1999, Cell Biochemistry and Biophysics, V30, P213, DOI 10.1007/BF02738068; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; DURIEUX ME, 1993, AM J PHYSIOL, V264, pC1360, DOI 10.1152/ajpcell.1993.264.5.C1360; GHOSH TK, 1994, J BIOL CHEM, V269, P22628; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; Gonda K, 1999, BIOCHEM J, V337, P67, DOI 10.1042/0264-6021:3370067; GOODEMOTE KA, 1995, J BIOL CHEM, V270, P10272, DOI 10.1074/jbc.270.17.10272; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Im DS, 1997, AM J PHYSIOL-GASTR L, V272, pG1091, DOI 10.1152/ajpgi.1997.272.5.G1091; Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; MACLENNAN AJ, 1994, MOL CELL NEUROSCI, V5, P201, DOI 10.1006/mcne.1994.1024; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Mathes C, 1998, J BIOL CHEM, V273, P25020, DOI 10.1074/jbc.273.39.25020; MATTIE M, 1994, J BIOL CHEM, V269, P3181; Noh SJ, 1998, J CELL PHYSIOL, V176, P412, DOI 10.1002/(SICI)1097-4652(199808)176:2<412::AID-JCP20>3.0.CO;2-3; Okajima F, 1996, FEBS LETT, V379, P260, DOI 10.1016/0014-5793(95)01526-4; Okamoto H, 1998, J BIOL CHEM, V273, P27104, DOI 10.1074/jbc.273.42.27104; OKAZAKI H, 1993, BIOCHEM BIOPH RES CO, V190, P1104, DOI 10.1006/bbrc.1993.1163; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Postma FR, 1996, EMBO J, V15, P2388, DOI 10.1002/j.1460-2075.1996.tb00595.x; Rakhit S, 1999, BIOCHEM J, V338, P643, DOI 10.1042/0264-6021:3380643; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Sato K, 1999, FEBS LETT, V443, P25, DOI 10.1016/S0014-5793(98)01676-7; Spiegel S, 1998, ANN NY ACAD SCI, V845, P11, DOI 10.1111/j.1749-6632.1998.tb09658.x; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; SU Y, 1994, J BIOL CHEM, V269, P16512; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Valet P, 1998, J CLIN INVEST, V101, P1431, DOI 10.1172/JCI806; Van Brocklyn JR, 1999, J BIOL CHEM, V274, P4626, DOI 10.1074/jbc.274.8.4626; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; vanKoppen CJ, 1996, J BIOL CHEM, V271, P2082, DOI 10.1074/jbc.271.4.2082; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484; Yatomi Y, 1997, J BIOCHEM, V121, P969; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zondag GCM, 1998, BIOCHEM J, V330, P605, DOI 10.1042/bj3300605; ZUHERINGDORF DM, 1998, EMBO J, V17, P2830; ZUHERINGDORF DM, 1996, N-S ARCH PHARMACOL, V354, P397	56	173	188	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					288	296		10.1074/jbc.275.1.288	http://dx.doi.org/10.1074/jbc.275.1.288			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617617	hybrid			2022-12-27	WOS:000085951600041
J	Gerlach, AC; Gangopadhyay, NN; Devor, DC				Gerlach, AC; Gangopadhyay, NN; Devor, DC			Kinase-dependent regulation of the intermediate conductance, calcium-dependent potassium channel, hIK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL LINE; CA2+-ACTIVATED K+ CHANNELS; HUMAN T-LYMPHOCYTES; PROTEIN-KINASE; CHLORIDE SECRETION; CA2+ CHANNELS; T84 CELLS; PHOSPHORYLATION; MODULATION; CARBACHOL	We determined the effect of nucleotides and protein kinase A (PKA) on the Ca2+-dependent gating of the cloned intermediate conductance, Ca2+-dependent K+ channel, hIK1, In Xenopus oocytes, during two-electrode voltage-clamp, forskolin plus isobutylmethylxanthine induced a Ca2+-dependent increase in hIK1 activity. In excised inside-out patches, addition of ATP induced a Ca2+-dependent increase in hIK1 activity (NPo). In contrast, neither nonhydrolyzable (AMP-PNP, AMP-PCP) nor hydrolyzable ATP analogs (GTP, CTP, UTP, and ITP) activated hIK1. The ATP-dependent activation of hIK1 required Mg2+ and was reversed by either exogenous alkaline phosphatase or the PKA inhibitor PKI5-24. The Ca2+ dependence of hIK1 activation was best fit with a stimulatory constant (K-s) of 350 nM and a Hill coefficient (n) of 2.3. ATP increased NPo at [Ca2+] > 100 nM while having no effect on K-s or n. Mutation of the single PKA consensus phosphorylation site at serine 334 to alanine (S334A) had no effect on the PKA-dependent activation during either two-electrode voltage-clamp or in excised inside-out patches, When expressed in HEK293 cells, ATP activated hIK1 in a Mg2+-dependent fashion, being reversed by alkaline phosphatase. Neither PKI5-24 nor CaMKII281-309 or PKC19-31 affected the ATP-dependent activation. Northern blot analysis revealed hIK1 expression in the T84 colonic cell line. Endogenous hIK1 was activated by ATP in a Mg2+- and PKI5-24-dependent fashion and was reversed by alkaline phosphatase, whereas CaMKII281-309 and PKC19-31 had no effect on the ATP-dependent activation. The Ca2+-dependent activation (LC, and n) was unaffected by ATP, In conclusion, hIK1 is activated by a membrane delimited PKA when endogenously expressed. Although the oocyte expression system recapitulates this regulation, expression in HEK293 cells does not, The effect of PKA on hIK1 gating is Ca2+-dependent and occurs via an increase in NPo without an effect on either Ca2+ affinity or apparent cooperativity.	Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Devor, DC (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, S312 Biomed Sci Tower,3500 Terr St, Pittsburgh, PA 15261 USA.				NIDDK NIH HHS [DK54941-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054941] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARRETT KE, 1993, AM J PHYSIOL, V265, pC859; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BRUGNARA C, 1995, J MEMBRANE BIOL, V147, P71, DOI 10.1007/BF00235398; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; DEPEYER JE, 1982, P NATL ACAD SCI-BIOL, V79, P4207; Devor DC, 1998, AM J PHYSIOL-CELL PH, V274, pC138, DOI 10.1152/ajpcell.1998.274.1.C138; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; DEVOR DC, 1993, AM J PHYSIOL, V265, pC1271, DOI 10.1152/ajpcell.1993.265.5.C1271; Devor DC, 1997, AM J PHYSIOL-CELL PH, V273, pC531, DOI 10.1152/ajpcell.1997.273.2.C531; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; DHARMSATHAPHORN K, 1986, J CLIN INVEST, V77, P348, DOI 10.1172/JCI112311; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P653, DOI 10.1016/0006-3002(58)90124-0; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MCCANN JD, 1990, AM J PHYSIOL, V258, pL334, DOI 10.1152/ajplung.1990.258.6.L334; Nara M, 1998, J BIOL CHEM, V273, P14920, DOI 10.1074/jbc.273.24.14920; Pellegrino R, 1998, PFLUG ARCH EUR J PHY, V436, P749, DOI 10.1007/s004240050698; Rader RK, 1996, J IMMUNOL, V156, P1425; REINHART PH, 1991, J NEUROSCI, V11, P1627; ROCH B, 1995, PFLUEGERS ARCH, V426, P355; Rufo PA, 1996, J CLIN INVEST, V98, P2066, DOI 10.1172/JCI119012; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SEIBERT FS, 1995, J BIOL CHEM, V270, P2158, DOI 10.1074/jbc.270.5.2158; SINGH AK, 1997, PEDIATR PULM, V14, P234; SYME CA, 1998, PEDIATR PULM, V17, P235; TABCHARANI JA, 1994, J MEMBRANE BIOL, V142, P241; TABCHARANI JA, 1994, J MEMBRANE BIOL, V142, P255; Tibbs VC, 1998, J BIOL CHEM, V273, P25783, DOI 10.1074/jbc.273.40.25783; VAJANAPHANICH M, 1995, J CLIN INVEST, V96, P386, DOI 10.1172/JCI118046; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; WANG J, 1999, J NEUROSCI, V19, P1; Wang ZW, 1996, AM J PHYSIOL-LUNG C, V271, pL100, DOI 10.1152/ajplung.1996.271.1.L100; WELSH MJ, 1985, P NATL ACAD SCI USA, V82, P8823, DOI 10.1073/pnas.82.24.8823; WONG SME, 1989, AM J PHYSIOL, V257, pC976, DOI 10.1152/ajpcell.1989.257.5.C976; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	46	91	95	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					585	598		10.1074/jbc.275.1.585	http://dx.doi.org/10.1074/jbc.275.1.585			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617655	hybrid			2022-12-27	WOS:000085951600079
J	Gulick, AM; Bauer, CB; Thoden, JB; Pate, E; Yount, RG; Rayment, I				Gulick, AM; Bauer, CB; Thoden, JB; Pate, E; Yount, RG; Rayment, I			X-ray structures of the Dictyostelium discoideum myosin motor domain with six non-nucleotide analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-FIBERS; ADENOSINE-TRIPHOSPHATASE; CRYSTAL-STRUCTURE; ATP ANALOGS; COMPLEX; ACTIN; KINETICS; BINDING; SUBFRAGMENT-1; ACTOMYOSIN	The three-dimensional structures of the truncated myosin head from Dictyostelium discoideum myosin II complexed with dinitrophenylaminoethyl-, dinitrophenylaminopropyl-, o--nitrophenylaminoethyl-, m-nitrophenylaminoethyl-, p-nitrophenylaminoethyl-, and o-nitrophenyl-N-methyl-aminoethyl-diphosphate . beryllium fluoride have been determined to better than 2.3-Angstrom resolution. The structure of the protein and nucleotide binding pocket in these complexes is very similar to that of S1dC . ADP . BeFx (Fisher, A. J., Smith, C. A., Thoden, J., Smith, R,, Sutoh, K., Holden, H. M., and Rayment, I. (1995) Biochemistry 34, 8960-8972). The position of the triphosphate-like moiety is essentially identical in all complexes. Furthermore, the alkyl-amino group plays the same role as the ribose by linking the triphosphate to the adenine binding pocket; however, none of the phenyl groups lie in the same position as adenine in S1dC . MgADP . BeFx, even though several of these nucleotide analogs are functionally equivalent to ATP, Rather the former location of adenine is occupied by water in the nanolog complexes, and the phenyl groups are organized in a manner that attempts to optimize their hydrogen bonding interactions with this constellation of solvent molecules. A comparison of the kinetic and structural properties of the nanologs relative to ATP suggests that the ability of a substrate to sustain tension and to generate movement correlates with a well defined interaction with the active site water structure observed in S1dC . MgADP . BeFx.	Univ Wisconsin, Inst Enzyme Res, Madison, WI 53705 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; Washington State Univ, Dept Math, Pullman, WA 99164 USA; Washington State Univ, Dept Chem, Pullman, WA 99164 USA; Washington State Univ, Dept Biochem & Biophys, Pullman, WA 99164 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington State University; Washington State University; Washington State University	Rayment, I (corresponding author), Univ Wisconsin, Inst Enzyme Res, 1710 Univ Ave, Madison, WI 53705 USA.	ivan_rayment@biochem.wise.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; Gulick, Andrew/0000-0003-4238-7453	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR008422, R01AR035186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK005195, R01DK005195] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR08422, AR35186] Funding Source: Medline; NIDDK NIH HHS [DK05195] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; BAGSHAW CR, 1973, BIOCHEM J, V133, P323, DOI 10.1042/bj1330323; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer CB, 1997, J MOL BIOL, V274, P394, DOI 10.1006/jmbi.1997.1325; CHIARONI A, 1971, ACTA CRYSTALL B-STRU, VB 27, P448, DOI 10.1107/S056774087100236X; CLEGG W, 1994, ACTA CRYSTALLOGR C, V50, P583, DOI 10.1107/S0108270193010972; Cope MJTV, 1996, STRUCTURE, V4, P969, DOI 10.1016/S0969-2126(96)00103-7; DENNY BJ, 1992, J MED CHEM, V35, P2315, DOI 10.1021/jm00090a023; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Ellena J, 1997, ACTA CRYSTALLOGR C, V53, P1930, DOI 10.1107/S0108270197007403; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; FISHER AJ, 1995, BIOPHYS J, V68, pS19; FISHER AJ, 1996, MOLDED; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; GEEVES MA, 1991, BIOCHEM J, V274, P1; GEEVES MA, 1984, J MUSCLE RES CELL M, V5, P351, DOI 10.1007/BF00818255; Giese KC, 1997, BIOCHEMISTRY-US, V36, P8465, DOI 10.1021/bi963141f; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P637, DOI 10.1146/annurev.ph.49.030187.003225; GOODY RS, 1977, EUR J BIOCHEM, V78, P317, DOI 10.1111/j.1432-1033.1977.tb11742.x; GREENE LE, 1980, J BIOL CHEM, V255, P543; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; HENRY GD, 1993, BIOCHEMISTRY-US, V32, P10451, DOI 10.1021/bi00090a022; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; JONES TA, 1985, METHOD ENZYMOL, V115, P157; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAIDA S, 1989, ACTA CRYSTALLOGR C, V45, P2025, DOI 10.1107/S0108270189008784; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuhlman PA, 1996, MOL BIOL CELL, V7, P1138; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Moschcovich L, 1998, BIOCHEMISTRY-US, V37, P15137, DOI 10.1021/bi980605w; Murphy CT, 1998, BIOCHEMISTRY-US, V37, P6738, DOI 10.1021/bi972903j; NAVAZA J, 1993, ACTA CRYSTALLOGR D, V49, P588, DOI 10.1107/S0907444993005141; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTWINOWSKI Z, 1986, DENZO; PANUNTO TW, 1987, J AM CHEM SOC, V109, P7786, DOI 10.1021/ja00259a030; PATE E, 1993, J BIOL CHEM, V268, P10046; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Rayment I, 1996, ANNU REV PHYSIOL, V58, P671; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; Rodgers DW, 1997, METHOD ENZYMOL, V276, P183, DOI 10.1016/S0076-6879(97)76059-2; RODGERS DW, 1994, STRUCTURE, V2, P1135, DOI 10.1016/S0969-2126(94)00116-2; Sellers JR, 1996, J MUSCLE RES CELL M, V17, P7, DOI 10.1007/BF00140320; SMITH CA, 1995, BIOCHEMISTRY-US, V34, P8973, DOI 10.1021/bi00028a005; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Tronrud DE, 1997, METHOD ENZYMOL, V277, P306, DOI 10.1016/S0076-6879(97)77017-4; WANG D, 1993, J MUSCLE RES CELL M, V14, P484, DOI 10.1007/BF00297211; WHITE HD, 1993, J BIOL CHEM, V268, P10039	54	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					398	408		10.1074/jbc.275.1.398	http://dx.doi.org/10.1074/jbc.275.1.398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617631	hybrid			2022-12-27	WOS:000085951600055
J	Hiser, L; Di Valentin, M; Hamer, AG; Hosler, JP				Hiser, L; Di Valentin, M; Hamer, AG; Hosler, JP			Cox11p is required for stable formation of the Cu-B and magnesium centers of cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYOE GENE-PRODUCT; RHODOBACTER-SPHAEROIDES; PARACOCCUS-DENITRIFICANS; ESCHERICHIA-COLI; HEME-A; SACCHAROMYCES-CEREVISIAE; 2.8 ANGSTROM; YEAST COX10; PROTEIN; METAL	Assembly of the core subunits of the aa(3)-type cytochrome c oxidase in mitochondria and aerobic bacteria such as Rhodobacter sphaeroides requires the association of three subunits and the formation of five to seven metal centers. Several assembly proteins are required for the late stages of oxidase assembly in eukaryotes; some of these are also present in Rb. sphaeroides, To investigate the role of one of these proteins, Cox11p, the mitochondrial-like oxidase of Rb. sphaeroides was overexpressed and purified from cells that lacked cox11, the gene for Cox11p. The oxidase that assembled in the absence of Cox11p lacked Cu-B at the active site and contained greatly reduced amounts of metal at the magnesium/manganese-binding site between subunits I and II. This inactive oxidase, however, did contain hemes a and a(3), Cu-A, and all three subunits, These results indicate that Cox11p is required at a late, perhaps final, step in the assembly of cytochrome oxidase, most likely the insertion of Cu-B. Oxidase which assembled in a strain with a low copy number of cox11 appeared nearly wild type, suggesting that Cox11p is required in substoichiometric amounts for its role in oxidase assembly.	Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	University of Mississippi; University of Mississippi Medical Center; Michigan State University	Hosler, JP (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, 2500 N State St, Jackson, MS 39216 USA.	hosler@fiona.umsmed.edu		di valentin, marilena/0000-0002-2915-8704	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025480, R01GM056824] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56824, GM25480] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AASA R, 1976, BIOCHIM BIOPHYS ACTA, V422, P260, DOI 10.1016/0005-2744(76)90137-6; CAO J, 1992, J BIOL CHEM, V267, P24273; Cobine P, 1999, FEBS LETT, V445, P27, DOI 10.1016/S0014-5793(99)00091-5; DONOHUE TJ, 1991, METHOD ENZYMOL, V204, P459; ESPE MP, 1995, BIOCHEMISTRY-US, V34, P7593, DOI 10.1021/bi00023a005; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; GARCIAHORSMAN JA, 1994, BIOCHEMISTRY-US, V33, P3113, DOI 10.1021/bi00176a046; GEREN LM, 1995, J BIOL CHEM, V270, P2466, DOI 10.1074/jbc.270.6.2466; GLERUM DM, 1994, P NATL ACAD SCI USA, V91, P8452, DOI 10.1073/pnas.91.18.8452; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P3120, DOI 10.1021/bi00176a047; HALTIA T, 1988, EUR J BIOCHEM, V172, P543, DOI 10.1111/j.1432-1033.1988.tb13923.x; HILL BC, 1991, J BIOL CHEM, V266, P2219; HILL J, 1992, BIOCHEMISTRY-US, V31, P11435, DOI 10.1021/bi00161a023; HOSLER JP, 1992, J BIOL CHEM, V267, P24264; HOSLER JP, 1995, BIOCHEMISTRY-US, V34, P7586, DOI 10.1021/bi00023a004; HUNDT E, 1980, FEBS LETT, V115, P95, DOI 10.1016/0014-5793(80)80734-4; Hung IH, 1998, J BIOL CHEM, V273, P1749, DOI 10.1074/jbc.273.3.1749; Hunter DJB, 1997, FEBS LETT, V412, P43, DOI 10.1016/S0014-5793(97)00735-7; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Liao GL, 1996, BBA-BIOENERGETICS, V1274, P109, DOI 10.1016/0005-2728(96)00014-X; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; MOGI T, 1994, MOL MICROBIOL, V14, P391, DOI 10.1111/j.1365-2958.1994.tb02174.x; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Ostermeier C, 1996, CURR OPIN STRUC BIOL, V6, P460, DOI 10.1016/S0959-440X(96)80110-2; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; SAIKI K, 1993, J BIOL CHEM, V268, P26041; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; SHAPLEIGH JP, 1992, P NATL ACAD SCI USA, V89, P4786, DOI 10.1073/pnas.89.11.4786; SISTROM WR, 1960, J GEN MICROBIOL, V22, P778, DOI 10.1099/00221287-22-3-778; STEFFENS GCM, 1987, EUR J BIOCHEM, V164, P295, DOI 10.1111/j.1432-1033.1987.tb11057.x; THOMPSON DA, 1983, BIOCHEMISTRY-US, V22, P3178, DOI 10.1021/bi00282a022; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TZAGOLOFF A, 1993, BIOCHEM MOL BIOL INT, V31, P593; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; van Niel CB, 1944, BACTERIOL REV, V8, P1; VANNESTE WH, 1966, BIOCHEMISTRY-US, V5, P838, DOI 10.1021/bi00867a005; Wakabayashi T, 1998, FEBS LETT, V440, P141, DOI 10.1016/S0014-5793(98)01431-8; WIELBURSKI A, 1983, BIOCHEM J, V212, P829, DOI 10.1042/bj2120829; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Zhen Y, 1998, PROTEIN EXPRES PURIF, V13, P326, DOI 10.1006/prep.1998.0903; Zhen YJ, 1999, J BIOL CHEM, V274, P38032, DOI 10.1074/jbc.274.53.38032	49	170	174	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					619	623		10.1074/jbc.275.1.619	http://dx.doi.org/10.1074/jbc.275.1.619			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617659	Green Published, hybrid			2022-12-27	WOS:000085951600083
J	Leonardi, A; Ellinger-Ziegelbauer, H; Franzoso, G; Brown, K; Siebenlist, U				Leonardi, A; Ellinger-Ziegelbauer, H; Franzoso, G; Brown, K; Siebenlist, U			Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TNF RECEPTOR-1; TERMINAL KINASE; JNK/SAPK ACTIVATION; SIGNAL TRANSDUCER; CELL-DEATH; FAMILY; ALPHA; TRAF2; BETA	Tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) is an intracellular protein involved in signal transduction from TNF receptor I and II and related receptors. TRAF2 is required for TNF-induced activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK), and TRAF2 can also mediate activation of NF-kappa B. Here we have identified the actin-binding protein Filamin (actin-binding protein-280) as a TRAF2-interacting protein. Filamin binds to the Ring zinc finger domain of TRAF2, Overexpressed Filamin inhibits TRAF2-induced activation of JNI/SAPK and of NF-kappa B. Furthermore, ectopically expressed Filamin inhibits NF-kappa B activation induced via TNF, interleukin-1, Toll receptors, and TRAF6 but not activation induced via overexpression of NIK, a downstream effector in these pathways. Importantly, TNF fails to activate SAPK or NF-kappa B in a human melanoma cell line deficient in Filamin. Reintroduction of Filamin into these cells restores the TNF response. The data imply a role for Filamin in inflammatory signal transduction pathways.	NIAID, Immune Activat Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Siebenlist, U (corresponding author), NIAID, Immune Activat Sect, Immunoregulat Lab, NIH, Bldg 10,Rm 11B16, Bethesda, MD 20892 USA.		Franzoso, Guido/GRR-8628-2022; leonardi, antonio/A-2887-2009	leonardi, antonio/0000-0001-8636-9623; Franzoso, Guido/0000-0002-0778-988X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000722, ZIAAI000722, Z01AI000723] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aizawa S, 1997, J BIOL CHEM, V272, P2042; Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; ANDREWS RK, 1991, J BIOL CHEM, V266, P7144; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Edwards DN, 1997, DEVELOPMENT, V124, P3855; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; HARTWIG J, 1995, PROTEIN PROFILE, V2, P739; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; ISRAEL DI, 1989, NUCLEIC ACIDS RES, V17, P4589, DOI 10.1093/nar/17.12.4589; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Natoli G, 1997, J BIOL CHEM, V272, P26079, DOI 10.1074/jbc.272.42.26079; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; OHTA Y, 1991, CELL, V67, P225; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Schwarzman AL, 1999, P NATL ACAD SCI USA, V96, P7932, DOI 10.1073/pnas.96.14.7932; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Shi CS, 1999, J IMMUNOL, V163, P3279; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; WERSCHE H, 1997, IMMUNITY, V7, P837; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	70	101	105	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					271	278		10.1074/jbc.275.1.271	http://dx.doi.org/10.1074/jbc.275.1.271			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617615	hybrid			2022-12-27	WOS:000085951600039
J	Park, JS; Boyer, S; Mitchell, K; Gilfor, D; Birrer, M; Darlington, G; El Deiry, W; Firestone, GL; Munger, K; Band, V; Fisher, PB; Dent, P				Park, JS; Boyer, S; Mitchell, K; Gilfor, D; Birrer, M; Darlington, G; El Deiry, W; Firestone, GL; Munger, K; Band, V; Fisher, PB; Dent, P			Expression of human papilloma virus E7 protein causes apoptosis and inhibits DNA synthesis in primary hepatocytes via increased expression of p21Cip-1/WAF1/MDA6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOGEN-ACTIVATED PROTEIN; CYCLIN-DEPENDENT KINASES; ADULT-RAT HEPATOCYTES; CELL-PROLIFERATION; P53 GENE; P53-INDEPENDENT INDUCTION; P21(WAF1/CIP1) EXPRESSION; HUMAN KERATINOCYTES; LIVER-REGENERATION; PRIMARY CULTURES	The impact of human papilloma virus (HPV16) E7 proteins and retinoblastoma (RB) antisense oligonucleotides upon mitogen-activated protein kinase (MAPK)-mediated inhibition of DNA synthesis via p21(Cip-1/WAF1/MDA6) (p21) was determined in primary hepatocytes. Prolonged activation of the MAPK pathway in p21(+/+) or p21(-/-) hepatocytes caused a large decrease and increase, respectively, in DNA synthesis. Either transfection with RE antisense oligonucleotides, expression of wild type E7, or RE binding mutant E7 (C24S) proteins increased p21 levels and reduced DNA synthesis in p21(+/+) hepatocytes. RE antisense oligonucleotides and E7 proteins increased apoptosis in p21(+/+), but not p21(-/-), hepatocytes. Expression of wild type E7 increased DNA synthesis above control levels in p21(-/-) cells, which was additive with prolonged MAPK activation. In contrast, expression of mutant E7 did not alter DNA synthesis above control levels in p21(-/-) cells and was supra-additive with prolonged MAPK activation. Antisense ablation of RE in p21(-/-) hepatocytes had a weak stimulatory effect upon DNA synthesis itself but enhanced the capacity of mutant E7 protein to stimulate DNA synthesis to the same level observed using wild type E7. The ability of prolonged MAPK activation to stimulate DNA synthesis in the presence of mutant E7 and antisense RE was additive. Collectively, the present data demonstrate that loss of RE function together with loss of pal function plays an important role in the E7- and MAPK-dependent modulation of apoptosis and DNA synthesis in primary hepatocytes.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Radiat Oncol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Urol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Pathol, New York, NY 10032 USA; Tufts Univ, Sch Med, New England Med Ctr, Dept Radiat Oncol, Boston, MA 02111 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77071 USA; NCI, Med Branch, NIH, Bethesda, MD 20181 USA; Univ Penn, Sch Med, Ctr Canc, Dept Med,Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Human Gene Therapy, Philadelphia, PA 19104 USA	Virginia Commonwealth University; Virginia Commonwealth University; Columbia University; Columbia University; Tufts Medical Center; Tufts University; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Dent, P (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Radiat Oncol, Richmond, VA 23298 USA.	PDENT@HSC.VCU.EDU	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266; Munger, Karl/0000-0003-3288-9935	NCI NIH HHS [R01CA35675, R01CA74468] Funding Source: Medline; NIDDK NIH HHS [R01DK52825] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074468, R01CA035675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052825] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311; Alesse E, 1998, CELL DEATH DIFFER, V5, P381, DOI 10.1038/sj.cdd.4400358; Auer KL, 1998, FEBS LETT, V436, P131, DOI 10.1016/S0014-5793(98)01074-6; Auer KL, 1998, BIOCHEM J, V336, P551, DOI 10.1042/bj3360551; Auer KL, 1998, MOL BIOL CELL, V9, P561, DOI 10.1091/mbc.9.3.561; Aziz N, 1999, MOL CELL BIOL, V19, P1101; Blagosklonny MV, 1997, CANCER RES, V57, P320; Boyer SN, 1996, CANCER RES, V56, P4620; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Carter S, 1998, ONCOGENE, V16, P2787, DOI 10.1038/sj.onc.1201802; Chellappan SP, 1998, CURR TOP MICROBIOL, V227, P57; CHEN TC, 1995, J PATHOL, V176, P243, DOI 10.1002/path.1711760306; Chinery R, 1997, NAT MED, V3, P1233, DOI 10.1038/nm1197-1233; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; Cram EJ, 1998, J BIOL CHEM, V273, P2008, DOI 10.1074/jbc.273.4.2008; CRISTIANO RJ, 1993, P NATL ACAD SCI USA, V90, P11548, DOI 10.1073/pnas.90.24.11548; Dent P, 1998, LEUKEMIA, V12, P1843, DOI 10.1038/sj.leu.2401222; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555; Enzenauer C, 1998, INTERVIROLOGY, V41, P80, DOI 10.1159/000024918; Fan GS, 1996, ONCOGENE, V12, P1909; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fernando GJP, 1999, CLIN EXP IMMUNOL, V115, P397; Fukasawa K, 1997, MOL CELL BIOL, V17, P506, DOI 10.1128/MCB.17.1.506; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Gao QS, 1999, MOL CELL BIOL, V19, P733; HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726; Hirai A, 1997, J BIOL CHEM, V272, P13; Imai Y, 1996, JPN J CANCER RES, V87, P1056, DOI 10.1111/j.1349-7006.1996.tb03110.x; Jian YC, 1999, CELL GROWTH DIFFER, V10, P101; Jian YC, 1998, ONCOGENE, V17, P2027, DOI 10.1038/sj.onc.1202142; Johannessen LE, 1999, BIOCHEM J, V337, P599, DOI 10.1042/0264-6021:3370599; Jones DL, 1997, GENE DEV, V11, P2101, DOI 10.1101/gad.11.16.2101; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Loyer P, 1996, J BIOL CHEM, V271, P11484, DOI 10.1074/jbc.271.19.11484; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mineta H, 1998, ANTICANCER RES, V18, P4765; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; Mitchell KO, 1999, CELL GROWTH DIFFER, V10, P223; Morozov A, 1997, J VIROL, V71, P3451, DOI 10.1128/JVI.71.5.3451-3457.1997; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; PHELPS WC, 1992, J VIROL, V66, P2418, DOI 10.1128/JVI.66.4.2418-2427.1992; Pu H, 1997, ACTA MED OKAYAMA, V51, P313; Ravi RK, 1999, J CELL BIOCHEM, V72, P458, DOI 10.1002/(SICI)1097-4644(19990315)72:4<458::AID-JCB2>3.0.CO;2-C; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Serfas MS, 1997, CELL GROWTH DIFFER, V8, P951; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Spector MS, 1997, MOL CELL BIOL, V17, P3556, DOI 10.1128/MCB.17.7.3556; Stoppler H, 1998, ONCOGENE, V17, P1207, DOI 10.1038/sj.onc.1202053; TERAMOTO T, 1994, CANCER RES, V54, P231; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Tombes RM, 1998, BIOCHEM J, V330, P1451; Vrana JA, 1999, RADIAT RES, V151, P559, DOI 10.2307/3580032; WATSON DK, 1986, P NATL ACAD SCI USA, V83, P1792, DOI 10.1073/pnas.83.6.1792; Westwick JK, 1996, AM J PHYSIOL-GASTR L, V271, pG780, DOI 10.1152/ajpgi.1996.271.5.G780; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Zauberman A, 1997, ONCOGENE, V15, P1705, DOI 10.1038/sj.onc.1201348; Zeng YX, 1996, ONCOGENE, V12, P1557	64	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					18	28		10.1074/jbc.275.1.18	http://dx.doi.org/10.1074/jbc.275.1.18			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617580	hybrid			2022-12-27	WOS:000085951600004
J	Yang, WL; Urano, J; Tamanoi, F				Yang, WL; Urano, J; Tamanoi, F			Protein farnesylation is critical for maintaining normal cell morphology and canavanine resistance in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYLGERANYLTRANSFERASE TYPE-I; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; FARNESYLTRANSFERASE INHIBITORS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; CANCER-TREATMENT; RAS PROTEINS; CAAX-BOX; TRANSFERASE	Protein farnesyltransferase (FTase) plays important roles in the growth and differentiation of eukaryotic cells. In this paper, we report the identification of the Schizosaccharomyces pombe gene cpp1(+) encoding the beta-subunit of FTase. The predicted amino acid sequence of the cpp1(+) gene product shares significant similarity with FTase beta-subunits from a variety of organisms. S. pombe FTase purified from E. coli exhibits high enzymatic activity toward the CAAX farnesylation motif substrates (where C represents cysteine, A represents aliphatic amino acid, and X is preferentially methionine, cysteine, serine, alanine, or glutamine) while showing little preference for CAAL geranylgeranylation motif substrates (where L represents leucine or phenylalanine). cpp1(+) is not essential for growth as shown by gene disruption; however, mutant cells exhibit rounded or irregular cell morphology, Expression of a geranylgeranylated mutant form, Ras1-CVIL, which can bypass farnesylation, rescues these morphological defects. We also identify a novel phenotype of cpp1(-) mutants, hypersensitivity to canavanine. This appears to be due to a 3-4-fold increase in the rate of arginine uptake as compared with wild-type cells. Expression of the geranylgeranylated mutant form of a novel farnesylated small GTPase, SpRheb, is able to suppress the elevated arginine uptake rate. These results demonstrate that protein farnesylation is critical for maintaining normal cell morphology through Ras1 and canavanine resistance through SpRheb.	Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Tamanoi, F (corresponding author), Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Jonsson Comprehens Canc Ctr, 1602 Mol Sci Bldg,609 Charles E Young Dr, Los Angeles, CA 90095 USA.				NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER; NCI NIH HHS [CA41996] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD M, 1986, CURR GENET, V10, P587, DOI 10.1007/BF00418125; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arellano M, 1999, J CELL SCI, V112, P3569; Arellano M, 1998, MOL MICROBIOL, V29, P1357, DOI 10.1046/j.1365-2958.1998.01009.x; Barrington RE, 1998, MOL CELL BIOL, V18, P85, DOI 10.1128/MCB.18.1.85; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; CALDWELL GA, 1994, P NATL ACAD SCI USA, V91, P1275, DOI 10.1073/pnas.91.4.1275; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Cox AD, 1997, BBA-REV CANCER, V1333, pF51, DOI 10.1016/S0304-419X(97)00011-5; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Danjoh I, 1996, EUR J BIOCHEM, V236, P847, DOI 10.1111/j.1432-1033.1996.00847.x; Del Villar K, 1999, J BIOL CHEM, V274, P27010, DOI 10.1074/jbc.274.38.27010; DelVillar K, 1997, J BIOL CHEM, V272, P680; DIAZ M, 1993, EMBO J, V12, P5245, DOI 10.1002/j.1460-2075.1993.tb06220.x; FANTES PA, 1984, J GEN MICROBIOL, V130, P3265; FINEGOLD AA, 1991, P NATL ACAD SCI USA, V88, P4448, DOI 10.1073/pnas.88.10.4448; FUKUI Y, 1986, CELL, V44, P329, DOI 10.1016/0092-8674(86)90767-1; Gelb MH, 1998, CURR OPIN CHEM BIOL, V2, P40, DOI 10.1016/S1367-5931(98)80034-3; Gibbs JB, 1997, CURR OPIN CHEM BIOL, V1, P197, DOI 10.1016/S1367-5931(97)80010-5; Gibbs JB, 1997, ANNU REV PHARMACOL, V37, P143, DOI 10.1146/annurev.pharmtox.37.1.143; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOODMAN LE, 1990, P NATL ACAD SCI USA, V87, P9665, DOI 10.1073/pnas.87.24.9665; GOODMAN LE, 1988, YEAST, V4, P271, DOI 10.1002/yea.320040405; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; Hirata D, 1998, J CELL SCI, V111, P149; HUGHES DA, 1995, SEMIN CELL BIOL, V6, P89, DOI 10.1016/1043-4682(95)90005-5; Lebowitz PF, 1997, CANCER RES, V57, P708; Long SB, 1998, BIOCHEMISTRY-US, V37, P9612, DOI 10.1021/bi980708e; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; NAKANO K, 1998, CELL STRUCT FUNCT S, V23, P118; NAKAYAMA N, 1988, MOL CELL BIOL, V8, P5410, DOI 10.1128/MCB.8.12.5410; NIELSEN O, 1995, SEMIN CELL BIOL, V6, P95, DOI 10.1016/1043-4682(95)90006-3; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; SATTLER I, 1996, REGULATION RAS SIGNA, P95; SEPPLORENZINO L, 1995, CANCER RES, V55, P5302; Strickland CL, 1998, BIOCHEMISTRY-US, V37, P16601, DOI 10.1021/bi981197z; SUN JZ, 1995, CANCER RES, V55, P4243; Suzuki N, 1998, P NATL ACAD SCI USA, V95, P15356, DOI 10.1073/pnas.95.26.15356; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; Verde F, 1998, CURR OPIN MICROBIOL, V1, P712, DOI 10.1016/S1369-5274(98)80120-3; Wang H, 1996, ANAL BIOCHEM, V237, P145, DOI 10.1006/abio.1996.0213; WHITEWAY MS, 1994, GENETICS, V137, P967; Yalovsky S, 1997, MOL CELL BIOL, V17, P1986, DOI 10.1128/MCB.17.4.1986; YANG ZB, 1993, PLANT PHYSIOL, V101, P667, DOI 10.1104/pp.101.2.667; Yokoyama K, 1998, J BIOL CHEM, V273, P26497, DOI 10.1074/jbc.273.41.26497; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; ZHAO YQ, 1995, DNA CELL BIOL, V14, P359, DOI 10.1089/dna.1995.14.359	53	30	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					429	438		10.1074/jbc.275.1.429	http://dx.doi.org/10.1074/jbc.275.1.429			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617635	hybrid			2022-12-27	WOS:000085951600059
J	Yu, CL; Jin, YJ; Burakoff, SJ				Yu, CL; Jin, YJ; Burakoff, SJ			Cytosolic tyrosine dephosphorylation of STAT5 - Potential role of SHP-2 in STAT5 regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCER; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTORS; PHOSPHATASE SHP-1; GENE-EXPRESSION; DNA-BINDING; ACTIVATION; PROTEIN; INDUCTION; RECEPTOR	STAT5, a member of the signal transducers and activators of transcription (STATs), is important in modulating T cell functions through interleukin-2 (IL-2) receptors, Like other STAT proteins, STAT5 undergoes a rapid activation and inactivation cycle upon cytokine stimulation. Tyrosine phosphorylation and dephosphorylation are critical in regulating STAT5 activity. A number of protein tyrosine kinases have been shown to phosphorylate STAT5; however, the phosphatases responsible for STAT5 dephosphorylation remain unidentified, Using CTLL-20 as a model system, we provide evidence that tyrosine dephosphorylation of STAT5 subsequent to IL-2-induced phosphorylation occurs in the absence of STAT5 nuclear translocation and new protein synthesis. Nevertheless, down-regulation of the upstream Janus kinase activity during the deactivation cycle of IL-2-induced signaling does involve new protein synthesis. These findings point to the constitutive presence of STAT5 tyrosine phosphatase activity in the cytosolic compartment. We further demonstrate that SHP-2, but not SHP-1, directly dephosphorylates STAT5 in an in vitro tyrosine phosphatase assay with purified proteins. Furthermore, tyrosine-phosphorylated STAT5 associates with the substrate-trapping mutant (Cys --> Ser) of SHP-2 but not SHP-1, These results suggest a potential role for cytoplasmic protein-tyrosine phosphatases in directly dephosphorylating STAT proteins and in maintaining a basal steady state level of STAT activity.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Burakoff, SJ (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.		Yu, Chao-Lan/D-1834-2011	Yu, Chao-Lan/0000-0002-9381-6011	NATIONAL CANCER INSTITUTE [F32CA079154, R01CA070758] Funding Source: NIH RePORTER; NCI NIH HHS [1-F32-CA-79154-01, CA-70758] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aman MJ, 1999, J BIOL CHEM, V274, P30266, DOI 10.1074/jbc.274.42.30266; Azam M, 1997, IMMUNITY, V6, P691, DOI 10.1016/S1074-7613(00)80445-8; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; Berchtold S, 1998, MOL ENDOCRINOL, V12, P556, DOI 10.1210/me.12.4.556; Callus BA, 1998, BLOOD, V91, P3182, DOI 10.1182/blood.V91.9.3182.3182_3182_3192; Cohney SJ, 1999, MOL CELL BIOL, V19, P4980; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Gadina M, 1998, J IMMUNOL, V160, P4657; Gebert CA, 1997, MOL ENDOCRINOL, V11, P400, DOI 10.1210/me.11.4.400; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Gu HH, 1997, J BIOL CHEM, V272, P16421, DOI 10.1074/jbc.272.26.16421; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Herrington J, 1999, J BIOL CHEM, V274, P5138, DOI 10.1074/jbc.274.8.5138; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Johnson HM, 1998, BIOCHEM BIOPH RES CO, V244, P607, DOI 10.1006/bbrc.1998.8254; Kim H, 1999, MOL CELL BIOL, V19, P5326; Lee CK, 1997, J BIOL CHEM, V272, P21872, DOI 10.1074/jbc.272.35.21872; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Meyer J, 1998, BLOOD, V91, P1901, DOI 10.1182/blood.V91.6.1901.1901_1901_1908; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Muller H, 1997, MOL CELL BIOL, V17, P5508; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Pratt JC, 1996, J BIOL CHEM, V271, P12137, DOI 10.1074/jbc.271.21.12137; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; Rayanade RJ, 1998, J IMMUNOL, V161, P325; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; Servidei T, 1998, J BIOL CHEM, V273, P6233, DOI 10.1074/jbc.273.11.6233; Shuai K, 1996, MOL CELL BIOL, V16, P4932; Strehlow I, 1998, J BIOL CHEM, V273, P28049, DOI 10.1074/jbc.273.43.28049; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; SWEITZER SM, 1995, J BIOL CHEM, V270, P16510, DOI 10.1074/jbc.270.28.16510; Symes A, 1997, CURR BIOL, V7, P697, DOI 10.1016/S0960-9822(06)00298-3; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Verdier F, 1998, J BIOL CHEM, V273, P28185, DOI 10.1074/jbc.273.43.28185; You M, 1997, J BIOL CHEM, V272, P23376, DOI 10.1074/jbc.272.37.23376; Yu CL, 1997, J BIOL CHEM, V272, P14017, DOI 10.1074/jbc.272.22.14017; Yu CL, 1997, J IMMUNOL, V159, P5206	47	124	130	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					599	604		10.1074/jbc.275.1.599	http://dx.doi.org/10.1074/jbc.275.1.599			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617656	hybrid			2022-12-27	WOS:000085951600080
J	Hasegawa, J; Shimahara, H; Mizutani, M; Uchiyama, S; Arai, H; Ishii, M; Kobayashi, Y; Ferguson, SJ; Sambongi, Y; Igarashi, Y				Hasegawa, J; Shimahara, H; Mizutani, M; Uchiyama, S; Arai, H; Ishii, M; Kobayashi, Y; Ferguson, SJ; Sambongi, Y; Igarashi, Y			Stabilization of Pseudomonas aeruginosa cytochrome c(551) by systematic amino acid substitutions based on the structure of thermophilic Hydrogenobacter thermophilus cytochrome c(552)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE CYTOCHROMES; ESCHERICHIA-COLI; PYROCOCCUS-FURIOSUS; YEAST ISO-1-CYTOCHROME-C; OXIDIZING BACTERIUM; PROTEIN STABILITY; THERMAL-STABILITY; NMR-SPECTROSCOPY; THERMOSTABILITY; EXPRESSION	A heterologous overexpression system for mesophilic Pseudomonas aeruginosa holocytochrome c(551) (PA c(551)) was established using Escherichia coli as a host organism. Amino acid residues were systematically substituted in three regions of PA c(551) with the corresponding residues from thermophilic Hydrogenobacter thermophilus cytochrome c(552) (HT c(552)), which has similar main chain folding to PA c(551), but is more stable to heat. Thermodynamic properties of PA c(551) with one of three single mutations (Phe-7 to Ala, Phe-34 to Tyr, or Val-78 to Ile) showed that these mutants had increased thermostability compared with that of the wild-type. Ala-7 and Ile-78 may contribute to the thermostability by tighter hydrophobic packing, which is indicated by the three dimensional structure comparison of PA c(551) with HT c(552). In the Phe-34 to Tyr mutant, the hydroxyl group of the Tyr residue and the guanidyl base of Arg-47 formed a hydrogen bond, which did not exist between the corresponding residues in HT c(552). We also found that stability of mutant proteins to denaturation by guanidine hydrochloride correlated with that against the thermal denaturation. These results and others described here suggest that significant stabilization of PA c(551) can be achieved through a few amino acid substitutions determined by molecular modeling with reference to the structure of HT c(552), The higher stability of HT c(552) may in part be attributed to some of these substitutions.	Daiichi Pharmaceut Co Ltd, Edogawa Ku, Tokyo 1348630, Japan; Osaka Univ, Fac Pharmaceut Sci, Suita, Osaka 5650871, Japan; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1130032, Japan; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Daiichi Sankyo Company Limited; Osaka University; University of Tokyo; University of Oxford	Hasegawa, J (corresponding author), Daiichi Pharmaceut Co Ltd, Edogawa Ku, 1-16-13 Kita Kasai, Tokyo 1348630, Japan.		UCHIYAMA, Susumu/F-9590-2017	UCHIYAMA, Susumu/0000-0002-5181-179X				ANDERSON DE, 1993, PROTEIN SCI, V2, P1285, DOI 10.1002/pro.5560020811; ARAI H, 1995, J FERMENT BIOENG, V79, P489, DOI 10.1016/0922-338X(95)91267-9; ARAI H, 1990, FEBS LETT, V261, P195; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Bogin O, 1998, PROTEIN SCI, V7, P1156, DOI 10.1002/pro.5560070509; BRITTON KL, 1995, EUR J BIOCHEM, V229, P688, DOI 10.1111/j.1432-1033.1995.tb20515.x; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Cutruzzola F, 1997, BIOCHEM J, V322, P35, DOI 10.1042/bj3220035; DARWIN A, 1993, J GEN MICROBIOL, V139, P1829, DOI 10.1099/00221287-139-8-1829; DAS G, 1989, P NATL ACAD SCI USA, V86, P496, DOI 10.1073/pnas.86.2.496; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eidsness MK, 1997, BIOCHEMISTRY-US, V36, P10406, DOI 10.1021/bi970110r; GANTER C, 1990, BIOCHEMISTRY-US, V29, P9395, DOI 10.1021/bi00492a013; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Grove J, 1996, MOL MICROBIOL, V19, P467, DOI 10.1046/j.1365-2958.1996.383914.x; Hasegawa J, 1998, BIOCHEMISTRY-US, V37, P9641, DOI 10.1021/bi9803067; Hayashi NR, 1999, INT J SYST BACTERIOL, V49, P783, DOI 10.1099/00207713-49-2-783; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MATSUURA Y, 1982, J MOL BIOL, V156, P389, DOI 10.1016/0022-2836(82)90335-7; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Page MD, 1998, TRENDS BIOCHEM SCI, V23, P103, DOI 10.1016/S0968-0004(98)01173-6; PALMER AG, 1992, J MAGN RESON, V96, P416, DOI 10.1016/0022-2364(92)90097-Q; Pollock WBR, 1998, BIOCHEMISTRY-US, V37, P6124, DOI 10.1021/bi972188d; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Sambongi Y, 1996, MOL MICROBIOL, V19, P1193, DOI 10.1111/j.1365-2958.1996.tb02465.x; SAMBONGI Y, 1992, BIOSCI BIOTECH BIOCH, V56, P990, DOI 10.1271/bbb.56.990; Sambongi Y, 1996, FEBS LETT, V398, P265, DOI 10.1016/S0014-5793(96)01256-2; SANBONGI Y, 1989, J BACTERIOL, V171, P65, DOI 10.1128/jb.171.1.65-69.1989; SANBONGI Y, 1989, BIOCHEMISTRY-US, V28, P9574, DOI 10.1021/bi00451a004; SANBONGI Y, 1991, EUR J BIOCHEM, V198, P7, DOI 10.1111/j.1432-1033.1991.tb15979.x; SANDBERG WS, 1989, SCIENCE, V245, P54, DOI 10.1126/science.2787053; SHUMANN J, 1993, PROTEIN SCI, V2, P1612; Sinha N, 1998, FEMS MICROBIOL LETT, V161, P1; SPASSOV VZ, 1995, PROTEIN SCI, V4, P1516, DOI 10.1002/pro.5560040809; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; TIMKOVICH R, 1990, BIOCHEMISTRY-US, V29, P7773, DOI 10.1021/bi00485a029; UBBINK M, 1992, J BACTERIOL, V174, P3707, DOI 10.1128/JB.174.11.3707-3714.1992; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9	44	78	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37533	37537		10.1074/jbc.274.53.37533	http://dx.doi.org/10.1074/jbc.274.53.37533			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608805	Green Published, hybrid			2022-12-27	WOS:000084528000005
J	Kelm, RJ; Elder, PK; Getz, MJ				Kelm, RJ; Elder, PK; Getz, MJ			The single-stranded DNA-binding proteins, Pur alpha, Pur beta, and MSY1 specifically interact with an exon 3-derived mouse vascular smooth muscle alpha-actin messenger RNA sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD SHOCK DOMAIN; T ALTERNATIVE EXON; Y-BOX PROTEINS; TRANSCRIPTION FACTOR; GENE-TRANSCRIPTION; RIBONUCLEOPROTEIN PARTICLES; STIMULATES TRANSCRIPTION; CELLULAR PROTEIN; CONTROL ELEMENT; GLIAL-CELLS	Amino acids 44-53 of mouse vascular smooth muscle alpha-actin are encoded by a region of exon 3 that bears structural similarity to an essential MCAT enhancer element in the 5' promoter of the gene. The single-stranded DNA-binding proteins, Pur alpha Pur beta, and MSY1, interact with each other and with opposite strands of the enhancer to repress transcription in fibroblasts (Sun, S., Stoflet, E. S., Cogan, J. G., Strauch, A. R., and Getz, M. J. (1995) Mol Cell. Biol. 15, 2429-2436; Kelm, R. J., Jr., Cogan, J. G., Elder, P. K., Strauch, A. R., and Getz, M.J. (1999) J. Biol. Chem 274, 14238-14245). In this study, we employed both recombinant and fibroblast-derived proteins 60 demonstrate that all three proteins specifically interact with the mRNA counterpart of the exon 3 sequence in cell-fi ee binding assays. When placed in the 5'-untranslated region of a reporter mRNA, the exon 3-derived sequence suppressed mRNA translation in transfected fibroblasts. Translational efficiency was restored by mutations that impaired mRNA binding of Pur alpha Pur beta, and MYS1, implying that these proteins can also participate in messenger ribonucleoprotein formation in living cells. Additionally, primary structure determinants required for interaction of Pur beta with single-stranded DNA, mRNA, and protein Ligands were mapped by deletion mutagenesis. These experiments reveal highly specific protein-mRNA interactions that are potentially important in regulating expression of the vascular smooth muscle cu-actin gene in fibroblasts.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Kelm, RJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	kelm.robert@mayo.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054281] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54281] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIOK S, 1994, MOL CELL BIOL, V14, P6004, DOI 10.1128/MCB.14.9.6004; BAUREN G, 1994, CELL, V76, P183, DOI 10.1016/0092-8674(94)90182-1; BOUVET P, 1995, J BIOL CHEM, V270, P28297; CHEN NN, 1995, P NATL ACAD SCI USA, V92, P1087, DOI 10.1073/pnas.92.4.1087; CHEN NN, 1995, J VIROL, V69, P5843, DOI 10.1128/JVI.69.9.5843-5848.1995; Chepenik LG, 1998, GENE, V210, P37, DOI 10.1016/S0378-1119(98)00033-X; COGAN JG, 1995, J BIOL CHEM, V270, P11310, DOI 10.1074/jbc.270.19.11310; DESCHAMPS S, 1992, J BIOL CHEM, V267, P13799; Ding Y, 1997, NEUROCHEM INT, V31, P45, DOI 10.1016/S0197-0186(96)00127-1; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Du Q, 1997, J BIOL CHEM, V272, P14990, DOI 10.1074/jbc.272.23.14990; EVDOKIMOVA VM, 1995, J BIOL CHEM, V270, P3186, DOI 10.1074/jbc.270.7.3186; Gallia GL, 1998, J BIOL CHEM, V273, P32662, DOI 10.1074/jbc.273.49.32662; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; HAAS S, 1995, J CELL BIOL, V130, P1171, DOI 10.1083/jcb.130.5.1171; HERAULT Y, 1993, CELL MOL BIOL RES, V39, P717; Herault Yann, 1995, Gene Expression, V4, P85; HUMPHREY MB, 1995, MOL CELL BIOL, V15, P3979; JIMENEZGARCIA LF, 1993, CELL, V73, P47, DOI 10.1016/0092-8674(93)90159-N; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; Kelm RJ, 1999, J BIOL CHEM, V274, P14238, DOI 10.1074/jbc.274.20.14238; Kelm RJ, 1996, J BIOL CHEM, V271, P24278, DOI 10.1074/jbc.271.39.24278; Kelm RJ, 1997, J BIOL CHEM, V272, P26727, DOI 10.1074/jbc.272.42.26727; Krachmarov CP, 1996, P NATL ACAD SCI USA, V93, P14112, DOI 10.1073/pnas.93.24.14112; LEWIN AS, 1995, MOL CELL BIOL, V15, P6971; Li WW, 1997, MOL CELL BIOL, V17, P61, DOI 10.1128/MCB.17.1.61; MA ZW, 1994, GENE, V149, P311, DOI 10.1016/0378-1119(94)90167-8; Matsumoto K, 1996, J BIOL CHEM, V271, P22706, DOI 10.1074/jbc.271.37.22706; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898; Safak R, 1999, MOL CELL BIOL, V19, P2712; SHIPLEY GD, 1985, P NATL ACAD SCI USA, V82, P4147, DOI 10.1073/pnas.82.12.4147; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; STOFLET ES, 1992, MOL BIOL CELL, V3, P1073, DOI 10.1091/mbc.3.10.1073; STRIPECKE R, 1994, MOL CELL BIOL, V14, P5898, DOI 10.1128/MCB.14.9.5898; SUN SQ, 1995, MOL CELL BIOL, V15, P2429; TAFURI SR, 1993, J BIOL CHEM, V268, P12213; TAFURI SR, 1993, J BIOL CHEM, V268, P24255; TAFURI SR, 1992, NEW BIOL, V4, P349; Thatikunta P, 1997, J CELL BIOCHEM, V67, P466, DOI 10.1002/(SICI)1097-4644(19971215)67:4<466::AID-JCB5>3.0.CO;2-Q; TING JPY, 1994, J EXP MED, V179, P1605, DOI 10.1084/jem.179.5.1605; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Tretiakova A, 1998, J BIOL CHEM, V273, P22241, DOI 10.1074/jbc.273.35.22241; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660; Zambrano N, 1997, BIOCHEM J, V328, P293, DOI 10.1042/bj3280293; ZOU YM, 1995, MOL CELL BIOL, V15, P2972	50	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38268	38275		10.1074/jbc.274.53.38268	http://dx.doi.org/10.1074/jbc.274.53.38268			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608902	hybrid			2022-12-27	WOS:000084528000102
J	Schaefer, AW; Kamiguchi, H; Wong, EV; Beach, CM; Landreth, G; Lemmon, V				Schaefer, AW; Kamiguchi, H; Wong, EV; Beach, CM; Landreth, G; Lemmon, V			Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; COATED VESICLE FORMATION; ANKYRIN-BINDING-ACTIVITY; X-LINKED HYDROCEPHALUS; NEURITE OUTGROWTH; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; MONOCLONAL-ANTIBODY; N-CAM	L1-mediated axon growth involves intracellular signaling, but the precise mechanisms involved are not yet clear, We report a role for the mitogen-activated protein kinase (MAPK) cascade in L1 signaling. L1 physically associates with the MAPK cascade components Raf-l, ERK2, and the previously identified p90(rsk) in brain. In vitro, ERK2 can phosphorylate L1 at Ser(1204) and Ser(1248) of the L1 cytoplasmic domain. These two serines are conserved in the L1 family of cell adhesion molecules, also being found in neurofascin and NrCAM, The ability of ERK2 to phosphorylate L1 suggests that L1 signaling could directly regulate L1 function by phosphorylation of the L1 cytoplasmic domain. In L1-expressing 3T3 cells, L1 cross-linking can activate ERK2, Remarkably, the activated ERK localizes with endocytosed vesicular L1 rather than cell surface L1, indicating that L1 internalization and signaling are coupled. Inhibition of L1 internalization with dominant-negative dynamin prevents activation of ERK, These results show that L1-generated signals activate the MAPK cascade in a manner most Likely to be important in regulating L1 intracellular trafficking.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Univ Kentucky, Macromol Struct Anal Facil, Lexington, KY 40536 USA; Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA	Case Western Reserve University; University of Kentucky; Case Western Reserve University	Lemmon, V (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Rm E661,2109 Adelbert Rd, Cleveland, OH 44106 USA.		Lemmon, Vance/A-7410-2010; Lemmon, Vance/A-2565-2008; Kamiguchi, Hiroyuki/N-5409-2015	Lemmon, Vance/0000-0003-3550-7576; Kamiguchi, Hiroyuki/0000-0003-1802-6324	NATIONAL EYE INSTITUTE [R01EY005285] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY005285] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; BRUMMENDORF T, 1994, PROTEIN PROFILE, V1, P963; BurdenGulley SM, 1996, CELL MOTIL CYTOSKEL, V35, P1, DOI 10.1002/(SICI)1097-0169(1996)35:1<1::AID-CM1>3.0.CO;2-F; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DahlinHuppe K, 1997, MOL CELL NEUROSCI, V9, P144, DOI 10.1006/mcne.1997.0608; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6; DOHERTY P, 1993, J CELL BIOL, V122, P181, DOI 10.1083/jcb.122.1.181; FINNEGAN SG, 1993, DEV BIOL, V156, P230, DOI 10.1006/dbio.1993.1072; Foster-Barber A, 1998, P NATL ACAD SCI USA, V95, P4673, DOI 10.1073/pnas.95.8.4673; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Fukuda T, 1997, J COMP NEUROL, V382, P141; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; HADJIARGYROU M, 1995, J NEUROSCI, V15, P574; Hall SG, 1997, J NEUROBIOL, V32, P325, DOI 10.1002/(SICI)1097-4695(199703)32:3<325::AID-NEU6>3.3.CO;2-N; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hassel B, 1997, J BIOL CHEM, V272, P28742, DOI 10.1074/jbc.272.45.28742; Hortsch M, 1996, NEURON, V17, P587, DOI 10.1016/S0896-6273(00)80192-0; HSIAO KM, 1994, P NATL ACAD SCI USA, V91, P5480, DOI 10.1073/pnas.91.12.5480; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; ITOH K, 1995, J NEUROSCI, V15, P2504, DOI 10.1523/JNEUROSCI.15-03-02504.1995; ITOH K, 1992, BRAIN RES, V580, P233, DOI 10.1016/0006-8993(92)90949-A; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Kamiguchi H, 1998, ANNU REV NEUROSCI, V21, P97, DOI 10.1146/annurev.neuro.21.1.97; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 1998, J NEUROSCI, V18, P3749, DOI 10.1523/jneurosci.18-10-03749.1998; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; KLINZ SG, 1995, J NEUROCHEM, V65, P84; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Kunz S, 1996, J CELL BIOL, V135, P253, DOI 10.1083/jcb.135.1.253; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LANDGREN E, 1995, ONCOGENE, V10, P2027; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LINSTEDT AD, 1992, J CELL BIOL, V117, P1077, DOI 10.1083/jcb.117.5.1077; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; MacFarlane JR, 1997, HUM MUTAT, V9, P512; MIURA M, 1991, FEBS LETT, V289, P91, DOI 10.1016/0014-5793(91)80915-P; Montgomery AMP, 1996, J CELL BIOL, V132, P475, DOI 10.1083/jcb.132.3.475; Ohta Y, 1996, J BIOL CHEM, V271, P11858, DOI 10.1074/jbc.271.20.11858; Okamoto N, 1997, J MED GENET, V34, P670, DOI 10.1136/jmg.34.8.670; Pancook JD, 1997, J IMMUNOL, V158, P4413; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Rose SPR, 1996, J PHYSIOLOGY-PARIS, V90, P387, DOI 10.1016/S0928-4257(97)87926-0; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; SALTON SRJ, 1983, J NEUROSCI, V3, P2420; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; SCIMECA JC, 1992, J BIOL CHEM, V267, P17369; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; STALLCUP WB, 1985, P NATL ACAD SCI USA, V82, P1276, DOI 10.1073/pnas.82.4.1276; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; VONBOHLEN F, 1992, EUR J NEUROSCI, V4, P896; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1994, DEVELOPMENT, V120, P1685; WILLIAMS EJ, 1994, J CELL BIOL, V124, P1029, DOI 10.1083/jcb.124.6.1029; Wong EV, 1996, J NEUROCHEM, V66, P779; Wong EV, 1995, NEUROSCI LETT, V200, P155, DOI 10.1016/0304-3940(95)12100-I; Wong EV, 1996, J BIOL CHEM, V271, P18217, DOI 10.1074/jbc.271.30.18217; Xie H, 1998, J CELL SCI, V111, P615; ZHAN X, 1994, J BIOL CHEM, V269, P20221; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773	83	152	155	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37965	37973		10.1074/jbc.274.53.37965	http://dx.doi.org/10.1074/jbc.274.53.37965			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608864	hybrid			2022-12-27	WOS:000084528000064
J	Sullivan, R; Price, LS; Koffer, A				Sullivan, R; Price, LS; Koffer, A			Rho controls cortical F-actin disassembly in addition to, but independently of, secretion in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; GUANINE-NUCLEOTIDE; FAMILY GTPASES; RAC; EXOCYTOSIS; KINASE; MYOSIN; DOMAIN; ORGANIZATION; CALMODULIN	Localized disassembly of cortical F-actin has long been considered necessary for facilitation of exocytosis. Exposure of permeabilized mast cells to calcium/ATP induces cortical F-actin disassembly (calmodulin-dependent) and secretion (calmodulin-independent). The delay in the onset of secretion is characteristic for the calcium/ATP response and is abolished by GTP. Here we report that a constitutively active mutant of Rho (V14RhoA) enhanced both secretion and cortical F-actin disassembly. In addition, V14RhoA mimicked GTP by abolishing the delay in secretion. Inhibition of Rho by C3 transferase prevented both secretion (similar to 80%) and F-actin disassembly (similar to 20%). Thus, both Rho GTPase and calcium/calmodulin contribute to the control of cortical F-actin disassembly. Stabilization of actin filaments by high concentrations of phalloidin or by a calmodulin-inhibitory peptide (based on the calmodulin-binding domain of myosin light chain kinase) did not affect the extent of secretion or the secretion-enhancing effects of V14RhoA These results further support the existence of divergent, Rho-dependent, pathways regulating actin and exocytosis. Furthermore, compound Y-27632, a specific inhibitor of Rho-associated protein kinase (p160(ROCK)), attenuated the Rho-induced loss of cortical F-actin without affecting secretion. A model is presented in which Rho regulates secretion and cortical F-actin in a manner dependent on and/or synergistic with calcium.	UCL, Dept Physiol, London WC1E 6JJ, England	University of London; University College London	Koffer, A (corresponding author), UCL, Dept Physiol, Univ St, London WC1E 6JJ, England.	a.koffer@ucl.ac.uk		Sullivan, Richard/0000-0002-6435-1825				Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; BOROVIKOV YS, 1995, J CELL SCI, V108, P657; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown AM, 1998, MOL BIOL CELL, V9, P1053, DOI 10.1091/mbc.9.5.1053; BUBB MR, 1994, J BIOL CHEM, V269, P14869; BURGOYNE RD, 1987, BIOSCIENCE REP, V7, P281, DOI 10.1007/BF01121449; CASTRESANA J, 1995, FEBS LETT, V374, P149, DOI 10.1016/0014-5793(95)01098-Y; COCKCROFT S, 1987, J CELL BIOL, V105, P2745, DOI 10.1083/jcb.105.6.2745; Freshney NW, 1997, FEBS LETT, V407, P111, DOI 10.1016/S0014-5793(97)00309-8; GUILLEMOT JC, 1997, J CELL SCI, V110, P215; HALL A, 1986, J BIOL CHEM, V261, P963; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; HOWELL TW, 1987, J CELL BIOL, V105, P191, DOI 10.1083/jcb.105.1.191; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KOFFER A, 1993, BIOCHIM BIOPHYS ACTA, V1176, P236; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; LILLIE THW, 1992, BIOCHEM J, V288, P181, DOI 10.1042/bj2880181; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; MARTELL AE, 1974, CRITICAL STABILITY C, pR11; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Murphy C, 1996, NATURE, V384, P427, DOI 10.1038/384427a0; NORMAN JC, 1994, J CELL BIOL, V126, P1005, DOI 10.1083/jcb.126.4.1005; Norman JC, 1996, MOL BIOL CELL, V7, P1429, DOI 10.1091/mbc.7.9.1429; PFEIFFER JR, 1985, J CELL BIOL, V101, P2145, DOI 10.1083/jcb.101.6.2145; PRICE LS, 1995, CURR BIOL, V5, P68, DOI 10.1016/S0960-9822(95)00018-2; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SCHMALZING G, 1995, J CELL BIOL, V130, P1319, DOI 10.1083/jcb.130.6.1319; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VOJTEK AB, 1995, CELL, V82, P527, DOI 10.1016/0092-8674(95)90023-3; Zhang L, 1996, NEURON, V17, P287, DOI 10.1016/S0896-6273(00)80160-9	36	60	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38140	38146		10.1074/jbc.274.53.38140	http://dx.doi.org/10.1074/jbc.274.53.38140			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608885	hybrid			2022-12-27	WOS:000084528000085
J	Uemura, N; Griffin, JD				Uemura, N; Griffin, JD			The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; PROTOONCOGENE PRODUCT P120(CBL); HUMAN B-CELLS; TYROSINE PHOSPHORYLATION; HEMATOPOIETIC-CELLS; BCR-ABL; C-CBL; SIGNALING PATHWAY; ANTIGEN RECEPTOR; BCR/ABL ONCOGENE	Crkl, an SH2-SH3-SH3 adapter protein, is one of the major tyrosine phosphoproteins detected in cells from patients with chronic myelogenous leukemia. Crkl binds to BCR/ABL through its N-terminal SH3 domain and is known to interact with several signaling proteins that have been implicated in integrin signaling, including Cb1, Cas, Hef-1, and paxillin. We have previously shown that overexpression of Crkl enhances adhesion to extracellular matrix proteins through beta(1) integrins. In this study, the effects of Crkl on spontaneous and chemokine-directed migration of the hematopoietic cell line Ba/F3 were examined. Full-length, SH2-, and SH3(N)-domain deletion mutants of Crkl were expressed transiently as fusion proteins with green fluorescent protein. Successfully transfected cells were isolated by fluorescence-activated cell sorting. The ability of these cells to migrate across a fibronectin-coated membrane, either spontaneously or in response to the chemokine stromal-derived factor-1 alpha, was determined. Cells expressing green fluorescent protein alone were mot distinguishable from untransfected or mock transfected Ba/F3 cells. However, Ba/F3 cells overexpressing full-length Crkl were found to have an increase in spontaneous migration of 2.8 +/- 0.6-fold in seven independent assays. The enhancement of migration required both the SH2 domain and the N-terminal SH3 domain. Migration in response to stromal-derived factor-1 alpha was not significantly enhanced by overexpression of Crkl. Overexpression of Crkii also augmented spontaneous migration but to a lesser degree than did Crkl. Because the SH2 domain was required for enhanced migration, we looked for changes in phosphotyrosine containing proteins coprecipitating with Crkl, but not Crkl Delta SH2, after integrin cross-linking. Full-length Crkl, but not Crkl Delta SH2, coprecipitated with a single major tyrosine phosphoprotein with an M-r of approximately 120 kDa, identified as chi. The major Crkl SH3-binding protein in these cells was found to be the guanine nucleotide exchange factor, C3G. Interestingly, overexpression of C3G; also enhanced migration, suggesting that a CbI-Crkl-C3G complex may be involved in migration signaling in Ba/F3 cells. These data suggest that Crkl is involved in signaling pathways that regulate migration, possibly through a complex with Cbl and C3G.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Griffin, JD (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA036167, R37CA036167] Funding Source: NIH RePORTER; NCI NIH HHS [CA36167] Funding Source: Medline; NIDDK NIH HHS [DK560654] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Altun-Gultekin ZF, 1998, MOL CELL BIOL, V18, P3044, DOI 10.1128/MCB.18.5.3044; Andoniou CE, 1996, ONCOGENE, V12, P1981; Arai A, 1999, BLOOD, V93, P3713, DOI 10.1182/blood.V93.11.3713.411a36_3713_3722; Astier A, 1997, LEUKEMIA LYMPHOMA, V28, P65, DOI 10.3109/10428199709058332; Barber DL, 1997, BLOOD, V89, P3166, DOI 10.1182/blood.V89.9.3166; Bhat A, 1998, J BIOL CHEM, V273, P32360, DOI 10.1074/jbc.273.48.32360; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; de Jong R, 1997, J BIOL CHEM, V272, P32649, DOI 10.1074/jbc.272.51.32649; de Jong R, 1998, ONCOGENE, V17, P2805, DOI 10.1038/sj.onc.1202207; Dolfi F, 1998, P NATL ACAD SCI USA, V95, P15394, DOI 10.1073/pnas.95.26.15394; FELLER SM, 1995, ONCOGENE, V10, P1465; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Gesbert F, 1998, J BIOL CHEM, V273, P3986, DOI 10.1074/jbc.273.7.3986; Gotoh A, 1997, CELL GROWTH DIFFER, V8, P721; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Heaney C, 1997, BLOOD, V89, P297, DOI 10.1182/blood.V89.1.297.297_297_306; Ichiba T, 1997, J BIOL CHEM, V272, P22215, DOI 10.1074/jbc.272.35.22215; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kolibaba KS, 1999, LEUKEMIA LYMPHOMA, V33, P119, DOI 10.3109/10428199909093732; Koval AP, 1998, J BIOL CHEM, V273, P14780, DOI 10.1074/jbc.273.24.14780; Kyono WT, 1998, J IMMUNOL, V161, P5555; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Ling P, 1999, MOL CELL BIOL, V19, P1359; Liu YH, 1999, J IMMUNOL, V162, P7095; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; NICHOLS GL, 1994, BLOOD, V84, P2912; ODA T, 1994, J BIOL CHEM, V269, P22925; Ojaniemi M, 1997, J BIOL CHEM, V272, P3780, DOI 10.1074/jbc.272.6.3780; Ojaniemi M, 1998, ONCOGENE, V16, P3159, DOI 10.1038/sj.onc.1201859; Ota J, 1998, BIOCHEM BIOPH RES CO, V252, P779, DOI 10.1006/bbrc.1998.9445; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Posern G, 1998, ONCOGENE, V16, P1903, DOI 10.1038/sj.onc.1201714; Posern G, 1998, J BIOL CHEM, V273, P24297, DOI 10.1074/jbc.273.38.24297; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Robertson H, 1997, BIOCHEM BIOPH RES CO, V240, P46, DOI 10.1006/bbrc.1997.7608; Salgia R, 1996, J BIOL CHEM, V271, P25198, DOI 10.1074/jbc.271.41.25198; SALGIA R, 1995, J BIOL CHEM, V270, P29145, DOI 10.1074/jbc.270.49.29145; Sattler M, 1997, ONCOGENE, V15, P2379, DOI 10.1038/sj.onc.1201422; Sattler M, 1996, ONCOGENE, V12, P839; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082; Senechal K, 1996, J BIOL CHEM, V271, P23255, DOI 10.1074/jbc.271.38.23255; TENHOEVE J, 1994, BLOOD, V84, P1731; TENHOEVE J, 1994, CANCER RES, V54, P2563; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Uemura N, 1997, LEUKEMIA, V11, P376, DOI 10.1038/sj.leu.2400590; Uemura N, 1999, ONCOGENE, V18, P3343, DOI 10.1038/sj.onc.1202689; Ware MD, 1996, BLOOD, V88, P2833, DOI 10.1182/blood.V88.8.2833.bloodjournal8882833; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556	60	92	96	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37525	37532		10.1074/jbc.274.53.37525	http://dx.doi.org/10.1074/jbc.274.53.37525			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608804	hybrid			2022-12-27	WOS:000084528000004
J	Urbanowski, JL; Piper, RC				Urbanowski, JL; Piper, RC			The iron transporter fth1p forms a complex with the Fet5 iron oxidase and resides on the vacuolar membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE ENCODES; GENE ENCODES; YEAST; PROTEIN; GOLGI; ENDOCYTOSIS; CHLORIDE	Iron transport across the plasmamembrane appears to be a unidirectional process whereby iron uptake is essentially irreversible. One of the major sequestration sites for iron is the vacuole that stores a variety of metals, either as a mechanism to detoxify the cell or as a reservoir of metal to enable the cell to grow when challenged by a low iron environment. Exactly how the vacuole contributes to the overall iron metabolism of the cell is unclear because mutations that affect vacuolar function also perturb the assembly of the plasma membrane high affinity transport system composed of a copper-containing iron oxidase, Fet3p, and an Fe3+-specific iron transporter, Ftr1p, Here, we characterize the iron transporter homologue Fth1p, which is similar to the high affinity plasma membrane iron transporter Ftr1p. We found that Fth1p was localized to the vacuolar surface and, like other proteins that function on the vacuole, did not undergo Pep4-dependent degradation. Co-immunoprecipitation experiments showed that Fth1p also associates with the Fet3p oxidase homologue, Fet5p; and disruption of the PETS gene results in the accumulation of Fth1p in the endoplasmic reticulum, We also found that loss of this protein complex leads to elevated transcriptional activity of the FET3 gene and compromises the ability of the cell to switch from fermentative metabolism to respiratory metabolism. Because the Fet5 protein is oriented such that the oxidase domain of Fet5p is lumenal, this complex may be responsible for mobilizing intravacuolar stores of iron.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Piper, RC (corresponding author), Univ Iowa, Dept Physiol & Biophys, Rm 5-660,Bowen Sci Bldg, Iowa City, IA 52242 USA.			Piper, Robert/0000-0001-9995-5699	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058202] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK25295] Funding Source: Medline; NIGMS NIH HHS [R01 GM58202-01, R01 GM058202] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BERKOWER C, 1994, MOL BIOL CELL, V5, P1185, DOI 10.1091/mbc.5.11.1185; COOPER A, 1989, MOL CELL BIOL, V9, P2706, DOI 10.1128/MCB.9.6.2706; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; Dix D, 1997, J BIOL CHEM, V272, P11770, DOI 10.1074/jbc.272.18.11770; DIX DR, 1994, J BIOL CHEM, V269, P26092; EIDE D, 1992, J BIOL CHEM, V267, P20774; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; ORDORIZZI G, 1998, CELL, V95, P847; Pinner E, 1997, J BIOL CHEM, V272, P28933, DOI 10.1074/jbc.272.46.28933; PIPER RC, 1994, EUR J CELL BIOL, V65, P305; Radisky DC, 1997, P NATL ACAD SCI USA, V94, P5662, DOI 10.1073/pnas.94.11.5662; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Spizzo T, 1997, MOL GEN GENET, V256, P547; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Stefan CJ, 1999, J BIOL CHEM, V274, P1835, DOI 10.1074/jbc.274.3.1835; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; WILCOX CA, 1992, MOL BIOL CELL, V3, P1653; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yu JM, 1998, J BIOL CHEM, V273, P21380, DOI 10.1074/jbc.273.33.21380; Yuan DS, 1997, J BIOL CHEM, V272, P25787, DOI 10.1074/jbc.272.41.25787	38	148	156	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38061	38070		10.1074/jbc.274.53.38061	http://dx.doi.org/10.1074/jbc.274.53.38061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608875	hybrid			2022-12-27	WOS:000084528000075
J	Schnackerz, KD; Tai, CH; Potsch, RKW; Cook, PF				Schnackerz, KD; Tai, CH; Potsch, RKW; Cook, PF			Substitution of pyridoxal 5 '-phosphate in D-serine dehydratase from Escherichia coli by cofactor analogues provides information on cofactor binding and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; ALPHA-AMINOACRYLATE INTERMEDIATE; BIOSYNTHETIC THREONINE DEAMINASE; SYNTHASE ALPHA(2)BETA(2) COMPLEX; TIME-RESOLVED FLUORESCENCE; TRYPTOPHAN SYNTHASE; SALMONELLA-TYPHIMURIUM; 3-DIMENSIONAL STRUCTURE; ACTIVE-SITES; ASPARTATE-AMINOTRANSFERASE	D-Serine dehydratase (DSD) is a pyridoxal 5'-phosphate-dependent enzyme that catalyzes the conversion of D-serine to pyruvate and ammonia. Spectral studies of enzyme species where the natural cofactor was substituted by pyridoxal 5'-sulfate (PLS), pyridoxal 5-deoxymethylene phosphonate (PDMP), and pyridoxal 5'-phosphate monomethyl ester (PLPMe) were used to gain insight into the structural basis for binding of cofactor and substrate analogues. PDMP-DSD exhibits 35% of the activity of the native enzyme, whereas PLS-DSD and PLPMe-DSD are catalytically inactive. The emission spectrum of native DSD when excited at 280 nm shows maxima at 335 and 530 nm, The energy transfer band at 530 nm is very likely generated as a result of the proximity of Trp-197 to the protonated internal Schiff base, The cofactor analogue-reconstituted DSD species exhibit emission intensities decreasing from PLS-DSD, to PLPMe-DSD, and PDMP-DSD, when excited at 415 nm. Large increases in fluorescence intensity at 530 (540) nm can be observed for cofactor analogue-reconstituted DSD in the presence of substrate analogues when excited at 415 nm, In the absence and presence of substrate analogues, virtually identical far UV CD spectra were obtained for all DSD species. The visible CD spectra of native DSD, PDMP-DSD, and PLS-DSD exhibit a band centered on the visible absorption maximum with nearly identical intensity. Addition of substrate analogues to native and cofactor analogue-reconstituted DSD species results in most cases in a decrease or elimination of ellipticity. The results are interpreted in terms of local conformational changes and/or changes in the orientation of the bound cofactor (analogue).	Univ Wurzburg, Biozentrum, Theodor Boveri Inst Biowissensch, D-97074 Wurzburg, Germany; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73072 USA	University of Wurzburg; University of Oklahoma System; University of Oklahoma - Norman	Schnackerz, KD (corresponding author), Univ Wurzburg, Biozentrum, Theodor Boveri Inst Biowissensch, Am Hubland, D-97074 Wurzburg, Germany.							AHMED SA, 1985, J BIOL CHEM, V260, P3716; ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; ARRIODUPONT M, 1971, BIOCHEM BIOPH RES CO, V44, P653, DOI 10.1016/S0006-291X(71)80133-X; ARRIODUPONT M, 1970, PHOTOCHEM PHOTOBIOL, V12, P297, DOI 10.1111/j.1751-1097.1970.tb06062.x; BALK H, 1981, BIOCHEMISTRY-US, V20, P6391, DOI 10.1021/bi00525a017; Benci S, 1997, BIOCHEMISTRY-US, V36, P15419, DOI 10.1021/bi970464i; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; BYRNE CR, 1988, J BACTERIOL, V170, P3150, DOI 10.1128/jb.170.7.3150-3157.1988; Cook PF, 1996, J BIOL CHEM, V271, P25842, DOI 10.1074/jbc.271.42.25842; COOK PF, 1992, BIOCHEMISTRY-US, V31, P2295; DOWHAN W, 1970, J BIOL CHEM, V245, P4629; DOWHAN W, 1970, J BIOL CHEM, V245, P4618; EHRLICH JH, 1973, H-S Z PHYSIOL CHEM, V354, P1183; EISENSTEIN E, 1994, J BIOL CHEM, V269, P29423; EISENSTEIN E, 1994, J BIOL CHEM, V269, P29416; FEDERIUK CS, 1983, J BIOL CHEM, V258, P5372; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; GOLDBERG ME, 1968, BIOCHEMISTRY-US, V7, P3662, DOI 10.1021/bi00850a045; GOLDBERG ME, 1967, BIOCHEMISTRY-US, V6, P2113, DOI 10.1021/bi00859a032; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; GROMAN E, 1977, P NATL ACAD SCI USA, V69, P3297; HUANG YZ, 1972, J BIOL CHEM, V247, P7358; HYDE CC, 1988, J BIOL CHEM, V263, P17857; ISOM HC, 1975, BIOCHEMISTRY-US, V14, P4291, DOI 10.1021/bi00690a024; KAYASTHA AM, 1991, INDIAN J BIOCHEM BIO, V28, P352; KURODA T, 1963, BITUMEN, V28, P21; LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P303; MARCEAU M, 1988, J BIOL CHEM, V263, P16926; MCCLURE GD, 1994, BIOCHEMISTRY-US, V33, P1674, DOI 10.1021/bi00173a009; MILES EW, 1977, J BIOL CHEM, V252, P6594; MIURA R, 1989, ARCH BIOCHEM BIOPHYS, V270, P526, DOI 10.1016/0003-9861(89)90535-3; MOSKOWITZ A, 1961, TETRAHEDRON, V13, P48; OH KJ, 1973, J BIOL CHEM, V248, P7370; PFEUFFER T, 1972, BIOCHEMISTRY-US, V11, P2125, DOI 10.1021/bi00761a020; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; Rhee S, 1996, BIOCHEMISTRY-US, V35, P4211, DOI 10.1021/bi952506d; SCHILTZ E, 1976, EUR J BIOCHEM, V71, P109, DOI 10.1111/j.1432-1033.1976.tb11095.x; SCHILTZ E, 1981, FEBS LETT, V134, P57, DOI 10.1016/0014-5793(81)80550-9; SCHIRCH V, 1978, BIOCHEM BIOPH RES CO, V85, P99; SCHNACKERZ KD, 1989, EUR J BIOCHEM, V185, P525, DOI 10.1111/j.1432-1033.1989.tb15145.x; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P1536, DOI 10.1021/bi00575a023; SCHNACKERZ KD, 1995, BIOCHEMISTRY-US, V34, P12152, DOI 10.1021/bi00038a008; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P3557, DOI 10.1021/bi00583a019; SCHNACKERZ KD, 1972, Z PHYSL CHEM, V353, P1565; Schneider TR, 1998, BIOCHEMISTRY-US, V37, P5394, DOI 10.1021/bi9728957; SHALTIEL S, 1970, BIOCHEM BIOPH RES CO, V41, P594, DOI 10.1016/0006-291X(70)90054-9; STRAMBINI GB, 1992, BIOCHEMISTRY-US, V31, P7527, DOI 10.1021/bi00148a013; Strambini GB, 1996, BIOCHEMISTRY-US, V35, P8392, DOI 10.1021/bi952919e; TOKUSHIGE M, 1980, BIOCHEM BIOPH RES CO, V96, P863, DOI 10.1016/0006-291X(80)91435-7; TORCHINSKY YM, 1986, PYRIDOXAL PHOSPHATE, P163; Vaccari S, 1996, BIOPHYS CHEM, V61, P9, DOI 10.1016/0301-4622(96)00020-8; Woehl EU, 1996, BIOCHEMISTRY-US, V35, P4776, DOI 10.1021/bi952938o; YORK SS, 1972, BIOCHEMISTRY-US, V11, P2733, DOI 10.1021/bi00764a029	55	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36935	36943		10.1074/jbc.274.52.36935	http://dx.doi.org/10.1074/jbc.274.52.36935			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601247	hybrid			2022-12-27	WOS:000084382700018
J	Segui, B; Andrieu-Abadie, N; Adam-Klages, S; Meilhac, O; Kreder, D; Garcia, V; Bruno, AP; Jaffrezou, JP; Salvayre, R; Kronke, M; Levade, T				Segui, B; Andrieu-Abadie, N; Adam-Klages, S; Meilhac, O; Kreder, D; Garcia, V; Bruno, AP; Jaffrezou, JP; Salvayre, R; Kronke, M; Levade, T			CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NEUTRAL SPHINGOMYELINASE; FACTOR RECEPTOR; B-CELLS; PROTEIN-KINASES; CYTOPLASMIC DOMAIN; GROWTH-INHIBITION; PHOSPHOLIPASE-C; DENDRITIC CELLS; LYMPHOMA-CELLS	The possibility that the sphingomyelin (SM)-ceramide pathway is activated by CD40, a transmembrane glycoprotein belonging to the tumor necrosis factor receptor superfamily and that plays a critical role in the regulation of immune responses has been investigated. We demonstrate that incubation of Epstein-Barr virus-transformed lymphoid cells with an anti-CD40 antibody acting as an agonist results in the stimulation of a neutral sphingomyelinase, hydrolysis of cellular SM, and concomitant ceramide generation. In addition, SM degradation was observed in acid sphingomyelinase-deficient cells, as well as after ligation by soluble CD40 ligand. The anti-CD40 antibody, as well as the soluble CD40 ligand induced a decrease in thymidine incorporation and morphological features of apoptosis, which were mimicked by cell-permeant or bacterial sphingomyelinase-produced ceramides, Stable expression of a dominant-negative form of the FAN protein (factor associated with neutral sphingomyelinase activation), which has been reported to mediate tumor necrosis factor-induced activation of neutral sphingomyelinase, significantly inhibited CD40 ligand-induced sphingomyelinase stimulation and apoptosis of transformed human fibroblasts, Transformed fibroblasts from FAN knockout mice were also protected from CD40-mediated cell death. Finally, anti-CD40 antibodies were able to coimmunoprecipitate FAN in control fibroblasts but not in cells expressing the dominant-negative form of FAN, indicating interaction between CD40 and FAN. Altogether, these results strongly suggest that CD40 ligation can activate via FAN a neutral sphingomyelinase-mediated ceramide pathway that is involved in the cell growth inhibitory effects of CD40.	CHU Rangueil, Inst Louis Bugnard, Biochim Lab, INSERM,U466, F-31403 Toulouse 4, France; Univ Kiel, Inst Immunol, D-24105 Kiel, Germany; Roche Biosci, Neurobiol Unit, Palo Alto, CA 94304 USA; Inst Claudius Regaud, INSERM, E9910, F-31052 Toulouse, France; Univ Cologne, Inst Med Mikrobiol & Hyg, D-50935 Cologne, Germany	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Kiel; Roche Holding; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; University of Cologne	Levade, T (corresponding author), CHU Rangueil, Inst Louis Bugnard, Biochim Lab, INSERM,U466, Batiment L3,1 Ave Jean Poulhes, F-31403 Toulouse 4, France.		Adam-Klages, Sabine/E-9761-2010; Meilhac, Olivier/N-4385-2017; Levade, Thierry/O-8948-2014; GARCIA, Virginie/W-8313-2019; Ségui, Bruno/O-8957-2014; Andrieu-Abadie, Nathalie/N-6793-2013	GARCIA, Virginie/0000-0002-9761-7036; Ségui, Bruno/0000-0002-6119-1889; Andrieu-Abadie, Nathalie/0000-0003-2698-1970; Meilhac, Olivier/0000-0002-3740-7539				Adam D, 1996, J BIOL CHEM, V271, P14617, DOI 10.1074/jbc.271.24.14617; AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; ANDRIEU N, 1994, BIOCHEM J, V303, P341, DOI 10.1042/bj3030341; Baker MP, 1998, BLOOD, V92, P2830, DOI 10.1182/blood.V92.8.2830.420k10_2830_2843; Ballou LR, 1996, BBA-LIPID LIPID MET, V1301, P273, DOI 10.1016/0005-2760(96)00004-5; Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; Bergamo A, 1997, BRIT J HAEMATOL, V97, P652, DOI 10.1046/j.1365-2141.1997.1032919.x; Chatelut M, 1997, CLIN CHIM ACTA, V262, P61, DOI 10.1016/S0009-8981(97)06527-3; Chung TW, 1997, J BIOL CHEM, V272, P3064, DOI 10.1074/jbc.272.5.3064; CIFONE MG, 1995, EMBO J, V14, P5859, DOI 10.1002/j.1460-2075.1995.tb00274.x; CUADRADO A, 1993, ONCOGENE, V8, P2959; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; Eliopoulos AG, 1996, ONCOGENE, V13, P2243; FARIS M, 1994, J EXP MED, V179, P1923, DOI 10.1084/jem.179.6.1923; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; FUNAKOSHI S, 1994, BLOOD, V83, P2787, DOI 10.1182/blood.V83.10.2787.2787; Goldstein MD, 1996, J IMMUNOL, V157, P2837; GRAVIELI Y, 1992, J CELL BIOL, V119, P493; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Grewal IS, 1996, IMMUNOL TODAY, V17, P410, DOI 10.1016/0167-5699(96)10030-X; Gulbins E, 1996, J IMMUNOL, V157, P2844; GULBINS E, 1995, IMMUNITY, V2, P1; Hanissian SH, 1997, IMMUNITY, V6, P379, DOI 10.1016/S1074-7613(00)80281-2; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; HEATH AW, 1993, CELL IMMUNOL, V152, P468, DOI 10.1006/cimm.1993.1305; Hess S, 1996, J EXP MED, V183, P159, DOI 10.1084/jem.183.1.159; Hostager BS, 1996, J IMMUNOL, V157, P1047; HU HM, 1994, J BIOL CHEM, V269, P30069; INOKUCHI JI, 1987, J LIPID RES, V28, P565; INUI S, 1990, EUR J IMMUNOL, V20, P1747, DOI 10.1002/eji.1830200819; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; Jaffrezou JP, 1996, EMBO J, V15, P2417, DOI 10.1002/j.1460-2075.1996.tb00599.x; KIM MY, 1991, J BIOL CHEM, V266, P484; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kreder D, 1999, EMBO J, V18, P2472, DOI 10.1093/emboj/18.9.2472; Lee HH, 1999, P NATL ACAD SCI USA, V96, P1421, DOI 10.1073/pnas.96.4.1421; LEVADE T, 1991, J BIOL CHEM, V266, P13519; LEVADE T, 1984, BIOCHIM BIOPHYS ACTA, V793, P321, DOI 10.1016/0005-2760(84)90337-0; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; Sakata N, 1995, J BIOL CHEM, V270, P30823, DOI 10.1074/jbc.270.51.30823; Sallusto F, 1996, J EXP MED, V184, P2411, DOI 10.1084/jem.184.6.2411; Sambrook J., 2002, MOL CLONING LAB MANU; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; Sutherland CL, 1996, J IMMUNOL, V157, P3381; TEPPER CG, 1995, P NATL ACAD SCI USA, V92, P8443, DOI 10.1073/pnas.92.18.8443; Testi R, 1996, TRENDS BIOCHEM SCI, V21, P468, DOI 10.1016/S0968-0004(96)10056-6; Tsukamoto N, 1999, P NATL ACAD SCI USA, V96, P1234, DOI 10.1073/pnas.96.4.1234; UCKUN FM, 1991, J BIOL CHEM, V266, P17478; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330, DOI 10.1016/S0952-7915(97)80078-7; VANVELDHOVEN PP, 1992, BIOCHEM BIOPH RES CO, V187, P209, DOI 10.1016/S0006-291X(05)81480-9; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; YANAGA F, 1992, FEBS LETT, V314, P297, DOI 10.1016/0014-5793(92)81493-6	59	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37251	37258		10.1074/jbc.274.52.37251	http://dx.doi.org/10.1074/jbc.274.52.37251			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601289	hybrid			2022-12-27	WOS:000084382700060
J	Kroog, GS; Jian, XY; Chen, L; Northup, JK; Battey, JF				Kroog, GS; Jian, XY; Chen, L; Northup, JK; Battey, JF			Phosphorylation uncouples the gastrin-releasing peptide receptor from G(q)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; MUSCARINIC CHOLINERGIC RECEPTORS; PROTEIN-KINASE-C; SF9 INSECT CELLS; BETA-2-ADRENERGIC RECEPTOR; DEPENDENT PHOSPHORYLATION; BOMBESIN RECEPTORS; 48-KDA PROTEIN; LIGAND-BINDING; ARRESTIN	Previous work on the desensitization of G protein-coupled receptors has focused on the role of arrestin binding following receptor phosphorylation. We have examined the hypothesis that phosphorylation alone contributes to desensitization. In this study we demonstrate that for the G(q)-coupled gastrin-releasing peptide receptor (GRP-R), phosphorylation by GRK2 to a stoichiometry of similar to 1 mol PO4/mol GRP-R is sufficient in the absence of arrestin to reduce the rate of receptor catalyzed G protein activation by approximately 80%. Furthermore, GRP-Rs exposed in vivo to agonist are rapidly phosphorylated to a similar stoichiometry and are desensitized to a similar degree. Finally, the molecular mechanism for both in vitro GRK2-induced and in vivo agonist-induced desensitization is primarily a decrease in the maximum velocity (V-max) for the catalysis of guanine nucleotide exchange by the GRP-R rather than a change in the affinity of the receptor for the alpha(q) or beta(gamma) subunits. Based on these results, we suggest that, for some G protein-coupled receptors, phosphorylation has a role in desensitization that is independent of arrestin.	NIDCD, Mol Biol Lab, NIH, Rockville, MD 20850 USA; NIDCD, Lab Cellular Biol, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Battey, JF (corresponding author), NIDCD, Mol Biol Lab, NIH, 5 Res Ct, Rockville, MD 20850 USA.	batteyj@nidcd.nih.gov						ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; DEBBURMAN SK, 1995, MOL PHARMACOL, V47, P224; DEBBURMAN SK, 1995, J BIOL CHEM, V270, P5742, DOI 10.1074/jbc.270.11.5742; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; DUA HS, 1992, EYE, V6, P594, DOI 10.1038/eye.1992.128; FAWZI AB, 1991, J BIOL CHEM, V266, P12194; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Grady EF, 1997, AM J PHYSIOL-GASTR L, V273, pG586, DOI 10.1152/ajpgi.1997.273.3.G586; HAGA K, 1992, J BIOL CHEM, V267, P2222; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; Hellmich MR, 1997, P NATL ACAD SCI USA, V94, P751, DOI 10.1073/pnas.94.2.751; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; KEENAN AK, 1987, FEBS LETT, V217, P287, DOI 10.1016/0014-5793(87)80680-4; KIM CM, 1993, RECEPTOR, V3, P39; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; Kroog GS, 1998, RESP PHARM & PHARMAC, P143; KROOG GS, 1995, J BIOL CHEM, V270, P8217, DOI 10.1074/jbc.270.14.8217; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; KUSUI T, 1995, BIOCHEMISTRY-US, V34, P8061, DOI 10.1021/bi00025a012; LEBACQVERHEYDEN AM, 1990, HDB EXPT PHARM, V95, P71; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MANTEY S, 1993, MOL PHARMACOL, V43, P762; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; POTTINGER JDD, 1991, BIOCHEM J, V279, P323, DOI 10.1042/bj2790323; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; RICHARDSON RM, 1992, J BIOL CHEM, V267, P22249; SPINDEL ER, 1990, MOL ENDOCRINOL, V4, P1956, DOI 10.1210/mend-4-12-1956; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	44	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36700	36706		10.1074/jbc.274.51.36700	http://dx.doi.org/10.1074/jbc.274.51.36700			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593975	hybrid			2022-12-27	WOS:000084279200094
J	Moncalian, G; Cabezon, E; Alkorta, I; Valle, M; Moro, F; Valpuesta, JM; Goni, FM; de la Cruz, F				Moncalian, G; Cabezon, E; Alkorta, I; Valle, M; Moro, F; Valpuesta, JM; Goni, FM; de la Cruz, F			Characterization of ATP and DNA binding activities of TrwB, the coupling protein essential in plasmid R388 conjugation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ADENOSINE 5'-TRIPHOSPHATE; BACTERIAL CONJUGATION; BACILLUS-SUBTILIS; INCW PLASMID-R388; RNA-POLYMERASE; GENE-PRODUCT; CLONED GENES; PURIFICATION; ORGANIZATION	TrwB is the conjugative coupling protein of plasmid R388, TrwB Delta N70 contains the soluble domain of TrwB, It was constructed by deletion of trwB sequences containing TrwB N-proximal transmembrane segments. Purified TrwB Delta N70 protein bound tightly the fluorescent ATP analogue TNP-ATP (K-s = 8.7 mu M) but did not show measurable ATPase or GTPase activity. A single ATP binding site was found per TrwB monomer, An intact ATP-binding site was essential for R388 conjugation, since a TrwB mutant with a single amino acid alteration in the ATP-binding signature (K136T) was transfer-deficient, TrwB Delta N70 also bound DNA nonspecifically. DNA binding enhanced TrwC nic cleavage, providing the first evidence that directly links TrwB with conjugative DNA processing. Since DNA bound by TrwB Delta N70 also showed increased negative superhelicity las shown by increased sensitivity to topoisomerase I), nic cleavage enhancement was assumed to be a consequence of the increased single-stranded nature of DNA around nic, The mutant protein TrwB(K136T)Delta N70 was indistinguishable from TrwB Delta N70 with respect to the above properties, indicating that TrwB ATP binding activity is not required for them. The reported properties of TrwB suggest potential functions for conjugative coupling proteins, both as triggers of conjugative DNA processing and as motors in the transport process.	Univ Cantabria, Dept Biol Mol, Unidad Asociada Ctr Invest Biol, Santander 39011, Spain; Univ Basque Country, Euskal Herriko Unibersitatea, Unidad Biofis, Ctr Mixto,CSIC, E-48080 Bilbao, Spain; Univ Basque Country, Euskal Herriko Unibersitatea, Dept Bioquim, E-48080 Bilbao, Spain; CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	de la Cruz, F (corresponding author), Univ Cantabria, Dept Biol Mol, Unidad Asociada Ctr Invest Biol, C Herrera Oria S-N, Santander 39011, Spain.	delacruz@medi.unican.es	Valpuesta, José M/T-1977-2017; Alkorta, Itziar/Y-6267-2019; Moncalian, Gabriel/K-3493-2014; de la Cruz, Fernando/L-2812-2014; Valle, Mikel/F-7598-2011; Valpuesta, Jose M/AAA-6002-2019; Moro Pérez, Fernando/P-3891-2015; Goni, Felix M/M-5425-2015; Alkorta, Itziar/N-4374-2014; Cabezon, Elena/K-5874-2014	Valpuesta, José M/0000-0001-7468-8053; Moncalian, Gabriel/0000-0002-3007-6490; de la Cruz, Fernando/0000-0003-4758-6857; Valle, Mikel/0000-0001-8268-6912; Moro Pérez, Fernando/0000-0002-3568-3388; Goni, Felix M/0000-0001-6270-9216; Alkorta, Itziar/0000-0002-1976-8904; Cabezon, Elena/0000-0002-6177-5016; ALCORTA CALVO, MIREN ITZIAR/0000-0001-6978-389X				BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrd DR, 1997, MOL MICROBIOL, V25, P1011, DOI 10.1046/j.1365-2958.1997.5241885.x; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; CABEZON E, 1994, J BACTERIOL, V176, P4455, DOI 10.1128/jb.176.14.4455-4458.1994; CAMILLONI G, 1988, NUCLEIC ACIDS RES, V16, P7071, DOI 10.1093/nar/16.14.7071; CLEWELL DB, 1993, BACTERIAL CONJUGATIO; DATTA N, 1972, J GEN MICROBIOL, V72, P349, DOI 10.1099/00221287-72-2-349; Dayan G, 1996, J BIOL CHEM, V271, P11652, DOI 10.1074/jbc.271.20.11652; DELACRUZ F, 1982, J BACTERIOL, V151, P222, DOI 10.1128/JB.151.1.222-228.1982; DisqueKochem C, 1997, J BACTERIOL, V179, P6133, DOI 10.1128/jb.179.19.6133-6137.1997; DIVITA G, 1993, J BIOL CHEM, V268, P13178; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; DRI AM, 1992, GENE, V120, P11, DOI 10.1016/0378-1119(92)90003-8; DUPONT Y, 1982, BIOCHEM BIOPH RES CO, V106, P1272, DOI 10.1016/0006-291X(82)91250-5; GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GUTFREUND H, 1972, ENZYMES PHYSICAL PRI, P71; HIRATSUKA T, 1973, BIOCHIM BIOPHYS ACTA, V320, P635, DOI 10.1016/0304-4165(73)90143-8; Hopwood D.A., 1993, BACTERIAL CONJUGATIO, P293, DOI DOI 10.1007/978-1-4757-9357-4_11; INOUYE S, 1991, DIRECTED MUTAGENESIS, P71; KINGSMAN A, 1978, J MOL BIOL, V122, P287, DOI 10.1016/0022-2836(78)90191-2; KROGH S, 1991, NUCLEIC ACIDS RES, V19, P1235, DOI 10.1093/nar/19.6.1235; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; LLOSA M, 1994, J MOL BIOL, V235, P448, DOI 10.1006/jmbi.1994.1005; LLOSA M, 1995, J MOL BIOL, V246, P54, DOI 10.1006/jmbi.1994.0065; LLOSA M, 1994, J BACTERIOL, V176, P3210, DOI 10.1128/jb.176.11.3210-3217.1994; Llosa M, 1996, J MOL BIOL, V264, P56, DOI 10.1006/jmbi.1996.0623; LOHMAN TM, 1989, J BIOL CHEM, V264, P10139; Moncalian G, 1997, J MOL BIOL, V270, P188, DOI 10.1006/jmbi.1997.1082; Moncalian G, 1999, MOL MICROBIOL, V31, P1643, DOI 10.1046/j.1365-2958.1999.01288.x; NELSON WC, 1995, J BIOL CHEM, V270, P28374; PANICKER MM, 1992, J BIOL CHEM, V267, P12761; Pansegrau W, 1996, PROG NUCLEIC ACID RE, V54, P197, DOI 10.1016/S0079-6603(08)60364-5; Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583; Sambrook J., 2002, MOL CLONING LAB MANU; Santini JM, 1998, J BACTERIOL, V180, P4093, DOI 10.1128/JB.180.16.4093-4101.1998; Sastre JI, 1998, J BACTERIOL, V180, P6039, DOI 10.1128/JB.180.22.6039-6042.1998; SCHERZINGER E, 1992, NUCLEIC ACIDS RES, V20, P41, DOI 10.1093/nar/20.1.41; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; VOLOGODSKII AV, 1992, J MOL BIOL, V227, P1224, DOI 10.1016/0022-2836(92)90533-P; WATANABE T, 1982, J BIOL CHEM, V257, P1510; Weber J, 1996, J BIOL CHEM, V271, P3474; WILKINS BM, 1998, NATO ASI SER H, V103, P43; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161; Zhang SY, 1997, MOL MICROBIOL, V25, P509, DOI 10.1046/j.1365-2958.1997.4861849.x	52	86	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36117	36124		10.1074/jbc.274.51.36117	http://dx.doi.org/10.1074/jbc.274.51.36117			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593894	hybrid			2022-12-27	WOS:000084279200013
J	Sengupta, PK; Ehrlich, M; Smith, BD				Sengupta, PK; Ehrlich, M; Smith, BD			A methylation-responsive MDBP/RFX site is in the first exon of the collagen alpha 2(I) promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; B VIRUS ENHANCER; CHICK-EMBRYO FIBROBLASTS; NUCLEAR ANTIGEN PROMOTER; MESSENGER-RNA LEVELS; TRANSCRIPTION FACTORS; REGULATORY REGIONS; CELL-CYCLE; GENE; REPRESSION	DNA methylation inhibits transcription driven by the collagen alpha 2(I) promoter and the 5' end of the gene in transient transfection and in vitro transcription assays. DNA-binding proteins in a unique family of ubiquitously expressed proteins, methylated DNA-binding protein (MDBP)/regulatory factor for X box (RFX), form specific complexes with a sequence overlapping the transcription start site of the collagen alpha 2(I) gene. Complex formation increased when the CPG site at +7 base pairs from the transcription start site was methylated, The identity of the protein was demonstrated by co-migration and cross-competition for a characteristic slowly migrating doublet complex formed on MDBP/RFX recognition sequences and the collagen sequences by band shift assays. A RFX1-specific antibody supershifted the collagen DNA-protein complexes. Furthermore, in vitro translated REX1 protein formed a specific complex with the collagen sequence that was also supershifted with the RFX1 antibody, MDBP/RFX displayed a higher affinity binding to the collagen sequence if the CPG at +7 was mutated in a manner similar to TpG. This same mutation within reporter constructs inhibited transcription in transfection and in vitro transcription assay. These results support the hypothesis that DNA methylation-induced inactivation of collagen alpha 2(I) gene transcription is mediated, in part, by increased binding of MDBP/RFX to the first exon in response to methylation in this region.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Boston Dept Vet Affairs Med Ctr, Boston, MA 02118 USA; Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Human Genet Program, New Orleans, LA 70112 USA	Boston University; Tulane University; Tulane University	Smith, BD (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	smith@biochem.bumc.bu.edu		Smith, Barbara/0000-0002-5375-7627	NCI NIH HHS [R01-CA23540] Funding Source: Medline; NHLBI NIH HHS [P5-HL56386] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA023540] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056386] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS SL, 1977, P NATL ACAD SCI USA, V74, P3399, DOI 10.1073/pnas.74.8.3399; Agami R, 1998, ONCOGENE, V16, P1779, DOI 10.1038/sj.onc.1201708; Blake C, 1996, INTERNET WORLD, V7, P70; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; GHAZAL P, 1987, P NATL ACAD SCI USA, V84, P3658, DOI 10.1073/pnas.84.11.3658; GUENETTE DK, 1992, BIOCHEM J, V283, P699, DOI 10.1042/bj2830699; HORNSTRA IK, 1994, MOL CELL BIOL, V14, P1419, DOI 10.1128/MCB.14.2.1419; HUANG LH, 1984, NATURE, V308, P293, DOI 10.1038/308293a0; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Iannello RC, 1997, MOL CELL BIOL, V17, P612, DOI 10.1128/MCB.17.2.612; KARPEN S, 1988, MOL CELL BIOL, V8, P5159, DOI 10.1128/MCB.8.12.5159; Katan Y, 1997, NUCLEIC ACIDS RES, V25, P3621, DOI 10.1093/nar/25.18.3621; Katan-Khaykovich Y, 1998, J BIOL CHEM, V273, P24504, DOI 10.1074/jbc.273.38.24504; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; KUDO S, 1995, J BIOL CHEM, V270, P13298, DOI 10.1074/jbc.270.22.13298; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; LABRIE C, 1995, NUCLEIC ACIDS RES, V23, P3732, DOI 10.1093/nar/23.18.3732; Lee BH, 1998, J VIROL, V72, P1138, DOI 10.1128/JVI.72.2.1138-1145.1998; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Liu MS, 1999, J BIOL CHEM, V274, P15433, DOI 10.1074/jbc.274.22.15433; MAHESWARAN S, 1993, P NATL ACAD SCI USA, V90, P5100, DOI 10.1073/pnas.90.11.5100; Nan XS, 1998, CIBA F SYMP, V214, P6; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Okuse K, 1997, MOL BRAIN RES, V46, P197, DOI 10.1016/S0169-328X(96)00302-6; OSTAPCHUK P, 1989, MOL CELL BIOL, V9, P2787, DOI 10.1128/MCB.9.7.2787; REINHOLD W, 1995, MOL CELL BIOL, V15, P3041; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; ROWE DW, 1978, BIOCHEMISTRY-US, V17, P1581, DOI 10.1021/bi00602a001; Samac S, 1998, BIOL CHEM, V379, P541; SANCHEZ CH, 1992, MOL CELL BIOL, V12, P4076, DOI 10.1128/MCB.12.9.4076; SANDMEYER S, 1981, CANCER RES, V41, P830; Schwarz S, 1997, NUCLEIC ACIDS RES, V25, P5052, DOI 10.1093/nar/25.24.5052; Sengupta PK, 1998, BBA-GENE STRUCT EXPR, V1443, P75, DOI 10.1016/S0167-4781(98)00188-2; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SIEGRIST CA, 1993, MOL CELL BIOL, V13, P6375, DOI 10.1128/MCB.13.10.6375; Singal R, 1997, P NATL ACAD SCI USA, V94, P13724, DOI 10.1073/pnas.94.25.13724; SMITH BD, 1980, BIOCHEMISTRY-US, V19, P1820, DOI 10.1021/bi00550a014; SMITH BD, 1988, BIOCHEM J, V253, P269, DOI 10.1042/bj2530269; Smith KJ, 1998, AM J DERMATOPATH, V20, P22, DOI 10.1097/00000372-199802000-00005; TONY Y, 1995, CURR BIOL, V5, P1; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; Umezawa A, 1997, MOL CELL BIOL, V17, P4885, DOI 10.1128/MCB.17.9.4885; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; WU SY, 1995, MOL CELL BIOL, V15, P1479; ZHANG XY, 1991, VIROLOGY, V182, P865, DOI 10.1016/0042-6822(91)90631-K; ZHANG XY, 1990, CANCER RES, V50, P6865; ZHANG XY, 1993, MOL CELL BIOL, V13, P6810, DOI 10.1128/MCB.13.11.6810; ZHANG XY, 1989, NUCLEIC ACIDS RES, V17, P1459, DOI 10.1093/nar/17.4.1459; ZHANG XY, 1990, NUCLEIC ACIDS RES, V18, P6253, DOI 10.1093/nar/18.21.6253; ZHANG XY, 1995, NUCLEIC ACIDS RES, V23, P3026, DOI 10.1093/nar/23.15.3026	52	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36649	36655		10.1074/jbc.274.51.36649	http://dx.doi.org/10.1074/jbc.274.51.36649			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593968	hybrid			2022-12-27	WOS:000084279200087
J	Kosa, JL; Sweasy, JB				Kosa, JL; Sweasy, JB			The E249K mutator mutant of DNA polymerase beta extends mispaired termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; HIV-1 REVERSE-TRANSCRIPTASE; CRYSTAL-STRUCTURES; NUCLEAR EXTRACT; HIGH FIDELITY; REPLICATION; MECHANISM; EXTENSION; SUBSTITUTE; SEQUENCE	The DNA polymerase beta mutant enzyme, which is altered from glutamic acid to lysine at position 249, exhibits a mutator phenotype in primer extension assays and in the herpes simplex virus-thymidine kinase (HSV-tk) forward mutation assay. The basis for this loss of accuracy was investigated by measurement of misincorporation fidelity in single turnover conditions. For the four misincorporation reactions investigated, the fidelity of the E249K mutant was not significantly different from wild type, implying that the mutator phenotype was not caused by a general inability to distinguish between correct and incorrect bases during the incorporation reaction. However, the discrimination between correct and incorrect substrates by the E249K enzyme occurred less during the conformational change and chemical steps and more during the initial binding step, compared with pol beta wild type. This implies that the E249R mutation alters the kinetic mechanism of nucleotide discrimination without reducing misincorporation fidelity. In a missing base primer extension assay, we observed that the mutant enzyme produced mispairs and extended them. This indicates that the altered fidelity of E249K could be due to loss of discrimination against mispaired primer termini, This was supported by the finding that the E249K enzyme extended a G:A mispair 8-fold more efficiently than wild type and a C:T mispair 4-fold more efficiently. These results demonstrate that an enhanced ability to extend mispairs can produce a mutator phenotype and that the Glu-249 side chain of DNA polymerase beta is critical for mispair extension fidelity.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Sweasy, JB (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.				NATIONAL CANCER INSTITUTE [R01CA080830] Funding Source: NIH RePORTER; NCI NIH HHS [CA 80830, R01 CA080830] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Andersen T, 1987, APPL GEOCHEM, V2, P163, DOI DOI 10.1016/0883-2927(87)90031-X; Beard WA, 1998, CHEM BIOL, V5, pR7, DOI 10.1016/S1074-5521(98)90081-3; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501; Clairmont CA, 1996, J BACTERIOL, V178, P656, DOI 10.1128/jb.178.3.656-661.1996; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Eckert KA, 1997, NUCLEIC ACIDS RES, V25, P1450, DOI 10.1093/nar/25.7.1450; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; JENKINS TM, 1992, SCIENCE, V258, P475, DOI 10.1126/science.1411545; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kosa JL, 1999, J BIOL CHEM, V274, P3851, DOI 10.1074/jbc.274.6.3851; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Li SX, 1999, BIOCHEMISTRY-US, V38, P4800, DOI 10.1021/bi9827058; MATSUKAGE A, 1987, J BIOL CHEM, V262, P8960; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Opresko PL, 1998, BIOCHEMISTRY-US, V37, P2111, DOI 10.1021/bi9722711; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PERRINO FW, 1989, P NATL ACAD SCI USA, V86, P8343, DOI 10.1073/pnas.86.21.8343; PERRINO FW, 1989, J BIOL CHEM, V264, P2898; Plug AW, 1997, P NATL ACAD SCI USA, V94, P1327, DOI 10.1073/pnas.94.4.1327; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; STEIN CA, 1994, J MED VIROL, V44, P115, DOI 10.1002/jmv.1890440203; Suzuki M, 1997, J BIOL CHEM, V272, P11228; SWEASY JB, 1992, J BIOL CHEM, V267, P1407; SWEASY JB, 1995, J BACTERIOL, V177, P2923, DOI 10.1128/jb.177.10.2923-2925.1995; TANTILLO C, 1994, J MOL BIOL, V243, P369, DOI 10.1006/jmbi.1994.1665	35	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35866	35872		10.1074/jbc.274.50.35866	http://dx.doi.org/10.1074/jbc.274.50.35866			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585471	hybrid			2022-12-27	WOS:000084187900083
J	Devireddy, LR; Jones, CJ				Devireddy, LR; Jones, CJ			Olf-1, a neuron-specific transcription factor, can activate the herpes simplex virus type 1-infected cell protein 0 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; REGULATORY ELEMENTS; ICPO PROMOTER; DNA-BINDING; JC VIRUS; LATENCY; REACTIVATION; CLONING; MUTANTS	Herpes simplex virus type 1 (HSV-1) establishes a lifelong latent infection in sensory neurons of infected individuals. Infected cell protein 0 (ICP0) is important for productive infection and reactivation from latency. Thus, activation of ICP0 expression in neurons is likely to be important for reactivation from latency, In a mouse neuroblastoma cell line, ICP0 promoter activity is high compared with other strong viral promoters. In contrast, promoter activity is low in non-neuronal cells. DNase I footprinting assays indicated that three distinct motifs in the ICP0 promoter are bound by nuclear factors. One of these motifs contains a binding site for a novel helix-loop-helix olfactory neuron-specific transcription factor (Olf-1). Gel shift assays and supershift assays using an Olf-1-specific antibody demonstrated that mouse neuroblastoma cells express Olf-1, which is bound to the Olf-1-like site in the ICP0 promoter. Deletion of the putative Olf-1 motif reduced ICP0 promoter activity more than 5-fold in mouse neuroblastoma cells and prevented trans-activation by an Olf-1 expression vector. We hypothesize that the Olf-1-binding site activates ICP0 promoter activity in neurons during reactivation from latency.	Univ Nebraska, Dept Vet & Biomed Sci, Ctr Biotechnol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Jones, CJ (corresponding author), Univ Nebraska, Dept Vet & Biomed Sci, Ctr Biotechnol, Fair St & E Campus Loop, Lincoln, NE 68583 USA.	cjones@unlnotes.unl.edu						CAI WZ, 1992, J VIROL, V66, P2904, DOI 10.1128/JVI.66.5.2904-2915.1992; CHODOSH LA, 1988, MOL CELL BIOL, V13, P11; CLEARY MA, 1993, GENE DEV, V7, P72, DOI 10.1101/gad.7.1.72; Davido DJ, 1996, J GEN VIROL, V77, P1853, DOI 10.1099/0022-1317-77-8-1853; Davido DJ, 1998, J GEN VIROL, V79, P2093, DOI 10.1099/0022-1317-79-9-2093; Davis JA, 1996, J NEUROSCI, V16, P5082; Devireddy LR, 1996, J MED VIROL, V49, P205; Devireddy LR, 1998, J VIROL, V72, P7294, DOI 10.1128/JVI.72.9.7294-7301.1998; EVERETT RD, 1989, J GEN VIROL, V70, P1185, DOI 10.1099/0022-1317-70-5-1185; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HENNIGHAUSEN L, 1987, METHOD ENZYMOL, V152, P721; Jones C, 1998, Adv Virus Res, V51, P81, DOI 10.1016/S0065-3527(08)60784-8; KUDRYCKI K, 1993, MOL CELL BIOL, V13, P3002, DOI 10.1128/MCB.13.5.3002; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; LIU X, 1990, BIOTECHNIQUES, V9, P168; Lium EK, 1998, J VIROL, V72, P7785, DOI 10.1128/JVI.72.10.7785-7795.1998; Nakshatri H, 1997, ANAL BIOCHEM, V249, P103, DOI 10.1006/abio.1997.2154; NAKSHATRI H, 1990, VIROLOGY, V177, P784, DOI 10.1016/0042-6822(90)90550-B; OHARE P, 1993, SEMIN VIROL, V4, P145, DOI 10.1006/smvy.1993.1010; OHARE P, 1988, CELL, V52, P435, DOI 10.1016/S0092-8674(88)80036-9; Reed RR, 1998, SCIENCE, V279, P193, DOI 10.1126/science.279.5348.193; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; STARNAUD R, 1993, MOL CELL BIOL, V13, P1590, DOI 10.1128/MCB.13.3.1590; STOW ND, 1986, J GEN VIROL, V67, P2571, DOI 10.1099/0022-1317-67-12-2571; Tamura TA, 1996, NEUROCHEM INT, V29, P573, DOI 10.1016/S0197-0186(96)00048-4; Tsai RYL, 1997, J NEUROSCI, V17, P4159; VERHAAGEN J, 1990, J NEUROSCI RES, V26, P31, DOI 10.1002/jnr.490260105; Wagner EK, 1997, CLIN MICROBIOL REV, V10, P419, DOI 10.1128/CMR.10.3.419; WANG MM, 1993, MOL CELL BIOL, V13, P5805, DOI 10.1128/MCB.13.9.5805; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 1997, J NEUROSCI, V17, P4149; ZHU XX, 1990, J VIROL, V64, P4489, DOI 10.1128/JVI.64.9.4489-4498.1990	32	16	17	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					77	81		10.1074/jbc.275.1.77	http://dx.doi.org/10.1074/jbc.275.1.77			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617588	hybrid			2022-12-27	WOS:000085951600012
J	El-Mir, MY; Nogueira, V; Fontaine, E; Averet, N; Rigoulet, M; Leverve, X				El-Mir, MY; Nogueira, V; Fontaine, E; Averet, N; Rigoulet, M; Leverve, X			Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; ANTIDIABETIC DRUG METFORMIN; ISOLATED RAT HEPATOCYTES; NITRIC-OXIDE; PHOSPHOINOSITIDE 3-KINASE; PYRUVATE-KINASE; DIABETIC RATS; MITOCHONDRIAL; GLUTATHIONE; BIGUANIDES	We report here a new mitochondrial regulation occurring only in intact cells. We have investigated the effects of dimethylbiguanide on isolated rat hepatocytes, permeabilized hepatocytes, and isolated liver mitochondria, Addition of dimethylbiguanide decreased oxygen consumption and mitochondrial membrane potential only in intact cells but not in permeabilized hepatocytes or isolated mitochondria. Permeabilized hepatocytes after dimethylbiguanide exposure and mitochondria isolated from dimethylbiguanide pretreated livers or animals were characterized by a significant inhibition of oxygen consumption with complex I substrates (glutamate and malate) but not with complex II (succinate) or complex IV (N,N,N',N'-tetramethyl-1,4-phenylenediamine dihydrochloride (TMPD)/ascorbate) substrates, Studies using functionally isolated complex I obtained from mitochondria isolated from dimethylbiguanide-pretreated livers or rats further confirmed that dimethylbiguanide action was located on the respiratory chain complex I. The dimethylbiguanide effect was temperature-dependent, oxygen consumption decreasing by 50, 20, and 0% at 37, 25, and 15 degrees C, respectively. This effect was not affected by insulin-signaling pathway inhibitors, nitric oxide precursor or inhibitors, oxygen radical scavengers, ceramide synthesis inhibitors, or chelation of intra- or extracellular Ca2+. Because it is established that dimethylbiguanide is not metabolized, these results suggest the existence of a new cell-signaling pathway targeted to the respiratory chain complex I with a persistent effect after cessation of the signaling process.	Univ Grenoble 1, Lab Bioenerget Fondamentale & Appl, F-38041 Grenoble 09, France; Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Leverve, X (corresponding author), Univ Grenoble 1, Lab Bioenerget Fondamentale & Appl, BP 53X, F-38041 Grenoble 09, France.	xavier.leverve@ujf-grenoble.fr	Fontaine, Eric/ABA-8853-2020	Fontaine, Eric/0000-0002-5204-9477				Almeida A, 1998, BRAIN RES, V790, P209, DOI 10.1016/S0006-8993(98)00064-X; ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; BAILEY CJ, 1992, DIABETES CARE, V15, P755, DOI 10.2337/diacare.15.6.755; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; BAILEY CJ, 1992, BRIT J PHARMACOL, V105, P1009, DOI 10.1111/j.1476-5381.1992.tb09093.x; Bergmeyer H.U, 1974, METHODS ENZYMATIC AN, V3; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, V4; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bolanos JP, 1997, J NEUROCHEM, V68, P2227; BOLANOS JP, 1994, J NEUROCHEM, V63, P910; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Dominguez LJ, 1996, ENDOCRINOLOGY, V137, P113, DOI 10.1210/en.137.1.113; ESPIE P, 1995, BBA-BIOENERGETICS, V1230, P139, DOI 10.1016/0005-2728(95)00045-K; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; EWIS SA, 1995, J APPL TOXICOL, V15, P387, DOI 10.1002/jat.2550150508; Ewis SA, 1997, J APPL TOXICOL, V17, P409, DOI 10.1002/(SICI)1099-1263(199711/12)17:6<409::AID-JAT462>3.0.CO;2-B; FONTAINE EM, 1995, BIOCHEM BIOPH RES CO, V213, P138, DOI 10.1006/bbrc.1995.2108; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GRIGORESCU F, 1991, DIABETES METAB, V17, P146; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; JALLING O, 1984, ACTA PHARMACOL TOX, V54, P327; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; Kessler A, 1998, BIOCHEM J, V330, P277, DOI 10.1042/bj3300277; KISELEV GV, 1975, UKR BIOKHIM ZH+, V47, P389; KLINGENBERG M, 1959, BIOCHEM Z, V331, P486; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Lee AJ, 1996, PHARMACOTHERAPY, V16, P327; LEVERVE XM, 1994, EUR J BIOCHEM, V224, P967, DOI 10.1111/j.1432-1033.1994.00967.x; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; PENTIKAINEN PJ, 1979, EUR J CLIN PHARMACOL, V16, P195, DOI 10.1007/BF00562061; PISON CM, 1995, AM J PHYSIOL-ENDOC M, V268, pE965, DOI 10.1152/ajpendo.1995.268.5.E965; Rieske J. S., 1967, METHOD ENZYMOL, V10, P239; Santos RF, 1997, DIABETES METAB, V23, P143; SCHAFER G, 1969, BIOCHIM BIOPHYS ACTA, V172, P334, DOI 10.1016/0005-2728(69)90077-2; SCHAFER G, 1972, EUR J BIOCHEM, V27, P364, DOI 10.1111/j.1432-1033.1972.tb01846.x; SCHAFER G, 1983, DIABETES METAB, V9, P148; Shepherd PR, 1996, J MOL ENDOCRINOL, V17, P175, DOI 10.1677/jme.0.0170175; SHOUKRY MI, 1980, J BIOCHEM BIOPH METH, V3, P219, DOI 10.1016/0165-022X(80)90060-3; STADLER J, 1991, AM J PHYSIOL, V260, pC910, DOI 10.1152/ajpcell.1991.260.5.C910; STADLER J, 1992, ANN SURG, V216, P539, DOI 10.1097/00000658-199211000-00003; Stith BJ, 1998, BIOCHEM PHARMACOL, V55, P533, DOI 10.1016/S0006-2952(97)00540-6; Stith BJ, 1996, ENDOCRINOLOGY, V137, P2990, DOI 10.1210/en.137.7.2990; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; UBL JJ, 1994, BIOCHEM J, V304, P561, DOI 10.1042/bj3040561; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; WIERNSPERGER N, 1995, DIABETES METAB REV, V11, pS3, DOI 10.1002/dmr.5610110503; WIERNSPERGER NF, 1996, HANDB EXP PHARM, V119, P305; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wright AD, 1998, DIABETES CARE, V21, P87; ZHANG Y, 1990, J BIOL CHEM, V265, P16330	54	1011	1044	4	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					223	228		10.1074/jbc.275.1.223	http://dx.doi.org/10.1074/jbc.275.1.223			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617608	hybrid			2022-12-27	WOS:000085951600032
J	Ota, S; Hazeki, K; Rao, N; Lupher, ML; Andoniou, CE; Druker, B; Band, H				Ota, S; Hazeki, K; Rao, N; Lupher, ML; Andoniou, CE; Druker, B; Band, H			The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; FACTOR RECEPTOR-ALPHA; PROTOONCOGENE C-CBL; ACTIVATED T-CELLS; EGF RECEPTOR; SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION SITES; IN-VIVO; PROTEIN	The proto oncogene product Cbl has emerged as a negative regulator of a number of protein-tyrosine kinases, including the ZAP-70/Syk tyrosine kinases that are critical for signaling in hematopoietic cells. The evolutionarily conserved N-terminal tyrosine kinase-binding domain is required for Cbl to associate with ZAP-70/Syk and for their subsequent negative regulation. However, the role of the remaining C-terminal regions of Cbl remains unclear. Here, we used a COS-7 cell reconstitution system to address this question. Analysis of a series of C-terminally truncated Cbl mutants revealed that the N-terminal half of the protein, including the TKB and RING finger domains, was sufficient to mediate negative regulation of Syk, Further truncations, which delete the RING finger domain, abrogated the negative regulatory effects of Cbl on Syk, Point mutations of conserved cysteine residues or a histidine in the RING finger domain, which are required for zinc binding, abrogated the ability of Cbl to negatively regulate Syk in COS-7 cells and Ramos B lymphocytic cells. In addition, Syk-dependent transactivation of a serum response element-luciferase reporter in transfected 293T cells was reduced by wild type Cbl; mutations of the RING finger domain or its deletion abrogated this effect. These results establish the RING finger domain as an essential element in Cbl-mediated negative regulation of a tyrosine kinase and reveal that the evolutionarily conserved N-terminal half of the protein is sufficient for this function.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Div Rheumatol Immunol & Allergy, Lymphocyte Biol Sect, Boston, MA 02115 USA; Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Oregon Health & Science University	Band, H (corresponding author), Smith Bldg,Rm 538C,1 Jimmy Fund Way, Boston, MA 02115 USA.		Andoniou, Christopher/B-6296-2013	Andoniou, Christopher/0000-0003-0566-3180; Druker, Brian/0000-0001-8331-8206	NCI NIH HHS [CA75075, CA64503, CA76118] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA064503, R01CA076118, R01CA064503, R01CA075075] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; BOWTELL DDL, 1995, ONCOGENE, V11, P1561; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Duprez E, 1999, J CELL SCI, V112, P381; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; FLIER JS, 1989, NEW ENGL J MED, V321, P1383, DOI 10.1056/NEJM198911163212007; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Hasegawa N, 1996, BIOCHEM BIOPH RES CO, V225, P627, DOI 10.1006/bbrc.1996.1221; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hu G, 1999, MOL CELL BIOL, V19, P724; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Langdon WY, 1995, AUST NZ J MED, V25, P859, DOI 10.1111/j.1445-5994.1995.tb02892.x; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; LILL NL, 2000, IN PRESS J BIOL CHEM, V275; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Liu YC, 1997, J BIOL CHEM, V272, P168; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lupher ML, 1999, IMMUNOL TODAY, V20, P375, DOI 10.1016/S0167-5699(99)01484-X; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Lupher ML, 1998, INT J BIOCHEM CELL B, V30, P439, DOI 10.1016/S1357-2725(97)00075-7; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Marengere LEM, 1997, J IMMUNOL, V159, P70; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Ota Y, 1996, J EXP MED, V184, P1713, DOI 10.1084/jem.184.5.1713; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Smit L, 1997, CRIT REV ONCOGENESIS, V8, P359, DOI 10.1615/CritRevOncog.v8.i4.50; SPITS H, 1983, HYBRIDOMA, V2, P423, DOI 10.1089/hyb.1983.2.423; Thien CBF, 1997, ONCOGENE, V15, P2909, DOI 10.1038/sj.onc.1201468; Thien CBF, 1998, IMMUNOL CELL BIOL, V76, P473, DOI 10.1046/j.1440-1711.1998.00768.x; van Leeuwen JEM, 1999, J BIOL CHEM, V274, P5153, DOI 10.1074/jbc.274.8.5153; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; WIENANDS J, 1995, INT IMMUNOL, V7, P1701, DOI 10.1093/intimm/7.11.1701; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Zhang ZH, 1999, J BIOL CHEM, V274, P4883, DOI 10.1074/jbc.274.8.4883; Zhao QH, 1996, MOL CELL BIOL, V16, P6765	57	79	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					414	422		10.1074/jbc.275.1.414	http://dx.doi.org/10.1074/jbc.275.1.414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617633	hybrid			2022-12-27	WOS:000085951600057
J	Lougheed, B; Ly, HD; Wakarchuk, WW; Withers, SG				Lougheed, B; Ly, HD; Wakarchuk, WW; Withers, SG			Glycosyl fluorides can function as substrates for nucleotide phosphosugar-dependent glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-SPECIFIED GLYCOSYLTRANSFERASES; D-GLUCOPYRANOSYL FLUORIDE; BLOOD-GROUP-A; ACCEPTOR ALPHA-L-FUCP-(1->2)-BETA-D-GALP-OR; OLIGOSACCHARIDE SYNTHESIS; CARBOHYDRATE-RECOGNITION; ENZYMATIC-SYNTHESIS; ORGANIC-SYNTHESIS; GLYCOBIOLOGY; STRATEGIES	alpha-Galactosyl fluoride is shown to function as a substrate, in place of uridine-5'-diphosphogalactose, for the alpha-galactosyltransferase from Neisseria meningitidis. The reaction only occurs in the presence of catalytic quantities of uridine 5'-diphosphate, In the presence of galactosyl accepters, the expected oligosaccharide product is formed in essentially quantitative yields, reaction having been performed on multi-milligram scales, In the absence of a suitable acceptor, the enzyme synthesizes uridine-5'-diphosphogalactose, as demonstrated through a coupled assay in which uridine-5'-diphosphogalactose is converted to uridine-5'-diphosphoglucuronic acid with conversion of NAD to NADH. These glycosyl fluoride substrates therefore offer the potential of an inexpensive alternative donor substrate in the synthesis of oligosaccharides as well a means of generating steady state concentrations of nucleotide diphosphate sugars for in situ use by other enzymes. Further, they should prove valuable as mechanistic probes.	Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0C6, Canada	University of British Columbia; National Research Council Canada	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.		Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679				BELL JE, 1976, J BIOL CHEM, V251, P3003; Beyer T A, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P23; Boons GJ, 1996, TETRAHEDRON, V52, P1095, DOI 10.1016/0040-4020(95)00897-7; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Danishefsky SJ, 1996, ANGEW CHEM INT EDIT, V35, P1380, DOI 10.1002/anie.199613801; DAVIES G, 1997, COMPREHENSIVE BIOL C, V1, P119; DOUGLAS SP, 1991, J AM CHEM SOC, V113, P5095, DOI 10.1021/ja00013a075; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Edebrink P, 1996, CARBOHYD RES, V295, P127, DOI 10.1016/S0008-6215(96)90132-9; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; GOLD AM, 1980, BIOCHEMISTRY-US, V19, P3766, DOI 10.1021/bi00557a018; HAYASHI M, 1984, CHEM LETT, P1747, DOI 10.1246/cl.1984.1747; HEHRE EJ, 1990, CARBOHYD RES, V198, P123, DOI 10.1016/0008-6215(90)84282-Y; ICHIKAWA Y, 1992, J AM CHEM SOC, V114, P9283, DOI 10.1021/ja00050a007; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; KOBATA A, 1993, ACCOUNTS CHEM RES, V26, P319, DOI 10.1021/ar00030a004; KOBAYASHI S, 1991, J AM CHEM SOC, V113, P3079, DOI 10.1021/ja00008a042; KONSTANTINIDIS AK, 1993, BIOCHEM J, V291, P833; Leatherbarrow R.J, 1990, GRAFIT VERSION 3 0; LINDHORST TK, 1995, CARBOHYD RES, V268, P93, DOI 10.1016/0008-6215(94)00317-9; LOWARY TL, 1993, CARBOHYD RES, V249, P163, DOI 10.1016/0008-6215(93)84068-H; LOWARY TL, 1994, CARBOHYD RES, V251, P33, DOI 10.1016/0008-6215(94)84275-2; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; MOREAU V, 1996, J CHEM SOC PERK T, V21, P525; NILSSON KGI, 1988, TRENDS BIOTECHNOL, V6, P256, DOI 10.1016/0167-7799(88)90058-3; PALCIC M M, 1991, Glycobiology, V1, P205, DOI 10.1093/glycob/1.2.205; PLESNER L, 1974, J BIOL CHEM, V249, P1119; Qiao L, 1996, J AM CHEM SOC, V118, P7653, DOI 10.1021/ja960274f; SALSAS E, 1975, J BIOL CHEM, V250, P3471; Sears P, 1996, P NATL ACAD SCI USA, V93, P12086, DOI 10.1073/pnas.93.22.12086; Sierks MR, 1996, BIOCHEMISTRY-US, V35, P1865, DOI 10.1021/bi951738+; Simon PM, 1996, DRUG DISCOV TODAY, V1, P522, DOI 10.1016/S1359-6446(96)10044-1; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; THIEM J, 1995, FEMS MICROBIOL REV, V16, P193; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Wakarchuk WW, 1998, PROTEIN ENG, V11, P295, DOI 10.1093/protein/11.4.295; WOLFRAM S, 1996, MATH VERSION 3 0; WONG CH, 1995, ANGEW CHEM INT EDIT, V34, P521, DOI 10.1002/anie.199505211; Zemplen G, 1929, BER DTSCH CHEM GES, V62, P1613, DOI 10.1002/cber.19290620640; Zopf D, 1996, LANCET, V347, P1017, DOI 10.1016/S0140-6736(96)90150-6	42	38	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37717	37722		10.1074/jbc.274.53.37717	http://dx.doi.org/10.1074/jbc.274.53.37717			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608830	hybrid			2022-12-27	WOS:000084528000030
J	Poderoso, JJ; Lisdero, C; Schopfer, F; Riobo, N; Carreras, MC; Cadenas, E; Boveris, A				Poderoso, JJ; Lisdero, C; Schopfer, F; Riobo, N; Carreras, MC; Cadenas, E; Boveris, A			The regulation of mitochondrial oxygen uptake by redox reactions involving nitric oxide and ubiquinol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; HYDROGEN-PEROXIDE; REVERSIBLE INHIBITION; SUPEROXIDE RADICALS; HEART-MITOCHONDRIA; RESPIRATION; PEROXYNITRITE; GENERATION; METABOLISM; REDUCTION	The reversible inhibitory effects of nitric oxide (. NO) on mitochondrial cytochrome oxidase and O-2 uptake are dependent on intramitochondrial . NO utilization. This study was aimed at establishing the mitochondrial pathways for . NO utilization that regulate O-2(radical anion) generation via reductive and oxidative reactions involving ubiquinol oxidation and peroxynitrite (ONOO-) formation. For this purpose, experimental models consisting of intact mitochondria, ubiquinone-depleted/reconstituted submitochondrial particles, and ONOO--supplemented mitochondrial membranes were used. The results obtained from these experimental approaches strongly suggest the occurrence of independent pathways for . NO utilization in mitochondria, which effectively compete with the binding of . NO to cytochrome oxidase, thereby releasing this inhibition and restoring O-2 uptake. The pathways for . NO utilization are discussed in terms of the steady-state levels of . NO and O-2(radical anion) and estimated as a function of O-2 tension. These calculations indicate that mitochondrial . NO decays primarily by pathways involving ONOO- formation and ubiquinol oxidation and, secondarily, by reversible binding to cytochrome oxidase.	Univ Buenos Aires, Univ Hosp, Sch Med, Lab Oxygen Metab, RA-1120 Buenos Aires, DF, Argentina; Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90089 USA; Univ Buenos Aires, Sch Pharm & Biochem, Lab Free Radical Biol, RA-1120 Buenos Aires, DF, Argentina	University of Buenos Aires; University of Southern California; University of Buenos Aires	Poderoso, JJ (corresponding author), Univ Buenos Aires, Univ Hosp, Sch Med, Lab Oxygen Metab, Cordoba 2351, RA-1120 Buenos Aires, DF, Argentina.	jpoderos@fmed.uba.ar	Schopfer, Francisco Jose/AAE-8125-2020; Galdo, Natalia Riobo-Del/AAP-2938-2020	Schopfer, Francisco Jose/0000-0001-9526-695X; Galdo, Natalia Riobo-Del/0000-0002-8942-7873	NATIONAL INSTITUTE ON AGING [R01AG016718] Funding Source: NIH RePORTER; NIA NIH HHS [1RO1AG16718-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Antunes F, 1996, FREE RADICAL BIO MED, V21, P917, DOI 10.1016/S0891-5849(96)00185-2; AUGUSTO O, 1994, ARCH BIOCHEM BIOPHYS, V310, P118, DOI 10.1006/abbi.1994.1147; BEAVIS AD, 1985, J BIOL CHEM, V260, P3424; BECKMAN JS, 1990, NATURE, V345, P27, DOI 10.1038/345027b0; Boczkowski J, 1999, FASEB J, V13, P1637, DOI 10.1096/fasebj.13.12.1637; Borutaite V, 1996, BIOCHEM J, V315, P295, DOI 10.1042/bj3150295; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; Boveris A, 1999, METHOD ENZYMOL, V301, P188; BOVERIS A, 1970, Archives of Biochemistry and Biophysics, V141, P641, DOI 10.1016/0003-9861(70)90184-0; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Boveris A, 1997, OXYGEN GENE EXPRESSI, P1; Brandt U, 1996, FEBS LETT, V387, P1, DOI 10.1016/0014-5793(96)00436-X; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Brown GC, 1997, MOL CELL BIOCHEM, V174, P189, DOI 10.1023/A:1006800322719; BROWN GC, 1995, FEBS LETT, V369, P136, DOI 10.1016/0014-5793(95)00763-Y; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; CADENAS E, 1999, ANTIOXIDANT FOOD SUP, P143; Carreras MC, 1996, METHOD ENZYMOL, V269, P65; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; DIONISI O, 1975, BIOCHIM BIOPHYS ACTA, V403, P292, DOI 10.1016/0005-2744(75)90059-5; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; FORD PC, 1993, FEBS LETT, V326, P1, DOI 10.1016/0014-5793(93)81748-O; Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5; Giuffre A, 1996, J BIOL CHEM, V271, P33404, DOI 10.1074/jbc.271.52.33404; Giulivi C, 1998, BIOCHEM J, V332, P673, DOI 10.1042/bj3320673; GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; Koivisto A, 1997, FEBS LETT, V417, P75, DOI 10.1016/S0014-5793(97)01258-1; Koppenol WH, 1996, METHOD ENZYMOL, V268, P7; Lizasoain I, 1996, BIOCHEM J, V314, P877, DOI 10.1042/bj3140877; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Packer MA, 1996, BIOCHEM MOL BIOL INT, V40, P527; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Poderoso JJ, 1998, AM J PHYSIOL-CELL PH, V274, pC112, DOI 10.1152/ajpcell.1998.274.1.C112; Poderoso JJ, 1999, FREE RADICAL BIO MED, V26, P925, DOI 10.1016/S0891-5849(98)00277-9; Sharpe MA, 1998, BIOCHEM J, V332, P9, DOI 10.1042/bj3320009; Sies H, 1997, J BIOL CHEM, V272, P27812, DOI 10.1074/jbc.272.44.27812; Stubauer G, 1998, BIOCHEM BIOPH RES CO, V245, P459, DOI 10.1006/bbrc.1998.8457; TAKEHARA Y, 1995, ARCH BIOCHEM BIOPHYS, V323, P27, DOI 10.1006/abbi.1995.0005; TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TYLER DD, 1975, BIOCHEM J, V147, P493, DOI 10.1042/bj1470493; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; ZHAO XJ, 1995, BIOCHEM BIOPH RES CO, V212, P1054, DOI 10.1006/bbrc.1995.2076	51	158	162	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37709	37716		10.1074/jbc.274.53.37709	http://dx.doi.org/10.1074/jbc.274.53.37709			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608829	hybrid			2022-12-27	WOS:000084528000029
J	Kang, F; Purich, DL; Southwick, FS				Kang, F; Purich, DL; Southwick, FS			Profilin promotes barbed-end actin filament assembly without lowering the critical concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACANTHAMOEBA-PROFILIN; F-ACTIN; POLYMORPHONUCLEAR LEUKOCYTES; SEQUESTERING PEPTIDE; THYMOSIN-BETA-4; MOTILITY; CELLS; POLYMERIZATION; INTERACTS; COMPLEXES	The mechanism of profilin-promoted actin polymerization has been systematically reinvestigated. Rates of barbed-end elongation onto Spectrin . 4.1 . Actin seeds were measured by right angle light scattering to avoid confounding effects of pyrenyl-actin, and KINSIM was used to analyze elongation progress curves. Without thymosin-beta 4, both actin and Profilin . Actin (P . A) are competent in barbed-end polymerization, and kinetic simulations yielded the same bimolecular rate constant (similar to 10 x 10(6) M-1 S-1) for actin monomer or Profilin . Actin. When measured in the absence of profilin, actin assembly curves over a 0.7-4 mu M, thymosin-beta 4 concentration range fit a simple monomer sequestering model (1 mu M K-D for Thymosin-beta 4 . Actin). The corresponding constant for Thymosin-beta 4 . pyrenyl-Actin, however, was significantly higher (similar to 9-10 mu M), suggesting that the fluorophore markedly weakens binding to thymosin-beta 4. With solutions of actin (2 mu M) and thymosin-beta 4 (2 or 4 mu M), the barbed-end assembly rate rose with increasing profilin concentration (0.7-2 mu M). Actin assembly in presence of thymosin-beta 4 and profilin fit a simple thermodynamic energy cycle, thereby disproving an earlier claim (D. Pantaloni and M. F. Carlier (1993) Cell 75, 1007-1014) that profilin promotes nonequilibrium filament assembly by accelerating hydrolysis of filament-bound ATP. Our findings indicate that profilin serves as a polymerization catalyst that captures actin monomers from Thymosin-beta 4 . Actin and ushers actin as a Profilin . Actin complex onto growing barbed filament ends.	Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Purich, DL (corresponding author), Univ Florida, Hlth Sci Ctr, Dept Biochem & Mol Biol, POB 100245, Gainesville, FL 32610 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034276, R01AI023262] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI023262, R01 AI034276, R01-AI23262, R01-AI24276] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; BERNE B J, 1974, Journal of Molecular Biology, V89, P755, DOI 10.1016/0022-2836(74)90049-7; Carlier MF, 1996, J BIOL CHEM, V271, P9231, DOI 10.1074/jbc.271.16.9231; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; CASSIMERIS L, 1992, J CELL BIOL, V119, P1261, DOI 10.1083/jcb.119.5.1261; COOPER JA, 1982, METHOD ENZYMOL, V82, P198; GOLDSCHMIDTCLERMONT PJ, 1991, J CELL BIOL, V113, P1081, DOI 10.1083/jcb.113.5.1081; HANNAPPEL E, 1986, ANAL BIOCHEM, V156, P390, DOI 10.1016/0003-2697(86)90270-8; KAISER DA, 1986, J CELL BIOL, V102, P221, DOI 10.1083/jcb.102.1.221; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Laine RO, 1997, J CELL BIOL, V138, P1255, DOI 10.1083/jcb.138.6.1255; LAL AA, 1985, J BIOL CHEM, V260, P132; LIN DC, 1978, J BIOL CHEM, V253, P1415; LINDBERG U, 1988, BIOCHIM BIOPHYS ACTA, V967, P391, DOI 10.1016/0304-4165(88)90102-X; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; PURICH DL, 1999, HDB BIOCH KINETICS, P247; SAFER D, 1991, J BIOL CHEM, V266, P4029; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2536, DOI 10.1073/pnas.87.7.2536; SAFER D, 1994, BIOESSAYS, V16, P473, DOI 10.1002/bies.950160706; SOUTHWICK FS, 1994, BIOESSAYS, V16, P885, DOI 10.1002/bies.950161206; SOUTHWICK FS, 1990, J CELL BIOL, V110, P1965, DOI 10.1083/jcb.110.6.1965; SPUDICH JA, 1971, J BIOL CHEM, V246, P4865; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; TANAKA M, 1985, EUR J BIOCHEM, V151, P291, DOI 10.1111/j.1432-1033.1985.tb09099.x; THERIOT JA, 1994, CELL, V76, P505, DOI 10.1016/0092-8674(94)90114-7; TILNEY LG, 1983, J CELL BIOL, V97, P112, DOI 10.1083/jcb.97.1.112; TOBACMAN LS, 1983, J BIOL CHEM, V258, P8806; TSENG PCH, 1984, J CELL BIOL, V98, P214, DOI 10.1083/jcb.98.1.214; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; WEBER A, 1992, BIOCHEMISTRY-US, V31, P6179, DOI 10.1021/bi00142a002; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; WEGNER A, 1982, J MOL BIOL, V161, P607, DOI 10.1016/0022-2836(82)90411-9; YOUNG CL, 1994, J BIOL CHEM, V269, P13997; YU FX, 1993, J BIOL CHEM, V268, P502; Zeile WL, 1998, P NATL ACAD SCI USA, V95, P13917, DOI 10.1073/pnas.95.23.13917; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381, DOI 10.1042/bj2580381	41	144	147	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36963	36972		10.1074/jbc.274.52.36963	http://dx.doi.org/10.1074/jbc.274.52.36963			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601251	hybrid			2022-12-27	WOS:000084382700022
J	Perkins, KJ; Byers, S; Yogalingam, G; Weber, B; Hopwood, JJ				Perkins, KJ; Byers, S; Yogalingam, G; Weber, B; Hopwood, JJ			Expression and characterization of wild type and mutant recombinant human sulfamidase - Implications for Sanfilippo (mucopolysaccharidosis IIIA) syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME TYPE-A; N-ACETYLGALACTOSAMINE 4-SULFATASE; MOLECULAR DEFECTS; IDENTIFICATION; MUTATIONS; PURIFICATION; GENE; VI	Mucopolysaccharidosis IIIA (MPS-IIIA) is an autosomal recessive lysosomal storage disorder caused by the deficiency of sulfamidase (NS; EC 3.10.1.1), resulting in defective degradation and storage of heparan sulfate. This paper reports the production and characterization of monoclonal and polyclonal antibodies against recombinant human sulfamidase (rhNS) to quantitate and characterize normal and mutant sulfamidase produced from the wild type NS expression vector. Glycosylation and phosphorylation studies of immunoprecipitated rhNS show that all five potential glycosylation sites are utilized, with three high mannose/hybrid oligosaccharides and two simpler chains, with at least one functional mannose B-phosphate group. An NS quantification system was developed to determine the effect of the three most common and severe patient mutations: S66W (Italy), R74C (Poland), and R245H (The Netherlands), The quantity and specific activity of expressed mutant rhNS was significantly lower than expressed normal rhNS, with 0.3, 0.2, and 0.05% of normal rhNS produced and 15, 17, and 83% of normal specific activity for S66W, R74C, and R245H observed, respectively. The recent structural elucidation of N-acetylgalactosamine-4-sulfatase was utilized to postulate the effect on the structure-function relationship of NS, The characterization of normal and mutated rhNS has relevance for efficient diagnosis and therapeutic developments for MPS-IIIA patients.	Womens & Childrens Hosp, Dept Chem Pathol, Lysosomal Disorders Res Unit, N Adelaide, SA 5006, Australia		Hopwood, JJ (corresponding author), Womens & Childrens Hosp, Dept Chem Pathol, Lysosomal Disorders Res Unit, 72 King William Rd, N Adelaide, SA 5006, Australia.			Byers, Sharon/0000-0001-5576-3636				ANSON DS, 1992, BIOCHEM J, V284, P789, DOI 10.1042/bj2840789; Bielicki J, 1998, BIOCHEM J, V329, P145, DOI 10.1042/bj3290145; Blanch L, 1997, HUM MOL GENET, V6, P787, DOI 10.1093/hmg/6.5.787; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BROOKS DA, 1990, J INHERIT METAB DIS, V13, P108, DOI 10.1007/BF01799338; Bunge S, 1997, HUM MUTAT, V10, P479, DOI 10.1002/(SICI)1098-1004(1997)10:6<479::AID-HUMU10>3.3.CO;2-4; CLEMENTS PR, 1985, EUR J BIOCHEM, V152, P21, DOI 10.1111/j.1432-1033.1985.tb09158.x; Di Natale P, 1998, HUM MUTAT, V11, P313, DOI 10.1002/(SICI)1098-1004(1998)11:4<313::AID-HUMU9>3.0.CO;2-P; FREEMAN C, 1986, BIOCHEM J, V234, P83, DOI 10.1042/bj2340083; HOPWOOD JJ, 1982, CLIN CHIM ACTA, V123, P241, DOI 10.1016/0009-8981(82)90168-1; HOPWOOD JJ, 1983, BIOCHEM INT, V6, P831; Karageorgos L E, 1996, DNA Res, V3, P269, DOI 10.1093/dnares/3.4.269; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Montfort M, 1998, HUM MUTAT, V12, P274, DOI 10.1002/(SICI)1098-1004(1998)12:4<274::AID-HUMU9>3.3.CO;2-Y; Neufeld EF, 1995, METABOLIC MOL BASES, P2465; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; SCOTT HS, 1995, NAT GENET, V11, P465, DOI 10.1038/ng1295-465; VANDEKAMP JJP, 1981, CLIN GENET, V20, P152; Weber B, 1998, J INHERIT METAB DIS, V21, P416, DOI 10.1023/A:1005362826552; Weber B, 1997, HUM MOL GENET, V6, P1573, DOI 10.1093/hmg/6.9.1573; Yogalingam G, 1996, J BIOL CHEM, V271, P27259, DOI 10.1074/jbc.271.44.27259	23	33	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37193	37199		10.1074/jbc.274.52.37193	http://dx.doi.org/10.1074/jbc.274.52.37193			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601282	hybrid			2022-12-27	WOS:000084382700053
J	Pongracz, J; Webb, P; Wang, KQ; Deacon, E; Lunn, OJ; Lord, JM				Pongracz, J; Webb, P; Wang, KQ; Deacon, E; Lunn, OJ; Lord, JM			Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PROTEOLYTIC ACTIVATION; EXPRESSION; ISOZYME; U937; BETA; DIFFERENTIATION; INVOLVEMENT; BCL-2; ALPHA	Neutrophils are short-lived leukocytes that die by apoptosis, Whereas stress-induced apoptosis is mediated by the p38 mitogen-activated protein (MAP) kinase pathway (Frasch, S, C., Nick, J, A., Fadok, V, A, Bratton, D, L,, Worthen, G, S., and Henson, P, M, (1998) J, Biol. Chem. 273, 8389-8397), signals regulating spontaneous neutrophil apoptosis have not been fully determined. In this study we found increased activation of protein kinase C (PKC)-beta and -delta in neutrophils undergoing spontaneous apoptosis, but we show that only activation of PKC-delta was directly involved in the induction of apoptosis, PKC-delta can be proteolytically activated by caspase 3, We detected the 40-kDa caspase-generated fragment of PKC-delta in apoptotic neutrophils and showed that the caspase 3: inhibitor Asp-Glu-Val-Asp-fluoromethylketone prevented generation of the 40-kDa PKC-delta fragment and delayed neutrophil apoptosis, In a cell-free system, removal of PKC-delta by immunoprecipitation reduced DNA fragmentation, whereas loss of PKC-alpha, -beta, or -zeta had no significant effect. Rottlerin and LY379196 inhibit PRC-delta and PKC-beta, respectively. Only Rottlerin was able to delay neutrophil apoptosis, Inhibitors of MAP-ERK-kinase 1 (PD98059) or p38 MAP kinase (SB202190) had no effect on neutrophil apoptosis, and activation of p42/44 and p38 MAP kinase did not increase in apoptotic neutrophils, We conclude that spontaneous neutrophil apoptosis involves activation of PKC-delta but is MAP kinase-independent.	Univ Birmingham, Sch Med, MRC, Ctr Immune Regulat,Div Immun & Infect, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Lord, JM (corresponding author), Univ Birmingham, Sch Med, MRC, Ctr Immune Regulat,Div Immun & Infect, Birmingham B15 2TT, W Midlands, England.		Webb, Paul/C-3285-2011; Pongracz, Judit E/N-7927-2018; Pongracz, Judit E/J-7517-2019	Pongracz, Judit E/0000-0002-0278-5556; Pongracz, Judit E/0000-0002-0278-5556; Lord, Janet/0000-0003-1030-6786				AFFORD SC, 1992, J BIOL CHEM, V267, P21612; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Brown SB, 1999, J IMMUNOL, V162, P480; BUNCE CM, 1988, ANAL BIOCHEM, V175, P67, DOI 10.1016/0003-2697(88)90362-4; DANG PMC, 1994, FEBS LETT, V349, P338, DOI 10.1016/0014-5793(94)00700-4; Deacon EM, 1997, J CLIN PATHOL-MOL PA, V50, P124, DOI 10.1136/mp.50.3.124; Edwards S.L., 1994, BIOCH PHYSL NEUTROPH; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Enari M, 1998, NATURE, V393, P396, DOI 10.1038/30782; EVANS CA, 1995, J CELL SCI, V108, P2591; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Frutos S, 1999, J BIOL CHEM, V274, P10765, DOI 10.1074/jbc.274.16.10765; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Griffiths G, 1996, BIOCHEM BIOPH RES CO, V222, P802, DOI 10.1006/bbrc.1996.0830; GSCWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93; HALLETT MB, 1995, IMMUNOL TODAY, V16, P264, DOI 10.1016/0167-5699(95)80178-2; HOGG JC, 1987, PHYSIOL REV, V67, P1249, DOI 10.1152/physrev.1987.67.4.1249; IWAI K, 1994, BLOOD, V84, P1201; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Jirousek MR, 1996, J MED CHEM, V39, P2664, DOI 10.1021/jm950588y; KNOX KA, 1993, EXP CELL RES, V207, P68, DOI 10.1006/excr.1993.1164; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Lee JY, 1996, J BIOL CHEM, V271, P13169, DOI 10.1074/jbc.271.22.13169; MACFARLANE DE, 1994, J BIOL CHEM, V269, P4327; MAJUMDAR S, 1991, J BIOL CHEM, V266, P9285; Mashima T, 1999, ONCOGENE, V18, P2423, DOI 10.1038/sj.onc.1202558; NAIRN AC, 1994, SEMIN CANCER BIOL, V5, P295; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Parmer TG, 1997, CELL GROWTH DIFFER, V8, P327; PONGRACZ J, 1995, EXP CELL RES, V218, P430, DOI 10.1006/excr.1995.1176; Pongracz J, 1996, LEUKEMIA RES, V20, P319, DOI 10.1016/0145-2126(95)00074-7; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Scheel-Toellner D, 1999, EUR J IMMUNOL, V29, P2603, DOI 10.1002/(SICI)1521-4141(199908)29:08<2603::AID-IMMU2603>3.0.CO;2-L; SMALLWOOD JI, 1992, J LEUKOCYTE BIOL, V51, P84, DOI 10.1002/jlb.51.1.84; Stringer RE, 1996, BRIT J HAEMATOL, V92, P169, DOI 10.1046/j.1365-2141.1996.00307.x; TSUTSUMI A, 1993, J IMMUNOL, V150, P1746; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Whelan RDH, 1998, ONCOGENE, V16, P1939, DOI 10.1038/sj.onc.1201725	38	164	169	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37329	37334		10.1074/jbc.274.52.37329	http://dx.doi.org/10.1074/jbc.274.52.37329			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601300	hybrid			2022-12-27	WOS:000084382700071
J	Garrison, TR; Zhang, YN; Pausch, M; Apanovitch, D; Aebersold, R; Dohlman, HG				Garrison, TR; Zhang, YN; Pausch, M; Apanovitch, D; Aebersold, R; Dohlman, HG			Feedback phosphorylation of an RGS protein by MAP kinase in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE REQUIRES; SIGNAL-TRANSDUCTION PATHWAY; PHEROMONE RESPONSE PATHWAY; ALPHA-SUBUNIT; MASS-SPECTROMETRY; POINT MUTATION; KSS1; GENE; DESENSITIZATION; SST2	Regulators of G protein signaling (RGS proteins) are well. known to accelerate G protein GTPase activity in vitro and to promote G protein desensitization in vivo. Less is known about how RGS proteins are themselves regulated. To address this question we purified the RGS in yeast, Sst2, and used electrospray ionization mass spectrometry to identify post-translational modifications. This analysis revealed that Sst2 is phosphorylated at Ser-539 and that phosphorylation occurs in response to pheromone stimulation. Ser-539 lies within a consensus mitogen-activated protein (MAP) kinase phosphorylation site, Pro-X-Ser-Pro. Phosphorylation is blocked by mutations in the MAP kinase genes (FUS3, KSS1), as well as by mutations in components needed for MAP kinase activation (STE11, STE7, STE4, STE18). Phosphorylation is also blocked by replacing Ser-539 with Ala, Asp, or Glu (but not Thr). These point mutations do not alter pheromone sensitivity, as determined by growth arrest and reporter transcription assays. However, phosphorylation appears to slow the rate of Sst2 degradation. These findings indicate that the G protein-regulated MAP kinase in yeast can act as a feedback regulator of Sst2, itself a regulator of G protein signaling.	Yale Univ, Sch Med, Dept Pharmacol, Boyer Ctr Mol Med, New Haven, CT 06536 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Wyeth Ayerst Res, Princeton, NJ 08543 USA	Yale University; University of Washington; University of Washington Seattle; Pfizer	Dohlman, HG (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, Boyer Ctr Mol Med, 295 Congress Ave,Room 436,POB 9812, New Haven, CT 06536 USA.	henrik.dohlman@yale.edu		Dohlman, Henrik/0000-0003-2443-0729	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055316, R29GM055316, R01GM059167] Funding Source: NIH RePORTER; NCRR NIH HHS [RR11823] Funding Source: Medline; NIGMS NIH HHS [R01 GM059167, GM59167, GM55316, R01 GM055316] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apanovitch DM, 1998, J BIOL CHEM, V273, P28597, DOI 10.1074/jbc.273.44.28597; Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; DAVIS JL, 1992, MOL CELL BIOL, V12, P1879, DOI 10.1128/MCB.12.4.1879; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; DIETZEL C, 1987, MOL CELL BIOL, V7, P4169, DOI 10.1128/MCB.7.12.4169; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Figeys D, 1996, NAT BIOTECHNOL, V14, P1579, DOI 10.1038/nbt1196-1579; Figeys D, 1998, ELECTROPHORESIS, V19, P2338, DOI 10.1002/elps.1150191314; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; HASSON MS, 1994, MOL CELL BIOL, V14, P1054, DOI 10.1128/MCB.14.2.1054; Kim E, 1999, P NATL ACAD SCI USA, V96, P6371, DOI 10.1073/pnas.96.11.6371; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; MA D, 1995, MOL BIOL CELL, V6, P889, DOI 10.1091/mbc.6.7.889; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Pausch Mark H., 1998, P196; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; RAMER SW, 1993, P NATL ACAD SCI USA, V90, P452, DOI 10.1073/pnas.90.2.452; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Sprague GF, 1998, GENE DEV, V12, P2817, DOI 10.1101/gad.12.18.2817; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; TYERS M, 1993, MOL CELL BIOL, V13, P5659, DOI 10.1128/MCB.13.9.5659; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750; ZHOU ZQ, 1993, MOL CELL BIOL, V13, P2069, DOI 10.1128/MCB.13.4.2069	35	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36387	36391		10.1074/jbc.274.51.36387	http://dx.doi.org/10.1074/jbc.274.51.36387			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593933	hybrid			2022-12-27	WOS:000084279200052
J	Harris, CM; Molla, G; Pilone, MS; Pollegioni, L				Harris, CM; Molla, G; Pilone, MS; Pollegioni, L			Studies on the reaction mechanism of Rhodotorula gracilis D-amino-acid oxidase - Role of the highly conserved Tyr-223 on substrate binding and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; 3-DIMENSIONAL STRUCTURE; KINETIC MECHANISM; CEPHALOSPORIN-C; RESOLUTION; ENZYME; COLI	We have studied D-amino-acid oxidase from Rhodotorula gracilis by site-directed mutagenesis for the purpose of determining the presence or absence of residues having a possible role in acid/base catalysis, Tyr-223, one of the very few conserved residues among D-amino-acid oxidases, has been mutated to phenylalanine and to serine, Both mutants are active catalysts in turnover with D-alanine, and they are reduced by D-alanine slightly faster than wild type enzyme. The Tyr-223 -> Phe mutant is virtually identical to the wild-type enzyme, whereas the Tyr-223 -> Ser mutant exhibits 60-fold slower substrate binding and at least 800-fold slower rate of product release relative to wild-type. These data eliminate Tyr-223 as an active site acid/base catalyst. These results underline the importance of Tyr-223 for substrate binding and exemplify the importance of steric interactions in RgDAAO catalysis.	Univ Insubria, Dept Biol Strutturale & Funz, I-21100 Varese, Italy	University of Insubria	Pollegioni, L (corresponding author), Univ Insubria, Dept Biol Strutturale & Funz, Via JH Dunant 3, I-21100 Varese, Italy.			Molla, Gianluca/0000-0003-3688-3397; POLLEGIONI, LOREDANO/0000-0003-1733-7243				CURTI B, 1992, CHEM BIOCH FLAVOENZY, P69; DALZIEL K, 1969, BIOCHEM J, V114, P547, DOI 10.1042/bj1140547; FAOTTO L, 1995, BIOTECHNOL LETT, V17, P193, DOI 10.1007/BF00127987; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDQVIST Y, 1989, J BIOL CHEM, V264, P3624; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MASSEY V, 1964, FED PROC, V23, P18; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Mattevi A, 1996, P NATL ACAD SCI USA, V93, P7496, DOI 10.1073/pnas.93.15.7496; Mattevi A, 1997, CURR OPIN STRUC BIOL, V7, P804, DOI 10.1016/S0959-440X(97)80150-9; MINNAERT K, 1965, BIOCHIM BIOPHYS ACTA, V110, P42, DOI 10.1016/S0926-6593(65)80093-5; MIURA R, 1988, BIOORG CHEM, V16, P97, DOI 10.1016/0045-2068(88)90039-9; Mizutani H, 1996, J BIOCHEM-TOKYO, V120, P14; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; MUH U, 1994, J BIOL CHEM, V269, P7994; PILONE MS, 1995, BIOTECHNOL LETT, V17, P199, DOI 10.1007/BF00127988; PILONE MS, 1998, RRD BIOTECH BIOENG 2, V1, P285; Pollegioni L, 1997, J BIOL CHEM, V272, P4924, DOI 10.1074/jbc.272.8.4924; Pollegioni L, 1997, J BIOTECHNOL, V58, P115, DOI 10.1016/S0168-1656(97)00142-9; POLLEGIONI L, 1994, J BIOL CHEM, V269, P31666; POLLEGIONI L, 1993, J BIOL CHEM, V268, P13850; POLLEGIONI L, 1992, BIOCHIM BIOPHYS ACTA, V1120, P11, DOI 10.1016/0167-4838(92)90418-D; PORTER DJT, 1977, J BIOL CHEM, V252, P4464; ROUVIEREFOURMY N, 1994, BIOCHEMISTRY-US, V33, P798, DOI 10.1021/bi00169a022; Sambrook J., 2002, MOL CLONING LAB MANU; Stegman LD, 1998, HUM GENE THER, V9, P185, DOI 10.1089/hum.1998.9.2-185; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Todone F, 1997, BIOCHEMISTRY-US, V36, P5853, DOI 10.1021/bi9630570; WALSH CT, 1971, J BIOL CHEM, V246, P6855; XIA ZX, 1987, P NATL ACAD SCI USA, V84, P2629, DOI 10.1073/pnas.84.9.2629	31	53	55	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36233	36240		10.1074/jbc.274.51.36233	http://dx.doi.org/10.1074/jbc.274.51.36233			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593911	hybrid			2022-12-27	WOS:000084279200030
J	Sargent, F; Stanley, NR; Berks, BC; Palmer, T				Sargent, F; Stanley, NR; Berks, BC; Palmer, T			Sec-independent protein translocation in Escherichia coli - A distinct and pivotal role for the TatB protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; HYDROGENASE ISOENZYMES; FORMATE DEHYDROGENASE; MUTATIONAL ANALYSIS; EXPORT PATHWAY; MEMBRANE; OPERON; GENE; REDUCTASE; EXPRESSION	In Escherichia coli, transmembrane translocation of proteins can proceed by a number of routes. A subset of periplasmic proteins are exported via the Tat pathway to which proteins are directed by N-terminal "transfer peptides" bearing the consensus (S/T)RRXFLK "twin-arginine" motif, The Tat system involves the integral membrane proteins TatA, TatB, TatC, and TatE, Of these, TatA, TatB, and TatE are homologues of the Hcf106 component of the Delta pH-dependent protein import system of plant thylakoids, Deletion of the tatB gene alone is sufficient to block the export of seven endogenous Tat substrates, including hydrogenase-g. Complementation analysis indicates that while TatA and TatE are functionally interchangeable, the TatB protein is functionally distinct. This conclusion is supported by the observation that Helicobacter pylori tatA will complement an E. coli tatA mutant, but not a tatB mutant. Analysis of Tat component stability in various tot deletion backgrounds shows that TatC is rapidly degraded in the absence of TatB suggesting that TatC complexes, and is stabilized by, TatB.	John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Sch Biol Sci, Ctr Metalloprot Spect & Biol, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Palmer, T (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England.	tracy.palmer@bbsrc.ac.uk		Sargent, Frank/0000-0002-6841-3624; Stanley-Wall, Nicola/0000-0002-5936-9721; Berks, Ben/0000-0001-9685-4067; Palmer, Tracy/0000-0001-9043-2592				ATLUNG T, 1989, J BACTERIOL, V171, P1683, DOI 10.1128/jb.171.3.1683-1691.1989; BALLANTINE SP, 1986, EUR J BIOCHEM, V156, P277, DOI 10.1111/j.1432-1033.1986.tb09578.x; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; BERG BL, 1991, J BIOL CHEM, V266, P22380; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; BILOUS PT, 1988, MOL MICROBIOL, V2, P785, DOI 10.1111/j.1365-2958.1988.tb00090.x; BILOUS PT, 1985, J BACTERIOL, V162, P1151, DOI 10.1128/JB.162.3.1151-1155.1985; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chanal A, 1998, MOL MICROBIOL, V30, P674, DOI 10.1046/j.1365-2958.1998.01095.x; COHEN N, 1956, ANN I PASTEUR PARIS, V91, P693; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Dalbey RE, 1999, TRENDS BIOCHEM SCI, V24, P17, DOI 10.1016/S0968-0004(98)01333-4; Danese PN, 1998, ANNU REV GENET, V32, P59, DOI 10.1146/annurev.genet.32.1.59; GRAHAM A, 1980, FEMS MICROBIOL LETT, V7, P145, DOI 10.1111/j.1574-6941.1980.tb01595.x; Gross R, 1998, ARCH MICROBIOL, V170, P50, DOI 10.1007/s002030050614; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; JAYARAMAN PS, 1987, J MOL BIOL, V196, P781, DOI 10.1016/0022-2836(87)90404-9; LIU JD, 1989, J BACTERIOL, V171, P1254, DOI 10.1128/jb.171.3.1254-1261.1989; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEJEAN V, 1994, MOL MICROBIOL, V11, P1169, DOI 10.1111/j.1365-2958.1994.tb00393.x; MENON NK, 1994, J BACTERIOL, V176, P4416, DOI 10.1128/jb.176.14.4416-4423.1994; MENON NK, 1990, J BACTERIOL, V172, P1969, DOI 10.1128/jb.172.4.1969-1977.1990; Miller J.H., 1992, SHORT COURSE BACTERI, P150; OSBORN MJ, 1972, J BIOL CHEM, V247, P3973; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rodrigue A, 1996, FEBS LETT, V392, P81, DOI 10.1016/0014-5793(96)00788-0; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1998, EUR J BIOCHEM, V255, P746, DOI 10.1046/j.1432-1327.1998.2550746.x; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; SAWERS RG, 1985, J BACTERIOL, V164, P1324, DOI 10.1128/JB.164.3.1324-1331.1985; Settles AM, 1998, TRENDS CELL BIOL, V8, P494, DOI 10.1016/S0962-8924(98)01387-7; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; SILVESTRO A, 1988, BIOCHIM BIOPHYS ACTA, V954, P1, DOI 10.1016/0167-4838(88)90049-0; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wanner B.L., 1996, ESCHERICHIA COLI SAL; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WU LF, 1993, FEMS MICROBIOL LETT, V104, P243	48	247	254	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36073	36082		10.1074/jbc.274.51.36073	http://dx.doi.org/10.1074/jbc.274.51.36073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593889	hybrid			2022-12-27	WOS:000084279200008
J	Teng-umnuay, P; van der Wel, H; West, CM				Teng-umnuay, P; van der Wel, H; West, CM			Identification of a UDP-GlcNAc : Skp1-hydroxyproline GlcNAc-transferase in the cytoplasm of Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE; TETRATRICOPEPTIDE REPEATS; CYTOSOLIC GLYCOPROTEIN; ENDOPLASMIC-RETICULUM; GLYCOSYLATION; PROTEINS; GLYCOSYLTRANSFERASES; NUCLEAR; FP21; PURIFICATION	Skp1 is a cytoplasmic and nuclear protein required for the ubiquitination of cell cycle regulatory proteins and transcriptional factors. In Dictyostelium, Skp1 is modified by a linear pentasaccharide, Gal alpha 1-6Gal alpha 1-Fuc alpha 1-2Gal beta 1-3GlcNAc, attached to a hydroxyproline (HyPro) residue at position 143. To study the formation of the GlcNAc-HyPro Linkage, an assay was developed for the transfer of [H-3]GlcNAc from UDP-[H-3]GlcNAc to Skp1-HyPro-143 or a synthetic Skp1 4-HyPro peptide. The cytosolic but not the particulate fraction of the cell mediated transfer in a time-, concentration-, and HyProdependent fashion. Incorporated radioactivity was alkali-resistant and was recovered as GlcNH(2) after acid hydrolysis, consistent with Linkage of GlcNAc to HyPro. The GlcNAc-transferase activity was purified 130,000-fold as a single component with a recovery of 5%. Key to the purification was the synthesis of a novel affinity resin linking UDP-GlcNAc at its 5-uridyl position. The purified activity had an apparent M-r of similar to 45,000 by gel filtration, required dithiothreitol and a divalent cation, and consisted predominantly of a M-r 51,000 band after SDS-polyacrylamide gel electrophoresis that was photoaffinity labeled with 5-I-125-[3-(p-azidosalicylamido)-1-propenyl-UDP-GlcNAc in a UDP-GlcNAc-sensitive fashion. Its apparent IL, values for UDP-GlcNAc and Skp1 were submicromolar. The presence of the enzyme in the cytosolic fraction, its dependence on a reducing environment, and its high affinity for UDP-GlcNAc strongly suggest that Skp1 is glycosylated by a HyPro GlcNAc-transferase that resides in the cytoplasm.	Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	West, CM (corresponding author), Box 100235,1600 SW Archer Rd, Gainesville, FL 32610 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037539] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM37539] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; DALE RMK, 1975, BIOCHEMISTRY-US, V14, P2447, DOI 10.1021/bi00682a027; FIELD MC, 1995, GLYCOBIOLOGY, V5, P463, DOI 10.1093/glycob/5.5.463; GONZALEZYANES B, 1992, J BIOL CHEM, V267, P9595; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Harlow E., 1999, USING ANTIBODIES LAB; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; HOLMES EH, 1990, J BIOL CHEM, V265, P13150; Ingram GC, 1997, EMBO J, V16, P6521, DOI 10.1093/emboj/16.21.6521; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; KOZAROV E, 1995, J BIOL CHEM, V270, P3022, DOI 10.1074/jbc.270.7.3022; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; Lubas WA, 1997, J BIOL CHEM, V272, P9316; MACLEAN N, 1984, EXPERIENTIA, V40, P1207, DOI 10.1007/BF01946648; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; ROQUEMORE EP, 1994, METHOD ENZYMOL, V230, P443; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173; Suzuki T, 1998, J BIOL CHEM, V273, P10083, DOI 10.1074/jbc.273.17.10083; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; West CM, 1996, J BIOL CHEM, V271, P12024, DOI 10.1074/jbc.271.20.12024; West CM, 1997, GENE, V200, P1, DOI 10.1016/S0378-1119(97)00194-7; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Zeng Y, 1996, ANAL BIOCHEM, V239, P99, DOI 10.1006/abio.1996.0296	29	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36392	36402		10.1074/jbc.274.51.36392	http://dx.doi.org/10.1074/jbc.274.51.36392			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593934	hybrid			2022-12-27	WOS:000084279200053
J	Yamasaki, R; Koshino, H; Kurono, S; Nishinaka, Y; McQuillen, DP; Kume, A; Gulati, S; Rice, PA				Yamasaki, R; Koshino, H; Kurono, S; Nishinaka, Y; McQuillen, DP; Kume, A; Gulati, S; Rice, PA			Structural and immunochemical characterization of a Neisseria gonorrhoeae epitope defined by a monoclonal antibody 2C7; the antibody recognizes a conserved epitope on specific lipo-oligosaccharides in spite of the presence of human carbohydrate epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM; GONOCOCCAL LIPOOLIGOSACCHARIDE; 2-DIMENSIONAL NMR; NEURAMINIC ACID; BLOOD-CELLS; BETA-CHAIN; LIPOPOLYSACCHARIDE; MENINGITIDIS; RESISTANCE; EXPRESSION	Lipo-oligosaccharides (LOS) produced by Neisseria gonorrhoeae are important antigenic and immunogenic components of the outer membrane complex. Previously, we showed that murine monoclonal antibody (mAb) 2C7 did not cross-react with human glycosphingolipids but identified the LOS epitope that is widely expressed in vivo and in vitro (Gulati, S., McQuillen, D. P., Mandrell, R. E., Jani, D. E,, and Rice, P. A. (1996) J. Infect. Dis. 174, 1223-1237). In the present study, we analyzed the structure of gonococcal strain WG LOS containing the 2C7 epitope and investigated the structural requirements for expression of the epitope, We determined that the WG LOS components are Hep[1]-elongated forms of 15253 LOS that have a lactose on both Hep[1] and Hep[2] (Yamasaki, a, Kerwood, D. E., Schneider, H., Quinn, a P., Griffiss, J. M., and Mandrell, a E, (1994) J. Biol. Chem. 269, 30345-30351). In addition, we found that expression of the 2C7 epitope within the LOS is blocked when the Hep[2]-lactose is elongated. Eased on the structural data of these LOS and the results obtained from immunochemical analyses, we conclude the following: 1) mAb 2C7 requires both the 15253 OS minimum structure and the N-linked fatty acids in the lipoidal moiety for expression of the epitope; 2) mAb 2C7 binds to the LOS that elongates the lactose on Hep[1] of the 15253 OS, but not the one on Hep[2]; and 3) the 2C7 epitope is expressed on gonococcal LOS despite the presence of human carbohydrate epitopes such as a lactosamine or its N-acetylgalactosaminylated (globo) form. Our study shows that the conserved epitope defined by mAb 2C7 could potentially be used as a safe site for the development of a vaccine candidate.	Tottori Univ, Dept Biochem & Biotechnol, Tottori 6808553, Japan; Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Boston Univ, Maxwell Finland Lab Infect Dis, Evans Mem Dept Clin Res, Boston, MA 02118 USA; Boston Univ, Dept Med, Boston, MA 02118 USA	Tottori University; RIKEN; Boston University; Boston University	Yamasaki, R (corresponding author), Tottori Univ, Dept Biochem & Biotechnol, Koyama Minami 4-101, Tottori 6808553, Japan.	yamasaki@muses.tottori-u.ac.jp	Koshino, Hiroyuki/N-7948-2015; Koshino, Hiroyuki/ABF-4899-2021	Koshino, Hiroyuki/0000-0002-0954-9839; Koshino, Hiroyuki/0000-0002-0954-9839	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032725, R01AI032725, R56AI032725] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32725, AI01061] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APICELLA MA, 1981, INFECT IMMUN, V34, P751, DOI 10.1128/IAI.34.3.751-756.1981; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; BOSLEGO JW, 1991, VACCINE, V9, P154, DOI 10.1016/0264-410X(91)90147-X; Brinton C., 1978, IMMUNOBIOLOGY NEISER, P155; BROOKS GF, 1989, CLIN MICROBIOL REV, V2, pS5, DOI 10.1128/CMR.2.Suppl.S5-10.1989; Erwin AL, 1996, J EXP MED, V184, P1233, DOI 10.1084/jem.184.4.1233; GIBSON BW, 1989, P NATL ACAD SCI USA, V86, P17, DOI 10.1073/pnas.86.1.17; GOTSCHLICH EC, 1994, J EXP MED, V180, P2181, DOI 10.1084/jem.180.6.2181; Gulati S, 1996, J INFECT DIS, V174, P1238, DOI 10.1093/infdis/174.6.1238; Gulati S, 1996, J INFECT DIS, V174, P1223, DOI 10.1093/infdis/174.6.1223; GUYMON LF, 1982, INFECT IMMUN, V36, P541, DOI 10.1128/IAI.36.2.541-547.1982; HAISHIMA Y, 1992, EUR J BIOCHEM, V203, P127, DOI 10.1111/j.1432-1033.1992.tb19837.x; HOLST O, 1993, EUR J BIOCHEM, V214, P703, DOI 10.1111/j.1432-1033.1993.tb17971.x; HOOK EW, 1984, INFECT IMMUN, V43, P706, DOI 10.1128/IAI.43.2.706-709.1984; KERWOOD DE, 1992, BIOCHEMISTRY-US, V31, P12760, DOI 10.1021/bi00166a008; Kurono S, 1998, J MASS SPECTROM, V33, P35, DOI 10.1002/(SICI)1096-9888(199801)33:1<35::AID-JMS607>3.0.CO;2-I; MANDRELL R, 1986, INFECT IMMUN, V54, P63, DOI 10.1128/IAI.54.1.63-69.1986; MANDRELL RE, 1990, J EXP MED, V171, P1649, DOI 10.1084/jem.171.5.1649; MANDRELL RE, 1994, METHOD ENZYMOL, V236, P231; MANDRELL RE, 1988, J EXP MED, V168, P107, DOI 10.1084/jem.168.1.107; Muhlecker W, 1999, GLYCOBIOLOGY, V9, P157, DOI 10.1093/glycob/9.2.157; NAIRN CA, 1988, J GEN MICROBIOL, V134, P3295; PARSONS NJ, 1988, MICROB PATHOGENESIS, V5, P303, DOI 10.1016/0882-4010(88)90103-9; Rice P.A., 1994, NEISSERIA 94, P483; RICE PA, 1982, J CLIN INVEST, V70, P157, DOI 10.1172/JCI110589; SCHNEIDER H, 1984, INFECT IMMUN, V45, P544, DOI 10.1128/IAI.45.3.544-549.1984; Tamura J, 1997, CARBOHYD RES, V305, P43, DOI 10.1016/S0008-6215(97)00225-5; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P851, DOI 10.1021/bi00217a039; YAMASAKI R, 1988, MOL IMMUNOL, V25, P799, DOI 10.1016/0161-5890(88)90116-2; YAMASAKI R, 1993, J BACTERIOL, V175, P4565, DOI 10.1128/JB.175.14.4565-4568.1993; YAMASAKI R, 1991, MOL IMMUNOL, V28, P1233, DOI 10.1016/0161-5890(91)90010-H; YAMASAKI R, 1994, J BIOL CHEM, V269, P30345; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P10566, DOI 10.1021/bi00107a028; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; ZHOU DG, 1994, J BIOL CHEM, V269, P11162	35	40	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36550	36558		10.1074/jbc.274.51.36550	http://dx.doi.org/10.1074/jbc.274.51.36550			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593954	hybrid			2022-12-27	WOS:000084279200073
J	Yan, F; Polk, DB				Yan, F; Polk, DB			Aminosalicylic acid inhibits I kappa B kinase alpha phosphorylation of I kappa B alpha in mouse intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; IKK-ALPHA; TRANSCRIPTION FACTOR; ULCERATIVE-COLITIS; TNF-ALPHA; BETA; ACTIVATION; DISEASE; SULFASALAZINE; MACROPHAGES	Tumor necrosis factor alpha (TNF alpha)-stimulated nuclear factor (NF) kappa B activation plays a key role in the pathogenesis of inflammatory bowel disease (IBD). Phosphorylation of NF kappa B inhibitory protein (I kappa B) leading to its degradation and NF kappa B activation, is regulated by the multimeric I kappa B kinase complex, including IKK alpha and IKK beta. We recently reported that 5-aminosalicylic acid (5-ASA) inhibits TNF alpha-regulated I kappa B degradation and NF kappa B activation. To determine the mechanism of Q-ASA inhibition of I kappa B degradation, we studied young adult mouse colon (YAMC) cells by immunodetection and in vitro kinase assays. We show 5-ASA inhibits TNF alpha-stimulated phosphorylation of I kappa B alpha in intact YAMC cells. Phosphorylation of a glutathione S-transferase-I kappa B alpha fusion protein by cellular extracts or immunoprecipitated IKK alpha isolated from cells treated with TNF alpha is inhibited by 5-ASA. Recombinant IKK alpha and IKK beta autophosphorylation and their phosphorylation of glutathione S-transferase-I kappa B alpha: are inhibited by 5-ASA. However, IKK alpha serine phosphorylation by its upstream kinase in either intact cells or cellular extracts is not blocked by 5-ASA. Surprisingly, immunodepletion of cellular extracts suggests IKK alpha is predominantly responsible for I kappa B alpha phosphorylation in intestinal epithelial cells. In summary, 5-ASA inhibits TNF alpha-stimulated IKK alpha kinase activity toward I kappa B alpha in intestinal epithelial cells. These findings suggest a novel role for 5-ASA in the management of IBD by disrupting TNF alpha activation of NF kappa B.	Vanderbilt Univ, Sch Med, Dept Pediat, Div Gastroenterol & Nutr, Nashville, TN 37232 USA	Vanderbilt University	Polk, DB (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Div Gastroenterol & Nutr, S4322 MCN,21st & Garland Ave, Nashville, TN 37232 USA.	d-brent.polk@mcmail.vanderbilt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007673, K08DK002212] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK07673, DK02212, DK56008] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbott DW, 1999, J BIOL CHEM, V274, P2732, DOI 10.1074/jbc.274.5.2732; AZADKHAN AK, 1977, LANCET, V2, P892; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; CASELLAS F, 1994, CLIN SCI, V87, P453, DOI 10.1042/cs0870453; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CRONSTEIN BN, 1994, INFLAMMATION, V18, P323, DOI 10.1007/BF01534273; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; ETTEHADI P, 1994, CLIN EXP IMMUNOL, V96, P146, DOI 10.1111/j.1365-2249.1994.tb06244.x; FIOCCHI C, 1995, FALK SYMP, V76, P252; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; JAMES SP, 1994, INFLAMM BOWEL DIS, P65; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Kaiser GC, 1999, GASTROENTEROLOGY, V116, P602, DOI 10.1016/S0016-5085(99)70182-4; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larrea E, 1996, HEPATOLOGY, V23, P210, DOI 10.1002/hep.510230203; Li J, 1998, J BIOL CHEM, V273, P30736, DOI 10.1074/jbc.273.46.30736; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Neurath MF, 1998, GUT, V43, P856, DOI 10.1136/gut.43.6.856; PEPPERCORN MA, 1973, GASTROENTEROLOGY, V64, P240; PESKAR BM, 1987, DIG DIS SCI S, V32, P51; PINALS RS, 1988, SEMIN ARTHRITIS RHEU, V17, P246, DOI 10.1016/0049-0172(88)90010-8; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SHANAHAN F, 1990, IMMUNOPHARMACOLOGY, V20, P217, DOI 10.1016/0162-3109(90)90037-F; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; TAN XD, 1993, AM J PATHOL, V142, P1858; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wilson L, 1999, GASTROENTEROLOGY, V117, P106, DOI 10.1016/S0016-5085(99)70556-1; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	44	63	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36631	36636		10.1074/jbc.274.51.36631	http://dx.doi.org/10.1074/jbc.274.51.36631			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593965	hybrid			2022-12-27	WOS:000084279200084
J	Anderson, VE; Zaniewski, RP; Kaczmarek, FS; Gootz, TD; Osheroff, N				Anderson, VE; Zaniewski, RP; Kaczmarek, FS; Gootz, TD; Osheroff, N			Quinolones inhibit DNA religation mediated by Staphylococcus aureus topoisomerase IV - Changes in drug mechanism across evolutionary boundaries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC TOPOISOMERASE; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; ANTINEOPLASTIC DRUGS; PRIMARY TARGET; ENZYME MECHANISM; NALIDIXIC-ACID; GYRASE GENES; IN-VITRO; II-ALPHA	Quinolones are the most active oral antibacterials in clinical use and act by increasing DNA cleavage mediated by prokaryotic type II topoisomerases. Although topoisomerase TV appears to be the primary cytotoxic target for most quinolones in Gram-positive bacteria, interactions between the enzyme and these drugs are poorly understood. Therefore, the effects of ciprofloxacin on the DNA cleavage and religation reactions of Staphylococcus aureus topoisomerase TV were characterized. Ciprofloxacin doubled DNA scission at 150 nM drug and increased cleavage similar to 9-fold at 5 mu M. Furthermore, it dramatically inhibited rates of DNA religation mediated by S. aureus topoisomerase TV. This inhibition of religation is in marked contrast to the effects of antineoplastic quinolones on eukaryotic topoisomerase II, and suggests that the mechanistic basis for quinolone action against type II topoisomerases has not been maintained across evolutionary boundaries. The apparent change in quinolone mechanism was not caused by an overt difference in the drug interaction domain on topoisomerase TV. Therefore, we propose that the mechanistic basis for quinolone action is regulated by subtle changes in drug orientation within the enzyme drug DNA ternary complex rather than gross differences in the site of drug binding.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med Hematol Oncol, Nashville, TN 37232 USA; Pfizer Inc, Pfizer Cent Res, Dept Canc Immunol & Infect Dis, Groton, CT 06340 USA	Vanderbilt University; Vanderbilt University; Pfizer	Osheroff, N (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 654 Med Res Bldg 1, Nashville, TN 37232 USA.				NCI NIH HHS [5 T32 CA09385] Funding Source: Medline; NIGMS NIH HHS [GM33944] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson VE, 1998, J BIOL CHEM, V273, P17879, DOI 10.1074/jbc.273.28.17879; BARRETT JF, 1989, ANTIMICROB AGENTS CH, V33, P1697, DOI 10.1128/AAC.33.10.1697; BERGERAT A, 1994, J BIOL CHEM, V269, P27663; Borde V, 1998, NUCLEIC ACIDS RES, V26, P2042, DOI 10.1093/nar/26.9.2042; Burden DA, 1996, J BIOL CHEM, V271, P29238, DOI 10.1074/jbc.271.46.29238; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Capranico G, 1998, BBA-GENE STRUCT EXPR, V1400, P185, DOI 10.1016/S0167-4781(98)00135-3; Champoux J J, 1994, Adv Pharmacol, V29A, P71; CLEMENT JJ, 1995, CANCER RES, V55, P830; CORBETT AH, 1991, J BIOL CHEM, V266, P19666; CORBETT AH, 1993, ANTIMICROB AGENTS CH, V37, P2599, DOI 10.1128/AAC.37.12.2599; CORBETT AH, 1993, CHEM RES TOXICOL, V6, P585, DOI 10.1021/tx00035a001; COUGHLIN SA, 1995, BIOCHEM PHARMACOL, V50, P111, DOI 10.1016/0006-2952(95)00016-S; Cove ME, 1997, NUCLEIC ACIDS RES, V25, P2716, DOI 10.1093/nar/25.14.2716; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Elsea SH, 1997, BIOCHEMISTRY-US, V36, P2919, DOI 10.1021/bi962488f; ELSEA SH, 1993, ANTIMICROB AGENTS CH, V37, P2179, DOI 10.1128/AAC.37.10.2179; ELSEA SH, 1995, J BIOL CHEM, V270, P1913, DOI 10.1074/jbc.270.4.1913; ELSEA SH, 1992, J BIOL CHEM, V267, P13150; FERRERO L, 1994, MOL MICROBIOL, V13, P641, DOI 10.1111/j.1365-2958.1994.tb00458.x; Fitzgibbon JE, 1998, ANTIMICROB AGENTS CH, V42, P2122, DOI 10.1128/AAC.42.8.2122; FREUDENREICH CH, 1994, P NATL ACAD SCI USA, V91, P11007, DOI 10.1073/pnas.91.23.11007; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Gootz TD, 1996, ANTIMICROB AGENTS CH, V40, P2691, DOI 10.1128/AAC.40.12.2691; Gootz TD, 1996, MED RES REV, V16, P433, DOI 10.1002/(SICI)1098-1128(199609)16:5<433::AID-MED3>3.0.CO;2-W; Gootz Thomas D., 1993, P139; GOSS WA, 1965, J BACTERIOL, V89, P1068, DOI 10.1128/JB.89.4.1068-1074.1965; HALLETT P, 1990, GENE, V93, P139, DOI 10.1016/0378-1119(90)90148-K; HANDE KR, 1993, BIOCHIM BIOPHYS ACTA, V1400, P173; HIROTA Y, 1968, COLD SPRING HARB SYM, V33, P677, DOI 10.1101/SQB.1968.033.01.077; Hooper D., 1993, QUINOLONE ANTIMICROB, Vsecond; Hooper DC, 1998, BBA-GENE STRUCT EXPR, V1400, P45, DOI 10.1016/S0167-4781(98)00127-4; HOOPER DC, 1991, NEW ENGL J MED, V324, P384, DOI 10.1056/NEJM199102073240606; Hooper DC, 1998, CLIN INFECT DIS, V27, pS54, DOI 10.1086/514923; HOPEWELL R, 1990, J BACTERIOL, V172, P3481, DOI 10.1128/jb.172.6.3481-3484.1990; HSIUNG YC, 1995, J BIOL CHEM, V270, P20359, DOI 10.1074/jbc.270.35.20359; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; KHODURSKY AB, 1995, P NATL ACAD SCI USA, V92, P11801, DOI 10.1073/pnas.92.25.11801; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; Kingma PS, 1997, BIOCHEMISTRY-US, V36, P5934, DOI 10.1021/bi970507v; Kingma PS, 1997, J BIOL CHEM, V272, P1148, DOI 10.1074/jbc.272.2.1148; Kingma PS, 1998, BBA-GENE STRUCT EXPR, V1400, P223, DOI 10.1016/S0167-4781(98)00138-9; Kingma PS, 1998, J BIOL CHEM, V273, P17999, DOI 10.1074/jbc.273.29.17999; KNAB AM, 1993, J BIOL CHEM, V268, P22322; KREUZER KN, 1979, J BACTERIOL, V140, P424, DOI 10.1128/JB.140.2.424-435.1979; LEVINE C, 1998, BIOCHIM BIOPHYS ACTA, V1998, P29; LIU LF, 1983, J BIOL CHEM, V258, P5365; LUTTINGER A, 1995, MOL MICROBIOL, V15, P601, DOI 10.1111/j.1365-2958.1995.tb02369.x; Marians KJ, 1997, J BIOL CHEM, V272, P9401; MAXWELL A, 1992, J ANTIMICROB CHEMOTH, V30, P409, DOI 10.1093/jac/30.4.409; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Munoz R, 1996, ANTIMICROB AGENTS CH, V40, P2252, DOI 10.1128/AAC.40.10.2252; Ng EY, 1996, ANTIMICROB AGENTS CH, V40, P1881, DOI 10.1128/AAC.40.8.1881; Pan XS, 1996, ANTIMICROB AGENTS CH, V40, P2321, DOI 10.1128/AAC.40.10.2321; Pechere JC, 1998, EUR J CLIN MICROBIOL, V17, P405, DOI 10.1007/BF01691573; PENG H, 1993, J BIOL CHEM, V268, P24481; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pommier Y., 1996, CANC CHEMOTHERAPY BI, P435; PRUSS GJ, 1982, CELL, V31, P35, DOI 10.1016/0092-8674(82)90402-0; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; ROBINSON MJ, 1992, ANTIMICROB AGENTS CH, V36, P751, DOI 10.1128/AAC.36.4.751; ROBINSON MJ, 1991, BIOCHEMISTRY-US, V30, P1807, DOI 10.1021/bi00221a012; ROBINSON MJ, 1991, J BIOL CHEM, V266, P14585; Sambrook J., 2002, MOL CLONING LAB MANU; SANDER M, 1983, J BIOL CHEM, V258, P8421; SPITZNER JR, 1995, MOL PHARMACOL, V48, P238; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WASSERMAN RA, 1993, CANCER RES, V53, P3591; YAMASHITA Y, 1992, CANCER RES, V52, P2818	73	35	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35927	35932		10.1074/jbc.274.50.35927	http://dx.doi.org/10.1074/jbc.274.50.35927			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585479	hybrid			2022-12-27	WOS:000084187900091
J	Appel, H; Gauthier, L; Pyrdol, J; Wucherpfennig, KW				Appel, H; Gauthier, L; Pyrdol, J; Wucherpfennig, KW			Kinetics of T-cell receptor binding by bivalent HLA-DR center dot peptide complexes that activate antigen-specific human T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; ALPHA-BETA; DROSOPHILA-MELANOGASTER; TRANSMEMBRANE REGION; DENDRITIC CELLS; CD3 COMPLEX; DIMERIZATION; CHAIN; TCR; ASSOCIATION	Monovalent major histocompatibility complex-peptide complexes dissociate within seconds from the T-cell receptor (TCR), indicating that dimerization/multimerization may be important during early stages of T-cell activation. Soluble bivalent HLA-DR2.myelin basic protein (MBP) peptide complexes were expressed by replacing the F(ab) arms of an IgG2a antibody with HLA-DR2.MBP peptide complexes. The binding of bivalent HLA-DR2.peptide complexes to recombinant TCR was examined by surface plasmon resonance, The bivalent nature greatly enhanced TCR binding and slowed dissociation from the TCR, with a t(1/2) of 2.1 to 4.6 min. Soluble bivalent HLA-DR2.MBP peptide complexes activated antigen-specific T-cells in the absence of antigen presenting cells. In contrast, soluble antibodies to the TCR.CD3 complex were ineffective, indicating that they failed to induce an active TCR dimer. TCR/CD3 antibodies induced T-cell proliferation when bound by antigen presenting cells that expressed Fc receptors, In the presence of dendritic cells, bivalent HLA-DR2.MBP peptide complexes induced T-cell activation at >100-fold lower concentrations than TCR/CD3 antibodies and were also superior to peptide or antigen. These results demonstrate that bivalent HLA-DR.peptide complexes represent effective ligands for activation of the TCR, The data support a role for TCR dimerization in early TCR signaling and kinetic proofreading.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	wucherpf@mbcrr.harvard.edu						ABASTADO JP, 1995, J EXP MED, V182, P439, DOI 10.1084/jem.182.2.439; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; BLUMBERG RS, 1990, P NATL ACAD SCI USA, V87, P7220, DOI 10.1073/pnas.87.18.7220; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BOUROUIS M, 1983, EMBO J, V2, P1099, DOI 10.1002/j.1460-2075.1983.tb01552.x; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Casares S, 1999, J EXP MED, V190, P543, DOI 10.1084/jem.190.4.543; CHERBAS L, 1994, METHOD CELL BIOL, V44, P161, DOI 10.1016/S0091-679X(08)60912-7; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; DELAHERA A, 1991, J EXP MED, V173, P7, DOI 10.1084/jem.173.1.7; Exley M, 1991, Semin Immunol, V3, P283; Fanger NA, 1996, J IMMUNOL, V157, P541; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Gauthier L, 1998, P NATL ACAD SCI USA, V95, P11828, DOI 10.1073/pnas.95.20.11828; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; HANSON DC, 1984, J IMMUNOL, V132, P1386; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; Kalandadze A, 1996, J BIOL CHEM, V271, P20156, DOI 10.1074/jbc.271.33.20156; Kamarck M E, 1987, Methods Enzymol, V151, P150, DOI 10.1016/S0076-6879(87)51017-5; KEARSE KP, 1995, IMMUNITY, V2, P391; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MANOLIOS N, 1994, EUR J IMMUNOL, V24, P84, DOI 10.1002/eji.1830240114; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MEUER SC, 1983, J EXP MED, V158, P988, DOI 10.1084/jem.158.3.988; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; OHerrin SM, 1997, J EXP MED, V186, P1333, DOI 10.1084/jem.186.8.1333; OLLO R, 1981, P NATL ACAD SCI-BIOL, V78, P2442, DOI 10.1073/pnas.78.4.2442; RATCLIFFE MJH, 1992, J IMMUNOL, V148, P1643; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; She J, 1999, INT IMMUNOL, V11, P845, DOI 10.1093/intimm/11.5.845; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Utz U, 1996, J VIROL, V70, P843, DOI 10.1128/JVI.70.2.843-851.1996; VANWAUWE JP, 1980, J IMMUNOL, V124, P2708; Wang BP, 1999, J IMMUNOL, V162, P88; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; WUCHERPFENNIG KW, 1995, P NATL ACAD SCI USA, V92, P11935, DOI 10.1073/pnas.92.25.11935	53	54	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					312	321		10.1074/jbc.275.1.312	http://dx.doi.org/10.1074/jbc.275.1.312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617620	hybrid			2022-12-27	WOS:000085951600044
J	Gilleron, M; Bala, L; Brando, T; Vercellone, A; Puzo, G				Gilleron, M; Bala, L; Brando, T; Vercellone, A; Puzo, G			Mycobacterium tuberculosis H37Rv parietal and cellular lipoarabinomannans - Characterization of the acyl- and glyco-forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVIS BCG; MANNOSYLATED-LIPOARABINOMANNANS; STRUCTURAL FEATURES; LIPOGLYCAN ANTIGENS; NMR-SPECTROSCOPY; MACROPHAGES; STRAINS; ANCHOR; LOCALIZATION; ACTIVATION	Mannosylated lipoarabinomannans are multifaceted molecules. They have been shown to exert an immunosuppressive role in the immunopathogenesis of tuberculosis. They are also described as antigens of host double negative alpha beta T-cells, Delimitation of ManLAMs epitopes require knowledge of the precise structure of these molecules, The two major functional domains (the cap motifs and the phosphatidylinositol anchor) of the parietal and cellular ManLAMs of Mycobacterium tuberculosis H37Rv were investigated here. Using capillary electrophoresis, we established that parietal and cellular ManLAMs share the same capping motifs, mono-, di-, and trimannosyl units with the same relative abundance. By P-31 NMR analysis of the native LAMs in Me2SO-d(6), the major acyl-form of both parietal and cellular H37Rv ManLAM anchors, typified by the P3 phosphorus resonance, comprised a diacylglycerol unit. Three other acyl-forms were characterized in the cellular ManLAMs, Comparative analysis of the cellular Mycobacterium bovis BCG and M. tuberculosis ManLAM acyl-forms revealed the presence of the same populations, but with different relative abundance. The biological importance of the H37Rv ManLAM acyl-form characterization is discussed, particularly concerning the molecular mechanisms of binding of ManLAMs to the CD1 proteins involved in the presentation of ManLAMs to T-cell receptors.			Gilleron, M (corresponding author), CNRS, Inst Pharmacol & Biol Struct, 205 Route Narbonne, F-31077 Toulouse, France.			GILLERON, Martine/0000-0002-2581-3302				BARNES PF, 1992, J IMMUNOL, V149, P541; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1986, J MAGN RESON, V67, P565, DOI 10.1016/0022-2364(86)90395-1; BRENNAN PJ, 1989, REV INFECT DIS, V11, P420; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; DELMAS C, 1997, TECHNIQUES GLYCOBIOL, P85; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4963; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Gilleron M, 1997, J BIOL CHEM, V272, P117; GILLERON M, 1999, GLYCANS CELL INTERAC; Guttman A, 1996, ANAL BIOCHEM, V233, P234, DOI 10.1006/abio.1996.0034; KHOO KH, 1995, J BIOL CHEM, V270, P12380, DOI 10.1074/jbc.270.21.12380; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; LERNER L, 1986, J MAGN RESON, V69, P375, DOI 10.1016/0022-2364(86)90091-0; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Monsarrat B, 1999, GLYCOBIOLOGY, V9, P335, DOI 10.1093/glycob/9.4.335; Nigou J, 1999, GLYCOCONJUGATE J, V16, P257, DOI 10.1023/A:1007046609341; Nigou J, 1997, J BIOL CHEM, V272, P23094, DOI 10.1074/jbc.272.37.23094; Nigou J, 1999, BIOCHEM J, V337, P453, DOI 10.1042/0264-6021:3370453; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; PRINZIS S, 1993, J GEN MICROBIOL, V139, P2649, DOI 10.1099/00221287-139-11-2649; RASTOGI N, 1991, RES MICROBIOL, V142, P464, DOI 10.1016/0923-2508(91)90121-P; Riedel DD, 1997, INFECT IMMUN, V65, P4620, DOI 10.1128/IAI.65.11.4620-4623.1997; ROACH TIA, 1993, J IMMUNOL, V150, P1886; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; SIBLEY LD, 1988, INFECT IMMUN, V56, P1232, DOI 10.1128/IAI.56.5.1232-1236.1988; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; VENISSE A, 1993, J BIOL CHEM, V268, P12401; VENISSE A, 1995, EUR J BIOCHEM, V231, P440, DOI 10.1111/j.1432-1033.1995.tb20717.x; Vercellone A, 1998, FRONT BIOSCI-LANDMRK, V3, pE149; Yoshida A, 1997, INFECT IMMUN, V65, P1953, DOI 10.1128/IAI.65.5.1953-1955.1997; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702	40	45	46	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					677	684		10.1074/jbc.275.1.677	http://dx.doi.org/10.1074/jbc.275.1.677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617666	hybrid			2022-12-27	WOS:000085951600090
J	Klarmann, GJ; Smith, RA; Schinazi, RF; North, TW; Preston, BD				Klarmann, GJ; Smith, RA; Schinazi, RF; North, TW; Preston, BD			Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S - Template interactions influence substrate recognition at the polymerase active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DOUBLE-STRANDED DNA; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; NUCLEOTIDE-SEQUENCE; CONFERS RESISTANCE; FELINE; FIDELITY; REPLICATION; 3'-AZIDO-3'-DEOXYTHYMIDINE	Studies of drug-resistant reverse transcriptases (RTs) reveal the roles of specific structural elements and amino acids in polymerase function. To characterize better the effects of RT/template interactions on dNTP substrate recognition, we examined the sensitivity of human immunodeficiency virus type 1 (HIV-1) RT containing a new mutation in a "template grip" residue (P157S) to the 5'-triphosphates of (-)-beta-2',3'-dideoxy-3'-thiacytidine (3TC), (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine (FTC), and 3'-azido-3'-deoxythymidine (AZT). A primer extension assay was used to monitor quantitatively drug monophosphate incorporation opposite each of multiple target sites. Wild-type and P157S RTs had similar catalytic activities and processivities on heteropolymeric RNA and DNA templates. When averaged over multiple template sites, P157S RT was 2-7-fold resistant to the 5'-triphosphates of 3TC, FTC, and AZT, Each drug triphosphate inhibited polymerization more efficiently on the DNA template compared with an RNA template of identical sequence. Moreover, chain termination by 3TC and FTC was strongly influenced by template sequence context. Incorporation of FTC and 3TC monophosphate varied up to 10-fold opposite 7 different G residues in the DNA template, and the P157S mutation altered this site specificity. In summary, these data identify Pro(157) as an important residue affecting nucleoside analog resistance and suggest that interactions between RT and the template strand influence dNTP substrate recognition at the RT active site. Our findings are discussed within the context of the HIV-1 RT structure.	Univ Utah, Dept Biochem, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Radiat Oncol, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Emory Univ, Sch Med, Dept Pediat, Decatur, GA 30033 USA; Emory Univ, Sch Med, Georgia Vet Affairs Res Ctr AIDS & HIV Invect, Decatur, GA 30033 USA; Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Emory University; Emory University; University of California System; University of California Davis	Preston, BD (corresponding author), Univ Utah, Dept Biochem, Eccles Inst Human Genet, 15 N 2030 E,Rm 2150, Salt Lake City, UT 84112 USA.	bpreston@hci.utah.edu	Schinazi, Raymond F/B-6777-2017		NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038755, R01AI034834] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA42014] Funding Source: Medline; NIAID NIH HHS [R01 AI38755, R01 AI34834] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABBOTTS J, 1993, J BIOL CHEM, V268, P10312; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Arts EJ, 1996, J VIROL, V70, P712, DOI 10.1128/JVI.70.2.712-720.1996; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; Bartholomeusz A., 1998, VIRAL HEPATITIS REV, V4, P167; Bebenek K, 1993, REVERSE TRANSCRIPTAS, P85; BOYER PL, 1995, ANTIMICROB AGENTS CH, V39, P1624, DOI 10.1128/AAC.39.7.1624; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; CARROLL SS, 1994, BIOCHEMISTRY-US, V33, P2113, DOI 10.1021/bi00174a018; Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P174; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Drosopoulos WC, 1996, J VIROL, V70, P4834, DOI 10.1128/JVI.70.7.4834-4838.1996; Elder JH, 1998, AIDS RES HUM RETROV, V14, P797, DOI 10.1089/aid.1998.14.797; Emini E. A., 1997, P637; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; HALL JD, 1985, P NATL ACAD SCI USA, V82, P3889, DOI 10.1073/pnas.82.11.3889; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HOONG LK, 1992, J ORG CHEM, V57, P5563, DOI 10.1021/jo00047a004; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang L, 1999, P NATL ACAD SCI USA, V96, P447, DOI 10.1073/pnas.96.2.447; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Ji XD, 1996, BIOCHEMISTRY-US, V35, P132, DOI 10.1021/bi951707e; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Klarmann GJ, 1997, J VIROL, V71, P9259, DOI 10.1128/JVI.71.12.9259-9269.1997; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LACEY SF, 1992, J BIOL CHEM, V267, P15789; LARDER BA, 1993, REVERSE TRANSCRIPTAS, P205; MCCLURE MA, 1993, REVERSE TRANSCRIPTAS, P425; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; NORTH TW, 1990, J BIOL CHEM, V265, P5121; NORTH TW, 1995, NAT MED, V1, P410, DOI 10.1038/nm0595-410; NORTH TW, 1990, ANTIMICROB AGENTS CH, V34, P1505, DOI 10.1128/AAC.34.8.1505; Nossal NG, 1998, GENETICS, V148, P1535; OLMSTED RA, 1989, P NATL ACAD SCI USA, V86, P8088, DOI 10.1073/pnas.86.20.8088; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; PATEL PH, 1994, P NATL ACAD SCI USA, V91, P549, DOI 10.1073/pnas.91.2.549; Pichoud C, 1999, HEPATOLOGY, V29, P230, DOI 10.1002/hep.510290119; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; PRASAD VR, 1991, P NATL ACAD SCI USA, V88, P11363, DOI 10.1073/pnas.88.24.11363; REHAKRANTZ LJ, 1988, J MOL BIOL, V202, P711, DOI 10.1016/0022-2836(88)90552-9; REMINGTON KM, 1991, J VIROL, V65, P308, DOI 10.1128/JVI.65.1.308-312.1991; REMINGTON KM, 1994, J VIROL, V68, P632, DOI 10.1128/JVI.68.2.632-637.1994; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schinazi R. F., 1999, INT ANTIVIRAL NEWS, V7, P46; SCHINAZI RF, 1992, ANTIMICROB AGENTS CH, V36, P2423, DOI 10.1128/AAC.36.11.2423; Smith RA, 1997, J VIROL, V71, P2357, DOI 10.1128/JVI.71.3.2357-2362.1997; Smith RA, 1998, J VIROL, V72, P2335, DOI 10.1128/JVI.72.3.2335-2340.1998; Smith RA, 1999, ANTIMICROB AGENTS CH, V43, P2077, DOI 10.1128/AAC.43.8.2077; Stahlhut MW, 1996, METHOD ENZYMOL, V275, P122; TALBOTT RL, 1989, P NATL ACAD SCI USA, V86, P5743, DOI 10.1073/pnas.86.15.5743; TANTILLO C, 1994, J MOL BIOL, V243, P369, DOI 10.1006/jmbi.1994.1665; Telesnitsky A., 1997, P121; Ueno T, 1997, BIOCHEMISTRY-US, V36, P1092, DOI 10.1021/bi962393d; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wilson JE, 1996, J BIOL CHEM, V271, P13656, DOI 10.1074/jbc.271.23.13656	64	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					359	366		10.1074/jbc.275.1.359	http://dx.doi.org/10.1074/jbc.275.1.359			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617626	hybrid			2022-12-27	WOS:000085951600050
J	Lee, DJ; Cox, D; Li, JC; Greenberg, S				Lee, DJ; Cox, D; Li, JC; Greenberg, S			Rad and Cdc42 are required for phagocytosis, but not NF-kappa B-dependent gene expression, in macrophages challenged with Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LISTERIA-MONOCYTOGENES INFECTION; BONE-MARROW MACROPHAGES; HUMAN ENDOTHELIAL-CELLS; TRANSCRIPTION FACTOR; MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-AUREUS; SIGNAL-TRANSDUCTION; NUCLEAR RESPONSES; HUMAN NEUTROPHILS; HUMAN MONOCYTES	Macrophages respond to Gram-negative bacterial pathogens by phagocytosis and pro-inflammatory gene expression. These responses may require GTPases that have been implicated in cytoskeletal alterations and activation of NF-kappa B. To determine the role of Rad and Cdc42 in signal transduction events triggered by Pseudomonas aeruginosa, we expressed GTP binding-deficient alleles of Rad or Cdc42, or Chim-GAP, a Rac1/Cdc42-specific GTPase-activating protein domain, in a subline of RAW 264.7 cells, and challenged the transfected cells with a laboratory strain of P. aeruginosa, PAO1. Expression of Rad N17, Cdc42 N17, or Chim-GAP led to a marked reduction of phagocytosis. In contrast, nuclear translocation of p65 NF-kappa B was unaffected by expression of the same constructs. Incubation of macrophages with PAO1 led to NF-kappa B-dependent expression of inducible nitric-oxide synthase, COX-2, and tumor necrosis factor-alpha, which was unaffected by inhibition of Rad or Cdc42 function. Isogenic strains of PAO1 that lacked surface adhesins were poorly ingested; however, they induced pro-inflammatory gene expression with an efficiency equal to that of PAO1, These results indicate that the signal transduction events leading to phagocytosis and pro-inflammatory protein expression are distinct. Rad and Cdc42 serve as effecters of phagocytosis, but not NF-kappa B-dependent gene expression, in the macrophage response to P. aeruginosa.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol PH8C, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Greenberg, S (corresponding author), Columbia Univ, Dept Med, 630 W 168th St, New York, NY 10032 USA.			Cox, Dianne/0000-0002-0591-9767	NHLBI NIH HHS [HL54164] Funding Source: Medline; NIAID NIH HHS [AI42848] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042848] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Allen WE, 1997, J CELL SCI, V110, P707; BRENNAN P, 1995, BBA-GENE STRUCT EXPR, V1260, P167, DOI 10.1016/0167-4781(94)00186-7; BUSAM K, 1992, INFECT IMMUN, V60, P2008, DOI 10.1128/IAI.60.5.2008-2015.1992; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DRAKE D, 1988, J GEN MICROBIOL, V134, P43; Fasshauer M, 1998, EUR J CELL BIOL, V77, P188, DOI 10.1016/S0171-9335(98)80106-4; Filler SG, 1996, INFECT IMMUN, V64, P2609, DOI 10.1128/IAI.64.7.2609-2617.1996; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; Fulton SA, 1996, INFECT IMMUN, V64, P2523, DOI 10.1128/IAI.64.7.2523-2531.1996; GOODRUM KJ, 1995, INFECT IMMUN, V63, P3715, DOI 10.1128/IAI.63.9.3715-3717.1995; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; HAUF N, 1994, INFECT IMMUN, V62, P2740, DOI 10.1128/IAI.62.7.2740-2747.1994; Hauf N, 1997, P NATL ACAD SCI USA, V94, P9394, DOI 10.1073/pnas.94.17.9394; Kadurugamuwa JL, 1997, J ANTIMICROB CHEMOTH, V40, P615, DOI 10.1093/jac/40.5.615; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; MAHENTHIRALINGAM E, 1995, INFECT IMMUN, V63, P4519, DOI 10.1128/IAI.63.11.4519-4523.1995; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; McDonald PP, 1997, FEBS LETT, V412, P583, DOI 10.1016/S0014-5793(97)00857-0; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; MUROI M, 1994, J BIOL CHEM, V269, P30561; NOEL RF, 1995, INFECT IMMUN, V63, P4046, DOI 10.1128/IAI.63.10.4046-4053.1995; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SCHWAN WR, 1994, P NATL ACAD SCI USA, V91, P6428, DOI 10.1073/pnas.91.14.6428; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHATTOCK RJ, 1994, J GEN VIROL, V75, P849, DOI 10.1099/0022-1317-75-4-849; SHIBATA Y, 1995, J IMMUNOL, V154, P2878; SPEERT DP, 1988, J CLIN INVEST, V82, P872, DOI 10.1172/JCI113692; Sporn LA, 1997, INFECT IMMUN, V65, P2786, DOI 10.1128/IAI.65.7.2786-2791.1997; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; TANG H, 1995, INFECT IMMUN, V63, P1278, DOI 10.1128/IAI.63.4.1278-1285.1995; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; TEBO JM, 1994, J IMMUNOL, V153, P4713; Tsakiridis T, 1998, J BIOL CHEM, V273, P28322, DOI 10.1074/jbc.273.43.28322; TSITSIKOV EN, 1995, INT IMMUNOL, V7, P1665, DOI 10.1093/intimm/7.10.1665; Vollebregt M, 1998, FEBS LETT, V432, P40, DOI 10.1016/S0014-5793(98)00821-7; Wilson R, 1998, THORAX, V53, P213, DOI 10.1136/thx.53.3.213; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; YAO L, 1995, INFECT IMMUN, V63, P1835, DOI 10.1128/IAI.63.5.1835-1839.1995	50	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					141	146		10.1074/jbc.275.1.141	http://dx.doi.org/10.1074/jbc.275.1.141			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617597	hybrid			2022-12-27	WOS:000085951600021
J	Son, YJ; Scranton, TW; Sunderland, WJ; Baek, SJ; Miner, JH; Sanes, JR; Carlson, SS				Son, YJ; Scranton, TW; Sunderland, WJ; Baek, SJ; Miner, JH; Sanes, JR; Carlson, SS			The synaptic vesicle protein SV2 is complexed with an alpha 5-containing laminin on the nerve terminal surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; KERATAN SULFATE; NEUROMUSCULAR-JUNCTION; TRANSMEMBRANE TRANSPORTER; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; ENDOCRINE-CELLS; ELECTRIC ORGAN; COLLAGEN-IV; IDENTIFICATION	Interactions between growing axons and synaptic basal lamina components direct the formation of neuromuscular junctions during nerve regeneration. Isoforms of laminin containing alpha 5 or beta 2 chains are potential basal lamina ligands for these interactions. The nerve terminal receptors are unknown. Here we show that SV2, a synaptic vesicle transmembrane proteoglycan, is complexed with a 900-kDa laminin on synaptosomes from the electric organ synapse that is similar to the neuromuscular junctions. Although two laminins are present on synaptosomes, only the 900-kDa laminin is associated with SV2. Other nerve terminal components are absent from this complex. The 900-kDa laminin contains an a5, a beta 1, and a novel gamma chain. To test whether SV2 directly binds the 900-kDa laminin, we looked for interaction between purified SV2 and laminin-1, a laminin isoform with a similar structure. We find SV2 binds with high affinity to purified laminin-1. Our results suggest that a synaptic vesicle component may act as a laminin receptor on the presynaptic plasma membrane; they also suggest a mechanism for activity-dependent adhesion at the synapse.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL)	Carlson, SS (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.				NINDS NIH HHS [NS22367] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERTS B, 1994, MOL BIOL CELL, P1213; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BINDRA PS, 1993, GENE, V137, P299, DOI 10.1016/0378-1119(93)90024-W; BROWN GM, 1994, BIOCHEMISTRY-US, V33, P4836, DOI 10.1021/bi00182a012; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; BUCKLEY KM, 1983, P NATL ACAD SCI-BIOL, V80, P7342, DOI 10.1073/pnas.80.23.7342; Carlson SS, 1996, PERSPECT DEV NEUROBI, V3, P373; CARLSON SS, 1978, BIOCHEMISTRY-US, V17, P1188, DOI 10.1021/bi00600a009; CARLSON SS, 1983, J BIOL CHEM, V258, P1082; COWAN D, 1990, BRAIN RES, V509, P1, DOI 10.1016/0006-8993(90)90301-Q; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; GINGRICH JA, 1992, FEBS LETT, V312, P115, DOI 10.1016/0014-5793(92)80917-6; GLICKSMAN MA, 1983, J NEUROCYTOL, V12, P661, DOI 10.1007/BF01181529; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HALL ZW, 1992, MOL NEUROBIOL, P90; HOCKFIELD S, 1993, MOL PROBES NERVOUS S; HORNE WA, 1993, P NATL ACAD SCI USA, V90, P3787, DOI 10.1073/pnas.90.9.3787; Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107; IWATA M, 1993, J NEUROSCI, V13, P195; IWATA M, 1991, J BIOL CHEM, V266, P323; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Janz R, 1998, J NEUROSCI, V18, P9269; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; KUSHNER PD, 1984, J NEUROCHEM, V43, P775, DOI 10.1111/j.1471-4159.1984.tb12799.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; LIM WA, 1991, METHOD ENZYMOL, V208, P196; MEHMET H, 1986, EUR J BIOCHEM, V157, P385, DOI 10.1111/j.1432-1033.1986.tb09680.x; MILJANICH GP, 1982, J CELL BIOL, V94, P88, DOI 10.1083/jcb.94.1.88; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; SANANTONIO JD, 1993, BIOCHEMISTRY-US, V32, P4746, DOI 10.1021/bi00069a008; SANES JR, 1983, ANNU REV PHYSIOL, V45, P581, DOI 10.1146/annurev.ph.45.030183.003053; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; SCRANTON TW, 1993, J NEUROCHEM, V61, P29, DOI 10.1111/j.1471-4159.1993.tb03535.x; Snow AD, 1996, EXP NEUROL, V138, P305, DOI 10.1006/exnr.1996.0069; STADLER H, 1982, EMBO J, V1, P1381, DOI 10.1002/j.1460-2075.1982.tb01326.x; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3; YEAGER RE, 1987, J NEUROSCI, V7, P2390; [No title captured]	55	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					451	460		10.1074/jbc.275.1.451	http://dx.doi.org/10.1074/jbc.275.1.451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617638	hybrid			2022-12-27	WOS:000085951600062
J	Francois, PP; Preissner, KT; Herrmann, M; Haugland, RP; Vaudaux, P; Lew, DP; Krause, KH				Francois, PP; Preissner, KT; Herrmann, M; Haugland, RP; Vaudaux, P; Lew, DP; Krause, KH			Vitronectin interaction with glycosaminoglycans - Kinetics, structural determinants, and role in binding to endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; S-PROTEIN VITRONECTIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; COAGULASE-NEGATIVE STAPHYLOCOCCI; MULTIMERIC VITRONECTIN; SELF-ASSOCIATION; AUREUS; IDENTIFICATION; ANTITHROMBIN; ADHESION	Vitronectin (VN) is a high affinity heparin-binding protein. The physiological role of this binding has hitherto received little attention, and its molecular determinants are subject to controversy. In this study, we characterized vitronectin interaction with heparin, heparin analogues, bacterial extracts, and cell surface glycosaminoglycans. As assessed by (i) fluorescence assays, (ii) precipitation with heparin-Sepharose beads, or (iii) Western blotting with antibodies against VN347-361 (the heparin-binding site), we demonstrate an exposure of the VN heparin-binding site in multimeric but not mo nomeric vitronectin. Through its heparin-binding site, vitronectin also bound other glycosaminoglycans and Staphylococcus aureus extracts. The kinetics of heparin binding to vitronectin were complex. After a fast association phase (tau = 0.3 s), a slow conversion of an unstable to a stable heparin-vitronectin complex (tau = 180 s) occurred. Heparin binding kinetics and transition to a stable complex were mimicked by VN347-361 demonstrating that this area is the fully functional heparin-binding site of vitronectin. Multimeric vitronectin bound to endothelial cells. This binding was blocked by soluble heparin and was not observed when endothelial cells were pretreated with glycosaminoglycan-removing enzymes. Glycosaminoglycan-dependent interaction of endothelial cells with multimeric vitronectin might be a relevant mechanism for removal of multimeric vitronectin from plasma. Conversion of an unstable to a stable glycosaminoglycan-vitronectin complex is likely to be relevant for association with endothelial cells under flow conditions.	Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Biol Aging Lab, CH-1211 Geneva, Switzerland; Max Planck Inst, Kerckhoff Klin, Haemostasis Res Unit, D-61231 Bad Nauheim, Germany; Mol Probes Inc, Eugene, OR 97402 USA; Univ Munster, Inst Med Microbiol, D-48129 Munster, Germany	University of Geneva; University of Geneva; Kerckhoff Clinic; Max Planck Society; University of Munster	Francois, PP (corresponding author), Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva 14, Switzerland.		Herrmann, Mathias/B-6475-2013; francois, patrice/AAL-5583-2020; Krause, Karl-Heinz/E-8030-2011	Herrmann, Mathias/0000-0003-2638-2257; Krause, Karl-Heinz/0000-0002-9033-6768; francois, patrice/0000-0002-0540-750X				BARLOW R, 1989, TRENDS PHARMACOL SCI, V10, P440, DOI 10.1016/S0165-6147(89)80006-9; BERGER W, 1994, BIOCHEMISTRY-US, V33, P11875, DOI 10.1021/bi00205a025; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; COLLIEC S, 1991, THROMB RES, V64, P143, DOI 10.1016/0049-3848(91)90114-C; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; DEAGOSTINI AI, 1994, J CELL BIOCHEM, V54, P174, DOI 10.1002/jcb.240540206; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Fay WP, 1999, BLOOD, V93, P1825, DOI 10.1182/blood.V93.6.1825.406k37_1825_1830; Gibson AD, 1999, J BIOL CHEM, V274, P6432, DOI 10.1074/jbc.274.10.6432; HEDMAN KS, 1983, CELL, V28, P663; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HESS S, 1995, THROMB HAEMOSTASIS, V74, P258; HUSSAIN M, 1992, J HOSP INFECT, V20, P173, DOI 10.1016/0195-6701(92)90085-Z; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147; JOZEFONVICZ J, 1992, PURE APPL CHEM, V64, P1783, DOI 10.1351/pac199264111783; KOST C, 1992, J BIOL CHEM, V267, P12098; LIANG OD, 1995, BBA-PROTEIN STRUCT M, V1250, P110, DOI 10.1016/0167-4838(95)00076-7; LIANG OD, 1994, J BIOCHEM-TOKYO, V116, P457, DOI 10.1093/oxfordjournals.jbchem.a124546; LIANG OD, 1993, BIOCHIM BIOPHYS ACTA, V1225, P57, DOI 10.1016/0925-4439(93)90122-H; Liang OD, 1997, FEBS LETT, V407, P169, DOI 10.1016/S0014-5793(97)00330-X; Lim BL, 1996, J BIOL CHEM, V271, P26739, DOI 10.1074/jbc.271.43.26739; MCGAVIN MH, 1993, INFECT IMMUN, V61, P2479, DOI 10.1128/IAI.61.6.2479-2485.1993; Patel JK., 1976, HDB STAT DISTRIBUTIO; PAULSSON M, 1992, J CLIN MICROBIOL, V30, P2006, DOI 10.1128/JCM.30.8.2006-2012.1992; PREISSNER KT, 1985, BIOCHEM J, V231, P349, DOI 10.1042/bj2310349; PREISSNER KT, 1990, J BIOL CHEM, V265, P18490; PREISSNER KT, 1987, J BIOL CHEM, V262, P12247; PREISSNER KT, 1990, NEW TRENDS HAEMOSTAS, P123; Rosenblatt S, 1997, BIOCHEM J, V324, P311, DOI 10.1042/bj3240311; Schrenzel J, 1995, BIOPHYS J, V69, P2378, DOI 10.1016/S0006-3495(95)80107-4; Seiffert D, 1997, J BIOL CHEM, V272, P9971; STOCKMANN A, 1993, J BIOL CHEM, V268, P22874; Tomasini B R, 1991, Prog Hemost Thromb, V10, P269; TOMASINI BR, 1988, BLOOD, V72, P903; TSCHOPP J, 1988, BIOCHEMISTRY-US, V27, P4103, DOI 10.1021/bi00411a029; Ueda H, 1998, J VET MED SCI, V60, P1169, DOI 10.1292/jvms.60.1169; VAUDAUX P, 1992, J BIOMAT SCI-POLYM E, V4, P89; Wells MJ, 1998, J BIOL CHEM, V273, P23440, DOI 10.1074/jbc.273.36.23440; Wilkins-Port CE, 1998, BBA-MOL CELL RES, V1404, P353, DOI 10.1016/S0167-4889(98)00076-7; Zhuang P, 1997, J BIOL CHEM, V272, P6858, DOI 10.1074/jbc.272.11.6858	43	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37611	37619		10.1074/jbc.274.53.37611	http://dx.doi.org/10.1074/jbc.274.53.37611			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608816	hybrid			2022-12-27	WOS:000084528000016
J	Meilinger, M; Gschwentner, C; Burger, I; Haumer, M; Wahrmann, M; Szollar, L; Nimpf, J; Huettinger, M				Meilinger, M; Gschwentner, C; Burger, I; Haumer, M; Wahrmann, M; Szollar, L; Nimpf, J; Huettinger, M			Metabolism of activated complement component C3 is mediated by the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA(2)-MACROGLOBULIN RECEPTOR; PSEUDOMONAS EXOTOXIN-A; ALPHA-2-MACROGLOBULIN RECEPTOR; RAT-LIVER; LACTOFERRIN; BINDING; LIGANDS; FAMILY; COMPLEXES; INHIBITOR	Complement component 3 (C3) and alpha(2)-macroglobulin evolved from a common, evolutionarily old, ancestor gene, Low density lipoprotein-receptor-related protein/alpha(2)-macroglobulin receptor (LRP/alpha(2)MR), a member of the low density lipoprotein receptor family, is responsible for the clearance of alpha(2)-macroglobulin-protease complexes. In this study, we examined whether C3 has conserved affinity for LRP/alpha(2)MR. Ligand blot experiments with human I-125-C3 On endosomal proteins show binding to a 600-kDa protein, indistinguishable from LRP/alpha(2)MR by the following criteria: it is competed by receptor-associated protein (the 39-kDa receptor-associated protein that impairs binding of all ligands to LRP/alpha 2MR) and by lactoferrin and Pseudomonas exotoxin, other well known ligands of the multifunctional receptor. Binding of C3 is sensitive to reduction of the receptor and is Ca2+-dependent. All these features are typical for cysteine-rich binding repeats of the low density lipoprotein receptor family. In LRP/alpha(2)MR, they are found in four cassettes (2, 8, 10, and 11 repeats), Ligand blotting to chicken LR8 demonstrates that a single 8-fold repeat is sufficient for binding. Confocal microscopy visualizes initial surface labeling of human fibroblasts incubated with fluorescent labeled C3, which changes after 5 min to an intracellular vesicular staining pattern that is abolished in the presence of receptor-associated protein, Cell uptake is abolished in mouse fibroblasts deficient in LRP/alpha(2)MR. Native plasma C3 is not internalized. We demonstrate that the capacity to internalize C3 is saturable and exhibits a K-D value of 17 nM. After intravenous injection, rat hepatocytes accumulate C3 in sedimentable vesicles with a density typical for endosomes. In conclusion, our ligand blot and uptake studies demonstrate the competence of the LRP/alpha(2)MR to bind and endocytose C3 and provide evidence for an LRP/alpha(2)MR-mediated system participating in C3 metabolism.	Univ Vienna, Dept Med Chem, A-1090 Vienna, Austria; Semmelweis Univ, Sch Med, Inst Pathophysiol, H-1089 Budapest, Hungary; Univ Vienna, Dept Mol Genet, A-1030 Vienna, Austria	University of Vienna; Semmelweis University; University of Vienna	Huettinger, M (corresponding author), Univ Vienna, Dept Med Chem, Wahringerstr 10, A-1090 Vienna, Austria.			Wahrmann, Markus/0000-0002-1301-8694; Nimpf, Johannes/0000-0002-9273-3492				ARMSTRONG PB, 1993, MOL IMMUNOL, V30, P929, DOI 10.1016/0161-5890(93)90017-6; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; GETTINS PGW, 1993, FEBS LETT, V332, P211, DOI 10.1016/0014-5793(93)80633-6; GOLDENBERG H, 1991, BIOCHIM BIOPHYS ACTA, V1067, P145, DOI 10.1016/0005-2736(91)90036-8; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HERZ J, 1991, J BIOL CHEM, V266, P21232; HUETTINGER M, 1992, J BIOL CHEM, V267, P18551; HUETTINGER M, 1988, CLIN BIOCHEM, V21, P87, DOI 10.1016/S0009-9120(88)80093-6; JANATOVA J, 1988, METHOD ENZYMOL, V162, P579; JENSEN LS, 1985, P NATL ACAD SCI USA, V82, P9; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LAMBRIS JD, 1994, ANN NY ACAD SCI, V712, P354, DOI 10.1111/j.1749-6632.1994.tb33593.x; Maslowska M, 1997, J LIPID RES, V38, P1; MAVROIDIS M, 1995, J IMMUNOL, V154, P2164; MEILINGER M, 1995, FEBS LETT, V360, P70, DOI 10.1016/0014-5793(95)00082-K; MOESTRUP SK, 1993, J BIOL CHEM, V268, P13691; NIMPF J, 1994, ANN NY ACAD SCI, V737, P145, DOI 10.1111/j.1749-6632.1994.tb44308.x; PANGBURN MK, 1992, J BIOL CHEM, V267, P8584; REID KBM, 1993, METHOD ENZYMOL, V223, P1; Schneider WJ, 1997, CURR OPIN LIPIDOL, V8, P315, DOI 10.1097/00041433-199710000-00011; SCHNEIDER WJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P303, DOI 10.1016/0304-4157(89)90023-3; Sniderman AD, 1998, ARTERIOSCL THROM VAS, V18, P147, DOI 10.1161/01.ATV.18.2.147; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; WILLNOW TE, 1994, J CELL SCI, V107, P719; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; YOCHEM J, 1993, P NATL ACAD SCI USA, V90, P4572, DOI 10.1073/pnas.90.10.4572; ZIERE GJ, 1992, J BIOL CHEM, V267, P11229	31	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38091	38096		10.1074/jbc.274.53.38091	http://dx.doi.org/10.1074/jbc.274.53.38091			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608878	hybrid			2022-12-27	WOS:000084528000078
J	Bogdanov, M; Dowhan, W				Bogdanov, M; Dowhan, W			Lipid-assisted protein folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BARREL MEMBRANE-PROTEIN; ESCHERICHIA-COLI; HEAT-SHOCK; OUTER-MEMBRANE; CONFORMATIONAL CHANGE; MOLECULAR CHAPERONES; LACTOSE PERMEASE; IN-VITRO; INSERTION; INTERMEDIATE		Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA	University of Texas System	Dowhan, W (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA.	wdowhan@bmb.med.uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017		NIGMS NIH HHS [GM-20487] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anfinsen C B, 1975, Adv Protein Chem, V29, P205, DOI 10.1016/S0065-3233(08)60413-1; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Booth Paula J., 1999, Current Opinion in Structural Biology, V9, P115, DOI 10.1016/S0959-440X(99)80015-3; Booth PJ, 1997, BIOCHEMISTRY-US, V36, P197, DOI 10.1021/bi962200m; Carpenter KA, 1997, BIOPOLYMERS, V42, P37, DOI 10.1002/(SICI)1097-0282(199707)42:1<37::AID-BIP4>3.3.CO;2-Z; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; Clark AC, 1999, J MOL BIOL, V285, P1777, DOI 10.1006/jmbi.1998.2403; Curran AR, 1999, BIOCHEMISTRY-US, V38, P9328, DOI 10.1021/bi982322+; de Cock H, 1999, EUR J BIOCHEM, V259, P96, DOI 10.1046/j.1432-1327.1999.00010.x; de Cock H, 1999, J BIOL CHEM, V274, P5114, DOI 10.1074/jbc.274.8.5114; deCock H, 1996, EMBO J, V15, P5567, DOI 10.1002/j.1460-2075.1996.tb00941.x; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Dowhan W, 1998, BBA-REV BIOMEMBRANES, V1376, P455, DOI 10.1016/S0304-4157(98)00013-6; Duan HW, 1997, J BIOL CHEM, V272, P31156, DOI 10.1074/jbc.272.49.31156; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Ellis RJ, 1997, BIOCHEM BIOPH RES CO, V238, P687, DOI 10.1006/bbrc.1997.7339; Ellis RJ, 1996, CELL STRESS CHAPERON, V1, P155, DOI 10.1379/1466-1268(1996)001<0155:DOMC>2.3.CO;2; Ellis RJ, 1998, TRENDS BIOCHEM SCI, V23, P43, DOI 10.1016/S0968-0004(98)01175-X; ENDO T, 1989, J BIOL CHEM, V264, P2951; Epand RM, 1998, BBA-REV BIOMEMBRANES, V1376, P353, DOI 10.1016/S0304-4157(98)00015-X; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Fenton WA, 1997, PROTEIN SCI, V6, P743; FREUDL R, 1986, J BIOL CHEM, V261, P1355; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HUANG KS, 1981, J BIOL CHEM, V256, P3802; JAHNIG F, 1997, MOL B INT U, P83; Kleinschmidt JB, 1999, BIOPHYS J, V76, pA106; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w; Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Kuznetsov G, 1998, NEW ENGL J MED, V339, P1688, DOI 10.1056/NEJM199812033392307; LONDON E, 1982, J BIOL CHEM, V257, P7003; Marsh D., 1993, PROTEIN LIPID INTERA, P41; Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1; MEL SF, 1993, BIOCHEMISTRY-US, V32, P2082, DOI 10.1021/bi00059a028; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Osterbye T, 1999, DIABETOLOGIA, V42, pA30; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PERALTA D, 1994, FEBS LETT, V339, P45, DOI 10.1016/0014-5793(94)80381-1; Perrett S, 1997, J MOL BIOL, V269, P892, DOI 10.1006/jmbi.1997.1081; Pillarisetti S, 1997, J BIOL CHEM, V272, P15753, DOI 10.1074/jbc.272.25.15753; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Rankin SE, 1998, BIOCHEMISTRY-US, V37, P12588, DOI 10.1021/bi980408x; SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x; Shin I, 1997, P NATL ACAD SCI USA, V94, P2848, DOI 10.1073/pnas.94.7.2848; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; SkorkoGlonek J, 1997, J BIOL CHEM, V272, P8974; Socci ND, 1998, PROTEINS, V32, P136, DOI 10.1002/(SICI)1097-0134(19980801)32:2<136::AID-PROT2>3.3.CO;2-5; Sun JZ, 1996, BIOCHEMISTRY-US, V35, P990, DOI 10.1021/bi952166w; SURREY T, 1995, J BIOL CHEM, V270, P28199; Surrey T, 1996, BIOCHEMISTRY-US, V35, P2283, DOI 10.1021/bi951216u; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; Torok Z, 1997, P NATL ACAD SCI USA, V94, P2192, DOI 10.1073/pnas.94.6.2192; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; vonHeijne G, 1997, MOL MICROBIOL, V24, P249, DOI 10.1046/j.1365-2958.1997.3351702.x; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; ZARDENETA G, 1992, J BIOL CHEM, V267, P5811	64	160	170	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36827	36830		10.1074/jbc.274.52.36827	http://dx.doi.org/10.1074/jbc.274.52.36827			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601231	hybrid			2022-12-27	WOS:000084382700002
J	Oh, S; Song, Y; Yim, J; Kim, TK				Oh, S; Song, Y; Yim, J; Kim, TK			The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT GENE; NORMAL HUMAN-CELLS; CELLULAR SENESCENCE; LIFE-SPAN; WT1; CANCER; HUMAN-CHROMOSOME-3; IMMORTALIZATION; MUTATIONS; MECHANISM	Regulation of the human telomerase reverse transcriptase (hTERT) gene is the primary determinant for telomerase enzyme activity, which is found in tumor cells but is largely absent from normal somatic cells. Recent studies have shown that Myc protein can transcriptionally activate the hTERT gene. However, little is known about the repression mechanism of the hTERT gene and telomerase enzyme. Here, we developed an expression cloning strategy to identify cDNAs whose products can repress hTERT promoter activity in telomerase-positive immortal cells. Using this screen, we isolated the Wilms' tumor 1 suppressor gene (WT1), WT1 can repress hTERT promoter activity in 293 kidney cells. The WT1 binding site on the hTERT promoter was identified by deletional analysis. Alteration of the WT1 binding site markedly derepresses transcription from an isolated hTERT promoter by inhibiting interaction of WT1 with DNA. These specific repression effects of WT1 were not observed in HeLa cells, which express no endogenous WT1. Furthermore, we show that WT1 can repress the endogenous hTERT promoter and telomerase enzyme activities. These results suggest that WT1 may be a transcriptional repressor of the hTERT gene, at least in some specific cells.	Seoul Natl Univ, Natl Creat Res Initiat Ctr Genet Reprogramming, Inst Mol Biol & Genet, Seoul 151742, South Korea; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Inst Chem & Cell Biol, Boston, MA 02115 USA	Seoul National University (SNU); Harvard University; Harvard Medical School	Kim, TK (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Genet Reprogramming, Inst Mol Biol & Genet, Seoul 151742, South Korea.	TK_Kim@hms.harvard.edu						Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; COPPES MJ, 1993, FASEB J, V7, P886, DOI 10.1096/fasebj.7.10.8393819; Cuthbert AP, 1999, JNCI-J NATL CANCER I, V91, P37, DOI 10.1093/jnci/91.1.37; Englert C, 1998, TRENDS BIOCHEM SCI, V23, P389, DOI 10.1016/S0968-0004(98)01277-8; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; Guan LS, 1998, J BIOL CHEM, V273, P27047, DOI 10.1074/jbc.273.42.27047; HABER DA, 1992, NEW BIOL, V4, P97; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hastie Nicholas D., 1992, Human Molecular Genetics, V1, P293; HENSLER PJ, 1994, MOL CELL BIOL, V14, P2291, DOI 10.1128/MCB.14.4.2291; Holt SE, 1997, EUR J CANCER, V33, P761, DOI 10.1016/S0959-8049(97)00066-X; Horikawa I, 1998, MOL CARCINOGEN, V22, P65, DOI 10.1002/(SICI)1098-2744(199806)22:2<65::AID-MC1>3.0.CO;2-J; Horikawa I, 1999, CANCER RES, V59, P826; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KIM TK, 1994, NATURE, V369, P252, DOI 10.1038/369252a0; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; NING Y, 1991, P NATL ACAD SCI USA, V88, P5635, DOI 10.1073/pnas.88.13.5635; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; OGATA T, 1995, JPN J CANCER RES, V86, P35, DOI 10.1111/j.1349-7006.1995.tb02985.x; Oh S, 1999, BIOCHEM BIOPH RES CO, V263, P361, DOI 10.1006/bbrc.1999.1366; OHMURA H, 1995, JPN J CANCER RES, V86, P899, DOI 10.1111/j.1349-7006.1995.tb02998.x; PARK S, 1993, NAT GENET, V5, P363, DOI 10.1038/ng1293-363; Rauscher FJ, 1997, CURR TOP MICROBIOL, V220, P151; Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shay JW, 1999, J NATL CANCER I, V91, P4, DOI 10.1093/jnci/91.1.4; Takakura M, 1999, CANCER RES, V59, P551; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; WRIGHT WE, 1995, TRENDS CELL BIOL, V5, P293, DOI 10.1016/S0962-8924(00)89044-3; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010	36	121	136	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37473	37478		10.1074/jbc.274.52.37473	http://dx.doi.org/10.1074/jbc.274.52.37473			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601322	hybrid			2022-12-27	WOS:000084382700093
J	Roshan, B; Kjelsberg, C; Spokes, K; Eldred, A; Crovello, CS; Cantley, LG				Roshan, B; Kjelsberg, C; Spokes, K; Eldred, A; Crovello, CS; Cantley, LG			Activated ERK2 interacts with and phosphorylates the docking protein GAB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; PTB DOMAIN; KINASE; SHC; ASSOCIATION; PHOSPHOTYROSINE; MODULATION; RESIDUES	Grb2-associated binder 1 (GAB1) is a docking protein found to associate with the activated c-MET receptor via the MET-binding domain (MBD) and appears to be critical for the tubulogenic actions of this receptor. Pull-down experiments with bacterially expressed MBD and fall-length GAB1 revealed the presence of c-MET as web as phosphorylated ERK2 (pERK2). By using purified pERK2 and non-pERK2, we found that GAB1 associates exclusively with the phosphorylated form of the enzyme and that this association does not require mediation by a third protein. When epitope-tagged GAB1 was cotransfected with constitutively active MEK1 into A293 cells, co-immunoprecipitation of GAB1 and pERK2 was observed, demonstrating that this interaction can occur in intact cells. In vitro, both the MBD and full-length GAB1 were found to be substrates for activated ERK2. In intact cells, epitope-tagged GAB1 was found to be basally phosphorylated on serine with an increase following co-transfection with constitutively active MEK1 and the appearance of novel phosphorylation sites detected by phosphopeptide mapping. Thus, it appears that GAB1 can associate directly with phosphorylated ERK2 via the MET-binding domain and that GAB1 then acts as a substrate for the enzyme.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Roshan, B (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Nephrol, 330 Brookline Ave,Dana 517, Boston, MA 02215 USA.		Eldred, A./AAS-3702-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054911, R01DK048871] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48871, DK54911] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARROS EJG, 1995, P NATL ACAD SCI USA, V92, P4412, DOI 10.1073/pnas.92.10.4412; Cantley LG, 1996, AM J PHYSIOL-RENAL, V271, pF1103, DOI 10.1152/ajprenal.1996.271.6.F1103; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Hanazono Y, 1996, BIOCHEM BIOPH RES CO, V222, P330, DOI 10.1006/bbrc.1996.0744; HARRISONFINDIK D, 1995, ONCOGENE, V10, P1385; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kjelsberg C, 1997, AM J PHYSIOL-RENAL, V272, pF222, DOI 10.1152/ajprenal.1997.272.2.F222; LoGrasso PV, 1996, P NATL ACAD SCI USA, V93, P12165, DOI 10.1073/pnas.93.22.12165; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Milia E, 1996, ONCOGENE, V13, P767; MORRISON P, 1993, J BIOL CHEM, V268, P15536; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; Pratt JC, 1996, J BIOL CHEM, V271, P12137, DOI 10.1074/jbc.271.21.12137; TRUB T, 1995, J BIOL CHEM, V270, P18205; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0	22	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36362	36368		10.1074/jbc.274.51.36362	http://dx.doi.org/10.1074/jbc.274.51.36362			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593929	hybrid			2022-12-27	WOS:000084279200048
J	Shin, OH; Ross, AH; Mihai, I; Exton, JH				Shin, OH; Ross, AH; Mihai, I; Exton, JH			Identification of arfophilin, a target protein for GTP-bound class II ADP-ribosylation factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI MEMBRANES; NUCLEOTIDE EXCHANGE; ACTIVATING PROTEIN; MAMMALIAN-CELLS; PLASMA-MEMBRANE; ARF PROTEINS; EXPRESSION; FAMILY	Yeast two-hybrid screening of a human kidney cDNA library using the GTP-bound form of a class II ADP-ribosylation factor (ARF5) identified a novel ARF5-binding protein with a calculated molecular mass of 82.4 kDa, which was named arfophilin, Northern hybridization analysis showed high level arfophilin mRNA expression in human heart and skeletal muscle. Arfophilin bound only to the active, GTP-bound form of ARF5 and did not bind to GTP-ARF3, which is a class I ARF. The N terminus of ARF5 (1-17 amino acids) was essential for binding to arfophilin. The GTP-bound form of ARF5 with amino acid residues in the N terminus mutated to those in ARF4 (another class II ARF) also bound to arfophilin, suggesting it is a target protein for GTP-bound forms of class II ARFs. The binding site for ARF on arfophilin was localized to the C terminus (residues 612-756), which contains putative coiled-coil structures. Recombinant arfophilin overexpressed in CHO-K1 cells was localized in the cytosol and translocated to a membrane fraction in association with GTP-bound ARF5. ARF5 containing the N terminus of ARF3 did not promote translocation indicating that class II ARFs are specific carriers for arfophilin.	Vanderbilt Univ, Howard Hughes Med Inst, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Physiol & Mol Biophys, Sch Med, Nashville, TN 37232 USA	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University	Exton, JH (corresponding author), Vanderbilt Univ, Howard Hughes Med Inst, Sch Med, 221 Kirkland Hall, Nashville, TN 37232 USA.							BALCH WE, 1992, J BIOL CHEM, V267, P13053; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Deitz SB, 1996, MOL CELL BIOL, V16, P3275; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Gaschet J, 1999, J BIOL CHEM, V274, P20040, DOI 10.1074/jbc.274.28.20040; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gress TM, 1996, ONCOGENE, V13, P1819; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KAHN RA, 1995, J BIOL CHEM, V270, P143, DOI 10.1074/jbc.270.1.143; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Liang JO, 1997, J BIOL CHEM, V272, P4141, DOI 10.1074/jbc.272.7.4141; Mansour SJ, 1999, P NATL ACAD SCI USA, V96, P7968, DOI 10.1073/pnas.96.14.7968; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Roth MG, 1999, CELL, V97, P149, DOI 10.1016/S0092-8674(00)80723-0; Sata M, 1999, P NATL ACAD SCI USA, V96, P2752, DOI 10.1073/pnas.96.6.2752; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TSAI SC, 1992, P NATL ACAD SCI USA, V89, P9272, DOI 10.1073/pnas.89.19.9272; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772	27	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36609	36615		10.1074/jbc.274.51.36609	http://dx.doi.org/10.1074/jbc.274.51.36609			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593962	hybrid			2022-12-27	WOS:000084279200081
J	Sorgen, PL; Bubb, MR; Cain, BD				Sorgen, PL; Bubb, MR; Cain, BD			Lengthening the second stalk of F1F0 ATP synthase in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-SUBUNIT; DELTA-SUBUNIT; SUPPRESSOR MUTATIONS; MUTAGENIC ANALYSIS; GAMMA-SUBUNIT; F-0 PARTS; 2ND STALK; F1-ATPASE; EPSILON; SECTOR	In Escherichia coli F1F0 ATP synthase, the two b subunits dimerize forming the peripheral second stalk linking the membrane F-0 sector to F-1. Previously, we have demonstrated that the enzyme could accommodate relatively large deletions in the b subunits while retaining function (Sorgen, P, L., Caviston, T, L., Perry, R. C., and Cain, B. D. (1998) J. Biol. Chem. 273, 27873-27878). The manipulations of b subunit length have been extended by construction of insertion mutations into the uncF(b) gene adding amino acids to the second stalk Mutants with insertions of seven amino acids were essentially identical to wild type strains, and mutants with insertions of up to 14 amino acids retained biologically significant levels of activity. Membranes prepared from these strains had readily detectable levels of F1F0-ATPase activity and proton pumping activity. However, the larger insertions resulted in decreasing levels of activity, and immunoblot analysis indicated that these reductions in activity correlated with reduced levels of b subunit in the membranes. Addition of 18 amino acids was sufficient to result in the loss of F1F0 ATP synthase function. Assuming the predicted alpha-helical structure for this area of the b subunit, the 14-amino acid insertion would result in the addition of enough material to lengthen the b subunit by as much as 20 Angstrom. The results of both insertion and deletion experiments support a model in which the second stalk is a flexible feature of the enzyme rather than a rigid rod-like structure.	Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Univ Florida, Dept Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cain, BD (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Box 100245, Gainesville, FL 32610 USA.	bcain@biochem.med.ufl.edu			NIGMS NIH HHS [GM43495] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043495] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ARIS JP, 1985, J BIOL CHEM, V260, P1207; Bulygin VV, 1998, J BIOL CHEM, V273, P31765, DOI 10.1074/jbc.273.48.31765; CAIN BD, 1986, J BIOL CHEM, V261, P43; CAIN BD, 1989, J BIOL CHEM, V264, P3292; CAPALDI RA, 1994, TRENDS BIOCHEM SCI, V19, P284, DOI 10.1016/0968-0004(94)90006-X; Caviston TL, 1998, FEBS LETT, V429, P201, DOI 10.1016/S0014-5793(98)00597-3; Cherepanov DA, 1999, FEBS LETT, V449, P1, DOI 10.1016/S0014-5793(99)00386-5; DECKERSHEBESTREIT G, 1992, J BIOL CHEM, V267, P12364; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; DUNN SD, 1992, J BIOL CHEM, V267, P7630; Dunn SD, 1998, J BIOL CHEM, V273, P8646, DOI 10.1074/jbc.273.15.8646; Fillingame RH, 1998, BBA-BIOENERGETICS, V1365, P135, DOI 10.1016/S0005-2728(98)00053-X; HARTZOG PE, 1994, J BIOL CHEM, V269, P32313; Hermolin J, 1999, J BIOL CHEM, V274, P17011, DOI 10.1074/jbc.274.24.17011; HERMOLIN J, 1983, J BIOL CHEM, V258, P4550; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MCCORMICK KA, 1993, J BIOL CHEM, V268, P24683; MCCORMICK KA, 1991, J BACTERIOL, V173, P7240, DOI 10.1128/jb.173.22.7240-7248.1991; McLachlin DT, 1998, J BIOL CHEM, V273, P15162, DOI 10.1074/jbc.273.24.15162; McLachlin DT, 1997, J BIOL CHEM, V272, P21233, DOI 10.1074/jbc.272.34.21233; Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ogilvie I, 1997, J BIOL CHEM, V272, P16652, DOI 10.1074/jbc.272.26.16652; PERLIN DS, 1983, J BIOL CHEM, V258, P9793; PORTER ACG, 1985, J BIOL CHEM, V260, P8182; Rodgers AJW, 1997, J BIOL CHEM, V272, P31058, DOI 10.1074/jbc.272.49.31058; ROGERS AJW, 1998, J BIOL CHEM, V273, P29406; Sabbert D, 1997, P NATL ACAD SCI USA, V94, P4401, DOI 10.1073/pnas.94.9.4401; Sawada K, 1997, J BIOL CHEM, V272, P30047, DOI 10.1074/jbc.272.48.30047; Sorgen PL, 1998, BIOCHEMISTRY-US, V37, P923, DOI 10.1021/bi972309+; Sorgen PL, 1998, J BIOL CHEM, V273, P27873, DOI 10.1074/jbc.273.43.27873; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Watts SD, 1996, J BIOL CHEM, V271, P28341, DOI 10.1074/jbc.271.45.28341; Wilkens S, 1998, NATURE, V393, P29, DOI 10.1038/29908; Yamane Y, 1998, J BIOL CHEM, V273, P7375, DOI 10.1074/jbc.273.13.7375; ZHANG Y, 1995, J BIOL CHEM, V270, P24609, DOI 10.1074/jbc.270.41.24609; ZHANG Y, 1994, J BIOL CHEM, V269, P10221	41	56	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36261	36266		10.1074/jbc.274.51.36261	http://dx.doi.org/10.1074/jbc.274.51.36261			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593914	hybrid			2022-12-27	WOS:000084279200033
J	Vadas, A; Monbouquette, HG; Johnson, E; Schroder, I				Vadas, A; Monbouquette, HG; Johnson, E; Schroder, I			Identification and characterization of a novel ferric reductase from the hyperthermophilic Archaeon Archaeoglobus fulgidus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE-REDUCING ARCHAEBACTERIUM; ESCHERICHIA-COLI; IRON REDUCTASE; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHARACTERIZATION; DEDUCED FUNCTIONS; PLASMA-MEMBRANE; SP-NOV; GENES; CLONING	Archaeoglobus fulgidus, a hyperthermophilic sulfate-reducing Archaeon, contains high Fe3+-EDTA reductase activity in its soluble protein fraction. The corresponding enzyme, which constitutes about 0.75% of the soluble protein, was purified 175-fold to homogeneity, Based on SDS-polyacrylamide gel electrophoresis, the ferric reductase consists of a single subunit with a M-r of 18,000, The M-r of the native enzyme was determined by size exclusion chromatography to be 40,000 suggesting that the native ferric reductase is a homodimer, The enzyme uses both NADH and NADPH as electron donors to reduce Fe3+-EDTA. Other Fe3+ complexes and dichlorophenolindophenol serve as alternative electron accepters, but uncomplexed Fe3+ is not utilized. The purified enzyme strictly requires FMN or FAD as a catalytic intermediate for Fe3+ reduction. Ferric reductase also reduces FMN and FAD, but not riboflavin, with NAD(P)H which classifies the enzyme as a NAD(P)H:flavin oxidoreductase. The enzyme exhibits a temperature optimum of 88 degrees C. When incubated at 85 degrees C, the enzyme activity half-life was 2 h, N-terminal sequence analysis of the purified ferric reductase resulted in the identification of the hypothetical gene, AF0830, of the A. fulgidus genomic sequence. The A. fulgidus ferric reductase shares amino acid sequence similarity with a family of NAD(P)H:FMN oxidoreductases but not with any ferric reductases suggesting that the A. fulgidus ferric reductase is a novel enzyme.	Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Schroder, I (corresponding author), Univ Calif Los Angeles, Dept Microbiol & Mol Genet, 1602 Mol Sci Bldg, Los Angeles, CA 90095 USA.		Monbouquette, Harold/GNW-3860-2022	Monbouquette, Harold/0000-0001-8144-8189	NHLBI NIH HHS [HL-16251] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aalen N, 1997, ARCH MICROBIOL, V168, P536, DOI 10.1007/s002030050533; AIBA H, 1996, DNA RES, V3, P137; Aubert C, 1998, APPL ENVIRON MICROB, V64, P1308; Barchini E, 1996, ARCH MICROBIOL, V166, P51, DOI 10.1007/s002030050354; Beltrametti F, 1997, APPL ENVIRON MICROB, V63, P2232, DOI 10.1128/AEM.63.6.2232-2239.1997; BERCZI A, 1995, ARCH BIOCHEM BIOPHYS, V320, P65, DOI 10.1006/abbi.1995.1343; BIBB MJ, 1994, GENE, V142, P31, DOI 10.1016/0378-1119(94)90351-4; BLANC V, 1995, J BACTERIOL, V177, P5206, DOI 10.1128/jb.177.18.5206-5214.1995; BRIAT JF, 1992, J GEN MICROBIOL, V138, P2475, DOI 10.1099/00221287-138-12-2475; BRUGGEMANN W, 1990, PHYSIOL PLANTARUM, V79, P339; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; COVES J, 1993, EUR J BIOCHEM, V211, P635, DOI 10.1111/j.1432-1033.1993.tb17591.x; DAHL C, 1993, J GEN MICROBIOL, V139, P1817, DOI 10.1099/00221287-139-8-1817; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; ESCHENBRENNER M, 1994, BIOCHEM BIOPH RES CO, V198, P127, DOI 10.1006/bbrc.1994.1018; FERNANDEZMORENO MA, 1992, J BIOL CHEM, V267, P19278; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; FONTECAVE M, 1994, BIOMETALS, V7, P3; Gibello A, 1997, ARCH MICROBIOL, V167, P160, DOI 10.1007/s002030050429; GORBY YA, 1991, APPL ENVIRON MICROB, V57, P867, DOI 10.1128/AEM.57.3.867-870.1991; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; HUYER M, 1989, J BACTERIOL, V171, P4031, DOI 10.1128/jb.171.7.4031-4037.1989; KENDREW SG, 1995, J BIOL CHEM, V270, P17339, DOI 10.1074/jbc.270.29.17339; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Knobel HR, 1996, J BACTERIOL, V178, P6123, DOI 10.1128/jb.178.21.6123-6132.1996; Langelandsvik AS, 1997, ARCH MICROBIOL, V168, P59, DOI 10.1007/s002030050470; LEFAOU AE, 1991, BIOL MET, V4, P126; LESUISSE E, 1990, BIOCHIM BIOPHYS ACTA, V1038, P253, DOI 10.1016/0167-4838(90)90213-Y; LOVLEY DR, 1993, ANNU REV MICROBIOL, V47, P263, DOI 10.1146/annurev.mi.47.100193.001403; MOODY MD, 1985, J BACTERIOL, V163, P1120, DOI 10.1128/JB.163.3.1120-1125.1985; ODOM JM, 1984, ANNU REV MICROBIOL, V38, P551, DOI 10.1146/annurev.mi.38.100184.003003; Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996; SCHRODER I, 1994, J BACTERIOL, V176, P4985, DOI 10.1128/jb.176.16.4985-4992.1994; Seeliger S, 1998, J BACTERIOL, V180, P3686, DOI 10.1128/JB.180.14.3686-3691.1998; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; Slobodkin A, 1997, INT J SYST BACTERIOL, V47, P541, DOI 10.1099/00207713-47-2-541; Sparla F, 1997, FEBS LETT, V414, P571, DOI 10.1016/S0014-5793(97)01073-9; SPEICH N, 1988, J GEN MICROBIOL, V134, P1419; SPYROU G, 1991, J BACTERIOL, V173, P3673, DOI 10.1128/JB.173.12.3673-3679.1991; Steen IH, 1997, ARCH MICROBIOL, V168, P412, DOI 10.1007/s002030050516; UETZ T, 1992, J BACTERIOL, V174, P1179, DOI 10.1128/jb.174.4.1179-1188.1992; Vargas M, 1998, NATURE, V395, P65, DOI 10.1038/25720; Wasserfallen A, 1998, EUR J BIOCHEM, V254, P325, DOI 10.1046/j.1432-1327.1998.2540325.x; Xu YR, 1997, J BACTERIOL, V179, P1112, DOI 10.1128/jb.179.4.1112-1116.1997; ZELLNER G, 1989, SYST APPL MICROBIOL, V11, P151, DOI 10.1016/S0723-2020(89)80055-4	45	50	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36715	36721		10.1074/jbc.274.51.36715	http://dx.doi.org/10.1074/jbc.274.51.36715			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593977	hybrid			2022-12-27	WOS:000084279200096
J	Ho, GY; MacKenzie, RG				Ho, GY; MacKenzie, RG			Functional characterization of mutations in melanocortin-4 receptor associated with human obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MOLECULAR-CLONING; FRAMESHIFT MUTATION; TRUNCATION MUTANTS; PLASMA-MEMBRANE; MSH RECEPTOR; V2 RECEPTOR; FOOD-INTAKE; LEPTIN; EXPRESSION	Melanocortin-4 receptor (MC4R) is a G protein-coupled receptor implicated in the regulation of body weight. Genetic studies in humans have identified two frameshift mutations of MC4R associated with a dominantly inherited form of obesity. We have generated and expressed the corresponding MC4R mutants in 293T cells and found that cells transfected with the truncation mutants failed to exhibit agonist binding or responsiveness despite retention of structural motifs potentially sufficient for binding and signaling. Immunofluorescence studies showed that the mutant proteins were expressed and localized in the intracellular compartment but absent from the plasma membrane, suggesting that these mutations disrupted the proper cellular transport of MC4R. Further studies identified a sequence in the cytoplasmic tail of MC4R necessary for the cell surface targeting. We further investigated a possible dominant-negative activity of the mutants on wildtype receptor function. Co-transfection studies showed that the mutants affected neither signaling nor cell surface expression of wild-type MC4R. We also characterized three human sequence variants of MC4R, but these exhibited identical affinities for peptide ligands and identical agonist responsiveness. Thus, unlike the obesity-associated MC4R truncation mutants, the polymorphisms of MC4R are unlikely to be contributors to human obesity.	Parke Davis Pharmaceut Res, Dept Cell Biol, Ann Arbor, MI 48105 USA	Pfizer	MacKenzie, RG (corresponding author), Parke Davis Pharmaceut Res, Dept Cell Biol, 2800 Plymouth Rd, Ann Arbor, MI 48105 USA.	Robert.MacKenzie@wl.com						Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1994, BIOCHEM BIOPH RES CO, V200, P1214, DOI 10.1006/bbrc.1994.1580; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Gotoda T, 1997, DIABETOLOGIA, V40, P976, DOI 10.1007/s001250050777; GRIFFON N, 1994, BIOCHEM BIOPH RES CO, V200, P1007, DOI 10.1006/bbrc.1994.1550; Gu W, 1999, DIABETES, V48, P635, DOI 10.2337/diabetes.48.3.635; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; Heymann JAW, 1997, P NATL ACAD SCI USA, V94, P4966, DOI 10.1073/pnas.94.10.4966; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; HO GY, 1995, J BIOL CHEM, V270, P27977, DOI 10.1074/jbc.270.46.27977; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kask A, 1998, EUR J PHARMACOL, V360, P15, DOI 10.1016/S0014-2999(98)00699-2; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; LABBE O, 1994, BIOCHEMISTRY-US, V33, P4543, DOI 10.1021/bi00181a015; Ling K, 1999, P NATL ACAD SCI USA, V96, P7922, DOI 10.1073/pnas.96.14.7922; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nimchinsky EA, 1997, J BIOL CHEM, V272, P29229, DOI 10.1074/jbc.272.46.29229; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Schulein R, 1996, BIOCHEM J, V313, P611, DOI 10.1042/bj3130611; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; UNSON CG, 1995, J BIOL CHEM, V270, P27720, DOI 10.1074/jbc.270.46.27720; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; XIONG X, 1995, CURR OPIN CELL BIOL, V7, P523; Yang YK, 1997, J BIOL CHEM, V272, P23000, DOI 10.1074/jbc.272.37.23000; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	49	104	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35816	35822		10.1074/jbc.274.50.35816	http://dx.doi.org/10.1074/jbc.274.50.35816			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585465	hybrid			2022-12-27	WOS:000084187900077
J	Chou, TT; Trojanowski, JQ; Lee, VMY				Chou, TT; Trojanowski, JQ; Lee, VMY			A novel apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE NEUROECTODERMAL TUMORS; TYROSINE KINASE-ACTIVITY; CELL-LINES; SIGNAL-TRANSDUCTION; PROTEIN; RAS; NGF; RECEPTORS; PHOSPHORYLATION; EXPRESSION	Nerve growth factor (NGF) induces apoptosis in a human medulloblastoma cell line (MED283) engineered to express TrkA (MED283-TrkA) (Muragaki, Y., Chou, T. T., Haplan, D. R., Trojanowski, J. Q., and Lee, V. M. (1997) J. Neurosci. 17, 530-542), To dissect the molecular signaling pathway that mediates this novel effect, specific receptor mutations in Trk have been employed, We showed that phosphorylation of tyrosine 490 is required for activation of phosphoinositide 3-OH kinase, whereas phosphorylation of tyrosine 785 is required for activation of phospholipase C-gamma, TrkA-mediated apoptosis was abolished when either the ATP-binding site or both tyrosines 490 and 785 were mutated. Because tyrosines 490 and 785 mediate redundant signaling through the Ras-extracellular signal-regulated kinase (Ras-ERK) pathway, we examined the role of Ras-ERK signaling in NGF-induced apoptosis, We found that MED283-TrkA cells expressing a dominant negative Ras inhibitor (N17Ras) failed to undergo ERK activation and apoptosis following NGF treatment, whereas the ERK kinase (mitogen-activated protein kinase kinase) inhibitors PD98059 and U0126 eliminated ERK activation but had no effect on apoptosis, We infer from these data that NGF-induced apoptosis is mediated by a novel Ras and/or Raf signaling pathway.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, 3rd Floor Maloney Bldg,36th & Spruce St, Philadelphia, PA 19104 USA.							ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BERG MM, 1992, J BIOL CHEM, V267, P13; BIGNER SH, 1990, CANCER RES, V50, P2347; Bruggers CS, 1998, J PEDIAT HEMATOL ONC, V20, P18, DOI 10.1097/00043426-199801000-00003; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; FRIEDMAN HS, 1985, J NEUROPATH EXP NEUR, V44, P592, DOI 10.1097/00005072-198511000-00005; FUNG KM, 1995, J NEUROPATH EXP NEUR, V54, P285, DOI 10.1097/00005072-199505000-00001; Giasson BI, 1996, J BIOL CHEM, V271, P30404, DOI 10.1074/jbc.271.48.30404; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hallberg B, 1998, ONCOGENE, V17, P691, DOI 10.1038/sj.onc.1201980; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kim JYH, 1999, CANCER RES, V59, P711; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LILLIEN LE, 1985, NATURE, V317, P632, DOI 10.1038/317632a0; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; Muragaki Y, 1997, J NEUROSCI, V17, P530; MURAGAKI Y, 1995, J COMP NEUROL, V356, P387, DOI 10.1002/cne.903560306; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; Rorke LB, 1997, BRAIN PATHOL, V7, P765, DOI 10.1111/j.1750-3639.1997.tb01063.x; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; YAN GZ, 1995, J NEUROSCI, V15, P6200; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	44	48	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					565	570		10.1074/jbc.275.1.565	http://dx.doi.org/10.1074/jbc.275.1.565			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617652	hybrid			2022-12-27	WOS:000085951600076
J	Ghoshal, K; Majumder, S; Li, ZL; Dong, XC; Jacob, ST				Ghoshal, K; Majumder, S; Li, ZL; Dong, XC; Jacob, ST			Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT-HOMOLOGOUS SEQUENCES; TRANSCRIPTION FACTOR MTF-1; BINDING-PROTEIN MECP2; RNA POLYMERASE-I; CPG METHYLATION; 5-METHYLCYTOSINE CONTENT; HISTONE DEACETYLASE; OXIDATIVE STRESS; ANTICANCER DRUGS; MOUSE	Metallothionein I can be induced in response to a variety of agents that include heavy metals and oxidative stress, On the contrary, its induction was suppressed in some lymphoid-derived cancer cells. The mechanism of this repression has not been elucidated. Here, we show silencing of MT I gene in a solid transplanted rat tumor as a result of promoter methylation at all the 21 CpG dinucleotides that span the region from -225 bp to +1 bp. By contrast, none of these CpG dinucleotides were methylated in the livers from the rats bearing the tumor, which was consistent with the efficient induction of the gene in this tissue by zinc sulfate. Genomic footprinting revealed lack of access of the transcriptional activators to the respective cis-acting elements of the methylated MT-I promoter in the hepatoma. The absence of footprinting was not due to inactivation of the metal regulatory transcription factor MTF-1, because it was highly active in the hepatoma. Treatment of the hepatoma bearing rats with 5-azacytidine, a demethylating agent, induced basal as well as heavy metal-activated MT-I gene expression in the hepatoma, implying that methylation was indeed responsible for silencing the gene. Bisulfite genomic sequencing showed significant (>90%) demethylation of CPG dinucleotides spanning MT-I promoter in the hepatoma following treatment with 5-AzaC, The hypermethylation of MT-I promoter was probably caused by significantly higher (as much as 7-fold) level of DNA methyl transferase activity as well as enhanced expression of its gene in the hepatoma relative to the host liver. These data elucidated for the first time the molecular mechanism for the silencing of a highly inducible gene in a solid tumor transplanted in an animal, as compared with the robust induction in the corresponding parental tissue and have discussed the probable reasons for the suppression of this gene in some tumors.	Ohio State Univ, Coll Med, Dept Med Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Jacob, ST (corresponding author), Ohio State Univ, Coll Med, Dept Med Biochem, 333 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.				NCI NIH HHS [CA 61321] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061321] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aniskovitch LP, 1997, ARCH BIOCHEM BIOPHYS, V341, P337, DOI 10.1006/abbi.1997.9976; Aniskovitch LP, 1998, ONCOGENE, V16, P1475, DOI 10.1038/sj.onc.1201659; Aschner M, 1997, TOXICOL APPL PHARM, V142, P229, DOI 10.1006/taap.1996.8054; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Baylin SB, 1998, ADV CANCER RES, V72, P141; Baylin SB, 1997, SCIENCE, V277, P1948, DOI 10.1126/science.277.5334.1948; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bossard P, 1997, METHODS, V11, P180, DOI 10.1006/meth.1996.0404; CAGATAY G, 1998, EMBO J, V17, P2846; Cai L, 1998, ANTICANCER RES, V18, P4667; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; COMPERE SJ, 1981, CELL, V25, P233, DOI 10.1016/0092-8674(81)90248-8; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; DATTA PK, 1993, CELL MOL BIOL RES, V39, P439; Datta PK, 1997, BIOCHEM BIOPH RES CO, V230, P159, DOI 10.1006/bbrc.1996.5655; DUCEMAN BW, 1981, J BIOL CHEM, V256, P755; Duncan EL, 1999, ONCOGENE, V18, P897, DOI 10.1038/sj.onc.1202370; FEINBERG AP, 1988, CANCER RES, V48, P1159; Fiala ES, 1998, CARCINOGENESIS, V19, P597, DOI 10.1093/carcin/19.4.597; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Ghoshal K, 1998, P NATL ACAD SCI USA, V95, P10390, DOI 10.1073/pnas.95.18.10390; Ghoshal K, 1998, J BIOL CHEM, V273, P27904, DOI 10.1074/jbc.273.43.27904; GLANVILLE N, 1981, NATURE, V292, P267, DOI 10.1038/292267a0; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Hiltunen MO, 1997, BRIT J CANCER, V76, P1124, DOI 10.1038/bjc.1997.522; Jacob ST, 1999, GENE EXPRESSION, V7, P301; Jaenisch R, 1998, CIBA F SYMP, V214, P200; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KAGI JHR, 1991, METHOD ENZYMOL, V205, P613; Kang YJ, 1999, AM J PHYSIOL-HEART C, V276, pH993, DOI 10.1152/ajpheart.1999.276.3.H993; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; KELLEY SL, 1988, SCIENCE, V241, P1813, DOI 10.1126/science.3175622; Kho MR, 1998, J MOL BIOL, V275, P67, DOI 10.1006/jmbi.1997.1430; KLOTH DM, 1995, BRIT J CANCER, V71, P712, DOI 10.1038/bjc.1995.139; KONDO Y, 1995, CANCER RES, V55, P2021; Kosaki K, 1997, AM J MED GENET, V73, P308; LAZO JS, 1995, J BIOL CHEM, V270, P5506, DOI 10.1074/jbc.270.10.5506; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LI E, 1993, COLD SPRING HARB SYM, V58, P297, DOI 10.1101/SQB.1993.058.01.035; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; Majumder S, 1999, J BIOL CHEM, V274, P28584, DOI 10.1074/jbc.274.40.28584; Mancini DN, 1998, ONCOGENE, V16, P1161, DOI 10.1038/sj.onc.1201630; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Nan XS, 1998, CIBA F SYMP, V214, P6; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Palmiter R D, 1987, Experientia Suppl, V52, P63; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; Ping DS, 1996, IMMUNITY, V4, P455, DOI 10.1016/S1074-7613(00)80412-4; Pogribny IP, 1997, CANCER LETT, V115, P31, DOI 10.1016/S0304-3835(97)04708-3; Quaife CJ, 1999, TOXICOL APPL PHARM, V155, P107, DOI 10.1006/taap.1998.8609; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Radtke F, 1996, BIOL CHEM H-S, V377, P47, DOI 10.1515/bchm3.1996.377.1.47; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; ROSE KM, 1981, P NATL ACAD SCI-BIOL, V78, P2833, DOI 10.1073/pnas.78.5.2833; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Schroeder M, 1997, BIOCHEM BIOPH RES CO, V235, P403, DOI 10.1006/bbrc.1997.6796; Schwemmle S, 1997, AM J HUM GENET, V60, P1354, DOI 10.1086/515456; Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105; Tajima S, 1998, J BIOCHEM-TOKYO, V123, P993, DOI 10.1093/oxfordjournals.jbchem.a022066; Tate P, 1996, NAT GENET, V12, P205, DOI 10.1038/ng0296-205; THIELE DJ, 1992, NUCLEIC ACIDS RES, V20, P1183, DOI 10.1093/nar/20.6.1183; Tollefsbol TO, 1997, J MOL BIOL, V269, P494, DOI 10.1006/jmbi.1997.1064; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	78	76	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					539	547		10.1074/jbc.275.1.539	http://dx.doi.org/10.1074/jbc.275.1.539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617649	hybrid			2022-12-27	WOS:000085951600073
J	Palacino, JJ; Berechid, BE; Alexander, P; Eckman, C; Younkin, S; Nye, JS; Wolozin, B				Palacino, JJ; Berechid, BE; Alexander, P; Eckman, C; Younkin, S; Nye, JS; Wolozin, B			Regulation of amyloid precursor protein processing by presenilin 1 (PS1) and PS2 in PS1 knockout cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; BETA-PROTEIN; KINASE-C; IN-VIVO; APOPTOSIS; GENE; MUTATIONS; RELEASE; MICE; EXPRESSION	The presenilin 1 (PS1) and PS2 proteins are thought to play roles in processing of amyloid precursor protein (APP), but the nature of this role is not fully understood. Recent studies have shown that PS1 is necessary for cleavage of APP at the gamma-secretase site. We now show that PS1 and PS2 participate in other aspects of APP processing. Fibroblasts generated from PS1 knockout mice have increased levels of the APP cleavage products, secreted APP (APPs), and APP C-terminal fragments, but lower secretion of APPs and A beta. We have also observed that loss of PS1 prevents protein kinase C or extracellular regulated kinase from increasing production of the APP cleavage products, APPs, and APP C-terminal fragments. Transfection of PS1 -/- cells with PS1 restores the responsiveness of APP processing to protein kinase C and extracellular regulated kinase. This suggests that the changes in APP processing in PS1 -/- cells result strictly from the absence of PS1. Transfection of PS1 -/- cells with PS2 is also able to correct the deficits in APP secretion, which suggests that the PS2 also has the ability to regulate APP processing, Finally, transfection of the truncated PS2 construct, Alg3, into cells lacking PS1 increases APP C-terminal fragments, This suggests that Alg3 can interfere with the processing of APP by PS2, These data point to roles for both PS1 and PS2 in regulating APP processing and suggest that the role of these proteins also includes coupling APP to signal transduction pathways.	Loyola Univ, Med Ctr, Dept Pharmacol, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Neurosci Program, Maywood, IL 60153 USA; Northwestern Univ, Dept Mol Pharmacol, Chicago, IL 60611 USA; Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; Mayo Clin, Dept Pharmacol, Jacksonville, FL 32224 USA	Loyola University Chicago; Loyola University Chicago; Northwestern University; Northwestern University; Mayo Clinic	Wolozin, B (corresponding author), Loyola Univ, Med Ctr, Dept Pharmacol, Bldg 102,Rm 3634,2160 S 1st Ave, Maywood, IL 60153 USA.		Nye, Jeffrey/G-6520-2012	Nye, Jeffrey/0000-0002-6056-281X	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH012479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013854] Funding Source: NIH RePORTER; NIA NIH HHS [AG13854] Funding Source: Medline; NIMH NIH HHS [1F31MH12479-01] Funding Source: Medline; NINDS NIH HHS [NS35566] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ancolio K, 1997, J NEUROCHEM, V69, P2494, DOI 10.1046/j.1471-4159.1997.69062494.x; Berechid BE, 1999, CURR BIOL, V9, P1493, DOI 10.1016/S0960-9822(00)80121-9; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Buxbaum JD, 1996, ANN NY ACAD SCI, V777, P327, DOI 10.1111/j.1749-6632.1996.tb34441.x; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; Davis JA, 1998, NEURON, V20, P603, DOI 10.1016/S0896-6273(00)80998-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Guo Q, 1997, J NEUROSCI, V17, P4212; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Mills J, 1997, J NEUROSCI, V17, P9415; Murayama M, 1998, FEBS LETT, V433, P73, DOI 10.1016/S0014-5793(98)00886-2; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Qian S, 1998, NEURON, V20, P611, DOI 10.1016/S0896-6273(00)80999-X; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1996, COLD SPRING HARB SYM, V61, P587; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Slack BE, 1997, BIOCHEM J, V327, P245, DOI 10.1042/bj3270245; SLACK BE, 1993, J BIOL CHEM, V268, P21097; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Vito P, 1997, J BIOL CHEM, V272, P28315, DOI 10.1074/jbc.272.45.28315; Vito P, 1996, J BIOL CHEM, V271, P31025, DOI 10.1074/jbc.271.49.31025; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Weidemann A, 1997, NAT MED, V3, P328, DOI 10.1038/nm0397-328; White AR, 1998, J NEUROSCI, V18, P6207; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wolozin B, 1998, NEUROBIOL AGING, V19, pS23, DOI 10.1016/S0197-4580(98)00041-4; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	45	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					215	222		10.1074/jbc.275.1.215	http://dx.doi.org/10.1074/jbc.275.1.215			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617607	hybrid			2022-12-27	WOS:000085951600031
J	Gardsvoll, H; Dano, K; Ploug, M				Gardsvoll, H; Dano, K; Ploug, M			Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT REGULATORY PROTEIN; LINKED-IMMUNOSORBENT-ASSAY; MUTATIONAL ANALYSIS; MONOCLONAL-ANTIBODY; NH2-TERMINAL DOMAIN; KAPPA-BUNGAROTOXIN; CELLULAR RECEPTOR; CRYSTAL-STRUCTURE; DISULFIDE BONDS; HUMAN-TUMOR	The urokinase-type plasminogen activator receptor (uPAR) is a glycolipid anchored multidomain member of the Ly-6/uPAR protein domain superfamily. Studies by site-directed photoaffinity labeling, chemical cross-linking, and ligand-induced protection against chemical modification have highlighted the possible involvement of uPAR domain I and particularly loop 3 thereof in ligand binding (Ploug, RI. (1998) Biochemistry 37, 16494-16505). Guided by these results we have now performed an alanine scanning analysis of this region in uPAR by site-directed mutagenesis and subsequently measured the effects thereof on the kinetics of uPA binding in real-time by surface plasmon resonance. Only four positions in loop 3 of uPAR domain I exhibited significant changes in the contribution to the free energy of uPA binding (Delta Delta G greater than or equal to 1.3 kcal mol(-1)) upon single-site substitutions to alanine (i.e. Arg(53), Leu(55), Tyr(57), and Leu(66)). The energetic impact of these four alanine substitutions was not caused by gross structural perturbations, since all monoclonal antibodies tested having conformation-dependent epitopes on this domain exhibited unaltered binding kinetics, These sites together with a three-dimensional structure for uPAR may provide an appropriate target for rational drug design aimed at developing new receptor binding antagonists with potential application in cancer therapy.	Rigshosp, Finsen Lab, DK-2100 Copenhagen O, Denmark	Rigshospitalet	Ploug, M (corresponding author), Rigshosp, Finsen Lab, Strandboulevarden 49, DK-2100 Copenhagen O, Denmark.			Ploug, Michael/0000-0003-2215-4265				Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Behrendt N, 1996, J BIOL CHEM, V271, P22885, DOI 10.1074/jbc.271.37.22885; BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; Bodian DL, 1997, J EXP MED, V185, P507, DOI 10.1084/jem.185.3.507; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bugge TH, 1998, ONCOGENE, V16, P3097, DOI 10.1038/sj.onc.1201869; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; CROWLEY CW, 1993, P NATL ACAD SCI USA, V90, P5021, DOI 10.1073/pnas.90.11.5021; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; DANO K, 1994, FIBRINOLYSIS, V8, P189, DOI 10.1016/0268-9499(94)90717-X; Dear AE, 1998, EUR J BIOCHEM, V252, P185, DOI 10.1046/j.1432-1327.1998.2520185.x; DEWAN JC, 1994, BIOCHEMISTRY-US, V33, P13147, DOI 10.1021/bi00248a026; ELLIS V, 1989, J BIOL CHEM, V264, P2185; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; Evans CP, 1997, CANCER RES, V57, P3594; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; HANSEN AP, 1994, BIOCHEMISTRY-US, V33, P4847, DOI 10.1021/bi00182a013; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; KOOK YH, 1994, EMBO J, V13, P3983, DOI 10.1002/j.1460-2075.1994.tb06714.x; Kussmann M, 1997, J MASS SPECTROM, V32, P593; List K, 1999, J IMMUNOL METHODS, V222, P125, DOI 10.1016/S0022-1759(98)00189-6; Luther T, 1997, AM J PATHOL, V150, P1231; Magdolen V, 1996, EUR J BIOCHEM, V237, P743, DOI 10.1111/j.1432-1033.1996.0743p.x; MASUCCI MT, 1991, J BIOL CHEM, V266, P8655; Menez A, 1998, TOXICON, V36, P1557, DOI 10.1016/S0041-0101(98)00148-2; Min HY, 1996, CANCER RES, V56, P2428; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; NIELSEN LS, 1988, J BIOL CHEM, V263, P2358; Noel LS, 1998, J BIOL CHEM, V273, P3878, DOI 10.1074/jbc.273.7.3878; NOVOKHATNY V, 1992, J BIOL CHEM, V267, P3878; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V204, P1212, DOI 10.1006/bbrc.1994.2592; OSSOWSKI L, 1991, CANCER RES, V51, P274; Petranka J, 1996, BLOOD CELL MOL DIS, V22, P281, DOI 10.1006/bcmd.1996.0111; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; PLOUG M, 1994, BIOCHEMISTRY-US, V33, P8991, DOI 10.1021/bi00196a017; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; PLOUG M, 1995, BIOCHEMISTRY-US, V34, P12524, DOI 10.1021/bi00039a006; Ploug M, 1998, BIOCHEMISTRY-US, V37, P16494, DOI 10.1021/bi981203r; PLOUG M, 1993, J BIOL CHEM, V268, P17539; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Ploug M, 1998, BIOCHEMISTRY-US, V37, P3612, DOI 10.1021/bi972787k; Resnati M, 1996, EMBO J, V15, P1572, DOI 10.1002/j.1460-2075.1996.tb00502.x; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; RONNE E, 1991, FEBS LETT, V288, P233, DOI 10.1016/0014-5793(91)81042-7; RONNE E, 1994, J IMMUNOL METHODS, V167, P91, DOI 10.1016/0022-1759(94)90078-7; RONNE E, 1995, BREAST CANCER RES TR, V33, P199, DOI 10.1007/BF00665944; Rosel M, 1998, ONCOGENE, V17, P1989, DOI 10.1038/sj.onc.1202079; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; TESSLER RJ, 1999, APMIS, V107, P168; Yu W, 1997, J CELL BIOL, V137, P767, DOI 10.1083/jcb.137.3.767	58	73	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37995	38003		10.1074/jbc.274.53.37995	http://dx.doi.org/10.1074/jbc.274.53.37995			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608868	hybrid			2022-12-27	WOS:000084528000068
J	Liao, YH; Kariya, K; Hu, CD; Shibatohge, M; Goshima, M; Okada, T; Watari, Y; Gao, XL; Jin, TG; Yamawaki-Kataoka, Y; Kataoka, T				Liao, YH; Kariya, K; Hu, CD; Shibatohge, M; Goshima, M; Okada, T; Watari, Y; Gao, XL; Jin, TG; Yamawaki-Kataoka, Y; Kataoka, T			RA-GEF, a novel Rap1A guanine nucleotide exchange factor containing a Ras/Rap1A-associating domain, is conserved between nematode and humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE EFFECTOR; BINDING PROTEINS; STRUCTURAL BASIS; MAP KINASE; HA-RAS; ACTIVATION; FAMILY; IDENTIFICATION; CLONING; REGION	A yeast two-hybrid screening for Ras-binding proteins in nematode Caenorhabditis elegans has identified a guanine nucleotide exchange factor (GEF) containing a Ras/Rap1A-associating (RA) domain, termed Ce-RA-GEF. Both Ce-RA-GEF and its human counterpart Hs-RA-GEF possessed a PSD-95/DlgA/ZO-1 (PDZ) domain and a Ras exchanger motif (REM) domain in addition to the RA and GEF domains. They also contained a region homologous to a cyclic nucleotide monophosphate-binding domain, which turned out to be incapable of binding cAMP or cGMP. Although the REM and GEF domains are conserved with other GEFs acting on Ras family small GTP-binding proteins, the RA and PDZ domains are unseen in any of them. Hs-RA-GEF exhibited not only a GTP-dependent binding activity to Rap1A at its RA domain but also an activity to stimulate GDP/GTP exchange of Rap1A both in vitro and in, vivo at the segment containing its REM and GEF domains. However, it did not exhibit any binding or GEF activity toward Ras. On the other hand, Ce-RA-GEF associated with and stimulated GDP/GTP exchange of both Ras and Rap1A These results indicate that Ce-RA-GEF and Hs-RA-G;EF define a novel class of Rap1A GEF molecules, which are conserved through evolution.	Kobe Univ, Sch Med, Dept Physiol 2, Chuo Ku, Kobe, Hyogo 6500017, Japan	Kobe University	Kataoka, T (corresponding author), Kobe Univ, Sch Med, Dept Physiol 2, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@kobe-u.ac.jp						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BLUMENTHAL T, 1997, C ELEGANS, V2, P117; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; BRICKMAN E, 1973, J BACTERIOL, V116, P582, DOI 10.1128/JB.116.2.582-587.1973; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Fam NP, 1997, MOL CELL BIOL, V17, P1396, DOI 10.1128/MCB.17.3.1396; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; GIBBS JB, 1995, METHOD ENZYMOL, V255, P118; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; Hu CD, 1995, J BIOL CHEM, V270, P30274, DOI 10.1074/jbc.270.51.30274; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; KRAUSE M, 1995, CAENORHABDITIS ELEGA, P513; KURODA Y, 1993, SCIENCE, V259, P683, DOI 10.1126/science.8430318; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; RANNELS SR, 1983, METHOD ENZYMOL, V99, P168; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; TAYLOR SS, 1989, J BIOL CHEM, V264, P8443; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	38	77	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37815	37820		10.1074/jbc.274.53.37815	http://dx.doi.org/10.1074/jbc.274.53.37815			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608844	hybrid			2022-12-27	WOS:000084528000044
J	Sawai, H; Domae, N; Nagan, N; Hannun, YA				Sawai, H; Domae, N; Nagan, N; Hannun, YA			Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HUMAN ACID SPHINGOMYELINASE; NIEMANN-PICK DISEASE; CANINE KIDNEY-CELLS; LYSOPHOSPHOLIPASE-D; INDUCED APOPTOSIS; ALKALINE SPHINGOMYELINASE; CELLULAR MEMBRANES; INITIATE APOPTOSIS; GENERATE CERAMIDE	Sphingolipids such as ceramide and sphingosine have been regarded as novel signal mediators in cells. However, the mechanisms of generation of these lipids upon various stimulation remain to be elucidated. Neutral sphingomyelinase (N-SMase) is one of the key enzymes in the generation of ceramide, and recently the cloning of a putative N-SMase was reported. Because the function of the protein was unclear in the previous report, we investigated the role it plays in cells. N-SMase activity in cells overexpressing the protein with hexa-histidine tag was immunoprecipitated with anti-hexa histidine antibody. The metabolism of ceramide and SM was not apparently affected in overexpressing cells. Radiolabeling experiments using [H-3]palmitic acid or [H-3] hexadecanol demonstrated an accumulation of 1-O-alkyl-sn-glycerol and a corresponding decrease of 1-alkyl-2-acyl-sn-glycero-3-phosphocholine in overexpressing cells. In vitro studies showed that both 1-acyl-2-lyso-sn-glycero-3-phosphocholine (lyso-PC) and 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-platelet activating factor (lyso-PAF)) are good substrates of the protein. In further radiolabeling experiments, 1-acyl-lyso-PC was predominantly and equally metabolized into diacyl-PC in both vector and overexpressing cells. On the other hand, 1-O-alkyl-lyso-PC (lyso-PAF) was metabolized into both diradyl-PC and 1-O-alkyl-glycerol in overexpressing cells but only into diradyl-PC in vector cells. These results suggest that the protein acts as lyso-PAF-PLC rather than lyso-PC-PLC or N-SMase in cells.	Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Osaka Dent Univ, Dept Med, Hirakata, Osaka 573, Japan; Med Univ S Carolina, Dept Med Lab Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043825, R37GM043825] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43825] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES BN, 1960, J BIOL CHEM, V235, P769; Arthur G, 1998, BBA-LIPID LIPID MET, V1390, P85, DOI 10.1016/S0005-2760(97)00163-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boesen-de Cock JGR, 1998, J BIOL CHEM, V273, P7560, DOI 10.1074/jbc.273.13.7560; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; DAVIS PA, 1981, ARCH BIOCHEM BIOPHYS, V211, P20, DOI 10.1016/0003-9861(81)90424-0; DUAN RD, 1995, BBA-LIPID LIPID MET, V1259, P49, DOI 10.1016/0005-2760(95)00137-2; Duan RD, 1997, HEPATOLOGY, V26, P823, DOI 10.1053/jhep.1997.v26.pm0009328299; Dziewanowska K, 1996, ARCH BIOCHEM BIOPHYS, V335, P102, DOI 10.1006/abbi.1996.0486; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; Goldkorn T, 1998, J CELL SCI, V111, P3209; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; KIM MY, 1991, J BIOL CHEM, V266, P484; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Liu B, 1998, J BIOL CHEM, V273, P34472, DOI 10.1074/jbc.273.51.34472; Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; OKAYASU T, 1986, BIOCHIM BIOPHYS ACTA, V876, P58; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; QUINTERN LE, 1989, EMBO J, V8, P2469, DOI 10.1002/j.1460-2075.1989.tb08382.x; QUINTERN LE, 1987, BIOCHIM BIOPHYS ACTA, V922, P323, DOI 10.1016/0005-2760(87)90055-5; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sawai H, 1997, J BIOL CHEM, V272, P2452; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; SNYDER F, 1990, AM J PHYSIOL, V259, pC697, DOI 10.1152/ajpcell.1990.259.5.C697; SNYDER F, 1995, BBA-LIPID LIPID MET, V1254, P231, DOI 10.1016/0005-2760(94)00192-2; STRUM JC, 1994, J BIOL CHEM, V269, P15493; STRUM JC, 1993, J BIOL CHEM, V268, P25500; TEPPER CG, 1995, P NATL ACAD SCI USA, V92, P8443, DOI 10.1073/pnas.92.18.8443; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; WARNE TR, 1995, J BIOL CHEM, V270, P11147, DOI 10.1074/jbc.270.19.11147; WYKLE RL, 1980, BIOCHIM BIOPHYS ACTA, V619, P58, DOI 10.1016/0005-2760(80)90242-8; WYKLE RL, 1974, J BIOL CHEM, V249, P1742; WYKLE RL, 1977, ARCH BIOCHEM BIOPHYS, V184, P149, DOI 10.1016/0003-9861(77)90336-8	42	86	94	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38131	38139		10.1074/jbc.274.53.38131	http://dx.doi.org/10.1074/jbc.274.53.38131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608884	hybrid			2022-12-27	WOS:000084528000084
J	Shallom, S; Zhang, K; Jiang, L; Rathod, PK				Shallom, S; Zhang, K; Jiang, L; Rathod, PK			Essential protein-protein interactions between Plasmodium falciparum thymidylate synthase and dihydrofolate reductase domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMALARIAL DRUG-RESISTANCE; ESCHERICHIA-COLI; IN-VITRO; EXPRESSION; MALARIA; PYRIMETHAMINE; GENE; PURIFICATION; COMBINATION; MECHANISM	In Plasmodium falciparum, dihydrofolate reductase and thymidylate synthase activities are conferred by a single 70-kDa bifunctional polypeptide (DHFR-TS, dihydrofolate reductase-thymidylate synthase) which assembles into a functional 140-kDa homodimer, In mammals, the two enzymes are smaller distinct molecules encoded on different genes, A 27-kDa amino domain of malarial DHFR-TS is sufficient to provide DHFR activity, but the structural requirements for TS function have not been established, Although the 3'-end of DHFR-TS has high homology to TS sequences from other species, expression of this protein fragment failed to yield active TS enzyme, and it failed to complement TS- Escherichia coli, Unexpectedly, even partial 5'-deletion of full-length DHFR-TS gene abolished TS function:on the 3'-end, Thus, it was hypothesized that the amino end of the bifunctional parasite protein plays an important role in TS function. When the 27-kDa amino domain (DHFR) was provided in trans, a previously inactive 40-kDa carboxyl domain from malarial DHFR-TS regained its TS function. Physical characterization of the "split enzymes" revealed that the 27- and the 40-kDa fragments of DHFR-TS had reassembled into a 140-kDa hybrid complex, Thus, in malarial DHFR-TS, there are physical interactions between the DHFR domain and the TS domain, and these interactions are necessary:to obtain a catalytically active TS. Interference with these essential protein-protein interactions could lead to new selective strategies to treat malaria resistant to traditional DHFR-TS inhibitors.	Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Catholic University of America	Rathod, PK (corresponding author), Catholic Univ Amer, Dept Biol, 620 Michigan Ave NE, Washington, DC 20064 USA.				NIAID NIH HHS [AI26912, AI40956, R01 AI026912] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040956, R01AI026912, R29AI026912] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BELFORT M, 1984, J BACTERIOL, V160, P371, DOI 10.1128/JB.160.1.371-378.1984; BEVERLEY SM, 1986, P NATL ACAD SCI USA, V83, P2584, DOI 10.1073/pnas.83.8.2584; BZIK DJ, 1987, P NATL ACAD SCI USA, V84, P8360, DOI 10.1073/pnas.84.23.8360; CANFIELD CJ, 1993, AM J TROP MED HYG, V49, P121, DOI 10.4269/ajtmh.1993.49.121; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; CHEN GX, 1987, MOL PHARMACOL, V32, P723; Elcock AH, 1996, J MOL BIOL, V262, P370, DOI 10.1006/jmbi.1996.0520; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; FOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014; GARRETT CE, 1984, MOL BIOCHEM PARASIT, V11, P257, DOI 10.1016/0166-6851(84)90070-7; HALL SJ, 1991, MOL BIOCHEM PARASIT, V45, P317, DOI 10.1016/0166-6851(91)90100-K; HekmatNejad M, 1996, ANTIMICROB AGENTS CH, V40, P1628, DOI 10.1128/AAC.40.7.1628; HekmatNejad M, 1997, EXP PARASITOL, V87, P222, DOI 10.1006/expr.1997.4228; HekmatNejad M, 1997, EXP PARASITOL, V85, P303, DOI 10.1006/expr.1997.4145; HILLCOAT BL, 1966, J BIOL CHEM, V241, P2995; HITCHINGS GH, 1960, CLIN PHARMACOL THER, V1, P570; HOUGHTON PJ, 1989, P NATL ACAD SCI USA, V86, P1377, DOI 10.1073/pnas.86.4.1377; Huennekens FM, 1996, PROTEIN SCI, V5, P1201; INGRAHAM HA, 1986, BIOCHEMISTRY-US, V25, P3225, DOI 10.1021/bi00359a022; KNIGHTON DR, 1994, NAT STRUCT BIOL, V1, P186, DOI 10.1038/nsb0394-186; LIUZZI M, 1994, NATURE, V372, P695, DOI 10.1038/372695a0; MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021; Nzila-Mounda A, 1998, ANTIMICROB AGENTS CH, V42, P164, DOI 10.1128/AAC.42.1.164; OAKS SC, 1991, MALARIA; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; RATHOD PK, 1994, ANTIMICROB AGENTS CH, V38, P476, DOI 10.1128/AAC.38.3.476; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; RUSSELL PB, 1951, J AM CHEM SOC, V73, P3763, DOI 10.1021/ja01152a060; SANO G, 1994, MOL BIOCHEM PARASIT, V63, P265, DOI 10.1016/0166-6851(94)90062-0; SIRAWARAPORN W, 1993, J BIOL CHEM, V268, P21637; SPINKS A, 1945, ANN TROP MED PARASIT, V39, P220, DOI 10.1080/00034983.1945.11685239; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; Trujillo M, 1996, BIOCHEMISTRY-US, V35, P6366, DOI 10.1021/bi952923q; White NJ, 1996, PARASITOL TODAY, V12, P399, DOI 10.1016/0169-4758(96)10055-7; WHITE NJ, 1992, J ANTIMICROB CHEMOTH, V30, P571, DOI 10.1093/jac/30.5.571; WINSTANLEY PA, 1995, ANTIMICROB AGENTS CH, V39, P948, DOI 10.1128/AAC.39.4.948; YOSHIOKA A, 1987, J BIOL CHEM, V262, P8235; Zutshi R, 1998, CURR OPIN CHEM BIOL, V2, P62, DOI 10.1016/S1367-5931(98)80036-7	40	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37781	37786		10.1074/jbc.274.53.37781	http://dx.doi.org/10.1074/jbc.274.53.37781			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608839	hybrid, Green Accepted			2022-12-27	WOS:000084528000039
J	Swanton, E; Bishop, N; Woodman, P				Swanton, E; Bishop, N; Woodman, P			Human rabaptin-5 is selectively cleaved by caspase-3 during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC MEMBRANE-FUSION; INTERLEUKIN-1-BETA CONVERTING-ENZYME; SMALL GTPASE RAB5; CELL-FREE SYSTEM; CYTOCHROME-C; CYSTEINE PROTEASE; GDP/GTP EXCHANGE; SNARE ACTIVATION; ENDOSOME FUSION; HL-60 CELLS	We have previously shown that Xenopus rabaptin-5 is cleaved in apoptotic extracts, with a concomitant reduction in the ability of these extracts to support endosomal membrane fusion (Cosulich, S. C., Horiuchi, H., Zerial, M., Clarke, P. R., and Woodman, P. G. (1997) EMBO J, 16, 6182-6191), In this report we demonstrate that caspase-dependent cleavage is a conserved feature of rabaptin-5. Human rabaptin-5 is cleaved at two sites (HSLD379 and DESD438) in, apoptotic HeLa extracts. Cleavage is: effected by caspase-3, since it is prevented when caspase-3 activity is either inhibited by Ac-DEVD-CHO or removed by immunodepletion. Moreover, an identical pattern of cleavage is observed using recombinant caspase-3, The action of caspase-3 is highly selective; neither caspase-2 nor caspase-7 are able to cleave recombinant or cytosolic rabaptin-5. Caspase-dependent cleavage of rabaptin-5 generates two physically separated coiled coil-forming domains, the C-terminal of which retains the ability to bind the Rab5 exchange factor rabex-5.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Woodman, P (corresponding author), Univ Manchester, Sch Biol Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.			Swanton, Eileithyia/0000-0002-3299-4228				BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Beere HM, 1996, MOL PHARMACOL, V49, P842; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Chandler JM, 1998, J BIOL CHEM, V273, P10815, DOI 10.1074/jbc.273.18.10815; Chinnaiyan AM, 1996, CURR BIOL, V6, P555; Cosulich SC, 1997, EMBO J, V16, P6182, DOI 10.1093/emboj/16.20.6182; Cosulich SC, 1996, CURR BIOL, V6, P997, DOI 10.1016/S0960-9822(02)00644-9; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; Gervais FG, 1998, J BIOL CHEM, V273, P17102, DOI 10.1074/jbc.273.27.17102; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; HARLOW E, 1988, ANTIBODIES LAB APPRO; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kidd VJ, 1998, ANNU REV PHYSIOL, V60, P533, DOI 10.1146/annurev.physiol.60.1.533; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; Martins LM, 1997, J BIOL CHEM, V272, P7421, DOI 10.1074/jbc.272.11.7421; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Ohya T, 1998, J BIOL CHEM, V273, P613, DOI 10.1074/jbc.273.1.613; Polverino AJ, 1997, J BIOL CHEM, V272, P7013, DOI 10.1074/jbc.272.11.7013; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Savill J, 1998, NATURE, V392, P442, DOI 10.1038/33025; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Swanton E, 1999, ONCOGENE, V18, P1781, DOI 10.1038/sj.onc.1202490; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; THORNBERRY NA, 1994, METHOD ENZYMOL, V244, P615; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; WOOD ER, 1990, J CELL BIOL, V111, P2839, DOI 10.1083/jcb.111.6.2839; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	48	26	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37583	37590		10.1074/jbc.274.53.37583	http://dx.doi.org/10.1074/jbc.274.53.37583			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608812	hybrid			2022-12-27	WOS:000084528000012
J	Wierzbicka-Patynowski, I; Niewiarowski, S; Marcinkiewicz, C; Calvete, JJ; Marcinkiewicz, MM; McLane, MA				Wierzbicka-Patynowski, I; Niewiarowski, S; Marcinkiewicz, C; Calvete, JJ; Marcinkiewicz, MM; McLane, MA			Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; GLUTATHIONE-S-TRANSFERASE; III CONNECTING SEGMENT; LIGAND-BINDING; SECONDARY STRUCTURE; VIPER VENOMS; GPIIB-IIIA; ALPHA-V-BETA-3 INTEGRINS; BETA(3) INTEGRIN; ESCHERICHIA-COLI	There are key differences between the amino acid residues of the RGD loops and the C termini of echistatin, a potent antagonist of alpha(IIb)beta(3), alpha(v)beta(3) and alpha(5)beta(1), and eristostatin, a similar disintegrin selectively inhibiting alpha(IIb)beta(3),. In order to identify echistatin motifs required for selective recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins, we expressed recombinant echistatin, eristostatin, and 15 hybrid molecules. We tested them for their ability to inhibit adhesion of different cell lines to fibronectin and von Willebrand factor and to express ligand-induced binding site epitope. The results showed that Asp(27) and Met(28) support recognition of both alpha(v)beta(3) and alpha(5)beta(1). Replacement of Met(28) with Asn completely abolished echistatin's ability to recognize each of the integrins, while replacement of Met(28) with Leu selectively decreased echistatin's ability to recognize alpha(5)beta(1) only. Eristostatin in which C-terminal WNG sequence was substituted with HKGPAT exhibited new activity with alpha(5)beta(1), which was 10-20-fold higher than that of wild type eristostatin, A hypothesis is proposed that the C terminus of echistatin interacts with separate sites on beta(1) and beta(3) integrin molecules.	Univ Delaware, McKinly Lab 057, Dept Med Technol, Newark, DE 19808 USA; Temple Univ, Dept Physiol, Philadelphia, PA 19140 USA; Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; CSIC, Inst Biomed, Valencia 46010, Spain	University of Delaware; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	McLane, MA (corresponding author), Univ Delaware, McKinly Lab 057, Dept Med Technol, Newark, DE 19808 USA.	mclane@udel.edu	Calvete, Juan/P-2555-2019; Calvete, Juan J/K-9619-2014	Calvete, Juan/0000-0001-5026-3122; Calvete, Juan J/0000-0001-5026-3122	NHLBI NIH HHS [HL 0777] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAJT ML, 1992, J BIOL CHEM, V267, P3789; BAJT ML, 1994, J BIOL CHEM, V269, P20913; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1; CALVETE JJ, 1994, BIOCHEM BIOPH RES CO, V202, P135, DOI 10.1006/bbrc.1994.1903; COOKE RM, 1991, EUR J BIOCHEM, V202, P323, DOI 10.1111/j.1432-1033.1991.tb16379.x; DALVIT C, 1991, EUR J BIOCHEM, V202, P315, DOI 10.1111/j.1432-1033.1991.tb16378.x; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; DU XP, 1993, J BIOL CHEM, V268, P23087; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KOMORIYA A, 1991, J BIOL CHEM, V266, P15075; Kumar CC, 1998, FEBS LETT, V429, P239; LANZA F, 1992, J CLIN INVEST, V89, P1995, DOI 10.1172/JCI115808; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; Marcinkiewicz C, 1999, J BIOL CHEM, V274, P12468, DOI 10.1074/jbc.274.18.12468; Marcinkiewicz C, 1997, BLOOD, V90, P1565, DOI 10.1182/blood.V90.4.1565.1565_1565_1575; McLane MA, 1998, P SOC EXP BIOL MED, V219, P109, DOI 10.3181/00379727-219-44322; MCLANE MA, 1994, BIOCHEM J, V301, P429, DOI 10.1042/bj3010429; McLane MA, 1996, FEBS LETT, V391, P139, DOI 10.1016/0014-5793(96)00716-8; Nakamura Y, 1998, NUCLEIC ACIDS RES, V26, P334, DOI 10.1093/nar/26.1.334; NIEWIAROWSKI S, 1994, SEMIN HEMATOL, V31, P289; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; SAUDEK V, 1991, EUR J BIOCHEM, V202, P329, DOI 10.1111/j.1432-1033.1991.tb16380.x; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1058; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STEINER B, 1993, J BIOL CHEM, V268, P6870; Wierzbicka I, 1997, THROMB RES, V85, P115, DOI 10.1016/S0049-3848(96)00228-9; WILLIAMS J, 1990, BIOCHIM BIOPHYS ACTA, V1039, P81, DOI 10.1016/0167-4838(90)90229-9; Yeh CH, 1998, BLOOD, V92, P3268, DOI 10.1182/blood.V92.9.3268.421k41_3268_3276	40	123	133	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37809	37814		10.1074/jbc.274.53.37809	http://dx.doi.org/10.1074/jbc.274.53.37809			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608843	hybrid			2022-12-27	WOS:000084528000043
J	Bellocq, A; Doublier, S; Suberville, S; Perez, J; Escoubet, B; Fouqueray, B; Puyol, DR; Baud, L				Bellocq, A; Doublier, S; Suberville, S; Perez, J; Escoubet, B; Fouqueray, B; Puyol, DR; Baud, L			Somatostatin increases glucocorticoid binding and signaling in macrophages by blocking the calpain-specific cleavage of Hsp 90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HEAT-SHOCK PROTEINS; FACTOR NF-KAPPA; RECEPTOR EXPRESSION; MESSENGER-RNA; TERMINAL REGION; DNA-BINDING; TNF-ALPHA; IN-VIVO; ACTIVATION	Somatostatin has direct anti-inflammatory actions and participates in the anti-inflammatory actions of glucocorticoids, but the mechanisms underlying this regulation remain poorly understood, The objective of this study was to evaluate whether somatostatin increases glucocorticoid responsiveness by up-regulating glucocorticoid receptor (GR) expression and signaling. Somatostatin promoted a time- and dose-dependent increase in [H-3]dexamethasone binding to RAW 264.7 macrophages. Cell exposure to 10 nM somatostatin for 18 h promoted a 2-fold increase in the number of GR sites per cell without significant modification of the affinity. Analysis of GR heterocomplex components demonstrated that somatostatin increased the level of heat shock protein (Hsp) 90, whereas the level of GR remained almost unchanged. The increase in Hsp 90 was associated with a decrease in the cleavage of its carboxyl-terminal domain. Evidence for the involvement of calpain inhibition in this process was obtained by the demonstration that 1) somatostatin induced a dose-dependent decrease in calpain activity and 2) calpain inhibitors, calpain inhibitor I and calpain, both abolished the cleavage of Hsp 90 and induced a dose-dependent increase in [H-3]dexamethasone binding. Increases in glucocorticoid binding after somatostatin treatment were associated with similar increases in the ability of GR to transactivate a minimal promoter containing two glucocorticoid response elements (GRE) and to interfere with the activation of nuclear factor-kappa B (NF-kappa B), Thus, the present findings indicate that somatostatin increases glucocorticoid binding and signaling by limiting the calpain-specific cleavage of GR-associated Hsp 90, This mechanism may represent a novel target for intervention to increase glucocorticoid responsiveness.	Hop Tenon, INSERM, U489, F-75020 Paris, France; Univ Paris 07, INSERM, U426, Paris, France; Univ Alcala de Henares, Madrid, Spain; Hosp Principe Asturias, Madrid, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidad de Alcala; Prince of Asturias University Hospital	Baud, L (corresponding author), Hop Tenon, INSERM, U489, 4 Rue Chine, F-75020 Paris, France.	laurent.baud@tnn.ap-hop-paris.fr	Puyol, Diego Rodriguez/AAG-9752-2020	Puyol, Diego Rodriguez/0000-0002-9125-9311; BELLOCQ, Agnes/0000-0002-9297-7534				ADEYEMI EO, 1990, PEPTIDES, V11, P869, DOI 10.1016/0196-9781(90)90206-K; Ahmed AA, 1998, SCAND J IMMUNOL, V48, P79; Bellocq A, 1998, J BIOL CHEM, V273, P5086, DOI 10.1074/jbc.273.9.5086; BERMUDEZ LE, 1990, LYMPHOKINE RES, V9, P137; BERTRAND F, 1995, J BIOL CHEM, V270, P24435, DOI 10.1074/jbc.270.41.24435; BLUM AM, 1992, J IMMUNOL, V149, P3621; BRONK SF, 1993, AM J PHYSIOL, V264, pG744, DOI 10.1152/ajpgi.1993.264.4.G744; Bronnegard M, 1996, AM J RESP CRIT CARE, V154, pS28; CADEPOND F, 1991, J BIOL CHEM, V266, P5834; Cong M, 1998, J BIOL CHEM, V273, P660, DOI 10.1074/jbc.273.1.660; Costas M, 1996, J CLIN INVEST, V98, P1409, DOI 10.1172/JCI118928; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; DESHPANDE RV, 1995, J BIOL CHEM, V270, P2497, DOI 10.1074/jbc.270.6.2497; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; DONG Y, 1989, J BIOL CHEM, V264, P13679; Elliott DE, 1998, J IMMUNOL, V160, P3997; Escoubet B, 1996, AM J PHYSIOL-CELL PH, V270, pC1343, DOI 10.1152/ajpcell.1996.270.5.C1343; Griscavage JM, 1996, P NATL ACAD SCI USA, V93, P3308, DOI 10.1073/pnas.93.8.3308; HONG DH, 1995, MOL CELL ENDOCRINOL, V108, P199, DOI 10.1016/0303-7207(95)03476-N; KAM JC, 1993, J IMMUNOL, V151, P3460; Kang KI, 1999, P NATL ACAD SCI USA, V96, P1439, DOI 10.1073/pnas.96.4.1439; KARALIS K, 1994, J CLIN INVEST, V93, P2000, DOI 10.1172/JCI117193; KARALIS K, 1995, ENDOCRINOLOGY, V136, P4133, DOI 10.1210/en.136.9.4133; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Kimura Y, 1998, NAT MED, V4, P915, DOI 10.1038/nm0898-915; KRAMER TH, 1989, J PHARMACOL EXP THER, V249, P544; LEROMANCER M, 1994, J BIOL CHEM, V269, P17464; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; MINAMI Y, 1993, J BIOL CHEM, V268, P9604; MOORE SK, 1989, J BIOL CHEM, V264, P5343; Patel YC, 1997, TRENDS ENDOCRIN MET, V8, P398, DOI 10.1016/S1043-2760(97)00168-9; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; REICHLIN S, 1983, NEW ENGL J MED, V309, P1495, DOI 10.1056/NEJM198312153092406; REICHLIN S, 1983, NEW ENGL J MED, V309, P1556, DOI 10.1056/NEJM198312223092506; SALKOWSKI CA, 1992, J IMMUNOL, V149, P4041; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SELDEN RF, 1996, CURRENT PROTOCOLS MO; Spahn JD, 1996, J IMMUNOL, V157, P2654; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; SREEDHARAN SP, 1989, J BIOL CHEM, V264, P949; Tanaka Y, 1995, CURR EYE RES, V14, P1125, DOI 10.3109/02713689508995819; Verheggen MM, 1996, EUR RESPIR J, V9, P2036, DOI 10.1183/09031936.96.09102036; Walker G, 1997, J BIOL CHEM, V272, P16679, DOI 10.1074/jbc.272.26.16679; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; Warriar N, 1996, J BIOL CHEM, V271, P18662, DOI 10.1074/jbc.271.31.18662; ZABEL U, 1991, J BIOL CHEM, V266, P252	47	39	41	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36891	36896		10.1074/jbc.274.52.36891	http://dx.doi.org/10.1074/jbc.274.52.36891			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601241	hybrid			2022-12-27	WOS:000084382700012
J	Teng, KK; Esposito, DK; Schwartz, GD; Lander, HM; Hempstead, BL				Teng, KK; Esposito, DK; Schwartz, GD; Lander, HM; Hempstead, BL			Activation of c-Ha-Ras by nitric oxide modulates survival responsiveness in neuronal PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; KINASE PHOSPHORYLATION; PHEOCHROMOCYTOMA CELLS; REDOX REGULATION; DIFFERENTIATION; PROTEIN; PATHWAY; APOPTOSIS; P21(RAS); SUPPRESSION	p21(c-Ha-Ras) (Bas) can be activated by the guanine nucleotide exchange factor mSOS1 or by S-nitrosylation of cysteine 118 via nitric oxide (NO), To determine whether these two Ras-activating mechanisms modulate distinct biological effects, a NO-nonresponsive Ras mutant (Ras(C118S)) was stably expressed in the PC12 cells, a cell line that generates NO upon nerve growth-factor treatment, We report here that RasC118S functions indistinguishably from wild type Ras in activating and maintaining the mSOS1- and Raf-1-dependent mitogen-activated protein kinase cascade necessary for neuronal differentiation. However, continuous (>5 days) exposure to nerve growth factor reveals that, in contrast to parental or wild-type Ras-overexpressing PC12 cells, Ras(C118S)-expressing PC12 cells cannot sustain the basal interaction between Ras and phosphatidylinositol 3-kinase, This results in spontaneous apoptosis of these cells despite the presence of nerve growth factor and serum. Thus unique downstream effector interactions and biological outcomes can be differentially modulated by distinct modes of Bas activation.	Cornell Univ, Weill Med Coll, Dept Med, Div Hematol & Oncol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University; Cornell University	Hempstead, BL (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, Div Hematol Oncol, Rm C-606,1300 York Ave, New York, NY 10021 USA.	blhempst@mail.med.cornell.edu		Teng, Kenneth/0000-0002-9392-2172	PHS HHS [N530687] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aleryani S, 1998, J BIOL CHEM, V273, P6041, DOI 10.1074/jbc.273.11.6041; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BUDAY L, 1995, ONCOGENE, V11, P1327; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Deora AA, 1998, J BIOL CHEM, V273, P29923, DOI 10.1074/jbc.273.45.29923; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Duhe RJ, 1998, P NATL ACAD SCI USA, V95, P126, DOI 10.1073/pnas.95.1.126; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kim YM, 1998, J BIOL CHEM, V273, P31437, DOI 10.1074/jbc.273.47.31437; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; LANDER HM, 1995, J BIOL CHEM, V270, P21195, DOI 10.1074/jbc.270.36.21195; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; MUTOH T, 1988, J BIOL CHEM, V263, P15853; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PAN ZH, 1993, J NEUROCHEM, V61, P1713, DOI 10.1111/j.1471-4159.1993.tb09808.x; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Stamler J S, 1995, Curr Top Microbiol Immunol, V196, P19; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; TENG KK, 1995, J BIOL CHEM, V270, P20677, DOI 10.1074/jbc.270.35.20677; Therrien M, 1998, CELL, V95, P343, DOI 10.1016/S0092-8674(00)81766-3; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773	50	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37315	37320		10.1074/jbc.274.52.37315	http://dx.doi.org/10.1074/jbc.274.52.37315			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601298	hybrid			2022-12-27	WOS:000084382700069
J	Bilcock, DT; Daniels, LE; Bath, AJ; Halford, SE				Bilcock, DT; Daniels, LE; Bath, AJ; Halford, SE			Reactions of type II restriction endonucleases with 8-base pair recognition sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA CLEAVAGE; SUPERCOILED DNA; SFII; ECORII; SEQUENCES; RECOMBINATION; RESOLVASE; SYSTEMS	Type II restriction endonucleases usually recognize 4-6-base pair (bp) sites on DNA and cleave each site in a separate reaction. A few type II endonucleases have 8-bp recognition sites, but these seem unsuited for restriction, since their sites are rare on most DNA. Moreover, only one endonuclease that recognizes a target containing 8 bp has been examined to date, and this enzyme, SfiI, needs two copies of this site for its DNA cleavage reaction. In this study, several endonucleases with 8-bp sites were tested on plasmids that have either one or two copies of the relevant sequence to determine if they also need two sites. SgfI, SrfI, FseI, PacI, PmeI, Sse8781I, and SdaI all acted through equal and independent reactions at each site. Asci cleaved the DNA with one site at the same rate as that with two sites but acted processively on the latter. In contrast, SgrAI. showed a marked preference for the plasmid with two sites and cleaved both sites on this DNA in a concerted manner, like SfiI. Endonucleases that require two copies of an 8-bp sequence may be widespread in nature, where, despite this seemingly inappropriate requirement, they may function in DNA restriction.	Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Halford, SE (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	s.halford@bris.ac.uk						Baldwin GS, 1999, J MOL BIOL, V288, P87, DOI 10.1006/jmbi.1999.2672; BAXTER BK, 1993, BIOCHEMISTRY-US, V32, P8291, DOI 10.1021/bi00083a033; Bilcock DT, 1999, MOL MICROBIOL, V31, P1243, DOI 10.1046/j.1365-2958.1999.01266.x; Bozic D, 1996, J MOL BIOL, V255, P176, DOI 10.1006/jmbi.1996.0015; Cao WG, 1999, BIOCHEMISTRY-US, V38, P8080, DOI 10.1021/bi9903796; CONRAD M, 1992, NUCLEIC ACIDS RES, V20, P5127, DOI 10.1093/nar/20.19.5127; Dorner LF, 1999, J MOL BIOL, V285, P1515, DOI 10.1006/jmbi.1998.2408; Embleton ML, 1999, J MOL BIOL, V289, P785, DOI 10.1006/jmbi.1999.2822; Erskine SG, 1997, BIOCHEMISTRY-US, V36, P7567, DOI 10.1021/bi970155s; GABBARA S, 1992, J BIOL CHEM, V267, P18623; GRASBY JA, 1992, BIOCHEMISTRY-US, V31, P7855, DOI 10.1021/bi00149a016; Gutfreund H, 1995, KINETICS LIFE SCI; Halford S E, 1994, Methods Mol Biol, V30, P385; HALFORD SE, 1980, BIOCHEM J, V191, P581, DOI 10.1042/bj1910581; Hallet B, 1997, FEMS MICROBIOL REV, V21, P157, DOI 10.1016/S0168-6445(97)00055-7; Horton JR, 1998, J MOL BIOL, V284, P1491, DOI 10.1006/jmbi.1998.2269; Jian HM, 1998, J MOL BIOL, V284, P287, DOI 10.1006/jmbi.1998.2170; KELLEHER JE, 1994, J BACTERIOL, V176, P5888, DOI 10.1128/jb.176.19.5888-5896.1994; KOBAYASHI I, 1996, EPIGENETIC MECH GENE, P155; KRUGER DH, 1988, NUCLEIC ACIDS RES, V16, P3997; MAXWELL A, 1980, BIOCHEM J, V203, P85; MEISEL A, 1992, NATURE, V355, P467, DOI 10.1038/355467a0; Mizuuchi K, 1999, BIOCHEMISTRY-US, V38, P4640, DOI 10.1021/bi990054p; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; Nobbs TJ, 1998, BIOL CHEM, V379, P599; NOBBS TJ, 1995, J MOL BIOL, V252, P399, DOI 10.1006/jmbi.1995.0506; Nobbs TJ, 1998, J MOL BIOL, V281, P419, DOI 10.1006/jmbi.1998.1966; Oram M, 1997, J MOL BIOL, V270, P396, DOI 10.1006/jmbi.1997.1109; Panne D, 1999, J MOL BIOL, V290, P49, DOI 10.1006/jmbi.1999.2894; PEIN CD, 1991, NUCLEIC ACIDS RES, V19, P5139, DOI 10.1093/nar/19.19.5139; QIANG BQ, 1987, METHOD ENZYMOL, V155, P15; QIANG BQ, 1984, NUCLEIC ACIDS RES, V12, P4507, DOI 10.1093/nar/12.11.4507; Reuter M, 1998, J BIOL CHEM, V273, P8294, DOI 10.1074/jbc.273.14.8294; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; Roberts R, 1993, NUCLEASES, P35; Roberts RJ, 1999, NUCLEIC ACIDS RES, V27, P312, DOI 10.1093/nar/27.1.312; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sasnauskas G, 1999, BIOCHEMISTRY-US, V38, P4028, DOI 10.1021/bi982456n; Siksnys V, 1999, J MOL BIOL, V291, P1105, DOI 10.1006/jmbi.1999.2977; Szczelkun MD, 1996, EMBO J, V15, P6335, DOI 10.1002/j.1460-2075.1996.tb01023.x; Szczelkun MD, 1996, EMBO J, V15, P1460, DOI 10.1002/j.1460-2075.1996.tb00488.x; TAYLOR JD, 1992, BIOCHEMISTRY-US, V28, P6198; Terry B J, 1987, Gene Amplif Anal, V5, P103; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; THOMAS M, 1975, J MOL BIOL, V91, P315, DOI 10.1016/0022-2836(75)90383-6; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; WENTZELL LM, 1995, J MOL BIOL, V248, P581, DOI 10.1006/jmbi.1995.0244; Wentzell LM, 1998, J MOL BIOL, V281, P433, DOI 10.1006/jmbi.1998.1967; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; YANG CC, 1992, BIOCHEMISTRY-US, V31, P9657, DOI 10.1021/bi00155a019; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	51	49	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36379	36386		10.1074/jbc.274.51.36379	http://dx.doi.org/10.1074/jbc.274.51.36379			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593932	hybrid			2022-12-27	WOS:000084279200051
J	Akamatsu, M; Aota, S; Suwa, A; Ueda, K; Amachi, T; Yamada, KM; Akiyama, SK; Kioka, N				Akamatsu, M; Aota, S; Suwa, A; Ueda, K; Amachi, T; Yamada, KM; Akiyama, SK; Kioka, N			Vinexin forms a signaling complex with Sos and modulates epidermal growth factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; GUANINE-NUCLEOTIDE EXCHANGE; PDGF-BETA-RECEPTORS; INSULIN-RECEPTOR; SH3 DOMAIN; CELL-ADHESION; STRESS FIBERS; EGF RECEPTOR; FACTOR HSOS1; RAS	Vinexin, a novel protein that plays a hey role in cell spreading and cytoskeletal organization, contains three SH3 domains and binds to vinculin through its first and second SH3 domains. We show here that the third SH3 domain binds to Sos, a guanine nucleotide exchange factor for Pas and Pac, both in vitro and in vivo. Point mutations in the third SH3 domain abolished the vinexin-Sos interaction. Stimulation of NIH/3T3 cells with serum, epidermal growth factor (EGF), or platelet derived growth factor (PDGF) decreased the electro phoretic mobility of Sos and concomitantly inhibited formation of the vinexin-Sos complex. Phosphatase treatment of lysates restored the binding of Sos to vinexin, suggesting that signaling from serum, EGF, or PDGF regulates the vinexin-Sos complex through the Sos phosphorylation. To evaluate the function of vinexin downstream of growth factors, we examined the effects of wild-type and mutant vinexin expression on extracellular signal-regulated kinase (Erk) and c-Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK) activation in response to EGF. Exogenous expression of vinexin beta in NIH/3T3 cells enhanced JNK/SAPK activation but did not affect Erk activation. Moreover mutations in the third SH3 domain abolished EGF activation of JNK/SAPK in a dominant-negative fashion, whereas they slightly stimulated Erk. Together these results suggest that vinexin can selectively modulate EGF-induced signal transduction pathways leading to JNK/SAPK kinase activation.	Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; Biomol Engn Res Inst, Suita, Osaka 565, Japan; NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA; NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kioka, N (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	nkioka@kais.kyoto-u.ac.jp		Kioka, Noriyuki/0000-0002-2708-537X; Ueda, Kazumitsu/0000-0003-2980-6078; Yamada, Kenneth/0000-0003-1512-6805	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000525, ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000525, Z01DE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES023025, Z01ES023025] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; CHERNIACK AD, 1995, J BIOL CHEM, V270, P1485, DOI 10.1074/jbc.270.4.1485; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FEIG LA, 1993, SCIENCE, V260, P767, DOI 10.1126/science.8484117; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; FELLER SM, 1995, ONCOGENE, V10, P1465; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; HU QJ, 1995, MOL CELL BIOL, V15, P1169; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; Lin TH, 1997, J BIOL CHEM, V272, P8849; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Okada S, 1996, J BIOL CHEM, V271, P25533, DOI 10.1074/jbc.271.41.25533; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Porfiri E, 1996, J BIOL CHEM, V271, P5871, DOI 10.1074/jbc.271.10.5871; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Sparks AB, 1996, NAT BIOTECHNOL, V14, P741, DOI 10.1038/nbt0696-741; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; Zhao H, 1998, J BIOL CHEM, V273, P12061, DOI 10.1074/jbc.273.20.12061	48	43	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35933	35937		10.1074/jbc.274.50.35933	http://dx.doi.org/10.1074/jbc.274.50.35933			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585480	hybrid			2022-12-27	WOS:000084187900092
J	Van der Kaay, J; Beck, M; Gray, A; Downes, CP				Van der Kaay, J; Beck, M; Gray, A; Downes, CP			Distinct phosphatidylinositol 3-kinase lipid products accumulate upon oxidative and osmotic stress and lead to different cellular responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PLECKSTRIN-HOMOLOGY DOMAINS; HEAT-SHOCK; SIGNAL-TRANSDUCTION; IN-VIVO; INSULIN; AKT; 3,4,5-TRISPHOSPHATE; PTDINS(3,4,5)P-3; 3-PHOSPHATE	Signaling by phosphatidylinositol (PI) 3-kinases is mediated by S-phosphoinositides, which bind to Pleckstrin homology (PH) domains that are present in a wide spectrum of proteins. PH domains can be classified into three groups based on their different lipid binding specificities. Distinct 3-phosphoinositides can accumulate upon PI 3-kinase activation in cells in response to different stimuli and mediate specific cellular responses. In Swiss 3T3 mouse fibroblasts, oxidative stress induced by I mM H2O2 caused almost exclusive accumulation of phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P-2), whereas osmotic stress increased both phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) and PtdIns(3,4)P-2 levels. The increase in PtdIns(3,4)P-2 levels, caused by oxidative stress, correlated with the activation of protein kinase B, which has a promiscuous PH domain that binds both PtdIns(3,4,5)P-3 and PtdIns(3,4)P-2. p70 S6 kinase, another signaling component downstream of PI 3-kinase, however, was not activated by this oxidative stress-induced increase in PtdIns(3,4)P-2 levels. Increased PtdIns(3,4,5)P-3 and PtdIns(3,4)P-2 levels in response to osmotic stress did not correlate with protein kinase B activation, because of concomitant activation of an inhibitory pathway, but p70 S6 kinase was activated by osmotic stress. These results demonstrate that PtdIns(3,4)P-2 can accumulate independently of PtdIns(3,4,5)P-3 and exerts a pattern of cellular responses that is distinct from that induced by accumulation of PtdIns(3,4,5)P-3.	Univ Dundee, Dept Biochem, Dundee DD1 5EH, Scotland; Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany; Inst Med Sci, Div Signal Transduct Therapy, Dundee DD1 5EH, Scotland	University of Dundee; Free University of Berlin; University of Dundee	Van der Kaay, J (corresponding author), Univ Dundee, Dept Biochem, Dundee DD1 5EH, Scotland.	jvdkaay@bad.dundee.ac.uk		Gray, Alexander/0000-0001-9227-0363				Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Banfic H, 1998, J BIOL CHEM, V273, P13, DOI 10.1074/jbc.273.1.13; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; CLARKE NG, 1981, BIOCHEM J, V195, P301, DOI 10.1042/bj1950301; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; CZECH MP, 1974, P NATL ACAD SCI USA, V71, P4173, DOI 10.1073/pnas.71.10.4173; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Lemmon MA, 1997, TRENDS CELL BIOL, V7, P237, DOI 10.1016/S0962-8924(97)01065-9; Lin RZ, 1997, J BIOL CHEM, V272, P31196, DOI 10.1074/jbc.272.49.31196; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Qin SF, 1997, J BIOL CHEM, V272, P2098; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Tanaka K, 1999, J BIOL CHEM, V274, P3919, DOI 10.1074/jbc.274.7.3919; van der Kaay J, 1998, Methods Mol Biol, V105, P109; vanderKaay J, 1997, J BIOL CHEM, V272, P5477, DOI 10.1074/jbc.272.9.5477; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X	36	104	105	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35963	35968		10.1074/jbc.274.50.35963	http://dx.doi.org/10.1074/jbc.274.50.35963			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585485	hybrid			2022-12-27	WOS:000084187900097
J	Babenko, AP; Gonzalez, G; Bryan, J				Babenko, AP; Gonzalez, G; Bryan, J			Pharmaco-topology of sulfonylurea receptors - Separate domains of the regulatory subunits of K-ATP channel isoforms are required for selective interaction with K+ channel openers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; BINDING; MUSCLE; DEPENDENCE; KIR6.2	The differential responsiveness of (SUR1/K(IR)6.2)(4) pancreatic beta-cell versus (SUR2A/K(IR)6.2)(4) sarcolemmal or (SUR2B/K(IR)6.0)(4) smooth muscle cell K-ATP channels to K+ channel openers (KCOs) is the basis for the selective prevention of hyperinsulinemia, myocardial infarction, nd acute hypertension. KCO-stimulation of K-ATP channels is a unique example of functional coupling between a transport ATPase and a K+ inward rectifier. KCO binding to SUR is Mg-ATP-dependent and antagonizes the inhibition of (K(IR)6.0)(4) pore opening by nucleotides. Patch-clamping of matched chimeric human SUR1-SUR2A/K(IR)6.2 channels was used to identify the SUR regions that specify the selective response of sarcolemmal versus beta-cell channels to cromakalim or pinacidil versus diazoxide. The SUR2 segment containing the 12th through 17th predicted transmembrane domains, TMD12-17, confers sensitivity to the benzopyran, cromakalim, and the pyridine, pinacidil, whereas an SUR1 segment which includes TMD6-11 and the first nucleotide-binding fold, NBF1, controls responsiveness to the benzothiadiazine, diazoxide, These data are incorporated into a functional topology model for the regulatory SUR subunits of K-ATP channels.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Babenko, AP (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.							Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ARENA JP, 1989, AM J PHYSIOL, V257, pH2092; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 1999, J BIOL CHEM, V274, P11587, DOI 10.1074/jbc.274.17.11587; Babenko AP, 1999, FEBS LETT, V445, P131, DOI 10.1016/S0014-5793(99)00102-7; Babenko AP, 1998, CIRC RES, V83, P1132, DOI 10.1161/01.RES.83.11.1132; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Babenko AP, 1999, FEBS LETT, V459, P367, DOI 10.1016/S0014-5793(99)01215-6; BABENKO AP, 1999, FRONTIERS DIABETES, P300; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; D'Hahan N, 1999, MOL PHARMACOL, V56, P308, DOI 10.1124/mol.56.2.308; D'hahan N, 1999, P NATL ACAD SCI USA, V96, P12162, DOI 10.1073/pnas.96.21.12162; Dickinson KEJ, 1997, MOL PHARMACOL, V52, P473, DOI 10.1124/mol.52.3.473; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; EDWARDS G, 1993, ANNU REV PHARMACOL, V33, P597, DOI 10.1146/annurev.pa.33.040193.003121; ESCANDE D, 1988, BIOCHEM BIOPH RES CO, V154, P620, DOI 10.1016/0006-291X(88)90184-2; Hambrock A, 1999, MOL PHARMACOL, V55, P832; Hambrock A, 1998, BRIT J PHARMACOL, V125, P577, DOI 10.1038/sj.bjp.0702109; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Stride BD, 1999, J BIOL CHEM, V274, P22877, DOI 10.1074/jbc.274.32.22877; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Uhde I, 1999, J BIOL CHEM, V274, P28079, DOI 10.1074/jbc.274.40.28079; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	35	102	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					717	720		10.1074/jbc.275.2.717	http://dx.doi.org/10.1074/jbc.275.2.717			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625598	hybrid			2022-12-27	WOS:000084836600002
J	Rubenhagen, R; Ronsch, H; Jung, H; Kramer, R; Morbach, S				Rubenhagen, R; Ronsch, H; Jung, H; Kramer, R; Morbach, S			Osmosensor and osmoregulator properties of the betaine carrier BetP from Corynebacterium glutamicum in proteoliposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCAL-ANESTHETIC TETRACAINE; ESCHERICHIA-COLI; GLYCINE BETAINE; POLYACRYLAMIDE GELS; COMPATIBLE SOLUTES; UPTAKE SYSTEM; CELL-WALL; PROTEINS; STRESS; PHYSIOLOGY	The secondary glycine betaine uptake system BetP of Corynebacterium glutamicum was purified from Escherichia coli membranes in strep-tagged form after heterologous expression of the betP gene and was reconstituted in E, coli lipids. BetP retained its kinetic properties (V-max and K-m for betaine and Na+) as compared with intact cells. The influence of driving forces (Na+ gradient and/or electrical potential) on betaine uptake was quantified in proteoliposomes. BetP was effectively regulated by the external osmolality and was stimulated by the local anesthetic tetracaine. A shift of the optimum of osmotic stimulation to higher osmolalities was linearly correlated with an increasing share of phosphatidyl glycerol, the major lipid of the C. glutamicum plasma membrane in the E. coli lipid proteoliposomes, This finding correlates with results demonstrating an identical shift when betP was expressed in E. coli instead of C. glutamicum. These data indicate that (i) BetP comprises all elements of osmosensing and osmoregulatory mechanisms of betaine uptake, (ii) osmoregulation of BetP is directly related to protein/membrane interactions, (iii) the turgor pressure presumably plays no major role in osmoregulation of BetP, and (iv) the regulatory properties of BetP may be related to the physical state of the surrounding membrane.	Univ Cologne, Inst Biochem, D-50674 Cologne, Germany; Univ Osnabruck, Abt Mikrobiol, Fachbereich Biol Chem, D-49069 Osnabruck, Germany	University of Cologne; University Osnabruck	Kramer, R (corresponding author), Univ Cologne, Inst Biochem, Zulpicher Str 47, D-50674 Cologne, Germany.		Jung, Heinrich/K-3790-2014	Jung, Heinrich/0000-0002-5450-3063				AUGER M, 1988, BIOCHEMISTRY-US, V27, P6086, DOI 10.1021/bi00416a038; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGER U, 1999, THESIS U BONN GERMAN; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; CREMER J, 1990, MOL GEN GENET, V220, P478, DOI 10.1007/BF00391757; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; CULHAM DE, 1993, J MOL BIOL, V229, P268, DOI 10.1006/jmbi.1993.1030; Epand RM, 1998, BBA-REV BIOMEMBRANES, V1376, P353, DOI 10.1016/S0304-4157(98)00015-X; FARWICK M, 1995, J BACTERIOL, V177, P4690, DOI 10.1128/jb.177.16.4690-4695.1995; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; HOISCHEN C, 1990, J BACTERIOL, V172, P3409, DOI 10.1128/jb.172.6.3409-3416.1990; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; KRAMER R, 1994, FEMS MICROBIOL REV, V13, P75, DOI 10.1111/j.1574-6976.1994.tb00036.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERT C, 1995, APPL ENVIRON MICROB, V61, P4334, DOI 10.1128/AEM.61.12.4334-4342.1995; LANDFALD B, 1986, J BACTERIOL, V165, P849, DOI 10.1128/jb.165.3.849-855.1986; Lichtinger T, 1998, BIOCHEMISTRY-US, V37, P15024, DOI 10.1021/bi980961e; LYTEN K, 1995, EMBO J, V14, P1360; MILNER JL, 1988, J BIOL CHEM, V263, P14900; NIKAIDO H, 1993, MOL MICROBIOL, V8, P1025, DOI 10.1111/j.1365-2958.1993.tb01647.x; Peter H, 1998, J BIOL CHEM, V273, P2567, DOI 10.1074/jbc.273.5.2567; Peter H, 1998, J BACTERIOL, V180, P6005, DOI 10.1128/JB.180.22.6005-6012.1998; Peter H, 1996, J BACTERIOL, V178, P5229, DOI 10.1128/jb.178.17.5229-5234.1996; PRASAD R, 1996, MANUAL MEMBRANE LIPI; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; SEDDON JM, 1993, PHOSPHOLIPID HDB, P404; SHIMOOKA T, 1992, BIOCHIM BIOPHYS ACTA, V1104, P261, DOI 10.1016/0005-2736(92)90039-O; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Strange K, 1996, NEWS PHYSIOL SCI, V11, P146; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Umaprasad G, 1998, J GENET, V77, P1, DOI 10.1007/BF02933035; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; WurglerMurphy SM, 1997, TRENDS BIOCHEM SCI, V22, P172, DOI 10.1016/S0968-0004(97)01036-0	39	101	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					735	741		10.1074/jbc.275.2.735	http://dx.doi.org/10.1074/jbc.275.2.735			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625602	hybrid			2022-12-27	WOS:000084836600006
J	Barroso, S; Richard, F; Nicolas-Etheve, D; Reversat, JL; Bernassau, JM; Kitabgi, P; Labbe-Jullie, C				Barroso, S; Richard, F; Nicolas-Etheve, D; Reversat, JL; Bernassau, JM; Kitabgi, P; Labbe-Jullie, C			Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN-RELEASING-HORMONE; PROTEIN-COUPLED RECEPTORS; CONSERVED EXTRACELLULAR CYSTEINES; AMINO-ACID-RESIDUES; NEUROKININ-1 RECEPTOR; NONPEPTIDE ANTAGONIST; DIRECTED MUTAGENESIS; DISULFIDE BOND; NK1 RECEPTOR; DOMAINS	The neurotensin receptor 1 (NTR1) subtype belongs to the family of G protein-coupled receptors and mediates most of the known effects of the neuropeptide including modulation of central dopaminergic transmission. This suggested that nonpeptide agonist mimetics acting at the NTR1 might be helpful in the treatment of Parkinson's disease and schizophrenia. Here, we attempted to define the molecular interactions between neurotensin-(8-13), the pharmacophore of neurotensin, and the rat NTR1, Mutagenesis of the NTR1 identified residues that interact with neurotensin, Structure-activity studies with neurotensin-(8-13) analogs identified the peptide residues that interact with the mutated amino acids in the receptor. By taking these data into account, computer-assisted modeling techniques were used to build a tridimensional model of the neurotensin-(8-13)-binding site in which the N-terminal tetrapeptide of neurotensin(8-13) fits in the third extracellular loop and the C-terminal dipeptide binds to residues at the junction between the extracellular and transmembrane domains of the receptor. Interestingly, the agonist binding site lies on top of the previously described NTR1-binding site for the nonpeptide neurotensin antagonist SR 48692, Our data provide a basis for understanding at the molecular level the agonist and antagonist binding modes and may help design nonpeptide agonist mimetics of the NTR1.	Univ Nice, Inst Pharmacol Mol & Cellulaire, CNRS, UPR 411, F-06560 Valbonne, France; Sanofi Rech, Ctr Montpellier, F-3418 Montpellier 04, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Sanofi-Aventis; Sanofi France	Labbe-Jullie, C (corresponding author), Univ Nice, Inst Pharmacol Mol & Cellulaire, CNRS, UPR 411, 660 Route Lucioles, F-06560 Valbonne, France.			Labbe-Jullie, Catherine/0000-0001-6398-3807				Almaula N, 1996, J BIOL CHEM, V271, P14672, DOI 10.1074/jbc.271.25.14672; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BALDWIN JM, 1997, J MOL BIOL, V213, P899; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; BEINBORN M, 1993, NATURE, V362, P348, DOI 10.1038/362348a0; Betancur C, 1997, TRENDS PHARMACOL SCI, V18, P372, DOI 10.1016/S0165-6147(97)01109-7; BHOGAL N, 1994, J BIOL CHEM, V269, P27269; BIDARD JN, 1993, BIOCHEM J, V291, P225, DOI 10.1042/bj2910225; Botto JM, 1997, MOL BRAIN RES, V46, P311, DOI 10.1016/S0169-328X(97)00006-5; CHABRY J, 1995, J BIOL CHEM, V270, P2439, DOI 10.1074/jbc.270.6.2439; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; Cook JVF, 1997, ENDOCRINOLOGY, V138, P2800, DOI 10.1210/en.138.7.2800; Dubuc I, 1999, J NEUROSCI, V19, P503, DOI 10.1523/JNEUROSCI.19-01-00503.1999; FONG TM, 1992, J BIOL CHEM, V267, P25664; FONG TM, 1992, BIOCHEMISTRY-US, V31, P11806, DOI 10.1021/bi00162a019; GETHER U, 1993, NATURE, V362, P345, DOI 10.1038/362345a0; GETHER U, 1993, P NATL ACAD SCI USA, V90, P6194, DOI 10.1073/pnas.90.13.6194; Gigoux V, 1998, J BIOL CHEM, V273, P14380, DOI 10.1074/jbc.273.23.14380; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; Huang RRC, 1995, BIOCHEMISTRY-US, V34, P16467, DOI 10.1021/bi00050a030; Jagerschmidt A, 1998, MOL PHARMACOL, V53, P878; JI H, 1994, J BIOL CHEM, V269, P16533; KAUPMANN K, 1995, EMBO J, V14, P727, DOI 10.1002/j.1460-2075.1995.tb07051.x; KITABGI P, 1989, NEUROCHEM INT, V14, P111, DOI 10.1016/0197-0186(89)90110-1; Labbe-Jullie C, 1998, J BIOL CHEM, V273, P16351, DOI 10.1074/jbc.273.26.16351; LABBEJULLIE C, 1995, MOL PHARMACOL, V47, P1050; LABBEJULLIE C, 1994, J PHARMACOL EXP THER, V271, P267; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Mazella J, 1996, J NEUROSCI, V16, P5613; MOUILLAC B, 1995, J BIOL CHEM, V270, P25771, DOI 10.1074/jbc.270.43.25771; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NIETO JL, 1986, INT J PEPT PROT RES, V28, P315; Pang YP, 1996, J BIOL CHEM, V271, P15060, DOI 10.1074/jbc.271.25.15060; PERLMAN JH, 1995, J BIOL CHEM, V270, P24682, DOI 10.1074/jbc.270.42.24682; Perlman JH, 1996, BIOCHEMISTRY-US, V35, P7643, DOI 10.1021/bi952202r; Perlman JH, 1997, BIOCHEMISTRY-US, V36, P15670, DOI 10.1021/bi9713310; Postina R, 1996, J BIOL CHEM, V271, P31593, DOI 10.1074/jbc.271.49.31593; PRESTI ME, 1993, AM J PHYSIOL, V264, pG399, DOI 10.1152/ajpgi.1993.264.3.G399; QUERE L, 1996, J CHEM SOC P1, V2, P2639; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; TRUMPPKALLMEYER S, 1992, J MED CHEM, V35, P3448, DOI 10.1021/jm00097a002; Turcatti G, 1997, J BIOL CHEM, V272, P21167, DOI 10.1074/jbc.272.34.21167; Valiquette M, 1996, J BIOL CHEM, V271, P18789, DOI 10.1074/jbc.271.31.18789; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; Vita N, 1998, EUR J PHARMACOL, V360, P265, DOI 10.1016/S0014-2999(98)00678-5; VITA N, 1993, FEBS LETT, V317, P139, DOI 10.1016/0014-5793(93)81509-X; Webb ML, 1996, BIOCHEMISTRY-US, V35, P2548, DOI 10.1021/bi951836v; XU GY, 1991, INT J PEPT PROT RES, V37, P528; YAMADA M, 1994, MOL PHARMACOL, V46, P470	51	73	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					328	336		10.1074/jbc.275.1.328	http://dx.doi.org/10.1074/jbc.275.1.328			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617622	hybrid			2022-12-27	WOS:000085951600046
J	Chang, T; Kuo, MC; Khoo, KH; Inoue, S; Inoue, Y				Chang, T; Kuo, MC; Khoo, KH; Inoue, S; Inoue, Y			Developmentally regulated expression of a peptide : N-Glycanase during germination of rice seeds (Oryza sativa) and its purification and characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-CELL SUSPENSION; I HEAVY-CHAINS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; ANIMAL-CELLS; GLYCOSYLATION; GLYCOSIDASE; PROTEINS; PNGASE; GLYCOPEPTIDASE	Peptide:N-glycanase (PNGase; EC 3.5.1.52) activity was detected in dormant rice seeds (Oryza sativa) and the imbibed rice grains. Time-course studies revealed that the enzyme activity remained almost constant until about 30 h after imbibition in both of endosperm- and embryo tissue-containing areas, and started to increase only in growing germ part, reached a peak at about 3-day stage, followed by a gradual decrease concomitant with a sharp increase in the coleoptile. The specific activity increased about g-fold at about 3-day stage. PN-Gase was purified to electrophoretic homogeneity from the extracts of germinated rice seeds at 24 h, and the apparent molecular weight of the purified enzyme, estimated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), was about 80,000. The purified enzyme was designated PNGase Os to denote its origin. The N-terminal sequence of the 10 residues was determined to be SYN-VASVAGL, The purified PNGase Os in SDS-PAGE appeared as a rather broad band, consistent with the presence of multiple glycoforms as indicated by chromatographic behavior on a Sephadex G-75 column. PNGase expressed in coleoptile under anoxia condition was also purified, and both of the purified enzymes were found to exhibit very similar, if not identical, electrophoretic mobility in SDS-PAGE. PNGase Os exhibited a broad pH-activity profile with an optimum of 4-5 and, interestingly, was significantly inactivated by K+ and Na+ at near the physiological concentration, 100 mM. These results are discussed in relation to other work.	Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	Academia Sinica - Taiwan	Inoue, Y (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.		Khoo, Kay-Hooi/E-1989-2019; Chen, Tianren/AAS-6018-2021	Khoo, Kay-Hooi/0000-0003-2906-406X; 				Berger S, 1995, BIOCHIMIE, V77, P751, DOI 10.1016/0300-9084(96)88193-4; BRUMMELL DA, 1987, PLANT CELL ENVIRON, V10, P523, DOI 10.1111/1365-3040.ep11603897; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; INOUE S, 1990, TRENDS GLYCOSCI GLYC, V2, P225; ISHIHARA H, 1979, J BIOL CHEM, V254, P715; ISHIZAWA K, 1984, PLANT CELL ENVIRON, V7, P239, DOI 10.1111/j.1365-3040.1984.tb01345.x; KITAJIMA K, 1995, ARCH BIOCHEM BIOPHYS, V319, P393, DOI 10.1006/abbi.1995.1309; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Ku H S, 1970, Planta, V90, P333, DOI 10.1007/BF00386385; LHERNOULD S, 1995, GLYCOCONJUGATE J, V12, P94, DOI 10.1007/BF00731874; LHERNOULD S, 1992, GLYCOCONJUGATE J, V9, P191, DOI 10.1007/BF00731164; NAPIER RM, 1995, NEW PHYTOL, V129, P167, DOI 10.1111/j.1469-8137.1995.tb04291.x; PLUMMER TH, 1987, EUR J BIOCHEM, V163, P167, DOI 10.1111/j.1432-1033.1987.tb10751.x; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; PRIEM B, 1994, BIOCHEM SOC T, V22, P398, DOI 10.1042/bst0220398; PRIEM B, 1992, PLANT PHYSIOL, V98, P399, DOI 10.1104/pp.98.1.399; PRIEM B, 1993, PLANT PHYSIOL, V102, P445, DOI 10.1104/pp.102.2.445; PRIEM B, 1990, GLYCOCONJUGATE J, V7, P121, DOI 10.1007/BF01050375; SEKO A, 1991, J BIOL CHEM, V266, P22110; Seko A, 1999, GLYCOBIOLOGY, V9, P887, DOI 10.1093/glycob/9.9.887; SEKO A, 1991, BIOCHEM BIOPH RES CO, V180, P165; SUGIYAMA K, 1983, BIOCHEM BIOPH RES CO, V112, P155, DOI 10.1016/0006-291X(83)91810-7; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; Suzuki T, 1998, J BIOL CHEM, V273, P10083, DOI 10.1074/jbc.273.17.10083; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Suzuki T, 1997, P NATL ACAD SCI USA, V94, P6244, DOI 10.1073/pnas.94.12.6244; Suzuki T, 1998, J BIOL CHEM, V273, P21526, DOI 10.1074/jbc.273.34.21526; SUZUKI T, 1995, GLYCOCONJUGATE J, V12, P183, DOI 10.1007/BF00731318; SUZUKI T, 1994, GLYCOCONJUGATE J, V11, P469, DOI 10.1007/BF00731283; SUZUKI T, 1995, J BIOL CHEM, V270, P15181, DOI 10.1074/jbc.270.25.15181; SUZUKI T, 1994, GLYCOBIOLOGY, V4, P777, DOI 10.1093/glycob/4.6.777; SUZUKI T, 1997, GLYCOSCIENCES STATUS, P122; TAGA EM, 1984, BIOCHEMISTRY-US, V23, P815, DOI 10.1021/bi00300a006; TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; YET MG, 1988, J BIOL CHEM, V263, P118; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	40	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					129	134		10.1074/jbc.275.1.129	http://dx.doi.org/10.1074/jbc.275.1.129			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617595	hybrid			2022-12-27	WOS:000085951600019
J	Osickova, A; Osicka, R; Maier, E; Benz, R; Sebo, P				Osickova, A; Osicka, R; Maier, E; Benz, R; Sebo, P			An amphipathic alpha-helix including glutamates 509 and 516 is crucial for membrane translocation of adenylate cyclase toxin and modulates formation and cation selectivity of its membrane channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-INVASIVE ACTIVITY; BORDETELLA-PERTUSSIS; ESCHERICHIA-COLI; MACROPHAGE APOPTOSIS; HEMOLYTIC ACTIVITIES; HYDROPHOBIC MOMENT; PORE FORMATION; IN-VIVO; CALMODULIN; PROTEIN	The Bordetella pertussis adenylate cyclase toxin-hemolysin (ACT or CyaA) is a multifunctional protein. It forms small cation-selective channels in target cell and lipid bilayer membranes and it delivers into cell cytosol the amino-terminal adenylate cyclase (AC) domain, which catalyzes uncontrolled conversion of ATP to cAMP and causes cell intoxication. Here, we demonstrate that membrane translocation of the AC domain into cells is selectively dissociated from ACT membrane insertion and channel formation when a helix-breaking proline residue is substituted for glutamate 509 (Glu-509) within a predicted transmembrane amphipathic alpha-helix. Neutral substitutions of Glu-509 had little effect on toxin activities. In contrast, charge reversal by lysine substitutions of the Glu-509 or of the adjacent Glu-516 residue reduced the capacity of the toxin to translocate the AC domain across membrane and enhanced significantly its specific hemolytic activity and channel forming capacity in lipid bilayer membranes. Combination of the E509K and E516K mutations in a single molecule further exacerbated hemolytic and channel forming activity and ablated translocation of the AC domain into cells. The lysine substitutions strongly decreased the cation selectivity of the channels, indicating that Glu-509 and Glu-516 are located within or close to the membrane channel. These results suggest that the structure including glutamate residues 509 and 516 is critical for AC membrane translocation and channel forming activity of ACT.	Acad Sci Czech Republ, Inst Microbiol, Cellular & Mol Microbiol Div, CZ-14220 Prague 4, Czech Republic; Univ Wurzburg, Theodor Boveri Inst, Biozentrum, Lehrstuhl Biotechnol, D-97074 Wurzburg, Germany	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Wurzburg	Sebo, P (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Cellular & Mol Microbiol Div, Videoska 1083, CZ-14220 Prague 4, Czech Republic.	sebo@biomed.cas.cz	SEBO, Peter/F-7423-2011; Osickova, Adriana/H-6841-2014; Osicka, Radim/H-6776-2014; SEBO, Peter/N-2043-2019	SEBO, Peter/0000-0002-9755-7715; Osickova, Adriana/0000-0002-5739-1183; Osicka, Radim/0000-0003-2626-5456; SEBO, Peter/0000-0002-9755-7715; Benz, Roland/0000-0002-9510-9265				BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; Basar T, 1999, J BIOL CHEM, V274, P10777, DOI 10.1074/jbc.274.16.10777; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BENZ R, 1994, EUR J BIOCHEM, V220, P339, DOI 10.1111/j.1432-1033.1994.tb18630.x; BENZ R, 1994, J BIOL CHEM, V269, P27231; BETSOU F, 1993, INFECT IMMUN, V61, P3583, DOI 10.1128/IAI.61.9.3583-3589.1993; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; EHRMANN IE, 1991, FEBS LETT, V278, P79, DOI 10.1016/0014-5793(91)80088-K; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GLASER P, 1989, EMBO J, V8, P967, DOI 10.1002/j.1460-2075.1989.tb03459.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; GORDON VM, 1989, J BIOL CHEM, V264, P14792; Gray M, 1998, J BIOL CHEM, V273, P18260, DOI 10.1074/jbc.273.29.18260; Gueirard P, 1998, INFECT IMMUN, V66, P1718, DOI 10.1128/IAI.66.4.1718-1725.1998; Guermonprez P, 1999, J IMMUNOL, V162, P1910; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; HANSKI E, 1989, TRENDS BIOCHEM SCI, V14, P459, DOI 10.1016/0968-0004(89)90106-0; HANSKI E, 1985, J BIOL CHEM, V260, P5526; HEWLETT EL, 1983, CLIN RES, V31, pA365; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; IWAKI M, 1995, MOL MICROBIOL, V17, P1015, DOI 10.1111/j.1365-2958.1995.mmi_17061015.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; KHELEF N, 1995, FEMS MICROBIOL LETT, V134, P27, DOI 10.1016/0378-1097(95)00375-F; KRISHTALIK LI, 1995, FEBS LETT, V369, P140, DOI 10.1016/0014-5793(95)00756-Y; LADANT D, 1988, J BIOL CHEM, V263, P2612; OTERO AS, 1995, J BIOL CHEM, V270, P9695, DOI 10.1074/jbc.270.17.9695; ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x; ROGEL A, 1992, J BIOL CHEM, V267, P22599; ROGEL A, 1991, J BIOL CHEM, V266, P3154; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; SEBO P, 1993, MOL MICROBIOL, V9, P999, DOI 10.1111/j.1365-2958.1993.tb01229.x; SEBO P, 1991, GENE, V104, P19, DOI 10.1016/0378-1119(91)90459-O; SZABO G, 1994, J BIOL CHEM, V269, P22496; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; WOLFF J, 1980, P NATL ACAD SCI-BIOL, V77, P3841, DOI 10.1073/pnas.77.7.3841	42	75	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37644	37650						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608820				2022-12-27	WOS:000084528000020
J	Drake, RR; Wilbert, TN; Hinds, TA; Gilbert, KM				Drake, RR; Wilbert, TN; Hinds, TA; Gilbert, KM			Differential ganciclovir-mediated cell killing by glutamine 125 mutants of herpes simplex virus type 1 thymidine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUICIDE-GENE-THERAPY; IN-VITRO; TUMOR; CANCER; DEATH; PHASE; LYMPHOCYTES; METABOLISM; REGRESSION; EXPRESSION	The therapeutic combination of the herpesvirus simplex virus type 1 (HSV-1) thymidine kinase (TK) gene and the prodrug, ganciclovir (GCV), has found great utility for the treatment of many types of cancer. After initial phosphorylation of GCV by HSV-1 TK, cellular kinases generate the toxic GCV-triphosphate metabolite that is incorporated into DNA and eventually leads to tumor cell death, The cellular and pharmacological mechanisms by which metabolites of GCV lead to cell death are still poorly defined. To bean to address these mechanisms, different mutated forms of HSV-1 TK at residue Gln-125 that have distinct substrate properties were expressed in mammalian cell lines. It was found that expression of the Asn-125 HSV-1 TK mutant in two cell lines, NIH3T3 and HCT-116, was equally effective as wild-type HSV-1 TK for metabolism and sensitivity to GCV, bystander effect killing and induction of apoptosis. The major difference between the two enzymes was the lack of deoxypyrimidine metabolism in the Asn-125 TK-expressing cells. In HCT-116 cells expressing the Glu-125 TK mutant, GCV metabolism was greatly attenuated, yet at higher GCV concentrations, cell sensitivity to the drug and bystander effect killing were diminished but still effective. Cell cycle analysis, 4',6'-diamidine-2'-phenylindoledihydrochloride staining, and caspase 3 activation assays indicated different cell death responses in the Glu-125 TK-expressing cells as compared with the wild-type HSV-1 TK or Asn-125 TK-expressing cells. A mechanistic hypothesis to explain these results based on the differences in GCV-triphosphate metabolite levels is presented.	Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Drake, RR (corresponding author), Univ Arkansas Med Sci, Dept Biochem, Slot 516,4301 W Markham, Little Rock, AR 72205 USA.				NCI NIH HHS [CA77938-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R41CA077938] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAM L, 1995, CANCER RES, V55, P5156; BI WL, 1993, HUM GENE THER, V4, P725, DOI 10.1089/hum.1993.4.6-725; Bi WL, 1997, CANCER GENE THER, V4, P246; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; Denning C, 1997, HUM GENE THER, V8, P1825, DOI 10.1089/hum.1997.8.15-1825; Drake RR, 1997, ANTIVIR RES, V35, P177, DOI 10.1016/S0166-3542(97)00027-2; FREEMAN SM, 1993, CANCER RES, V53, P5274; Freeman SM, 1997, LANCET, V349, P2, DOI 10.1016/S0140-6736(97)22001-5; Freeman SM, 1996, SEMIN ONCOL, V23, P31; Hall SJ, 1998, CANCER RES, V58, P3221; Halloran PJ, 1998, CANCER RES, V58, P3855; Hamel W, 1996, CANCER RES, V56, P2697; ILSLEY DD, 1995, BIOCHEMISTRY-US, V34, P2504, DOI 10.1021/bi00008a014; KANEKO Y, 1995, CANCER LETT, V96, P105, DOI 10.1016/0304-3835(95)03919-N; Kianmanesh AR, 1997, HUM GENE THER, V8, P1807, DOI 10.1089/hum.1997.8.15-1807; KIM YG, 1999, IN PRESS CANC GENE T; Klatzmann D, 1998, HUM GENE THER, V9, P2595, DOI 10.1089/hum.1998.9.17-2595; McMasters RA, 1998, HUM GENE THER, V9, P2253, DOI 10.1089/hum.1998.9.15-2253; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; Mullen CA, 1998, HUM GENE THER, V9, P2019, DOI 10.1089/hum.1998.9.14-2019; Rubsam LZ, 1999, CANCER RES, V59, P669; Rubsam LZ, 1998, CANCER RES, V58, P3873; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; SMEE DF, 1985, BIOCHEM PHARMACOL, V34, P1049, DOI 10.1016/0006-2952(85)90608-2; Sterman DH, 1998, HUM GENE THER, V9, P1083, DOI 10.1089/hum.1998.9.7-1083; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vile RG, 1997, INT J CANCER, V71, P267; WEI MX, 1998, CANCER RES, V58, P3221; Wei SJ, 1998, EXP CELL RES, V241, P66, DOI 10.1006/excr.1998.4005	30	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37186	37192		10.1074/jbc.274.52.37186	http://dx.doi.org/10.1074/jbc.274.52.37186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601281	hybrid			2022-12-27	WOS:000084382700052
J	Szegedy, MA; Maguire, ME				Szegedy, MA; Maguire, ME			The CorA Mg2+ transport protein of Salmonella typhimurium - Mutagenesis of conserved residues in the second membrane domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNESIUM TRANSPORT; ESCHERICHIA-COLI; REGULATORY CATION; MG-2+ TRANSPORT; RIBONUCLEASE-H; ION; BINDING; SYSTEM; METALLOBIOCHEMISTRY; ACTIVATION	Salmonella typhimurium CorA is the archetypal member of the largest family of Mg2+ transporters of the Bacteria and Archaea, It contains three transmembrane segments. There are no conserved charged residues within these segments indicating electrostatic interactions are not used in Mg2+ transport through CorA, Previous mutagenesis studies of CorA revealed a single face of the third transmembrane segment that is important for Mg2+ transport. In this study, we mutated hydroxyl-bearing and other conserved residues in the second transmembrane segment to identify residues involved in transport. Residues Ser(260), Thr(270) and Ser(274) appear to be important for transport and are oriented such that they would also line a face of an alpha-helix, In addition, the sequence (276)YGMNF(280), found in virtually all CorA homologues, is critical for CorA function because even conservative mutations are not tolerated at these residues. Finally, mutations of residues in the second transmembrane segment, unlike those in the third transmembrane segment, revealed cooperative behavior for the influx of Mg2+. We conclude that the second transmembrane segment forms a major part of the Mg2+ pore with the third transmembrane segment of CorA.	Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Szegedy, MA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxs100@po.cwru.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039447] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08056, GM39447] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cowan JA, 1998, CHEM REV, V98, P1067, DOI 10.1021/cr960436q; COWAN JA, 1991, INORG CHEM, V30, P2740, DOI 10.1021/ic00013a008; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GIBSON MM, 1991, MOL MICROBIOL, V5, P2753, DOI 10.1111/j.1365-2958.1991.tb01984.x; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; GRUBBS RD, 1989, METHOD ENZYMOL, V173, P546; GRUBBS RD, 1987, MAGNESIUM, V6, P113; HMIEL SP, 1989, J BACTERIOL, V171, P4742, DOI 10.1128/jb.171.9.4742-4751.1989; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; HUANG HW, 1994, EUR J BIOCHEM, V219, P253, DOI 10.1111/j.1432-1033.1994.tb19936.x; INESI G, 1980, J BIOL CHEM, V255, P3025; JOU RW, 1991, J AM CHEM SOC, V113, P6685, DOI 10.1021/ja00017a056; KEENAN D, 1995, CIRC RES, V77, P973, DOI 10.1161/01.RES.77.5.973; Kehres D G, 1998, Microb Comp Genomics, V3, P151, DOI 10.1089/omi.1.1998.3.151; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; MAGUIRE ME, 1990, MET IONS BIOL SYST, V26, P135; MAGUIRE ME, 1980, J BIOL CHEM, V255, P1030; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; NELSON DL, 1971, J BIOL CHEM, V246, P3042; QUIGLEY GJ, 1978, P NATL ACAD SCI USA, V75, P64, DOI 10.1073/pnas.75.1.64; ROMANI A, 1993, CIRC RES, V72, P1139, DOI 10.1161/01.RES.72.6.1139; ROMANI A, 1990, NATURE, V346, P841, DOI 10.1038/346841a0; ROMANI A, 1990, FEBS LETT, V269, P37, DOI 10.1016/0014-5793(90)81113-3; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; SMITH RL, 1993, J BIOL CHEM, V268, P14071; Smith RL, 1998, J BIOL CHEM, V273, P28663, DOI 10.1074/jbc.273.44.28663; Smith RL, 1998, MICROBIOL-SGM, V144, P1835, DOI 10.1099/00221287-144-7-1835; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; SMITH RL, 1995, J BACTERIOL, V177, P1638, DOI 10.1128/jb.177.6.1638-1640.1995; SNAVELY MD, 1989, J BACTERIOL, V171, P4761, DOI 10.1128/jb.171.9.4761-4766.1989; SNAVELY MD, 1991, J BIOL CHEM, V266, P824; SNAVELY MD, 1989, J BACTERIOL, V171, P4752, DOI 10.1128/jb.171.9.4752-4760.1989; Tepperman K, 1997, AM J PHYSIOL-CELL PH, V273, pC2065, DOI 10.1152/ajpcell.1997.273.6.C2065; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X	36	57	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36973	36979		10.1074/jbc.274.52.36973	http://dx.doi.org/10.1074/jbc.274.52.36973			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601252	hybrid			2022-12-27	WOS:000084382700023
J	Thanos, CD; Faham, S; Goodwill, KE; Cascio, D; Phillips, M; Bowie, JU				Thanos, CD; Faham, S; Goodwill, KE; Cascio, D; Phillips, M; Bowie, JU			Monomeric structure of the human EphB2 sterile alpha motif domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; PROTEIN-KINASE; IN-VITRO; LIGAND; BINDING; SAM; EXPRESSION; GUIDANCE; SYSTEM; ELF-1	The sterile a motif (SAM) domain is a protein module found in many diverse signaling proteins. SAM domains in some systems have been shown to self-associate. Previous crystal structures of an EphA4-SAM domain dimer (Stapleton, D,, Balan, I., Pawson, T,, and Sicheri, F, (1999) Not, Struct. Biol. 6, 44-49) and a possible EphB2-SAM oligomer (Thanos, C, D,, Goodwill, K, E,, and Bowie, J, U, (1999) Science 283, 833-836) both revealed large interfaces comprising an exchange of N-terminal peptide arms. Within the arm, a conserved hydrophobic residue (Tyr-8 in the EphB2-SAM structure or Phe-910 in the EphA4-SAM structure) is anchored into a hydrophobic cleft on a neighboring molecule. Here we have solved a new crystal form of the human EphB2-SAM domain that has the same overall SARI domain fold yet has no substantial intermolecular contacts. In the new structure, the N-terminal peptide arm of the EphB2-SAM domain protrudes out from the core of the molecule, leaving both the arm (including Tyr-8) and the hydrophobic cleft solvent-exposed, To verify that Tyr-8 is solvent-exposed in solution, we made a Tyr-8 to Ala-8 mutation and found that the EphB2-SAM domain structure and stability were only slightly altered. These results suggest that Tyr-8 is not part of the hydrophobic core of the EphB2-SAM domain and is conserved for functional reasons. Cystallographic evidence suggests a possible role for the N-terminal arm in oligomerization, In the absence of a direct demonstration of biological relevance, however, the functional role of the N-terminal arm remains an open question.	Univ Calif Los Angeles, DOE Lab Struct Biol & Mol Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bowie, JU (corresponding author), Univ Calif Los Angeles, DOE Lab Struct Biol & Mol Med, Los Angeles, CA 90095 USA.							Barr MM, 1996, MOL CELL BIOL, V16, P5597; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Chi SW, 1999, EMBO J, V18, P4438, DOI 10.1093/emboj/18.16.4438; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; Donoghue MJ, 1996, MOL CELL NEUROSCI, V8, P185, DOI 10.1006/mcne.1996.0056; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Hsueh YP, 1998, NEURON, V21, P1227, DOI 10.1016/S0896-6273(00)80641-8; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kyba M, 1998, DEV GENET, V22, P74, DOI 10.1002/(SICI)1520-6408(1998)22:1<74::AID-DVG8>3.3.CO;2-V; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; Schultz J, 1997, PROTEIN SCI, V6, P249; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Slupsky CM, 1998, P NATL ACAD SCI USA, V95, P12129, DOI 10.1073/pnas.95.21.12129; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tu H, 1997, MOL CELL BIOL, V17, P5876, DOI 10.1128/MCB.17.10.5876; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Xu QL, 1996, NATURE, V381, P319, DOI 10.1038/381319a0; Xu QL, 1995, DEVELOPMENT, V121, P4005	41	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37301	37306		10.1074/jbc.274.52.37301	http://dx.doi.org/10.1074/jbc.274.52.37301			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601296	hybrid			2022-12-27	WOS:000084382700067
J	Hudrisier, D; Riond, J; Mazarguil, H; Oldstone, MBA; Gairin, JE				Hudrisier, D; Riond, J; Mazarguil, H; Oldstone, MBA; Gairin, JE			Genetically encoded and post-translationally modified forms of a major histocompatibility complex class I-restricted antigen bearing a glycosylation motif are independently processed and co-presented to cytotoxic T lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHORIOMENINGITIS VIRUS; ENDOPLASMIC-RETICULUM; VIRAL-INFECTION; GLYCOPROTEIN EPITOPE; MEMBRANE-PROTEIN; ANCHOR RESIDUES; CELL RESPONSE; PEPTIDES; H-2D(B); RECOGNITION	The mechanisms by which antigenic peptides bearing a glycosylation site may be processed from viral glycoproteins, post-translationally modified, and presented by major histocompatibility complex class I molecules remain poorly understood. With the aim of exploring these processes, we have dissected the structural and functional properties of the MHC-restricted peptide GP92-101 (CSANNSHHYI) generated from the lymphocytic choriomeningitis virus (LCMV) GP1 glycoprotein. LCMV GP92-101 bears a glycosylation motif -NXS- that is naturally N-glycosylated in the mature viral glycoprotein, displays high affinity for H-2D(b) molecules, and elicits a CD8(+) cytotoxic T lymphocyte response. By analyzing the functional. properties of natural and synthetic peptides and by identifying the viral sequence(s) from the pool of naturally occurring peptides, we demonstrated that multiple forms of LCMV GP92-101 were generated hom the viral glycoprotein and co-presented at the surface of LCMV-infected cells. They corresponded to non-glycosylated and post-translationally modified sequences (conversion of Asn-95 to Asp or alteration of Cys-92). The glycosylated form, despite its potential immunogenicity, was not detected. These data illustrate that distinct, non-mutually exclusive antigen presentation pathways may occur simultaneously within a cell to generate structurally and functionally different peptides from a single genetically encoded sequence, thus contributing to increasing the diversity of the T cell repertoire.	CNRS, Inst Pharmacol & Biol Struct, UPR 9062, F-31400 Toulouse, France; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Scripps Research Institute	Hudrisier, D (corresponding author), CNRS, Inst Pharmacol & Biol Struct, UPR 9062, 205 Route Narbonne, F-31400 Toulouse, France.		Riond, Joelle/R-6414-2016	Riond, Joelle/0000-0002-6281-2376; Hudrisier, Denis/0000-0002-3631-9561				Anton LC, 1998, J IMMUNOL, V160, P4859; Bacik I, 1997, J EXP MED, V186, P479, DOI 10.1084/jem.186.4.479; Carson RT, 1999, J IMMUNOL, V162, P1; Chen WS, 1999, J EXP MED, V189, P1757, DOI 10.1084/jem.189.11.1757; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; DUDLER T, 1995, EUR J IMMUNOL, V25, P538, DOI 10.1002/eji.1830250235; Elliott T, 1997, ADV IMMUNOL, V65, P47, DOI 10.1016/S0065-2776(08)60741-5; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; Ferris RL, 1996, J IMMUNOL, V156, P834; Ferris RL, 1999, J IMMUNOL, V162, P1324; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; Gallimore A, 1998, EUR J IMMUNOL, V28, P3301, DOI 10.1002/(SICI)1521-4141(199810)28:10<3301::AID-IMMU3301>3.0.CO;2-Q; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Glithero A, 1999, IMMUNITY, V10, P63, DOI 10.1016/S1074-7613(00)80007-2; Groettrup M, 1996, IMMUNOL TODAY, V17, P429, DOI 10.1016/0167-5699(96)10051-7; HAURUM JS, 1994, J EXP MED, V180, P739, DOI 10.1084/jem.180.2.739; Haurum JS, 1995, EUR J IMMUNOL, V25, P3270, DOI 10.1002/eji.1830251211; HUDRISIER D, 1995, MOL IMMUNOL, V32, P895, DOI 10.1016/0161-5890(95)00043-E; Hudrisier D, 1996, J BIOL CHEM, V271, P17829, DOI 10.1074/jbc.271.30.17829; Hudrisier D, 1998, J IMMUNOL, V161, P553; HUDRISIER D, 1996, THESIS P SABATIER U; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; Kessler B, 1998, J IMMUNOL, V161, P6939; KLAVINSKIS LS, 1990, VIROLOGY, V178, P393, DOI 10.1016/0042-6822(90)90336-P; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Mosse CA, 1998, J EXP MED, V187, P37, DOI 10.1084/jem.187.1.37; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; OLDSTONE MBA, 1988, J EXP MED, V168, P559, DOI 10.1084/jem.168.2.559; OLDSTONE MBA, 1995, J VIROL, V69, P7423, DOI 10.1128/JVI.69.12.7423-7429.1995; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; SCHULZ M, 1989, EUR J IMMUNOL, V19, P1657, DOI 10.1002/eji.1830190921; Selby M, 1999, J IMMUNOL, V162, P669; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Speir JA, 1999, IMMUNITY, V10, P51, DOI 10.1016/S1074-7613(00)80006-0; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; WIDMANN C, 1992, J IMMUNOL METHODS, V155, P95, DOI 10.1016/0022-1759(92)90275-X; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wood P, 1998, J EXP MED, V188, P773, DOI 10.1084/jem.188.4.773; WRIGHT KE, 1990, VIROLOGY, V177, P175, DOI 10.1016/0042-6822(90)90471-3; Yewdell JW, 1996, J IMMUNOL, V157, P1823; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6	47	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36274	36280		10.1074/jbc.274.51.36274	http://dx.doi.org/10.1074/jbc.274.51.36274			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593916	hybrid			2022-12-27	WOS:000084279200035
J	Kuhns, JJ; Batalia, MA; Yan, SQ; Collins, EJ				Kuhns, JJ; Batalia, MA; Yan, SQ; Collins, EJ			Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIC T-LYMPHOCYTES; CLASS-I; HIGH-AFFINITY; HER2/NEU-DERIVED PEPTIDE; ANTIGEN PRESENTATION; MAXIMUM-LIKELIHOOD; OVARIAN-CANCER; MHC; MOLECULES; AMINO	Class I major histocompatibility complex (MHC) molecules bind short peptides derived from proteins synthesized within the cell. These complexes of peptide and class I MHC (pMHC) are transported from the endoplasmic reticulum to the cell surface. If a clonotypic T cell receptor expressed on a circulating T cell binds to the pMHC complex, the cell presenting the pMHC is killed. In this manner, some tumor cells expressing aberrant proteins are recognized and removed by the immune system. However, not all tumors are recognized efficiently. One reason hypothesized for poor T cell recognition of tumor-associated peptides is poor binding of those peptides to class I MHC molecules. Many peptides, derived from the proto-oncogene HER-2/neu have been shown to be recognized by cytotoxic T cells derived from HLA-A2(+) patients with breast cancer and other adenocarcinomas. Seven of these peptides were found to bind with intermediate to poor affinity. In particular, GP2 (HER-2/neu residues 654-662) binds very poorly even though it is predicted to bind web based upon the presence of the correct HLA-A2.1 peptide-binding motif. Altering the anchor residues to those most favored by HLA-A2.1 did not significantly improve binding affinity. The crystallographic structure shows that unlike other class I-peptide structures, the center of the peptide does not assume one specific conformation and does not make stabilizing contacts with the peptide-binding cleft.	Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Collins, EJ (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, CB 7290,804 M E Jones Bldg, Chapel Hill, NC 27599 USA.				NATIONAL CANCER INSTITUTE [P50CA058223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029324] Funding Source: NIH RePORTER; NCI NIH HHS [CA 58223] Funding Source: Medline; NIAID NIH HHS [AI 29324] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Batalia MA, 1997, BIOPOLYMERS, V43, P281, DOI 10.1002/(SICI)1097-0282(1997)43:4<281::AID-BIP3>3.0.CO;2-R; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1992, XPLOR VERSION 3 1; Chan S, 1998, IMMUNOL REV, V165, P195, DOI 10.1111/j.1600-065X.1998.tb01240.x; CHEN Y, 1994, J IMMUNOL, V152, P2874; COLBERT RA, 1994, IMMUNITY, V1, P121, DOI 10.1016/1074-7613(94)90105-8; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; FALL K, 1991, NATURE, V351, P290; Fisk B, 1995, J IMMUNOTHER, V18, P197, DOI 10.1097/00002371-199511000-00001; FISK B, 1995, J EXP MED, V181, P2109, DOI 10.1084/jem.181.6.2109; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kono K, 1998, INT J CANCER, V78, P202, DOI 10.1002/(SICI)1097-0215(19981005)78:2<202::AID-IJC14>3.0.CO;2-C; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Lehner PJ, 1998, CURR BIOL, V8, pR605, DOI 10.1016/S0960-9822(98)70387-2; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Morgan CS, 1997, PROTEIN SCI, V6, P1771, DOI 10.1002/pro.5560060819; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P432, DOI 10.1073/pnas.92.2.432; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Romero P, 1997, J IMMUNOL, V159, P2366; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; TSOMIDES TJ, 1991, P NATL ACAD SCI USA, V88, P11276, DOI 10.1073/pnas.88.24.11276; YOSHINO I, 1994, CANCER RES, V54, P3387; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359	38	58	90	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36422	36427		10.1074/jbc.274.51.36422	http://dx.doi.org/10.1074/jbc.274.51.36422			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593938	Green Published, hybrid			2022-12-27	WOS:000084279200057
J	Ro, HS; Miles, EW				Ro, HS; Miles, EW			Structure and function of the tryptophan synthase alpha(2)beta(2) complex - Roles of beta subunit histidine 86	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID AMINOTRANSFERASE; D-SERINE DEHYDRATASE; INDUCED CONFORMATIONAL-CHANGES; NUCLEAR MAGNETIC-RESONANCE; ESCHERICHIA-COLI; PYRIDOXAL 5'-PHOSPHATE; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURES; INTERSUBUNIT COMMUNICATION; CATALYTIC MECHANISM	To probe the structural and functional roles of active-site residues in the tryptophan synthase alpha(2)beta(2) complex from Salmonella typhimurium, we have determined the effects of mutation of His(86) in the beta subunit. His(86) is located adjacent to beta subunit Lys(87), which forms an internal aldimine with the pyridoxal phosphate and catalyzes the abstraction of the alpha-proton of L-serine. The replacement of His(86) by leucine (H86L) weakened pyridoxal phosphate binding similar to 20-fold and abolished the circular dichroism signals of the bound coenzyme and of a reaction intermediate. Correlation of these results with previous crystal structures indicates that beta-His(86) plays a structural role in binding pyridoxal phosphate and in stabilizing the correct orientation of pyridoxal phosphate in the active site of the beta subunit. The H86L mutation also altered the pH profiles of absorbance and fluorescence signals and shifted the pH optimum for the synthesis of L-tryptophan from pH 7.5 to 8.8. We propose that the interaction of His(86) with the phosphate of pyridoxal phosphate and with Lys(87) lowers the pK(a) of Lys(87) in the wild-type alpha(2)beta(2) complex and thereby facilitates catalysis by Lys(87) in the physiological pH range.	NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Miles, EW (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bldg 8,Rm 225,8 Ctr Dr,MSC 0830, Bethesda, MD 20892 USA.	EdithM@intra.niddk.nih.gov	Ro, Hyeon-Su/V-7023-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK034002, Z01DK024140, ZIHDK034002, Z01DK034002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams E, 1979, Methods Enzymol, V62, P407; AHMED SA, 1991, J BIOL CHEM, V266, P21548; AHMED SA, 1994, J BIOL CHEM, V269, P16486; Ahmed SA, 1996, J BIOL CHEM, V271, P29100, DOI 10.1074/jbc.271.46.29100; ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; ANDERSON KS, 1991, J BIOL CHEM, V266, P8020; BALK H, 1981, BIOCHEMISTRY-US, V20, P6391, DOI 10.1021/bi00525a017; BANIK U, 1995, J BIOL CHEM, V270, P7944, DOI 10.1074/jbc.270.14.7944; BARTHOLMES P, 1976, BIOCHEMISTRY-US, V15, P4712, DOI 10.1021/bi00666a027; BORK P, 1990, BIOCHEM BIOPH RES CO, V171, P1319, DOI 10.1016/0006-291X(90)90830-G; BRZOVIC PS, 1992, BIOCHEMISTRY-US, V31, P3831, DOI 10.1021/bi00130a014; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; CRAWFORD IP, 1964, P NATL ACAD SCI USA, V51, P390, DOI 10.1073/pnas.51.3.390; Fan YX, 1999, BIOCHEMISTRY-US, V38, P7881, DOI 10.1021/bi990307e; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; GOLDBERG ME, 1968, BIOCHEMISTRY-US, V7, P3662, DOI 10.1021/bi00850a045; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hur O, 1996, BIOCHEMISTRY-US, V35, P7378, DOI 10.1021/bi960240k; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Jansonius J.N., 1987, BIOL MACROMOLECULES, P187; Jhee KH, 1998, J BIOL CHEM, V273, P11417, DOI 10.1074/jbc.273.19.11417; Jhee KH, 1998, BIOCHEMISTRY-US, V37, P14591, DOI 10.1021/bi981325j; JOHNSON GF, 1970, J BIOL CHEM, V245, P5560; JUDD CT, 1978, J THEOR BIOL, V75, P503, DOI 10.1016/0022-5193(78)90359-4; KAWASAKI H, 1987, J BIOL CHEM, V262, P10678; KAYASTHA AM, 1991, INDIAN J BIOCHEM BIO, V28, P352; KISHIMOTO K, 1995, J BIOCHEM-TOKYO, V117, P691, DOI 10.1093/oxfordjournals.jbchem.a124765; LANE AN, 1984, EMBO J, V3, P279, DOI 10.1002/j.1460-2075.1984.tb01797.x; LANE AN, 1983, EUR J BIOCHEM, V129, P571; MARCEAU M, 1988, J BIOL CHEM, V263, P16934; MARCEAU M, 1988, J BIOL CHEM, V263, P16926; Miles E W, 1995, Subcell Biochem, V24, P207; Miles E W, 1979, Adv Enzymol Relat Areas Mol Biol, V49, P127; MILES EW, 1991, ADV ENZYMOL RAMB, V64, P93; MILES EW, 1987, METHOD ENZYMOL, V142, P398; MILES EW, 1989, J BIOL CHEM, V264, P6280; MILES EW, 1977, J BIOL CHEM, V252, P6594; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Pan P, 1997, TRENDS BIOCHEM SCI, V22, P22, DOI 10.1016/S0968-0004(96)10066-9; Peracchi A, 1996, BIOCHEMISTRY-US, V35, P1872, DOI 10.1021/bi951889c; Rhee S, 1998, BIOCHEMISTRY-US, V37, P10653, DOI 10.1021/bi980779d; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; Ro HS, 1999, J BIOL CHEM, V274, P31189, DOI 10.1074/jbc.274.44.31189; ROY M, 1988, BIOCHEMISTRY-US, V27, P8661, DOI 10.1021/bi00423a023; RUVINOV SB, 1995, J BIOL CHEM, V270, P17333, DOI 10.1074/jbc.270.29.17333; SCHIRCH L, 1975, J BIOL CHEM, V250, P1939; SCHNACKERZ KD, 1983, BIOCHEM BIOPH RES CO, V111, P817, DOI 10.1016/0006-291X(83)91372-4; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P1536, DOI 10.1021/bi00575a023; Schneider TR, 1998, BIOCHEMISTRY-US, V37, P5394, DOI 10.1021/bi9728957; SHALTIEL S, 1970, BIOCHEM BIOPH RES CO, V41, P594, DOI 10.1016/0006-291X(70)90054-9; SUGIO S, 1995, BIOCHEMISTRY-US, V34, P9661, DOI 10.1021/bi00030a002; Sugio S, 1998, PROTEIN ENG, V11, P613, DOI 10.1093/protein/11.8.613; TONEY MD, 1995, J MOL BIOL, V245, P151, DOI 10.1006/jmbi.1994.0014; Yang LH, 1997, J BIOL CHEM, V272, P7859, DOI 10.1074/jbc.272.12.7859; Yang LH, 1996, PROTEIN EXPRES PURIF, V8, P126, DOI 10.1006/prep.1996.0082; YANG XJ, 1993, J BIOL CHEM, V268, P22269	56	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36439	36445		10.1074/jbc.274.51.36439	http://dx.doi.org/10.1074/jbc.274.51.36439			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593940	hybrid			2022-12-27	WOS:000084279200059
J	Sevrioukova, IF; Hazzard, JT; Tollin, G; Poulos, TL				Sevrioukova, IF; Hazzard, JT; Tollin, G; Poulos, TL			The FMN to heme electron transfer in cytochrome P450BM-3 - Effect of chemical modification of cysteines engineered at the FMN-heme domain interaction site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LASER FLASH-PHOTOLYSIS; FLAVOCYTOCHROME P-450 BM3; C PEROXIDASE; METHYLAMINE DEHYDROGENASE; BACILLUS-MEGATERIUM; FLAVOPROTEIN DOMAIN; TRANSIENT KINETICS; CRYSTAL-STRUCTURE; TRANSFER COMPLEX; DIRECTED MUTAGENESIS	The crystal structure of the complex between the heme and FMN-containing domains of Bacillus megaterium cytochrome P450BM-3 (Sevrioukova, I. F., Li, H., Zhang, H., Peterson, J. A., and Poulos, T. L. (1999) Proc. Natl, Acad, Sci, U. S. A. 96, 1863-1868) indicates that the proximal side of the heme domain molecule is the docking site for the FMN domain and that the Pro(382)-Gln(387) peptide may provide an electron transfer (ET) path from the FMN to the heme iron. In order to evaluate whether ET complexes formed in solution by the heme and FMN domains are structurally relevant to that seen in the crystal structure, we utilized site-directed mutagenesis to introduce Cys residues at positions 104 and 387, which are sites of close contact between the domains in the crystal structure and at position 372 as a control. Cys residues were modified with a bulky sulfhydryl reagent, 1-dimethylamino-naphthalene-5-sulfonate-L-cystine (dansylcystine (DC)), to prevent the FMN domain from binding at the site seen in the crystal structure. The DC modification of Cys(372) and Cys(387) resulted in a S fold decrease in the rates of interdomain ET in the reconstituted system consisting of the separate heme and FMN domains and had no effect on heme reduction in the intact heme/FMN-binding fragment of P450BM-3. DC modification of Cys(104) caused a 10-20-fold decrease in the interdomain ET reaction rate in both the reconstituted system and the intact heme/FMN domain. This indicates that the proximal side of the heme domain molecule represents the FMN domain binding site in both the crystallized and solution complexes, with the area around residue 104 being the most critical for the redox partner docking.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Program Macromol Struct, Irvine, CA 92697 USA; Univ Arizona, Dept Biochem, Tucson, AZ 85721 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Arizona	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042614, R01GM033688] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33688, GM19749, GM42614] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BODDUPALLI SS, 1992, J BIOL CHEM, V267, P10375; CHEN LY, 1992, BIOCHEMISTRY-US, V31, P4959, DOI 10.1021/bi00136a006; CHEN LY, 1994, SCIENCE, V264, P86, DOI 10.1126/science.8140419; CHEN ZW, 1994, SCIENCE, V266, P430, DOI 10.1126/science.7939681; CORIN AF, 1993, BIOCHEMISTRY-US, V32, P2756, DOI 10.1021/bi00062a004; CORRELL CC, 1992, SCIENCE, V2, P2112; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5468, DOI 10.1021/bi00367a018; DARWISH K, 1991, PROTEIN ENG, V4, P701, DOI 10.1093/protein/4.6.701; Davidson VL, 1997, BIOCHEMISTRY-US, V36, P12733, DOI 10.1021/bi971353m; DAVIDSON VL, 1995, J BIOL CHEM, V270, P23941, DOI 10.1074/jbc.270.41.23941; DEISENHOFER J, 1984, J MOL BIOL, V180, P385, DOI 10.1016/S0022-2836(84)80011-X; EDMONDSO.DE, 1972, BIOCHEMISTRY-US, V11, P1133, DOI 10.1021/bi00757a003; Erman JE, 1997, BIOCHEMISTRY-US, V36, P4054, DOI 10.1021/bi962632x; GONVINDARAJ S, 1994, BIOCHEM BIOPH RES CO, V203, P1745, DOI 10.1006/bbrc.1994.2388; Govindaraj S, 1997, J BIOL CHEM, V272, P7915, DOI 10.1074/jbc.272.12.7915; Hazzard JT, 1997, J BIOL CHEM, V272, P7922, DOI 10.1074/jbc.272.12.7922; HURLEY JK, 1994, ARCH BIOCHEM BIOPHYS, V312, P480, DOI 10.1006/abbi.1994.1335; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; KNAFF DB, 1981, BIOCHEMISTRY-US, V20, P4333, DOI 10.1021/bi00518a015; LAVIS PC, 1974, BIOCHEMISTRY-US, V13, P3042; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; LI HY, 1991, J BIOL CHEM, V266, P11909; LI HY, 1995, ACTA CRYSTALLOGR D, V51, P21, DOI 10.1107/S0907444994009194; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Merli A, 1996, J BIOL CHEM, V271, P9177, DOI 10.1074/jbc.271.16.9177; MEYER TE, 1995, ARCH BIOCHEM BIOPHYS, V318, P457, DOI 10.1006/abbi.1995.1254; MEYER TE, 1993, BIOCHEMISTRY-US, V32, P4552, DOI 10.1021/bi00068a010; MEYER TE, 1993, BIOCHEMISTRY-US, V32, P622, DOI 10.1021/bi00053a030; MILES CS, 1992, BIOCHEM J, V285, P187, DOI 10.1042/bj2850187; Miller MA, 1996, BIOCHEMISTRY-US, V35, P667, DOI 10.1021/bi952557a; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Munro AW, 1996, EUR J BIOCHEM, V239, P403, DOI 10.1111/j.1432-1033.1996.0403u.x; Murataliev MB, 1997, BIOCHEMISTRY-US, V36, P8401, DOI 10.1021/bi970026b; NARHI LO, 1986, J BIOL CHEM, V261, P7160; OMURA T, 1964, J BIOL CHEM, V239, P2370; OSTER T, 1991, J BIOL CHEM, V266, P22718; Pacheco A, 1999, J BIOL INORG CHEM, V4, P390, DOI 10.1007/s007750050325; Pappa HS, 1996, BIOCHEMISTRY-US, V35, P4837, DOI 10.1021/bi952935b; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; PORTER TD, 1991, TRENDS BIOCHEM SCI, V16, P154, DOI 10.1016/0968-0004(91)90059-5; POULOS TL, 1980, J BIOL CHEM, V255, P322; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; RUETTINGER RT, 1989, J BIOL CHEM, V264, P10987; Sevrioukova I, 1996, BIOCHEMISTRY-US, V35, P7058, DOI 10.1021/bi960060a; Sevrioukova I, 1996, BIOCHIMIE, V78, P744, DOI 10.1016/S0300-9084(97)82532-1; Sevrioukova I, 1997, ARCH BIOCHEM BIOPHYS, V340, P231, DOI 10.1006/abbi.1997.9895; Sevrioukova I, 1996, BIOCHEMISTRY-US, V35, P7528, DOI 10.1021/bi960330p; SEVRIOUKOVA IF, 1995, BIOCHIMIE, V77, P562, DOI 10.1016/0300-9084(96)88172-7; SEVRIOUKOVA IF, 1995, ARCH BIOCHEM BIOPHYS, V317, P397, DOI 10.1006/abbi.1995.1180; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SHARP RE, 1994, BIOCHEMISTRY-US, V33, P5115, DOI 10.1021/bi00183a015; SULLIVAN EP, 1993, BIOCHEMISTRY-US, V32, P12465, DOI 10.1021/bi00097a026; TOLLIN G, 1993, BIOPHYS CHEM, V48, P259, DOI 10.1016/0301-4622(93)85014-9; TOMLINSON G, 1989, BIOCHEM CELL BIOL, V67, P337, DOI 10.1139/o89-053; WALKER MC, 1992, BIOCHEMISTRY-US, V31, P2798, DOI 10.1021/bi00125a021; WALKER MC, 1990, ARCH BIOCHEM BIOPHYS, V281, P76, DOI 10.1016/0003-9861(90)90415-U; WHITE P, 1993, BIOCHEM J, V291, P89, DOI 10.1042/bj2910089; WU C, 1972, P NATL ACAD SCI USA, V69, P1104, DOI 10.1073/pnas.69.5.1104; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M	60	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36097	36106		10.1074/jbc.274.51.36097	http://dx.doi.org/10.1074/jbc.274.51.36097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593892	hybrid			2022-12-27	WOS:000084279200011
J	Ajiro, K				Ajiro, K			Histone H2B phosphorylation in mammalian apoptotic cells - An association with DNA fragmentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREMATURE CHROMOSOME CONDENSATION; PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION PATHWAYS; CHROMATIN CONDENSATION; H3 PHOSPHORYLATION; PHORBOL ESTERS; OKADAIC ACID; DEATH; THYMOCYTES; ACTIVATION	Histone phosphorylation was investigated in several mammalian cells undergoing apoptosis (human HL-60 and HeLa, mouse FM3A and N18 cells, and rat thymocytes). Among the four nucleosomal core histones (H2A, H2B, H3, and H4), H2B, which is not usually phosphorylated in quiescent or growing cells, was found to be phosphorylated after treatment with various apoptotic inducers. The H2B was phosphorylated around the time when nucleosomal DNA fragmentation was initiated and, like this fragmentation, was completely blocked with Z-Asp-CH2-DCB, an inhibitor of ICE or ICE-like caspase. The involved single phosphopeptide of H2B proved to be phosphorylatable in vitro with a protein kinase C, and the site Ser-32 was tentatively identified. Despite typical apoptotic chromatin condensation, the H3 phosphorylation was at a low level, and the sites where phosphorylation did occur did not include any mitosis-specific phosphopeptides, Phosphorylation of H4 was increased, but the other two histone proteins (H1 and H2A) were not appreciably changed. These observations imply that 1) H2B phosphorylation occurs universally in apoptotic cells and is associated with apoptosis-specific nucleosomal DNA fragmentation, 2) chromatin condensation in apoptosis occurs by a different biochemical mechanism from those operating during mitosis or premature chromosome condensation, and 3) this unique phosphorylation of H2B is a useful biochemical hallmark of apoptotic cells.	Aichi Canc Ctr, Res Inst, Cell Biol Lab, Nagoya, Aichi 4648681, Japan	Aichi Cancer Center	Ajiro, K (corresponding author), Aichi Canc Ctr, Res Inst, Cell Biol Lab, Nagoya, Aichi 4648681, Japan.							AJIRO K, 1985, J BIOL CHEM, V260, P5379; AJIRO K, 1983, J BIOL CHEM, V258, P4534; AJIRO K, 1981, BIOCHEMISTRY-US, V20, P1445, DOI 10.1021/bi00509a007; AJIRO K, 1982, SOMAT CELL GENET, V8, P377, DOI 10.1007/BF01538894; AJIRO K, 1981, BIOCHEMISTRY-US, V20, P1454, DOI 10.1021/bi00509a008; Allera C, 1997, J BIOL CHEM, V272, P10817; ARENDS MJ, 1990, AM J PATHOL, V136, P593; BRADBURY EM, 1992, BIOESSAYS, V14, P9; BUTLER AP, 1986, J BIOL CHEM, V261, P9421; CARY PD, 1982, EUR J BIOCHEM, V127, P137, DOI 10.1111/j.1432-1033.1982.tb06847.x; CSORDAS A, 1990, BIOCHEM J, V265, P23, DOI 10.1042/bj2650023; DOWD DR, 1992, MOL CELL BIOL, V12, P3600, DOI 10.1128/MCB.12.8.3600; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GURLEY LR, 1983, ANAL BIOCHEM, V129, P132, DOI 10.1016/0003-2697(83)90061-1; GURLEY LR, 1975, J BIOL CHEM, V250, P3936; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; HANKS SK, 1983, EXP CELL RES, V148, P293, DOI 10.1016/0014-4827(83)90153-2; HASHIMOTO E, 1976, J BIOL CHEM, V251, P6287; Hendzel MJ, 1998, J BIOL CHEM, V273, P24470, DOI 10.1074/jbc.273.38.24470; HOHMANN P, 1983, MOL CELL BIOCHEM, V57, P81; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; KAUFMANN SH, 1989, CANCER RES, V49, P5870; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Lavin MF, 1996, EXPERIENTIA, V52, P979, DOI 10.1007/BF01920107; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; MARUSHIGE Y, 1995, ANTICANCER RES, V15, P267; MASHIMA T, 1995, BIOCHEM BIOPH RES CO, V209, P907, DOI 10.1006/bbrc.1995.1584; MCCONKEY DJ, 1990, J IMMUNOL, V145, P1227; MCCONKEY DJ, 1989, J BIOL CHEM, V264, P13399; McConkey DJ, 1996, STEM CELLS, V14, P619, DOI 10.1002/stem.140619; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; Odaka C, 1996, MICROSC RES TECHNIQ, V34, P267, DOI 10.1002/(SICI)1097-0029(19960615)34:3<267::AID-JEMT9>3.0.CO;2-M; OJEDA F, 1990, CELL IMMUNOL, V125, P535, DOI 10.1016/0008-8749(90)90106-2; PAULSON JR, 1982, J BIOL CHEM, V257, P6064; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; SHIBATA K, 1993, J BIOL CHEM, V268, P18431; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; SUN XM, 1992, BIOCHEM PHARMACOL, V44, P2131; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; UCKER DS, 1991, NEW BIOL, V3, P103; van Holde K.E., 1988, CHROMATIN; Vodenicharov MD, 1996, CANCER LETT, V106, P51, DOI 10.1016/0304-3835(96)04300-5; Waring P, 1997, J BIOL CHEM, V272, P17929, DOI 10.1074/jbc.272.29.17929; Wolffe A., 1995, CHROMATIN STRUCTURE; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yamauchi Y, 1998, EXP CELL RES, V238, P317, DOI 10.1006/excr.1997.3841; Yoshida M, 1997, EXP CELL RES, V232, P225, DOI 10.1006/excr.1997.3538; Zunino SJ, 1996, AM J PATHOL, V149, P653; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0	52	92	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					439	443		10.1074/jbc.275.1.439	http://dx.doi.org/10.1074/jbc.275.1.439			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617636	hybrid			2022-12-27	WOS:000085951600060
J	Sugiura, T; Kondo, S; Kishimoto, S; Miyashita, T; Nakane, S; Kodaka, T; Suhara, Y; Takayama, H; Waku, K				Sugiura, T; Kondo, S; Kishimoto, S; Miyashita, T; Nakane, S; Kodaka, T; Suhara, Y; Takayama, H; Waku, K			Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor - Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MEDIATED IMMUNE MODULATION; ADENYLATE-CYCLASE; RAT-BRAIN; NG108-15 CELLS; SELECTIVE ANTAGONIST; PERIPHERAL-TISSUES; SPLEEN-CELLS; FACTOR-ALPHA; T-CELLS	We examined the effect of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, on the intracellular free Ca2+ concentrations in HL-60 cells that ex press the cannabinoid CB2 receptor. We found that 2-arachidonoylglycerol induces a rapid transient increase in intracellular free Ca2+ concentrations in HL-60 cells. The response was affected by neither cyclooxygenase inhibitors nor lipoxygenase inhibitors, suggesting that arachidonic acid metabolites are not involved. Consistent with this notion, free arachidonic acid was devoid of any agonistic activity. Importantly, the Ca2+ transient induced by 2-arachidonoylglycerol was blocked by pretreatment of the cells with SR144528, CB2 receptor-specific antagonist, but not with SR141716A, a CB1 receptor-specific antagonist, indicating the involvement of the CB2 receptor but not the CB1 receptor in this cellular response. G(i) or G(o) is also assumed to be involved, because pertussis toxin treatment of the cells abolished the response. We further examined the structure-activity relationship. We found that 2-arachidonoylglycerol is the most potent compound among a number of naturally occurring cannabimimetic molecules. Interestingly, anandamide and N-palmitoylethanolamine, other putative endogenous ligands, were found to be a weak partial agonist and an inactive ligand, respectively, These results strongly suggest that the CB2 receptor is originally a 2-arachidonoylglycerol receptor, and 2-arachidonoylglycerol is the intrinsic natural ligand for the CB2 receptor that is abundant in the immune system.	Teikyo Univ, Fac Pharmaceut Sci, Kanagawa 1990195, Japan	Teikyo University	Sugiura, T (corresponding author), Teikyo Univ, Fac Pharmaceut Sci, Kanagawa 1990195, Japan.			Suhara, Yoshitomo/0000-0002-4770-2910				BAYEWITCH M, 1995, FEBS LETT, V375, P143, DOI 10.1016/0014-5793(95)01207-U; Berdyshev EV, 1997, EUR J PHARMACOL, V330, P231, DOI 10.1016/S0014-2999(97)01007-8; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; BLANCHARD DK, 1986, INT J IMMUNOPHARMACO, V8, P819, DOI 10.1016/0192-0561(86)90020-2; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Cadas H, 1997, J NEUROSCI, V17, P1226; Carayon P, 1998, BLOOD, V92, P3605, DOI 10.1182/blood.V92.10.3605.422k05_3605_3615; Coffey RG, 1996, BIOCHEM PHARMACOL, V52, P743, DOI 10.1016/0006-2952(96)00356-5; Condie R, 1996, J BIOL CHEM, V271, P13175, DOI 10.1074/jbc.271.22.13175; DEROCQ JM, 1995, FEBS LETT, V369, P177, DOI 10.1016/0014-5793(95)00746-V; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DEWEY WL, 1986, PHARMACOL REV, V38, P151; Di Marzo V, 1998, BIOCHEM J, V331, P15; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; FACCI L, 1995, P NATL ACAD SCI USA, V92, P3376, DOI 10.1073/pnas.92.8.3376; Felder CC, 1996, FEBS LETT, V393, P231, DOI 10.1016/0014-5793(96)00891-5; FISCHERSTENGER K, 1993, J PHARMACOL EXP THER, V267, P1558; FRIDE E, 1995, J PHARMACOL EXP THER, V272, P699; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; HOLLISTER LE, 1992, J PSYCHOACTIVE DRUGS, V24, P159, DOI 10.1080/02791072.1992.10471635; Jbilo O, 1999, FEBS LETT, V448, P273, DOI 10.1016/S0014-5793(99)00380-4; JIN WZ, 1994, J NEUROSCI, V14, P1920; KAMINSKI NE, 1992, MOL PHARMACOL, V42, P736; KAMINSKI NE, 1994, BIOCHEM PHARMACOL, V48, P1899, DOI 10.1016/0006-2952(94)90588-6; Kempe K, 1996, J BIOL CHEM, V271, P17287, DOI 10.1074/jbc.271.29.17287; Kishimoto S, 1996, J IMMUNOL, V157, P4126; KLEIN TW, 1991, J TOXICOL ENV HEALTH, V32, P465, DOI 10.1080/15287399109531496; Kondo S, 1998, FEBS LETT, V429, P152, DOI 10.1016/S0014-5793(98)00581-X; KUSHER DI, 1994, CELL IMMUNOL, V154, P99, DOI 10.1006/cimm.1994.1060; LEE M, 1995, J PHARMACOL EXP THER, V275, P529; LYNN AB, 1994, J PHARMACOL EXP THER, V268, P1612; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McCoy KL, 1999, J PHARMACOL EXP THER, V289, P1620; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R, 1998, EUR J PHARMACOL, V362, pR1, DOI 10.1016/S0014-2999(98)00777-8; MECHOULAM R, 1995, CANNABINOID RECEPTOR, P233; Ouyang YL, 1998, MOL PHARMACOL, V53, P676, DOI 10.1124/mol.53.4.676; PRESCOTT SM, 1983, J BIOL CHEM, V258, P764; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; SCHMID PC, 1996, FEBS LETT, V385, P124; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; SPECTER S, 1991, J LEUKOCYTE BIOL, V50, P423, DOI 10.1002/jlb.50.5.423; SPECTER S, 1990, INT J IMMUNOPHARMACO, V12, P261, DOI 10.1016/0192-0561(90)90081-W; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Sugiura T, 1996, EUR J BIOCHEM, V240, P53, DOI 10.1111/j.1432-1033.1996.0053h.x; Sugiura T, 1996, BIOCHEM BIOPH RES CO, V229, P58, DOI 10.1006/bbrc.1996.1757; Sugiura T, 1997, J BIOCHEM-TOKYO, V122, P890; SUGIURA T, 1994, P JPN C BIOCH LIPIDS, V36, P71; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; ZHENG ZM, 1992, INT J IMMUNOPHARMACO, V14, P1445	57	314	337	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					605	612		10.1074/jbc.275.1.605	http://dx.doi.org/10.1074/jbc.275.1.605			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617657	hybrid			2022-12-27	WOS:000085951600081
J	Zhang, CC; Shapiro, DJ				Zhang, CC; Shapiro, DJ			Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MAP KINASE; TAMOXIFEN; PROLIFERATION; ANTIESTROGENS; TRANSCRIPTION; EXPRESSION; GROWTH; GENE	17 beta-Estradiol (E-2) or the antiestrogen, 4-hydroxytamoxifen (OHT), induce apoptosis in stably transfected estrogen receptor (ER)-positive HeLa-ER5 cells, p38 mitogen-activated protein kinase is implicated in cellular processes involving apoptosis. The p38 kinase inhibitor, SB203580, partially protects HeLa-ER5 cells against apoptosis induced by E-2 or by OHT. E-2 induces the p38 pathway 12-36-fold in ER-positive cell lines, while OHT induces p38 activity 2-5-fold. In an ER-positive cell line selected for resistance to E-2-induced apoptosis, E-2 no longer induced p38, and the ER no longer bound to the estrogen response element, while GIFT induced both p38 and apoptosis. In cells selected for resistance to OHT-induced apoptosis, OHT no longer induced p38, while E-2 induced p38 and apoptosis, and transactivated an estrogen response element-containing reporter gene. In MCF-7 cells, whose growth is stimulated by estrogen, E-2 did not induce p38 or apoptosis, while OHT induced both p38 and apoptosis, and SB203580 protected against OHT-induced apoptosis, This work shows that E-2 and OHT activate the p38 pathway, suggests that they use different pathways for p38 activation, and links activation of the p38 pathway to apoptosis induced by E-2 and by OHT.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Shapiro, DJ (corresponding author), Univ Illinois, Dept Biochem, 413 RAL,600 S Mathews Ave, Urbana, IL 61801 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016720] Funding Source: NIH RePORTER; NICHD NIH HHS [HD16720] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AITKEN SC, 1985, CANCER RES, V45, P2608; Chen HM, 1996, J CELL BIOCHEM, V61, P9, DOI 10.1002/(SICI)1097-4644(19960401)61:1<9::AID-JCB2>3.3.CO;2-2; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; CORADINI D, 1994, ANTICANCER RES, V14, P1059; DAUVOIS S, 1993, J CELL SCI, V106, P1377; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Endoh H, 1997, BIOCHEM BIOPH RES CO, V235, P99, DOI 10.1006/bbrc.1997.6746; Fattman CL, 1998, CANCER LETT, V130, P103, DOI 10.1016/S0304-3835(98)00121-9; GUENDA A, 1995, FEBS LETT, V364, P229; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; JORDAN VC, 1991, J NATL CANCER I, V83, P492, DOI 10.1093/jnci/83.7.492; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; KUSHNER PJ, 1990, MOL ENDOCRINOL, V4, P1465, DOI 10.1210/mend-4-10-1465; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; MARTINEZ JD, 1996, ONCOGENE, V12, P953; MCGAHON AJ, 1995, METHODS CELL BIOL CE, V46, P174; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; MINE DM, 1994, J BIOL CHEM, V269, P9253; Montano MM, 1997, P NATL ACAD SCI USA, V94, P2581, DOI 10.1073/pnas.94.6.2581; Morey AK, 1997, ENDOCRINOLOGY, V138, P3330, DOI 10.1210/en.138.8.3330; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; PERRY RR, 1995, ANN SURG ONCOL, V2, P238, DOI 10.1007/BF02307030; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zajchowski DA, 1997, J STEROID BIOCHEM, V62, P373, DOI 10.1016/S0960-0760(97)00052-6; Zhang CC, 1999, MOL ENDOCRINOL, V13, P632, DOI 10.1210/me.13.4.632	35	83	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					479	486		10.1074/jbc.275.1.479	http://dx.doi.org/10.1074/jbc.275.1.479			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617642	hybrid			2022-12-27	WOS:000085951600066
J	Carlotti, F; Chapman, R; Dower, SK; Qwarnstrom, EE				Carlotti, F; Chapman, R; Dower, SK; Qwarnstrom, EE			Activation of nuclear factor kappa B in single living cells - Dependence of nuclear translocation and anti-apoptotic function on EGFPRELA concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; GREEN FLUORESCENT PROTEIN; INTERLEUKIN-1 RECEPTOR COMPLEX; TRANSCRIPTION FACTOR; FACTOR-ALPHA; DNA-BINDING; IN-VITRO; PHOSPHORYLATION; KINASE; SIGNAL	We have studied the dynamics of nuclear translocation during nuclear factor kappa B activation by using a p65(RELA)-enhanced green fluorescent protein (EGFP) fusion construct. Quantitation of expression levels indicates that EGFPRELA can be detected at physiological concentrations of about 60,000 molecules per cell. Stimulation of transfected fibroblasts with interleukin (IL)-1 beta caused nuclear translocation of EGFPRELA, typically resulting in a 30-fold increase in nuclear protein at maximum induction and a concomitant 20% decrease in cytoplasmic levels. The response of individual cells to IL-1 beta was graded, and the kinetics of nuclear translocation were dependent on the dose of IL-1 beta and the level of EGFPRELA expression, The rate of nuclear uptake was saturable, and the time lag for uptake increased at higher EGFPRELA expression levels. Furthermore, nuclear translocation was reduced at less than saturating doses of IL-1 beta suggesting that the pathway is limited by incoming signals. The response to IL-1 beta was biphasic, demonstrating a decline in nuclear import rate at expression levels above three to four times endogenous, This correlated with the anti-apoptotic function of EGFPRELA which was more prominent at low expression levels and demonstrated successively less protection at higher levels, In comparison, transfection of p50 had ho effect on the level of apoptosis and demonstrated some toxicity in combination with EGFPRELA.	Univ Sheffield, Sch Med, Div Mol & Genet Med, Sheffield S10 2JF, S Yorkshire, England; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA	University of Sheffield; University of Washington; University of Washington Seattle	Qwarnstrom, EE (corresponding author), Univ Sheffield, Sch Med, Div Mol & Genet Med, Sheffield S10 2JF, S Yorkshire, England.			dower, steve/0000-0002-4675-4225; Qwarnstrom, Eva/0000-0003-4417-8663				ABBADIE C, 1993, CELL, V75, P899, DOI 10.1016/0092-8674(93)90534-W; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Carey KL, 1996, J CELL BIOL, V133, P985, DOI 10.1083/jcb.133.5.985; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DIEHL JA, 1995, J BIOL CHEM, V270, P2703, DOI 10.1074/jbc.270.6.2703; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; DOWER SK, 1986, P NATL ACAD SCI USA, V83, P1060, DOI 10.1073/pnas.83.4.1060; DRUKER BJ, 1994, J BIOL CHEM, V269, P5387; DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Grimm S, 1996, J CELL BIOL, V134, P13, DOI 10.1083/jcb.134.1.13; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; LAN QX, 1994, BIOCHEM BIOPH RES CO, V201, P950, DOI 10.1006/bbrc.1994.1794; LIN YC, 1995, P NATL ACAD SCI USA, V92, P552, DOI 10.1073/pnas.92.2.552; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; QWARNSTROM EE, 1994, J BIOL CHEM, V269, P30765; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; RODRIGUEZ MS, 1995, MOL CELL BIOL, V15, P2413; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; SCHMITZ ML, 1995, J BIOL CHEM, V270, P15576, DOI 10.1074/jbc.270.26.15576; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	50	59	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37941	37949		10.1074/jbc.274.53.37941	http://dx.doi.org/10.1074/jbc.274.53.37941			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608861	hybrid			2022-12-27	WOS:000084528000061
J	Liu, LA; Engvall, E				Liu, LA; Engvall, E			Sarcoglycan isoforms in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; GIRDLE MUSCULAR-DYSTROPHY; EXTRACELLULAR-MATRIX; EPSILON-SARCOGLYCAN; GAMMA-SARCOGLYCAN; DELTA-SARCOGLYCAN; BETA-SARCOGLYCAN; GENE; CELLS; MOUSE	The heterotetrameric sarcoglycan complex, composed of alpha-, beta-, gamma-, and delta-sarcoglycans, is an important component of the dystrophin-associated glycoprotein assembly in striated muscle, Mutations in any of the four genes encoding sarcoglycans cause a deficiency in all sarcoglycans in the sarcolemma and produce one of four types of limb-girdle muscular dystrophy. A fifth widely expressed sarcoglycan, epsilon-sarcoglycan, has been recently described. epsilon-Sarcoglycan is homologous to alpha-sarcoglycan, but whether it associates with the other sarcoglycans in muscle is not known. In this study, we use wild type and alpha-sarcoglycan-deficient mice to analyze the localization and association of sarcoglycans in skeletal muscle in vivo. The amounts of beta-, gamma-, and delta-sarcoglycans are reduced in alpha-sarcoglycan mutants, whereas the amount of epsilon-sarcoglycan is unchanged, We show here that epsilon-sarcoglycan is complexed with beta-, gamma-, and delta-sarcoglycans in both wild type and alpha-sarcoglycan mutant mice, We also use C2C12 myocytes to study the temporal expression and organization of sarcoglycan complexes during muscle cell differentiation in vitro. In C2C12 cells, alpha- and epsilon-sarcoglycans form separate complexes with beta-, gamma-, and delta-sarcoglycans, Both types of complexes are expressed at the cell surface and presumed to be functional, These results suggest that epsilon-sarcoglycan serves a function similar to that of alpha-sarcoglycan and that residual beta-, gamma-, and delta-sarcoglycan seen in mutant mice and epsilon-sarcoglycan-deficient patients is due to its association with epsilon-sarcoglycan.	Burnham Inst, La Jolla, CA 92037 USA; Stockholm Univ, Wenner Gren Inst, Dept Dev Biol, S-10691 Stockholm, Sweden	Sanford Burnham Prebys Medical Discovery Institute; Stockholm University	Engvall, E (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; Betto R, 1999, J BIOL CHEM, V274, P7907, DOI 10.1074/jbc.274.12.7907; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; Bonnemann CG, 1999, J CHILD NEUROL, V14, P31; Bushby K, 1996, NEUROMUSCULAR DISORD, V6, P439, DOI 10.1016/S0960-8966(96)00392-6; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Chan YM, 1998, J CELL BIOL, V143, P2033, DOI 10.1083/jcb.143.7.2033; Cohen MW, 1997, J CELL BIOL, V136, P1047, DOI 10.1083/jcb.136.5.1047; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Crosbie RH, 1997, J BIOL CHEM, V272, P31221, DOI 10.1074/jbc.272.50.31221; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 1999, J BIOL CHEM, V274, P26609, DOI 10.1074/jbc.274.37.26609; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Ettinger AJ, 1997, J BIOL CHEM, V272, P32534, DOI 10.1074/jbc.272.51.32534; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hack AA, 1999, P NATL ACAD SCI USA, V96, P10723, DOI 10.1073/pnas.96.19.10723; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; Holt KH, 1998, J BIOL CHEM, V273, P34667, DOI 10.1074/jbc.273.52.34667; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; Liu L, 1997, BIOCHEM BIOPH RES CO, V235, P227, DOI 10.1006/bbrc.1997.6757; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MCMAHON DK, 1994, AM J PHYSIOL, V266, pC1795, DOI 10.1152/ajpcell.1994.266.6.C1795; McNally EM, 1998, FEBS LETT, V422, P27, DOI 10.1016/S0014-5793(97)01593-7; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Nigro V, 1996, HUM MOL GENET, V5, P1179, DOI 10.1093/hmg/5.8.1179; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Ohno S, 1999, CELL MOL LIFE SCI, V55, P824, DOI 10.1007/s000180050336; OSULLIVAN MJ, 1979, ANAL BIOCHEM, V100, P100, DOI 10.1016/0003-2697(79)90117-9; Ozawa E, 1998, MUSCLE NERVE, V21, P421, DOI 10.1002/(SICI)1097-4598(199804)21:4<421::AID-MUS1>3.3.CO;2-W; OZAWA E, 1995, HUM MOL GENET, V4, P1711, DOI 10.1093/hmg/4.suppl_1.1711; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; Yoshida T, 1998, J BIOL CHEM, V273, P1583, DOI 10.1074/jbc.273.3.1583	50	80	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38171	38176		10.1074/jbc.274.53.38171	http://dx.doi.org/10.1074/jbc.274.53.38171			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608889	hybrid			2022-12-27	WOS:000084528000089
J	Silvera, D; Gamarnik, AV; Andino, R				Silvera, D; Gamarnik, AV; Andino, R			The N-terminal K homology domain of the poly(rC)-binding protein is a major determinant for binding to the poliovirus 5 '-untranslated region and acts as an inhibitor of viral translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGILE-X-SYNDROME; 5'-NONCODING REGION; RNA-BINDING; BINDING-PROTEIN-2; REPLICATION; COMPLEX; VIRUS; END; FORMS; FMR1	The poly(rC)-binding proteins (PCBP1 and PCBP2) are RNA-binding proteins whose RNA recognition motifs are composed of three K homology (IM) domains These proteins are involved in both the stabilization and translational regulation of several cellular and viral RNAs. PCBP1 and PCBP2 specifically interact with both the BI-element known as the cloverleaf structure and the large stem-loop IV RNA of the poliovirus 5'-untranslated region. We have found that the first KH domain of PCBP2 (KH1) specifically interacts with the viral RNAs, and together with viral protein 3CD, KH1 forms a high affinity ternary ribonucleoprotein complex with the cloverleaf RNA, resembling the full-length PCBP protein. Furthermore, KH1 acts as a dominant-negative mutant to inhibit translation from a poliovirus reporter gene in both Xenopus laevis oocytes and HeLa cell in vitro translation extracts.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.				NIAID NIH HHS [AI40085] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040085, R01AI040085] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andino R, 1999, TRENDS MICROBIOL, V7, P76, DOI 10.1016/S0966-842X(98)01446-2; ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2; BARTON DJ, 1993, J VIROL, V67, P822, DOI 10.1128/JVI.67.2.822-831.1993; Belsham GJ, 1996, MICROBIOL REV, V60, P499, DOI 10.1128/MMBR.60.3.499-511.1996; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Blyn LB, 1996, P NATL ACAD SCI USA, V93, P11115, DOI 10.1073/pnas.93.20.11115; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Gamarnik AV, 1997, RNA, V3, P882; Gamarnik AV, 1996, EMBO J, V15, P5988, DOI 10.1002/j.1460-2075.1996.tb00985.x; Graff J, 1998, J VIROL, V72, P9668, DOI 10.1128/JVI.72.12.9668-9675.1998; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; Jackson RJ, 1997, CURR OPIN GENET DEV, V7, P233, DOI 10.1016/S0959-437X(97)80133-5; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Musco G, 1997, NAT STRUCT BIOL, V4, P712, DOI 10.1038/nsb0997-712; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Parsley TB, 1997, RNA, V3, P1124; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SEKURA CJM, 1987, METHOD ENZYMOL, V152, P284; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193	29	56	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38163	38170		10.1074/jbc.274.53.38163	http://dx.doi.org/10.1074/jbc.274.53.38163			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608888	hybrid			2022-12-27	WOS:000084528000088
J	Sloan, JS; Dombek, KM; Young, ET				Sloan, JS; Dombek, KM; Young, ET			Post-translational regulation of Adr1 activity is mediated by its DNA binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ADR1; DEPENDENT PROTEIN-KINASE; REPRESSIBLE ALCOHOL-DEHYDROGENASE; GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE; ADH2 EXPRESSION; NUCLEAR-LOCALIZATION; GLUCOSE REPRESSION; MULTIPLE MECHANISMS; GENE-EXPRESSION	1ADRI encodes a transcriptional activator that regulates genes involved in carbon source utilization in Saccharomyces cerevisiae. ADR1 is itself repressed by glucose, but the significance of this repression for regulating target genes is not known. To test if the reduction in Adr1 levels contributes to glucose repression of ADH2 expression, we generated yeast strains in which the level of Adr1 produced during growth in glucose-containing medium is similar to that present in wildtype cells grown in the absence of glucose. In these Adr1-overproducing strains, ADH2 expression remained tightly repressed, and UAS1, the element in the ADH2 promoter that binds Adr1, was sufficient to maintain glucose repression. Post-translational modification of Adr1 activity is implicated in repression, since ADH2 derepression occurred in the absence of de novo protein synthesis. The N-terminal 172 amino acids of Adr1, containing the DNA binding and nuclear localization domains, fused to the Herpesvirus VP16-encoded transcription activation domain, conferred regulated expression at UAS1, Nuclear localization of an Adr1-GFP fusion protein was not glucose-regulated, suggesting that the DNA binding domain of Adr1 is sufficient to confer regulated expression on target genes, A Ga14-Adr1 fusion protein was unable to confer glucose repression at GALA-dependent promoters, suggesting that regulation mediated by ADR1 is specific to UAS1.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Young, ET (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	ety@u.washington.edu			NIGMS NIH HHS [GM26079] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026079] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEIER DR, 1985, MOL CELL BIOL, V5, P1743, DOI 10.1128/MCB.5.7.1743; BEMIS LT, 1988, MOL CELL BIOL, V8, P2125, DOI 10.1128/MCB.8.5.2125; BLUMBERG H, 1988, MOL CELL BIOL, V8, P1868, DOI 10.1128/MCB.8.5.1868; BLUMBERG H, 1987, NATURE, V328, P443, DOI 10.1038/328443a0; BLUMBERG H, 1987, THESIS U WASHINGTON; CHERRY JR, 1989, CELL, V56, P409, DOI 10.1016/0092-8674(89)90244-4; Chiang YC, 1996, J BIOL CHEM, V271, P32359, DOI 10.1074/jbc.271.50.32359; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; CIRIACY M, 1979, MOL GEN GENET, V176, P427, DOI 10.1007/BF00333107; COOK WJ, 1994, MOL CELL BIOL, V14, P629, DOI 10.1128/MCB.14.1.629; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DENIS CL, 1991, MOL GEN GENET, V229, P395, DOI 10.1007/BF00267461; DENIS CL, 1992, MOL CELL BIOL, V12, P1507, DOI 10.1128/MCB.12.4.1507; DENIS CL, 1991, J BIOL CHEM, V266, P17932; DENIS CL, 1987, MOL GEN GENET, V208, P101, DOI 10.1007/BF00330429; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; DOMBEK KM, 1993, MOL CELL BIOL, V13, P4391, DOI 10.1128/MCB.13.7.4391; DONOVIEL MS, 1995, MOL CELL BIOL, V15, P3442; DOWBEK KM, 1999, MOL CELL BIOL, V19, P6029; EISEN A, 1988, MOL CELL BIOL, V8, P4552, DOI 10.1128/MCB.8.10.4552; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IRANI M, 1987, MOL CELL BIOL, V7, P1233, DOI 10.1128/MCB.7.3.1233; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; KARNITZ L, 1992, GENETICS, V132, P351; Komarnitsky PB, 1998, MOL CELL BIOL, V18, P5861, DOI 10.1128/MCB.18.10.5861; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; LAMPHIER MS, 1992, P NATL ACAD SCI USA, V89, P5922, DOI 10.1073/pnas.89.13.5922; Legrand-Poels S, 1998, J PHOTOCH PHOTOBIO B, V45, P1, DOI 10.1016/S1011-1344(98)00118-3; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Moser MJ, 1997, J CELL SCI, V110, P1805; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Ostling J, 1996, MOL CELL BIOL, V16, P753; PRATT WB, 1993, J STEROID BIOCHEM, V46, P269, DOI 10.1016/0960-0760(93)90216-J; RandezGil F, 1997, MOL CELL BIOL, V17, P2502, DOI 10.1128/MCB.17.5.2502; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SHERO JH, 1991, METHOD ENZYMOL, V194, P749; SIDOROVA JM, 1995, MOL BIOL CELL, V6, P1641, DOI 10.1091/mbc.6.12.1641; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON M, 1992, YEAST, V8, P303, DOI 10.1002/yea.320080407; SIMON MM, 1995, MOL GEN GENET, V249, P289, DOI 10.1007/BF00290529; STONE G, 1993, EMBO J, V12, P1375, DOI 10.1002/j.1460-2075.1993.tb05782.x; TAYLOR WE, 1990, P NATL ACAD SCI USA, V87, P4098, DOI 10.1073/pnas.87.11.4098; THUKRAL SK, 1991, MOL CELL BIOL, V11, P1566, DOI 10.1128/MCB.11.3.1566; THUKRAL SK, 1989, MOL CELL BIOL, V9, P2360, DOI 10.1128/MCB.9.6.2360; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; VALLARI RC, 1992, MOL CELL BIOL, V12, P1663, DOI 10.1128/MCB.12.4.1663; Verdone L, 1997, J BIOL CHEM, V272, P30828, DOI 10.1074/jbc.272.49.30828; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Young ET, 1998, J BIOL CHEM, V273, P32080, DOI 10.1074/jbc.273.48.32080; YU J, 1989, MOL CELL BIOL, V9, P34, DOI 10.1128/MCB.9.1.34	59	28	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37575	37582		10.1074/jbc.274.53.37575	http://dx.doi.org/10.1074/jbc.274.53.37575			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608811	hybrid			2022-12-27	WOS:000084528000011
J	Cho, HP; Nakamura, M; Clarke, SD				Cho, HP; Nakamura, M; Clarke, SD			Cloning, expression, and fatty acid regulation of the human Delta-5 desaturase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL GENOMIC SCAN; ARACHIDONIC-ACID; DOCOSAHEXAENOIC ACID; PRETERM INFANTS; PIMA-INDIANS; RAT-LIVER; GENE; METABOLISM; BRAIN; N-3	Arachidonic (20:4(n-6)), eicosapentaenoic (20:5(n-3)), and docosahexaenoic (22:6(n-3)) acids are major components of brain and retina phospholipids, substrates for eicosanoid production, and regulators of nuclear transcription factors. One of the two rate-limiting steps in the production of these polyenoic fatty acids is the desaturation of 20:3(n-6) and 20:4(n-3) by Delta-5 desaturase, This report describes the cloning and expression of the human Delta-5 desaturase, and it compares the structural characteristics and nutritional regulation of the Delta-5 and Delta-6 desaturases, The open reading frame of the human Delta-5 desaturase encodes a 444-amino acid peptide which is identical in size to the Delta-6 desaturase and which shares 61% identity with the human Delta-6 desaturase, The Delta-5 desaturase contains two membrane-spanning domains, three histidine-rich regions, and a cytochrome b(5) domain that all align perfectly with the same domains located in the Delta-6 desaturase. Expression of the open reading frame in Chinese hamster ovary cells instilled the ability:to convert 20:3(n-6) to 20:4(n-6), Northern analysis revealed that many human tissues including skeletal muscle, lung, placenta, kidney, and pancreas expressed Delta-5 desaturase mRNA, but Delta-5 desaturase was most abundant in the liver, brain, and heart. However, in all tissues, the abundance of Delta-5 desaturase mRNA was much lower than that observed for the Delta-6 desaturase. When rats were fed a diet containing 10% safflower oil or menhaden fish oil, the level of hepatic mRNA for Delta-5 and Delta-6 desaturase was only 25% of that found in the liver of rats fed a fat-free diet or a diet containing triolein, Finally, a BLAST and Genemap search of the human genome revealed that the Delta-5 and Delta-6 desaturase genes reside in reverse orientation on chromosome 11 and that they are separated by <11,000 base pairs.	Univ Texas, Nutr Sci Program, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Clarke, SD (corresponding author), Univ Texas, Nutr Sci Program, 117 CEA, Austin, TX 78712 USA.	stevedclarke@mail.utexas.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053872] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 53872] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Birch EE, 1998, PEDIATR RES, V44, P201, DOI 10.1203/00006450-199808000-00011; BOURRE JM, 1990, LIPIDS, V25, P354, DOI 10.1007/BF02544347; Brenner R., 1989, R FACTORS INFLUENCIN, VVolume 1989, P45; CARLSON SE, 1993, P NATL ACAD SCI USA, V90, P1073, DOI 10.1073/pnas.90.3.1073; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIANSEN EN, 1991, BIOCHIM BIOPHYS ACTA, V1082, P57, DOI 10.1016/0005-2760(91)90299-W; Clarke SD, 1997, ANN NY ACAD SCI, V827, P178, DOI 10.1111/j.1749-6632.1997.tb51833.x; Crawford MA, 1997, AM J CLIN NUTR, V66, P1032, DOI 10.1093/ajcn/66.4.1032S; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; HOLMAN RT, 1983, P NATL ACAD SCI-BIOL, V80, P2375, DOI 10.1073/pnas.80.8.2375; Horrobin DF, 1997, DIABETES, V46, pS90, DOI 10.2337/diab.46.2.S90; IGAL RA, 1991, MOL CELL ENDOCRINOL, V77, P217, DOI 10.1016/0303-7207(91)90077-6; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; Marzo I, 1996, BBA-LIPID LIPID MET, V1301, P263, DOI 10.1016/0005-2760(96)00051-3; Michaelson LV, 1998, FEBS LETT, V439, P215, DOI 10.1016/S0014-5793(98)01385-4; Michaelson LV, 1998, J BIOL CHEM, V273, P19055, DOI 10.1074/jbc.273.30.19055; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; NEURINGER M, 1994, J PEDIATR-US, V125, pS39, DOI 10.1016/S0022-3476(06)80735-3; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Pan DA, 1995, J CLIN INVEST, V96, P2802, DOI 10.1172/JCI118350; PELUFFO RO, 1976, BIOCHIM BIOPHYS ACTA, V441, P25, DOI 10.1016/0005-2760(76)90277-0; Piomelli D, 1993, CURR OPIN CELL BIOL, V5, P274, DOI 10.1016/0955-0674(93)90116-8; POISSON JPG, 1991, J NUTR BIOCHEM, V2, P60, DOI 10.1016/0955-2863(91)90030-9; SAMUELSSON B, 1983, BIOSCIENCE REP, V3, P791, DOI 10.1007/BF01133779; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; Stuhlmeier KM, 1997, J BIOL CHEM, V272, P24679, DOI 10.1074/jbc.272.39.24679; Tsuboyama-Kasaoka N, 1999, BIOCHEM BIOPH RES CO, V257, P879, DOI 10.1006/bbrc.1999.0555; UAUY R, 1992, J PEDIATR-US, V120, pS168, DOI 10.1016/S0022-3476(05)81252-1; Werkman SH, 1996, LIPIDS, V31, P91, DOI 10.1007/BF02522417; WOLF BA, 1986, J BIOL CHEM, V261, P3501; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577	40	407	438	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37335	37339		10.1074/jbc.274.52.37335	http://dx.doi.org/10.1074/jbc.274.52.37335			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601301	hybrid			2022-12-27	WOS:000084382700072
J	Feng, JH; Ito, M; Ichikawa, K; Isaka, N; Nishikawa, M; Hartshorne, DJ; Nakano, T				Feng, JH; Ito, M; Ichikawa, K; Isaka, N; Nishikawa, M; Hartshorne, DJ; Nakano, T			Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; BINDING PROTEIN-RHO; MYOTONIC-DYSTROPHY KINASE; ACTIN STRESS FIBERS; REGULATORY SUBUNITS; CA2+ SENSITIZATION; MOLECULAR-CLONING; CATALYTIC SUBUNIT; ARACHIDONIC-ACID; TARGET SUBUNIT-1	It is clear from several studies that myosin phosphatase (MP) can be inhibited via a pathway that involves RhoA. However, the mechanism of inhibition is not established; These studies were carried out to test the hypothesis that Rho-kinase (Rho-associated kinase) via phosphorylation of the myosin phosphatase target subunit 1 (MYPT1) inhibited MP activity and to identify relevant sites of phosphorylation. Phosphorylation by Rho-kinase inhibited MP activity and this reflected a decrease in V-max. Activity of MP with different substrates also was inhibited by phosphorylation, Two major;sites of phosphorylation on MYPT1 were Thr(695) and Thr(850). Various point mutations were designed for these phosphorylation sites. Following thiophosphorylation by Rho kinase and assays of phosphatase activity it was determined that Thr(695) was responsible for inhibition. A site- and phosphorylation-specific antibody was developed for the sequence flanking Thr(695) and this recognized only phosphorylated Thr(695) in both native and recombinant MYPT1. Using this antibody it was shown that stimulation of serum-starved Swiss 3T3 cells by lysophosphatidic acid, thought to activate RhoA pathways, induced an increase in Thr(695) phosphorylation on MYPT1 and this effect was blocked by a Rho-kinase inhibitor, Y-27632. In summary, these results offer strong support for a physiological role of Rho-kinase in regulation of MP activity.	Mie Univ, Sch Med, Dept Internal Med 1, Tsu, Mie 5148507, Japan; Mie Univ, Sch Med, Dept Internal Med 2, Tsu, Mie 5148507, Japan; Univ Arizona, Muscle Biol Grp, Tucson, AZ 85721 USA	Mie University; Mie University; University of Arizona	Ito, M (corresponding author), Mie Univ, Sch Med, Dept Internal Med 1, Tsu, Mie 5148507, Japan.	m-ito@din.medic.mie-u.ac.jp			NHLBI NIH HHS [HL23615] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL023615] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Beavo J A, 1974, Methods Enzymol, V38, P299; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; COHEN P, 1988, METHOD ENZYMOL, V159, P390; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Fujioka M, 1998, GENOMICS, V49, P59, DOI 10.1006/geno.1998.5222; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Gailly P, 1997, J PHYSIOL-LONDON, V500, P95, DOI 10.1113/jphysiol.1997.sp022002; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; GONG MC, 1992, J BIOL CHEM, V267, P21492; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, V2, P423; HATHAWAY DR, 1983, ANAL BIOCHEM, V135, P37, DOI 10.1016/0003-2697(83)90726-1; Hirano K, 1997, J BIOL CHEM, V272, P3683, DOI 10.1074/jbc.272.6.3683; Hirano M, 1999, BIOCHEM BIOPH RES CO, V254, P490, DOI 10.1006/bbrc.1998.9973; HIRATA K, 1992, J BIOL CHEM, V267, P8719; ICHIKAWA K, 1993, BIOCHEM BIOPH RES CO, V193, P827, DOI 10.1006/bbrc.1993.1700; Ichikawa K, 1996, BIOCHEMISTRY-US, V35, P6313, DOI 10.1021/bi960208q; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Ito M, 1997, BIOCHEMISTRY-US, V36, P7607, DOI 10.1021/bi9702647; Johnson D, 1997, EUR J BIOCHEM, V244, P931, DOI 10.1111/j.1432-1033.1997.00931.x; Johnson DF, 1996, EUR J BIOCHEM, V239, P317, DOI 10.1111/j.1432-1033.1996.0317u.x; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; KUBOTA Y, 1992, AM J PHYSIOL, V262, pC405, DOI 10.1152/ajpcell.1992.262.2.C405; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MR, 1997, J BIOL CHEM, V272, P5063, DOI 10.1074/jbc.272.8.5063; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Nakai K, 1997, BLOOD, V90, P3936, DOI 10.1182/blood.V90.10.3936; NISHIKAWA M, 1985, J BIOL CHEM, V260, P8978; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SELLERS JR, 1985, CURR TOP CELL REGUL, V27, P51; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Suzuki Y, 1999, BLOOD, V93, P3408, DOI 10.1182/blood.V93.10.3408.410k37_3408_3417; TAKAHASHI K, 1986, BIOCHEM BIOPH RES CO, V141, P20, DOI 10.1016/S0006-291X(86)80328-X; Takahashi N, 1997, GENOMICS, V44, P150, DOI 10.1006/geno.1997.4859; Tanaka J, 1998, BIOCHEMISTRY-US, V37, P16697, DOI 10.1021/bi980782x; Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRINKLEMULCAHY L, 1995, J BIOL CHEM, V270, P18191, DOI 10.1074/jbc.270.31.18191; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WALSH MP, 1983, METHOD ENZYMOL, V99, P279; Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460; Zhao SM, 1997, J BIOL CHEM, V272, P28368, DOI 10.1074/jbc.272.45.28368	57	424	437	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37385	37390		10.1074/jbc.274.52.37385	http://dx.doi.org/10.1074/jbc.274.52.37385			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601309	hybrid			2022-12-27	WOS:000084382700080
J	Iakhiaev, A; Pendurthi, UR; Voigt, J; Ezban, M; Rao, LVM				Iakhiaev, A; Pendurthi, UR; Voigt, J; Ezban, M; Rao, LVM			Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; VEIN ENDOTHELIAL-CELLS; LUNG-CANCER CELLS; FACTOR-XA; IN-VIVO; ENDOCYTOSIS; THROMBOMODULIN; DEGRADATION; MECHANISM; SURFACES	Vascular injury leads to the exposure of blood to fibroblasts and smooth muscle cells within the vessel wall. These cells constitutively express tissue factor (TF), the cellular receptor for plasma clotting factor VIIa (FVIIa). Formation of TF . FVIIa complexes on cell surfaces triggers the blood coagulation cascade. In the present study, we have investigated the fate of TF . FVIIa complexes formed on the cell surface of fibroblasts in the presence and absence of plasma inhibitor, tissue factor pathway inhibitor (TFPI), FVIIa bound to TF on the cell surface was internalized and degraded without depleting the cell surface TF antigen and activity. TFPI significantly enhanced the TF-specific internalization and degradation of FVIIa, TFPI-enhanced internalization and degradation of FVIIa requires the C-terminal domain of TFPI and factor Xa, TFPI . Xa-mediated internalization of FVIIa was associated with the depletion of TF from the cell surface. A majority of the internalized FVIIa was degraded, but a small portion of the internalized FVIIa recycles back to the cell surface as an intact protein. In addition to TF, other cell surface components, such as low density lipoprotein receptor-related protein (LRP) and heparan sulfates, are essential for TFPI . Xa-induced internalization of FVIIa, Acidification of cytosol, which selectively inhibits the endocytotic pathway via coated pits, inhibited TFPI . Xa-mediated internalization but not the basal internalization of FVIIa, Overall, our data support the concept that FVIIa bound to cell surface TF was endocytosed by two different pathways. FVIIa complexed with TF in the absence of the inhibitor was internalized via a LRP-independent and probably noncoated pit pathway, whereas FVIIa complexed with TF along with the inhibitor was internalized via LRP-dependent coated pit pathway.	Univ Texas, Ctr Hlth, Dept Biochem, Tyler, TX 75708 USA; Univ Texas, Ctr Hlth, Dept Mol Biol, Tyler, TX 75708 USA; Novo Nordisk AS, DK-2760 Malov, Denmark	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Novo Nordisk	Rao, LVM (corresponding author), Univ Texas, Ctr Hlth, Dept Biochem, 11937 US Hwy 271, Tyler, TX 75708 USA.	rao@uthct.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058869] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58869] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bach RR, 1997, BLOOD, V89, P3270, DOI 10.1182/blood.V89.9.3270; BAJAJ SP, 1981, PREP BIOCHEM, V11, P397, DOI 10.1080/00327488108065531; CALLANDER NS, 1992, J BIOL CHEM, V267, P876; CHANG GTG, 1995, THROMB HAEMOSTASIS, V73, P231; DRAKE TA, 1989, AM J PATHOL, V134, P1087; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Hamik A, 1999, J BIOL CHEM, V274, P4962, DOI 10.1074/jbc.274.8.4962; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Kojima T, 1996, J BIOL CHEM, V271, P5914, DOI 10.1074/jbc.271.10.5914; LE DT, 1992, J BIOL CHEM, V267, P15447; MARUYAMA I, 1985, J BIOL CHEM, V260, P5432; MARUYAMA I, 1987, BLOOD, V69, P1481; Mast AE, 1997, BIOCHEM J, V327, P577; MORRISSEY JH, 1988, THROMB RES, V52, P247, DOI 10.1016/0049-3848(88)90084-9; Mulder AB, 1996, BLOOD, V88, P1306, DOI 10.1182/blood.V88.4.1306.bloodjournal8841306; NARITA M, 1995, J BIOL CHEM, V270, P24800, DOI 10.1074/jbc.270.42.24800; RAO LVM, 1995, BLOOD, V85, P121, DOI 10.1182/blood.V85.1.121.bloodjournal851121; Rao LVM, 1998, BLOOD COAGUL FIBRIN, V9, pS27; RAO LVM, 1992, THROMB HAEMOSTASIS, V67, P654; RAO LVM, 1988, THROMB RES, V51, P373, DOI 10.1016/0049-3848(88)90373-8; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SCHWARTZ AL, 1995, PEDIATR RES, V38, P835, DOI 10.1203/00006450-199512000-00003; Semeraro N, 1997, THROMB HAEMOSTASIS, V78, P759; Sevinsky JR, 1996, J CELL BIOL, V133, P293, DOI 10.1083/jcb.133.2.293; Sorensen BB, 1997, J BIOL CHEM, V272, P11863, DOI 10.1074/jbc.272.18.11863; Sorensen BB, 1998, BLOOD COAGUL FIBRIN, V9, pS67; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; TEASDALE MS, 1994, IMMUNOL CELL BIOL, V72, P480, DOI 10.1038/icb.1994.72; THIM L, 1988, BIOCHEMISTRY-US, V27, P7785, DOI 10.1021/bi00420a030; WARSHAWSKY I, 1994, P NATL ACAD SCI USA, V91, P6664, DOI 10.1073/pnas.91.14.6664; WARSHAWSKY I, 1995, J CLIN INVEST, V95, P1773, DOI 10.1172/JCI117855; Warshawsky I, 1996, J BIOL CHEM, V271, P25873, DOI 10.1074/jbc.271.42.25873; WATTS C, 1985, J CELL BIOL, V100, P633, DOI 10.1083/jcb.100.2.633; WESSELSCHMIDT R, 1993, BLOOD COAGUL FIBRIN, V4, P661, DOI 10.1097/00001721-199304050-00001	35	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36995	37003		10.1074/jbc.274.52.36995	http://dx.doi.org/10.1074/jbc.274.52.36995			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601255	hybrid			2022-12-27	WOS:000084382700026
J	Komuro, A; Saeki, M; Kato, S				Komuro, A; Saeki, M; Kato, S			Association of two nuclear proteins, Npw38 and NpwBP, via the interaction between the WW domain and a novel proline-rich motif containing glycine and arginine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; LIDDLES-SYNDROME; BINDING PROTEIN; DYSTROPHIN; HOMOLOGY; NEDD4	We have previously reported a nuclear protein possessing a WW domain, Npw38 (Komuro, A., Saeki, M,, and Kato, S, (1999) Nucleic Acids Res. 27, 1957-1965), Here we report a Npw38-binding protein, NpwBP, isolated from HeLa cell nuclear extracts and its characterization using a cloned cDNA, NpwBP contains two proline-rich regions that are capable of binding to the WW domain of Npw38, The binding analysis using an oligopeptide-immobilized membrane revealed that the WW domain of Npw38 preferentially recognizes a short proline-rich sequence, PPGPPP, surrounded by an arginine residue, so we named it a PGR motif, Localization analysis using green fluorescent protein fusion protein and immunostaining showed that Npw38 and NpwBP are colocalized in the same subnuclear region. Coimmunoprecipitation experiments confirmed the association between Npw38 and NpwBP, which were expressed as epitope-tagged forms in COS7 cells. Furthermore, the N-terminal region of NpwBP has binding ability for poly(rG) and G-rich single-stranded DNA. These results suggest that NpwBP is a physiological ligand of Npw88 and that the Npw38NpwBP complex may function as a component of an mRNA factory in the nucleus.	Sagami Chem Res Ctr, Japan Sci & Technol Corp, Kato Cytoprot Network Project, Sagamihara, Kanagawa 2290012, Japan	Japan Science & Technology Agency (JST)	Kato, S (corresponding author), Sagami Chem Res Ctr, Japan Sci & Technol Corp, Kato Cytoprot Network Project, 4-4-1 Nishi Ohnuma, Sagamihara, Kanagawa 2290012, Japan.							ANDRE B, 1994, BIOCHEM BIOPH RES CO, V205, P1201, DOI 10.1006/bbrc.1994.2793; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Espanel X, 1999, J BIOL CHEM, V274, P17284, DOI 10.1074/jbc.274.24.17284; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; HOFMANN K, 1995, FEBS LETT, V358, P153, DOI 10.1016/0014-5793(94)01415-W; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Komuro A, 1999, NUCLEIC ACIDS RES, V27, P1957, DOI 10.1093/nar/27.9.1957; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Rentschler S, 1999, BIOL CHEM, V380, P431, DOI 10.1515/BC.1999.057; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S	20	71	74	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36513	36519		10.1074/jbc.274.51.36513	http://dx.doi.org/10.1074/jbc.274.51.36513			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593949	hybrid			2022-12-27	WOS:000084279200068
J	Michaely, P; Kamal, A; Anderson, RGW; Bennett, V				Michaely, P; Kamal, A; Anderson, RGW; Bennett, V			A requirement for ankyrin binding to clathrin during coated pit budding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE ANKYRIN; ANION-EXCHANGER; ANNEXIN-VI; SPECTRIN; IDENTIFICATION; PROTEINS; RECEPTOR; REPEATS; DOMAIN; CELLS	Recent studies suggest that the mobility of clathrin-coated pits at the cell surface are restricted by an actin cytoskeleton and that there is an obligate reduction in the amount of spectrin on membranes during coated pit budding. The spectrin-actin cytoskeleton associates with membranes primarily through ankyrins, which interact with the cytoplasmic region of numerous integral membrane proteins. We now report that the fourth repeat domain (D4) of ankyrin, binds to the N-terminal domain of clathrin heavy chain with high affinity. Addition of peptides containing the D4 region inhibited clathrin-coated pit budding in vitro. In addition, microinjection of D4 containing peptides blocked the endocytosis of fluorescent low density lipoprotein (LDL). Ankyrin, peptides that contained repeat domains other than D4 had no effect on either in vitro budding or internalization of LDL. Finally, immunofluorescence shows that ankyrin is uniformly associated with endosomes that contain fluorescent LDL. These results suggest that ankyrin plays a role in the budding of clathrin-coated pits during endocytosis.	Univ Texas, SW Med Ctr, Dept Cell Biol & Neurosci, Dallas, TX 75235 USA; Duke Univ, Dept Cell Biol, Howard Hughes Med Inst, Durham, NC 27710 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Duke University; Howard Hughes Medical Institute	Michaely, P (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol & Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.				NHLBI NIH HHS [HL20948] Funding Source: Medline; NIDDK NIH HHS [DK29808] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK029808, R01DK029808] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson R G, 1986, Methods Enzymol, V129, P201; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Beck KA, 1996, AM J PHYSIOL-CELL PH, V270, pC1263, DOI 10.1152/ajpcell.1996.270.5.C1263; BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; BENNETT V, 1979, NATURE, V281, P597, DOI 10.1038/281597a0; BLACK JD, 1988, J CELL BIOL, V106, P97, DOI 10.1083/jcb.106.1.97; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; CONRADI S, 1969, ACTA PHYSIOL SCAND, P53; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; KARLSSON U, 1967, J ULTRA MOL STRUCT R, V17, P137, DOI 10.1016/S0022-5320(67)80026-1; Kibbey RG, 1998, J CELL BIOL, V142, P59, DOI 10.1083/jcb.142.1.59; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; LIN HC, 1992, CELL, V70, P283, DOI 10.1016/0092-8674(92)90102-I; LUX SE, 1989, P NATL ACAD SCI USA, V86, P9089, DOI 10.1073/pnas.86.23.9089; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; MICHAELY P, 1995, J BIOL CHEM, V270, P22050, DOI 10.1074/jbc.270.37.22050; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; OTTO E, 1991, J CELL BIOL, V114, P241, DOI 10.1083/jcb.114.2.241; PETERS LL, 1993, SEMIN HEMATOL, V30, P85; RODMAN JS, 1986, EUR J CELL BIOL, V42, P319; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; VIGERS GPA, 1986, EMBO J, V5, P2079, DOI 10.1002/j.1460-2075.1986.tb04469.x	31	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35908	35913		10.1074/jbc.274.50.35908	http://dx.doi.org/10.1074/jbc.274.50.35908			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585476	hybrid			2022-12-27	WOS:000084187900088
J	Curtis, CL; Hughes, CE; Flannery, CR; Little, CB; Harwood, JL; Caterson, B				Curtis, CL; Hughes, CE; Flannery, CR; Little, CB; Harwood, JL; Caterson, B			n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE-INHIBITION; RHEUMATOID-ARTHRITIS; INTERGLOBULAR DOMAIN; EXPRESSION; CYCLOOXYGENASE-1; SUPPLEMENTATION; INTERLEUKIN-1; CHONDROCYTES; AGGRECANASE; FRAGMENTS	This study describes specific molecular mechanisms by which supplementation, with n-3 fatty acids (i.e. those present in fish oils) can modulate the expression and activity of degradative and inflammatory factors that cause cartilage destruction during arthritis. Our data show that incorporation of n-3 fatty acids (but not other polyunsaturated or saturated fatty acids) into articular cartilage chondrocyte membranes results in a dose-dependent reduction in: (i) the expression and activity of proteoglycan degrading enzymes (aggrecanases) and (ii) the expression of inflammation-inducible cytokines (interleukin (IL)-1 alpha and tumor necrosis factor (TNF)-alpha) and cyclooxygenase (COX-2), but not the constitutively expressed cyclooxygenase COX-1. These findings provide evidence that n-3 fatty acid supplementation can specifically affect regulatory mechanisms involved in chondrocyte gene transcription and thus further advocate a beneficial role for dietary fish oil supplementation in alleviation of several of the physiological parameters that cause and propogate arthritic disease.	Cardiff Univ, Sch Biomed Sci, Connect Tissue Biol Labs, Cardiff CF10 3US, S Glam, Wales	Cardiff University	Caterson, B (corresponding author), Cardiff Univ, Sch Biomed Sci, Connect Tissue Biol Labs, Museum Ave,Biomed Sci Bldg, Cardiff CF10 3US, S Glam, Wales.	caterson@Cardiff.ac.uk	Harwood, John L/A-4308-2010; Little, Christopher B/A-9280-2015	Little, Christopher B/0000-0002-0353-7634; Caterson, Bruce/0000-0001-6016-0661; Harwood, John/0000-0003-2377-2612; Hughes, Clare/0000-0003-4726-5877				Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Anderson GD, 1996, J CLIN INVEST, V97, P2672, DOI 10.1172/JCI118717; Ariza-Ariza R, 1998, SEMIN ARTHRITIS RHEU, V27, P366, DOI 10.1016/S0049-0172(98)80016-4; Arner EC, 1998, OSTEOARTHR CARTILAGE, V6, P214, DOI 10.1053/joca.1998.0114; Arner EC, 1999, J BIOL CHEM, V274, P6594, DOI 10.1074/jbc.274.10.6594; AYDELOTTE MB, 1992, CONNECT TISSUE RES, V28, P143, DOI 10.3109/03008209209014233; BANG HO, 1971, LANCET, V1, P1143, DOI 10.1016/S0140-6736(71)91658-8; Blanco FJ, 1999, J RHEUMATOL, V26, P1366; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Flannery CR, 1999, MATRIX BIOL, V18, P225, DOI 10.1016/S0945-053X(99)00024-4; GARBUS J, 1963, J BIOL CHEM, V238, P59; Griswold DE, 1996, MED RES REV, V16, P181, DOI 10.1002/(SICI)1098-1128(199603)16:2<181::AID-MED3>3.0.CO;2-X; Gurr MI, 1991, LIPID BIOCH INTRO; Hughes CE, 1998, J BIOL CHEM, V273, P30576, DOI 10.1074/jbc.273.46.30576; ILIE MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kremer JM, 1996, LIPIDS, V31, pS243, DOI 10.1007/BF02637084; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; Little CB, 1999, BIOCHEM J, V344, P61, DOI 10.1042/0264-6021:3440061; LOULAKIS P, 1992, BIOCHEM J, V284, P589, DOI 10.1042/bj2840589; Okuyama H, 1996, PROG LIPID RES, V35, P409, DOI 10.1016/S0163-7827(96)00012-4; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; SICARD B, 1985, THROMB HAEMOSTASIS, V53, P264; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; SPERLING RI, 1993, J CLIN INVEST, V91, P651, DOI 10.1172/JCI116245; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; TYLER JA, 1985, BIOCHEM J, V227, P869, DOI 10.1042/bj2270869; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Volker D, 1996, J CLIN BIOCHEM NUTR, V20, P83	33	195	204	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					721	724		10.1074/jbc.275.2.721	http://dx.doi.org/10.1074/jbc.275.2.721			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625599	hybrid			2022-12-27	WOS:000084836600003
J	Lutterbach, B; Westendorf, JJ; Linggi, B; Isaac, S; Seto, E; Hiebert, SW				Lutterbach, B; Westendorf, JJ; Linggi, B; Isaac, S; Seto, E; Hiebert, SW			A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA SEGMENTATION GENE; ACUTE LYMPHOBLASTIC-LEUKEMIA; RUNT DOMAIN; AML1 GENE; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTIONAL ACTIVATION; CLEIDOCRANIAL DYSPLASIA; FUNCTIONAL DOMAINS; C/EBP-ALPHA; N-COR	AML1 is one of the most frequently translocated genes in human leukemia. Here we demonstrate that acute myeloid leukemia-1 (AML-1) (Runx-1) represses transcription from a native promoter, p21(Waf1/Cip1). Unexpectedly, this repression did not require interactions with the Groucho co-repressor. To define the mechanism of repression, we asked whether other co-repressors could interact with AML-1. We demonstrate that AML-1 interacts with the mSin3 co-repressors. Moreover, endogenous AML-1 associated with endogenous mSin3A in mammalian cells. A deletion mutant of AML-1 that did not interact with mSin3A failed to repress transcription. The AML-1/mSin3 association suggests a mechanism of repression for the chromosomal translocation fusion proteins that disrupt AML-1.	Vanderbilt Univ, Sch Med, Vanderbilt Canc Ctr, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Canc Ctr, Dept Med, Nashville, TN 37232 USA; Bethel Coll, Dept Biol, N Newton, KS 67117 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	Vanderbilt University; Vanderbilt University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Hiebert, SW (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Canc Ctr, Dept Biochem, Med Res Bldg 2,Rm 512,23rd & Pierce, Nashville, TN 37232 USA.	hiebert@mcmail.vanderbilt.edu	Hiebert, Scott W/C-9979-2010		NATIONAL CANCER INSTITUTE [R01CA064140, R01CA077274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013726] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA77274, R01-CA64140] Funding Source: Medline; NIA NIH HHS [R01-AG13726] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; EL DW, 1993, CELL, V75, P817; ERICKSON P, 1992, BLOOD, V80, P1825; Fenrick R, 1998, J CELL BIOCHEM, P194; Fenrick R, 1999, MOL CELL BIOL, V19, P6566; GERGEN JP, 1988, GENE DEV, V2, P1179, DOI 10.1101/gad.2.9.1179; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; HERNANDEZMUNAIN C, 1995, MOL CELL BIOL, V15, P3090; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LENNY N, 1995, ONCOGENE, V11, P1761; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Mayall TP, 1997, GENE DEV, V11, P887, DOI 10.1101/gad.11.7.887; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; MITANI K, 1994, EMBO J, V13, P504, DOI 10.1002/j.1460-2075.1994.tb06288.x; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Muscat GEO, 1998, NUCLEIC ACIDS RES, V26, P2899, DOI 10.1093/nar/26.12.2899; NISSON PE, 1992, CANCER GENET CYTOGEN, V63, P81, DOI 10.1016/0165-4608(92)90384-K; NUCIFORA G, 1995, BLOOD, V86, P1; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; ROMANA SP, 1995, BLOOD, V85, P3662, DOI 10.1182/blood.V85.12.3662.bloodjournal85123662; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Shurtleff SA, 1995, LEUKEMIA, V9, P1985; SUN WW, 1995, J VIROL, V69, P4941, DOI 10.1128/JVI.69.8.4941-4949.1995; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Uchida H, 1999, ONCOGENE, V18, P1015, DOI 10.1038/sj.onc.1202383; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Wong CW, 1998, MOL CELL BIOL, V18, P5500, DOI 10.1128/MCB.18.9.5500; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746; Zhang DE, 1996, MOL CELL BIOL, V16, P1231	47	214	220	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					651	656		10.1074/jbc.275.1.651	http://dx.doi.org/10.1074/jbc.275.1.651			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617663	hybrid			2022-12-27	WOS:000085951600087
J	Sasaki, N; Asukagawa, H; Yasuda, R; Hiratsuka, T; Sutoh, K				Sasaki, N; Asukagawa, H; Yasuda, R; Hiratsuka, T; Sutoh, K			Deletion of the myopathy loop of Dictyostelium myosin II and its impact on motor functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; REGULATORY LIGHT-CHAIN; DISCOIDEUM MYOSIN; IN-VIVO; F-ACTIN; DOMAIN; SITE; BINDING; GENE; PHOSPHORYLATION	One of the putative actin-binding sites of Dictyosteliun myosin II is the beta-strand-turn-beta-strand structure (Ile(398)-Leu-Ala-Gly-Arg-Asp(403)-Leu-Val(405)) the "myopathy loop," which is located at the distal end of the upper 50-kDa subdomain and next to the conserved arginine (Arg(397)), whose mutation in human cardiac myosin results in familial hypertrophic cardiomyopathy. The myopathy loop contains the TEDS residue (Asp(403)), which is a target of the heavy-chain kinase in myosin I, Moreover, the loop contains a cluster of hydrophobic residues (Ile(398), Leu(399), Leu(404), and Val(405)), whose side chains are fully exposed to the solvent. In our study, the myopathy loop was deleted from Dictyostelium myosin II to investigate its functional roles. The mutation abolished hydrophobic interactions of actin and myosin in the strong binding state during the ATPase cycle. Association of the mutant myosin and actin was maintained only through ionic interactions under these conditions. Without strong hydrophobic interactions, the mutant myosin still exhibited motor functions, although at low levels. It is likely that the observed defects resulted mainly from a loss of the cluster of hydrophobic residues, since replacement of Asp(403) or Arg(402) with alanine generated a mutant with less severe or no defects compared with those of the deletion mutant.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; Keio Univ, Fac Sci & Technol, Dept Phys, Yokohama, Kanagawa 2238522, Japan; Asahikawa Med Coll, Dept Chem, Hokkaido 0788510, Japan	University of Tokyo; Keio University; Asahikawa Medical College	Sutoh, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan.	sutoh@bio.c.u-tokyo.ac.jp	Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297				BAGSHAW CR, 1973, BIOCHEM J, V133, P323, DOI 10.1042/bj1330323; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; CHISHOLM RL, 1988, MOL CELL BIOL, V8, P794, DOI 10.1128/MCB.8.2.794; DE LA, 1987, SCIENCE, V236, P1086; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Fujita H, 1997, J CLIN INVEST, V99, P1010, DOI 10.1172/JCI119228; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; KUBALEK EW, 1992, MOL BIOL CELL, V3, P1455, DOI 10.1091/mbc.3.12.1455; Kuhlman PA, 1998, J MUSCLE RES CELL M, V19, P491, DOI 10.1023/A:1005304408812; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; LEE SF, 1995, J BIOL CHEM, V270, P11776, DOI 10.1074/jbc.270.20.11776; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; OHALLORAN TJ, 1990, P NATL ACAD SCI USA, V87, P8110, DOI 10.1073/pnas.87.20.8110; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Sasaki N, 1998, J BIOL CHEM, V273, P20334, DOI 10.1074/jbc.273.32.20334; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; Suzuki Y, 1997, BIOCHEM BIOPH RES CO, V234, P701, DOI 10.1006/bbrc.1997.6671; SWEENEY HL, 1994, J BIOL CHEM, V269, P1603; TAFURI SR, 1989, MOL CELL BIOL, V9, P3073, DOI 10.1128/MCB.9.7.3073; UYEDA TQP, 1993, SCIENCE, V262, P1867, DOI 10.1126/science.8266074; UYEDA TQP, 1994, NATURE, V368, P567, DOI 10.1038/368567a0; WARRICK HM, 1986, P NATL ACAD SCI USA, V83, P9433, DOI 10.1073/pnas.83.24.9433	33	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37840	37844		10.1074/jbc.274.53.37840	http://dx.doi.org/10.1074/jbc.274.53.37840			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608848	hybrid			2022-12-27	WOS:000084528000048
J	Sharp, DA; Kratowicz, SA; Sank, MJ; George, DL				Sharp, DA; Kratowicz, SA; Sank, MJ; George, DL			Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; RING FINGER DOMAIN; SOFT-TISSUE SARCOMAS; HUMAN TUMOR-CELLS; P53-ASSOCIATED PROTEIN; ENHANCED TRANSLATION; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; P53-BINDING PROTEIN; GENE	The MDM2 oncoprotein has transforming potential that can be activated by overexpression, and it represents a critical regulator of the p53 tumor suppressor protein. To identify other factors with a potential role in influencing the expression and/or function of MDM2, we utilized a yeast two-hybrid screening protocol. Here we report that MDM2 physically interacts with a structurally related protein termed MDMX The results obtained in these studies provide evidence that C-terminal RING finger domains, contained within both of these proteins, play an important role in mediating the association: between MDM2 and MDMX. The interaction of these proteins interferes with MDM2 degradation, leading to an increase in the steady-state levels of MDM2. MDMX also inhibits MDM2-mediated p53 degradation, with subsequent accumulation of p53. Taken together, these data indicate that MDMX has the potential to regulate the expression and function of the MDM2 oncoprotein.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	George, DL (corresponding author), Univ Penn, Sch Med, Dept Genet, 713 Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.				NCI NIH HHS [CA-66741] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066741] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BODDY MN, 1994, TRENDS BIOCHEM SCI, V19, P198, DOI 10.1016/0968-0004(94)90020-5; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; CAHILLYSNYDER L, 1987, SOMAT CELL MOLEC GEN, V13, P235, DOI 10.1007/BF01535205; Capoulade C, 1998, ONCOGENE, V16, P1603, DOI 10.1038/sj.onc.1201702; Chang YC, 1998, CELL GROWTH DIFFER, V9, P79; CHEN CY, 1994, P NATL ACAD SCI USA, V91, P2684, DOI 10.1073/pnas.91.7.2684; Chen JD, 1996, MOL CELL BIOL, V16, P2445; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; CORDONCARDO C, 1994, CANCER RES, V54, P794; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Freedman DA, 1999, CANCER RES, V59, P1; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; JUVEN T, 1993, ONCOGENE, V8, P3411; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kubbutat MHG, 1999, CELL GROWTH DIFFER, V10, P87; Lai ZH, 1998, BIOCHEMISTRY-US, V37, P17005, DOI 10.1021/bi980596r; Landers JE, 1997, CANCER RES, V57, P3562; LANDERS JE, 1994, ONCOGENE, V9, P2745; LEACH FS, 1993, CANCER RES, V53, P2231; LUNA RMD, 1995, NATURE, V378, P203; Maki CG, 1996, CANCER RES, V56, P2649; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; MURPHY M, 1993, CELL GROWTH DIFFER, V4, P715; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; OLSON DC, 1993, ONCOGENE, V8, P2353; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Rallapalli R, 1999, J BIOL CHEM, V274, P8299, DOI 10.1074/jbc.274.12.8299; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	50	242	252	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38189	38196		10.1074/jbc.274.53.38189	http://dx.doi.org/10.1074/jbc.274.53.38189			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608892	hybrid			2022-12-27	WOS:000084528000092
J	Wang, KF; Zhen, YJ; Sadoski, R; Grinnell, S; Geren, L; Ferguson-Miller, S; Durham, B; Millett, F				Wang, KF; Zhen, YJ; Sadoski, R; Grinnell, S; Geren, L; Ferguson-Miller, S; Durham, B; Millett, F			Definition of the interaction domain for cytochrome c on cytochrome c oxidase - II. Rapid kinetic analysis of electron transfer from cytochrome c to Rhodobacter sphaeroides cytochrome oxidase surface mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEADY-STATE KINETICS; IONIC-STRENGTH; PARACOCCUS-DENITRIFICANS; TRANSFER PROTEINS; OXYFERRYL HEME; HIGH-AFFINITY; BINDING-SITE; PEROXIDASE; DERIVATIVES; REDUCTION	The reaction between cytochrome c (Cc) and Rhodobacter sphaeroides cytochrome c oxidase (CcO) was studied using a cytochrome c derivative labeled with ruthenium trisbipyridine at lysine 55 (Ru-55-Cc). Plash photolysis of a 1:1 complex between Ru-55-Cc and CcO at low ionic strength results in electron transfer from photoreduced heme c to Cu-A with an intracomplex rate constant of k(a) = 4 x 10(4) s(-1), followed by electron transfer from Cu-A to heme a with a rate constant of k(b) = 9 x 10(4) s(-1). The effects of CcO surface mutations on the kinetics follow the order D214N > E157Q > E148Q > D195N > D151N/E152Q approximate to D188N/E189Q approximate to wild type, indicating that the acidic residues Asp(214), Glu(157), Glu(148) and Asp(195) On subunit II interact electrostatically with the lysines surrounding the heme crevice of Cc. Mutating the highly conserved tryptophan residue, Trp(143), to Phe or Ala decreased the intracomplex electron transfer rate constant k(a) by 450- and 1200 fold, respectively, without affecting the dissociation constant K-D. It therefore appears that the indole ring of Trp(143) mediates electron transfer from the heme group of Cc to Cu-A These results are consistent with steady-state kinetic results (Zhen, Y., Hoganson, C. W., Babcock, G. T., and Ferguson-Miller, S. (1999) J. Biol Chem 274, 3803238041) and a computational docking analysis (Roberts, V. A, and Pique, M. E. (1999) J. Biol Chem. 274, 38051-38060).	Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA	University of Arkansas System; University of Arkansas Fayetteville; Michigan State University	Millett, F (corresponding author), Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.	millett@comp.uark.edu		Zhen, Eugene/0000-0002-0162-5665	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026916, R01GM026916] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26916, GM20488] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERATAN DN, 1992, J PHYS CHEM-US, V96, P2852, DOI 10.1021/j100186a014; BLAIR DF, 1982, BIOCHEMISTRY-US, V21, P6928, DOI 10.1021/bi00269a048; BLAIR DF, 1983, CHEM SCRIPTA, V21, P43; Brzezinski P, 1996, BIOCHEMISTRY-US, V35, P5611, DOI 10.1021/bi960260m; CANN JR, 1970, INTERACTING MOL; COOPER CE, 1990, BIOCHIM BIOPHYS ACTA, V1017, P187, DOI 10.1016/0005-2728(90)90184-6; DURHAM B, 1989, BIOCHEMISTRY-US, V28, P8659, DOI 10.1021/bi00447a057; ELTIS LD, 1991, BIOCHEMISTRY-US, V30, P3663, DOI 10.1021/bi00229a011; FABIAN M, 1987, FEBS LETT, V213, P396, DOI 10.1016/0014-5793(87)81529-6; FERGUSONMILLER S, 1978, J BIOL CHEM, V253, P149; FERGUSONMILLER S, 1976, J BIOL CHEM, V251, P1104; FERGUSONMILLER S, 1988, INTEGRATION MITOCHON, P23; GARBER EAE, 1990, BIOCHIM BIOPHYS ACTA, V1015, P279, DOI 10.1016/0005-2728(90)90032-Y; GEREN L, 1991, BIOCHEMISTRY-US, V30, P9450, DOI 10.1021/bi00103a009; GEREN LM, 1995, J BIOL CHEM, V270, P2466, DOI 10.1074/jbc.270.6.2466; HAHM S, 1994, BIOCHEMISTRY-US, V33, P1473, DOI 10.1021/bi00172a025; HAHM S, 1992, BIOCHEMISTRY-US, V31, P3472, DOI 10.1021/bi00128a022; HAZZARD JT, 1991, BIOCHEMISTRY-US, V30, P213, DOI 10.1021/bi00215a031; HEACOCK DH, 1993, J BIOL CHEM, V268, P27171; HILL BC, 1991, J BIOL CHEM, V266, P2219; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KOBAYASHI K, 1989, J BIOL CHEM, V264, P7976; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; LAPPALAINEN P, 1995, BIOCHEMISTRY-US, V34, P5824, DOI 10.1021/bi00017a014; LARSSON S, 1995, P NATL ACAD SCI USA, V92, P7167, DOI 10.1073/pnas.92.16.7167; LEMASTERS JJ, 1978, FEBS LETT, V88, P10, DOI 10.1016/0014-5793(78)80595-X; LIU RQ, 1995, BIOCHIMIE, V77, P549, DOI 10.1016/0300-9084(96)88171-5; MARCUS RA, 1956, J CHEM PHYS, V24, P966, DOI 10.1063/1.1742723; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; Mei HK, 1996, BIOCHEMISTRY-US, V35, P15800, DOI 10.1021/bi961487k; MILLETT F, 1983, BIOCHEMISTRY-US, V22, P546, DOI 10.1021/bi00272a004; MORGAN JE, 1989, BIOCHEMISTRY-US, V28, P6975, DOI 10.1021/bi00443a030; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; NILSSON T, 1992, P NATL ACAD SCI USA, V89, P6497, DOI 10.1073/pnas.89.14.6497; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; OSHEROFF N, 1980, J BIOL CHEM, V255, P8245; PAN LP, 1993, BIOCHEMISTRY-US, V32, P8492, DOI 10.1021/bi00084a014; RIEDER R, 1980, J BIOL CHEM, V255, P4732; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; SCHROEDL NA, 1977, BIOCHEMISTRY-US, V16, P4961, DOI 10.1021/bi00642a003; SCOTT JR, 1994, J AM CHEM SOC, V116, P7356, DOI 10.1021/ja00095a045; SINJORGO KMC, 1986, BIOCHIM BIOPHYS ACTA, V850, P108, DOI 10.1016/0005-2728(86)90014-9; SMITH HT, 1977, BIOCHEMISTRY-US, V16, P4971, DOI 10.1021/bi00642a005; SMITH HT, 1981, J BIOL CHEM, V256, P4984; SMITH MB, 1980, BIOCHIM BIOPHYS ACTA, V592, P303, DOI 10.1016/0005-2728(80)90191-7; STAUDENMAYER N, 1977, BIOCHEMISTRY-US, V16, P600, DOI 10.1021/bi00623a007; STAUDENMAYER N, 1976, BIOCHEMISTRY-US, V15, P3198, DOI 10.1021/bi00660a007; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Wang KF, 1996, BIOCHEMISTRY-US, V35, P15107, DOI 10.1021/bi9611117; WILLIAMS PA, 1995, NAT STRUCT BIOL, V2, P975, DOI 10.1038/nsb1195-975; WILLIE A, 1992, BIOCHEMISTRY-US, V31, P7237, DOI 10.1021/bi00147a005; WILLIE A, 1993, BIOCHEMISTRY-US, V32, P7519, DOI 10.1021/bi00080a025; WILMS J, 1981, BIOCHIM BIOPHYS ACTA, V635, P13, DOI 10.1016/0005-2728(81)90003-7; WILSON DF, 1976, ARCH BIOCHEM BIOPHYS, V175, P160, DOI 10.1016/0003-9861(76)90495-1; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; WITT H, 1995, BBA-BIOENERGETICS, V1230, P74, DOI 10.1016/0005-2728(95)00050-S; Witt H, 1998, EUR J BIOCHEM, V251, P367, DOI 10.1046/j.1432-1327.1998.2510367.x; WRIGHT JL, 1998, ADV CHEM SER, V254, P99; WUTTKE DS, 1992, SCIENCE, V256, P1007, DOI 10.1126/science.256.5059.1007; Zaslavsky D, 1998, BIOCHEMISTRY-US, V37, P14910, DOI 10.1021/bi981490z; Zhen YJ, 1999, J BIOL CHEM, V274, P38032, DOI 10.1074/jbc.274.53.38032	62	79	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38042	38050		10.1074/jbc.274.53.38042	http://dx.doi.org/10.1074/jbc.274.53.38042			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608873	Green Submitted, hybrid			2022-12-27	WOS:000084528000073
J	Kim, YO; Koh, HJ; Kim, SH; Jo, SH; Huh, JW; Jeong, KS; Lee, IJ; Song, BJ; Huh, TL				Kim, YO; Koh, HJ; Kim, SH; Jo, SH; Huh, JW; Jeong, KS; Lee, IJ; Song, BJ; Huh, TL			Identification and functional characterization of a novel, tissue-specific NAD(+)-dependent isocitrate dehydrogenase beta subunit isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; OLIGONUCLEOTIDE PROBES; BINDING-SITES; BOVINE HEART; FATTY-ACIDS; PIG; PROTEIN; CLONING; PURIFICATION	To understand the interactions and functional role of each of the three mitochondrial NAD(+)-dependent isocitrate dehydrogenase (IDH) subunits (alpha, beta, and gamma), we have characterized human cDNAs encoding two beta isoforms (beta(1) and beta(2)) and the gamma subunit. Analysis of deduced amino acid sequences revealed that beta(1) and beta(2) encode 349 and 354 amino acids, respectively, and the two isoforms only differ in the most carboxyl 28 amino acids. The gamma cDNA encodes 354 amino acids and is almost identical to monkey IDH gamma. Northern analyses revealed that the smaller beta(2) transcript (1.3 kilobases) is primarily expressed in heart and skeletal muscle, whereas the larger beta(1) mRNA (1.6 kilobases) is prevalent in nonmuscle tissues. Sequence analysis of the IDH beta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins results from alternative splicing of a single transcript. Among the various combinations of human IDH subunits co-expressed in bacteria, alpha beta gamma, alpha beta, and alpha gamma combinations exhibited significant amounts of IDH activity, whereas subunits produced alone and beta gamma showed no detectable activity. These data suggest that the alpha is the catalytic subunit and that at least one of the other two subunits plays an essential supporting role for activity. Substitution of beta(1) with beta(2) in the co-expression system lowered the pH optimum for IDH activity from 8.0 to 7.6. This difference in optimal pH was analogous to what was observed in mouse kidney and brain (beta(1) prevalent; optimal pH 8.0) versus heart (beta(2) prevalent; pH 7.6) mitochondria, Experiments with a specially designed splicing reporter constrdct stably transfected into HT1080 cells indicate that acidic conditions favor a splicing pattern responsible for the muscle- and heart-specific beta(2) isoform. Taken together, these data indicate a regulatory role of IDH beta isoforms in determining the pH optimum for IDH activity through the tissue-specific alternative splicing.	Kyungpook Natl Univ, Coll Nat Sci, Dept Genet Engn, Taegu 702701, South Korea; Korea Green Cross Corp, Cent Res Inst, Yongin, South Korea; NIAAA, Lab Membrane Biochem & Biophys, Rockville, MD 20852 USA	Kyungpook National University; Green Cross Corporation; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Huh, TL (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Dept Genet Engn, Taegu 702701, South Korea.			Kim, Yong-Ou/0000-0002-2040-2002				ANDREADIS A, 1987, ANNU REV CELL BIOL, V3, P207, DOI 10.1146/annurev.cellbio.3.1.207; AOGAICHI T, 1980, ARCH BIOCHEM BIOPHYS, V204, P350, DOI 10.1016/0003-9861(80)90043-0; APOSTOLAKOS D, 1982, CURR MICROBIOL, V7, P45, DOI 10.1007/BF01570979; BARNES LD, 1971, BIOCHEMISTRY-US, V10, P3939, DOI 10.1021/bi00797a022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; BREITBART RE, 1993, DEVELOPMENT, V118, P1095; COHEN PF, 1971, BIOCHIM BIOPHYS ACTA, V242, P325, DOI 10.1016/0005-2744(71)90224-5; CUPP JR, 1992, J BIOL CHEM, V267, P16417; CUPP JR, 1993, BIOCHEMISTRY-US, V32, P9323, DOI 10.1021/bi00087a010; CUPP JR, 1991, J BIOL CHEM, V266, P22199; DICKSON G, 1987, CELL, V50, P1119, DOI 10.1016/0092-8674(87)90178-4; EHRLICH RS, 1982, J BIOL CHEM, V257, P4769; EHRLICH RS, 1981, J BIOL CHEM, V256, P560; ELZINGA SDJ, 1993, NUCLEIC ACIDS RES, V21, P5328, DOI 10.1093/nar/21.23.5328; ENDO H, 1994, J BIOL CHEM, V269, P12488; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIORGIO NA, 1970, J BIOL CHEM, V245, P5469; Henke B, 1998, J BIOL CHEM, V273, P3702, DOI 10.1074/jbc.273.6.3702; HUANG YC, 1990, BIOCHEMISTRY-US, V29, P8266, DOI 10.1021/bi00488a010; HUH TL, 1993, BIOCHEM J, V292, P705, DOI 10.1042/bj2920705; Ichida M, 1998, J BIOL CHEM, V273, P8492, DOI 10.1074/jbc.273.14.8492; ILLINGWORTH JA, 1970, BIOCHEM J, V118, P253, DOI 10.1042/bj1180253; KIM YO, 1995, BIOCHEM J, V308, P63, DOI 10.1042/bj3080063; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LOVERDE AW, 1973, J NEUROCHEM, V20, P441, DOI 10.1111/j.1471-4159.1973.tb12143.x; MATSUDA C, 1994, BIOCHEM BIOPH RES CO, V200, P671, DOI 10.1006/bbrc.1994.1503; NICHOLS BJ, 1995, BIOCHEM J, V310, P917, DOI 10.1042/bj3100917; PLAUT GWE, 1983, BIOCHIM BIOPHYS ACTA, V760, P300, DOI 10.1016/0304-4165(83)90177-0; PLAUT GWE, 1983, BIOCH METABOLIC PROC, P285; PLAUT GWE, 1970, CURR TOP CELL REGUL, V2, P1; RAMACHANDRAN N, 1980, J BIOL CHEM, V255, P8859; ROSENBERG HF, 1990, BIOTECHNIQUES, V8, P384; RUTTER GA, 1989, BIOCHEM J, V263, P445, DOI 10.1042/bj2630445; Sambrook J., 1989, MOL CLONING, pA1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; van Roermund CWT, 1998, EMBO J, V17, P677, DOI 10.1093/emboj/17.3.677; WANG YC, 1992, J BIOL CHEM, V267, P12004; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783	41	38	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36866	36875		10.1074/jbc.274.52.36866	http://dx.doi.org/10.1074/jbc.274.52.36866			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601238	hybrid			2022-12-27	WOS:000084382700009
J	Kominato, Y; Hata, Y; Takizawa, H; Tsuchiya, T; Tsukada, J; Yamamoto, F				Kominato, Y; Hata, Y; Takizawa, H; Tsuchiya, T; Tsukada, J; Yamamoto, F			Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promoter region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A; CARBOHYDRATE ANTIGENS; SUPPRESSOR GENE; BLADDER-TUMORS; CPG ISLAND; INACTIVATION; TRANSCRIPTION; CARCINOMAS; LUNG; DEACETYLASE	We have investigated the regulatory role of DNA methylation in the expression of the human histo-blood group ABO genes. The ABO gene promoter region contains a CpG island whose methylation status correlates well with gene expression in the cell lines tested. The CPG island was found hypomethylated in some cell lines that expressed ABO genes, whereas the other cell lines that did not express ABO genes were hypermethylated. Whereas constitutive transcriptional activity of the ABO gene promoter was demonstrated in both expressor and nonexpressor cell lines by transient transfection of reporter constructs containing the ABO gene promoter sequence, HhaI methylase-catalyzed in vitro methylation of the promoter region prior to DNA transfection suppressed the promoter activity when introduced into the expressor gastric cancer cell line KATOIII cells. On the other hand, in the nonexpressor gastric cancer cell line MKN28 cells, treatment with DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine resulted in demethylation of the ABO:gene promoter and appearance of A-transferase messages, as well as A-antigens synthesized by A-transferase. Taken together, these studies suggest that DNA methylation of the ABO gene promoter may play an important role in the regulation of ABO gene expression.	Toyama Med & Pharmaceut Univ, Fac Med, Dept Legal Med, Toyama 9300194, Japan; Tokyo Med & Dent Univ, Med Res Inst, Tokyo 1130034, Japan; Univ Occupat & Environm Hlth, Sch Med, Kitakyushu, Fukuoka 8070804, Japan; Univ Occupat & Environm Hlth, Sch Hlth Sci, Dept Internal Med 1, Kitakyushu, Fukuoka 8070804, Japan; Burnham Inst, La Jolla, CA 92037 USA	University of Toyama; Tokyo Medical & Dental University (TMDU); University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Sanford Burnham Prebys Medical Discovery Institute	Kominato, Y (corresponding author), Toyama Med & Pharmaceut Univ, Fac Med, Dept Legal Med, 2630 Sugitani, Toyama 9300194, Japan.		Yamamoto, Fumiichiro/F-1478-2016	Yamamoto, Fumiichiro/0000-0001-9690-7034				ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; ANTEQUERA F, 1993, DNA METHYLATION MOL, P169; Baylin SB, 1998, ADV CANCER RES, V72, P141; Benvenuto G, 1996, MOL CELL BIOL, V16, P2736; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; CORDONCARDO C, 1986, LAB INVEST, V55, P444; DABELSTEEN E, 1982, J INVEST DERMATOL, V79, P3, DOI 10.1111/1523-1747.ep12510411; DAVID L, 1993, CANCER RES, V53, P5494; DUVIC M, 1994, J INVEST DERMATOL, V102, P462, DOI 10.1111/1523-1747.ep12373021; EALSH CP, 1999, GENE DEV, V13, P26; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; GINSBURG V, 1972, ADV ENZYMOL RAMB, V36, P131; GOZALEZULUETA M, 1995, CANCER RES, V55, P4531; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.iy.02.040184.000535; Haslam DB, 1996, P NATL ACAD SCI USA, V93, P10697, DOI 10.1073/pnas.93.20.10697; Herman JG, 1996, CANCER RES, V56, P722; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herman JG, 1997, CANCER RES, V57, P837; HERMAN JG, 1995, CANCER RES, V55, P4525; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; JUHL BR, 1986, CANCER, V57, P1768, DOI 10.1002/1097-0142(19860501)57:9<1768::AID-CNCR2820570910>3.0.CO;2-E; KABAT EA, 1973, CARBOHYDRATES SOLUTI, P334; Kominato Y, 1997, J BIOL CHEM, V272, P25890, DOI 10.1074/jbc.272.41.25890; KOMINATO Y, 1992, EUR J IMMUNOGENET, V19, P1, DOI 10.1111/j.1744-313X.1992.tb00042.x; Landsteiner K., 1900, ZBL BAKT, V27, P357; LEE JS, 1991, NEW ENGL J MED, V324, P1084, DOI 10.1056/NEJM199104183241603; Lu S, 1997, P NATL ACAD SCI USA, V94, P4692, DOI 10.1073/pnas.94.9.4692; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; MIYAKE M, 1992, NEW ENGL J MED, V327, P14, DOI 10.1056/NEJM199207023270103; MORGAN WTJ, 1969, BRIT MED BULL, V25, P30, DOI 10.1093/oxfordjournals.bmb.a070666; MUMMANENI P, 1995, J BIOL CHEM, V270, P788, DOI 10.1074/jbc.270.2.788; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ngo V, 1996, MOL CELL BIOL, V16, P3245; Orlow I, 1998, INT J CANCER, V75, P819, DOI 10.1002/(SICI)1097-0215(19980316)75:6<819::AID-IJC1>3.0.CO;2-Y; Orntoft TF, 1996, CANCER RES, V56, P1031; ORNTOFT TF, 1990, APMIS S17, V98, P1; PATTNAIK AK, 1986, J VIROL, V60, P994, DOI 10.1128/JVI.60.3.994-1001.1986; RACE RR, 1975, BLOOD GROUPS MAN, P8; RIDEOUT WM, 1994, MOL CELL BIOL, V14, P6143, DOI 10.1128/MCB.14.9.6143; Salvatore P, 1998, FEBS LETT, V421, P152, DOI 10.1016/S0014-5793(97)01553-6; Shima M, 1992, JPN J TRANSFUSION ME, V38, P542; SHIMADA I, 1999, IN PRESS LEGAL MED; Singal R, 1997, P NATL ACAD SCI USA, V94, P13724, DOI 10.1073/pnas.94.25.13724; Warnecke PM, 1999, MOL CELL BIOL, V19, P164; Watkins W M, 1980, Adv Hum Genet, V10, P1; WHITE T, 1990, BIOCHEMISTRY-US, V29, P2740, DOI 10.1021/bi00463a017; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YAMAMOTO F, 1995, GLYCOBIOLOGY, V5, P51, DOI 10.1093/glycob/5.1.51; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416	55	69	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37240	37250		10.1074/jbc.274.52.37240	http://dx.doi.org/10.1074/jbc.274.52.37240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601288	hybrid			2022-12-27	WOS:000084382700059
J	Schmidt, PJ; Ramos-Gomez, M; Culotta, VC				Schmidt, PJ; Ramos-Gomez, M; Culotta, VC			A gain of superoxide dismutase (SOD) activity obtained with CCS, the copper metallochaperone for SOD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CEREVISIAE LYS7 GENE; SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; CU,ZN-SUPEROXIDE DISMUTASE; ATX1 GENE; K-M; YEAST; CHAPERONE; IDENTIFICATION	The incorporation of copper ions into the cytosolic superoxide dismutase (SOD1) is accomplished in vivo by the action of the copper metallochaperone CCS (popper chaperone for SOD1), Mammalian CCS is comprised of three distinct protein domains, with a central region exhibiting remarkable homology (approximately 50% identity) to SOD1 itself, Conserved in CCS are all the SOD1 zinc binding ligands and three of four histidine copper binding ligands, In CCS the fourth histidine is replaced by an aspartate (Asp(200)). Despite this conservation of sequence between SOD1 and CCS, CCS exhibited no detectable SOD activity, Surprisingly, however, a single D200H mutation, targeting the fourth potential copper ligand in CCS, granted significant superoxide scavenging activity to this metallochaperone that was readily detected with CCS expressed in yeast. This mutation did not inhibit the metallochaperone capacity of CCS, and in fact, D200H CCS appears to represent a bifunctional SOD that can self-activate itself with copper. The aspartate at CCS position 200 is well conserved among mammalian CCS molecules, and we propose that this residue has evolved to preclude deleterious reactions involving copper bound to CCS.	Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Culotta, VC (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, 615 N Wolfe St,Room 7032, Baltimore, MD 21205 USA.	vculotta@jhsph.edu		Ramos-Gomez, Minerva/0000-0002-0763-4108	NIGMS NIH HHS [GM 50016] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050016, R01GM050016] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amaravadi R, 1997, HUM GENET, V99, P329, DOI 10.1007/s004390050367; BatinicHaberle I, 1997, ARCH BIOCHEM BIOPHYS, V343, P225, DOI 10.1006/abbi.1997.0157; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; BILINSKI T, 1985, BIOCHEM BIOPH RES CO, V130, P533, DOI 10.1016/0006-291X(85)90449-8; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BORDERS CL, 1985, ARCH BIOCHEM BIOPHYS, V241, P472, DOI 10.1016/0003-9861(85)90572-7; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; CULOTTA VC, 1995, J BIOL CHEM, V270, P29991; DEALVARE LR, 1976, BIOCHEM BIOPH RES CO, V69, P687, DOI 10.1016/0006-291X(76)90930-X; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Gamonet F, 1998, EUR J BIOCHEM, V251, P716, DOI 10.1046/j.1432-1327.1998.2510716.x; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; GRALLA EB, 1992, ADV GENET, V30, P251, DOI 10.1016/S0065-2660(08)60322-3; HORECKA J, 1995, GENE, V162, P87, DOI 10.1016/0378-1119(95)00325-Z; Hung IH, 1998, J BIOL CHEM, V273, P1749, DOI 10.1074/jbc.273.3.1749; Klomp LWJ, 1997, J BIOL CHEM, V272, P9221, DOI 10.1074/jbc.272.14.9221; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; LENGFELDER E, 1981, CLIN RES PROC, V17, P73; Lin SJ, 1996, MOL CELL BIOL, V16, P6303; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Liochev SI, 1997, ARCH BIOCHEM BIOPHYS, V346, P263, DOI 10.1006/abbi.1997.0298; LIPPARD SJ, 1994, PRINCIPLES BIOINORGA, P45; LIU XF, 1992, J BIOL CHEM, V267, P18298; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nishihara E, 1998, NEUROREPORT, V9, P3259, DOI 10.1097/00001756-199810050-00023; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Petrovic N, 1996, J BIOL CHEM, V271, P28331, DOI 10.1074/jbc.271.45.28331; Poulos TL, 1999, NAT STRUCT BIOL, V6, P709, DOI 10.1038/11464; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; ROSSI L, 1994, BIOCHEM BIOPH RES CO, V203, P1028, DOI 10.1006/bbrc.1994.2285; Rossi L, 1997, BIOMETALS, V10, P257, DOI 10.1023/A:1018364130807; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; SHERMAN F, 1978, METHODS YEAST GENETI, P163; SIKORSKI RS, 1989, GENETICS, V122, P19; Srinivasan C, 1998, BIOCHEMISTRY-US, V37, P7572, DOI 10.1021/bi980418y; STEINKUHLER C, 1994, BIOCHEM J, V302, P687, DOI 10.1042/bj3020687; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Yim HS, 1997, J BIOL CHEM, V272, P8861; YIM MB, 1993, J BIOL CHEM, V268, P4099; YIM MB, 1990, P NATL ACAD SCI USA, V87, P5006, DOI 10.1073/pnas.87.13.5006; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	52	62	66	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36952	36956		10.1074/jbc.274.52.36952	http://dx.doi.org/10.1074/jbc.274.52.36952			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601249	hybrid			2022-12-27	WOS:000084382700020
J	Yu, H; Kopito, RR				Yu, H; Kopito, RR			The role of multiubiquitination in dislocation and degradation of the alpha subunit of the T cell antigen receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; ENDOPLASMIC-RETICULUM DEGRADATION; I HEAVY-CHAINS; MEMBRANE-PROTEIN; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; SECRETORY PROTEIN; ER DEGRADATION; CYTOSOL; MUTANT; TRANSLOCATION	Unassembled alpha subunits of the T cell receptor (TCR alpha) are degraded by proteasomes following their dislocation from the endoplasmic reticulum membrane. We previously demonstrated that a variant of TCR alpha lacking lysines (K alpha R) is degraded by this pathway with kinetics indistinguishable from those of the wild type protein (Yu, H., Kaung, G., Kobayashi, S., and Kopito, R. R. (1997) J. Biol. Chem. 272, 20800-20804), demonstrating that ubiquitination on lysines is not required for TCR alpha degradation by the proteasome. Here, we show that dislocation and degradation of TCR alpha and K alpha R are sup pressed by dominant negative ubiquitin coexpression and by mutations in the ubiquitin activating enzyme, indicating that their degradation requires a functional ubiquitin pathway. A cytoplasmic TCR alpha variant that mimics a dislocated degradation intermediate was degraded 5 times more rapidly than full-length TCR alpha, suggesting that dislocation from the endoplasmic reticulum membrane is the rate-limiting step in TCR alpha degradation. We conclude that ubiquitination is required both for dislocation and for targeting TCR alpha chains to the proteasome.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Kopito, RR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.				NIDDK NIH HHS [DK43994] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043994] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECKER MLB, 1989, CELL, V58, P911, DOI 10.1016/0092-8674(89)90943-4; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHIEN Y, 1984, NATURE, V312, P31, DOI 10.1038/312031a0; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hegde RS, 1997, CELL, V91, P575, DOI 10.1016/S0092-8674(00)80445-6; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KULKA RG, 1988, J BIOL CHEM, V263, P15726; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; SAITO T, 1987, NATURE, V325, P125, DOI 10.1038/325125a0; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	45	102	104	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36852	36858		10.1074/jbc.274.52.36852	http://dx.doi.org/10.1074/jbc.274.52.36852			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601236	hybrid			2022-12-27	WOS:000084382700007
J	Golovkin, M; Reddy, ASN				Golovkin, M; Reddy, ASN			An SC35-like protein and a novel serine/arginine-rich protein interact with Arabidopsis U1-70K protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SMALL NUCLEAR RIBONUCLEOPROTEIN; SPLICE-SITE SELECTION; SR-PROTEINS; INTRANUCLEAR DISTRIBUTION; DISTINCT FUNCTIONS; PREMESSENGER RNA; HIGHER-PLANTS; 70K PROTEIN; SERINE-RICH	The U1 small nuclear ribonucleoprotein 70-kDa protein, a U1 small nuclear ribonucleoprotein-specific protein, has been shown to have multiple roles in nuclear precursor mRNA processing in animals. By using the C-terminal arginine-rich region of Arabidopsis U1-'IOII protein in the yeast two-hybrid system, we have identified an SC35-like (SR33) and a novel plant serine/arginine-rich (SR) protein (SR45) that interact with the plant U1-70K The SR33 and SR45 proteins share several features with SR proteins including modular domains typical of splicing factors in the SR family of proteins. However, both plant SR proteins are rich in proline, and SR45, unlike most animal SR proteins, has two distinct arginine/serine-rich domains separated by an RNA recognition motif. By using coprecipitation assays we confirmed the interaction of plant U1-70K with SR33 and SR45 proteins. Furthermore, in vivo and in vitro protein-protein interaction experiments have shown that SR33 protein interacts with itself and with SR45 protein but not with two other members (SRZ21 and SRZ22) of the SR family that are known to interact with the Arabidopsis full-length U-70H only. A Clk/Sty protein kinase (AFC-8) from Arabidopsis phosphorylated four SR proteins (SR33, SR45, SRZ21, and SRZ22). Coprecipitation studies have confirmed the interaction of SR proteins with AFC2 kinase, and the interaction between AFC2 and SR33 is modulated by the phosphorylation status of these proteins. These and our previous results suggest that the plant U1-70B: interacts with at least four distinct members of the SR family including SR45 with its two arginine/serine-rich domains, and the interaction between the SR proteins and AFC2 is modulated by phosphorylation. The interaction of plant U1-70K with a novel set of proteins suggests the early stages of spliceosome assembly, and intron recognition in plants is likely to be different from animals.	Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Reddy, ASN (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	reddy@lamar.colostate.edu		Reddy, Anireddy/0000-0002-4038-4091				AYANE M, 1991, NUCLEIC ACIDS RES, V19, P1273, DOI 10.1093/nar/19.6.1273; BENDER J, 1994, P NATL ACAD SCI USA, V91, P12105, DOI 10.1073/pnas.91.25.12105; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; Brown JWS, 1998, ANNU REV PLANT PHYS, V49, P77, DOI 10.1146/annurev.arplant.49.1.77; Brown JWS, 1996, PLANT MOL BIOL, V32, P531, DOI 10.1007/BF00019105; Burge CB, 1999, RNA WORLD, P525; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Cao WH, 1997, RNA, V3, P1456; Cao WH, 1998, J BIOL CHEM, V273, P20629, DOI 10.1074/jbc.273.32.20629; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Domon C, 1998, J BIOL CHEM, V273, P34603, DOI 10.1074/jbc.273.51.34603; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FU XD, 1995, RNA, V1, P663; FU XD, 1992, SCIENCE, V256, P535, DOI 10.1126/science.1373910; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; Gniadkowski M, 1996, NUCLEIC ACIDS RES, V24, P619, DOI 10.1093/nar/24.4.619; Golovkin M, 1996, PLANT CELL, V8, P1421, DOI 10.1105/tpc.8.8.1421; Golovkin M, 1998, PLANT CELL, V10, P1637, DOI 10.1105/tpc.10.10.1637; GOODALL GJ, 1989, CELL, V58, P473, DOI 10.1016/0092-8674(89)90428-5; Goodall GJ, 1991, OXFORD SURVEYS PLANT, V7, P255; GORALSKI TJ, 1989, CELL, V56, P1011, DOI 10.1016/0092-8674(89)90634-X; Graveley BR, 1998, MOL CELL, V1, P765, DOI 10.1016/S1097-2765(00)80076-3; Graveley BR, 1999, CURR BIOL, V9, pR6, DOI 10.1016/S0960-9822(99)80032-3; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; Kanopka A, 1996, NATURE, V381, P535, DOI 10.1038/381535a0; Ko CH, 1998, PLANT MOL BIOL, V36, P573, DOI 10.1023/A:1005932620374; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Kuroyanagi N, 1998, BIOCHEM BIOPH RES CO, V242, P357, DOI 10.1006/bbrc.1997.7913; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; LAZAR G, 1995, P NATL ACAD SCI USA, V92, P7672, DOI 10.1073/pnas.92.17.7672; Lopato S, 1999, PLANT MOL BIOL, V39, P761, DOI 10.1023/A:1006129615846; Lopato S, 1999, GENE DEV, V13, P987, DOI 10.1101/gad.13.8.987; Lopato S, 1996, PLANT CELL, V8, P2255, DOI 10.1105/tpc.8.12.2255; LUEHRSEN KR, 1994, PLANT MOL BIOL, V24, P449, DOI 10.1007/BF00024113; LUEHRSEN KR, 1994, GENE DEV, V8, P1117, DOI 10.1101/gad.8.9.1117; MacMillan AM, 1997, P NATL ACAD SCI USA, V94, P133, DOI 10.1073/pnas.94.1.133; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; Misteli T, 1999, CURR BIOL, V9, pR198, DOI 10.1016/S0960-9822(99)80128-6; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Murray MV, 1999, GENE DEV, V13, P87, DOI 10.1101/gad.13.1.87; PAUTOT V, 1989, GENE, V77, P133, DOI 10.1016/0378-1119(89)90367-3; POPIELARZ M, 1995, J BIOL CHEM, V270, P17830, DOI 10.1074/jbc.270.30.17830; PUIG O, 1998, GENE DEV, V12, P569; RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898; Reddy ASN, 1996, J BIOL CHEM, V271, P7052, DOI 10.1074/jbc.271.12.7052; ROSBASH M, 1991, TRENDS BIOCHEM SCI, V16, P187, DOI 10.1016/0968-0004(91)90073-5; ROSCIGNO RF, 1995, RNA, V1, P692; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneider S, 1996, BIOTECHNIQUES, V20, P960; Schuler MA, 1998, LOOK BEYOND TRANSCRIPTION, P1; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Simpson GG, 1996, PLANT MOL BIOL, V32, P1, DOI 10.1007/BF00039375; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stark JM, 1998, P NATL ACAD SCI USA, V95, P2163, DOI 10.1073/pnas.95.5.2163; Tacke R, 1997, P NATL ACAD SCI USA, V94, P1148, DOI 10.1073/pnas.94.4.1148; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; TARN WY, 1995, P NATL ACAD SCI USA, V92, P2504, DOI 10.1073/pnas.92.7.2504; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; VANSANTEN VL, 1987, GENE, V56, P253, DOI 10.1016/0378-1119(87)90142-9; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yeakley JM, 1999, J CELL BIOL, V145, P447, DOI 10.1083/jcb.145.3.447; ZAHLER AM, 1995, P NATL ACAD SCI USA, V92, P2642, DOI 10.1073/pnas.92.7.2642; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799; Zhang WJ, 1998, MOL CELL BIOL, V18, P676, DOI 10.1128/MCB.18.2.676	82	97	118	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36428	36438		10.1074/jbc.274.51.36428	http://dx.doi.org/10.1074/jbc.274.51.36428			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593939	hybrid			2022-12-27	WOS:000084279200058
J	Khwaja, A; Tatton, L				Khwaja, A; Tatton, L			Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-DEATH INDUCTION; INDUCED APOPTOSIS; TNF-ALPHA; PERMEABILITY TRANSITION; SUPEROXIDE-DISMUTASE; TRANSCRIPTION FACTOR; CD95 FAS/APO-1; ACTIVATION; PROTEIN	Tumor necrosis factor (TNF) alpha initiates the activation of a pro-apoptotic pathway involving the recruitment of the death domain containing protein FADD and the subsequent activation of specific proteases (caspases). Many cells are resistant, however, to the cytotoxic effects of TNF alpha due to the concurrent activation of pro-survival pathways involving the transcription factor NP kappa B and TRAF2. Here we show that the TNF alpha-activated FADD/caspase pathway can also exert an unexpected pro-survival effect. Inhibition of this pathway in NIH3T3 fibroblasts or U937 leukemic cells by peptide caspase inhibitors or expression of dominant-negative FADD leads to rapid death following treatment with TNF alpha, whereas control cells are TNF alpha-resistant. FADD/caspase inhibited cells die by a non-apoptotic mechanism caused by increased production of reactive oxygen species which precedes loss of the mitochondrial membrane potential. Cytotoxicity can be prevented by preincubation with antioxidants including reduced glutathione or by expression of a dominant-negative Rac GTP-binding protein. These results indicate that caspase activation in response to TNF alpha as anti-necrotic as well as pro-apoptotic effects and extend our understanding of the biological role of these proteases.	UCL, Sch Med, Dept Haematol, London WC1E 6HX, England	University of London; University College London; UCL Medical School	Khwaja, A (corresponding author), UCL, Sch Med, Dept Haematol, 98 Chenies Mews, London WC1E 6HX, England.	a.khwaja@ucl.ac.uk	Khwaja, Asim/C-1509-2008					Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Bokoch G M, 1994, Curr Opin Hematol, V1, P53; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Higuchi M, 1998, ONCOGENE, V17, P2515, DOI 10.1038/sj.onc.1202485; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kunstle G, 1997, IMMUNOL LETT, V55, P5, DOI 10.1016/S0165-2478(96)02642-9; Lee SY, 1998, J EXP MED, V188, P1381, DOI 10.1084/jem.188.7.1381; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Nobel CSI, 1997, CHEM RES TOXICOL, V10, P1319, DOI 10.1021/tx970131m; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; RUFF MR, 1981, INFECT IMMUN, V31, P380, DOI 10.1128/IAI.31.1.380-385.1981; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Sidoti-de Fraisse C, 1998, ONCOGENE, V17, P1639, DOI 10.1038/sj.onc.1202094; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; VICIANA PR, 1997, CELL, V89, P457; Wajant H, 1998, CURR BIOL, V8, P113, DOI 10.1016/S0960-9822(98)70042-9; Wallach D, 1997, TRENDS BIOCHEM SCI, V22, P107, DOI 10.1016/S0968-0004(97)01015-3; Wallach D, 1997, FEBS LETT, V410, P96, DOI 10.1016/S0014-5793(97)00553-X; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	46	77	84	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36817	36823		10.1074/jbc.274.51.36817	http://dx.doi.org/10.1074/jbc.274.51.36817			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593992	hybrid			2022-12-27	WOS:000084279200111
J	Mochizuki, Y; Takenawa, T				Mochizuki, Y; Takenawa, T			Novel inositol polyphosphate 5-phosphatase localizes at membrane ruffles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MOLECULAR-CLONING; HUMAN-PLATELETS; PHOSPHOLIPASE-D; DOMAIN; POLYPHOSPHATE-5-PHOSPHATASE; IDENTIFICATION; SYNAPTOJANIN; ACTIVATION	We have cloned a novel inositol polyphosphate 5-phosphatase from the rat brain cDNA library. It contains two highly conserved 5-phosphatase motifs, both of which are essential for its enzymatic activity. Interestingly, the proline content of this protein is high and concentrated in its N- and C-terminal regions. One putative SH3-binding motif and six 14-3-3 zeta-binding motifs were found in the amino acid sequence. This enzyme hydrolyzed phosphate at the D-5 position of inositol 1,4,5-trisphosphate, inositol 1,3,4,5-tetrakisphosphate, and phosphatidylinositoI 4,5-bisphosphate, consistent with the substrate specificity of type II 5-phosphatase, OCRL, synaptojanin and synaptojanin 2, already characterized B-phosphatases. When the Myc-epitope-tagged enzyme was expressed in COS-7 cells and stained with anti-Myc polyclonal antibody, a signal was observed at ruffling membranes and in the cytoplasm. me prepared several deletion mutants and demonstrated that the 123 N-terminal amino acids (311-433) and a C-terminal proline-rich region containing 277 amino acids (725-1001) were essential for its localization to ruffling membranes. This enzyme might regulate the level of inositol and phosphatidylinositoI polyphosphates at membrane ruffles.	Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Takenawa, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1088639, Japan.	takenawa@ims.u-tokyo.ac.jp						Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Auethavekiat V, 1997, J BIOL CHEM, V272, P1786, DOI 10.1074/jbc.272.3.1786; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Campbell JK, 1997, BIOCHEMISTRY-US, V36, P15363, DOI 10.1021/bi9708085; Communi D, 1996, J BIOL CHEM, V271, P11676, DOI 10.1074/jbc.271.20.11676; CONNOLLY TM, 1985, J BIOL CHEM, V260, P7868; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Haffner C, 1997, FEBS LETT, V419, P175, DOI 10.1016/S0014-5793(97)01451-8; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HEJNA JA, 1995, GENOMICS, V29, P285, DOI 10.1006/geno.1995.1247; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Jefferson AB, 1996, BIOCHEMISTRY-US, V35, P7890, DOI 10.1021/bi9602627; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Khvotchev M, 1998, J BIOL CHEM, V273, P2306, DOI 10.1074/jbc.273.4.2306; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Matzaris M, 1998, J BIOL CHEM, V273, P8256, DOI 10.1074/jbc.273.14.8256; MATZARIS M, 1994, J BIOL CHEM, V269, P3397; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Nemoto Y, 1997, J BIOL CHEM, V272, P30817, DOI 10.1074/jbc.272.49.30817; Oh ES, 1998, J BIOL CHEM, V273, P10624, DOI 10.1074/jbc.273.17.10624; Pappan K, 1997, J BIOL CHEM, V272, P7055, DOI 10.1074/jbc.272.11.7055; Pesesse X, 1998, FEBS LETT, V437, P301, DOI 10.1016/S0014-5793(98)01255-1; Pesesse X, 1997, BIOCHEM BIOPH RES CO, V239, P697, DOI 10.1006/bbrc.1997.7538; Randazzo PA, 1997, J BIOL CHEM, V272, P7688; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; ROSS TS, 1991, J BIOL CHEM, V266, P20283; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Seet LF, 1998, BIOCHEM BIOPH RES CO, V247, P116, DOI 10.1006/bbrc.1998.8564; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; VERJANS B, 1994, BIOCHEM J, V300, P85, DOI 10.1042/bj3000085; Vollenweider P, 1999, MOL CELL BIOL, V19, P1081; Wisniewski D, 1999, BLOOD, V93, P2707, DOI 10.1182/blood.V93.8.2707.408k17_2707_2720; Woscholski R, 1998, FEBS LETT, V432, P5, DOI 10.1016/S0014-5793(98)00820-5; Woscholski R, 1997, J BIOL CHEM, V272, P9625; Zhang L, 1998, Methods Mol Biol, V105, P47; Zhang XL, 1998, J BIOL CHEM, V273, P1574, DOI 10.1074/jbc.273.3.1574; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	49	48	52	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36790	36795		10.1074/jbc.274.51.36790	http://dx.doi.org/10.1074/jbc.274.51.36790			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593988	hybrid			2022-12-27	WOS:000084279200107
J	Roje, S; Wang, H; McNeil, SD; Raymond, RK; Appling, DR; Shachar-Hill, Y; Bohnert, HJ; Hanson, AD				Roje, S; Wang, H; McNeil, SD; Raymond, RK; Appling, DR; Shachar-Hill, Y; Bohnert, HJ; Hanson, AD			Isolation, characterization, and functional expression of cDNAs encoding NADH-dependent methylenetetrahydrofolate reductase from higher plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; MOLECULAR-BIOLOGY; PURIFICATION; MITOCHONDRIAL; BIOCHEMISTRY; EXTRACTION; LEAVES; BLOOD; CELLS; LIVER	Methylenetetrahydrofolate reductase (MTHFR) is the least understood enzyme of folate-mediated one-carbon metabolism in plants. Genomics-based approaches were used to identify one maize and two Arabidopsis cDNAs specifying proteins homologous to MTHFRs from other organisms. These cDNAs encode functional MTHFRs, as evidenced by their ability to complement a yeast met12 met13 mutant, and by the presence of MTHFR activity in extracts of complemented yeast cells. Deduced sequence analysis shows that the plant MTHFR polypeptides are of similar size (66 kDa) and domain structure to other eukaryotic MTHFRs, and lack obvious targeting sequences. Southern analyses and genomic evidence indicate that Arabidopsis has two MTHFR genes and that maize has at least two, A carboxyl terminal polyhistidine tag was added to one Arabidopsis MTHFR, and used to purify the enzyme 640-fold to apparent homogeneity, Size exclusion chromatography and denaturing gel electrophoresis of the recombinant enzyme indicate that it exists as a dimer of approximate to 66-kDa subunits, Unlike mammalian MTHFR, the plant enzymes strongly prefer NADH to NADPH, and are not inhibited by S-adenosylmethionine, An NADH-dependent MTHFR reaction could be reversible in plant cytosol, where the NADH/NAD ratio is 10(-3). Consistent with this, leaf tissues metabolized [methyl-C-14]methyltetrahydrofolate to serine, sugars, and starch. A reversible MTHFR reaction would obviate the need for inhibition by S-adenosylmethionine to prevent excessive conversion of methylene- to methyltetrahydrofolate.	Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; Univ Arizona, Dept Biochem, Tucson, AZ 85721 USA; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	State University System of Florida; University of Florida; University of Arizona; University of Texas System; University of Texas Austin; New Mexico State University	Hanson, AD (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.		Bohnert, Hans J/A-7104-2009; Shachar-Hill, Yair/B-6165-2013	Shachar-Hill, Yair/0000-0001-8793-5084; Roje, Sanja/0000-0002-6302-5382	NCRR NIH HHS [RR09276] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR009276] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; ATKINS CA, 1971, CAN J BOTANY, V49, P1225, DOI 10.1139/b71-171; Bagley PJ, 1998, P NATL ACAD SCI USA, V95, P13217, DOI 10.1073/pnas.95.22.13217; BESSON V, 1995, PLANT PHYSIOL BIOCH, V33, P665; BOUDET AM, 1995, NEW PHYTOL, V129, P203, DOI 10.1111/j.1469-8137.1995.tb04292.x; Bourgis F, 1999, PLANT CELL, V11, P1485, DOI 10.1105/tpc.11.8.1485; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen LF, 1997, PLANT PHYSIOL, V115, P299, DOI 10.1104/pp.115.1.299; CLANDININ MT, 1972, BIOCHEM J, V128, P29, DOI 10.1042/bj1280029; Cossins E. A., 1980, The biochemistry of plants. A comprehensive treatise. Volume 2. Metabolism and respiration., P365; Cossins EA, 1997, PHYTOCHEMISTRY, V45, P437, DOI 10.1016/S0031-9422(96)00833-3; COSSINS EA, 1972, PHYTOCHEMISTRY, V11, P2481, DOI 10.1016/S0031-9422(00)88521-0; COSSINS EA, 1987, BIOCH PLANTS, V11, P317, DOI DOI 10.1016/B978-0-12-675411-7.50015-X; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; FEDEC P, 1976, PHYTOCHEMISTRY, V15, P359, DOI 10.1016/S0031-9422(00)86822-3; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; GOYETTE P, 1994, NAT GENET, V7, P196; GREGORY JF, 1984, J NUTR, V114, P341, DOI 10.1093/jn/114.2.341; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; GUSTINCICH S, 1991, BIOTECHNIQUES, V11, P298; HEINEKE D, 1991, PLANT PHYSIOL, V95, P1131, DOI 10.1104/pp.95.4.1131; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; IMESON HC, 1988, J PLANT PHYSIOL, V132, P465, DOI 10.1016/S0176-1617(88)80064-6; JAMES F, 1995, J BIOL CHEM, V270, P22344, DOI 10.1074/jbc.270.38.22344; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; Lassner MW., 1989, PLANT MOL BIOL REP, V7, P116, DOI DOI 10.1007/BF02669627; MATTHEWS RG, 1986, METHOD ENZYMOL, V122, P372; Matthews RG, 1998, EUR J PEDIATR, V157, pS54, DOI 10.1007/PL00014305; Nuccio ML, 1999, CURR OPIN PLANT BIOL, V2, P128, DOI 10.1016/S1369-5266(99)80026-0; OLIVER DJ, 1994, ANNU REV PLANT PHYS, V45, P323, DOI 10.1146/annurev.pp.45.060194.001543; OSTREM JA, 1987, PLANT PHYSIOL, V84, P1271; RAYMOND RK, 1999, IN PRESS ARCH BIOCH, V372; Sambrook J., 2002, MOL CLONING LAB MANU; Sheppard CA, 1999, J BACTERIOL, V181, P718, DOI 10.1128/JB.181.3.718-725.1999; VANONI MA, 1984, BIOCHEMISTRY-US, V23, P5272, DOI 10.1021/bi00317a027; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; WOHLFARTH G, 1991, ARCH MICROBIOL, V155, P378; Zhao WN, 1997, J BIOL CHEM, V272, P21811, DOI 10.1074/jbc.272.35.21811; ZHOU JM, 1990, BIOCHEM MED METAB B, V43, P234, DOI 10.1016/0885-4505(90)90029-Z	41	59	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36089	36096		10.1074/jbc.274.51.36089	http://dx.doi.org/10.1074/jbc.274.51.36089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593891	hybrid			2022-12-27	WOS:000084279200010
J	Whittaker, MM; Kersten, PJ; Cullen, D; Whittaker, JW				Whittaker, MM; Kersten, PJ; Cullen, D; Whittaker, JW			Identification of catalytic residues in glyoxal oxidase by targeted mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; GALACTOSE-OXIDASE; ACTIVE-SITE; PHANEROCHAETE-CHRYSOSPORIUM; APOGALACTOSE OXIDASE; PICHIA-PASTORIS; ENZYME; EXPRESSION; MECHANISM; TYROSINE-495	Glyoxal oxidase is a copper metalloenzyme produced by the wood-rot fungus Phanerochaete chrysosporium as an essential component of its extracellular lignin degradation pathways. Previous spectroscopic studies on glyoxal oxidase have demonstrated that it contains a free radical-coupled copper active site remarkably similar to that found in another fungal metalloenzyme, galactose oxidase. Alignment of primary structures has allowed four catalytic residues of glyoxal oxidase to be targeted for site-directed mutagenesis in the recombinant protein. Three glyoxal oxidase mutants have been heterologously expressed in both a filamentous fungus (Aspergillus nidulans) and in a methylotrophic yeast (Pichia pastoris), the latter expression system producing as much as 2 g of protein per liter of culture medium under conditions of high density methanol-induced fermentation. Biochemical and spectroscopic characterization of the mutant enzymes supports structural correlation ions between galactose oxidase and glyoxal oxidase, clearly identifying the catalytically important residues in glyoxal oxidase and demonstrating the functions of each of these residues.	Oregon Grad Inst Sci & Technol, Dept Biochem & Mol Biol, Portland, OR USA; USDA, Forest Prod Lab, Madison, WI 53705 USA	United States Department of Agriculture (USDA); United States Forest Service	Whittaker, JW (corresponding author), Oregon Grad Inst Sci & Technol, Dept Biochem & Mol Biol, Portland, OR USA.	jim@mb.ogi.edu	Cullen, Daniel/AAN-5484-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046749] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 46749] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARON AJ, 1994, J BIOL CHEM, V269, P25095; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; CULLEN D, 1987, NUCLEIC ACIDS RES, V15, P9163, DOI 10.1093/nar/15.22.9163; Frey PA, 1997, CURR OPIN CHEM BIOL, V1, P347, DOI 10.1016/S1367-5931(97)80072-5; Gerfen GJ, 1996, J PHYS CHEM-US, V100, P16739, DOI 10.1021/jp960709l; Higgins DR, 1998, METH MOL B, V103, P1; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; Itoh S, 1997, INORG CHEM, V36, P1407, DOI 10.1021/ic961144a; KERSTEN PJ, 1995, J BACTERIOL, V177, P6106, DOI 10.1128/jb.177.21.6106-6110.1995; KERSTEN PJ, 1987, J BACTERIOL, V169, P2195, DOI 10.1128/jb.169.5.2195-2201.1987; KERSTEN PJ, 1993, P NATL ACAD SCI USA, V90, P7411, DOI 10.1073/pnas.90.15.7411; Knowles P. F., 1994, PERSPECTIVES BIO INO, V2, P207; KUAN IC, 1993, P NATL ACAD SCI USA, V90, P1242, DOI 10.1073/pnas.90.4.1242; Kurland C, 1996, CURR OPIN BIOTECH, V7, P489, DOI 10.1016/S0958-1669(96)80050-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PARAST CV, 1995, BIOCHEMISTRY-US, V34, P2393, DOI 10.1021/bi00008a001; Reynolds MP, 1997, J BIOL INORG CHEM, V2, P327, DOI 10.1007/s007750050139; Reynolds MP, 1995, BIOCHEM SOC T, V23, pS510, DOI 10.1042/bst023510s; Rogers MS, 1998, INORG CHIM ACTA, V276, P175; Stansfield I, 1998, J MOL BIOL, V282, P13, DOI 10.1006/jmbi.1998.1976; Stratton J, 1998, METH MOL B, V103, P107; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; STUBBE JA, 1989, ANNU REV BIOCHEM, V58, P257; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; VANGERVEN L, 1963, PARAMAGNETIC RESONAN, V2, P905; Whittaker JW, 1998, PURE APPL CHEM, V70, P903, DOI 10.1351/pac199870040903; WHITTAKER JW, 1994, MET IONS BIOL SYST, V30, P315; WHITTAKER JW, 1991, J AM CHEM SOC, V113, P5528, DOI 10.1021/ja00015a003; WHITTAKER MM, 1988, J BIOL CHEM, V263, P6074; WHITTAKER MM, 1993, J AM CHEM SOC, V115, P10029, DOI 10.1021/ja00075a019; WHITTAKER MM, 1993, BIOPHYS J, V64, P762, DOI 10.1016/S0006-3495(93)81437-1; Whittaker MM, 1998, J BIOL CHEM, V273, P22188, DOI 10.1074/jbc.273.35.22188; Whittaker MM, 1996, J BIOL CHEM, V271, P681, DOI 10.1074/jbc.271.2.681; WHITTAKER MM, 1990, J BIOL CHEM, V265, P9610; Whittaker MM, 1998, BIOCHEMISTRY-US, V37, P8426, DOI 10.1021/bi980328t; Zurita D, 1997, J BIOL INORG CHEM, V2, P46, DOI 10.1007/s007750050105	38	90	91	5	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36226	36232		10.1074/jbc.274.51.36226	http://dx.doi.org/10.1074/jbc.274.51.36226			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593910	hybrid			2022-12-27	WOS:000084279200029
J	Yang, PR; Pimental, R; Lai, D; Marcus, S				Yang, PR; Pimental, R; Lai, D; Marcus, S			Direct activation of the fission yeast PAK Shk1 by the novel SH3 domain protein, Skb5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P21-ACTIVATED KINASE PAK1; XENOPUS OOCYTES; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; PHEROMONE RESPONSE; CELL POLARITY; FAMILY; GENE; HOMOLOG; INTERACTS	The pal-activated kinase (PAK) homolog Shk1 is essential for cell viability in the fission yeast Schizosaccharomyces pombe. Roles have been established for Shk1 in the regulation of cell morphology, sexual differentiation, and mitosis in S. pombe. In this report, we describe the genetic and molecular characterization of a novel SH3 domain protein, Skb5, identified as a result of a two-hybrid screen for Shk1 interacting proteins. S. pombe cells carrying a deletion of the skb5 gene exhibit no discernible phenotypic defects under normal growth conditions, but when subjected to hypertonic stress, become spheroidal in shape and growth impaired. Both of these defects can be suppressed by overexpression of the Shk1 modulator, Skb1. The growth inhibition that results from overexpression of Shk1 in S. pombe cells is markedly suppressed by a null mutation in the skb5 gene, suggesting that Skb5 contributes positively to the function of Shk1 in vivo. Consistent with this notion, we show that Skb5 stimulates Shk1 catalytic function in S. pombe cells. Furthermore, and perhaps most significantly, we show that bacterially expressed recombinant Skb5 protein directly stimulates the catalytic activity of recombinant Shk1 kinase in vitro. These and additional data described herein demonstrate that Skb5 is a direct activator of Shk1 in fission yeast.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Marcus, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA.				NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053239] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA16672] Funding Source: Medline; NIGMS NIH HHS [R01GM53239] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; DORAI T, 1990, MOL CELL BIOL, V10, P4068, DOI 10.1128/MCB.10.8.4068; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Faure S, 1997, EMBO J, V16, P5550, DOI 10.1093/emboj/16.18.5550; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Gilbreth M, 1998, P NATL ACAD SCI USA, V95, P14781, DOI 10.1073/pnas.95.25.14781; Gilbreth M, 1996, P NATL ACAD SCI USA, V93, P13802, DOI 10.1073/pnas.93.24.13802; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; MARCUS S, 1995, P NATL ACAD SCI USA, V92, P6180, DOI 10.1073/pnas.92.13.6180; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; OTTILIE S, 1995, EMBO J, V14, P5908, DOI 10.1002/j.1460-2075.1995.tb00278.x; POLVERINO A, 1995, J BIOL CHEM, V270, P26067, DOI 10.1074/jbc.270.44.26067; RAMER SW, 1993, P NATL ACAD SCI USA, V90, P452, DOI 10.1073/pnas.90.2.452; Rose MD., 1990, METHODS YEAST GENETI; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1998, J BIOL CHEM, V273, P18490, DOI 10.1074/jbc.273.29.18490; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; SHIBUYA EK, 1992, P NATL ACAD SCI USA, V89, P9831, DOI 10.1073/pnas.89.20.9831; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Yang PR, 1998, J BIOL CHEM, V273, P18481, DOI 10.1074/jbc.273.29.18481; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	33	22	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36052	36057		10.1074/jbc.274.51.36052	http://dx.doi.org/10.1074/jbc.274.51.36052			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593886	hybrid			2022-12-27	WOS:000084279200005
J	Abid, MR; Li, Y; Anthony, C; De Benedetti, A				Abid, MR; Li, Y; Anthony, C; De Benedetti, A			Translational regulation of ribonucleotide reductase by eukaryotic initiation factor 4E links protein synthesis to the control of DNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-BINDING PROTEIN; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; SMALL-SUBUNIT; MALIGNANT TRANSFORMATION; R2 COMPONENT; CELL-GROWTH; EXPRESSION; YEAST; IDENTIFICATION	Ribonucleotide reductase synthesizes dNDPs, a specific and limiting step in DNA synthesis, and can participate in neoplastic transformation when overexpressed, The small subunit (ribonucleotide reductase 2 (RNR2)) was cloned as a major product in a subtraction library from eukaryotic initiation factor 4E (eIF4E)-transformed cells (Chinese hamster ovary-4E (CHO-4E)), CHO-4E cells have 20-40-fold elevated RNR2 protein, reflecting an increased distribution of RNR2 mRNA to the heavy polysomes, CHO-4E cells display an altered cell cycle with shortened S phase, similar to cells selected for RNR2 overexpression with hydroxyurea, The function of ribonucleotide reductase as a checkpoint component of S progression was studied in yeast in which elevated eIF4E rescued S-arrested rnr2-68(ts) cells, by increasing recruitment of its mRNA to polysomes, Crosses between rnr2-68(ts) and mutant eIF4E (cdc33-1(ts)) engendered conditional synthetic lethality, with extreme sensitivity to hydroxyurea and the microtubule depolymerizing agent, benomyl. The double mutant (cdc33-1 rnr2-68) also identified a unique terminal phenotype, arrested with small bud and a randomly distributed single nucleus, which is distinct from those of both parental single mutants. This phenotype defines eIF4E and RNR2 as determinants in an important cell cycle checkpoint, in early/mid-S phase. These results also provide a link between protein and DNA synthesis and provide an explanation for cell cycle alterations induced by elevated eIF4E.	Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	De Benedetti, A (corresponding author), Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	adeben@lsumc.edu		de benedetti, arrigo/0000-0002-4198-8647	NATIONAL CANCER INSTITUTE [R29CA069148] Funding Source: NIH RePORTER; NCI NIH HHS [CA69148] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS A, 1997, METHODS YEAST GENETI, P193; ALI MA, 1991, P NATL ACAD SCI USA, V88, P8257, DOI 10.1073/pnas.88.18.8257; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; ALTMANN M, 1987, MOL CELL BIOL, V7, P998, DOI 10.1128/MCB.7.3.998; AMARA FM, 1995, NUCLEIC ACIDS RES, V23, P1461, DOI 10.1093/nar/23.9.1461; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; BRENNER C, 1988, MOL CELL BIOL, V8, P3556, DOI 10.1128/MCB.8.8.3556; CHAUDHURI MM, 1992, BIOCHIM BIOPHYS ACTA, V1171, P117, DOI 10.1016/0167-4781(92)90151-O; De Benedetti A, 1999, INT J BIOCHEM CELL B, V31, P59, DOI 10.1016/S1357-2725(98)00132-0; De Benedetti Arrigo, 1994, Molecular and Cellular Differentiation, V2, P347; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; DEBENEDETTI A, 1991, MOL CELL BIOL, V11, P5435, DOI 10.1128/MCB.11.11.5435; DeFatta RJ, 1999, INT J CANCER, V80, P516, DOI 10.1002/(SICI)1097-0215(19990209)80:4<516::AID-IJC6>3.3.CO;2-Z; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; ERIKSSON S, 1984, ADV EXP MED BIOL, V165, P407; Fan HZ, 1998, CANCER RES, V58, P1650; Fan HZ, 1996, P NATL ACAD SCI USA, V93, P14036, DOI 10.1073/pnas.93.24.14036; GEBALLE AP, 1994, TRENDS BIOCHEM SCI, V19, P159, DOI 10.1016/0968-0004(94)90277-1; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Graff JR, 1997, BIOCHEM BIOPH RES CO, V240, P15, DOI 10.1006/bbrc.1997.7592; Huang AP, 1997, CANCER RES, V57, P4876; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; JENSEN RA, 1994, P NATL ACAD SCI USA, V91, P9257, DOI 10.1073/pnas.91.20.9257; KEREKATTE V, 1995, INT J CANCER, V64, P27, DOI 10.1002/ijc.2910640107; Kevil CG, 1996, INT J CANCER, V65, P785, DOI 10.1002/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kulsh J, 1997, MED HYPOTHESES, V49, P297, DOI 10.1016/S0306-9877(97)90193-6; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; MOORE SA, 1988, J BIOL CHEM, V263, P9674; MORLEY SJ, 1994, MOL BIOL REP, V19, P221, DOI 10.1007/BF00986964; Nathan CAO, 1997, ONCOGENE, V15, P579, DOI 10.1038/sj.onc.1201216; PELLETIER J, 1987, BIOCHEM CELL BIOL, V65, P576, DOI 10.1139/o87-074; RAUE HA, 1991, METHOD ENZYMOL, V194, P453; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; Rhoads RE, 1991, CURR OPIN CELL BIOL, V3, P1019, DOI 10.1016/0955-0674(91)90123-G; ROZELL B, 1986, J ORAL PATHOL MED, V15, P261, DOI 10.1111/j.1600-0714.1986.tb00619.x; Ruan HJ, 1996, J BIOL CHEM, V271, P29576, DOI 10.1074/jbc.271.47.29576; SARABIA MJF, 1993, MOL GEN GENET, V238, P241, DOI 10.1007/BF00279553; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; SORELLS DL, 1998, HEAD NECK-J SCI SPEC, V21, P60; STANDART N, 1986, J CELL BIOL, V103, P2129, DOI 10.1083/jcb.103.6.2129; THELANDER L, 1986, MOL CELL BIOL, V6, P3433, DOI 10.1128/MCB.6.10.3433; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; YEN TJ, 1988, MOL CELL BIOL, V8, P1224, DOI 10.1128/MCB.8.3.1224; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; ZHOU BS, 1995, CANCER RES, V55, P1328	54	39	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35991	35998		10.1074/jbc.274.50.35991	http://dx.doi.org/10.1074/jbc.274.50.35991			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585489	hybrid			2022-12-27	WOS:000084187900101
J	Kusnetsov, V; Landsberger, M; Meurer, J; Oelmuller, R				Kusnetsov, V; Landsberger, M; Meurer, J; Oelmuller, R			The assembly of the CAAT-box binding complex at a photosynthesis gene promoter is regulated by light, cytokinin, and the stage of the plastids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; FACTOR CBF/NF-Y; NF-Y; DNA-BINDING; IN-VIVO; TRANSCRIPTION FACTOR; NUCLEAR GENES; EXPRESSION; PROTEINS; ELEMENTS	A functionally important region in the promoter of the spinach photosynthesis gene AtpC, which encodes the subunit gamma of the chloroplast ATP synthase, is located immediately upstream of the CAAT-box, A single nucleotide exchange in this region (AAATTCAAT --> AAGATCAAT) uncouples the expression of an AtpC promoter::uidA gene fusion from the regulation by light, cytokinin, and functional plastids and results in a high constitutive expression of the reporter gene. By screening an Arabidopsis thaliana expression library with a double-stranded wild-type oligonucleotide from this promoter region, we have isolated cDNAs from Arabidopsis libraries that code for plant homologs of the CAAT-box binding factor (CBF)-C, Binding occurs only in the presence of nuclear extracts, consistent with reports from metazoa CBFs that the subunits A and B in addition to C are required for the formation of the CBF-DNA complex. At least eight genes with homologies to CBF-C are present in the Arabidopsis genome; one of them exhibits striking similarities to the gene for the human global transcriptional repressor Drap1, In gel mobility shift assays, low binding activity of CBF to the wild-type AtpC promoter sequence was observed with nuclear extracts from tissue with low AtpC expression levels, i.e. extracts from etiolated and photobleached seedlings, whereas high binding activity was detectable with extracts from tissues with high AtpC expression levels, i.e. extracts from light-grown seedlings and etiolated seedlings treated with cytokinin, Binding to the mutant sequence, which directs constitutive high level uidA expression in vivo, is significantly stronger than to the wild-type sequence. The data are consistent with the idea that the assembly of CBF at the AtpC promoter is regulated in response to light and cytokinin and that the low level of expression in etiolated and photobleached material is caused by an inhibitory effect. The structure/function relationships of the Arabidopsis CBFs are discussed in relation to their regulatory function in AtpC gene expression.	Univ Jena, Inst Allgemeine Bot, Lehrstuhl Pflanzenphysiol, D-07743 Jena, Germany; Russian Acad Sci, Inst Plant Physiol, Moscow 127276, Russia	Friedrich Schiller University of Jena; Russian Academy of Sciences; Timiryazev Institute of Plant Physiology	Oelmuller, R (corresponding author), Univ Jena, Inst Allgemeine Bot, Lehrstuhl Pflanzenphysiol, Dornburger Str 159, D-07743 Jena, Germany.	Ralf.Oelmueller@rz.uni-jena.de	Meurer, Jörg/F-8479-2010; Kusnetsov, Victor/P-9774-2016	Meurer, Jörg/0000-0003-2973-9514; Kusnetsov, Victor/0000-0003-4979-6137				ARCOT SS, 1989, J BIOL CHEM, V264, P2343; Bi WM, 1997, J BIOL CHEM, V272, P26562, DOI 10.1074/jbc.272.42.26562; BOLLE C, 1994, PLANT PHYSIOL, V105, P1355, DOI 10.1104/pp.105.4.1355; Bolle C, 1996, PLANT J, V9, P21, DOI 10.1046/j.1365-313X.1996.09010021.x; BROWN AM, 1993, J BIOL CHEM, V268, P26328; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; CLAUSMEYER S, 1993, J BIOL CHEM, V268, P13869; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; FILATOV D, 1995, J BIOL CHEM, V270, P25239, DOI 10.1074/jbc.270.42.25239; FRAMSON P, 1993, J BIOL CHEM, V268, P4989; GOLDSMITH ME, 1993, J BIOL CHEM, V268, P5856; GUSTAFSON TA, 1989, P NATL ACAD SCI USA, V86, P2162, DOI 10.1073/pnas.86.7.2162; Hasegawa T, 1996, NUCLEIC ACIDS RES, V24, P3253, DOI 10.1093/nar/24.16.3253; HATAMOCHI A, 1988, J BIOL CHEM, V263, P5940; Herrmann R. G., 1991, Plant molecular biology 2. Proceedings of a NATO Advanced Study Institute, 14-23 May 1990, Elmau, Germany., P411; HSIAO KM, 1994, GENE DEV, V8, P1526, DOI 10.1101/gad.8.13.1526; Hung HL, 1996, J BIOL CHEM, V271, P2323, DOI 10.1074/jbc.271.4.2323; Isaacs RJ, 1996, J BIOL CHEM, V271, P16741, DOI 10.1074/jbc.271.28.16741; JACKSON SM, 1995, J BIOL CHEM, V270, P21445, DOI 10.1074/jbc.270.37.21445; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; Kusnetsov V, 1996, MOL GEN GENET, V252, P631, DOI 10.1007/BF02173968; KUSNETSOV VV, 1994, PLANTA, V194, P318, DOI 10.1007/BF00197531; LIWEBER M, 1994, J IMMUNOL, V153, P4122; LUBBERSTEDT T, 1994, MOL GEN GENET, V242, P602, DOI 10.1007/BF00285284; MAIRE P, 1989, SCIENCE, V244, P343, DOI 10.1126/science.2711183; MAITY SN, 1988, SCIENCE, V241, P582, DOI 10.1126/science.3399893; Maity SN, 1996, METHOD ENZYMOL, V273, P217; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; OELMULLER R, 1995, MOL GEN GENET, V246, P478, DOI 10.1007/BF00290451; OELMULLER R, 1993, MOL GEN GENET, V237, P261, DOI 10.1007/BF00282808; Roy B, 1996, J BIOL CHEM, V271, P28995, DOI 10.1074/jbc.271.46.28995; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Tezuka KI, 1996, J BIOL CHEM, V271, P22713, DOI 10.1074/jbc.271.37.22713; WRIGHT KL, 1994, EMBO J, V13, P4042, DOI 10.1002/j.1460-2075.1994.tb06721.x; Yeung K, 1997, MOL CELL BIOL, V17, P36, DOI 10.1128/MCB.17.1.36; Zwicker J, 1997, TRENDS GENET, V13, P3, DOI 10.1016/S0168-9525(96)30112-1	40	79	91	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					36009	36014		10.1074/jbc.274.50.36009	http://dx.doi.org/10.1074/jbc.274.50.36009			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585491	hybrid			2022-12-27	WOS:000084187900103
J	Tanner, KG; Kyte, J				Tanner, KG; Kyte, J			Dimerization of the extracellular domain of the receptor for epidermal growth factor containing the membrane-spanning segment in response to treatment with epidermal growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEU ONCOGENE; POINT MUTATION; BINDING-DOMAIN; MIXED MICELLES; EGF RECEPTOR; ACTIVATION; AFFINITY; SPHINGOMYELIN; EXPRESSION; PROTEINS	A recombinant fragment of the human receptor for epidermal growth factor containing both its extracellular domain and its membrane-spanning segment, when dissolved with Triton X-100, was observed to dimerize in response to addition of epidermal growth factor (EGF) even at the lowest concentration of this fragment that could be assayed (4 nM). Consequently, the dissociation constant for the dimer of this fragment is at least 10,000-fold smaller than that for dimers of soluble, recombinant forms of the extracellular domain lacking the membrane-spanning segment. The second-order rate constant for dimerization of the fragment containing the extracellular domain and the membrane-spanning segment was estimated to be greater than 0.3 nM(-1) min(-1), more than 10-fold that of the native enzyme under the same conditions. This result suggests that the cytoplasmic domain of the intact enzyme sterically hinders its dimerization. When EGF is removed from the dimer of the fragment, the rate constant for its dissociation is greater than 0.2 min(-1), more than 40-fold that of the native enzyme. This result suggests that interfaces between cytoplasmic domains of intact EGF receptor impart significant stabilization to the dimer of the enzyme.	Univ Calif San Diego, Dept Chem 0506, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kyte, J (corresponding author), Univ Calif San Diego, Dept Chem 0506, 9500 Gilman Dr, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047968] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-07233] Funding Source: Medline; NIGMS NIH HHS [GM-47968] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BROWN PM, 1994, EUR J BIOCHEM, V225, P223, DOI 10.1111/j.1432-1033.1994.00223.x; CADENA DL, 1993, PROTEIN EXPRES PURIF, V4, P177, DOI 10.1006/prep.1993.1024; CANALS F, 1992, BIOCHEMISTRY-US, V31, P4493, DOI 10.1021/bi00133a016; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Cohen BM, 1996, J BIOL CHEM, V271, P4813; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; GUNTHER N, 1990, J BIOL CHEM, V265, P22082; HURWITZ DR, 1991, J BIOL CHEM, V266, P22035; KUSHNER LM, 1954, J PHYS CHEM-US, V58, P1163, DOI 10.1021/j150522a024; KYTE J, 1995, STRUCTURE PROTEIN CH, P521; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAX I, 1991, J BIOL CHEM, V266, P13828; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Philo JS, 1996, BIOCHEMISTRY-US, V35, P1681, DOI 10.1021/bi9524272; ROBSON RJ, 1979, BIOCHIM BIOPHYS ACTA, V573, P489, DOI 10.1016/0005-2760(79)90223-6; Sherrill JM, 1996, BIOCHEMISTRY-US, V35, P5705, DOI 10.1021/bi9602268; Siegel PM, 1996, P NATL ACAD SCI USA, V93, P8878, DOI 10.1073/pnas.93.17.8878; Tanford C, 1980, HYDROPHOBIC EFFECT, P42; Tanner KG, 1997, BIOCHEMISTRY-US, V36, P14889, DOI 10.1021/bi9706834; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WEDEGAERTNER PB, 1989, J BIOL CHEM, V264, P11346; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YEDGAR S, 1974, BIOCHIM BIOPHYS ACTA, V363, P98, DOI 10.1016/0005-2736(74)90009-1	27	65	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35985	35990		10.1074/jbc.274.50.35985	http://dx.doi.org/10.1074/jbc.274.50.35985			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585488	hybrid			2022-12-27	WOS:000084187900100
J	Blaeser, F; Ho, N; Prywes, R; Chatila, TA				Blaeser, F; Ho, N; Prywes, R; Chatila, TA			Ca2+-dependent gene expression mediated by MEF2 transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE TYPE-IV/GR; CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; ORPHAN STEROID-RECEPTOR; C-JUN PROMOTER; CYCLOSPORINE-A; T-LYMPHOCYTES; MADS BOX; MYOGENIC LINEAGE; INDUCIBLE MEMBER; THYROID-HORMONE	Ca2+ induction of a subset of cellular and viral immediate-early activation genes in lymphocytes has been previously mapped to response elements recognized by the MEF2 family of transcription factors. Here, we demonstrate that Ca2+ activation of MEF2 response elements in T lymphocytes is mediated in synergy by two Ca2+/calmodulin-dependent enzymes, the phosphatase calcineurin, and the kinase type IV/Gr (CaMKIV/Gr), which promote transcription by the MEF2 family members MEF2A and MEF2D. Calcineurin up-regulates the activity of both factors by an NFAT-dependent mechanism, while CaMKIV/Gr selectively and independently activates MEF2D. These results identify MEF2 proteins as effecters of a pathway of gene induction in T lymphocytes which integrates diverse Ca2+ activation signals and may be broadly operative in several tissues.	Washington Univ, Sch Med, Dept Pediat, Div Immunol Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Columbia University	Chatila, TA (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Immunol Rheumatol, 1 Childrens Pl, St Louis, MO 63110 USA.			Chatila, Talal/0000-0001-7439-2762				Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Black BL, 1996, J BIOL CHEM, V271, P26659, DOI 10.1074/jbc.271.43.26659; Borras AM, 1996, J VIROL, V70, P3894, DOI 10.1128/JVI.70.6.3894-3901.1996; BREITBART RE, 1993, DEVELOPMENT, V118, P1095; CALNAN BJ, 1995, IMMUNITY, V3, P273; Chatila T, 1997, J VIROL, V71, P6560, DOI 10.1128/JVI.71.9.6560-6567.1997; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Coso OA, 1997, J BIOL CHEM, V272, P20691, DOI 10.1074/jbc.272.33.20691; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Cron RQ, 1999, J IMMUNOL, V162, P860; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; ENSLEN H, 1994, J BIOL CHEM, V269, P20872; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GOLDFELD AE, 1995, VIROLOGY, V209, P225, DOI 10.1006/viro.1995.1247; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HAN TH, 1995, MOL CELL BIOL, V15, P2907; HANISSIAN SH, 1993, J BIOL CHEM, V268, P20055; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HAZEL TG, 1991, MOL CELL BIOL, V11, P3229; Ho N, 1996, J EXP MED, V184, P101, DOI 10.1084/jem.184.1.101; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; KAUSHAL S, 1994, SCIENCE, V266, P1236, DOI 10.1126/science.7973707; KINCAID RL, 1990, J BIOL CHEM, V265, P11312; LEIFER D, 1993, P NATL ACAD SCI USA, V90, P1546, DOI 10.1073/pnas.90.4.1546; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; Mao ZX, 1996, J BIOL CHEM, V271, P14371, DOI 10.1074/jbc.271.24.14371; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; MARTIN JF, 1993, P NATL ACAD SCI USA, V90, P5282, DOI 10.1073/pnas.90.11.5282; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NGHIEM P, 1993, J BIOL CHEM, V268, P5471; NGHIEM P, 1994, NATURE, V371, P347, DOI 10.1038/371347a0; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WATSON MA, 1989, MOL CELL BIOL, V9, P4213, DOI 10.1128/MCB.9.10.4213; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879	56	167	174	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					197	209		10.1074/jbc.275.1.197	http://dx.doi.org/10.1074/jbc.275.1.197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617605	hybrid			2022-12-27	WOS:000085951600029
J	Melloni, E; Averna, M; Salamino, F; Sparatore, B; Minafra, R; Pontremoli, S				Melloni, E; Averna, M; Salamino, F; Sparatore, B; Minafra, R; Pontremoli, S			Acyl-CoA-binding protein is a potent m-calpain activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROCYTE CALPAIN; CELL-DIFFERENTIATION; SKELETAL-MUSCLE; IDENTIFICATION; MEMBRANE; SYSTEM; RAT; LOCALIZATION; NEUTROPHILS; SENSITIVITY	Acyl-CoA-binding protein, a 20-kDa homodimer that exerts many physiological functions, promotes activation of the classic calpain forms, most markedly that of the m-isozyme, This protein factor was purified from rat skeletal muscle and was also expressed in Escherichia coli. Both native and recombinant acyl-CoA-binding proteins show the same molecular properties and an identical capacity to decrease the [Ca2+] required for m-calpain activity. The binding of long chain acyl-CoAs to acyl-CoA-binding protein does not modify the activating effect on calpains. Acyl-CoA-binding protein seems to be involved in the m-calpain regulation process, whereas the previously identified UK114 activator is a specific modulator of m-calpain. Acyl-CoA-binding protein is proposed as a new component of the Ca2+-dependent proteolytic system. A comparative analysis among levels of classic calpains and their activator proteins is also reported.	Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy	University of Genoa	Melloni, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Viale Benedetto XV 1, I-16132 Genoa, Italy.	melloni@csita.unige.it	AVERNA, MONICA/R-5719-2019	AVERNA, MONICA/0000-0002-9463-7533				CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Davies EV, 1998, BIOCHEM BIOPH RES CO, V248, P679, DOI 10.1006/bbrc.1998.9031; Dutt P, 1998, FEBS LETT, V436, P367, DOI 10.1016/S0014-5793(98)01167-3; Frolov A, 1998, J BIOL CHEM, V273, P11049, DOI 10.1074/jbc.273.18.11049; Fulceri R, 1997, BIOCHEM J, V325, P423, DOI 10.1042/bj3250423; FYRST H, 1995, BIOCHEM J, V306, P793, DOI 10.1042/bj3060793; GERSUK VH, 1995, GENOMICS, V25, P469, DOI 10.1016/0888-7543(95)80047-P; GLATZ JFC, 1995, PROSTAG LEUKOTR ESS, V52, P121, DOI 10.1016/0952-3278(95)90010-1; Goll DE, 1990, INTRACELLULAR CALCIU, P3; Gossett RE, 1998, ARCH BIOCHEM BIOPHYS, V350, P201, DOI 10.1006/abbi.1997.0521; Han YQ, 1999, J BIOL CHEM, V274, P787, DOI 10.1074/jbc.274.2.787; MELLONI E, 1988, P NATL ACAD SCI USA, V85, P3835, DOI 10.1073/pnas.85.11.3835; Melloni E, 1998, BIOCHEM BIOPH RES CO, V249, P583, DOI 10.1006/bbrc.1998.9200; Melloni E, 1998, J BIOL CHEM, V273, P12827, DOI 10.1074/jbc.273.21.12827; Michetti M, 1997, BIOCHEM J, V325, P721, DOI 10.1042/bj3250721; Michetti M, 1996, FEBS LETT, V392, P11, DOI 10.1016/0014-5793(96)00775-2; MOCCHETTI I, 1986, P NATL ACAD SCI USA, V83, P7221, DOI 10.1073/pnas.83.19.7221; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; OHTA Y, 1976, P NATL ACAD SCI USA, V73, P1232, DOI 10.1073/pnas.73.4.1232; PONTREMOLI S, 1991, ARCH BIOCHEM BIOPHYS, V288, P646, DOI 10.1016/0003-9861(91)90247-G; PONTREMOLI S, 1990, J BIOL CHEM, V265, P706; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO K, 1995, EUR J BIOCHEM, V230, P25, DOI 10.1111/j.1432-1033.1995.0025i.x; Sparatore B, 1996, FEBS LETT, V386, P95, DOI 10.1016/0014-5793(96)00418-8; Swinnen JV, 1998, J BIOL CHEM, V273, P19938, DOI 10.1074/jbc.273.32.19938; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6	28	57	62	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					82	86		10.1074/jbc.275.1.82	http://dx.doi.org/10.1074/jbc.275.1.82			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617589	hybrid			2022-12-27	WOS:000085951600013
J	Eguchi, S; Iwasaki, H; Ueno, H; Frank, GD; Motley, ED; Eguchi, K; Marumo, F; Hirata, Y; Inagami, T				Eguchi, S; Iwasaki, H; Ueno, H; Frank, GD; Motley, ED; Eguchi, K; Marumo, F; Hirata, Y; Inagami, T			Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells - Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BETA-GAMMA-SUBUNITS; PHOSPHATIDYLINOSITOL 3-KINASE; COUPLED RECEPTORS; TYROSINE KINASE; IN-VIVO; PHOSPHOINOSITIDE 3-KINASE; CARDIAC-HYPERTROPHY; EGF RECEPTOR; PATHWAYS	Activation of p70 S6 kinase (p70(S6K)) by growth factors requires multiple signal inputs involving phosphoinositide 3-kinase (PI3K), its effector Akt, and an unidentified kinase that phosphorylates Ser/Thr residues (Ser(411), Ser(418), Ser(424), and Thr(421)) clustered at its autoinhibitory domain. However, the mechanism by which G protein-coupled receptors activate p70(S6K) remains largely uncertain, By using vascular smooth muscle cells in which we have demonstrated Ras/extracellular signal-regulated kinase (ERK) activation through Ca2+- dependent, epidermal growth factor (EGF) receptor transactivation by G(q)-coupled angiotensin II (Ang II) receptor, we present a unique cross-talk required for Ser(411) phosphorylation of p70(S6K) by Ang II. Both p70(S6K) Ser(411) and Akt Ser(473) phosphorylation by Ang II appear to involve EGF receptor transactivation and were inhibited by dominant-negative Ras, whereas the phosphorylation of p70(S6K) and ERK but not Akt was sensitive to the MEK inhibitor. By contrast, the phosphorylation of p70(S6K) and Akt but not ERK was sensitive to PI3K inhibitors. Similar inhibitory pattern on these phosphorylation sites by EGF but not insulin was observed. Taken together with the inhibition of Ang II-induced p70(S6K) activation by dominant-negative Ras and the MEK inhibitor, we conclude that Ang II-initiated activation of p70(S6K) requires both ERK cascade and PI3K/Akt cascade that bifurcate at the point of EGF receptor-dependent Ras activation.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Tokyo Med & Dent Univ, Dept Internal Med 2, Tokyo 1138519, Japan; Kyushu Univ, Sch Med, Dept Cardiol, Fukuoka 8128582, Japan; Meharry Med Coll, Dept Anat & Physiol, Nashville, TN 37208 USA	Vanderbilt University; Tokyo Medical & Dental University (TMDU); Kyushu University; Meharry Medical College	Eguchi, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.				NHLBI NIH HHS [HL03220, HL-58205, HL-35323] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058205, R01HL058205, R01HL035323, K08HL003220] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akimoto K, 1998, BIOCHEM J, V335, P417, DOI 10.1042/bj3350417; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; Berk BC, 1999, J AM SOC NEPHROL, V10, pS62; Bokemeyer D, 1998, HYPERTENSION, V32, P661, DOI 10.1161/01.HYP.32.4.661; Brinson AE, 1998, J BIOL CHEM, V273, P1711, DOI 10.1074/jbc.273.3.1711; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Conus NM, 1998, J BIOL CHEM, V273, P4776, DOI 10.1074/jbc.273.8.4776; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; EGUCHI S, 1994, ENDOCRINOLOGY, V134, P222, DOI 10.1210/en.134.1.222; Eguchi S, 1999, HYPERTENSION, V33, P201, DOI 10.1161/01.HYP.33.1.201; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Eguchi S, 1996, J BIOL CHEM, V271, P14169, DOI 10.1074/jbc.271.24.14169; Eguchi S, 1999, EUR J PHARMACOL, V376, P203, DOI 10.1016/S0014-2999(99)00357-X; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GIASSON E, 1995, J BIOL CHEM, V270, P5225, DOI 10.1074/jbc.270.10.5225; Graves LM, 1997, J BIOL CHEM, V272, P1920, DOI 10.1074/jbc.272.3.1920; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Inagami T, 1999, J AM SOC NEPHROL, V10, pS57; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Koyama H, 1998, CIRC RES, V82, P713, DOI 10.1161/01.RES.82.6.713; Laser M, 1998, J BIOL CHEM, V273, P24610, DOI 10.1074/jbc.273.38.24610; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; PETRITSCH C, 1995, EUR J BIOCHEM, V230, P431, DOI 10.1111/j.1432-1033.1995.0431h.x; Polakiewicz RD, 1998, J BIOL CHEM, V273, P23534, DOI 10.1074/jbc.273.36.23534; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; RODRIGUEZ VP, 1994, NATURE, V370, P527; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; Sabri A, 1998, CIRC RES, V83, P841, DOI 10.1161/01.RES.83.8.841; SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040; SAKAUE M, 1995, MOL CELL BIOL, V15, P379, DOI 10.1128/MCB.15.1.379; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; Saward L, 1997, CIRC RES, V81, P249, DOI 10.1161/01.RES.81.2.249; Schmitz U, 1998, CIRC RES, V82, P1272, DOI 10.1161/01.RES.82.12.1272; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Scott PH, 1997, FEBS LETT, V409, P171, DOI 10.1016/S0014-5793(97)00500-0; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Takahashi T, 1999, AM J PHYSIOL-HEART C, V276, pH1927, DOI 10.1152/ajpheart.1999.276.6.H1927; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Ueno H, 1997, ARTERIOSCL THROM VAS, V17, P898, DOI 10.1161/01.ATV.17.5.898; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Wilson M, 1996, J BIOL CHEM, V271, P8537, DOI 10.1074/jbc.271.15.8537; Yamakawa T, 1998, HYPERTENSION, V31, P248, DOI 10.1161/01.HYP.31.1.248; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Zwick E, 1997, J BIOL CHEM, V272, P24767, DOI 10.1074/jbc.272.40.24767	85	154	159	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36843	36851		10.1074/jbc.274.52.36843	http://dx.doi.org/10.1074/jbc.274.52.36843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601235	hybrid			2022-12-27	WOS:000084382700006
J	Kanaani, J; Lissin, D; Kash, SF; Baekkeskov, S				Kanaani, J; Lissin, D; Kash, SF; Baekkeskov, S			The hydrophilic isoform of glutamate decarboxylase, GAD67, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane-anchored isoform, GAD65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC-ACID; PANCREATIC BETA-CELLS; 67-KDA ISOFORM; 65-KDA ISOFORM; GOLGI-COMPLEX; CLEFT-PALATE; BINDING-SITE; 2 FORMS; RAT; BRAIN	GAD67, the larger isoform of the gamma-aminobutyric acid-synthesizing enzyme glutamic acid decarboxylase, is a hydrophilic soluble molecule, postulated to localize at nerve terminals and membrane compartments by heterodimerization with the smaller membrane-anchored isoform GAD65. We here show that the dimerization region in GAD65 is distinct from the NH2-terminal membrane-anchoring region and that a membrane anchoring GAD65 subunit can indeed target a soluble subunit to membrane compartments by dimerization. However, only a fraction of membrane-bound GAD67 is engaged in a heterodimer with GAD65 in rat brain. Furthermore, in GAD65-/- mouse brain, GAD67, which no longer partitions into the Triton X-114 detergent phase, still anchors to membranes at similar levels as in wild-type mice. Similarly, in primary cultures of neurons derived from GAD65-/- mice, GAD67 is targeted to nerve terminals, where it co-localizes with the synaptic vesicle marker SV2, Thus, axonal targeting and membrane anchoring is an intrinsic property of GAD67 and does not require GAD65. The results suggest that three distinct moieties of glutamate decarboxylase localize to membrane compartments, an amphiphilic GAD65 homodimer, an amphiphilic GAD65/67 heterodimer, tethered to membranes via the GAD65 subunit, and a hydrophilic GAD67 homodimer, which associates with membranes by a distinct mechanism.	Univ Calif San Francisco, Hormone Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Baekkeskov, S (corresponding author), Univ Calif San Francisco, Hormone Res Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.			Baekkeskov, Steinunn/0000-0003-0878-3188	NIDDK NIH HHS [DK41822, DK47043] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041822] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; CHANG YC, 1988, J NEUROSCI, V8, P2123; CHRISTGAU S, 1991, J BIOL CHEM, V266, P21257; CHRISTGAU S, 1992, J CELL BIOL, V118, P309, DOI 10.1083/jcb.118.2.309; Condie BG, 1997, P NATL ACAD SCI USA, V94, P11451, DOI 10.1073/pnas.94.21.11451; DIRKX R, 1995, J BIOL CHEM, V270, P2241, DOI 10.1074/jbc.270.5.2241; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; ITOH M, 1981, NEUROCHEM RES, V6, P1283, DOI 10.1007/BF00964349; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; LEGAY F, 1987, J NEUROCHEM, V48, P1022, DOI 10.1111/j.1471-4159.1987.tb05620.x; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; MARTIN DL, 1991, J NEUROSCI, V11, P2725; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; MICHALIK M, 1993, DIABETES, V42, P1506, DOI 10.2337/diabetes.42.10.1506; MILLER LP, 1980, BRAIN RES BULL, V5, P89, DOI 10.1016/0361-9230(80)90014-3; Namchuk M, 1997, J BIOL CHEM, V272, P1548, DOI 10.1074/jbc.272.3.1548; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Qu KB, 1998, PROTEIN SCI, V7, P1092, DOI 10.1002/pro.5560070503; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; RICHTER W, 1993, P NATL ACAD SCI USA, V90, P2832, DOI 10.1073/pnas.90.7.2832; Schwartz HL, 1999, J MOL BIOL, V287, P983, DOI 10.1006/jmbi.1999.2655; Sheikh SN, 1996, J NEUROCHEM, V66, P2082; SHI YG, 1994, J CELL BIOL, V124, P927, DOI 10.1083/jcb.124.6.927; Sloviter RS, 1996, J COMP NEUROL, V373, P593; SOLIMENA M, 1993, P NATL ACAD SCI USA, V90, P3073, DOI 10.1073/pnas.90.7.3073; SOLIMENA M, 1994, J CELL BIOL, V126, P331, DOI 10.1083/jcb.126.2.331; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Sukhareva B S, 1994, Mol Biol (Mosk), V28, P1407; Zekzer D, 1998, J CLIN INVEST, V101, P68, DOI 10.1172/JCI119878	41	54	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37200	37209		10.1074/jbc.274.52.37200	http://dx.doi.org/10.1074/jbc.274.52.37200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601283	hybrid			2022-12-27	WOS:000084382700054
J	Silakowski, B; Schairer, HU; Ehret, H; Kunze, B; Weinig, S; Nordsiek, G; Brandt, P; Blocker, H; Hofle, G; Beyer, S; Muller, R				Silakowski, B; Schairer, HU; Ehret, H; Kunze, B; Weinig, S; Nordsiek, G; Brandt, P; Blocker, H; Hofle, G; Beyer, S; Muller, R			New lessons of combinatorial biosynthesis from myxobacteria - The myxothiazol biosynthetic gene cluster of Stigmatella aurantiaca DW4/3-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYXOCOCCUS-XANTHUS DEVELOPMENT; POLYKETIDE SYNTHASE GENES; FRUITING BODY FORMATION; BIOLOGICAL PROPERTIES; PEPTIDE SYNTHETASES; GLIDING BACTERIA; MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCES-AVERMITILIS; MOLECULAR ANALYSIS; BACILLUS-SUBTILIS	The biosynthetic mta gene cluster responsible for myxothiazol formation from the fruiting body forming myxobacterium Stigmatella aurantiaca DW4/3-1 was sequenced and analyzed. Myxothiazol, an inhibitor of the electron transport via the bc(1)-complex of the respiratory chain, is biosynthesized by a unique combination of several polyketide synthases (PKS) and nonribosomal peptide synthetases (NRPS), which are activated by the 4'-phosphopantetheinyl transferase MtaA. Genomic replacement of a fragment of mtaB and insertion of a kanamycin resistance gene into mtaA both impaired myxothiazol synthesis. Genes mtaC and mtaD encode the enzymes for bis-thiazol(ine) formation and chain extension on one pure NRPS (MtaC) and on a unique combination of PKS and NRPS (MtaD), The genes mtaE and mtaF encode PKSs including peptide fragments with homology to methyltransferases, These methyltransferase modules are assumed to be necessary for the formation of the proposed methoxy- and beta-methoxy-acrylate intermediates of myxothiazol biosynthesis. The last gene of the cluster, mtaG, again resembles a NRPS and provides insight into the mechanism of the formation of the terminal amide of myxothiazol, The carbon backbone of an amino acid added to the myxothiazol-acid is assumed to be removed via an unprecedented module with homology to monooxygenases within MtaG.	Gesell Biotechnol Forsch mbH, Abt NBI MX, D-38124 Braunschweig, Germany; Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmazeut Biol, D-38106 Braunschweig, Germany	Gesellschaft fur Biotechnologische Forschung mbH; Ruprecht Karls University Heidelberg; Braunschweig University of Technology	Muller, R (corresponding author), Gesell Biotechnol Forsch mbH, Abt NBI MX, Mascheroder Weg 1, D-38124 Braunschweig, Germany.	rom@gbf.de	Müller, Rolf/B-1559-2008	Müller, Rolf/0000-0002-1042-5665				August PR, 1998, CHEM BIOL, V5, P69, DOI 10.1016/S1074-5521(98)90141-7; Beyer S, 1999, BBA-GENE STRUCT EXPR, V1445, P185, DOI 10.1016/S0167-4781(99)00041-X; BOLLAG DM, 1995, CANCER RES, V55, P2325; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Cane DE, 1997, CHEM REV, V97, P2463, DOI 10.1021/cr970097g; Chen S, 1999, EUR J BIOCHEM, V261, P98, DOI 10.1046/j.1432-1327.1999.00244.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CORTES J, 1990, NATURE, V348, P176, DOI 10.1038/348176a0; DENOYA CD, 1995, J BACTERIOL, V177, P3504, DOI 10.1128/jb.177.12.3504-3511.1995; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; DOWNARD J, 1993, J BACTERIOL, V175, P7762, DOI 10.1128/JB.175.24.7762-7770.1993; DOWNARD J, 1995, MOL MICROBIOL, V16, P171, DOI 10.1111/j.1365-2958.1995.tb02290.x; Dworkin M, 1996, MICROBIOL REV, V60, P70, DOI 10.1128/MMBR.60.1.70-102.1996; Gaisser S, 1997, MOL GEN GENET, V253, P415, DOI 10.1007/s004380050339; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P11637, DOI 10.1021/bi9812571; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; GERTH K, 1983, J ANTIBIOT, V36, P1150, DOI 10.7164/antibiotics.36.1150; Gerth K, 1996, J ANTIBIOT, V49, P560, DOI 10.7164/antibiotics.49.560; GERTH K, 1980, J ANTIBIOT, V33, P1474, DOI 10.7164/antibiotics.33.1474; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; HAFNER EW, 1991, J ANTIBIOT, V44, P349, DOI 10.7164/antibiotics.44.349; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; Hendrickson L, 1999, CHEM BIOL, V6, P429, DOI 10.1016/S1074-5521(99)80061-1; Hofle G., 1995, SEKUNDARMETABOLISMUS, P61; IKEDA H, 1997, POLYKETIDE NONRIBOSO, V7, P2591; Kakavas SJ, 1997, J BACTERIOL, V179, P7515, DOI 10.1128/jb.179.23.7515-7522.1997; KATZ L, 1993, ANNU REV MICROBIOL, V47, P875, DOI 10.1146/annurev.mi.47.100193.004303; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Kleinkauf H, 1997, BIOTECHNOLOGY, V7, P277; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Konz D, 1997, CHEM BIOL, V4, P927, DOI 10.1016/S1074-5521(97)90301-X; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; Kulathila R, 1999, NAT PROD REP, V16, P145, DOI 10.1039/a801346b; KUNZE B, 1984, J ANTIBIOT, V37, P454, DOI 10.7164/antibiotics.37.454; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Marsden AFA, 1998, SCIENCE, V279, P199, DOI 10.1126/science.279.5348.199; Merkler DJ, 1999, J AM CHEM SOC, V121, P4904, DOI 10.1021/ja990517e; MOCEK U, 1993, J AM CHEM SOC, V115, P7557, DOI 10.1021/ja00070a001; Molnar I, 1996, GENE, V169, P1, DOI 10.1016/0378-1119(95)00799-7; Muhlradt PF, 1997, CANCER RES, V57, P3344; NEUMANN B, 1992, TRENDS GENET, V8, P332, DOI 10.1016/0168-9525(92)90269-A; NICOLAOU KC, 1998, ANGEW CHEM, V110, P2120; Paitan Y, 1999, J MOL BIOL, V286, P465, DOI 10.1006/jmbi.1998.2478; POSPIECH A, 1995, MICROBIOL-SGM, V141, P1793, DOI 10.1099/13500872-141-8-1793; Purwantini E, 1998, J BACTERIOL, V180, P2212, DOI 10.1128/JB.180.8.2212-2219.1998; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; QUALLS GT, 1978, DEV BIOL, V66, P270, DOI 10.1016/0012-1606(78)90291-9; Reichenbach H, 2000, SPR DESKT EDIT CHEM, P149; REICHENBACH H, 1993, MYXOBACTERIA, V2, P347; Reichenbach H, 1993, MYXOBACTERIA, P13; Reichenbach H., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_26; Roy RS, 1999, NAT PROD REP, V16, P249, DOI 10.1039/a806930a; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneider A, 1998, ARCH MICROBIOL, V169, P404, DOI 10.1007/s002030050590; Schoofs L, 1997, PEPTIDES, V18, P145, DOI 10.1016/S0196-9781(96)00236-7; SCHUPP T, 1995, J BACTERIOL, V177, P3673, DOI 10.1128/jb.177.13.3673-3679.1995; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; SHIMKETS LJ, 1993, MYXOBACTERIA, V2, P85; Silakowski B, 1998, J BACTERIOL, V180, P1241, DOI 10.1128/JB.180.5.1241-1247.1998; Silakowski B, 1996, J BACTERIOL, V178, P6706, DOI 10.1128/jb.178.23.6706-6713.1996; SILAKOWSKI B, 1997, THESIS U HEIDELBERG; STACHELHAUS T, 1995, J BIOL CHEM, V270, P6163, DOI 10.1074/jbc.270.11.6163; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROWITZSCHKIENAST W, 1986, LIEBIGS ANN CHEM, P93; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	68	224	233	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37391	37399		10.1074/jbc.274.52.37391	http://dx.doi.org/10.1074/jbc.274.52.37391			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601310	hybrid			2022-12-27	WOS:000084382700081
J	Verdino, P; Keller, W; Strohmaier, H; Bischof, K; Lindner, H; Koraimann, G				Verdino, P; Keller, W; Strohmaier, H; Bischof, K; Lindner, H; Koraimann, G			The essential transfer protein TraM binds to DNA as a tetramer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; CRYSTAL-STRUCTURE; FLUORESCENCE; CONFORMATION; EXPRESSION; PLASMID-R1; REPRESSOR; COMPLEX; DOMAIN	The TraM proteins encoded by F-like plasmids are sequence specific DNA binding proteins that are essential for conjugative DNA transfer. We investigated the quarternary structure and the DNA binding properties of the TraM wild-type protein of the resistance plasmid R1 and two mutant forms thereof. Size-exclusion chromatography and differential scanning calorimetry showed that purified TraM protein (amino acids 2-127) forms stable tetramers in solution. A truncated version of the protein termed TraMM26 (amino acids 2-56) forms dimers, Thus, the dimerization and tetramerization domains can be assigned to the N-terminal and C-terminal domains of TraM, respectively. Further analyses using chemical cross-linking and light scattering corroborated the preferentially tetrameric nature of the protein but also suggest that TraM has a tendency to form higher aggregates. Band-shift and fluorescence spectroscopy investigations of TraM-DNA complexes revealed that the TraM protein is also tetrameric when bound to its minimal DNA binding site, The deduced binding constant in the range of 10(8) M-1 demonstrated a very strong binding of TraM to its preferred DNA sequence. Secondary structure analysis based on CD measurements showed that TraM is mainly cu-helical with a significant increase in alpha-helicity (48 to 58%) upon DNA-binding, indicating an induced fit mechanism.	Karl Franzens Univ Graz, Inst Phys Chem, A-8010 Graz, Austria; Karl Franzens Univ Graz, Inst Mikrobiol, A-8010 Graz, Austria	University of Graz; University of Graz	Keller, W (corresponding author), Karl Franzens Univ Graz, Inst Phys Chem, Heinrichstr 28, A-8010 Graz, Austria.	walter.keller@kfunigraz.ac.at	Keller, Walter/AAW-1501-2021; Koraimann, Günther/H-3835-2019	Keller, Walter/0000-0002-2261-958X; Koraimann, Günther/0000-0002-8937-3027				[Anonymous], 1996, ESCHERICHIA COLI SAL; BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpenter M L, 1994, Methods Mol Biol, V30, P313; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CLEWELL DB, 1993, BACTERIAL CONJUGATIO; DisqueKochem C, 1997, J BACTERIOL, V179, P6133, DOI 10.1128/jb.179.19.6133-6137.1997; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; KELLY RC, 1976, J BIOL CHEM, V251, P7240; KORONAKIS VE, 1985, GENE AMST, V3, P79; Kupelwieser G, 1998, J MOL BIOL, V275, P81, DOI 10.1006/jmbi.1997.1436; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; Leharne SA, 1998, BIOCALORIMETRY, P157; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Pansegrau W, 1996, PROG NUCLEIC ACID RE, V54, P197, DOI 10.1016/S0079-6603(08)60364-5; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; Plugariu C, 1998, J PEPT RES, V51, P244; Polzleitner E, 1997, MOL MICROBIOL, V25, P495, DOI 10.1046/j.1365-2958.1997.4831853.x; Rost B, 1996, METHOD ENZYMOL, V266, P525; SCHNABLEGGER H, 1991, APPL OPTICS, V30, P4889, DOI 10.1364/AO.30.004889; SCHWAB M, 1991, MOL MICROBIOL, V5, P439, DOI 10.1111/j.1365-2958.1991.tb02127.x; SCHWAB M, 1993, MOL MICROBIOL, V7, P795, DOI 10.1111/j.1365-2958.1993.tb01170.x; Taylor I, 1994, Methods Mol Biol, V30, P327; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WOGER W, 1997, TECHNICAL TIPS ONLIN; YANG JT, 1986, METHOD ENZYMOL, V130, P208; ZECHNER EL, 1999, HORIZONTAL GENE POOL, P87	30	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37421	37428		10.1074/jbc.274.52.37421	http://dx.doi.org/10.1074/jbc.274.52.37421			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601314	hybrid			2022-12-27	WOS:000084382700085
J	Fyfe, GK; Zhang, P; Canessa, CM				Fyfe, GK; Zhang, P; Canessa, CM			The second hydrophobic domain contributes to the kinetic properties of epithelial sodium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE NA+ CHANNEL; MEMBRANE TOPOLOGY; AMILORIDE; SUBUNITS; MUTATION; RESIDUES	The epithelial sodium channel (ENaC) is the prototype of a new class of ion channels known as the ENaC/Deg family. The hallmarks of ENaC are a high selectivity for Na+, block by amiloride, small conductance, and slow kinetics that are voltage-independent. We have investigated the contribution of the second hydrophobic domain of each of the homologous subunits alpha, beta, and gamma to the kinetic properties of ENaC. Chimeric subunits were constructed between alpha and beta subunits (alpha-beta) and between gamma and beta subunits (gamma-beta), Chimeric and wild-type subunits were expressed in various combinations in Xenopus oocytes. Analysis of whole-cell and unitary currents made it possible to correlate functional properties with specific sequences in the subunits. Functional channels were generated without the second transmembrane domain from a subunits, indicating that it is not essential to form functional pores. The open probability and kinetics varied with the different channels and were influenced by the second hydrophobic domains. Amiloride affinity, Li+/Na+ selectivity, and single channel conductance were also affected by this segment.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	cecilia.canessa@yale.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054062] Funding Source: NIH RePORTER; NHLBI NIH HHS [I-P50HL55007] Funding Source: Medline; NIDDK NIH HHS [5-RO1-DK54062] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Fuller CM, 1997, BIOPHYS J, V72, P1622, DOI 10.1016/S0006-3495(97)78808-8; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; GarciaAnoveros J, 1996, CURR BIOL, V6, P541, DOI 10.1016/S0960-9822(02)00537-7; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; RENARD S, 1994, J BIOL CHEM, V269, P12981; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; SUI J, 1995, NPO ANAL PROGRAM; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; WALDMANN R, 1995, J BIOL CHEM, V270, P11735, DOI 10.1074/jbc.270.20.11735	19	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36415	36421		10.1074/jbc.274.51.36415	http://dx.doi.org/10.1074/jbc.274.51.36415			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593937	hybrid			2022-12-27	WOS:000084279200056
J	Katz, SS; Weinrauch, Y; Munford, RS; Elsbach, P; Weiss, J				Katz, SS; Weinrauch, Y; Munford, RS; Elsbach, P; Weiss, J			Deacylation of lipopolysaccharide in whole Escherichia coli during destruction by cellular and extracellular components of a rabbit peritoneal inflammatory exudate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM LIPOPOLYSACCHARIDES; PERMEABILITY-INCREASING PROTEIN; BACTERIAL LIPOPOLYSACCHARIDES; ACYLOXYACYL HYDROLASE; LEUKOCYTE ENZYME; APOPTOTIC CELLS; OUTER-MEMBRANE; HUMAN-SERUM; LIPID-A; ENDOTOXIN	Deacylation of purified lipopolysaccharides (LPS) markedly reduces its toxicity toward mammals, However, the biological significance of LPS deacylation during infection of the mammalian host is uncertain, particularly because the ability of acyloxyacyl hydrolase, the leukocyte enzyme that deacylates purified LPS, to attack LPS residing in the bacterial cell envelope has not been established, We recently showed that the cellular and extracellular components of a rabbit sterile inflammatory exudate are capable of extensive and selective removal of secondary acyl chains from purified LPS, We now report that LPS as a constituent of the bacterial envelope is also subject to deacylation in the same inflammatory setting, Using Escherichia coli LCD25, a strain that exclusively incorporates radiolabeled acetate into fatty acids, we quantitated LPS deacylation as the loss of radiolabeled secondary (laurate and myristate) and primary fatty acids (5-hydroxymyristate) from the LPS backbone. Isolated mononuclear cells and neutrophils removed 50% and 20-30%, respectively, of the secondary acyl chains of the LPS of ingested whole bacteria. When bacteria were killed extracellularly during incubation with ascitic fluid, no LPS deacylation occurred, In this setting, the addition of neutrophils had no effect, but addition of mononuclear cells resulted in removal of >40% of the secondary acyl chains by 20 h, Deacylation of LPS was always restricted to the secondary acyl chains. Thus, in an inflammatory exudate, primarily in mononuclear phagocytes, the LPS in whole bacteria undergoes substantial and selective acyloxyacyl hydrolase-like deacylation, both after phagocytosis of intact bacteria and after uptake of LPS shed from extracellularly killed bacteria, This study demonstrates for the first time that the destruction of Gram-negative bacteria by a mammalian host is not restricted to degradation of phospholipids, protein, and RNA, but also includes extensive deacylation of the envelope LPS.	NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX USA; Univ Iowa, Sch Med, Dept Med & Microbiol, Inflammat Program, Iowa City, IA 52242 USA	New York University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Iowa	Elsbach, P (corresponding author), NYU, Sch Med, Dept Microbiol, 550 1St Ave, New York, NY 10016 USA.			Weiss, Jerrold/0000-0003-1476-4485; Katz, Seth/0000-0001-8941-950X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI018188, R01AI018188, R37AI018188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK005472] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 18188] Funding Source: Medline; NIDDK NIH HHS [R37 DK 05472] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bligh E., 1959, CAN J BIOCH PHYSL, V37, P11; CRONAN JE, 1973, CHEM PHYS LIPIDS, V11, P196, DOI 10.1016/0009-3084(73)90019-4; DEDRICK RL, 1995, INFECT IMMUN, V63, P1362, DOI 10.1128/IAI.63.4.1362-1368.1995; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; DEVOE IW, 1976, J BACTERIOL, V125, P258, DOI 10.1128/JB.125.1.258-266.1976; DUNCAN RL, 1984, J IMMUNOL, V132, P1416; DUNCAN RL, 1986, J IMMUNOL, V136, P2924; ELSBACH P, 1973, J BACTERIOL, V115, P490, DOI 10.1128/JB.115.2.490-497.1973; ERWIN AL, 1991, LAB INVEST, V65, P138; ERWIN AL, 1992, BACTERIAL ENDOTOXIC, V1, P405; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FREUDENBERG MA, 1984, REV INFECT DIS, V6, P483; FREUDENBERG MA, 1991, MICROB PATHOGENESIS, V10, P93, DOI 10.1016/0882-4010(91)90070-Q; GE YM, 1994, J INFECT DIS, V169, P95, DOI 10.1093/infdis/169.1.95; HALL CL, 1983, P NATL ACAD SCI-BIOL, V80, P6671, DOI 10.1073/pnas.80.21.6671; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; Iovine NM, 1997, P NATL ACAD SCI USA, V94, P10973, DOI 10.1073/pnas.94.20.10973; Katz SS, 1996, INFECT IMMUN, V64, P3592, DOI 10.1128/IAI.64.9.3592-3600.1996; MUNFORD RS, 1992, J IMMUNOL METHODS, V148, P115, DOI 10.1016/0022-1759(92)90164-O; MUNFORD RS, 1985, INFECT IMMUN, V48, P464, DOI 10.1128/IAI.48.2.464-473.1985; MUNFORD RS, 1992, J BIOL CHEM, V267, P10116; MUNFORD RS, 1989, J BIOL CHEM, V264, P15613; MUNFORD RS, 1982, J CLIN INVEST, V70, P877, DOI 10.1172/JCI110684; PATRIARC.P, 1972, BIOCHIM BIOPHYS ACTA, V280, P45, DOI 10.1016/0005-2760(72)90211-1; Savill J, 1998, NATURE, V392, P442, DOI 10.1038/33025; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; TAKADA H, 1989, CRIT REV MICROBIOL, V16, P477, DOI 10.3109/10408418909104475; TESH VL, 1986, J IMMUNOL, V137, P1329; Watson RWG, 1996, J IMMUNOL, V156, P3986; Weinrauch Y, 1999, INFECT IMMUN, V67, P3376, DOI 10.1128/IAI.67.7.3376-3382.1999; WEINRAUCH Y, 1995, J CLIN INVEST, V95, P1916, DOI 10.1172/JCI117873; Weinrauch Y, 1996, J CLIN INVEST, V97, P250, DOI 10.1172/JCI118399; WEISS J, 1987, INFECT IMMUN, V55, P2142, DOI 10.1128/IAI.55.9.2142-2147.1987; WENSINK J, 1981, EUR J BIOCHEM, V116, P331, DOI 10.1111/j.1432-1033.1981.tb05338.x; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; WRIGHT SD, 1991, J EXP MED, V173, P1281, DOI 10.1084/jem.173.5.1281; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025	38	35	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36579	36584		10.1074/jbc.274.51.36579	http://dx.doi.org/10.1074/jbc.274.51.36579			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593958	hybrid			2022-12-27	WOS:000084279200077
J	Ladomery, MR; Slight, J; McGhee, S; Hastie, ND				Ladomery, MR; Slight, J; McGhee, S; Hastie, ND			Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear Poly(A)(+) ribonucleoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SPLICING FACTOR; FRASIER-SYNDROME; SUBNUCLEAR LOCALIZATION; KIDNEY DEVELOPMENT; HNRNP PARTICLES; PROTEINS; TRANSCRIPTION; CELLS; EXPRESSION	The tumor suppressor gene WT1 encodes a zinc finger protein, which consists of four C-terminal C-2-H-2 zinc fingers of the Kruppel type, and at the N terminus a Q/P-rich trans-regulatory domain, both characteristic of transcription factors. However, recent findings suggest that WT1 may also be involved in a post-transcriptional process. Specifically, WT1 isoforms containing the alternatively spliced exon 9 (+lysine-threonine-serine (BTrS)) preferentially associate with nuclear speckles and coimmunoprecipitate splicing antigens (Larsson, S. H., Charlieu, J.-P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, IM., Ross, A., Cuzin, F., van Heyningen, V., and Hastie, N. D. (1995) Cell 81, 391-401); furthermore, WT1 has been shown to interact with the ubiquitous splicing factor U2AF65 (Davies, R. C., Calvo, C., Larsson, S. H, Lamond, A. I., and Hastie, N. D. (1998) Genes Dev. 12, 3217-3225) and binds to RNA in vitro (Caricasole, A., Duarte, A., Larsson, S. H., Hastie, N. D., Little, M., Holmes, G., Todorov, I., and Ward, A. (1996) Proc. Natl. Acad, Sci. U: S. A. 93, 7562-7566; Bardeesy, N., and Pelletier, J. (1998) Nucleic Acids Res. 26, 1784-1792), To extend these findings, we have fractionated nuclear extracts to see if particles containing WT1 have the properties of ribonucleoprotein (RNP). In summary, WT1 is enriched by oligo(dT) chromatography, as are U2AF65, the U5 small nuclear RNP-associated protein pile and hnRNP Al. Gel filtration and sedimentation profiles suggest that WT1 is present in RNase-sensitive particles, >2 MDa in size, peaking at similar to 60 S, and similar to 1.27 g/cm(3) on Nycodenz. Similar results were obtained from two cell lines expressing WT1, fetal kidneys (day E17), and transiently transfected cells, suggesting that the presence of WT1 protein in nuclear poly(A)(+) RNP is a general aspect of WT1 function.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Hastie, ND (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	Nick.Hastie@hgu.mrc.ac.uk						Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Bardeesy N, 1998, NUCLEIC ACIDS RES, V26, P1784, DOI 10.1093/nar/26.7.1784; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; BIRNIE GD, 1976, BIOL SEPARATIONS IOD, P193; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; BROSI R, 1993, SCIENCE, V262, P102, DOI 10.1126/science.8211112; Bruening W, 1996, J BIOL CHEM, V271, P8646, DOI 10.1074/jbc.271.15.8646; BUCKINGHAM ME, 1976, BIOL SEPARATIONS IOD, P71; BUCKLER AJ, 1991, MOL CELL BIOL, V11, P1707, DOI 10.1128/MCB.11.3.1707; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191; DARNBROUGH CH, 1981, EUR J BIOCHEM, V113, P415, DOI 10.1111/j.1432-1033.1981.tb05081.x; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; DAVIS MR, 1992, INT J CANCER, V52, P881, DOI 10.1002/ijc.2910520609; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; DREYFUSS G, 1984, MOL CELL BIOL, V4, P415, DOI 10.1128/MCB.4.3.415; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; FEINBERG AP, 1994, J CELL SCI, P7; FORD T, 1983, ANAL BIOCHEM, V128, P232, DOI 10.1016/0003-2697(83)90370-6; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Graves LE, 1999, NATURE, V399, P802, DOI 10.1038/21682; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HASTIE ND, 1994, ANNU REV GENET, V28, P523; Herbert TP, 1999, NUCLEIC ACIDS RES, V27, P1747, DOI 10.1093/nar/27.7.1747; HOUSSAIS JF, 1976, BIOL SEPARATIONS IOD, P81; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; JEFFERY WR, 1977, J BIOL CHEM, V252, P3525; JIMENEZGARCIA LF, 1993, CELL, V73, P47, DOI 10.1016/0092-8674(93)90159-N; Kennedy D, 1996, NAT GENET, V12, P329, DOI 10.1038/ng0396-329; KENT J, 1995, ONCOGENE, V11, P1781; Kikuchi H, 1998, J MED GENET, V35, P45, DOI 10.1136/jmg.35.1.45; KISH VM, 1975, J MOL BIOL, V95, P227, DOI 10.1016/0022-2836(75)90392-7; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; Kramer A., 1995, PREMRNA PROCESSING, P35; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; Ladomery M, 1997, BIOESSAYS, V19, P903, DOI 10.1002/bies.950191010; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; LEE KAW, 1990, METHOD ENZYMOL, V181, P20; Maheswaran S, 1998, GENE DEV, V12, P1108, DOI 10.1101/gad.12.8.1108; Mayo MW, 1999, EMBO J, V18, P3990, DOI 10.1093/emboj/18.14.3990; Medalia O, 1997, J STRUCT BIOL, V120, P228, DOI 10.1006/jsbi.1997.3926; Menke AL, 1998, INT REV CYTOL, V181, P151, DOI 10.1016/S0074-7696(08)60418-0; MIRIAMI E, 1995, J MOL BIOL, V246, P254, DOI 10.1006/jmbi.1994.0081; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; OKEEFE RT, 1994, J CELL BIOL, V124, P249, DOI 10.1083/jcb.124.3.249; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Puvion E, 1996, EXP CELL RES, V229, P217, DOI 10.1006/excr.1996.0363; RASSOULZADEGAN M, 1993, CELL, V75, P997, DOI 10.1016/0092-8674(93)90543-Y; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; Reddy JC, 1996, BBA-REV CANCER, V1287, P1, DOI 10.1016/0304-419X(95)00014-7; RICKWOOD D, 1975, FEBS LETT, V50, P102, DOI 10.1016/0014-5793(75)80467-4; Samarina OP, 1996, BIOESSAYS, V18, P595, DOI 10.1002/bies.950180712; Schmidt-Zachmann MS, 1998, MOL BIOL CELL, V9, P143, DOI 10.1091/mbc.9.1.143; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; SPANN P, 1989, P NATL ACAD SCI USA, V86, P466, DOI 10.1073/pnas.86.2.466; Sperling R, 1997, J MOL BIOL, V267, P570, DOI 10.1006/jmbi.1997.0898; TAFURI SR, 1993, J BIOL CHEM, V268, P24255; VISA N, 1993, EXP CELL RES, V208, P19, DOI 10.1006/excr.1993.1218; WAGENMAKERS AJM, 1980, EUR J BIOCHEM, V112, P323, DOI 10.1111/j.1432-1033.1980.tb07207.x; Wolffe AP, 1996, INT J BIOCHEM CELL B, V28, P247, DOI 10.1016/1357-2725(95)00141-7; YAMANAKA A, 1995, SOIL SCI PLANT NUTR, V41, P183, DOI 10.1080/00380768.1995.10419575; Yitzhaki S, 1996, P NATL ACAD SCI USA, V93, P8830, DOI 10.1073/pnas.93.17.8830; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0	68	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36520	36526		10.1074/jbc.274.51.36520	http://dx.doi.org/10.1074/jbc.274.51.36520			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593950	hybrid			2022-12-27	WOS:000084279200069
J	Tomasevic, N; Peculis, B				Tomasevic, N; Peculis, B			Identification of a U8 snoRNA-specific binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNAS; RIBOSOMAL-RNA; PSEUDOURIDINE SYNTHASE; YEAST; FIBRILLARIN; ELEMENTS; SEQUENCE; CBF5P; COMPLEX; U3	Eukaryotic nucleoli contain a large and diverse population of small nucleolar ribonucleoprotein particles (snoRNPs) that play diverse and essential roles in ribosome biogenesis. We previously demonstrated that U8 snoRNP is essential for processing of both 5.8 and 28 S rRNA. The RNA component of the U8 RNP particle is necessary but not sufficient for processing. Using an electrophoretic mobility sift assay, we enriched for U8-specific binding proteins from Xenopus ovary extracts. UV cross-linking reactions with partially purified fractions implicated a 29-kDa protein directly binding to U8 RNA. This protein interacted specifically and with high affinity with U8 snoRNA; it did not bind other snoRNAs and is probably not a common component of all snoRNPs. This is the first report of a protein component specific to an snoRNP essential for processing of the large ribosomal subunit in vertebrates.	NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Peculis, B (corresponding author), NIDDK, Genet & Biochem Branch, NIH, 10 Ctr Dr 10-8N322, Bethesda, MD 20892 USA.							AMIRI KA, 1994, J BACTERIOL, V176, P2124, DOI 10.1128/jb.176.7.2124-2127.1994; APOSTOL BL, 1991, NUCLEIC ACIDS RES, V19, P1853, DOI 10.1093/nar/19.8.1853; ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BURGE B, 1999, SPLICING PRECURSORS; Cadwell C, 1997, MOL CELL BIOL, V17, P6175, DOI 10.1128/MCB.17.10.6175; Ganot P, 1997, GENE DEV, V11, P941, DOI 10.1101/gad.11.7.941; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; GIRARD JP, 1992, EMBO J, V11, P673, DOI 10.1002/j.1460-2075.1992.tb05099.x; Gunnewiek JMTK, 1997, CLIN EXP RHEUMATOL, V15, P549; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; JANSEN RP, 1991, J CELL BIOL, V113, P715, DOI 10.1083/jcb.113.4.715; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; MEIER UT, 1994, J CELL BIOL, V127, P1505, DOI 10.1083/jcb.127.6.1505; O'Reilly Marc, 1999, Current Opinion in Structural Biology, V9, P56, DOI 10.1016/S0959-440X(99)80008-6; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; PARKER KA, 1987, MOL CELL BIOL, V7, P2899, DOI 10.1128/MCB.7.8.2899; Peculis B, 1997, CURR BIOL, V7, pR480, DOI 10.1016/S0960-9822(06)00242-9; Peculis BA, 1996, CURR BIOL, V6, P1413, DOI 10.1016/S0960-9822(96)00745-2; PECULIS BA, 1994, GENE DEV, V8, P2241, DOI 10.1101/gad.8.18.2241; PECULIS BA, 1993, CELL, V73, P1233, DOI 10.1016/0092-8674(93)90651-6; TOLLERVEY D, 1991, EMBO J, V10, P573, DOI 10.1002/j.1460-2075.1991.tb07984.x; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; TYC K, 1989, EMBO J, V8, P3113, DOI 10.1002/j.1460-2075.1989.tb08463.x; VENEMA J, 1999, IN PRESS ANN REV GEN, V33; Watkins NJ, 1998, RNA, V4, P1549, DOI 10.1017/S1355838298980761; Watkins NJ, 1996, RNA, V2, P118; Watkins NJ, 1998, RNA, V4, P582, DOI 10.1017/S1355838298980128; Wu P, 1998, J BIOL CHEM, V273, P16453, DOI 10.1074/jbc.273.26.16453	34	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35914	35920		10.1074/jbc.274.50.35914	http://dx.doi.org/10.1074/jbc.274.50.35914			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585477	hybrid			2022-12-27	WOS:000084187900089
J	Ceschini, S; Lupidi, G; Coletta, M; Pon, CL; Fioretti, E; Angeletti, M				Ceschini, S; Lupidi, G; Coletta, M; Pon, CL; Fioretti, E; Angeletti, M			Multimeric self-assembly equilibria involving the histone-like protein H-NS - A thermodynamic study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; ESCHERICHIA-COLI; GENE-EXPRESSION; CURVED DNA; REPRESSOR; DIMERIZATION; TOPOLOGY; INVITRO; DOMAIN	The thermodynamic parameters affecting protein-protein multimeric self-assembly equilibria of the histone-like protein H-NS were quantified by "large zone" gel-permeation chromatography. The abundance of the different association states (monomer, dimer, and tetramer) were found to be strictly dependent on the monomeric concentration and affected by physical (temperature) and chemical (cations) parameters. On the basis of the results obtained in this study and the available structural information concerning this protein, a mechanism is proposed to explain the association behavior also in relation to the functional properties of the protein.	Univ Camerino, Post Grad Sch Clin Biochem, Dept Mol Cellular & Anim Biol, I-62032 Camerino, MC, Italy; Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy	University of Camerino; University of Rome Tor Vergata	Angeletti, M (corresponding author), Univ Camerino, Post Grad Sch Clin Biochem, Dept Mol Cellular & Anim Biol, I-62032 Camerino, MC, Italy.		Coletta, Massimo/N-9049-2015; Coletta, Massimiliano/GSN-5927-2022; Angeletti, Mauro/AAC-5597-2019	Angeletti, Mauro/0000-0001-6719-5517; COLETTA, Massimiliano/0000-0002-5489-9467; Lupidi, Giulio/0000-0001-9452-0741				Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; BECKETT D, 1991, ANAL BIOCHEM, V196, P69, DOI 10.1016/0003-2697(91)90118-D; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENOWITZ M, 1990, BIOCHEMISTRY-US, V29, P3374, DOI 10.1021/bi00465a033; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; Creighton T.E., 1993, PROTEINS; FALCONI M, 1988, MOL MICROBIOL, V2, P323, DOI 10.1111/j.1365-2958.1988.tb00035.x; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Falconi M, 1996, MOL MICROBIOL, V19, P965, DOI 10.1046/j.1365-2958.1996.436961.x; HIGGINS CF, 1990, MOL MICROBIOL, V4, P2007, DOI 10.1111/j.1365-2958.1990.tb00559.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LUCHT JM, 1994, J BIOL CHEM, V269, P6578; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; PON CL, 1988, MOL GEN GENET, V212, P199, DOI 10.1007/BF00334684; PRESS WH, 1986, NUMERICAL RECIPES AR; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; ROYER CA, 1990, BIOCHEMISTRY-US, V29, P2959; SHINDO H, 1995, FEBS LETT, V360, P125, DOI 10.1016/0014-5793(95)00079-O; SPASSKY A, 1984, NUCLEIC ACIDS RES, V12, P5321, DOI 10.1093/nar/12.13.5321; SPURIO R, 1992, MOL GEN GENET, V231, P201, DOI 10.1007/BF00279792; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Terwilliger TC, 1996, BIOCHEMISTRY-US, V35, P16652, DOI 10.1021/bi961050c; TIPPNER D, 1995, J BIOL CHEM, V270, P22243, DOI 10.1074/jbc.270.38.22243; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; Ueguchi C, 1997, J MOL BIOL, V274, P145, DOI 10.1006/jmbi.1997.1381; UEGUCHI C, 1993, EMBO J, V12, P1039, DOI 10.1002/j.1460-2075.1993.tb05745.x; USSERY DW, 1994, BIOCHIMIE, V76, P968, DOI 10.1016/0300-9084(94)90022-1; Valdes R Jr, 1979, Methods Enzymol, V61, P125	30	53	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					729	734		10.1074/jbc.275.2.729	http://dx.doi.org/10.1074/jbc.275.2.729			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625601	hybrid			2022-12-27	WOS:000084836600005
J	Kosova, B; Pante, N; Rollenhagen, C; Podtelejnikov, A; Mann, M; Aebi, U; Hurt, E				Kosova, B; Pante, N; Rollenhagen, C; Podtelejnikov, A; Mann, M; Aebi, U; Hurt, E			Mlp2p, a component of nuclear pore attached intranuclear filaments, associates with Nic96p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; SCANNING ELECTRON-MICROSCOPY; SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; MONOCLONAL-ANTIBODIES; MATRIX PROTEIN; BINDING-SITES; COMPLEX; YEAST	A fraction of the yeast nucleoporin Nic96p is localized at the terminal ring of the nuclear basket. When Nic96p was affinity purified from glutaraldehyde-treated spheroplasts, it was found to be associated with Mlp2p. Mlp2p, together with Mlp1p, are the yeast Tpr homologues, which form the nuclear pore attached intranuclear filaments (Strambio-de-Castillia, C., Blobel, G., and Rout, M. P. (1499) J. Cell Biol. 144, 839-855). Double disruption mutants of MLP1 and MLP2 are viable and apparently not impaired in nucleocytoplasmic transport. However, overproduction of MLP1 causes nuclear accumulation of poly(A)(+) RNA in a chromatin-free area of the nucleus.	Biochem Zentrum Heidelberg, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hurt, E (corresponding author), Biochem Zentrum Heidelberg, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.		Kosova, Buket/AAG-4736-2019; Mann, Matthias/A-3454-2013; Podtelejnikov, Alexandre/B-6120-2017; Ed Hurt, Dr./AAE-8874-2019; Pante, Nelly/GVR-8478-2022	Kosova, Buket/0000-0003-3636-6082; Mann, Matthias/0000-0003-1292-4799; Podtelejnikov, Alexandre/0000-0002-8124-6584; Ed Hurt, Dr./0000-0002-4535-8255; 				AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Arlucea J, 1998, J STRUCT BIOL, V124, P51, DOI 10.1006/jsbi.1998.4054; Bailer SM, 1998, EMBO J, V17, P1107, DOI 10.1093/emboj/17.4.1107; Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475; BEVEN A, 1991, J CELL SCI, V98, P293; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; BYRD DA, 1994, J CELL BIOL, V127, P1515, DOI 10.1083/jcb.127.6.1515; Clubb BH, 1998, J CELL BIOCHEM, V70, P240, DOI 10.1002/(SICI)1097-4644(19980801)70:2<240::AID-JCB10>3.0.CO;2-R; CORDES VC, 1993, J CELL BIOL, V123, P1333, DOI 10.1083/jcb.123.6.1333; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cordes VC, 1998, EXP CELL RES, V245, P43, DOI 10.1006/excr.1998.4246; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; FELDHERR CM, 1984, J CELL BIOL, V99, P2216, DOI 10.1083/jcb.99.6.2216; FRANKE WW, 1970, J ULTRA MOL STRUCT R, V30, P288, DOI 10.1016/S0022-5320(70)80064-8; FRANKE WW, 1974, CELL NUCLEUS; GEORGATOS SD, 1994, J CELL BIOCHEM, V55, P69, DOI 10.1002/jcb.240550108; GERACE L, 1986, TRENDS BIOCHEM SCI, V11, P443, DOI 10.1016/0968-0004(86)90243-4; GOLDBERG MW, 1992, J CELL BIOL, V119, P1429, DOI 10.1083/jcb.119.6.1429; GOLDBERG MW, 1995, CURR OPIN CELL BIOL, V7, P301, DOI 10.1016/0955-0674(95)80083-2; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; GRANDI P, 1995, J CELL BIOL, V130, P1263, DOI 10.1083/jcb.130.6.1263; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Gueth-Hallonet C, 1998, EXP CELL RES, V243, P434, DOI 10.1006/excr.1998.4178; GuethHallonet C, 1997, EXP CELL RES, V233, P21, DOI 10.1006/excr.1997.3557; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; HANER M, 1997, CELL BIOL LAB HDB, V3, P292; HINSHAW JE, 1994, BIOCHEM PHARMACOL, V47, P15, DOI 10.1016/0006-2952(94)90432-4; Hurwitz ME, 1998, P NATL ACAD SCI USA, V95, P11241, DOI 10.1073/pnas.95.19.11241; JACKSON DA, 1988, EMBO J, V7, P3667, DOI 10.1002/j.1460-2075.1988.tb03248.x; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; KALLAJOKI M, 1991, EMBO J, V10, P3351, DOI 10.1002/j.1460-2075.1991.tb04899.x; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KOLLING R, 1993, MOL GEN GENET, V237, P359; Kunzler M, 1998, FEBS LETT, V433, P185, DOI 10.1016/S0014-5793(98)00892-8; Maniatis T., 1982, MOL CLONING LAB MANU; MELCHIOR F, 1995, J CELL BIOL, V131, P571, DOI 10.1083/jcb.131.3.571; Merdes A, 1998, J CELL SCI, V111, P71; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729; Pante N, 1995, INT REV CYTOL, V162B, P225; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ris H, 1997, SCANNING, V19, P368, DOI 10.1002/sca.4950190504; RIS H, 1993, J STRUCT BIOL, V111, P148, DOI 10.1006/jsbi.1993.1045; Ris H., 1989, I PHYS C SER, V98, P657; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; SHERMAN F, 1990, METHOD ENZYMOL, V194, P3; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; WILKEN N, 1995, EUR J CELL BIOL, V68, P211; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zimowska G, 1997, J CELL SCI, V110, P927	64	70	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					343	350		10.1074/jbc.275.1.343	http://dx.doi.org/10.1074/jbc.275.1.343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617624	hybrid, Green Published			2022-12-27	WOS:000085951600048
J	Webster, K; Parish, J; Pandya, M; Stern, PL; Clarke, AR; Gaston, K				Webster, K; Parish, J; Pandya, M; Stern, PL; Clarke, AR; Gaston, K			The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p59-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA CELL-LINES; ONCOGENIC HUMAN PAPILLOMAVIRUSES; TUMOR-SUPPRESSOR PROTEIN; E7 PROTEIN; MEDIATES ASSOCIATION; HUMAN KERATINOCYTES; E6 ONCOPROTEIN; DNA-BINDING; P53; TYPE-16	The human papillomavirus (HPV) E2 protein regulates viral gene expression and is also required for viral replication. HPV-transformed cells often contain chromosomally integrated copies of the HPV genome in which the viral E2 gene is disrupted. We have shown previously that re-expression of the HPV 16 E2 protein in HPV 16-transformed cells results in cell death via apoptosis. Here we show that the HPV 16 E2 protein can induce apoptosis in both HPV-transformed and non-HPV-transformed cell lines. E2-induced apoptosis is abrogated by a trans-dominant negative mutant of p53 or by overexpression of the HPV 16 E6 protein, but is increased by overexpression of wild-type p53. We show that mutations that block the DNA binding activity of E2 do not impair the ability of this protein to induce apoptosis. In contrast, removal of both N-terminal domains from the E2 dimer completely blocks E2-induced cell death. Heterodimers formed between wild-type E2 and N-terminally deleted E2 proteins also fail to induce cell death. Our data suggest that neither the DNA binding activity of E2 nor other HPV proteins are required for the induction of apoptosis by E2 and that E2-induced cell death occurs via a p53-dependent pathway.	Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; Christie Hosp NHS Trust, Paterson Inst Canc Res, Manchester M20 9BX, Lancs, England	University of Bristol; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research	Gaston, K (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England.	Kevin.Gaston@Bristol.ac.uk	Parish, Joanna L/L-4820-2015; Gaston, Kevin/K-9237-2019	Parish, Joanna L/0000-0002-7111-4211; Gaston, Kevin/0000-0002-7349-5513				BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; BARSOUM J, 1992, J VIROL, V66, P3941, DOI 10.1128/JVI.66.6.3941-3945.1992; Bartholomew JS, 1997, CANCER RES, V57, P937; BOUVARD V, 1994, EMBO J, V13, P5451, DOI 10.1002/j.1460-2075.1994.tb06880.x; Boyer SN, 1996, CANCER RES, V56, P4620; BUTZ K, 1995, ONCOGENE, V10, P927; CAMPO MS, 1994, CARCINOGENESIS, V15, P1597, DOI 10.1093/carcin/15.8.1597; CAMPO MS, 1992, CANCER RES, V52, P6898; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; CROOK T, 1991, ONCOGENE, V6, P873; CROOK T, 1996, PAPILLOMAVIRUS REV C, P55; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; DOWHANICK JJ, 1995, J VIROL, V69, P7791, DOI 10.1128/JVI.69.12.7791-7799.1995; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; Frattini MG, 1997, EMBO J, V16, P318, DOI 10.1093/emboj/16.2.318; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Goodwin EC, 1998, J VIROL, V72, P3925, DOI 10.1128/JVI.72.5.3925-3934.1998; Gottlieb TM, 1998, SEMIN CANCER BIOL, V8, P359, DOI 10.1006/scbi.1998.0098; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260; HOWES KA, 1994, GENE DEV, V8, P1300, DOI 10.1101/gad.8.11.1300; HU TH, 1995, INT J ONCOL, V6, P167; HUBBERT NL, 1992, J VIROL, V66, P6237, DOI 10.1128/JVI.66.10.6237-6241.1992; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HWANG ES, 1993, J VIROL, V67, P3720, DOI 10.1128/JVI.67.7.3720-3729.1993; Hwang ES, 1996, ONCOGENE, V12, P795; Jones DL, 1997, J VIROL, V71, P2905, DOI 10.1128/JVI.71.4.2905-2912.1997; Jones DL, 1997, VIROLOGY, V239, P97, DOI 10.1006/viro.1997.8851; KNIGHT JD, 1991, P NATL ACAD SCI USA, V88, P3204, DOI 10.1073/pnas.88.8.3204; Kovelman R, 1996, J VIROL, V70, P7549, DOI 10.1128/JVI.70.11.7549-7560.1996; LECHNER MS, 1992, EMBO J, V11, P3045, DOI 10.1002/j.1460-2075.1992.tb05375.x; PAN HC, 1994, GENE DEV, V8, P1285, DOI 10.1101/gad.8.11.1285; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159; SanchezPerez AM, 1997, J GEN VIROL, V78, P3009, DOI 10.1099/0022-1317-78-11-3009; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Stoppler H, 1998, ONCOGENE, V17, P1207, DOI 10.1038/sj.onc.1202053; THIERRY F, 1996, PAPILLOMAVIRUS REV C, P21; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602	43	111	118	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					87	94		10.1074/jbc.275.1.87	http://dx.doi.org/10.1074/jbc.275.1.87			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617590	hybrid			2022-12-27	WOS:000085951600014
J	Lim, SE; Longley, MJ; Copeland, WC				Lim, SE; Longley, MJ; Copeland, WC			The mitochondrial p55 accessory subunit of human DNA polymerase gamma enhances DNA binding, promotes processive DNA synthesis, and confers N-ethylmaleimide resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; DROSOPHILA EMBRYOS; CATALYTIC SUBUNIT; IDENTIFICATION; PURIFICATION; REPLICATION; BACTERIOPHAGE-T7; EXONUCLEASE; PROTEIN; EXCISION	Human DNA polymerase gamma is composed of a 140-kDa catalytic subunit and a smaller accessory protein variously reported to be 43-54 kDa. Immunoblot analysis of the purified, heterodimeric native human polymerase gamma complex identified the accessory subunit as 55 kDa, We isolated the full-length cDNA encoding a 55-kDa polypeptide, expressed the cDNA in Escherichia coli and purified the 55-kDa protein to homogeneity, Recombinant Hp55 forms a high affinity, salt-stable complex with Hp140 during protein affinity chromatography. Immunoprecipitation, gel filtration, and sedimentation analyses revealed a 190-kDa complex indicative of a native heterodimer, Reconstitution of Hp140 Hp55 raises the salt optimum of Hp140, stimulates the polymerase and exonuclease activities, and increases the processivity of the enzyme by several 100-fold. Similar to Hp140, isolated Hp55 binds DNA with moderate strength and was a specificity for double-stranded primer-template DNA. However, Hp140 Hp55 has a surprisingly high affinity for DNA, and kinetic analyses indicate Hp55 enhances the affinity of Hp140 for primer termini by 2 orders of magnitude. Thus the enhanced DNA binding caused by Hp55 is the basis for the salt tolerance and high processivity characteristic of DNA polymerase gamma, Observation of native DNA polymerase gamma both as an Hp140 monomer and as a heterodimer with Hp55 supports the notion that the two forms act in mitochondrial DNA repair and replication. Additionally, association of Hp55 with Hp140 protects the polymerase from inhibition by N-ethylmaleimide.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953				BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; GRAY H, 1992, J BIOL CHEM, V267, P5835; HUBER HE, 1987, J BIOL CHEM, V262, P16224; HUGHES MJ, 1992, J BIOL CHEM, V267, P23876; INSDORF NF, 1989, J BIOL CHEM, V264, P21491; Jonsson ZO, 1997, BIOESSAYS, V19, P967, DOI 10.1002/bies.950191106; KELMAN Z, 1995, NUCLEIC ACIDS RES, V23, P3613, DOI 10.1093/nar/23.18.3613; KORNBERG A, 1992, DNA REPLICATION, P209; KUNKEL TA, 1994, P NATL ACAD SCI USA, V91, P6830, DOI 10.1073/pnas.91.15.6830; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MOSBAUGH DW, 1988, NUCLEIC ACIDS RES, V16, P5645, DOI 10.1093/nar/16.12.5645; OLSON MW, 1992, J BIOL CHEM, V267, P23136; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; ROPP PA, 1995, GENE, V165, P103, DOI 10.1016/0378-1119(95)00412-Y; Sambrook J., 2002, MOL CLONING LAB MANU; SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; TABOR S, 1987, J BIOL CHEM, V262, P16212; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; Wang YX, 1997, J BIOL CHEM, V272, P13640, DOI 10.1074/jbc.272.21.13640; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; WILLIAMS AJ, 1993, J BIOL CHEM, V268, P24855; WYMAN C, 1995, CURR BIOL, V5, P334, DOI 10.1016/S0960-9822(95)00065-0	31	174	180	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38197	38203		10.1074/jbc.274.53.38197	http://dx.doi.org/10.1074/jbc.274.53.38197			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608893	hybrid			2022-12-27	WOS:000084528000093
J	McKiernan, CJ; Friedlander, M				McKiernan, CJ; Friedlander, M			The retinal rod Na+/Ca2+,K+ exchanger contains a noncleaved signal sequence required for translocation of the N terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-CA2+ EXCHANGER; TRANSMEMBRANE GLYCOPROTEIN; ENDOPLASMIC-RETICULUM; FUNCTIONAL EXPRESSION; PROTEIN TRANSLOCATION; MEMBRANE INTEGRATION; SECRETORY PROTEINS; PRECURSOR; CHAPERONE; RECEPTOR	The retinal rod Na+/Ca2+,K+ exchanger (RodX) is a polytopic membrane protein found in photoreceptor outer segments where it is the principal extruder of Ca2+ ions during light adaptation. We have examined the role of the N-terminal 65 amino acids in targeting, translocation, and integration of the RodX using an in vitro translation/translocation system, cDNAs encoding human RodX and bovine RodX through the first transmembrane domain were correctly targeted and integrated into microsomal membranes; deletion of the N-terminal 65 amino acids (aa) resulted in a translation product that was not targeted or integrated. Deletion of the first 65 aa had no effect on membrane targeting of full-length RodX, but the N-terminal hydrophilic domain no longer translocated. Chimeric constructs encoding the first 65 aa of bovine RodX fused to globin were translocated across microsomal membranes, demonstrating that the sequence could function heterologously. Studies of fresh bovine retinal extracts demonstrated that the first 65 aa are present in the native protein. These data demonstrate that the first 65 aa of RodX constitute an uncleaved signal sequence required for the efficient membrane targeting and proper membrane integration of RodX.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Friedlander, M (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd,MB-28, La Jolla, CA 92037 USA.				NEI NIH HHS [5F32 EY06820] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006820] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAMOWSKI D, 1995, J NEUROCHEM, V65, P782; ANDERSON DJ, 1982, J CELL BIOL, V93, P501, DOI 10.1083/jcb.93.2.501; Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; Cooper CB, 1999, BIOCHEMISTRY-US, V38, P6276, DOI 10.1021/bi983068o; DOBNER PR, 1987, P NATL ACAD SCI USA, V84, P3516, DOI 10.1073/pnas.84.10.3516; Driessen AJM, 1998, CURR OPIN MICROBIOL, V1, P216, DOI 10.1016/S1369-5274(98)80014-3; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRIEDLANDER M, 1985, NATURE, V318, P338, DOI 10.1038/318338a0; FURMAN I, 1995, J BIOL CHEM, V270, P19120, DOI 10.1074/jbc.270.32.19120; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; Hajek P, 1997, MOL CELL BIOL, V17, P7169, DOI 10.1128/MCB.17.12.7169; Haynes RL, 1997, J BIOL CHEM, V272, P17126, DOI 10.1074/jbc.272.27.17126; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HRYSHKO LV, 1993, BIOCHIM BIOPHYS ACTA, V1151, P35, DOI 10.1016/0005-2736(93)90068-B; KABACK HR, 1992, MOL BIOL RECEPTORS T, P98; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LINGAPPA VR, 1978, J BIOL CHEM, V253, P8667; LOO TW, 1995, J BIOL CHEM, V270, P19345, DOI 10.1074/jbc.270.33.19345; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; NICOLL DA, 1989, J BIOL CHEM, V264, P16207; PHILIPSON K D, 1992, Current Opinion in Cell Biology, V4, P678, DOI 10.1016/0955-0674(92)90089-U; REILANDER H, 1992, EMBO J, V11, P1689, DOI 10.1002/j.1460-2075.1992.tb05219.x; SAHINTOTH M, 1995, BIOCHEM BIOPH RES CO, V212, P968, DOI 10.1006/bbrc.1995.2064; Tucker JE, 1998, INVEST OPHTH VIS SCI, V39, P435; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17	26	6	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38177	38182		10.1074/jbc.274.53.38177	http://dx.doi.org/10.1074/jbc.274.53.38177			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608890	hybrid			2022-12-27	WOS:000084528000090
J	Murata, S; Kawahara, H; Tohma, S; Yamamoto, K; Kasahara, M; Nabeshima, Y; Tanaka, K; Chiba, T				Murata, S; Kawahara, H; Tohma, S; Yamamoto, K; Kasahara, M; Nabeshima, Y; Tanaka, K; Chiba, T			Growth retardation in mice lacking the proteasome activator PA28 gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; PROTEIN ACTIVATOR; PA28 SUBUNITS; ALPHA-SUBUNIT; BETA-SUBUNIT; GAMMA; REGULATOR; PURIFICATION; LOCALIZATION; LIGANDS	The proteasome activator PA28 binds to both ends of the central catalytic machine, known as the 20 S proteasome, in opposite orientations to form the enzymatically active proteasome. The PA28 family is composed of three members designated alpha, beta, and gamma; PA28 alpha and PA28 beta form the heteropolymer mainly located in the cytoplasm, whereas PA28 gamma forms a homopolymer that predominantly occurs in the nucleus. Available evidence indicates that the heteropolymer of PA28 alpha and PA28 beta is involved in the processing of intracellular antigens, but the function of PA28 gamma remains elusive. To investigate the role of PA28 gamma in vivo, we generated mice deficient in the PA28 gamma gene. The PA28 gamma-deficient mice were born without appreciable abnormalities in all tissues examined, but their growth after birth was retarded compared with that of PA28 gamma(+/-) or PA28 gamma(+/+) mice. We also investigated the effects of the PA28 gamma deficiency using cultured embryonic fibroblasts; cells lacking PA28 gamma were larger and displayed a lower saturation density than their wild-type counterparts. Neither the expression of PA28 alpha/beta nor the subcellular localization of PA28 alpha was affected in PA28 gamma(-/-) cells. These results indicate that PA28 gamma functions as a regulator of cell proliferation and body growth in mice and suggest that neither PA28 alpha: nor PA28 beta compensates for the PA28 gamma deficiency.	Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Inst Mol & Cellular Sci, Bunkyo Ku, Tokyo 1138655, Japan; Grad Univ Adv Studies, Sch Adv Sci, Dept Biosyst Sci, Hayama 2400193, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi 3320012, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol, Sakyo Ku, Kyoto 6190237, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tokyo; University of Tokyo; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Kyoto University	Chiba, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.		Kasahara, Masanori/G-7651-2011; Murata, Shigeo/A-1426-2010; Yamamoto, Kazuhiko/N-5096-2015	Murata, Shigeo/0000-0002-3177-3503; 				AHN JY, 1995, FEBS LETT, V366, P37, DOI 10.1016/0014-5793(95)00492-R; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4; GRAY CW, 1994, J MOL BIOL, V236, P7, DOI 10.1006/jmbi.1994.1113; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hendil KB, 1998, BIOCHEM J, V332, P749, DOI 10.1042/bj3320749; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kandil E, 1997, IMMUNOGENETICS, V46, P337, DOI 10.1007/s002510050281; Kohda K, 1998, J IMMUNOL, V160, P4923; MA CP, 1992, J BIOL CHEM, V267, P10515; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; RECHSTEINER M, 1998, UBIQUITIN BIOL CELL, P147; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimbara N, 1998, J BIOL CHEM, V273, P23062, DOI 10.1074/jbc.273.36.23062; Song XL, 1996, J BIOL CHEM, V271, P26410, DOI 10.1074/jbc.271.42.26410; Soza A, 1997, FEBS LETT, V413, P27, DOI 10.1016/S0014-5793(97)00864-8; Tanahashi N, 1997, GENES CELLS, V2, P195, DOI 10.1046/j.1365-2443.1997.d01-308.x; Tanaka K, 1998, BIOCHEM BIOPH RES CO, V247, P537, DOI 10.1006/bbrc.1998.8617; Tanaka K, 1998, IMMUNOL REV, V163, P161; Wojcik C, 1998, EUR J CELL BIOL, V77, P151, DOI 10.1016/S0171-9335(98)80083-6; Zhang ZG, 1999, BIOCHEMISTRY-US, V38, P5651, DOI 10.1021/bi990056+	29	144	154	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38211	38215		10.1074/jbc.274.53.38211	http://dx.doi.org/10.1074/jbc.274.53.38211			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608895	hybrid			2022-12-27	WOS:000084528000095
J	Pical, C; Westergren, T; Dove, SK; Larsson, C; Sommarin, M				Pical, C; Westergren, T; Dove, SK; Larsson, C; Sommarin, M			Salinity and hyperosmotic stress induce rapid increases in phosphatidylinositol 4,5-bisphosphate, diacylglycerol pyrophosphate, and phosphatidylcholine in Arabidopsis thaliana cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE C-GAMMA; SPIRODELA-POLYRHIZA L; STOMATAL GUARD-CELLS; 4,5-PHOSPHORYLATED PHOSPHATIDYLINOSITOLS; INOSITOL 1,4,5-TRISPHOSPHATE; OSMOTIC-STRESS; MEMBRANE; CALCIUM; PROTEIN; PLANTS	In animal cells, phosphoinositides are key components of the inositol 1,4,5-trisphosphate/diacylglycerol-based signaling pathway, but also have many other cellular functions. These lipids are also believed to fulfill similar functions in plant cells, although many details concerning the components of a plant phosphoinositide system, and their regulation are still missing. Only recently have the different phosphoinositide isomers been unambiguously identified in plant cells. Another problem that hinders the study of the function of phosphoinositides and their derivatives, as well as the regulation of their metabolism, in plant cells is the need for a homogenous, easily obtainable material, from which the extraction and purification of phospholipids is relatively easy and quantitatively reproducible. We present here a thorough characterization of the phospholipids purified from [P-32]orthophosphate- and myo-[2-H-3]inositol-radiolabded Arabidopsis thaliana suspension-cultured cells. We then show that NaCl treatment induces dramatic increases in the levels of phosphatidylinositol 4,5-bisphosphate and diacylglycerol pyrophosphate and also affects the turnover of phosphatidylcholine. The increase in phosphatidylinositol 4,5-bisphosphate was also observed with a non-ionic hyperosmotic shock. In contrast, the increase in diacylglycerol pyrophosphate and the turnover of phosphatidylcholine mere relatively specific to salt treatments as only minor changes in the metabolism of these two phospholipids were detected when the cells were treated with sorbitol instead of NaCl.	Univ Lund, Dept Plant Biochem, SE-22100 Lund, Sweden; Univ Birmingham, Ctr Clin Res Immunol & Signalling, Birmingham B15 2TT, W Midlands, England	Lund University; University of Birmingham	Pical, C (corresponding author), Univ Lund, Dept Plant Biochem, POB 117, SE-22100 Lund, Sweden.							ALEXANDRE J, 1990, NATURE, V343, P567, DOI 10.1038/343567a0; Ashcroft FM, 1998, SCIENCE, V282, P1059, DOI 10.1126/science.282.5391.1059; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLATT MR, 1990, NATURE, V346, P766, DOI 10.1038/346766a0; BREARLEY CA, 1993, BIOCHEM J, V290, P145, DOI 10.1042/bj2900145; Brearley CA, 1997, BIOCHEM J, V324, P123, DOI 10.1042/bj3240123; BREARLEY CA, 1992, BIOCHEM J, V283, P255, DOI 10.1042/bj2830255; BREARLEY CA, 1995, BIOCHEM J, V311, P1001, DOI 10.1042/bj3111001; BREARLEY CA, 1997, SIGNALLING INOSITIDE, P1; CHO MH, 1993, PLANT PHYSIOL, V103, P637, DOI 10.1104/pp.103.2.637; COTE GG, 1989, PLANT PHYSIOL, V90, P1422, DOI 10.1104/pp.90.4.1422; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; DOVE SK, 1999, SIGNAL TRANSDUCTION, P255; DROBAK BK, 1994, PLANT J, V6, P389, DOI 10.1046/j.1365-313X.1994.06030389.x; DROBAK BK, 1988, PLANT PHYSIOL, V87, P217, DOI 10.1104/pp.87.1.217; DROBAK BK, 1992, BIOCHEM J, V288, P697, DOI 10.1042/bj2880697; EINSPAHR KJ, 1988, J BIOL CHEM, V263, P5775; EPSTEIN E, 1980, SCIENCE, V210, P399, DOI 10.1126/science.210.4468.399; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; HANSON AD, 1983, PLANT PHYSIOL, V71, P692, DOI 10.1104/pp.71.3.692; HIRAYAMA T, 1995, P NATL ACAD SCI USA, V92, P3903, DOI 10.1073/pnas.92.9.3903; IRVINE RF, 1989, PLANT PHYSIOL, V89, P888, DOI 10.1104/pp.89.3.888; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Kopka J, 1998, PLANT PHYSIOL, V116, P239, DOI 10.1104/pp.116.1.239; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LESTER RL, 1978, INOSITOL METABOLISM, P83; LIU B, 1994, PLANT CELL, V6, P303, DOI 10.1105/tpc.6.2.303; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; LYNCH J, 1989, PLANT PHYSIOL, V90, P1271, DOI 10.1104/pp.90.4.1271; Meijer HJG, 1999, PLANTA, V208, P294; Mikami K, 1998, PLANT J, V15, P563, DOI 10.1046/j.1365-313X.1998.00227.x; MUNNIK T, 1994, BIOCHEM J, V298, P269, DOI 10.1042/bj2980269; Munnik T, 1996, J BIOL CHEM, V271, P15708, DOI 10.1074/jbc.271.26.15708; MUNNIK T, 1994, PLANTA, V193, P89, DOI 10.1007/BF00191611; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Nuccio ML, 1998, PLANT J, V16, P487, DOI 10.1046/j.1365-313x.1998.00316.x; Oh ES, 1998, J BIOL CHEM, V273, P10624, DOI 10.1074/jbc.273.17.10624; PARMAR PN, 1993, PLANT J, V4, P255, DOI 10.1046/j.1365-313X.1993.04020255.x; PICAL C, 1997, PLANT PHYSIOL, V114, P747; Rhodes D., 1994, CELLULAR MOL PHYSL C, P347; SHI JR, 1995, PLANT J, V8, P381, DOI 10.1046/j.1365-313X.1995.08030381.x; WELTERS P, 1994, P NATL ACAD SCI USA, V91, P11398, DOI 10.1073/pnas.91.24.11398; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Xue HW, 1999, J BIOL CHEM, V274, P5738, DOI 10.1074/jbc.274.9.5738; YANG WN, 1993, J BIOL CHEM, V268, P392; Zhu JK, 1997, CRIT REV PLANT SCI, V16, P253, DOI 10.1080/713608147	52	143	149	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38232	38240		10.1074/jbc.274.53.38232	http://dx.doi.org/10.1074/jbc.274.53.38232			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608898	hybrid			2022-12-27	WOS:000084528000098
J	Yeo, EJ; Briggs, WT; Wagner, C				Yeo, EJ; Briggs, WT; Wagner, C			Inhibition of glycine N-methyltransferase by 5-methyltetrahydrofolate pentaglutamate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-GROUP METABOLISM; FOLATE BINDING-PROTEIN; RAT-LIVER CYTOSOL; PURIFICATION; FOLYLPOLYGLUTAMATES; DEOXYHEMOGLOBIN; IDENTIFICATION; DERIVATIVES	Glycine N-methyltransferase (EC 2.1.1.20) catalyzes the methylation of glycine by S-adenosylmethionine to form sarcosine and S-adenosylhomocysteine. The enzyme was previously shown to be abundant in both the liver and pancreas of the rat, to consist of four identical monomers, and to contain tightly bound folate polyglutamates in vivo. We now report that the inhibition of glycine N-methyltransferase by (GS)-5-CH3-H(4)PteGlu(5) is noncompetitive with regard to both S-adenosylmethionine and glycine, The enzyme exhibits strong positive cooperativity with respect to S-adenosylmethionine. Cooperativity increases with increasing concentrations of 5-CH3-H(4)PteGlu(5) and is greater at physiological pH than at pH 9.0, the pH optimum. Under the same conditions, cooperativity is much greater for the pancreatic form of the enzyme. The V-max for the liver form of the enzyme is approximately twice that of the pancreatic enzyme, while K-m values for each substrate are similar in the liver and pancreatic enzymes. For the liver enzyme, at pH 7.0 half-maximal inhibition is seen at a concentration of about 0.2 mu M (6S)-5-CH3-H(4)PteGl(5), while at pH 9.0 this value is increased to about 1 mu M. For the liver form of the enzyme, 50% inhibition with respect to S-adenosylmethionine at pH 7.4 occurs at about 0.27 mu M. The dissociation constant, K-s obtained from binding data at pH 7.4 is 0.095, About 1 mol of (6S)-5-CH3-H(4)PteGlu(5) was bound per tetramer at pH 7.0, and 1.6 mol were bound at pH 9.0, The degree of binding and inhibition were closely parallel at each pH, At equal concentrations of (6R,6S)- and (6S)-5-CH3-H(4)PteGlu(5), the natural (6S) form was about twice as inhibitory. These studies indicate that glycine N-methyltransferase is a highly allosteric enzyme, which is consistent with its role as a regulator of methyl group metabolism in both the liver and the pancreas.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Wagner, C (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 620 Light Hall, Nashville, TN 37232 USA.							ARNONE A, 1986, J BIOL CHEM, V261, P5853; BALAGHI M, 1992, J NUTR, V122, P1391, DOI 10.1093/jn/122.7.1391; BENESCH RE, 1985, J BIOL CHEM, V260, P4653; BENESCH RE, 1983, P NATL ACAD SCI-BIOL, V80, P6202, DOI 10.1073/pnas.80.20.6202; BLUMENSTEIN J, 1960, BIOCHEM BIOPH RES CO, V3, P259, DOI 10.1016/0006-291X(60)90235-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANTONI GL, 1978, TRANSMETHYLATION, P155; COOK RJ, 1984, P NATL ACAD SCI-BIOL, V81, P3631, DOI 10.1073/pnas.81.12.3631; Dahlquist F W, 1978, Methods Enzymol, V48, P270; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; GIULIDORI P, 1981, CLIN CHEM, V27, P2041; HEADY JE, 1973, J BIOL CHEM, V248, P69; HORNE D W, 1989, Biofactors, V2, P65; Horne D W, 1980, Methods Enzymol, V66, P545; KERR SJ, 1972, J BIOL CHEM, V247, P4248; KONISHI K, 1987, BIOCHEMISTRY-US, V26, P8496, DOI 10.1021/bi00399a069; KONISHI K, 1988, J BIOL CHEM, V263, P13381; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; OGAWA H, 1982, J BIOL CHEM, V257, P3447; Ogawa H, 1997, BIOCHEM J, V327, P407, DOI 10.1042/bj3270407; OGAWA H, 1984, BIOCHEM BIOPH RES CO, V124, P44, DOI 10.1016/0006-291X(84)90913-6; SEGEL IH, 1993, ENZYME KINETICS WILE, P15; SUZUKI N, 1980, ARCH BIOCHEM BIOPHYS, V199, P236, DOI 10.1016/0003-9861(80)90277-5; WAGNER C, 1985, BIOCHEM BIOPH RES CO, V127, P746, DOI 10.1016/S0006-291X(85)80006-1; WILSON SD, 1986, METHOD ENZYMOL, V122, P269, DOI 10.1016/0076-6879(86)22181-3; YEO EJ, 1992, J BIOL CHEM, V267, P24669; ZAMIEROWSKI MM, 1977, J BIOL CHEM, V252, P933; ZAPPIA V, 1983, METHOD ENZYMOL, V94, P57	28	44	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37559	37564		10.1074/jbc.274.53.37559	http://dx.doi.org/10.1074/jbc.274.53.37559			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608809	hybrid			2022-12-27	WOS:000084528000009
J	Yousef, GM; Diamandis, EP				Yousef, GM; Diamandis, EP			The new kallikrein-like gene, KLK-L2 - Molecular characterization, mapping, tissue expression, and hormonal regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; HUMAN GLANDULAR KALLIKREIN; SEQUENCE-ANALYSIS; SERINE-PROTEASE; POSITIONAL CLONING; CDNA; LOCUS; IDENTIFICATION; TRYPSIN; BREAST	Since in rodents the kallikreins are represented by a large multi-gene family, the restriction of this family in humans to three genes is somewhat surprising. In an effort to identify new human kallikrein genes, we examined a genomic area of about 300 kilobases on chromosome 19q13.3-q13.4, a region that contains most of the currently known kallikreins. By using the positional candidate approach, we were able to identify a new gene named KLK-L2 (for kallikrein-like gene 2). Screening of human EST libraries allowed us to delineate the full genomic and cDNA structure of the new gene. KLK-L2 consists of 5 coding exons and 4 introns and has significant similarities to other members of the kallikrein multi-gene family. Homology studies suggest that the protein is likely secreted. KLK-L2 is expressed mainly in breast, brain, and testis and to a lesser extent in many other tissues. KLK-L2 is up-regulated by estrogens and progestins in the breast cancer cell line BT-474.	Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Diamandis, EP (corresponding author), Mt Sinai Hosp, Dept Pathol & Lab Med, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.			Diamandis, Eleftherios/0000-0002-1589-820X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisowicz A, 1996, MOL MED, V2, P624, DOI 10.1007/BF03401646; ASHLEY PL, 1985, BIOCHEMISTRY-US, V24, P4520, DOI 10.1021/bi00338a006; BAKER AR, 1985, DNA-J MOLEC CELL BIO, V4, P445, DOI 10.1089/dna.1985.4.445; Boehm T, 1998, METHODS, V14, P152, DOI 10.1006/meth.1997.0574; CLEMENTS J, 1997, KININ SYSTEM, P71; Clements JA, 1996, CLIN ENDOCRINOL, V44, P223, DOI 10.1046/j.1365-2265.1996.661481.x; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DAYHOFF MO, 1976, FED PROC, V35, P2132; Diamandis EP, 1998, TRENDS ENDOCRIN MET, V9, P310, DOI 10.1016/S1043-2760(98)00082-4; EVANS BA, 1988, BIOCHEMISTRY-US, V27, P3124, DOI 10.1021/bi00409a003; EVANS BA, 1987, J BIOL CHEM, V262, P8027; FUKUSHIMA D, 1985, BIOCHEMISTRY-US, V24, P8037, DOI 10.1021/bi00348a030; Goyal J, 1998, CANCER RES, V58, P4782; IIDA Y, 1990, J THEOR BIOL, V145, P523, DOI 10.1016/S0022-5193(05)80486-2; IRWIN DM, 1988, J MOL BIOL, V200, P31, DOI 10.1016/0022-2836(88)90331-2; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LIN FK, 1993, BIOCHIM BIOPHYS ACTA, V1173, P325, DOI 10.1016/0167-4781(93)90131-V; Little SP, 1997, J BIOL CHEM, V272, P25135, DOI 10.1074/jbc.272.40.25135; Liu XL, 1996, CANCER RES, V56, P3371; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; MURRAY SR, 1990, J CADIOVASC PHARM S6, V15, P7; NADEAU JH, 1992, MAMM GENOME, V3, P480, DOI 10.1007/BF00778825; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; OESTERLING JE, 1991, J UROLOGY, V145, P907, DOI 10.1016/S0022-5347(17)38491-4; RICHARDS RI, 1991, GENOMICS, V11, P77, DOI 10.1016/0888-7543(91)90103-L; RIEGMAN PHJ, 1989, FEBS LETT, V247, P123, DOI 10.1016/0014-5793(89)81253-0; RIEGMAN PHJ, 1992, GENOMICS, V14, P6, DOI 10.1016/S0888-7543(05)80275-7; SAUNDERS AM, 1990, GENOMICS, V8, P525, DOI 10.1016/0888-7543(90)90040-2; SCHEDLICH LJ, 1987, DNA-J MOLEC CELL BIO, V6, P429, DOI 10.1089/dna.1987.6.429; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; Stenman UH, 1999, CLIN CHEM, V45, P753; Takayama TK, 1997, J BIOL CHEM, V272, P21582, DOI 10.1074/jbc.272.34.21582; Yamashiro K, 1997, BBA-GENE STRUCT EXPR, V1350, P11, DOI 10.1016/S0167-4781(96)00187-X; Yoshida S, 1998, GENE, V213, P9, DOI 10.1016/S0378-1119(98)00232-7	37	90	92	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37511	37516		10.1074/jbc.274.53.37511	http://dx.doi.org/10.1074/jbc.274.53.37511			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608802	hybrid			2022-12-27	WOS:000084528000002
J	Bhasin, A; Goryshin, IY; Reznikoff, WS				Bhasin, A; Goryshin, IY; Reznikoff, WS			Hairpin formation in Tn5 transposition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-I; V(D)J RECOMBINATION; TN10 TRANSPOSITION; STRAND TRANSFER; RAG2 PROTEINS; ACTIVE-SITE; 2 STEPS; INTERMEDIATE; CLEAVAGE; MU	The initial chemical steps in Tn5 transposition result in blunt end cleavage of the transposon from the donor DNA. We demonstrate that this cleavage occurs via a hairpin intermediate. The first step is a 3' hydrolytic nick by transposase. The free 3'OH then attacks the phosphodiester bond on the opposite strand, forming a hairpin at the transposon end. In addition to forming precise hairpins, Tn5 transposase can form imprecise hairpins. This is the first example of imprecise hairpin formation on transposon end DNA. To undergo strand transfer, the hairpin must to be resolved by a transposase-catalyzed hydrolytic cleavage. We show that both precise and imprecise hairpins are opened by transposase. A transposition mechanism utilizing a hairpin intermediate allows a single transposase active site to cleave both 3' and 5' strands without massive protein/DNA rearrangements.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Reznikoff, WS (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.				NIGMS NIH HHS [GM50692] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; BAINTON R, 1991, CELL, V65, P805, DOI 10.1016/0092-8674(91)90388-F; BERG DE, 1989, MOBILE DNA, P185; BOLLAND S, 1995, P NATL ACAD SCI USA, V92, P7814, DOI 10.1073/pnas.92.17.7814; Bolland S, 1996, CELL, V84, P223, DOI 10.1016/S0092-8674(00)80977-0; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; Colot V, 1998, MOL CELL BIOL, V18, P4337, DOI 10.1128/MCB.18.7.4337; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; HANIFORD D, 1994, EMBO J, V13, P3401, DOI 10.1002/j.1460-2075.1994.tb06643.x; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; KULKOSKY J, 1995, VIROLOGY, V206, P448, DOI 10.1016/S0042-6822(95)80060-3; Maxam A M, 1980, Methods Enzymol, V65, P499; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; MIZUUCHI K, 1983, CELL, V35, P785, DOI 10.1016/0092-8674(83)90111-3; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; MORISATO D, 1984, CELL, V39, P181, DOI 10.1016/0092-8674(84)90204-6; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; REZNIKOFF WS, 1993, ANNU REV MICROBIOL, V47, P945, DOI 10.1146/annurev.mi.47.100193.004501; SAKAI J, 1995, EMBO J, V14, P4374, DOI 10.1002/j.1460-2075.1995.tb00112.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sarnovsky RJ, 1996, EMBO J, V15, P6348, DOI 10.1002/j.1460-2075.1996.tb01024.x; SASAKAWA C, 1981, MOL GEN GENET, V182, P19, DOI 10.1007/BF00422761; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SYVANEN M, 1982, J MOL BIOL, V158, P203, DOI 10.1016/0022-2836(82)90429-6; Ton-Hoang B, 1998, EMBO J, V17, P1169, DOI 10.1093/emboj/17.4.1169; Watson MA, 1996, CELL, V85, P435, DOI 10.1016/S0092-8674(00)81121-6; Zhou M, 1998, J MOL BIOL, V276, P913, DOI 10.1006/jmbi.1997.1579	30	116	120	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37021	37029		10.1074/jbc.274.52.37021	http://dx.doi.org/10.1074/jbc.274.52.37021			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601258	hybrid			2022-12-27	WOS:000084382700029
J	de Mena, IR; Fernandez-Moreno, MA; Bornstein, B; Kaguni, LS; Garesse, R				de Mena, IR; Fernandez-Moreno, MA; Bornstein, B; Kaguni, LS; Garesse, R			Structure and regulated expression of the delta-aminolevulinate synthase gene from Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROID 5-AMINOLEVULINATE SYNTHASE; NUCLEO-MITOCHONDRIAL INTERACTIONS; IRON-RESPONSIVE ELEMENTS; FRIEND-LEUKEMIA CELLS; DNA-BINDING PROTEINS; YEAST ACTIVATOR HAP1; H-CHAIN EXPRESSION; SEA-URCHIN EMBRYO; MESSENGER-RNA; HEME-BIOSYNTHESIS	The structure of the single copy gene encoding the putative housekeeping isoform of Drosophila melanogaster delta-aminolevulinate synthase (ALAS) has been determined. Southern and immunoblot analyses suggest that only the housekeeping isoform of the enzyme exists in Drosophila. We have localized a critical region for promoter activity to a sequence of 121 base pairs that contains a motif that is potentially recognized by factors of the nuclear respiratory factor-1 (NRF-1)/P3A2 family, flanked by two AP4 sites. Heme inhibits the expression of the gene by blocking the interaction of putative regulatory proteins to its 5' proximal region, a mechanism different from those proposed for other hemin-regulated promoters. Northern and in situ RNA hybridization experiments show that maternal alas mRNA is stored in the egg; its steady-state level decreases rapidly during the first hours of development and increases again after gastrulation in a period where the synthesis of several mRNAs encoding metabolic enzymes is activated. In the syncytial blastoderm, the alas mRNA is ubiquitously distributed and decreases in abundance substantially through cellular blastoderm. Late in embryonic development alas shows a specific pattern of expression, with an elevated mRNA level in oenocytes, suggesting an important role of these cells in the biosynthesis of hemoproteins in Drosophila.	Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed Alberto Sols,Dept Bioquim, E-28029 Madrid, Spain; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Michigan State University	Garesse, R (corresponding author), Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed Alberto Sols,Dept Bioquim, C Arzobispo Morcillo 4, E-28029 Madrid, Spain.	rafael.garesse@uam.es	Garesse, Rafael/F-3836-2012; Fernandez-Moreno, Miguel Angel/K-4425-2017	Fernandez-Moreno, Miguel Angel/0000-0002-3461-0726				ARKHIPOVA IR, 1995, GENETICS, V139, P1359; BRAIDOTTI G, 1993, J BIOL CHEM, V268, P1109; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; CALLEJA M, 1993, J BIOL CHEM, V268, P18891; CALZONE FJ, 1991, DEVELOPMENT, V112, P335; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COCCIA EM, 1995, BLOOD, V86, P1570, DOI 10.1182/blood.V86.4.1570.bloodjournal8641570; COCCIA EM, 1992, MOL CELL BIOL, V12, P3015, DOI 10.1128/MCB.12.7.3015; Cohen SM., 1993, DEV DROSOPHILA MELAN; CONBOY JG, 1992, J BIOL CHEM, V267, P18753; COSTANZO MC, 1990, ANNU REV GENET, V24, P91; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Demerec M, 1994, BIOL DROSOPHILA; DeSimone S, 1996, DEVELOPMENT, V122, P31; DESIMONE SM, 1993, MOL CELL BIOL, V13, P3641, DOI 10.1128/MCB.13.6.3641; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DORIT RL, 1994, CURRENT PROTOCOLS MO; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P147, DOI 10.1007/BF02110029; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Gray NK, 1996, P NATL ACAD SCI USA, V93, P4925, DOI 10.1073/pnas.93.10.4925; GRIVELL LA, 1995, CRIT REV BIOCHEM MOL, V30, P121, DOI 10.3109/10409239509085141; GRIVELL LA, 1989, EUR J BIOCHEM, V182, P477, DOI 10.1111/j.1432-1033.1989.tb14854.x; HALDI ML, 1995, MOL GEN GENET, V248, P229, DOI 10.1007/BF02190805; HAYASHI N, 1983, BIOCHEM BIOPH RES CO, V115, P700, DOI 10.1016/S0006-291X(83)80201-0; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HOOG C, 1991, DEVELOPMENT, V112, P351; KAPPAS A, 1995, METABOLIC MOL BASES, V2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lenka N, 1998, PROG NUCLEIC ACID RE, V61, P309, DOI 10.1016/S0079-6603(08)60830-2; MARTINEZARIAS A, 1993, DEV DROSOPHILA MELAN, V1, P517; Marziali G, 1997, MOL CELL BIOL, V17, P1387, DOI 10.1128/MCB.17.3.1387; MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2; MAY BK, 1986, CURR TOP CELL REGUL, V28, P233; MAY BK, 1990, MOL BIOL MED, V7, P405; Moyes CD, 1998, J EXP BIOL, V201, P299; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; PADMANABAN G, 1989, TRENDS BIOCHEM SCI, V14, P492, DOI 10.1016/0968-0004(89)90182-5; PENA P, 1995, BIOCHEM J, P887; Ponka P, 1997, BLOOD, V89, P1; Reddy SV, 1998, BLOOD, V91, P1793, DOI 10.1182/blood.V91.5.1793.1793_1793_1801; Reddy SV, 1996, BLOOD, V88, P2288, DOI 10.1182/blood.V88.6.2288.bloodjournal8862288; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846; SCHOENHAUT DS, 1989, NUCLEIC ACIDS RES, V17, P7013, DOI 10.1093/nar/17.17.7013; SHAWLEE RL, 1991, MOL GEN GENET, V230, P225, DOI 10.1007/BF00290672; SOELLER WC, 1993, MOL CELL BIOL, V13, P7961, DOI 10.1128/MCB.13.12.7961; SRIVASTAVA G, 1988, J BIOL CHEM, V263, P5202; SRIVASTAVA G, 1990, MOL PHARMACOL, V38, P486; Talamillo A, 1998, MOL BIOL REP, V25, P87, DOI 10.1023/A:1006868306735; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40; WALLACE DC, 1993, TRENDS GENET, V9, P128, DOI 10.1016/0168-9525(93)90207-X; WIGGLESWORTH VB, 1970, PRINCIPLES INSECT PH, P411; YAMAMOTO M, 1988, J BIOL CHEM, V263, P15973; Yoshima T, 1998, J BIOL CHEM, V273, P25466, DOI 10.1074/jbc.273.39.25466; Zeviani M, 1997, J BIOENERG BIOMEMBR, V29, P121, DOI 10.1023/A:1022633912917; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; ZHANG L, 1994, J BIOL CHEM, V269, P14643; ZHANG L, 1994, GENETICS, V136, P813; Zhang L, 1996, EMBO J, V15, P4676, DOI 10.1002/j.1460-2075.1996.tb00844.x; Zhang L, 1998, MOL CELL BIOL, V18, P3819, DOI 10.1128/MCB.18.7.3819	69	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37321	37328		10.1074/jbc.274.52.37321	http://dx.doi.org/10.1074/jbc.274.52.37321			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601299	hybrid			2022-12-27	WOS:000084382700070
J	Plant, PJ; Manolson, MF; Grinstein, S; Demaurex, N				Plant, PJ; Manolson, MF; Grinstein, S; Demaurex, N			Alternative mechanisms of vacuolar acidification in H+-ATPase-deficient yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; PLASMA-MEMBRANE ATPASE; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR PH; NEUROSPORA-CRASSA; MOTIVE FORCE; CELLS; TRANSPORT; VESICLES; MUTANTS	Acidification of the endosomal/lysosomal pathway by the vacuolar-type proton translocating ATPase (V-ATPase) is necessary for a variety of essential eukaryotic cellular functions. Nevertheless, yeasts lacking V-ATPase activity (Delta vma) are viable when grown at low pH, suggesting alternative methods of organellar acidification. This was confirmed by directly measuring the vacuolar pH by ratio fluorescence imaging. When Delta vma yeasts were cultured and tested in the acidic conditions required for growth of V-ATPase-deficient mutants, the vacuolar pH was 5.9. Fluid-phase pinocytosis of acidic extracellular medium cannot account for these observations, because the V-ATPase-independent vacuolar acidification was unaffected in mutants deficient in endocytosis, Similarly, internalization of the plasmalemmal H+-ATPase (Pma1p) was-ruled out, because overexpression of Pma1p failed to complement the Delta vma phenotype and did not potentiate the vacuolar acidification. To test whether weak electrolytes present in the culture medium could ferry acid equivalents to the vacuole, wildtype and the Delta vma yeasts were subjected to sudden changes in extracellular pH, In both cell types, the vacuoles rapidly alkalinized when external pH was raised from 5.5 (the approximate pH of the culture medium) to 7.5 and re-acidified when the yeasts were returned to a medium of pH 5.5. Importantly, these rapid pH changes were only observed when NH4+, routinely added as a nitrogen source, was present. The NH4+-dependent acidification was not due to efflux of NH, from the vacuole, as cells equilibrated to pH 7.5 in the absence of weak electrolytes rapidly acidified when challenged with an acidic medium containing NH4+. These findings suggest that although NH, can act as a cell-permeant proton scavenger, NH4+ may function as a protonophore, facilitating equilibration of the pH across the plasma and vacuolar membranes of yeast. The high concentration of NH4+ frequently added as a nitrogen source to yeast culture media together with effective NH4+ transporters thereby facilitate vacuolar acidification when cells are suspended in acidic solutions.	Univ Geneva, Med Ctr, Dept Physiol, CH-1211 Geneva 4, Switzerland; Univ Toronto, Dept Biochem, Toronto, ON M5S 2Z9, Canada; Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada	University of Geneva; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Demaurex, N (corresponding author), Univ Geneva, Med Ctr, Dept Physiol, 1 Michel Servet, CH-1211 Geneva 4, Switzerland.	Nicolas.Demaurex@medicine.unige.ch		Manolson, Morris/0000-0001-8755-5460; Demaurex, Nicolas/0000-0002-9933-6772				ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; ANRAKU Y, 1996, HDB BIOL PHYS, V2, P93; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BOWMAN BJ, 1992, J BIOENERG BIOMEMBR, V24, P361, DOI 10.1007/BF00762529; BOYER MJ, 1994, METHOD CELL BIOL, V41, P135; Carmelo V, 1997, BBA-BIOMEMBRANES, V1325, P63, DOI 10.1016/S0005-2736(96)00245-3; CIMPRICH P, 1995, FEMS MICROBIOL LETT, V130, P245; CREEK KE, 1984, LYSOSOM BIOL PATHOL, P63; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; DENHOLLANDER JA, 1981, BIOCHEMISTRY-US, V20, P5871, DOI 10.1021/bi00523a034; Ferea TL, 1996, GENETICS, V143, P147; Forgac M, 1998, FEBS LETT, V440, P258, DOI 10.1016/S0014-5793(98)01425-2; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; Forster C, 1999, J BIOL CHEM, V274, P9442, DOI 10.1074/jbc.274.14.9442; FOURY F, 1990, J BIOL CHEM, V265, P18554; GOFFEAU A, 1981, BIOCHIM BIOPHYS ACTA, V639, P197, DOI 10.1016/0304-4173(81)90010-0; GRINSTEIN S, 1992, J EXP BIOL, V172, P179; Guldfeldt LU, 1998, APPL ENVIRON MICROB, V64, P530; HAWORTH RS, 1991, BIOCHIM BIOPHYS ACTA, V1098, P79; HAWORTH RS, 1993, MOL CELL BIOCHEM, V124, P131, DOI 10.1007/BF00929205; IMAI T, 1995, J BIOTECHNOL, V38, P165, DOI 10.1016/0168-1656(94)00130-5; JOHNSON EIM, 1989, J ENDOCRINOL, V122, P391, DOI 10.1677/joe.0.1220391; MAHNENSMITH RL, 1985, CIRC RES, V56, P773, DOI 10.1161/01.RES.56.6.773; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883, DOI 10.1152/ajpcell.1998.274.4.C883; NAKAMOTO RK, 1991, J BIOL CHEM, V266, P7940; NAKAMOTO RK, 1989, J BIOENERG BIOMEMBR, V21, P621, DOI 10.1007/BF00808117; NEGULESCU PA, 1990, METHOD ENZYMOL, V192, P38; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; OHYA Y, 1991, J BIOL CHEM, V266, P13971; PREISIG PA, 1990, AM J PHYSIOL, V259, pF587, DOI 10.1152/ajprenal.1990.259.4.F587; PRESTON RA, 1989, P NATL ACAD SCI USA, V86, P7027, DOI 10.1073/pnas.86.18.7027; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; SCHLESSER A, 1988, J BIOL CHEM, V263, P19480; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; SLAVIK J, 1984, BIOCHIM BIOPHYS ACTA, V766, P679, DOI 10.1016/0005-2728(84)90129-4; SLAVIK J, 1982, FEBS LETT, V140, P22, DOI 10.1016/0014-5793(82)80512-7; SLAYMAN CL, 1994, J EXP BIOL, V196, P419; SZE H, 1985, ANNU REV PLANT PHYS, V36, P175, DOI 10.1146/annurev.pp.36.060185.001135; TANIDA I, 1995, J BIOL CHEM, V270, P10113, DOI 10.1074/jbc.270.17.10113; THEVELEIN JM, 1987, J GEN MICROBIOL, V133, P2191; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; Wall SM, 1997, AM J PHYSIOL-RENAL, V273, pF857, DOI 10.1152/ajprenal.1997.273.6.F857; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737	51	81	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37270	37279		10.1074/jbc.274.52.37270	http://dx.doi.org/10.1074/jbc.274.52.37270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601292	Green Published, hybrid			2022-12-27	WOS:000084382700063
J	Lesieur, C; Frutiger, S; Hughes, G; Kellner, R; Pattus, F; van der Goot, FG				Lesieur, C; Frutiger, S; Hughes, G; Kellner, R; Pattus, F; van der Goot, FG			Increased stability upon heptamerization of the pore-forming toxin aerolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-CHANNEL; PROTEOLYTIC ACTIVATION; STAPHYLOCOCCUS-AUREUS; MASS-SPECTROMETRY; LIPID BILAYERS; ALPHA-TOXIN; OLIGOMERIZATION; PROAEROLYSIN; PROTEINS; INSERTION	Aerolysin is a bacterial pore-forming toxin that is secreted as an inactive precursor, which is then processed at its COOH terminus and finally forms a circular heptameric ring which inserts into membranes to form a pore. We have analyzed the stability of the precursor proaerolysin and the heptameric complex. Equilibrium unfolding induced by urea and guanidinium hydrochloride was monitored by measuring the intrinsic tryptophan fluorescence of the protein. Proaerolysin was found to unfold in two steps corresponding to the unfolding of the large COOH-terminal lobe followed by the unfolding of the small NH2-terminal domain. We show that proaerolysin contains two disulfide bridges which strongly contribute to the stability of the toxin and protect it from proteolytic attack. The stability of aerolysin was greatly enhanced by polymerization into a heptamer. Two regions of the protein, corresponding to amino acids 130-307 and 401-427, were identified, by limited proteolysis, NH2-terminal sequencing and matrix-assisted laser desorption ionization-time of flight, as being responsible for stability and maintenance of the heptamer. These regions are presumably involved in monomer/monomer interactions in the heptameric protein and are exclusively composed of beta structure. The stability of the aerolysin heptamer is reminiscent of that of pathogenic, fimbrial protein aggregates found in a variety of neurodegenerative diseases.	Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; Ctr Med Univ Geneva, Dept Med Biochem, CH-1211 Geneva, Switzerland; Merck KGAA, Preclin Res & Dev, D-64271 Darmstadt, Germany; Ecole Super Biotechnol Strasbourg, UPR 9050 CNRS, F-67400 Illkirch, France	University of Geneva; University of Geneva; Merck KGaA; Centre National de la Recherche Scientifique (CNRS)	van der Goot, FG (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.		van der Goot, Gisou G/B-2279-2012	van der Goot, Gisou G/0000-0002-8522-274X				Antson AA, 1996, CURR OPIN STRUC BIOL, V6, P142, DOI 10.1016/S0959-440X(96)80067-4; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Buckley JT, 1995, BIOCHEMISTRY-US, V34, P16450, DOI 10.1021/bi00050a028; BUCKLEY JT, 1990, BIOCHEM CELL BIOL, V68, P221, DOI 10.1139/o90-029; Cabiaux V, 1997, BIOCHEMISTRY-US, V36, P15224, DOI 10.1021/bi971216p; Capaldi RA, 1991, CURR OPIN STRUC BIOL, V1, P562, DOI 10.1016/S0959-440X(05)80078-8; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; HARDIE KR, 1995, MOL MICROBIOL, V17, P1035, DOI 10.1111/j.1365-2958.1995.mmi_17061035.x; Hough DW, 1999, CURR OPIN CHEM BIOL, V3, P39, DOI 10.1016/S1367-5931(99)80008-8; HOWARD SP, 1985, J BACTERIOL, V163, P336, DOI 10.1128/JB.163.1.336-340.1985; HOWARD SP, 1982, BIOCHEMISTRY-US, V21, P1662, DOI 10.1021/bi00536a029; Jaenicke R, 1996, NATURWISSENSCHAFTEN, V83, P544; Janek K, 1999, BIOCHEMISTRY-US, V38, P8246, DOI 10.1021/bi990510+; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURIERE M, 1993, ANAL BIOCHEM, V212, P206, DOI 10.1006/abio.1993.1313; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604; Moniatte M, 1996, FEBS LETT, V384, P269, DOI 10.1016/0014-5793(96)00328-6; Moniatte M, 1997, INT J MASS SPECTROM, V169, P179, DOI 10.1016/S0168-1176(97)00213-9; Orpiszewski J, 1999, J MOL BIOL, V289, P413, DOI 10.1006/jmbi.1999.2768; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Parker MW, 1996, MOL MICROBIOL, V19, P205, DOI 10.1046/j.1365-2958.1996.355887.x; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Rossjohn J, 1998, BIOCHEMISTRY-US, V37, P741, DOI 10.1021/bi9721039; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCHRAGGER H, 1987, ANAL BIOCHEM, V166, P368; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; VANDERGOOT FG, 1992, BIOCHEMISTRY-US, V31, P8566, DOI 10.1021/bi00151a026; VANDERGOOT FG, 1994, J BIOL CHEM, V269, P30496; VANDERGOOT FG, 1993, J BIOL CHEM, V268, P18272; VANDERGOOT FG, 1993, BIOCHEMISTRY-US, V32, P2636, DOI 10.1021/bi00061a023; Vecsey-Semjen B, 1999, BIOCHEMISTRY-US, V38, P4296, DOI 10.1021/bi982472k; WALEV I, 1994, MICROB PATHOGENESIS, V17, P187, DOI 10.1006/mpat.1994.1065; WILMSEN HU, 1990, J MEMBRANE BIOL, V115, P71, DOI 10.1007/BF01869107; WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788	37	35	35	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36722	36728		10.1074/jbc.274.51.36722	http://dx.doi.org/10.1074/jbc.274.51.36722			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593978	hybrid			2022-12-27	WOS:000084279200097
J	Lin, X; Sikkink, RA; Rusnak, F; Barber, DL				Lin, X; Sikkink, RA; Rusnak, F; Barber, DL			Inhibition of calcineurin phosphatase activity by a calcineurin B homologous protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE-T ACTIVATION; KEY SIGNALING ENZYME; BINDING DOMAIN; AUTOINHIBITORY DOMAIN; CARDIAC-HYPERTROPHY; CELL ACTIVATION; CYCLOSPORINE-A; NF-AT; CALMODULIN; CALCIUM	Calcineurin, a Ca2+/calmodulin-stimulated protein phosphatase, plays a key role in T-cell activation by regulating the activity of NFAT (nuclear factor of activated (T) under bar cells), a family of transcription factors required for the synthesis of several cytokine genes. Calcineurin is the target of the immunosuppressive drugs cyclosporin A and FK506 complexed with their cytoplasmic receptors cyclophilin and FKBP12, respectively. In this study we report that calcineurin is also the target of a recently identified Ca2+-binding protein, CHP (for calcineurin homologous protein), which shares a high degree of homology with the regulatory B subunit of calcineurin and with calmodulin, In Jurkat and HeLa cells, overexpression of CHP specifically impaired the nuclear translocation and transcriptional activity of NFAT but had no effect on AP-1 transcriptional activity and only a small (<25%) inhibitory effect on the transcriptional activity of NF kappa B. Further study indicated that CHP inhibits calcineurin activity, In cells overexpressing CHP, the phosphatase activity of immunoprecipitated calcineurin was inhibited by similar to 50%; and in a reconstituted assay, the activity of purified calcineurin was inhibited up to 97% by the addition of purified recombinant CHP in a dose-dependent manner. Moreover, pro longed activation of Jurkat cells was associated with a decreased abundance of CHP, suggesting a possible regulatory mechanism allowing activation of calcineurin. CHP, therefore, is a previously unrecognized endogenous inhibitor of calcineurin activity.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic	Barber, DL (corresponding author), Univ Calif San Francisco, Dept Stomatol, Box 0512,HSW 604, San Francisco, CA 94143 USA.				NIDDK NIH HHS [DK40259] Funding Source: Medline; NIGMS NIH HHS [GM46865, GM 47413] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040259, R29DK040259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046865, R01GM047413] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; CHANG HY, 1995, NATURE, V376, P686, DOI 10.1038/376686a0; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HUBBARD MJ, 1989, BIOCHEMISTRY-US, V28, P1868, DOI 10.1021/bi00430a066; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; KAWAMURA A, 1995, J BIOL CHEM, V270, P15463, DOI 10.1074/jbc.270.26.15463; KINCAID RL, 1988, P NATL ACAD SCI USA, V85, P8983, DOI 10.1073/pnas.85.23.8983; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; MILAN D, 1994, CELL, V79, P437, DOI 10.1016/0092-8674(94)90253-4; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; PERRINO BA, 1992, J BIOL CHEM, V267, P15965; POMIES P, 1995, BIOCHEMISTRY-US, V34, P5104, DOI 10.1021/bi00015a022; Raufman JP, 1997, BBA-MOL CELL RES, V1357, P73, DOI 10.1016/S0167-4889(97)00023-2; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; RUFF VA, 1995, J BIOL CHEM, V270, P22602, DOI 10.1074/jbc.270.38.22602; SCHNEIDER G, 1995, IMMUNOBIOLOGY, V193, P268, DOI 10.1016/S0171-2985(11)80554-1; SCHREIBER SL, 1992, CELL, V70, P365, DOI 10.1016/0092-8674(92)90158-9; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SIKKINK R, 1995, BIOCHEMISTRY-US, V34, P8348, DOI 10.1021/bi00026a016; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; SWANSON SKH, 1992, P NATL ACAD SCI USA, V89, P3741, DOI 10.1073/pnas.89.9.3741; SZOLLOSI J, 1991, CYTOMETRY, V12, P707, DOI 10.1002/cyto.990120804; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421	43	100	113	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36125	36131		10.1074/jbc.274.51.36125	http://dx.doi.org/10.1074/jbc.274.51.36125			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593895	hybrid			2022-12-27	WOS:000084279200014
J	Ueno, M; Masutani, H; Arai, RJ; Yamauchi, A; Hirota, K; Sakai, T; Inamoto, T; Yamaoka, Y; Yodoi, J; Nikaido, T				Ueno, M; Masutani, H; Arai, RJ; Yamauchi, A; Hirota, K; Sakai, T; Inamoto, T; Yamaoka, Y; Yodoi, J; Nikaido, T			Thioredoxin-dependent redox regulation of p53-mediated p21 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL LEUKEMIA; DNA-BINDING ACTIVITY; HTLV-I; CYSTEINE RESIDUES; OXIDATIVE STRESS; REPAIR ENZYME; WILD-TYPE; P53; EXPRESSION; PROTEIN	Thioredoxin (TRX) is a dithiol-reducing enzyme that is induced by various oxidative stresses. TRX regulates the activity of DNA-binding proteins, including Jun/Fos and nuclear factor-KB. TRX also interacts with an intranuclear reducing molecule redox factor 1 (Ref-1), which enhances the activity of Jun/Fos. Here, we have investigated the role of TRX in the regulation of p53 activity. Electrophoretic mobility shift assay showed that TRX augmented the DNA binding activity of p53 and also further potentiated Ref-l-enhanced p53 activity. Luciferase assay revealed that transfection of TRX enhanced p53-dependent expression of p21 and further intensified Ref-1-mediated p53 activation. Furthermore, Western blot analysis revealed that p53-dependent induction of p21 protein was also facilitated by transfection with TRX. Overexpression of transdominant negative mutant TRX (mTRX) suppressed the effects of TRX or Ref-1, showing a functional interaction between TRX and Ref-1. cis-Diamminedichloroplatinum (II) (CDDP) induced p53 activation and p21 transactivation. The p53-dependent p21 transactivation induced by CDDP was inhibited by mTRX overexpression, suggesting that TRX-dependent redox regulation is physiologically involved in p53 regulation. CDDP also stimulated translocation of TRX from the cytosol into the nucleus. Hence, TRX-dependent redox regulation of p53 activity indicates coupling of the oxidative stress response and p53-dependent repair mechanism.	Inst Virus Res, Dept Biol Responses, Shogoin, Japan; Kyoto Univ Hosp, Dept Anaesthesia, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Surg Gastroenterol, Kyoto 6068507, Japan; Kyoto Prefectural Univ Med, Dept Prevent Med, Kyoto 6020841, Japan; Shinshu Univ, Sch Med, Dept Obstet & Gynecol, Matsumoto, Nagano 3908621, Japan	Kyoto University; Kyoto University; Kyoto Prefectural University of Medicine; Shinshu University	Yodoi, J (corresponding author), Inst Virus Res, Dept Biol Responses, 53 Kawahara Cho, Shogoin, Japan.	yodoi@virus.kyoto-u.ac.jp	Inamoto, Teruo/ABD-2935-2020; Arai, Roberto/I-3590-2012; Masutani, Hiroshi/B-5114-2014; Hirota, Kiichi/E-9181-2010	Hirota, Kiichi/0000-0003-1110-0827; Masutani, Hiroshi/0000-0001-7633-2827				Akamatsu Y, 1997, J BIOL CHEM, V272, P14497, DOI 10.1074/jbc.272.23.14497; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; FUJII S, 1991, CANCER, V68, P1583, DOI 10.1002/1097-0142(19911001)68:7<1583::AID-CNCR2820680720>3.0.CO;2-N; HAINAUT P, 1993, CANCER RES, V53, P4469; Hayashi S, 1997, NUCLEIC ACIDS RES, V25, P4035, DOI 10.1093/nar/25.20.4035; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lotem J, 1996, P NATL ACAD SCI USA, V93, P9166, DOI 10.1073/pnas.93.17.9166; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; MAKINO S, 1992, IMMUNOLOGY, V76, P578; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; Masutani H, 1996, IMMUNOL LETT, V54, P67, DOI 10.1016/S0165-2478(96)02651-X; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; NAKAMURA H, 1994, IMMUNOL LETT, V42, P75, DOI 10.1016/0165-2478(94)90038-8; NAKAMURA H, 1992, CANCER-AM CANCER SOC, V69, P2091, DOI 10.1002/1097-0142(19920415)69:8<2091::AID-CNCR2820690814>3.0.CO;2-X; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; OHIRA A, 1994, LAB INVEST, V70, P279; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Pearson GD, 1998, J BIOL CHEM, V273, P5431, DOI 10.1074/jbc.273.10.5431; Pise-Masison CA, 1998, J VIROL, V72, P1165, DOI 10.1128/JVI.72.2.1165-1170.1998; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; SEKI S, 1991, J BIOL CHEM, V266, P20797; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; TAKAHASHI R, 1997, LEUKEMIA, V3, P331; WANG Y, 1993, GENE DEV, V7, P2575, DOI 10.1101/gad.7.12b.2575; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; YAMAMOTO M, 1994, EXP CELL RES, V210, P94, DOI 10.1006/excr.1994.1014; YODOI J, 1991, ADV CANCER RES, V57, P381	40	359	370	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35809	35815		10.1074/jbc.274.50.35809	http://dx.doi.org/10.1074/jbc.274.50.35809			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585464	hybrid, Green Submitted			2022-12-27	WOS:000084187900076
J	Huang, C; Morales, G; Vagi, A; Chanasyk, K; Ferrazzi, M; Burklow, C; Qiu, WT; Feyfant, E; Sali, A; Stevens, RL				Huang, C; Morales, G; Vagi, A; Chanasyk, K; Ferrazzi, M; Burklow, C; Qiu, WT; Feyfant, E; Sali, A; Stevens, RL			Formation of enzymatically active, homotypic, and heterotypic tetramers of mouse mast cell tryptases - Dependence on a conserved Trp-rich domain on the surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LUNG TRYPTASE; HUMAN-SKIN TRYPTASE; MOLECULAR-CLONING; SERINE PROTEASES; SPONTANEOUS INACTIVATION; COMPLEMENTARY-DNA; PURIFICATION; EXPRESSION; CDNA; GENE	Mouse mast cell protease (mMCP) 6 and mMCP-7 are homologous tryptases stored in granules as macromolecular complexes with heparin and/or chondroitin sulfate E containing serglycin proteoglycans, When pro-mMCP-7 and pseudozymogen forms of this tryptase and mMCP-6 were separately expressed in insect cells, all three recombinant proteins were secreted into the conditioned medium as properly folded, enzymatically inactive 33-kDa monomers, However, when their propeptides were removed, mMCP 6 and mMCP-7 became enzymatically active and spontaneously assumed an similar to 150-kDa tetramer structure. Heparin was not required for this structural change. When incubated at 37 degrees C, recombinant mMCP-7 progressively lost its enzymatic activity in a time-dependent manner. Its N-linked glycans helped regulate the thermal stability of mMCP-7. However, the ability of this tryptase to form the enzymatically active tetramer was more dependent on a highly conserved Trp-rich domain on its surface. Although recombinant mMCP-6 and mMCP-7 preferred to form homotypic tetramers, these tryptases readily formed heterotypic tetramers in vitro. This latter finding indicates that the tetramer structural unit is a novel way the mast cell uses to assemble varied combinations of tryptases.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Rockefeller Univ, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rockefeller University	Stevens, RL (corresponding author), Brigham & Womens Hosp, Dept Med, Smith Bldg,Rm 616B,75 Francis St, Boston, MA 02115 USA.	rstevens@rics.bwh.harvard.edu			NHLBI NIH HHS [HL-36110, HL-63284] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063284, P01HL036110] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Addington AK, 1996, BIOCHEMISTRY-US, V35, P13511, DOI 10.1021/bi960042t; BRAGANZA VJ, 1991, BIOCHEMISTRY-US, V30, P4997, DOI 10.1021/bi00234a023; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; CHU W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P83, DOI 10.1016/0167-4838(92)90340-J; CROMLISH JA, 1987, J BIOL CHEM, V262, P1363; DEYOUNG MB, 1987, ARCH BIOCHEM BIOPHYS, V254, P222, DOI 10.1016/0003-9861(87)90098-1; Erba F, 1998, PEPTIDES, V19, P437, DOI 10.1016/S0196-9781(97)00423-3; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Friend DS, 1998, J IMMUNOL, V160, P5537; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; Ghildyal N, 1996, J EXP MED, V184, P1061, DOI 10.1084/jem.184.3.1061; GURISH MF, 1995, IMMUNITY, V3, P175, DOI 10.1016/1074-7613(95)90087-X; HARVIMA IT, 1988, BIOCHIM BIOPHYS ACTA, V957, P71, DOI 10.1016/0167-4838(88)90158-6; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; HUANG RY, 1991, EUR J IMMUNOL, V21, P1611, DOI 10.1002/eji.1830210706; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Hunt JE, 1997, J BIOL CHEM, V272, P29158, DOI 10.1074/jbc.272.46.29158; IDE H, 1995, J BIOCHEM-TOKYO, V118, P210, DOI 10.1093/oxfordjournals.jbchem.a124880; JAMES MNG, 1986, NATURE, V319, P33, DOI 10.1038/319033a0; JOHNSON DA, 1992, PROTEIN SCI, V1, P370; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; MURAKUMO Y, 1995, BIOCHEM J, V309, P921, DOI 10.1042/bj3090921; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; PRICKETT KS, 1989, BIOTECHNIQUES, V7, P580; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; SCHECHTER NM, 1995, BIOCHEMISTRY-US, V34, P10628, DOI 10.1021/bi00033a038; SCHECHTER NM, 1993, BIOCHEMISTRY-US, V32, P2617, DOI 10.1021/bi00061a020; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; SCHWARTZ LB, 1990, J IMMUNOL, V144, P2304; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SMITH TJ, 1984, J BIOL CHEM, V259, P1046; Svendsen L., 1972, THROMB RES, V1, P267, DOI 10.1016/0049-3848(72)90023-0; TRONG HL, 1989, BIOCHEMISTRY-US, V28, P391; VANDERSLICE P, 1989, BIOCHEMISTRY-US, V28, P4148, DOI 10.1021/bi00436a004; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784	49	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					351	358		10.1074/jbc.275.1.351	http://dx.doi.org/10.1074/jbc.275.1.351			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617625	hybrid			2022-12-27	WOS:000085951600049
J	Naltner, A; Ghaffari, M; Whitsett, JA; Yan, C				Naltner, A; Ghaffari, M; Whitsett, JA; Yan, C			Retinoic acid stimulation of the human surfactant protein B promoter is thyroid transcription factor 1 site-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY SURFACTANT; NUCLEAR RECEPTORS; RESPONSE ELEMENT; BINDING PROTEIN; VITAMIN-A; BRONCHOPULMONARY DYSPLASIA; HISTONE ACETYLTRANSFERASE; TUBULAR MYELIN; DIRECT REPEATS; CO-REPRESSOR	Surfactant B (SP-B) is a 79-amino acid peptide critical to postnatal respiratory adaptation. Expression of SP-B by respiratory epithelial cells is regulated by developmental and hormonal influences at the level of gene transcription. Previous studies supported the role of retinoic acids (RA) and their receptors (RARs) in SP-B gene transcription. In the present study, RAR alpha was detected in mouse alveolar type II epithelial cells where SP-B is synthesized and processed. Deletion and site-specific mutagenesis analysis identified clustered retinoic acid-responsive element sites in the 5'-flanking enhancer region of the hSP-B gene that bound RAR alpha proteins. RAR coactivators ACTR, SRC-1, and transcriptional intermediary factor 2 (TIF2) stimulated human (h) SP-B promoter activity in a dose-dependent fashion in pulmonary adenocarcinoma H441 cells. In addition, an RAR-associated protein, CREB-binding protein (CBP), potentiated the effects of RAR on hSP-B promoter activity in H441 cells. Importantly, RA stimulation of the hSP-B promoter depends on tissue-specific thyroid transcription factor (TTF-1) DNA-binding sites. TTF-1 protein synergistically stimulated the hSP-B promoter with RAR alpha, CBP, and nuclear receptor coactivators in H441 cells. In addition, TTF-1 interacted directly with RAR alpha and TIF2 in the mammalian two-hybrid system. These findings support a model in which RAR/retinoid X receptor, TTF-1, coactivators, and CBP form a transcription activation complex in the upstream enhancer region of the hSP-B gene.	Childrens Hosp, Med Ctr, Div Pulm Biol, TCHRF, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Yan, C (corresponding author), Childrens Hosp, Med Ctr, Div Pulm Biol, TCHRF, 3333 Burnet Ave, Cincinnati, OH 45229 USA.				NHLBI NIH HHS [HL-61803, HL-56387, HL38859, R01 HL061803] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061803, R01HL038859, R37HL038859, P01HL056387, P50HL056387] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ballard PL, 1996, AM J RESP CELL MOL, V14, P599, DOI 10.1165/ajrcmb.14.6.8652188; BAMMISTER AJ, 1996, NATURE, V384, P641; Bogue CW, 1996, AM J PHYSIOL-LUNG C, V271, pL862, DOI 10.1152/ajplung.1996.271.5.L862; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; Clark JC, 1997, AM J RESP CELL MOL, V16, P46, DOI 10.1165/ajrcmb.16.1.8998078; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; DAMOREBRUNO MA, 1992, AM J PHYSIOL, V262, pL40, DOI 10.1152/ajplung.1992.262.1.L40; DOLLE P, 1990, DEVELOPMENT, V110, P1133; DURAND B, 1994, EMBO J, V13, P5370, DOI 10.1002/j.1460-2075.1994.tb06872.x; George TN, 1998, AM J PHYSIOL-LUNG C, V274, pL560, DOI 10.1152/ajplung.1998.274.4.L560; GEORGE TN, 1997, PEDIATR RES, V41, P693; Ghaffari M, 1999, AM J PHYSIOL-LUNG C, V276, pL398, DOI 10.1152/ajplung.1999.276.3.L398; GLASSER SW, 1987, P NATL ACAD SCI USA, V84, P4007, DOI 10.1073/pnas.84.12.4007; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; JACOBS KA, 1987, J BIOL CHEM, V262, P9808; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Massaro GD, 1997, NAT MED, V3, P675, DOI 10.1038/nm0697-675; Massaro GD, 1996, AM J PHYSIOL-LUNG C, V270, pL305, DOI 10.1152/ajplung.1996.270.2.L305; MASUYAMA H, 1995, BIOL NEONATE, V67, P264, DOI 10.1159/000244174; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; METZLER MD, 1993, ENDOCRINOLOGY, V133, P1990, DOI 10.1210/en.133.5.1990; MIZUNO K, 1991, MOL CELL BIOL, V11, P4927, DOI 10.1128/MCB.11.10.4927; Moghal N, 1998, MOL CELL BIOL, V18, P6666, DOI 10.1128/MCB.18.11.6666; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONATE SA, 1995, SCIENCE, V270, P1354; OREILLY MA, 1991, AM J PHYSIOL, V260, pL37, DOI 10.1152/ajplung.1991.260.2.L37; Panariello L, 1996, J BIOL CHEM, V271, P25524, DOI 10.1074/jbc.271.41.25524; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; PHELPS DS, 1988, AM REV RESPIR DIS, V137, P939, DOI 10.1164/ajrccm/137.4.939; POULAIN FR, 1992, AM J PHYSIOL, V262, pL730, DOI 10.1152/ajplung.1992.262.6.L730; SCHRADER M, 1994, NATURE, V370, P382, DOI 10.1038/370382a0; Sever-Chroneos Z, 1999, AM J PHYSIOL-LUNG C, V277, pL79, DOI 10.1152/ajplung.1999.277.1.L79; SHENAI JP, 1981, J PEDIATR-US, V99, P302, DOI 10.1016/S0022-3476(81)80484-2; SHENAI JP, 1985, PEDIATR RES, V19, P185, DOI 10.1203/00006450-198502000-00007; SHENAI JP, 1987, J PEDIATR-US, V111, P269, DOI 10.1016/S0022-3476(87)80086-0; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; SUZUKI Y, 1989, AM REV RESPIR DIS, V140, P75, DOI 10.1164/ajrccm/140.1.75; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WHITSETT JA, 1995, PHYSIOL REV, V75, P749, DOI 10.1152/physrev.1995.75.4.749; WILLIAMS MC, 1991, AM J RESP CELL MOL, V5, P41, DOI 10.1165/ajrcmb/5.1.41; Yan C, 1997, J BIOL CHEM, V272, P17327, DOI 10.1074/jbc.272.28.17327; Yan C, 1998, AM J PHYSIOL-LUNG C, V275, pL239, DOI 10.1152/ajplung.1998.275.2.L239; YAN C, 1995, J BIOL CHEM, V270, P24852, DOI 10.1074/jbc.270.42.24852; YAN C, 1992, P NATL ACAD SCI USA, V89, P8859, DOI 10.1073/pnas.89.19.8859; YANG N, 1991, P NATL ACAD SCI USA, V88, P3559, DOI 10.1073/pnas.88.9.3559; ZECHEL C, 1994, EMBO J, V13, P1425, DOI 10.1002/j.1460-2075.1994.tb06396.x	64	53	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					56	62		10.1074/jbc.275.1.56	http://dx.doi.org/10.1074/jbc.275.1.56			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617585	hybrid			2022-12-27	WOS:000085951600009
J	Onodera, S; Kaneda, K; Mizue, Y; Koyama, Y; Fujinaga, M; Nishihira, J				Onodera, S; Kaneda, K; Mizue, Y; Koyama, Y; Fujinaga, M; Nishihira, J			Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; COLLAGENASE GENE-EXPRESSION; EPIDERMAL GROWTH-FACTOR; HUMAN SKIN FIBROBLASTS; TISSUE INHIBITOR; FACTOR MIF; TRANSCRIPTIONAL ACTIVATION; INTERSTITIAL COLLAGENASE; TRANSDUCTION PATHWAYS; STROMELYSIN PROMOTER	Neutral matrix metalloproteinases (MMPs) are responsible for the pathological features of rheumatoid arthritis (RA) such as degradation of cartilage. We herein show the up-regulation of MMP-1 (interstitial collagenase) and MMP-3 (stromelysin) mRNAs of cultured synovial fibroblasts retrieved from rheumatoid arthritis (RA) patients in response to macrophage migration inhibitory factor (MIF). The elevation of MMP-1 and MMP-3 mRNA was dose-dependent and started at 6 h post-stimulation by MIF, reached the maximum level at 24 h, and was sustained at least up to 36 h. Interleukin (IL)-1 beta mRNA was also up-regulated by MIF. These events were preceded by up-regulation of c-jun and c-fos mRNA. Tissue inhibitor of metalloproteinase (TIMP)-1, a common inhibitor of these proteases, was slightly upregulated by MIF, Similarly, mRNA up-regulation of MMP-1 and MMP-3 was observed in the synovial fibroblasts of patients with osteoarthritis. However, their expression levels were much lower than those of RA synovial fibroblasts. The mRNA up-regulation by MIF was inhibited by the tyrosine kinase inhibitors genestein and herbimycin A, as well as the protein kinase C inhibitors staurosporine and H-7. On the other hand, the inhibition was not seen after the addition of the cyclic AMP dependent kinase inhibitor, H-8. The mRNA upregulation of MMPs was also inhibited by curcumin, an inhibitor of transcription factor AP-1, whereas interleukin-1 receptor antagonist, an IL-1 receptor antagonist, failed to inhibit the mRNA up-regulation, Considering these results, it is suggested that 1) MTF plays an important role in the tissue destruction of rheumatoid joints via induction of the proteinases, and 2) MIF up-regulates MMP-1 and MMP-3 via tyrosine kinase-, protein kinase C-, and AP-1- dependent pathways, bypassing IL-1 beta signal transduction.	Hokkaido Univ, Sch Med, Cent Res Inst, Sapporo, Hokkaido 060, Japan; Hokkaido Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido 060, Japan; Hokkaido Univ, Sch Med, Dept Orthopaed, Sapporo, Hokkaido 060, Japan; Sapporo Immunodiagnost Labs, Sapporo, Hokkaido 001, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Nishihira, J (corresponding author), Hokkaido Univ, Sch Med, Cent Res Inst, Sapporo, Hokkaido 060, Japan.	j_nisihi@med.hokudai.ac.jp		Mizue, Yuka/0000-0002-2208-0772				ALVAROGRACIA JM, 1990, J CLIN INVEST, V86, P1790, DOI 10.1172/JCI114908; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Callaghan MM, 1996, J LEUKOCYTE BIOL, V59, P125, DOI 10.1002/jlb.59.1.125; CASE JP, 1990, J IMMUNOL, V145, P3755; Cawston T.E., 1986, PROTEINASE INHIBITOR, P589; CONCA W, 1989, J CLIN INVEST, V83, P1753, DOI 10.1172/JCI114077; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; DAYER JM, 1977, SCIENCE, V195, P181, DOI 10.1126/science.188134; DAYER JM, 1986, J CLIN INVEST, V77, P645, DOI 10.1172/JCI112350; DELANY AM, 1992, J CELL BIOCHEM, V50, P400, DOI 10.1002/jcb.240500409; EVANSON JM, 1968, J CLIN INVEST, V47, P2639, DOI 10.1172/JCI105947; EVERSON JM, 1967, SCIENCE, V158, P499, DOI 10.1126/science.158.3800.499; FINI ME, 1994, J BIOL CHEM, V269, P11291; FIRESTEIN GS, 1991, ARTHRITIS RHEUM, V34, P1094, DOI 10.1002/art.1780340905; FRISCH SM, 1987, J BIOL CHEM, V262, P16300; GAY S, 1993, ANN RHEUM DIS, V52, pS39, DOI 10.1136/ard.52.Suppl_1.S39; GAY S, 1989, RHEUMATOL INT, V9, P105; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GRAVALLESE EM, 1991, ARTHRITIS RHEUM-US, V34, P1076, DOI 10.1002/art.1780340903; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; IWAKURA Y, 1995, J IMMUNOL, V155, P1588; Jumblatt MM, 1997, CURR EYE RES, V16, P428, DOI 10.1076/ceyr.16.5.428.7048; KERR LD, 1988, SCIENCE, V242, P1424, DOI 10.1126/science.2462278; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; Keyszer G, 1998, ARTHRITIS RHEUM, V41, P1378, DOI 10.1002/1529-0131(199808)41:8<1378::AID-ART6>3.0.CO;2-J; Kishima Koji, 1994, Medical Journal of Kinki University, V19, P47; KLARESKOG L, 1982, SCAND J IMMUNOL, V15, P501, DOI 10.1111/j.1365-3083.1982.tb00676.x; KRANE SM, 1986, MED CLIN N AM, V70, P263, DOI 10.1016/S0025-7125(16)30953-1; LAFYATIS R, 1990, MOL ENDOCRINOL, V4, P973, DOI 10.1210/mend-4-7-973; Lambert CA, 1998, J BIOL CHEM, V273, P23143, DOI 10.1074/jbc.273.36.23143; LYONS JG, 1993, J BIOL CHEM, V268, P19143; MACKAY AR, 1992, INVAS METAST, V12, P168; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; MCCACHREN SS, 1991, ARTHRITIS RHEUM-US, V34, P1085; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Muller-Ladner U, 1996, Curr Opin Rheumatol, V8, P210; MUNOZ E, 1990, J IMMUNOL, V144, P964; MURPHY G, 1987, BIOCHEM J, V248, P265, DOI 10.1042/bj2480265; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123; NISHIHIRA J, 1995, BBA-PROTEIN STRUCT M, V1247, P159, DOI 10.1016/0167-4838(94)00215-3; NISHINO T, 1995, MOL MED, V1, P781, DOI 10.1007/BF03401892; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OKADA Y, 1986, J BIOL CHEM, V261, P14245; Onodera S, 1999, CYTOKINE, V11, P163, DOI 10.1006/cyto.1998.0402; REITAMO S, 1994, J CLIN INVEST, V94, P2489, DOI 10.1172/JCI117618; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SUBDECK BD, 1994, J BIOL CHEM, V269, P30022; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Takahashi N, 1998, MOL MED, V4, P707, DOI 10.1007/BF03401765; UEHARA Y, 1991, METHOD ENZYMOL, V201, P370; Vincenti MP, 1996, ARTHRITIS RHEUM-US, V39, P574, DOI 10.1002/art.1780390406; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; Watkins DN, 1997, AM J RESP CELL MOL, V16, P629, DOI 10.1165/ajrcmb.16.6.9191464; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; Werb Z., 1989, TXB RHEUMATOLOGY, P300; WU JJ, 1991, J BIOL CHEM, V266, P5625; YOUNG CL, 1984, ARTHRITIS RHEUM, V27, P32, DOI 10.1002/art.1780270106	71	211	237	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					444	450		10.1074/jbc.275.1.444	http://dx.doi.org/10.1074/jbc.275.1.444			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617637	hybrid			2022-12-27	WOS:000085951600061
J	Sajid, M; Withers-Martinez, C; Blackman, MJ				Sajid, M; Withers-Martinez, C; Blackman, MJ			Maturation and specificity of Plasmodium falciparum subtilisin-like protease-1, a malaria merozoite subtilisin-like serine protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN-1; INTRAERYTHROCYTIC STAGE; SECRETORY PATHWAY; PROPEPTIDE; LOCALIZATION; INVASION; GLYCOSYLATION; TRANSLOCATION; ENDOPROTEASE; REQUIREMENTS	Plasmodium falciparum subtilisin-like protease-1 (Pf-SUB-1) is a protein belonging to the subtilisin-like superfamily of serine proteases (subtilases), PfSUB-1 undergoes extensive posttranslational proteolytic processing. The primary translation product is converted in the parasite endoplasmic reticulum to p54. This is further processed to p47, which accumulates in secretory organelles within the merozoite, Here, we present a detailed study of this processing. In vitro translated PfSUB-1 showed no capacity to undergo autocatalytic processing. However, parasite extracts contain a protease that cleaves the in vitro translated pro-protein between Asp(219) and Asn(220) to form two products of 31 (p31) and 54 kDa; the latter was indistinguishable from authentic p54 and remained complexed with p31 in a noncovalent interaction characteristic of that between a subtilase prodomain and its cognate catalytic domain. Cross-linking studies showed that this complex also exists in the parasite. Expression of PfSUB-1 in recombinant baculovirus also resulted in processing to p54, Mutation of the predicted active site serine abolished processing. Recombinant p54 was secreted in a complex with p31, and could be further converted to p47 in vitro. Conversion required calcium, was an intramolecular autocatalytic process, and involved a second cleavage between Asp(251) and Ala(252). A decapeptide based on sequence flanking Asp(219) was efficiently cleaved by recombinant PfSUB-1. We conclude that Pf-SUB-1. is a subtilase with an unusual substrate specificity and that it is activated by two autocatalytic processing steps.	Natl Inst Med Res, Div Parasitol, London NW7 1AA, England	MRC National Institute for Medical Research	Blackman, MJ (corresponding author), Natl Inst Med Res, Div Parasitol, Mill Hill, London NW7 1AA, England.							Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Barale JC, 1999, P NATL ACAD SCI USA, V96, P6445, DOI 10.1073/pnas.96.11.6445; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; BLACKMAN MJ, 1993, MOL BIOCHEM PARASIT, V62, P103, DOI 10.1016/0166-6851(93)90182-W; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; BRAUNBRETON C, 1992, P NATIONAL ACADEMY S, V89, P9647; Cheng D, 1999, J BIOL CHEM, V274, P22805, DOI 10.1074/jbc.274.32.22805; DEALMEIDA MLC, 1983, NATURE, V302, P349, DOI 10.1038/302349a0; DIECKMANNSCHUPPERT A, 1992, EUR J BIOCHEM, V205, P815, DOI 10.1111/j.1432-1033.1992.tb16846.x; DLUZEWSKI AR, 1986, EXP PARASITOL, V62, P416, DOI 10.1016/0014-4894(86)90050-0; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; Hackett F, 1999, MOL BIOCHEM PARASIT, V103, P183, DOI 10.1016/S0166-6851(99)00122-X; Harlow E., 1988, ANTIBODIES LAB MANUA; HIRTZLIN J, 1995, EUR J BIOCHEM, V232, P765, DOI 10.1111/j.1432-1033.1995.tb20871.x; Howard RF, 1998, MOL BIOCHEM PARASIT, V92, P111, DOI 10.1016/S0166-6851(97)00238-7; JACOBS M, 1993, MOL MICROBIOL, V8, P957, DOI 10.1111/j.1365-2958.1993.tb01640.x; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; KIMARA EA, 1996, J BIOL CHEM, V271, P14452; Lamango NS, 1999, ARCH BIOCHEM BIOPHYS, V362, P275, DOI 10.1006/abbi.1998.1033; LAU JTY, 1983, J BIOL CHEM, V258, P5255; Li YY, 1996, J MOL BIOL, V262, P591, DOI 10.1006/jmbi.1996.0537; Marshall VM, 1997, INFECT IMMUN, V65, P4460, DOI 10.1128/IAI.65.11.4460-4467.1997; MATTHEWS G, 1994, J BIOL CHEM, V269, P588; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; MCPHERSON RA, 1993, MOL BIOCHEM PARASIT, V62, P233, DOI 10.1016/0166-6851(93)90112-B; MIDDLETON RB, 1993, BIOCHEM J, V296, P511, DOI 10.1042/bj2960511; MISUMI Y, 1991, J BIOL CHEM, V266, P16954; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; POWER SD, 1986, P NATL ACAD SCI USA, V83, P3096, DOI 10.1073/pnas.83.10.3096; RAGGE K, 1990, MOL BIOCHEM PARASIT, V42, P93, DOI 10.1016/0166-6851(90)90116-4; Rosenthal PJ, 1999, ADV PARASIT, V43, P105, DOI 10.1016/S0065-308X(08)60242-0; Scougall K, 1998, BIOCHEM J, V334, P531, DOI 10.1042/bj3340531; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; SHENNAN KIJ, 1995, J BIOL CHEM, V270, P1402, DOI 10.1074/jbc.270.3.1402; Shinde U., 1995, INTRAMOLECULAR CHAPE, P1; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Soldati D, 1998, MOL BIOCHEM PARASIT, V96, P37, DOI 10.1016/S0166-6851(98)00090-5; STAFFORD WHL, 1994, MOL BIOCHEM PARASIT, V66, P157, DOI 10.1016/0166-6851(94)90048-5; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; TILNEY LG, 1993, MOL BIOL, V4, P323; Volkov A, 1996, J MOL BIOL, V262, P595, DOI 10.1006/jmbi.1996.0538; Ward GE, 1997, PARASITOL TODAY, V13, P57, DOI 10.1016/S0169-4758(96)10080-6; WILCOX CA, 1991, J CELL BIOL, V115, P297, DOI 10.1083/jcb.115.2.297; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; WITHERSMARTINEZ C, 1999, IN PRESS PROTEIN ENG	50	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					631	641		10.1074/jbc.275.1.631	http://dx.doi.org/10.1074/jbc.275.1.631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617661	hybrid			2022-12-27	WOS:000085951600085
J	Szerencsei, RT; Tucker, JE; Cooper, CB; Winkfein, RJ; Farrell, PJ; Iatrou, K; Schnetkamp, PPM				Szerencsei, RT; Tucker, JE; Cooper, CB; Winkfein, RJ; Farrell, PJ; Iatrou, K; Schnetkamp, PPM			Minimal domain requirement for cation transport by the potassium-dependent Na/Ca-K exchanger - Comparison with an NCKX paralog from Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; NA-CA; CALCIUM; PHOTORECEPTORS; SODIUM; EXPRESSION; EXTRUSION; CLONING	The retinal rod Na/Ca-K exchanger (NCKX) is a unique calcium extrusion protein utilizing both inward sodium gradient and outward potassium gradient. Three mammalian rod NCKX cDNAs have been cloned to date, but quantitative analysis of NCKX function in heterologous systems has proven difficult, Here, we describe a simple system for quantitative analysis of NCKX function; stable transformation of cultured insect cells with the novel pEA1/153A vector containing NCKX cDNAs was combined with measurements of potassium-dependent Ca-45 uptake in sodium-loaded cells, We carried out structure-function studies on NCKX with the following results: 1) two-thirds of the full-length sequence of bovine NCKX could be deleted without affecting potassium-dependent calcium transport and without affecting key properties of the potassium binding site; 2) the affinity of NCKX for potassium was about 10-fold greater in choline medium when compared with lithium medium; this shift was observed in rod outer segments or in cells expressing fall-length rod NCKX, the above deletion mutant, or a distantly related NCKX paralog cloned from Caenorhabditis elegans. We conclude that the potassium binding site is highly conserved among members of the NCKX family and is formed by residues located within the two sets of transmembrane spanning segments in the NCKX sequence.	Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Univ Calgary, MRC, Grp Ion Channels & Transporters, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary	Schnetkamp, PPM (corresponding author), Univ Calgary, Dept Physiol & Biophys, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	pschnetk@ucalgary.ca						Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; Cooper CB, 2000, METHOD ENZYMOL, V315, P847; Cooper CB, 1999, BIOCHEMISTRY-US, V38, P6276, DOI 10.1021/bi983068o; Farrell PJ, 1998, BIOTECHNOL BIOENG, V60, P656, DOI 10.1002/(SICI)1097-0290(19981220)60:6<656::AID-BIT2>3.0.CO;2-9; Hilgemann DW, 1996, BIOPHYS J, V71, P759, DOI 10.1016/S0006-3495(96)79275-5; Kim TSY, 1998, J BIOL CHEM, V273, P16561, DOI 10.1074/jbc.273.26.16561; LAGNADO L, 1991, J GEN PHYSIOL, V98, P479, DOI 10.1085/jgp.98.3.479; LAGNADO L, 1990, J MEMBRANE BIOL, V113, P177, DOI 10.1007/BF01870070; Li XF, 1999, J BIOL CHEM, V274, P8153, DOI 10.1074/jbc.274.12.8153; PHILIPSON KD, 2000, IN PRESS ANN REV PHY; REILANDER H, 1992, EMBO J, V11, P1689, DOI 10.1002/j.1460-2075.1992.tb05219.x; SCHNETKAMP PPM, 1995, AM J PHYSIOL-CELL PH, V269, pC1153, DOI 10.1152/ajpcell.1995.269.5.C1153; SCHNETKAMP PPM, 1989, PROG BIOPHYS MOL BIO, V54, P1, DOI 10.1016/0079-6107(89)90007-2; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P198; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P22975; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; SCHNETKAMP PPM, 1995, CELL CALCIUM, V18, P322, DOI 10.1016/0143-4160(95)90028-4; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Tsoi M, 1998, J BIOL CHEM, V273, P4155, DOI 10.1074/jbc.273.7.4155; Tucker JE, 1998, INVEST OPHTH VIS SCI, V39, P435	22	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					669	676		10.1074/jbc.275.1.669	http://dx.doi.org/10.1074/jbc.275.1.669			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617665	hybrid			2022-12-27	WOS:000085951600089
J	Beraud-Dufour, S; Paris, S; Chabre, M; Antonny, B				Beraud-Dufour, S; Paris, S; Chabre, M; Antonny, B			Dual interaction of ADP ribosylation factor 1 with Sec7 domain and with lipid membranes during catalysis of guanine nucleotide exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR ARNO; PHOSPHOLIPASE-D; ARF GTPASE; PROTEIN; GDP; MYRISTOYLATION; ACTIVATION; BINDING; CYTOHESIN-1; COATOMER	Sec7 domains catalyze the replacement of GDP by GTP on the G protein ADP-ribosylation factor 1 (myrARF1) by interacting with its switch I and II regions and by destabilizing, through a glutamic finger, the P-phosphate of the bound G;DP, The myristoylated N-terminal helix that allows myrARF1 to interact with membrane lipids in a GTP-dependent manner is located some distance from the Sec7 domain-binding region. However, these two regions are connected. Measuring the binding to liposomes of functional or abortive complexes between myrARF1 and the Sec7 domain of ARNO demonstrates that myrARF1, in complex with the Sec7 domain, adopts a high affinity state for membrane lipids, similar to that of the free G;TP-bound form. This tight membrane attachment does not depend on the release of GDP induced by the Sec7 domain but is partially inhibited by the uncompetitive inhibitor brefeldin A. These results suggest that the conformational switch of the N-terminal helix of myrARF1 to the membrane-bound form is an early event in the nucleotide exchange pathway and is a prerequisite for a structural rearrangement at the myrARF1-GDP/Sec7 domain interface that allows the glutamic finger to expel GDP from myrARF1.	CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Antonny, B (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, 401 Barker Hall, Berkeley, CA 94720 USA.		Antonny, Bruno/ABH-7434-2020; BERAUD-DUFOUR, Sophie/M-4641-2016	Antonny, Bruno/0000-0002-9166-8668; BERAUD-DUFOUR, Sophie/0000-0002-0062-6842				AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Betz SF, 1998, P NATL ACAD SCI USA, V95, P7909, DOI 10.1073/pnas.95.14.7909; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; FRANCO M, 1993, J BIOL CHEM, V268, P24531; Franco M, 1996, J BIOL CHEM, V271, P1573, DOI 10.1074/jbc.271.3.1573; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Jones DH, 1999, BIOCHEM J, V341, P185, DOI 10.1042/0264-6021:3410185; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Losonczi JA, 1998, BIOCHEMISTRY-US, V37, P706, DOI 10.1021/bi9717791; Meacci E, 1997, P NATL ACAD SCI USA, V94, P1745, DOI 10.1073/pnas.94.5.1745; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Pacheco-Rodriguez G, 1999, J BIOL CHEM, V274, P12438, DOI 10.1074/jbc.274.18.12438; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Roth MG, 1999, CELL, V97, P149, DOI 10.1016/S0092-8674(00)80723-0; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sata M, 1999, P NATL ACAD SCI USA, V96, P2752, DOI 10.1073/pnas.96.6.2752; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	34	57	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37629	37636		10.1074/jbc.274.53.37629	http://dx.doi.org/10.1074/jbc.274.53.37629			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608818	hybrid			2022-12-27	WOS:000084528000018
J	de Rooij, J; Boenink, NM; van Triest, M; Cool, RH; Wittinghofer, A; Bos, JL				de Rooij, J; Boenink, NM; van Triest, M; Cool, RH; Wittinghofer, A; Bos, JL			PDZ-GEF1, a guanine nucleotide exchange factor specific for Rap1 and Rap2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; MOUSE LYMPHOMA-CELLS; SMALL GTPASE RAP1; BINDING SITE-A; CYCLIC-AMP; REGULATORY SUBUNIT; RAT-1 FIBROBLASTS; STRUCTURAL BASIS; PDZ DOMAINS; H-RAS	The small GTPase Rap1 has been implicated in a variety of cellular processes including the control of cell morphology, proliferation, and differentiation. Stimulation of a large variety of cell surface receptors results in the rapid activation of Rap1, i.e. an increase in the GTP-bound form. This activation is mediated by second messengers like calcium, cAMP, and diacylglycerol, but additional pathways may exist as well. Here we describe a ubiquitously expressed guanine nucleotide exchange factor of 200 kDa that activates Rap1 both in vivo and in vitro. This exchange factor has two putative regulatory domains: a domain with an amino acid sequence related to cAMP-binding domains and a PDZ domain. Therefore, we named it PDZ-GEF1. PDZ-GEFs are closely related to Epacs, Rap-specific exchange factors with a genuine cAMP binding site, that are directly regulated by cAMP. The domain related to cAMP-binding domains, like the cAMP binding site in Epac, serves as a negative regulatory domain. However, PDZ-GEF1 does not interact with cAMP or cGMP. Interestingly, PDZ-GEF1 also activates Rap2, a close relative of Rap1. This is the first example of an exchange factor acting on Rap2. We conclude that PDZ-GEF1 is a guanine nucleotide exchange factor, specific for Rap1 and Rap2, that is controlled by a negative regulatory domain.	Univ Utrecht, Physiol Chem Lab, NL-3584 CG Utrecht, Netherlands; Univ Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Utrecht University; Utrecht University; Max Planck Society	Bos, JL (corresponding author), Univ Utrecht, Physiol Chem Lab, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	j.l.bos@med.uu.nl	de rooij, johan/C-1325-2019	Cool, Robbert/0000-0002-9845-2202				ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; Bauer B, 1999, J BIOL CHEM, V274, P17763, DOI 10.1074/jbc.274.25.17763; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; DEVRIESSMITS AMM, 1995, METHOD ENZYMOL, V255, P156; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; GORMAN KB, 1994, SOMAT CELL MOLEC GEN, V20, P301, DOI 10.1007/BF02254719; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Ishiki M, 1997, ENDOCRINOLOGY, V138, P4950, DOI 10.1210/en.138.11.4950; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kedra D, 1997, HUM GENET, V100, P611, DOI 10.1007/s004390050562; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; M'Rabet L, 1998, BLOOD, V92, P2133, DOI 10.1182/blood.V92.6.2133.418k19_2133_2140; MCKNIGHT GS, 1988, RECENT PROG HORM RES, V44, P307; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; Nancy V, 1999, J BIOL CHEM, V274, P8737, DOI 10.1074/jbc.274.13.8737; NEITZEL JJ, 1991, BIOCHEMISTRY-US, V30, P733, DOI 10.1021/bi00217a023; OGREID D, 1988, J BIOL CHEM, V263, P17397; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Posern G, 1998, J BIOL CHEM, V273, P24297, DOI 10.1074/jbc.273.38.24297; Reedquist KA, 1998, J BIOL CHEM, V273, P4944, DOI 10.1074/jbc.273.9.4944; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; STEINBERG RA, 1991, J BIOL CHEM, V266, P3547; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; van den Berghe N, 1999, J BIOL CHEM, V274, P11078, DOI 10.1074/jbc.274.16.11078; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Wolthuis RMF, 1997, EMBO J, V16, P6748, DOI 10.1093/emboj/16.22.6748; Wolthuis RMF, 1996, ONCOGENE, V13, P353; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	49	102	105	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38125	38130		10.1074/jbc.274.53.38125	http://dx.doi.org/10.1074/jbc.274.53.38125			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608883	hybrid, Green Published			2022-12-27	WOS:000084528000083
J	Jacob-Dubuisson, F; El-Hamel, C; Saint, N; Guedin, S; Willery, E; Molle, G; Locht, C				Jacob-Dubuisson, F; El-Hamel, C; Saint, N; Guedin, S; Willery, E; Molle, G; Locht, C			Channel formation by FhaC, the outer membrane protein involved in the secretion of the Bordetella pertussis filamentous hemagglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; SEQUENCE SIMILARITIES; ACCESSORY GENES; HEMOLYSIN; PURIFICATION; PORINS; IDENTIFICATION; TRANSPORT	Many virulence factors of pathogenic microorganisms are presented at the cell surface, However, protein secretion across the outer membrane of Gram-negative bacteria remains poorly understood. Here we used the extremely efficient secretion of the Bordetella pertussis filamentous hemagglutinin (FHA) to decipher this process. FHA secretion requires a single specific accessory protein, FhaC, the prototype of a family of proteins necessary for the extracellular localization of various virulence proteins in Gram-negative bacteria. We show that FhaC is heat-modifiable and localized in the outer membrane. Circular dichroism spectra indicated that FhaC is rich in beta-strands, in agreement with structural predictions for this protein. We further demonstrated that FhaC forms pores in artificial membranes, as evidenced by single-channel conductance measurements through planar lipid bilayers, as well as by liposome swelling assays and patch-clamp experiments using proteoliposomes, Single-channel conductance appeared to fluctuate very fast, suggesting that the FhaC channels frequently assume a closed conformation. We thus propose that FhaC forms a specific beta-barrel channel in the outer membrane for the outward translocation of FHA.	Inst Pasteur, Inst Biol Lille, INSERM, U447, F-59019 Lille, France; Fac Sci Rouen, Inst Rech Multidisciplinaire Peptides 23, CNRS, Unite Mixte Rech 6522, F-76821 Mt St Aignan, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS)	Jacob-Dubuisson, F (corresponding author), Inst Pasteur, Inst Biol Lille, INSERM, U447, 1 Rue Calmette, F-59019 Lille, France.		Locht, Camille/L-3516-2018; Saint, Nathalie/S-5286-2016; Jacob-Dubuisson, Françoise/F-1610-2018	Saint, Nathalie/0000-0001-5219-9486; Jacob-Dubuisson, Françoise/0000-0002-5102-1704				BARENKAMP SJ, 1994, INFECT IMMUN, V62, P3320, DOI 10.1128/IAI.62.8.3320-3328.1994; BENZ R, 1993, ZBL BAKT-INT J MED M, V278, P187, DOI 10.1016/S0934-8840(11)80836-4; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Bitter W, 1999, TRENDS MICROBIOL, V7, P4, DOI 10.1016/S0966-842X(98)01398-5; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; BUEHLER LK, 1991, J BIOL CHEM, V266, P24446; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; FREUDL R, 1987, J BACTERIOL, V169, P66, DOI 10.1128/jb.169.1.66-71.1987; Guedin S, 1998, MOL MICROBIOL, V29, P763, DOI 10.1046/j.1365-2958.1998.00970.x; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hirono I, 1997, MOL MICROBIOL, V24, P851, DOI 10.1046/j.1365-2958.1997.3971760.x; ISHIDATE K, 1986, J BIOL CHEM, V261, P428; JacobDubuisson F, 1996, MOL MICROBIOL, V19, P65, DOI 10.1046/j.1365-2958.1996.349883.x; JacobDubuisson F, 1997, J BACTERIOL, V179, P775, DOI 10.1128/jb.179.3.775-783.1997; JEANTEUR D, 1991, MOL MICROBIOL, V5, P2153, DOI 10.1111/j.1365-2958.1991.tb02145.x; Konninger UW, 1999, MOL MICROBIOL, V32, P1212, DOI 10.1046/j.1365-2958.1999.01433.x; Koronakis V, 1997, MOL MICROBIOL, V23, P617, DOI 10.1046/j.1365-2958.1997.d01-1880.x; Lambert-Buisine C, 1998, MOL MICROBIOL, V28, P1283, DOI 10.1046/j.1365-2958.1998.00892.x; Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635; LOCHT C, 1992, EMBO J, V11, P3175, DOI 10.1002/j.1460-2075.1992.tb05394.x; LOCHT C, 1993, MOL MICROBIOL, V9, P653, DOI 10.1111/j.1365-2958.1993.tb01725.x; Marciano DK, 1999, SCIENCE, V284, P1516, DOI 10.1126/science.284.5419.1516; MENOZZI FD, 1994, INFECT IMMUN, V62, P769, DOI 10.1128/IAI.62.3.769-778.1994; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; NIKAIDO H, 1991, J BIOL CHEM, V266, P770; Palmer KL, 1995, MOL MICROBIOL, V18, P821, DOI 10.1111/j.1365-2958.1995.18050821.x; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rappuoli R, 1994, Curr Top Microbiol Immunol, V192, P319; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; Taylor R, 1998, J BIOL CHEM, V273, P31113, DOI 10.1074/jbc.273.47.31113; Thanassi DG, 1998, P NATL ACAD SCI USA, V95, P3146, DOI 10.1073/pnas.95.6.3146; WILLEMS RJL, 1994, MOL MICROBIOL, V11, P337, DOI 10.1111/j.1365-2958.1994.tb00314.x; YOSHIMURA F, 1983, J BIOL CHEM, V258, P2308	39	87	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37731	37735		10.1074/jbc.274.53.37731	http://dx.doi.org/10.1074/jbc.274.53.37731			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608832	hybrid			2022-12-27	WOS:000084528000032
J	Lebel, M; Spillare, EA; Harris, CC; Leder, P				Lebel, M; Spillare, EA; Harris, CC; Leder, P			The Werner syndrome gene product co-purifies with the DNA replication complex and interacts with PCNA and topoisomerase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI; POLY(ADP-RIBOSE) POLYMERASE; SYNDROME PROTEIN; HELICASE; HOMOLOG; SGS1; RECQ; HYBRIDIZATION; CLONING	Werner syndrome (WS) is a recessive disorder characterized by genomic instability and by the premature onset of a number of age-related diseases. To understand the molecular basis of this disease, we deleted a segment of the murine Wrn gene and created Wrn-deficient embryonic stem (ES) cells. At the molecular level, wild type-but not mutant-WS protein co-purifies through a series of centrifugation, chromatography, and sucrose gradient steps with the well characterized 17 S multiprotein DNA replication complex. Furthermore, wild type WS protein co-immunoprecipitates with a prominent component of the multiprotein replication complex, proliferating cell nuclear antigen (PCNA), In vitro studies also indicate that PCNA binds to a region in the N terminus portion of the WS protein containing a potential 3'-5' exonuclease domain. Finally, human WS protein also co-immunoprecipitates with both PCNA and topoisomerase I. These results suggest that the WS protein interacts with several components of the DNA replication fork.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Leder, P (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.				DIVISION OF BASIC SCIENCES - NCI [Z01BC005794] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Banin S, 1996, CURR BIOL, V6, P981, DOI 10.1016/S0960-9822(02)00642-5; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Dantzer F, 1998, NUCLEIC ACIDS RES, V26, P1891, DOI 10.1093/nar/26.8.1891; Elli R, 1996, CANCER GENET CYTOGEN, V87, P112, DOI 10.1016/0165-4608(95)00294-4; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FARAGHER RGA, 1993, P NATL ACAD SCI USA, V90, P12030, DOI 10.1073/pnas.90.24.12030; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; HARLOW E, 1988, ANTIBODIES LABORATOR, P421; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Imamura O, 1997, GENOMICS, V41, P298, DOI 10.1006/geno.1997.4661; Jonsson ZO, 1997, BIOESSAYS, V19, P967, DOI 10.1002/bies.950191106; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Okada M, 1998, BIOL PHARM BULL, V21, P235; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; SAITOH A, 1995, NUCLEIC ACIDS RES, V23, P2014, DOI 10.1093/nar/23.11.2014; SALK D, 1981, HUM GENET, V58, P310, DOI 10.1007/BF00294930; SATO K, 1988, GERONTOLOGY, V34, P212, DOI 10.1159/000212956; SCAPPATICCI S, 1990, ANN GENET-PARIS, V33, P5; SCHONBERG S, 1984, AM J HUM GENET, V36, P387; Schulz VP, 1996, HUM GENET, V97, P750; SimbulanRosenthal CM, 1996, BIOCHEMISTRY-US, V35, P11622, DOI 10.1021/bi953010z; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355; Suzuki N, 1997, NUCLEIC ACIDS RES, V25, P2973, DOI 10.1093/nar/25.15.2973; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; Walther AP, 1999, NUCLEIC ACIDS RES, V27, P656, DOI 10.1093/nar/27.2.656; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; Watt PM, 1996, GENETICS, V144, P935; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; WU Y, 1994, J CELL BIOCHEM, V54, P32, DOI 10.1002/jcb.240540105; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1997, AM J HUM GENET, V60, P330; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	37	195	197	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37795	37799		10.1074/jbc.274.53.37795	http://dx.doi.org/10.1074/jbc.274.53.37795			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608841	hybrid			2022-12-27	WOS:000084528000041
J	Decottignies, A; Owsianik, G; Ghislain, M				Decottignies, A; Owsianik, G; Ghislain, M			Casein kinase I-dependent phosphorylation and stability of the yeast multidrug transporter Pdr5p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; HUMAN P-GLYCOPROTEIN; MEMBRANE H+-ATPASE; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; PROTEIN-KINASE; GENE-PRODUCT; ESCHERICHIA-COLI; DRUG-RESISTANCE; ABC PROTEINS	The pleiotropic drug resistance protein, Pdr5p, is an ATP-binding cassette transporter of the plasma membrane of Saccharomyces cerevisiae, Overexpression of Pdr5p results in increased cell resistance to a variety of cytotoxic compounds, a phenotype reminiscent of the multiple drug resistance seen in tumor cells. Pdr5p and two other yeast ATP-binding cassette transporters, Snq2p and Yor1p, were found to be phosphorylated on serine residues in vitro, Mutations in the plasma membrane-bound casein kinase I isoforms, Yck1p and Yck2p, abolished Pdr5p phosphorylation and modified the multiple drug resistance profile. We showed Pdr5p to be ubiquitylated when overexpressed. However, instability of Pdr5p was only seen in Yck1p- and Yck2p-deficient strains, in which it was degraded in the vacuole via a Pep4p-dependent mechanism. Our results suggest that casein kinase I activity is required for membrane trafficking of Pdr5p to the cell surface. In the absence of functional Yck1p and Yck2p, Pdr5p is transported to the vacuole for degradation.	Catholic Univ Louvain, Unite Biochim Physiol, B-1348 Louvain, Belgium	Universite Catholique Louvain	Ghislain, M (corresponding author), Catholic Univ Louvain, Unite Biochim Physiol, Croix Sud 2-20, B-1348 Louvain, Belgium.	ghislain@fysa.ucl.ac.be						AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; ANTONSSON B, 1994, J BIOL CHEM, V269, P16821; BALZI E, 1994, J BIOL CHEM, V269, P2206; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; BERKOWER C, 1994, MOL BIOL CELL, V5, P1185, DOI 10.1091/mbc.5.11.1185; BISSINGER PH, 1994, J BIOL CHEM, V269, P4180; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; CAPIEAUX E, 1993, J BIOL CHEM, V268, P21895; CHAMBERS TC, 1994, BIOCHEM J, V299, P309, DOI 10.1042/bj2990309; CHAMBERS TC, 1993, J BIOL CHEM, V268, P4592; CHAMBERS TC, 1992, MOL PHARMACOL, V41, P1008; Cui ZF, 1996, J BIOL CHEM, V271, P14712, DOI 10.1074/jbc.271.25.14712; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; DELAHODDE A, 1995, MOL CELL BIOL, V15, P4043; EGNER R, 1995, MOL CELL BIOL, V15, P5879; Egner R, 1996, FEBS LETT, V378, P177, DOI 10.1016/0014-5793(95)01450-0; Egner R, 1998, MOL BIOL CELL, V9, P523, DOI 10.1091/mbc.9.2.523; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Germann UA, 1996, J BIOL CHEM, V271, P1708, DOI 10.1074/jbc.271.3.1708; GERMANN UA, 1993, CYTOTECHNOLOGY, V12, P33, DOI 10.1007/BF00744657; GOFFEAU A, 1988, METHOD ENZYMOL, V157, P528; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Kolaczkowski M, 1998, MICROB DRUG RESIST, V4, P143, DOI 10.1089/mdr.1998.4.143; KOLAROV J, 1988, J BIOL CHEM, V263, P10613; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; KUO CL, 1983, MOL CELL BIOL, V3, P1730, DOI 10.1128/MCB.3.10.1730; Lin SJ, 1997, J BIOL CHEM, V272, P9215; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahe Y, 1996, J BIOL CHEM, V271, P25167, DOI 10.1074/jbc.271.41.25167; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; MCDONOUGH JP, 1982, J BIOL CHEM, V257, P4579; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; SERVOS J, 1993, MOL GEN GENET, V236, P214, DOI 10.1007/BF00277115; Szabo K, 1997, J BIOL CHEM, V272, P23165, DOI 10.1074/jbc.272.37.23165; Taglicht D, 1998, METHOD ENZYMOL, V292, P130; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WANG PC, 1992, MOL BIOL CELL, V3, P275, DOI 10.1091/mbc.3.3.275; WATANABE M, 1994, J BIOL CHEM, V269, P16829; Wendland B, 1998, CURR OPIN CELL BIOL, V10, P513, DOI 10.1016/S0955-0674(98)80067-7; Ziman M, 1996, MOL BIOL CELL, V7, P1909, DOI 10.1091/mbc.7.12.1909	62	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37139	37146		10.1074/jbc.274.52.37139	http://dx.doi.org/10.1074/jbc.274.52.37139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601275	hybrid			2022-12-27	WOS:000084382700046
J	Kim, PK; Hollerbach, C; Trimble, WS; Leber, B; Andrews, DW				Kim, PK; Hollerbach, C; Trimble, WS; Leber, B; Andrews, DW			Identification of the endoplasmic reticulum targeting signal in vesicle-associated membrane proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOACTIVATABLE PHOSPHOLIPIDS; RECOGNITION PARTICLE; MICROSOMAL-MEMBRANES; EMBEDDED SEGMENT; CYTOCHROME B(5); PLASMA-MEMBRANE; CROSS-LINKING; SYNAPTOBREVIN; TRANSPORT; BINDING	The vesicle-associated membrane proteins (Vamp(s)) function as soluble N-ethylmaleimide-sensitive factor attachment receptor proteins in the intracellular trafficking of vesicles. The membrane attachment of Vamps requires a carboxyl-terminal hydrophobic sequence termed an insertion sequence. Unlike other insertion sequence-containing proteins, targeting of the highly homologous Vamp1 and Vamp2 to the endoplasmic reticulum requires ATP and a membrane bound receptor. To determine if this mechanism of targeting to the endoplasmic reticulum extends to other Vamps, we compared the membrane binding of Vamp1 and Vamp2 with the distantly related Vamp8. Similar to the other Vamps, Vamp8 requires both ATP and a membrane component to target to the endoplasmic reticulum, Furthermore, binding curves for the three Vamps overlap, suggesting a common receptor-mediated process. We identified a minimal endoplasmic reticulum targeting domain that is both necessary and sufficient to confer receptor-mediated, ATP-dependent, binding of a heterologous protein to microsomes. Surprisingly, this conserved sequence includes four positively charged amino acids spaced along an amphipathic sequence, which unlike the carboxyl-terminal targeting sequence in mitochondrial Vamp isoforms, is amino-terminal to the insertion sequence. Because Vamps do not bind to phospholipid vesicles, it is likely that these residues mediate an interaction with a protein, rather than bind to acidic phospholipids, Therefore, we suggest that a bipartite motif is required for the specific targeting and integration of Vamps into the endoplasmic reticulum with receptor-mediated recognition of specifically configured positive residues leading to the insertion of the hydrophobic tail into the membrane.	McMaster Univ, Med Ctr, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X5, Canada	McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Andrews, DW (corresponding author), McMaster Univ, Med Ctr, Dept Biochem, Rm 4H-41,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.			Andrews, David/0000-0002-9266-7157; Leber, Brian/0000-0001-5502-1480				ANDERSON DJ, 1983, P NATL ACAD SCI-BIOL, V80, P7249, DOI 10.1073/pnas.80.23.7249; ANDREWS DW, 1993, MOL CELL BIOL, V13, P4703, DOI 10.1128/MCB.13.8.4703; ANDREWS DW, 1989, J CELL BIOL, V108, P797, DOI 10.1083/jcb.108.3.797; Bock JB, 1997, NATURE, V387, P133, DOI 10.1038/387133a0; BUSER CA, 1994, BIOCHEMISTRY-US, V33, P13093, DOI 10.1021/bi00248a019; DESILVESTRIS M, 1995, FEBS LETT, V370, P69, DOI 10.1016/0014-5793(95)00797-D; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; ENOCH HG, 1979, J BIOL CHEM, V254, P6483; FALCONE D, 1991, MOL CELL BIOL, V11, P2656, DOI 10.1128/MCB.11.5.2656; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Greenawalt J W, 1974, Methods Enzymol, V31, P633; Greenawalt J W, 1974, Methods Enzymol, V31, P310; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; HUGHES MJ, 1996, BIOTECHNIQUES, V20, P192; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; JANIAK F, 1994, BIOCHEM J, V300, P191, DOI 10.1042/bj3000191; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; KUTAY U, 1993, TRENDS CELL BIOL, V3, P73; Litovchick L, 1998, J BIOL CHEM, V273, P29043, DOI 10.1074/jbc.273.44.29043; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Pedrazzini E, 1996, P NATL ACAD SCI USA, V93, P4207, DOI 10.1073/pnas.93.9.4207; RACHUBINSKI RA, 1980, J CELL BIOL, V84, P705, DOI 10.1083/jcb.84.3.705; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; Rossetto O, 1996, J CELL BIOL, V132, P167, DOI 10.1083/jcb.132.1.167; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SILVERMAN L, 1992, J CELL BIOL, V119, P415, DOI 10.1083/jcb.119.2.415; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SYMONS LJ, 1987, ANAL BIOCHEM, V164, P382, DOI 10.1016/0003-2697(87)90508-2; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9128; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9136; TRIMBLE WS, 1991, ANNU REV NEUROSCI, V14, P93, DOI 10.1146/annurev.ne.14.030191.000521; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	37	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36876	36882		10.1074/jbc.274.52.36876	http://dx.doi.org/10.1074/jbc.274.52.36876			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601239	hybrid			2022-12-27	WOS:000084382700010
J	O'Sullivan, GA; Mohammed, N; Foran, PG; Lawrence, GW; Dolly, JO				O'Sullivan, GA; Mohammed, N; Foran, PG; Lawrence, GW; Dolly, JO			Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25 - Identification of the minimal essential C-terminal residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTOSOMAL-ASSOCIATED PROTEIN; SYNAPTIC VESICLE FUSION; CLOSTRIDIAL NEUROTOXINS; SNARE COMPLEX; SEROTYPE-A; IN-VITRO; SUBSTRATE; INTACT; ACTIVATION; PALMITOYLATION	Botulinum neurotoxin (BoNT) types A and B selectively block exocytosis by cleavage of SNAP-25 and synaptobrevin, respectively; in humans, many months are required for full recovery from the resultant neuromuscular paralysis. To decipher the molecular basis for such prolonged poisoning, intoxication in adreno-chromaffin cells was monitored over 2 months. Exocytosis from BoNT/B-treated cells resumed after 56 days because of the appearance of intact synaptobrevin. However, inhibition continued in BoNT/A-treated cells, throughout the same interval, with a continued predominance of cleaved SNAP-25-(1-197) over the intact protein. When recovery from poisoning was attempted by transfection of the latter cells with the gene encoding full-length SNAP-25-(1-206), no restoration of exocytosis ensued even after 3 weeks. To ascertain if this failure was because of the persistence of the toxin's protease activity, the cells were transfected with BoNT/A-resistant SNAP-25 constructs; importantly, exocytosis was rescued. C-terminal truncation of the toxin-insensitive SNAP-25 revealed that residues 1-201, 1-202, 1-203 afforded a significant return of exocytosis, unlike shorter forms 1-197, -198, -199, or -200; accordingly, mutants M202A or L203A of full-length SNAP-25 rescued secretion. These findings give insights into the C-terminal functional domain of SNAP-25, demonstrate the longevity of BoNT/A protease, and provide the prospect of a therapy for botulism.	Imperial Coll, Dept Biochem, London SW7 2AY, England	Imperial College London	Dolly, JO (corresponding author), Imperial Coll, Dept Biochem, London SW7 2AY, England.		O'Sullivan, Gregory A/F-8355-2011; Dolly, Oliver/G-1532-2012; Dolly, Oliver/ABH-6677-2020; Lawrence, Gary/F-3949-2012	O'Sullivan, Gregory A/0000-0003-0428-041X; Dolly, Oliver/0000-0002-0861-5320; Dolly, Oliver/0000-0002-0861-5320; 				ANGAUTPETIT D, 1990, NEUROSCIENCE, V37, P799, DOI 10.1016/0306-4522(90)90109-H; BARK IC, 1995, P NATL ACAD SCI USA, V92, P1510, DOI 10.1073/pnas.92.5.1510; BARTELS F, 1994, J BIOL CHEM, V269, P8122; BINZ T, 1994, J BIOL CHEM, V269, P1617; Cava TJ, 1995, EUR J NEUROL, V2, P57; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Cherington M, 1998, MUSCLE NERVE, V21, P701, DOI 10.1002/(SICI)1097-4598(199806)21:6<701::AID-MUS1>3.0.CO;2-B; Criado M, 1999, P NATL ACAD SCI USA, V96, P7256, DOI 10.1073/pnas.96.13.7256; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; Ekong TAN, 1997, MICROBIOL-SGM, V143, P3337, DOI 10.1099/00221287-143-10-3337; Eleopra R, 1998, NEUROSCI LETT, V256, P135, DOI 10.1016/S0304-3940(98)00775-7; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; Gonelle-Gispert C, 1999, BIOCHEM J, V339, P159, DOI 10.1042/0264-6021:3390159; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HOLZ RW, 1995, METHOD ENZYMOL, V257, P221; Lane SR, 1997, J NEUROCHEM, V69, P1864; Lawrence GW, 1997, BIOCHEMISTRY-US, V36, P3061, DOI 10.1021/bi9622478; Lawrence GW, 1996, EUR J BIOCHEM, V236, P877, DOI 10.1111/j.1432-1033.1996.00877.x; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; Pellizzari R, 1999, PHILOS T R SOC B, V354, P259, DOI 10.1098/rstb.1999.0377; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; RISINGER C, 1993, J BIOL CHEM, V268, P24408; Sadoul K, 1997, J BIOL CHEM, V272, P33023, DOI 10.1074/jbc.272.52.33023; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Shone CC, 1995, CURR TOP MICROBIOL, V195, P143; Sloop RR, 1997, NEUROLOGY, V49, P189, DOI 10.1212/WNL.49.1.189; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Williamson LC, 1996, J BIOL CHEM, V271, P7694, DOI 10.1074/jbc.271.13.7694; WILSON SP, 1987, J NEUROSCI METH, V19, P163, DOI 10.1016/0165-0270(87)90031-8	36	55	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36897	36904		10.1074/jbc.274.52.36897	http://dx.doi.org/10.1074/jbc.274.52.36897			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601242	hybrid			2022-12-27	WOS:000084382700013
J	Olson, LJ; Hancock, MK; Dix, D; Kim, JJP; Dahms, NM				Olson, LJ; Hancock, MK; Dix, D; Kim, JJP; Dahms, NM			Mutational analysis of the binding site residues of the bovine cation-dependent mannose 6-phosphate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-II; LYSOSOMAL-ENZYME RECOGNITION; LIGAND INTERACTIONS; ARGININE RESIDUES; HUMAN FIBROBLASTS; CLONING; EXPRESSION; CELLS; CDNA; MANNOSE-6-PHOSPHATE	Mannose 6-phosphate receptors (MPRs) deliver soluble acid hydrolases to the lysosome in higher eukaryotic cells. The two MPRs, the cation-dependent MPR (CD-MPR) and the insulin-like growth factor II/cation-independent MPR, carry out this process by binding with high affinity to mannose 6-phosphate residues found on the N-linked oligosaccharides of their ligands, To elucidate the key amino acids involved in conveying this carbohydrate specificity, site-directed mutagenesis studies were conducted on the extracytoplasmic domain of the bovine CD-MPR. Single amino acid substitutions of the residues that form the binding pocket were generated, and the mutant constructs were expressed in transiently transfected COS-l cells. Following metabolic labeling, mutant CD-MPRs were tested for their ability to bind pentamannosyl phosphate-containing affinity columns, Of the eight amino acids mutated, four (Gln-66, Arg-lll, Glu-133, and Tyr-143) were found to be essential for ligand binding. In addition, mutation of the single histidine residue, His-105, within the binding site diminished the binding of the receptor to ligand, but did not eliminate the ability of the CD-MPR to release ligand under acidic conditions.	Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Dahms, NM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK042667, R56DK042667, R01DK042667] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42667] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BABA T, 1988, CARBOHYD RES, V177, P153, DOI 10.1016/0008-6215(88)85049-3; Blanchard F, 1998, J BIOL CHEM, V273, P20886, DOI 10.1074/jbc.273.33.20886; DAHMS NM, 1993, J BIOL CHEM, V268, P5457; DAHMS NM, 1987, CELL, V50, P181, DOI 10.1016/0092-8674(87)90214-5; FISCHER HD, 1980, J BIOL CHEM, V255, P5069; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; KAPLAN A, 1977, J CLIN INVEST, V60, P1088, DOI 10.1172/JCI108860; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KOVACINA KS, 1989, MOL ENDOCRINOL, V3, P901, DOI 10.1210/mend-3-6-901; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE SJ, 1988, J BIOL CHEM, V263, P3521; LI M, 1990, ARCH BIOCHEM BIOPHYS, V283, P150, DOI 10.1016/0003-9861(90)90625-9; LOBEL P, 1988, J BIOL CHEM, V263, P2563; LUDWIG T, 1994, GENE, V142, P311, DOI 10.1016/0378-1119(94)90282-8; MA ZM, 1991, J BIOL CHEM, V266, P10589; MACDONALD RG, 1988, SCIENCE, V239, P1134, DOI 10.1126/science.2964083; Marron-Terada PG, 1998, BIOCHEMISTRY-US, V37, P17223, DOI 10.1021/bi981883y; MunierLehmann H, 1996, BIOCHEM SOC T, V24, P133, DOI 10.1042/bst0240133; Olson LJ, 1999, J BIOL CHEM, V274, P29889, DOI 10.1074/jbc.274.42.29889; OSHIMA A, 1988, J BIOL CHEM, V263, P2553; POHLMANN R, 1987, P NATL ACAD SCI USA, V84, P5575, DOI 10.1073/pnas.84.16.5575; Punnonen EL, 1996, EUR J BIOCHEM, V237, P809, DOI 10.1111/j.1432-1033.1996.0809p.x; PURCHIO AF, 1988, J BIOL CHEM, V263, P14211; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; STEIN M, 1987, BIOL CHEM H-S, V368, P937, DOI 10.1515/bchm3.1987.368.2.937; TONG PY, 1989, J BIOL CHEM, V264, P7962; TONG PY, 1989, J BIOL CHEM, V264, P7970; ULLRICH K, 1978, BIOCHEM J, V170, P643, DOI 10.1042/bj1700643; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WENDLAND M, 1991, J BIOL CHEM, V266, P2917; WESTLUND B, 1991, J BIOL CHEM, V266, P23233; WOODEN SK, 1991, MOL CELL BIOL, V11, P5612, DOI 10.1128/MCB.11.11.5612; ZHANG Y, 1993, BIOCHEM J, V295, P841, DOI 10.1042/bj2950841; ZHOU M, 1995, P NATL ACAD SCI USA, V92, P9762, DOI 10.1073/pnas.92.21.9762	34	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36905	36911		10.1074/jbc.274.52.36905	http://dx.doi.org/10.1074/jbc.274.52.36905			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601243	hybrid			2022-12-27	WOS:000084382700014
J	Wakita, N; Takigawa, M				Wakita, N; Takigawa, M			Activation of epidermal growth factor receptor promotes late terminal differentiation of cell-matrix interaction-disrupted keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CULTURED HUMAN KERATINOCYTES; LINKED ENVELOPE FORMATION; FACTOR-ALPHA; FACTOR EGF; NEURONAL DIFFERENTIATION; TYROSINE PHOSPHORYLATION; EXPRESSION; TRANSGLUTAMINASE; INTEGRIN	The biological effects of epidermal growth factor receptor (EGFR) activation may differ between epidermal suprabasal and basal keratinocytes, since growth factors are mitogenic in adherent cells only in the presence of cell-extracellular matrix (ECM) interaction, To investigate biological effects of EGFR activation on keratinocytes without cell-ECM interaction, we cultured normal human keratinocytes on polyhydroxyethyl-methacrylate-coated plates, which disrupt cell-ECM but not cell-cell interaction. The cells initially expressed keratin 10 (K10) and then profilaggrin, mimicking sequential differentiation of epidermal suprabasal keratinocytes, The addition of EGF or transforming growth factor-alpha promoted late terminal differentiation (profilaggrin expression, type 1 transglutaminase expression and activity, and cornified envelope formation) of the suspended keratinocytes, while suppressing K10 expression, an early: differentiation marker. These effects were attenuated by EGFR tyrosine kinase inhibitor PD153035 or an anti-EGFR monoclonal antibody, whereas protein kinase C inhibitors H7 and bisindolylmaleimide I or mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD98059 abolished profilaggrin up-regulation but not K10 suppression. Since the antidifferentiative role of EGFR on cell-ECM interaction-conserved keratinocytes has been well documented, our results indicate that the biological effects of EGFR:on keratinocytes are influenced by cell-ECM interaction and suggest that EGFR activation promotes rather than inhibits the terminal differentiation of suprabasal epidermal keratinocytes.	Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine	Wakita, N (corresponding author), Hamamatsu Univ Sch Med, Dept Dermatol, 3600 Handa Cho, Hamamatsu, Shizuoka 4313192, Japan.	wakita@hama-med.ac.jp						ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; CHEN JD, 1993, EXP CELL RES, V209, P216, DOI 10.1006/excr.1993.1304; CHEN TC, 1995, J INVEST DERMATOL, V104, P113, DOI 10.1111/1523-1747.ep12613601; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELUCA M, 1994, JOURNAL OF DERMATOLOGY, VOL 21, NO 11, NOVEMBER 1994, P821, DOI 10.1111/j.1346-8138.1994.tb03296.x; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; FLECKMAN P, 1985, J INVEST DERMATOL, V85, P507, DOI 10.1111/1523-1747.ep12277306; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Haugh JM, 1999, J BIOL CHEM, V274, P8958, DOI 10.1074/jbc.274.13.8958; Hines MD, 1996, J BIOL CHEM, V271, P6245, DOI 10.1074/jbc.271.11.6245; Hohl D, 1996, J INVEST DERMATOL, V106, P801, DOI 10.1111/1523-1747.ep12346460; Huang CS, 1998, P NATL ACAD SCI USA, V95, P156, DOI 10.1073/pnas.95.1.156; JETTEN AM, 1990, METHOD ENZYMOL, V190, P42; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; KUBILUS J, 1985, J INVEST DERMATOL, V85, P513, DOI 10.1111/1523-1747.ep12277310; Lee YS, 1998, J INVEST DERMATOL, V111, P762, DOI 10.1046/j.1523-1747.1998.00365.x; Li LW, 1996, J INVEST DERMATOL, V106, P254, DOI 10.1111/1523-1747.ep12340654; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MARCHESE C, 1990, J CELL PHYSIOL, V144, P326, DOI 10.1002/jcp.1041440219; Mark MD, 1997, J BIOL CHEM, V272, P17238, DOI 10.1074/jbc.272.27.17238; MCGOVERN UB, 1995, BRIT J DERMATOL, V132, P892; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; MITEV V, 1995, BIOCHEM BIOPH RES CO, V208, P245, DOI 10.1006/bbrc.1995.1330; Moghal N, 1998, MOL CELL BIOL, V18, P6666, DOI 10.1128/MCB.18.11.6666; Monzon RI, 1996, ENDOCRINOLOGY, V137, P1727, DOI 10.1210/en.137.5.1727; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; NANNEY LB, 1984, J INVEST DERMATOL, V83, P385, DOI 10.1111/1523-1747.ep12264708; Pai R, 1998, DIGEST DIS SCI, V43, p14S; Pillai S, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 1, APRIL 1996, V1, P39; REYNOLDS NJ, 1993, BIOCHEM J, V294, P535, DOI 10.1042/bj2940535; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; Rutberg SE, 1996, ONCOGENE, V13, P167; SAKAI Y, 1994, CELL GROWTH DIFFER, V5, P527; SLAUGHTER TF, 1992, ANAL BIOCHEM, V205, P166, DOI 10.1016/0003-2697(92)90594-W; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Toker A., 1998, FRONT BIOSCI-LANDMRK, V3, P1134, DOI 10.2741/A350; VEGA QC, 1992, MOL CELL BIOL, V12, P128, DOI 10.1128/MCB.12.1.128; WAKITA H, 1995, J INVEST DERMATOL, V105, P536, DOI 10.1111/1523-1747.ep12323426; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; Xia YP, 1996, J CELL BIOL, V132, P727, DOI 10.1083/jcb.132.4.727	45	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37285	37291		10.1074/jbc.274.52.37285	http://dx.doi.org/10.1074/jbc.274.52.37285			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601294	hybrid, Green Submitted			2022-12-27	WOS:000084382700065
J	Regier, DS; Waite, KA; Wallin, R; McPhail, LC				Regier, DS; Waite, KA; Wallin, R; McPhail, LC			A phosphatidic acid-activated protein kinase and conventional protein kinase C isoforms phosphorylate p22(phox) NADPH oxidase component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; STIMULATED HUMAN-NEUTROPHILS; PHOSPHOLIPASE-D ACTIVATION; DIFFERENTIATED HL60 CELLS; RESPIRATORY BURST; PLASMA-MEMBRANE; CYTOCHROME-B; SUPEROXIDE GENERATION; SIGNAL-TRANSDUCTION	Using a phosphorylation-dependent cell-free system to study NADPH oxidase activation (McPhail, L. C., Qualliotine-Mann, D., and Waite, K. A. (1995) Proc. Natl. Acad Sci. U.S.A. 92, 7931-7935), we previously showed that p47(phox), a cytosolic NADPH oxidase component, is phosphorylated, Now, we show that p22(phox), a subunit of the NADPH oxidase component flavocytochrome b(558), also is phosphorylated. Phosphorylation is selectively activated by phosphatidic acid (PA) versus other lipids and occurs on a threonine residue in p22(phox). We identified two protein kinase families capable of phosphorylating p22(phox): 1). potentially novel, partially purified PA-activated protein kinase(s) known to phosphorylate p47(phox) and postulated to mediate the phosphorylation-dependent activation of NADPH oxidase by PA and 2) conventional, but not novel or atypical, isoforms of protein kinase C (PKC). In contrast, all classes of PKC isoforms could phosphorylate p47(phox). In a gel retardation assay both the phosphatidic acid-dependent kinase and conventional PKC isoforms phosphorylated all molecules of p22(phox). These findings suggest that phosphorylation of p22(phox) by conventional PRC and/or a novel PA-activated protein kinase regulates the activation/assembly of NADPH oxidase.	Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Div Infect Dis, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Div Rheumatol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	McPhail, LC (corresponding author), Wake Forest Univ, Sch Med, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA.		McPhail, Linda C/D-9505-2013	McPhail, Linda C/0000-0002-8670-306X	NATIONAL CANCER INSTITUTE [T32CA009422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022564] Funding Source: NIH RePORTER; NCI NIH HHS [CA-09422] Funding Source: Medline; NIAID NIH HHS [R01 AI022564, R01-AI22564] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGWU DE, 1989, BIOCHEM BIOPH RES CO, V159, P79, DOI 10.1016/0006-291X(89)92407-8; AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; AGWU DE, 1989, J BIOL CHEM, V264, P1405; Ahmed S, 1998, J BIOL CHEM, V273, P15693, DOI 10.1074/jbc.273.25.15693; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; BAULDRY SA, 1992, J BIOL CHEM, V267, P25141; BAULDRY SA, 1992, J BIOL CHEM, V267, P323; BAULDRY SA, 1991, J BIOL CHEM, V266, P4173; BELLAVITE P, 1988, J BIOL CHEM, V263, P8210; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; BONSER RW, 1989, BIOCHEM J, V264, P617, DOI 10.1042/bj2640617; BOURGOIN S, 1991, AGENTS ACTIONS, V34, P32, DOI 10.1007/BF01993230; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CALDWELL SE, 1988, J CLIN INVEST, V81, P1485, DOI 10.1172/JCI113480; COCKCROFT S, 1984, BIOCHIM BIOPHYS ACTA, V795, P37, DOI 10.1016/0005-2760(84)90102-4; COCKCROFT S, 1992, BIOCHIM BIOPHYS ACTA, V1113, P135, DOI 10.1016/0304-4157(92)90036-A; CROSS AR, 1995, J BIOL CHEM, V270, P17075, DOI 10.1074/jbc.270.29.17075; DANG PMC, 1994, FEBS LETT, V349, P338, DOI 10.1016/0014-5793(94)00700-4; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; DELLABIANCA V, 1991, BIOCHEM BIOPH RES CO, V177, P948, DOI 10.1016/0006-291X(91)90630-P; DUSI S, 1993, BIOCHEM J, V290, P173, DOI 10.1042/bj2900173; ElBenna J, 1996, J BIOL CHEM, V271, P6374; ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; ElBenna J, 1997, J BIOL CHEM, V272, P17204, DOI 10.1074/jbc.272.27.17204; Escriou V, 1996, BIOCHEM BIOPH RES CO, V219, P930, DOI 10.1006/bbrc.1996.0335; FALLMAN M, 1992, J BIOL CHEM, V267, P2656; Fuchs A, 1997, EUR J BIOCHEM, V249, P531, DOI 10.1111/j.1432-1033.1997.00531.x; GARCIA RC, 1988, BIOCHEM J, V252, P901, DOI 10.1042/bj2520901; GERARD C, 1986, J CLIN INVEST, V77, P61, DOI 10.1172/JCI112302; HARPER AM, 1984, BIOCHEM J, V219, P519, DOI 10.1042/bj2190519; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Hsu MF, 1997, BRIT J PHARMACOL, V120, P917, DOI 10.1038/sj.bjp.0700974; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; KANAHO Y, 1991, J IMMUNOL, V146, P3536; Kent JD, 1996, J IMMUNOL, V157, P4641; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; KORCHAK HM, 1988, J BIOL CHEM, V263, P11098; Korchak HM, 1998, J BIOL CHEM, V273, P27292, DOI 10.1074/jbc.273.42.27292; KOSHKIN V, 1993, FEBS LETT, V327, P57, DOI 10.1016/0014-5793(93)81039-3; Koshkin V, 1995, BBA-BIOENERGETICS, V1232, P225, DOI 10.1016/0005-2728(95)00123-9; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; LHEUREUX GP, 1995, BLOOD, V85, P522, DOI 10.1182/blood.V85.2.522.bloodjournal852522; MAJUMDAR S, 1991, J BIOL CHEM, V266, P9285; MCPHAIL LC, 1983, J CLIN INVEST, V72, P192, DOI 10.1172/JCI110957; MCPHAIL LC, 1995, P NATL ACAD SCI USA, V92, P7931, DOI 10.1073/pnas.92.17.7931; MCPHAIL LC, 1993, NATURAL IMMUNE SYSTE, P63; MESHULAM T, 1995, J LEUKOCYTE BIOL, V57, P842, DOI 10.1002/jlb.57.6.842; MEYER T, 1989, INT J CANCER, V43, P851, DOI 10.1002/ijc.2910430519; NACCACHE PH, 1993, ARTHRITIS RHEUM, V36, P117, DOI 10.1002/art.1780360119; NEWBURGER PE, 1994, J CLIN INVEST, V94, P1205, DOI 10.1172/JCI117437; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; OLSON SC, 1990, FEBS LETT, V272, P209; Park JW, 1997, J BIOL CHEM, V272, P11035; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; QUALLIOTINEMANN D, 1993, J BIOL CHEM, V268, P23843; QUINN MT, 1995, METHOD ENZYMOL, V255, P476; QUINN MT, 1992, J BIOL CHEM, V267, P7303; ROSSI F, 1990, BIOCHEM BIOPH RES CO, V168, P320, DOI 10.1016/0006-291X(90)91711-Z; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Sergeant S, 1997, J IMMUNOL, V159, P2877; SMALLWOOD JI, 1992, J LEUKOCYTE BIOL, V51, P84, DOI 10.1002/jlb.51.1.84; SOZZANI S, 1994, BLOOD, V84, P3895, DOI 10.1182/blood.V84.11.3895.bloodjournal84113895; SUCHARD SJ, 1994, J BIOL CHEM, V269, P8063; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; Waite KA, 1997, J BIOL CHEM, V272, P15569, DOI 10.1074/jbc.272.24.15569; WOODMAN RC, 1995, BLOOD, V85, P231, DOI 10.1182/blood.V85.1.231.bloodjournal851231	79	63	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36601	36608		10.1074/jbc.274.51.36601	http://dx.doi.org/10.1074/jbc.274.51.36601			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593961	hybrid			2022-12-27	WOS:000084279200080
J	Shumilla, JA; Broderick, RJ; Wang, YP; Barchowsky, A				Shumilla, JA; Broderick, RJ; Wang, YP; Barchowsky, A			Chromium(VI) inhibits the transcriptional activity of nuclear factor-kappa B by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBP-INDUCED STIMULATION; HUMAN LUNG-CELLS; IN-VITRO; INFLAMMATORY CYTOKINES; C-JUN; ACTIVATION; DNA; EXPRESSION; COMPLEXES; MECHANISM	Chromium(VI) regulation of gene expression has been attributed to the generation of reactive chromium and oxygen species, DNA damage, and alterations in mRNA stability. However, the effects of Cr(VI) on signal transduction leading to gene expression are not resolved. Therefore, this study investigated the effects of Cr(VI) on basal and tumor necrosis factor-alpha (TNF-alpha)-induced transcriptional competence of nuclear factor-kappa B (NF-kappa B) in A549 human lung carcinoma cells. Pretreatment of A549 cells with nontoxic levels of Cr(VI) inhibited TNF-alpha-stimulated expression of the endogenous gene for interleukin-8 and of an NF-kappa B-driven luciferase gene construct, but not expression of urokinase, a gene with a more complex promoter. Chromium did not inhibit TNF-alpha-stimulated I kappa B alpha degradation or translocation of NF-kappa B-binding proteins to the nucleus, However, Cr(VI) pretreatments prevented TNF-alpha-stimulated interactions between the p65 subunit of NF-kappa B and the transcriptional cofactor cAMP-responsive element-binding protein-binding protein (CBP), This inhibition was not the result of an effect of chromium on the protein kinase A catalytic activity required for p65/CBP interactions. In contrast, Cr(VI) caused concentration-dependent increases in c-Jun/CBP interactions. These data indicate that nontoxic levels of hexavalent chromium selectively inhibit NF-kappa B transcriptional competence by inhibiting interactions with coactivators of transcription rather than DNA binding.	Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Barchowsky, A (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, 7650 Remsen, Hanover, NH 03755 USA.				NHLBI NIH HHS [HL52738] Funding Source: Medline; NIEHS NIH HHS [ES07373] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alcedo J A, 1990, Int Rev Exp Pathol, V31, P85; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bannister AJ, 1995, ONCOGENE, V11, P2509; Barchowsky A, 1996, FREE RADICAL BIO MED, V21, P783, DOI 10.1016/0891-5849(96)00174-8; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V338, P165, DOI 10.1006/abbi.1996.9849; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dubrovskaya VA, 1998, CARCINOGENESIS, V19, P1401, DOI 10.1093/carcin/19.8.1401; DUDEK EJ, 1994, NEW J CHEM, V18, P411; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Hida K, 1997, AM J PATHOL, V150, P2125; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lee SK, 1998, J BIOL CHEM, V273, P16651, DOI 10.1074/jbc.273.27.16651; LENGYEL E, 1995, BBA-MOL CELL RES, V1268, P65, DOI 10.1016/0167-4889(95)00050-3; Martin BD, 1998, CHEM RES TOXICOL, V11, P1402, DOI 10.1021/tx9801559; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; MATTAGAJASINGH SN, 1995, MOL CELL BIOCHEM, V142, P61, DOI 10.1007/BF00928914; MILLER CA, 1988, MOL CARCINOGEN, V1, P125; MILLER CA, 1989, CARCINOGENESIS, V10, P667, DOI 10.1093/carcin/10.4.667; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Samet JM, 1998, AM J PHYSIOL-LUNG C, V275, pL551, DOI 10.1152/ajplung.1998.275.3.L551; SHAINKINKESTENBAUM R, 1991, J TRACE ELEM ELECT H, V5, P197; Shumilla JA, 1999, TOXICOL APPL PHARM, V158, P288, DOI 10.1006/taap.1999.8704; Shumilla JA, 1998, ARCH BIOCHEM BIOPHYS, V349, P356, DOI 10.1006/abbi.1997.0470; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Tian L, 1996, TOXICOL APPL PHARM, V141, P540, DOI 10.1006/taap.1996.0320; WETTERHAHN KE, 1989, BIOL TRACE ELEM RES, V21, P405, DOI 10.1007/BF02917282; Xu J, 1996, CARCINOGENESIS, V17, P1511, DOI 10.1093/carcin/17.7.1511; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhitkovich A, 1996, BIOCHEMISTRY-US, V35, P7275, DOI 10.1021/bi960147w; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	35	69	69	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36207	36212		10.1074/jbc.274.51.36207	http://dx.doi.org/10.1074/jbc.274.51.36207			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593907	hybrid			2022-12-27	WOS:000084279200026
J	Yates, PA; Burman, RW; Mummaneni, P; Krussel, S; Turker, MS				Yates, PA; Burman, RW; Mummaneni, P; Krussel, S; Turker, MS			Tandem B1 elements located in a mouse methylation center provide a target for de novo DNA methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSINE METHYLATION; DENOVO METHYLATION; CELLS; GENE; SEQUENCES; REPEATS; PATTERNS; UPSTREAM; REGIONS; LOCUS	A cis-acting methylation center that signals de novo DNA methylation is located upstream of the mouse Aprt gene. In the current study, two approaches were taken to determine if tandem B1 repetitive elements found at the 3' end of the methylation center contribute to the methylation signal. First, bisulfite genomic sequencing demonstrated that CpG sites within the B1 elements were methylated at relative levels of 43% in embryonal stem cells deficient for the maintenance DNA methyltransferase when compared with wild type embryonal stem cells. Second, the ability of the BI elements to signal de novo methylation upon stable transfection into mouse embryonal carcinoma cells was examined, This approach demonstrated that the B1 elements were methylated de novo to a high level in the embryonal carcinoma cells and that the B1 elements acted synergistically, The results from these experiments provide strong evidence that the tandem B1 repetitive elements provide a significant fraction of the methylation center signal. By extension, they also support the hypothesis that one role for DNA methylation in mammals is to protect the genome from expression and transposition of parasitic elements.	Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; NICHD, Sect Neuroendocrinol, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA	Oregon Health & Science University; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Turker, MS (corresponding author), Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, L606,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				PHS HHS [T32] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baylin SB, 1998, ADV CANCER RES, V72, P141; Bestor TH, 1998, CIBA F SYMP, V214, P187; BOLDEN AH, 1986, MOL CELL BIOL, V6, P1135, DOI 10.1128/MCB.6.4.1135; BOLDEN AH, 1985, NUCLEIC ACIDS RES, V13, P3479, DOI 10.1093/nar/13.10.3479; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; HASSE A, 1994, J BIOL CHEM, V269, P1821; HELLMANNBLUMBERG U, 1993, MOL CELL BIOL, V13, P4523, DOI 10.1128/MCB.13.8.4523; Hertz JM, 1999, J BIOL CHEM, V274, P24232, DOI 10.1074/jbc.274.34.24232; JAHNER D, 1985, NATURE, V315, P594, DOI 10.1038/315594a0; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; LABUDA D, 1991, J MOL EVOL, V32, P405, DOI 10.1007/BF02101280; Lei H, 1996, DEVELOPMENT, V122, P3195; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; LIU WM, 1993, NUCLEIC ACIDS RES, V21, P1351, DOI 10.1093/nar/21.6.1351; McDonald LE, 1997, BIOTECHNIQUES, V22, P272, DOI 10.2144/97222bm16; MUMMANENI P, 1993, J BIOL CHEM, V268, P552; Paulin R, 1998, NUCLEIC ACIDS RES, V26, P5009, DOI 10.1093/nar/26.21.5009; QUENTIN Y, 1994, NUCLEIC ACIDS RES, V22, P2222, DOI 10.1093/nar/22.12.2222; SCHMID CW, 1982, SCIENCE, V216, P1065, DOI 10.1126/science.6281889; SINNETT D, 1991, J BIOL CHEM, V266, P8675; TURKER M, 1995, MUTAT RES-FUND MOL M, V329, P97, DOI 10.1016/0027-5107(95)00046-L; Turker MS, 1999, SEMIN CANCER BIOL, V9, P329, DOI 10.1006/scbi.1999.0133; TURKER MS, 1991, SOMAT CELL MOLEC GEN, V17, P151, DOI 10.1007/BF01232972; TURKER MS, 1989, SOMAT CELL MOLEC GEN, V15, P159, DOI 10.1007/BF01535077; TURKER MS, 1989, J BIOL CHEM, V264, P11632; TURKER MS, 1994, ADV EXP MED BIOL, V111, P647; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; WARD C, 1987, J BIOL CHEM, V262, P11057; Warnecke PM, 1998, DEV GENET, V22, P111, DOI 10.1002/(SICI)1520-6408(1998)22:2&lt;111::AID-DVG1&gt;3.0.CO;2-9; Woodcock DM, 1998, GENE, V206, P63, DOI 10.1016/S0378-1119(97)00566-0; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	32	71	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36357	36361		10.1074/jbc.274.51.36357	http://dx.doi.org/10.1074/jbc.274.51.36357			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593928	hybrid			2022-12-27	WOS:000084279200047
J	Freire, E; Coelho-Sampaio, T				Freire, E; Coelho-Sampaio, T			Self-assembly of laminin induced by acidic pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANES; BINDING DOMAIN; ATTACHMENT; GLYCOPROTEIN; PROTEINS; CELLS; POLYMERIZATION; DYSTROGLYCAN; CYTOSKELETON	The supramolecular architecture of the basement membrane is provided by two enmeshed networks of collagen IV and laminin, The laminin network is maintained exclusively by interactions among individual laminin molecules and does not depend on the presence of other extracellular matrix components. Laminin polymers can be obtained in vitro either in solution or in association with the surface of bilayers containing acidic lipids, In this work, we have tested the hypothesis that the negative charges present on acidic lipids establish an acid microenvironment that is directly responsible for inducing laminin aggregation. Using light-scattering measurements, we show that laminin does not aggregate on vesicles of neutral lipids, whereas instantaneous aggregation occurs to progressively greater extents as the proportion of acidic phospholipids in the vesicles is increased. Aggregation of laminin induced by vesicles containing acidic phospholipids occurs very rapidly, so that maximal aggregation for each condition is reached within 1 min after laminin dilution. Aggregation depends on the presence of Ca2+ ions, is reversed by increasing ionic strength, and can be detected at laminin concentrations as low as 6 nM. In addition, we show that, in the absence of vesicles, acidification of the bulk solution can also induce laminin self-polymerization through a process that exhibits the same properties as lipid-induced polymerization. The fact that there is a correspondence between the processes of self-polymerization of laminin in acidic medium and in neutral medium but in the presence of vesicles containing negatively charged lipids leads us to propose that the microenvironment of an acidic surface may trigger the assembly of laminin networks. In vivo, such an acidic microenvironment would be provided by negatively charged sialic acid and sulfate groups present in the glycocalyx surrounding the cells.	Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Coelho-Sampaio, T (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941 Rio De Janeiro, Brazil.							Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; Aumailley M, 1996, J INVEST DERMATOL, V106, P209, DOI 10.1111/1523-1747.ep12340471; BATTAGLIA C, 1992, EUR J BIOCHEM, V208, P359, DOI 10.1111/j.1432-1033.1992.tb17195.x; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P832; CHERESH DA, 1986, J CELL BIOL, V102, P688, DOI 10.1083/jcb.102.3.688; COOPER AR, 1983, DEV BIOL, V96, P467, DOI 10.1016/0012-1606(83)90183-5; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; EDGAR D, 1988, J CELL BIOL, V106, P1299, DOI 10.1083/jcb.106.4.1299; Ekblom P, 1996, CURR OPIN CELL BIOL, V8, P700, DOI 10.1016/S0955-0674(96)80112-8; ENGEL J, 1981, J MOL BIOL, V150, P97, DOI 10.1016/0022-2836(81)90326-0; GEE SH, 1993, J BIOL CHEM, V268, P14972; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; KALB E, 1991, J BIOL CHEM, V266, P19047; KLEINMAN HK, 1993, VITAM HORM, V47, P161, DOI 10.1016/S0083-6729(08)60446-X; LAITINEN J, 1987, FEBS LETT, V217, P94, DOI 10.1016/0014-5793(87)81250-4; Malinda KM, 1996, INT J BIOCHEM CELL B, V28, P957, DOI 10.1016/1357-2725(96)00042-8; MARTINEZHERNAND.A, 1983, LAB INVEST, V48, P657; MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772; NURCOMBE V, 1992, PHARMACOL THERAPEUT, V56, P247, DOI 10.1016/0163-7258(92)90019-V; PANAYOTOU G, 1989, CELL, V56, P93, DOI 10.1016/0092-8674(89)90987-2; PAULSSON M, 1988, EUR J BIOCHEM, V177, P477, DOI 10.1111/j.1432-1033.1988.tb14397.x; RAMSDEN JJ, 1993, BIOPOLYMERS, V33, P475, DOI 10.1002/bip.360330313; ROBERTS DD, 1985, P NATL ACAD SCI USA, V82, P1306, DOI 10.1073/pnas.82.5.1306; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145; STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526; SUGRUE SP, 1981, J CELL BIOL, V91, P45, DOI 10.1083/jcb.91.1.45; TARABOLETTI G, 1990, J BIOL CHEM, V265, P12253; TERRANOVA VP, 1986, J CELL PHYSIOL, V127, P473, DOI 10.1002/jcp.1041270318; TERRANOVA VP, 1980, CELL, V22, P719, DOI 10.1016/0092-8674(80)90548-6; TERRANOVA VP, 1982, CANCER RES, V42, P2265; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; UTANI A, 1994, J BIOL CHEM, V269, P19167; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Wettreich A, 1999, J BIOL CHEM, V274, P31468, DOI 10.1074/jbc.274.44.31468; YURCHENCO PD, 1990, J BIOL CHEM, V265, P3981; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767	42	40	42	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					817	822		10.1074/jbc.275.2.817	http://dx.doi.org/10.1074/jbc.275.2.817			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625612	hybrid			2022-12-27	WOS:000084836600016
J	Bearne, SL; Blouin, C				Bearne, SL; Blouin, C			Inhibition of Escherichia coli glucosamine-6 phosphate synthase by reactive intermediate analogues - The role of the 2-amino function in catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; FRUCTOSE 6-PHOSPHATE; ENZYME CATALYSIS; PHOSPHOGLUCOSE ISOMERASE; BINDING-SITE; MECHANISM; SYNTHETASE; AMIDOTRANSFERASES; DERIVATIVES; SUBSTRATE	Glucosamine-6-phosphate synthase (GlmS) catalyzes the formation of D-glucosamine 6-phosphate from D-fructose 6-phosphate using L-glutamine as the ammonia source. Because N-acetylglucosamine is an essential building block of both bacterial cell walls and fungal cell wall chitin, the enzyme is a potential target for antibacterial and antifungal agents. The most potent carbohydrate-based inhibitor of GlmS reported to date is 2-amino-2-deoxy-D-glucitol 6-phosphate, an analogue of the putative cis-enolamine intermediate formed during catalysis. The interaction of a series of structurally related cis-enolamine intermediate analogues with GlmS is described. Although arabinose oxime 6-phosphate is identified as a good competitive inhibitor of GlmS with an inhibition constant equal to 1.2 (+/-0.3) mM, the presence of the amino function at the 2-position is shown to be important for potent inhibition. Comparison of the binding affinities of 2-deoxy-D-glucitol 6-phosphate and 2-amino-2-deoxy-D-glucitol 6-phosphate indicates that the amino function contributes -4.1 (+/-0.1) kcal/mol to the free energy of inhibitor binding. Similarly, comparison of the binding affinities of 2-deoxy-D-glucose 6-phosphate and D-glucosamine 6-phosphate indicates that the amino function contributes -3.0 (+/-0.1) kcal/mol to the free energy of product binding. Interactions between GlmS and the 2-amino function of its ligands contribute to the uniform binding of the product and the cis-enolamine intermediate as evidenced by the similar contribution of the amino group to the free energy of binding of D-glucosamine 6-phosphate and 2-amino-2-deoxy-D-glucitol 6-phosphate, respectively.	Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada	Dalhousie University	Bearne, SL (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada.		Bearne, Stephen/ABF-8338-2021	Blouin, Christian/0000-0002-4434-4142				ALBERY WJ, 1977, ANGEW CHEM INT EDIT, V16, P285, DOI 10.1002/anie.197702851; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; ANDRUSZKIEWICZ R, 1986, INT J PEPT PROT RES, V27, P449; AUVIN S, 1991, BIOORG CHEM, V19, P143, DOI 10.1016/0045-2068(91)90030-S; BADET B, 1988, BIOCHEMISTRY-US, V27, P2282, DOI 10.1021/bi00407a006; BADETDENISOT MA, 1995, BIOORG MED CHEM LETT, V5, P815, DOI 10.1016/0960-894X(95)00119-E; BADETDENISOT MA, 1993, B SOC CHIM FR, V130, P249; Bearne SL, 1996, J BIOL CHEM, V271, P3052; BEARNE SL, 1995, BIOCHEMISTRY-US, V34, P11515, DOI 10.1021/bi00036a026; BIGHAM EC, 1984, J MED CHEM, V27, P717, DOI 10.1021/jm00372a003; BUCHANAN JM, 1973, ADV ENZYMOL RAMB, V39, P91; CHIRGWIN JM, 1975, J BIOL CHEM, V250, P7272; CHMARA H, 1986, BIOCHIM BIOPHYS ACTA, V870, P357, DOI 10.1016/0167-4838(86)90240-2; CLARKE J, 1977, CLIN EXP DERMATOL, V2, P167, DOI 10.1111/j.1365-2230.1977.tb01561.x; COLLINS KD, 1974, J BIOL CHEM, V249, P136; CORIZZI V, 1992, J CHEM SOC CHEM COMM, P189, DOI 10.1039/c39920000189; DENISOT MA, 1991, ARCH BIOCHEM BIOPHYS, V288, P225, DOI 10.1016/0003-9861(91)90188-O; DYSON JED, 1968, J BIOL CHEM, V243, P1401; FARBER GK, 1989, BIOCHEMISTRY-US, V28, P7289, DOI 10.1021/bi00444a022; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Fersht AR, 1999, STRUCTURE MECHANISM, P340; FINCH P, 1975, J CHEM SOC PERK T 1, P1682, DOI 10.1039/p19750001682; FINCH P, 1979, CARBOHYD RES, V76, P225, DOI 10.1016/0008-6215(79)80021-X; GHOSH S, 1960, J BIOL CHEM, V235, P1265; GOLINELLIPIMPANEAU B, 1989, J AM CHEM SOC, V111, P3029, DOI 10.1021/ja00190a042; GRACY RW, 1968, J BIOL CHEM, V243, P5410; Hockett RC, 1935, J AM CHEM SOC, V57, P2265, DOI 10.1021/ja01314a067; HOCKETT RC, 1939, J AM CHEM SOC, V61, P2111; HOLLER E, 1973, BIOCHEMISTRY-US, V12, P1150, DOI 10.1021/bi00730a021; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; KATI WM, 1989, SCIENCE, V243, P1591, DOI 10.1126/science.2928795; Kort M.J., 1970, ADV CARBOHYD CHEM BI, VVolume 25, P311, DOI DOI 10.1016/S0065-2318(08)60431-X; KUCHARCZYK N, 1990, BIOCHEMISTRY-US, V29, P3668, DOI 10.1021/bi00467a012; LELOIR LF, 1957, METHOD ENZYMOL, V3, P840, DOI 10.1016/S0076-6879(57)03459-X; Leriche C, 1997, EUR J BIOCHEM, V245, P418, DOI 10.1111/j.1432-1033.1997.00418.x; Leriche C, 1996, J AM CHEM SOC, V118, P1797, DOI 10.1021/ja953614q; LOLIS E, 1990, ANNU REV BIOCHEM, V59, P597, DOI 10.1146/annurev.bi.59.070190.003121; Massiere F, 1998, CELL MOL LIFE SCI, V54, P205, DOI 10.1007/s000180050145; MEI BG, 1990, J BACTERIOL, V172, P3512, DOI 10.1128/jb.172.6.3512-3514.1990; MIDELFORT CF, 1977, BIOCHEMISTRY-US, V16, P1590, DOI 10.1021/bi00627a010; MILEWSKI S, 1992, BIOCHIM BIOPHYS ACTA, V1115, P225, DOI 10.1016/0304-4165(92)90058-3; MULIVOR R, 1973, J MOL BIOL, V76, P123, DOI 10.1016/0022-2836(73)90084-3; NOLTMANN EA, 1972, ENZYMES, V6, P271; Oliva G, 1995, STRUCTURE, V3, P1323, DOI 10.1016/S0969-2126(01)00270-2; PIERCE J, 1985, J AM CHEM SOC, V107, P2448, DOI 10.1021/ja00294a041; ROESTAMADJI J, 1995, J AM CHEM SOC, V117, P11060, DOI 10.1021/ja00150a004; ROSE IA, 1981, PHILOS T ROY SOC B, V293, P131, DOI 10.1098/rstb.1981.0067; ROSE IA, 1975, ADV ENZYMOL RAMB, V43, P491; SALAS M, 1965, J BIOL CHEM, V240, P561; SANTI DV, 1971, BIOCHEMISTRY-US, V10, P4813, DOI 10.1021/bi00801a032; SCHRAY KJ, 1973, J BIOL CHEM, V248, P2219; STREET IP, 1986, BIOCHEMISTRY-US, V25, P6021, DOI 10.1021/bi00368a028; Teplyakov A, 1998, STRUCTURE, V6, P1047, DOI 10.1016/S0969-2126(98)00105-1; Teplyakov A, 1999, PROTEIN SCI, V8, P596; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002; WOLFENDEN R, 1976, ANNU REV BIOPHYS BIO, V5, P271, DOI 10.1146/annurev.bb.05.060176.001415; WOLFENDEN R, 1974, MOL CELL BIOCHEM, V3, P207, DOI 10.1007/BF01686645; WOLFENDEN R, 1970, BIOCHEMISTRY-US, V9, P3404, DOI 10.1021/bi00819a018; WOLFENDEN R, 1987, ENZYME MECHANISMS, P97; WOODRUFF WW, 1979, J BIOL CHEM, V254, P5866; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203	61	42	43	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					135	140		10.1074/jbc.275.1.135	http://dx.doi.org/10.1074/jbc.275.1.135			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617596	hybrid, Green Submitted			2022-12-27	WOS:000085951600020
J	Ozer, J; Moore, PA; Lieberman, PM				Ozer, J; Moore, PA; Lieberman, PM			A testis-specific transcription factor IIA (TFIIA tau) stimulates TATA-binding protein-DNA binding and transcription activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; BASAL TRANSCRIPTION; GENE-TRANSCRIPTION; GLOBAL REPRESSOR; COMPLEX; YEAST; TBP; SUBUNITS; DOMAIN; DROSOPHILA	The general transcription factor IIA (TFIIA) stimulates RNA polymerase II-specific transcription by stabilizing the association of the TATA-binding protein (TBP) with promoter DNA, inhibiting repressors of TBP, and facilitating activator-dependent conformational changes in the preinitiation complex. TFIIA is encoded by two genes (alpha beta and gamma) that are highly conserved between human and yeast. Here, we report the molecular cloning of a novel human gene that shares significant sequence similarity to the evolutionarily conserved amino- and carboxyl-terminal domains of TFIIA alpha beta. The TFIIA-related protein (TFIIA tau) was cloned from a testis-specific cDNA library, and its mRNA is expressed predominantly in testis tissue as determined by expressed sequence tag data base analysis and Northern blotting analysis. The TFIIA complex reconstituted with the testis-specific subunit, TFIIA (tau+gamma), formed the TFIIA-TBP-TATA DNA (T-A) and TFIIA-TFIIB-TBP-TATA DNA (TAB) complexes indistinguishably hom TFIIA (alpha beta+gamma), TFIIA (tau+gamma) supported basal and activated transcription for most activators in reactions reconstituted with TFIIA-depleted nuclear extracts. However, TFIIA (tau+gamma) was reduced relative to TFIIA (alpha beta+gamma) for stimulating transcription with at least one activator, suggesting that these two forms of TFIIA have activator specificity. These results suggest that TFIIA tau may be important for testis specific transcription regulation.	Wistar Inst, Philadelphia, PA 19104 USA; Human Genome Sci, Rockville, MD 20850 USA	The Wistar Institute; GlaxoSmithKline; Human Genome Sciences Inc	Lieberman, PM (corresponding author), Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.				NIGMS NIH HHS [GM 54687-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054687] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1990, J MOL BIOL, V215, P413; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Bjorklund S, 1996, TRENDS BIOCHEM SCI, V21, P335, DOI 10.1016/0968-0004(96)10051-7; BURATOWSKI S, 1992, CELL, V71, P221, DOI 10.1016/0092-8674(92)90351-C; BURATOWSKI S, 1988, NATURE, V334, P37, DOI 10.1038/334037a0; CAREY M, 1992, J VIROL, V66, P4803, DOI 10.1128/JVI.66.8.4803-4813.1992; CHI TH, 1995, NATURE, V377, P254, DOI 10.1038/377254a0; Chi TH, 1996, GENE DEV, V10, P2540, DOI 10.1101/gad.10.20.2540; Clemens KE, 1996, MOL CELL BIOL, V16, P4656; CROWLEY TE, 1993, NATURE, V361, P557, DOI 10.1038/361557a0; DEJONG J, 1995, P NATL ACAD SCI USA, V92, P3313, DOI 10.1073/pnas.92.8.3313; DEJONG J, 1993, GENE DEV, V7, P2220, DOI 10.1101/gad.7.11.2220; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; GE H, 1994, J BIOL CHEM, V269, P17136; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; IMBALZANO AN, 1994, J BIOL CHEM, V269, P8280; INOSTROZA JA, 1992, CELL, V70, P477; KANG JJ, 1995, MOL CELL BIOL, V15, P1234; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KIROV N, 1995, EMBO J, V15, P7079; Kobayashi N, 1998, MOL CELL BIOL, V18, P4023, DOI 10.1128/MCB.18.7.4023; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; MA DM, 1993, GENE DEV, V7, P2246, DOI 10.1101/gad.7.11.2246; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MOQDATERI Z, 1996, NATURE, V383, P188; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Ozer J, 1996, J BIOL CHEM, V271, P11182, DOI 10.1074/jbc.271.19.11182; Ozer J, 1998, J BIOL CHEM, V273, P14293, DOI 10.1074/jbc.273.23.14293; OZER J, 1994, GENE DEV, V8, P2324, DOI 10.1101/gad.8.19.2324; Ozer J, 1998, MOL CELL BIOL, V18, P2559, DOI 10.1128/MCB.18.5.2559; PARVIN JD, 1992, CELL, V68, P1135, DOI 10.1016/0092-8674(92)90084-P; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; RANISH JA, 1991, J BIOL CHEM, V266, P19320; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; SUN XQ, 1994, GENE DEV, V8, P2336, DOI 10.1101/gad.8.19.2336; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Walker SS, 1996, NATURE, V383, P185, DOI 10.1038/383185a0; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; YOKOMORI K, 1993, GENE DEV, V7, P2235, DOI 10.1101/gad.7.11.2235; YOKOMORI K, 1994, GENE DEV, V8, P2313, DOI 10.1101/gad.8.19.2313	59	56	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					122	128		10.1074/jbc.275.1.122	http://dx.doi.org/10.1074/jbc.275.1.122			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617594	hybrid			2022-12-27	WOS:000085951600018
J	Smith, JK; Reed, RB; Francis, SH; Grimes, K; Corbin, JD				Smith, JK; Reed, RB; Francis, SH; Grimes, K; Corbin, JD			Distinguishing the roles of the two different cGMP-binding sites for modulating phosphorylation of exogenous substrate (heterophosphorylation) and autophosphorylation of cGMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APPARENT CONFORMATIONAL CHANGE; I-BETA; CYCLIC-GMP; SMOOTH-MUSCLE; BOVINE AORTA; CAMP; ACTIVATION; PURIFICATION; SPECIFICITY; INCREASES	The role of each of the two different cGMP-binding sites (referred to as slow and fast sites) of type I cGMP-dependent protein kinase (PKG) in altering the rate of catalysis of phosphorylation of exogenous substrates (heterophosphorylation) or the rate of autophosphorylation has not been resolved. In the present study, the cGMP concentration required for half-maximal activation (A(50)) of wild-type PKG type I beta (WT) was 5-fold higher for heterophosphorylation than for autophosphorylation. cGMP occupation of the slow site was associated with an increase in the autophosphorylation rate, whereas occupation of the fast and slow site together was associated with a decrease in the autophosphorylation rate compared with the rate observed with occupation of the slow site alone. The contributions of each cGMP-binding site were investigated using PKG mutants containing substitutions of an invariant threonine residue that is critical for high affinity cGMP-binding in each site. Site-directed mutagenesis of Thr-317 of the fast site (T317A) increased the cGMP A(50) for heterophosphorylation 4-fold at 30 degrees C, with nominal effect on cGMP A(50) for autophosphorylation compared with WT. The analogous slow site mutation (T193A) increased the cGMP A(50) for heterophosphorylation and autophosphorylation 32- and 64-fold, respectively. Compared with WT, the cGMP A(50) of the double mutant (T193A/T317A) for heterophosphorylation was increased 300-fold, whereas the cGMP A(50) for autophosphorylation was similar to that of T193A. Thus, occupation of both cGMP-binding sites of PKG is required for maximal stimulation of heterophosphorylation, whereas occupation of the slow site alone is sufficient for stimulation of the rate of autophosphorylation, and additional occupation of the fast site reduces this rate.	Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Corbin, JD (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Light Hall 702, Nashville, TN 37232 USA.	jackie.corbin@mcmail.vanderbilt.edu			NCI NIH HHS [CA68485] Funding Source: Medline; NIDDK NIH HHS [DK40029, 5T32 DK07563] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563, R01DK040029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTENHOFEN W, 1991, P NATL ACAD SCI USA, V88, P9868, DOI 10.1073/pnas.88.21.9868; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENG HC, 1986, J BIOL CHEM, V261, P989; Chu DM, 1998, J BIOL CHEM, V273, P14649, DOI 10.1074/jbc.273.23.14649; Chu DM, 1997, J BIOL CHEM, V272, P31922, DOI 10.1074/jbc.272.50.31922; CORBIN JD, 1983, J BIOL CHEM, V258, P1391; CORBIN JD, 1986, J BIOL CHEM, V261, P1208; DOSKELAND SO, 1987, J BIOL CHEM, V262, P3534; Francis S H, 1994, Adv Pharmacol, V26, P115, DOI 10.1016/S1054-3589(08)60053-8; FRANCIS SH, 1991, METHOD ENZYMOL, V200, P332; FRANCIS SH, 1988, MOL PHARMACOL, V34, P506; Francis SH, 1996, J BIOL CHEM, V271, P20748, DOI 10.1074/jbc.271.34.20748; GLASS DB, 1982, J BIOL CHEM, V257, P1196; HOFMANN F, 1983, FEBS LETT, V164, P350, DOI 10.1016/0014-5793(83)80315-9; HOFMANN F, 1985, EUR J BIOCHEM, V147, P361, DOI 10.1111/j.1432-1033.1985.tb08758.x; HOFMANN F, 1992, BIOCHIM BIOPHYS ACTA, V1135, P51, DOI 10.1016/0167-4889(92)90165-8; LANDGRAF W, 1986, EUR J BIOCHEM, V154, P113, DOI 10.1111/j.1432-1033.1986.tb09365.x; LANDGRAF W, 1990, BIOCHEMISTRY-US, V29, P9921, DOI 10.1021/bi00494a024; LINCOLN TM, 1983, ADV CYCL NUCL RES<D>, V15, P139; LINCOLN TM, 1994, HYPERTENSION, V23, P1141, DOI 10.1161/01.HYP.23.6.1141; POHLER D, 1995, FEBS LETT, V374, P419, DOI 10.1016/0014-5793(95)01168-E; Reed RB, 1996, J BIOL CHEM, V271, P17570, DOI 10.1074/jbc.271.29.17570; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; SANDBERG M, 1989, FEBS LETT, V255, P321, DOI 10.1016/0014-5793(89)81114-7; SMITH J, 1993, FASEB J, V7, pA1123; Smith JA, 1996, J BIOL CHEM, V271, P20756, DOI 10.1074/jbc.271.34.20756; Walter U, 1989, REV PHYSL BIOCH PHAR, V113, P41; WEBER IT, 1989, BIOCHEMISTRY-US, V28, P6122, DOI 10.1021/bi00440a059; WOLFE L, 1989, J BIOL CHEM, V264, P7734; WYATT TA, 1991, J BIOL CHEM, V266, P21274; Zhao JK, 1997, J BIOL CHEM, V272, P31929, DOI 10.1074/jbc.272.50.31929	31	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					154	158		10.1074/jbc.275.1.154	http://dx.doi.org/10.1074/jbc.275.1.154			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617599	hybrid			2022-12-27	WOS:000085951600023
J	Fivaz, M; Velluz, MC; van der Goot, FG				Fivaz, M; Velluz, MC; van der Goot, FG			Dimer dissociation of the pore-forming toxin aerolysin precedes receptor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-CHANNEL; ANCHORED PROTEIN; PROAEROLYSIN; ACTIVATION; INSERTION	The pore-forming toxin aerolysin is secreted by Aeromonas hydrophila as an inactive precursor. Based on chemical cross-linking and gel filtration, we show here that proaerolysin exists as a monomer at low concentrations but is dimeric above 0.1 mg/ml. At intermediate concentrations, monomers and dimers appeared to be in rapid equilibrium, All together our data indicate that, at low concentrations, the toxin is a monomer and that this species is competent for receptor binding. In contrast, a mutant toxin that forms a covalent dimer was unable to bind to target cells.	Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland	University of Geneva	van der Goot, FG (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.		van der Goot, Gisou G/B-2279-2012	van der Goot, Gisou G/0000-0002-8522-274X; Fivaz, Marc/0000-0003-1003-7934				Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; BUCKLEY JT, 1990, BIOCHEM CELL BIOL, V68, P221, DOI 10.1139/o90-029; Cabiaux V, 1997, BIOCHEMISTRY-US, V36, P15224, DOI 10.1021/bi971216p; Cowell S, 1997, MOL MICROBIOL, V25, P343, DOI 10.1046/j.1365-2958.1997.4691828.x; HARDIE KR, 1995, MOL MICROBIOL, V17, P1035, DOI 10.1111/j.1365-2958.1995.mmi_17061035.x; HOWARD SP, 1985, J BACTERIOL, V163, P336, DOI 10.1128/JB.163.1.336-340.1985; HOWARD SP, 1982, BIOCHEMISTRY-US, V21, P1662, DOI 10.1021/bi00536a029; Krause KH, 1998, J BIOL CHEM, V273, P18122, DOI 10.1074/jbc.273.29.18122; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Moniatte M, 1996, FEBS LETT, V384, P269, DOI 10.1016/0014-5793(96)00328-6; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; Nelson KL, 1999, CELL MICROBIOL, V1, P69, DOI 10.1046/j.1462-5822.1999.00009.x; Parker MW, 1996, MOL MICROBIOL, V19, P205, DOI 10.1046/j.1365-2958.1996.355887.x; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Rossjohn J, 1998, J STRUCT BIOL, V121, P92, DOI 10.1006/jsbi.1997.3947; VANDERGOOT FG, 1992, BIOCHEMISTRY-US, V31, P8566, DOI 10.1021/bi00151a026; VANDERGOOT FG, 1993, J BIOL CHEM, V268, P18272; WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x	21	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37705	37708		10.1074/jbc.274.53.37705	http://dx.doi.org/10.1074/jbc.274.53.37705			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608828	hybrid			2022-12-27	WOS:000084528000028
J	Schulz, S; Huber, A; Schwab, K; Paulsen, R				Schulz, S; Huber, A; Schwab, K; Paulsen, R			A novel G gamma isolated from Drosophila constitutes a visual G protein gamma subunit of the fly compound eye	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ-DOMAIN PROTEIN; PHOTORECEPTOR-MEMBRANES; GENE; NORPA; INAD; PHOTOTRANSDUCTION; MELANOGASTER; RHODOPSIN; PHOSPHORYLATION; LOCALIZATION	Visual transduction in the compound eye of flies is a well established model system for the study of G protein-coupled transduction pathways. To characterize key components of the phototransduction cascade we performed substractive hybridization screening. We cloned the cDNA coding for the visual G gamma (G gamma(e)) subunit from Drosophila which had so far eluded identification at,the molecular level. Northern blot analysis revealed the presence of a major, 1.4-kilobase(kb) G gamma(e) transcript and two minor transcripts of 1.8 and 6 kb in size. The major 1.4-kb mRNA is expressed preferentially in the eye. The spatial expression pattern determined for G gamma(e) as well as co-immunoprecipitation experiments demonstrated that G gamma(e) dimerizes with G beta(e) to form the heterodimeric G beta gamma subunit which functions in visual transduction in the Drosophila compound eye. G gamma(e) shares common characteristics with the visual G gamma subunits of human rod and cone photoreceptors although different classes of G alpha subunits are employed in vertebrate and invertebrate phototransduction. By the molecular cloning and characterization of the visual gamma subunit of Drosophila one of the few missing links in the well studied Drosophila phototransduction cascade has been characterized to complete our knowledge about the Drosophila visual transduction pathway.	Univ Karlsruhe, Inst Zool, Dept Cell & Neurobiol, D-76128 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Huber, A (corresponding author), Univ Karlsruhe, Inst Zool, Dept Cell & Neurobiol, Kornblumenstr 13, D-76128 Karlsruhe, Germany.	DC05@rz.unl-karlsruhe.de		Huber, Armin/0000-0003-3977-089X				Bentrop J, 1997, EMBO J, V16, P1600, DOI 10.1093/emboj/16.7.1600; BENTROP J, 1986, EUR J BIOCHEM, V161, P61, DOI 10.1111/j.1432-1033.1986.tb10124.x; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chou WH, 1999, DEVELOPMENT, V126, P607; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P81, DOI 10.1007/BF00592572; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; HUBER A, 1994, EUR J CELL BIOL, V63, P219; HUBER A, 1990, J BIOL CHEM, V265, P17906; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; KISSELEV O, 1995, J BIOL CHEM, V270, P25356, DOI 10.1074/jbc.270.43.25356; KISSELEV O, 1993, J BIOL CHEM, V268, P24519; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; Kisselev OG, 1999, P NATL ACAD SCI USA, V96, P4898, DOI 10.1073/pnas.96.9.4898; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; LOTT JS, 1992, FEBS LETT, V312, P241, DOI 10.1016/0014-5793(92)80943-B; MCKAY RR, 1995, J BIOL CHEM, V270, P13271, DOI 10.1074/jbc.270.22.13271; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; PAULSEN R, 1984, J COMP PHYSIOL, V155, P47, DOI 10.1007/BF00610930; Pearn MT, 1996, J BIOL CHEM, V271, P4937; PLANGGER A, 1994, J BIOL CHEM, V269, P26969; RAY K, 1992, J BIOL CHEM, V267, P6086; RAY K, 1995, J BIOL CHEM, V270, P21765, DOI 10.1074/jbc.270.37.21765; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEUWLY S, 1991, J BIOL CHEM, V266, P24314; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Selinger Z., 1987, Progress in Clinical and Biological Research, V249, P169; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Ueda H, 1998, J BIOCHEM-TOKYO, V124, P1033, DOI 10.1093/oxfordjournals.jbchem.a022196; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B	45	21	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37605	37610		10.1074/jbc.274.53.37605	http://dx.doi.org/10.1074/jbc.274.53.37605			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608815	hybrid			2022-12-27	WOS:000084528000015
J	Silverstein, AM; Galigniana, MD; Kanelakis, KC; Radanyi, C; Renoir, JM; Pratt, WB				Silverstein, AM; Galigniana, MD; Kanelakis, KC; Radanyi, C; Renoir, JM; Pratt, WB			Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90, and cytoplasmic dynein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; TETRATRICOPEPTIDE REPEAT DOMAIN; ARYL-HYDROCARBON RECEPTOR; CYCLE CONTROL PROTEIN; ROUS-SARCOMA VIRUS; PROGESTERONE-RECEPTOR; STEROID-RECEPTOR; FK506-BINDING PROTEIN; BINDING-PROTEIN; CYCLOSPORINE-A	FKBP52 is a high molecular mass immunophilin possessing peptidylprolyl isomerase (PPIase) activity that is inhibited by the immunosuppressant drug FK506, FKBP52 is a component of steroid receptor . hsp90 heterocomplexes, and it binds to hsp90 via a region containing three tetratricopeptide repeats (TPRs), Here we demonstrate by cross-linking of the purified proteins that there is one binding site for FKBP52/dimer of hsp90, This accounts for the common heterotetrameric structure of native receptor heterocomplexes being 1 molecule of receptor, 2 molecules of hsp90, and 1 molecule of a TPR domain protein. Immunoadsorption of FKBP52 from reticulocyte lysate also yields co-immunoadsorption of cytoplasmic dynein, and we show that co-immunoadsorption of dynein is competed by a fragment of FKBP52 containing its PPIase domain, but not by a TPR domain fragment that blocks FKBP52 binding to hsp90, Using purified proteins, we also show that FKBP52 binds directly to the hsp90-free glucocorticoid receptor. Because neither the PPIase fragment nor the TPR fragment affects the binding of FKBP52 to the glucocorticoid receptor under conditions in which they block FKBP52 binding to dynein or hsp90, respectively, different regions of FKBP52 must determine its association with these three proteins.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; Fac Pharm, CNRS, UMR 8612, F-92296 Chatenay Malabry, France	University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Pratt, WB (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 1301 Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.		RADANYI, Christine/A-8921-2008	GALIGNIANA, MARIO/0000-0002-9130-8574	NATIONAL CANCER INSTITUTE [R01CA028010] Funding Source: NIH RePORTER; NCI NIH HHS [CA28010] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; CALLEBAUT I, 1992, P NATL ACAD SCI USA, V89, P6270, DOI 10.1073/pnas.89.14.6270; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; CHAMBRAUD B, 1993, BIOCHEM BIOPH RES CO, V196, P160, DOI 10.1006/bbrc.1993.2229; Chambraud B, 1999, P NATL ACAD SCI USA, V96, P2104, DOI 10.1073/pnas.96.5.2104; Chen H, 1997, J BIOL CHEM, V272, P25873, DOI 10.1074/jbc.272.41.25873; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; CZAR MJ, 1994, MOL ENDOCRINOL, V8, P1731, DOI 10.1210/me.8.12.1731; Dey B, 1996, MOL BIOL CELL, V7, P1405, DOI 10.1091/mbc.7.9.1405; ERHART JC, 1988, ONCOGENE, V3, P595; GRAMMATIKAKIS N, 1995, J BIOL CHEM, V270, P16198, DOI 10.1074/jbc.270.27.16198; HOFFMANN K, 1995, BIOCHEM J, V307, P5, DOI 10.1042/bj3070005; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; HUTCHISON KA, 1994, J BIOL CHEM, V269, P5043; LEBEAU MC, 1994, BIOCHEM BIOPH RES CO, V203, P750, DOI 10.1006/bbrc.1994.2246; LEBEAU MC, 1992, J BIOL CHEM, V267, P4281; LEBIHAN S, 1993, BIOCHEM BIOPH RES CO, V195, P600, DOI 10.1006/bbrc.1993.2088; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Ma Q, 1997, J BIOL CHEM, V272, P8878; MASSOL N, 1992, BIOCHEM BIOPH RES CO, V187, P1330, DOI 10.1016/0006-291X(92)90448-T; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Nair SC, 1997, MOL CELL BIOL, V17, P594, DOI 10.1128/MCB.17.2.594; OWENSGRILLO JK, 1995, J BIOL CHEM, V270, P20479, DOI 10.1074/jbc.270.35.20479; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; Perdew GH, 1997, BIOCHEMISTRY-US, V36, P3600, DOI 10.1021/bi9612529; PERROTAPPLANAT M, 1995, J CELL SCI, V108, P2037; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; RADANYI C, 1994, P NATL ACAD SCI USA, V91, P11197, DOI 10.1073/pnas.91.23.11197; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; RATAJCZAK T, 1993, J BIOL CHEM, V268, P13187; REHBERGER P, 1992, P NATL ACAD SCI USA, V89, P8001, DOI 10.1073/pnas.89.17.8001; RENOIR JM, 1995, P NATL ACAD SCI USA, V92, P4977, DOI 10.1073/pnas.92.11.4977; REXIN M, 1991, J BIOL CHEM, V266, P24601; REXIN M, 1988, FEBS LETT, V241, P234, DOI 10.1016/0014-5793(88)81068-8; RUFF VA, 1992, J BIOL CHEM, V267, P21285; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; SEGNITZ B, 1995, P NATL ACAD SCI USA, V92, P2179, DOI 10.1073/pnas.92.6.2179; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; SMITH DF, 1993, J BIOL CHEM, V268, P24270; SMITH DF, 1993, J BIOL CHEM, V268, P18365; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; WHITELAW ML, 1991, J BIOL CHEM, V266, P16436; YEM AW, 1992, J BIOL CHEM, V267, P2868; YEM AW, 1993, BIOCHEMISTRY-US, V32, P12571, DOI 10.1021/bi00210a004; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	62	152	159	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36980	36986		10.1074/jbc.274.52.36980	http://dx.doi.org/10.1074/jbc.274.52.36980			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601253	hybrid			2022-12-27	WOS:000084382700024
J	Wang, QMJ; Bhattacharyya, D; Garfield, S; Nacro, K; Marquez, VE; Blumberg, PM				Wang, QMJ; Bhattacharyya, D; Garfield, S; Nacro, K; Marquez, VE; Blumberg, PM			Differential localization of protein kinase C delta by phorbol esters and related compounds using a fusion protein with green fluorescent protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPROMOTING 12-DEOXYPHORBOL 13-ESTERS; NIH 3T3 FIBROBLASTS; CD-1 MOUSE SKIN; 12-MYRISTATE 13-ACETATE; LIVING CELLS; BINDING; BRYOSTATIN; DOMAINS; TRANSLOCATION; ISOZYMES	Enzyme localization often plays a controlling role in determining its activity and specificity. Protein kinase C (PKC) has long been known to translocate in response to physiological stimuli as well as to exogenous ligands such as the phorbol esters, We report here that different phorbol derivatives and related ligands, selected for differences in chemical structure and profile of biological activity, induce distinct patterns of redistribution of PKC delta, Localization of a PKC delta-green fluorescent protein (GFP) fusion construct was monitored in living Chinese hamster ovary cells as a function of ligand, concentration, and time using confocal laser scanning microscopy, delta-PKC-GFP was expressed predominantly in the cytoplasm, with some in the nucleus and perinuclear region. Phorbol 12-myristate 13-acetate (PMA) induced plasma membrane translocation followed by slower nuclear membrane translocation. As the concentration of PMA increased, the proportion of nuclear to plasma membrane localization increased markedly. In contrast to PMA, bryostatin 1, a unique activator of PKC that induces a subset of PIMA mediated responses while antagonizing others, at all doses induced almost exclusively nuclear membrane translocation, Like PMA, the complete tumor promoter 12-deoxyphorbol 13-tetradecanoate induced plasma membrane and slower nuclear membrane translocation, whereas the inhibitor of tumor promotion 12-deoxyphorbol 13-phenylacetate, which differs only in its side chain, induced a distinctive distribution of PKC delta-GFP, Finally, the novel constrained diacylglycerol derivative B8-DL-B8 induced a slow Golgi localization. We speculate that differential control of PRC delta localization may provide an interesting strategy for producing ligands with differential biological consequences.	NCI, Mol Mechanisms Tumor Promot Sect, Cellular Carcinogenesis & Tumor Promot Lab, NIH, Bethesda, MD 20892 USA; NCI, Expt Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; NCI, Med Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blumberg, PM (corresponding author), NCI, Mol Mechanisms Tumor Promot Sect, Cellular Carcinogenesis & Tumor Promot Lab, NIH, Bldg 37,Rm 3A01,37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.	blumberp@dc37a.nci.nih.gov	Marquez, Victor/AAP-3549-2021; Wang, Qiming Jane/B-6064-2012	Wang, Qiming Jane/0000-0002-9502-4851				BERKOW RL, 1985, BIOCHEM BIOPH RES CO, V131, P1109, DOI 10.1016/0006-291X(85)90205-0; BLUMBERG PM, 1992, ALFRED BENZON SYMP S, V33, P273; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; DELLAQUILA ML, 1988, CANCER RES, V48, P3702; DONG LQ, 1993, CELL GROWTH DIFFER, V4, P793; FURSTENBERGER G, 1972, PLANTA MED, V22, P241; GERMANO P, 1994, J BIOL CHEM, V269, P23102; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Hurley JH, 1997, PROTEIN SCI, V6, P477; HYATT SL, 1994, BIOCHEMISTRY-US, V33, P1223, DOI 10.1021/bi00171a023; HYATT SL, 1990, MOL CARCINOGEN, V3, P45, DOI 10.1002/mc.2940030202; ISAKOV N, 1993, J IMMUNOL, V150, P1195; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; KIELBASSA K, 1995, J BIOL CHEM, V270, P6156, DOI 10.1074/jbc.270.11.6156; KOPELOVICH L, 1980, EXP CELL BIOL, V48, P207; KRAFT AS, 1986, P NATL ACAD SCI USA, V83, P1334, DOI 10.1073/pnas.83.5.1334; LITTLE JB, 1985, CARCINOGENESIS, V6, P1703, DOI 10.1093/carcin/6.12.1703; Marquez VE, 1999, PHARMACOL THERAPEUT, V82, P251, DOI 10.1016/S0163-7258(98)00048-5; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1990, CELL REGUL, V1, P693, DOI 10.1091/mbc.1.9.693; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Ohmori S, 1998, MOL CELL BIOL, V18, P5263, DOI 10.1128/MCB.18.9.5263; PEARS C, 1995, J BIOSCIENCE, V20, P311, DOI 10.1007/BF02703836; Pluda J M, 1996, Oncology (Williston Park), V10, P740; Prekeris R, 1996, J CELL BIOL, V132, P77, DOI 10.1083/jcb.132.1.77; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; SCHMIDT R, 1989, J CANCER RES CLIN, V115, P516, DOI 10.1007/BF00391351; Shirai Y, 1998, J CELL BIOL, V143, P511, DOI 10.1083/jcb.143.2.511; SMITH JB, 1985, BIOCHEM BIOPH RES CO, V132, P939, DOI 10.1016/0006-291X(85)91898-4; SOSSIN WS, 1993, TRENDS BIOCHEM SCI, V18, P207, DOI 10.1016/0968-0004(93)90189-T; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; SZALLASI Z, 1994, MOL PHARMACOL, V46, P840; SZALLASI Z, 1993, CANCER RES, V53, P2507; SZALLASI Z, 1992, CARCINOGENESIS, V13, P2161, DOI 10.1093/carcin/13.11.2161; ZAYED S, 1984, PLANTA MED, V8, P65; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	42	163	172	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37233	37239		10.1074/jbc.274.52.37233	http://dx.doi.org/10.1074/jbc.274.52.37233			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601287	hybrid			2022-12-27	WOS:000084382700058
J	Bolivar, J; Diaz, I; Iglesias, C; Valdivia, MM				Bolivar, J; Diaz, I; Iglesias, C; Valdivia, MM			Molecular cloning of a zinc finger autoantigen transiently associated with interphase nucleolus and mitotic centromeres and midbodies - Orthologous proteins with nine cxxc motifs highly conserved from nematodes to humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE-DISEASES; CELL BIOLOGY; LOCALIZATION; GENES; DOMAINS; MOUSE; KINETOCHORE; SEQUENCE; KRUPPEL; GATA-4	We have cloned a novel human autoimmune antigen in a patient suffering from rheumatoid arthritis with high levels of antibodies to the nucleolus organizer regions. Initially the human autoimmune serum was used to select a cDNA of 317 amino acids from a hamster expression library. Using the hamster DNA as a probe, we isolated the human homologous cDNA of 320 amino acids. Human and hamster polypeptides share a 95% amino acid homology, The deduced 36-kDa protein contains a putative amino-terminal NLS signal, nine cysteine-X-X-cysteine motifs highly conserved, and a carboxyl-terminal poly acidic region. Several homologous expressed sequence tags have been identified in data bases suggesting that orthologous proteins are present throughout evolution from worms to humans. A Drosophila expressed sequence tag was further completely sequenced for a full-length protein with 60% amino acid identity to the human homologue. Northern blot analysis revealed that this novel protein is widely distributed in human tissues with significantly higher expression levels in heart and skeletal muscle, Specific antibodies to the recombinant protein and transfection experiments demonstrated by immunofluorescence the localization of the protein predominantly but not exclusively to the nucleolus of interphase mammalian cells, In actinomycin D-treated cells the protein remains associated with the nucleolus but is not segregated, like other ribosomal factors such as upstream binding factor. In mitosis the protein was found to be associated with centromeres and concentrated at the midbody in cytokinesis. Transient distribution of this evolutionarily conserved zinc finger nucleolar autoantigen to the mitotic centromeres may provide the means for several aspects of cell cycle control and transcriptional regulation.	Univ Cadiz, Fac Ciencias, Dept Bioquim & Biol Mol, Cadiz 11510, Spain	Universidad de Cadiz	Valdivia, MM (corresponding author), Univ Cadiz, Fac Ciencias, Dept Bioquim & Biol Mol, Cadiz 11510, Spain.		BOLIVAR, JORGE/G-4322-2015; Valdivia, Manuel Jesús Martínez/ABG-8867-2020; Diaz, Isabel/I-8840-2014	BOLIVAR, JORGE/0000-0002-2645-9528; Valdivia, Manuel Jesús Martínez/0000-0002-2888-849X; Diaz, Isabel/0000-0001-9865-902X				ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; ASHWORTH A, 1989, GENOMICS, V4, P323, DOI 10.1016/0888-7543(89)90337-6; ASHWORTH A, 1991, MAMM GENOME, V1, P196, DOI 10.1007/BF00351068; BELLEFROID EJ, 1989, DNA-J MOLEC CELL BIO, V8, P377, DOI 10.1089/dna.1.1989.8.377; Bolivar J, 1996, GENE, V176, P257, DOI 10.1016/0378-1119(96)00207-7; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; CasciolaRosen L, 1996, P NATL ACAD SCI USA, V93, P1624, DOI 10.1073/pnas.93.4.1624; CHAN EKL, 1991, J EXP MED, V174, P1239, DOI 10.1084/jem.174.5.1239; CONDEMI JJ, 1987, JAMA-J AM MED ASSOC, V258, P2920, DOI 10.1001/jama.258.20.2920; FISHKIND DJ, 1995, CURR OPIN CELL BIOL, V7, P23, DOI 10.1016/0955-0674(95)80041-7; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Garcia SN, 1999, CELL, V97, P825, DOI 10.1016/S0092-8674(00)80794-1; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Goenechea L. G., 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P841; Haber JE, 1999, CELL, V97, P829, DOI 10.1016/S0092-8674(00)80795-3; HOOVERS JM, 1992, GENOMICS, V2, P254; KAPTEIN R, 1991, CURR OPIN STRUC BIOL, V2, P109; KELLEY C, 1993, DEVELOPMENT, V118, P817; KLUG A, 1987, COLD SPRING HARB SYM, V52, P473, DOI 10.1101/SQB.1987.052.01.054; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Meisner H, 1991, CURR OPIN CELL BIOL, V3, P474, DOI 10.1016/0955-0674(91)90076-B; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; Mushegian AR, 1998, GENOME RES, V8, P590, DOI 10.1101/gr.8.6.590; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; Ochs RL, 1996, MOL BIOL CELL, V7, P1015, DOI 10.1091/mbc.7.7.1015; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; RATTNER JB, 1990, CELL MOTIL CYTOSKEL, V17, P227, DOI 10.1002/cm.970170309; RENDON MC, 1992, EXP CELL RES, V200, P393, DOI 10.1016/0014-4827(92)90187-D; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; ROSEN A, 1995, J EXP MED, V181, P1557, DOI 10.1084/jem.181.4.1557; Sambrook J., 2002, MOL CLONING LAB MANU; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; SINHA AA, 1990, SCIENCE, V248, P1380, DOI 10.1126/science.1972595; STEITZ JA, 1988, SCI AM, V258, P56, DOI 10.1038/scientificamerican0688-56; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; TAN EM, 1989, J CLIN INVEST, V84, P1, DOI 10.1172/JCI114127; TAN EM, 1989, ADV IMMUNOL, V44, P93; Towbin H, 1979, 10 1073 PNAS 76 9 43, V76, P4350, DOI [10.1073/pnas.76.9.4350, DOI 10.1073/PNAS.76.9.4350]; Wells WAE, 1996, TRENDS CELL BIOL, V6, P228, DOI 10.1016/0962-8924(96)10018-0; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x	43	20	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36456	36464		10.1074/jbc.274.51.36456	http://dx.doi.org/10.1074/jbc.274.51.36456			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593942	hybrid			2022-12-27	WOS:000084279200061
J	Chen, KS; Tilley, GJ; Sridhar, V; Prasad, GS; Stout, CD; Armstrong, FA; Burgess, BK				Chen, KS; Tilley, GJ; Sridhar, V; Prasad, GS; Stout, CD; Armstrong, FA; Burgess, BK			Alteration of the reduction potential of the [4Fe-4S](2+/+) cluster of Azotobacter vinelandii ferredoxin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEINS; SITE-DIRECTED MUTAGENESIS; CONSERVED PROLINE RESIDUES; FERROUS FE4S4 CLUSTER; REDOX POTENTIALS; CYTOCHROME-C; ELECTROSTATIC INTERACTIONS; CLOSTRIDIUM-PASTEURIANUM; ANGSTROM RESOLUTION; CIRCULAR-DICHROISM	The [4Fe-4S]2(+/+) cluster of Azotobacter vinelandii ferredoxin I (FdI) has an unusually low reduction potential (E-0') relative to other structurally similar ferredoxins. Previous attempts to raise that E-0' by modification of surface charged residues were unsuccessful, In this study mutants were designed to alter the E-0' by substitution of polar residues for nonpolar residues near the cluster and by modification of backbone amides, Three FdI variants, P21G;, I40N, and I40Q, were purified and characterized, and electrochemical E-0' measurements show that all had altered E-0' relative to native FdI, For P21G FdI and I40Q FdI, the E-0' increased by +42 and +53 mV, respectively validating the importance of dipole orientation in control of E-0'. Protein Dipole Langevin Dipole calculations based on models for those variants accurately predicted the direction of the change in E-0' while overestimating the magnitude, For I40N Pdl, initial calculations based on the model predicted a +168 mV change in E-0' while a -33 mV change was observed. The x-ray structure of that variant, which was determined to 2.8 Angstrom revealed a number of changes in backbone and side chain dipole orientation and in solvent accessibility, that were not predicted by the model and that were Likely to influence E-0'. Subsequent Protein Dipole Langevin Dipole calculations (using the actual I40N x-ray structures) did quite accurately predict the observed change in E-0'.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Oxford, Dept Chem, Oxford OX1 3QR, England; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California Irvine; University of Oxford; Scripps Research Institute	Burgess, BK (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	bburgess@uci.edu			NIGMS NIH HHS [GM-36325, GM-48495, GM-45209] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048495, R01GM045209, R01GM036325] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angove HC, 1997, J AM CHEM SOC, V119, P8730, DOI 10.1021/ja9712837; ARMSTRONG FA, 1993, METHOD ENZYMOL, V227, P479, DOI 10.1016/0076-6879(93)27020-H; BACKES G, 1991, J AM CHEM SOC, V113, P2055, DOI 10.1021/ja00006a027; BEINERT H, 1990, FASEB J, V4, P2483, DOI 10.1096/fasebj.4.8.2185975; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bertini I, 1997, J BIOL INORG CHEM, V2, P114, DOI 10.1007/s007750050114; Bertini I, 1996, PROG BIOPHYS MOL BIO, V66, P43, DOI 10.1016/S0079-6107(96)00016-8; Bian SM, 1996, BIOCHEMISTRY-US, V35, P14544, DOI 10.1021/bi961658l; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; Busch JLH, 1997, BIOCHEM J, V323, P95, DOI 10.1042/bj3230095; CAMMACK R, 1992, ADV INORG CHEM, V38, P281, DOI 10.1016/S0898-8838(08)60066-5; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; CHURG AK, 1986, BIOCHEMISTRY-US, V25, P1675, DOI 10.1021/bi00355a035; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; Dauter Z, 1997, BIOCHEMISTRY-US, V36, P16065, DOI 10.1021/bi972155y; GAILLARD J, 1993, BIOCHEMISTRY-US, V32, P9881, DOI 10.1021/bi00089a002; Gao-Sheridan HS, 1998, J BIOL CHEM, V273, P33692, DOI 10.1074/jbc.273.50.33692; GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83; HEERING HA, 1995, EUR J BIOCHEM, V232, P811, DOI 10.1111/j.1432-1033.1995.811zz.x; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; HOWARD JB, 1991, ADV PROTEIN CHEM, V42, P199; IISMAA SE, 1991, J BIOL CHEM, V266, P21563; IWAGAMI SG, 1995, PROTEIN SCI, V4, P2562, DOI 10.1002/pro.5560041213; JENSEN GM, 1994, BIOCHEMISTRY-US, V33, P10911, DOI 10.1021/bi00202a010; JOHNSON MK, 1994, ENCY INORGANIC CHEM, P1896; LANGEN R, 1992, J MOL BIOL, V224, P589, DOI 10.1016/0022-2836(92)90546-V; LANGEN R, 1992, J BIOL CHEM, V267, P25625; LESLIE AGW, 1994, ACTA CRYSTALLOGR D, V50, P760; LINDAHL PA, 1990, J CLUST SCI, V1, P29; LUCHINAT C, 1994, BIOCHEM BIOPH RES CO, V203, P436, DOI 10.1006/bbrc.1994.2201; Macedo AL, 1996, BIOCHEM BIOPH RES CO, V229, P524, DOI 10.1006/bbrc.1996.1837; MARTIN AE, 1990, P NATL ACAD SCI USA, V87, P598, DOI 10.1073/pnas.87.2.598; Mauk AG, 1997, J BIOL INORG CHEM, V2, P119, DOI 10.1007/s007750050115; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MOORE GR, 1983, FEBS LETT, V161, P171, DOI 10.1016/0014-5793(83)81001-1; NaraySzabo G, 1997, J BIOL INORG CHEM, V2, P135, DOI 10.1007/s007750050117; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; PARSON WW, 1985, BIOCHIM BIOPHYS ACTA, V1017, P251; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; PRZYSIECKI CT, 1985, BIOCHEMISTRY-US, V24, P2542, DOI 10.1021/bi00331a022; QUINKAL I, 1994, PROTEIN ENG, V7, P681, DOI 10.1093/protein/7.5.681; REES DC, 1985, P NATL ACAD SCI USA, V82, P3082, DOI 10.1073/pnas.82.10.3082; SCHEJTER A, 1984, BIOCHEMISTRY-US, V23, P1081, DOI 10.1021/bi00301a007; SHEN B, 1995, P NATL ACAD SCI USA, V92, P10064, DOI 10.1073/pnas.92.22.10064; SHEN BH, 1994, J BIOL CHEM, V269, P8564; SHEN BH, 1993, J BIOL CHEM, V268, P25928; SOLA M, 1989, BIOCHEMISTRY-US, V28, P5261, DOI 10.1021/bi00438a051; Soriano A, 1996, BIOCHEMISTRY-US, V35, P12479, DOI 10.1021/bi960974x; STEPHENS PJ, 1991, BIOCHEMISTRY-US, V30, P3200, DOI 10.1021/bi00227a007; Stephens PJ, 1996, CHEM REV, V96, P2491, DOI 10.1021/cr950045w; STOMBAUGH NA, 1976, BIOCHEMISTRY-US, V15, P2633, DOI 10.1021/bi00657a024; STOUT CD, 1989, J MOL BIOL, V205, P545, DOI 10.1016/0022-2836(89)90225-8; Stout CD, 1998, J MOL BIOL, V278, P629, DOI 10.1006/jmbi.1998.1732; VAZQUEZ A, 1994, PROTEIN EXPRES PURIF, V5, P96, DOI 10.1006/prep.1994.1014; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Warshel A, 1997, J BIOL INORG CHEM, V2, P143, DOI 10.1007/s007750050119; WARSHEL A, 1984, Q REV BIOPHYS, V17, P283, DOI 10.1017/S0033583500005333; WATT GD, 1994, J INORG BIOCHEM, V53, P281, DOI 10.1016/0162-0134(94)85115-8	61	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36479	36487		10.1074/jbc.274.51.36479	http://dx.doi.org/10.1074/jbc.274.51.36479			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593945	hybrid			2022-12-27	WOS:000084279200064
J	Hogg, RC; Miranda, LP; Craik, DJ; Lewis, RJ; Alewood, PF; Adams, DJ				Hogg, RC; Miranda, LP; Craik, DJ; Lewis, RJ; Alewood, PF; Adams, DJ			Single amino acid substitutions in alpha-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR-SPECTROSCOPY; CRYSTAL-STRUCTURE; PEPTIDE; SUBUNIT; BUNGAROTOXIN; TRANSMISSION; DIVERSITY; BINDING; GANGLIA; LIGAND	The alpha-conotoxins, a class of nicotinic acetylcholine receptor (nAChR) antagonists, are emerging as important probes of the role played by different nAChR subtypes in cell function and communication, In this study, the native alpha-conotoxins PnIA and PnIB were found to cause concentration-dependent inhibition of the ACh-induced current in all rat parasympathetic neurons examined, with IC50 values of 14 and 33 nM, and a maximal reduction in current amplitude of 87% and 71%, respectively. The modified alpha-conotoxin [N11S]PnIA reduced the ACh-induced current with an IC50 value of 375 nM and a maximally effective concentration caused 91% block, [A10L]PnIA was the most potent inhibitor, reducing the ACh-induced current in similar to 80% of neurons, with an IC50 value of 1.4 nM and 46% maximal block of the total current, The residual current was not inhibited further by alpha-bungarotoxin, but was further reduced by the cu-conotoxins PnIA or PnIB, and by mecamylamine. H-1 NMR studies indicate that PnIA, PnIB, and the analogues, [A10L]PnIA and [N11S]PnIA, have identical backbone structures. We propose that positions 10 and II of PnIA and PnIB influence potency and determine selectivity among alpha 7 and other nAChR subtypes, including alpha 3 beta 2 and alpha 3 beta 4, Four distinct components of the nicotinic ACh-induced current in mammalian parasympathetic neurons have been dissected with these conopeptides.	Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Adams, DJ (corresponding author), Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia.		Lewis, Richard J/E-8674-2013; Adams, David/J-9125-2014; Craik, David/B-1695-2010; Adams, David John/K-3578-2019; Lewis, Richard/T-8763-2019	Lewis, Richard J/0000-0003-3470-923X; Adams, David/0000-0002-7030-2288; Craik, David/0000-0003-0007-6796; Adams, David John/0000-0002-7030-2288; Lewis, Richard/0000-0003-3470-923X; Alewood, Paul/0000-0001-7454-6522				ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Broxton N, 1998, P AUST NEUROSCI SOC, V9, P128; CARPINO LA, 1993, J AM CHEM SOC, V115, P4397, DOI 10.1021/ja00063a082; CARPINO LA, 1996, Patent No. 5580981; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Chang KT, 1999, J NEUROSCI, V19, P3701; CHIAPPINELLI VA, 1978, NEUROCHEM RES, V3, P465, DOI 10.1007/BF00966328; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Cuevas J, 1998, J NEUROSCI, V18, P10335; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; FIEBER LA, 1991, J PHYSIOL-LONDON, V434, P215, DOI 10.1113/jphysiol.1991.sp018466; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Gehrmann J, 1999, J MED CHEM, V42, P2364, DOI 10.1021/jm990114p; Hill JM, 1998, BIOCHEMISTRY-US, V37, P15621, DOI 10.1021/bi981535w; Hu SH, 1996, STRUCTURE, V4, P417, DOI 10.1016/S0969-2126(96)00047-0; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON DS, 1995, MOL PHARMACOL, V48, P194; Lewis TM, 1997, J PHYSIOL-LONDON, V505, P299, DOI 10.1111/j.1469-7793.1997.299bb.x; Li XY, 1998, J NEUROSCI, V18, P1904; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; Miranda LP, 1999, P NATL ACAD SCI USA, V96, P1181, DOI 10.1073/pnas.96.4.1181; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Poth K, 1997, J NEUROSCI, V17, P586; Quiram PA, 1998, J BIOL CHEM, V273, P11007, DOI 10.1074/jbc.273.18.11007; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Servent D, 1998, J PHYSIOLOGY-PARIS, V92, P107, DOI 10.1016/S0928-4257(98)80146-0; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yu CR, 1998, J PHYSIOL-LONDON, V509, P651, DOI 10.1111/j.1469-7793.1998.651bm.x; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9	37	78	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36559	36564		10.1074/jbc.274.51.36559	http://dx.doi.org/10.1074/jbc.274.51.36559			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593955	hybrid, Green Published			2022-12-27	WOS:000084279200074
J	Meng, JW; Glick, JL; Polakis, P; Casey, PJ				Meng, JW; Glick, JL; Polakis, P; Casey, PJ			Functional interaction between G alpha(z) and Rap1GAP suggests a novel form of cellular cross-talk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; HETEROTRIMERIC G-PROTEINS; ALPHA-SUBUNIT; PERTUSSIS TOXIN; BETA-GAMMA; ADENYLYL-CYCLASE; BINDING PROTEIN; HUMAN PLATELETS; DROSOPHILA NF1; P115 RHOGEF	G(z) is a member of the G(i) family of trimeric G proteins whose primary role in cell physiology is still unknown. In an ongoing effort to elucidate the cellular functions of G(z), the yeast two-hybrid system was employed to identify proteins that specifically interact with a mutationally activated form of G alpha(z). One of the molecules uncovered in this screen was Rap1GAP, a previously identified protein that specifically stimulates GTP hydrolytic activity of the monomeric G protein Rap1 and thus is believed to function as a down-regulator of Rap1 signaling. Like G(z), the precise role of Rap1 in cell physiology is poorly understood. Biochemical analysis using purified recombinant proteins revealed that the physical interaction between G alpha(z) and Rap1GAP blocks the ability of RGSs (regulators of G protein signaling) to stimulate GTP hydrolysis of the alpha subunit, and also attenuates the ability of activated G alpha(z) to inhibit adenylyl cyclase, Structure-function analyses indicate that the first 74 amino-terminal residues of Rap1GAP, a region distinct from the catalytic core domain responsible for the GAP activity toward Rap1, is required for this interaction. Co-precipitation assays revealed that G alpha(z), Rap1GAP, and Rap1 can form a stable complex. These data suggest that Rap1GAP acts as a signal integrator to somehow coordinate and/or integrate G(z) signaling and Rap1 signaling in cells.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Onyx Pharmaceut, Dept Mol Biol, Emeryville, CA 94608 USA	Duke University; Duke University	Casey, PJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.		Meng, Jingwei/K-8880-2015	Casey, Patrick/0000-0002-7366-9309	NIGMS NIH HHS [GM 55717] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM055717, R01GM055717] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmadian MR, 1997, FEBS LETT, V408, P315, DOI 10.1016/S0014-5793(97)00422-5; Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; FIELDS TA, 1995, J BIOL CHEM, V270, P23119, DOI 10.1074/jbc.270.39.23119; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; GAGNON AW, 1991, BLOOD, V78, P1247; Glick JL, 1998, J BIOL CHEM, V273, P26008, DOI 10.1074/jbc.273.40.26008; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; HALENBECK R, 1990, J BIOL CHEM, V265, P21922; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; HINTON DR, 1990, J NEUROSCI, V10, P2763; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LINDER ME, 1991, J BIOL CHEM, V266, P4654; LOUNSBURY KM, 1991, J BIOL CHEM, V266, P22051; LOUNSBURY KM, 1993, J BIOL CHEM, V268, P3494; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; MOOMAW JF, 1995, METHOD ENZYMOL, V250, P12; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; RUBINFELD B, 1992, MOL CELL BIOL, V12, P4634, DOI 10.1128/MCB.12.10.4634; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; TAUSSIG R, 1993, J BIOL CHEM, V268, P9; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang J, 1998, J BIOL CHEM, V273, P26014, DOI 10.1074/jbc.273.40.26014; WILSON PT, 1995, J BIOL CHEM, V270, P9667, DOI 10.1074/jbc.270.16.9667; WONG YH, 1995, ONCOGENE, V10, P1927; WONG YH, 1992, SCIENCE, V255, P339, DOI 10.1126/science.1347957	41	73	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36663	36669		10.1074/jbc.274.51.36663	http://dx.doi.org/10.1074/jbc.274.51.36663			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593970	hybrid			2022-12-27	WOS:000084279200089
J	O'Brien, TW; Fiesler, SE; Denslow, ND; Thiede, B; Wittmann-Liebold, B; Mougey, EB; Sylvester, JE; Graack, HR				O'Brien, TW; Fiesler, SE; Denslow, ND; Thiede, B; Wittmann-Liebold, B; Mougey, EB; Sylvester, JE; Graack, HR			Mammalian mitochondrial ribosomal proteins (2) - Amino acid sequencing, characterization, and identification of corresponding gene sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR GENES; YEAST; L2; NUCLEOTIDES; PREDICTION; CLONING; FETAL	Four different classes of mammalian mitochondrial ribosomal proteins were identified and characterized. Mature proteins were purified from bovine liver and subjected to N-terminal or matrix-assisted laser desorption mass spectroscopic amino acid sequencing after tryptic in-gel digestion and high pressure liquid chromatography separation of the resulting peptides. Peptide sequences obtained were used to virtually screen expressed sequence tag data bases from human, mouse, and rat. Consensus cDNAs were assembled in silico from various expressed sequence tag sequences identified. Deduced mammalian protein sequences were characterized and compared with ribosomal protein sequences of Escherichia coli and yeast mitochondria, Significant sequence similarities to ribosomal proteins of other sources were detected for three out of four different mammalian protein classes determined. However, the sequence conservation between mitochondrial ribosomal proteins of mammalian and yeast origin is much less than the sequence conservation between cytoplasmic ribosomal proteins of the same species. In particular, this is shown for the mammalian counterparts of the E. coli EcoL2 ribosomal protein (MRP-L14), that do not conserve the specific and functional highly important His(229) residue of E. coli and the corresponding yeast mitochondrial Rml2p.	Free Univ Berlin, Inst Biol Genet, AG Kress, D-14195 Berlin, Germany; Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Nemours Childrens Clin, Jacksonville, FL 32207 USA	Free University of Berlin; State University System of Florida; University of Florida; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Graack, HR (corresponding author), Free Univ Berlin, Inst Biol Genet, AG Kress, Arnimallee 7, D-14195 Berlin, Germany.	graack@zedat.fu-berlin.de		Mougey, Edward/0000-0003-1190-6660	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015438] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM15438] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; Cooperman BS, 1995, BIOCHEM CELL BIOL, V73, P1087, DOI 10.1139/o95-117; DENSLOW ND, 1991, J BIOL CHEM, V266, P9586; DENSLOW ND, 1984, J BIOL CHEM, V259, P9867; *GEN COMP GROUP, 1997, GCG WISC PACK VERS 9; Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; HEROLD M, 1987, J BIOL CHEM, V262, P8826; KITAKAWA M, 1990, NUCLEIC ACIDS RES, V18, P1521, DOI 10.1093/nar/18.6.1521; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Marty L, 1996, J BIOL CHEM, V271, P11468, DOI 10.1074/jbc.271.19.11468; MATSUSHITA Y, 1993, EUR J BIOCHEM, V214, P577, DOI 10.1111/j.1432-1033.1993.tb17956.x; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OBRIEN TW, 1980, ORG EXPRESSION MITOC, P301; Otto A, 1996, ELECTROPHORESIS, V17, P1643, DOI 10.1002/elps.1150171027; OU JH, 1987, NUCLEIC ACIDS RES, V15, P8919, DOI 10.1093/nar/15.21.8919; Pan C, 1997, J BIOL CHEM, V272, P8165, DOI 10.1074/jbc.272.13.8165; PIETROMONACO SF, 1986, J MOL EVOL, V24, P110, DOI 10.1007/BF02099958; SCHIEBER GL, 1982, J BIOL CHEM, V257, P8781; Shah ZH, 1997, GENE, V204, P55, DOI 10.1016/S0378-1119(97)00521-0; TSANG P, 1995, HUM MOL GENET, V4, P1499, DOI 10.1093/hmg/4.9.1499; Uhlein M, 1998, BIOCHEM J, V331, P423; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101	26	30	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36043	36051		10.1074/jbc.274.51.36043	http://dx.doi.org/10.1074/jbc.274.51.36043			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593885	hybrid			2022-12-27	WOS:000084279200004
J	Rohacs, T; Chen, J; Prestwich, GD; Logothetis, DE				Rohacs, T; Chen, J; Prestwich, GD; Logothetis, DE			Distinct specificities of inwardly rectifying K+ channels for phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; RECTIFIER POTASSIUM CHANNELS; GTP-BINDING PROTEINS; BETA-GAMMA-SUBUNITS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SIGNALING MOLECULES; CELLULAR ROLES; I-KACH; ACTIVATION; RECEPTOR	Activation of several inwardly rectifying K+ channels (I(ir) requires the presence of phosphatidylinositol 4,5-bisphosphate (PtdIns( 4,5)P-2). The constitutively active Kir2.1 (IRK1) channels interact with PtdIns(4,5)P-2 strongly, whereas the G-protein activated Kir3.1/3.4 channels (GIRK1/GIRK4), show only weak interactions with PtdIns(4,5)P-2. We investigated whether these inwardly rectifying K+ channels displayed distinct specificities for different phosphoinositides. IRK1, but not GIRK1/GIRK4 channels, showed a marked specificity toward phosphates in the 4,5 head group positions. GIRK1/GIRK4 channels were activated with a similar efficacy by PtdIns(3,4)P-2, PtdIns(3,5)P-2, PtdIns(4,5)P-2, and PtdIns(3,4,5)P-3. In contrast, IRK1 channels were not activated by PtdIns(3,4)P-2 and only marginally by high concentrations of PtdIns(3,5)P-2. Similarly, high concentrations of PtdIns(3,4,5)P-3 were required to activate IRK1 channels. For either channel, PtdIns(4)P was much less effective than PtdIns(4,5)P, whereas PtdIns was inactive. In contrast to the dependence on the position of phosphates of the phospholipid head group, GIRK1/GIRK4, but not IRK1 channel activation, showed a remarkable dependence on the phospholipid acyl chains. GIRKI/GIRK4 channels were activated most effectively by the natural arachidonyl stearyl PtdIns(4,5)P, and much less by the synthetic dipalmitoyl analog, whereas IRK1 channels were activated equally by dipalmitoyl and arachidonyl stearyl PtdIns(4,5)P,. Incorporation of PtdInsP(2) into the membrane is necessary for activation, as the short chain water soluble diC(4) PtdIns(4,5)P-2 did not activate either channel, whereas activation by diC(8) PtdIns(4, 5)P-2 required high concentrations.	NYU, Dept Physiol & Biophys, Mt Sinai Sch Med, New York, NY 10029 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Icahn School of Medicine at Mount Sinai; New York University; Utah System of Higher Education; University of Utah	Logothetis, DE (corresponding author), NYU, Dept Physiol & Biophys, Mt Sinai Sch Med, 1 Gustave L Levy Pl,Box 1218, New York, NY 10029 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-59949] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Downes CPH, 1989, INOSITOL LIPIDS CELL, P1; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; FLANAGAN LA, 1997, BIOPHYS J, V73, P140; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; Hilgemann Donald W., 1995, P307; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Hsuan JJ, 1998, ADV CANCER RES, V74, P167, DOI 10.1016/S0065-230X(08)60767-8; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; JACQUES JP, 1999, J GEN PHYSIOL, V114, P673; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kim D, 1999, J PHYSIOL-LONDON, V517, P59, DOI 10.1111/j.1469-7793.1999.0059z.x; Kobrinsky E, 1999, BIOPHYS J, V76, pA411; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Liou HH, 1999, P NATL ACAD SCI USA, V96, P5820, DOI 10.1073/pnas.96.10.5820; Logothetis DE, 1999, J PHYSIOL-LONDON, V520, P630, DOI 10.1111/j.1469-7793.1999.00630.x; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lupu VD, 1998, J BIOL CHEM, V273, P14067, DOI 10.1074/jbc.273.23.14067; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Peng JR, 1998, TETRAHEDRON LETT, V39, P3965, DOI 10.1016/S0040-4039(98)00737-0; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Prestwich GD, 1996, ACCOUNTS CHEM RES, V29, P503, DOI 10.1021/ar960136v; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rohacs T, 1999, BIOPHYS J, V76, pA410; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Sui JL, 1999, ADV SEC MESS PHOSPH, V33, P179; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; VIVAUDOU MB, 1991, J MEMBRANE BIOL, V122, P165, DOI 10.1007/BF01872639; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Zhainazarov AB, 1999, J NEUROSCI, V19, P2929; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	46	162	163	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36065	36072		10.1074/jbc.274.51.36065	http://dx.doi.org/10.1074/jbc.274.51.36065			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593888	hybrid			2022-12-27	WOS:000084279200007
J	Shah, OJ; Antonetti, DA; Kimball, SR; Jefferson, LS				Shah, OJ; Antonetti, DA; Kimball, SR; Jefferson, LS			Leucine, glutamine, and tyrosine reciprocally modulate the translation initiation factors eIF4F and eIF2B in perfused rat liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; NUCLEOTIDE-EXCHANGE FACTOR; AMINO-ACID AVAILABILITY; PROTEIN-SYNTHESIS; PHAS-I; RETICULOCYTE LYSATE; MAMMALIAN TARGET; PLASMA-MEMBRANE; CELL-GROWTH; PHOSPHORYLATION	Leucine, glutamine, and tyrosine, three amino acids playing key modulatory roles in hepatic proteolysis, were evaluated for activation of signaling pathways involved in regulation of liver protein synthesis. Furthermore, because leucine signals to effecters that lie distal to the mammalian target of rapamycin, these downstream factors were selected for study as candidate mediators of amino acid signaling. Using the perfused rat liver as a model system, we observed a 25% stimulation of protein synthesis in response to balanced hyperaminoacidemia, whereas amino acid imbalance due to elevated concentrations of leucine, glutamine, and tyrosine resulted in a protein synthetic depression of roughly 50% compared with normoaminoacidemic controls. The reduction in protein synthesis accompanying amino acid imbalance became manifest at high physiologic concentrations and was dictated by the guanine nucleotide exchange activity of translation initiation factor eIF2B. Paradoxically, this phenomenon occurred concomitantly with assembly of the mRNA cap recognition complex, eIF4F as well as activation of the 70-kDa ribosomal S6 kinase, p70(S6k). Dual and reciprocal modulation of eIF4F and eIF2B was leucine-specific because isoleucine, a structural analog, was ineffective in these regards. Thus, we conclude that amino acid imbalance, heralded by leucine, initiates a liver-specific translational failsafe mechanism that deters protein synthesis under unfavorable circumstances despite promotion of the eIF4F complex.	Penn State Univ Hosp, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Jefferson, LS (corresponding author), Penn State Univ Hosp, Coll Med, Dept Cellular & Mol Physiol, POB 850, Hershey, PA 17033 USA.	jjefferson@psu.edu		antonetti, david/0000-0003-1130-6577	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK013499, R01DK013499] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 13499] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AROOR AR, 1994, BIOCHEMISTRY-US, V33, P3350, DOI 10.1021/bi00177a028; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; BUSE MG, 1975, J CLIN INVEST, V56, P1250, DOI 10.1172/JCI108201; CRANDALL EA, 1983, DIABETES, V32, P222, DOI 10.2337/diabetes.32.3.222; FLAIM KE, 1982, J BIOL CHEM, V257, P2932; Fox HL, 1998, AM J PHYSIOL-CELL PH, V274, pC206, DOI 10.1152/ajpcell.1998.274.1.C206; GLANVILLE NT, 1985, CAN J PHYSIOL PHARM, V63, P487, DOI 10.1139/y85-084; GROSS M, 1989, J BIOL CHEM, V264, P21879; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; HAYSTEAD TAJ, 1994, J BIOL CHEM, V269, P23185; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Jefferson LS, 1999, INT J BIOCHEM CELL B, V31, P191, DOI 10.1016/S1357-2725(98)00141-1; Kawasome H, 1998, P NATL ACAD SCI USA, V95, P5033, DOI 10.1073/pnas.95.9.5033; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1996, AM J PHYSIOL-CELL PH, V270, pC705, DOI 10.1152/ajpcell.1996.270.2.C705; KIMBALL SR, 1991, BIOCHEM BIOPH RES CO, V177, P1082, DOI 10.1016/0006-291X(91)90649-R; Kimball SR, 1996, PROG NUCLEIC ACID RE, V54, P165, DOI 10.1016/S0079-6603(08)60363-3; Kimball SR, 1996, INT J BIOCHEM CELL B, V28, P285, DOI 10.1016/1357-2725(95)00143-3; KIMBALL SR, 1991, J BIOL CHEM, V266, P1969; KIMBALL SR, 1989, AM J PHYSIOL, V256, pC28, DOI 10.1152/ajpcell.1989.256.1.C28; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; LUNN PG, 1976, BRIT J NUTR, V36, P219, DOI 10.1079/BJN19760074; MIOTTO G, 1994, J BIOL CHEM, V269, P25348; MIOTTO G, 1992, J BIOL CHEM, V267, P22066; Mortimore G. E., 1994, CELLULAR PROTEOLYTIC, P65; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; MORTIMORE GE, 1987, J BIOL CHEM, V262, P16322; MORTIMORE GE, 1994, BIOCHEM BIOPH RES CO, V203, P200, DOI 10.1006/bbrc.1994.2168; NAIR KS, 1995, DIABETES ANN, V9; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; POSO AR, 1982, J BIOL CHEM, V257, P2114; Rau M, 1996, J BIOL CHEM, V271, P8983, DOI 10.1074/jbc.271.15.8983; ROWLANDS AG, 1988, EUR J BIOCHEM, V175, P93, DOI 10.1111/j.1432-1033.1988.tb14170.x; SCHARFF R, 1966, BIOCHEM J, V99, P173, DOI 10.1042/bj0990173; SMITH R, 1983, P NUTR SOC, V42, P473, DOI 10.1079/PNS19830054; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Webb BLJ, 1997, INT J BIOCHEM CELL B, V29, P1127, DOI 10.1016/S1357-2725(97)00039-3; Welsh GI, 1997, FEBS LETT, V410, P418, DOI 10.1016/S0014-5793(97)00579-6; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; WERT JJ, 1992, BIOCHEM BIOPH RES CO, V186, P1327, DOI 10.1016/S0006-291X(05)81551-7; Xu G, 1998, J BIOL CHEM, V273, P4485, DOI 10.1074/jbc.273.8.4485; Yoshizawa F, 1998, AM J PHYSIOL-ENDOC M, V275, pE814, DOI 10.1152/ajpendo.1998.275.5.E814	56	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36168	36175		10.1074/jbc.274.51.36168	http://dx.doi.org/10.1074/jbc.274.51.36168			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593901	hybrid			2022-12-27	WOS:000084279200020
J	Peng, HF; Jackson, V				Peng, HF; Jackson, V			In vitro studies on the maintenance of transcription-induced stress by histones and polyamines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME-ASSEMBLY PROTEIN; CLOSED CIRCULAR DNA; SINGLE-STRANDED-DNA; R-LOOP FORMATION; ESCHERICHIA-COLI; TOPOISOMERASE-I; RNA-POLYMERASE; OMEGA-PROTEIN; PLASMID DNA; COILED DNA	Several factors were evaluated to determine their role in facilitating the presence of transcription-induced stresses in a circular. DNA, Transcription was done with T7 RNA polymerase in the presence of E. coli topoisomerase I and closed circular DNA Positive stress was observed in hypotonic conditions or when one of the polyamines, spermidine or spermine, were present. Polycations such as polylysine, polyarginine, histone H1, histones H2A-H2B, and protamine were observed to induce minimal positive stress. It is known that polyamines influence DNA structure by causing both self-association and sequence-specific structural alterations (polyamine-induced localized bending). Experimental evidence indicates that the likely cause of the positive stress is the induced bending. In order to evaluate protein-mediated bending, transcription was done on nucleosomes, A minimum of three nucleosomes on a DNA of 6055 bp was sufficient to generate very high levels of positive stress. Histones H3-H4 in the absence of H2A-H2B were responsible for this effect. Since these histones by themselves are able to maintain negative coils on DNA, it is concluded that protein-mediated bending is yet another mechanism for placing rotational restriction on DNA, The bending of DNA by either polyamines or histones is an effective mechanism for promoting transcription-induced stresses at physiological ionic strength.	Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Jackson, V (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.							ANDERSON P, 1978, BIOCHEMISTRY-US, V17, P594, DOI 10.1021/bi00597a006; Basu HS, 1997, EUR J BIOCHEM, V243, P247, DOI 10.1111/j.1432-1033.1997.0247a.x; BASU HS, 1987, NUCLEIC ACIDS RES, V15, P5873, DOI 10.1093/nar/15.14.5873; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BRILL SJ, 1988, CELL, V54, P403, DOI 10.1016/0092-8674(88)90203-6; BROOKS W, 1994, J BIOL CHEM, V269, P18155; CHRISTIANSEN C, 1977, J MOL BIOL, V115, P441, DOI 10.1016/0022-2836(77)90164-4; COOK DN, 1992, P NATL ACAD SCI USA, V88, P9675; Cozzarelli N.R., 1990, DNA TOPOLOGY ITS BIO; DAVIS RH, 1992, MICROBIOL REV, V56, P280, DOI 10.1128/MMBR.56.2.280-290.1992; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; DROGE P, 1994, BIOESSAYS, V16, P91, DOI 10.1002/bies.950160205; DROLET M, 1994, J BIOL CHEM, V269, P2068; FEURSTEIN BG, 1990, NUCLEIC ACIDS RES, V18, P1271; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; GAMPER HB, 1982, CELL, V29, P81, DOI 10.1016/0092-8674(82)90092-7; GARTENBERG MR, 1993, P NATL ACAD SCI USA, V90, P10514, DOI 10.1073/pnas.90.22.10514; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; GIAEVER GN, 1988, CELL, V55, P849, DOI 10.1016/0092-8674(88)90140-7; Howell ML, 1996, BIOCHEMISTRY-US, V35, P15373, DOI 10.1021/bi961881i; ISHIMI Y, 1987, EUR J BIOCHEM, V162, P19, DOI 10.1111/j.1432-1033.1987.tb10535.x; ISHMI Y, 1991, J BIOL CHEM, V266, P7025; JACKSON S, 1994, BIOCHEMISTRY-US, V33, P5392, DOI 10.1021/bi00184a006; JACKSON V, 1995, BIOCHEMISTRY-US, V34, P10607, DOI 10.1021/bi00033a036; JACKSON V, 1993, BIOCHEMISTRY-US, V32, P5901, DOI 10.1021/bi00073a024; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; KING GC, 1986, BIOCHEMISTRY-US, V25, P36, DOI 10.1021/bi00349a006; KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0; KOO HS, 1990, J BIOL CHEM, V265, P12300; KRASNOW MA, 1982, J BIOL CHEM, V257, P2687; KUNG VT, 1977, J BIOL CHEM, V252, P5398; LEE MS, 1991, EMBO J, V10, P607, DOI 10.1002/j.1460-2075.1991.tb07988.x; LEE MS, 1991, P NATL ACAD SCI USA, V89, P11461; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LIU LF, 1981, P NATL ACAD SCI-BIOL, V78, P3487, DOI 10.1073/pnas.78.6.3487; LIU LF, 1976, J MOL BIOL, V106, P439, DOI 10.1016/0022-2836(76)90095-4; LOCKSHON D, 1983, NUCLEIC ACIDS RES, V11, P2999, DOI 10.1093/nar/11.10.2999; LODGE JK, 1989, J BACTERIOL, V171, P2181, DOI 10.1128/jb.171.4.2181-2187.1989; LYNN RM, 1989, PROTEINS, V6, P231, DOI 10.1002/prot.340060305; MANNING GS, 1985, CELL BIOPHYS, V7, P57, DOI 10.1007/BF02788639; MARQUET R, 1988, J BIOMOL STRUCT DYN, V6, P235, DOI 10.1080/07391102.1988.10507710; MARQUET R, 1987, BIOCHIM BIOPHYS ACTA, V909, P165, DOI 10.1016/0167-4781(87)90074-1; Masse E, 1997, J BIOL CHEM, V272, P12816, DOI 10.1074/jbc.272.19.12816; MORGAN JE, 1986, ARCH BIOCHEM BIOPHYS, V246, P225, DOI 10.1016/0003-9861(86)90467-4; MURPHY LD, 1995, BIOPHYS CHEM, V57, P71, DOI 10.1016/0301-4622(95)00047-2; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; OSTRANDER EA, 1990, SCIENCE, V249, P1261, DOI 10.1126/science.2399463; Pelta J, 1996, J BIOL CHEM, V271, P5656, DOI 10.1074/jbc.271.10.5656; Pelta J, 1996, BIOPHYS J, V71, P48, DOI 10.1016/S0006-3495(96)79232-9; Peng HF, 1997, BIOCHEMISTRY-US, V36, P12371, DOI 10.1021/bi971046g; PFAFFLE P, 1990, J BIOL CHEM, V265, P16830; PFAFFLE P, 1990, J BIOL CHEM, V265, P16821; Phoenix P, 1997, J BIOL CHEM, V272, P1473, DOI 10.1074/jbc.272.3.1473; PRUSS GJ, 1986, P NATL ACAD SCI USA, V83, P8952, DOI 10.1073/pnas.83.23.8952; PULLEYBLANK DE, 1975, P NATL ACAD SCI USA, V72, P4280, DOI 10.1073/pnas.72.11.4280; RAHMOUNI AR, 1992, J MOL BIOL, V223, P131, DOI 10.1016/0022-2836(92)90721-U; Raspaud E, 1998, BIOPHYS J, V74, P381, DOI 10.1016/S0006-3495(98)77795-1; Rybenkov VV, 1997, NUCLEIC ACIDS RES, V25, P1412, DOI 10.1093/nar/25.7.1412; SARHAN S, 1989, BIOL CHEM H-S, V370, P1279, DOI 10.1515/bchm3.1989.370.2.1279; SCHMID N, 1991, BIOCHEMISTRY-US, V30, P4357, DOI 10.1021/bi00231a035; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; SRIVENUGOPAL KS, 1985, BIOCHEMISTRY-US, V24, P4766, DOI 10.1021/bi00339a009; SRIVENUGOPAL KS, 1987, NUCLEIC ACIDS RES, V15, P2563, DOI 10.1093/nar/15.6.2563; Stewart L, 1996, J BIOL CHEM, V271, P7593, DOI 10.1074/jbc.271.13.7593; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; van Holde KE., 1989, SPRINGER SERIES MOL; WANG JC, 1971, J MOL BIOL, V55, P523, DOI 10.1016/0022-2836(71)90334-2; WANG JC, 1982, COLD SPRING HARB SYM, V47, P85, DOI 10.1101/SQB.1983.047.01.011; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WOLFFE AP, 1989, P NATL ACAD SCI USA, V86, P9817, DOI 10.1073/pnas.86.24.9817; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; XIAO L, 1991, NUCLEIC ACIDS RES, V19, P3701, DOI 10.1093/nar/19.13.3701; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	75	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					657	668		10.1074/jbc.275.1.657	http://dx.doi.org/10.1074/jbc.275.1.657			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617664	hybrid			2022-12-27	WOS:000085951600088
J	Svergun, DI; Petoukhov, MV; Koch, MHJ; Konig, S				Svergun, DI; Petoukhov, MV; Koch, MHJ; Konig, S			Crystal versus solution structures of thiamine diphosphate-dependent enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PYRUVATE DECARBOXYLASE; RAY SOLUTION-SCATTERING; X-RAY; SYNCHROTRON-RADIATION; SUBSTRATE ACTIVATION; SACCHAROMYCES-CEREVISIAE; QUATERNARY STRUCTURE; ANGSTROM RESOLUTION; ZYMOMONAS-MOBILIS; BREWERS-YEAST	The quaternary structures of the thiamine diphosphate-dependent enzymes transketolase (EC 2.2.1.1; from Saccharomyces cerevisiae), pyruvate oxidase (EC 1.2.3.3; from Lactobacillus plantarum), and pyruvate decarboxylase (EC 4.1.1.1; from Zymomonas mobilis and brewers' yeast, the latter in the native and pyruvamide-activated forms) were examined by synchrotron x-ray solution scattering. The experimental scattering data were compared with the curves calculated from the crystallographic models of these multisubunit enzymes. For all enzymes noted above, except the very compact pyruvate decarboxylase from Z. mobilis, there were significant differences between the experimental and calculated profiles. The changes in relative positions of the subunits in solution were determined by rigid body refinement, For pyruvate oxidase and transketolase, which have tight intersubunit contacts in the crystal, relatively small modifications of the quaternary structure (root mean square displacements of 0.23 and 0.27 nm, respectively) sufficed to fit the experimental data, For the enzymes with looser contacts (the native and activated forms of yeast pyruvate decarboxylase), large modifications of the crystallographic models (root mean square displacements of 0.58 and 1.53 nm, respectively) were required. A clear correlation was observed between the magnitude of the distortions induced by the crystal environment and the interfacial area between subunits.	DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia; Univ Halle Wittenberg, Fachbereich Biochem Biotechnol, Inst Biochem, D-06099 Halle, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; Martin Luther University Halle Wittenberg	Svergun, DI (corresponding author), DESY, European Mol Biol Lab, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.		Petoukhov, Maxim V/R-7371-2016; Koenig, Stephan/GRX-2480-2022	Petoukhov, Maxim V/0000-0001-6760-4595; Svergun, Dmitri/0000-0003-0830-5696				Aleshin AE, 1999, BIOCHEMISTRY-US, V38, P8359, DOI 10.1021/bi990523n; ALVAREZ FJ, 1995, J AM CHEM SOC, V117, P1678, DOI 10.1021/ja00111a002; Arjunan P, 1996, J MOL BIOL, V256, P590, DOI 10.1006/jmbi.1996.0111; BAUMANN S, 1997, THESIS M LUTHER U HA; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bilgin N, 1998, BIOCHEMISTRY-US, V37, P8163, DOI 10.1021/bi9802869; BOULIN C, 1986, NUCL INSTRUM METH A, V249, P399, DOI 10.1016/0168-9002(86)90694-7; BOULIN CJ, 1988, NUCL INSTRUM METH A, V269, P312, DOI 10.1016/0168-9002(88)90895-9; Dietrich A, 1997, FEBS LETT, V400, P42, DOI 10.1016/S0014-5793(96)01326-9; Dobritzsch D, 1998, J BIOL CHEM, V273, P20196, DOI 10.1074/jbc.273.32.20196; DOBRITZSCH D, 1995, THESIS M LUTHER U HA; DYDA F, 1993, BIOCHEMISTRY-US, V32, P6165, DOI 10.1021/bi00075a008; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Furey W, 1998, BBA-PROTEIN STRUCT M, V1385, P253, DOI 10.1016/S0167-4838(98)00073-9; FUREY W, 1996, P 4 INT M BIOCH PHYS, P103; GABRIEL A, 1982, NUCL INSTRUM METHODS, V201, P223, DOI 10.1016/0167-5087(82)90031-X; GROSSMANN JG, 1993, BIOCHEMISTRY-US, V32, P7360, DOI 10.1021/bi00080a005; HUBNER G, 1990, FEBS LETT, V266, P17, DOI 10.1016/0014-5793(90)81495-A; HUBNER G, 1978, EUR J BIOCHEM, V92, P175, DOI 10.1111/j.1432-1033.1978.tb12735.x; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; KONIG S, 1992, BIOCHEMISTRY-US, V31, P8726; KONIG S, 1990, BIOMED BIOCHIM ACTA, V49, P465; KONIG S, 1993, EUR BIOPHYS J BIOPHY, V22, P185; Konig S, 1998, BIOCHEMISTRY-US, V37, P5329, DOI 10.1021/bi972125v; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; Lu GG, 1997, FEBS LETT, V403, P249, DOI 10.1016/S0014-5793(97)00057-4; MULLER YA, 1994, J MOL BIOL, V237, P315, DOI 10.1006/jmbi.1994.1233; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; NIKKOLA M, 1994, J MOL BIOL, V238, P387, DOI 10.1006/jmbi.1994.1299; NINIO J, 1972, J MOL BIOL, V71, P217, DOI 10.1016/0022-2836(72)90347-6; PAVLOV MY, 1983, BIOPOLYMERS, V22, P1507, DOI 10.1002/bip.360220607; PLETCHER J, 1972, J AM CHEM SOC, V94, P3998, DOI 10.1021/ja00766a058; PRINTZ MP, 1972, J BIOL CHEM, V247, P7109; Schellenberger A, 1998, BBA-PROTEIN STRUCT M, V1385, P173; SCHELLENBERGER A, 1967, ANGEW CHEM, V79, P1050; SCHUMACHER G, 1991, P INT M BIOCH PHYS T, P300; SIEBER M, 1983, BIOMED BIOCHIM ACTA, V42, P343; Stone DB, 1999, BIOCHEMISTRY-US, V38, P4938, DOI 10.1021/bi982374z; SUN SX, 1995, J AM CHEM SOC, V117, P7317, DOI 10.1021/ja00133a004; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1998, BIOPHYS J, V75, P2212, DOI 10.1016/S0006-3495(98)77665-9; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1997, J APPL CRYSTALLOGR, V30, P798, DOI 10.1107/S0021889897001714; Svergun DI, 1997, PROTEINS, V27, P110; SVERGUN DI, 1994, ACTA CRYSTALLOGR A, V50, P391, DOI 10.1107/S0108767393013492; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; WIKNER C, 1994, J BIOL CHEM, V269, P32144	48	42	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					297	302		10.1074/jbc.275.1.297	http://dx.doi.org/10.1074/jbc.275.1.297			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617618	hybrid			2022-12-27	WOS:000085951600042
J	Forlino, A; Porter, FD; Lee, EJ; Westphal, H; Marini, JC				Forlino, A; Porter, FD; Lee, EJ; Westphal, H; Marini, JC			Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha 1(I) G349C substitution - Variability in phenotype in BrtlIV mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-ALPHA-1(I) COLLAGEN GENE; TRIPLE-HELICAL DOMAIN; GLYCINE SUBSTITUTIONS; PATERNAL MOSAICISM; TRANSGENIC MICE; CRE RECOMBINASE; MUTATIONS; COL1A1; PROCOLLAGEN; SERINE	We utilized the Cre/lox recombination system to develop the first knock-in murine model for osteogenesis imperfecta (OI). The moderately severe OI phenotype was obtained from an alpha 1(I) Gly(349) --> CyS substitution in type I collagen, reproducing the mutation in a type IV OI child. We introduced four single nucleotide (nt) changes into murine collal exon 23: the disease causing G --> T transversion (nt 1546), an adjacent G --> T change (nt 1551) to generate a GUC ribozyme cleavage site, and two transversions (nt 1567 C --> A and nt 1569 C --> G;) to cause a Leu --> Met substitution, We also introduced a 3.2-kilobase pair transcription/translation stop cassette in intron 22, flanked by directly repeating lox recombination sites. After homologous recombination in ES cells, two male chimeras were obtained, Chimeras were mated with transgenic females expressing Cre recombinase to remove the stop cassette from a portion of the progeny's cells. To generate mice with full expression of the Gly(349) --> CYS mutation, these offspring were then mated with wild-type females. Skeletal staining and bone histology of the F2 revealed a classical OI phenotype with deformity, fragility, osteoporosis and disorganized trabecular structure. We designate these mice Brt1IV (Brittle IV). Brt1IV mice have phenotypic variability ranging from perinatal lethality to long term survival with reproductive success. The phenotypic variability is not associated with differences in expression levels of the mutant allele in total RNA derived from tissue extracts. Expression of the mutant protein is also equivalent in different phenotypes. Thus, these mice are an excellent model for delineation of the modifying factors postulated to affect human OI phenotypes. In addition, we generated knock-in mice carrying an "intronic" inclusion by mating chimeras with wild-type females. Alternative splicing involving the stop cassette results in retention of non-collagenous sequences. These mice reproduce the lethal phenotype of similar human mutations and are designated BrtIII.	NICHD, SCTD, HDB, NIH, Bethesda, MD 20892 USA; NICHD, Lab Mammalian genet & Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Marini, JC (corresponding author), NICHD, SCTD, HDB, NIH, Bldg 10,Rm 9S241,10 Ctr Dr,MSC-1830, Bethesda, MD 20892 USA.		Forlino, Antonella/H-5385-2015	Forlino, Antonella/0000-0002-6385-1182	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000408] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BATEMAN JF, 1992, BIOCHEM J, V288, P131, DOI 10.1042/bj2880131; Byers Peter H., 1993, P317; CHIPMAN SD, 1993, P NATL ACAD SCI USA, V90, P1701, DOI 10.1073/pnas.90.5.1701; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; GENOVESE C, 1989, J BIOL CHEM, V264, P9632; GRANGE DK, 1990, NUCLEIC ACIDS RES, V18, P4227, DOI 10.1093/nar/18.14.4227; Grassi G, 1997, NUCLEIC ACIDS RES, V25, P3451, DOI 10.1093/nar/25.17.3451; HOESS RH, 1990, NUCLEIC ACIDS MOL BI, V4, P99; Hormuzdi SG, 1998, MOL CELL BIOL, V18, P3368, DOI 10.1128/MCB.18.6.3368; INOUYE M, 1976, Congenital Anomalies, V16, P171; KHILLAN JS, 1991, J BIOL CHEM, V266, P23373; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lund AM, 1997, HUM MUTAT, V9, P378, DOI 10.1002/(SICI)1098-1004(1997)9:4<378::AID-HUMU16>3.3.CO;2-5; MACKAY K, 1993, HUM MOL GENET, V2, P1155, DOI 10.1093/hmg/2.8.1155; Marini J C, 1988, Adv Pediatr, V35, P391; MARINI JC, 1993, AM J HUM GENET, V53, P1199; MARINI JC, 1993, J BIOL CHEM, V268, P2667; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; MOTTES M, 1993, HUM MUTAT, V2, P196, DOI 10.1002/humu.1380020308; NAMIKAWA C, 1995, HUM GENET, V95, P666; Nuytinck L, 1997, EUR J HUM GENET, V5, P161; PETERKOFSKY B, 1986, J BIOL CHEM, V261, P6818; ROSE NJ, 1994, HUM MUTAT, V3, P391, DOI 10.1002/humu.1380030411; Sarafova AP, 1998, HUM MUTAT, V11, P395, DOI 10.1002/(SICI)1098-1004(1998)11:5<395::AID-HUMU7>3.3.CO;2-W; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; STACEY A, 1988, NATURE, V332, P131, DOI 10.1038/332131a0; STERNBERG N, 1986, J MOL BIOL, V187, P197, DOI 10.1016/0022-2836(86)90228-7; SUPERTIFURGA A, 1989, J MED GENET, V26, P358, DOI 10.1136/jmg.26.6.358; VALLI M, 1991, J BIOL CHEM, V266, P1872; VIRDI AS, 1994, HUM GENET, V93, P287, DOI 10.1007/BF00212024; WILLING MC, 1992, AM J HUM GENET, V51, P508; Zhuang JP, 1996, HUM MUTAT, V7, P89, DOI 10.1002/(SICI)1098-1004(1996)7:2<89::AID-HUMU1>3.3.CO;2-#	36	100	106	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37923	37931		10.1074/jbc.274.53.37923	http://dx.doi.org/10.1074/jbc.274.53.37923			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608859	hybrid			2022-12-27	WOS:000084528000059
J	Giesemann, T; Rathke-Hartlieb, S; Rothkegel, M; Bartsch, JW; Buchmeier, S; Jockusch, BM; Jockusch, H				Giesemann, T; Rathke-Hartlieb, S; Rothkegel, M; Bartsch, JW; Buchmeier, S; Jockusch, BM; Jockusch, H			A role for polyproline motifs in the spinal muscular atrophy protein SMN - Profilins bind to and colocalize with SMN in nuclear gems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON GENE; TRANSCRIPTION FACTOR LEF-1; BETA-CATENIN; SURVIVAL; ACTIN; COMPLEX; CELLS; VASP; LOCALIZATION; PLAKOGLOBIN	Spinal muscular atrophy (SMA) is an autosomal, recessive disorder characterized by the loss of a-motoneurons in the spinal cord followed by atrophy of skeletal muscles. SMA-determining candidate genes, SMN1 and SMN2, have been identified on human chromosome 5q. The corresponding SMN protein is expressed ubiquitously. It is coded by seven exons and contains conspicuous proline-rich motifs in its COOH-terminal third (exons 4, 5, and 6). Such motifs are known to bind to profilins (PFNs), small proteins engaged in the control of actin dynamics. We tested whether profilins interact with SMN via its polyproline stretches. Using the yeast two-hybrid system we show that profilins bind to SMN and that this binding depends on its proline-rich motifs, These results were confirmed by coimmunoprecipitation and by in vitro binding studies. Two PFN isoforms, I and II, are known, of which II is characteristic for central nervous system tissue. me show by in situ hybridization that both PFNs are highly expressed in mouse spinal cord and that PFN II is expressed predominantly in neurons. In motoneurons, the primary target of neurodegeneration in SMA, profilins are highly concentrated and colocalize with SMN in the cytoplasm of the cell body and in nuclear gems. Likewise, SMN and PFN I colocalize in gems of HeLa cells. Although SMN interacts with both profilin isoforms, binding of PFN II was stronger than of PFN I in all assays employed. Because the SMN genes are expressed ubiquitously, our findings suggest that the interaction of PFN II with SMN may be involved in neuron-specific effects of SMN mutations.	Univ Bielefeld, Dept Dev Biol & Mol Pathol, D-33501 Bielefeld, Germany; Tech Univ Carolo Wilhelmina Braunschweig, Dept Cell Biol, Inst Zool, D-38092 Braunschweig, Germany	University of Bielefeld; Braunschweig University of Technology	Jockusch, H (corresponding author), Univ Bielefeld, Dept Dev Biol & Mol Pathol, W7, D-33501 Bielefeld, Germany.	h.jockusch@biologie.uni-bielefeld.de	Bartsch, Joerg Walter/AAB-2951-2020	Bartsch, Prof. Joerg Walter/0000-0002-2773-3357; , Martin/0000-0001-5041-4429				Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; DiDonato CJ, 1997, GENOME RES, V7, P339, DOI 10.1101/gr.7.4.339; Domke T, 1997, FEBS LETT, V411, P291, DOI 10.1016/S0014-5793(97)00719-9; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Francis JW, 1998, P NATL ACAD SCI USA, V95, P6492, DOI 10.1073/pnas.95.11.6492; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GIEHL K, 1994, EUR J BIOCHEM, V226, P681, DOI 10.1111/j.1432-1033.1994.tb20096.x; Giesemann T., 1999, European Journal of Cell Biology, V78, P88; Gonsior SM, 1999, J CELL SCI, V112, P797; Hahnen E, 1997, HUM MOL GENET, V6, P821, DOI 10.1093/hmg/6.5.821; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; JOCKUSCH H, 1997, MOL BIOL NEURON, P21; LAMBRECHTS A, 1995, EUR J BIOCHEM, V230, P281, DOI 10.1111/j.1432-1033.1995.0281i.x; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Mattaj IW, 1998, CURR BIOL, V8, pR93, DOI 10.1016/S0960-9822(98)70055-7; Mayboroda O, 1997, CELL MOTIL CYTOSKEL, V37, P166, DOI 10.1002/(SICI)1097-0169(1997)37:2<166::AID-CM9>3.0.CO;2-6; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Rudiger M, 1997, BIOTECHNIQUES, V23, P96, DOI 10.2144/97231bm20; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Talbot K, 1997, HUM MOL GENET, V6, P497, DOI 10.1093/hmg/6.3.497; vanderSteege G, 1996, AM J HUM GENET, V59, P834; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Wiedemann P, 1996, J BIOL CHEM, V271, P29915, DOI 10.1074/jbc.271.47.29915; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; WITKE W, 1993, MOL BIOL CELL, V4, P149	43	166	169	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37908	37914		10.1074/jbc.274.53.37908	http://dx.doi.org/10.1074/jbc.274.53.37908			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608857	hybrid			2022-12-27	WOS:000084528000057
J	Kannt, A; Pfitzner, U; Ruitenberg, M; Hellwig, P; Ludwig, B; Mantele, W; Fendler, K; Michel, H				Kannt, A; Pfitzner, U; Ruitenberg, M; Hellwig, P; Ludwig, B; Mantele, W; Fendler, K; Michel, H			Mutation of Arg-54 strongly influences heme composition and rate and directionality of electron transfer in Paracoccus denitrificans cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTON PUMP; SITE; PROTEIN; REDUCTION; OXYGEN; TRANSLOCATION; SPECTROSCOPY; PURIFICATION; SPHAEROIDES	The effect of a single site mutation of Arg-54 to methionine in Paracoccus denitrificans cytochrome c oxidase was studied using a combination of optical spectroscopy, electrochemical and rapid kinetics techniques, and time-resolved measurements of electrical membrane potential. The mutation resulted in a blue-shift of the heme a alpha-band by 15 nm and partial occupation of the low-spin heme site by heme O. Additionally, there was a marked decrease in the midpoint potential of the low-spin heme, resulting in slow reduction of this heme species. A stopped-flow investigation of the reaction with ferrocytochrome c yielded a kinetic difference spectrum resembling that of heme a(3). This observation, and the absence of transient absorbance changes at the corresponding wavelength of the low-spin heme, suggests that, in the mutant enzyme, electron transfer from Cu-A to the binuclear center may not occur via heme a but that instead direct electron transfer to the high-spin heme is the dominating process. This was supported by charge translocation measurements where Delta psi generation was completely inhibited in the presence of HCN. Our results thus provide an example for how the interplay between protein and cofactors can modulate the functional properties of the enzyme complex.	Max Planck Inst Biophys, Abt Mol Membranbiol, D-60528 Frankfurt, Germany; Univ Frankfurt, Inst Biochem, D-60439 Frankfurt, Germany; Univ Frankfurt, Inst Biophys, D-60590 Frankfurt, Germany; Max Planck Inst Biophys, Biophys Chem Abt, D-60596 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society	Michel, H (corresponding author), Max Planck Inst Biophys, Abt Mol Membranbiol, Heinrich Hoffmann Str 7, D-60528 Frankfurt, Germany.		Kannt, Aimo/AAZ-6898-2020	hellwig, petra/0000-0001-6294-5163; Fendler, Klaus/0000-0002-5699-7060; Kannt, Aimo/0000-0002-5197-2286				ADELROTH P, 1995, BIOCHEMISTRY-US, V34, P2844; Adelroth P, 1998, BBA-BIOENERGETICS, V1367, P107, DOI 10.1016/S0005-2728(98)00142-X; ANTALIS TM, 1982, J BIOL CHEM, V257, P6194; BABCOCK GT, 1983, BIOCHEMISTRY-US, V22, P2314, DOI 10.1021/bi00279a002; BAMBERG E, 1979, BIOPHYS STRUCT MECH, V5, P277, DOI 10.1007/BF02426663; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brzezinski P, 1996, BIOCHEMISTRY-US, V35, P5611, DOI 10.1021/bi960260m; CALLAHAN PM, 1983, BIOCHEMISTRY-US, V22, P452, DOI 10.1021/bi00271a031; CAUGHEY WS, 1975, J BIOL CHEM, V250, P7602; GEREN LM, 1995, J BIOL CHEM, V270, P2466, DOI 10.1074/jbc.270.6.2466; GERHUS E, 1990, J BACTERIOL, V172, P2392, DOI 10.1128/jb.172.5.2392-2400.1990; Gropp T, 1998, BBA-BIOMEMBRANES, V1368, P184, DOI 10.1016/S0005-2736(97)00162-4; Hartung K, 1997, BIOPHYS J, V72, P2503, DOI 10.1016/S0006-3495(97)78895-7; HARTZELL CR, 1976, BIOCHIM BIOPHYS ACTA, V423, P323, DOI 10.1016/0005-2728(76)90189-4; HAZZARD JT, 1991, BIOCHEMISTRY-US, V30, P213, DOI 10.1021/bi00215a031; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P1685, DOI 10.1021/bi982282+; HILL BC, 1994, J BIOL CHEM, V269, P2419; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kannt A, 1998, J BIOENERG BIOMEMBR, V30, P81, DOI 10.1023/A:1020563629032; Kannt A, 1998, BIOPHYS J, V74, P708, DOI 10.1016/S0006-3495(98)73996-7; KLEYMANN G, 1995, BIO-TECHNOL, V13, P155, DOI 10.1038/nbt0295-155; LARSSON S, 1995, P NATL ACAD SCI USA, V92, P7167, DOI 10.1073/pnas.92.16.7167; LUDWIG B, 1986, METHOD ENZYMOL, V126, P153; MATSUSHITA K, 1992, J BIOL CHEM, V267, P24748; Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; MOGI T, 1994, MOL MICROBIOL, V14, P391, DOI 10.1111/j.1365-2958.1994.tb02174.x; MOODY AJ, 1991, FEBS LETT, V293, P101, DOI 10.1016/0014-5793(91)81161-Z; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILSSON T, 1992, P NATL ACAD SCI USA, V89, P6497, DOI 10.1073/pnas.89.14.6497; OLIVEBERG M, 1991, BIOCHEMISTRY-US, V30, P7053, DOI 10.1021/bi00243a003; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Papa S, 1998, FEBS LETT, V439, P1, DOI 10.1016/S0014-5793(98)01305-2; Pfitzner U, 1998, J BIOENERG BIOMEMBR, V30, P89, DOI 10.1023/A:1020515713103; PUUSTINEN A, 1991, P NATL ACAD SCI USA, V88, P6122, DOI 10.1073/pnas.88.14.6122; PUUSTINEN A, 1992, BIOCHEMISTRY-US, V31, P10363, DOI 10.1021/bi00157a026; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Ramirez BE, 1995, P NATL ACAD SCI USA, V92, P11949, DOI 10.1073/pnas.92.26.11949; Regan JJ, 1998, J BIOENERG BIOMEMBR, V30, P35, DOI 10.1023/A:1020551326307; Schroter T, 1998, FEBS LETT, V432, P109, DOI 10.1016/S0014-5793(98)00839-4; SONE N, 1991, FEBS LETT, V288, P154, DOI 10.1016/0014-5793(91)81024-3; TSUDZUKI T, 1971, ARCH BIOCHEM BIOPHYS, V145, P149, DOI 10.1016/0003-9861(71)90021-X; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANNESTE WH, 1966, BIOCHEMISTRY-US, V5, P838, DOI 10.1021/bi00867a005; VERKHOVSKY MI, 1995, BIOCHEMISTRY-US, V34, P7483, DOI 10.1021/bi00022a023; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; WEINSTEIN JD, 1983, J BIOL CHEM, V258, P6799; WIKSTROM MKF, 1981, CYTOCHROME OXIDASE S, P88; WILSON DF, 1972, BIOCHIM BIOPHYS ACTA, V256, P277, DOI 10.1016/0005-2728(72)90058-8; WINKLER JR, 1995, BIOPHYS CHEM, V54, P199, DOI 10.1016/0301-4622(94)00156-E; Witt H, 1998, EUR J BIOCHEM, V251, P367, DOI 10.1046/j.1432-1327.1998.2510367.x; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	53	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37974	37981		10.1074/jbc.274.53.37974	http://dx.doi.org/10.1074/jbc.274.53.37974			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608865	hybrid			2022-12-27	WOS:000084528000065
J	Papoff, G; Hausler, P; Eramo, A; Pagano, MG; Di Leve, G; Signore, A; Ruberti, G				Papoff, G; Hausler, P; Eramo, A; Pagano, MG; Di Leve, G; Signore, A; Ruberti, G			Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR RECEPTOR; FAS-MEDIATED APOPTOSIS; SIGNALING COMPLEX DISC; TNF RECEPTOR; SOLUBLE FAS; CELL-DEATH; FAS/APO-1 CD95; HEART-FAILURE; SERUM LEVELS	The CD95 death receptor plays an important role in several physiological and pathological apoptotic processes involving in particular the immune system. CD95 ligation leads to clustering of the receptor cytoplasmic "death domains" and recruitment of the zymogen form of caspase-8 to the cell surface. Activation of this protease through self-cleavage, followed by activation of downstream effector caspases, culminates in cleavage of a set of cellular proteins resulting in apoptosis with disassembly of the cell. It is very well known that the extracellular region of the CD95 receptor is required for CD95L interaction and that the death domain is necessary for the induction of the apoptotic signaling. Here, we identified and characterized a novel CD95 ligand- and death domain-independent oligomerization domain mapping to the NH2-terminal extracellular region of the CD95 receptor. In vitro and in vivo studies indicated that this domain, conserved among all soluble CD95 variants, mediates homo-oligomerization of the CD95 receptor and of the soluble CD95 proteins, as well as hetero-oligomerization of the receptor with the soluble variants. These results offer new insight into the mechanism of apoptosis inhibition mediated by the soluble CD95 proteins and suggest a role of the extracellular oligomerization domain in the regulation of the non-signaling state of the CD95 receptor.	CNR, Inst Cell Biol, I-00016 Monterotondo, Rome, Italy; Univ Roma La Sapienza, Med Clin 2, NuMED Grp, I-00161 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome	Ruberti, G (corresponding author), CNR, Inst Cell Biol, Campus Adriano Buzzati Traverso,Via E Ramarini 32, I-00016 Monterotondo, Rome, Italy.	gruberti@ibc.rm.cnr.it	Eramo, Adriana/K-6694-2016; Signore, Alberto/E-5812-2010; PAPOFF, GIULIANA/AAX-9520-2020	Eramo, Adriana/0000-0002-0814-6683; Signore, Alberto/0000-0001-8923-648X; PAPOFF, GIULIANA/0000-0003-2251-8794; RUBERTI, Giovina/0000-0003-2367-9709				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cascino I, 1996, J IMMUNOL, V156, P13; CASCINO I, 1995, J IMMUNOL, V154, P2706; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Fadeel B, 1995, INT IMMUNOL, V7, P1967, DOI 10.1093/intimm/7.12.1967; Fields Stanley, 1993, Methods (Orlando), V5, P116, DOI 10.1006/meth.1993.1016; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Giordano C, 1997, SCIENCE, V275, P960, DOI 10.1126/science.275.5302.960; Goel N, 1995, ARTHRITIS RHEUM, V38, P1738, DOI 10.1002/art.1780381206; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Hausler P, 1998, EUR J IMMUNOL, V28, P57, DOI 10.1002/(SICI)1521-4141(199801)28:01<57::AID-IMMU57>3.0.CO;2-8; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; ITOH N, 1993, J BIOL CHEM, V268, P10932; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jodo S, 1997, CLIN EXP IMMUNOL, V107, P89, DOI 10.1046/j.1365-2249.1997.d01-901.x; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Knipping E, 1995, ARTHRITIS RHEUM, V38, P1735, DOI 10.1002/art.1780381205; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; LIU CD, 1995, BIOCHEM J, V310, P957, DOI 10.1042/bj3100957; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Midis GP, 1996, CANCER RES, V56, P3870; MITA E, 1994, BIOCHEM BIOPH RES CO, V204, P468, DOI 10.1006/bbrc.1994.2483; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nozawa K, 1997, ARTHRITIS RHEUM, V40, P1126, DOI 10.1002/art.1780400617; Okuyama M, 1997, AM J CARDIOL, V79, P1698, DOI 10.1016/S0002-9149(97)00228-2; Orlinick JR, 1997, J BIOL CHEM, V272, P28889, DOI 10.1074/jbc.272.46.28889; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Papoff G, 1996, J IMMUNOL, V156, P4622; PETER ME, 1995, CELL DEATH DIFFER, V2, P163; Prasad NKA, 1998, J IMMUNOL, V161, P3781; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; RODSETH LE, 1994, J MOL BIOL, V239, P332, DOI 10.1006/jmbi.1994.1371; Ruberti G, 1996, ADV EXP MED BIOL, V406, P125; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; SIGNORE A, 1992, NUCL MED COMMUN, V13, P713, DOI 10.1097/00006231-199213100-00003; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; Starling GC, 1997, J EXP MED, V185, P1487, DOI 10.1084/jem.185.8.1487; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Toyozaki T, 1998, AM J CARDIOL, V81, P798, DOI 10.1016/S0002-9149(97)01032-1; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Walker PR, 1998, CURR OPIN IMMUNOL, V10, P564, DOI 10.1016/S0952-7915(98)80225-2; Yufu Y, 1998, AM J HEMATOL, V58, P334, DOI 10.1002/(SICI)1096-8652(199808)58:4<334::AID-AJH15>3.0.CO;2-7	55	122	125	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38241	38250		10.1074/jbc.274.53.38241	http://dx.doi.org/10.1074/jbc.274.53.38241			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608899	hybrid			2022-12-27	WOS:000084528000099
J	Dupuy, C; Ohayon, R; Valent, A; Noel-Hudson, MS; Deme, D; Virion, A				Dupuy, C; Ohayon, R; Valent, A; Noel-Hudson, MS; Deme, D; Virion, A			Purification of a novel flavoprotein involved in the thyroid NADPH oxidase - Cloning of the porcine and human cDNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT H2O2 GENERATION; PHENYLARSINE OXIDE; HYDROGEN-PEROXIDE; PLASMA-MEMBRANE; CA2+; THYROTROPIN; INHIBITION; ACTIVATION; FOLLICLES; FRACTION	Hydrogen peroxide is the final electron acceptor for the biosynthesis of thyroid hormone catalyzed by thyroperoxidase at the apical surface of thyrocytes, Pig and human thyroid plasma membrane contain a Ca2+-dependent NAD(P)H oxidase that generates H2O2 by transferring electrons from NAD(P)H to molecular oxygen. We purified from pig thyroid plasma membrane a flavoprotein which constitutes the main, if not the sole, component of the thyroid NAD(P)H oxidase, Microsequences permitted the cloning of porcine and human full-length cDNAs encoding, respectively, 1207- and 1210-amino acid proteins with a predicted molecular mass of 138 kDa (p138(Tox)). Human and porcine p138(Tox) have 86.7% identity. The strongest similarity was to a predicted polypeptide encoded by a Caenorhabditis cDNA and with rbohA, a protein involved in the Arabidopsis NADPH oxidase. p138(Tox) shows also similarity to the p65(Mox) and to the gp91(Phox) in their C-terminal region and have consensus sequences for FAD- and NADPH-binding sites. Compared with gp91(Phox), p138(Tox) shows an extended N-terminal containing two EF-hand motifs that may account for its calcium-dependent activity, whereas three of four sequences implicated in the interaction of gp91(Phox) With the p47(Phox) cytosolic factor are absent in p138(Tox). The expression of porcine p138(Tox) mRNA analyzed by Northern blot is specific of thyroid tissue and induced by cyclic AMP showing that p138(Tox) is a differentiation marker of thyrocytes. The gene of human p138(Tox) has been localized on chromosome 15q15.	Fac Pharm, INSERM, U486, Inst Signalisat & Innovat Therapeut, F-92296 Chatenay Malabry, France; Inst Gustave Roussy, Lab Cytogenet & Genet Oncol, CNRS, Unite Mixte Rech 1599, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy	Virion, A (corresponding author), Fac Pharm, INSERM, U486, Inst Signalisat & Innovat Therapeut, 5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.							Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BJORKMAN U, 1981, J ULTRA MOL STRUCT R, V74, P105, DOI 10.1016/S0022-5320(81)80113-X; BJORKMAN U, 1984, ENDOCRINOLOGY, V115, P392; Carvalho DP, 1996, ENDOCRINOLOGY, V137, P1007, DOI 10.1210/en.137.3.1007; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; De Keulenaer GW, 1998, BIOCHEM J, V329, P653; DEME D, 1985, FEBS LETT, V186, P107, DOI 10.1016/0014-5793(85)81349-1; DEME D, 1994, BIOCHEM J, V301, P75, DOI 10.1042/bj3010075; Doussiere J, 1998, EUR J BIOCHEM, V251, P649, DOI 10.1046/j.1432-1327.1998.2510649.x; DUPUY C, 1989, EUR J BIOCHEM, V185, P597, DOI 10.1111/j.1432-1033.1989.tb15155.x; EKHOLM R, 1981, MOL CELL ENDOCRINOL, V24, P141, DOI 10.1016/0303-7207(81)90056-3; Gorin Y, 1996, EUR J BIOCHEM, V240, P807, DOI 10.1111/j.1432-1033.1996.0807h.x; Gorin Y, 1997, BIOCHEM J, V321, P383, DOI 10.1042/bj3210383; HAYE B, 1985, MOL CELL ENDOCRINOL, V43, P41, DOI 10.1016/0303-7207(85)90040-1; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECABEC V, 1995, J BIOL CHEM, V270, P2067; Leseney AM, 1999, BIOCHIMIE, V81, P373, DOI 10.1016/S0300-9084(99)80084-4; NAKAMURA Y, 1987, J BIOCHEM-TOKYO, V102, P1121, DOI 10.1093/oxfordjournals.jbchem.a122150; RASPE E, 1995, ENDOCRINOLOGY, V136, P965, DOI 10.1210/en.136.3.965; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Taurog Alvin, 1996, P47; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valent A, 1997, EUR J HUM GENET, V5, P102, DOI 10.1159/000484742; Valent A, 1996, HUM GENET, V98, P12, DOI 10.1007/s004390050152; VIRION A, 1984, MOL CELL ENDOCRINOL, V36, P95, DOI 10.1016/0303-7207(84)90088-1; [No title captured]	28	353	370	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37265	37269		10.1074/jbc.274.52.37265	http://dx.doi.org/10.1074/jbc.274.52.37265			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601291	hybrid			2022-12-27	WOS:000084382700062
J	Luo, DC; Guerin, E; Ludwig, MG; Stoll, I; Basset, P; Anglard, P				Luo, DC; Guerin, E; Ludwig, MG; Stoll, I; Basset, P; Anglard, P			Transcriptional induction of stromelysin-3 in mesodermal cells is mediated by an upstream CCAAT/enhancer-binding protein element associated with a DNase I-hypersensitive site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MAMMARY-GLAND; MATRIX METALLOPROTEINASE; GENE-EXPRESSION; BREAST-CANCER; MESSENGER-RNA; C/EBP-BETA; POSTTRANSCRIPTIONAL REGULATION; TISSUE INHIBITOR; RETINOIC ACID; AP-1	Stromelysin-3 (ST3) is a matrix metalloproteinase whose synthesis is markedly increased in stromal fibroblasts of most invasive human carcinomas. In the present study, we have investigated the molecular mechanisms by which high levels of ST3 expression can be induced. In contrast to the early and transient induction of interstitial collagenase by 12-O-tetradecanoylphorbol-13-acetate (TPA), the fibroblastic induction of ST3 was found to be delayed and to require protein neosynthesis. We demonstrated that this induction is transcriptional and does not result from changes in RNA stability. By looking next to promoter regions accessible to DNase I upon gene induction, we have identified two distal elements and have characterized their role in the transcriptional regulation of ST3. The first one is a TPA-responsive element that controls the base-line ST3 promoter activity but is not required for its activation. We demonstrate that ST3 gene induction is actually mediated by the second element, a C/EBP-binding site, by showing: (i) that this element becomes accessible in cells induced to express ST3, (ii) that endogenous C/EBP beta binds to the ST3 promoter, and (iii) that this binding leads to ST3 transcriptional activation. Our study provides new insights into the regulation of ST3 and suggests an additional role for C/EBP transcription factors in tissue remodeling processes associated with this MMP.	Univ Strasbourg 1, INSERM, CNRS,Communaute Urbaine Strasbourg, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Anglard, P (corresponding author), Univ Strasbourg 1, INSERM, CNRS,Communaute Urbaine Strasbourg, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, France.	anglard@titus.u-strasbg.fr	Anglard, Patrick/M-6618-2019; Guerin, Eric/R-3426-2016	Anglard, Patrick/0000-0001-5701-441X; GUERIN, ERIC/0000-0003-1388-2834				Ahmad A, 1998, AM J PATHOL, V152, P721; Ahmad A, 1997, INT J CANCER, V73, P290, DOI 10.1002/(SICI)1097-0215(19971009)73:2<290::AID-IJC21>3.0.CO;2-I; An MR, 1996, MOL CELL BIOL, V16, P2295; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ANGLARD P, 1995, J BIOL CHEM, V270, P20337, DOI 10.1074/jbc.270.35.20337; Basset P, 1997, CRIT REV ONCOL HEMAT, V26, P43, DOI 10.1016/S1040-8428(97)00010-3; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; BELLARD M, 1989, METHOD ENZYMOL, V170, P317; Borden P, 1997, CRIT REV EUKAR GENE, V7, P159, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.90; BUTTICE G, 1991, NUCLEIC ACIDS RES, V19, P3723, DOI 10.1093/nar/19.13.3723; Cairns BR, 1998, TRENDS BIOCHEM SCI, V23, P20, DOI 10.1016/S0968-0004(97)01160-2; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chenard MP, 1996, INT J CANCER, V69, P448, DOI 10.1002/(SICI)1097-0215(19961220)69:6<448::AID-IJC5>3.3.CO;2-4; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Delany AM, 1998, J BIOL CHEM, V273, P16595, DOI 10.1074/jbc.273.26.16595; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; Doyle GAR, 1997, J BIOL CHEM, V272, P11840, DOI 10.1074/jbc.272.18.11840; Guerin E, 1997, J BIOL CHEM, V272, P11088; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; LEFEBVRE O, 1992, J CELL BIOL, V119, P997, DOI 10.1083/jcb.119.4.997; LEFEBVRE O, 1995, DEVELOPMENT, V121, P947; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Logan SK, 1996, J BIOL CHEM, V271, P774, DOI 10.1074/jbc.271.2.774; Lotan R, 1996, FASEB J, V10, P1031, DOI 10.1096/fasebj.10.9.8801164; Mari BP, 1998, J BIOL CHEM, V273, P618, DOI 10.1074/jbc.273.1.618; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; Masson R, 1998, J CELL BIOL, V140, P1535, DOI 10.1083/jcb.140.6.1535; NANBU R, 1994, MOL CELL BIOL, V14, P4920, DOI 10.1128/MCB.14.7.4920; Noel AC, 1996, J CLIN INVEST, V97, P1924, DOI 10.1172/JCI118624; Nuchprayoon I, 1997, BLOOD, V89, P4546, DOI 10.1182/blood.V89.12.4546; Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67; Osada S, 1996, J BIOL CHEM, V271, P3891; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; PATTERTON D, 1995, DEV BIOL, V167, P252, DOI 10.1006/dbio.1995.1021; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; RAY A, 1994, MOL CELL BIOL, V14, P4324, DOI 10.1128/MCB.14.6.4324; RODGERS WH, 1994, J CLIN INVEST, V94, P946, DOI 10.1172/JCI117461; ROUYER N, 1994, INVAS METAST, V14, P269; Sabatakos G, 1998, BIOCHEM J, V334, P205, DOI 10.1042/bj3340205; SANTAVICCA M, 1995, INT J CANCER, V64, P336, DOI 10.1002/ijc.2910640510; Schonbeck U, 1999, J EXP MED, V189, P843, DOI 10.1084/jem.189.5.843; Schroen DJ, 1996, GENE EXPRESSION, V6, P197; Singer CF, 1997, J CLIN ENDOCR METAB, V82, P1917, DOI 10.1210/jc.82.6.1917; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Vincenti MP, 1996, CRIT REV EUKAR GENE, V6, P391, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.40; Welm AL, 1999, MOL CELL BIOL, V19, P1695; XIE B, 1994, J IMMUNOL, V152, P3637; YANGYEN HF, 1991, NEW BIOL, V3, P1206; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922	53	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37177	37185		10.1074/jbc.274.52.37177	http://dx.doi.org/10.1074/jbc.274.52.37177			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601280	hybrid			2022-12-27	WOS:000084382700051
J	Morillas, M; Swietnicki, W; Gambetti, P; Surewicz, WK				Morillas, M; Swietnicki, W; Gambetti, P; Surewicz, WK			Membrane environment alters the conformational structure of the recombinant human prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PH-DEPENDENT STABILITY; DOMAIN PRP(121-231); CULTURED-CELLS; PRP 27-30; SCRAPIE; BINDING; MPRP(23-231); CONVERSION; VESICLES; DISEASE	The prion protein (PrP) in a living cell is associated with cellular membranes. However, all previous biophysical studies with the recombinant prion protein have been performed in an aqueous solution. To determine the effect of a membrane environment on the conformational structure of PrP, we studied the interaction of the recombinant human prion protein with model lipid membranes. The protein was found to bind to acidic lipid-containing membrane vesicles. This interaction is pH-dependent and becomes particularly strong under acidic conditions. Spectroscopic data show that membrane binding of PrP results in a significant ordering of the N-terminal part of the molecule. The folded C-terminal domain, on the other hand, becomes destabilized upon binding to the membrane surface, especially at low pH. Overall, these results show that the conformational structure and stability of the recombinant human PrP in a membrane environment are substantially different from those of the free protein in solution. These observations have important implications for understanding the mechanism of the conversion between the normal (PrPC) and pathogenic (PrPSc) forms of prion protein.	Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.		Swietnicki, Wieslaw/GOP-2576-2022; Swietnicki, Wieslaw/AAU-1536-2020; Swietnicki, Wieslaw/AAL-2452-2021	Swietnicki, Wieslaw/0000-0002-9354-8184; Morillas, Manuel/0000-0002-6489-6737	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038604] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38604] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Butko P, 1997, BIOCHEMISTRY-US, V36, P12862, DOI 10.1021/bi9702389; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Ehrlich LS, 1996, BIOCHEMISTRY-US, V35, P3933, DOI 10.1021/bi952337x; ETFINK MR, 1981, ANAL BIOCHEM, V114, P199; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hornemann S, 1996, J MOL BIOL, V261, P614, DOI 10.1006/jmbi.1996.0487; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kelly JW, 1998, P NATL ACAD SCI USA, V95, P930, DOI 10.1073/pnas.95.3.930; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; MOSIOR M, 1991, BIOPHYS J, V60, P149, DOI 10.1016/S0006-3495(91)82038-0; MUGA A, 1993, J BIOL CHEM, V268, P1553; MUGA A, 1991, BIOCHEMISTRY-US, V30, P7219, DOI 10.1021/bi00243a025; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; Pinheiro TJT, 1997, BIOCHEMISTRY-US, V36, P13122, DOI 10.1021/bi971235z; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; SAFAR J, 1991, J INFECT DIS, V163, P488, DOI 10.1093/infdis/163.3.488; Shin I, 1997, P NATL ACAD SCI USA, V94, P2848, DOI 10.1073/pnas.94.7.2848; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; SUREWICZ WK, 1984, BIOCHEMISTRY-US, V23, P6072, DOI 10.1021/bi00320a026; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Tatulian SA, 1997, J MOL BIOL, V268, P809, DOI 10.1006/jmbi.1997.1014; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Weissmann C, 1996, FEBS LETT, V389, P3, DOI 10.1016/0014-5793(96)00610-2; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r	45	227	231	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					36859	36865		10.1074/jbc.274.52.36859	http://dx.doi.org/10.1074/jbc.274.52.36859			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601237	hybrid			2022-12-27	WOS:000084382700008
J	Ohtaki, T; Kumano, S; Ishibashi, Y; Ogi, K; Matsui, H; Harada, M; Kitada, C; Kurokawa, T; Onda, H; Fujino, M				Ohtaki, T; Kumano, S; Ishibashi, Y; Ogi, K; Matsui, H; Harada, M; Kitada, C; Kurokawa, T; Onda, H; Fujino, M			Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CLONED HUMAN; RECEPTOR; RAT; EXPRESSION; IDENTIFICATION; INTESTINE; SEQUENCE; CELLS	Galanin is a widely distributed neuropeptide with a variety of physiological functions. Three galanin receptor subtypes, GALR1, GALR2, and GALR3, have been reported. We isolated a novel galanin-like peptide (GALP) from porcine hypothalamus by observing its activity for increasing [S-35]GTP gamma S binding to a membrane preparation of GALR2-transfected cells. The peptide had 60 amino acid residues and a non-amidated C terminus. The amino acid sequence of GALP-(9-21) was completely identical to that of galanin-(1-13). A cloned porcine GALP cDNA indicated that GALP was processed from a 120-amino acid GALP precursor protein. The structures of rat and human GALP-(1-60) were deduced from cloned cDNA, which indicated that the amino acid sequences 1-24 and 41-53 were highly conserved between humans, rats, and pigs. Receptor binding studies revealed that porcine GALP-(1-60) had a high affinity for the GALR2 receptor (IC50 = 0.24 nM) and a lower affinity for the GALR1 receptor (IC50 = 4.3 nM). In contrast, galanin showed high affinity for the GALR1 (IC50 = 0.097 nM) and GALR2 receptors (IC50 = 0.48 nM). GALP is therefore an endogenous ligand that preferentially binds the GALR2 receptor, whereas galanin is relatively non-selective.	Takeda Chem Ind Ltd, Pharmaceut Discovery Res Div, Discovery Res Labs 1, Tsukuba, Ibaraki 3004293, Japan; Takeda Chem Ind Ltd, Pharmaceut Discovery Res Div, Discovery Res Labs 3, Yodogawa Ku, Osaka 5328686, Japan; Takeda Chem Ind Ltd, Chuo Ku, Osaka 5408645, Japan	Takeda Chemical Industries; Takeda Chemical Industries; Takeda Chemical Industries	Ohtaki, T (corresponding author), Takeda Chem Ind Ltd, Pharmaceut Discovery Res Div, Discovery Res Labs 1, Wadai 10, Tsukuba, Ibaraki 3004293, Japan.							BARTFAI T, 1993, CRIT REV NEUROBIOL, V7, P229; BELL GI, 1983, NATURE, V302, P716, DOI 10.1038/302716a0; CRAWLEY JN, 1995, REGUL PEPTIDES, V59, P1, DOI 10.1016/0167-0115(95)00083-N; EVANS HF, 1991, ENDOCRINOLOGY, V129, P1682, DOI 10.1210/endo-129-3-1682; HABERTORTOLI E, 1994, P NATL ACAD SCI USA, V91, P9780, DOI 10.1073/pnas.91.21.9780; Howard AD, 1997, FEBS LETT, V405, P285, DOI 10.1016/S0014-5793(97)00196-8; Kolakowski LF, 1998, J NEUROCHEM, V71, P2239; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Masuda Y, 1996, J PHARMACOL EXP THER, V279, P675; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ohtaki T, 1998, J BIOL CHEM, V273, P15464, DOI 10.1074/jbc.273.25.15464; Parker EM, 1995, MOL BRAIN RES, V34, P179, DOI 10.1016/0169-328X(95)00159-P; ROKAEUS A, 1984, NEUROSCI LETT, V47, P161, DOI 10.1016/0304-3940(84)90423-3; ROKAEUS A, 1986, P NATL ACAD SCI USA, V83, P6287, DOI 10.1073/pnas.83.17.6287; SILLARD R, 1992, PEPTIDES, V13, P1055, DOI 10.1016/0196-9781(92)90005-N; Smith KE, 1997, J BIOL CHEM, V272, P24612, DOI 10.1074/jbc.272.39.24612; Smith KE, 1998, J BIOL CHEM, V273, P23321, DOI 10.1074/jbc.273.36.23321; TATEMOTO K, 1983, FEBS LETT, V164, P124, DOI 10.1016/0014-5793(83)80033-7; VRONTAKIS ME, 1987, J BIOL CHEM, V262, P16755; Wang SK, 1997, J BIOL CHEM, V272, P31949, DOI 10.1074/jbc.272.51.31949; Wang ZL, 1997, J CLIN INVEST, V100, P189, DOI 10.1172/JCI119512	21	225	239	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37041	37045		10.1074/jbc.274.52.37041	http://dx.doi.org/10.1074/jbc.274.52.37041			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601261	hybrid			2022-12-27	WOS:000084382700032
J	Giannoukos, G; Silverstein, AM; Pratt, WB; Simons, SS				Giannoukos, G; Silverstein, AM; Pratt, WB; Simons, SS			The seven amino acids (547-553) of rat glucocorticoid receptor required for steroid and hsp90 binding contain a functionally independent LXXLL motif that is critical for steroid binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CARBOXYL-TERMINAL REGIONS; NUCLEAR-RECEPTOR; ANDROGEN RECEPTOR; PROGESTERONE-RECEPTOR; MOLECULAR CHAPERONES; RETINOIC ACID; DOMAIN; ACTIVATION; CELLS	Hsp90 association with glucocorticoid receptors (GRs) is required for steroid binding. We recently reported that seven amino acids (547-553) overlapping the aminoterminal end of the rat GR ligand-binding domain are necessary for hsp90 binding, and consequently steroid binding. The role of a LXXLL motif at the COOH terminus of this sequence has now been analyzed by determining the properties of Leu to Ser mutations in full-length GR and glutathione S-transferase chimeras. Surprisingly, these mutations decreased steroid binding capacity without altering receptor levels, steroid binding affinity, or hsp90 binding. Single mutations in the context of the full-length receptor did not affect the transcriptional activity but the double mutant (L550S/L553S) was virtually inactive. This biological inactivity was found to be due to an increased rate of steroid dissociation from the activated mutant complex, These results, coupled with those from trypsin digestion studies, suggest a model in which the GR ligand-binding domain is viewed as having a "hinged pocket," with the hinge being in the region of the trypsin digestion site at Arg(651). The pocket would normally be kept shut via the intramolecular interactions of the LXXLL motif at amino acids 550-554 acting as a hydrophobic clasp.	NIDDK, LMCB, Steroid Hormones Sect, NIH, Bethesda, MD 20892 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan	Simons, SS (corresponding author), NIDDK, LMCB, Steroid Hormones Sect, NIH, Bldg 8,Rm B2A-07, Bethesda, MD 20892 USA.				NIDDK NIH HHS [DK31573] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031573, R37DK031573, Z01DK057800] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENHAMOU B, 1992, SCIENCE, V255, P206, DOI 10.1126/science.1372753; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; Caamano CA, 1998, J BIOL CHEM, V273, P20473, DOI 10.1074/jbc.273.32.20473; CADEPOND F, 1991, J BIOL CHEM, V266, P5834; CHAKRABORTI PK, 1991, J BIOL CHEM, V266, P22075; DALMAN FC, 1991, J BIOL CHEM, V266, P3482; DANZE P M, 1990, Steroids, V55, P10, DOI 10.1016/0039-128X(90)90067-L; deCastro M, 1996, MOL MED, V2, P597, DOI 10.1007/BF03401643; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Doesburg P, 1997, BIOCHEMISTRY-US, V36, P1052, DOI 10.1021/bi961775g; Enmark E, 1996, MOL ENDOCRINOL, V10, P1293, DOI 10.1210/me.10.11.1293; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HOECK W, 1989, J BIOL CHEM, V264, P14396; HOWARD KJ, 1990, J BIOL CHEM, V265, P11928; HUANG Y, 1999, IN PRESS MOL CELL EN; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; KAINE JL, 1975, MOL PHARMACOL, V11, P578; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LEE SY, 1995, MOL ENDOCRINOL, V9, P826, DOI 10.1210/me.9.7.826; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MATTIONI T, 1994, METHOD CELL BIOL, V43, P335; McInerney EM, 1996, P NATL ACAD SCI USA, V93, P10069, DOI 10.1073/pnas.93.19.10069; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MILHON J, 1994, J STEROID BIOCHEM, V51, P11, DOI 10.1016/0960-0760(94)90110-4; Modarress KJ, 1997, J BIOL CHEM, V272, P23986, DOI 10.1074/jbc.272.38.23986; MOGUILEWSKY M, 1984, J STEROID BIOCHEM, V20, P271, DOI 10.1016/0022-4731(84)90216-4; PAKDEL F, 1993, J STEROID BIOCHEM, V46, P663, DOI 10.1016/0960-0760(93)90307-I; POWERS JH, 1993, CANCER RES, V53, P4059; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; PRATT WB, 1993, STEROID HORMONE ACTI, P64; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Ruddon RW, 1997, J BIOL CHEM, V272, P3125, DOI 10.1074/jbc.272.6.3125; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; SCHMIDT TJ, 1982, PHYSIOL REV, V62, P1131, DOI 10.1152/physrev.1982.62.4.1131; SCHMIDT TJ, 1980, NATURE, V286, P507, DOI 10.1038/286507a0; SCHOWALTER DB, 1991, J BIOL CHEM, V266, P21165; SHYAMALA G, 1980, J BIOL CHEM, V255, P6028; SIMONS SS, 1984, BIOCHEMISTRY-US, V23, P6876, DOI 10.1021/bi00321a092; SIMONS SS, 1989, J BIOL CHEM, V264, P11493; SIMONS SS, 1994, VITAM HORM, V48, P49; Stancato LF, 1996, J BIOL CHEM, V271, P8831, DOI 10.1074/jbc.271.15.8831; SZAPARY D, 1993, MOL ENDOCRINOL, V7, P941, DOI 10.1210/me.7.8.941; Tetel MJ, 1997, MOL ENDOCRINOL, V11, P1114, DOI 10.1210/me.11.8.1114; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Xu M, 1999, MOL CELL ENDOCRINOL, V155, P85, DOI 10.1016/S0303-7207(99)00110-0; Xu M, 1998, J BIOL CHEM, V273, P13918, DOI 10.1074/jbc.273.22.13918; Xu M, 1996, J BIOL CHEM, V271, P21430, DOI 10.1074/jbc.271.35.21430; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	57	41	42	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36527	36536		10.1074/jbc.274.51.36527	http://dx.doi.org/10.1074/jbc.274.51.36527			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593951	hybrid			2022-12-27	WOS:000084279200070
J	Glenn, DJ; Maurer, RA				Glenn, DJ; Maurer, RA			MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein hormone alpha-subunit gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GONADOTROPIN-RELEASING-HORMONE; MESSENGER RIBONUCLEIC-ACID; TRANSCRIPTIONAL ACTIVATION DOMAIN; LOOP-HELIX PROTEINS; LUTEINIZING-HORMONE; HOMEODOMAIN PROTEINS; ESCHERICHIA-COLI; 2-HYBRID SYSTEM; MAMMALIAN-CELLS; INTERACTOR NLI	Tissue-specific expression of the cr-subunit gene of glycoprotein hormones involves an enhancer element designated the pituitary glycoprotein basal element, which interacts with the LIM homeodomain transcription factor, Lhx2, In the present studies we have explored the function of the LIM domain of Lhx2 in stimulating ct-subunit transcription. When fused to the GAL4 DNA-binding domain, the LIM domain of Lhx2 was shown to contain a transcriptional activation domain. Furthermore, in the context of an cu-subunit reporter gene in which a GAL4-binding site replaced the pituitary glycoprotein basal element, the LIM domain enhanced both basal and Ras-mediated transcription. In addition, a synergistic response to Ras activation was observed when the Lhx2 LIM domain and the transactivation domain of Elk1 are directed to a minimal reporter gene. A yeast two-hybrid screen identified the recently described melanocyte-specific gene-related gene 1 (MRG1) as an Lhx2 LIM-interacting protein. MRG1 was shown to bind Lhx2 in vitro, and a co-immunoprecipitation assay provided evidence that endogenous MRG1 forms a complex with Lhx2 in alpha T3-1 cells. Expression of MRG1 in alpha T3-1 cells enhanced cr-subunit reporter gene activity. MRG1 was also shown to bind in vitro to the TATA-binding protein and the transcriptional coactivator, p300. These data suggest a model in which the Lhx2 LIM domain activates transcription through interaction with MRG1 leading to recruitment of p300/CBP and the TATA-binding protein.	Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University	Maurer, RA (corresponding author), Oregon Hlth Sci Univ, Dept Cell & Dev Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NIDDK NIH HHS [DK36407] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036407] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; ANDREWS WV, 1988, J BIOL CHEM, V263, P13755; Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; ARCHER VEV, 1994, P NATL ACAD SCI USA, V91, P316, DOI 10.1073/pnas.91.1.316; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; BEDOUELLE H, 1988, EUR J BIOCHEM, V171, P541, DOI 10.1111/j.1432-1033.1988.tb13823.x; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bisotto S, 1996, J BIOL CHEM, V271, P17746, DOI 10.1074/jbc.271.30.17746; Breen JJ, 1998, J BIOL CHEM, V273, P4712, DOI 10.1074/jbc.273.8.4712; BURRIN JM, 1989, MOL ENDOCRINOL, V3, P1643, DOI 10.1210/mend-3-10-1643; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Fernandez-Funez P, 1998, EMBO J, V17, P6846, DOI 10.1093/emboj/17.23.6846; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; GONG ZY, 1994, BIOCHEMISTRY-US, V33, P15149, DOI 10.1021/bi00254a026; HAMERNIK DL, 1988, ENDOCRINOLOGY, V122, P959, DOI 10.1210/endo-122-3-959; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Jurata LW, 1998, CURR TOP MICROBIOL, V228, P75; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KING Y, 1997, MOL CELL BIOL, V17, P4750; Konrat R, 1997, J BIOL CHEM, V272, P12001, DOI 10.1074/jbc.272.18.12001; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LALLOZ MRA, 1988, ENDOCRINOLOGY, V122, P1681, DOI 10.1210/endo-122-4-1681; LEUNG K, 1987, MOL ENDOCRINOL, V1, P724, DOI 10.1210/mend-1-10-724; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Meier BC, 1999, MOL CELL ENDOCRINOL, V147, P65, DOI 10.1016/S0303-7207(98)00213-5; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; MORCILLO P, 1997, GENE DEV, V11, P2720; PAPAVASILIOU SS, 1986, P NATL ACAD SCI USA, V83, P4026, DOI 10.1073/pnas.83.11.4026; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; PerezAlvarado GC, 1996, J MOL BIOL, V257, P153, DOI 10.1006/jmbi.1996.0153; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Richards JP, 1996, J BIOL CHEM, V271, P13716, DOI 10.1074/jbc.271.23.13716; ROBERSON MS, 1995, MOL CELL BIOL, V15, P3531; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; SANCHEZGARCIA I, 1993, EMBO J, V12, P4243, DOI 10.1002/j.1460-2075.1993.tb06108.x; SCHNEIKERT J, 1992, ONCOGENE, V7, P249; SCHODERBEK WE, 1992, MOL ENDOCRINOL, V6, P893, DOI 10.1210/me.6.6.893; SCHODERBEK WE, 1993, J BIOL CHEM, V268, P3903; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; Shioda T, 1998, P NATL ACAD SCI USA, V95, P9785, DOI 10.1073/pnas.95.17.9785; Shioda T, 1997, GENE, V204, P235, DOI 10.1016/S0378-1119(97)00551-9; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; STANLEY HF, 1988, MOL ENDOCRINOL, V2, P1302, DOI 10.1210/mend-2-12-1302; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WIERMAN ME, 1989, ENDOCRINOLOGY, V124, P272, DOI 10.1210/endo-124-1-272; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; Yang BS, 1996, MOL CELL BIOL, V16, P538	71	89	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36159	36167		10.1074/jbc.274.51.36159	http://dx.doi.org/10.1074/jbc.274.51.36159			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593900	hybrid			2022-12-27	WOS:000084279200019
J	Roura, S; Miravet, S; Piedra, J; de Herreros, AG; Dunach, M				Roura, S; Miravet, S; Piedra, J; de Herreros, AG; Dunach, M			Regulation of E-cadherin/catenin association by tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; BETA-CATENIN; CELL-ADHESION; FACTOR RECEPTOR; CARCINOMA-CELLS; ALPHA-CATENIN; COMPLEX; PROTEIN; KINASE; SUBSTRATE	Alteration of cadherin-mediated cell-cell adhesion is frequently associated to tyrosine phosphorylation of p120- and beta-catenins. We have examined the role of this modification in these proteins in the control of beta-catenin/E-cadherin binding using in vitro assays with recombinant proteins. Recombinant pp60(c-src) efficiently phosphorylated both catenins in vitro, with stoichiometries of 1.5 and 2.0 mol of phosphate/mol of protein for beta-catenin and p120-catenin, respectively. pp60(c-src) phosphorylation had opposing effects on the affinities of beta-catenin and p120 for the cytosolic domain of E-cadherin; it decreased tin the case of beta-catenin) or increased (for p120) catenin/E-cadherin binding. How ever, a role for p120-catenin in the modulation of beta-catenin/E-cadherin binding was not observed, since addition of phosphorylated p120-catenin did not modify the affinity of phosphorylated (or unphosphorylated) beta-catenin far E-cadherin, The phosphorylated Tyr residues were identified as Tyr-86 and Tyr-654. Experiments using point mutants in these two residues indicated that, although Tyr-86 was a better substrate for pp60(c-src), only modification of Tyr-654 was relevant for the interaction with E-cadherin. Transient transfections of different mutants demonstrated that Tyr-654 is phosphorylated in conditions in which adherens junctions are disrupted and evidenced that binding of beta-catenin to E-cadherin in vivo is controlled by phosphorylation of beta-catenin Tyr-654.	Univ Pompeu Fabra, Inst Municipal Invest Med, Unitat Biol Cellular & Mol, Barcelona 08003, Spain; Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Biofis, Bellaterra 08193, Spain	Pompeu Fabra University; Autonomous University of Barcelona	de Herreros, AG (corresponding author), Univ Pompeu Fabra, Inst Municipal Invest Med, Unitat Biol Cellular & Mol, C Dr Aiguader 80, Barcelona 08003, Spain.		Dunach, Mireia/E-3604-2015; de Herreros, A Garcia/H-3104-2014	Dunach, Mireia/0000-0001-9844-5603; de Herreros, A Garcia/0000-0001-5270-0808; Roura, Santiago/0000-0003-4063-9661				ABERLE H, 1994, J CELL SCI, V107, P3655; BARTH AI, 1997, CURR OPIN CELL BIOL, V9, P693; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Cowin P, 1996, CURR OPIN CELL BIOL, V8, P56, DOI 10.1016/S0955-0674(96)80049-4; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; DOWNING JR, 1991, ONCOGENE, V6, P607; Fujii K, 1996, EXP CELL RES, V223, P50, DOI 10.1006/excr.1996.0057; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Johnson TM, 1997, J PEPT RES, V50, P365; KANNER SB, 1991, MOL CELL BIOL, V11, P713, DOI 10.1128/MCB.11.2.713; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; MCCREA PD, 1991, J BIOL CHEM, V266, P4514; McMurray JS, 1998, ARCH BIOCHEM BIOPHYS, V355, P124, DOI 10.1006/abbi.1998.0707; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; Obama H, 1997, J BIOL CHEM, V272, P11017; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Rosato R, 1998, MOL CELL BIOL, V18, P5762, DOI 10.1128/MCB.18.10.5762; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; Shibata T, 1996, ONCOGENE, V13, P883; Skoudy A, 1996, BIOCHEM J, V317, P279, DOI 10.1042/bj3170279; STADDON JM, 1995, J CELL SCI, V108, P609; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Takeda H, 1995, J CELL BIOL, V131, P1839, DOI 10.1083/jcb.131.6.1839; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; TSUKITA S, 1991, J CELL BIOL, V113, P867, DOI 10.1083/jcb.113.4.867; UEHARA Y, 1989, BIOCHEM BIOPH RES CO, V163, P803, DOI 10.1016/0006-291X(89)92293-6; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779	35	491	503	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36734	36740		10.1074/jbc.274.51.36734	http://dx.doi.org/10.1074/jbc.274.51.36734			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593980	hybrid			2022-12-27	WOS:000084279200099
J	Yokosaki, Y; Matsuura, N; Sasaki, T; Murakami, I; Schneider, H; Higashiyama, S; Saitoh, Y; Yamakido, M; Taooka, Y; Sheppard, D				Yokosaki, Y; Matsuura, N; Sasaki, T; Murakami, I; Schneider, H; Higashiyama, S; Saitoh, Y; Yamakido, M; Taooka, Y; Sheppard, D			The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEOPLASTIC TRANSFORMATION; ALPHA(4)BETA(1) INTEGRIN; EPITHELIAL INTEGRINS; POTENTIAL ROLES; CELL ATTACHMENT; SMOOTH-MUSCLE; III REPEAT; TENASCIN; EXPRESSION; ADHESION		Natl Hiroshima Hosp, Dept Internal Med, Higashihiroshima 7390041, Japan; Natl Hiroshima Hosp, Dept Neurosurg, Higashihiroshima 7390041, Japan; Natl Hiroshima Hosp, Dept Lab Med, Higashihiroshima 7390041, Japan; Osaka Univ, Sch Allied Hlth Sci, Dept Pathol, Suita, Osaka 5650871, Japan; Osaka Univ, Fac Med, Dept Biochem, Suita, Osaka 5650871, Japan; Univ London Imperial Coll Sci Technol & Med, Gene Therapy Res Grp, Mol Genet Sect, Div Biomed Sci, London SW7 2AZ, England; Kumamoto Univ, Sch Med, Dept Neurosurg, Kumamoto 8600811, Japan; Hiroshima Univ, Sch Med, Dept Internal Med 2, Hiroshima 7348551, Japan; Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA	Osaka University; Osaka University; Imperial College London; Kumamoto University; Hiroshima University; University of California System; University of California San Francisco	Yokosaki, Y (corresponding author), Natl Hiroshima Hosp, Dept Internal Med, 513 Jike, Higashihiroshima 7390041, Japan.	yokosaki@hirosima.hosp.go.jp			NHLBI NIH HHS [HL53949, HL47412, HL/AI33259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL053949, R01HL053949, R01HL047412, R01HL033259] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bayless KJ, 1998, J CELL SCI, V111, P1165; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; HART SL, 1995, GENE THER, V2, P552; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; NASU K, 1995, BIOCHEM J, V307, P257, DOI 10.1042/bj3070257; O'Regan AW, 1999, J IMMUNOL, V162, P1024; OBRIEN ER, 1994, ARTERIOSCLER THROMB, V14, P1648, DOI 10.1161/01.ATV.14.10.1648; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; Panda D, 1997, P NATL ACAD SCI USA, V94, P9308, DOI 10.1073/pnas.94.17.9308; PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SAITOH Y, 1995, LAB INVEST, V72, P55; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; SENGER DR, 1988, CANCER RES, V48, P5770; SENGER DR, 1989, ANTICANCER RES, V9, P1291; Sheppard D, 1996, BIOESSAYS, V18, P655, DOI 10.1002/bies.950180809; SINGH RP, 1990, J EXP MED, V171, P1931, DOI 10.1084/jem.171.6.1931; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Wang A, 1996, AM J RESP CELL MOL, V15, P664, DOI 10.1165/ajrcmb.15.5.8918373; Weber Georg F., 1996, Cytokine and Growth Factor Reviews, V7, P241, DOI 10.1016/S1359-6101(96)00030-5; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; YEDNOCK TA, 1995, J BIOL CHEM, V270, P28740, DOI 10.1074/jbc.270.48.28740; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423	35	269	297	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36328	36334		10.1074/jbc.274.51.36328	http://dx.doi.org/10.1074/jbc.274.51.36328			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593924	hybrid			2022-12-27	WOS:000084279200043
J	Zheng, T; Nicchitta, CV				Zheng, T; Nicchitta, CV			Structural determinants for signal sequence function in the mammalian endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PROTEIN TRANSLOCATION; METHIONINE-RICH DOMAIN; RECOGNITION PARTICLE; MICROSOMAL-MEMBRANES; PRESECRETORY PROTEINS; ESCHERICHIA-COLI; NASCENT PREPROLACTIN; CHEMICAL ALKYLATION; GTP-BINDING; ER-MEMBRANE	Signal sequences function in protein targeting to and translocation across the endoplasmic reticulum membrane. To investigate the structural requirements for signal sequence function, chimeras of the Escherichia coli LamB signal peptide and prolactin were prepared. The LamB signal peptide was chosen by virtue of the extensive biophysical and biological characterization of its activity. In vitro, nascent prolactin chains bearing the LamB signal peptide (LamB) were targeted in a signal recognition particle (SRP)-dependent manner to rough microsomes but remained protease- and salt-sensitive and translocated at low efficiency. Full translocation activity was obtained in a gain of function mutant (LamB*) in which three hydrophobic residues in the LamB hydrophobic core were converted to leucine residues. Cross-linking studies demonstrated that the LamB* signal sequence displayed markedly enhanced interactions with SRP and integral membrane proteins, In contrast, chemically denatured LamB and LamB*-precursors bound with identical efficiencies and in a salt-resistant manner to rough microsomes, suggesting that during de novo synthesis the signal sequence of LamB-bearing precursors assumes a conformation refractory to translocation, These data indicate that a leucine-rich signal sequence is necessary for optimal interaction with SRP and suggest that SRP, by maintaining the signal sequence in a conformation suitable for membrane binding, performs a chaperone function.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Nicchitta, CV (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	c.nicchitta@cellbio.duke.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047897] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47897] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Qahtani A, 1998, BIOCHEM J, V331, P521, DOI 10.1042/bj3310521; Belin D, 1996, EMBO J, V15, P468, DOI 10.1002/j.1460-2075.1996.tb00379.x; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BRIGGS MS, 1985, SCIENCE, V228, P1096, DOI 10.1126/science.3158076; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; DAYHOFF MO, 1972, ATLAS PROTEIN SEQUEN, P89; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; HIGH S, 1993, J BIOL CHEM, V268, P26745; HORTSCH M, 1986, J CELL BIOL, V103, P241, DOI 10.1083/jcb.103.1.241; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; JONES JD, 1994, BIOPHYS J, V67, P1546, DOI 10.1016/S0006-3495(94)80628-9; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; LUTCKE H, 1992, EMBO J, V11, P1543, DOI 10.1002/j.1460-2075.1992.tb05199.x; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Moller I, 1998, FEBS LETT, V441, P1, DOI 10.1016/S0014-5793(98)01440-9; Murphy EC, 1997, J CELL BIOL, V136, P1213, DOI 10.1083/jcb.136.6.1213; Neuhof A, 1998, MOL BIOL CELL, V9, P103, DOI 10.1091/mbc.9.1.103; NICCHITTA CV, 1989, J CELL BIOL, V108, P789, DOI 10.1083/jcb.108.3.789; NICCHITTA CV, 1995, J CELL BIOL, V129, P957, DOI 10.1083/jcb.129.4.957; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OKUN MM, 1990, J BIOL CHEM, V265, P7478; Raden D, 1998, MOL BIOL CELL, V9, P117, DOI 10.1091/mbc.9.1.117; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHLENSTEDT G, 1992, J BIOL CHEM, V267, P24328; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; THRIFT RN, 1991, J CELL BIOL, V112, P809, DOI 10.1083/jcb.112.5.809; Voglino L, 1998, BIOCHEMISTRY-US, V37, P12241, DOI 10.1021/bi9805792; Voglino L, 1999, BIOCHEMISTRY-US, V38, P7509, DOI 10.1021/bi990099q; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WALTER P, 1981, J CELL BIOL, V91, P551, DOI 10.1083/jcb.91.2.551; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WATANABE M, 1986, NATURE, V323, P71, DOI 10.1038/323071a0; WATERS MG, 1986, J CELL BIOL, V102, P1543, DOI 10.1083/jcb.102.5.1543; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; WIEDMANN M, 1987, NATURE, V328, P830, DOI 10.1038/328830a0; WOLIN SL, 1993, J CELL BIOL, V121, P1211, DOI 10.1083/jcb.121.6.1211; ZIMMERMANN R, 1990, BIOCHIMIE, V72, P95, DOI 10.1016/0300-9084(90)90134-3; ZOPF D, 1993, J CELL BIOL, V120, P1113, DOI 10.1083/jcb.120.5.1113; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	53	18	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36623	36630		10.1074/jbc.274.51.36623	http://dx.doi.org/10.1074/jbc.274.51.36623			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593964	hybrid			2022-12-27	WOS:000084279200083
J	Delahay, RM; Knutton, S; Shaw, RK; Hartland, EL; Pallen, MJ; Frankel, G				Delahay, RM; Knutton, S; Shaw, RK; Hartland, EL; Pallen, MJ; Frankel, G			The coiled-coil domain of EspA is essential for the assembly of the type III secretion translocon on the surface of enteropathogenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-CULTURE CELLS; EPITHELIAL-CELLS; SALMONELLA-TYPHIMURIUM; PROTEIN TRANSLOCATION; GENETIC-LOCUS; PATHOGENS; FLAGELLIN; SYSTEMS; ALPHA	Enteropathogenic E. coli (EPEC) utilize a type III secretion system to deliver virulence-associated effector proteins to the host cell. Four proteins, EspA, EspE, EspD, and Tir, which are integral to the formation of characteristic "attaching and effacing" (A/E) intestinal lesions, are known to be exported via the EPEC type III secretion system. Recent work demonstrated that EspA is a major component of a filamentous structure, elaborated on the surface of EPEC, which is required for translocation of EspB and Tir, The carboxyl terminus of EspA is predicted to comprise an alpha-helical region, which demonstrates heptad periodicity whereby positions a and d in the heptad repeat unit abcdefg are occupied by hydrophobic residues, indicating a propensity for coiled-coil interactions. Here we demonstrate multimeric EspA isoforms in EPEC culture supernatants and EspA:EspA interaction on solid phase. Non-conservative amino acid substitution of specific EspA heptad residues generated EPEC mutants defective in filament assembly but which retained the ability to induce A/E lesions; additional mutation totally abolished EspA filament assembly and A/E lesion formation. These results demonstrate a similarity to flagellar biosynthesis and indicate that the coiled-coil domain of EspA is required for assembly of the EspA filament-associated type III secretion translocon.	Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AZ, England; Univ Birmingham, Inst Child Hlth, Birmingham B4 6NH, W Midlands, England; St Bartholomews & Royal London Sch Med & Dent, Dept Med Microbiol, London EC1A 7BE, England	Imperial College London; University of Birmingham; University of London; Queen Mary University London	Frankel, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AZ, England.	g.frankel@ic.ac.uk	Pallen, Mark J./E-7619-2011; Hartland, Elizabeth/O-2569-2014	Hartland, Elizabeth/0000-0003-4254-2863; Delahay, Rob/0000-0002-7108-565X; Pallen, Mark/0000-0003-1807-3657				Adu-Bobie J, 1998, J CLIN MICROBIOL, V36, P662, DOI 10.1128/JCM.36.3.662-668.1998; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; Elliott SJ, 1999, MOL MICROBIOL, V33, P1176, DOI 10.1046/j.1365-2958.1999.01559.x; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Forest KT, 1997, GENE, V192, P165, DOI 10.1016/S0378-1119(97)00008-5; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Frankel GM, 1999, SYMP SOC GEN MICROBI, V57, P197; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; HYMAN HC, 1991, J MOL BIOL, V220, P79, DOI 10.1016/0022-2836(91)90382-G; IKEDA T, 1985, J MOL BIOL, V184, P735, DOI 10.1016/0022-2836(85)90317-1; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; KANTO S, 1991, J MOL BIOL, V219, P471, DOI 10.1016/0022-2836(91)90187-B; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kenny B, 1996, MOL MICROBIOL, V20, P313, DOI 10.1111/j.1365-2958.1996.tb02619.x; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; KUWAJIMA G, 1988, J BACTERIOL, V170, P3305, DOI 10.1128/jb.170.7.3305-3309.1988; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Pallen MJ, 1997, MOL MICROBIOL, V25, P423, DOI 10.1046/j.1365-2958.1997.4901850.x; PARRY D A D, 1992, Current Opinion in Cell Biology, V4, P94, DOI 10.1016/0955-0674(92)90064-J; ROSQVIST R, 1995, EMBO J, V14, P4187, DOI 10.1002/j.1460-2075.1995.tb00092.x; Wachter C, 1999, MOL MICROBIOL, V31, P1695, DOI 10.1046/j.1365-2958.1999.01303.x; Wainwright LA, 1998, MOL MICROBIOL, V27, P1247, DOI 10.1046/j.1365-2958.1998.00771.x; Wolff C, 1998, MOL MICROBIOL, V28, P143, DOI 10.1046/j.1365-2958.1998.00782.x; YOKOSEKI T, 1995, MICROBIOL-SGM, V141, P1715, DOI 10.1099/13500872-141-7-1715	31	59	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	1999	274	50					35969	35974		10.1074/jbc.274.50.35969	http://dx.doi.org/10.1074/jbc.274.50.35969			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	264NG	10585486	hybrid			2022-12-27	WOS:000084187900098
J	Okochi, M; Walter, J; Koyama, A; Nakajo, S; Baba, M; Iwatsubo, T; Meijer, L; Kahle, PJ; Haass, C				Okochi, M; Walter, J; Koyama, A; Nakajo, S; Baba, M; Iwatsubo, T; Meijer, L; Kahle, PJ; Haass, C			Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SYSTEM ATROPHY; CASEIN KINASE-II; A-BETA COMPONENT; CAMP-REGULATED PHOSPHOPROTEIN; GLIAL CYTOPLASMIC INCLUSIONS; CENTRAL-NERVOUS-SYSTEM; LEWY BODY DISEASE; ALZHEIMERS-DISEASE; NACP/ALPHA-SYNUCLEIN; PRECURSOR PROTEIN	alpha-Synuclein has been implicated in the pathogenesis of Parkinson's disease, since rare autosomal dominant mutations are associated with early onset of the disease and alpha-synuclein was found to be a major constituent of Lewy bodies. We have analyzed alpha-synuclein expression in transfected cell lines. In pulse-chase experiments alpha-synuclein appeared to be stable over long periods (t(1/2) 54 h) and no endoproteolytic processing was observed. alpha-Synuclein was constitutively phosphorylated in human kidney 293 cells as well as in rat pheochromocytoma PC12 cells. In both cell lines phosphorylation was highly sensitive to phosphatases, since okadaic acid markedly stabilized phosphate incorporation. Phosphoamino acid analysis revealed that phosphorylation occurred predominantly on serine. Using site-directed mutagenesis we have identified a major phosphorylation site at serine 129 within the C-terminal domain of alpha-synuclein. An additional site, which was phosphorylated less efficiently, was mapped to serine 87. The major phosphorylation site was located within a consensus recognition sequence of casein kinase 1 (CK-1). In vitro experiments and two-dimensional phosphopeptide mapping provided further evidence that serine 129 was phosphorylated by CK-1 and CK-2. Moreover, phosphorylation of serine 129 was reduced in vivo upon inhibition of CK-1 or CK-2. These data demonstrate that alpha-synuclein is constitutively phosphorylated within its C terminus and may indicate that the function of alpha-synuclein is regulated by phosphorylation/dephosphorylation.	Univ Munich, Adolf Butenandt Inst, Dept Biochem, D-80336 Munich, Germany; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan; Showa Univ, Sch Pharmaceut Sci, Biol Chem Lab, Tokyo, Japan; CNRS, Biol Stn, F-29682 Roscoff, France	University of Munich; University of Tokyo; Showa University; Centre National de la Recherche Scientifique (CNRS)	Haass, C (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Biochem, Schillerst 44, D-80336 Munich, Germany.	chaass@pbm.med.uni-muenchen.de	Wang, Caihong/T-5837-2019; MEIJER, Laurent/ABE-7465-2021; Walter, Jochen/B-3677-2014	Wang, Caihong/0000-0002-6808-3709; Okochi, Masayasu/0000-0002-2318-7651; Walter, Jochen/0000-0002-4678-2912; , laurent/0000-0003-3511-4916				AHMED K, 1994, CELL MOL BIOL RES, V40, P1; Arawaka S, 1998, NEUROLOGY, V51, P887, DOI 10.1212/WNL.51.3.887; Arima K, 1998, BRAIN RES, V808, P93, DOI 10.1016/S0006-8993(98)00734-3; Baba M, 1998, AM J PATHOL, V152, P879; BENNETT MK, 1993, J NEUROSCI, V13, P1701; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CHARRIAUTMARLANGUE C, 1991, P NATL ACAD SCI USA, V88, P10232, DOI 10.1073/pnas.88.22.10232; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; COHEN P, 1991, METHOD ENZYMOL, V201, P389; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DESDOUITS F, 1995, J BIOL CHEM, V270, P8772, DOI 10.1074/jbc.270.15.8772; DIAZNIDO J, 1988, J CELL BIOL, V106, P2057, DOI 10.1083/jcb.106.6.2057; Farrer M, 1998, ANN NEUROL, V43, P394, DOI 10.1002/ana.410430320; FERNANDEZ J, 1994, ANAL BIOCHEM, V218, P112, DOI 10.1006/abio.1994.1148; Gai WP, 1998, LANCET, V352, P547, DOI 10.1016/S0140-6736(05)79256-4; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; GIRAULT JA, 1989, J BIOL CHEM, V264, P21748; GROSS SD, 1995, J CELL BIOL, V130, P711, DOI 10.1083/jcb.130.3.711; Grunberg J, 1998, BIOCHEMISTRY-US, V37, P2263, DOI 10.1021/bi972106l; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hollander BA, 1999, CELL MOTIL CYTOSKEL, V43, P114, DOI 10.1002/(SICI)1097-0169(1999)43:2<114::AID-CM3>3.3.CO;2-D; HUANG FL, 1991, METHODS ENZYMOL, V200, P454; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; ISSINGER OG, 1993, PHARMACOL THERAPEUT, V59, P1, DOI 10.1016/0163-7258(93)90039-G; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JELINEK T, 1993, BIOTECHNIQUES, V15, P628; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; MAROTEAUX L, 1991, MOL BRAIN RES, V11, P335, DOI 10.1016/0169-328X(91)90043-W; MARSHAK DR, 1991, METHOD ENZYMOL, V200, P134; NAKAJO S, 1990, J NEUROCHEM, V55, P2031, DOI 10.1111/j.1471-4159.1990.tb05792.x; NAKAJO S, 1993, EUR J BIOCHEM, V217, P1057, DOI 10.1111/j.1432-1033.1993.tb18337.x; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SHIBAYAMAIMAZU T, 1993, BRAIN RES, V622, P17, DOI 10.1016/0006-8993(93)90796-P; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Takeda A, 1998, AM J PATHOL, V152, P367; TAWFIC S, 1994, J BIOL CHEM, V269, P7489; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Tomita T, 1998, NEUROREPORT, V9, P911, DOI 10.1097/00001756-199803300-00027; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; UEDA K, 1994, BIOCHEM BIOPH RES CO, V205, P1366, DOI 10.1006/bbrc.1994.2816; VANCURA A, 1994, J BIOL CHEM, V269, P19271; Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445, DOI 10.1007/s004010050918; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Walter J, 1996, J BIOL CHEM, V271, P111, DOI 10.1074/jbc.271.1.111; Walter J, 1997, P NATL ACAD SCI USA, V94, P5349, DOI 10.1073/pnas.94.10.5349; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414	66	406	422	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2000	275	1					390	397		10.1074/jbc.275.1.390	http://dx.doi.org/10.1074/jbc.275.1.390			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295DN	10617630	hybrid			2022-12-27	WOS:000085951600054
J	Fernandez, MR; Biosca, JA; Torres, D; Crosas, B; Pares, X				Fernandez, MR; Biosca, JA; Torres, D; Crosas, B; Pares, X			A double residue substitution in the coenzyme-binding site accounts for the different kinetic properties between yeast and human formaldehyde dehydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-III ALCOHOL; HUMAN-LIVER; SACCHAROMYCES-CEREVISIAE; ENZYMATIC-PROPERTIES; GENE DISRUPTION; RAT-LIVER; CLASS-P; CLASS-I; GLUTATHIONE; PURIFICATION	Glutathione-dependent formaldehyde dehydrogenase (FALDH) is the main enzymatic system for formaldehyde detoxification in all eukaryotic and many prokaryotic organisms. The enzyme of yeasts and some bacteria exhibits about 10-fold higher k(cat) and K-m values than those of the enzyme from animals and plants. Typically Thr-269 and Glu-267 are found in the coenzyme-binding site of yeast FALDH, but Ile-269 and Asp-267 are present in the FALDH of animals. By site-directed mutagenesis we have prepared the T269I and the D267E mutants and the D267E/T269I double mutant of Saccharomyces cerevisiae FALDH with the aim of investigating the role of these residues in the kinetics. The T269I and the D267E mutants have identical kinetic properties as compared with the wild-type enzyme, although T269I is highly unstable. In contrast, the D267E/T269I double mutant is stable and shows low K-m, (2.5 mu M) and low k(cat) (285 min(-1)) values with S-hydroxymethylglutathione, similar to those of the human enzyme. Therefore, the simultaneous exchange at both residues is the structural basis of the two distinct FALDH kinetic types. The local structural perturbations imposed by the substitutions are suggested by molecular modeling studies. Finally, we have studied the effect of FALDH deletion and overexpression on the growth of S. cerevisiae, It is concluded that the FALDH gene is not essential but enhances the resistance against formaldehyde (0.3-1 mM), Moreover, the wild-type enzyme (with high k(cat) and K-m) provides more resistance than the double mutant (with low k(cat) and K-m).	Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Fac Sci, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Pares, X (corresponding author), Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Fac Sci, E-08193 Barcelona, Spain.		Fernandez, Maria Rosario R/F-4015-2016; Biosca, Josep/G-3137-2013; Pares, Xavier/K-8228-2017	Fernandez, Maria Rosario R/0000-0002-1750-7786; Biosca, Josep/0000-0003-2794-3124; Torres Navarro, Damaso/0000-0003-3272-6079; Pares, Xavier/0000-0002-5071-9465				ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ALLAIS JJ, 1983, AGR BIOL CHEM TOKYO, V47, P1509, DOI 10.1080/00021369.1983.10865804; Barber RD, 1996, J BACTERIOL, V178, P1386, DOI 10.1128/jb.178.5.1386-1393.1996; BECKER DM, 1994, CURRENT PROTOCOLS MO, V2; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown T., 1993, CURRENT PROTOCOLS MO, V1; CLELAND WW, 1979, METHOD ENZYMOL, V189, P436; CORMACK B, 1997, CURRENT PROTOCOLS MO, V2; DANIELSSON O, 1994, P NATL ACAD SCI USA, V91, P4980, DOI 10.1073/pnas.91.11.4980; EKLUND H, 1984, BIOCHEMISTRY-US, V23, P5982, DOI 10.1021/bi00320a014; FAN F, 1995, BIOCHEMISTRY-US, V34, P4709, DOI 10.1021/bi00014a027; FERNANDEZ MR, 1995, FEBS LETT, V370, P23; FERNANDEZ MR, 1993, FEBS LETT, V328, P235, DOI 10.1016/0014-5793(93)80934-M; Fersht A, 1999, STRUCTURE MECH PROTE, P362; FUJIWARA K, 1984, J BIOL CHEM, V259, P664; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GIRI PR, 1989, BRAIN RES, V481, P131; GULTHEIL WG, 1992, BIOCHEMISTRY-US, V31, P475; HALLIER E, 1994, ARCH TOXICOL, V68, P423, DOI 10.1007/s002040050092; HOLMQUIST B, 1991, BIOCHEM BIOPH RES CO, V178, P1371, DOI 10.1016/0006-291X(91)91045-E; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Jornvall H, 1997, ADV EXP MED BIOL, V414, P281; KOIVUSALO M, 1989, FEBS LETT, V257, P105, DOI 10.1016/0014-5793(89)81797-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACK M, 1988, MOL GEN GENET, V211, P260, DOI 10.1007/BF00330602; Martinez MC, 1996, EUR J BIOCHEM, V241, P849, DOI 10.1111/j.1432-1033.1996.00849.x; MOULIS JM, 1991, BIOCHEMISTRY-US, V30, P5743, DOI 10.1021/bi00237a016; PARES X, 1981, BIOCHEM BIOPH RES CO, V98, P122, DOI 10.1016/0006-291X(81)91878-7; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; POURMOTABBED T, 1989, J BIOL CHEM, V264, P17384; RAS J, 1995, J BACTERIOL, V177, P247, DOI 10.1128/jb.177.1.247-251.1995; ROSE ZB, 1962, J BIOL CHEM, V237, P3279; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SASNAUSKAS K, 1992, GENE, V122, P207, DOI 10.1016/0378-1119(92)90052-Q; Shafqat J, 1996, P NATL ACAD SCI USA, V93, P5595, DOI 10.1073/pnas.93.11.5595; SHARA MA, 1992, J CHROMATOGR-BIOMED, V576, P221, DOI 10.1016/0378-4347(92)80196-W; UOTILA L, 1974, J BIOL CHEM, V249, P7653; UOTILA L, 1979, BIOCHEM J, V177, P869, DOI 10.1042/bj1770869; UOTILA L, 1980, BIOCHIM BIOPHYS ACTA, V616, P153, DOI 10.1016/0005-2744(80)90133-3; Uotila L., 1989, COENZYMES COFACTOR A, P517; WAGNER FW, 1984, BIOCHEMISTRY-US, V23, P2193, DOI 10.1021/bi00305a014; WAYDHAS C, 1978, EUR J BIOCHEM, V89, P143, DOI 10.1111/j.1432-1033.1978.tb20906.x; WEHNER EP, 1993, MOL GEN GENET, V237, P351, DOI 10.1007/BF00279438; Yang ZN, 1997, J MOL BIOL, V265, P330, DOI 10.1006/jmbi.1996.0731; Yu PH, 1997, NEUROCHEM RES, V22, P615, DOI 10.1023/A:1022478221421	46	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37869	37875		10.1074/jbc.274.53.37869	http://dx.doi.org/10.1074/jbc.274.53.37869			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608852	hybrid			2022-12-27	WOS:000084528000052
J	Huang, LW; Sankar, S; Lin, C; Kontos, CD; Schroff, AD; Cha, EH; Feng, SM; Li, SF; Yu, ZM; Van Etten, RL; Blanar, MA; Peters, KG				Huang, LW; Sankar, S; Lin, C; Kontos, CD; Schroff, AD; Cha, EH; Feng, SM; Li, SF; Yu, ZM; Van Etten, RL; Blanar, MA; Peters, KG			HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-INDUCED ANGIOGENESIS; NITRIC-OXIDE SYNTHASE; RAT AORTA; IN-VIVO; INHIBITION; KINASE; EXPRESSION; PERMEABILITY; DOWNSTREAM; CELLS	Angiogenesis is a tightly controlled process in which signaling by the receptors for vascular endothelial growth factor (VEGF) plays a key role. In order to define signaling pathways downstream of VEGF receptors (VEGFR), the kinase domain of VEGFRS (Flk-1) was used as a bait to screen a human fetal heart library in the yeast two-hybrid system. One of the signaling molecules identified in this effort was HCPTPA, a low molecular weight, cytoplasmic protein tyrosine phosphatase. Although HCPTPA possesses no identifiable phosphotyrosine binding domains (i.e. SH2 or phosphotyrosine binding domains), it bound specifically to active, autophosphorylated VEGFR2 but not to a mutated, kinase-inactive VEGFR2. Recombinant VEGFR2 and endogenous VEGFR2 were substrates for recombinant HCPTPA, and HCPTPA was co-expressed with VEGFR2 in endothelial cell. Lines, suggesting that HCPTPA may be It negative regulator of VEGFR2 signal transduction. To pursue this possibility, an adenovirus directing the expression of HCPTPA was constructed. When used to infect cultured endothelial cells, this adenovirus directed high level expression of HCPTPA that resulted in impairment of VEGF-mediated VEGFR2 autophosphorylation and mitogen-activated protein kinase activation. Adenovirus-mediated overexpression of HCPTPA also inhibited VEGF-induced cellular responses (endothelial cell migration and proliferation) and inhibited angiogenesis in the rat aortic ring assay. Taken together, these findings indicate that HCPTPA may be an important regulator of VEGF mediated signaling and biological activity. Potential interactions with other signaling pathways and possible therapeutic implications are discussed.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; Bristol Myers Squibb Pharmaceut Res Inst, Dept Cardiovasc Drug Discovery, Princeton, NJ 08543 USA	Duke University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Bristol-Myers Squibb	Peters, KG (corresponding author), Procter & Gamble Co, Hlth Care Res Ctr, POB 8006, Mason, OH 45040 USA.			Kontos, Christopher/0000-0002-8056-3115				BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; BERTI A, 1994, FEBS LETT, V349, P7, DOI 10.1016/0014-5793(94)00620-2; Bucciantini M, 1998, FEBS LETT, V422, P213, DOI 10.1016/S0014-5793(98)00009-X; CASELLI A, 1995, FEBS LETT, V374, P249, DOI 10.1016/0014-5793(95)01120-4; CASELLI A, 1994, J BIOL CHEM, V269, P24878; Channon KM, 1996, CARDIOVASC RES, V32, P962; Cheng SY, 1996, P NATL ACAD SCI USA, V93, P8502, DOI 10.1073/pnas.93.16.8502; Chiarugi P, 1996, BIOCHEM BIOPH RES CO, V219, P21, DOI 10.1006/bbrc.1996.0174; CLYMAN RI, 1994, CELL ADHES COMMUN, V1, P333, DOI 10.3109/15419069409097264; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5850; FANTL WJ, 1996, GROW FACT CYTOK  A&B, V1, P179; FENG GS, 1994, TRENDS GENET, V10, P54, DOI 10.1016/0168-9525(94)90149-X; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hariawala MD, 1996, J SURG RES, V63, P77, DOI 10.1006/jsre.1996.0226; HUANG LW, 1995, ONCOGENE, V11, P2097; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kontos CD, 1998, MOL CELL BIOL, V18, P4131, DOI 10.1128/MCB.18.7.4131; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Lin PN, 1998, P NATL ACAD SCI USA, V95, P8829, DOI 10.1073/pnas.95.15.8829; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Millauer B, 1996, CANCER RES, V56, P1615; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; NICOSIA RF, 1990, LAB INVEST, V63, P115; Nicosia RF, 1997, AM J PATHOL, V151, P1379; NICOSIA RF, 1994, IN VITRO CELL DEV-AN, V30A, P394, DOI 10.1007/BF02634360; NICOSIA RF, 1992, ATHEROSCLEROSIS, V95, P191, DOI 10.1016/0021-9150(92)90022-9; NICOSIA RF, 1995, LAB INVEST, V73, P658; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Rigacci S, 1996, J BIOL CHEM, V271, P1278, DOI 10.1074/jbc.271.3.1278; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sellke FW, 1996, AM J PHYSIOL-HEART C, V271, pH713, DOI 10.1152/ajpheart.1996.271.2.H713; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; vanderZee R, 1997, CIRCULATION, V95, P1030; WO YYP, 1992, J BIOL CHEM, V267, P10856; Wu HM, 1996, AM J PHYSIOL-HEART C, V271, pH2735, DOI 10.1152/ajpheart.1996.271.6.H2735; YAMAUCHI K, 1995, P NATL ACAD SCI USA, V92, P664, DOI 10.1073/pnas.92.3.664; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765; Zhang M, 1998, J BIOL CHEM, V273, P21714, DOI 10.1074/jbc.273.34.21714; Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451	48	72	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38183	38188		10.1074/jbc.274.53.38183	http://dx.doi.org/10.1074/jbc.274.53.38183			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608891	hybrid			2022-12-27	WOS:000084528000091
J	Leng, J; Klemke, RL; Reddy, AC; Cheresh, DA				Leng, J; Klemke, RL; Reddy, AC; Cheresh, DA			Potentiation of cell migration by adhesion-dependent cooperative signals from the GTPase Rac and Raf kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ACTIN STRESS FIBERS; GROWTH-FACTOR; INTEGRIN ALPHA(V)BETA(3); EPITHELIAL-CELLS; FOCAL ADHESIONS; RHO-GTPASES; MYOSIN-II; CDC42; BINDING	The small GTPase Rac is thought to regulate cell movement by influencing actin cytoskeletal organization and membrane ruffling. However, cell migration also depends on the activation of mitogen-activated protein kinase (MAPK), which can regulate myosin motor function, an event critical for cell contraction. Evidence is provided that, during active cell adhesion to the extracellular matrix, Rac potentiates the MAPK pathway and influences cell migration by selectively synergizing with Raf kinase but not with Ras or MAPK kinase. In fact, the synergy between Rac and Raf kinase increases the chemotactic sensitivity of cells to epidermal growth factor by 1000-fold. Therefore, the role of Rac in cell migration not only depends on its ability to regulate actin cytoskeletal organization but also on its capacity to potentiate chemokine activation of MAPK in a manner that depends on active cell adhesion to the extracellular matrix.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Cheresh, DA (corresponding author), Scripps Res Inst, Dept Immunol, IMM24,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NCI NIH HHS [CA45728, CA50286] Funding Source: Medline; NHLBI NIH HHS [HL54444] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050286, R37CA050286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054444] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Burridge K, 1997, TRENDS CELL BIOL, V7, P342, DOI 10.1016/S0962-8924(97)01127-6; Cary LA, 1996, J CELL SCI, V109, P1787; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; Clark RAF, 1996, AM J PATHOL, V148, P1407; CONRAD PA, 1993, J CELL BIOL, V120, P1381, DOI 10.1083/jcb.120.6.1381; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Dyson S, 1998, CELL, V93, P557, DOI 10.1016/S0092-8674(00)81185-X; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; GOUGH AH, 1993, J CELL BIOL, V121, P1095, DOI 10.1083/jcb.121.5.1095; Guillemot JC, 1997, J CELL SCI, V110, P2215; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KOLEGA J, 1993, MOL BIOL CELL, V4, P819, DOI 10.1091/mbc.4.8.819; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Xie H, 1998, J CELL SCI, V111, P615	47	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					37855	37861		10.1074/jbc.274.53.37855	http://dx.doi.org/10.1074/jbc.274.53.37855			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608850	hybrid			2022-12-27	WOS:000084528000050
J	Mueller, C; Corazza, N; Trachsel-Loseth, S; Eugster, HP; Buhler-Jungo, M; Brunner, T; Imboden, MA				Mueller, C; Corazza, N; Trachsel-Loseth, S; Eugster, HP; Buhler-Jungo, M; Brunner, T; Imboden, MA			Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNF alpha) mediates effects distinct from those of wild-type TNF alpha in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MICE; METALLOPROTEINASE INHIBITOR; INTERLEUKIN-12 PRODUCTION; EXPERIMENTAL HEPATITIS; MONOCLONAL-ANTIBODY; INTERFERON-GAMMA; RECEPTOR; EXPRESSION; CELLS; RESPONSES	Tumor necrosis factor-alpha (TNF alpha) exists in two biologically active forms, a 26-kDa transmembrane form and a proteolytically cleaved and secreted form. We sequentially inactivated all three known cleavage sites of mouse TNF alpha by mutating the corresponding DNA sequences. A murine T cell hybridoma transfected with the nonsecretable mutant TNF alpha efficiently lysed L929 target cells in a cell contact-dependent manner and induced expression of vascular cell adhesion molecule-1 on mouse endothelioma cells. A genomic mouse TNF alpha clone encoding this mutant was subsequently introduced as a transgene into TNF alpha(-/-) lymphotoxin-alpha(-/-) mice. The 3' AU-rich regulatory elements of the TNF locus were maintained in the transgene to assure adequate gene regulation. Transmembrane TNF alpha transgenic mice were fully protected from endotoxic shock, and no TNF alpha bioactivity was detectable in the serum after stimulation with lipopolysaccharide. Activated CD4 T cells from these animals, however, lysed L929 cells in a cell contact-dependent way. After administration of Lipopolysaccharide, transmembrane TNF alpha transgenic mice produced significantly higher levels of interleukin-12 than wild-type mice or TNF-deficient mice. This indicates that transmembrane TNF alpha may greatly affect the course of a cellular immune responses in vivo and exerts quantitatively and qualitatively distinct functions from secreted TNF alpha in vitro and in vivo.	Univ Bern, Dept Pathol, Div Immunopathol, CH-3010 Bern, Switzerland; Univ Zurich, Dept Clin Immunol, CH-8044 Zurich, Switzerland; ZLB Cent Lab, CH-3000 Bern, Switzerland	University of Bern; University of Zurich	Mueller, C (corresponding author), Univ Bern, Dept Pathol, Div Immunopathol, Murtenstr 31, CH-3010 Bern, Switzerland.	christoph.mueller@pathology.unibe.ch	Mueller, Christoph/F-2233-2014	Mueller, Christoph/0000-0002-3921-8678				Alexopoulou L, 1997, EUR J IMMUNOL, V27, P2588, DOI 10.1002/eji.1830271018; Bean AGD, 1999, J IMMUNOL, V162, P3504; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; CSEH K, 1989, J BIOL CHEM, V264, P16256; DECOSTER E, 1995, J BIOL CHEM, V270, P18473, DOI 10.1074/jbc.270.31.18473; Douni E, 1996, J INFLAMM, V47, P27; ELLIOTT MJ, 1994, LANCET, V344, P1125, DOI 10.1016/S0140-6736(94)90632-7; ENGLARD S, 1990, METHOD ENZYMOL, V182, P285; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; ESPEVIK T, 1987, IMMUNOLOGY, V61, P443; Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23; FLESCH IEA, 1995, J EXP MED, V181, P1615, DOI 10.1084/jem.181.5.1615; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Haraldsen G, 1996, J IMMUNOL, V156, P2558; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hodge-Dufour J, 1998, P NATL ACAD SCI USA, V95, P13806, DOI 10.1073/pnas.95.23.13806; Hunger RE, 1996, J CLIN INVEST, V98, P954, DOI 10.1172/JCI118879; Kagi D, 1999, J IMMUNOL, V162, P4598; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; MUELLER C, 1988, J EXP MED, V167, P1124, DOI 10.1084/jem.167.3.1124; Pakala SV, 1999, J EXP MED, V189, P1053, DOI 10.1084/jem.189.7.1053; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PECK R, 1989, CELL IMMUNOL, V122, P1, DOI 10.1016/0008-8749(89)90143-3; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Peschon JJ, 1998, J IMMUNOL, V160, P943; RobacheGallea S, 1997, EUR J IMMUNOL, V27, P1275, DOI 10.1002/eji.1830270532; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SEMON D, 1987, NUCLEIC ACIDS RES, V15, P9083, DOI 10.1093/nar/15.21.9083; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; SLECKMAN BP, 1987, NATURE, V328, P351, DOI 10.1038/328351a0; Solorzano CC, 1997, J IMMUNOL, V158, P414; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Trinchieri G, 1998, IMMUNOL RES, V17, P269, DOI 10.1007/BF02786451; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; WAHL SM, 1993, CURRENT PROTOCOLS IM, V1; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7	47	66	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38112	38118		10.1074/jbc.274.53.38112	http://dx.doi.org/10.1074/jbc.274.53.38112			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608881	hybrid, Green Published			2022-12-27	WOS:000084528000081
J	Saam, JR; Gordon, JI				Saam, JR; Gordon, JI			Inducible gene knockouts in the small intestinal and colonic epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SMALL-INTESTINE; SITE-SPECIFIC RECOMBINATION; TETRACYCLINE-RESPONSIVE PROMOTER; STEM-CELL DIFFERENTIATION; RABBIT URINARY-BLADDER; BINDING PROTEIN GENE; TRANSGENIC MICE; CRE RECOMBINASE; MAMMALIAN-CELLS; STOCHASTIC-THEORY	We have developed two systems for performing Cre-mediated recombination of target genes in the rapidly self-renewing mouse small intestinal and colonic epithelium, When expression of Cre recombinase is placed directly under the control of transcriptional regulatory elements from a fatty acid-binding protein gene (Fabp), deletion of loxP flanked (floxed) DNA sequences is initiated as early as embryonic day 13.5, well before completion of intestinal morphogenesis. By embryonic day 16.5, Fabp-Cre also directs recombination in all cell layers of the transitional epithelium that lines the renal calyces and pelvis, meters, and bladder, Fabp-Cre expression and recombination are maintained in both epithelia throughout adulthood. The second system allows recombination to be induced only in the gut and at any period during adulthood. This system uses Fabp regulatory elements to direct expression of a reverse tetracycline-regulated transactivator (rtTA), Another transgene encodes Cre under the control of tet operator sequences and a minimal promoter from human cytomegalovirus (tetO-P-hCMV-Cre). In the absence of a doxycycline inducer, no basal recombination is detectable in the gut of adult tri-transgenic mice containing Fabp-rtTA, tetO-P-hCMV-Cre, plus a floxed reporter gene. After 4 days of oral administration of doxycycline, recombination of the reporter is apparent in the small intestinal, cecal, and colonic epithelium, After doxycycline is withdrawn, the recombined locus persists for at least 60 days, indicating that recombination has occurred in epithelial cell progenitors that have long residency times in the proliferative units of the intestine (crypts of Lieberkuhn), This inducible system should have a number of applications for examining gene function at selected times in postnatal life, under selected physiologic or pathophysiologic conditions.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009724, R01DK030292, R37DK030292] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK09724, DK30292, DK39760] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; AYRES PH, 1985, J UROLOGY, V133, P506, DOI 10.1016/S0022-5347(17)49042-2; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; BJERKNES M, 1986, BIOPHYS J, V49, P1223, DOI 10.1016/S0006-3495(86)83751-1; BJERKNES M, 1994, J THEOR BIOL, V168, P349, DOI 10.1006/jtbi.1994.1115; Brocard J, 1998, NUCLEIC ACIDS RES, V26, P4086, DOI 10.1093/nar/26.17.4086; CALVERT R, 1990, ANAT REC, V227, P199, DOI 10.1002/ar.1092270208; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; CHENG H, 1974, AM J ANAT, V141, P481, DOI 10.1002/aja.1001410404; CHENG H, 1974, AM J ANAT, V141, P503, DOI 10.1002/aja.1001410405; CROSSMAN MW, 1994, J CELL BIOL, V126, P1547, DOI 10.1083/jcb.126.6.1547; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; FARSUND T, 1978, VIRCHOWS ARCH B, V26, P215; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Jezernik K, 1997, CELL BIOL INT, V21, P1, DOI 10.1006/cbir.1996.0109; JOST SP, 1986, CELL TISSUE KINET, V19, P155, DOI 10.1111/j.1365-2184.1986.tb00725.x; Kerr DE, 1998, NAT BIOTECHNOL, V16, P75, DOI 10.1038/nbt0198-75; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; LEWIS SA, 1976, J MEMBRANE BIOL, V28, P1, DOI 10.1007/BF01869689; LEWIS SA, 1976, J MEMBRANE BIOL, V28, P41, DOI 10.1007/BF01869690; LI YQ, 1994, J CELL SCI, V107, P3271; LIN JH, 1995, P NATL ACAD SCI USA, V92, P679, DOI 10.1073/pnas.92.3.679; LOPEZ MJ, 1995, J BIOL CHEM, V270, P885, DOI 10.1074/jbc.270.25.14989; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; SENECOFF JF, 1986, J BIOL CHEM, V261, P7380; Simon TC, 1997, J BIOL CHEM, V272, P10652; STEWART FA, 1980, CELL TISSUE KINET, V13, P75, DOI 10.1111/j.1365-2184.1980.tb00451.x; StOnge L, 1996, NUCLEIC ACIDS RES, V24, P3875, DOI 10.1093/nar/24.19.3875; Truschel ST, 1999, J BIOL CHEM, V274, P15020, DOI 10.1074/jbc.274.21.15020; Tung J, 1997, AM J PHYSIOL-GASTR L, V273, pG83, DOI 10.1152/ajpgi.1997.273.1.G83; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Wong MH, 1996, P NATL ACAD SCI USA, V93, P9588, DOI 10.1073/pnas.93.18.9588; WRIGHT NA, 1982, CELL TISSUE KINET, V15, P595, DOI 10.1111/j.1365-2184.1982.tb01066.x; Zhang ZT, 1999, CANCER RES, V59, P3512	45	161	165	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 31	1999	274	53					38071	38082		10.1074/jbc.274.53.38071	http://dx.doi.org/10.1074/jbc.274.53.38071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	270GW	10608876	hybrid			2022-12-27	WOS:000084528000076
J	Arnold, JJ; Ghosh, SKB; Cameron, CE				Arnold, JJ; Ghosh, SKB; Cameron, CE			Poliovirus RNA-dependent RNA polymerase (3D(pol)) - Divalent cation modulation of primer, template, and nucleotide selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS REVERSE-TRANSCRIPTASE; HEPATITIS-C VIRUS; ESCHERICHIA-COLI; DNA-POLYMERASE; PROTEIN 3AB; VIRAL-RNA; IN-VITRO; IDENTIFICATION; REPLICATION; MECHANISM	We have analyzed the divalent cation specificity of poliovirus RNA-dependent RNA polymerase, 3D(pol). The following preference was observed: Mn2+ > Co2+ > Ni2+ > Fe2+ > Mg2+ > Ca2+ > Cu2+, and Zn2+ was incapable of supporting 3D(pol)-catalyzed nucleotide incorporation. In the presence of Mn2+, 3D(pol) activity was increased by greater than 10-fold relative to that in the presence of Mg2+. Steady-state kinetic analysis revealed that the increased activity observed in the presence of Mn2+ was due, primarily, to a reduction in the K-M value for 3D(pol) binding to primer/template, without any significant effect on the K-M value for nucleotide. The ability of 3D(pol) to catalyze RNA synthesis de novo was also stimulated approximately 10-fold by using Mn2+, and the enzyme was now capable of also utilizing a DNA template for primer-independent RNA synthesis. Interestingly, the use of Mn2+ as divalent cation permitted 3D(pol) activity to be monitored by following extension of 5'-P-32-end- labeled, heteropolymeric RNA primer/templates. The kinetics of primer extension were biphasic because of the enzyme binding to primer/template in both possible orientations. When bound in the incorrect orientation, 3D(pol) was capable of efficient addition of nucleotides to the blunt-ended duplex; this activity was also apparent in the presence of Mg2+. In the presence of Mn2+, 3D(pol) efficiently utilized dNTPs, ddNTPs, and incorrect NTPs. On average, three incorrect nucleotides could be incorporated by 3D(pol). The ability of 3D(pol) to incorporate the correct dNTP, but not the correct ddNTP, was also observed in the presence of Mg2+. Taken together, these results provide the first glimpse into the nucleotide specificity and fidelity of the poliovirus polymerase and suggest novel alternatives for the design of primer/templates to study the mechanism of 3D(pol)-catalyzed nucleotide incorporation.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.		Ghosh, Saikat/AAD-1176-2022		NATIONAL CANCER INSTITUTE [K01CA075118] Funding Source: NIH RePORTER; NCI NIH HHS [CA75118] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adkins S, 1998, RNA, V4, P455; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Arnold JJ, 1999, BIOTECHNIQUES, V27, P450, DOI 10.2144/99273bm11; Arnold JJ, 1999, J BIOL CHEM, V274, P2706, DOI 10.1074/jbc.274.5.2706; BARTON DJ, 1995, J VIROL, V69, P5516, DOI 10.1128/JVI.69.9.5516-5527.1995; Beckman MTL, 1998, J BIOL CHEM, V273, P6724, DOI 10.1074/jbc.273.12.6724; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Binz P. A., 1999, INTERNET RESOURCES P, P277; BROOKS RR, 1978, BIOCHEM J, V171, P725, DOI 10.1042/bj1710725; Buck KW, 1996, ADV VIRUS RES, V47, P159, DOI 10.1016/S0065-3527(08)60736-8; Carroll SS, 1996, METHOD ENZYMOL, V275, P365; CHO MW, 1993, J VIROL, V67, P3010, DOI 10.1128/JVI.67.6.3010-3018.1993; CIRINO NM, 1995, BIOCHEMISTRY-US, V34, P9936, DOI 10.1021/bi00031a016; DIAMOND SE, 1994, J VIROL, V68, P863, DOI 10.1128/JVI.68.2.863-876.1994; Gamarnik AV, 1996, EMBO J, V15, P5988, DOI 10.1002/j.1460-2075.1996.tb00985.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; GRABBARA S, 1996, METHOD ENZYMOL, V275, P276; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HOUGHTON M, 1996, FIELDS VIROLOGY, V1, P1035; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang Y, 1997, BIOCHEMISTRY-US, V36, P13718, DOI 10.1021/bi971609o; ISHIHAMA A, 1994, ARCH VIROL, V134, P235, DOI 10.1007/BF01310564; JABLONSKI SA, 1995, J VIROL, V69, P1532, DOI 10.1128/JVI.69.3.1532-1539.1995; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; KATI WM, 1992, J BIOL CHEM, V267, P25988; KNOLL DA, STRUCTURE EXPRESSION, V2, P123; LAMB RA, 1996, VIROLOGY, V1, P1177; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; NEUFELD KL, 1994, J VIROL, V68, P5811, DOI 10.1128/JVI.68.9.5811-5818.1994; NEUFELD KL, 1991, J BIOL CHEM, V266, P24212; PALMENBERG A, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1371, DOI 10.1073/pnas.71.4.1371; PATA JD, 1995, RNA, V1, P466; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; PAUL AV, 1994, J BIOL CHEM, V269, P29173; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; PLOTCH SJ, 1989, J VIROL, V63, P216, DOI 10.1128/JVI.63.1.216-225.1989; Richards OC, 1998, J BIOL CHEM, V273, P12832, DOI 10.1074/jbc.273.21.12832; RUECKERT RR, 1996, FIELDS VIROLOGY, V1, P609; Serra MJ, 1995, METHOD ENZYMOL, V259, P242; SPIEGELMAN S, 1968, COLD SPRING HARB SYM, V33, P101, DOI 10.1101/SQB.1968.033.01.015; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; THOMPSON JE, 1994, J AM CHEM SOC, V116, P5467, DOI 10.1021/ja00091a060; Vazquez AL, 1998, J VIROL, V72, P2999; Xiang WK, 1995, RNA, V1, P892; Xiang WK, 1997, SEMIN VIROL, V8, P256, DOI 10.1006/smvy.1997.0128; Xiang WK, 1998, J VIROL, V72, P6732, DOI 10.1128/JVI.72.8.6732-6741.1998	47	92	97	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37060	37069		10.1074/jbc.274.52.37060	http://dx.doi.org/10.1074/jbc.274.52.37060			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601264	hybrid			2022-12-27	WOS:000084382700035
J	Hsiang, BN; Zhu, YJ; Wang, ZQ; Wu, YL; Sasseville, V; Yang, WP; Kirchgessner, TG				Hsiang, BN; Zhu, YJ; Wang, ZQ; Wu, YL; Sasseville, V; Yang, WP; Kirchgessner, TG			A novel human hepatic organic anion transporting polypeptide (OATP2) - Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID; FUNCTIONAL-CHARACTERIZATION; DEHYDROEPIANDROSTERONE-SULFATE; EXPRESSION CLONING; CARDIAC-GLYCOSIDES; UPTAKE SYSTEM; PRAVASTATIN; TAUROCHOLATE; SUBSTRATE; DRUGS	A novel human organic transporter, OATP2, has been identified that transports taurocholic acid, the adrenal androgen dehydroepiandrosterone sulfate, and thyroid hormone, as well as the hydroxymethylglutaryl-CoA reductase inhibitor, pravastatin. OATP2 is expressed exclusively in liver in contrast to all other known transporter subtypes that are found in both hepatic and nonhepatic tissues. OATP2 is considerably diverged from other family members, sharing only 42% sequence identity with the four other subtypes. Furthermore, unlike other subtypes, OATP2 did not transport digoxin or aldosterone. The rat isoform oatp1 was also shown to transport pravastatin, whereas other members of the OATP family, i.e. rat oatp2, human OATP, and the prostaglandin transporter, did not. Cis-inhibition studies indicate that both OATP2 and roatp1 also transport other statins including lovastatin, simvastatin, and atorvastatin. In summary, OATP2 is a novel organic anion transport protein that has overlapping but not identical substrate specificities with each of the other subtypes and, with its liver-specific expression, represents a functionally distinct OATP isoform, Furthermore, the identification of oatp1 and OATP2 as pravastatin transporters suggests that they are responsible for the hepatic uptake of this liver-specific hydroxymethylglutaryl-CoA reductase inhibitor in rat and man.	Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab Res, Princeton, NJ 08543 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Hopewell, NJ 08543 USA	Bristol-Myers Squibb; Bristol-Myers Squibb	Kirchgessner, TG (corresponding author), Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab Res, Rm K3111,POB 4000, Princeton, NJ 08543 USA.			wang, zhaoqing/0000-0003-1515-4945				Abe T, 1999, J BIOL CHEM, V274, P17159, DOI 10.1074/jbc.274.24.17159; Abe T, 1998, J BIOL CHEM, V273, P22395, DOI 10.1074/jbc.273.35.22395; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BATES GW, 1998, CURR OPIN ENDOCRINOL, V5, P357; Bergwerk AJ, 1996, AM J PHYSIOL-GASTR L, V271, pG231, DOI 10.1152/ajpgi.1996.271.2.G231; Bossuyt X, 1996, J PHARMACOL EXP THER, V276, P891; Bossuyt X, 1996, J HEPATOL, V25, P733, DOI 10.1016/S0168-8278(96)80246-7; Crouse JR, 1997, ARCH INTERN MED, V157, P1305, DOI 10.1001/archinte.157.12.1305; Evans AM, 1996, CLIN EXP PHARMACOL P, V23, P970, DOI 10.1111/j.1440-1681.1996.tb01151.x; Fukumura S, 1998, PHARMACEUT RES, V15, P72, DOI 10.1023/A:1011900820409; *GEN COMP GROUP, 1999, WISC PACK VERS 9 1; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; Kanai N, 1996, AM J PHYSIOL-RENAL, V270, pF319, DOI 10.1152/ajprenal.1996.270.2.F319; Kanai N, 1996, AM J PHYSIOL-RENAL, V270, pF326, DOI 10.1152/ajprenal.1996.270.2.F326; Kontaxi M, 1996, J PHARMACOL EXP THER, V279, P1507; Kullak-Ublick GA, 1998, FEBS LETT, V424, P173, DOI 10.1016/S0014-5793(98)00168-9; KULLAKUBLICK GA, 1994, HEPATOLOGY, V20, P411; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; Longcope C, 1996, J ENDOCRINOL, V150, pS125; Longcope C, 1995, ANN NY ACAD SCI, V774, P143, DOI 10.1111/j.1749-6632.1995.tb17378.x; Meier PJ, 1997, HEPATOLOGY, V26, P1667, DOI 10.1002/hep.510260641; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; OKUDAIRA K, 1992, PHARMACEUT RES, V9, P1152, DOI 10.1023/A:1015895520584; PARKER RA, 1990, J LIPID RES, V31, P1271; Plehn JF, 1999, CIRCULATION, V99, P216, DOI 10.1161/01.CIR.99.2.216; REUTER S, 1995, J STEROID BIOCHEM, V54, P227, DOI 10.1016/0960-0760(95)00132-J; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; SHI XY, 1995, J BIOL CHEM, V270, P25591, DOI 10.1074/jbc.270.43.25591; SINGHVI SM, 1990, BRIT J CLIN PHARMACO, V29, P239, DOI 10.1111/j.1365-2125.1990.tb03626.x; Smith SC, 1997, AM J CARDIOL, V80, pH10, DOI 10.1016/S0002-9149(97)00815-1; STEEN H, 1992, BIOCHEM PHARMACOL, V44, P2323, DOI 10.1016/0006-2952(92)90676-A; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Swirski Richard A., 1992, Methods (Orlando), V4, P133, DOI 10.1016/1046-2023(92)90045-A; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wolkoff AW, 1996, SEMIN LIVER DIS, V16, P121, DOI 10.1055/s-2007-1007225; YAMAZAKI M, 1993, AM J PHYSIOL, V264, pG36, DOI 10.1152/ajpgi.1993.264.1.G36; Yamazaki M, 1996, BIOPHARM DRUG DISPOS, V17, P775; ZIEGLER K, 1992, BIOCHIM BIOPHYS ACTA, V1139, P203	42	531	557	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37161	37168		10.1074/jbc.274.52.37161	http://dx.doi.org/10.1074/jbc.274.52.37161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601278	hybrid			2022-12-27	WOS:000084382700049
J	Mattingly, RR				Mattingly, RR			Phosphorylation of serine 916 of Ras-GRF1 contributes to the activation of exchange factor activity by muscarinic receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; FACTOR RAS-GRF; PROTEIN-MEDIATED SIGNALS; FACTOR CDC25(MM); TYROSINE KINASE; CYCLIC-AMP; CALCIUM; DOMAIN; CLONING; BRAIN	The Ras-GRF1 exchange factor is strongly implicated in the control of neuronal Ras. The activity of Ras-GRF1 is regulated by increases in intracellular calcium and the release of G beta gamma subunits from heterotrimeric G-proteins, Increases in Ras-GRF1 activity toward has that are stimulated by receptors coupled to G-proteins are associated with enhanced phosphorylation of Ras-GRF1 on one or more serine residues. Co-expression of Ras-GRF1 with subtype 1 human muscarinic receptors in COS-7 cells allowed mapping of a carbachol-stimulated phosphorylation site to a region composed of residues 916-976, Site-directed mutagenesis replaced each of the serine residues within this region with alanine and demonstrated that serine 916 is a major site of in vivo phosphorylation of Ras-GRF1 in both COS-7 cells and NIH-3T3 fibroblasts. Serine 916 was a substrate for protein kinase A both in vivo and in vitro, suggesting a novel link between the cAMP and Ras signaling systems. Carbachol-dependent phosphorylation of serine 916 occurred through a protein kinase A-independent pathway, however. Full-length Ras-GRF1 that contains an alanine 916 mutation was only partially activated by carbachol, suggesting that phosphorylation at residue 916 is necessary for full activation. Phosphorylation of serine 916 in response to forskolin treatment did not, however, increase the activity of Ras-GRF1, indicating that it is not sufficient for activation.	Wayne State Univ, Dept Pharmacol, Detroit, MI 48201 USA; Barbara Ann Karmanos Canc Inst, Program Mol Biol & Genet, Detroit, MI 48201 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute	Mattingly, RR (corresponding author), Wayne State Univ, Dept Pharmacol, 540 E Canfield Ave, Detroit, MI 48201 USA.	r.mattingly@wayne.edu			NCI NIH HHS [CA-38888] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038888] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anborgh PH, 1999, MOL CELL BIOL, V19, P4611; Baouz S, 1997, J BIOL CHEM, V272, P6671, DOI 10.1074/jbc.272.10.6671; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Barik S, 1993, Methods Mol Biol, V15, P277, DOI 10.1385/0-89603-244-2:277; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOURNE HR, 1995, NATURE, V376, P727, DOI 10.1038/376727a0; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Buchsbaum R, 1996, MOL CELL BIOL, V16, P4888; BUDAY L, 1993, MOL CELL BIOL, V13, P1903, DOI 10.1128/MCB.13.3.1903; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CEN H, 1993, MOL CELL BIOL, V13, P7718, DOI 10.1128/MCB.13.12.7718; CHENG HC, 1986, J BIOL CHEM, V261, P989; COCCETTI P, 1995, BIOCHEM BIOPH RES CO, V206, P253, DOI 10.1006/bbrc.1995.1035; CONNELLY PA, 1987, J BIOL CHEM, V262, P4324; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Fam NP, 1997, MOL CELL BIOL, V17, P1396, DOI 10.1128/MCB.17.3.1396; Fan WT, 1998, CURR BIOL, V8, P935, DOI 10.1016/S0960-9822(07)00376-4; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; FERRARI C, 1994, EXP CELL RES, V210, P353, DOI 10.1006/excr.1994.1048; Finkbeiner S, 1998, BIOESSAYS, V20, P691, DOI 10.1002/(SICI)1521-1878(199809)20:9<691::AID-BIES1>3.3.CO;2-H; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Freshney NW, 1997, FEBS LETT, V407, P111, DOI 10.1016/S0014-5793(97)00309-8; Giglione C, 1998, J BIOL CHEM, V273, P34737, DOI 10.1074/jbc.273.52.34737; Guerrero C, 1996, ONCOGENE, V12, P1097; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376; Itier JM, 1998, NATURE, V393, P125, DOI 10.1038/30120; Kiyono M, 1999, P NATL ACAD SCI USA, V96, P4826, DOI 10.1073/pnas.96.9.4826; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MATTINGLY RR, 1994, MOL CELL BIOL, V14, P7943, DOI 10.1128/MCB.14.12.7943; Mattingly RR, 1999, CELL SIGNAL, V11, P603, DOI 10.1016/S0898-6568(99)00034-0; Mattingly RR, 1998, IN VITRO MOL TOXICOL, V11, P57; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; McKiernan CJ, 1996, MOL CELL BIOL, V16, P4985; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; RUSSELL M, 1994, MOL CELL BIOL, V14, P2343, DOI 10.1128/MCB.14.4.2343; SCHMIDT W, 1990, J BIOL CHEM, V265, P15489; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SHOU CC, 1995, ONCOGENE, V10, P1887; Sturani E, 1997, EXP CELL RES, V235, P117, DOI 10.1006/excr.1997.3660; TAKAHASHI M, 1991, EUR J PHARMACOL, V200, P293; WEI W, 1994, GENE, V151, P279, DOI 10.1016/0378-1119(94)90671-8; WEI W, 1993, MOL BRAIN RES, V19, P339, DOI 10.1016/0169-328X(93)90136-D; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667; Wulczyn FG, 1998, NUCLEIC ACIDS RES, V26, P1724, DOI 10.1093/nar/26.7.1724; Zippel R, 1997, MOL BRAIN RES, V48, P140; Zippel R, 1996, ONCOGENE, V12, P2697	52	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37379	37384		10.1074/jbc.274.52.37379	http://dx.doi.org/10.1074/jbc.274.52.37379			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601308	hybrid			2022-12-27	WOS:000084382700079
J	Yuasa, K; Michibata, H; Omori, K; Yanaka, N				Yuasa, K; Michibata, H; Omori, K; Yanaka, N			A novel interaction of cGMP-dependent protein kinase I with troponin T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT RII; CARDIAC TROPONIN; ANCHORING PROTEINS; MOLECULAR-CLONING; SKELETAL-MUSCLE; SMOOTH-MUSCLE; CA2+ CURRENT; EXPRESSION; BINDING; PHOSPHORYLATION	cGMP-dependent protein kinase (cGK) is a major intracellular receptor of cGMP and is implicated in several signal transduction pathways. To identify proteins that participate in the cGMP/cGK signaling pathway, we employed the yeast two-hybrid system with cGK I alpha as bait. cDNAs encoding slow skeletal troponin T (skTnT) were isolated from both mouse embryo and human skeletal muscle cDNA libraries, The skTnT protein interacted with cGK I beta but not with cGK II nor cAMP-dependent protein kinase, The yeast two-hybrid and in vitro binding assays revealed that the N-terminal region of cGK I alpha, containing the leucine zipper motif, is sufficient for the association with skTnT, In vivo analysis, mutations in cGK I alpha, which disrupted the leucine zipper motif, were shown to completely abolish the binding to skTnT. Furthermore, cGK I also interacted with cardiac TnT (CTnT) but not with cardiac troponin I (cTnI), Together with the observations that cTnI is a good substrate for cGK I and is effectively phosphorylated in the presence of cTnT in vitro, these findings suggest that TnT functions as an anchoring protein for cGK I and that cGK I may participate in the regulation of muscle contraction through phosphorylation of TnI.	Tanabe Seiyaku Co Ltd, Discovery Res Lab, Yodogawa Ku, Osaka 5328505, Japan; Tanabe Seiyaku Co Ltd, Discovery Res Lab, Toda, Saitama 3358505, Japan	Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation	Yanaka, N (corresponding author), Tanabe Seiyaku Co Ltd, Discovery Res Lab, Yodogawa Ku, 16-89 Kashima 3 Chome, Osaka 5328505, Japan.		Yanaka, Noriyuki/P-9096-2016					ALHILLAWI E, 1994, EUR J BIOCHEM, V225, P1195, DOI 10.1111/j.1432-1033.1994.1195b.x; BLUMENTHAL DK, 1978, J BIOL CHEM, V253, P334; Chu DM, 1997, J BIOL CHEM, V272, P31922, DOI 10.1074/jbc.272.50.31922; COLBRAN JL, 1992, J BIOL CHEM, V267, P9589; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; FUJII M, 1995, FEBS LETT, V375, P263, DOI 10.1016/0014-5793(95)01223-2; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; HOFMANN F, 1992, BIOCHIM BIOPHYS ACTA, V1135, P51, DOI 10.1016/0167-4889(92)90165-8; HUGGINS JP, 1989, BIOCHEM J, V260, P829, DOI 10.1042/bj2600829; Jideama NM, 1996, J BIOL CHEM, V271, P23277, DOI 10.1074/jbc.271.38.23277; Jin JP, 1998, GENE, V214, P121, DOI 10.1016/S0378-1119(98)00214-5; Kaumann A, 1999, CIRCULATION, V99, P65, DOI 10.1161/01.CIR.99.1.65; LINCOLN TM, 1976, P NATL ACAD SCI USA, V73, P2559, DOI 10.1073/pnas.73.8.2559; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; LINCOLN TM, 1978, J BIOL CHEM, V253, P337; MACMILLANCROW LA, 1994, BIOCHEMISTRY-US, V33, P8035, DOI 10.1021/bi00192a007; MERY PF, 1991, P NATL ACAD SCI USA, V88, P1197, DOI 10.1073/pnas.88.4.1197; MESNARD L, 1993, FEBS LETT, V328, P139, DOI 10.1016/0014-5793(93)80981-Y; MITTMANN K, 1990, FEBS LETT, V273, P41, DOI 10.1016/0014-5793(90)81046-Q; MITTMANN K, 1992, FEBS LETT, V302, P133, DOI 10.1016/0014-5793(92)80423-E; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; OBAR RA, 1989, NEURON, V3, P639, DOI 10.1016/0896-6273(89)90274-2; OYEN O, 1989, FEBS LETT, V246, P57, DOI 10.1016/0014-5793(89)80253-4; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; PFITZER G, 1982, FEBS LETT, V149, P171, DOI 10.1016/0014-5793(82)81095-8; RUBINO HM, 1989, NEURON, V3, P631, DOI 10.1016/0896-6273(89)90273-0; SANDBERG M, 1989, FEBS LETT, V255, P321, DOI 10.1016/0014-5793(89)81114-7; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SHAH AM, 1994, CIRC RES, V74, P970, DOI 10.1161/01.RES.74.5.970; Stefancsik R, 1998, P NATL ACAD SCI USA, V95, P957, DOI 10.1073/pnas.95.3.957; SUMII K, 1995, CIRC RES, V77, P803, DOI 10.1161/01.RES.77.4.803; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; Vo NK, 1998, BIOCHEM BIOPH RES CO, V246, P831, DOI 10.1006/bbrc.1998.8722; WAHLER GM, 1995, AM J PHYSIOL-CELL PH, V268, pC45, DOI 10.1152/ajpcell.1995.268.1.C45; Wang X, 1997, J NEUROCHEM, V68, P443; WERNET W, 1989, FEBS LETT, V251, P191, DOI 10.1016/0014-5793(89)81453-X; WYATT TA, 1991, J BIOL CHEM, V266, P21274; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; Zhao JK, 1997, J BIOL CHEM, V272, P31929, DOI 10.1074/jbc.272.50.31929	47	64	66	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	1999	274	52					37429	37434		10.1074/jbc.274.52.37429	http://dx.doi.org/10.1074/jbc.274.52.37429			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	267WR	10601315	hybrid			2022-12-27	WOS:000084382700086
J	Chang, MS; Sasaki, H; Campbell, MS; Kraeft, SK; Sutherland, R; Yang, CY; Liu, Y; Auclair, D; Hao, LN; Sonoda, H; Ferland, LH; Chen, LB				Chang, MS; Sasaki, H; Campbell, MS; Kraeft, SK; Sutherland, R; Yang, CY; Liu, Y; Auclair, D; Hao, LN; Sonoda, H; Ferland, LH; Chen, LB			HRad17 colocalizes with NHP2L1 in the nucleolus and redistributes after UV irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATAXIA-TELANGIECTASIA GENE; DNA-DAMAGE CHECKPOINT; SCHIZOSACCHAROMYCES-POMBE RAD1(+); DEPENDENT PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; NUCLEAR-PROTEIN; FISSION YEAST; HUMAN HOMOLOG; RNA	The rad17 gene of Schizosaccharomyces pombe plays an important role as a checkpoint protein following DNA damage and during DNA replication. The human homologue of S, pombe rad17, Hrad17, was recently identified, but its function has not yet been established. Using the yeast two-hybrid system, we determined that HRad17 can interact with a nucleolar protein, NHP2L1. This interaction was also demonstrated biochemically, in human cells. Immunofluorescence studies revealed that HRad17 and NHP2L1 colocalize to the nucleolus, and immunogold labeling further resolved the location of NHP2L1 to the dense fibrillar component of the nucleolus. Interestingly, the localization of HRad17 in the nucleolus was altered in response to UV irradiation. These results provide some insight into the DNA damage and replication checkpoint mechanisms of HRad17.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Chen, LB (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Rm SM1058,44 Binney St, Boston, MA 02115 USA.			CHANG, MAU-SUN/0000-0002-3703-2386	NATIONAL CANCER INSTITUTE [P01CA038493] Funding Source: NIH RePORTER; NCI NIH HHS [CA38493-12] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bao SD, 1999, CANCER RES, V59, P2023; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P1604, DOI 10.1093/nar/23.9.1604; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; CARR AM, 1995, SEMIN CELL BIOL, V6, P65, DOI 10.1016/1043-4682(95)90002-0; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; DUNDR M, 1993, EXP CELL RES, V208, P275, DOI 10.1006/excr.1993.1247; Freire R, 1998, GENE DEV, V12, P2560, DOI 10.1101/gad.12.16.2560; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; GRIFFITHS DJF, 1995, EMBO J, V14, P5812, DOI 10.1002/j.1460-2075.1995.tb00269.x; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Guarente L, 1997, GENE DEV, V11, P2449, DOI 10.1101/gad.11.19.2449; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; HOZAK P, 1994, J CELL SCI, V107, P639; Johnson FB, 1998, CURR OPIN CELL BIOL, V10, P332, DOI 10.1016/S0955-0674(98)80008-2; Kitazono A, 1998, BIOESSAYS, V20, P391, DOI 10.1002/(SICI)1521-1878(199805)20:5<391::AID-BIES6>3.0.CO;2-R; KOLODRUBETZ D, 1991, YEAST, V7, P79, DOI 10.1002/yea.320070202; KOONIN EV, 1994, NUCLEIC ACIDS RES, V22, P2166, DOI 10.1093/nar/22.11.2166; Kostrub CF, 1998, EMBO J, V17, P2055, DOI 10.1093/emboj/17.7.2055; Li L, 1999, ONCOGENE, V18, P1689, DOI 10.1038/sj.onc.1202469; Lieberman HB, 1996, P NATL ACAD SCI USA, V93, P13890, DOI 10.1073/pnas.93.24.13890; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; MURRAY AW, 1995, CURR OPIN GENET DEV, V5, P5, DOI 10.1016/S0959-437X(95)90046-2; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Park MS, 1996, P NATL ACAD SCI USA, V93, P8368, DOI 10.1073/pnas.93.16.8368; Parker AE, 1998, J BIOL CHEM, V273, P18340, DOI 10.1074/jbc.273.29.18340; Parker AE, 1998, J BIOL CHEM, V273, P18332, DOI 10.1074/jbc.273.29.18332; Paulovich AG, 1997, GENETICS, V145, P45; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Saito H, 1996, CYTOGENET CELL GENET, V72, P191, DOI 10.1159/000134186; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SCHEER U, 1984, P NATL ACAD SCI-BIOL, V81, P1431, DOI 10.1073/pnas.81.5.1431; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Siede W, 1996, NUCLEIC ACIDS RES, V24, P1669, DOI 10.1093/nar/24.9.1669; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; THIRY M, 1989, EUR J CELL BIOL, V50, P235; THIRY M, 1993, J CELL SCI, V105, P33; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wang JYJ, 1998, CURR OPIN CELL BIOL, V10, P240, DOI 10.1016/S0955-0674(98)80146-4; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Weinert T, 1997, SCIENCE, V277, P1450, DOI 10.1126/science.277.5331.1450; Westendorf JM, 1998, MOL BIOL CELL, V9, P437, DOI 10.1091/mbc.9.2.437; Wu XT, 1997, MUTAT RES-DNA REPAIR, V385, P13, DOI 10.1016/S0921-8777(97)00035-9; XU YH, 1994, J HISTOCHEM CYTOCHEM, V42, P1365, DOI 10.1177/42.10.7930519	51	38	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36544	36549		10.1074/jbc.274.51.36544	http://dx.doi.org/10.1074/jbc.274.51.36544			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593953	hybrid			2022-12-27	WOS:000084279200072
J	Eisenreich, W; Rieder, C; Grammes, C; Hessler, G; Adam, KP; Becker, H; Arigoni, D; Bacher, A				Eisenreich, W; Rieder, C; Grammes, C; Hessler, G; Adam, KP; Becker, H; Arigoni, D; Bacher, A			Biosynthesis of a Neo-epi-verrucosane diterpene in the liverwort Fossombronia alaskana - A retrobiosynthetic NMR study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-13-C-13 COUPLING-CONSTANTS; EUBACTERIUM CHLOROFLEXUS-AURANTIACUS; MEVALONATE-INDEPENDENT PATHWAY; 1-DEOXY-D-XYLULOSE 5-PHOSPHATE; ISOPRENOID BIOSYNTHESIS; TERPENOID BIOSYNTHESIS; ESCHERICHIA-COLI; NEOVERRUCOSANE-TYPE; HIGHER-PLANTS; PRECURSOR	The biosynthesis of the diterpene 8 alpha-acetoxy-13 alpha-hydroxy-5-oxo-13-epi-neoverrucosane in the arctic Liverwort Fossombronia alaskana was studied by incorporation experiments using [1-C-13]- and [U-C-13(6)]glucose as precursors. The C-13-labeling patterns of acetyl-CoA, pyruvate, and phosphoenolpyruvate in intermediary metabolism were reconstructed from the C-13 NMR data of biosynthetic amino acids (leucine, alanine, phenylalanine) and were used to predict hypothetical labeling patterns for isopentenyl pyrophosphate formed via the mevalonate pathway and the deoxyxylulose pathway. The labeling patterns observed for the neoverrucosane diterpene were consistent with the intermediate formation of geranyllinaloyl pyrophosphate assembled from dimethylallyl pyrophosphate and three molecules of isopentenyl pyrophosphate generated predominantly or entirely via 1-deoxyxylulose 5-phosphate. The experimental data can be integrated into a detailed biosynthetic scheme involving a 1,5-hydride shift. The postulated involvement of the 1,5-hydride shift was confirmed by an incorporation experiment with [6,6-H-2(2)]glucose.	Tech Univ Munich, Lehrstuhl Organ Chem & Biochem, Inst Organ Chem & Biochem, D-85747 Garching, Germany; Univ Saarland, D-66041 Saarbrucken, Germany; Swiss Fed Inst Technol, Organ Chem Lab, CH-8092 Zurich, Switzerland	Technical University of Munich; Saarland University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Eisenreich, W (corresponding author), Tech Univ Munich, Lehrstuhl Organ Chem & Biochem, Inst Organ Chem & Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.	wolfgang.eisenreich@ch.tum.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279				Adam KP, 1998, ARCH BIOCHEM BIOPHYS, V354, P181, DOI 10.1006/abbi.1998.0666; Adam KP, 1998, PHYTOCHEMISTRY, V48, P953, DOI 10.1016/S0031-9422(97)00992-8; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; ASAKAWA Y, 1988, PHYTOCHEMISTRY, V27, P3509, DOI 10.1016/0031-9422(88)80757-X; Bacher A, 1998, FEMS MICROBIOL REV, V22, P567; BARFIELD M, 1975, J AM CHEM SOC, V97, P2631, DOI 10.1021/ja00843a008; BARFIELD M, 1983, J AM CHEM SOC, V105, P3411, DOI 10.1021/ja00349a005; BENESOVA V, 1975, COLLECT CZECH CHEM C, V40, P658, DOI 10.1135/cccc19750658; Broers STJ, 1994, THESIS EIDGENOSSISCH; Cartayrade A., 1994, 2 S EUR NETW PLANT T; COMPAGNONE RS, 1995, J NAT PRODUCTS, V58, P145, DOI 10.1021/np50115a024; DODDRELL D, 1974, J AM CHEM SOC, V96, P1241, DOI 10.1021/ja00811a057; EISENREICH W, 1993, EUR J BIOCHEM, V215, P619, DOI 10.1111/j.1432-1033.1993.tb18073.x; Eisenreich W, 1998, CHEM BIOL, V5, pR221, DOI 10.1016/S1074-5521(98)90002-3; EISENREICH W, 1991, J BIOL CHEM, V266, P9622; FUKUYAMA Y, 1988, PHYTOCHEMISTRY, V27, P1797, DOI 10.1016/0031-9422(88)80446-1; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Grammes C, 1997, PHYTOCHEMISTRY, V44, P1495, DOI 10.1016/S0031-9422(96)00781-9; HASHIMOTO T, 1995, PHYTOCHEMISTRY, V38, P119, DOI 10.1016/0031-9422(94)00570-J; HAYASHI S, 1978, CHEM LETT, P953, DOI 10.1246/cl.1978.953; HEFTER J, 1993, J GEN MICROBIOL, V139, P2757, DOI 10.1099/00221287-139-11-2757; HORBACH S, 1993, FEMS MICROBIOL LETT, V111, P135, DOI 10.1111/j.1574-6968.1993.tb06375.x; KUBO I, 1984, J ORG CHEM, V49, P4644, DOI 10.1021/jo00198a013; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; MATSUO A, 1978, J CHEM SOC CHEM COMM, P198, DOI 10.1039/c39780000198; MATSUO A, 1984, Z NATURFORSCH B, V39, P1281, DOI 10.1515/znb-1984-0923; NAKAMURA H, 1990, S PAP 59 ANN M CHEM, P1197; NOZAKI H, 1980, J CHEM SOC PERK T 2, P763, DOI 10.1039/p29800000763; Piel J, 1998, ANGEW CHEM INT EDIT, V37, P2478, DOI 10.1002/(SICI)1521-3773(19981002)37:18<2478::AID-ANIE2478>3.0.CO;2-Q; Putra SR, 1998, TETRAHEDRON LETT, V39, P23, DOI 10.1016/S0040-4039(97)10458-0; QURESHI N, 1981, BIOSYNTHESIS ISOPREN, V1, P47; Rieder C, 1998, J BIOL CHEM, V273, P18099, DOI 10.1074/jbc.273.29.18099; Rohmer M, 1998, PROG DRUG RES, V50, P135; Sagner S, 1998, TETRAHEDRON LETT, V39, P2091, DOI 10.1016/S0040-4039(98)00296-2; Sagner S, 1998, CHEM COMMUN, P221, DOI 10.1039/a707083g; Schwarz M, 1994, THESIS EIDGENOSSISCH; Schwender J, 1997, FEBS LETT, V414, P129, DOI 10.1016/S0014-5793(97)01002-8; Seto H, 1998, TETRAHEDRON LETT, V39, P9497, DOI 10.1016/S0040-4039(98)02154-6; Seto H, 1996, TETRAHEDRON LETT, V37, P7979, DOI 10.1016/0040-4039(96)01787-X; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; TAKAOKA D, 1979, J CHEM SOC PERK T 1, P2711, DOI 10.1039/p19790002711; TAKAOKA D, 1983, PHYTOCHEMISTRY, V22, P1653, DOI 10.1016/0031-9422(83)80103-4; Tanaka J, 1997, CHEM LETT, P489, DOI 10.1246/cl.1997.489; Toyota M, 1996, PHYTOCHEMISTRY, V43, P1057, DOI 10.1016/S0031-9422(96)00383-4; WU CL, 1988, J HATTORI BOT LAB, V64, P151; Zeidler JG, 1997, Z NATURFORSCH C, V52, P15	48	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36312	36320		10.1074/jbc.274.51.36312	http://dx.doi.org/10.1074/jbc.274.51.36312			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593922	hybrid			2022-12-27	WOS:000084279200041
J	Michels, AA; Kanon, B; Bensaude, O; Kampinga, HH				Michels, AA; Kanon, B; Bensaude, O; Kampinga, HH			Heat shock protein (Hsp) 40 mutants inhibit Hsp70 in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP70/HSC70; FINGER-LIKE DOMAIN; SUBSTRATE-BINDING; ATPASE ACTIVITY; REACTION CYCLE; DNAJ HOMOLOG; IN-VIVO; AGGREGATION; HSC70; DENATURATION	Heat shock protein (Hsp) 70 and Hsp40 expressed in mammalian cells had been previously shown to cooperate in accelerating the reactivation of heat-denatured firefly luciferase (Michels, A. A., Kanon, B., Konings, A. W. T., Ohtsuka, K,, Bensaude, O., and Kampinga, H. H. (1997) J. Biol. Chem. 272, 33283-33289), We now provide further evidence for a functional interaction between Hsp70 and the J-domain of Hsp40 with denatured luciferase resulting in reactivation of heat-denatured luciferase within living mammalian cells. The stimulating effect of Hsp40 on the Hsp70-mediated refolding is lost when the proteins cannot interact as accomplished by their expression in different intracellular compartments, Likewise, the cooperation between Hsp40 and Hsp70 is lost by introduction of a point mutation in the conserved HPD motif of the Hsp40 J domain or by deletion of the four C-terminal amino acids of Hsp70 (EEVD motif), Most strikingly, co-expression of a truncated protein restricted to the J-domain of Hsp40 had a dominant negative effect on Hsp70-facilitated luciferase reactivation. Taken together, these experiments indicate for the first time that the Hsp70/Hsp40 chaperones functionally interact with a heat-denatured protein within mammalian cells. The dominant negative effect of the Hsp40 J-domain on the activity of Hsp70 demonstrates the importance of J-domain-containing proteins in Hsp70-dependent processes.	Univ Groningen, Fac Med Sci, Dept Radiobiol, NL-9713 BZ Groningen, Netherlands; Ecole Normale Super, Mol Genet Lab, F-75230 Paris 05, France	University of Groningen; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Kampinga, HH (corresponding author), Univ Groningen, Fac Med Sci, Dept Radiobiol, Bloemsingel 1, NL-9713 BZ Groningen, Netherlands.			Michels, Annemieke/0000-0002-1735-1697; Kampinga, Harm/0000-0002-8966-8466; Bensaude, Olivier/0000-0002-0259-6608				Auger I, 1997, J CLIN INVEST, V99, P1818, DOI 10.1172/JCI119348; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Cheetham ME, 1996, BIOCHEM J, V319, P103, DOI 10.1042/bj3190103; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DUBOIS MF, 1991, J BIOL CHEM, V266, P9707; Eggers DK, 1997, MOL BIOL CELL, V8, P1559, DOI 10.1091/mbc.8.8.1559; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Gebauer M, 1998, MOL CELL BIOL, V18, P6238, DOI 10.1128/MCB.18.11.6238; Gebauer M, 1997, FEBS LETT, V417, P109, DOI 10.1016/S0014-5793(97)01267-2; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hohfeld J, 1998, BIOL CHEM, V379, P269; HOHFELD J, 1995, CELL, V83, P589; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Johnson JL, 1997, CELL, V90, P201, DOI 10.1016/S0092-8674(00)80327-X; KAMPINGA HH, 1993, J CELL SCI, V104, P11; KANG KI, 1994, P NATL ACAD SCI USA, V91, P340, DOI 10.1073/pnas.91.1.340; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; KRIEGLER M, 1990, GENE TRANSFER EXPRES, P96; Leng CH, 1998, PROTEIN SCI, V7, P1186, DOI 10.1002/pro.5560070513; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; MICHELS AA, 1995, EUR J BIOCHEM, V234, P382, DOI 10.1111/j.1432-1033.1995.382_b.x; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Nagata H, 1998, BIOCHEMISTRY-US, V37, P6924, DOI 10.1021/bi980164g; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; OHTSUKA K, 1993, BIOCHEM BIOPH RES CO, V197, P235, DOI 10.1006/bbrc.1993.2466; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; PINTO M, 1991, J BIOL CHEM, V266, P13941; Qian YQ, 1996, J MOL BIOL, V260, P224, DOI 10.1006/jmbi.1996.0394; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Sheng Q, 1997, J VIROL, V71, P9410, DOI 10.1128/JVI.71.12.9410-9416.1997; STEGE GJJ, 1994, EXP CELL RES, V214, P279, DOI 10.1006/excr.1994.1259; STEGE GJJ, 1994, INT J HYPERTHER, V10, P659, DOI 10.3109/02656739409022446; SUBJECK JR, 1982, BRIT J RADIOL, V55, P579, DOI 10.1259/0007-1285-55-656-579; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Ungewickell E, 1997, J BIOL CHEM, V272, P19594, DOI 10.1074/jbc.272.31.19594; WALL D, 1994, J BIOL CHEM, V269, P5446; Zeiner M, 1997, EMBO J, V16, P5483, DOI 10.1093/emboj/16.18.5483	54	56	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	1999	274	51					36757	36763		10.1074/jbc.274.51.36757	http://dx.doi.org/10.1074/jbc.274.51.36757			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266AV	10593983	hybrid			2022-12-27	WOS:000084279200102
